data_2kw7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kw7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.7 t . . . . . 0 CA--C 1.543 0.705 0 CA-C-O 121.329 0.585 . . . . 71.349999999999994 112.106 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -113.35 144.62 42.45 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.937 -0.574 . . . . 71.129999999999995 111.75 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.697 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 9.8 mtmp? -122.29 171.18 6.71 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 115.648 -0.705 . . . . 74.209999999999994 109.693 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.697 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 4.4 Cg_endo -45.61 -49.84 10.16 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.769 2.313 . . . . 72.310000000000002 113.963 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.79 10.78 10.56 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.421 0.526 . . . . 74.239999999999995 112.421 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 5' ' ' LYS . 38.6 m-20 -95.14 -14.86 23.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.082 0.467 . . . . 74.239999999999995 110.579 168.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.476 HG22 HD22 ' A' ' 56' ' ' LEU . 38.9 t -89.03 128.67 51.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.085 -0.507 . . . . 75.450000000000003 110.453 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.59 118.44 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.225 1.95 . . . . 70.299999999999997 112.29 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -63.82 78.48 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.032 0.444 . . . . 62.299999999999997 111.759 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ASP . 35.7 m -63.76 -39.45 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 111.981 0.363 . . . . 73.439999999999998 111.981 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.417 HE22 ' HG ' ' A' ' 20' ' ' LEU . 27.0 mm-40 -72.93 6.2 2.78 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.907 -0.496 . . . . 64.239999999999995 111.941 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.486 ' O ' HD21 ' A' ' 14' ' ' LEU . 8.9 tt -94.75 -20.99 19.03 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.354 0.597 . . . . 74.420000000000002 109.773 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.85 -56.0 0.56 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.828 -0.624 . . . . 72.510000000000005 111.653 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' VAL . 8.1 m-20 -78.49 77.96 4.96 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.034 0.445 . . . . 73.010000000000005 111.925 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.0 p -90.09 -11.22 41.99 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.623 0.249 . . . . 73.25 111.654 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -102.04 -8.85 21.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.822 0.304 . . . . 74.030000000000001 111.822 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -99.44 -58.6 1.89 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.975 0.417 . . . . 74.329999999999998 110.856 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.417 ' HG ' HE22 ' A' ' 13' ' ' GLN . 5.3 mp 70.03 -16.2 0.3 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.274 0.842 . . . . 71.439999999999998 113.274 175.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.3 t -86.0 144.14 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.111 -0.368 . . . . 74.400000000000006 111.513 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -145.28 103.12 3.81 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.379 -0.373 . . . . 74.150000000000006 111.271 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.423 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 26.1 t70 -103.36 109.63 21.32 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.999 0.428 . . . . 74.099999999999994 111.478 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -111.45 -29.88 7.61 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.089 -0.505 . . . . 75.209999999999994 110.708 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.29 -31.46 67.51 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.74 0.644 . . . . 74.239999999999995 112.74 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.88 25.77 51.69 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.899 -0.667 . . . . 75.409999999999997 112.231 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.477 HD13 HD12 ' A' ' 92' ' ' LEU . 97.8 mt -96.41 -33.61 11.83 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.733 0.302 . . . . 73.540000000000006 111.109 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.83 -176.02 5.88 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.183 0.516 . . . . 75.219999999999999 111.323 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.0 t -152.69 158.68 42.71 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.787 -0.449 . . . . 71.219999999999999 109.787 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -45.06 -48.86 11.8 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.521 0.563 . . . . 73.230000000000004 112.521 -173.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 35' ' ' VAL . . . -57.51 -55.91 28.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.86 0.362 . . . . 72.439999999999998 111.776 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -57.34 -42.73 82.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.991 0.424 . . . . 75.230000000000004 111.496 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -64.47 -46.45 83.01 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.122 -0.49 . . . . 60.5 111.533 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.485 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 18.9 tp10 -65.53 -41.12 93.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.863 0.363 . . . . 74.310000000000002 111.524 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 31' ' ' ALA . 96.6 t -62.4 -39.66 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.116 0.484 . . . . 74.019999999999996 110.468 174.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.5 ttm -68.26 -36.86 80.07 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 111.028 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 34' ' ' GLU . 92.7 m-20 -56.11 -47.23 78.48 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.969 0.414 . . . . 73.019999999999996 110.46 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.41 -37.9 92.69 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.04 -0.6 . . . . 71.319999999999993 112.786 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.443 ' O ' HG13 ' A' ' 43' ' ' ILE . 66.5 mtt180 -65.95 -54.54 24.96 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.824 0.345 . . . . 74.5 111.251 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.97 -42.72 99.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.858 0.361 . . . . 74.209999999999994 111.472 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -61.69 -40.45 95.04 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.334 -0.394 . . . . 74.099999999999994 111.292 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.34 92.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.894 0.378 . . . . 73.439999999999998 110.981 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.615 HG21 ' HB ' ' A' ' 49' ' ' VAL . 51.5 mt -67.7 -39.39 82.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.085 0.469 . . . . 73.400000000000006 110.85 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.453 ' NH1' ' HG2' ' A' ' 50' ' ' GLU . 8.9 tpt180 -59.06 -29.86 67.63 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.762 -0.654 . . . . 75.430000000000007 111.407 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.1 t -93.64 -66.48 0.92 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.266 -0.424 . . . . 64.340000000000003 111.474 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 t -50.37 -60.95 2.48 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.371 0.508 . . . . 60.539999999999999 112.371 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -94.88 -3.1 49.39 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.477 -0.329 . . . . 74.200000000000003 111.601 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 63.83 13.41 7.49 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.364 0.505 . . . . 75.420000000000002 112.364 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.615 ' HB ' HG21 ' A' ' 43' ' ' ILE . 63.3 t -84.83 128.29 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.334 0.494 . . . . 63.030000000000001 112.334 -174.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.453 ' HG2' ' NH1' ' A' ' 44' ' ' ARG . 29.9 mt-10 -80.2 95.35 6.25 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.066 -0.515 . . . . 71.439999999999998 110.026 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -112.81 103.23 11.23 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.868 0.366 . . . . 75.120000000000005 110.733 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.85 133.81 49.03 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.19 0.441 . . . . 74.519999999999996 112.19 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.59 127.72 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.363 -0.38 . . . . 74.0 111.042 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.0 t -127.64 139.58 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.798 0.332 . . . . 74.430000000000007 111.354 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.423 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 19.6 p -124.04 130.22 52.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.701 0.286 . . . . 72.510000000000005 110.368 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.476 HD22 HG22 ' A' ' 9' ' ' VAL . 71.7 mt -125.71 142.72 42.88 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-O 120.724 0.297 . . . . 75.540000000000006 111.644 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.491 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 32.5 Cg_exo -61.89 -49.16 7.22 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.549 2.166 . . . . 70.439999999999998 112.175 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.431 ' HA ' ' OD1' ' A' ' 93' ' ' ASP . 46.8 m -155.17 145.8 22.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.235 -0.439 . . . . 70.099999999999994 111.733 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.604 HG12 HG13 ' A' ' 91' ' ' VAL . 32.1 pt -112.4 -5.08 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.093 0.473 . . . . 72.140000000000001 110.71 170.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.27 -109.95 2.97 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 115.929 -0.578 . . . . 73.420000000000002 113.113 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -108.72 2.25 21.69 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.213 0.449 . . . . 75.109999999999999 112.213 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.95 140.39 97.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.186 0.439 . . . . 75.040000000000006 112.186 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.505 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 47.4 Cg_endo -68.49 121.44 8.38 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.359 2.039 . . . . 73.340000000000003 112.266 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.8 tp -58.64 -51.22 70.86 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.849 0.685 . . . . 72.140000000000001 112.849 -174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.404 ' HG2' ' HE ' ' A' ' 98' ' ' ARG . 38.8 mt-10 -62.84 -48.24 79.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.852 0.358 . . . . 73.129999999999995 111.58 -178.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.505 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 6.1 m-20 -61.99 -37.48 84.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.698 0.285 . . . . 63.329999999999998 111.542 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.488 ' HE2' ' HA ' ' A' ' 5' ' ' LYS . 41.3 t80 -56.06 -53.79 52.82 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.876 0.37 . . . . 73.030000000000001 111.358 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.49 HG22 ' HB3' ' A' ' 98' ' ' ARG . 70.3 p -55.0 -46.2 75.15 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.289 -0.414 . . . . 74.120000000000005 111.764 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 48.4 tp -58.62 -49.15 78.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.935 0.398 . . . . 64.400000000000006 111.357 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.405 ' HE3' ' HG3' ' A' ' 6' ' ' PRO . 29.0 mtpp -57.76 -43.24 85.35 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.798 0.332 . . . . 73.310000000000002 111.765 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.475 HD22 HD23 ' A' ' 87' ' ' LEU . 44.6 tp -67.96 -43.58 78.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.137 0.494 . . . . 71.420000000000002 111.302 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.45 95.31 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.237 0.458 . . . . 73.219999999999999 112.237 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 47.3 mtm180 -63.26 -47.1 83.81 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.147 0.425 . . . . 75.329999999999998 112.147 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.414 ' NE2' ' HB2' ' A' ' 6' ' ' PRO . 10.7 pt20 -67.81 -31.49 71.38 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.845 0.355 . . . . 75.219999999999999 111.639 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -76.41 -15.35 59.96 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.663 0.268 . . . . 75.109999999999999 111.682 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.27 -37.02 3.54 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.192 -0.528 . . . . 64.120000000000005 113.0 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 45.1 t . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.518 0.562 . . . . 75.140000000000001 112.518 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 41.0 t30 . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 110.262 -0.273 . . . . 73.549999999999997 110.262 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.581 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.0 OUTLIER -56.35 -98.89 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 112.637 0.606 . . . . 72.030000000000001 112.637 -177.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.564 ' HB2' ' HA ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -86.02 81.64 8.41 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.894 -1.128 . . . . 73.420000000000002 111.074 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -147.47 142.68 10.43 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.63 -0.714 . . . . 74.420000000000002 112.873 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 99' ' ' PHE . 40.2 tp -151.47 128.73 11.23 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.806 0.442 . . . . 75.420000000000002 111.084 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.475 HD23 HD22 ' A' ' 71' ' ' LEU . 55.7 tp -109.28 144.29 37.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.948 0.404 . . . . 75.319999999999993 111.269 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.0 tp -130.43 125.96 35.79 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.312 -0.404 . . . . 75.209999999999994 110.414 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.6 t -127.0 125.09 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.878 0.371 . . . . 75.450000000000003 111.895 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.501 HD22 HD13 ' A' ' 135' ' ' LEU . 18.9 tp -101.0 134.1 44.5 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.928 -0.578 . . . . 74.329999999999998 110.531 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.604 HG13 HG12 ' A' ' 59' ' ' ILE . 48.2 t -118.92 109.67 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.803 0.335 . . . . 74.129999999999995 110.978 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 67.4 tp -59.49 -44.19 93.12 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.938 0.718 . . . . 74.299999999999997 112.938 -174.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' A' ' 58' ' ' SER . 1.2 p-10 -69.12 -17.9 63.9 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.08 0.467 . . . . 75.329999999999998 111.478 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -103.86 -18.81 14.49 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.323 -0.399 . . . . 65.129999999999995 111.573 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 57.93 27.21 14.37 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.254 0.549 . . . . 64.530000000000001 111.688 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -121.61 157.66 30.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.18 0.514 . . . . 62.240000000000002 111.653 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.28 158.69 38.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.675 -0.693 . . . . 65.299999999999997 110.066 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.49 ' HB3' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -148.59 130.97 15.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.945 0.403 . . . . 74.310000000000002 111.262 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.554 ' HB3' HD11 ' A' ' 86' ' ' LEU . 89.1 m-85 -97.12 153.23 18.09 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.124 -0.489 . . . . 72.310000000000002 111.246 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.23 111.81 8.71 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 122.18 -0.325 . . . . 74.109999999999999 110.515 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.408 HG21 HD12 ' A' ' 86' ' ' LEU . 20.4 p -101.11 142.51 32.45 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.341 0.591 . . . . 70.349999999999994 111.974 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -75.54 -94.14 0.16 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.816 -0.707 . . . . 75.030000000000001 113.008 174.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -147.62 -29.39 0.34 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.174 0.511 . . . . 72.239999999999995 111.577 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.28 -12.74 83.95 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.054 -0.593 . . . . 71.019999999999996 113.122 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.605 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 96.3 mt -103.85 1.19 31.17 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.113 0.412 . . . . 75.200000000000003 112.113 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.27 -23.89 67.62 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.241 0.543 . . . . 65.329999999999998 111.22 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.84 7.72 81.36 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.131 -0.486 . . . . 72.209999999999994 113.179 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.605 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 29.3 m-85 -133.87 -62.69 0.76 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.301 0.572 . . . . 74.140000000000001 111.038 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.31 90.61 14.48 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.563 -0.744 . . . . 73.340000000000003 111.991 -174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.6 148.12 41.63 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 121.744 1.63 . . . . 73.329999999999998 112.226 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -48.68 -42.65 35.42 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.151 0.426 . . . . 74.230000000000004 112.151 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.79 -44.89 95.6 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.107 -0.568 . . . . 52.43 113.13 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.71 -50.54 72.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.117 0.484 . . . . 74.400000000000006 110.625 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.8 mt -57.77 -38.41 75.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 74.319999999999993 111.136 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.7 t -66.33 -38.37 87.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.15 -0.477 . . . . 72.409999999999997 110.959 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -65.6 -44.93 85.07 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.6 -0.273 . . . . 74.430000000000007 111.13 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 74.2 mt -50.96 -35.62 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.078 0.466 . . . . 72.540000000000006 111.212 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.492 ' O ' ' HB2' ' A' ' 122' ' ' MET . 64.6 mt -57.19 -48.46 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.09 -0.504 . . . . 70.340000000000003 110.786 174.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.434 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 31.2 m-70 -72.71 -33.82 66.71 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.389 -0.369 . . . . 71.400000000000006 111.857 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -72.36 -43.27 64.28 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.264 0.838 . . . . 72.120000000000005 113.264 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.419 HH21 ' CD ' ' A' ' 137' ' ' GLU . 15.7 mmm180 -118.45 -49.01 2.48 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.805 0.668 . . . . 72.540000000000006 112.805 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.746 ' HE2' ' HA3' ' A' ' 138' ' ' GLY . 13.2 mmt -59.67 -56.28 23.9 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.748 0.647 . . . . 74.209999999999994 112.748 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 118' ' ' ILE . 50.5 mm -55.26 -55.21 42.04 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 113.055 0.761 . . . . 74.510000000000005 113.055 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 9.8 Cg_endo -52.41 -32.98 54.7 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.282 1.988 . . . . 73.409999999999997 113.067 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 86.2 m-70 -79.85 -46.54 16.69 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.57 0.211 . . . . 74.140000000000001 111.57 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -56.8 -33.78 67.03 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.853 0.359 . . . . 75.25 111.323 178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 83.2 mtp180 -63.1 -39.44 94.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.028 0.442 . . . . 74.519999999999996 111.045 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.4 m -82.12 -11.37 58.79 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.408 -0.36 . . . . 62.100000000000001 111.625 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.61 5.47 60.11 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.486 -0.388 . . . . 73.310000000000002 112.832 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.654 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.75 77.4 9.78 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.877 0.37 . . . . 71.349999999999994 111.869 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -66.44 -41.08 89.68 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.002 -0.436 . . . . 74.439999999999998 111.514 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.15 87.61 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.023 0.439 . . . . 71.409999999999997 111.747 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.654 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 16.8 mp0 -63.7 -43.73 95.75 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.355 -0.384 . . . . 73.219999999999999 111.181 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.35 -52.96 48.51 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.965 -0.636 . . . . 54.420000000000002 112.536 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.501 HD13 HD22 ' A' ' 90' ' ' LEU . 95.9 mt -58.1 -51.65 68.83 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.013 0.375 . . . . 74.409999999999997 112.013 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 81.6 p -56.58 -50.78 70.93 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.914 0.339 . . . . 72.439999999999998 111.914 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 121' ' ' ARG . 27.2 mt-10 -72.15 -31.64 66.16 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.366 0.506 . . . . 72.230000000000004 112.366 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.746 ' HA3' ' HE2' ' A' ' 122' ' ' MET . . . -58.63 -46.46 93.26 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.323 -0.941 . . . . 74.540000000000006 112.1 171.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 135' ' ' LEU . 98.7 t -63.6 -47.11 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.845 0.355 . . . . 64.340000000000003 111.212 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.93 -37.68 80.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.275 -0.42 . . . . 73.329999999999998 111.444 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.521 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -60.76 -52.37 65.4 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.923 0.392 . . . . 71.209999999999994 110.821 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.0 t -56.69 -46.69 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.36 0.6 . . . . 73.450000000000003 110.926 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -53.39 -51.23 63.22 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.651 -0.704 . . . . 71.430000000000007 111.692 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -65.59 -31.06 71.89 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.383 0.512 . . . . 71.030000000000001 112.383 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 141' ' ' ALA . 95.8 t -58.28 -48.65 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.111 0.482 . . . . 74.519999999999996 110.556 174.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.79 -49.25 60.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.122 -0.49 . . . . 64.409999999999997 110.968 176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 CA--C 1.542 0.647 0 CA-C-N 115.65 -0.705 . . . . 72.430000000000007 112.229 -177.032 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.2 t . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 112.812 0.671 . . . . 75.420000000000002 112.812 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -116.55 158.73 23.19 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.55 -0.75 . . . . 75.439999999999998 110.353 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -127.22 160.44 59.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.61 -0.268 . . . . 74.25 111.292 176.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 57.6 Cg_endo -70.92 64.95 2.5 Favored 'Trans proline' 0 C--N 1.358 1.026 0 C-N-CA 122.458 2.105 . . . . 73.25 111.803 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -174.4 -35.47 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.157 -0.929 . . . . 74.439999999999998 110.394 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -71.82 -40.55 69.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.138 0.494 . . . . 65.120000000000005 110.693 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.93 126.2 41.98 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.426 -0.806 . . . . 65.319999999999993 111.905 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.65 123.06 11.14 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.681 2.254 . . . . 70.530000000000001 112.849 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -66.89 87.88 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.207 0.527 . . . . 71.420000000000002 111.084 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -69.71 -21.37 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.583 0.586 . . . . 75.150000000000006 112.583 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.539 HE22 ' HG ' ' A' ' 20' ' ' LEU . 27.9 mm-40 -70.11 -35.88 74.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.601 -0.687 . . . . 74.5 110.797 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.59 -33.68 64.74 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.819 -0.628 . . . . 74.200000000000003 109.996 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.18 -86.94 0.26 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.926 -0.579 . . . . 65.0 112.343 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.92 77.55 2.03 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.545 0.572 . . . . 72.439999999999998 112.545 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.4 t -72.76 -0.8 14.27 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.981 0.419 . . . . 60.310000000000002 111.354 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -81.0 -31.77 34.54 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.101 0.408 . . . . 73.439999999999998 112.101 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -100.41 -43.84 6.1 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.132 0.419 . . . . 75.230000000000004 112.132 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.539 ' HG ' HE22 ' A' ' 13' ' ' GLN . 5.0 mp 64.79 17.97 11.23 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.883 0.473 . . . . 73.319999999999993 111.983 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.59 130.71 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 112.106 0.41 . . . . 75.099999999999994 112.106 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.8 m -124.49 103.58 8.25 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.383 -0.372 . . . . 71.239999999999995 111.175 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.503 ' HB2' HD13 ' A' ' 28' ' ' LEU . 27.4 t70 -102.47 109.05 20.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.804 0.335 . . . . 74.530000000000001 111.148 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -118.97 -21.96 7.49 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.8 0.333 . . . . 74.019999999999996 111.258 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.55 -24.59 67.65 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.019 0.377 . . . . 71.409999999999997 112.019 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.39 43.27 16.26 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.272 -0.489 . . . . 64.530000000000001 112.727 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.5 mt -115.4 -30.98 6.08 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.356 0.502 . . . . 65.239999999999995 112.356 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.515 HD21 ' HB1' ' A' ' 132' ' ' ALA . 95.0 mt -75.58 106.68 7.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.006 0.431 . . . . 75.420000000000002 111.66 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -73.72 157.18 36.98 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.493 -0.321 . . . . 71.299999999999997 110.535 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -51.82 -55.25 21.03 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.032 0.752 . . . . 64.409999999999997 113.032 -170.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.07 -38.2 75.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.704 0.288 . . . . 75.140000000000001 111.574 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -71.35 -30.28 65.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.795 0.331 . . . . 61.229999999999997 111.065 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.87 -51.92 67.62 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.628 -0.26 . . . . 73.25 110.307 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -57.9 -32.87 68.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.745 0.307 . . . . 73.239999999999995 111.497 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.48 ' O ' ' HD2' ' A' ' 39' ' ' ARG . 91.5 t -60.0 -53.93 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.083 0.468 . . . . 72.439999999999998 110.98 174.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 46.5 ttm -69.87 -49.54 51.34 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.43 -0.35 . . . . 75.109999999999999 111.383 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -50.65 -52.49 39.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.726 0.41 . . . . 74.129999999999995 110.997 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.77 -43.31 94.65 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 116.211 -0.449 . . . . 61.420000000000002 113.174 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.545 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -58.93 -55.59 33.19 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.595 0.236 . . . . 73.0 111.322 177.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 mt -63.51 -47.22 82.58 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.374 0.607 . . . . 75.310000000000002 111.318 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -57.63 -47.08 83.19 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.612 -0.722 . . . . 74.230000000000004 111.345 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.31 93.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.56 -0.291 . . . . 75.519999999999996 111.521 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 39' ' ' ARG . 80.1 mt -60.54 -47.74 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.749 0.309 . . . . 75.239999999999995 111.152 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -64.8 -33.34 75.76 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 120.963 0.411 . . . . 73.340000000000003 111.217 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.8 t -82.73 -2.09 53.32 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.421 0.629 . . . . 71.049999999999997 111.289 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.3 m -130.09 -72.19 0.58 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.059 0.457 . . . . 75.200000000000003 111.377 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -79.75 -12.63 59.78 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.152 0.427 . . . . 73.5 112.152 -175.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.85 18.89 11.24 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.914 0.486 . . . . 73.430000000000007 112.105 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.746 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 94.2 t -86.0 132.79 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.457 -0.338 . . . . 75.430000000000007 111.199 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -86.77 96.29 10.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.222 0.534 . . . . 72.430000000000007 110.293 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -114.02 109.47 18.5 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.687 -0.688 . . . . 75.439999999999998 110.256 -175.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -117.7 142.77 46.87 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.112 0.412 . . . . 73.030000000000001 112.112 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.8 t -123.94 133.65 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.848 0.356 . . . . 75.140000000000001 111.39 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.407 HG21 HD21 ' A' ' 71' ' ' LEU . 48.4 t -126.53 137.99 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 122.497 0.319 . . . . 65.409999999999997 111.143 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 24.8 p -120.12 123.01 42.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.86 0.362 . . . . 74.329999999999998 111.159 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -127.17 147.24 61.01 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 120.629 0.252 . . . . 72.329999999999998 111.521 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.06 -57.52 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.372 2.048 . . . . 75.200000000000003 112.374 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 25.0 m -145.42 148.65 33.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.41 -0.359 . . . . 64.530000000000001 111.248 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.462 HD12 ' NE2' ' A' ' 94' ' ' GLN . 28.7 pt -110.2 -2.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.305 0.574 . . . . 73.340000000000003 110.631 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.0 -113.43 5.07 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.66 -0.7 . . . . 75.230000000000004 114.329 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.42 1.28 53.85 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.489 0.552 . . . . 75.430000000000007 112.489 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.67 141.82 28.82 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 111.799 0.296 . . . . 74.319999999999993 111.799 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.76 143.11 18.38 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.858 2.372 . . . . 62.140000000000001 112.411 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.24 -51.35 70.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.1 0.407 . . . . 75.340000000000003 112.1 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.49 -35.13 79.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.275 0.472 . . . . 75.040000000000006 112.275 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.38 -42.24 83.72 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.257 0.551 . . . . 64.530000000000001 110.437 175.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.414 ' CD2' ' HD3' ' A' ' 6' ' ' PRO . 24.8 t80 -60.49 -53.38 58.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.737 -0.665 . . . . 71.010000000000005 111.884 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.411 ' OG1' ' NH1' ' A' ' 98' ' ' ARG . 22.0 p -51.12 -48.45 61.75 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.122 0.786 . . . . 62.039999999999999 113.122 -174.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 52.5 tp -66.71 -46.51 75.29 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.821 0.344 . . . . 72.209999999999994 111.724 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -64.82 -38.14 89.97 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.118 0.414 . . . . 75.209999999999994 112.118 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 54' ' ' VAL . 63.3 tp -69.26 -40.76 77.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.154 0.502 . . . . 74.010000000000005 110.522 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.64 95.57 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.267 0.469 . . . . 73.030000000000001 112.267 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 53.8 mtp180 -60.65 -49.54 77.12 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.204 0.446 . . . . 75.129999999999995 112.204 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.645 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 11.8 pt20 -66.26 -21.09 66.28 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 120.947 0.404 . . . . 72.230000000000004 111.426 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.645 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 22.9 m0 -90.07 7.33 38.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.868 0.366 . . . . 74.409999999999997 111.406 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.18 -50.71 4.3 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.308 -0.473 . . . . 73.409999999999997 113.5 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 113.377 0.88 . . . . 75.409999999999997 113.377 -176.291 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.563 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 37.4 t30 . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 110.102 -0.333 . . . . 72.140000000000001 110.102 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.6 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -39.13 -67.13 0.23 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.765 1.024 . . . . 75.109999999999999 113.765 -170.11 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.746 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 81.1 m-20 -96.86 25.81 5.04 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.676 -0.64 . . . . 71.340000000000003 111.702 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.44 127.54 8.04 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.98 -0.629 . . . . 75.299999999999997 113.16 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 53.2 tp -145.05 119.3 9.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.081 0.467 . . . . 71.109999999999999 111.052 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.3 tp -117.45 142.08 47.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.883 0.373 . . . . 61.409999999999997 111.642 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.6 tp -128.68 118.71 23.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.031 -0.531 . . . . 74.230000000000004 110.754 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 57.5 t -113.8 129.43 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.864 0.364 . . . . 63.32 111.969 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.81 HD22 HD13 ' A' ' 135' ' ' LEU . 12.3 tp -102.37 124.09 47.32 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.966 0.506 . . . . 73.230000000000004 111.023 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 59' ' ' ILE . 58.3 t -111.82 98.33 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.912 0.387 . . . . 74.0 111.118 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.1 tp -54.5 -40.4 68.51 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.017 -0.538 . . . . 73.340000000000003 111.656 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 14.2 t70 -51.73 -37.46 51.15 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.861 -0.609 . . . . 61.0 112.427 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.462 ' NE2' HD12 ' A' ' 59' ' ' ILE . 49.9 mt-30 -112.87 -6.59 13.79 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.203 0.446 . . . . 74.219999999999999 112.203 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HG2' ' HE1' ' A' ' 131' ' ' TYR . 99.6 mtt180 57.58 24.28 10.24 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.126 0.489 . . . . 73.540000000000006 111.628 -174.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -106.84 147.38 29.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.074 0.464 . . . . 75.319999999999993 111.725 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 90' ' ' LEU . 15.3 m -133.53 157.44 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.693 -0.685 . . . . 73.109999999999999 110.342 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.411 ' NH1' ' OG1' ' A' ' 68' ' ' THR . 76.6 ttt-85 -148.44 137.73 21.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.081 0.4 . . . . 75.400000000000006 112.081 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 97.1 m-85 -96.08 151.84 19.09 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.975 -0.557 . . . . 75.310000000000002 110.628 173.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 9.2 tp10 -138.01 114.53 10.42 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.435 -0.166 . . . . 71.329999999999998 110.715 175.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 p -98.06 157.14 16.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.728 0.775 . . . . 62.520000000000003 113.076 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -98.54 171.98 25.76 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.172 -0.922 . . . . 74.409999999999997 112.153 167.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -51.88 -24.67 6.56 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.991 0.738 . . . . 72.319999999999993 112.991 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.61 -16.56 75.31 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.905 -0.664 . . . . 73.530000000000001 112.951 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.445 HD13 HG13 ' A' ' 49' ' ' VAL . 93.6 mt -108.27 -10.81 15.32 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.366 0.506 . . . . 70.219999999999999 112.366 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -49.75 -32.44 13.72 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.675 0.62 . . . . 74.340000000000003 112.675 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.76 -22.38 64.21 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.03 -0.605 . . . . 72.109999999999999 113.978 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -102.97 -38.62 7.28 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.394 0.616 . . . . 73.010000000000005 111.471 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.473 ' HB3' HD23 ' A' ' 114' ' ' LEU . 25.7 mt -127.66 78.1 75.31 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 115.735 -0.666 . . . . 72.129999999999995 111.234 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.28 163.31 36.7 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.148 1.898 . . . . 73.219999999999999 112.722 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -52.56 -44.88 66.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.253 0.464 . . . . 75.349999999999994 112.253 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.62 98.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.259 -0.496 . . . . 73.329999999999998 113.169 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 109' ' ' LEU . 58.2 tp -65.39 -49.25 69.98 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 122.441 -0.446 . . . . 74.209999999999994 110.955 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 109' ' ' LEU . 91.0 mt -55.62 -44.17 76.8 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.054 0.454 . . . . 65.340000000000003 110.842 176.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -60.67 -43.47 97.63 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.937 -0.574 . . . . 72.439999999999998 111.102 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -57.52 -53.2 60.8 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.646 -0.252 . . . . 74.5 111.249 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.9 mt -50.82 -40.65 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.955 0.407 . . . . 73.219999999999999 111.213 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.672 ' O ' ' HB2' ' A' ' 122' ' ' MET . 77.8 mt -59.09 -44.85 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.03 -0.532 . . . . 73.019999999999996 111.248 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -83.23 -22.58 33.06 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.644 -0.66 . . . . 61.219999999999999 112.163 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.95 -55.89 3.84 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.532 0.333 . . . . 74.329999999999998 111.711 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.57 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 25.7 mtp180 -118.63 6.83 11.64 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.106 0.78 . . . . 74.340000000000003 113.106 -172.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.789 ' HE3' ' HA3' ' A' ' 138' ' ' GLY . 17.0 mmt -108.79 -62.8 1.42 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.025 0.441 . . . . 75.239999999999995 111.412 174.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.465 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 28.7 mm -47.33 -53.1 31.3 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 113.907 1.077 . . . . 73.310000000000002 113.907 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 13.7 Cg_endo -54.2 -34.5 79.31 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.225 1.95 . . . . 73.430000000000007 112.771 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 96.4 m-70 -77.97 -43.1 30.69 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.34 -0.391 . . . . 72.349999999999994 111.294 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.492 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.7 m-30 -59.75 -42.26 92.85 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.756 0.312 . . . . 75.209999999999994 111.258 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -59.3 -35.85 74.52 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.073 0.463 . . . . 75.409999999999997 111.247 176.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.2 m -82.77 -16.81 46.46 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.026 -0.534 . . . . 74.230000000000004 112.019 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.89 -2.62 52.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.467 -0.397 . . . . 71.219999999999999 112.796 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.782 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.3 m-20 -81.78 62.96 5.83 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 122.51 -0.406 . . . . 75.150000000000006 111.242 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.529 ' HE1' ' HG2' ' A' ' 95' ' ' ARG . 97.1 m-85 -58.72 -60.45 3.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.296 0.48 . . . . 73.299999999999997 112.296 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.515 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -63.75 -35.46 80.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.957 0.408 . . . . 73.200000000000003 111.949 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 6.9 tp10 -58.59 -50.16 74.83 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.19 0.519 . . . . 75.349999999999994 110.845 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.33 -46.83 93.62 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 115.859 -0.61 . . . . 72.430000000000007 112.874 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.81 HD13 HD22 ' A' ' 90' ' ' LEU . 85.2 mt -51.44 -48.9 62.58 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.039 0.447 . . . . 75.030000000000001 111.293 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.5 m -61.82 -38.4 88.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.084 -0.507 . . . . 72.319999999999993 111.506 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 5.3 mm-40 -64.2 -45.87 86.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.732 0.301 . . . . 75.530000000000001 111.668 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.789 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -62.8 -46.48 93.55 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.069 -0.586 . . . . 75.450000000000003 112.883 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 135' ' ' LEU . 79.1 t -57.77 -48.6 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.065 0.46 . . . . 75.120000000000005 111.2 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.26 -41.12 83.58 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.233 -0.439 . . . . 75.439999999999998 111.009 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 121' ' ' ARG . . . -59.65 -51.54 69.36 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 111.309 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 138' ' ' GLY . 97.5 t -56.33 -48.92 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.986 0.422 . . . . 74.340000000000003 110.978 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.442 ' OE1' ' HG3' ' A' ' 39' ' ' ARG . 65.0 tt0 -52.92 -44.13 66.78 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.15 -0.477 . . . . 70.329999999999998 111.701 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.27 -35.64 81.66 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.398 0.518 . . . . 75.530000000000001 112.398 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.86 -46.31 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.395 0.616 . . . . 72.530000000000001 110.581 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.08 -35.75 71.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.783 -0.644 . . . . 63.130000000000003 111.17 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 N--CA 1.468 0.431 0 CA-C-N 116.308 -0.405 . . . . 70.299999999999997 110.963 -177.118 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 120.936 0.398 . . . . 63.200000000000003 111.764 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -123.77 139.72 53.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.12 0.486 . . . . 73.329999999999998 111.66 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.571 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 34.9 mmtp -106.18 167.07 10.13 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.894 -0.594 . . . . 73.209999999999994 109.564 169.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 18.2 Cg_endo -58.58 -16.88 32.14 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.756 1.637 . . . . 63.299999999999997 112.307 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.56 -16.63 28.42 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.031 -0.531 . . . . 75.099999999999994 111.941 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.97 -30.22 21.43 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.958 0.409 . . . . 70.450000000000003 111.079 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.39 123.27 85.07 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.038 -0.528 . . . . 74.25 111.741 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.37 117.26 3.46 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.812 2.341 . . . . 74.120000000000005 113.23 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' A' ' 14' ' ' LEU . 80.5 m-20 -68.5 79.16 0.27 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.321 0.489 . . . . 75.430000000000007 112.321 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 m -65.92 -53.47 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 111.684 0.253 . . . . 75.400000000000006 111.684 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.451 ' NE2' ' HG ' ' A' ' 20' ' ' LEU . 1.5 mp0 -70.45 1.76 4.69 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.75 0.648 . . . . 72.510000000000005 112.75 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.704 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 8.8 tt -109.15 -40.98 4.8 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.813 0.34 . . . . 71.439999999999998 110.759 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.07 -63.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.211 0.449 . . . . 71.109999999999999 112.211 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.52 -71.84 0.18 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.069 0.462 . . . . 62.140000000000001 111.3 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 m 73.73 -22.61 0.24 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.836 1.051 . . . . 64.120000000000005 113.836 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.522 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 9.4 t -82.32 -12.66 57.84 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.483 0.658 . . . . 70.430000000000007 110.769 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . 14.7 ptt-85 -126.87 145.19 50.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.614 -0.721 . . . . 74.340000000000003 109.186 171.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HG ' ' NE2' ' A' ' 13' ' ' GLN . 5.7 mp -119.47 14.66 12.84 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.85 0.357 . . . . 74.310000000000002 111.445 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.61 123.58 68.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.071 0.397 . . . . 74.010000000000005 112.071 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.6 m -120.66 102.98 8.77 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.39 -0.368 . . . . 65.109999999999999 110.824 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.4 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 25.7 t70 -97.73 103.73 15.69 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.034 0.445 . . . . 61.119999999999997 111.366 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.429 ' HB2' HD22 ' A' ' 56' ' ' LEU . 5.3 mm-40 -110.96 -28.42 8.36 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.335 -0.393 . . . . 71.0 111.632 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -64.08 -25.27 68.03 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.004 0.372 . . . . 73.409999999999997 112.004 172.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.55 44.58 9.29 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.016 -0.611 . . . . 62.409999999999997 112.354 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -115.93 -21.58 9.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.621 0.369 . . . . 75.129999999999995 111.593 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.0 mt -96.8 111.17 23.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.778 0.323 . . . . 70.5 111.536 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.5 t -67.55 151.06 47.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.505 0.193 . . . . 65.310000000000002 111.081 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -51.2 -42.67 61.06 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.306 0.484 . . . . 72.120000000000005 112.306 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.44 -40.03 94.97 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.105 0.479 . . . . 72.420000000000002 111.539 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -67.29 -39.95 86.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.872 0.368 . . . . 73.530000000000001 110.797 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.59 -42.39 98.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.315 -0.402 . . . . 62.130000000000003 111.487 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.05 -53.68 52.78 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.009 0.433 . . . . 74.420000000000002 111.107 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.72 -45.29 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.331 -0.395 . . . . 73.140000000000001 111.647 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 52.1 ttm -61.14 -47.98 83.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.638 -0.255 . . . . 65.349999999999994 111.5 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 56.0 m-80 -60.22 -37.75 81.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.662 0.267 . . . . 64.340000000000003 110.997 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.23 95.66 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.917 -0.659 . . . . 73.140000000000001 112.882 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.537 ' O ' HG13 ' A' ' 43' ' ' ILE . 98.6 mtt180 -64.0 -55.51 21.81 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.996 0.427 . . . . 75.120000000000005 110.872 174.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.85 -49.82 76.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.099 -0.501 . . . . 72.420000000000002 112.242 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 18' ' ' THR . 30.9 ttp180 -58.09 -40.38 80.96 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.192 -0.458 . . . . 74.510000000000005 111.104 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.45 89.5 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.166 -0.47 . . . . 74.030000000000001 111.422 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 39' ' ' ARG . 86.4 mt -58.43 -49.45 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.752 0.311 . . . . 73.439999999999998 111.627 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 57.2 ttp180 -69.42 -26.84 64.82 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.14 -0.35 . . . . 74.040000000000006 111.529 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -82.13 -22.63 36.07 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.858 0.361 . . . . 75.0 111.098 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 m -102.8 -66.08 0.95 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.125 -0.489 . . . . 72.439999999999998 111.62 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -84.35 -8.99 58.82 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.302 -0.408 . . . . 71.109999999999999 112.017 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 68.54 15.01 9.15 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.939 0.495 . . . . 71.340000000000003 112.318 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.723 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 89.3 t -86.22 119.27 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.019 0.438 . . . . 73.310000000000002 111.934 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -78.15 96.13 5.1 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 74.340000000000003 110.184 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -115.76 106.1 13.48 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.388 -0.369 . . . . 74.120000000000005 110.722 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.65 146.63 34.47 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.942 0.401 . . . . 71.319999999999993 112.055 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.89 114.79 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.939 0.4 . . . . 75.510000000000005 111.284 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.446 ' HB ' HG22 ' A' ' 89' ' ' VAL . 48.7 t -118.88 132.7 68.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.839 0.352 . . . . 74.349999999999994 111.492 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 32.0 p -110.38 125.58 53.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.94 0.4 . . . . 73.430000000000007 111.129 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 24' ' ' GLU . 55.1 mt -131.55 142.16 44.33 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.445 -0.343 . . . . 75.340000000000003 110.85 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.589 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 22.5 Cg_exo -64.59 -67.35 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.373 2.049 . . . . 74.120000000000005 112.076 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.9 t -133.64 157.74 45.0 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.135 0.493 . . . . 75.140000000000001 111.32 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 pt -120.35 9.9 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.915 -0.584 . . . . 72.219999999999999 111.078 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.0 -119.62 5.26 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 113.118 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -112.04 3.82 17.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.391 0.276 . . . . 72.349999999999994 111.722 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.86 139.14 96.71 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 111.795 0.295 . . . . 65.239999999999995 111.795 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.715 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 57.1 Cg_endo -71.07 125.31 11.34 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.354 2.036 . . . . 70.230000000000004 111.826 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.456 ' HG ' ' HB2' ' A' ' 98' ' ' ARG . 44.2 tp -56.25 -41.75 76.26 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.509 0.559 . . . . 74.329999999999998 112.509 -173.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.07 -35.16 79.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.106 0.479 . . . . 73.239999999999995 112.134 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.715 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 5.8 m-20 -86.74 -28.23 23.18 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.109 0.481 . . . . 73.230000000000004 111.356 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -57.37 -50.24 73.59 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.924 -0.58 . . . . 74.439999999999998 110.782 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 p -58.11 -37.65 74.96 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.769 -0.65 . . . . 72.519999999999996 112.049 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -62.25 -38.33 88.87 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 120.708 0.29 . . . . 63.020000000000003 111.671 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -66.97 -38.76 86.66 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.92 0.39 . . . . 74.040000000000006 111.554 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.537 HD23 HD23 ' A' ' 87' ' ' LEU . 45.5 tp -72.07 -42.61 66.0 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.173 0.511 . . . . 63.240000000000002 111.345 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.49 -44.4 95.99 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.302 0.482 . . . . 74.409999999999997 112.302 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -68.43 -25.2 64.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.046 0.387 . . . . 74.239999999999995 112.046 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -70.66 -42.67 70.5 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.997 0.427 . . . . 73.409999999999997 110.828 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -82.04 -15.7 52.69 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.157 -0.474 . . . . 74.040000000000006 112.256 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.58 9.37 64.7 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.881 -0.676 . . . . 62.439999999999998 112.75 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 t . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 120.869 0.366 . . . . 64.329999999999998 110.726 178.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.482 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 45.0 t30 . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 120.517 0.198 . . . . 64.420000000000002 111.136 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.57 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.0 OUTLIER -62.62 -90.15 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 112.668 0.618 . . . . 74.420000000000002 112.668 -177.654 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.723 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.1 m-20 -88.26 32.87 0.75 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.004 -1.06 . . . . 71.400000000000006 112.095 -173.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.67 127.72 8.76 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.171 -0.537 . . . . 72.420000000000002 113.694 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.6 tp -142.53 119.85 11.57 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.206 0.527 . . . . 74.099999999999994 111.042 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.537 HD23 HD23 ' A' ' 71' ' ' LEU . 56.7 tp -114.94 122.25 45.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.335 -0.393 . . . . 74.120000000000005 111.453 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.4 tp -111.36 114.04 26.92 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.36 -0.382 . . . . 74.0 111.003 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.446 HG22 ' HB ' ' A' ' 54' ' ' VAL . 84.5 t -119.06 131.56 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.866 0.365 . . . . 72.0 111.619 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.527 ' HB2' HD21 ' A' ' 135' ' ' LEU . 30.3 tp -106.22 130.74 54.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.249 -0.432 . . . . 74.439999999999998 111.362 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.734 HG12 HE21 ' A' ' 94' ' ' GLN . 86.2 t -106.12 109.7 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.372 -0.376 . . . . 73.439999999999998 111.101 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 69.0 tp -60.87 -41.01 95.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.131 0.419 . . . . 65.129999999999995 112.131 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.09 -47.31 85.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.219 0.533 . . . . 73.310000000000002 111.699 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.734 HE21 HG12 ' A' ' 91' ' ' VAL . 45.8 mt-30 -87.44 -15.35 37.96 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.981 -0.554 . . . . 73.010000000000005 112.356 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 95' ' ' ARG . 56.0 mtt180 58.99 36.43 24.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.098 0.407 . . . . 74.140000000000001 112.098 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -144.74 157.79 44.04 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.955 0.407 . . . . 71.230000000000004 111.519 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.565 HG23 ' SD ' ' A' ' 122' ' ' MET . 10.2 m -117.87 171.61 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.244 0.545 . . . . 74.299999999999997 112.066 -174.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.456 ' HB2' ' HG ' ' A' ' 64' ' ' LEU . 27.8 tpt180 -136.81 129.04 29.78 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.957 -0.565 . . . . 73.129999999999995 111.348 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -103.11 107.89 18.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.184 -0.462 . . . . 73.140000000000001 110.391 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -102.43 111.96 24.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.473 0.178 . . . . 71.030000000000001 110.897 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 p -103.86 150.36 24.22 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.238 0.542 . . . . 74.420000000000002 111.871 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -85.27 -145.0 7.46 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.795 -0.717 . . . . 64.349999999999994 112.171 169.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.15 -25.84 21.62 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 122.514 -0.404 . . . . 73.450000000000003 111.745 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.9 -28.52 62.55 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.017 -0.611 . . . . 61.240000000000002 113.697 -170.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.435 HD11 HG12 ' A' ' 49' ' ' VAL . 96.9 mt -99.3 -0.67 40.74 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.744 0.646 . . . . 74.430000000000007 112.744 -174.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -61.48 -27.21 68.42 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.959 0.409 . . . . 74.439999999999998 112.052 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.35 3.6 86.91 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.429 -0.415 . . . . 74.239999999999995 113.667 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -126.54 -38.7 2.07 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.072 0.463 . . . . 74.099999999999994 111.583 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.491 ' HB3' HD21 ' A' ' 114' ' ' LEU . 17.4 mt -129.82 78.71 74.67 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.892 -0.595 . . . . 74.530000000000001 111.61 -171.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.21 151.36 48.97 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.442 2.095 . . . . 75.010000000000005 112.168 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -50.41 -35.29 27.76 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.299 0.481 . . . . 74.340000000000003 112.299 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.75 -48.95 80.92 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.177 -0.535 . . . . 65.209999999999994 112.559 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.0 tp -60.03 -44.98 94.27 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.093 0.473 . . . . 72.030000000000001 110.94 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 109' ' ' LEU . 85.4 mt -58.71 -39.17 80.04 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.994 -0.548 . . . . 74.209999999999994 111.105 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.8 t -65.28 -39.74 92.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.98 0.419 . . . . 72.530000000000001 110.89 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -57.04 -48.73 77.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.175 -0.466 . . . . 75.299999999999997 110.911 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.4 mt -53.05 -47.71 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.2 0.524 . . . . 75.239999999999995 111.386 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 122' ' ' MET . 67.5 mt -60.09 -55.64 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.008 -0.542 . . . . 75.439999999999998 111.697 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.467 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 49.4 m-70 -70.27 -35.4 73.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.036 0.754 . . . . 74.540000000000006 113.036 -173.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.15 -38.12 21.08 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.259 0.837 . . . . 71.409999999999997 113.259 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.461 ' HD3' ' HB3' ' A' ' 141' ' ' ALA . 35.9 mtp180 -111.74 -33.3 6.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.275 0.843 . . . . 72.319999999999993 113.275 -173.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.565 ' SD ' HG23 ' A' ' 97' ' ' VAL . 53.5 mtt -84.41 -54.0 5.07 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.759 0.652 . . . . 73.540000000000006 112.759 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.496 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 46.9 mm -48.86 -50.25 62.64 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 113.257 0.836 . . . . 64.129999999999995 113.257 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 9.5 Cg_endo -51.98 -46.09 34.56 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 122.221 1.947 . . . . 65.230000000000004 112.852 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -70.06 -40.89 74.8 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.859 0.318 . . . . 74.120000000000005 111.859 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.0 m-30 -58.43 -41.17 84.43 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.023 0.439 . . . . 74.420000000000002 111.292 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -70.69 -39.44 73.49 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.066 0.46 . . . . 74.329999999999998 110.798 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.8 t -68.73 -22.36 64.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 111.569 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.13 -10.19 24.76 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.522 -0.371 . . . . 72.230000000000004 113.34 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.736 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 69.4 m-20 -85.57 77.39 9.86 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.503 -0.41 . . . . 70.030000000000001 111.707 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -62.58 -41.86 99.21 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.147 0.499 . . . . 65.200000000000003 110.945 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.23 -45.91 82.74 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.964 -0.562 . . . . 64.140000000000001 111.987 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.736 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 21.1 mm-40 -68.09 -32.39 72.68 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 111.86 0.319 . . . . 72.420000000000002 111.86 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 122' ' ' MET . . . -59.38 -44.89 96.26 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.386 -0.912 . . . . 50.310000000000002 111.753 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 90' ' ' LEU . 94.2 mt -66.08 -44.4 84.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.877 0.325 . . . . 74.349999999999994 111.877 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.491 ' HG ' ' HA ' ' A' ' 133' ' ' GLU . 88.8 p -62.5 -38.81 91.36 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.664 0.268 . . . . 72.230000000000004 111.191 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -66.14 -41.28 90.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.775 0.321 . . . . 73.129999999999995 111.416 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.503 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -60.14 -48.56 85.51 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.842 -0.694 . . . . 73.230000000000004 112.58 175.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 135' ' ' LEU . 89.3 t -56.39 -47.04 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.028 0.442 . . . . 75.420000000000002 111.055 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.448 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 44.3 tp -60.14 -39.77 87.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.864 -0.607 . . . . 74.540000000000006 111.069 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.461 ' HB3' ' HD3' ' A' ' 121' ' ' ARG . . . -61.89 -52.14 65.33 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.874 0.369 . . . . 65.340000000000003 111.51 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.85 -45.19 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.091 0.472 . . . . 74.299999999999997 110.978 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -54.6 -47.6 73.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.05 -0.523 . . . . 72.420000000000002 111.222 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 96.3 mt-30 -56.49 -45.57 80.91 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.394 -0.367 . . . . 74.109999999999999 111.757 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 141' ' ' ALA . 60.6 t -57.15 -44.79 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.17 0.509 . . . . 73.319999999999993 111.285 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.2 -45.51 76.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.118 -0.492 . . . . 75.239999999999995 111.607 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 120.825 0.345 . . . . 73.25 111.713 176.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 121.108 0.48 . . . . 74.400000000000006 111.241 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -91.43 125.32 36.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.213 0.53 . . . . 71.450000000000003 111.793 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 9.6 mtmp? -94.96 159.02 34.02 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.898 -0.592 . . . . 74.420000000000002 110.187 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 48.0 Cg_endo -66.6 -2.66 7.82 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.229 1.953 . . . . 74.129999999999995 113.039 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -107.28 -8.76 16.27 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.211 -0.449 . . . . 74.219999999999999 110.93 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.41 -26.89 19.65 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.002 0.43 . . . . 71.109999999999999 110.601 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.6 t -57.13 128.13 77.35 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.872 -0.604 . . . . 72.439999999999998 111.662 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.85 109.07 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.659 2.24 . . . . 74.409999999999997 112.721 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -69.19 77.92 0.35 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.042 0.449 . . . . 65.25 111.236 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 13' ' ' GLN . 28.6 m -67.64 -51.3 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.263 0.468 . . . . 74.329999999999998 112.263 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.418 ' N ' HG22 ' A' ' 12' ' ' VAL . 27.9 mm-40 -56.97 -21.2 28.47 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.06 0.393 . . . . 73.519999999999996 112.06 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.68 -52.72 34.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.038 0.447 . . . . 75.310000000000002 109.967 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.28 -65.79 0.98 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.424 -0.353 . . . . 75.219999999999999 111.544 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -98.27 101.79 13.34 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.115 0.483 . . . . 70.120000000000005 111.966 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.7 p -82.79 -3.64 56.92 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.164 0.507 . . . . 74.5 110.522 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -78.91 -37.41 39.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.846 -0.616 . . . . 75.329999999999998 111.74 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -102.18 125.97 49.02 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.25 0.548 . . . . 71.209999999999994 110.527 173.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD13 ' N ' ' A' ' 20' ' ' LEU . 4.6 mp -109.33 8.62 25.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.274 0.559 . . . . 75.230000000000004 110.623 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.8 t -101.37 142.73 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.796 -0.638 . . . . 75.430000000000007 111.656 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.2 m -145.42 103.41 3.82 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.456 -0.338 . . . . 71.400000000000006 110.865 175.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.478 ' HB2' HD13 ' A' ' 28' ' ' LEU . 28.8 t70 -105.05 96.76 6.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.223 0.535 . . . . 74.049999999999997 111.59 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -97.45 -38.45 9.6 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.019 0.437 . . . . 71.310000000000002 110.336 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.586 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -57.09 -43.85 82.6 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.483 0.549 . . . . 74.439999999999998 112.483 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.19 36.3 6.34 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.03 -0.605 . . . . 71.409999999999997 112.301 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' A' ' 92' ' ' LEU . 86.5 mt -103.6 -15.99 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.847 0.356 . . . . 75.319999999999993 111.443 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.478 HD13 ' HB2' ' A' ' 23' ' ' ASP . 96.6 mt -90.8 -165.91 1.46 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.162 0.506 . . . . 74.349999999999994 111.553 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -161.68 153.52 19.18 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.966 -0.561 . . . . 73.030000000000001 110.019 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -47.93 -43.29 28.98 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.279 0.474 . . . . 72.400000000000006 112.279 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.14 -49.64 71.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.116 0.484 . . . . 75.209999999999994 111.622 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.459 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 12.5 mm-40 -71.33 -38.27 71.68 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.208 -0.451 . . . . 71.530000000000001 111.731 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.83 -36.48 84.03 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.044 0.45 . . . . 74.5 111.089 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.52 -54.97 23.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.139 -0.482 . . . . 64.25 110.918 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.8 -43.89 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.082 0.468 . . . . 72.439999999999998 111.282 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.41 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.6 ttm -64.22 -49.58 71.4 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.106 -0.497 . . . . 74.120000000000005 111.049 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -57.33 -48.17 79.66 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.636 0.255 . . . . 75.409999999999997 111.27 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.35 92.13 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.093 -0.575 . . . . 50.549999999999997 112.952 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.6 ' NH1' HD13 ' A' ' 140' ' ' LEU . 60.1 mtt180 -70.42 -49.9 44.11 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.983 0.364 . . . . 75.340000000000003 111.983 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 36' ' ' MET . 92.6 mt -55.18 -46.96 75.83 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.258 0.551 . . . . 75.439999999999998 111.042 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 41' ' ' ARG . 40.9 ttm180 -61.74 -42.77 99.4 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.811 -0.631 . . . . 74.25 110.76 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.05 79.62 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 111.198 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.544 HG21 ' HB ' ' A' ' 49' ' ' VAL . 81.8 mt -67.79 -41.6 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.052 0.453 . . . . 74.439999999999998 110.747 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 44.8 ttt180 -68.01 -27.85 66.91 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.022 0.439 . . . . 71.219999999999999 111.2 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.3 t -85.75 -32.22 21.98 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.074 0.464 . . . . 63.240000000000002 111.403 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 t -82.66 -61.9 1.75 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.079 0.466 . . . . 75.230000000000004 111.884 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.43 ' HE1' ' HA ' ' A' ' 147' ' ' ASP . 43.7 m-70 -102.22 -0.39 33.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.876 -0.602 . . . . 75.140000000000001 111.602 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.48 10.81 5.13 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.843 0.457 . . . . 72.299999999999997 111.892 -176.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.544 ' HB ' HG21 ' A' ' 43' ' ' ILE . 78.6 t -77.38 111.44 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.042 0.449 . . . . 71.420000000000002 111.142 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HG2' ' HE ' ' A' ' 44' ' ' ARG . 40.7 mt-10 -82.16 95.92 7.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.676 0.75 . . . . 73.519999999999996 110.138 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -107.96 103.11 12.27 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.13 -0.941 . . . . 73.209999999999994 111.007 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.66 139.7 38.59 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.403 0.52 . . . . 65.120000000000005 112.403 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.5 t -124.08 119.42 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.982 0.42 . . . . 75.319999999999993 111.487 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.16 139.11 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.471 -0.331 . . . . 75.140000000000001 111.533 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 24.2 p -118.05 126.82 53.02 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.941 0.401 . . . . 73.430000000000007 111.015 176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 61.6 mt -125.68 140.95 37.8 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 120.672 0.272 . . . . 63.219999999999999 111.633 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.586 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 27.6 Cg_exo -62.89 -61.3 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.698 2.265 . . . . 63.310000000000002 113.019 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 78.2 p -148.17 145.41 28.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.814 0.302 . . . . 74.400000000000006 111.814 -176.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 91' ' ' VAL . 34.5 pt -127.82 5.02 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.011 0.434 . . . . 73.409999999999997 111.593 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.6 -136.52 29.73 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.991 -0.624 . . . . 73.140000000000001 113.39 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -87.99 15.58 7.1 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.515 -0.403 . . . . 74.140000000000001 111.704 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.3 125.0 91.56 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 120.726 0.298 . . . . 74.439999999999998 111.607 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.93 108.84 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.262 1.974 . . . . 74.310000000000002 112.249 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.4 tp -57.94 -29.43 65.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.943 0.401 . . . . 74.530000000000001 112.042 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -63.66 -32.62 74.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.24 0.543 . . . . 75.329999999999998 111.147 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.82 -33.1 16.63 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.457 0.646 . . . . 61.340000000000003 110.355 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -52.67 -51.76 58.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.913 0.885 . . . . 73.230000000000004 112.051 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.4 p -60.52 -31.21 70.29 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.476 0.547 . . . . 75.150000000000006 112.476 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.606 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.5 tp -56.06 -53.71 53.71 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.962 0.41 . . . . 71.420000000000002 110.987 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -60.84 -33.3 72.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.991 0.424 . . . . 75.209999999999994 112.093 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.475 HD22 HD21 ' A' ' 87' ' ' LEU . 34.3 tp -74.4 -54.95 6.59 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.994 0.426 . . . . 74.140000000000001 111.647 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.83 71.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.192 0.442 . . . . 74.430000000000007 112.192 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 57.5 mtp180 -64.89 -48.43 74.26 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.028 0.381 . . . . 71.049999999999997 112.028 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.543 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 10.5 pt20 -71.27 -25.53 62.49 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.933 0.397 . . . . 73.329999999999998 111.161 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.543 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 19.5 m0 -79.59 -4.93 53.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.538 -0.301 . . . . 75.019999999999996 111.744 174.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.33 -43.52 2.73 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.26 -0.495 . . . . 71.319999999999993 113.425 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 113.4 0.889 . . . . 72.209999999999994 113.4 -178.856 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.3 t30 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 121.242 0.544 . . . . 74.5 112.091 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' A' ' 85' ' ' GLY . 25.7 p-10 -157.74 -136.57 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.925 -0.579 . . . . 65.219999999999999 109.916 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.55 ' HA ' ' HG ' ' A' ' 105' ' ' LEU . 17.0 p-10 -72.64 26.91 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.494 -0.754 . . . . 74.209999999999994 112.543 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 83' ' ' ASN . . . -84.21 150.18 25.81 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.616 -0.326 . . . . 51.299999999999997 112.533 173.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 tp -142.66 127.04 17.72 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.89 0.376 . . . . 75.299999999999997 111.156 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.475 HD21 HD22 ' A' ' 71' ' ' LEU . 60.6 tp -108.21 133.78 51.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.844 0.354 . . . . 74.540000000000006 111.66 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.44 117.39 22.05 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.073 -0.512 . . . . 73.409999999999997 110.814 177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.99 129.83 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.729 0.3 . . . . 71.340000000000003 111.766 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.47 134.11 50.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.127 0.571 . . . . 75.319999999999993 111.078 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.486 HG23 HD11 ' A' ' 59' ' ' ILE . 87.1 t -118.63 105.3 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.926 0.394 . . . . 64.349999999999994 111.262 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.464 ' HB2' HD13 ' A' ' 27' ' ' LEU . 68.1 tp -53.76 -39.21 65.18 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.114 -0.494 . . . . 62.140000000000001 112.017 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 31.7 t70 -50.77 -32.32 19.45 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.781 0.66 . . . . 74.109999999999999 112.781 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -123.67 -3.47 8.26 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.278 0.473 . . . . 73.239999999999995 112.278 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 61.25 11.15 3.4 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.398 0.518 . . . . 74.420000000000002 112.398 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -97.09 159.86 14.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.054 0.454 . . . . 73.519999999999996 111.341 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.69 HG23 ' SD ' ' A' ' 122' ' ' MET . 13.3 m -131.14 172.26 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.985 -0.552 . . . . 75.0 110.525 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -146.39 128.68 15.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.905 0.383 . . . . 64.239999999999995 111.639 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -103.97 125.19 50.17 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.692 -0.686 . . . . 74.239999999999995 110.434 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -120.21 117.12 27.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.999 0.428 . . . . 74.239999999999995 111.175 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.541 HG21 HD11 ' A' ' 114' ' ' LEU . 11.6 p -85.5 155.72 21.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.608 0.718 . . . . 64.540000000000006 112.584 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.72 -179.33 36.29 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.4 -0.818 . . . . 74.310000000000002 111.844 167.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -63.11 -11.13 17.81 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.874 0.47 . . . . 73.349999999999994 112.256 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.15 -32.03 13.17 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.584 -0.341 . . . . 74.239999999999995 113.475 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 84' ' ' ASN . 48.1 mt -97.24 -5.04 37.79 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.402 0.89 . . . . 63.219999999999999 113.402 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -28.63 44.96 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.882 0.697 . . . . 74.109999999999999 112.882 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.69 -19.15 71.46 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.238 -0.506 . . . . 72.329999999999998 113.822 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -105.82 -40.17 5.81 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.936 0.398 . . . . 75.140000000000001 111.91 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.492 ' HB3' HD21 ' A' ' 114' ' ' LEU . 26.8 mt -130.48 88.25 47.75 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.102 -0.499 . . . . 74.319999999999993 112.222 -170.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.63 159.25 28.48 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.154 1.903 . . . . 74.25 112.045 172.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -50.46 -36.74 34.9 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.306 0.484 . . . . 72.329999999999998 112.306 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.71 -50.14 69.11 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.02 -0.609 . . . . 75.439999999999998 112.793 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.29 -43.28 99.14 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.874 0.368 . . . . 74.140000000000001 110.988 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.541 HD11 HG21 ' A' ' 101' ' ' THR . 89.6 mt -57.52 -45.09 85.43 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.28 -0.418 . . . . 73.150000000000006 110.886 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.2 m -64.4 -34.63 78.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 111.075 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -62.45 -48.17 80.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.476 -0.329 . . . . 74.109999999999999 110.716 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.2 mt -52.37 -45.78 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.338 0.59 . . . . 71.299999999999997 110.928 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 122' ' ' MET . 63.6 mt -60.75 -55.82 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.427 -0.806 . . . . 74.329999999999998 111.887 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.438 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 10.3 t-80 -75.94 -28.25 57.89 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.721 0.637 . . . . 75.439999999999998 112.721 -170.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.97 -49.46 17.64 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.232 0.456 . . . . 72.140000000000001 112.232 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -112.21 -44.22 3.44 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.147 0.795 . . . . 75.129999999999995 113.147 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.69 ' SD ' HG23 ' A' ' 97' ' ' VAL . 50.8 mtt -62.67 -50.99 69.01 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.524 0.565 . . . . 72.219999999999999 112.524 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.563 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 25.7 mm -53.51 -55.54 33.89 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 112.278 0.473 . . . . 74.450000000000003 112.278 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.563 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 83.7 Cg_exo -50.22 -46.14 30.15 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 122.15 1.9 . . . . 52.020000000000003 113.015 176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.437 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 61.0 m-70 -65.41 -49.14 70.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.847 0.314 . . . . 72.409999999999997 111.847 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.4 m-30 -61.37 -32.95 72.87 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.894 0.378 . . . . 74.25 111.495 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -69.31 -41.19 77.05 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.97 0.414 . . . . 71.430000000000007 110.599 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.0 t -74.24 -21.56 59.72 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.957 0.408 . . . . 63.009999999999998 111.661 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 112.16 -4.7 26.96 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.43 -0.414 . . . . 74.519999999999996 113.673 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.65 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 79.7 m-20 -83.8 77.49 9.87 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.323 0.49 . . . . 65.420000000000002 112.323 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -71.54 -39.48 70.68 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.899 0.38 . . . . 75.439999999999998 111.521 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.25 70.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.897 0.38 . . . . 70.439999999999998 111.332 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.65 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 20.2 mm-40 -61.98 -42.5 99.2 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.146 -0.479 . . . . 73.400000000000006 111.542 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.03 -50.64 64.2 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.184 -0.531 . . . . 72.219999999999999 112.959 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.54 -41.03 98.48 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.56 -0.377 . . . . 70.420000000000002 111.47 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -57.38 -54.76 43.13 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.395 -0.366 . . . . 61.140000000000001 111.5 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -68.64 -26.13 65.18 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.248 -0.283 . . . . 74.219999999999999 111.607 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.562 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -63.23 -44.8 96.5 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.822 -0.704 . . . . 74.349999999999994 112.225 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.68 -49.83 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.007 0.432 . . . . 73.239999999999995 110.865 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.6 HD13 ' NH1' ' A' ' 39' ' ' ARG . 54.6 tp -57.69 -41.01 80.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.115 -0.493 . . . . 74.400000000000006 111.526 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.43 -51.84 65.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.925 0.393 . . . . 73.319999999999993 111.59 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.408 HG13 HD11 ' A' ' 109' ' ' LEU . 86.9 t -60.77 -46.48 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.124 0.488 . . . . 74.150000000000006 110.841 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -52.27 -41.09 62.55 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.913 -0.585 . . . . 62.210000000000001 111.625 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 98.2 mt-30 -61.15 -48.82 79.85 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.818 0.342 . . . . 73.450000000000003 111.325 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.57 -48.29 86.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.185 -0.461 . . . . 75.319999999999993 111.657 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.21 -56.81 10.69 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.278 -0.419 . . . . 73.0 111.456 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.43 ' HA ' ' HE1' ' A' ' 47' ' ' HIS . 31.2 t70 . . . . . 0 CA--C 1.541 0.634 0 CA-C-N 116.06 -0.518 . . . . 74.510000000000005 111.752 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.533 HG22 ' HA3' ' A' ' 60' ' ' GLY . 60.6 t . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 115.005 1.483 . . . . 74.400000000000006 115.005 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 58' ' ' SER . 23.1 m-85 -112.61 126.48 55.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.102 -0.499 . . . . 74.340000000000003 110.528 169.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.548 ' HZ1' ' HB3' ' A' ' 5' ' ' LYS . 9.4 mtpm? -111.38 158.9 34.89 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.178 -0.464 . . . . 74.230000000000004 110.906 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -49.44 -40.78 44.7 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.767 2.311 . . . . 75.010000000000005 113.799 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -82.78 -5.96 59.18 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.409 0.522 . . . . 72.400000000000006 112.409 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.68 -30.39 18.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.244 0.545 . . . . 73.420000000000002 110.279 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.3 130.44 93.53 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.886 -0.597 . . . . 75.530000000000001 110.832 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.56 118.55 5.47 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.239 1.959 . . . . 75.530000000000001 112.652 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.653 HD21 ' HB3' ' A' ' 14' ' ' LEU . 1.0 OUTLIER -61.18 79.9 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.496 0.554 . . . . 73.549999999999997 112.496 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.08 -44.45 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.539 0.57 . . . . 73.140000000000001 112.539 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -61.25 -15.93 39.97 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.073 0.397 . . . . 75.129999999999995 112.073 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.653 ' HB3' HD21 ' A' ' 11' ' ' ASN . 9.6 tt -86.26 -32.83 20.91 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.869 0.366 . . . . 72.340000000000003 110.601 176.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -124.72 -70.73 0.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.316 -0.402 . . . . 72.219999999999999 111.792 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -77.83 36.24 0.21 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.522 0.564 . . . . 61.32 112.522 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.4 p -70.0 1.84 4.16 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.014 0.435 . . . . 72.329999999999998 111.368 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -70.72 -52.81 18.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.837 0.351 . . . . 72.340000000000003 111.169 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 26.8 ptt180 -88.9 -25.78 21.94 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.051 -0.522 . . . . 61.439999999999998 111.753 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.578 HD13 ' HE ' ' A' ' 44' ' ' ARG . 5.4 mp 66.61 3.04 2.75 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.996 0.739 . . . . 73.129999999999995 112.996 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 59.5 t -99.63 151.26 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 122.504 0.322 . . . . 74.409999999999997 111.617 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -133.07 121.69 23.04 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.479 0.311 . . . . 73.549999999999997 110.436 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.87 95.92 5.03 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.147 0.795 . . . . 74.329999999999998 113.147 -172.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HB2' HD22 ' A' ' 56' ' ' LEU . 6.3 mp0 -102.08 -53.07 3.01 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.247 0.546 . . . . 70.409999999999997 110.549 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.45 -28.18 65.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.049 -0.523 . . . . 72.430000000000007 111.89 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.01 31.41 79.36 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 116.265 -0.425 . . . . 64.439999999999998 113.655 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.2 mt -78.73 -23.67 45.31 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.001 0.429 . . . . 72.450000000000003 111.213 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.51 HD21 ' HB1' ' A' ' 132' ' ' ALA . 82.9 mt -80.82 116.24 20.71 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.098 -0.501 . . . . 75.540000000000006 111.687 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.8 t -70.64 154.89 41.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 110.159 -0.311 . . . . 74.099999999999994 110.159 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -58.89 -32.7 69.74 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.902 0.334 . . . . 74.019999999999996 111.902 -175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.77 -46.92 83.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.313 0.577 . . . . 71.150000000000006 110.784 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.87 -38.28 85.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.903 -0.59 . . . . 74.409999999999997 111.569 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -64.07 -49.17 73.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.995 -0.282 . . . . 73.349999999999994 110.78 172.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.04 -34.57 43.84 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.4 0.619 . . . . 74.510000000000005 111.091 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 45.1 t -82.62 -52.56 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.695 -0.684 . . . . 73.409999999999997 111.842 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 48.8 ttm -66.08 -51.67 55.99 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.172 -0.33 . . . . 75.349999999999994 111.749 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -52.84 -43.04 65.73 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.107 0.48 . . . . 73.019999999999996 110.304 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.39 -43.33 99.48 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.817 -0.629 . . . . 75.010000000000005 112.714 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 35' ' ' VAL . 95.0 mtt180 -57.86 -54.93 41.29 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.654 0.264 . . . . 65.099999999999994 111.08 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.7 mt -61.87 -45.27 94.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.123 0.487 . . . . 71.129999999999995 111.454 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -60.01 -40.55 89.63 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.113 -0.494 . . . . 75.510000000000005 111.106 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.46 -44.55 86.85 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.361 -0.382 . . . . 74.310000000000002 111.196 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 39' ' ' ARG . 82.1 mt -57.85 -48.3 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.906 0.384 . . . . 74.319999999999993 110.809 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.578 ' HE ' HD13 ' A' ' 20' ' ' LEU . 58.3 ttp85 -61.92 -32.48 72.88 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.317 -0.401 . . . . 73.200000000000003 111.621 177.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -80.63 -28.37 37.0 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.959 0.355 . . . . 73.109999999999999 111.959 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -99.57 -68.68 0.8 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.105 0.409 . . . . 73.209999999999994 112.105 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -85.96 -9.95 55.98 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.845 0.313 . . . . 73.450000000000003 111.845 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.46 14.14 9.28 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.591 0.589 . . . . 73.319999999999993 112.591 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.1 t -72.56 133.72 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.026 0.441 . . . . 72.549999999999997 111.758 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -86.5 95.87 9.86 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.275 0.56 . . . . 64.349999999999994 110.434 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -111.61 105.29 13.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.993 -0.549 . . . . 72.329999999999998 110.656 -174.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.95 120.54 40.8 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.208 0.447 . . . . 73.340000000000003 112.208 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t -111.15 128.81 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.803 0.335 . . . . 73.140000000000001 111.055 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG23 HD21 ' A' ' 71' ' ' LEU . 44.0 t -128.01 141.31 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 122.403 0.281 . . . . 71.340000000000003 111.22 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 p -125.88 120.76 31.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.849 0.357 . . . . 74.25 111.379 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.409 HD22 ' HB2' ' A' ' 24' ' ' GLU . 85.2 mt -125.24 135.85 27.41 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-O 120.755 0.312 . . . . 74.140000000000001 111.468 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 72.8 Cg_endo -76.19 -25.23 10.27 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.394 2.063 . . . . 74.219999999999999 113.296 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.806 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 32.5 m -155.89 151.93 27.68 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.236 -0.29 . . . . 71.319999999999993 111.196 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 62' ' ' ALA . 31.0 pt -125.15 -32.27 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.855 0.36 . . . . 72.430000000000007 111.027 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.533 ' HA3' HG22 ' A' ' 3' ' ' VAL . . . 67.16 -116.6 8.21 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.268 -0.491 . . . . 73.230000000000004 113.626 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.24 67.36 9.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.612 0.72 . . . . 71.420000000000002 111.562 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' HD11 ' A' ' 59' ' ' ILE . . . -159.42 106.97 1.5 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.509 -0.768 . . . . 61.549999999999997 110.808 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.678 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 18.2 Cg_endo -57.03 138.86 88.16 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.818 2.345 . . . . 74.209999999999994 113.119 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 tp -54.69 -56.1 22.77 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.203 0.816 . . . . 73.340000000000003 113.203 -172.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.545 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 23.3 mt-10 -76.25 -9.62 58.77 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.255 0.465 . . . . 73.420000000000002 112.255 -173.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.678 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 4.3 m-20 -90.45 -34.55 15.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.96 0.409 . . . . 75.439999999999998 110.49 170.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -59.86 -50.51 73.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.181 -0.463 . . . . 75.329999999999998 110.678 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.7 p -55.4 -42.68 74.4 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.115 -0.493 . . . . 75.209999999999994 111.629 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.46 -54.62 37.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.43 -0.35 . . . . 73.230000000000004 111.559 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -61.23 -41.86 97.61 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.021 0.378 . . . . 72.049999999999997 112.021 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 54' ' ' VAL . 48.7 tp -65.39 -43.62 90.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.248 0.547 . . . . 74.310000000000002 110.964 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.25 72.97 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.849 0.357 . . . . 74.310000000000002 111.433 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -59.3 -53.84 53.65 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.046 0.388 . . . . 72.450000000000003 112.046 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.504 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.1 pt20 -64.54 -31.21 72.33 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.87 0.367 . . . . 72.420000000000002 111.734 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.504 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 42.1 m0 -85.97 8.23 21.3 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.027 0.38 . . . . 55.310000000000002 112.027 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.96 -49.86 4.17 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 114.385 0.514 . . . . 71.310000000000002 114.385 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.514 ' HA ' ' HB3' ' A' ' 82' ' ' ASN . 27.1 m . . . . . 0 CA--C 1.546 0.791 0 N-CA-C 113.162 0.801 . . . . 74.340000000000003 113.162 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.614 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 32.8 t-20 . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 110.031 -0.359 . . . . 75.150000000000006 110.031 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.641 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.0 OUTLIER -41.3 -44.95 2.86 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.367 0.877 . . . . 75.549999999999997 113.367 -178.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.512 ' H ' ' ND2' ' A' ' 83' ' ' ASN . 9.6 t30 -105.16 17.66 23.68 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.214 0.53 . . . . 71.239999999999995 111.905 -172.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.75 140.7 15.16 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.094 -0.574 . . . . 61.219999999999999 114.26 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 100' ' ' GLU . 51.7 tp -143.92 134.85 25.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.743 0.417 . . . . 74.120000000000005 110.858 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 60.0 tp -125.65 140.28 52.85 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.048 0.452 . . . . 72.200000000000003 111.778 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.8 tp -137.35 108.2 6.67 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.96 -0.564 . . . . 72.540000000000006 110.493 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.65 124.02 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 111.95 0.352 . . . . 75.25 111.95 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.587 ' HA ' HG12 ' A' ' 97' ' ' VAL . 36.8 tp -95.71 114.91 26.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.288 -0.415 . . . . 75.329999999999998 111.075 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.03 94.15 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 120.899 0.38 . . . . 71.340000000000003 111.128 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 52.8 tp -60.09 -27.61 67.14 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.819 0.342 . . . . 74.120000000000005 111.293 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.806 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 16.3 t0 -52.18 -35.13 48.03 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.831 0.824 . . . . 65.420000000000002 110.72 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.427 ' NE2' HD12 ' A' ' 59' ' ' ILE . 71.1 mt-30 -120.68 8.8 10.66 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.124 -0.944 . . . . 72.409999999999997 110.891 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 36.21 52.25 0.87 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.555 1.142 . . . . 70.150000000000006 113.536 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -153.33 162.32 41.41 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.881 -0.6 . . . . 73.400000000000006 110.91 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.651 HG23 ' SD ' ' A' ' 122' ' ' MET . 5.5 m -123.8 172.43 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.302 0.572 . . . . 74.239999999999995 112.186 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.545 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 65.6 ttt-85 -147.16 138.19 23.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.834 -0.621 . . . . 75.040000000000006 111.218 172.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -91.17 151.42 20.96 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.029 0.442 . . . . 74.200000000000003 111.083 173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 17.2 tp10 -137.64 112.58 9.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.288 -0.414 . . . . 74.319999999999993 110.595 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.6 p -99.69 136.33 39.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.328 0.585 . . . . 74.409999999999997 112.528 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -76.99 -178.89 47.75 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.584 -0.817 . . . . 50.43 112.154 168.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -62.36 -18.69 62.13 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.355 0.872 . . . . 75.319999999999993 113.355 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.559 ' N ' ' HA ' ' A' ' 83' ' ' ASN . . . -88.04 -40.71 6.51 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.768 -0.73 . . . . 60.310000000000002 112.581 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.631 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 95.0 mt -69.16 -6.73 30.6 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.267 0.469 . . . . 73.510000000000005 112.267 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -58.57 -23.98 59.79 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.261 0.553 . . . . 75.200000000000003 110.913 173.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.09 22.51 39.05 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.119 -0.491 . . . . 74.409999999999997 113.209 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.631 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 68.3 m-85 -141.55 -57.48 0.48 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.264 0.554 . . . . 74.049999999999997 110.953 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.9 mt -113.36 91.92 21.31 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.563 -0.744 . . . . 75.510000000000005 111.675 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.96 151.73 81.6 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.545 2.163 . . . . 70.109999999999999 112.509 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -54.49 -41.62 69.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.949 0.404 . . . . 74.450000000000003 111.61 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.59 -47.51 89.69 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.335 -0.459 . . . . 64.310000000000002 112.903 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.3 tp -56.12 -50.7 70.36 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.868 0.366 . . . . 74.310000000000002 111.056 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.08 -36.34 74.92 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.357 -0.383 . . . . 71.510000000000005 111.382 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 m -64.99 -41.3 95.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.397 -0.365 . . . . 73.049999999999997 111.095 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -64.35 -44.8 90.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.588 -0.278 . . . . 74.030000000000001 111.136 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.8 mt -52.59 -48.1 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.1 0.476 . . . . 74.120000000000005 110.682 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.0 mt -61.53 -37.07 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.224 -0.444 . . . . 74.5 111.6 176.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.454 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 7.6 t-80 -83.3 -28.41 29.11 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.05 0.759 . . . . 75.299999999999997 113.05 -173.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.96 -48.32 4.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.129 0.418 . . . . 72.209999999999994 112.129 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.666 ' HE ' ' HA ' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -84.61 -15.33 45.92 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.497 0.554 . . . . 73.140000000000001 112.497 -175.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.651 ' SD ' HG23 ' A' ' 97' ' ' VAL . 60.7 mtt -120.79 -54.77 2.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.688 0.996 . . . . 73.209999999999994 113.688 -176.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.487 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 12.8 mm -46.38 -54.47 18.08 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.202 0.816 . . . . 73.209999999999994 113.202 -175.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.487 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 51.6 Cg_exo -55.28 -34.29 87.9 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.767 1.644 . . . . 71.120000000000005 112.572 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 96.0 m-70 -76.05 -50.47 14.68 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 111.772 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.9 m-30 -56.37 -44.01 79.75 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.832 0.349 . . . . 73.340000000000003 111.421 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -61.43 -31.08 71.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.121 0.486 . . . . 75.439999999999998 111.127 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -88.4 0.67 55.96 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.002 -0.545 . . . . 74.129999999999995 111.747 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.72 -7.41 79.79 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.336 -0.459 . . . . 73.519999999999996 113.096 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.805 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 13.2 m120 -75.54 67.69 2.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.757 0.423 . . . . 74.510000000000005 111.472 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -67.74 -54.34 20.12 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.066 -0.397 . . . . 72.340000000000003 111.65 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.51 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -61.51 -42.97 99.61 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.976 0.417 . . . . 72.0 111.514 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.805 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 1.3 mp0 -58.15 -43.09 87.18 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.234 -0.439 . . . . 54.340000000000003 111.259 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.91 99.95 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.148 -0.549 . . . . 75.200000000000003 112.437 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.438 HD13 HD22 ' A' ' 90' ' ' LEU . 93.3 mt -59.7 -42.43 92.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.737 0.303 . . . . 75.310000000000002 111.129 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.5 t -57.68 -48.75 78.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.524 -0.307 . . . . 73.439999999999998 111.26 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -62.15 -43.85 97.92 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.956 0.407 . . . . 64.439999999999998 111.057 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.492 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -59.87 -54.2 39.48 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 116.166 -0.47 . . . . 63.329999999999998 113.385 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.25 -47.62 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.99 0.424 . . . . 63.530000000000001 111.379 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.486 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 48.5 tp -61.48 -38.36 87.0 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.187 -0.46 . . . . 65.030000000000001 111.047 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -61.37 -50.87 71.16 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.928 0.394 . . . . 71.420000000000002 111.263 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.26 -45.91 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.134 0.493 . . . . 71.349999999999994 110.818 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -54.82 -43.06 72.62 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.922 -0.581 . . . . 74.129999999999995 111.395 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 79.2 mt-30 -62.88 -41.3 99.35 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.704 0.261 . . . . 74.310000000000002 111.704 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 141' ' ' ALA . 58.0 t -59.35 -50.09 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.858 0.361 . . . . 73.129999999999995 111.131 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -58.67 -44.26 90.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.497 0.665 . . . . 74.230000000000004 110.464 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 CA--C 1.547 0.83 0 CA-C-N 115.433 -0.803 . . . . 63.149999999999999 111.506 177.063 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 CA--C 1.543 0.698 0 N-CA-C 112.448 0.536 . . . . 74.519999999999996 112.448 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -90.12 174.16 7.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.757 0.789 . . . . 72.439999999999998 112.354 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.471 ' H ' ' HB2' ' A' ' 8' ' ' ASP . 30.6 mmtp -132.31 153.27 81.19 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.924 -1.035 . . . . 74.140000000000001 109.404 170.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 11.1 Cg_endo -56.47 -29.35 77.64 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 121.898 1.732 . . . . 63.039999999999999 112.437 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -83.82 -12.56 55.44 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.168 0.433 . . . . 64.530000000000001 112.168 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.471 ' HB2' ' H ' ' A' ' 5' ' ' LYS . 3.0 m-20 -81.97 -27.32 33.29 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.92 0.39 . . . . 73.430000000000007 111.366 172.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.62 129.62 91.47 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 116.315 -0.402 . . . . 73.329999999999998 111.554 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -52.44 126.94 22.23 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.892 2.395 . . . . 75.099999999999994 113.329 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.425 ' C ' HD21 ' A' ' 11' ' ' ASN . 0.2 OUTLIER -71.93 73.2 0.86 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.889 0.375 . . . . 73.329999999999998 111.0 -178.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.95 -38.56 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 112.263 0.468 . . . . 74.450000000000003 112.263 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.58 HE22 ' HG ' ' A' ' 20' ' ' LEU . 25.5 mm-40 -72.53 74.89 1.06 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.606 0.717 . . . . 71.109999999999999 110.825 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt 177.06 -56.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.629 -1.168 . . . . 72.519999999999996 108.338 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.08 -47.86 5.61 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.259 -0.882 . . . . 74.310000000000002 110.93 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.667 ' HB3' ' HB3' ' A' ' 19' ' ' ARG . 7.8 m-20 -96.57 49.16 1.09 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.776 -0.647 . . . . 72.019999999999996 111.79 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.7 m -67.14 -13.8 62.29 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.501 -0.318 . . . . 73.109999999999999 111.657 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.6 p -97.87 -3.2 39.13 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.741 0.305 . . . . 72.420000000000002 111.489 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.667 ' HB3' ' HB3' ' A' ' 16' ' ' ASP . 78.9 ttt180 -105.21 -56.38 2.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.015 0.436 . . . . 71.409999999999997 110.977 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.58 ' HG ' HE22 ' A' ' 13' ' ' GLN . 5.3 mp 69.96 -13.62 0.41 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.731 0.812 . . . . 71.420000000000002 113.069 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.3 t -93.43 148.61 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.207 0.527 . . . . 72.040000000000006 112.124 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.7 m -143.54 102.61 3.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.2 -0.455 . . . . 72.540000000000006 110.591 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.416 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 23.8 t70 -106.1 93.06 4.41 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.292 0.568 . . . . 71.219999999999999 111.079 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.418 ' HB2' HD21 ' A' ' 56' ' ' LEU . 31.5 mm-40 -94.11 -37.01 11.82 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.957 -0.565 . . . . 65.430000000000007 110.841 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.24 -34.11 68.27 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.346 0.499 . . . . 64.129999999999995 112.346 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.74 47.29 6.78 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.824 -0.703 . . . . 61.520000000000003 112.06 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.7 mt -114.07 -33.32 5.74 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.909 0.385 . . . . 64.439999999999998 111.405 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.51 106.15 5.97 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.616 -0.266 . . . . 63.530000000000001 110.959 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.5 t -51.77 145.25 9.81 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.375 -0.375 . . . . 64.340000000000003 111.193 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -49.54 -30.5 8.59 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.27 0.47 . . . . 74.409999999999997 112.27 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 35' ' ' VAL . . . -73.58 -51.09 18.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.749 0.309 . . . . 72.219999999999999 111.216 175.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -60.98 -42.12 97.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.87 0.367 . . . . 71.409999999999997 111.946 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -59.49 -54.18 49.53 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.312 0.577 . . . . 75.140000000000001 110.027 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -52.97 -52.61 57.56 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.438 -0.801 . . . . 74.400000000000006 112.085 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 31' ' ' ALA . 76.7 t -59.71 -41.99 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 111.855 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 48.2 ttm -61.34 -42.83 99.32 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.584 -0.28 . . . . 73.319999999999993 111.032 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -53.16 -51.94 60.4 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.06 0.457 . . . . 61.420000000000002 111.17 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.65 -38.02 93.16 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.166 -0.54 . . . . 44.520000000000003 113.242 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.456 ' O ' HG13 ' A' ' 43' ' ' ILE . 99.5 mtt180 -64.87 -54.64 27.76 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.656 -0.32 . . . . 73.209999999999994 111.458 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.69 -43.79 93.92 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.037 0.446 . . . . 73.400000000000006 111.379 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -57.64 -45.88 84.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.081 -0.509 . . . . 75.200000000000003 111.101 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.14 86.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.129 -0.487 . . . . 71.450000000000003 111.531 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.7 mt -56.19 -47.65 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.027 0.441 . . . . 65.400000000000006 111.375 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -62.66 -34.58 77.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.183 0.516 . . . . 74.129999999999995 110.711 178.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.8 m -89.75 -1.91 58.12 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.132 -0.486 . . . . 74.409999999999997 112.134 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.9 p -122.01 -61.87 1.45 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.011 0.434 . . . . 75.420000000000002 111.535 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -92.27 -2.18 56.61 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.831 0.348 . . . . 73.140000000000001 111.63 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 66.46 11.5 8.08 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.711 0.634 . . . . 71.230000000000004 112.711 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.443 ' HB ' HG21 ' A' ' 43' ' ' ILE . 62.9 t -80.74 117.47 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.0 0.429 . . . . 72.230000000000004 111.619 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -78.59 96.58 5.52 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.443 0.639 . . . . 74.319999999999993 110.454 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.83 106.89 15.31 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.445 -0.798 . . . . 74.209999999999994 110.778 -172.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.98 144.89 40.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.742 0.306 . . . . 74.420000000000002 111.789 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.45 128.44 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.745 0.307 . . . . 65.209999999999994 111.43 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.559 HG23 HD22 ' A' ' 71' ' ' LEU . 58.1 t -129.98 134.97 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 120.708 0.29 . . . . 73.120000000000005 111.582 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.416 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 39.3 p -120.99 125.32 47.08 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.946 0.403 . . . . 73.430000000000007 111.626 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 24' ' ' GLU . 85.1 mt -127.21 145.78 55.52 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-O 120.667 0.27 . . . . 71.200000000000003 111.246 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.581 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 57.8 Cg_endo -72.16 -45.14 0.69 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.228 1.952 . . . . 71.400000000000006 112.997 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.5 m -149.33 137.55 20.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.651 0.262 . . . . 73.400000000000006 111.23 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.5 pt -119.28 9.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 121.097 0.475 . . . . 71.150000000000006 111.407 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.12 -136.39 32.58 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.292 -0.48 . . . . 45.210000000000001 113.082 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -91.4 7.38 41.39 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.603 -0.351 . . . . 74.209999999999994 111.478 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.74 136.14 92.52 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.12 0.415 . . . . 72.510000000000005 112.12 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.59 132.83 24.44 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.586 2.19 . . . . 74.349999999999994 112.447 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.7 tp -62.63 -34.31 76.79 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.731 0.301 . . . . 75.540000000000006 111.758 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -73.94 -43.17 59.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.012 0.434 . . . . 73.109999999999999 111.303 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -61.61 -37.36 83.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.325 0.583 . . . . 74.510000000000005 110.149 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.411 ' CD2' ' HD3' ' A' ' 6' ' ' PRO . 36.3 t80 -58.79 -60.07 4.42 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.405 -0.816 . . . . 72.409999999999997 111.15 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.3 p -55.56 -41.68 73.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.101 -0.5 . . . . 75.200000000000003 111.751 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -55.65 -52.29 64.33 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 111.784 0.29 . . . . 74.400000000000006 111.784 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE3' ' HG2' ' A' ' 6' ' ' PRO . 34.7 mtmt -64.92 -46.31 82.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.736 0.303 . . . . 72.400000000000006 111.507 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.559 HD22 HG23 ' A' ' 54' ' ' VAL . 40.1 tp -60.88 -42.85 98.74 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.983 0.421 . . . . 75.120000000000005 111.201 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.63 -45.88 81.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.275 -0.42 . . . . 61.299999999999997 112.048 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -73.76 -24.72 59.9 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.785 0.326 . . . . 73.510000000000005 111.743 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -66.62 -40.41 88.78 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.029 0.442 . . . . 75.409999999999997 110.886 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 49.5 m0 -93.24 -15.91 25.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.304 -0.407 . . . . 75.239999999999995 111.837 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 72.48 44.65 40.5 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.481 -0.39 . . . . 70.349999999999994 113.374 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 121.017 0.436 . . . . 65.140000000000001 111.711 -177.717 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 112.88 0.696 . . . . 61.219999999999999 112.88 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -154.55 -151.13 0.34 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.907 0.483 . . . . 74.340000000000003 110.209 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -67.95 77.8 0.22 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.815 0.816 . . . . 74.299999999999997 111.68 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.52 143.25 12.47 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.338 -0.846 . . . . 64.540000000000006 111.47 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 99' ' ' PHE . 31.3 tp -137.37 123.63 20.56 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.142 0.471 . . . . 72.540000000000006 111.591 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.5 tp -109.16 122.54 47.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.616 -0.265 . . . . 74.349999999999994 111.303 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.6 tp -114.19 111.75 22.05 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.516 0.326 . . . . 74.510000000000005 111.22 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.94 127.84 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.781 0.324 . . . . 62.009999999999998 111.794 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.541 HD21 HD13 ' A' ' 135' ' ' LEU . 23.1 tp -104.52 121.86 44.35 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.268 -0.424 . . . . 72.209999999999994 111.138 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.408 HG12 ' NE2' ' A' ' 94' ' ' GLN . 48.6 t -104.26 103.82 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.853 -0.158 . . . . 75.319999999999993 110.885 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.581 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 65.1 tp -57.34 -36.92 71.76 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.802 0.667 . . . . 72.040000000000006 112.802 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -50.99 -56.52 12.08 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 120.744 0.307 . . . . 73.25 111.704 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.585 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 8.4 pm0 -98.33 9.18 43.65 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.87 0.367 . . . . 75.420000000000002 111.537 174.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.464 ' HB2' ' HE1' ' A' ' 131' ' ' TYR . 40.2 ptt180 35.95 46.43 0.35 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.508 1.123 . . . . 73.219999999999999 113.707 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.585 ' HE ' ' HG3' ' A' ' 94' ' ' GLN . 26.8 ptt180 -126.45 154.64 43.41 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.891 0.377 . . . . 73.239999999999995 111.15 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.633 HG22 ' SD ' ' A' ' 122' ' ' MET . 5.7 m -122.42 171.18 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.234 -0.439 . . . . 74.230000000000004 111.804 -176.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.4 ttt85 -148.63 128.82 13.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.256 -0.429 . . . . 72.329999999999998 111.719 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.701 ' HB3' HD12 ' A' ' 86' ' ' LEU . 72.0 m-85 -92.66 118.78 31.4 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.303 -0.408 . . . . 74.319999999999993 110.013 170.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -103.93 112.29 25.2 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.542 0.211 . . . . 74.439999999999998 111.441 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.599 HG21 HD11 ' A' ' 114' ' ' LEU . 7.7 p -96.31 133.24 40.93 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.141 0.496 . . . . 74.319999999999993 111.528 177.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.79 -63.52 2.7 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.953 -0.641 . . . . 73.519999999999996 112.518 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -168.59 -53.4 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.918 0.39 . . . . 72.519999999999996 111.838 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -54.15 -31.82 49.59 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 114.699 0.639 . . . . 73.019999999999996 114.699 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.403 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 64.8 mt -78.82 -10.69 59.87 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.906 0.706 . . . . 71.420000000000002 112.906 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -57.54 -31.81 66.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.904 0.383 . . . . 72.420000000000002 111.284 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.96 -25.08 75.57 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.075 -0.583 . . . . 72.319999999999993 113.326 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -102.1 -67.77 0.86 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.414 -0.462 . . . . 64.140000000000001 111.276 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.607 ' HA ' HD22 ' A' ' 113' ' ' LEU . 1.6 mp -120.56 93.42 48.41 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 116.427 -0.351 . . . . 72.129999999999995 111.463 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.54 157.97 57.98 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.972 1.781 . . . . 71.120000000000005 111.529 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.522 ' HA ' HD13 ' A' ' 114' ' ' LEU . 10.0 p-10 -49.25 -33.78 13.57 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.325 0.491 . . . . 71.400000000000006 112.325 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.43 -45.51 96.25 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.956 -0.64 . . . . 63.5 112.991 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.607 HD22 ' HA ' ' A' ' 109' ' ' LEU . 53.0 tp -64.37 -35.41 80.78 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.032 0.444 . . . . 75.430000000000007 110.937 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 101' ' ' THR . 89.1 mt -59.94 -45.27 93.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.896 0.379 . . . . 72.230000000000004 110.894 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.4 m -63.78 -36.34 83.57 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.368 -0.378 . . . . 62.329999999999998 111.091 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -55.16 -46.02 75.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.094 -0.503 . . . . 74.5 111.104 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.3 -51.99 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.317 -0.401 . . . . 71.519999999999996 111.498 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.2 mt -56.58 -55.69 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.239 0.542 . . . . 74.340000000000003 112.193 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.453 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 20.3 t-80 -71.0 -30.92 67.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.694 0.628 . . . . 75.140000000000001 112.694 -169.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -88.0 -44.51 10.94 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.385 0.513 . . . . 72.349999999999994 112.385 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -98.46 -44.55 6.46 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.687 0.625 . . . . 74.420000000000002 112.687 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.633 ' SD ' HG22 ' A' ' 97' ' ' VAL . 47.4 mtt -72.68 -48.57 37.98 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.033 0.753 . . . . 75.530000000000001 113.033 -175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG1' ' HA ' ' A' ' 119' ' ' HIS . 29.8 mm -49.79 -55.26 24.61 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 113.185 0.809 . . . . 63.32 113.185 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 16.9 Cg_endo -56.61 -38.67 95.06 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.0 1.8 . . . . 62.539999999999999 112.477 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -66.25 -49.39 67.33 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 111.602 0.223 . . . . 63.509999999999998 111.602 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.1 m-30 -59.69 -35.84 75.29 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.756 0.313 . . . . 72.129999999999995 111.271 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -67.29 -36.27 81.2 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.95 0.405 . . . . 71.439999999999998 111.554 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 m -78.1 -22.01 49.61 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.858 0.361 . . . . 72.040000000000006 111.588 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.41 0.32 32.93 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.442 -0.409 . . . . 73.340000000000003 112.865 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.791 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 83.2 m-20 -82.3 74.27 9.28 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.63 -0.335 . . . . 64.25 111.685 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.464 ' HE1' ' HB2' ' A' ' 95' ' ' ARG . 96.9 m-85 -70.93 -44.42 66.18 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.838 0.351 . . . . 75.109999999999999 111.298 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.51 -46.61 85.28 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.963 0.411 . . . . 70.409999999999997 111.406 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.791 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 27.3 mm-40 -62.25 -49.38 75.96 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.066 -0.516 . . . . 72.239999999999995 111.415 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.67 -51.59 51.46 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.427 -0.416 . . . . 63.43 113.154 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.541 HD13 HD21 ' A' ' 90' ' ' LEU . 78.2 mt -62.07 -43.38 98.96 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.604 -0.351 . . . . 75.209999999999994 111.504 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.7 t -57.84 -57.57 12.19 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.252 0.464 . . . . 63.5 112.252 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.42 -19.81 57.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.913 0.338 . . . . 72.019999999999996 111.913 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.486 ' HA3' ' HE2' ' A' ' 122' ' ' MET . . . -63.79 -50.37 61.74 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.674 -0.774 . . . . 72.140000000000001 111.766 171.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.6 -44.98 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.044 0.449 . . . . 73.319999999999993 110.81 172.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 56.2 tp -59.37 -38.05 79.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.074 -0.512 . . . . 73.420000000000002 111.165 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -60.24 -44.8 94.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.801 0.334 . . . . 73.120000000000005 111.086 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.41 HG13 HD21 ' A' ' 109' ' ' LEU . 90.7 t -59.27 -52.73 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.106 0.479 . . . . 74.25 110.856 174.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -53.05 -43.67 66.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.913 -0.585 . . . . 65.019999999999996 111.888 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 83.6 mm-40 -59.3 -37.93 78.97 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.924 0.342 . . . . 74.400000000000006 111.924 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 141' ' ' ALA . 91.5 t -64.23 -35.84 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.064 0.459 . . . . 73.209999999999994 111.173 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.25 -57.83 5.96 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.368 -0.378 . . . . 74.150000000000006 111.648 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.972 0.415 . . . . 75.340000000000003 111.485 177.801 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 112.734 0.642 . . . . 73.109999999999999 112.734 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -111.12 126.74 55.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.984 -0.553 . . . . 75.209999999999994 111.86 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -105.73 163.89 16.15 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 116.189 -0.459 . . . . 70.540000000000006 109.814 171.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 10.0 Cg_endo -51.53 -29.37 31.72 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.566 2.177 . . . . 63.329999999999998 114.118 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -82.87 -17.68 42.99 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.438 0.533 . . . . 72.319999999999993 112.438 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.88 -34.89 64.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.074 0.464 . . . . 72.319999999999993 110.527 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.401 HG23 HD21 ' A' ' 56' ' ' LEU . 64.9 t -64.7 127.05 92.08 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 115.84 -0.618 . . . . 72.25 111.466 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.21 133.0 31.38 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.376 2.05 . . . . 70.549999999999997 113.059 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.71 HD21 ' HB2' ' A' ' 14' ' ' LEU . 8.1 t30 -74.54 77.12 1.97 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.37 0.605 . . . . 75.420000000000002 110.69 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -59.79 -31.0 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 113.151 0.797 . . . . 73.430000000000007 113.151 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.34 -9.03 10.24 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.307 0.484 . . . . 75.209999999999994 112.307 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.71 ' HB2' HD21 ' A' ' 11' ' ' ASN . 8.1 tt -76.14 -41.68 49.23 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.209 0.528 . . . . 74.219999999999999 110.383 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.89 -51.68 3.36 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.043 -0.526 . . . . 74.030000000000001 112.39 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -114.85 86.59 2.47 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.017 0.747 . . . . 74.299999999999997 113.017 -173.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.4 p -78.89 -6.73 56.87 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.569 0.7 . . . . 75.209999999999994 110.398 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -93.06 -0.44 57.1 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.802 -0.636 . . . . 60.130000000000003 111.128 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -113.31 -63.09 1.49 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.126 -0.488 . . . . 75.310000000000002 111.323 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp 64.62 -0.02 1.04 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.224 0.61 . . . . 72.540000000000006 112.489 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.0 t -103.81 130.09 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.067 0.46 . . . . 73.530000000000001 111.816 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -125.72 112.59 16.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.972 -0.558 . . . . 73.420000000000002 110.094 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.68 100.4 7.59 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.363 0.505 . . . . 64.230000000000004 112.363 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HB2' HD22 ' A' ' 56' ' ' LEU . 4.5 mp0 -98.54 -37.75 9.43 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.919 0.39 . . . . 75.340000000000003 110.937 173.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -57.24 -31.27 65.37 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.74 0.644 . . . . 61.119999999999997 112.74 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.44 39.44 8.33 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.836 -0.697 . . . . 61.100000000000001 112.328 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.18 -38.43 5.99 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.063 0.459 . . . . 72.109999999999999 111.286 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -90.6 98.88 12.04 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.184 0.516 . . . . 75.439999999999998 111.362 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.1 m -72.36 173.05 9.27 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.402 -0.363 . . . . 72.340000000000003 111.584 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -49.97 -47.3 52.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.29 0.478 . . . . 71.530000000000001 112.29 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.44 -47.27 76.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.932 0.396 . . . . 65.209999999999994 111.4 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -55.81 -43.63 77.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.198 -0.456 . . . . 73.519999999999996 111.132 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.76 -55.08 37.42 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.369 -0.378 . . . . 75.120000000000005 111.132 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.7 -38.87 61.37 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.053 0.454 . . . . 74.510000000000005 111.848 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.57 -43.0 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.002 0.43 . . . . 71.040000000000006 111.615 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 47.0 ttm -73.22 -45.99 52.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.636 0.255 . . . . 75.109999999999999 111.16 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -50.76 -42.79 58.01 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.901 0.48 . . . . 64.540000000000006 111.031 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.24 -47.55 90.5 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.154 -0.475 . . . . 64.120000000000005 113.561 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.465 ' O ' HG13 ' A' ' 43' ' ' ILE . 9.9 ptp180 -74.45 -34.73 63.24 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.439 -0.448 . . . . 75.109999999999999 112.064 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 51' ' ' PHE . 89.8 mt -67.91 -41.65 82.32 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.5 0.667 . . . . 72.040000000000006 110.487 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -59.13 -39.58 82.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.378 -0.828 . . . . 74.319999999999993 110.352 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.42 85.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.944 -0.571 . . . . 74.409999999999997 111.422 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 143' ' ' GLN . 77.2 mt -58.45 -51.9 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 111.735 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 62.7 ttp85 -65.14 -34.01 77.38 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.772 0.32 . . . . 75.109999999999999 111.592 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -76.46 -23.59 53.85 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.831 0.348 . . . . 61.25 111.66 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -100.02 -69.9 0.75 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.663 0.246 . . . . 74.420000000000002 111.663 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -87.05 -5.6 59.0 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.523 0.564 . . . . 64.430000000000007 112.523 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 67.08 19.83 10.42 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.493 0.553 . . . . 73.319999999999993 112.493 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.7 t -90.57 133.99 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.695 0.284 . . . . 70.349999999999994 111.627 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.3 96.97 10.78 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.072 0.463 . . . . 74.209999999999994 110.658 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -103.59 97.97 7.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.783 -0.644 . . . . 74.129999999999995 109.759 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.07 141.94 34.97 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.131 0.419 . . . . 74.420000000000002 112.131 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.93 123.9 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.454 -0.339 . . . . 72.349999999999994 111.119 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -121.61 136.01 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.399 0.28 . . . . 72.420000000000002 111.391 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -120.5 123.75 43.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.912 0.386 . . . . 72.109999999999999 111.432 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.439 HD22 ' HB2' ' A' ' 24' ' ' GLU . 76.3 mt -124.15 145.36 48.11 Favored Pre-proline 0 N--CA 1.471 0.625 0 O-C-N 122.164 -0.335 . . . . 74.349999999999994 111.792 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.41 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 27.9 Cg_exo -63.11 -55.99 0.66 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.739 2.293 . . . . 74.019999999999996 112.542 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.452 ' HG ' ' HB2' ' A' ' 93' ' ' ASP . 44.6 m -150.78 148.58 28.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.758 0.314 . . . . 73.219999999999999 111.394 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 91' ' ' VAL . 24.4 pt -118.24 -6.65 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 120.956 0.408 . . . . 74.25 111.777 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.53 -116.18 8.43 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.535 -0.364 . . . . 62.020000000000003 113.841 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.3 -13.12 53.31 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.713 0.292 . . . . 73.230000000000004 111.761 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . . . -65.49 124.83 88.29 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.606 -0.27 . . . . 64.120000000000005 111.329 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.3 Cg_endo -80.14 131.71 8.95 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.427 2.084 . . . . 74.549999999999997 112.607 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.4 HD23 ' HG3' ' A' ' 96' ' ' ARG . 61.4 tp -59.33 -42.28 91.08 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.422 0.527 . . . . 64.340000000000003 112.422 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -60.1 -44.29 94.96 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.031 0.443 . . . . 74.019999999999996 111.493 -177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 6.0 m-20 -74.48 -33.19 62.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.957 0.408 . . . . 75.349999999999994 110.809 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 56' ' ' LEU . 37.3 t80 -56.6 -55.35 35.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.298 -0.41 . . . . 74.310000000000002 111.383 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.9 p -54.69 -46.07 74.06 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.285 -0.416 . . . . 74.340000000000003 111.66 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.573 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.0 tp -59.2 -54.59 45.19 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.375 -0.375 . . . . 75.400000000000006 111.327 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -58.94 -44.22 91.37 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.107 0.41 . . . . 74.340000000000003 112.107 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.587 HD21 HD21 ' A' ' 87' ' ' LEU . 54.7 tp -62.42 -45.35 93.5 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.156 0.503 . . . . 74.349999999999994 110.926 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.68 -35.99 81.45 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.905 0.384 . . . . 42.020000000000003 111.792 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 78.4 mtp180 -61.67 -53.98 48.93 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.511 -0.313 . . . . 73.030000000000001 111.595 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.492 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 10.3 pt20 -64.87 -33.73 76.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 111.987 0.366 . . . . 75.129999999999995 111.987 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.492 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 26.9 m0 -74.28 -4.48 36.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.929 0.395 . . . . 74.150000000000006 111.956 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.33 -1.01 72.64 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.277 -0.487 . . . . 75.420000000000002 113.414 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 121.291 0.567 . . . . 73.400000000000006 110.937 -177.157 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.65 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 25.3 t-20 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 110.201 -0.296 . . . . 75.510000000000005 110.201 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.649 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.0 OUTLIER -36.43 -63.65 0.38 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 113.958 1.096 . . . . 63.109999999999999 113.958 -176.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.597 ' H ' ' ND2' ' A' ' 83' ' ' ASN . 2.9 p-10 -94.5 35.16 1.23 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.861 -0.524 . . . . 71.310000000000002 111.864 -176.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.4 139.2 15.45 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.136 -0.554 . . . . 73.540000000000006 113.933 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 46.6 tp -149.98 122.93 8.76 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.009 0.433 . . . . 74.129999999999995 110.846 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.587 HD21 HD21 ' A' ' 71' ' ' LEU . 62.9 tp -122.95 131.79 53.87 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.937 0.399 . . . . 70.200000000000003 111.924 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.7 tp -121.35 117.3 26.61 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.146 -0.479 . . . . 72.25 110.889 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.22 124.73 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.943 0.402 . . . . 73.349999999999994 111.852 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.509 ' HA ' HG13 ' A' ' 97' ' ' VAL . 30.2 tp -103.47 118.59 37.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.056 -0.52 . . . . 75.5 111.007 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 59' ' ' ILE . 57.6 t -99.41 101.22 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.539 -0.3 . . . . 73.450000000000003 110.868 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.2 tp -48.93 -46.49 43.21 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.857 0.463 . . . . 74.109999999999999 111.994 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.452 ' HB2' ' HG ' ' A' ' 58' ' ' SER . 27.5 t70 -45.27 -48.36 12.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.973 0.731 . . . . 73.109999999999999 112.973 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -111.15 4.58 19.42 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.18 0.437 . . . . 75.430000000000007 112.18 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 43.52 26.06 0.1 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.331 1.052 . . . . 74.239999999999995 113.467 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.4 ' HG3' HD23 ' A' ' 64' ' ' LEU . 11.0 ptm85 -105.02 152.25 22.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.922 0.392 . . . . 73.540000000000006 111.042 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 90' ' ' LEU . 3.4 m -136.63 165.86 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.177 -0.465 . . . . 71.439999999999998 110.771 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -149.63 135.32 18.56 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.797 0.332 . . . . 73.329999999999998 111.61 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.523 ' HB2' HD11 ' A' ' 114' ' ' LEU . 80.8 m-85 -93.86 102.35 14.47 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.102 -0.499 . . . . 71.340000000000003 110.024 172.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -81.87 111.37 18.01 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 110.329 -0.249 . . . . 61.329999999999998 110.329 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.9 p -93.15 141.01 28.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.578 0.704 . . . . 74.150000000000006 112.581 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -84.37 166.81 42.37 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.676 -0.774 . . . . 70.439999999999998 111.743 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -54.28 -19.63 5.67 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.16 0.8 . . . . 75.549999999999997 113.16 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.531 ' N ' ' HA ' ' A' ' 83' ' ' ASN . . . -85.11 -20.52 57.25 Favored Glycine 0 N--CA 1.463 0.462 0 C-N-CA 120.815 -0.707 . . . . 65.230000000000004 112.805 -173.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.41 -4.3 29.27 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.351 0.26 . . . . 72.129999999999995 111.587 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -51.59 -39.95 58.91 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.269 0.47 . . . . 75.319999999999993 112.269 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.43 -12.51 58.76 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.225 -0.512 . . . . 53.140000000000001 114.113 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -118.38 -48.65 2.5 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.066 0.46 . . . . 73.109999999999999 111.7 -176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.549 ' HB3' HD21 ' A' ' 114' ' ' LEU . 30.8 mt -118.02 86.44 25.81 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.92 -0.582 . . . . 75.099999999999994 112.296 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 88.9 Cg_endo -82.84 158.55 15.97 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.27 1.98 . . . . 74.129999999999995 112.398 172.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.45 -35.21 8.23 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.908 0.336 . . . . 72.140000000000001 111.908 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.27 -51.03 59.42 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.107 -0.568 . . . . 65.530000000000001 113.122 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 64.9 tp -62.73 -45.87 90.7 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.073 0.464 . . . . 71.129999999999995 110.674 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.549 HD21 ' HB3' ' A' ' 109' ' ' LEU . 67.7 mt -59.22 -38.46 80.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.936 -0.575 . . . . 73.239999999999995 110.972 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.5 t -61.81 -40.14 94.21 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.174 -0.467 . . . . 62.310000000000002 110.942 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.45 -48.76 76.37 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.935 -0.306 . . . . 72.409999999999997 110.901 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.2 mt -50.71 -45.66 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.099 0.476 . . . . 74.099999999999994 110.908 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.522 ' O ' HG12 ' A' ' 123' ' ' ILE . 68.2 mt -64.9 -56.83 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.01 -0.541 . . . . 72.310000000000002 112.189 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -76.02 -34.37 59.68 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.602 0.964 . . . . 62.509999999999998 113.602 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.25 -32.59 33.27 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.858 0.361 . . . . 75.310000000000002 111.716 -171.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -123.57 -56.19 1.7 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.286 0.476 . . . . 74.329999999999998 112.286 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 91.4 mtp -64.06 -43.86 94.2 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.554 0.946 . . . . 74.310000000000002 113.554 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 118' ' ' ILE . 38.2 mm -57.54 -50.29 88.96 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 112.18 0.437 . . . . 74.120000000000005 112.18 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.438 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 86.9 Cg_exo -45.0 -44.7 14.77 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.204 1.936 . . . . 74.109999999999999 112.948 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -64.1 -51.9 61.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.614 -0.266 . . . . 72.099999999999994 111.535 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -56.95 -39.78 75.2 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.781 0.324 . . . . 74.25 111.664 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -67.44 -36.02 80.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.218 0.532 . . . . 72.319999999999993 110.994 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.5 t -74.28 -16.83 60.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.25 -0.432 . . . . 72.319999999999993 111.067 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.31 53.2 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 116.283 -0.417 . . . . 70.409999999999997 112.659 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.887 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 94.8 m-20 -81.31 72.0 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.052 0.454 . . . . 62.140000000000001 111.966 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -67.07 -45.65 76.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.825 0.345 . . . . 73.510000000000005 111.079 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.58 -47.33 67.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.05 0.452 . . . . 72.329999999999998 111.357 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.887 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 11.3 tp10 -59.75 -41.27 90.61 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.032 -0.531 . . . . 61.100000000000001 110.721 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.77 -53.96 34.42 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.831 -0.622 . . . . 63.350000000000001 113.258 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.2 -44.81 71.91 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 122.462 -0.434 . . . . 75.540000000000006 111.348 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.2 t -56.01 -51.67 66.95 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.231 0.456 . . . . 75.409999999999997 112.231 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -34.6 62.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.628 0.232 . . . . 73.510000000000005 111.628 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.82 -48.15 87.48 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.111 -0.566 . . . . 51.25 112.378 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.72 -43.74 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.17 0.51 . . . . 55.240000000000002 110.932 173.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.95 -38.97 87.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.971 -0.559 . . . . 74.420000000000002 110.795 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.3 96.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.095 0.474 . . . . 64.219999999999999 111.045 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.47 -51.43 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.139 -0.482 . . . . 74.109999999999999 111.427 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.466 ' HB2' HD12 ' A' ' 43' ' ' ILE . 10.2 tt0 -54.18 -40.19 67.3 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 121.128 -0.229 . . . . 75.400000000000006 111.536 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -57.29 -43.42 83.17 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.83 0.307 . . . . 74.519999999999996 111.83 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.79 -51.12 76.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.902 0.382 . . . . 73.299999999999997 111.15 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.62 -46.51 88.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.184 0.516 . . . . 73.129999999999995 111.079 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 CA--C 1.544 0.723 0 CA-C-N 115.783 -0.644 . . . . 55.109999999999999 111.263 177.406 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 121.061 0.458 . . . . 74.0 112.038 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -93.01 134.51 35.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.422 0.527 . . . . 75.120000000000005 112.422 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 1.3 mptm? -107.52 163.3 17.24 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.148 -0.478 . . . . 72.109999999999999 110.124 169.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 13.6 Cg_endo -54.87 -26.64 49.4 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.176 1.918 . . . . 72.519999999999996 112.716 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.44 -29.49 59.7 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.385 -0.371 . . . . 75.040000000000006 111.933 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.63 -29.65 56.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.929 0.395 . . . . 74.239999999999995 111.585 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.621 HG11 HG22 ' A' ' 22' ' ' THR . 50.5 t -62.87 127.55 90.77 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 116.185 -0.461 . . . . 74.299999999999997 111.494 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.64 130.39 31.37 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.66 2.24 . . . . 74.140000000000001 112.949 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -69.8 76.65 0.46 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.242 0.544 . . . . 63.340000000000003 112.045 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 m -58.29 -49.56 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.482 0.549 . . . . 73.140000000000001 112.482 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -60.89 -17.91 53.35 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.837 -0.54 . . . . 75.209999999999994 112.054 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.66 -52.33 5.6 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.869 0.366 . . . . 75.200000000000003 110.21 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.99 -75.84 0.49 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.526 -0.306 . . . . 71.319999999999993 111.703 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.92 48.76 0.61 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.47 0.545 . . . . 74.540000000000006 112.47 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 82.9 p -63.84 -9.21 13.69 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.963 0.411 . . . . 62.119999999999997 111.344 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -89.86 -26.08 20.69 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.085 -0.507 . . . . 74.310000000000002 111.374 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.523 ' HD2' ' O ' ' A' ' 21' ' ' VAL . 12.3 ttm180 -85.03 -45.1 12.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.913 0.387 . . . . 73.540000000000006 110.864 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 40' ' ' LEU . 5.5 mp 59.15 15.12 3.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.484 0.713 . . . . 62.119999999999997 112.382 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.523 ' O ' ' HD2' ' A' ' 19' ' ' ARG . 88.0 t -129.39 126.1 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.965 0.412 . . . . 72.150000000000006 111.696 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.621 HG22 HG11 ' A' ' 9' ' ' VAL . 86.7 m -99.66 102.93 14.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.915 0.388 . . . . 71.420000000000002 110.11 173.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.439 ' HA ' ' HG1' ' A' ' 55' ' ' THR . 5.3 p-10 -100.98 98.18 8.67 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.371 0.605 . . . . 60.539999999999999 111.886 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -126.46 -30.85 2.81 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.835 0.35 . . . . 74.409999999999997 111.325 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.11 -19.54 45.44 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 111.708 0.262 . . . . 54.340000000000003 111.708 171.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.74 40.02 98.22 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.505 -0.378 . . . . 73.400000000000006 113.697 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.1 mt -105.39 -2.73 23.48 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.083 0.401 . . . . 72.439999999999998 112.083 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.87 -175.1 2.79 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.931 0.396 . . . . 75.239999999999995 111.907 -176.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.9 t -158.79 170.4 22.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.665 0.386 . . . . 72.400000000000006 110.484 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -44.68 -45.33 9.69 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.956 0.725 . . . . 72.010000000000005 112.956 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.417 ' O ' HG21 ' A' ' 35' ' ' VAL . . . -70.14 -55.95 8.09 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.288 -0.257 . . . . 74.420000000000002 111.632 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -55.59 -45.87 77.35 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 111.847 0.314 . . . . 74.239999999999995 111.847 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.68 -54.9 36.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.422 -0.354 . . . . 71.319999999999993 111.085 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.98 -41.27 82.65 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.178 0.436 . . . . 75.319999999999993 112.178 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 90.9 t -64.51 -50.06 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.887 0.375 . . . . 74.519999999999996 110.807 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.1 ttm -60.51 -43.7 96.79 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.532 -0.304 . . . . 72.439999999999998 111.478 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.48 -44.63 89.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.882 0.372 . . . . 74.109999999999999 111.011 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.88 -44.59 97.21 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.172 -0.537 . . . . 55.119999999999997 112.716 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.535 ' O ' HG13 ' A' ' 43' ' ' ILE . 5.8 mmp_? -55.34 -55.41 31.9 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.006 0.431 . . . . 73.120000000000005 110.96 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.431 ' HB3' HD23 ' A' ' 20' ' ' LEU . 87.7 mt -60.59 -44.39 96.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.032 -0.531 . . . . 73.430000000000007 111.891 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -63.16 -39.41 94.58 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.725 0.297 . . . . 75.120000000000005 110.863 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.93 -42.48 98.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.949 0.404 . . . . 74.319999999999993 111.017 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.3 mt -57.63 -47.18 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.014 -0.539 . . . . 73.519999999999996 111.453 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 14.4 ptm180 -77.67 -24.95 49.21 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.959 -0.463 . . . . 73.129999999999995 111.927 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.4 t -70.06 -35.5 74.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.945 0.402 . . . . 62.020000000000003 111.027 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.1 t -95.7 -56.43 2.68 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.132 -0.486 . . . . 73.239999999999995 112.215 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -98.44 -12.64 21.15 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.302 0.482 . . . . 73.0 112.302 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.36 20.85 11.88 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.518 0.562 . . . . 73.340000000000003 112.518 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.425 ' HB ' HG21 ' A' ' 43' ' ' ILE . 92.7 t -81.79 125.55 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.0 0.428 . . . . 75.239999999999995 111.129 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -84.34 97.15 9.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.276 0.56 . . . . 74.299999999999997 110.662 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.59 105.3 15.26 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.392 -0.822 . . . . 74.450000000000003 110.647 -173.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.22 117.11 33.44 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.146 0.424 . . . . 72.439999999999998 112.146 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.55 112.54 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.164 0.507 . . . . 75.239999999999995 111.502 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.476 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 58.1 t -107.56 143.26 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 122.912 0.485 . . . . 74.510000000000005 111.463 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.439 ' HG1' ' HA ' ' A' ' 23' ' ' ASP . 49.8 p -133.81 122.52 23.37 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.718 0.294 . . . . 74.040000000000006 110.893 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -127.71 141.8 42.19 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 120.561 0.219 . . . . 74.140000000000001 111.295 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.76 -48.23 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.506 2.138 . . . . 71.010000000000005 113.062 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.917 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 67.6 p -155.78 145.02 20.78 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.021 0.378 . . . . 72.030000000000001 112.021 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.4 HG12 HG12 ' A' ' 91' ' ' VAL . 36.5 pt -123.86 -3.49 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.749 0.309 . . . . 73.329999999999998 111.494 176.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.42 47.22 6.99 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.219 -0.515 . . . . 75.319999999999993 113.169 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 56.96 20.35 5.29 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.174 0.435 . . . . 74.340000000000003 112.174 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.95 151.65 97.16 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.396 -0.365 . . . . 72.019999999999996 111.834 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.525 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 29.4 Cg_endo -60.59 117.32 4.07 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.841 2.361 . . . . 74.099999999999994 113.14 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.82 -51.83 65.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.868 0.692 . . . . 74.109999999999999 112.868 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -31.71 72.67 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.125 0.488 . . . . 74.329999999999998 111.588 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 63' ' ' PRO . 10.4 t70 -68.84 -34.8 76.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.205 0.526 . . . . 75.5 110.835 173.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -65.91 -55.94 14.32 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.859 -0.61 . . . . 75.129999999999995 110.892 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.5 p -56.97 -42.81 80.85 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.813 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.8 tp -53.03 -53.09 55.37 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.924 0.392 . . . . 74.540000000000006 111.953 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.604 ' HG2' HH21 ' A' ' 73' ' ' ARG . 37.8 mtmm -71.33 -36.88 71.7 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.314 0.487 . . . . 75.209999999999994 112.314 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.7 tp -65.85 -37.59 86.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.201 0.524 . . . . 75.109999999999999 111.257 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.74 84.12 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.297 -0.41 . . . . 74.329999999999998 111.616 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.604 HH21 ' HG2' ' A' ' 70' ' ' LYS . 41.3 mtm105 -58.91 -49.66 76.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.272 0.471 . . . . 73.239999999999995 112.272 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.459 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 11.7 pt20 -64.63 -15.27 60.96 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.135 0.42 . . . . 75.519999999999996 112.135 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.459 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 45.5 m0 -103.4 14.88 30.44 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.776 0.322 . . . . 75.519999999999996 111.543 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.37 -53.32 4.65 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.113 -0.565 . . . . 64.209999999999994 113.651 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.49 ' HA ' ' HB3' ' A' ' 82' ' ' ASN . 31.0 m . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 113.505 0.928 . . . . 72.5 113.505 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.537 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 42.5 t30 . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 120.76 0.314 . . . . 75.239999999999995 111.027 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.622 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -41.07 -60.65 1.16 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.2 1.185 . . . . 74.239999999999995 114.2 -171.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.622 ' H ' ' ND2' ' A' ' 83' ' ' ASN . 4.8 p-10 -95.04 24.27 4.99 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.044 -0.41 . . . . 73.420000000000002 112.034 -174.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.16 137.6 13.52 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.027 -0.606 . . . . 72.319999999999993 113.549 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 99' ' ' PHE . 49.1 tp -144.53 119.96 10.31 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.015 0.436 . . . . 74.140000000000001 111.246 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 63.1 tp -109.32 141.47 41.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.944 0.402 . . . . 70.439999999999998 111.363 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.1 tp -129.7 127.79 41.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.378 -0.374 . . . . 74.409999999999997 110.022 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 65.8 t -128.19 116.6 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 122.116 -0.365 . . . . 74.140000000000001 111.882 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.643 ' HA ' HG13 ' A' ' 97' ' ' VAL . 30.2 tp -95.45 120.97 36.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.247 -0.433 . . . . 72.209999999999994 111.001 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.572 HG11 ' HB3' ' A' ' 93' ' ' ASP . 60.1 t -110.5 99.94 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.771 0.319 . . . . 70.239999999999995 111.059 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.3 tp -53.76 -39.1 65.08 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.898 0.38 . . . . 75.420000000000002 111.457 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.917 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 56.1 t0 -39.33 -52.98 2.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.915 0.886 . . . . 72.319999999999993 112.061 173.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.449 ' OE1' ' HD2' ' A' ' 96' ' ' ARG . 11.1 pt20 -108.53 -4.21 17.41 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.227 0.455 . . . . 74.420000000000002 112.227 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 59.32 27.56 16.67 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.524 0.564 . . . . 73.140000000000001 112.524 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HD2' ' OE1' ' A' ' 94' ' ' GLN . 87.0 mtt180 -120.41 155.84 32.63 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.079 0.466 . . . . 74.430000000000007 111.39 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.7 HG22 ' SD ' ' A' ' 122' ' ' MET . 3.6 m -134.64 169.64 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.658 -0.701 . . . . 74.239999999999995 110.958 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -150.83 141.03 22.22 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.965 0.358 . . . . 74.230000000000004 111.965 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.475 ' HB3' HD11 ' A' ' 86' ' ' LEU . 97.0 m-85 -100.8 113.87 27.17 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.87 -0.605 . . . . 74.319999999999993 110.31 172.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -98.59 112.02 24.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 110.31 -0.256 . . . . 64.140000000000001 110.31 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.1 p -98.6 152.58 19.44 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.996 0.739 . . . . 72.530000000000001 112.996 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -88.57 166.95 34.85 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.394 -0.821 . . . . 72.150000000000006 111.906 168.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -65.17 1.0 1.11 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.979 0.733 . . . . 70.129999999999995 112.979 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.86 -42.46 6.02 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.496 -0.641 . . . . 71.239999999999995 111.496 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.52 -12.76 60.29 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.319 -0.441 . . . . 73.420000000000002 111.777 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -56.96 -17.29 9.13 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.216 0.45 . . . . 72.230000000000004 112.216 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.68 -7.55 85.84 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.179 -0.534 . . . . 74.329999999999998 113.598 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.1 -49.81 1.02 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.099 0.475 . . . . 75.230000000000004 111.822 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.2 mt -112.36 90.13 13.72 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.006 -0.543 . . . . 75.129999999999995 112.194 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.99 157.16 23.7 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.363 2.042 . . . . 75.040000000000006 112.893 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.49 -34.39 35.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.804 0.441 . . . . 70.519999999999996 111.949 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.91 -50.04 63.65 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.108 -0.568 . . . . 64.319999999999993 113.049 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.43 -45.43 88.49 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.156 0.503 . . . . 73.530000000000001 110.863 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 118' ' ' ILE . 80.0 mt -59.0 -39.53 82.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.881 -0.599 . . . . 74.409999999999997 110.946 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.3 t -57.46 -44.4 84.78 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.978 -0.555 . . . . 73.230000000000004 111.316 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -57.42 -51.59 68.8 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.777 0.322 . . . . 75.400000000000006 110.959 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 64.0 mt -50.91 -40.25 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.017 0.437 . . . . 75.319999999999993 111.328 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.612 HG21 HG21 ' A' ' 97' ' ' VAL . 76.8 mt -62.79 -56.41 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.124 -0.489 . . . . 72.209999999999994 111.991 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.463 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 10.5 t-80 -83.58 -23.49 31.94 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.14 0.792 . . . . 74.310000000000002 113.14 -171.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -91.82 -49.5 6.22 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 111.74 0.274 . . . . 74.420000000000002 111.74 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -79.42 -54.42 5.94 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.829 0.347 . . . . 75.030000000000001 111.484 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.7 ' SD ' HG22 ' A' ' 97' ' ' VAL . 61.9 mtt -82.6 -58.93 2.69 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.851 1.056 . . . . 72.129999999999995 113.851 -168.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.47 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 23.7 mm -43.2 -52.47 12.37 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 113.709 1.003 . . . . 73.319999999999993 113.709 -173.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.47 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 76.4 Cg_exo -51.65 -41.55 60.8 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.769 1.646 . . . . 61.43 113.056 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 91.3 m-70 -73.1 -40.51 64.92 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.237 -0.289 . . . . 72.420000000000002 111.679 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 122' ' ' MET . 15.9 m-30 -56.54 -40.45 75.14 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.118 0.485 . . . . 71.200000000000003 110.986 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -76.07 -37.13 58.61 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.121 -0.49 . . . . 72.209999999999994 111.325 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.5 m -66.19 -30.01 70.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.701 0.286 . . . . 64.109999999999999 111.676 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 123.51 -3.23 9.49 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.23 -0.509 . . . . 72.310000000000002 113.721 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 97.2 m-20 -104.07 87.49 2.78 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.086 0.402 . . . . 74.129999999999995 112.086 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -71.27 -45.12 63.88 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.175 0.512 . . . . 73.099999999999994 110.486 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.58 -48.06 82.65 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.962 -0.563 . . . . 71.030000000000001 111.755 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 29.2 tt0 -62.44 -38.58 90.28 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.291 -0.413 . . . . 73.140000000000001 111.111 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.27 -51.14 60.66 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.064 -0.589 . . . . 74.420000000000002 112.769 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.481 HD13 HD22 ' A' ' 90' ' ' LEU . 99.4 mt -57.67 -43.41 84.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.922 0.391 . . . . 72.519999999999996 110.895 175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.0 t -51.77 -56.91 11.06 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.986 -0.552 . . . . 74.010000000000005 111.894 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -63.34 -32.22 73.58 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.821 0.304 . . . . 73.510000000000005 111.821 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.17 54.06 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.959 -0.638 . . . . 74.040000000000006 112.408 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.6 t -59.12 -48.62 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.03 0.443 . . . . 73.209999999999994 111.066 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 62.3 tp -53.22 -46.55 69.16 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.774 -0.648 . . . . 71.420000000000002 111.073 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.03 87.36 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.164 -0.471 . . . . 71.430000000000007 111.657 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.96 -56.4 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.414 -0.357 . . . . 75.0 111.423 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -59.44 -35.37 73.91 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.297 0.48 . . . . 74.409999999999997 112.297 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 16.6 mm-40 -59.6 -34.13 72.36 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 122.112 -0.368 . . . . 75.329999999999998 111.587 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 65.4 t -66.21 -42.68 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.904 0.383 . . . . 74.420000000000002 110.719 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.85 -56.53 8.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.118 -0.492 . . . . 74.409999999999997 111.37 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 . . . . . 0 N--CA 1.467 0.425 0 CA-C-N 116.561 -0.29 . . . . 72.219999999999999 111.34 176.963 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.7 t . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.067 0.461 . . . . 71.209999999999994 111.586 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -99.16 113.25 25.39 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.443 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.652 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 2.9 mppt? -95.57 169.03 9.83 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.515 -0.55 . . . . 74.150000000000006 109.515 171.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.652 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 10.2 Cg_endo -51.01 -24.31 13.87 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.201 1.934 . . . . 65.329999999999998 113.198 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.42 -21.23 35.82 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 111.955 0.354 . . . . 74.349999999999994 111.955 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -82.94 -27.79 30.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.883 0.373 . . . . 70.450000000000003 110.977 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.9 t -76.87 120.81 83.24 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.104 -0.498 . . . . 75.430000000000007 111.234 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.43 127.73 21.71 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.335 2.023 . . . . 63.399999999999999 112.552 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -72.69 74.97 1.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.087 0.47 . . . . 74.319999999999993 111.473 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.0 m -57.62 -41.56 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 112.479 0.548 . . . . 72.109999999999999 112.479 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.516 HE22 ' HG ' ' A' ' 20' ' ' LEU . 25.4 mm-40 -75.74 -5.1 44.08 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.456 0.539 . . . . 74.209999999999994 112.456 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.0 tt -102.79 -32.33 9.86 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.151 0.5 . . . . 73.400000000000006 110.222 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.21 -61.35 1.38 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.534 0.568 . . . . 75.299999999999997 112.534 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -79.9 -52.49 7.8 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.489 0.552 . . . . 73.400000000000006 112.489 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.9 t 70.14 -61.75 0.45 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.624 0.769 . . . . 71.150000000000006 112.072 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.9 p -60.0 -32.92 71.31 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.906 0.384 . . . . 75.409999999999997 111.01 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -92.18 109.07 20.43 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.004 -0.369 . . . . 64.340000000000003 110.004 169.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.516 ' HG ' HE22 ' A' ' 13' ' ' GLN . 3.8 mp -97.11 15.02 23.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.436 0.636 . . . . 62.329999999999998 110.385 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.19 137.06 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.532 -0.758 . . . . 74.25 111.795 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 54' ' ' VAL . 30.4 m -119.81 103.25 9.2 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.901 0.382 . . . . 65.140000000000001 110.727 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -100.59 99.49 10.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.289 0.566 . . . . 73.230000000000004 112.438 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -118.49 -43.28 2.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.062 -0.517 . . . . 75.319999999999993 111.264 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.34 -24.65 67.45 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.28 0.844 . . . . 73.430000000000007 113.28 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.78 9.57 86.81 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.764 -0.732 . . . . 72.319999999999993 113.378 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.88 -14.3 60.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.978 0.418 . . . . 73.299999999999997 111.705 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.4 mt -103.09 139.36 38.72 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.41 -0.359 . . . . 74.310000000000002 110.969 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.2 t -106.23 159.99 15.69 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.328 -0.233 . . . . 74.409999999999997 110.835 175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -45.26 -48.95 12.8 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.556 0.947 . . . . 74.0 113.556 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.47 -48.73 76.45 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.79 0.328 . . . . 74.120000000000005 111.844 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -60.82 -40.6 93.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.867 0.365 . . . . 72.150000000000006 111.524 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.13 -45.26 92.78 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.232 -0.44 . . . . 74.519999999999996 110.778 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.0 -49.93 74.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.766 0.317 . . . . 75.219999999999999 111.607 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.12 -40.64 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.218 0.532 . . . . 74.430000000000007 111.154 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.504 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.5 ttm -63.1 -49.89 72.68 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.948 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -59.05 -40.58 85.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.609 0.242 . . . . 55.130000000000003 111.211 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.6 -46.49 93.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.108 -0.568 . . . . 52.299999999999997 112.91 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 43' ' ' ILE . 79.4 mtm180 -69.14 -43.41 74.41 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.823 0.305 . . . . 74.530000000000001 111.823 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 36' ' ' MET . 88.7 mt -61.32 -47.5 85.61 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.195 0.522 . . . . 72.209999999999994 111.054 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -62.72 -37.0 84.79 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.926 -0.579 . . . . 72.409999999999997 110.896 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.23 98.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.342 -0.39 . . . . 74.120000000000005 110.776 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.8 mt -59.82 -45.76 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.817 0.341 . . . . 73.239999999999995 110.779 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -58.51 -31.73 68.16 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.954 0.407 . . . . 73.329999999999998 111.001 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.9 t -93.79 -13.52 27.25 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.364 0.505 . . . . 51.229999999999997 112.364 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.8 m -106.8 -63.59 1.27 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.296 0.57 . . . . 74.099999999999994 111.29 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -90.97 -8.3 49.63 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.486 -0.779 . . . . 71.010000000000005 111.198 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 67.33 5.93 4.55 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.279 0.631 . . . . 74.25 112.247 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.663 HG21 ' HB2' ' A' ' 84' ' ' ASN . 99.8 t -79.63 130.97 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 122.922 0.489 . . . . 73.129999999999995 111.987 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.402 ' HB2' HG13 ' A' ' 77' ' ' VAL . 1.8 mp0 -79.81 96.53 6.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.915 0.388 . . . . 73.109999999999999 110.297 174.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.402 ' HE2' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -104.78 98.78 8.47 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.424 -0.353 . . . . 73.329999999999998 110.492 -176.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.03 120.75 42.25 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.534 0.568 . . . . 74.340000000000003 112.534 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.92 137.49 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-O 121.025 0.441 . . . . 74.400000000000006 111.359 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.572 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 61.7 t -130.76 140.18 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.603 0.361 . . . . 72.209999999999994 111.037 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -128.61 122.46 30.96 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.624 0.249 . . . . 73.239999999999995 111.183 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.3 mt -128.23 140.85 39.49 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 111.622 0.23 . . . . 72.329999999999998 111.622 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.15 -55.97 1.91 Allowed 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.516 2.144 . . . . 74.219999999999999 112.248 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.3 t -155.62 148.97 24.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.341 -0.39 . . . . 73.319999999999993 111.817 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.73 20.47 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.353 0.597 . . . . 74.5 110.196 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.42 39.65 91.46 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.202 -0.523 . . . . 64.099999999999994 113.175 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.02 16.03 3.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.151 0.58 . . . . 72.409999999999997 112.293 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.01 151.41 80.53 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 122.055 -0.403 . . . . 73.420000000000002 111.775 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -56.97 110.15 0.55 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.685 2.256 . . . . 73.010000000000005 112.654 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.6 tp -52.19 -46.02 65.41 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.891 0.7 . . . . 75.129999999999995 112.891 -176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.551 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 38.3 mt-10 -66.71 -25.32 66.47 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.126 0.417 . . . . 73.519999999999996 112.126 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 23.3 t70 -75.39 -45.57 38.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.379 0.609 . . . . 75.219999999999999 110.02 173.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -57.65 -47.5 82.06 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.521 -0.763 . . . . 73.209999999999994 111.821 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.3 p -55.71 -50.17 71.05 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.78 0.324 . . . . 75.140000000000001 111.595 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.2 tp -55.33 -51.18 67.57 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.956 0.408 . . . . 74.430000000000007 111.36 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 66' ' ' ASP . 55.6 mtpt -60.24 -47.02 87.76 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.198 0.444 . . . . 75.150000000000006 112.198 -178.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.2 tp -66.18 -47.6 73.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.933 0.397 . . . . 75.019999999999996 111.732 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.584 ' HB1' HD22 ' A' ' 87' ' ' LEU . . . -61.57 -32.81 72.92 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.227 0.454 . . . . 65.420000000000002 112.227 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 44.3 mtm180 -59.53 -48.59 81.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.013 0.375 . . . . 72.219999999999999 112.013 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.578 ' NE2' ' HB2' ' A' ' 6' ' ' PRO . 11.5 pt20 -70.48 -13.62 62.19 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.818 0.342 . . . . 75.349999999999994 111.479 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.508 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 32.3 m0 -96.42 -17.43 20.59 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.854 0.359 . . . . 74.430000000000007 110.778 173.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.31 46.64 94.02 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 116.31 -0.405 . . . . 63.509999999999998 113.408 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 50' ' ' GLU . 57.7 t . . . . . 0 CA--C 1.546 0.822 0 N-CA-C 112.572 0.582 . . . . 71.409999999999997 112.572 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 103' ' ' TYR . 56.4 t30 . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 107.567 -1.272 . . . . 73.099999999999994 107.567 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.469 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -74.96 -122.07 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.733 -0.605 . . . . 72.400000000000006 111.489 177.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.663 ' HB2' HG21 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -83.72 70.61 10.37 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.911 -0.493 . . . . 75.099999999999994 112.056 -176.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -107.17 144.71 15.94 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.098 -0.501 . . . . 64.010000000000005 112.685 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.718 HD12 ' HB3' ' A' ' 99' ' ' PHE . 42.6 tp -145.16 124.59 13.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.875 0.369 . . . . 75.219999999999999 111.475 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.584 HD22 ' HB1' ' A' ' 72' ' ' ALA . 54.8 tp -111.54 138.26 48.31 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.756 0.312 . . . . 64.409999999999997 111.038 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.0 tp -128.26 102.52 6.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.708 0.29 . . . . 75.040000000000006 110.682 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 63.1 t -105.11 119.63 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.063 0.394 . . . . 73.519999999999996 112.063 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.543 ' HA ' HG13 ' A' ' 97' ' ' VAL . 41.9 tp -98.96 115.86 29.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.11 0.481 . . . . 65.310000000000002 111.109 175.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.427 HG11 ' H ' ' A' ' 94' ' ' GLN . 71.3 t -101.17 104.49 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.27 -0.423 . . . . 73.340000000000003 111.007 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.0 tp -55.75 -42.44 75.43 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.892 0.377 . . . . 71.540000000000006 111.638 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -50.99 -36.68 40.5 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.244 0.545 . . . . 74.209999999999994 111.771 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.427 ' H ' HG11 ' A' ' 91' ' ' VAL . 72.0 mt-30 -105.99 -10.19 16.7 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.108 -0.496 . . . . 75.310000000000002 111.933 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 53.4 35.13 19.69 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.675 0.62 . . . . 73.209999999999994 112.675 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -142.58 162.93 34.19 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.974 0.416 . . . . 75.340000000000003 111.874 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.577 HG23 ' SD ' ' A' ' 122' ' ' MET . 3.7 m -133.43 171.89 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.068 -0.515 . . . . 71.140000000000001 111.589 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 47.4 ttt85 -148.59 137.67 21.7 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.475 -0.329 . . . . 74.299999999999997 111.524 171.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.718 ' HB3' HD12 ' A' ' 86' ' ' LEU . 96.9 m-85 -93.0 108.4 19.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 110.543 172.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.04 122.41 37.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.577 0.227 . . . . 71.5 110.727 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.3 p -100.49 160.8 14.05 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.932 1.086 . . . . 74.310000000000002 113.932 -172.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -103.56 -164.24 25.3 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.932 -1.031 . . . . 74.409999999999997 111.809 167.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 5.3 t80 -76.56 -17.0 59.46 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.128 0.49 . . . . 73.099999999999994 111.591 -176.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.09 -23.46 57.17 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.236 -0.507 . . . . 72.450000000000003 113.205 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.4 mt -103.34 -4.21 24.51 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.012 0.434 . . . . 71.200000000000003 110.95 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -53.55 -35.44 60.75 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.812 -0.631 . . . . 64.209999999999994 111.174 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.39 18.05 58.14 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 121.244 -0.503 . . . . 72.150000000000006 113.88 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -137.83 -54.63 0.66 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.301 0.55 . . . . 63.32 111.44 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.65 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.5 mt -114.78 86.14 12.65 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.6 -0.727 . . . . 71.120000000000005 112.102 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.13 153.83 19.02 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.156 1.904 . . . . 72.219999999999999 112.404 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.38 -43.71 5.28 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.865 0.691 . . . . 74.310000000000002 112.865 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.91 -50.13 68.56 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.218 -0.515 . . . . 55.140000000000001 113.251 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.68 -48.15 83.08 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.969 0.414 . . . . 72.439999999999998 111.025 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.65 HD21 ' HB3' ' A' ' 109' ' ' LEU . 76.3 mt -58.31 -39.09 78.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.088 -0.505 . . . . 74.510000000000005 111.217 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.9 t -63.21 -37.23 86.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.11 -0.495 . . . . 71.420000000000002 111.335 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -70.61 -37.81 73.9 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 122.262 -0.274 . . . . 75.120000000000005 111.284 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 62.3 mt -55.15 -43.5 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.474 0.654 . . . . 74.129999999999995 110.04 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.7 mt -64.59 -52.9 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.45 -0.795 . . . . 74.140000000000001 111.489 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.5 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 5.4 t-80 -69.78 -39.35 76.68 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.6 0.593 . . . . 74.430000000000007 112.6 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.31 -39.41 22.92 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.753 0.649 . . . . 74.140000000000001 112.753 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -103.57 -46.29 4.59 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.602 0.593 . . . . 73.230000000000004 112.602 -174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.577 ' SD ' HG23 ' A' ' 97' ' ' VAL . 50.5 mtt -78.89 -48.01 15.44 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.185 0.809 . . . . 71.140000000000001 113.185 -173.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.5 ' CG1' ' HA ' ' A' ' 119' ' ' HIS . 23.0 mm -50.09 -52.23 55.04 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 112.98 0.733 . . . . 74.450000000000003 112.98 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 14.0 Cg_endo -55.7 -38.42 94.33 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 121.807 1.671 . . . . 63.240000000000002 112.315 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 41.5 m-70 -71.14 -51.4 25.18 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.04 0.385 . . . . 61.340000000000003 112.04 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.4 m-30 -55.92 -44.84 78.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.775 0.321 . . . . 75.129999999999995 111.297 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -62.57 -37.03 84.59 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.946 0.403 . . . . 72.010000000000005 111.16 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -77.3 -5.97 51.43 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.405 -0.361 . . . . 64.230000000000004 111.911 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.33 2.58 68.04 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.314 -0.469 . . . . 71.109999999999999 113.317 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 90.6 m-20 -89.35 76.46 7.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.826 0.346 . . . . 73.209999999999994 111.841 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -70.75 -46.07 63.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.004 0.431 . . . . 73.129999999999995 111.259 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.65 98.18 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.108 -0.496 . . . . 62.310000000000002 111.603 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 18.3 mm-40 -65.58 -42.91 91.2 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.348 -0.387 . . . . 74.439999999999998 110.902 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.33 -51.28 60.1 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.317 -0.468 . . . . 64.519999999999996 112.923 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.506 ' HA ' ' HE3' ' A' ' 122' ' ' MET . 95.9 mt -60.57 -38.65 85.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.015 0.436 . . . . 74.519999999999996 111.102 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.0 t -57.21 -57.98 10.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.987 -0.551 . . . . 73.430000000000007 112.345 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -76.11 -19.64 58.35 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 120.638 -0.425 . . . . 74.409999999999997 111.582 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.456 ' HA3' ' HE2' ' A' ' 122' ' ' MET . . . -61.79 -47.23 91.59 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.838 -0.696 . . . . 75.230000000000004 111.815 171.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.2 -46.25 96.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.205 0.526 . . . . 75.310000000000002 110.842 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.4 tp -55.34 -38.02 68.22 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.771 -0.649 . . . . 74.540000000000006 111.441 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.402 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -62.47 -55.47 27.32 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.197 -0.456 . . . . 61.439999999999998 111.379 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.402 ' HB ' ' HE2' ' A' ' 51' ' ' PHE . 66.7 t -57.46 -43.37 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.261 -0.427 . . . . 71.439999999999998 111.134 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -52.73 -45.36 66.95 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.122 -0.49 . . . . 73.349999999999994 111.367 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -69.52 -35.29 75.35 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.061 0.393 . . . . 73.239999999999995 112.061 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 141' ' ' ALA . 96.5 t -62.05 -51.59 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.944 0.402 . . . . 75.519999999999996 111.01 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.21 -45.14 95.78 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.923 0.392 . . . . 75.209999999999994 111.015 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.008 0.432 . . . . 75.0 111.029 175.792 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.6 t . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 113.609 0.966 . . . . 74.099999999999994 113.609 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -107.41 130.02 54.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.952 -0.567 . . . . 73.200000000000003 110.973 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 26.1 mtpp -105.24 168.69 8.02 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 116.521 -0.309 . . . . 72.549999999999997 110.708 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 59.7 Cg_endo -69.62 58.19 1.47 Allowed 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.675 2.25 . . . . 71.049999999999997 112.65 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -176.85 -26.55 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.54 -0.755 . . . . 72.219999999999999 109.967 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.83 -35.04 67.19 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.268 0.556 . . . . 73.430000000000007 110.297 169.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.591 HG23 HD22 ' A' ' 56' ' ' LEU . 49.0 t -64.17 118.38 45.86 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.667 -0.697 . . . . 73.519999999999996 111.566 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HG2' HG23 ' A' ' 22' ' ' THR . 12.2 Cg_endo -56.14 121.9 10.81 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.45 2.1 . . . . 55.43 112.596 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.551 HD21 HD11 ' A' ' 14' ' ' LEU . 13.2 p-10 -72.63 70.64 0.94 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.356 0.598 . . . . 74.340000000000003 111.886 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -58.03 -43.58 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.792 -0.64 . . . . 75.049999999999997 112.641 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.457 ' NE2' ' HG ' ' A' ' 20' ' ' LEU . 8.2 tp-100 -71.46 -14.09 62.03 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.227 0.454 . . . . 74.099999999999994 112.227 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.551 HD11 HD21 ' A' ' 11' ' ' ASN . 10.1 tt -88.29 -29.99 19.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.118 0.485 . . . . 73.510000000000005 110.685 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.53 -35.35 13.64 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.131 0.491 . . . . 73.530000000000001 111.751 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD2' ' HG2' ' A' ' 19' ' ' ARG . 20.7 t70 -134.15 142.31 47.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.947 0.403 . . . . 74.040000000000006 111.244 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.7 p -107.64 -6.82 16.69 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.393 0.516 . . . . 63.240000000000002 112.393 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.1 p -75.57 -30.8 59.77 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.109 -0.369 . . . . 75.400000000000006 111.678 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.448 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 3.5 ptp85 -119.84 159.7 24.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.847 0.356 . . . . 74.319999999999993 111.051 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HG ' ' NE2' ' A' ' 13' ' ' GLN . 4.7 mp -132.72 14.47 4.4 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.71 0.29 . . . . 74.340000000000003 111.722 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.453 HG22 ' HB ' ' A' ' 53' ' ' VAL . 65.0 t -112.08 128.64 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 112.286 0.476 . . . . 71.530000000000001 112.286 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.444 HG23 ' HG2' ' A' ' 10' ' ' PRO . 89.3 m -100.55 109.79 21.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.004 0.431 . . . . 63.140000000000001 110.979 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -92.31 93.16 8.49 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.288 0.566 . . . . 73.430000000000007 112.352 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 55' ' ' THR . 10.2 mm-40 -106.65 -59.69 1.76 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.945 0.402 . . . . 75.010000000000005 110.536 174.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.55 74.6 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.473 -0.33 . . . . 73.510000000000005 111.856 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.79 50.14 70.92 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.312 -0.471 . . . . 60.310000000000002 112.929 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.619 HD23 HD21 ' A' ' 92' ' ' LEU . 97.7 mt -90.59 12.36 19.1 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.202 0.445 . . . . 72.25 112.202 -176.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mp -124.4 163.47 21.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.283 0.563 . . . . 75.150000000000006 111.597 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.7 t -82.97 155.9 23.74 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.764 -0.653 . . . . 70.140000000000001 110.914 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -53.05 -40.88 64.29 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.876 0.37 . . . . 75.549999999999997 111.896 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' O ' HG21 ' A' ' 35' ' ' VAL . . . -64.81 -46.36 82.3 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.9 0.381 . . . . 75.510000000000005 111.25 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -59.47 -41.06 88.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.484 -0.325 . . . . 71.140000000000001 111.619 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -55.78 -54.48 43.95 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.316 0.579 . . . . 75.340000000000003 110.912 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.27 -48.88 70.71 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.729 -0.669 . . . . 60.5 111.814 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 31' ' ' ALA . 99.0 t -64.4 -42.69 96.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.166 -0.47 . . . . 64.340000000000003 112.093 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.558 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.5 ttm -62.38 -51.1 68.95 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.199 -0.313 . . . . 74.439999999999998 110.937 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 59.4 m-80 -60.95 -38.38 85.67 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.643 0.259 . . . . 75.329999999999998 111.055 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.52 -48.36 86.57 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.045 -0.598 . . . . 75.019999999999996 112.9 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 43' ' ' ILE . 86.4 mtm180 -64.42 -46.17 84.36 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.843 0.312 . . . . 72.25 111.843 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 36' ' ' MET . 81.7 mt -56.32 -41.43 76.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.35 0.595 . . . . 75.510000000000005 110.867 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -67.63 -39.06 84.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.769 -0.65 . . . . 75.540000000000006 111.264 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.81 88.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.121 0.486 . . . . 75.409999999999997 110.823 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.429 HG23 ' HB2' ' A' ' 47' ' ' HIS . 70.8 mt -60.35 -41.88 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.1 -0.5 . . . . 73.540000000000006 110.681 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.473 ' NE ' ' HG2' ' A' ' 50' ' ' GLU . 12.7 tpt180 -50.85 -33.09 22.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.816 -0.629 . . . . 74.230000000000004 111.688 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.1 t -99.49 -60.2 1.58 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.323 -0.399 . . . . 73.5 111.741 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.7 t -59.29 -45.95 89.87 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.525 0.565 . . . . 71.239999999999995 112.525 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.429 ' HB2' HG23 ' A' ' 43' ' ' ILE . 91.1 m-70 -104.31 -9.26 18.67 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.776 0.322 . . . . 71.420000000000002 111.41 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.74 -5.68 1.4 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.216 0.821 . . . . 74.319999999999993 113.216 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.98 123.41 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.04 0.447 . . . . 74.200000000000003 111.994 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HG2' ' NE ' ' A' ' 44' ' ' ARG . 38.1 mt-10 -75.97 96.24 3.73 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.84 -0.43 . . . . 70.409999999999997 109.84 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.65 107.75 18.91 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.268 -0.424 . . . . 65.430000000000007 110.902 -173.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.14 147.16 37.93 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.042 0.386 . . . . 71.109999999999999 112.042 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.453 ' HB ' HG22 ' A' ' 21' ' ' VAL . 58.5 t -128.57 135.81 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.919 0.39 . . . . 74.230000000000004 111.264 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.433 HG21 HD23 ' A' ' 71' ' ' LEU . 60.5 t -128.56 134.47 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.713 0.292 . . . . 72.230000000000004 111.25 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 80.6 p -119.11 122.6 42.45 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.723 0.297 . . . . 72.349999999999994 111.385 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.591 HD22 HG23 ' A' ' 9' ' ' VAL . 89.7 mt -125.98 140.05 35.85 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-O 120.732 0.301 . . . . 71.409999999999997 111.57 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.3 -35.19 14.5 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.116 1.877 . . . . 75.140000000000001 112.432 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 73.3 p -161.37 144.87 12.77 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.351 0.5 . . . . 75.420000000000002 112.351 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 91' ' ' VAL . 32.3 pt -123.89 -11.4 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 121.002 0.43 . . . . 75.430000000000007 111.597 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.76 -113.47 5.76 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 114.386 0.514 . . . . 74.310000000000002 114.386 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -89.97 11.52 20.26 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.044 0.45 . . . . 62.340000000000003 112.044 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.2 118.87 71.71 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.924 -0.485 . . . . 63.409999999999997 111.88 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.658 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 29.1 Cg_endo -63.19 126.75 18.52 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.58 2.187 . . . . 75.439999999999998 112.346 176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.3 -45.5 80.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.943 0.72 . . . . 74.239999999999995 112.943 -171.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 1.2 pm0 -70.16 -36.04 74.43 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.35 0.5 . . . . 73.519999999999996 112.35 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.658 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 10.2 m-20 -71.99 -35.89 69.6 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.993 -0.442 . . . . 75.329999999999998 110.976 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.486 ' CZ ' HD13 ' A' ' 56' ' ' LEU . 58.2 t80 -59.21 -56.58 20.26 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.812 0.339 . . . . 61.119999999999997 111.181 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 47.1 p -52.76 -44.56 66.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.116 -0.493 . . . . 64.329999999999998 111.651 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.648 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 58.7 tp -61.7 -57.06 13.42 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.336 -0.393 . . . . 70.010000000000005 111.634 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -61.38 -34.92 76.13 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.145 0.424 . . . . 71.439999999999998 112.145 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 54' ' ' VAL . 58.7 tp -69.79 -48.41 59.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.185 0.517 . . . . 74.310000000000002 111.097 177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.34 -31.73 73.0 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.074 0.398 . . . . 54.520000000000003 112.074 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 24.2 mtp180 -62.42 -50.05 73.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.026 0.38 . . . . 75.430000000000007 112.026 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.619 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 12.3 pt20 -67.88 -32.92 73.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.936 0.398 . . . . 73.140000000000001 111.088 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.619 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 27.7 m0 -71.45 -15.89 62.35 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.526 -0.307 . . . . 74.310000000000002 111.68 175.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.58 -39.15 3.07 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.277 -0.487 . . . . 72.209999999999994 112.746 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 19.4 t . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 122.88 0.472 . . . . 65.349999999999994 112.158 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.486 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 24.4 t30 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.864 0.364 . . . . 73.040000000000006 111.165 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.14 123.86 23.78 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.672 -0.643 . . . . 75.140000000000001 111.527 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.881 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 3.6 p-10 46.22 41.27 8.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.198 0.999 . . . . 74.25 112.753 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.11 145.31 16.58 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.86 -0.609 . . . . 72.099999999999994 111.861 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.448 HD12 ' HB3' ' A' ' 99' ' ' PHE . 55.9 tp -144.87 131.0 19.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.953 0.377 . . . . 70.349999999999994 111.218 -177.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.4 tp -119.29 123.62 44.68 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.838 0.352 . . . . 75.120000000000005 111.478 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.5 tp -111.26 110.03 20.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.892 0.377 . . . . 74.430000000000007 110.972 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' A' ' 54' ' ' VAL . 93.1 t -110.52 129.15 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 122.181 -0.324 . . . . 72.219999999999999 111.811 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.527 ' HB2' HD22 ' A' ' 135' ' ' LEU . 43.5 tp -107.25 119.41 39.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.979 0.419 . . . . 73.25 111.037 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 59' ' ' ILE . 94.0 t -102.93 100.82 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.307 -0.406 . . . . 75.400000000000006 111.207 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.619 HD21 HD23 ' A' ' 27' ' ' LEU . 62.4 tp -59.19 -39.14 81.63 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.171 0.434 . . . . 73.099999999999994 112.171 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 14.9 t70 -47.53 -47.15 28.09 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.154 0.582 . . . . 74.420000000000002 112.189 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -108.46 8.79 27.56 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.126 -0.488 . . . . 70.230000000000004 111.103 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 32.77 58.01 0.43 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.552 1.141 . . . . 73.219999999999999 113.782 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -150.16 160.97 43.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.477 -0.783 . . . . 74.430000000000007 111.129 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.509 HG22 ' SD ' ' A' ' 122' ' ' MET . 4.3 m -126.21 171.8 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.057 0.456 . . . . 75.230000000000004 112.029 -174.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 98' ' ' ARG . 28.7 ttt85 -150.15 135.46 18.05 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.246 -0.434 . . . . 73.230000000000004 111.826 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.448 ' HB3' HD12 ' A' ' 86' ' ' LEU . 95.9 m-85 -94.01 115.04 27.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.144 -0.48 . . . . 74.109999999999999 110.154 171.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -101.1 112.66 25.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.844 0.354 . . . . 71.120000000000005 110.87 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.462 HG21 HD11 ' A' ' 114' ' ' LEU . 2.9 p -88.59 148.37 24.11 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.678 0.751 . . . . 72.049999999999997 112.921 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -90.46 -170.23 43.44 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.225 -0.898 . . . . 74.329999999999998 112.199 168.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -24.6 65.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.055 0.455 . . . . 72.209999999999994 111.637 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.881 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -75.18 -30.47 58.84 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.003 -0.617 . . . . 61.399999999999999 113.432 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.13 -0.91 57.84 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.979 0.733 . . . . 74.349999999999994 112.979 -171.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -53.33 -32.06 47.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.906 0.335 . . . . 74.510000000000005 111.906 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.65 4.45 69.13 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.42 -0.419 . . . . 55.509999999999998 113.827 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -125.02 -60.11 1.37 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.381 0.61 . . . . 75.420000000000002 111.444 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.07 87.14 27.81 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.697 -0.683 . . . . 75.329999999999998 111.086 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.73 167.93 16.33 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.54 2.16 . . . . 75.209999999999994 113.558 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.08 -48.8 33.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.585 0.587 . . . . 70.420000000000002 112.585 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.37 -46.62 91.64 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.264 -0.493 . . . . 72.109999999999999 113.43 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.15 -48.94 77.86 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.891 0.377 . . . . 72.25 111.584 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.462 HD11 HG21 ' A' ' 101' ' ' THR . 86.8 mt -59.34 -43.03 92.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.277 -0.42 . . . . 75.540000000000006 111.275 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.4 t -63.41 -37.54 87.67 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.087 -0.506 . . . . 61.539999999999999 111.108 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -60.12 -55.34 35.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.394 -0.366 . . . . 73.450000000000003 111.219 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.9 mt -49.19 -46.21 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.044 0.449 . . . . 74.239999999999995 111.666 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.412 ' O ' HG12 ' A' ' 123' ' ' ILE . 58.2 mt -60.14 -54.91 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.135 0.493 . . . . 73.340000000000003 111.415 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -83.72 -9.17 59.02 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.176 0.806 . . . . 54.219999999999999 113.176 -173.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.12 -40.78 7.03 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.223 0.453 . . . . 73.430000000000007 112.223 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.07 -31.08 2.15 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.516 0.932 . . . . 74.25 113.516 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.509 ' SD ' HG22 ' A' ' 97' ' ' VAL . 36.0 mtt -69.04 -40.54 78.52 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.904 0.705 . . . . 73.420000000000002 112.904 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.477 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 46.7 mm -48.12 -57.04 11.4 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 112.894 0.702 . . . . 74.420000000000002 112.894 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.08 -37.64 86.95 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.053 1.835 . . . . 72.340000000000003 112.967 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -63.48 -53.09 57.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.802 0.334 . . . . 74.439999999999998 111.043 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.1 m-85 -59.63 -32.88 70.84 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.546 -0.297 . . . . 74.040000000000006 111.456 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 60.4 mtp85 -66.67 -43.32 84.84 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.241 0.544 . . . . 74.420000000000002 111.03 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.0 t -75.56 -0.82 21.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.858 -0.61 . . . . 73.530000000000001 112.112 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.15 3.93 90.03 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.182 -0.533 . . . . 74.109999999999999 112.48 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.751 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.2 m-20 -84.31 55.07 3.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.831 0.452 . . . . 64.340000000000003 111.349 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -56.22 -41.28 75.4 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.172 0.511 . . . . 71.310000000000002 110.91 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.81 -50.54 73.4 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.725 -0.67 . . . . 73.409999999999997 111.809 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.751 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 39.9 mm-40 -61.13 -40.02 92.22 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.342 -0.39 . . . . 73.219999999999999 111.739 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.49 -53.28 42.26 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.077 -0.582 . . . . 72.150000000000006 112.556 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.527 HD22 ' HB2' ' A' ' 90' ' ' LEU . 83.4 mt -61.15 -43.21 99.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.054 0.454 . . . . 75.340000000000003 111.187 175.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.8 t -60.37 -52.5 64.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.645 0.609 . . . . 52.229999999999997 112.645 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -27.25 59.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.601 0.239 . . . . 74.329999999999998 111.045 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.35 91.36 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.025 -0.607 . . . . 71.519999999999996 112.168 171.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 135' ' ' LEU . 56.7 t -56.59 -48.13 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.146 0.498 . . . . 71.439999999999998 110.806 172.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 50.8 tp -58.45 -40.59 83.05 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.767 -0.651 . . . . 72.109999999999999 111.157 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -58.64 -52.3 66.28 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.022 0.439 . . . . 74.349999999999994 111.031 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 81.1 t -57.26 -48.35 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.153 -0.476 . . . . 64.129999999999995 111.132 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -53.71 -43.19 68.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.916 -0.583 . . . . 74.049999999999997 111.53 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 96.5 mt-30 -68.4 -33.4 74.17 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 111.993 0.368 . . . . 73.530000000000001 111.993 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 141' ' ' ALA . 91.0 t -63.99 -55.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.068 0.461 . . . . 75.230000000000004 110.729 175.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.0 mt -53.23 -45.04 68.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.919 -0.582 . . . . 71.109999999999999 111.533 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 CA--C 1.541 0.609 0 CA-C-N 116.194 -0.457 . . . . 75.219999999999999 111.9 -178.394 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 120.481 0.181 . . . . 74.439999999999998 110.707 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.41 ' CG ' HD23 ' A' ' 56' ' ' LEU . 44.8 m-85 -112.29 159.6 18.48 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.862 0.839 . . . . 65.219999999999999 113.242 -176.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 30.1 mmmt -126.02 158.79 64.83 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 114.867 -1.061 . . . . 73.230000000000004 109.935 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HB2' HE22 ' A' ' 74' ' ' GLN . 9.6 Cg_endo -51.8 -52.27 9.35 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.283 1.988 . . . . 74.430000000000007 113.219 -177.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.44 2.52 32.26 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.074 -0.391 . . . . 72.129999999999995 111.729 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 21.4 t70 -93.89 -13.32 27.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.279 0.561 . . . . 63.149999999999999 110.29 175.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 5' ' ' LYS . 69.4 t -82.7 133.56 49.02 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.908 -0.587 . . . . 74.340000000000003 110.871 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -52.99 111.09 0.57 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.298 1.999 . . . . 53.119999999999997 112.417 177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.466 ' HA ' ' CE2' ' A' ' 75' ' ' TRP . 10.9 p-10 -68.7 78.92 0.29 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.623 0.725 . . . . 75.430000000000007 112.351 -177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 17' ' ' SER . 29.2 m -78.26 10.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.988 0.736 . . . . 73.129999999999995 112.988 -177.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 15.7 mm100 -121.22 18.35 11.53 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.559 0.695 . . . . 70.239999999999995 110.518 171.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 tt -134.64 -45.27 0.74 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.455 -0.793 . . . . 65.230000000000004 109.181 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.37 -75.12 0.59 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.991 -0.549 . . . . 72.319999999999993 111.199 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.2 55.39 2.83 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.27 0.47 . . . . 55.119999999999997 112.27 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 58.2 m -67.46 -9.45 42.11 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.252 0.464 . . . . 74.239999999999995 112.252 -178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -86.78 -9.65 55.36 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.297 0.57 . . . . 72.510000000000005 111.496 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 19' ' ' ARG . 8.6 tpt180 -94.18 -62.25 1.37 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.986 -0.552 . . . . 74.439999999999998 111.041 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 40' ' ' LEU . 5.5 mp 74.68 -14.83 0.69 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.965 0.906 . . . . 75.129999999999995 111.884 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.82 146.93 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 122.669 0.387 . . . . 75.430000000000007 111.252 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 m -150.54 102.66 3.05 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.045 -0.409 . . . . 75.340000000000003 112.02 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 32.5 t70 -93.81 108.19 19.99 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.895 0.378 . . . . 74.400000000000006 111.46 176.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.518 ' HB2' HD22 ' A' ' 56' ' ' LEU . 6.6 mm-40 -113.37 -30.55 6.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.917 0.389 . . . . 71.439999999999998 110.922 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.56 -23.12 66.83 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.491 0.552 . . . . 64.420000000000002 112.491 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.42 45.46 6.92 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.084 -0.579 . . . . 60.219999999999999 112.731 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.504 HD11 HD13 ' A' ' 92' ' ' LEU . 83.5 mt -119.19 -32.75 4.32 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.106 0.41 . . . . 62.149999999999999 112.106 -175.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.1 132.69 36.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.178 0.514 . . . . 74.120000000000005 111.574 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.9 t -86.91 172.27 10.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.159 -0.473 . . . . 74.439999999999998 111.249 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -56.81 -40.68 76.42 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 111.906 0.336 . . . . 73.409999999999997 111.906 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.33 80.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.711 0.291 . . . . 72.319999999999993 111.254 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -56.02 -41.21 74.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.703 0.287 . . . . 74.340000000000003 111.169 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -59.98 -55.92 28.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.131 0.491 . . . . 75.5 111.489 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.403 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 8.0 tp10 -69.33 -43.04 74.49 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.472 0.545 . . . . 71.349999999999994 112.472 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.4 t -59.64 -39.84 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.088 0.471 . . . . 74.109999999999999 110.861 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.508 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.2 ttm -68.39 -43.09 78.04 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.387 -0.37 . . . . 70.420000000000002 110.789 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 34' ' ' GLU . 88.4 m-20 -51.07 -55.97 14.93 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.9 0.381 . . . . 73.430000000000007 111.486 177.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.47 -37.82 76.83 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.181 -0.533 . . . . 75.109999999999999 113.384 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -62.84 -53.59 51.81 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.174 0.512 . . . . 73.329999999999998 110.811 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.536 ' HB3' HD23 ' A' ' 20' ' ' LEU . 57.1 mt -61.72 -31.23 71.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.964 -0.562 . . . . 75.150000000000006 111.318 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.4 mtm-85 -74.5 -39.33 62.5 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.405 -0.362 . . . . 75.230000000000004 111.586 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.28 89.85 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.896 0.379 . . . . 64.519999999999996 111.563 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.04 -42.07 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.004 0.43 . . . . 70.310000000000002 111.704 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -74.22 -25.28 59.58 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.036 0.384 . . . . 74.5 112.036 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.5 t -66.67 -28.35 68.39 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.655 0.741 . . . . 74.549999999999997 109.641 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.6 p -104.64 -70.57 0.77 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.056 -0.974 . . . . 74.340000000000003 112.027 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -76.86 -9.86 58.97 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.436 0.532 . . . . 70.109999999999999 112.436 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.25 13.41 8.75 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.233 0.457 . . . . 65.420000000000002 112.233 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.544 ' HA ' ' HB2' ' A' ' 84' ' ' ASN . 85.9 t -79.01 129.89 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.445 0.535 . . . . 74.519999999999996 112.445 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.96 97.33 9.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.612 0.72 . . . . 74.219999999999999 110.477 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.483 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.1 t80 -103.49 105.62 15.91 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.295 -0.866 . . . . 73.420000000000002 110.507 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.55 140.6 37.31 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.406 0.521 . . . . 74.510000000000005 112.406 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -126.07 122.9 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 122.722 0.409 . . . . 74.540000000000006 111.273 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.57 138.88 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.853 0.358 . . . . 75.409999999999997 111.804 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.404 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 17.9 p -117.08 126.05 52.24 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.887 0.375 . . . . 75.099999999999994 110.902 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 24' ' ' GLU . 33.7 mt -131.45 146.59 62.6 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.634 -0.257 . . . . 72.319999999999993 110.686 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 37.6 Cg_exo -57.87 -68.68 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.119 1.88 . . . . 73.120000000000005 111.682 174.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.414 ' HA ' HG13 ' A' ' 91' ' ' VAL . 60.3 p -142.3 157.83 44.39 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.186 0.517 . . . . 61.140000000000001 110.94 175.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.3 pt -110.15 23.66 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.009 -0.541 . . . . 71.329999999999998 111.11 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.64 -144.18 30.01 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.094 -0.503 . . . . 45.549999999999997 112.244 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -96.29 9.69 40.32 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.296 0.569 . . . . 63.119999999999997 111.01 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.3 141.78 86.29 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 112.01 0.374 . . . . 72.340000000000003 112.01 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.572 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 43.6 Cg_endo -67.91 145.17 67.32 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.561 2.174 . . . . 72.200000000000003 112.801 177.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.3 tp -61.68 -46.77 88.27 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.443 0.535 . . . . 75.420000000000002 112.443 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.33 -53.09 62.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.221 0.452 . . . . 65.439999999999998 112.221 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.572 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 5.3 m-20 -60.06 -33.77 72.51 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.682 0.253 . . . . 70.140000000000001 111.682 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -64.45 -55.15 22.75 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.674 0.273 . . . . 73.319999999999993 111.274 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.5 p -58.78 -39.76 81.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.8 0.333 . . . . 70.040000000000006 111.259 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 57.2 tp -59.88 -55.04 39.11 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.292 -0.413 . . . . 74.519999999999996 111.145 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -60.27 -32.5 71.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.17 0.433 . . . . 74.349999999999994 112.17 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.603 HD23 HD23 ' A' ' 87' ' ' LEU . 34.9 tp -73.03 -48.43 36.23 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.987 0.422 . . . . 65.439999999999998 111.249 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.2 86.33 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.846 0.313 . . . . 73.209999999999994 111.846 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 67.8 mtp180 -61.44 -54.2 46.55 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.926 0.343 . . . . 74.340000000000003 111.926 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.447 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 11.9 pt20 -64.4 -27.28 68.9 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.861 0.362 . . . . 74.420000000000002 111.51 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 40.9 m0 -80.24 -2.27 44.27 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.889 0.329 . . . . 74.239999999999995 111.889 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.27 -46.39 3.4 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.26 -0.495 . . . . 51.030000000000001 113.473 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.533 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 17.8 m . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 112.811 0.671 . . . . 71.010000000000005 112.811 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.533 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 67.3 t30 . . . . . 0 CA--C 1.542 0.641 0 CA-C-O 121.218 0.532 . . . . 72.450000000000003 111.607 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -70.9 138.9 50.53 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.846 -0.534 . . . . 71.340000000000003 112.083 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.781 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 36.3 p30 40.53 27.25 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.208 1.559 . . . . 73.019999999999996 115.208 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.88 123.83 7.61 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.785 -0.721 . . . . 73.319999999999993 111.882 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.6 tp -134.4 121.92 21.83 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.023 0.412 . . . . 73.510000000000005 111.307 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.603 HD23 HD23 ' A' ' 71' ' ' LEU . 57.4 tp -113.14 137.48 51.38 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.822 0.344 . . . . 75.530000000000001 111.754 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.3 tp -127.15 105.16 8.38 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.534 0.334 . . . . 74.239999999999995 110.876 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.84 129.69 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 111.9 0.333 . . . . 64.310000000000002 111.9 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HA ' HG13 ' A' ' 97' ' ' VAL . 27.6 tp -107.91 128.94 55.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.251 -0.431 . . . . 75.409999999999997 111.069 175.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.539 HG12 ' NE2' ' A' ' 94' ' ' GLN . 59.9 t -105.94 109.14 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.59 -0.277 . . . . 72.510000000000005 110.536 174.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.569 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 62.5 tp -55.94 -55.81 28.25 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.627 0.603 . . . . 73.329999999999998 112.627 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.61 -24.63 61.42 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.573 0.583 . . . . 73.349999999999994 112.573 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.539 ' NE2' HG12 ' A' ' 91' ' ' VAL . 40.3 mt-30 -103.45 -7.05 21.24 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.578 -0.283 . . . . 64.209999999999994 111.547 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 33.27 49.84 0.23 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.241 1.016 . . . . 75.400000000000006 113.254 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -141.87 155.11 45.54 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.573 -0.74 . . . . 74.239999999999995 110.317 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' A' ' 90' ' ' LEU . 5.8 m -128.49 171.74 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.84 0.353 . . . . 74.439999999999998 111.429 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.5 ttt85 -149.15 133.16 17.16 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.404 -0.362 . . . . 74.420000000000002 111.809 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 97.1 m-85 -95.03 112.51 24.2 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.01 -0.541 . . . . 75.120000000000005 110.401 172.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 15.6 tp10 -94.31 111.94 23.7 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.581 0.229 . . . . 74.219999999999999 110.428 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 p -98.15 145.51 26.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.033 0.753 . . . . 64.310000000000002 113.033 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -97.06 -173.99 34.53 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.298 -0.864 . . . . 50.329999999999998 112.142 167.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -63.71 -27.86 69.5 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.147 0.499 . . . . 70.420000000000002 112.054 -175.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.781 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -73.45 -9.0 77.2 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 120.935 -0.65 . . . . 40.530000000000001 113.692 -172.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.1 mt -129.24 4.87 5.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.636 0.606 . . . . 73.310000000000002 112.636 -175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.72 -41.59 97.83 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.913 0.387 . . . . 64.340000000000003 111.116 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.94 -23.38 69.37 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.325 -0.464 . . . . 62.229999999999997 113.22 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -92.41 -66.87 0.89 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.676 0.274 . . . . 75.329999999999998 111.655 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.606 ' HA ' HD23 ' A' ' 113' ' ' LEU . 3.0 mp -117.16 94.95 46.23 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.829 0.307 . . . . 73.049999999999997 111.829 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.42 174.68 11.6 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.659 2.239 . . . . 73.129999999999995 112.607 174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.86 -44.32 59.56 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.318 0.488 . . . . 74.329999999999998 112.318 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -59.65 -50.2 70.35 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.197 -0.525 . . . . 73.239999999999995 113.546 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.606 HD23 ' HA ' ' A' ' 109' ' ' LEU . 36.0 tp -60.76 -49.13 78.71 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.828 0.347 . . . . 73.120000000000005 111.404 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 118' ' ' ILE . 92.8 mt -56.34 -48.61 76.43 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 111.231 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.3 m -61.56 -36.41 80.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 111.367 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.402 ' NH2' HD13 ' A' ' 113' ' ' LEU . 44.3 ttp180 -65.45 -50.14 66.49 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.548 -0.296 . . . . 75.510000000000005 110.973 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.81 -47.37 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.23 0.538 . . . . 71.310000000000002 110.617 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 114' ' ' LEU . 84.0 mt -59.03 -57.11 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.749 -0.659 . . . . 71.549999999999997 112.383 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -84.21 -22.46 30.87 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.364 0.875 . . . . 74.230000000000004 113.364 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.19 -38.15 17.95 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.034 0.445 . . . . 63.340000000000003 111.787 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -113.25 -59.19 2.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 112.153 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.9 mtp -62.51 -48.4 79.74 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.241 0.83 . . . . 74.450000000000003 113.241 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.447 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 27.1 mm -57.76 -50.79 86.17 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.421 0.526 . . . . 72.129999999999995 112.421 -177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 85.0 Cg_exo -47.15 -34.8 18.33 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.348 2.032 . . . . 75.140000000000001 112.998 174.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -72.97 -49.25 30.25 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.629 0.252 . . . . 73.120000000000005 111.182 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.421 ' HD2' HD13 ' A' ' 123' ' ' ILE . 23.7 m-85 -57.4 -45.02 85.0 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.016 0.376 . . . . 73.439999999999998 112.016 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -62.3 -23.94 67.01 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.22 0.533 . . . . 73.230000000000004 111.1 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.0 m -92.77 7.43 43.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.062 -0.517 . . . . 54.100000000000001 111.559 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.75 -0.43 82.06 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.364 -0.446 . . . . 73.409999999999997 113.493 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.87 70.72 10.68 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 122.519 -0.4 . . . . 71.430000000000007 111.545 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -70.57 -42.33 71.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.016 0.436 . . . . 73.129999999999995 110.557 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.3 90.89 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.998 -0.546 . . . . 71.439999999999998 111.213 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.774 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 18.6 mp0 -59.69 -53.27 59.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.367 -0.379 . . . . 75.140000000000001 111.088 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.57 -49.87 59.4 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.359 -0.448 . . . . 70.030000000000001 113.647 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 139' ' ' VAL . 96.4 mt -65.67 -46.9 77.37 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.572 -0.369 . . . . 75.299999999999997 111.818 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 92.7 p -61.67 -50.53 72.13 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.716 0.293 . . . . 73.549999999999997 111.684 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -27.16 60.15 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.7 -0.227 . . . . 74.019999999999996 111.285 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.13 -47.62 79.44 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.12 -0.562 . . . . 74.0 112.402 173.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 135' ' ' LEU . 75.3 t -58.27 -44.13 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.253 0.549 . . . . 74.040000000000006 110.562 173.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.496 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 41.0 tp -63.96 -35.91 82.22 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.884 -0.598 . . . . 74.019999999999996 110.83 177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.63 -43.5 97.44 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.94 0.4 . . . . 72.230000000000004 111.282 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.87 -47.54 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.171 0.51 . . . . 73.030000000000001 110.671 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -56.16 -36.73 68.63 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.02 -0.536 . . . . 65.549999999999997 111.673 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 18.7 mm-40 -57.3 -29.84 64.24 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 120.82 0.343 . . . . 73.409999999999997 111.809 176.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.53 -49.68 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.851 0.358 . . . . 73.049999999999997 111.139 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -71.76 -58.3 3.59 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.071 0.397 . . . . 74.230000000000004 112.071 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 111.871 0.323 . . . . 75.420000000000002 111.871 179.025 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.023 0.44 . . . . 74.510000000000005 112.167 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.13 126.61 50.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.128 -0.487 . . . . 73.099999999999994 111.137 173.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 9' ' ' VAL . 67.6 mttm -89.04 151.46 46.96 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.446 -0.343 . . . . 75.400000000000006 110.983 176.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.484 ' HD3' ' CE2' ' A' ' 67' ' ' PHE . 39.7 Cg_endo -64.88 -19.63 64.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.872 1.714 . . . . 72.109999999999999 111.663 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.409 ' HA ' HE22 ' A' ' 74' ' ' GLN . 18.5 mt-10 -88.83 -7.69 55.72 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.391 -0.822 . . . . 75.510000000000005 111.165 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -112.52 2.04 16.12 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.908 -0.587 . . . . 63.549999999999997 111.876 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 5' ' ' LYS . 61.8 t -81.28 130.92 60.51 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.512 -0.313 . . . . 73.239999999999995 110.447 174.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.01 116.89 1.89 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.877 2.385 . . . . 72.409999999999997 113.314 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -68.29 70.29 0.16 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.005 0.431 . . . . 74.439999999999998 112.035 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -60.56 -25.42 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.7 0.63 . . . . 74.510000000000005 112.7 -175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -73.98 -25.09 59.74 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.901 0.381 . . . . 75.310000000000002 111.219 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tt -93.84 -32.61 13.87 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.076 -0.511 . . . . 72.409999999999997 111.038 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.88 -47.3 10.46 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.202 0.445 . . . . 54.299999999999997 112.202 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 18' ' ' THR . 18.4 m-20 -106.4 -65.62 1.07 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.592 0.59 . . . . 73.439999999999998 112.592 -177.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.8 p 61.65 0.72 0.51 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.985 0.914 . . . . 74.219999999999999 112.139 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 16' ' ' ASP . 5.8 t -110.5 -36.68 5.69 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.678 0.391 . . . . 70.439999999999998 111.641 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -87.11 -49.3 7.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.862 0.363 . . . . 72.239999999999995 111.629 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp 65.45 13.92 9.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.26 0.624 . . . . 74.230000000000004 112.155 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.8 t -102.41 128.72 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.0 0.428 . . . . 73.510000000000005 111.651 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 m -129.74 112.4 13.59 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.274 -0.421 . . . . 74.140000000000001 110.931 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -124.04 102.23 7.64 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.007 0.432 . . . . 70.310000000000002 111.894 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HB2' HD23 ' A' ' 56' ' ' LEU . 4.7 mp0 -102.93 -38.7 7.25 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.292 -0.413 . . . . 74.239999999999995 110.98 173.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.1 -20.92 66.3 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.074 0.768 . . . . 73.140000000000001 113.074 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.6 38.78 27.23 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.916 -0.659 . . . . 70.150000000000006 112.693 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.1 mt -100.81 -28.42 12.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.719 0.295 . . . . 74.019999999999996 111.393 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.2 mt -99.05 107.53 19.96 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.737 0.303 . . . . 75.109999999999999 111.321 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.1 t -74.57 160.53 30.76 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.353 -0.217 . . . . 75.200000000000003 110.903 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -46.47 -36.29 6.49 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.729 0.64 . . . . 74.5 112.729 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.49 -52.02 63.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.948 0.404 . . . . 65.409999999999997 111.333 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.497 ' HG3' ' HB1' ' A' ' 132' ' ' ALA . 14.6 mm100 -62.07 -40.7 96.7 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.928 0.394 . . . . 71.340000000000003 110.741 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.27 -44.74 88.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.211 -0.45 . . . . 74.430000000000007 110.865 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -57.93 -52.26 66.24 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.132 0.491 . . . . 75.340000000000003 111.126 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.69 -45.9 96.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.212 -0.449 . . . . 64.019999999999996 111.622 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 43.9 ttm -62.78 -44.38 96.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.503 -0.317 . . . . 75.030000000000001 111.375 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -53.55 -47.83 69.66 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.169 0.509 . . . . 72.450000000000003 110.656 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.85 -36.11 92.29 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.059 -0.591 . . . . 53.43 113.086 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.57 ' O ' HG13 ' A' ' 43' ' ' ILE . 6.2 mmp_? -67.3 -56.27 10.48 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.816 0.341 . . . . 74.239999999999995 111.12 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.62 -47.25 84.57 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.175 -0.466 . . . . 72.319999999999993 111.746 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -58.54 -45.99 87.77 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 111.19 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.76 80.81 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.908 0.385 . . . . 65.409999999999997 111.386 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.4 mt -65.64 -48.64 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.878 0.37 . . . . 53.420000000000002 111.424 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 48.5 ttt180 -66.83 -28.16 68.13 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.11 -0.369 . . . . 73.349999999999994 111.625 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 t -76.67 -49.73 15.43 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.804 0.335 . . . . 74.230000000000004 111.632 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.2 t -82.83 -54.18 5.3 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.323 0.49 . . . . 65.310000000000002 112.323 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -87.56 -22.3 24.89 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.115 -0.493 . . . . 74.25 111.505 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 71.43 17.68 5.7 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.235 0.614 . . . . 73.319999999999993 111.443 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.787 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 84.2 t -87.48 119.25 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.106 -0.497 . . . . 74.310000000000002 111.284 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -80.96 96.69 7.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.244 0.545 . . . . 74.200000000000003 110.283 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -110.49 109.65 20.09 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.631 -0.713 . . . . 74.349999999999994 110.645 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.33 142.16 42.36 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.444 0.535 . . . . 63.5 112.444 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.22 132.82 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.321 -0.4 . . . . 70.120000000000005 111.214 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.483 HG23 HD21 ' A' ' 71' ' ' LEU . 41.8 t -130.92 138.79 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 122.463 0.305 . . . . 72.129999999999995 111.534 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 p -124.49 122.85 38.77 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.093 0.473 . . . . 75.519999999999996 111.573 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 24' ' ' GLU . 42.8 mt -131.85 145.36 57.14 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 116.516 -0.311 . . . . 71.439999999999998 110.92 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.59 -68.63 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.13 1.887 . . . . 71.040000000000006 112.684 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 m -131.0 156.04 45.8 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.207 -0.308 . . . . 71.120000000000005 110.785 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 91' ' ' VAL . 27.8 pt -122.21 2.08 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 121.14 0.495 . . . . 73.25 111.886 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.95 -122.7 10.2 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.211 -0.519 . . . . 74.109999999999999 113.178 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -103.49 4.95 36.54 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.978 0.362 . . . . 70.420000000000002 111.978 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.08 118.49 70.94 Favored Pre-proline 0 CA--C 1.538 0.497 0 O-C-N 122.402 -0.186 . . . . 74.209999999999994 110.685 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.474 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 32.0 Cg_endo -63.94 131.37 30.62 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.145 1.897 . . . . 71.209999999999994 112.354 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.5 tp -48.01 -40.4 22.6 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.41 0.522 . . . . 65.400000000000006 112.41 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.45 -45.37 91.2 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.215 0.45 . . . . 71.530000000000001 112.215 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 22.9 t70 -71.66 -34.57 69.83 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.464 0.649 . . . . 73.010000000000005 110.228 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.484 ' CE2' ' HD3' ' A' ' 6' ' ' PRO . 21.6 t80 -58.77 -52.37 65.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.521 -0.763 . . . . 74.310000000000002 110.914 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.5 p -61.74 -40.42 95.05 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.266 -0.425 . . . . 75.340000000000003 111.19 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.9 tp -57.48 -52.74 64.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.28 -0.418 . . . . 71.409999999999997 111.278 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 56.4 mtpt -60.35 -49.28 78.2 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.942 0.401 . . . . 74.439999999999998 111.764 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.483 HD21 HG23 ' A' ' 54' ' ' VAL . 34.2 tp -59.6 -45.03 93.12 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.338 -0.392 . . . . 73.420000000000002 111.735 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -48.19 73.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.348 0.499 . . . . 73.040000000000006 112.348 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.481 ' NH2' ' HG2' ' A' ' 70' ' ' LYS . 14.4 ptt180 -68.08 -31.38 70.97 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.916 0.388 . . . . 72.340000000000003 111.321 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.409 HE22 ' HA ' ' A' ' 7' ' ' GLU . 7.9 tt0 -70.91 -39.35 72.77 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.022 0.439 . . . . 53.329999999999998 111.246 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.409 ' CZ2' HD13 ' A' ' 71' ' ' LEU . 41.0 m0 -80.49 8.53 7.54 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.199 0.444 . . . . 73.540000000000006 112.199 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.5 -42.0 2.74 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.159 -0.543 . . . . 72.540000000000006 113.585 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 113.535 0.939 . . . . 71.420000000000002 113.535 -178.059 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 109.458 -0.571 . . . . 70.239999999999995 109.458 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.56 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -59.89 -99.08 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 112.968 0.729 . . . . 72.540000000000006 112.968 -178.102 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.787 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 15.3 m120 -76.22 78.05 3.02 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.506 -0.746 . . . . 73.319999999999993 111.778 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.9 135.49 7.72 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.162 -0.542 . . . . 52.100000000000001 112.809 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 99' ' ' PHE . 57.1 tp -147.26 119.89 8.56 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.752 0.31 . . . . 74.409999999999997 110.662 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.475 HD23 HD22 ' A' ' 71' ' ' LEU . 60.8 tp -107.55 132.81 52.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.856 0.36 . . . . 65.230000000000004 111.745 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.0 tp -121.85 112.23 18.09 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.378 -0.374 . . . . 73.140000000000001 111.127 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.18 126.9 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.878 0.37 . . . . 72.150000000000006 111.629 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.415 ' HA ' HG13 ' A' ' 97' ' ' VAL . 29.7 tp -109.84 120.64 43.11 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 111.335 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.548 HG22 HD11 ' A' ' 59' ' ' ILE . 51.8 t -100.92 103.46 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.581 -0.281 . . . . 74.439999999999998 110.745 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.1 tp -52.19 -44.89 64.95 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.307 0.484 . . . . 72.540000000000006 112.307 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.86 -31.55 66.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.036 -0.529 . . . . 73.540000000000006 112.249 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.484 HE22 HD13 ' A' ' 59' ' ' ILE . 51.2 mt-30 -110.56 -6.12 14.95 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.037 0.384 . . . . 75.150000000000006 112.037 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 42.17 31.02 0.22 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.672 0.789 . . . . 74.450000000000003 112.003 -171.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 58.2 mtt180 -107.25 142.33 37.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.774 -0.648 . . . . 74.329999999999998 110.972 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.415 HG13 ' HA ' ' A' ' 90' ' ' LEU . 4.1 m -131.01 163.14 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.973 0.416 . . . . 74.340000000000003 111.124 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -148.41 137.03 21.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.411 -0.359 . . . . 72.310000000000002 111.329 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.62 ' HB3' HD11 ' A' ' 86' ' ' LEU . 89.9 m-85 -100.08 113.5 26.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.019 -0.537 . . . . 74.409999999999997 110.104 173.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -95.76 114.45 26.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.372 -0.232 . . . . 73.420000000000002 110.372 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.54 147.67 23.83 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.213 0.819 . . . . 73.239999999999995 113.213 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -97.77 178.37 32.3 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.122 -0.944 . . . . 52.409999999999997 112.539 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -62.72 -19.38 63.86 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.444 0.535 . . . . 73.109999999999999 112.444 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.74 -18.24 56.82 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.032 -0.604 . . . . 73.349999999999994 113.33 -177.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.57 HD11 HG12 ' A' ' 49' ' ' VAL . 91.4 mt -111.54 -4.54 14.76 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.889 0.7 . . . . 72.010000000000005 112.889 -175.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -58.76 -30.51 67.58 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.082 0.401 . . . . 71.120000000000005 112.082 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.49 -18.24 79.27 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.042 -0.599 . . . . 73.340000000000003 113.062 174.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -93.28 -57.39 2.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.277 0.56 . . . . 75.120000000000005 111.831 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.552 ' HB3' HD21 ' A' ' 114' ' ' LEU . 12.5 mt -119.64 89.0 40.39 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.611 -0.722 . . . . 75.400000000000006 112.253 -169.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.09 148.29 85.2 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.25 1.967 . . . . 74.329999999999998 111.571 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.25 -27.64 62.25 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.007 0.432 . . . . 74.349999999999994 111.385 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.53 -49.38 56.49 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.155 -0.545 . . . . 54.039999999999999 112.589 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.32 -44.26 84.03 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.158 0.504 . . . . 74.299999999999997 111.064 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 109' ' ' LEU . 89.6 mt -58.31 -43.17 88.02 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.263 -0.426 . . . . 60.43 111.083 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.6 m -62.88 -36.89 84.81 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.852 0.358 . . . . 74.040000000000006 111.118 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -60.21 -53.46 57.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.355 -0.384 . . . . 74.420000000000002 110.149 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.6 mt -51.53 -42.4 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.916 0.389 . . . . 73.219999999999999 111.234 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 114' ' ' LEU . 76.6 mt -58.67 -55.87 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.818 0.342 . . . . 72.319999999999993 111.478 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -76.22 -9.72 58.85 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.506 0.558 . . . . 75.439999999999998 112.506 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -95.42 -45.36 7.14 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.162 0.43 . . . . 74.230000000000004 112.162 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.667 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 92.6 mtt180 -127.59 -4.11 5.97 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.599 0.962 . . . . 74.140000000000001 113.599 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.75 ' HE3' ' HA3' ' A' ' 138' ' ' GLY . 17.0 mmt -103.46 -63.27 1.2 Allowed 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.85 -0.531 . . . . 73.510000000000005 111.786 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 43.5 mm -50.07 -49.97 72.05 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 112.719 0.637 . . . . 65.209999999999994 112.719 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 11.1 Cg_endo -52.76 -37.19 75.74 Favored 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.366 2.044 . . . . 61.409999999999997 112.874 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.41 ' NE2' ' HG3' ' A' ' 137' ' ' GLU . 86.5 m-70 -77.61 -48.65 16.34 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.543 -0.299 . . . . 74.129999999999995 111.434 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.7 m-85 -57.06 -40.12 76.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.772 0.32 . . . . 73.329999999999998 111.42 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -59.35 -35.78 74.5 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.997 0.427 . . . . 74.129999999999995 111.291 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.2 t -84.18 -3.44 58.15 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.247 -0.433 . . . . 73.340000000000003 111.691 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.42 6.68 88.45 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.111 -0.566 . . . . 65.120000000000005 112.888 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.682 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.6 m-20 -84.08 55.79 3.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.688 0.395 . . . . 70.0 111.72 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -56.43 -44.35 80.34 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.06 0.392 . . . . 64.340000000000003 112.06 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.497 ' HB1' ' HG3' ' A' ' 32' ' ' GLN . . . -66.85 -32.77 74.26 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.94 0.4 . . . . 74.120000000000005 112.042 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 53.3 mt-10 -76.54 -43.39 39.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.391 -0.368 . . . . 74.439999999999998 111.508 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.64 -49.75 67.82 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.389 -0.434 . . . . 73.219999999999999 112.994 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.608 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 92.2 mt -56.64 -39.75 74.22 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.746 0.308 . . . . 72.540000000000006 111.445 176.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.8 t -60.8 -45.69 93.43 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.085 0.469 . . . . 72.319999999999993 111.047 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 38.0 mm-40 -61.85 -44.86 95.98 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.996 -0.547 . . . . 72.430000000000007 111.819 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.75 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -60.88 -47.54 90.74 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.166 -0.54 . . . . 74.430000000000007 113.072 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 135' ' ' LEU . 83.4 t -60.55 -50.02 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.885 0.374 . . . . 73.209999999999994 111.511 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.93 -38.33 85.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.376 -0.374 . . . . 74.439999999999998 111.269 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.93 -54.63 44.76 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.996 0.427 . . . . 70.030000000000001 111.331 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.437 HG13 HD12 ' A' ' 109' ' ' LEU . 99.5 t -57.53 -47.7 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.147 -0.479 . . . . 71.040000000000006 111.133 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.411 HE22 ' NH1' ' A' ' 39' ' ' ARG . 63.4 tt0 -53.74 -37.7 63.62 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 111.817 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 144' ' ' GLN . 14.5 mm-40 -72.89 -38.99 66.76 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 111.609 0.225 . . . . 62.350000000000001 111.609 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.53 -42.87 95.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.998 0.427 . . . . 75.510000000000005 110.985 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 49' ' ' VAL . 77.2 mt -64.43 -49.9 69.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.124 -0.489 . . . . 73.129999999999995 111.168 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 CA--C 1.538 0.516 0 CA-C-N 115.657 -0.701 . . . . 71.349999999999994 112.232 -176.075 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG11 ' HE3' ' A' ' 5' ' ' LYS . 97.8 t . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 121.372 0.606 . . . . 73.109999999999999 111.613 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -87.81 135.61 33.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.852 -0.613 . . . . 62.509999999999998 111.936 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HE3' HG11 ' A' ' 3' ' ' VAL . 25.7 mmtp -100.93 158.99 30.76 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.47 -0.567 . . . . 74.329999999999998 109.47 169.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 9.5 Cg_endo -56.65 -32.08 89.46 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.43 1.42 . . . . 73.310000000000002 112.038 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -78.13 -12.72 60.01 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.483 0.549 . . . . 75.030000000000001 112.483 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -85.35 -18.04 34.97 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.953 0.406 . . . . 75.420000000000002 110.976 173.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.474 HG22 HD21 ' A' ' 56' ' ' LEU . 60.3 t -79.03 128.0 77.72 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.137 -0.483 . . . . 73.010000000000005 111.388 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.23 108.25 0.32 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.301 2.0 . . . . 74.530000000000001 111.899 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.496 ' ND2' HD11 ' A' ' 14' ' ' LEU . 14.7 p-10 -66.57 82.14 0.1 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.741 0.781 . . . . 74.420000000000002 112.158 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.42 1.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.487 -0.779 . . . . 71.310000000000002 113.0 -177.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.649 HE22 ' HG ' ' A' ' 20' ' ' LEU . 28.0 mm-40 -100.7 9.99 41.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.834 0.35 . . . . 75.549999999999997 111.305 174.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.496 HD11 ' ND2' ' A' ' 11' ' ' ASN . 10.1 tt -124.11 -46.0 1.96 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.442 -0.344 . . . . 74.400000000000006 111.35 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.77 -68.29 0.7 Allowed 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.146 -0.346 . . . . 70.230000000000004 111.654 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -80.07 -61.95 1.83 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.942 0.349 . . . . 73.010000000000005 111.942 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 m 63.11 7.06 2.55 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.656 0.383 . . . . 62.340000000000003 111.818 -174.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -99.26 -43.69 6.51 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.119 0.414 . . . . 64.349999999999994 112.119 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -82.51 -35.92 26.9 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.581 0.585 . . . . 74.439999999999998 112.581 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.649 ' HG ' HE22 ' A' ' 13' ' ' GLN . 6.8 mp 63.19 3.83 1.44 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.735 0.643 . . . . 71.549999999999997 112.735 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.5 t -108.8 154.32 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.663 0.385 . . . . 74.439999999999998 111.166 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.3 m -142.5 108.74 5.25 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.479 0.311 . . . . 75.25 111.031 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.528 ' HA ' ' HG1' ' A' ' 55' ' ' THR . 20.7 p-10 -107.74 73.67 0.92 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.521 0.676 . . . . 73.510000000000005 112.616 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -79.18 -38.09 36.69 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.289 0.566 . . . . 71.129999999999995 110.453 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.19 66.59 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.918 -0.583 . . . . 71.400000000000006 112.403 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.26 19.2 73.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.152 -0.547 . . . . 74.010000000000005 113.195 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.11 0.12 54.27 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.053 0.39 . . . . 64.409999999999997 112.053 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -109.95 103.59 12.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.916 0.388 . . . . 74.019999999999996 111.04 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.7 t -70.33 165.98 21.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.368 -0.378 . . . . 64.239999999999995 111.403 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -46.72 -57.73 4.56 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.426 0.898 . . . . 74.099999999999994 113.426 -172.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.571 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . . . -68.06 -42.93 79.75 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.021 0.378 . . . . 74.530000000000001 112.021 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -62.26 -33.43 74.61 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.259 0.552 . . . . 74.319999999999993 111.069 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -74.2 -53.22 10.28 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.668 -0.696 . . . . 74.239999999999995 111.038 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.571 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 11.6 pt-20 -59.65 -43.59 93.85 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.129 0.418 . . . . 73.239999999999995 112.129 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.0 t -65.8 -33.67 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.143 0.497 . . . . 71.140000000000001 110.91 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.433 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 50.8 ttm -65.34 -40.5 93.75 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 122.052 -0.405 . . . . 72.409999999999997 110.651 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.475 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -57.93 -56.36 22.95 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.989 0.423 . . . . 74.010000000000005 111.703 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.57 -43.03 85.83 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.306 -0.473 . . . . 72.340000000000003 113.416 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.439 ' O ' HG13 ' A' ' 43' ' ' ILE . 73.4 mtm180 -62.55 -45.1 94.48 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 111.756 0.28 . . . . 74.209999999999994 111.756 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 36' ' ' MET . 89.1 mt -64.1 -50.84 66.71 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.025 0.44 . . . . 75.420000000000002 111.431 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -60.21 -37.79 81.37 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.272 -0.422 . . . . 74.200000000000003 111.447 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.33 -44.23 88.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.943 0.401 . . . . 73.310000000000002 111.271 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.651 HG23 ' HB ' ' A' ' 49' ' ' VAL . 63.5 mt -61.58 -38.79 81.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.937 0.398 . . . . 74.329999999999998 111.265 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 57.3 ttp180 -74.03 -33.24 63.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.917 0.389 . . . . 74.129999999999995 111.238 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.2 t -66.87 -38.53 86.5 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.1 0.476 . . . . 73.120000000000005 111.08 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.0 t -92.61 -61.67 1.55 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.99 -0.55 . . . . 62.32 112.162 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -91.91 -4.97 54.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.649 0.611 . . . . 74.129999999999995 112.649 -173.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.86 26.85 14.4 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.185 0.439 . . . . 65.329999999999998 112.185 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' HG23 ' A' ' 43' ' ' ILE . 62.5 t -90.7 128.31 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 112.215 0.45 . . . . 74.219999999999999 112.215 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -86.56 97.45 10.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.389 -0.369 . . . . 75.409999999999997 110.419 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.09 105.99 14.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.846 0.355 . . . . 74.439999999999998 110.539 -177.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.63 142.1 42.96 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.456 0.539 . . . . 65.140000000000001 112.456 -175.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.18 118.17 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.989 0.423 . . . . 74.400000000000006 111.437 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.535 HG23 HD22 ' A' ' 71' ' ' LEU . 61.8 t -114.62 142.27 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 122.516 0.326 . . . . 71.430000000000007 111.752 -178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.528 ' HG1' ' HA ' ' A' ' 23' ' ' ASP . 73.3 p -130.88 123.51 29.15 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.756 0.313 . . . . 62.43 111.293 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.474 HD21 HG22 ' A' ' 9' ' ' VAL . 68.2 mt -120.65 139.24 28.58 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 111.749 0.277 . . . . 72.340000000000003 111.749 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.506 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 83.2 Cg_endo -81.81 -11.75 11.25 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.634 2.222 . . . . 61.350000000000001 113.315 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.746 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 31.0 t -169.77 138.77 1.87 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.97 0.359 . . . . 73.340000000000003 111.97 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 3' ' ' VAL . 28.6 pt -136.86 -0.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 120.984 0.421 . . . . 74.329999999999998 110.365 170.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.27 -158.58 52.12 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 116.133 -0.485 . . . . 54.329999999999998 113.219 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.46 69.94 2.28 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.367 0.603 . . . . 73.200000000000003 110.873 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.55 142.44 41.88 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.731 -0.668 . . . . 73.040000000000006 111.26 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 77.1 Cg_endo -79.27 116.67 3.66 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.415 2.076 . . . . 75.439999999999998 113.092 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.51 -38.09 83.24 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.116 0.413 . . . . 73.450000000000003 112.116 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.03 -8.86 48.94 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.968 0.413 . . . . 74.209999999999994 111.967 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 31.1 t70 -96.59 -39.21 9.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.544 0.688 . . . . 74.239999999999995 109.632 170.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.454 ' CZ ' HD13 ' A' ' 56' ' ' LEU . 43.3 t80 -55.2 -50.21 69.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.038 -0.983 . . . . 73.120000000000005 111.785 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -52.68 -49.39 65.38 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.858 0.361 . . . . 73.549999999999997 111.809 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.7 tp -59.57 -49.72 76.66 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.242 -0.436 . . . . 72.420000000000002 111.576 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -60.56 -47.74 84.84 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.243 0.46 . . . . 74.510000000000005 112.243 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.535 HD22 HG23 ' A' ' 54' ' ' VAL . 51.2 tp -61.52 -47.85 83.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.242 0.544 . . . . 74.519999999999996 110.766 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.23 77.24 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.07 -0.514 . . . . 74.200000000000003 112.01 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -61.14 -52.37 65.12 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.844 0.354 . . . . 72.329999999999998 111.709 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.519 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 12.1 pt20 -72.05 -21.64 61.5 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 111.774 0.287 . . . . 75.439999999999998 111.774 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.519 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 30.3 m0 -91.03 -16.04 28.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.561 0.219 . . . . 74.519999999999996 111.451 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.51 40.44 99.11 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.387 -0.435 . . . . 74.510000000000005 113.238 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 112.547 0.573 . . . . 73.310000000000002 112.547 -175.81 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' TYR . 65.1 t30 . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 109.732 -0.47 . . . . 72.030000000000001 109.732 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.422 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -76.62 -109.3 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.623 -0.673 . . . . 64.200000000000003 112.505 -178.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.629 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.7 m-20 -81.23 78.98 7.97 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.433 -0.792 . . . . 75.340000000000003 111.724 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.93 140.69 11.65 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.164 -0.541 . . . . 64.129999999999995 113.339 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 99' ' ' PHE . 53.3 tp -148.77 124.61 10.57 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.858 0.463 . . . . 74.400000000000006 110.573 178.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.514 HD22 HD23 ' A' ' 71' ' ' LEU . 59.0 tp -115.1 132.68 56.52 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.696 0.284 . . . . 64.200000000000003 111.509 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.4 tp -122.4 123.25 40.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.795 0.438 . . . . 64.299999999999997 110.158 174.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 51.1 t -124.4 126.54 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.122 0.416 . . . . 72.0 112.122 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.641 ' HB2' HD21 ' A' ' 135' ' ' LEU . 24.1 tp -103.31 124.93 49.58 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.201 -0.454 . . . . 72.519999999999996 110.774 172.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.33 98.97 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.443 -0.344 . . . . 65.129999999999995 111.513 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.506 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 65.1 tp -55.68 -31.01 62.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.041 0.448 . . . . 70.0 111.561 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.746 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 11.5 t70 -49.97 -47.99 52.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.29 0.636 . . . . 75.400000000000006 111.759 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.494 ' OE1' ' HD2' ' A' ' 96' ' ' ARG . 8.9 pt20 -125.45 6.35 7.64 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.343 0.498 . . . . 72.209999999999994 112.343 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 56.91 30.79 18.58 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.063 0.764 . . . . 74.219999999999999 113.063 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.494 ' HD2' ' OE1' ' A' ' 94' ' ' GLN . 84.5 mtt180 -107.19 149.13 28.05 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.203 0.525 . . . . 75.519999999999996 111.676 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.633 HG13 ' HA ' ' A' ' 90' ' ' LEU . 5.9 m -139.27 160.97 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.675 -0.693 . . . . 64.200000000000003 111.165 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -160.32 145.55 14.86 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.648 0.611 . . . . 74.349999999999994 112.648 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.478 ' HB3' HD12 ' A' ' 86' ' ' LEU . 96.8 m-85 -97.27 146.77 24.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.764 -0.653 . . . . 73.409999999999997 110.323 169.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 5.9 tp10 -135.62 113.0 10.62 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.284 -0.26 . . . . 74.439999999999998 110.632 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 p -95.76 160.88 14.26 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.455 0.909 . . . . 72.409999999999997 113.455 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.42 -177.24 21.33 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 114.964 -1.017 . . . . 72.109999999999999 112.202 168.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' ASN . 19.5 t80 -65.34 -11.13 38.86 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.012 0.525 . . . . 73.120000000000005 112.337 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.67 -6.96 79.44 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.876 -0.678 . . . . 52.420000000000002 113.091 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.406 HD12 HG12 ' A' ' 49' ' ' VAL . 97.5 mt -127.67 -12.48 5.45 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.062 0.764 . . . . 73.109999999999999 113.062 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -17.97 16.7 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.373 0.879 . . . . 75.030000000000001 113.373 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.04 -26.19 69.41 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.148 -0.548 . . . . 54.409999999999997 113.079 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -106.38 -44.07 4.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.933 0.397 . . . . 75.540000000000006 111.917 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.5 mt -119.23 84.53 28.12 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 112.59 0.589 . . . . 74.420000000000002 112.59 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.32 162.65 25.27 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.113 1.875 . . . . 72.120000000000005 112.251 171.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.33 -34.9 67.01 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.644 -177.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.75 -50.18 66.37 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.019 -0.61 . . . . 73.239999999999995 113.046 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.68 -45.79 88.66 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.867 0.365 . . . . 64.299999999999997 111.151 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.408 ' O ' HG13 ' A' ' 118' ' ' ILE . 94.5 mt -58.35 -43.63 88.41 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.364 -0.38 . . . . 74.430000000000007 110.935 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.5 m -62.67 -38.5 90.57 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.418 -0.356 . . . . 73.549999999999997 111.037 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -58.04 -53.46 57.95 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.979 0.419 . . . . 72.239999999999995 110.659 174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.2 mt -54.22 -49.48 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.006 0.431 . . . . 73.140000000000001 111.222 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.554 ' O ' HG12 ' A' ' 123' ' ' ILE . 96.9 mt -57.94 -56.81 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.974 -0.557 . . . . 75.150000000000006 111.936 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.406 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 46.2 m-70 -72.69 -40.87 65.89 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.828 0.677 . . . . 74.200000000000003 112.828 -173.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -78.84 -44.51 22.84 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.565 0.58 . . . . 75.129999999999995 112.565 -171.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -109.55 -32.91 6.95 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.199 0.814 . . . . 74.25 113.199 -173.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.548 ' HB3' ' HE2' ' A' ' 126' ' ' PHE . 85.4 mtp -87.94 -51.64 5.71 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.091 0.774 . . . . 73.030000000000001 113.091 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 118' ' ' ILE . 48.1 mm -51.77 -49.24 84.52 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 112.735 0.642 . . . . 73.530000000000001 112.735 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 87.1 Cg_exo -48.27 -28.81 11.83 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 122.665 2.243 . . . . 72.019999999999996 113.694 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.456 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 79.4 m-70 -83.32 -52.16 6.79 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.674 0.25 . . . . 72.299999999999997 111.674 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.548 ' HE2' ' HB3' ' A' ' 122' ' ' MET . 50.1 m-85 -56.83 -44.36 82.0 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.948 0.404 . . . . 73.450000000000003 111.468 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 123' ' ' ILE . 2.9 ptm180 -71.07 -10.26 59.46 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.279 -0.419 . . . . 74.030000000000001 111.64 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.9 m -110.41 -1.96 16.84 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 111.892 0.33 . . . . 74.349999999999994 111.892 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.61 -17.79 35.87 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.963 -0.637 . . . . 65.140000000000001 114.075 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.753 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 93.7 m-20 -80.08 81.32 6.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.322 0.561 . . . . 74.019999999999996 111.571 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -71.11 -54.65 10.33 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.873 0.368 . . . . 74.349999999999994 111.638 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.26 74.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.138 0.494 . . . . 73.010000000000005 111.842 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.753 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 5.5 mm-40 -74.52 -31.6 62.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.375 -0.375 . . . . 63.039999999999999 111.36 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.28 -42.4 57.42 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.029 -0.605 . . . . 75.310000000000002 112.366 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 90' ' ' LEU . 95.4 mt -62.32 -47.63 83.43 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.85 0.357 . . . . 65.400000000000006 111.611 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.3 p -59.28 -37.25 77.21 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.435 -0.348 . . . . 64.519999999999996 111.693 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -59.66 -48.78 80.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.719 0.295 . . . . 71.450000000000003 111.214 172.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.8 -50.48 67.2 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.024 -0.608 . . . . 63.009999999999998 112.941 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.0 t -57.75 -48.47 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.944 0.402 . . . . 74.430000000000007 111.314 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 55.1 tp -60.76 -41.08 94.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.237 -0.438 . . . . 74.120000000000005 111.292 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.39 -49.43 77.6 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.856 0.36 . . . . 72.409999999999997 111.324 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.49 -44.56 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.276 -0.42 . . . . 74.430000000000007 111.254 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -53.22 -41.88 65.79 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.15 -0.477 . . . . 74.319999999999993 111.306 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 85.1 mm-40 -60.26 -48.31 82.3 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.539 -0.3 . . . . 75.0 111.451 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.72 -49.63 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.021 0.378 . . . . 75.439999999999998 112.021 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 89.2 mt -70.36 -57.06 5.25 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.903 0.383 . . . . 73.109999999999999 111.77 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 120.989 0.424 . . . . 72.129999999999995 111.708 -176.481 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 112.896 0.702 . . . . 71.519999999999996 112.896 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.05 152.3 45.99 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.776 -0.647 . . . . 73.409999999999997 111.201 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -114.53 169.22 6.86 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 75.140000000000001 110.569 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.36 51.28 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.873 2.382 . . . . 74.120000000000005 112.117 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.36 -28.09 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.916 -0.583 . . . . 72.430000000000007 110.457 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -68.26 -28.76 67.49 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.289 0.566 . . . . 65.200000000000003 110.465 171.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.643 HG12 HG23 ' A' ' 22' ' ' THR . 60.7 t -70.46 122.27 85.97 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.481 -0.781 . . . . 74.409999999999997 111.525 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.419 ' HG2' HG21 ' A' ' 22' ' ' THR . 21.9 Cg_endo -61.1 119.86 7.24 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.323 2.015 . . . . 74.230000000000004 112.049 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . 5.6 p30 -64.23 85.89 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.954 0.724 . . . . 73.239999999999995 112.954 -176.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.32 0.48 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 112.505 0.557 . . . . 72.439999999999998 112.505 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -121.87 5.51 9.92 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.087 0.403 . . . . 72.219999999999999 112.087 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 6.8 tt -115.14 -54.73 2.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.427 -0.583 . . . . 74.239999999999995 109.427 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.72 -55.28 35.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.124 0.488 . . . . 72.340000000000003 110.839 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -127.46 -179.57 4.97 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.093 -0.503 . . . . 75.450000000000003 110.768 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.6 p -130.27 -11.53 4.11 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.644 -0.253 . . . . 73.5 111.615 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -81.0 -45.64 16.28 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.932 0.716 . . . . 72.530000000000001 112.932 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.627 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 32.5 tpt180 -52.67 -61.91 1.98 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.203 0.445 . . . . 73.209999999999994 112.203 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 40' ' ' LEU . 17.5 mt 63.19 6.99 2.57 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.218 0.451 . . . . 70.140000000000001 112.218 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.627 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 95.4 t -133.64 121.42 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.842 0.353 . . . . 73.420000000000002 111.774 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.643 HG23 HG12 ' A' ' 9' ' ' VAL . 89.0 m -111.88 102.8 11.04 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.77 0.319 . . . . 75.299999999999997 110.807 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' ' HG1' ' A' ' 55' ' ' THR . 7.6 p-10 -99.72 84.34 2.91 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.454 0.645 . . . . 74.530000000000001 111.936 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.57 ' HG2' HG22 ' A' ' 22' ' ' THR . 40.2 mm-40 -96.32 -44.83 7.06 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.115 -0.493 . . . . 73.420000000000002 110.786 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.64 -25.36 60.04 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.147 0.425 . . . . 62.439999999999998 112.147 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.99 44.59 45.37 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.376 -0.44 . . . . 54.210000000000001 113.14 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 92' ' ' LEU . 85.3 mt -102.27 -22.29 14.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.916 0.388 . . . . 72.129999999999995 111.884 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.4 mt -93.32 108.47 20.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.717 0.294 . . . . 74.340000000000003 111.12 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.512 ' HB2' ' OE1' ' A' ' 32' ' ' GLN . 49.1 m -78.52 162.08 26.58 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.534 -0.303 . . . . 71.510000000000005 111.117 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -44.98 -45.53 10.62 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.176 0.806 . . . . 75.140000000000001 113.176 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.88 -53.28 53.08 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.8 0.333 . . . . 74.019999999999996 111.708 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.534 ' HG2' ' HB1' ' A' ' 132' ' ' ALA . 22.6 mp0 -55.9 -40.63 73.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.065 0.46 . . . . 72.299999999999997 110.69 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.82 -52.8 63.89 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.095 -0.502 . . . . 75.109999999999999 111.02 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -55.12 -40.62 70.7 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.94 0.4 . . . . 71.230000000000004 111.608 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.05 -44.65 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.072 0.463 . . . . 75.319999999999993 111.715 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 52.1 ttm -70.35 -51.82 27.16 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.871 0.323 . . . . 71.230000000000004 111.871 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -54.48 -50.35 67.95 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.389 -0.369 . . . . 61.399999999999999 111.709 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.7 -38.06 86.34 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.001 -0.618 . . . . 71.439999999999998 113.59 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' ILE . 81.7 mtm180 -72.01 -49.52 36.25 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.95 0.375 . . . . 71.439999999999998 111.375 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' HB3' HD11 ' A' ' 20' ' ' LEU . 87.9 mt -57.14 -52.66 64.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.021 0.438 . . . . 75.25 111.049 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -54.64 -41.64 70.3 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.055 -0.521 . . . . 75.040000000000006 111.375 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.15 97.8 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.933 0.397 . . . . 70.340000000000003 111.389 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.478 ' HA ' ' HD2' ' A' ' 47' ' ' HIS . 74.0 mt -64.91 -42.79 95.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.978 0.418 . . . . 73.25 111.083 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.49 ' NH1' ' HG2' ' A' ' 50' ' ' GLU . 8.4 tpt180 -61.46 -38.69 88.14 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.159 -0.473 . . . . 71.530000000000001 111.518 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.3 t -83.36 -41.96 17.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.238 0.459 . . . . 74.0 112.238 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -82.3 -62.49 1.61 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.124 0.488 . . . . 74.019999999999996 112.042 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.478 ' HD2' ' HA ' ' A' ' 43' ' ' ILE . 51.7 m-70 -83.06 -14.3 54.08 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.093 -0.503 . . . . 64.150000000000006 111.655 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.11 17.21 10.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.827 0.451 . . . . 72.340000000000003 111.846 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.654 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 96.8 t -87.28 129.89 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.147 0.498 . . . . 75.299999999999997 111.339 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HG2' ' NH1' ' A' ' 44' ' ' ARG . 27.3 mt-10 -83.3 96.41 8.49 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.095 -0.502 . . . . 71.239999999999995 110.654 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -119.27 101.63 8.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.174 -0.466 . . . . 70.510000000000005 110.505 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.4 133.99 54.88 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.319 0.488 . . . . 63.219999999999999 112.319 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.16 112.73 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.078 0.466 . . . . 75.310000000000002 111.313 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.657 ' HB ' HG22 ' A' ' 89' ' ' VAL . 57.4 t -109.11 134.14 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.374 -0.375 . . . . 73.150000000000006 111.107 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.533 ' HG1' ' HA ' ' A' ' 23' ' ' ASP . 69.1 p -119.81 122.2 40.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.879 0.371 . . . . 63.009999999999998 111.472 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.535 HD21 HG23 ' A' ' 9' ' ' VAL . 77.9 mt -128.32 140.61 38.84 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.402 -0.363 . . . . 73.329999999999998 111.013 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 19.7 Cg_endo -61.29 -47.02 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.982 1.788 . . . . 75.400000000000006 112.078 175.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.406 ' HA ' HG11 ' A' ' 91' ' ' VAL . 43.8 t -157.72 145.63 18.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.94 0.4 . . . . 61.039999999999999 111.525 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 pt -101.66 9.08 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.196 0.522 . . . . 71.109999999999999 111.202 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.73 -133.95 18.16 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.154 -0.546 . . . . 72.0 113.305 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.43 -19.39 28.12 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.938 0.348 . . . . 75.150000000000006 111.938 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.58 143.99 89.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.555 0.576 . . . . 72.219999999999999 112.555 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.2 Cg_endo -75.77 127.7 10.35 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.565 2.177 . . . . 75.219999999999999 112.131 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.07 -32.61 72.25 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.341 0.497 . . . . 72.530000000000001 112.341 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.731 ' HG2' ' HD3' ' A' ' 98' ' ' ARG . 44.2 mt-10 -62.56 -43.2 99.4 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.176 0.513 . . . . 74.299999999999997 111.702 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.567 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 2.2 m-20 -76.96 -33.08 57.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.979 -0.555 . . . . 74.319999999999993 110.903 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -59.12 -52.7 64.6 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.052 -0.522 . . . . 65.230000000000004 110.941 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.8 p -59.32 -41.78 89.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.307 -0.406 . . . . 74.129999999999995 111.728 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 48.5 tp -57.16 -49.17 76.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.958 0.408 . . . . 64.450000000000003 111.217 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -62.33 -47.07 85.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.93 0.395 . . . . 72.109999999999999 111.51 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.05 -36.97 83.21 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.102 0.477 . . . . 74.099999999999994 111.429 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.51 -38.59 71.12 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.265 0.468 . . . . 73.409999999999997 112.265 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 25.9 mtp180 -61.79 -47.99 82.68 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.41 0.522 . . . . 70.25 112.41 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.5 pt20 -59.44 -38.1 79.81 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.885 0.374 . . . . 74.010000000000005 111.842 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.42 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 50.0 m0 -78.11 -4.61 48.27 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 111.817 0.303 . . . . 74.510000000000005 111.817 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.41 -35.05 3.02 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.045 -0.598 . . . . 73.200000000000003 112.578 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.592 ' HA ' HD21 ' A' ' 82' ' ' ASN . 46.9 t . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 123.382 0.673 . . . . 75.219999999999999 112.751 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.652 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 14.7 t30 . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 120.361 0.124 . . . . 71.200000000000003 110.933 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.653 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -43.26 -72.42 0.06 Allowed 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 114.407 1.262 . . . . 75.349999999999994 114.407 -168.403 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.654 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 5.1 m-20 -87.98 21.79 2.59 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.508 -0.745 . . . . 73.420000000000002 112.286 -173.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 77' ' ' VAL . . . -81.51 128.22 8.34 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.02 -0.609 . . . . 63.32 114.468 -175.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 54.5 tp -145.12 118.81 9.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.785 0.434 . . . . 71.129999999999995 110.56 173.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.2 tp -116.1 126.82 54.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.88 0.372 . . . . 74.549999999999997 111.664 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 33.1 tp -116.07 111.86 20.91 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.03 -0.532 . . . . 72.239999999999995 110.813 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.657 HG22 ' HB ' ' A' ' 54' ' ' VAL . 70.4 t -118.23 130.07 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.714 0.293 . . . . 71.140000000000001 111.553 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.4 tp -109.72 125.88 53.12 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.96 0.41 . . . . 62.299999999999997 111.508 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 58' ' ' SER . 47.8 t -99.93 105.61 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.113 -0.494 . . . . 72.25 110.294 173.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.46 ' HB2' HD13 ' A' ' 27' ' ' LEU . 51.6 tp -57.09 -62.84 1.47 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.147 0.795 . . . . 74.409999999999997 113.147 -174.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.37 -27.16 68.87 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.283 0.475 . . . . 75.109999999999999 112.283 -171.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -97.14 -10.94 24.97 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.705 0.288 . . . . 73.510000000000005 111.343 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 50.97 67.39 0.95 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.562 0.696 . . . . 74.519999999999996 112.322 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -159.98 150.87 19.12 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.912 -0.586 . . . . 72.420000000000002 111.095 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.2 m -129.66 171.56 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.986 0.422 . . . . 75.140000000000001 111.759 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.731 ' HD3' ' HG2' ' A' ' 65' ' ' GLU . 6.0 mmm180 -141.11 153.5 45.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.327 0.584 . . . . 72.409999999999997 112.288 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.695 ' HB3' HD12 ' A' ' 114' ' ' LEU . 30.5 m-85 -129.86 111.49 12.63 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.265 -0.88 . . . . 72.239999999999995 110.129 175.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.7 tp10 -105.05 112.37 25.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.809 -0.178 . . . . 74.219999999999999 110.779 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 p -96.46 147.33 23.94 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.759 0.79 . . . . 73.319999999999993 112.874 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -95.41 174.13 31.93 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.178 -0.919 . . . . 65.519999999999996 112.696 171.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -56.02 -22.31 26.45 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.961 0.726 . . . . 75.420000000000002 112.961 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.68 -41.03 11.43 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.898 -0.668 . . . . 62.329999999999998 112.464 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.433 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 85.5 mt -81.1 -6.88 59.33 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.72 0.637 . . . . 72.329999999999998 112.72 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -59.57 -12.59 6.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.521 0.563 . . . . 72.109999999999999 112.521 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.96 -12.99 62.99 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.168 -0.539 . . . . 73.219999999999999 113.326 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -117.32 -47.47 2.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.08 0.467 . . . . 72.549999999999997 111.947 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.59 93.04 48.77 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 115.886 -0.597 . . . . 73.150000000000006 112.435 -168.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.62 160.51 31.48 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.293 1.995 . . . . 74.099999999999994 111.968 170.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -55.31 -36.55 66.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.679 0.276 . . . . 72.230000000000004 111.721 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.73 -49.12 82.13 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.258 -0.496 . . . . 65.519999999999996 113.21 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 tp -60.12 -44.05 95.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.012 0.434 . . . . 75.230000000000004 111.272 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 99' ' ' PHE . 84.1 mt -62.31 -43.88 97.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.064 0.459 . . . . 74.129999999999995 110.969 177.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.4 t -64.42 -33.86 76.85 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.061 -0.518 . . . . 70.230000000000004 111.045 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -59.12 -52.3 66.33 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.004 -0.544 . . . . 74.549999999999997 110.385 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.23 -46.28 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.237 0.541 . . . . 75.439999999999998 110.937 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.429 HD11 ' HD2' ' A' ' 99' ' ' PHE . 72.4 mt -56.56 -56.01 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.584 -0.734 . . . . 64.349999999999994 111.79 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -81.38 -18.18 46.44 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.914 0.709 . . . . 73.510000000000005 112.914 -171.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -79.95 -58.59 3.09 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.683 0.278 . . . . 75.010000000000005 111.59 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -114.26 -34.64 5.25 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.201 0.815 . . . . 74.129999999999995 113.201 -174.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 118' ' ' ILE . 85.8 mtp -68.59 -47.5 66.6 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.327 0.491 . . . . 75.439999999999998 112.327 -174.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 26.3 mm -55.63 -55.26 42.4 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 112.983 0.735 . . . . 74.439999999999998 112.983 -178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 11.6 Cg_endo -54.78 -42.61 67.02 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.928 1.752 . . . . 74.349999999999994 112.536 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -60.88 -48.13 83.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.57 0.224 . . . . 73.109999999999999 111.412 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.521 ' HD1' ' HA ' ' A' ' 131' ' ' TYR . 22.9 m-30 -56.39 -47.49 78.84 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.879 0.371 . . . . 64.340000000000003 111.288 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -64.88 -33.14 75.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.907 0.384 . . . . 75.420000000000002 111.197 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.7 m -82.15 -1.15 47.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.498 -0.319 . . . . 54.109999999999999 111.773 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.69 -16.6 60.18 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.151 -0.547 . . . . 72.239999999999995 113.595 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.851 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 92.7 m-20 -80.05 65.24 5.14 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.234 0.517 . . . . 75.319999999999993 111.995 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.521 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 96.5 m-85 -64.05 -32.46 74.03 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.858 0.361 . . . . 73.200000000000003 111.154 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.534 ' HB1' ' HG2' ' A' ' 32' ' ' GLN . . . -71.02 -50.84 29.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.986 0.422 . . . . 74.219999999999999 111.417 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.851 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 5.8 mp0 -57.16 -42.44 81.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.144 -0.48 . . . . 74.209999999999994 111.606 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.0 -52.08 54.47 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.421 -0.419 . . . . 72.549999999999997 113.037 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.04 -39.95 96.26 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.915 0.388 . . . . 65.109999999999999 111.516 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.8 t -60.93 -43.88 98.01 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.159 0.429 . . . . 75.230000000000004 112.159 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -75.26 -28.78 59.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.485 0.179 . . . . 73.439999999999998 111.485 177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.01 -49.08 82.43 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.69 -0.767 . . . . 71.450000000000003 111.965 172.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.87 -49.13 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.068 0.461 . . . . 75.030000000000001 111.203 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 52.7 tp -58.44 -40.49 82.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.983 -0.553 . . . . 75.209999999999994 111.494 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -59.31 -46.79 87.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.859 0.361 . . . . 72.310000000000002 111.446 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.24 -47.17 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.052 0.453 . . . . 61.340000000000003 111.168 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -51.79 -45.76 63.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.177 -0.465 . . . . 73.310000000000002 111.677 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 84.5 mm-40 -59.34 -42.04 90.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.935 0.398 . . . . 73.329999999999998 111.464 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 141' ' ' ALA . 85.5 t -60.73 -50.78 79.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 120.856 0.36 . . . . 73.200000000000003 111.17 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.64 -56.49 20.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.876 0.325 . . . . 74.239999999999995 111.876 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.096 0.406 . . . . 73.530000000000001 112.096 -175.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.4 t . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 121.263 0.554 . . . . 74.200000000000003 110.449 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -75.37 148.29 39.35 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.481 0.658 . . . . 73.340000000000003 112.521 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.497 ' HG2' ' HD2' ' A' ' 6' ' ' PRO . 6.9 tttp -130.74 157.97 76.23 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 115.365 -0.834 . . . . 75.439999999999998 109.754 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.497 ' HD2' ' HG2' ' A' ' 5' ' ' LYS . 77.8 Cg_exo -52.14 -26.06 25.07 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.431 2.088 . . . . 71.319999999999993 113.373 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -88.48 -16.47 32.66 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.08 0.4 . . . . 72.420000000000002 112.08 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -94.23 -24.85 17.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.901 0.381 . . . . 70.450000000000003 111.148 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.4 t -61.79 129.9 91.95 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.268 -0.424 . . . . 75.129999999999995 111.764 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.44 114.56 1.81 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.618 2.212 . . . . 63.100000000000001 112.851 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -71.19 77.07 0.71 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.878 0.37 . . . . 72.299999999999997 111.399 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.7 m -62.87 -44.64 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 122.267 -0.271 . . . . 64.109999999999999 111.471 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -64.4 -14.88 59.05 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.054 0.454 . . . . 73.219999999999999 111.884 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.54 -49.66 7.04 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.998 0.428 . . . . 73.299999999999997 110.004 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.12 -74.9 0.49 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.208 0.447 . . . . 73.530000000000001 112.208 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -109.18 81.49 1.45 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.501 0.667 . . . . 61.229999999999997 111.223 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.47 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 60.6 p -72.99 -29.85 63.36 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.915 -0.584 . . . . 71.340000000000003 112.101 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.5 m -65.25 -15.55 62.61 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.939 0.4 . . . . 75.120000000000005 111.832 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.419 ' C ' ' H ' ' A' ' 21' ' ' VAL . 26.3 ttt85 -75.56 -55.45 5.66 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.616 -0.265 . . . . 75.209999999999994 110.93 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 17' ' ' SER . 1.3 mt 72.46 -26.7 0.18 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.639 0.776 . . . . 72.140000000000001 112.635 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.419 ' H ' ' C ' ' A' ' 19' ' ' ARG . 61.6 t -86.63 141.01 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 122.895 0.478 . . . . 74.420000000000002 111.19 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 m -147.13 104.85 3.71 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.594 0.235 . . . . 73.209999999999994 111.307 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.424 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 33.6 t70 -106.99 109.77 21.74 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.165 0.507 . . . . 74.319999999999993 111.827 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -109.31 -39.51 5.2 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.042 0.449 . . . . 73.310000000000002 110.602 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.81 -23.28 17.45 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.868 0.692 . . . . 73.420000000000002 112.868 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.05 45.3 7.66 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.849 -0.691 . . . . 72.019999999999996 112.703 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 131' ' ' TYR . 69.6 mt -117.72 -42.21 2.87 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.966 0.412 . . . . 75.430000000000007 111.558 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.03 104.6 14.22 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.834 0.349 . . . . 74.25 111.43 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 t -74.02 165.07 25.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.693 -0.23 . . . . 72.400000000000006 111.07 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -50.5 -55.77 14.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.017 0.747 . . . . 75.109999999999999 113.017 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . . . -59.0 -31.49 68.85 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.868 0.366 . . . . 54.140000000000001 111.916 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -73.84 -33.52 64.15 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.048 0.451 . . . . 74.099999999999994 110.649 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -69.29 -41.72 76.43 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.32 -0.4 . . . . 71.540000000000006 111.339 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 11.4 pt-20 -64.64 -38.96 92.8 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 111.996 0.369 . . . . 71.049999999999997 111.996 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.59 -49.16 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.267 0.556 . . . . 72.340000000000003 110.728 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.0 ttm -68.44 -29.34 67.97 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.068 -0.514 . . . . 73.420000000000002 110.916 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -65.13 -56.08 14.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.043 -0.526 . . . . 75.120000000000005 110.778 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.57 92.3 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.912 -0.661 . . . . 62.109999999999999 112.25 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.495 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.4 tpp180 -56.76 -54.48 45.83 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.184 0.594 . . . . 73.420000000000002 111.169 176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.57 -46.13 67.08 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.184 0.438 . . . . 70.239999999999995 112.184 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -58.57 -39.11 79.38 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.002 0.43 . . . . 74.150000000000006 110.926 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.71 81.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.193 -0.458 . . . . 61.130000000000003 111.077 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.567 ' HA ' ' HD2' ' A' ' 47' ' ' HIS . 66.2 mt -65.09 -45.59 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.657 0.265 . . . . 75.209999999999994 111.654 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 50.0 ttp180 -68.35 -26.65 65.7 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.095 -0.378 . . . . 75.319999999999993 111.838 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 t -89.15 -52.56 5.0 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.137 0.494 . . . . 74.329999999999998 111.155 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.1 m -72.22 -43.8 63.89 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.516 0.562 . . . . 74.219999999999999 112.516 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.567 ' HD2' ' HA ' ' A' ' 43' ' ' ILE . 75.3 m-70 -105.41 -15.91 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.343 0.497 . . . . 74.409999999999997 112.343 -175.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 68.02 20.69 9.03 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.128 0.49 . . . . 74.319999999999993 111.932 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.497 ' HB ' HG21 ' A' ' 43' ' ' ILE . 81.5 t -96.26 124.71 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.916 0.389 . . . . 74.409999999999997 111.239 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.47 97.31 9.96 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.437 0.637 . . . . 70.200000000000003 110.886 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.31 107.62 16.95 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.352 -0.84 . . . . 75.400000000000006 110.564 -176.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.76 145.17 38.56 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.057 0.391 . . . . 75.109999999999999 112.057 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.41 120.92 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.96 0.41 . . . . 74.200000000000003 111.381 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.39 128.94 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.299 -0.41 . . . . 71.109999999999999 111.614 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 22.3 p -110.79 123.72 50.62 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.922 0.391 . . . . 73.329999999999998 111.102 177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.8 mt -122.15 140.52 32.53 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 120.741 0.305 . . . . 62.520000000000003 111.275 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.15 -48.95 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.296 1.997 . . . . 72.200000000000003 112.65 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.7 p -150.88 144.91 25.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.699 0.285 . . . . 72.140000000000001 111.623 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.7 pt -120.78 11.0 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.115 0.483 . . . . 73.140000000000001 111.044 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.28 -124.03 24.4 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.272 -0.49 . . . . 54.399999999999999 113.142 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.15 16.27 24.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.884 0.373 . . . . 71.430000000000007 111.417 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . . . -77.36 138.41 63.87 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 112.031 0.382 . . . . 62.229999999999997 112.031 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 62' ' ' ALA . 4.6 Cg_exo -77.0 121.44 5.82 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.728 2.285 . . . . 65.209999999999994 111.808 175.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.6 tp -55.74 -39.3 70.96 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.914 0.387 . . . . 73.099999999999994 111.364 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.29 -45.43 84.13 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.12 -0.491 . . . . 73.510000000000005 112.037 175.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.63 -17.56 50.88 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.418 0.628 . . . . 73.329999999999998 110.871 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -76.78 -56.15 4.86 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.794 -0.639 . . . . 74.430000000000007 111.279 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.7 p -53.22 -52.53 58.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.573 0.583 . . . . 74.540000000000006 112.573 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.507 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 42.1 tp -53.31 -54.52 35.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.213 -0.449 . . . . 71.530000000000001 111.872 -177.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -61.77 -40.19 94.28 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.443 0.535 . . . . 74.209999999999994 112.443 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD23 HD22 ' A' ' 87' ' ' LEU . 63.0 tp -62.31 -45.46 93.13 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.326 0.584 . . . . 75.140000000000001 110.715 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.79 -30.21 66.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.061 -0.518 . . . . 65.140000000000001 112.113 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 75.8 mtp180 -64.59 -49.14 72.31 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.748 0.277 . . . . 74.099999999999994 111.748 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.79 -32.88 74.67 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.723 0.297 . . . . 74.319999999999993 111.439 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -74.23 -15.43 60.99 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.956 0.408 . . . . 75.409999999999997 110.986 173.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.56 27.15 72.99 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.374 -0.441 . . . . 74.409999999999997 113.359 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.451 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 22.4 t . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 112.131 0.419 . . . . 70.319999999999993 112.131 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 103' ' ' TYR . 66.3 t30 . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.136 0.493 . . . . 53.350000000000001 110.74 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.34 148.3 32.23 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.448 0.536 . . . . 74.030000000000001 112.448 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.473 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 3.6 m-20 58.04 19.35 5.89 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.058 0.762 . . . . 74.340000000000003 113.058 174.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 77' ' ' VAL . . . -106.27 132.09 10.96 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.801 -0.714 . . . . 71.230000000000004 113.487 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.632 HD12 HG21 ' A' ' 101' ' ' THR . 46.4 tp -147.17 126.89 13.4 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.023 0.44 . . . . 75.129999999999995 111.202 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.451 HD22 HD23 ' A' ' 71' ' ' LEU . 64.1 tp -120.22 134.24 55.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.822 0.344 . . . . 72.239999999999995 111.418 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.6 tp -119.41 111.79 18.6 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.175 -0.466 . . . . 65.0 110.75 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.96 130.47 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.799 0.333 . . . . 65.420000000000002 111.611 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.499 ' HB2' HD23 ' A' ' 135' ' ' LEU . 28.4 tp -110.04 124.42 51.43 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.183 -0.462 . . . . 73.219999999999999 111.096 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -105.07 105.81 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.746 0.307 . . . . 72.329999999999998 110.786 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 tp -57.78 -40.29 79.51 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.028 0.381 . . . . 75.340000000000003 112.028 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.2 -32.12 71.88 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.255 0.465 . . . . 74.430000000000007 112.255 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -105.29 -7.94 18.59 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 122.157 -0.339 . . . . 73.120000000000005 111.735 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 95' ' ' ARG . 48.8 mtm180 55.0 33.23 19.8 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.168 0.587 . . . . 75.219999999999999 112.531 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -137.54 161.64 35.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.853 0.359 . . . . 74.25 111.455 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.7 171.93 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.225 -0.443 . . . . 72.040000000000006 111.307 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -152.13 133.94 14.82 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.979 0.418 . . . . 70.140000000000001 111.894 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.512 ' HB3' HD11 ' A' ' 86' ' ' LEU . 97.4 m-85 -95.01 122.3 37.53 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.911 -0.586 . . . . 63.450000000000003 110.179 171.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -107.4 112.33 25.08 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.998 -0.371 . . . . 72.120000000000005 109.998 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.632 HG21 HD12 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -98.95 148.06 24.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.622 0.725 . . . . 64.230000000000004 112.696 -177.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -93.07 172.74 33.93 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.163 -0.926 . . . . 73.420000000000002 112.531 170.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' ASN . 55.3 t80 -54.61 -31.29 56.81 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.069 0.548 . . . . 74.540000000000006 111.925 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.473 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -67.74 -19.23 71.12 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 116.08 -0.509 . . . . 75.129999999999995 113.312 -177.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.446 HD13 HG11 ' A' ' 49' ' ' VAL . 91.3 mt -117.58 -5.49 11.18 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.94 0.348 . . . . 74.040000000000006 111.94 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -49.79 -44.05 48.75 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.858 0.463 . . . . 73.439999999999998 111.836 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.34 -25.41 75.49 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 114.468 0.547 . . . . 73.209999999999994 114.468 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -97.96 -35.43 10.47 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.324 0.583 . . . . 75.219999999999999 110.88 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.522 ' HB3' HD22 ' A' ' 114' ' ' LEU . 53.2 mt -126.57 73.45 74.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.366 -0.834 . . . . 73.150000000000006 110.701 -177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.04 156.17 52.12 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.075 1.85 . . . . 70.109999999999999 112.447 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -46.81 -45.88 20.37 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 112.672 0.619 . . . . 75.409999999999997 112.672 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.34 -39.08 96.75 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.399 -0.429 . . . . 74.340000000000003 113.537 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.5 tp -67.32 -47.21 71.23 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 122.511 -0.405 . . . . 73.439999999999998 111.138 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 109' ' ' LEU . 89.4 mt -58.0 -43.9 86.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.152 -0.476 . . . . 75.340000000000003 110.823 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 t -60.35 -41.57 93.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.972 -0.558 . . . . 74.409999999999997 110.981 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 43.3 ttm105 -57.93 -53.87 53.31 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.176 -0.466 . . . . 74.230000000000004 111.52 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.0 mt -51.99 -47.4 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.957 0.408 . . . . 71.310000000000002 111.215 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 114' ' ' LEU . 80.4 mt -55.72 -50.56 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.07 -0.513 . . . . 73.329999999999998 111.39 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.442 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 3.6 t-80 -80.39 -19.28 46.65 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.843 0.683 . . . . 74.140000000000001 112.843 -171.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -102.48 -46.74 4.68 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.488 0.922 . . . . 63.43 113.488 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.405 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 66.6 mtp180 -106.75 4.26 27.46 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.037 0.754 . . . . 75.209999999999994 113.037 -175.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 60.4 mtp -125.33 -51.9 1.63 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.61 0.596 . . . . 73.519999999999996 112.61 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.513 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 22.5 mm -51.77 -49.58 82.57 Favored Pre-proline 0 N--CA 1.48 1.029 0 N-CA-C 113.252 0.834 . . . . 65.120000000000005 113.252 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 14.7 Cg_endo -55.05 -29.51 65.59 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 122.143 1.896 . . . . 74.109999999999999 112.634 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.3 -50.61 15.49 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.518 -0.31 . . . . 73.510000000000005 110.769 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.449 ' HD1' ' HA ' ' A' ' 131' ' ' TYR . 21.8 m-85 -57.53 -42.3 82.6 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.711 0.291 . . . . 75.120000000000005 111.6 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -62.19 -35.54 79.18 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.966 0.412 . . . . 73.420000000000002 111.16 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.5 m -83.07 -1.9 53.96 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 111.921 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.58 -4.77 79.87 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.315 -0.469 . . . . 75.319999999999993 113.203 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.581 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.5 m-20 -81.36 67.52 7.33 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.526 -0.397 . . . . 72.5 111.418 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.449 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 97.6 m-85 -61.68 -47.83 83.55 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.009 0.433 . . . . 75.209999999999994 111.875 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.9 87.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.94 0.4 . . . . 74.349999999999994 111.791 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 19.7 mm-40 -67.15 -39.7 86.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.437 -0.347 . . . . 74.430000000000007 111.444 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.41 -44.64 95.15 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.898 -0.668 . . . . 55.450000000000003 112.611 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 90' ' ' LEU . 95.4 mt -60.96 -45.04 96.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.698 0.285 . . . . 75.519999999999996 111.27 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.0 m -55.38 -49.29 72.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.469 -0.332 . . . . 73.150000000000006 111.789 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 44.3 mm-40 -65.68 -40.99 92.94 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.969 0.359 . . . . 75.209999999999994 111.969 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.76 -50.91 62.55 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 120.934 -0.651 . . . . 72.530000000000001 112.733 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.21 -50.63 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.967 0.413 . . . . 73.120000000000005 111.552 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.449 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 58.5 tp -57.5 -45.58 84.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.163 -0.471 . . . . 74.019999999999996 111.17 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -57.6 -48.18 80.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.96 0.41 . . . . 72.129999999999995 111.628 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.16 -52.38 59.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.222 -0.444 . . . . 71.400000000000006 111.638 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -53.81 -42.09 68.03 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.807 0.337 . . . . 65.129999999999995 111.392 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 98.6 mt-30 -58.72 -46.69 86.77 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.392 -0.367 . . . . 71.430000000000007 111.178 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 141' ' ' ALA . 62.9 t -57.81 -50.11 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.83 0.348 . . . . 73.510000000000005 111.134 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.33 -48.27 79.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.431 -0.35 . . . . 73.430000000000007 111.72 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.002 0.429 . . . . 44.450000000000003 111.386 -179.175 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.7 t . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.173 0.511 . . . . 73.310000000000002 112.298 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -97.93 129.27 44.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.084 -0.507 . . . . 73.230000000000004 111.257 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 68.1 mttm -105.86 164.18 15.53 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.861 -0.609 . . . . 72.049999999999997 110.29 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 31.9 Cg_endo -62.19 -15.0 41.43 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.965 1.777 . . . . 61.520000000000003 112.349 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -94.46 -0.83 54.43 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.182 -0.463 . . . . 71.239999999999995 111.737 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -97.67 -34.5 10.91 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.017 0.436 . . . . 71.140000000000001 110.873 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.69 122.11 65.98 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 115.964 -0.562 . . . . 70.049999999999997 111.601 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.62 126.93 19.38 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.728 2.285 . . . . 74.420000000000002 112.863 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -75.34 83.47 2.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.486 0.66 . . . . 74.230000000000004 111.492 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.57 -26.61 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.902 0.704 . . . . 73.239999999999995 112.902 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -61.0 -15.72 35.02 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.249 0.463 . . . . 75.409999999999997 112.249 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -75.72 -51.45 12.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.992 0.425 . . . . 72.5 110.338 176.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.65 -69.28 0.78 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.012 0.434 . . . . 63.310000000000002 111.561 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' A' ' 19' ' ' ARG . 3.2 m-20 -80.9 57.07 2.93 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.339 0.59 . . . . 75.319999999999993 112.021 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.3 p -65.47 -17.25 64.41 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.163 -0.471 . . . . 75.519999999999996 110.99 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 77.7 p -95.02 3.63 54.68 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.2 -0.455 . . . . 70.230000000000004 111.976 176.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 16' ' ' ASP . 13.2 ttm180 -105.34 -53.58 2.63 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.965 0.412 . . . . 73.549999999999997 110.7 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp 66.09 1.43 1.93 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.411 0.684 . . . . 74.310000000000002 112.705 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.3 t -107.54 140.82 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.904 0.383 . . . . 75.310000000000002 111.853 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 m -131.4 103.67 6.57 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.39 -0.368 . . . . 71.099999999999994 110.52 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.578 ' HA ' ' HG1' ' A' ' 55' ' ' THR . 12.3 p-10 -100.64 96.5 7.39 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.648 0.737 . . . . 71.349999999999994 112.179 -178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -100.72 -44.57 5.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.823 -0.626 . . . . 62.509999999999998 110.899 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.84 -24.04 67.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.26 0.467 . . . . 53.200000000000003 112.26 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.84 28.74 70.21 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.261 -0.495 . . . . 73.150000000000006 113.374 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.466 HD13 ' HB2' ' A' ' 92' ' ' LEU . 94.3 mt -86.5 7.38 26.27 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.541 -0.387 . . . . 74.430000000000007 111.668 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -116.46 121.94 43.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.458 -0.337 . . . . 74.319999999999993 111.543 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.1 m -65.38 146.06 55.38 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.176 -0.305 . . . . 74.219999999999999 110.176 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -48.39 -46.27 36.97 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.77 0.656 . . . . 72.239999999999995 112.77 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.485 ' O ' HG21 ' A' ' 35' ' ' VAL . . . -61.0 -46.7 89.72 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.225 -0.297 . . . . 64.519999999999996 111.186 175.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 15.0 mm-40 -57.71 -37.88 74.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.62 0.248 . . . . 75.310000000000002 111.572 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -54.66 -54.72 38.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.257 0.551 . . . . 75.150000000000006 110.347 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -66.29 -42.06 88.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.752 -0.658 . . . . 74.120000000000005 111.718 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG21 ' O ' ' A' ' 31' ' ' ALA . 85.9 t -59.0 -36.64 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.24 0.543 . . . . 74.310000000000002 110.851 176.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 42.5 ttm -71.9 -44.55 63.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.47 -0.332 . . . . 72.510000000000005 110.711 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -53.15 -54.42 36.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.855 0.36 . . . . 72.540000000000006 111.144 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.22 -33.15 57.72 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 116.157 -0.474 . . . . 74.209999999999994 113.626 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.52 HH12 ' HB3' ' A' ' 136' ' ' SER . 85.0 mtm180 -75.15 -49.13 20.51 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.643 -0.328 . . . . 75.25 111.567 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.84 -48.88 77.14 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.473 0.654 . . . . 75.349999999999994 111.0 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HD3' ' O ' ' A' ' 18' ' ' THR . 33.0 ttp180 -55.8 -42.44 75.62 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.279 -0.873 . . . . 74.230000000000004 111.643 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.76 75.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.855 0.359 . . . . 63.100000000000001 111.526 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.429 HG21 ' HB ' ' A' ' 49' ' ' VAL . 68.0 mt -61.29 -44.77 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.184 0.516 . . . . 74.209999999999994 111.241 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.583 ' HE ' ' HG2' ' A' ' 50' ' ' GLU . 1.5 tmt_? -61.9 -33.1 73.62 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.813 -0.63 . . . . 74.310000000000002 110.784 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.9 t -78.24 -48.6 15.41 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.976 0.361 . . . . 75.299999999999997 111.976 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.2 t -84.06 -68.03 0.75 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.04 0.385 . . . . 65.420000000000002 112.04 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -69.97 -13.6 62.31 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 111.767 0.284 . . . . 72.319999999999993 111.767 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 66.15 14.88 9.86 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.856 0.462 . . . . 72.420000000000002 111.916 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.666 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 61.6 t -84.42 115.8 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.324 -0.398 . . . . 72.310000000000002 110.914 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.583 ' HG2' ' HE ' ' A' ' 44' ' ' ARG . 36.8 mt-10 -76.31 95.58 3.8 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.335 0.588 . . . . 72.239999999999995 110.22 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.68 104.3 13.27 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.441 -0.799 . . . . 73.329999999999998 110.313 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.01 142.53 39.54 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.266 0.469 . . . . 70.310000000000002 112.266 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.6 t -123.22 126.33 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.003 0.43 . . . . 65.239999999999995 111.291 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.42 139.4 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 122.622 0.369 . . . . 74.310000000000002 111.076 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.578 ' HG1' ' HA ' ' A' ' 23' ' ' ASP . 76.7 p -121.04 122.63 40.5 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.817 0.342 . . . . 64.310000000000002 111.474 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -129.19 142.25 44.56 Favored Pre-proline 0 N--CA 1.471 0.624 0 CA-C-N 116.531 -0.304 . . . . 72.219999999999999 111.144 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.89 -55.57 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.268 1.979 . . . . 63.340000000000003 112.348 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.0 p -151.07 147.02 26.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.625 0.25 . . . . 74.5 111.305 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.7 pt -116.89 9.2 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.097 0.475 . . . . 75.439999999999998 111.819 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.23 -138.2 32.31 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.117 -0.563 . . . . 64.109999999999999 112.938 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -92.71 15.26 14.89 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.519 -0.401 . . . . 64.109999999999999 111.989 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.89 131.07 76.97 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.651 -0.25 . . . . 75.120000000000005 111.186 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.589 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 56.7 Cg_endo -71.7 125.51 11.18 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.259 1.972 . . . . 74.430000000000007 112.538 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.5 tp -62.37 -38.33 89.14 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.582 0.586 . . . . 74.120000000000005 112.582 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -61.32 -39.04 89.06 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.761 0.791 . . . . 74.409999999999997 110.759 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.589 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 2.0 m-20 -76.64 -37.02 57.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.041 -0.981 . . . . 71.120000000000005 110.918 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -55.05 -52.68 62.43 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.753 -0.658 . . . . 74.439999999999998 110.85 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.5 p -62.18 -36.46 81.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.974 -0.557 . . . . 71.439999999999998 111.966 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.2 tp -57.01 -50.32 73.1 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.128 0.489 . . . . 73.450000000000003 110.711 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -59.12 -50.33 74.47 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.094 -0.503 . . . . 75.219999999999999 111.756 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.447 HD23 HD23 ' A' ' 87' ' ' LEU . 27.9 tp -64.67 -42.58 95.27 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.989 0.423 . . . . 74.340000000000003 111.451 -176.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.5 93.83 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.855 0.36 . . . . 74.319999999999993 111.514 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -62.28 -52.47 63.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.466 -0.334 . . . . 74.120000000000005 111.771 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.405 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 10.3 pt20 -63.43 -28.01 69.69 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.907 0.336 . . . . 72.120000000000005 111.907 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.405 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 44.9 m0 -86.61 -2.64 58.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.335 0.495 . . . . 74.430000000000007 112.335 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.16 12.18 68.38 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.917 -0.659 . . . . 72.450000000000003 113.416 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 41.3 t . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 120.996 0.426 . . . . 73.299999999999997 110.91 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 42.9 t30 . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 120.615 0.245 . . . . 73.239999999999995 110.624 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.502 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -68.48 -97.36 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 O-C-N 121.958 -0.464 . . . . 72.549999999999997 112.217 -178.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.666 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.2 m-20 -77.51 77.19 4.04 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.982 -0.449 . . . . 72.409999999999997 111.438 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.78 130.93 4.39 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.996 -0.621 . . . . 64.530000000000001 113.315 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.2 tp -144.51 123.05 12.45 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.933 0.396 . . . . 74.200000000000003 110.964 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.447 HD23 HD23 ' A' ' 71' ' ' LEU . 61.7 tp -112.97 135.11 54.1 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.864 0.364 . . . . 73.010000000000005 111.402 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 55.8 tp -124.98 120.81 32.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.695 0.398 . . . . 63.450000000000003 110.956 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 87.0 t -125.21 126.99 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.844 0.354 . . . . 75.239999999999995 111.53 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.47 HD22 HD13 ' A' ' 135' ' ' LEU . 29.6 tp -101.44 120.08 39.74 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.119 -0.491 . . . . 75.420000000000002 111.335 178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.9 t -104.61 102.28 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.867 0.365 . . . . 74.310000000000002 111.157 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.466 ' HB2' HD13 ' A' ' 27' ' ' LEU . 61.7 tp -56.87 -35.06 68.47 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 111.895 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -51.2 -36.49 41.65 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.832 0.679 . . . . 74.25 112.832 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -129.2 3.49 5.21 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.153 0.427 . . . . 74.109999999999999 112.153 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 57.37 20.82 6.24 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.939 0.399 . . . . 71.450000000000003 112.021 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -94.76 141.07 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 75.430000000000007 111.364 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.652 HG23 ' SD ' ' A' ' 122' ' ' MET . 4.4 m -129.89 144.66 37.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.769 -0.651 . . . . 74.329999999999998 110.497 177.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 14.6 tpt180 -121.32 128.48 52.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.856 0.36 . . . . 75.040000000000006 111.707 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.597 ' HB3' HD12 ' A' ' 114' ' ' LEU . 71.8 m-85 -100.69 102.29 13.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.089 -0.505 . . . . 73.409999999999997 109.755 171.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -98.51 112.88 24.77 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.898 0.38 . . . . 63.119999999999997 112.008 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.5 p -102.02 152.37 21.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.522 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.62 -95.44 0.61 Allowed Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.786 -0.721 . . . . 74.129999999999995 111.905 171.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -142.72 -23.56 0.64 Allowed 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.526 -0.397 . . . . 73.040000000000006 111.715 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.32 -29.61 75.68 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.858 -0.687 . . . . 74.439999999999998 113.3 -176.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.563 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 86.8 mt -92.93 0.32 57.38 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.447 0.536 . . . . 75.409999999999997 112.447 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -62.34 -19.99 63.92 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.003 0.43 . . . . 73.5 111.548 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.6 11.62 68.27 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.283 -0.484 . . . . 75.219999999999999 113.13 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.563 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 34.8 m-85 -136.58 -57.47 0.74 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.469 0.652 . . . . 74.310000000000002 110.355 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.475 ' HB3' HD21 ' A' ' 114' ' ' LEU . 12.2 mt -118.56 79.49 15.94 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.11 -0.95 . . . . 74.409999999999997 111.25 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.89 146.54 94.96 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.183 1.922 . . . . 74.140000000000001 112.714 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -51.28 -32.67 25.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 116.155 -0.475 . . . . 74.439999999999998 111.301 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.12 -44.82 75.2 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.36 -0.448 . . . . 73.120000000000005 113.143 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 tp -60.55 -49.69 76.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.207 0.527 . . . . 73.140000000000001 110.873 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.597 HD12 ' HB3' ' A' ' 99' ' ' PHE . 76.7 mt -56.93 -37.28 71.27 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.712 -0.676 . . . . 72.230000000000004 111.191 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.6 t -56.79 -46.85 81.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.122 -0.49 . . . . 63.25 111.383 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -65.11 -41.59 94.77 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.944 -0.302 . . . . 74.349999999999994 111.18 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.575 HG22 ' HD3' ' A' ' 121' ' ' ARG . 65.4 mt -50.34 -39.67 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.038 0.447 . . . . 75.200000000000003 111.19 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 122' ' ' MET . 62.3 mt -60.35 -51.01 77.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.007 -0.542 . . . . 75.409999999999997 111.363 175.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.404 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 12.9 m-70 -81.56 -19.1 42.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.821 0.674 . . . . 74.310000000000002 112.821 -175.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.498 ' HB3' ' HD2' ' A' ' 121' ' ' ARG . 9.3 t70 -83.36 -49.09 9.7 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.109 0.411 . . . . 72.400000000000006 112.109 -173.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.575 ' HD3' HG22 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -119.18 -31.25 4.75 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.155 0.798 . . . . 74.439999999999998 113.155 -177.3 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.722 ' HE1' ' HA3' ' A' ' 138' ' ' GLY . 37.0 mtt -73.28 -56.71 4.71 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.967 0.729 . . . . 74.510000000000005 112.967 -176.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.499 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 44.4 mm -50.58 -52.14 58.56 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.954 0.724 . . . . 73.209999999999994 112.954 -176.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 10.3 Cg_endo -52.23 -29.58 38.43 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.237 1.958 . . . . 72.450000000000003 113.254 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -84.15 -48.19 10.09 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.925 0.343 . . . . 74.310000000000002 111.925 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.2 m-85 -55.78 -46.64 77.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.279 0.561 . . . . 75.430000000000007 111.34 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -65.48 -17.04 64.26 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.727 -0.669 . . . . 73.239999999999995 111.722 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.2 t -90.05 -13.59 35.6 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.12 -0.491 . . . . 74.349999999999994 110.939 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.71 -0.61 61.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.982 -0.447 . . . . 73.319999999999993 111.982 -172.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.789 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.57 68.04 10.29 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.96 0.504 . . . . 74.310000000000002 111.202 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.401 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 96.1 m-85 -70.8 -48.24 55.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.661 0.267 . . . . 73.109999999999999 111.701 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.338 0.589 . . . . 61.310000000000002 111.289 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.789 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 9.2 tp10 -61.6 -50.19 73.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.578 -0.737 . . . . 71.150000000000006 110.884 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.81 -47.21 91.62 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.21 -0.45 . . . . 62.020000000000003 113.6 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.47 HD13 HD22 ' A' ' 90' ' ' LEU . 90.9 mt -57.72 -44.53 86.04 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 122.585 -0.362 . . . . 75.109999999999999 111.285 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.52 ' HB3' HH12 ' A' ' 39' ' ' ARG . 43.7 m -60.18 -44.06 95.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.474 -0.33 . . . . 73.310000000000002 111.557 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -61.07 -40.2 92.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.775 0.321 . . . . 75.200000000000003 111.5 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.722 ' HA3' ' HE1' ' A' ' 122' ' ' MET . . . -62.22 -51.32 57.49 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.944 -0.646 . . . . 74.349999999999994 112.835 176.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.21 -46.6 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.206 0.527 . . . . 74.329999999999998 111.265 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 47.8 tp -59.7 -39.42 84.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.847 -0.615 . . . . 74.209999999999994 111.413 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 145' ' ' VAL . . . -62.52 -50.5 71.1 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.922 0.392 . . . . 71.549999999999997 111.158 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.26 -48.5 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.112 0.482 . . . . 74.239999999999995 111.106 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -51.28 -40.37 58.79 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.8 -0.636 . . . . 74.109999999999999 111.751 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 79.8 mt-30 -69.74 -42.55 73.79 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 111.948 0.351 . . . . 73.439999999999998 111.948 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 141' ' ' ALA . 57.4 t -58.34 -50.8 77.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.803 0.335 . . . . 75.439999999999998 111.617 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.3 mt -53.21 -48.1 68.38 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.454 -0.339 . . . . 71.120000000000005 111.794 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 120.935 0.398 . . . . 75.420000000000002 112.025 -179.224 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 120.907 0.384 . . . . 72.219999999999999 111.69 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -94.08 139.94 30.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.268 0.556 . . . . 65.010000000000005 112.072 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 56.8 mtpt -111.71 163.25 18.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.714 -0.675 . . . . 73.209999999999994 110.012 173.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 16.5 Cg_endo -55.38 -23.73 39.75 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.392 2.062 . . . . 71.209999999999994 112.854 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.34 -22.81 38.18 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.22 -0.446 . . . . 74.439999999999998 111.839 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -91.76 -19.69 22.32 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.83 0.347 . . . . 72.450000000000003 111.599 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.29 120.73 80.19 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.488 -0.324 . . . . 73.349999999999994 111.213 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.47 111.2 0.69 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.667 2.245 . . . . 75.319999999999993 112.978 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -70.81 82.57 0.64 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.346 0.593 . . . . 74.219999999999999 110.832 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.82 -28.31 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.414 0.524 . . . . 75.329999999999998 112.414 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -72.15 -24.53 61.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.893 0.378 . . . . 75.340000000000003 111.842 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tt -75.57 -39.71 57.72 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.19 -0.67 . . . . 73.219999999999999 109.19 171.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.86 -80.13 0.08 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.863 -0.608 . . . . 64.340000000000003 112.16 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -121.93 109.03 14.12 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.661 0.267 . . . . 74.010000000000005 111.584 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 p -59.12 -24.9 63.38 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.857 0.361 . . . . 73.230000000000004 111.765 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.4 m -61.78 -26.36 68.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.399 -0.364 . . . . 74.510000000000005 111.517 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -114.6 112.68 23.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.221 0.534 . . . . 74.310000000000002 110.954 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 4.6 mp -101.5 7.59 42.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.075 -0.511 . . . . 70.239999999999995 110.751 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 16.4 t -119.5 116.47 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.64 0.607 . . . . 73.010000000000005 112.64 -172.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.0 m -104.44 105.79 16.04 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.402 -0.363 . . . . 72.319999999999993 111.157 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.433 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 30.2 t70 -96.56 101.67 13.32 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 111.345 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HB2' HD22 ' A' ' 56' ' ' LEU . 27.7 mm-40 -103.77 -39.55 6.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.003 0.43 . . . . 71.030000000000001 111.065 177.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.85 -21.58 57.12 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.913 0.709 . . . . 65.409999999999997 112.913 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.22 55.46 5.16 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.938 -0.649 . . . . 64.230000000000004 112.486 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -122.13 -47.76 2.13 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.873 0.368 . . . . 74.329999999999998 111.466 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.22 115.24 13.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.136 0.493 . . . . 72.219999999999999 111.931 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 90.8 p -71.1 162.07 30.06 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.018 -0.537 . . . . 71.530000000000001 111.241 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -53.49 -35.51 60.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.123 0.487 . . . . 65.409999999999997 110.872 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.69 -48.48 69.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.932 -0.576 . . . . 75.299999999999997 111.244 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -60.46 -42.73 96.77 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.574 0.226 . . . . 74.310000000000002 111.59 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.01 -44.84 95.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.776 0.322 . . . . 72.430000000000007 110.926 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -54.57 -55.18 32.05 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.031 0.443 . . . . 74.400000000000006 111.238 177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.89 -46.08 97.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.897 -0.592 . . . . 75.040000000000006 111.811 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.509 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 50.0 ttm -66.84 -52.12 47.51 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.529 -0.305 . . . . 74.030000000000001 111.742 -176.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -62.88 -37.67 87.85 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.407 0.146 . . . . 75.430000000000007 111.236 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.67 -48.24 85.89 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.006 -0.616 . . . . 62.25 112.532 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 48.1 mtp180 -64.0 -47.55 79.85 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.308 0.243 . . . . 72.150000000000006 111.608 177.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 36' ' ' MET . 85.4 mt -58.57 -52.72 64.47 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.129 0.49 . . . . 74.299999999999997 111.361 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -60.18 -34.87 74.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.027 -0.533 . . . . 75.450000000000003 110.862 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.21 96.89 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.845 0.355 . . . . 60.0 111.143 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.519 HG21 ' HB ' ' A' ' 49' ' ' VAL . 70.8 mt -62.25 -42.27 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.488 -0.324 . . . . 75.519999999999996 110.78 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 28.1 tpt180 -61.51 -37.63 84.42 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.989 0.423 . . . . 74.530000000000001 111.088 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.4 m -70.11 -31.51 69.1 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.129 0.418 . . . . 65.400000000000006 112.129 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.6 t -98.72 -64.54 1.03 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.004 0.372 . . . . 65.329999999999998 112.004 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -87.5 -10.56 51.43 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.5 0.556 . . . . 71.329999999999998 112.5 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 69.08 3.46 4.07 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.312 0.486 . . . . 74.230000000000004 112.312 -176.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.835 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 93.2 t -64.45 122.62 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 121.008 0.432 . . . . 75.329999999999998 111.459 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -88.84 95.54 10.33 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.3 0.572 . . . . 75.219999999999999 109.865 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -113.17 102.7 10.62 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.646 -0.706 . . . . 74.239999999999995 111.013 -172.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -105.17 145.86 30.01 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.356 0.502 . . . . 74.329999999999998 112.356 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 61.3 t -124.23 138.3 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.394 -0.366 . . . . 75.340000000000003 110.933 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.1 t -133.29 143.31 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 122.231 -0.293 . . . . 64.200000000000003 111.118 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 28.4 p -125.54 123.15 38.5 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.803 0.335 . . . . 71.450000000000003 110.752 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 24' ' ' GLU . 81.8 mt -127.39 143.22 46.48 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 122.245 -0.284 . . . . 75.519999999999996 111.515 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.74 -61.48 0.28 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.598 2.199 . . . . 75.040000000000006 112.519 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.8 p -149.35 146.41 27.5 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.973 0.416 . . . . 72.129999999999995 112.046 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.468 HG12 HG13 ' A' ' 91' ' ' VAL . 31.9 pt -110.6 5.0 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.957 -0.565 . . . . 74.409999999999997 110.682 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.92 -120.4 22.02 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.886 -0.597 . . . . 73.299999999999997 113.526 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -97.83 4.86 49.65 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.895 0.378 . . . . 72.420000000000002 111.788 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.46 140.44 92.47 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 120.672 0.272 . . . . 74.329999999999998 111.731 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.5 Cg_endo -75.99 125.86 8.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.321 2.014 . . . . 75.340000000000003 112.518 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.3 tp -58.62 -42.01 87.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.046 0.451 . . . . 74.510000000000005 111.711 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.73 -59.68 4.19 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.875 -0.602 . . . . 74.219999999999999 111.057 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.649 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 3.3 m-20 -62.97 -41.53 99.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.705 -0.68 . . . . 64.129999999999995 111.627 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -53.62 -49.96 66.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.274 -0.421 . . . . 74.299999999999997 111.763 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.3 p -57.48 -48.86 78.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.412 -0.358 . . . . 75.439999999999998 111.891 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.4 -45.42 88.39 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.844 0.354 . . . . 75.530000000000001 111.712 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 66' ' ' ASP . 31.7 mmmt -56.25 -45.51 80.02 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.999 0.428 . . . . 74.329999999999998 111.661 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.42 -38.13 65.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.214 0.53 . . . . 75.219999999999999 111.297 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.81 -35.45 72.87 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.292 -0.413 . . . . 72.200000000000003 112.103 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -61.31 -53.91 50.66 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.321 0.489 . . . . 75.129999999999995 112.321 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.617 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 7.2 pt20 -67.06 -27.44 67.38 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.383 0.512 . . . . 75.409999999999997 112.383 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.617 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 16.3 m0 -80.74 -12.22 59.49 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.884 0.328 . . . . 74.420000000000002 111.884 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.76 -2.16 66.57 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.266 -0.492 . . . . 74.239999999999995 114.029 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.543 0.674 0 N-CA-C 112.714 0.635 . . . . 71.099999999999994 112.714 -177.474 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.45 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 23.0 t-20 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 121.244 0.545 . . . . 73.200000000000003 111.064 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.679 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.0 OUTLIER -51.38 -64.29 0.86 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 112.772 0.656 . . . . 73.510000000000005 112.772 177.102 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.835 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 18.3 m120 -88.02 8.16 27.86 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.683 -0.636 . . . . 75.310000000000002 112.146 -177.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.99 124.62 9.23 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 114.735 0.654 . . . . 75.340000000000003 114.735 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.615 HD12 ' HB3' ' A' ' 99' ' ' PHE . 50.9 tp -144.23 119.59 10.26 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.705 0.402 . . . . 71.299999999999997 110.755 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.6 tp -110.99 135.44 51.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.817 0.341 . . . . 74.400000000000006 111.564 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -120.84 108.14 13.57 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.741 0.305 . . . . 74.230000000000004 110.863 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.0 t -108.5 120.15 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.075 0.398 . . . . 75.150000000000006 112.075 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.536 ' HB2' HD21 ' A' ' 135' ' ' LEU . 29.2 tp -100.1 129.4 46.13 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.193 -0.458 . . . . 73.219999999999999 111.014 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.468 HG13 HG12 ' A' ' 59' ' ' ILE . 44.2 t -116.98 107.79 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.462 -0.335 . . . . 65.109999999999999 110.683 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.1 tp -53.47 -44.36 68.91 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.044 0.449 . . . . 71.519999999999996 111.504 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -57.64 -33.5 68.36 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.95 -0.568 . . . . 71.200000000000003 112.265 177.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -92.66 -11.95 32.82 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 122.241 -0.287 . . . . 74.349999999999994 111.62 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 54.64 29.05 10.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.995 0.518 . . . . 73.409999999999997 111.891 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -149.81 173.53 13.64 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.09 0.471 . . . . 73.120000000000005 111.908 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.526 HG23 ' SD ' ' A' ' 122' ' ' MET . 8.9 m -135.41 171.93 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.877 -0.601 . . . . 74.409999999999997 111.056 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -145.8 141.52 28.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.926 0.393 . . . . 73.420000000000002 111.532 168.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.667 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 79.0 m-85 -98.36 124.9 43.27 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.887 -0.597 . . . . 75.420000000000002 110.373 172.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.99 119.25 38.92 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.275 -0.266 . . . . 73.409999999999997 110.726 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.565 HG21 HD13 ' A' ' 114' ' ' LEU . 18.5 p -98.19 139.11 34.47 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.03 0.443 . . . . 75.409999999999997 111.847 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -68.39 -80.84 0.21 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.582 -0.818 . . . . 54.32 112.297 173.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -155.66 -43.62 0.08 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.934 0.397 . . . . 74.319999999999993 112.044 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.535 ' H ' ' HA ' ' A' ' 83' ' ' ASN . . . -62.13 -41.76 99.71 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.516 -0.374 . . . . 71.510000000000005 113.617 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 88.2 mt -71.15 -3.08 18.13 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.251 0.834 . . . . 74.430000000000007 113.251 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -60.85 -15.49 30.89 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.939 -0.476 . . . . 70.319999999999993 112.03 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.7 1.18 80.95 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.177 -0.535 . . . . 62.049999999999997 113.301 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -136.94 -54.36 0.71 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.332 0.587 . . . . 74.019999999999996 111.452 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.6 mt -117.25 86.62 21.67 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.578 -0.737 . . . . 73.439999999999998 111.821 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.39 159.0 22.78 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.332 2.021 . . . . 75.430000000000007 112.529 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.428 ' HA ' HD12 ' A' ' 114' ' ' LEU . 14.3 t70 -45.91 -40.22 9.82 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 120.977 0.417 . . . . 74.420000000000002 111.746 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.03 72.11 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.336 -0.459 . . . . 70.310000000000002 113.284 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.26 -40.2 96.74 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.03 0.443 . . . . 75.230000000000004 111.095 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 86.1 mt -57.66 -48.17 80.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.052 -0.522 . . . . 72.340000000000003 111.127 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.4 t -69.08 -34.48 75.19 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.106 0.479 . . . . 63.329999999999998 110.804 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 116' ' ' ARG . 15.4 ttm180 -56.56 -53.92 51.93 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.115 -0.493 . . . . 72.430000000000007 110.904 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.12 -41.69 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.027 0.441 . . . . 72.340000000000003 111.528 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 60.4 mt -58.61 -54.51 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.165 0.507 . . . . 74.200000000000003 110.888 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -75.1 -14.9 60.62 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.28 -0.418 . . . . 70.329999999999998 112.008 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -79.21 -53.04 7.36 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.226 0.454 . . . . 74.329999999999998 112.226 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -133.72 -23.68 1.79 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.202 0.816 . . . . 73.200000000000003 113.202 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.846 ' HE2' ' HA3' ' A' ' 138' ' ' GLY . 36.4 mtt -67.56 -53.6 26.96 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.509 0.559 . . . . 74.319999999999993 112.509 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.444 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 47.7 mm -51.38 -53.63 47.44 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 112.85 0.685 . . . . 74.450000000000003 112.85 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 10.5 Cg_endo -53.58 -41.98 69.44 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.989 1.793 . . . . 74.319999999999993 112.623 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.468 ' CD2' ' HG3' ' A' ' 137' ' ' GLU . 60.5 m-70 -64.47 -50.68 66.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.279 -0.263 . . . . 75.530000000000001 111.491 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.6 m-85 -56.4 -45.25 80.72 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.854 0.359 . . . . 73.540000000000006 111.431 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 58.6 mtp180 -62.49 -34.82 77.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.963 0.411 . . . . 75.239999999999995 110.988 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.6 m -80.82 -4.44 54.69 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.104 -0.498 . . . . 62.310000000000002 111.87 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.7 -8.44 63.78 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.517 -0.373 . . . . 62.509999999999998 113.601 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.756 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.4 m-20 -78.81 72.41 5.33 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 122.327 -0.513 . . . . 63.109999999999999 112.139 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -71.45 -56.13 6.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.018 0.437 . . . . 65.010000000000005 111.177 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.91 89.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 111.468 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.756 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 9.4 tp10 -68.56 -46.43 69.48 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.17 -0.468 . . . . 74.109999999999999 110.768 176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.84 -41.75 67.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.579 -0.343 . . . . 52.149999999999999 113.267 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 90' ' ' LEU . 83.4 mt -60.65 -48.79 80.2 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.888 0.375 . . . . 75.239999999999995 111.178 175.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -60.56 -38.85 85.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.326 -0.397 . . . . 74.5 110.941 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.468 ' HG3' ' CD2' ' A' ' 125' ' ' HIS . 15.7 mm-40 -58.44 -51.37 70.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 111.503 175.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.846 ' HA3' ' HE2' ' A' ' 122' ' ' MET . . . -58.76 -47.94 87.71 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.9 -0.667 . . . . 75.340000000000003 112.444 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.29 -39.68 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.968 0.413 . . . . 74.400000000000006 111.218 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.45 ' HG ' HE21 ' A' ' 144' ' ' GLN . 27.9 tp -70.88 -33.99 71.15 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.381 -0.372 . . . . 74.409999999999997 110.667 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.52 -50.79 57.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.847 0.356 . . . . 74.200000000000003 110.86 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.7 t -57.47 -47.34 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.116 0.484 . . . . 75.299999999999997 110.535 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -53.81 -46.91 71.24 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.051 -0.522 . . . . 74.140000000000001 111.82 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.45 HE21 ' HG ' ' A' ' 140' ' ' LEU . 74.4 mt-30 -57.42 -38.1 73.82 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.841 0.353 . . . . 75.109999999999999 111.426 177.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.98 -49.08 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.707 0.289 . . . . 72.230000000000004 111.029 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.36 -58.21 4.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.867 0.321 . . . . 72.299999999999997 111.867 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 121.045 0.45 . . . . 72.510000000000005 111.845 178.383 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 121.044 0.449 . . . . 74.140000000000001 111.754 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -91.59 141.17 29.0 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.109 0.48 . . . . 75.310000000000002 111.405 174.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.761 ' HB2' ' HZ2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -111.45 158.35 36.52 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 116.316 -0.402 . . . . 74.310000000000002 110.647 175.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 64.4 Cg_endo -70.93 19.31 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.819 2.346 . . . . 64.450000000000003 114.541 -173.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.632 ' HA ' HE22 ' A' ' 74' ' ' GLN . 0.0 OUTLIER -126.38 -12.07 6.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.756 0.313 . . . . 63.009999999999998 111.657 173.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -97.45 -19.27 18.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.947 0.403 . . . . 54.009999999999998 111.121 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.21 130.92 84.04 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.322 -0.399 . . . . 73.040000000000006 111.412 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.04 110.84 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.828 2.352 . . . . 75.430000000000007 113.173 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -70.96 98.0 1.53 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 111.215 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 13' ' ' GLN . 27.8 m -93.26 -50.25 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 113.495 0.924 . . . . 73.0 113.495 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.564 ' HG3' HG22 ' A' ' 77' ' ' VAL . 15.1 mm100 -53.77 -33.75 56.85 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.654 1.353 . . . . 71.239999999999995 114.654 -169.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -77.48 5.34 9.1 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.617 0.599 . . . . 74.200000000000003 112.617 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.02 -51.56 0.06 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.196 0.522 . . . . 75.319999999999993 111.498 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -83.14 47.67 1.27 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.3 -0.409 . . . . 72.430000000000007 111.256 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 m -61.0 -11.79 9.32 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.689 0.626 . . . . 74.409999999999997 112.689 -176.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -77.71 -30.7 51.91 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.176 0.512 . . . . 65.219999999999999 110.635 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.455 ' HA ' ' OD1' ' A' ' 37' ' ' ASN . 13.0 ttm105 -108.34 95.04 5.39 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.452 0.644 . . . . 74.310000000000002 110.761 175.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 20' ' ' LEU . 3.9 mp -88.89 13.6 12.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.812 -0.631 . . . . 73.209999999999994 111.04 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.54 127.36 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.326 -0.397 . . . . 74.439999999999998 111.773 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.0 m -121.1 103.16 8.81 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.439 -0.346 . . . . 73.239999999999995 110.619 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -99.51 101.99 13.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.989 0.424 . . . . 73.349999999999994 111.495 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -103.0 -34.42 8.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.214 0.53 . . . . 75.510000000000005 110.714 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.32 -28.26 69.08 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.51 0.559 . . . . 71.150000000000006 112.51 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.68 28.43 51.36 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.886 -0.673 . . . . 71.120000000000005 112.432 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.51 -17.2 22.64 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.824 0.345 . . . . 74.519999999999996 111.319 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.4 mt -107.62 114.19 28.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.924 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 t -65.93 152.73 43.86 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.341 -0.224 . . . . 63.539999999999999 110.467 175.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -45.03 -51.78 9.61 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.854 0.687 . . . . 74.230000000000004 112.854 -174.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 35' ' ' VAL . . . -60.28 -50.26 74.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.646 0.26 . . . . 71.120000000000005 111.452 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -58.09 -39.87 79.68 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.177 0.513 . . . . 73.129999999999995 111.426 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -50.73 71.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.906 -0.588 . . . . 74.530000000000001 110.621 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.06 -30.75 71.8 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.724 0.297 . . . . 73.239999999999995 111.371 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 31' ' ' ALA . 74.8 t -62.01 -46.37 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.951 0.405 . . . . 72.129999999999995 110.35 172.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.695 ' SD ' HG23 ' A' ' 139' ' ' VAL . 51.7 tpp -60.3 -43.85 95.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.422 -0.354 . . . . 75.239999999999995 110.356 175.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.537 ' HB3' ' NH2' ' A' ' 41' ' ' ARG . 60.3 m-80 -56.74 -38.19 72.04 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.468 -0.333 . . . . 73.200000000000003 110.658 173.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.6 -46.32 94.65 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.887 -0.673 . . . . 60.409999999999997 112.203 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.5 mmp_? -57.61 -55.74 30.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.023 0.44 . . . . 75.019999999999996 111.174 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.87 -45.58 91.9 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.099 -0.5 . . . . 73.120000000000005 112.098 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.537 ' NH2' ' HB3' ' A' ' 37' ' ' ASN . 36.3 ttm180 -62.15 -40.75 97.03 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.018 0.527 . . . . 75.430000000000007 110.929 -178.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.64 -46.52 89.42 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.338 -0.392 . . . . 54.210000000000001 111.011 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.418 HG21 ' HB ' ' A' ' 49' ' ' VAL . 76.1 mt -59.79 -44.7 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.124 0.488 . . . . 73.140000000000001 110.96 175.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 31.7 tpt180 -62.42 -26.81 68.69 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.097 -0.501 . . . . 72.109999999999999 111.76 177.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.1 m -84.84 -54.06 4.93 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.148 0.499 . . . . 72.0 110.76 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.2 m -71.91 -56.9 4.87 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.719 -0.673 . . . . 73.439999999999998 112.42 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -96.32 -10.57 27.51 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.115 0.413 . . . . 75.430000000000007 112.115 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 70.55 1.47 3.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.974 0.731 . . . . 71.239999999999995 112.974 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HB ' HG21 ' A' ' 43' ' ' ILE . 99.2 t -66.59 132.09 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 112.352 0.501 . . . . 71.310000000000002 112.352 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HB3' HG11 ' A' ' 77' ' ' VAL . 44.3 mt-10 -82.18 96.74 7.93 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.08 0.466 . . . . 74.129999999999995 110.533 174.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -119.11 108.72 15.04 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 110.507 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.47 146.02 42.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.875 0.369 . . . . 73.439999999999998 111.971 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.4 t -128.38 121.74 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.831 0.348 . . . . 72.239999999999995 111.418 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.7 t -121.78 132.37 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 122.325 0.25 . . . . 75.239999999999995 111.419 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -116.59 123.06 46.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.927 0.394 . . . . 53.140000000000001 111.288 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.409 HD11 ' CZ ' ' A' ' 67' ' ' PHE . 83.8 mt -118.16 145.24 36.55 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-O 120.788 0.328 . . . . 74.409999999999997 111.37 177.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.95 -43.01 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.535 2.157 . . . . 74.329999999999998 112.354 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.89 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 23.8 m -153.14 143.47 22.46 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.055 0.391 . . . . 74.450000000000003 112.055 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.473 ' HB ' ' HB1' ' A' ' 62' ' ' ALA . 35.8 pt -128.67 -14.38 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.083 0.468 . . . . 74.540000000000006 110.653 172.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.04 -117.32 8.45 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.236 -0.438 . . . . 53.409999999999997 113.725 174.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.42 2.67 46.87 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.815 0.302 . . . . 74.450000000000003 111.815 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HB1' ' HB ' ' A' ' 59' ' ' ILE . . . -72.88 120.88 83.26 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 111.524 0.194 . . . . 64.040000000000006 111.524 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 31.8 Cg_endo -64.48 137.06 53.41 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.443 2.095 . . . . 73.319999999999993 112.654 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.97 -49.08 40.34 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.236 0.458 . . . . 72.439999999999998 112.236 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.26 -32.85 73.61 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.998 0.428 . . . . 74.120000000000005 111.849 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.578 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 3.4 m-20 -74.21 -38.55 63.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.89 0.376 . . . . 71.129999999999995 111.016 173.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 48.6 t80 -56.77 -54.15 49.68 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.995 0.426 . . . . 74.420000000000002 111.062 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.493 ' OG1' ' NH1' ' A' ' 98' ' ' ARG . 40.7 p -51.84 -42.48 62.62 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.959 -0.564 . . . . 75.040000000000006 111.441 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.3 tp -58.42 -54.8 42.89 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.133 -0.485 . . . . 73.25 111.657 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 14.9 mmmm -66.67 -42.29 86.77 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.628 0.603 . . . . 63.130000000000003 112.628 -173.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.3 tp -68.57 -47.98 65.4 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.207 0.527 . . . . 73.310000000000002 111.261 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.479 ' HB3' HD22 ' A' ' 87' ' ' LEU . . . -68.55 -31.04 69.98 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.453 0.538 . . . . 64.120000000000005 112.453 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 70' ' ' LYS . 13.3 ptm180 -70.67 -38.95 73.79 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.092 -0.243 . . . . 72.140000000000001 111.436 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.632 HE22 ' HA ' ' A' ' 7' ' ' GLU . 3.6 pt20 -72.51 -24.69 61.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.044 0.45 . . . . 62.409999999999997 110.811 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.515 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 39.6 m0 -88.69 -17.2 30.47 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.487 -0.324 . . . . 75.010000000000005 111.221 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.64 38.08 95.71 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.472 -0.394 . . . . 74.400000000000006 113.613 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.564 HG22 ' HG3' ' A' ' 13' ' ' GLN . 45.0 t . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 112.173 0.434 . . . . 71.219999999999999 112.173 -176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 103' ' ' TYR . 3.5 m-20 . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 121.242 0.544 . . . . 75.25 112.053 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -97.36 -139.44 0.28 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.13 -0.486 . . . . 73.219999999999999 111.137 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.542 ' HA ' ' HG ' ' A' ' 105' ' ' LEU . 7.3 p30 -69.12 43.88 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.322 0.86 . . . . 54.109999999999999 113.322 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -92.49 140.39 15.09 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.934 -0.651 . . . . 61.420000000000002 112.74 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 99' ' ' PHE . 52.0 tp -143.05 119.74 11.14 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.871 0.367 . . . . 64.319999999999993 111.03 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 72' ' ' ALA . 58.4 tp -111.94 122.32 47.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.836 0.351 . . . . 73.150000000000006 111.216 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.3 tp -109.97 106.2 15.65 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.307 -0.406 . . . . 75.209999999999994 110.745 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 59.9 t -107.06 117.4 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 111.925 0.343 . . . . 73.109999999999999 111.925 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.487 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.9 tp -96.88 122.27 39.66 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.305 -0.407 . . . . 74.120000000000005 110.677 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.453 HG12 HG12 ' A' ' 59' ' ' ILE . 61.0 t -111.04 102.9 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.665 0.269 . . . . 74.439999999999998 111.176 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.5 tp -51.86 -41.74 62.08 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.0 0.428 . . . . 73.439999999999998 111.367 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.89 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 19.1 t0 -45.76 -43.16 12.82 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.5 0.72 . . . . 70.019999999999996 112.451 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -106.19 -6.79 18.26 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 111.906 0.336 . . . . 71.109999999999999 111.906 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.404 ' NH2' ' O ' ' A' ' 126' ' ' PHE . 77.9 mtp180 55.23 26.84 8.9 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.732 0.777 . . . . 74.219999999999999 110.509 -174.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -112.75 164.24 13.61 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.171 -0.922 . . . . 72.420000000000002 111.528 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.65 HG22 ' SD ' ' A' ' 122' ' ' MET . 11.1 m -137.42 171.75 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.025 -0.534 . . . . 75.310000000000002 110.511 172.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.493 ' NH1' ' OG1' ' A' ' 68' ' ' THR . 38.5 ttt-85 -153.04 142.82 22.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.788 0.327 . . . . 74.25 111.621 172.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HD11 ' A' ' 86' ' ' LEU . 95.1 m-85 -101.22 118.05 36.21 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.045 -0.525 . . . . 74.329999999999998 110.659 173.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.45 ' CD ' HH12 ' A' ' 98' ' ' ARG . 5.6 tp10 -105.64 112.6 25.74 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 110.346 -0.242 . . . . 74.420000000000002 110.346 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.8 p -103.27 158.89 16.01 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.791 0.805 . . . . 74.319999999999993 113.038 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.5 -175.65 25.04 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 114.907 -1.042 . . . . 73.420000000000002 111.464 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -61.83 -24.17 66.72 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.405 -0.468 . . . . 74.040000000000006 112.009 -176.142 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.4 -20.27 79.64 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.928 -0.653 . . . . 74.450000000000003 113.203 -173.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 84' ' ' ASN . 91.8 mt -109.11 -7.5 15.31 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.407 0.521 . . . . 75.219999999999999 112.407 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -56.4 -25.72 50.95 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.11 0.411 . . . . 65.319999999999993 112.11 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.79 -21.26 59.89 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.169 -0.539 . . . . 62.009999999999998 113.62 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.435 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 82.0 m-85 -102.42 -53.74 2.83 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.268 0.556 . . . . 72.209999999999994 111.409 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -113.77 87.97 13.17 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.485 -0.78 . . . . 71.239999999999995 111.418 -173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 108' ' ' TYR . 6.5 Cg_exo -73.99 161.63 40.75 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.396 2.064 . . . . 70.120000000000005 112.34 176.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -51.45 -44.09 62.26 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.167 0.432 . . . . 74.340000000000003 112.167 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.51 -45.13 94.94 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.227 -0.511 . . . . 65.239999999999995 113.198 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.12 -42.94 99.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.767 0.318 . . . . 65.329999999999998 111.164 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.0 -44.75 91.72 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.012 0.434 . . . . 72.239999999999995 110.827 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.7 m -61.91 -36.63 81.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.086 -0.506 . . . . 74.219999999999999 111.053 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -60.9 -56.38 21.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.215 -0.448 . . . . 74.109999999999999 111.59 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.5 mt -50.63 -43.43 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.902 0.382 . . . . 73.129999999999995 111.684 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 122' ' ' MET . 64.3 mt -61.23 -51.31 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.296 -0.411 . . . . 74.010000000000005 111.754 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.445 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 25.1 m-70 -74.02 -48.17 31.99 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.025 0.75 . . . . 70.239999999999995 113.025 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.35 -54.19 22.79 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.592 0.59 . . . . 73.200000000000003 112.592 -174.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -97.33 -45.14 6.6 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.604 0.594 . . . . 75.030000000000001 112.604 -172.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.65 ' SD ' HG22 ' A' ' 97' ' ' VAL . 49.3 mtt -73.32 -54.26 8.79 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.708 1.003 . . . . 64.129999999999995 113.708 -173.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.489 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 32.8 mm -47.48 -51.86 40.9 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 113.391 0.886 . . . . 72.329999999999998 113.391 -175.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 72.0 Cg_exo -50.49 -39.59 54.79 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.155 1.903 . . . . 72.299999999999997 113.048 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.449 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 85.5 m-70 -74.42 -49.95 20.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.6 -0.273 . . . . 74.340000000000003 111.656 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.6 m-30 -56.34 -43.13 78.76 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.598 0.221 . . . . 61.310000000000002 111.598 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.5 -42.36 87.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.921 0.391 . . . . 63.409999999999997 111.302 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.7 m -74.94 -13.46 60.53 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.268 -0.423 . . . . 62.210000000000001 111.75 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.48 -0.69 59.89 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.286 -0.483 . . . . 72.129999999999995 112.52 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.606 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.8 m-20 -80.37 66.66 5.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.737 0.415 . . . . 74.299999999999997 111.303 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -65.13 -46.02 82.66 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.174 -0.329 . . . . 73.430000000000007 111.785 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.69 95.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.007 0.432 . . . . 72.310000000000002 111.462 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 51.9 mm-40 -59.82 -47.2 86.69 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.146 -0.479 . . . . 72.230000000000004 111.365 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.71 93.13 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.302 -0.475 . . . . 74.510000000000005 113.008 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.35 -43.05 96.86 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.808 0.337 . . . . 65.239999999999995 111.051 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.4 t -56.21 -53.48 56.63 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 70.109999999999999 111.904 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -68.4 -33.45 74.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.609 0.242 . . . . 72.019999999999996 111.395 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.555 ' HA3' ' HE2' ' A' ' 122' ' ' MET . . . -61.18 -52.46 51.74 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.072 -0.585 . . . . 64.430000000000007 112.712 176.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.695 HG23 ' SD ' ' A' ' 36' ' ' MET . 90.8 t -62.63 -43.6 98.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.023 0.44 . . . . 74.209999999999994 111.227 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.19 -38.36 76.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.262 -0.427 . . . . 74.310000000000002 110.929 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -61.31 -51.84 67.18 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.9 0.381 . . . . 72.219999999999999 111.052 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 85.7 t -54.32 -49.7 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.162 0.506 . . . . 75.049999999999997 110.972 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.409 ' HB2' HD12 ' A' ' 43' ' ' ILE . 36.5 tt0 -53.43 -46.5 69.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.974 -0.557 . . . . 72.219999999999999 111.653 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -65.09 -34.22 77.89 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.943 0.349 . . . . 64.239999999999995 111.943 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 141' ' ' ALA . 92.8 t -63.28 -49.07 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.064 0.459 . . . . 73.239999999999995 111.004 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.85 -57.06 8.79 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.051 0.453 . . . . 74.430000000000007 111.425 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.541 0.604 0 CA-C-N 116.12 -0.491 . . . . 73.230000000000004 111.943 -177.041 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.1 t . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 113.133 0.79 . . . . 75.019999999999996 113.133 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -109.1 152.56 24.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.742 -0.663 . . . . 73.209999999999994 111.518 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.491 ' O ' HG21 ' A' ' 9' ' ' VAL . 40.7 mtmt -111.91 157.95 38.15 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.207 -0.451 . . . . 73.329999999999998 110.335 173.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.518 ' HD3' ' CE2' ' A' ' 67' ' ' PHE . 30.3 Cg_endo -62.33 -26.11 76.89 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.912 1.741 . . . . 71.340000000000003 111.323 176.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.447 ' HA ' HE22 ' A' ' 74' ' ' GLN . 18.1 mt-10 -79.26 -20.2 48.71 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.566 -0.743 . . . . 74.340000000000003 111.067 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -94.06 -24.49 17.58 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.855 -0.611 . . . . 62.32 111.511 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 5' ' ' LYS . 95.6 t -66.71 132.52 94.06 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.226 -0.443 . . . . 71.510000000000005 111.648 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.08 121.05 9.19 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.633 2.222 . . . . 73.409999999999997 113.106 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.531 ' OD1' ' HB3' ' A' ' 14' ' ' LEU . 2.8 p30 -70.34 85.95 0.59 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.477 0.547 . . . . 73.329999999999998 112.477 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.66 -26.77 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 112.223 0.453 . . . . 72.319999999999993 112.223 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.548 HE22 ' HA ' ' A' ' 20' ' ' LEU . 1.6 mp0 -87.22 31.29 0.73 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.593 0.711 . . . . 74.219999999999999 111.365 173.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.531 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 4.7 tt -143.43 -50.75 0.33 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.378 -0.971 . . . . 64.299999999999997 108.378 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -109.52 120.37 42.29 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.604 -0.725 . . . . 73.409999999999997 110.307 170.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 6.8 m-20 71.13 48.42 0.37 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.329 0.652 . . . . 72.310000000000002 111.646 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -59.45 -11.96 5.36 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.961 0.726 . . . . 61.229999999999997 112.961 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 t -60.86 -34.67 74.96 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.142 -0.349 . . . . 75.019999999999996 111.319 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 19' ' ' ARG . 8.0 ptp85 -97.12 132.48 42.86 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.096 0.474 . . . . 72.219999999999999 110.375 175.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.548 ' HA ' HE22 ' A' ' 13' ' ' GLN . 5.6 mp -108.63 12.67 25.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.153 0.501 . . . . 74.030000000000001 110.896 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.7 t -110.75 146.94 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.135 -0.484 . . . . 72.299999999999997 111.478 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 m -131.21 124.17 30.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.359 -0.382 . . . . 74.409999999999997 110.57 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' HA ' ' HG1' ' A' ' 55' ' ' THR . 8.4 p-10 -114.35 86.03 2.35 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.405 0.621 . . . . 73.310000000000002 112.492 -174.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.04 -38.48 8.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.908 0.385 . . . . 74.420000000000002 110.75 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.1 -26.65 64.08 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.982 0.42 . . . . 72.349999999999994 111.126 170.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.91 25.74 75.21 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.254 -0.498 . . . . 74.420000000000002 113.234 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.06 10.89 12.96 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.928 0.344 . . . . 74.400000000000006 111.928 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.457 HD23 HD12 ' A' ' 135' ' ' LEU . 97.0 mt -120.17 119.96 34.79 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.838 0.351 . . . . 74.329999999999998 111.438 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 31.5 t -81.05 159.49 24.77 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.554 -0.294 . . . . 74.219999999999999 110.72 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -54.61 -40.54 69.0 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.169 0.803 . . . . 72.150000000000006 113.169 -173.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.32 91.9 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.071 0.462 . . . . 75.420000000000002 111.247 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' A' ' 29' ' ' SER . 18.4 mp0 -66.93 -41.05 87.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.786 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.97 -44.05 91.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.968 0.413 . . . . 72.439999999999998 110.713 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -57.56 -57.58 12.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.754 -0.657 . . . . 75.319999999999993 111.552 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.73 -47.17 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.154 -0.475 . . . . 74.299999999999997 111.771 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.462 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.2 ttm -61.78 -51.56 67.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.528 -0.305 . . . . 74.049999999999997 111.662 -177.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -64.82 -35.76 82.15 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 121.01 -0.276 . . . . 63.509999999999998 111.326 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.77 -47.21 87.48 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.997 -0.62 . . . . 52.329999999999998 112.691 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.49 ' O ' HG13 ' A' ' 43' ' ' ILE . 7.4 mtp180 -67.06 -49.71 64.22 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.782 0.289 . . . . 74.430000000000007 111.782 176.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 36' ' ' MET . 91.2 mt -56.31 -41.18 75.55 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.267 0.556 . . . . 74.239999999999995 111.404 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -61.87 -46.63 88.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.078 -0.51 . . . . 75.349999999999994 110.419 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.21 86.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.984 0.421 . . . . 74.0 111.437 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 39' ' ' ARG . 75.9 mt -58.14 -49.8 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.365 -0.38 . . . . 75.519999999999996 111.434 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 26.3 ttp85 -69.09 -25.74 64.58 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.853 0.316 . . . . 75.299999999999997 111.853 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.9 t -83.28 -33.42 25.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.089 0.471 . . . . 73.109999999999999 111.892 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.7 t -97.24 -67.22 0.86 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.139 0.495 . . . . 73.439999999999998 111.672 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -74.27 -16.47 60.94 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.264 -0.425 . . . . 74.299999999999997 111.386 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 71.02 9.88 6.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.205 0.602 . . . . 74.329999999999998 112.087 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.857 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 85.8 t -81.41 122.52 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.98 0.419 . . . . 75.329999999999998 111.861 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.71 96.66 7.61 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.178 0.513 . . . . 73.219999999999999 110.226 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -111.94 105.13 13.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.909 -0.587 . . . . 73.400000000000006 110.863 -175.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.04 145.4 29.94 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.58 0.585 . . . . 73.129999999999995 112.58 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.53 107.76 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.022 0.439 . . . . 73.140000000000001 110.902 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.67 134.94 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.846 0.355 . . . . 74.010000000000005 111.53 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.403 ' HG1' ' HA ' ' A' ' 23' ' ' ASP . 62.9 p -113.52 122.53 47.56 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.753 0.311 . . . . 72.329999999999998 111.111 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -130.23 137.0 29.89 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 120.848 0.356 . . . . 75.310000000000002 111.542 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.09 -53.94 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.598 2.199 . . . . 65.010000000000005 113.264 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 20.3 m -141.75 136.11 30.42 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.17 -0.331 . . . . 73.209999999999994 111.649 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.469 HD12 ' NE2' ' A' ' 94' ' ' GLN . 31.9 pt -106.81 -28.91 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.92 0.39 . . . . 75.030000000000001 110.89 174.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.29 -116.53 7.18 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.124 -0.489 . . . . 44.420000000000002 114.229 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.78 -23.33 66.69 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.348 0.499 . . . . 72.349999999999994 112.348 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.28 128.17 86.53 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.4 0.519 . . . . 65.109999999999999 112.4 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.696 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 61.2 Cg_endo -73.38 136.11 23.49 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.581 2.187 . . . . 72.540000000000006 112.156 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.1 tp -52.57 -47.71 66.67 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.979 0.733 . . . . 74.200000000000003 112.979 -174.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.3 -58.24 8.44 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.132 -0.355 . . . . 71.109999999999999 111.628 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.696 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 1.8 m-20 -59.71 -29.79 68.35 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.743 0.306 . . . . 72.540000000000006 111.507 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CE2' ' HD3' ' A' ' 6' ' ' PRO . 26.5 t80 -61.52 -55.35 32.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.309 -0.405 . . . . 73.329999999999998 110.768 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.2 p -57.3 -39.85 76.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.297 -0.411 . . . . 74.230000000000004 111.325 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.494 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 53.9 tp -57.79 -53.98 52.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.4 -0.364 . . . . 74.439999999999998 111.469 177.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -51.87 -52.66 48.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.909 0.385 . . . . 72.219999999999999 111.673 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.404 HD23 HD23 ' A' ' 87' ' ' LEU . 33.6 tp -63.04 -38.61 91.89 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 111.3 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.86 -44.19 93.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.293 -0.412 . . . . 71.25 111.793 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 20.6 mtm180 -66.95 -40.67 87.59 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.798 0.332 . . . . 75.150000000000006 110.927 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.447 HE22 ' HA ' ' A' ' 7' ' ' GLU . 7.7 tt0 -58.64 -42.06 87.42 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.016 0.436 . . . . 73.340000000000003 111.402 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -87.29 7.39 28.87 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.354 0.502 . . . . 71.329999999999998 112.354 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.71 -42.58 3.14 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.125 -0.559 . . . . 74.310000000000002 113.921 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 113.647 0.98 . . . . 72.299999999999997 113.647 -176.105 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.412 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 53.3 t30 . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 109.392 -0.595 . . . . 73.120000000000005 109.392 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -53.65 -93.03 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 112.761 0.652 . . . . 73.010000000000005 112.761 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.857 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.1 m-20 -78.52 74.86 5.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.572 -0.705 . . . . 60.32 111.945 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.19 139.15 9.86 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.166 -0.54 . . . . 55.210000000000001 113.174 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 99' ' ' PHE . 47.7 tp -152.89 127.84 9.64 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.889 0.376 . . . . 75.140000000000001 111.131 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.404 HD23 HD23 ' A' ' 71' ' ' LEU . 64.0 tp -117.39 124.55 49.14 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.936 0.398 . . . . 74.519999999999996 112.045 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 45.4 tp -111.89 121.55 45.34 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.085 -0.507 . . . . 74.519999999999996 110.78 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.8 t -122.93 121.96 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 120.821 0.343 . . . . 75.329999999999998 111.82 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.669 ' HA ' HG13 ' A' ' 97' ' ' VAL . 35.0 tp -96.21 118.46 32.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.173 -0.467 . . . . 71.140000000000001 111.282 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.2 t -103.61 100.1 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.634 0.254 . . . . 75.109999999999999 111.099 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.8 tp -54.01 -40.65 67.19 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.119 0.485 . . . . 73.400000000000006 111.474 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 25.3 t70 -48.38 -30.69 5.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.523 0.729 . . . . 73.430000000000007 112.872 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 43.2 mt-30 -125.5 1.56 7.63 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.361 -0.212 . . . . 75.140000000000001 111.557 -178.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 9.3 ptp180 47.06 27.15 0.72 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.088 0.955 . . . . 73.140000000000001 112.278 -173.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 90.5 mtt180 -117.04 154.59 30.7 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.041 0.448 . . . . 74.219999999999999 111.498 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.669 HG13 ' HA ' ' A' ' 90' ' ' LEU . 4.1 m -134.32 171.26 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.912 -0.585 . . . . 75.420000000000002 111.328 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -152.29 144.42 23.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.831 0.348 . . . . 73.109999999999999 111.681 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.679 ' HB3' HD11 ' A' ' 86' ' ' LEU . 77.9 m-85 -104.49 105.58 15.75 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.991 -0.55 . . . . 73.109999999999999 110.372 173.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -83.13 112.58 19.95 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.118 -0.364 . . . . 75.5 110.308 177.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 109' ' ' LEU . 1.6 p -88.9 143.36 26.93 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.374 0.879 . . . . 72.239999999999995 113.374 -176.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -90.87 -177.97 43.66 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 114.894 -1.048 . . . . 71.519999999999996 112.384 168.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -60.93 -25.06 66.51 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.588 0.588 . . . . 74.420000000000002 112.588 -175.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.4 -22.85 57.95 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.886 -0.674 . . . . 74.120000000000005 113.413 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 86' ' ' LEU . 93.5 mt -108.84 4.77 23.89 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.535 0.569 . . . . 74.549999999999997 112.535 -174.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -56.79 -38.63 72.81 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.043 0.449 . . . . 74.120000000000005 111.889 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.85 -42.7 10.78 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.317 -0.468 . . . . 70.140000000000001 113.382 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -72.07 -41.7 67.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.137 0.494 . . . . 75.519999999999996 111.791 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.605 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.0 mt -131.75 83.9 56.21 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 115.974 -0.557 . . . . 74.400000000000006 111.991 -170.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.49 155.81 24.82 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.402 2.068 . . . . 60.439999999999998 112.365 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.0 -36.2 12.29 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.511 0.56 . . . . 74.319999999999993 112.511 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.46 -50.12 69.99 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.126 -0.559 . . . . 74.409999999999997 112.912 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.52 -42.71 99.22 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.276 0.56 . . . . 74.540000000000006 111.028 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.659 HD13 ' HB2' ' A' ' 99' ' ' PHE . 65.5 mt -62.43 -40.75 97.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.665 -0.698 . . . . 75.129999999999995 111.132 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.4 m -71.22 -32.25 68.58 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.178 -0.465 . . . . 75.049999999999997 111.419 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -56.02 -55.95 26.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.729 -0.214 . . . . 71.239999999999995 111.002 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.7 mt -51.0 -47.11 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.137 0.494 . . . . 72.420000000000002 111.031 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.564 ' O ' HG12 ' A' ' 123' ' ' ILE . 61.1 mt -55.97 -51.51 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.8 -0.636 . . . . 73.25 111.615 177.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -81.57 -11.45 59.15 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.944 0.72 . . . . 73.439999999999998 112.944 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -86.48 -52.42 5.59 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.788 0.292 . . . . 71.340000000000003 111.788 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.99 -39.86 2.06 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.109 0.781 . . . . 74.430000000000007 113.109 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.51 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 45.3 mtt -51.52 -52.64 45.23 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.664 0.616 . . . . 73.129999999999995 112.664 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.635 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 49.9 mm -53.01 -56.8 19.98 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 111.992 0.367 . . . . 73.400000000000006 111.992 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 82.6 Cg_exo -48.09 -47.08 20.35 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.301 2.001 . . . . 71.049999999999997 113.328 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -62.97 -49.19 75.68 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.695 0.284 . . . . 75.0 111.637 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.1 m-30 -57.49 -42.31 82.45 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.819 0.303 . . . . 73.519999999999996 111.819 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 70.5 mtp180 -66.66 -30.77 71.11 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.999 0.428 . . . . 71.430000000000007 111.152 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.9 m -78.08 -14.09 59.62 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.399 -0.364 . . . . 75.120000000000005 111.478 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.18 -7.02 62.02 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.292 -0.48 . . . . 72.230000000000004 112.473 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.719 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.9 m-20 -79.78 57.01 2.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.866 0.365 . . . . 74.510000000000005 111.602 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -61.63 -37.79 85.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.915 0.388 . . . . 71.239999999999995 111.322 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.404 ' HB1' ' HG2' ' A' ' 32' ' ' GLN . . . -64.87 -49.83 68.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.164 -0.471 . . . . 65.239999999999995 111.376 176.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.719 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 14.6 mp0 -63.03 -35.47 80.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.954 -0.566 . . . . 72.540000000000006 111.69 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.91 -55.12 30.1 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.152 -0.547 . . . . 72.530000000000001 112.352 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.457 HD12 HD23 ' A' ' 28' ' ' LEU . 89.0 mt -58.64 -38.17 77.52 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.39 -0.477 . . . . 73.510000000000005 110.949 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 58.0 m -60.02 -47.54 85.43 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.119 -0.491 . . . . 61.549999999999997 112.088 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.19 -36.02 66.47 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.102 -0.374 . . . . 73.0 111.207 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.452 ' HA3' ' HE2' ' A' ' 122' ' ' MET . . . -60.36 -49.73 75.38 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.31 -0.472 . . . . 71.319999999999993 113.031 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 135' ' ' LEU . 53.2 t -53.11 -47.76 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.055 0.455 . . . . 73.209999999999994 111.255 175.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 53.6 tp -62.8 -42.86 99.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.125 -0.489 . . . . 75.319999999999993 110.805 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.78 -47.68 84.71 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.962 0.41 . . . . 63.229999999999997 111.585 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.82 -47.37 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.331 -0.395 . . . . 64.299999999999997 111.246 176.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -56.67 -40.53 75.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.417 -0.356 . . . . 75.140000000000001 111.464 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 18.3 mm-40 -53.98 -35.13 61.49 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.195 0.442 . . . . 74.200000000000003 112.195 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.98 -42.23 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 120.993 0.425 . . . . 74.0 111.014 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.5 mt -71.08 -44.89 64.79 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.094 0.473 . . . . 74.120000000000005 111.218 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 116.067 -0.515 . . . . 62.039999999999999 111.768 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 121.408 0.623 . . . . 64.310000000000002 111.533 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -72.78 157.71 36.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.486 -0.779 . . . . 71.519999999999996 112.592 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.666 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 33.8 mmtp -136.58 160.76 65.37 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 114.965 -1.016 . . . . 72.319999999999993 109.808 174.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.88 -41.41 63.34 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.396 2.064 . . . . 74.519999999999996 112.834 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -86.49 7.65 25.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.979 0.419 . . . . 71.129999999999995 111.758 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.666 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 29.8 t70 -106.03 -34.26 7.63 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.166 0.508 . . . . 74.319999999999993 110.268 174.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 5' ' ' LYS . 65.1 t -65.89 129.58 94.3 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.675 -0.693 . . . . 75.510000000000005 111.503 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.44 123.99 13.84 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.498 2.132 . . . . 75.25 112.497 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -69.67 91.39 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.058 0.456 . . . . 75.530000000000001 111.947 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -69.98 -38.37 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.278 -0.419 . . . . 75.120000000000005 111.971 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 14.3 mm100 -64.77 170.25 4.35 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.8 -0.562 . . . . 62.439999999999998 110.79 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 20.2 mt 73.88 -41.6 0.49 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.423 0.527 . . . . 74.439999999999998 112.423 -173.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.09 -62.89 1.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.297 0.48 . . . . 73.519999999999996 112.297 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -84.76 32.39 0.52 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.113 0.482 . . . . 64.409999999999997 111.715 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -71.42 12.92 0.28 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.549 0.574 . . . . 71.120000000000005 112.549 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.2 p -77.47 -42.55 35.41 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.91 0.386 . . . . 74.409999999999997 110.974 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -98.71 -32.6 11.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.114 -0.494 . . . . 71.340000000000003 112.033 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.593 HD21 ' HG3' ' A' ' 44' ' ' ARG . 5.3 mp 62.18 11.98 4.77 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.069 0.396 . . . . 73.239999999999995 112.069 -176.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.07 136.03 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.797 0.332 . . . . 72.519999999999996 111.688 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.505 HG21 ' HG2' ' A' ' 24' ' ' GLU . 24.8 m -110.81 106.71 15.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.42 -0.355 . . . . 75.099999999999994 110.417 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -95.94 78.01 3.19 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.432 0.634 . . . . 65.129999999999995 112.361 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.505 ' HG2' HG21 ' A' ' 22' ' ' THR . 21.0 mm-40 -102.45 -46.65 4.71 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.042 0.449 . . . . 74.450000000000003 110.909 176.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.36 -23.74 67.54 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.168 0.433 . . . . 62.0 112.168 174.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.87 33.8 88.04 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.367 -0.444 . . . . 75.530000000000001 113.481 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.476 HD13 ' HB2' ' A' ' 92' ' ' LEU . 94.3 mt -92.02 12.62 21.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.09 0.404 . . . . 70.230000000000004 112.09 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -121.62 125.78 47.5 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.04 0.448 . . . . 75.310000000000002 111.472 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.3 t -77.26 172.29 13.51 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.121 -0.491 . . . . 65.439999999999998 110.712 173.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -54.72 -47.62 73.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.985 0.422 . . . . 54.310000000000002 111.331 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' O ' HG21 ' A' ' 35' ' ' VAL . . . -63.74 -48.28 77.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.41 -0.359 . . . . 64.5 111.533 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -59.69 -42.84 93.87 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.15 0.5 . . . . 72.109999999999999 111.339 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -64.84 -47.44 77.94 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.623 -0.717 . . . . 72.329999999999998 109.949 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.98 -53.76 54.4 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.168 -0.469 . . . . 74.519999999999996 111.982 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 31' ' ' ALA . 99.0 t -54.8 -47.16 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.961 0.41 . . . . 75.450000000000003 111.246 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.448 ' HE2' ' HB3' ' A' ' 135' ' ' LEU . 44.1 ttm -63.01 -42.97 99.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.442 -0.344 . . . . 74.310000000000002 111.227 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.416 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -57.09 -48.66 78.06 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.969 0.414 . . . . 74.209999999999994 111.094 176.382 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.9 -47.19 90.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.155 -0.475 . . . . 73.5 113.002 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 43' ' ' ILE . 99.6 mtt180 -62.6 -54.84 33.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 111.901 0.334 . . . . 74.340000000000003 111.901 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' A' ' 51' ' ' PHE . 70.9 mt -58.2 -48.17 81.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.868 0.366 . . . . 71.200000000000003 111.419 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -58.21 -47.05 84.68 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.331 -0.395 . . . . 62.539999999999999 111.098 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.9 -45.11 86.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.195 -0.457 . . . . 72.129999999999995 111.339 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.565 HG21 ' HB ' ' A' ' 49' ' ' VAL . 64.3 mt -65.97 -46.32 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.086 0.469 . . . . 71.310000000000002 111.274 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.593 ' HG3' HD21 ' A' ' 20' ' ' LEU . 5.5 tmm_? -65.9 -26.04 67.43 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 111.417 -176.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 t -91.77 -54.54 3.83 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.807 0.337 . . . . 75.230000000000004 111.549 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.3 t -67.63 -58.8 4.05 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.307 0.484 . . . . 74.010000000000005 112.307 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.49 -11.29 52.15 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.396 -0.365 . . . . 72.530000000000001 111.5 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.08 24.04 12.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.905 0.482 . . . . 51.020000000000003 111.993 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.565 ' HB ' HG21 ' A' ' 43' ' ' ILE . 90.2 t -96.28 117.28 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.24 -0.436 . . . . 73.239999999999995 111.576 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.03 96.16 2.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.082 0.467 . . . . 72.230000000000004 110.432 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.418 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -104.44 98.59 8.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.769 -0.65 . . . . 74.140000000000001 109.984 -179.063 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -102.52 119.71 39.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.1 0.407 . . . . 72.109999999999999 112.1 -175.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.454 HG23 HD23 ' A' ' 88' ' ' LEU . 96.0 t -104.91 110.86 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.282 0.563 . . . . 73.129999999999995 111.4 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.449 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 48.4 t -106.55 121.93 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.08 -0.509 . . . . 63.329999999999998 111.081 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 p -106.58 121.87 45.17 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.816 0.341 . . . . 74.340000000000003 110.92 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -126.4 139.63 35.13 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.553 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.55 -56.68 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.335 2.024 . . . . 70.319999999999993 112.86 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.6 p -144.96 139.48 27.57 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 111.933 0.345 . . . . 74.099999999999994 111.933 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.593 HG12 HG13 ' A' ' 91' ' ' VAL . 35.3 pt -117.65 -10.84 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 121.112 0.482 . . . . 73.349999999999994 110.826 171.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.27 -127.99 32.93 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.177 -0.465 . . . . 64.129999999999995 114.04 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.81 -16.62 63.84 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.841 0.682 . . . . 72.340000000000003 112.841 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.12 130.6 50.5 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 112.936 0.717 . . . . 54.140000000000001 112.936 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.629 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 60.6 Cg_endo -72.0 133.19 21.09 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.747 2.298 . . . . 73.239999999999995 112.054 174.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.57 -48.19 82.1 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.934 0.716 . . . . 73.409999999999997 112.934 -171.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -67.85 -45.87 73.4 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.117 -0.364 . . . . 73.329999999999998 111.918 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.629 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 33.3 m-20 -61.85 -37.85 86.04 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.979 0.418 . . . . 62.140000000000001 110.857 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.46 -50.07 75.05 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.125 -0.489 . . . . 72.340000000000003 111.042 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 78.0 p -63.14 -48.33 78.91 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.594 -0.275 . . . . 63.409999999999997 111.313 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.487 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 54.4 tp -54.87 -46.73 74.77 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.097 0.475 . . . . 72.310000000000002 111.196 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -54.86 -49.51 70.93 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.003 0.43 . . . . 74.319999999999993 111.66 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 tp -67.97 -36.61 80.35 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.054 -0.521 . . . . 74.219999999999999 111.639 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 77' ' ' VAL . . . -67.77 -39.94 84.08 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.388 -0.369 . . . . 71.0 111.776 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 41.1 mtp-105 -57.43 -54.23 49.18 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.077 0.399 . . . . 74.25 112.077 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.446 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.5 pt20 -64.28 -23.04 67.16 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.347 0.499 . . . . 75.409999999999997 112.347 -177.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.446 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 40.8 m0 -92.17 -15.29 27.82 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.809 0.3 . . . . 75.200000000000003 111.809 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.71 30.03 60.43 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.226 -0.512 . . . . 74.120000000000005 113.122 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 3.4 t . . . . . 0 N--CA 1.475 0.819 0 C-N-CA 123.0 0.52 . . . . 74.200000000000003 109.725 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.411 ' H ' ' HA3' ' A' ' 102' ' ' GLY . 6.1 m120 . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 121.312 0.577 . . . . 74.540000000000006 112.306 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.411 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.2 OUTLIER -83.65 136.32 34.26 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.382 -0.372 . . . . 71.319999999999993 111.631 176.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.602 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 2.0 m-20 52.29 21.89 1.82 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.944 0.72 . . . . 71.340000000000003 112.944 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.66 129.43 9.89 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.205 -0.521 . . . . 60.140000000000001 113.176 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.593 HD12 ' HB3' ' A' ' 99' ' ' PHE . 39.8 tp -142.32 119.47 11.43 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.193 0.521 . . . . 75.099999999999994 111.441 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.8 tp -107.2 139.88 40.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.368 -0.378 . . . . 73.430000000000007 111.279 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.454 HD23 HG23 ' A' ' 53' ' ' VAL . 53.5 tp -131.76 114.06 14.29 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.529 -0.305 . . . . 75.019999999999996 111.04 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.27 121.51 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.076 0.399 . . . . 73.219999999999999 112.076 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.577 ' HA ' HG13 ' A' ' 97' ' ' VAL . 24.1 tp -101.37 129.29 47.34 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 111.223 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.593 HG13 HG12 ' A' ' 59' ' ' ILE . 31.9 t -115.02 99.2 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.92 0.39 . . . . 53.140000000000001 111.29 176.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.476 ' HB2' HD13 ' A' ' 27' ' ' LEU . 67.1 tp -51.54 -41.23 60.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.162 0.585 . . . . 72.120000000000005 112.357 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.22 -43.15 52.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.407 0.683 . . . . 71.140000000000001 112.748 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -118.54 8.51 12.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.104 0.409 . . . . 72.209999999999994 112.104 -174.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 59.46 20.02 8.41 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.706 1.002 . . . . 74.140000000000001 113.706 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -122.17 154.23 37.73 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.669 -0.644 . . . . 73.439999999999998 112.194 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.761 HG23 ' SD ' ' A' ' 122' ' ' MET . 6.3 m -129.24 171.39 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.654 -0.703 . . . . 64.329999999999998 111.382 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -147.66 130.08 15.76 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.34 -0.391 . . . . 74.030000000000001 111.842 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.698 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 93.8 m-85 -90.45 141.95 28.23 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.922 -0.581 . . . . 73.040000000000006 109.441 168.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -133.04 112.29 11.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.961 0.41 . . . . 73.450000000000003 111.914 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.584 HG21 HD13 ' A' ' 86' ' ' LEU . 17.5 p -106.83 142.02 37.13 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.008 -0.542 . . . . 63.420000000000002 111.223 175.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA3' ' H ' ' A' ' 82' ' ' ASN . . . -87.37 -83.98 1.17 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.805 -0.712 . . . . 63.409999999999997 113.724 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -137.1 -41.53 0.58 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.004 0.43 . . . . 75.219999999999999 111.397 -174.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.602 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -58.52 -39.43 93.11 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.257 -0.429 . . . . 72.340000000000003 114.071 -175.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.514 HD12 HG12 ' A' ' 49' ' ' VAL . 93.3 mt -91.97 -2.6 56.66 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.013 0.746 . . . . 74.439999999999998 113.013 -174.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -57.64 -21.66 40.99 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.556 0.576 . . . . 73.209999999999994 112.556 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.74 -28.58 56.76 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.91 -0.662 . . . . 71.439999999999998 112.894 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -109.97 -60.31 1.81 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.898 0.38 . . . . 64.549999999999997 111.043 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.425 HD13 HD13 ' A' ' 105' ' ' LEU . 16.3 mt -111.77 88.31 9.53 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.171 0.588 . . . . 72.030000000000001 111.563 -178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.16 152.26 18.39 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.969 1.779 . . . . 61.409999999999997 112.102 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -47.85 -36.32 11.81 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.685 0.279 . . . . 70.200000000000003 111.709 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.17 -49.9 73.52 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.253 -0.499 . . . . 61.420000000000002 113.182 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.73 -44.58 96.46 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.259 0.552 . . . . 74.439999999999998 111.045 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.698 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 66.6 mt -60.54 -44.54 96.0 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.753 -0.658 . . . . 64.209999999999994 110.874 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -59.74 -38.29 81.32 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.823 -0.626 . . . . 74.319999999999993 110.934 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.4 ttt-85 -60.27 -56.23 24.04 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.068 -0.514 . . . . 74.349999999999994 110.947 175.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 60.2 mt -51.01 -39.48 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 120.821 0.343 . . . . 75.329999999999998 111.784 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.524 ' O ' HG12 ' A' ' 123' ' ' ILE . 77.6 mt -55.84 -56.17 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.53 -0.305 . . . . 75.150000000000006 111.033 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -77.4 -23.59 50.63 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.382 0.512 . . . . 72.120000000000005 112.382 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -78.25 -40.31 37.58 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.164 0.431 . . . . 62.32 112.164 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 -126.12 -54.18 1.5 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.262 0.838 . . . . 73.129999999999995 113.262 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.761 ' SD ' HG23 ' A' ' 97' ' ' VAL . 38.5 mtt -59.21 -53.65 55.91 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.052 0.76 . . . . 71.010000000000005 113.052 -175.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.62 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 mm -53.86 -53.4 58.26 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 111.677 0.251 . . . . 74.120000000000005 111.677 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 92.3 Cg_exo -47.68 -48.18 16.45 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 122.287 1.991 . . . . 71.310000000000002 113.423 174.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -62.5 -46.96 86.07 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.706 0.262 . . . . 72.219999999999999 111.706 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -60.69 -41.33 94.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.738 0.304 . . . . 75.409999999999997 111.361 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 79.8 mtp180 -63.2 -31.43 72.58 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.045 0.45 . . . . 75.120000000000005 111.27 176.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.2 t -82.87 -18.37 40.54 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.261 -0.427 . . . . 64.340000000000003 111.449 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.88 1.92 34.27 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.545 -0.359 . . . . 73.510000000000005 113.571 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.863 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 85.7 m-20 -94.07 82.07 4.16 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.411 -0.464 . . . . 74.420000000000002 112.152 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -71.53 -53.63 13.18 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.225 -0.297 . . . . 74.209999999999994 111.455 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.79 -45.96 85.3 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.093 0.473 . . . . 65.400000000000006 111.554 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 7.1 tp10 -56.21 -53.16 60.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.041 -0.527 . . . . 72.340000000000003 111.178 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.87 -43.64 96.52 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.409 -0.424 . . . . 74.340000000000003 113.514 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.499 HD13 HD21 ' A' ' 90' ' ' LEU . 93.8 mt -59.77 -56.48 21.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.03 0.443 . . . . 73.420000000000002 111.413 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 30.8 t -56.18 -54.31 46.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.382 0.512 . . . . 74.400000000000006 112.382 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -30.25 60.96 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 111.576 0.213 . . . . 74.420000000000002 111.576 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.87 -48.0 86.6 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.201 -0.523 . . . . 52.210000000000001 112.408 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.3 t -57.79 -44.94 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.132 0.491 . . . . 75.420000000000002 110.606 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.3 tp -58.44 -37.4 75.34 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.953 -0.567 . . . . 61.509999999999998 111.391 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.6 97.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.092 0.472 . . . . 74.0 111.173 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.406 HG13 HD21 ' A' ' 109' ' ' LEU . 63.8 t -65.77 -45.93 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.788 -0.642 . . . . 75.239999999999995 110.764 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -53.87 -43.33 69.5 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.789 -0.641 . . . . 75.540000000000006 111.255 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -52.35 -41.0 62.69 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.277 0.473 . . . . 73.519999999999996 112.277 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.11 -36.4 76.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.871 0.367 . . . . 74.129999999999995 111.666 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.0 -54.82 24.35 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.601 -0.272 . . . . 74.209999999999994 111.324 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 CA--C 1.543 0.675 0 CA-C-O 120.848 0.356 . . . . 73.420000000000002 111.948 176.983 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' HG3' ' OG ' ' A' ' 58' ' ' SER . 49.6 ttm . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.964 0.412 . . . . 74.439999999999998 111.625 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -110.56 122.51 47.94 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.581 -0.281 . . . . 73.120000000000005 110.679 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.7 t -72.47 127.17 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.329 0.585 . . . . 71.349999999999994 112.106 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -113.35 144.62 42.45 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.937 -0.574 . . . . 71.129999999999995 111.75 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.697 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 9.8 mtmp? -122.29 171.18 6.71 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 115.648 -0.705 . . . . 74.209999999999994 109.693 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.697 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 4.4 Cg_endo -45.61 -49.84 10.16 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.769 2.313 . . . . 72.310000000000002 113.963 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.79 10.78 10.56 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.421 0.526 . . . . 74.239999999999995 112.421 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 5' ' ' LYS . 38.6 m-20 -95.14 -14.86 23.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.082 0.467 . . . . 74.239999999999995 110.579 168.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.476 HG22 HD22 ' A' ' 56' ' ' LEU . 38.9 t -89.03 128.67 51.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.085 -0.507 . . . . 75.450000000000003 110.453 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.59 118.44 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.225 1.95 . . . . 70.299999999999997 112.29 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -63.82 78.48 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.032 0.444 . . . . 62.299999999999997 111.759 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ASP . 35.7 m -63.76 -39.45 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 111.981 0.363 . . . . 73.439999999999998 111.981 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.417 HE22 ' HG ' ' A' ' 20' ' ' LEU . 27.0 mm-40 -72.93 6.2 2.78 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.907 -0.496 . . . . 64.239999999999995 111.941 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.486 ' O ' HD21 ' A' ' 14' ' ' LEU . 8.9 tt -94.75 -20.99 19.03 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.354 0.597 . . . . 74.420000000000002 109.773 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.85 -56.0 0.56 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.828 -0.624 . . . . 72.510000000000005 111.653 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' VAL . 8.1 m-20 -78.49 77.96 4.96 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.034 0.445 . . . . 73.010000000000005 111.925 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.0 p -90.09 -11.22 41.99 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.623 0.249 . . . . 73.25 111.654 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -102.04 -8.85 21.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.822 0.304 . . . . 74.030000000000001 111.822 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -99.44 -58.6 1.89 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.975 0.417 . . . . 74.329999999999998 110.856 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.417 ' HG ' HE22 ' A' ' 13' ' ' GLN . 5.3 mp 70.03 -16.2 0.3 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.274 0.842 . . . . 71.439999999999998 113.274 175.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.3 t -86.0 144.14 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.111 -0.368 . . . . 74.400000000000006 111.513 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -145.28 103.12 3.81 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.379 -0.373 . . . . 74.150000000000006 111.271 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.423 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 26.1 t70 -103.36 109.63 21.32 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.999 0.428 . . . . 74.099999999999994 111.478 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -111.45 -29.88 7.61 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.089 -0.505 . . . . 75.209999999999994 110.708 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.29 -31.46 67.51 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.74 0.644 . . . . 74.239999999999995 112.74 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.88 25.77 51.69 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.899 -0.667 . . . . 75.409999999999997 112.231 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.477 HD13 HD12 ' A' ' 92' ' ' LEU . 97.8 mt -96.41 -33.61 11.83 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.733 0.302 . . . . 73.540000000000006 111.109 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.83 -176.02 5.88 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.183 0.516 . . . . 75.219999999999999 111.323 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.0 t -152.69 158.68 42.71 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.787 -0.449 . . . . 71.219999999999999 109.787 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -45.06 -48.86 11.8 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.521 0.563 . . . . 73.230000000000004 112.521 -173.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 35' ' ' VAL . . . -57.51 -55.91 28.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.86 0.362 . . . . 72.439999999999998 111.776 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -57.34 -42.73 82.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.991 0.424 . . . . 75.230000000000004 111.496 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -64.47 -46.45 83.01 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.122 -0.49 . . . . 60.5 111.533 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.485 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 18.9 tp10 -65.53 -41.12 93.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.863 0.363 . . . . 74.310000000000002 111.524 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 31' ' ' ALA . 96.6 t -62.4 -39.66 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.116 0.484 . . . . 74.019999999999996 110.468 174.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.5 ttm -68.26 -36.86 80.07 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 111.028 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 34' ' ' GLU . 92.7 m-20 -56.11 -47.23 78.48 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.969 0.414 . . . . 73.019999999999996 110.46 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.41 -37.9 92.69 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.04 -0.6 . . . . 71.319999999999993 112.786 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.443 ' O ' HG13 ' A' ' 43' ' ' ILE . 66.5 mtt180 -65.95 -54.54 24.96 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.824 0.345 . . . . 74.5 111.251 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.97 -42.72 99.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.858 0.361 . . . . 74.209999999999994 111.472 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -61.69 -40.45 95.04 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.334 -0.394 . . . . 74.099999999999994 111.292 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.34 92.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.894 0.378 . . . . 73.439999999999998 110.981 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.615 HG21 ' HB ' ' A' ' 49' ' ' VAL . 51.5 mt -67.7 -39.39 82.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.085 0.469 . . . . 73.400000000000006 110.85 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.453 ' NH1' ' HG2' ' A' ' 50' ' ' GLU . 8.9 tpt180 -59.06 -29.86 67.63 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.762 -0.654 . . . . 75.430000000000007 111.407 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.1 t -93.64 -66.48 0.92 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.266 -0.424 . . . . 64.340000000000003 111.474 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 37.3 t -50.37 -60.95 2.48 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.371 0.508 . . . . 60.539999999999999 112.371 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -94.88 -3.1 49.39 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.477 -0.329 . . . . 74.200000000000003 111.601 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 63.83 13.41 7.49 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.364 0.505 . . . . 75.420000000000002 112.364 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.615 ' HB ' HG21 ' A' ' 43' ' ' ILE . 63.3 t -84.83 128.29 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.334 0.494 . . . . 63.030000000000001 112.334 -174.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' HG2' ' NH1' ' A' ' 44' ' ' ARG . 29.9 mt-10 -80.2 95.35 6.25 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.066 -0.515 . . . . 71.439999999999998 110.026 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -112.81 103.23 11.23 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.868 0.366 . . . . 75.120000000000005 110.733 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.85 133.81 49.03 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.19 0.441 . . . . 74.519999999999996 112.19 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.59 127.72 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.363 -0.38 . . . . 74.0 111.042 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.0 t -127.64 139.58 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.798 0.332 . . . . 74.430000000000007 111.354 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.423 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 19.6 p -124.04 130.22 52.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.701 0.286 . . . . 72.510000000000005 110.368 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.476 HD22 HG22 ' A' ' 9' ' ' VAL . 71.7 mt -125.71 142.72 42.88 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-O 120.724 0.297 . . . . 75.540000000000006 111.644 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.491 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 32.5 Cg_exo -61.89 -49.16 7.22 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.549 2.166 . . . . 70.439999999999998 112.175 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.463 ' OG ' ' HG3' ' A' ' 1' ' ' MET . 46.8 m -155.17 145.8 22.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.235 -0.439 . . . . 70.099999999999994 111.733 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.604 HG12 HG13 ' A' ' 91' ' ' VAL . 32.1 pt -112.4 -5.08 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.093 0.473 . . . . 72.140000000000001 110.71 170.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.27 -109.95 2.97 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 115.929 -0.578 . . . . 73.420000000000002 113.113 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -108.72 2.25 21.69 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.213 0.449 . . . . 75.109999999999999 112.213 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.95 140.39 97.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.186 0.439 . . . . 75.040000000000006 112.186 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.505 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 47.4 Cg_endo -68.49 121.44 8.38 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.359 2.039 . . . . 73.340000000000003 112.266 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.8 tp -58.64 -51.22 70.86 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.849 0.685 . . . . 72.140000000000001 112.849 -174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.404 ' HG2' ' HE ' ' A' ' 98' ' ' ARG . 38.8 mt-10 -62.84 -48.24 79.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.852 0.358 . . . . 73.129999999999995 111.58 -178.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.505 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 6.1 m-20 -61.99 -37.48 84.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.698 0.285 . . . . 63.329999999999998 111.542 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.488 ' HE2' ' HA ' ' A' ' 5' ' ' LYS . 41.3 t80 -56.06 -53.79 52.82 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.876 0.37 . . . . 73.030000000000001 111.358 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.49 HG22 ' HB3' ' A' ' 98' ' ' ARG . 70.3 p -55.0 -46.2 75.15 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.289 -0.414 . . . . 74.120000000000005 111.764 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 48.4 tp -58.62 -49.15 78.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.935 0.398 . . . . 64.400000000000006 111.357 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' HE3' ' HG3' ' A' ' 6' ' ' PRO . 29.0 mtpp -57.76 -43.24 85.35 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.798 0.332 . . . . 73.310000000000002 111.765 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.475 HD22 HD23 ' A' ' 87' ' ' LEU . 44.6 tp -67.96 -43.58 78.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.137 0.494 . . . . 71.420000000000002 111.302 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.45 95.31 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.237 0.458 . . . . 73.219999999999999 112.237 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 47.3 mtm180 -63.26 -47.1 83.81 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.147 0.425 . . . . 75.329999999999998 112.147 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.414 ' NE2' ' HB2' ' A' ' 6' ' ' PRO . 10.7 pt20 -67.81 -31.49 71.38 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.845 0.355 . . . . 75.219999999999999 111.639 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -76.41 -15.35 59.96 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.663 0.268 . . . . 75.109999999999999 111.682 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 79' ' ' ASN . . . 95.27 -37.02 3.54 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.192 -0.528 . . . . 64.120000000000005 113.0 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 45.1 t -54.35 -22.51 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.518 0.562 . . . . 75.140000000000001 112.518 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.62 22.69 4.33 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.223 -0.513 . . . . 73.150000000000006 112.918 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.427 ' HB2' ' HA2' ' A' ' 76' ' ' GLY . 18.8 t-20 -67.55 98.74 0.7 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.493 -0.416 . . . . 71.040000000000006 110.978 -177.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 44.88 64.19 1.46 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.808 -0.633 . . . . 73.239999999999995 111.355 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.578 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 3.3 mptp? 60.38 76.69 0.35 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.722 -0.672 . . . . 74.329999999999998 112.457 175.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 41.0 t30 -72.5 148.57 44.93 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.698 -0.683 . . . . 73.549999999999997 110.262 175.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.581 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.0 OUTLIER -56.35 -98.89 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 112.637 0.606 . . . . 72.030000000000001 112.637 -177.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.564 ' HB2' ' HA ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -86.02 81.64 8.41 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.894 -1.128 . . . . 73.420000000000002 111.074 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -147.47 142.68 10.43 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.63 -0.714 . . . . 74.420000000000002 112.873 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 99' ' ' PHE . 40.2 tp -151.47 128.73 11.23 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.806 0.442 . . . . 75.420000000000002 111.084 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.475 HD23 HD22 ' A' ' 71' ' ' LEU . 55.7 tp -109.28 144.29 37.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.948 0.404 . . . . 75.319999999999993 111.269 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.0 tp -130.43 125.96 35.79 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.312 -0.404 . . . . 75.209999999999994 110.414 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.6 t -127.0 125.09 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.878 0.371 . . . . 75.450000000000003 111.895 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.501 HD22 HD13 ' A' ' 135' ' ' LEU . 18.9 tp -101.0 134.1 44.5 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.928 -0.578 . . . . 74.329999999999998 110.531 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.604 HG13 HG12 ' A' ' 59' ' ' ILE . 48.2 t -118.92 109.67 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.803 0.335 . . . . 74.129999999999995 110.978 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 57' ' ' PRO . 67.4 tp -59.49 -44.19 93.12 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.938 0.718 . . . . 74.299999999999997 112.938 -174.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' A' ' 58' ' ' SER . 1.2 p-10 -69.12 -17.9 63.9 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.08 0.467 . . . . 75.329999999999998 111.478 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -103.86 -18.81 14.49 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.323 -0.399 . . . . 65.129999999999995 111.573 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 57.93 27.21 14.37 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.254 0.549 . . . . 64.530000000000001 111.688 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -121.61 157.66 30.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.18 0.514 . . . . 62.240000000000002 111.653 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.28 158.69 38.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.675 -0.693 . . . . 65.299999999999997 110.066 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.49 ' HB3' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -148.59 130.97 15.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.945 0.403 . . . . 74.310000000000002 111.262 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.554 ' HB3' HD11 ' A' ' 86' ' ' LEU . 89.1 m-85 -97.12 153.23 18.09 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.124 -0.489 . . . . 72.310000000000002 111.246 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.23 111.81 8.71 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 122.18 -0.325 . . . . 74.109999999999999 110.515 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.408 HG21 HD12 ' A' ' 86' ' ' LEU . 20.4 p -101.11 142.51 32.45 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.341 0.591 . . . . 70.349999999999994 111.974 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -75.54 -94.14 0.16 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.816 -0.707 . . . . 75.030000000000001 113.008 174.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.451 ' HB2' ' HB3' ' A' ' 81' ' ' LYS . 25.0 t80 -147.62 -29.39 0.34 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.174 0.511 . . . . 72.239999999999995 111.577 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.28 -12.74 83.95 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.054 -0.593 . . . . 71.019999999999996 113.122 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.605 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 96.3 mt -103.85 1.19 31.17 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.113 0.412 . . . . 75.200000000000003 112.113 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.27 -23.89 67.62 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.241 0.543 . . . . 65.329999999999998 111.22 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.84 7.72 81.36 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.131 -0.486 . . . . 72.209999999999994 113.179 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.605 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 29.3 m-85 -133.87 -62.69 0.76 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.301 0.572 . . . . 74.140000000000001 111.038 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.31 90.61 14.48 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.563 -0.744 . . . . 73.340000000000003 111.991 -174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.6 148.12 41.63 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 121.744 1.63 . . . . 73.329999999999998 112.226 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -48.68 -42.65 35.42 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.151 0.426 . . . . 74.230000000000004 112.151 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.79 -44.89 95.6 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.107 -0.568 . . . . 52.43 113.13 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.71 -50.54 72.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.117 0.484 . . . . 74.400000000000006 110.625 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.8 mt -57.77 -38.41 75.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 74.319999999999993 111.136 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.7 t -66.33 -38.37 87.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.15 -0.477 . . . . 72.409999999999997 110.959 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -65.6 -44.93 85.07 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.6 -0.273 . . . . 74.430000000000007 111.13 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 74.2 mt -50.96 -35.62 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.078 0.466 . . . . 72.540000000000006 111.212 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.492 ' O ' ' HB2' ' A' ' 122' ' ' MET . 64.6 mt -57.19 -48.46 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.09 -0.504 . . . . 70.340000000000003 110.786 174.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.434 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 31.2 m-70 -72.71 -33.82 66.71 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.389 -0.369 . . . . 71.400000000000006 111.857 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -72.36 -43.27 64.28 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.264 0.838 . . . . 72.120000000000005 113.264 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.419 HH21 ' CD ' ' A' ' 137' ' ' GLU . 15.7 mmm180 -118.45 -49.01 2.48 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.805 0.668 . . . . 72.540000000000006 112.805 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.746 ' HE2' ' HA3' ' A' ' 138' ' ' GLY . 13.2 mmt -59.67 -56.28 23.9 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.748 0.647 . . . . 74.209999999999994 112.748 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 118' ' ' ILE . 50.5 mm -55.26 -55.21 42.04 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 113.055 0.761 . . . . 74.510000000000005 113.055 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 9.8 Cg_endo -52.41 -32.98 54.7 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.282 1.988 . . . . 73.409999999999997 113.067 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 86.2 m-70 -79.85 -46.54 16.69 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.57 0.211 . . . . 74.140000000000001 111.57 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -56.8 -33.78 67.03 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.853 0.359 . . . . 75.25 111.323 178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 83.2 mtp180 -63.1 -39.44 94.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.028 0.442 . . . . 74.519999999999996 111.045 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.4 m -82.12 -11.37 58.79 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.408 -0.36 . . . . 62.100000000000001 111.625 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.61 5.47 60.11 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.486 -0.388 . . . . 73.310000000000002 112.832 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.654 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.75 77.4 9.78 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.877 0.37 . . . . 71.349999999999994 111.869 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -66.44 -41.08 89.68 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.002 -0.436 . . . . 74.439999999999998 111.514 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.15 87.61 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.023 0.439 . . . . 71.409999999999997 111.747 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.654 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 16.8 mp0 -63.7 -43.73 95.75 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.355 -0.384 . . . . 73.219999999999999 111.181 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.35 -52.96 48.51 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.965 -0.636 . . . . 54.420000000000002 112.536 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.501 HD13 HD22 ' A' ' 90' ' ' LEU . 95.9 mt -58.1 -51.65 68.83 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.013 0.375 . . . . 74.409999999999997 112.013 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 81.6 p -56.58 -50.78 70.93 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.914 0.339 . . . . 72.439999999999998 111.914 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 121' ' ' ARG . 27.2 mt-10 -72.15 -31.64 66.16 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.366 0.506 . . . . 72.230000000000004 112.366 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.746 ' HA3' ' HE2' ' A' ' 122' ' ' MET . . . -58.63 -46.46 93.26 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.323 -0.941 . . . . 74.540000000000006 112.1 171.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 135' ' ' LEU . 98.7 t -63.6 -47.11 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.845 0.355 . . . . 64.340000000000003 111.212 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.93 -37.68 80.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.275 -0.42 . . . . 73.329999999999998 111.444 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.521 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -60.76 -52.37 65.4 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.923 0.392 . . . . 71.209999999999994 110.821 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.0 t -56.69 -46.69 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.36 0.6 . . . . 73.450000000000003 110.926 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -53.39 -51.23 63.22 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.651 -0.704 . . . . 71.430000000000007 111.692 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -65.59 -31.06 71.89 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.383 0.512 . . . . 71.030000000000001 112.383 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 141' ' ' ALA . 95.8 t -58.28 -48.65 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.111 0.482 . . . . 74.519999999999996 110.556 174.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.79 -49.25 60.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.122 -0.49 . . . . 64.409999999999997 110.968 176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -56.6 -32.27 65.1 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.65 -0.705 . . . . 72.430000000000007 112.229 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.34 -22.39 56.82 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.212 -0.518 . . . . 73.219999999999999 113.484 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.7 t -92.77 -50.68 5.45 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 122.429 -0.454 . . . . 73.400000000000006 111.83 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.431 HD12 ' HB3' ' A' ' 154' ' ' HIS . 94.0 mt -92.01 84.52 5.33 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.566 0.698 . . . . 71.209999999999994 111.0 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.8 -22.02 65.09 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.199 -0.909 . . . . 51.539999999999999 112.26 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -127.2 149.02 50.17 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.573 0.225 . . . . 71.019999999999996 111.559 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 46' ' ' SER . 42.9 t60 -45.31 106.37 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.429 -0.351 . . . . 74.450000000000003 111.087 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.431 ' HB3' HD12 ' A' ' 150' ' ' LEU . 16.7 t-80 -112.5 118.04 34.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.261 0.553 . . . . 74.310000000000002 112.386 -170.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -108.68 131.79 54.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.081 -0.509 . . . . 75.349999999999994 110.495 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -74.25 -82.13 0.06 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.591 0.589 . . . . 73.430000000000007 112.591 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.834 -0.603 . . . . 75.129999999999995 111.708 -176.802 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.768 0.318 . . . . 74.319999999999993 111.347 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -163.09 124.85 2.52 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.521 -0.309 . . . . 73.329999999999998 111.168 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.2 t -73.18 123.51 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 112.812 0.671 . . . . 75.420000000000002 112.812 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -116.55 158.73 23.19 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.55 -0.75 . . . . 75.439999999999998 110.353 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -127.22 160.44 59.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.61 -0.268 . . . . 74.25 111.292 176.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 57.6 Cg_endo -70.92 64.95 2.5 Favored 'Trans proline' 0 C--N 1.358 1.026 0 C-N-CA 122.458 2.105 . . . . 73.25 111.803 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -174.4 -35.47 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.157 -0.929 . . . . 74.439999999999998 110.394 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -71.82 -40.55 69.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.138 0.494 . . . . 65.120000000000005 110.693 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.93 126.2 41.98 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.426 -0.806 . . . . 65.319999999999993 111.905 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.65 123.06 11.14 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.681 2.254 . . . . 70.530000000000001 112.849 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -66.89 87.88 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.207 0.527 . . . . 71.420000000000002 111.084 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -69.71 -21.37 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.583 0.586 . . . . 75.150000000000006 112.583 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.539 HE22 ' HG ' ' A' ' 20' ' ' LEU . 27.9 mm-40 -70.11 -35.88 74.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.601 -0.687 . . . . 74.5 110.797 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.59 -33.68 64.74 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.819 -0.628 . . . . 74.200000000000003 109.996 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.18 -86.94 0.26 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.926 -0.579 . . . . 65.0 112.343 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.92 77.55 2.03 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.545 0.572 . . . . 72.439999999999998 112.545 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.4 t -72.76 -0.8 14.27 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.981 0.419 . . . . 60.310000000000002 111.354 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -81.0 -31.77 34.54 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.101 0.408 . . . . 73.439999999999998 112.101 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -100.41 -43.84 6.1 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.132 0.419 . . . . 75.230000000000004 112.132 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.539 ' HG ' HE22 ' A' ' 13' ' ' GLN . 5.0 mp 64.79 17.97 11.23 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.883 0.473 . . . . 73.319999999999993 111.983 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.59 130.71 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 112.106 0.41 . . . . 75.099999999999994 112.106 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.8 m -124.49 103.58 8.25 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.383 -0.372 . . . . 71.239999999999995 111.175 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.503 ' HB2' HD13 ' A' ' 28' ' ' LEU . 27.4 t70 -102.47 109.05 20.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.804 0.335 . . . . 74.530000000000001 111.148 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -118.97 -21.96 7.49 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.8 0.333 . . . . 74.019999999999996 111.258 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.55 -24.59 67.65 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.019 0.377 . . . . 71.409999999999997 112.019 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.39 43.27 16.26 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.272 -0.489 . . . . 64.530000000000001 112.727 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.5 mt -115.4 -30.98 6.08 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.356 0.502 . . . . 65.239999999999995 112.356 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.515 HD21 ' HB1' ' A' ' 132' ' ' ALA . 95.0 mt -75.58 106.68 7.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.006 0.431 . . . . 75.420000000000002 111.66 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -73.72 157.18 36.98 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.493 -0.321 . . . . 71.299999999999997 110.535 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -51.82 -55.25 21.03 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.032 0.752 . . . . 64.409999999999997 113.032 -170.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.07 -38.2 75.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.704 0.288 . . . . 75.140000000000001 111.574 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -71.35 -30.28 65.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.795 0.331 . . . . 61.229999999999997 111.065 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.87 -51.92 67.62 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.628 -0.26 . . . . 73.25 110.307 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -57.9 -32.87 68.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.745 0.307 . . . . 73.239999999999995 111.497 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.48 ' O ' ' HD2' ' A' ' 39' ' ' ARG . 91.5 t -60.0 -53.93 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.083 0.468 . . . . 72.439999999999998 110.98 174.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 46.5 ttm -69.87 -49.54 51.34 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.43 -0.35 . . . . 75.109999999999999 111.383 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -50.65 -52.49 39.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.726 0.41 . . . . 74.129999999999995 110.997 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.77 -43.31 94.65 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 116.211 -0.449 . . . . 61.420000000000002 113.174 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.545 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -58.93 -55.59 33.19 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.595 0.236 . . . . 73.0 111.322 177.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 mt -63.51 -47.22 82.58 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.374 0.607 . . . . 75.310000000000002 111.318 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -57.63 -47.08 83.19 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.612 -0.722 . . . . 74.230000000000004 111.345 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.31 93.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.56 -0.291 . . . . 75.519999999999996 111.521 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 39' ' ' ARG . 80.1 mt -60.54 -47.74 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.749 0.309 . . . . 75.239999999999995 111.152 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -64.8 -33.34 75.76 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 120.963 0.411 . . . . 73.340000000000003 111.217 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.8 t -82.73 -2.09 53.32 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.421 0.629 . . . . 71.049999999999997 111.289 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 154' ' ' HIS . 48.3 m -130.09 -72.19 0.58 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.059 0.457 . . . . 75.200000000000003 111.377 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.662 ' ND1' ' HB2' ' A' ' 150' ' ' LEU . 93.3 m-70 -79.75 -12.63 59.78 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.152 0.427 . . . . 73.5 112.152 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.85 18.89 11.24 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.914 0.486 . . . . 73.430000000000007 112.105 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.746 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 94.2 t -86.0 132.79 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.457 -0.338 . . . . 75.430000000000007 111.199 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -86.77 96.29 10.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.222 0.534 . . . . 72.430000000000007 110.293 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -114.02 109.47 18.5 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.687 -0.688 . . . . 75.439999999999998 110.256 -175.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -117.7 142.77 46.87 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.112 0.412 . . . . 73.030000000000001 112.112 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.8 t -123.94 133.65 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.848 0.356 . . . . 75.140000000000001 111.39 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.407 HG21 HD21 ' A' ' 71' ' ' LEU . 48.4 t -126.53 137.99 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 122.497 0.319 . . . . 65.409999999999997 111.143 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 24.8 p -120.12 123.01 42.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.86 0.362 . . . . 74.329999999999998 111.159 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -127.17 147.24 61.01 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 120.629 0.252 . . . . 72.329999999999998 111.521 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.06 -57.52 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.372 2.048 . . . . 75.200000000000003 112.374 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 25.0 m -145.42 148.65 33.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.41 -0.359 . . . . 64.530000000000001 111.248 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.462 HD12 ' NE2' ' A' ' 94' ' ' GLN . 28.7 pt -110.2 -2.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.305 0.574 . . . . 73.340000000000003 110.631 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.0 -113.43 5.07 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.66 -0.7 . . . . 75.230000000000004 114.329 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.42 1.28 53.85 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.489 0.552 . . . . 75.430000000000007 112.489 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.67 141.82 28.82 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 111.799 0.296 . . . . 74.319999999999993 111.799 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.76 143.11 18.38 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.858 2.372 . . . . 62.140000000000001 112.411 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.24 -51.35 70.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.1 0.407 . . . . 75.340000000000003 112.1 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.49 -35.13 79.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.275 0.472 . . . . 75.040000000000006 112.275 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.38 -42.24 83.72 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.257 0.551 . . . . 64.530000000000001 110.437 175.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.414 ' CD2' ' HD3' ' A' ' 6' ' ' PRO . 24.8 t80 -60.49 -53.38 58.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.737 -0.665 . . . . 71.010000000000005 111.884 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.411 ' OG1' ' NH1' ' A' ' 98' ' ' ARG . 22.0 p -51.12 -48.45 61.75 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.122 0.786 . . . . 62.039999999999999 113.122 -174.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 52.5 tp -66.71 -46.51 75.29 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.821 0.344 . . . . 72.209999999999994 111.724 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -64.82 -38.14 89.97 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.118 0.414 . . . . 75.209999999999994 112.118 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 54' ' ' VAL . 63.3 tp -69.26 -40.76 77.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.154 0.502 . . . . 74.010000000000005 110.522 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.64 95.57 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.267 0.469 . . . . 73.030000000000001 112.267 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 53.8 mtp180 -60.65 -49.54 77.12 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.204 0.446 . . . . 75.129999999999995 112.204 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.645 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 11.8 pt20 -66.26 -21.09 66.28 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 120.947 0.404 . . . . 72.230000000000004 111.426 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.645 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 22.9 m0 -90.07 7.33 38.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.868 0.366 . . . . 74.409999999999997 111.406 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.455 ' HA2' ' ND2' ' A' ' 79' ' ' ASN . . . 86.18 -50.71 4.3 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.308 -0.473 . . . . 73.409999999999997 113.5 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -54.47 -26.22 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 113.377 0.88 . . . . 75.409999999999997 113.377 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.08 -9.27 59.62 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.973 -0.632 . . . . 73.109999999999999 114.349 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.455 ' ND2' ' HA2' ' A' ' 76' ' ' GLY . 93.9 m-20 -53.83 101.7 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.599 0.7 . . . . 74.349999999999994 111.317 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 38.03 40.49 0.31 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.698 0.799 . . . . 70.239999999999995 112.132 -173.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.7 OUTLIER 65.48 83.43 0.17 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.115 -0.948 . . . . 74.129999999999995 112.013 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.563 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 37.4 t30 -68.46 138.79 55.54 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.994 -0.548 . . . . 72.140000000000001 110.102 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.6 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -39.13 -67.13 0.23 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.765 1.024 . . . . 75.109999999999999 113.765 -170.11 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.746 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 81.1 m-20 -96.86 25.81 5.04 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.676 -0.64 . . . . 71.340000000000003 111.702 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.44 127.54 8.04 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.98 -0.629 . . . . 75.299999999999997 113.16 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 53.2 tp -145.05 119.3 9.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.081 0.467 . . . . 71.109999999999999 111.052 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.3 tp -117.45 142.08 47.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.883 0.373 . . . . 61.409999999999997 111.642 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.6 tp -128.68 118.71 23.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.031 -0.531 . . . . 74.230000000000004 110.754 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 57.5 t -113.8 129.43 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.864 0.364 . . . . 63.32 111.969 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.81 HD22 HD13 ' A' ' 135' ' ' LEU . 12.3 tp -102.37 124.09 47.32 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.966 0.506 . . . . 73.230000000000004 111.023 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 59' ' ' ILE . 58.3 t -111.82 98.33 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.912 0.387 . . . . 74.0 111.118 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.1 tp -54.5 -40.4 68.51 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.017 -0.538 . . . . 73.340000000000003 111.656 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 14.2 t70 -51.73 -37.46 51.15 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.861 -0.609 . . . . 61.0 112.427 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.462 ' NE2' HD12 ' A' ' 59' ' ' ILE . 49.9 mt-30 -112.87 -6.59 13.79 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.203 0.446 . . . . 74.219999999999999 112.203 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HG2' ' HE1' ' A' ' 131' ' ' TYR . 99.6 mtt180 57.58 24.28 10.24 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.126 0.489 . . . . 73.540000000000006 111.628 -174.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -106.84 147.38 29.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.074 0.464 . . . . 75.319999999999993 111.725 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 90' ' ' LEU . 15.3 m -133.53 157.44 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.693 -0.685 . . . . 73.109999999999999 110.342 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.411 ' NH1' ' OG1' ' A' ' 68' ' ' THR . 76.6 ttt-85 -148.44 137.73 21.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.081 0.4 . . . . 75.400000000000006 112.081 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 97.1 m-85 -96.08 151.84 19.09 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.975 -0.557 . . . . 75.310000000000002 110.628 173.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 9.2 tp10 -138.01 114.53 10.42 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.435 -0.166 . . . . 71.329999999999998 110.715 175.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 p -98.06 157.14 16.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.728 0.775 . . . . 62.520000000000003 113.076 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -98.54 171.98 25.76 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.172 -0.922 . . . . 74.409999999999997 112.153 167.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -51.88 -24.67 6.56 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.991 0.738 . . . . 72.319999999999993 112.991 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.61 -16.56 75.31 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.905 -0.664 . . . . 73.530000000000001 112.951 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.445 HD13 HG13 ' A' ' 49' ' ' VAL . 93.6 mt -108.27 -10.81 15.32 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.366 0.506 . . . . 70.219999999999999 112.366 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -49.75 -32.44 13.72 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.675 0.62 . . . . 74.340000000000003 112.675 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.76 -22.38 64.21 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.03 -0.605 . . . . 72.109999999999999 113.978 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -102.97 -38.62 7.28 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.394 0.616 . . . . 73.010000000000005 111.471 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.473 ' HB3' HD23 ' A' ' 114' ' ' LEU . 25.7 mt -127.66 78.1 75.31 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 115.735 -0.666 . . . . 72.129999999999995 111.234 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.28 163.31 36.7 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.148 1.898 . . . . 73.219999999999999 112.722 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -52.56 -44.88 66.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.253 0.464 . . . . 75.349999999999994 112.253 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.62 98.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.259 -0.496 . . . . 73.329999999999998 113.169 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 109' ' ' LEU . 58.2 tp -65.39 -49.25 69.98 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 122.441 -0.446 . . . . 74.209999999999994 110.955 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 109' ' ' LEU . 91.0 mt -55.62 -44.17 76.8 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.054 0.454 . . . . 65.340000000000003 110.842 176.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -60.67 -43.47 97.63 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.937 -0.574 . . . . 72.439999999999998 111.102 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -57.52 -53.2 60.8 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.646 -0.252 . . . . 74.5 111.249 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.9 mt -50.82 -40.65 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.955 0.407 . . . . 73.219999999999999 111.213 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.672 ' O ' ' HB2' ' A' ' 122' ' ' MET . 77.8 mt -59.09 -44.85 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.03 -0.532 . . . . 73.019999999999996 111.248 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -83.23 -22.58 33.06 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.644 -0.66 . . . . 61.219999999999999 112.163 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.95 -55.89 3.84 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.532 0.333 . . . . 74.329999999999998 111.711 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.57 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 25.7 mtp180 -118.63 6.83 11.64 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.106 0.78 . . . . 74.340000000000003 113.106 -172.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.789 ' HE3' ' HA3' ' A' ' 138' ' ' GLY . 17.0 mmt -108.79 -62.8 1.42 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.025 0.441 . . . . 75.239999999999995 111.412 174.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.465 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 28.7 mm -47.33 -53.1 31.3 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 113.907 1.077 . . . . 73.310000000000002 113.907 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 13.7 Cg_endo -54.2 -34.5 79.31 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.225 1.95 . . . . 73.430000000000007 112.771 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 96.4 m-70 -77.97 -43.1 30.69 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.34 -0.391 . . . . 72.349999999999994 111.294 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.492 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.7 m-30 -59.75 -42.26 92.85 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.756 0.312 . . . . 75.209999999999994 111.258 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -59.3 -35.85 74.52 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.073 0.463 . . . . 75.409999999999997 111.247 176.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.2 m -82.77 -16.81 46.46 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.026 -0.534 . . . . 74.230000000000004 112.019 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.89 -2.62 52.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.467 -0.397 . . . . 71.219999999999999 112.796 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.782 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.3 m-20 -81.78 62.96 5.83 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 122.51 -0.406 . . . . 75.150000000000006 111.242 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.529 ' HE1' ' HG2' ' A' ' 95' ' ' ARG . 97.1 m-85 -58.72 -60.45 3.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.296 0.48 . . . . 73.299999999999997 112.296 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.515 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -63.75 -35.46 80.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.957 0.408 . . . . 73.200000000000003 111.949 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 6.9 tp10 -58.59 -50.16 74.83 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.19 0.519 . . . . 75.349999999999994 110.845 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.33 -46.83 93.62 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 115.859 -0.61 . . . . 72.430000000000007 112.874 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.81 HD13 HD22 ' A' ' 90' ' ' LEU . 85.2 mt -51.44 -48.9 62.58 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.039 0.447 . . . . 75.030000000000001 111.293 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.5 m -61.82 -38.4 88.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.084 -0.507 . . . . 72.319999999999993 111.506 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 5.3 mm-40 -64.2 -45.87 86.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.732 0.301 . . . . 75.530000000000001 111.668 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.789 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -62.8 -46.48 93.55 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.069 -0.586 . . . . 75.450000000000003 112.883 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 135' ' ' LEU . 79.1 t -57.77 -48.6 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.065 0.46 . . . . 75.120000000000005 111.2 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.26 -41.12 83.58 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.233 -0.439 . . . . 75.439999999999998 111.009 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 121' ' ' ARG . . . -59.65 -51.54 69.36 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 111.309 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 138' ' ' GLY . 97.5 t -56.33 -48.92 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.986 0.422 . . . . 74.340000000000003 110.978 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.442 ' OE1' ' HG3' ' A' ' 39' ' ' ARG . 65.0 tt0 -52.92 -44.13 66.78 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.15 -0.477 . . . . 70.329999999999998 111.701 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.27 -35.64 81.66 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.398 0.518 . . . . 75.530000000000001 112.398 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.86 -46.31 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.395 0.616 . . . . 72.530000000000001 110.581 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.08 -35.75 71.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.783 -0.644 . . . . 63.130000000000003 111.17 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.74 -52.69 64.02 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.308 -0.405 . . . . 70.299999999999997 110.963 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.22 41.12 1.77 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.071 -0.585 . . . . 74.219999999999999 112.674 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 56.8 m -155.0 -58.24 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.004 0.43 . . . . 74.219999999999999 111.23 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.662 ' HB2' ' ND1' ' A' ' 47' ' ' HIS . 41.5 mt -107.15 22.17 16.4 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.466 -0.334 . . . . 74.430000000000007 111.835 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -49.48 -38.74 31.16 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.913 0.708 . . . . 74.120000000000005 112.913 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -65.86 -9.15 26.51 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.246 0.461 . . . . 75.519999999999996 112.246 -174.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -91.22 4.58 51.93 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.912 0.338 . . . . 74.420000000000002 111.912 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 8.7 p-80 -61.25 139.58 58.12 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.03 0.752 . . . . 71.430000000000007 113.03 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -116.18 -30.99 5.81 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.365 -0.379 . . . . 72.230000000000004 111.429 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 76.7 t60 66.4 20.9 10.94 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.158 0.504 . . . . 75.450000000000003 111.928 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 26.9 t60 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.637 -0.696 . . . . 73.5 111.054 -179.498 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptp . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.45 0.167 . . . . 72.150000000000006 111.172 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.487 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 20.2 ttm180 -168.11 130.89 1.52 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.786 0.327 . . . . 75.450000000000003 111.482 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.82 133.6 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.936 0.398 . . . . 63.200000000000003 111.764 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -123.77 139.72 53.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.12 0.486 . . . . 73.329999999999998 111.66 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.571 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 34.9 mmtp -106.18 167.07 10.13 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.894 -0.594 . . . . 73.209999999999994 109.564 169.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 18.2 Cg_endo -58.58 -16.88 32.14 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.756 1.637 . . . . 63.299999999999997 112.307 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.56 -16.63 28.42 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.031 -0.531 . . . . 75.099999999999994 111.941 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.97 -30.22 21.43 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.958 0.409 . . . . 70.450000000000003 111.079 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.39 123.27 85.07 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.038 -0.528 . . . . 74.25 111.741 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.37 117.26 3.46 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.812 2.341 . . . . 74.120000000000005 113.23 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' A' ' 14' ' ' LEU . 80.5 m-20 -68.5 79.16 0.27 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.321 0.489 . . . . 75.430000000000007 112.321 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 m -65.92 -53.47 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 111.684 0.253 . . . . 75.400000000000006 111.684 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' NE2' ' HG ' ' A' ' 20' ' ' LEU . 1.5 mp0 -70.45 1.76 4.69 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.75 0.648 . . . . 72.510000000000005 112.75 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.704 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 8.8 tt -109.15 -40.98 4.8 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.813 0.34 . . . . 71.439999999999998 110.759 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.07 -63.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.211 0.449 . . . . 71.109999999999999 112.211 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.52 -71.84 0.18 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.069 0.462 . . . . 62.140000000000001 111.3 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 m 73.73 -22.61 0.24 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.836 1.051 . . . . 64.120000000000005 113.836 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.522 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 9.4 t -82.32 -12.66 57.84 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.483 0.658 . . . . 70.430000000000007 110.769 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . 14.7 ptt-85 -126.87 145.19 50.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.614 -0.721 . . . . 74.340000000000003 109.186 171.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HG ' ' NE2' ' A' ' 13' ' ' GLN . 5.7 mp -119.47 14.66 12.84 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.85 0.357 . . . . 74.310000000000002 111.445 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.61 123.58 68.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.071 0.397 . . . . 74.010000000000005 112.071 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.6 m -120.66 102.98 8.77 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.39 -0.368 . . . . 65.109999999999999 110.824 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.4 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 25.7 t70 -97.73 103.73 15.69 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.034 0.445 . . . . 61.119999999999997 111.366 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.429 ' HB2' HD22 ' A' ' 56' ' ' LEU . 5.3 mm-40 -110.96 -28.42 8.36 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.335 -0.393 . . . . 71.0 111.632 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -64.08 -25.27 68.03 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.004 0.372 . . . . 73.409999999999997 112.004 172.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.55 44.58 9.29 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.016 -0.611 . . . . 62.409999999999997 112.354 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -115.93 -21.58 9.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.621 0.369 . . . . 75.129999999999995 111.593 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.0 mt -96.8 111.17 23.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.778 0.323 . . . . 70.5 111.536 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.5 t -67.55 151.06 47.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.505 0.193 . . . . 65.310000000000002 111.081 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -51.2 -42.67 61.06 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.306 0.484 . . . . 72.120000000000005 112.306 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.44 -40.03 94.97 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.105 0.479 . . . . 72.420000000000002 111.539 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -67.29 -39.95 86.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.872 0.368 . . . . 73.530000000000001 110.797 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.59 -42.39 98.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.315 -0.402 . . . . 62.130000000000003 111.487 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.05 -53.68 52.78 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.009 0.433 . . . . 74.420000000000002 111.107 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.72 -45.29 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.331 -0.395 . . . . 73.140000000000001 111.647 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 52.1 ttm -61.14 -47.98 83.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.638 -0.255 . . . . 65.349999999999994 111.5 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 56.0 m-80 -60.22 -37.75 81.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.662 0.267 . . . . 64.340000000000003 110.997 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.23 95.66 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.917 -0.659 . . . . 73.140000000000001 112.882 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.537 ' O ' HG13 ' A' ' 43' ' ' ILE . 98.6 mtt180 -64.0 -55.51 21.81 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.996 0.427 . . . . 75.120000000000005 110.872 174.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.85 -49.82 76.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.099 -0.501 . . . . 72.420000000000002 112.242 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 18' ' ' THR . 30.9 ttp180 -58.09 -40.38 80.96 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.192 -0.458 . . . . 74.510000000000005 111.104 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.45 89.5 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.166 -0.47 . . . . 74.030000000000001 111.422 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 39' ' ' ARG . 86.4 mt -58.43 -49.45 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.752 0.311 . . . . 73.439999999999998 111.627 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 57.2 ttp180 -69.42 -26.84 64.82 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.14 -0.35 . . . . 74.040000000000006 111.529 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -82.13 -22.63 36.07 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.858 0.361 . . . . 75.0 111.098 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 154' ' ' HIS . 45.6 m -102.8 -66.08 0.95 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.125 -0.489 . . . . 72.439999999999998 111.62 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.633 ' ND1' ' HB2' ' A' ' 150' ' ' LEU . 83.7 m-70 -84.35 -8.99 58.82 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.302 -0.408 . . . . 71.109999999999999 112.017 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 68.54 15.01 9.15 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.939 0.495 . . . . 71.340000000000003 112.318 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.723 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 89.3 t -86.22 119.27 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.019 0.438 . . . . 73.310000000000002 111.934 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -78.15 96.13 5.1 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 74.340000000000003 110.184 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -115.76 106.1 13.48 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.388 -0.369 . . . . 74.120000000000005 110.722 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.65 146.63 34.47 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.942 0.401 . . . . 71.319999999999993 112.055 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.89 114.79 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.939 0.4 . . . . 75.510000000000005 111.284 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.446 ' HB ' HG22 ' A' ' 89' ' ' VAL . 48.7 t -118.88 132.7 68.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.839 0.352 . . . . 74.349999999999994 111.492 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 32.0 p -110.38 125.58 53.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.94 0.4 . . . . 73.430000000000007 111.129 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 24' ' ' GLU . 55.1 mt -131.55 142.16 44.33 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.445 -0.343 . . . . 75.340000000000003 110.85 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.589 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 22.5 Cg_exo -64.59 -67.35 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.373 2.049 . . . . 74.120000000000005 112.076 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.9 t -133.64 157.74 45.0 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.135 0.493 . . . . 75.140000000000001 111.32 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 pt -120.35 9.9 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.915 -0.584 . . . . 72.219999999999999 111.078 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.0 -119.62 5.26 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 113.118 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -112.04 3.82 17.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.391 0.276 . . . . 72.349999999999994 111.722 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.86 139.14 96.71 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 111.795 0.295 . . . . 65.239999999999995 111.795 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.715 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 57.1 Cg_endo -71.07 125.31 11.34 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.354 2.036 . . . . 70.230000000000004 111.826 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.456 ' HG ' ' HB2' ' A' ' 98' ' ' ARG . 44.2 tp -56.25 -41.75 76.26 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.509 0.559 . . . . 74.329999999999998 112.509 -173.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.07 -35.16 79.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.106 0.479 . . . . 73.239999999999995 112.134 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.715 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 5.8 m-20 -86.74 -28.23 23.18 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.109 0.481 . . . . 73.230000000000004 111.356 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -57.37 -50.24 73.59 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.924 -0.58 . . . . 74.439999999999998 110.782 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 p -58.11 -37.65 74.96 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.769 -0.65 . . . . 72.519999999999996 112.049 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -62.25 -38.33 88.87 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 120.708 0.29 . . . . 63.020000000000003 111.671 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -66.97 -38.76 86.66 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.92 0.39 . . . . 74.040000000000006 111.554 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.537 HD23 HD23 ' A' ' 87' ' ' LEU . 45.5 tp -72.07 -42.61 66.0 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.173 0.511 . . . . 63.240000000000002 111.345 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.49 -44.4 95.99 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.302 0.482 . . . . 74.409999999999997 112.302 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.442 ' CB ' ' HA ' ' A' ' 79' ' ' ASN . 15.0 ptp180 -68.43 -25.2 64.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.046 0.387 . . . . 74.239999999999995 112.046 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -70.66 -42.67 70.5 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.997 0.427 . . . . 73.409999999999997 110.828 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -82.04 -15.7 52.69 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.157 -0.474 . . . . 74.040000000000006 112.256 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.58 9.37 64.7 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.881 -0.676 . . . . 62.439999999999998 112.75 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 t -86.72 -12.17 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.869 0.366 . . . . 64.329999999999998 110.726 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.86 67.31 0.13 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.905 -0.664 . . . . 72.209999999999994 113.435 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.442 ' HA ' ' CB ' ' A' ' 73' ' ' ARG . 2.3 m-20 -59.23 -46.48 88.37 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.304 0.573 . . . . 71.049999999999997 110.536 176.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.494 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -135.71 -83.79 0.39 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.178 -0.919 . . . . 75.420000000000002 109.227 169.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -123.03 85.35 2.41 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.263 0.554 . . . . 75.439999999999998 110.892 169.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.482 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 45.0 t30 -71.12 153.5 42.48 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.823 -0.626 . . . . 64.420000000000002 111.136 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.57 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.0 OUTLIER -62.62 -90.15 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 112.668 0.618 . . . . 74.420000000000002 112.668 -177.654 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.723 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.1 m-20 -88.26 32.87 0.75 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.004 -1.06 . . . . 71.400000000000006 112.095 -173.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.67 127.72 8.76 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.171 -0.537 . . . . 72.420000000000002 113.694 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.6 tp -142.53 119.85 11.57 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.206 0.527 . . . . 74.099999999999994 111.042 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.537 HD23 HD23 ' A' ' 71' ' ' LEU . 56.7 tp -114.94 122.25 45.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.335 -0.393 . . . . 74.120000000000005 111.453 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.4 tp -111.36 114.04 26.92 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.36 -0.382 . . . . 74.0 111.003 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.446 HG22 ' HB ' ' A' ' 54' ' ' VAL . 84.5 t -119.06 131.56 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.866 0.365 . . . . 72.0 111.619 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.527 ' HB2' HD21 ' A' ' 135' ' ' LEU . 30.3 tp -106.22 130.74 54.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.249 -0.432 . . . . 74.439999999999998 111.362 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.734 HG12 HE21 ' A' ' 94' ' ' GLN . 86.2 t -106.12 109.7 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.372 -0.376 . . . . 73.439999999999998 111.101 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 69.0 tp -60.87 -41.01 95.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.131 0.419 . . . . 65.129999999999995 112.131 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.09 -47.31 85.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.219 0.533 . . . . 73.310000000000002 111.699 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.734 HE21 HG12 ' A' ' 91' ' ' VAL . 45.8 mt-30 -87.44 -15.35 37.96 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.981 -0.554 . . . . 73.010000000000005 112.356 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 95' ' ' ARG . 56.0 mtt180 58.99 36.43 24.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.098 0.407 . . . . 74.140000000000001 112.098 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -144.74 157.79 44.04 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.955 0.407 . . . . 71.230000000000004 111.519 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.565 HG23 ' SD ' ' A' ' 122' ' ' MET . 10.2 m -117.87 171.61 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.244 0.545 . . . . 74.299999999999997 112.066 -174.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.456 ' HB2' ' HG ' ' A' ' 64' ' ' LEU . 27.8 tpt180 -136.81 129.04 29.78 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.957 -0.565 . . . . 73.129999999999995 111.348 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -103.11 107.89 18.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.184 -0.462 . . . . 73.140000000000001 110.391 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -102.43 111.96 24.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.473 0.178 . . . . 71.030000000000001 110.897 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 p -103.86 150.36 24.22 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.238 0.542 . . . . 74.420000000000002 111.871 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -85.27 -145.0 7.46 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.795 -0.717 . . . . 64.349999999999994 112.171 169.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.15 -25.84 21.62 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 122.514 -0.404 . . . . 73.450000000000003 111.745 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.9 -28.52 62.55 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.017 -0.611 . . . . 61.240000000000002 113.697 -170.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.435 HD11 HG12 ' A' ' 49' ' ' VAL . 96.9 mt -99.3 -0.67 40.74 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.744 0.646 . . . . 74.430000000000007 112.744 -174.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -61.48 -27.21 68.42 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.959 0.409 . . . . 74.439999999999998 112.052 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.35 3.6 86.91 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.429 -0.415 . . . . 74.239999999999995 113.667 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -126.54 -38.7 2.07 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.072 0.463 . . . . 74.099999999999994 111.583 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.491 ' HB3' HD21 ' A' ' 114' ' ' LEU . 17.4 mt -129.82 78.71 74.67 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.892 -0.595 . . . . 74.530000000000001 111.61 -171.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.21 151.36 48.97 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.442 2.095 . . . . 75.010000000000005 112.168 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -50.41 -35.29 27.76 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.299 0.481 . . . . 74.340000000000003 112.299 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.75 -48.95 80.92 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.177 -0.535 . . . . 65.209999999999994 112.559 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.0 tp -60.03 -44.98 94.27 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.093 0.473 . . . . 72.030000000000001 110.94 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 109' ' ' LEU . 85.4 mt -58.71 -39.17 80.04 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.994 -0.548 . . . . 74.209999999999994 111.105 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.8 t -65.28 -39.74 92.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.98 0.419 . . . . 72.530000000000001 110.89 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -57.04 -48.73 77.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.175 -0.466 . . . . 75.299999999999997 110.911 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.4 mt -53.05 -47.71 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.2 0.524 . . . . 75.239999999999995 111.386 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 122' ' ' MET . 67.5 mt -60.09 -55.64 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.008 -0.542 . . . . 75.439999999999998 111.697 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.467 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 49.4 m-70 -70.27 -35.4 73.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.036 0.754 . . . . 74.540000000000006 113.036 -173.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.15 -38.12 21.08 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.259 0.837 . . . . 71.409999999999997 113.259 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.461 ' HD3' ' HB3' ' A' ' 141' ' ' ALA . 35.9 mtp180 -111.74 -33.3 6.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.275 0.843 . . . . 72.319999999999993 113.275 -173.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.565 ' SD ' HG23 ' A' ' 97' ' ' VAL . 53.5 mtt -84.41 -54.0 5.07 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.759 0.652 . . . . 73.540000000000006 112.759 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.496 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 46.9 mm -48.86 -50.25 62.64 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 113.257 0.836 . . . . 64.129999999999995 113.257 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 9.5 Cg_endo -51.98 -46.09 34.56 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 122.221 1.947 . . . . 65.230000000000004 112.852 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -70.06 -40.89 74.8 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.859 0.318 . . . . 74.120000000000005 111.859 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.0 m-30 -58.43 -41.17 84.43 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.023 0.439 . . . . 74.420000000000002 111.292 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -70.69 -39.44 73.49 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.066 0.46 . . . . 74.329999999999998 110.798 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.8 t -68.73 -22.36 64.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 111.569 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.13 -10.19 24.76 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.522 -0.371 . . . . 72.230000000000004 113.34 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.736 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 69.4 m-20 -85.57 77.39 9.86 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.503 -0.41 . . . . 70.030000000000001 111.707 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -62.58 -41.86 99.21 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.147 0.499 . . . . 65.200000000000003 110.945 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.23 -45.91 82.74 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.964 -0.562 . . . . 64.140000000000001 111.987 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.736 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 21.1 mm-40 -68.09 -32.39 72.68 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 111.86 0.319 . . . . 72.420000000000002 111.86 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 122' ' ' MET . . . -59.38 -44.89 96.26 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.386 -0.912 . . . . 50.310000000000002 111.753 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 90' ' ' LEU . 94.2 mt -66.08 -44.4 84.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.877 0.325 . . . . 74.349999999999994 111.877 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.491 ' HG ' ' HA ' ' A' ' 133' ' ' GLU . 88.8 p -62.5 -38.81 91.36 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.664 0.268 . . . . 72.230000000000004 111.191 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -66.14 -41.28 90.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.775 0.321 . . . . 73.129999999999995 111.416 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.503 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -60.14 -48.56 85.51 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.842 -0.694 . . . . 73.230000000000004 112.58 175.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 135' ' ' LEU . 89.3 t -56.39 -47.04 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.028 0.442 . . . . 75.420000000000002 111.055 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.448 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 44.3 tp -60.14 -39.77 87.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.864 -0.607 . . . . 74.540000000000006 111.069 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.461 ' HB3' ' HD3' ' A' ' 121' ' ' ARG . . . -61.89 -52.14 65.33 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.874 0.369 . . . . 65.340000000000003 111.51 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.85 -45.19 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.091 0.472 . . . . 74.299999999999997 110.978 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -54.6 -47.6 73.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.05 -0.523 . . . . 72.420000000000002 111.222 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 96.3 mt-30 -56.49 -45.57 80.91 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.394 -0.367 . . . . 74.109999999999999 111.757 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 141' ' ' ALA . 60.6 t -57.15 -44.79 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.17 0.509 . . . . 73.319999999999993 111.285 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.2 -45.51 76.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.118 -0.492 . . . . 75.239999999999995 111.607 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 151' ' ' GLU . 65.8 m-20 -61.9 -22.41 65.55 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.825 0.345 . . . . 73.25 111.713 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.26 4.69 85.78 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.073 -0.584 . . . . 61.549999999999997 112.833 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.1 m -130.59 -50.69 1.07 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.466 0.543 . . . . 74.349999999999994 112.466 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.633 ' HB2' ' ND1' ' A' ' 47' ' ' HIS . 56.0 mt -117.44 31.25 6.83 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.553 0.341 . . . . 75.329999999999998 111.72 -174.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 0.3 OUTLIER -50.13 -38.26 38.19 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.669 0.988 . . . . 73.120000000000005 113.669 -173.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -73.97 2.56 8.4 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.609 0.596 . . . . 73.430000000000007 112.609 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 157' ' ' HIS . 55.3 m170 -96.42 122.38 39.25 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.026 -0.421 . . . . 74.5 111.894 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 79.3 t60 -152.54 -65.66 0.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.14 -0.482 . . . . 73.439999999999998 110.821 172.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -81.57 -14.06 57.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.578 0.704 . . . . 75.430000000000007 110.451 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -141.62 115.86 9.43 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.295 -0.866 . . . . 74.340000000000003 110.094 171.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 153' ' ' HIS . 17.9 p-80 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 119.04 -0.505 . . . . 75.430000000000007 112.09 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.054 0.454 . . . . 73.400000000000006 111.74 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -164.4 138.47 5.36 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.827 -0.624 . . . . 75.329999999999998 110.27 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.64 102.17 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.108 0.48 . . . . 74.400000000000006 111.241 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -91.43 125.32 36.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.213 0.53 . . . . 71.450000000000003 111.793 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 9.6 mtmp? -94.96 159.02 34.02 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.898 -0.592 . . . . 74.420000000000002 110.187 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 48.0 Cg_endo -66.6 -2.66 7.82 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.229 1.953 . . . . 74.129999999999995 113.039 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -107.28 -8.76 16.27 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.211 -0.449 . . . . 74.219999999999999 110.93 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.41 -26.89 19.65 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.002 0.43 . . . . 71.109999999999999 110.601 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.6 t -57.13 128.13 77.35 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.872 -0.604 . . . . 72.439999999999998 111.662 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.85 109.07 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.659 2.24 . . . . 74.409999999999997 112.721 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -69.19 77.92 0.35 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.042 0.449 . . . . 65.25 111.236 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 13' ' ' GLN . 28.6 m -67.64 -51.3 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.263 0.468 . . . . 74.329999999999998 112.263 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.418 ' N ' HG22 ' A' ' 12' ' ' VAL . 27.9 mm-40 -56.97 -21.2 28.47 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.06 0.393 . . . . 73.519999999999996 112.06 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.68 -52.72 34.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.038 0.447 . . . . 75.310000000000002 109.967 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.28 -65.79 0.98 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.424 -0.353 . . . . 75.219999999999999 111.544 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -98.27 101.79 13.34 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.115 0.483 . . . . 70.120000000000005 111.966 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.7 p -82.79 -3.64 56.92 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.164 0.507 . . . . 74.5 110.522 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -78.91 -37.41 39.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.846 -0.616 . . . . 75.329999999999998 111.74 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -102.18 125.97 49.02 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.25 0.548 . . . . 71.209999999999994 110.527 173.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD13 ' N ' ' A' ' 20' ' ' LEU . 4.6 mp -109.33 8.62 25.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.274 0.559 . . . . 75.230000000000004 110.623 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.8 t -101.37 142.73 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.796 -0.638 . . . . 75.430000000000007 111.656 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.2 m -145.42 103.41 3.82 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.456 -0.338 . . . . 71.400000000000006 110.865 175.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' HB2' HD13 ' A' ' 28' ' ' LEU . 28.8 t70 -105.05 96.76 6.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.223 0.535 . . . . 74.049999999999997 111.59 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -97.45 -38.45 9.6 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.019 0.437 . . . . 71.310000000000002 110.336 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.586 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -57.09 -43.85 82.6 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.483 0.549 . . . . 74.439999999999998 112.483 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.19 36.3 6.34 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.03 -0.605 . . . . 71.409999999999997 112.301 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' A' ' 92' ' ' LEU . 86.5 mt -103.6 -15.99 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.847 0.356 . . . . 75.319999999999993 111.443 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.478 HD13 ' HB2' ' A' ' 23' ' ' ASP . 96.6 mt -90.8 -165.91 1.46 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.162 0.506 . . . . 74.349999999999994 111.553 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -161.68 153.52 19.18 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.966 -0.561 . . . . 73.030000000000001 110.019 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -47.93 -43.29 28.98 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.279 0.474 . . . . 72.400000000000006 112.279 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.14 -49.64 71.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.116 0.484 . . . . 75.209999999999994 111.622 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.459 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 12.5 mm-40 -71.33 -38.27 71.68 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.208 -0.451 . . . . 71.530000000000001 111.731 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.83 -36.48 84.03 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.044 0.45 . . . . 74.5 111.089 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.52 -54.97 23.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.139 -0.482 . . . . 64.25 110.918 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.8 -43.89 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.082 0.468 . . . . 72.439999999999998 111.282 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.41 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.6 ttm -64.22 -49.58 71.4 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.106 -0.497 . . . . 74.120000000000005 111.049 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -57.33 -48.17 79.66 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.636 0.255 . . . . 75.409999999999997 111.27 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.35 92.13 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.093 -0.575 . . . . 50.549999999999997 112.952 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.6 ' NH1' HD13 ' A' ' 140' ' ' LEU . 60.1 mtt180 -70.42 -49.9 44.11 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.983 0.364 . . . . 75.340000000000003 111.983 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 36' ' ' MET . 92.6 mt -55.18 -46.96 75.83 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.258 0.551 . . . . 75.439999999999998 111.042 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 41' ' ' ARG . 40.9 ttm180 -61.74 -42.77 99.4 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.811 -0.631 . . . . 74.25 110.76 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.05 79.62 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 111.198 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.544 HG21 ' HB ' ' A' ' 49' ' ' VAL . 81.8 mt -67.79 -41.6 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.052 0.453 . . . . 74.439999999999998 110.747 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 44.8 ttt180 -68.01 -27.85 66.91 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.022 0.439 . . . . 71.219999999999999 111.2 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 13.3 t -85.75 -32.22 21.98 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.074 0.464 . . . . 63.240000000000002 111.403 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 t -82.66 -61.9 1.75 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.079 0.466 . . . . 75.230000000000004 111.884 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.58 ' ND1' HD13 ' A' ' 150' ' ' LEU . 43.7 m-70 -102.22 -0.39 33.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.876 -0.602 . . . . 75.140000000000001 111.602 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.48 10.81 5.13 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.843 0.457 . . . . 72.299999999999997 111.892 -176.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.544 ' HB ' HG21 ' A' ' 43' ' ' ILE . 78.6 t -77.38 111.44 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.042 0.449 . . . . 71.420000000000002 111.142 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HG2' ' HE ' ' A' ' 44' ' ' ARG . 40.7 mt-10 -82.16 95.92 7.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.676 0.75 . . . . 73.519999999999996 110.138 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -107.96 103.11 12.27 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.13 -0.941 . . . . 73.209999999999994 111.007 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.66 139.7 38.59 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.403 0.52 . . . . 65.120000000000005 112.403 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.5 t -124.08 119.42 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.982 0.42 . . . . 75.319999999999993 111.487 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.16 139.11 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.471 -0.331 . . . . 75.140000000000001 111.533 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 24.2 p -118.05 126.82 53.02 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.941 0.401 . . . . 73.430000000000007 111.015 176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 61.6 mt -125.68 140.95 37.8 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 120.672 0.272 . . . . 63.219999999999999 111.633 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.586 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 27.6 Cg_exo -62.89 -61.3 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.698 2.265 . . . . 63.310000000000002 113.019 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 78.2 p -148.17 145.41 28.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.814 0.302 . . . . 74.400000000000006 111.814 -176.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 91' ' ' VAL . 34.5 pt -127.82 5.02 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.011 0.434 . . . . 73.409999999999997 111.593 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.6 -136.52 29.73 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.991 -0.624 . . . . 73.140000000000001 113.39 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -87.99 15.58 7.1 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.515 -0.403 . . . . 74.140000000000001 111.704 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.3 125.0 91.56 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 120.726 0.298 . . . . 74.439999999999998 111.607 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.93 108.84 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.262 1.974 . . . . 74.310000000000002 112.249 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.4 tp -57.94 -29.43 65.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.943 0.401 . . . . 74.530000000000001 112.042 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -63.66 -32.62 74.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.24 0.543 . . . . 75.329999999999998 111.147 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.82 -33.1 16.63 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.457 0.646 . . . . 61.340000000000003 110.355 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -52.67 -51.76 58.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.913 0.885 . . . . 73.230000000000004 112.051 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.4 p -60.52 -31.21 70.29 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.476 0.547 . . . . 75.150000000000006 112.476 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.606 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.5 tp -56.06 -53.71 53.71 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.962 0.41 . . . . 71.420000000000002 110.987 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -60.84 -33.3 72.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.991 0.424 . . . . 75.209999999999994 112.093 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.475 HD22 HD21 ' A' ' 87' ' ' LEU . 34.3 tp -74.4 -54.95 6.59 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.994 0.426 . . . . 74.140000000000001 111.647 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.521 ' HB2' ' HA3' ' A' ' 78' ' ' GLY . . . -57.17 -36.83 71.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.192 0.442 . . . . 74.430000000000007 112.192 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 57.5 mtp180 -64.89 -48.43 74.26 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.028 0.381 . . . . 71.049999999999997 112.028 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.543 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 10.5 pt20 -71.27 -25.53 62.49 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.933 0.397 . . . . 73.329999999999998 111.161 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.543 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 19.5 m0 -79.59 -4.93 53.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.538 -0.301 . . . . 75.019999999999996 111.744 174.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.33 -43.52 2.73 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.26 -0.495 . . . . 71.319999999999993 113.425 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -53.81 -18.91 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 113.4 0.889 . . . . 72.209999999999994 113.4 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 72' ' ' ALA . . . -141.43 39.34 1.43 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.754 -0.736 . . . . 70.019999999999996 113.83 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 17.5 p-10 -67.21 82.74 0.13 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.26 0.552 . . . . 74.409999999999997 110.679 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 60.13 50.16 6.73 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.591 0.71 . . . . 74.200000000000003 109.702 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 3.7 mptp? 65.5 81.84 0.2 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.365 -0.834 . . . . 72.120000000000005 111.191 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -62.54 -76.47 0.06 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.482 -0.781 . . . . 74.5 112.091 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' A' ' 85' ' ' GLY . 25.7 p-10 -157.74 -136.57 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.925 -0.579 . . . . 65.219999999999999 109.916 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.55 ' HA ' ' HG ' ' A' ' 105' ' ' LEU . 17.0 p-10 -72.64 26.91 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.494 -0.754 . . . . 74.209999999999994 112.543 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 83' ' ' ASN . . . -84.21 150.18 25.81 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.616 -0.326 . . . . 51.299999999999997 112.533 173.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.3 tp -142.66 127.04 17.72 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.89 0.376 . . . . 75.299999999999997 111.156 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.475 HD21 HD22 ' A' ' 71' ' ' LEU . 60.6 tp -108.21 133.78 51.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.844 0.354 . . . . 74.540000000000006 111.66 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.44 117.39 22.05 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.073 -0.512 . . . . 73.409999999999997 110.814 177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.99 129.83 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.729 0.3 . . . . 71.340000000000003 111.766 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.47 134.11 50.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.127 0.571 . . . . 75.319999999999993 111.078 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.486 HG23 HD11 ' A' ' 59' ' ' ILE . 87.1 t -118.63 105.3 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.926 0.394 . . . . 64.349999999999994 111.262 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.464 ' HB2' HD13 ' A' ' 27' ' ' LEU . 68.1 tp -53.76 -39.21 65.18 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.114 -0.494 . . . . 62.140000000000001 112.017 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 31.7 t70 -50.77 -32.32 19.45 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.781 0.66 . . . . 74.109999999999999 112.781 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -123.67 -3.47 8.26 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.278 0.473 . . . . 73.239999999999995 112.278 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 61.25 11.15 3.4 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.398 0.518 . . . . 74.420000000000002 112.398 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -97.09 159.86 14.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.054 0.454 . . . . 73.519999999999996 111.341 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.69 HG23 ' SD ' ' A' ' 122' ' ' MET . 13.3 m -131.14 172.26 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.985 -0.552 . . . . 75.0 110.525 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -146.39 128.68 15.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.905 0.383 . . . . 64.239999999999995 111.639 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -103.97 125.19 50.17 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.692 -0.686 . . . . 74.239999999999995 110.434 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -120.21 117.12 27.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.999 0.428 . . . . 74.239999999999995 111.175 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.541 HG21 HD11 ' A' ' 114' ' ' LEU . 11.6 p -85.5 155.72 21.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.608 0.718 . . . . 64.540000000000006 112.584 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.72 -179.33 36.29 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.4 -0.818 . . . . 74.310000000000002 111.844 167.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -63.11 -11.13 17.81 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.874 0.47 . . . . 73.349999999999994 112.256 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.15 -32.03 13.17 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.584 -0.341 . . . . 74.239999999999995 113.475 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 84' ' ' ASN . 48.1 mt -97.24 -5.04 37.79 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.402 0.89 . . . . 63.219999999999999 113.402 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -28.63 44.96 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.882 0.697 . . . . 74.109999999999999 112.882 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.69 -19.15 71.46 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.238 -0.506 . . . . 72.329999999999998 113.822 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -105.82 -40.17 5.81 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.936 0.398 . . . . 75.140000000000001 111.91 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.492 ' HB3' HD21 ' A' ' 114' ' ' LEU . 26.8 mt -130.48 88.25 47.75 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.102 -0.499 . . . . 74.319999999999993 112.222 -170.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.63 159.25 28.48 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.154 1.903 . . . . 74.25 112.045 172.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -50.46 -36.74 34.9 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.306 0.484 . . . . 72.329999999999998 112.306 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.71 -50.14 69.11 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.02 -0.609 . . . . 75.439999999999998 112.793 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.29 -43.28 99.14 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.874 0.368 . . . . 74.140000000000001 110.988 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.541 HD11 HG21 ' A' ' 101' ' ' THR . 89.6 mt -57.52 -45.09 85.43 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.28 -0.418 . . . . 73.150000000000006 110.886 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.2 m -64.4 -34.63 78.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 111.075 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -62.45 -48.17 80.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.476 -0.329 . . . . 74.109999999999999 110.716 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.2 mt -52.37 -45.78 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.338 0.59 . . . . 71.299999999999997 110.928 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 122' ' ' MET . 63.6 mt -60.75 -55.82 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.427 -0.806 . . . . 74.329999999999998 111.887 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.438 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 10.3 t-80 -75.94 -28.25 57.89 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.721 0.637 . . . . 75.439999999999998 112.721 -170.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.97 -49.46 17.64 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.232 0.456 . . . . 72.140000000000001 112.232 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -112.21 -44.22 3.44 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.147 0.795 . . . . 75.129999999999995 113.147 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.69 ' SD ' HG23 ' A' ' 97' ' ' VAL . 50.8 mtt -62.67 -50.99 69.01 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.524 0.565 . . . . 72.219999999999999 112.524 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.563 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 25.7 mm -53.51 -55.54 33.89 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 112.278 0.473 . . . . 74.450000000000003 112.278 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.563 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 83.7 Cg_exo -50.22 -46.14 30.15 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 122.15 1.9 . . . . 52.020000000000003 113.015 176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.437 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 61.0 m-70 -65.41 -49.14 70.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.847 0.314 . . . . 72.409999999999997 111.847 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.4 m-30 -61.37 -32.95 72.87 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.894 0.378 . . . . 74.25 111.495 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -69.31 -41.19 77.05 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.97 0.414 . . . . 71.430000000000007 110.599 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.0 t -74.24 -21.56 59.72 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.957 0.408 . . . . 63.009999999999998 111.661 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 112.16 -4.7 26.96 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.43 -0.414 . . . . 74.519999999999996 113.673 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.65 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 79.7 m-20 -83.8 77.49 9.87 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.323 0.49 . . . . 65.420000000000002 112.323 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -71.54 -39.48 70.68 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.899 0.38 . . . . 75.439999999999998 111.521 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.25 70.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.897 0.38 . . . . 70.439999999999998 111.332 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.65 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 20.2 mm-40 -61.98 -42.5 99.2 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.146 -0.479 . . . . 73.400000000000006 111.542 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.03 -50.64 64.2 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.184 -0.531 . . . . 72.219999999999999 112.959 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.54 -41.03 98.48 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.56 -0.377 . . . . 70.420000000000002 111.47 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -57.38 -54.76 43.13 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.395 -0.366 . . . . 61.140000000000001 111.5 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -68.64 -26.13 65.18 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.248 -0.283 . . . . 74.219999999999999 111.607 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.562 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -63.23 -44.8 96.5 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.822 -0.704 . . . . 74.349999999999994 112.225 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.68 -49.83 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.007 0.432 . . . . 73.239999999999995 110.865 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.6 HD13 ' NH1' ' A' ' 39' ' ' ARG . 54.6 tp -57.69 -41.01 80.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.115 -0.493 . . . . 74.400000000000006 111.526 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.43 -51.84 65.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.925 0.393 . . . . 73.319999999999993 111.59 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.408 HG13 HD11 ' A' ' 109' ' ' LEU . 86.9 t -60.77 -46.48 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.124 0.488 . . . . 74.150000000000006 110.841 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -52.27 -41.09 62.55 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.913 -0.585 . . . . 62.210000000000001 111.625 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 98.2 mt-30 -61.15 -48.82 79.85 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.818 0.342 . . . . 73.450000000000003 111.325 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.57 -48.29 86.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.185 -0.461 . . . . 75.319999999999993 111.657 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.21 -56.81 10.69 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.278 -0.419 . . . . 73.0 111.456 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.43 ' HA ' ' HE1' ' A' ' 47' ' ' HIS . 31.2 t70 -62.53 -27.92 69.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.06 -0.518 . . . . 74.510000000000005 111.752 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.92 -39.42 28.19 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.99 -0.624 . . . . 63.340000000000003 113.013 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.6 m -65.11 -40.26 94.28 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.187 0.44 . . . . 75.010000000000005 112.187 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.58 HD13 ' ND1' ' A' ' 47' ' ' HIS . 43.0 mt -78.4 80.02 4.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.501 0.667 . . . . 73.450000000000003 112.248 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -22.72 22.61 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.624 -0.716 . . . . 75.200000000000003 110.247 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -57.18 -38.79 74.15 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.252 -0.885 . . . . 73.040000000000006 111.886 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -162.94 155.23 18.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.344 -0.389 . . . . 71.150000000000006 110.028 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -92.96 -177.49 4.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.446 0.535 . . . . 73.340000000000003 112.446 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -47.97 147.23 2.14 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.226 1.195 . . . . 74.549999999999997 114.226 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 45' ' ' SER . 94.0 m-70 -86.08 -173.32 4.52 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.562 -0.745 . . . . 74.049999999999997 111.066 174.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.8 -0.619 . . . . 74.340000000000003 112.049 179.244 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.57 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.638 0.256 . . . . 72.25 111.041 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 58' ' ' SER . 17.4 ptp180 -109.8 -1.55 17.83 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.735 0.302 . . . . 71.329999999999998 111.74 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.533 HG22 ' HA3' ' A' ' 60' ' ' GLY . 60.6 t 52.6 107.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 115.005 1.483 . . . . 74.400000000000006 115.005 170.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 58' ' ' SER . 23.1 m-85 -112.61 126.48 55.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.102 -0.499 . . . . 74.340000000000003 110.528 169.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.548 ' HZ1' ' HB3' ' A' ' 5' ' ' LYS . 9.4 mtpm? -111.38 158.9 34.89 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.178 -0.464 . . . . 74.230000000000004 110.906 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -49.44 -40.78 44.7 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.767 2.311 . . . . 75.010000000000005 113.799 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -82.78 -5.96 59.18 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.409 0.522 . . . . 72.400000000000006 112.409 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.68 -30.39 18.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.244 0.545 . . . . 73.420000000000002 110.279 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.3 130.44 93.53 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.886 -0.597 . . . . 75.530000000000001 110.832 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.56 118.55 5.47 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.239 1.959 . . . . 75.530000000000001 112.652 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.653 HD21 ' HB3' ' A' ' 14' ' ' LEU . 1.0 OUTLIER -61.18 79.9 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.496 0.554 . . . . 73.549999999999997 112.496 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.08 -44.45 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.539 0.57 . . . . 73.140000000000001 112.539 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -61.25 -15.93 39.97 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.073 0.397 . . . . 75.129999999999995 112.073 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.653 ' HB3' HD21 ' A' ' 11' ' ' ASN . 9.6 tt -86.26 -32.83 20.91 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.869 0.366 . . . . 72.340000000000003 110.601 176.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -124.72 -70.73 0.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.316 -0.402 . . . . 72.219999999999999 111.792 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -77.83 36.24 0.21 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.522 0.564 . . . . 61.32 112.522 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.4 p -70.0 1.84 4.16 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.014 0.435 . . . . 72.329999999999998 111.368 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -70.72 -52.81 18.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.837 0.351 . . . . 72.340000000000003 111.169 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 26.8 ptt180 -88.9 -25.78 21.94 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.051 -0.522 . . . . 61.439999999999998 111.753 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.578 HD13 ' HE ' ' A' ' 44' ' ' ARG . 5.4 mp 66.61 3.04 2.75 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.996 0.739 . . . . 73.129999999999995 112.996 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 59.5 t -99.63 151.26 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 122.504 0.322 . . . . 74.409999999999997 111.617 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -133.07 121.69 23.04 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.479 0.311 . . . . 73.549999999999997 110.436 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.87 95.92 5.03 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.147 0.795 . . . . 74.329999999999998 113.147 -172.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HB2' HD22 ' A' ' 56' ' ' LEU . 6.3 mp0 -102.08 -53.07 3.01 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.247 0.546 . . . . 70.409999999999997 110.549 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.45 -28.18 65.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.049 -0.523 . . . . 72.430000000000007 111.89 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.01 31.41 79.36 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 116.265 -0.425 . . . . 64.439999999999998 113.655 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.2 mt -78.73 -23.67 45.31 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.001 0.429 . . . . 72.450000000000003 111.213 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.51 HD21 ' HB1' ' A' ' 132' ' ' ALA . 82.9 mt -80.82 116.24 20.71 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.098 -0.501 . . . . 75.540000000000006 111.687 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.8 t -70.64 154.89 41.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 110.159 -0.311 . . . . 74.099999999999994 110.159 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -58.89 -32.7 69.74 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.902 0.334 . . . . 74.019999999999996 111.902 -175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.77 -46.92 83.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.313 0.577 . . . . 71.150000000000006 110.784 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.87 -38.28 85.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.903 -0.59 . . . . 74.409999999999997 111.569 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -64.07 -49.17 73.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.995 -0.282 . . . . 73.349999999999994 110.78 172.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.04 -34.57 43.84 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.4 0.619 . . . . 74.510000000000005 111.091 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 45.1 t -82.62 -52.56 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.695 -0.684 . . . . 73.409999999999997 111.842 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 48.8 ttm -66.08 -51.67 55.99 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.172 -0.33 . . . . 75.349999999999994 111.749 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -52.84 -43.04 65.73 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.107 0.48 . . . . 73.019999999999996 110.304 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.39 -43.33 99.48 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.817 -0.629 . . . . 75.010000000000005 112.714 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 35' ' ' VAL . 95.0 mtt180 -57.86 -54.93 41.29 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.654 0.264 . . . . 65.099999999999994 111.08 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.7 mt -61.87 -45.27 94.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.123 0.487 . . . . 71.129999999999995 111.454 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -60.01 -40.55 89.63 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.113 -0.494 . . . . 75.510000000000005 111.106 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.46 -44.55 86.85 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.361 -0.382 . . . . 74.310000000000002 111.196 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 39' ' ' ARG . 82.1 mt -57.85 -48.3 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.906 0.384 . . . . 74.319999999999993 110.809 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.578 ' HE ' HD13 ' A' ' 20' ' ' LEU . 58.3 ttp85 -61.92 -32.48 72.88 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.317 -0.401 . . . . 73.200000000000003 111.621 177.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -80.63 -28.37 37.0 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.959 0.355 . . . . 73.109999999999999 111.959 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -99.57 -68.68 0.8 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.105 0.409 . . . . 73.209999999999994 112.105 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -85.96 -9.95 55.98 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.845 0.313 . . . . 73.450000000000003 111.845 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.46 14.14 9.28 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.591 0.589 . . . . 73.319999999999993 112.591 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.1 t -72.56 133.72 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.026 0.441 . . . . 72.549999999999997 111.758 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -86.5 95.87 9.86 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.275 0.56 . . . . 64.349999999999994 110.434 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -111.61 105.29 13.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.993 -0.549 . . . . 72.329999999999998 110.656 -174.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.95 120.54 40.8 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.208 0.447 . . . . 73.340000000000003 112.208 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t -111.15 128.81 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.803 0.335 . . . . 73.140000000000001 111.055 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG23 HD21 ' A' ' 71' ' ' LEU . 44.0 t -128.01 141.31 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 122.403 0.281 . . . . 71.340000000000003 111.22 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 p -125.88 120.76 31.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.849 0.357 . . . . 74.25 111.379 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.409 HD22 ' HB2' ' A' ' 24' ' ' GLU . 85.2 mt -125.24 135.85 27.41 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-O 120.755 0.312 . . . . 74.140000000000001 111.468 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 72.8 Cg_endo -76.19 -25.23 10.27 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.394 2.063 . . . . 74.219999999999999 113.296 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.806 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 32.5 m -155.89 151.93 27.68 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.236 -0.29 . . . . 71.319999999999993 111.196 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 62' ' ' ALA . 31.0 pt -125.15 -32.27 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.855 0.36 . . . . 72.430000000000007 111.027 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.533 ' HA3' HG22 ' A' ' 3' ' ' VAL . . . 67.16 -116.6 8.21 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.268 -0.491 . . . . 73.230000000000004 113.626 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.24 67.36 9.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.612 0.72 . . . . 71.420000000000002 111.562 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' HD11 ' A' ' 59' ' ' ILE . . . -159.42 106.97 1.5 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.509 -0.768 . . . . 61.549999999999997 110.808 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.678 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 18.2 Cg_endo -57.03 138.86 88.16 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.818 2.345 . . . . 74.209999999999994 113.119 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 tp -54.69 -56.1 22.77 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.203 0.816 . . . . 73.340000000000003 113.203 -172.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.545 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 23.3 mt-10 -76.25 -9.62 58.77 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.255 0.465 . . . . 73.420000000000002 112.255 -173.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.678 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 4.3 m-20 -90.45 -34.55 15.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.96 0.409 . . . . 75.439999999999998 110.49 170.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -59.86 -50.51 73.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.181 -0.463 . . . . 75.329999999999998 110.678 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.7 p -55.4 -42.68 74.4 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.115 -0.493 . . . . 75.209999999999994 111.629 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.46 -54.62 37.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.43 -0.35 . . . . 73.230000000000004 111.559 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -61.23 -41.86 97.61 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.021 0.378 . . . . 72.049999999999997 112.021 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 54' ' ' VAL . 48.7 tp -65.39 -43.62 90.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.248 0.547 . . . . 74.310000000000002 110.964 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.25 72.97 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.849 0.357 . . . . 74.310000000000002 111.433 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.3 mtp180 -59.3 -53.84 53.65 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.046 0.388 . . . . 72.450000000000003 112.046 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.504 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.1 pt20 -64.54 -31.21 72.33 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.87 0.367 . . . . 72.420000000000002 111.734 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.504 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 42.1 m0 -85.97 8.23 21.3 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.027 0.38 . . . . 55.310000000000002 112.027 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.96 -49.86 4.17 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 114.385 0.514 . . . . 71.310000000000002 114.385 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.514 ' HA ' ' HB3' ' A' ' 82' ' ' ASN . 27.1 m -50.86 -33.99 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 113.162 0.801 . . . . 74.340000000000003 113.162 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.71 13.84 22.43 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.931 -0.652 . . . . 72.120000000000005 113.312 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 25.2 t-20 -58.57 -48.6 80.37 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.223 0.535 . . . . 71.040000000000006 110.974 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.92 46.44 0.77 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.584 -0.735 . . . . 71.230000000000004 109.979 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 62.91 76.13 0.38 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.304 -0.862 . . . . 73.150000000000006 112.153 -177.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.614 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 32.8 t-20 -67.43 119.86 12.95 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.373 -0.376 . . . . 75.150000000000006 110.031 174.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.641 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.0 OUTLIER -41.3 -44.95 2.86 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.367 0.877 . . . . 75.549999999999997 113.367 -178.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.512 ' H ' ' ND2' ' A' ' 83' ' ' ASN . 9.6 t30 -105.16 17.66 23.68 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.214 0.53 . . . . 71.239999999999995 111.905 -172.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.75 140.7 15.16 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.094 -0.574 . . . . 61.219999999999999 114.26 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 100' ' ' GLU . 51.7 tp -143.92 134.85 25.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.743 0.417 . . . . 74.120000000000005 110.858 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 60.0 tp -125.65 140.28 52.85 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.048 0.452 . . . . 72.200000000000003 111.778 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.8 tp -137.35 108.2 6.67 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.96 -0.564 . . . . 72.540000000000006 110.493 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.65 124.02 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 111.95 0.352 . . . . 75.25 111.95 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.587 ' HA ' HG12 ' A' ' 97' ' ' VAL . 36.8 tp -95.71 114.91 26.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.288 -0.415 . . . . 75.329999999999998 111.075 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.03 94.15 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 120.899 0.38 . . . . 71.340000000000003 111.128 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 52.8 tp -60.09 -27.61 67.14 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.819 0.342 . . . . 74.120000000000005 111.293 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.806 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 16.3 t0 -52.18 -35.13 48.03 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.831 0.824 . . . . 65.420000000000002 110.72 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.427 ' NE2' HD12 ' A' ' 59' ' ' ILE . 71.1 mt-30 -120.68 8.8 10.66 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.124 -0.944 . . . . 72.409999999999997 110.891 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 36.21 52.25 0.87 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.555 1.142 . . . . 70.150000000000006 113.536 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -153.33 162.32 41.41 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.881 -0.6 . . . . 73.400000000000006 110.91 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.651 HG23 ' SD ' ' A' ' 122' ' ' MET . 5.5 m -123.8 172.43 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.302 0.572 . . . . 74.239999999999995 112.186 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.545 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 65.6 ttt-85 -147.16 138.19 23.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.834 -0.621 . . . . 75.040000000000006 111.218 172.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -91.17 151.42 20.96 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.029 0.442 . . . . 74.200000000000003 111.083 173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 17.2 tp10 -137.64 112.58 9.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.288 -0.414 . . . . 74.319999999999993 110.595 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.6 p -99.69 136.33 39.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.328 0.585 . . . . 74.409999999999997 112.528 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -76.99 -178.89 47.75 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.584 -0.817 . . . . 50.43 112.154 168.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -62.36 -18.69 62.13 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.355 0.872 . . . . 75.319999999999993 113.355 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.559 ' N ' ' HA ' ' A' ' 83' ' ' ASN . . . -88.04 -40.71 6.51 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.768 -0.73 . . . . 60.310000000000002 112.581 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.631 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 95.0 mt -69.16 -6.73 30.6 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.267 0.469 . . . . 73.510000000000005 112.267 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -58.57 -23.98 59.79 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.261 0.553 . . . . 75.200000000000003 110.913 173.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.09 22.51 39.05 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.119 -0.491 . . . . 74.409999999999997 113.209 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.631 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 68.3 m-85 -141.55 -57.48 0.48 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.264 0.554 . . . . 74.049999999999997 110.953 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.9 mt -113.36 91.92 21.31 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.563 -0.744 . . . . 75.510000000000005 111.675 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.96 151.73 81.6 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.545 2.163 . . . . 70.109999999999999 112.509 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -54.49 -41.62 69.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.949 0.404 . . . . 74.450000000000003 111.61 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.59 -47.51 89.69 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.335 -0.459 . . . . 64.310000000000002 112.903 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.3 tp -56.12 -50.7 70.36 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.868 0.366 . . . . 74.310000000000002 111.056 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.08 -36.34 74.92 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.357 -0.383 . . . . 71.510000000000005 111.382 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 m -64.99 -41.3 95.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.397 -0.365 . . . . 73.049999999999997 111.095 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -64.35 -44.8 90.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.588 -0.278 . . . . 74.030000000000001 111.136 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.8 mt -52.59 -48.1 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.1 0.476 . . . . 74.120000000000005 110.682 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.0 mt -61.53 -37.07 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.224 -0.444 . . . . 74.5 111.6 176.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.454 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 7.6 t-80 -83.3 -28.41 29.11 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.05 0.759 . . . . 75.299999999999997 113.05 -173.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.96 -48.32 4.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.129 0.418 . . . . 72.209999999999994 112.129 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.666 ' HE ' ' HA ' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -84.61 -15.33 45.92 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.497 0.554 . . . . 73.140000000000001 112.497 -175.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.651 ' SD ' HG23 ' A' ' 97' ' ' VAL . 60.7 mtt -120.79 -54.77 2.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.688 0.996 . . . . 73.209999999999994 113.688 -176.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.487 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 12.8 mm -46.38 -54.47 18.08 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.202 0.816 . . . . 73.209999999999994 113.202 -175.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.487 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 51.6 Cg_exo -55.28 -34.29 87.9 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.767 1.644 . . . . 71.120000000000005 112.572 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 96.0 m-70 -76.05 -50.47 14.68 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 111.772 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.9 m-30 -56.37 -44.01 79.75 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.832 0.349 . . . . 73.340000000000003 111.421 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -61.43 -31.08 71.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.121 0.486 . . . . 75.439999999999998 111.127 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -88.4 0.67 55.96 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.002 -0.545 . . . . 74.129999999999995 111.747 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.72 -7.41 79.79 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.336 -0.459 . . . . 73.519999999999996 113.096 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.805 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 13.2 m120 -75.54 67.69 2.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.757 0.423 . . . . 74.510000000000005 111.472 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -67.74 -54.34 20.12 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.066 -0.397 . . . . 72.340000000000003 111.65 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.51 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -61.51 -42.97 99.61 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.976 0.417 . . . . 72.0 111.514 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.805 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 1.3 mp0 -58.15 -43.09 87.18 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.234 -0.439 . . . . 54.340000000000003 111.259 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.91 99.95 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.148 -0.549 . . . . 75.200000000000003 112.437 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.438 HD13 HD22 ' A' ' 90' ' ' LEU . 93.3 mt -59.7 -42.43 92.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.737 0.303 . . . . 75.310000000000002 111.129 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.5 t -57.68 -48.75 78.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.524 -0.307 . . . . 73.439999999999998 111.26 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -62.15 -43.85 97.92 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.956 0.407 . . . . 64.439999999999998 111.057 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.492 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -59.87 -54.2 39.48 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 116.166 -0.47 . . . . 63.329999999999998 113.385 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.25 -47.62 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.99 0.424 . . . . 63.530000000000001 111.379 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.486 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 48.5 tp -61.48 -38.36 87.0 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.187 -0.46 . . . . 65.030000000000001 111.047 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -61.37 -50.87 71.16 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.928 0.394 . . . . 71.420000000000002 111.263 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.26 -45.91 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.134 0.493 . . . . 71.349999999999994 110.818 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -54.82 -43.06 72.62 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.922 -0.581 . . . . 74.129999999999995 111.395 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 79.2 mt-30 -62.88 -41.3 99.35 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.704 0.261 . . . . 74.310000000000002 111.704 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 141' ' ' ALA . 58.0 t -59.35 -50.09 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.858 0.361 . . . . 73.129999999999995 111.131 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -58.67 -44.26 90.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.497 0.665 . . . . 74.230000000000004 110.464 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -66.13 -14.61 62.09 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.433 -0.803 . . . . 63.149999999999999 111.506 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.8 0.4 86.45 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.519 -0.372 . . . . 45.340000000000003 113.177 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 96.5 p -118.17 -52.12 2.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.915 0.388 . . . . 74.120000000000005 110.543 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 82.5 mt 65.32 5.92 3.37 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.838 0.681 . . . . 74.239999999999995 112.838 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -102.0 21.67 14.37 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.858 0.361 . . . . 63.240000000000002 111.821 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -130.39 89.24 2.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.439 -0.346 . . . . 75.420000000000002 110.959 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -131.1 7.86 4.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.672 0.273 . . . . 73.030000000000001 111.65 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -109.93 130.07 55.58 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.198 0.523 . . . . 74.530000000000001 112.157 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -132.12 130.25 40.93 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.939 -0.573 . . . . 73.409999999999997 109.62 174.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -104.34 168.78 8.87 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.771 0.656 . . . . 73.549999999999997 112.771 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 115.379 -0.828 . . . . 60.240000000000002 110.917 174.233 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.725 0.297 . . . . 73.530000000000001 111.051 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -169.12 11.23 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.303 -0.408 . . . . 75.209999999999994 111.573 171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.53 123.47 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.448 0.536 . . . . 74.519999999999996 112.448 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -90.12 174.16 7.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.757 0.789 . . . . 72.439999999999998 112.354 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.471 ' H ' ' HB2' ' A' ' 8' ' ' ASP . 30.6 mmtp -132.31 153.27 81.19 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.924 -1.035 . . . . 74.140000000000001 109.404 170.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 11.1 Cg_endo -56.47 -29.35 77.64 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 121.898 1.732 . . . . 63.039999999999999 112.437 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -83.82 -12.56 55.44 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.168 0.433 . . . . 64.530000000000001 112.168 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.471 ' HB2' ' H ' ' A' ' 5' ' ' LYS . 3.0 m-20 -81.97 -27.32 33.29 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.92 0.39 . . . . 73.430000000000007 111.366 172.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.62 129.62 91.47 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 116.315 -0.402 . . . . 73.329999999999998 111.554 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -52.44 126.94 22.23 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.892 2.395 . . . . 75.099999999999994 113.329 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.425 ' C ' HD21 ' A' ' 11' ' ' ASN . 0.2 OUTLIER -71.93 73.2 0.86 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.889 0.375 . . . . 73.329999999999998 111.0 -178.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.95 -38.56 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 112.263 0.468 . . . . 74.450000000000003 112.263 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.58 HE22 ' HG ' ' A' ' 20' ' ' LEU . 25.5 mm-40 -72.53 74.89 1.06 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.606 0.717 . . . . 71.109999999999999 110.825 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt 177.06 -56.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.629 -1.168 . . . . 72.519999999999996 108.338 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.08 -47.86 5.61 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.259 -0.882 . . . . 74.310000000000002 110.93 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.667 ' HB3' ' HB3' ' A' ' 19' ' ' ARG . 7.8 m-20 -96.57 49.16 1.09 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.776 -0.647 . . . . 72.019999999999996 111.79 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.7 m -67.14 -13.8 62.29 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.501 -0.318 . . . . 73.109999999999999 111.657 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.6 p -97.87 -3.2 39.13 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.741 0.305 . . . . 72.420000000000002 111.489 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.667 ' HB3' ' HB3' ' A' ' 16' ' ' ASP . 78.9 ttt180 -105.21 -56.38 2.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.015 0.436 . . . . 71.409999999999997 110.977 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.58 ' HG ' HE22 ' A' ' 13' ' ' GLN . 5.3 mp 69.96 -13.62 0.41 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.731 0.812 . . . . 71.420000000000002 113.069 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.3 t -93.43 148.61 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.207 0.527 . . . . 72.040000000000006 112.124 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.7 m -143.54 102.61 3.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.2 -0.455 . . . . 72.540000000000006 110.591 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.416 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 23.8 t70 -106.1 93.06 4.41 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.292 0.568 . . . . 71.219999999999999 111.079 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.418 ' HB2' HD21 ' A' ' 56' ' ' LEU . 31.5 mm-40 -94.11 -37.01 11.82 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.957 -0.565 . . . . 65.430000000000007 110.841 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.24 -34.11 68.27 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.346 0.499 . . . . 64.129999999999995 112.346 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.74 47.29 6.78 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.824 -0.703 . . . . 61.520000000000003 112.06 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.7 mt -114.07 -33.32 5.74 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.909 0.385 . . . . 64.439999999999998 111.405 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.51 106.15 5.97 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.616 -0.266 . . . . 63.530000000000001 110.959 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.5 t -51.77 145.25 9.81 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.375 -0.375 . . . . 64.340000000000003 111.193 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -49.54 -30.5 8.59 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.27 0.47 . . . . 74.409999999999997 112.27 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 35' ' ' VAL . . . -73.58 -51.09 18.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.749 0.309 . . . . 72.219999999999999 111.216 175.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -60.98 -42.12 97.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.87 0.367 . . . . 71.409999999999997 111.946 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -59.49 -54.18 49.53 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.312 0.577 . . . . 75.140000000000001 110.027 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -52.97 -52.61 57.56 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.438 -0.801 . . . . 74.400000000000006 112.085 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 31' ' ' ALA . 76.7 t -59.71 -41.99 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 111.855 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 48.2 ttm -61.34 -42.83 99.32 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.584 -0.28 . . . . 73.319999999999993 111.032 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -53.16 -51.94 60.4 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.06 0.457 . . . . 61.420000000000002 111.17 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.65 -38.02 93.16 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.166 -0.54 . . . . 44.520000000000003 113.242 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.456 ' O ' HG13 ' A' ' 43' ' ' ILE . 99.5 mtt180 -64.87 -54.64 27.76 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.656 -0.32 . . . . 73.209999999999994 111.458 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.69 -43.79 93.92 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.037 0.446 . . . . 73.400000000000006 111.379 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -57.64 -45.88 84.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.081 -0.509 . . . . 75.200000000000003 111.101 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.14 86.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.129 -0.487 . . . . 71.450000000000003 111.531 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.7 mt -56.19 -47.65 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.027 0.441 . . . . 65.400000000000006 111.375 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.459 ' HD3' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -62.66 -34.58 77.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.183 0.516 . . . . 74.129999999999995 110.711 178.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.8 m -89.75 -1.91 58.12 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.132 -0.486 . . . . 74.409999999999997 112.134 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.9 p -122.01 -61.87 1.45 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.011 0.434 . . . . 75.420000000000002 111.535 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -92.27 -2.18 56.61 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.831 0.348 . . . . 73.140000000000001 111.63 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 66.46 11.5 8.08 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.711 0.634 . . . . 71.230000000000004 112.711 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.443 ' HB ' HG21 ' A' ' 43' ' ' ILE . 62.9 t -80.74 117.47 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.0 0.429 . . . . 72.230000000000004 111.619 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -78.59 96.58 5.52 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.443 0.639 . . . . 74.319999999999993 110.454 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.83 106.89 15.31 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.445 -0.798 . . . . 74.209999999999994 110.778 -172.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.98 144.89 40.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.742 0.306 . . . . 74.420000000000002 111.789 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.45 128.44 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.745 0.307 . . . . 65.209999999999994 111.43 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.559 HG23 HD22 ' A' ' 71' ' ' LEU . 58.1 t -129.98 134.97 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 120.708 0.29 . . . . 73.120000000000005 111.582 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.416 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 39.3 p -120.99 125.32 47.08 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.946 0.403 . . . . 73.430000000000007 111.626 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 24' ' ' GLU . 85.1 mt -127.21 145.78 55.52 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-O 120.667 0.27 . . . . 71.200000000000003 111.246 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.581 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 57.8 Cg_endo -72.16 -45.14 0.69 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.228 1.952 . . . . 71.400000000000006 112.997 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.5 m -149.33 137.55 20.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.651 0.262 . . . . 73.400000000000006 111.23 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.5 pt -119.28 9.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 121.097 0.475 . . . . 71.150000000000006 111.407 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.12 -136.39 32.58 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.292 -0.48 . . . . 45.210000000000001 113.082 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -91.4 7.38 41.39 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.603 -0.351 . . . . 74.209999999999994 111.478 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.74 136.14 92.52 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.12 0.415 . . . . 72.510000000000005 112.12 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.59 132.83 24.44 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.586 2.19 . . . . 74.349999999999994 112.447 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.7 tp -62.63 -34.31 76.79 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.731 0.301 . . . . 75.540000000000006 111.758 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -73.94 -43.17 59.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.012 0.434 . . . . 73.109999999999999 111.303 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -61.61 -37.36 83.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.325 0.583 . . . . 74.510000000000005 110.149 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.411 ' CD2' ' HD3' ' A' ' 6' ' ' PRO . 36.3 t80 -58.79 -60.07 4.42 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.405 -0.816 . . . . 72.409999999999997 111.15 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.3 p -55.56 -41.68 73.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.101 -0.5 . . . . 75.200000000000003 111.751 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -55.65 -52.29 64.33 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 111.784 0.29 . . . . 74.400000000000006 111.784 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE3' ' HG2' ' A' ' 6' ' ' PRO . 34.7 mtmt -64.92 -46.31 82.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.736 0.303 . . . . 72.400000000000006 111.507 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.559 HD22 HG23 ' A' ' 54' ' ' VAL . 40.1 tp -60.88 -42.85 98.74 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.983 0.421 . . . . 75.120000000000005 111.201 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.63 -45.88 81.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.275 -0.42 . . . . 61.299999999999997 112.048 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.478 ' HA ' ' ND2' ' A' ' 79' ' ' ASN . 36.6 ptt180 -73.76 -24.72 59.9 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.785 0.326 . . . . 73.510000000000005 111.743 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -66.62 -40.41 88.78 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.029 0.442 . . . . 75.409999999999997 110.886 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 49.5 m0 -93.24 -15.91 25.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.304 -0.407 . . . . 75.239999999999995 111.837 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 72.48 44.65 40.5 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.481 -0.39 . . . . 70.349999999999994 113.374 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.97 -76.92 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.017 0.436 . . . . 65.140000000000001 111.711 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.76 71.8 0.38 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 121.434 -0.412 . . . . 74.409999999999997 112.285 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 0.9 OUTLIER -74.13 46.56 0.25 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.278 0.473 . . . . 73.049999999999997 112.278 -177.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 79' ' ' ASN . 43.6 tt0 71.62 -28.1 0.18 Allowed 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 113.158 0.799 . . . . 74.310000000000002 113.158 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -144.51 32.8 1.18 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.64 0.607 . . . . 60.329999999999998 112.64 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 79' ' ' ASN . 9.8 m-20 -79.49 -101.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.88 0.696 . . . . 61.219999999999999 112.88 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -154.55 -151.13 0.34 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.907 0.483 . . . . 74.340000000000003 110.209 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -67.95 77.8 0.22 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.815 0.816 . . . . 74.299999999999997 111.68 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.52 143.25 12.47 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.338 -0.846 . . . . 64.540000000000006 111.47 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 99' ' ' PHE . 31.3 tp -137.37 123.63 20.56 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.142 0.471 . . . . 72.540000000000006 111.591 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.5 tp -109.16 122.54 47.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.616 -0.265 . . . . 74.349999999999994 111.303 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.6 tp -114.19 111.75 22.05 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.516 0.326 . . . . 74.510000000000005 111.22 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.94 127.84 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.781 0.324 . . . . 62.009999999999998 111.794 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.541 HD21 HD13 ' A' ' 135' ' ' LEU . 23.1 tp -104.52 121.86 44.35 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.268 -0.424 . . . . 72.209999999999994 111.138 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.408 HG12 ' NE2' ' A' ' 94' ' ' GLN . 48.6 t -104.26 103.82 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.853 -0.158 . . . . 75.319999999999993 110.885 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.581 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 65.1 tp -57.34 -36.92 71.76 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.802 0.667 . . . . 72.040000000000006 112.802 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -50.99 -56.52 12.08 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 120.744 0.307 . . . . 73.25 111.704 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.585 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 8.4 pm0 -98.33 9.18 43.65 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.87 0.367 . . . . 75.420000000000002 111.537 174.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.464 ' HB2' ' HE1' ' A' ' 131' ' ' TYR . 40.2 ptt180 35.95 46.43 0.35 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.508 1.123 . . . . 73.219999999999999 113.707 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' HE ' ' HG3' ' A' ' 94' ' ' GLN . 26.8 ptt180 -126.45 154.64 43.41 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.891 0.377 . . . . 73.239999999999995 111.15 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.633 HG22 ' SD ' ' A' ' 122' ' ' MET . 5.7 m -122.42 171.18 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.234 -0.439 . . . . 74.230000000000004 111.804 -176.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.4 ttt85 -148.63 128.82 13.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.256 -0.429 . . . . 72.329999999999998 111.719 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.701 ' HB3' HD12 ' A' ' 86' ' ' LEU . 72.0 m-85 -92.66 118.78 31.4 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.303 -0.408 . . . . 74.319999999999993 110.013 170.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -103.93 112.29 25.2 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.542 0.211 . . . . 74.439999999999998 111.441 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.599 HG21 HD11 ' A' ' 114' ' ' LEU . 7.7 p -96.31 133.24 40.93 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.141 0.496 . . . . 74.319999999999993 111.528 177.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 81' ' ' LYS . . . -73.79 -63.52 2.7 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.953 -0.641 . . . . 73.519999999999996 112.518 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -168.59 -53.4 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.918 0.39 . . . . 72.519999999999996 111.838 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -54.15 -31.82 49.59 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 114.699 0.639 . . . . 73.019999999999996 114.699 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.403 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 64.8 mt -78.82 -10.69 59.87 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.906 0.706 . . . . 71.420000000000002 112.906 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -57.54 -31.81 66.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.904 0.383 . . . . 72.420000000000002 111.284 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.96 -25.08 75.57 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.075 -0.583 . . . . 72.319999999999993 113.326 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.4 ' HE1' HD23 ' A' ' 150' ' ' LEU . 74.0 m-85 -102.1 -67.77 0.86 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.414 -0.462 . . . . 64.140000000000001 111.276 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.607 ' HA ' HD22 ' A' ' 113' ' ' LEU . 1.6 mp -120.56 93.42 48.41 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 116.427 -0.351 . . . . 72.129999999999995 111.463 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.54 157.97 57.98 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.972 1.781 . . . . 71.120000000000005 111.529 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.522 ' HA ' HD13 ' A' ' 114' ' ' LEU . 10.0 p-10 -49.25 -33.78 13.57 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.325 0.491 . . . . 71.400000000000006 112.325 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.43 -45.51 96.25 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.956 -0.64 . . . . 63.5 112.991 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.607 HD22 ' HA ' ' A' ' 109' ' ' LEU . 53.0 tp -64.37 -35.41 80.78 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.032 0.444 . . . . 75.430000000000007 110.937 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 101' ' ' THR . 89.1 mt -59.94 -45.27 93.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.896 0.379 . . . . 72.230000000000004 110.894 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.4 m -63.78 -36.34 83.57 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.368 -0.378 . . . . 62.329999999999998 111.091 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -55.16 -46.02 75.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.094 -0.503 . . . . 74.5 111.104 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.3 -51.99 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.317 -0.401 . . . . 71.519999999999996 111.498 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.2 mt -56.58 -55.69 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.239 0.542 . . . . 74.340000000000003 112.193 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.453 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 20.3 t-80 -71.0 -30.92 67.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.694 0.628 . . . . 75.140000000000001 112.694 -169.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -88.0 -44.51 10.94 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.385 0.513 . . . . 72.349999999999994 112.385 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -98.46 -44.55 6.46 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.687 0.625 . . . . 74.420000000000002 112.687 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.633 ' SD ' HG22 ' A' ' 97' ' ' VAL . 47.4 mtt -72.68 -48.57 37.98 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.033 0.753 . . . . 75.530000000000001 113.033 -175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG1' ' HA ' ' A' ' 119' ' ' HIS . 29.8 mm -49.79 -55.26 24.61 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 113.185 0.809 . . . . 63.32 113.185 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 16.9 Cg_endo -56.61 -38.67 95.06 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.0 1.8 . . . . 62.539999999999999 112.477 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -66.25 -49.39 67.33 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 111.602 0.223 . . . . 63.509999999999998 111.602 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.1 m-30 -59.69 -35.84 75.29 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.756 0.313 . . . . 72.129999999999995 111.271 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -67.29 -36.27 81.2 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.95 0.405 . . . . 71.439999999999998 111.554 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 m -78.1 -22.01 49.61 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.858 0.361 . . . . 72.040000000000006 111.588 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.41 0.32 32.93 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.442 -0.409 . . . . 73.340000000000003 112.865 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.791 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 83.2 m-20 -82.3 74.27 9.28 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.63 -0.335 . . . . 64.25 111.685 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.464 ' HE1' ' HB2' ' A' ' 95' ' ' ARG . 96.9 m-85 -70.93 -44.42 66.18 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.838 0.351 . . . . 75.109999999999999 111.298 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.51 -46.61 85.28 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.963 0.411 . . . . 70.409999999999997 111.406 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.791 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 27.3 mm-40 -62.25 -49.38 75.96 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.066 -0.516 . . . . 72.239999999999995 111.415 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.67 -51.59 51.46 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.427 -0.416 . . . . 63.43 113.154 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.541 HD13 HD21 ' A' ' 90' ' ' LEU . 78.2 mt -62.07 -43.38 98.96 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.604 -0.351 . . . . 75.209999999999994 111.504 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.7 t -57.84 -57.57 12.19 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.252 0.464 . . . . 63.5 112.252 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.42 -19.81 57.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.913 0.338 . . . . 72.019999999999996 111.913 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.486 ' HA3' ' HE2' ' A' ' 122' ' ' MET . . . -63.79 -50.37 61.74 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.674 -0.774 . . . . 72.140000000000001 111.766 171.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.6 -44.98 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.044 0.449 . . . . 73.319999999999993 110.81 172.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 56.2 tp -59.37 -38.05 79.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.074 -0.512 . . . . 73.420000000000002 111.165 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -60.24 -44.8 94.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.801 0.334 . . . . 73.120000000000005 111.086 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.41 HG13 HD21 ' A' ' 109' ' ' LEU . 90.7 t -59.27 -52.73 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.106 0.479 . . . . 74.25 110.856 174.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -53.05 -43.67 66.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.913 -0.585 . . . . 65.019999999999996 111.888 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 83.6 mm-40 -59.3 -37.93 78.97 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.924 0.342 . . . . 74.400000000000006 111.924 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 141' ' ' ALA . 91.5 t -64.23 -35.84 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.064 0.459 . . . . 73.209999999999994 111.173 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.25 -57.83 5.96 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.368 -0.378 . . . . 74.150000000000006 111.648 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.73 -33.15 74.99 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.972 0.415 . . . . 75.340000000000003 111.485 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.71 -45.26 85.89 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 116.26 -0.427 . . . . 60.450000000000003 113.541 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 87.8 p -73.37 -31.5 63.95 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 122.242 -0.564 . . . . 71.099999999999994 111.319 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.4 HD23 ' HE1' ' A' ' 108' ' ' TYR . 74.2 mt -92.98 40.05 1.05 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.914 0.388 . . . . 74.319999999999993 111.809 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.85 17.97 1.4 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.756 0.313 . . . . 54.140000000000001 111.647 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -54.69 125.15 18.74 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.451 0.301 . . . . 72.420000000000002 110.702 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 17.7 p80 47.11 42.09 12.42 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.191 0.996 . . . . 71.150000000000006 113.146 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 74.22 0.88 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.616 0.722 . . . . 70.519999999999996 110.808 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -92.15 93.51 8.74 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.914 -0.584 . . . . 74.540000000000006 111.645 -173.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -100.75 -9.56 21.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.024 0.44 . . . . 74.310000000000002 111.038 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 44.7 m80 . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.97 -0.538 . . . . 74.25 111.043 175.56 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ttt . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.662 0.268 . . . . 72.400000000000006 111.54 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -126.41 122.4 35.2 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.813 0.339 . . . . 74.400000000000006 110.355 174.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t -88.02 125.76 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 112.734 0.642 . . . . 73.109999999999999 112.734 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -111.12 126.74 55.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.984 -0.553 . . . . 75.209999999999994 111.86 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -105.73 163.89 16.15 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 116.189 -0.459 . . . . 70.540000000000006 109.814 171.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 10.0 Cg_endo -51.53 -29.37 31.72 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.566 2.177 . . . . 63.329999999999998 114.118 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -82.87 -17.68 42.99 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.438 0.533 . . . . 72.319999999999993 112.438 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.88 -34.89 64.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.074 0.464 . . . . 72.319999999999993 110.527 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.401 HG23 HD21 ' A' ' 56' ' ' LEU . 64.9 t -64.7 127.05 92.08 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 115.84 -0.618 . . . . 72.25 111.466 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.21 133.0 31.38 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.376 2.05 . . . . 70.549999999999997 113.059 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.71 HD21 ' HB2' ' A' ' 14' ' ' LEU . 8.1 t30 -74.54 77.12 1.97 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.37 0.605 . . . . 75.420000000000002 110.69 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -59.79 -31.0 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 113.151 0.797 . . . . 73.430000000000007 113.151 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.34 -9.03 10.24 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.307 0.484 . . . . 75.209999999999994 112.307 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.71 ' HB2' HD21 ' A' ' 11' ' ' ASN . 8.1 tt -76.14 -41.68 49.23 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.209 0.528 . . . . 74.219999999999999 110.383 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.89 -51.68 3.36 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.043 -0.526 . . . . 74.030000000000001 112.39 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -114.85 86.59 2.47 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.017 0.747 . . . . 74.299999999999997 113.017 -173.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.4 p -78.89 -6.73 56.87 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.569 0.7 . . . . 75.209999999999994 110.398 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -93.06 -0.44 57.1 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.802 -0.636 . . . . 60.130000000000003 111.128 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -113.31 -63.09 1.49 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.126 -0.488 . . . . 75.310000000000002 111.323 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp 64.62 -0.02 1.04 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.224 0.61 . . . . 72.540000000000006 112.489 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.0 t -103.81 130.09 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.067 0.46 . . . . 73.530000000000001 111.816 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -125.72 112.59 16.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.972 -0.558 . . . . 73.420000000000002 110.094 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.68 100.4 7.59 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.363 0.505 . . . . 64.230000000000004 112.363 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HB2' HD22 ' A' ' 56' ' ' LEU . 4.5 mp0 -98.54 -37.75 9.43 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.919 0.39 . . . . 75.340000000000003 110.937 173.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -57.24 -31.27 65.37 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.74 0.644 . . . . 61.119999999999997 112.74 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.44 39.44 8.33 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.836 -0.697 . . . . 61.100000000000001 112.328 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.18 -38.43 5.99 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.063 0.459 . . . . 72.109999999999999 111.286 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -90.6 98.88 12.04 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.184 0.516 . . . . 75.439999999999998 111.362 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.1 m -72.36 173.05 9.27 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.402 -0.363 . . . . 72.340000000000003 111.584 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -49.97 -47.3 52.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.29 0.478 . . . . 71.530000000000001 112.29 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.44 -47.27 76.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.932 0.396 . . . . 65.209999999999994 111.4 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -55.81 -43.63 77.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.198 -0.456 . . . . 73.519999999999996 111.132 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.76 -55.08 37.42 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.369 -0.378 . . . . 75.120000000000005 111.132 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.7 -38.87 61.37 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.053 0.454 . . . . 74.510000000000005 111.848 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.57 -43.0 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.002 0.43 . . . . 71.040000000000006 111.615 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 47.0 ttm -73.22 -45.99 52.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.636 0.255 . . . . 75.109999999999999 111.16 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -50.76 -42.79 58.01 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.901 0.48 . . . . 64.540000000000006 111.031 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.24 -47.55 90.5 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.154 -0.475 . . . . 64.120000000000005 113.561 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.465 ' O ' HG13 ' A' ' 43' ' ' ILE . 9.9 ptp180 -74.45 -34.73 63.24 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.439 -0.448 . . . . 75.109999999999999 112.064 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 51' ' ' PHE . 89.8 mt -67.91 -41.65 82.32 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.5 0.667 . . . . 72.040000000000006 110.487 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -59.13 -39.58 82.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.378 -0.828 . . . . 74.319999999999993 110.352 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.42 85.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.944 -0.571 . . . . 74.409999999999997 111.422 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 143' ' ' GLN . 77.2 mt -58.45 -51.9 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 111.735 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 62.7 ttp85 -65.14 -34.01 77.38 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.772 0.32 . . . . 75.109999999999999 111.592 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -76.46 -23.59 53.85 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.831 0.348 . . . . 61.25 111.66 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -100.02 -69.9 0.75 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.663 0.246 . . . . 74.420000000000002 111.663 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -87.05 -5.6 59.0 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.523 0.564 . . . . 64.430000000000007 112.523 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 67.08 19.83 10.42 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.493 0.553 . . . . 73.319999999999993 112.493 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.7 t -90.57 133.99 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.695 0.284 . . . . 70.349999999999994 111.627 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.3 96.97 10.78 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.072 0.463 . . . . 74.209999999999994 110.658 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -103.59 97.97 7.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.783 -0.644 . . . . 74.129999999999995 109.759 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.07 141.94 34.97 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.131 0.419 . . . . 74.420000000000002 112.131 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.93 123.9 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.454 -0.339 . . . . 72.349999999999994 111.119 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -121.61 136.01 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.399 0.28 . . . . 72.420000000000002 111.391 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -120.5 123.75 43.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.912 0.386 . . . . 72.109999999999999 111.432 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.439 HD22 ' HB2' ' A' ' 24' ' ' GLU . 76.3 mt -124.15 145.36 48.11 Favored Pre-proline 0 N--CA 1.471 0.625 0 O-C-N 122.164 -0.335 . . . . 74.349999999999994 111.792 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.41 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 27.9 Cg_exo -63.11 -55.99 0.66 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.739 2.293 . . . . 74.019999999999996 112.542 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.452 ' HG ' ' HB2' ' A' ' 93' ' ' ASP . 44.6 m -150.78 148.58 28.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.758 0.314 . . . . 73.219999999999999 111.394 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 91' ' ' VAL . 24.4 pt -118.24 -6.65 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 120.956 0.408 . . . . 74.25 111.777 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.53 -116.18 8.43 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.535 -0.364 . . . . 62.020000000000003 113.841 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.3 -13.12 53.31 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.713 0.292 . . . . 73.230000000000004 111.761 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . . . -65.49 124.83 88.29 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.606 -0.27 . . . . 64.120000000000005 111.329 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.3 Cg_endo -80.14 131.71 8.95 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.427 2.084 . . . . 74.549999999999997 112.607 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.4 HD23 ' HG3' ' A' ' 96' ' ' ARG . 61.4 tp -59.33 -42.28 91.08 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.422 0.527 . . . . 64.340000000000003 112.422 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -60.1 -44.29 94.96 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.031 0.443 . . . . 74.019999999999996 111.493 -177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 6.0 m-20 -74.48 -33.19 62.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.957 0.408 . . . . 75.349999999999994 110.809 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 56' ' ' LEU . 37.3 t80 -56.6 -55.35 35.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.298 -0.41 . . . . 74.310000000000002 111.383 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.9 p -54.69 -46.07 74.06 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.285 -0.416 . . . . 74.340000000000003 111.66 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.573 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.0 tp -59.2 -54.59 45.19 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.375 -0.375 . . . . 75.400000000000006 111.327 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -58.94 -44.22 91.37 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.107 0.41 . . . . 74.340000000000003 112.107 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.587 HD21 HD21 ' A' ' 87' ' ' LEU . 54.7 tp -62.42 -45.35 93.5 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.156 0.503 . . . . 74.349999999999994 110.926 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.68 -35.99 81.45 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.905 0.384 . . . . 42.020000000000003 111.792 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 78.4 mtp180 -61.67 -53.98 48.93 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.511 -0.313 . . . . 73.030000000000001 111.595 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.492 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 10.3 pt20 -64.87 -33.73 76.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 111.987 0.366 . . . . 75.129999999999995 111.987 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.492 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 26.9 m0 -74.28 -4.48 36.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.929 0.395 . . . . 74.150000000000006 111.956 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.59 ' HA2' HD22 ' A' ' 79' ' ' ASN . . . 78.33 -1.01 72.64 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.277 -0.487 . . . . 75.420000000000002 113.414 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 t -102.94 15.17 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.291 0.567 . . . . 73.400000000000006 110.937 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.11 28.49 0.3 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.265 -0.969 . . . . 71.319999999999993 114.535 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.59 HD22 ' HA2' ' A' ' 76' ' ' GLY . 60.3 m-80 -67.31 89.01 0.2 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.113 0.957 . . . . 74.400000000000006 110.228 175.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 57.65 66.06 1.21 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.714 -0.675 . . . . 73.439999999999998 110.816 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 11.8 mptt 59.78 91.95 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.561 -0.745 . . . . 74.409999999999997 112.473 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.65 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 25.3 t-20 -84.52 119.33 25.05 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 110.201 -0.296 . . . . 75.510000000000005 110.201 176.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.649 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.0 OUTLIER -36.43 -63.65 0.38 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 113.958 1.096 . . . . 63.109999999999999 113.958 -176.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.597 ' H ' ' ND2' ' A' ' 83' ' ' ASN . 2.9 p-10 -94.5 35.16 1.23 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.861 -0.524 . . . . 71.310000000000002 111.864 -176.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.4 139.2 15.45 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.136 -0.554 . . . . 73.540000000000006 113.933 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 46.6 tp -149.98 122.93 8.76 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.009 0.433 . . . . 74.129999999999995 110.846 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.587 HD21 HD21 ' A' ' 71' ' ' LEU . 62.9 tp -122.95 131.79 53.87 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.937 0.399 . . . . 70.200000000000003 111.924 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.7 tp -121.35 117.3 26.61 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.146 -0.479 . . . . 72.25 110.889 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.22 124.73 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.943 0.402 . . . . 73.349999999999994 111.852 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.509 ' HA ' HG13 ' A' ' 97' ' ' VAL . 30.2 tp -103.47 118.59 37.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.056 -0.52 . . . . 75.5 111.007 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 59' ' ' ILE . 57.6 t -99.41 101.22 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.539 -0.3 . . . . 73.450000000000003 110.868 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.2 tp -48.93 -46.49 43.21 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.857 0.463 . . . . 74.109999999999999 111.994 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.452 ' HB2' ' HG ' ' A' ' 58' ' ' SER . 27.5 t70 -45.27 -48.36 12.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.973 0.731 . . . . 73.109999999999999 112.973 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -111.15 4.58 19.42 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.18 0.437 . . . . 75.430000000000007 112.18 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 43.52 26.06 0.1 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.331 1.052 . . . . 74.239999999999995 113.467 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.4 ' HG3' HD23 ' A' ' 64' ' ' LEU . 11.0 ptm85 -105.02 152.25 22.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.922 0.392 . . . . 73.540000000000006 111.042 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 90' ' ' LEU . 3.4 m -136.63 165.86 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.177 -0.465 . . . . 71.439999999999998 110.771 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -149.63 135.32 18.56 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.797 0.332 . . . . 73.329999999999998 111.61 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.523 ' HB2' HD11 ' A' ' 114' ' ' LEU . 80.8 m-85 -93.86 102.35 14.47 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.102 -0.499 . . . . 71.340000000000003 110.024 172.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -81.87 111.37 18.01 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 110.329 -0.249 . . . . 61.329999999999998 110.329 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.9 p -93.15 141.01 28.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.578 0.704 . . . . 74.150000000000006 112.581 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -84.37 166.81 42.37 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.676 -0.774 . . . . 70.439999999999998 111.743 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -54.28 -19.63 5.67 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.16 0.8 . . . . 75.549999999999997 113.16 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.531 ' N ' ' HA ' ' A' ' 83' ' ' ASN . . . -85.11 -20.52 57.25 Favored Glycine 0 N--CA 1.463 0.462 0 C-N-CA 120.815 -0.707 . . . . 65.230000000000004 112.805 -173.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.41 -4.3 29.27 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.351 0.26 . . . . 72.129999999999995 111.587 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -51.59 -39.95 58.91 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.269 0.47 . . . . 75.319999999999993 112.269 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.43 -12.51 58.76 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.225 -0.512 . . . . 53.140000000000001 114.113 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -118.38 -48.65 2.5 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.066 0.46 . . . . 73.109999999999999 111.7 -176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.549 ' HB3' HD21 ' A' ' 114' ' ' LEU . 30.8 mt -118.02 86.44 25.81 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.92 -0.582 . . . . 75.099999999999994 112.296 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 88.9 Cg_endo -82.84 158.55 15.97 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.27 1.98 . . . . 74.129999999999995 112.398 172.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.45 -35.21 8.23 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.908 0.336 . . . . 72.140000000000001 111.908 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.27 -51.03 59.42 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.107 -0.568 . . . . 65.530000000000001 113.122 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 64.9 tp -62.73 -45.87 90.7 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.073 0.464 . . . . 71.129999999999995 110.674 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.549 HD21 ' HB3' ' A' ' 109' ' ' LEU . 67.7 mt -59.22 -38.46 80.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.936 -0.575 . . . . 73.239999999999995 110.972 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.5 t -61.81 -40.14 94.21 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.174 -0.467 . . . . 62.310000000000002 110.942 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.45 -48.76 76.37 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.935 -0.306 . . . . 72.409999999999997 110.901 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.2 mt -50.71 -45.66 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.099 0.476 . . . . 74.099999999999994 110.908 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.522 ' O ' HG12 ' A' ' 123' ' ' ILE . 68.2 mt -64.9 -56.83 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.01 -0.541 . . . . 72.310000000000002 112.189 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -76.02 -34.37 59.68 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.602 0.964 . . . . 62.509999999999998 113.602 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.25 -32.59 33.27 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.858 0.361 . . . . 75.310000000000002 111.716 -171.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -123.57 -56.19 1.7 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.286 0.476 . . . . 74.329999999999998 112.286 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 91.4 mtp -64.06 -43.86 94.2 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.554 0.946 . . . . 74.310000000000002 113.554 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 118' ' ' ILE . 38.2 mm -57.54 -50.29 88.96 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 112.18 0.437 . . . . 74.120000000000005 112.18 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.438 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 86.9 Cg_exo -45.0 -44.7 14.77 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.204 1.936 . . . . 74.109999999999999 112.948 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -64.1 -51.9 61.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.614 -0.266 . . . . 72.099999999999994 111.535 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -56.95 -39.78 75.2 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.781 0.324 . . . . 74.25 111.664 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -67.44 -36.02 80.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.218 0.532 . . . . 72.319999999999993 110.994 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.5 t -74.28 -16.83 60.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.25 -0.432 . . . . 72.319999999999993 111.067 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.31 53.2 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 116.283 -0.417 . . . . 70.409999999999997 112.659 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.887 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 94.8 m-20 -81.31 72.0 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.052 0.454 . . . . 62.140000000000001 111.966 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -67.07 -45.65 76.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.825 0.345 . . . . 73.510000000000005 111.079 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.58 -47.33 67.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.05 0.452 . . . . 72.329999999999998 111.357 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.887 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 11.3 tp10 -59.75 -41.27 90.61 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.032 -0.531 . . . . 61.100000000000001 110.721 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.77 -53.96 34.42 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.831 -0.622 . . . . 63.350000000000001 113.258 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.2 -44.81 71.91 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 122.462 -0.434 . . . . 75.540000000000006 111.348 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.2 t -56.01 -51.67 66.95 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.231 0.456 . . . . 75.409999999999997 112.231 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -34.6 62.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.628 0.232 . . . . 73.510000000000005 111.628 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.82 -48.15 87.48 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.111 -0.566 . . . . 51.25 112.378 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.72 -43.74 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.17 0.51 . . . . 55.240000000000002 110.932 173.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.95 -38.97 87.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.971 -0.559 . . . . 74.420000000000002 110.795 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.3 96.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.095 0.474 . . . . 64.219999999999999 111.045 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.47 -51.43 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.139 -0.482 . . . . 74.109999999999999 111.427 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.466 ' HB2' HD12 ' A' ' 43' ' ' ILE . 10.2 tt0 -54.18 -40.19 67.3 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 121.128 -0.229 . . . . 75.400000000000006 111.536 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -57.29 -43.42 83.17 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.83 0.307 . . . . 74.519999999999996 111.83 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.79 -51.12 76.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.902 0.382 . . . . 73.299999999999997 111.15 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.62 -46.51 88.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.184 0.516 . . . . 73.129999999999995 111.079 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -59.7 -31.32 69.48 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.783 -0.644 . . . . 55.109999999999999 111.263 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.8 -22.8 75.68 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.28 -0.486 . . . . 73.409999999999997 112.715 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 28.8 t -83.08 -65.51 1.0 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.986 0.422 . . . . 75.5 111.131 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.1 mt -122.14 86.25 2.55 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.328 0.585 . . . . 75.120000000000005 110.941 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.17 39.67 0.19 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.865 -0.607 . . . . 75.420000000000002 111.981 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -133.2 108.98 9.13 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.148 -0.345 . . . . 73.549999999999997 110.954 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -57.66 137.99 55.86 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.888 0.375 . . . . 74.340000000000003 111.445 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -103.21 118.73 37.45 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.498 -0.319 . . . . 75.510000000000005 111.006 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -90.27 -9.69 46.99 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.976 0.417 . . . . 74.420000000000002 111.104 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -74.59 112.54 10.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.507 -0.315 . . . . 73.420000000000002 111.401 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 17.4 p80 . . . . . 0 C--O 1.254 1.332 0 CA-C-N 116.69 -0.232 . . . . 73.239999999999995 111.136 -179.58 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ttt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.768 0.318 . . . . 75.420000000000002 111.047 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.404 ' HD2' ' CE2' ' A' ' 4' ' ' TYR . 34.6 ttm180 -156.58 106.8 2.33 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.413 -0.358 . . . . 73.329999999999998 110.073 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.96 103.38 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.061 0.458 . . . . 74.0 112.038 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.404 ' CE2' ' HD2' ' A' ' 2' ' ' ARG . 15.3 m-85 -93.01 134.51 35.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.422 0.527 . . . . 75.120000000000005 112.422 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 1.3 mptm? -107.52 163.3 17.24 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.148 -0.478 . . . . 72.109999999999999 110.124 169.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 13.6 Cg_endo -54.87 -26.64 49.4 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.176 1.918 . . . . 72.519999999999996 112.716 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.44 -29.49 59.7 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.385 -0.371 . . . . 75.040000000000006 111.933 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.63 -29.65 56.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.929 0.395 . . . . 74.239999999999995 111.585 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.621 HG11 HG22 ' A' ' 22' ' ' THR . 50.5 t -62.87 127.55 90.77 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 116.185 -0.461 . . . . 74.299999999999997 111.494 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.64 130.39 31.37 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.66 2.24 . . . . 74.140000000000001 112.949 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -69.8 76.65 0.46 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.242 0.544 . . . . 63.340000000000003 112.045 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 m -58.29 -49.56 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.482 0.549 . . . . 73.140000000000001 112.482 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -60.89 -17.91 53.35 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.837 -0.54 . . . . 75.209999999999994 112.054 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.66 -52.33 5.6 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.869 0.366 . . . . 75.200000000000003 110.21 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.99 -75.84 0.49 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.526 -0.306 . . . . 71.319999999999993 111.703 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.92 48.76 0.61 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.47 0.545 . . . . 74.540000000000006 112.47 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 82.9 p -63.84 -9.21 13.69 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.963 0.411 . . . . 62.119999999999997 111.344 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -89.86 -26.08 20.69 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.085 -0.507 . . . . 74.310000000000002 111.374 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.523 ' HD2' ' O ' ' A' ' 21' ' ' VAL . 12.3 ttm180 -85.03 -45.1 12.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.913 0.387 . . . . 73.540000000000006 110.864 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 40' ' ' LEU . 5.5 mp 59.15 15.12 3.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.484 0.713 . . . . 62.119999999999997 112.382 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' O ' ' HD2' ' A' ' 19' ' ' ARG . 88.0 t -129.39 126.1 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.965 0.412 . . . . 72.150000000000006 111.696 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.621 HG22 HG11 ' A' ' 9' ' ' VAL . 86.7 m -99.66 102.93 14.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.915 0.388 . . . . 71.420000000000002 110.11 173.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.439 ' HA ' ' HG1' ' A' ' 55' ' ' THR . 5.3 p-10 -100.98 98.18 8.67 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.371 0.605 . . . . 60.539999999999999 111.886 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -126.46 -30.85 2.81 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.835 0.35 . . . . 74.409999999999997 111.325 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.11 -19.54 45.44 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 111.708 0.262 . . . . 54.340000000000003 111.708 171.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.74 40.02 98.22 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.505 -0.378 . . . . 73.400000000000006 113.697 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.1 mt -105.39 -2.73 23.48 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.083 0.401 . . . . 72.439999999999998 112.083 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.87 -175.1 2.79 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.931 0.396 . . . . 75.239999999999995 111.907 -176.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.9 t -158.79 170.4 22.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.665 0.386 . . . . 72.400000000000006 110.484 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -44.68 -45.33 9.69 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.956 0.725 . . . . 72.010000000000005 112.956 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.417 ' O ' HG21 ' A' ' 35' ' ' VAL . . . -70.14 -55.95 8.09 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.288 -0.257 . . . . 74.420000000000002 111.632 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -55.59 -45.87 77.35 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 111.847 0.314 . . . . 74.239999999999995 111.847 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.68 -54.9 36.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.422 -0.354 . . . . 71.319999999999993 111.085 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.98 -41.27 82.65 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.178 0.436 . . . . 75.319999999999993 112.178 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 90.9 t -64.51 -50.06 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.887 0.375 . . . . 74.519999999999996 110.807 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.1 ttm -60.51 -43.7 96.79 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.532 -0.304 . . . . 72.439999999999998 111.478 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.48 -44.63 89.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.882 0.372 . . . . 74.109999999999999 111.011 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.88 -44.59 97.21 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.172 -0.537 . . . . 55.119999999999997 112.716 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' O ' HG13 ' A' ' 43' ' ' ILE . 5.8 mmp_? -55.34 -55.41 31.9 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.006 0.431 . . . . 73.120000000000005 110.96 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.431 ' HB3' HD23 ' A' ' 20' ' ' LEU . 87.7 mt -60.59 -44.39 96.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.032 -0.531 . . . . 73.430000000000007 111.891 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -63.16 -39.41 94.58 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.725 0.297 . . . . 75.120000000000005 110.863 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.93 -42.48 98.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.949 0.404 . . . . 74.319999999999993 111.017 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.3 mt -57.63 -47.18 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.014 -0.539 . . . . 73.519999999999996 111.453 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 14.4 ptm180 -77.67 -24.95 49.21 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.959 -0.463 . . . . 73.129999999999995 111.927 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.4 t -70.06 -35.5 74.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.945 0.402 . . . . 62.020000000000003 111.027 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.1 t -95.7 -56.43 2.68 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.132 -0.486 . . . . 73.239999999999995 112.215 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -98.44 -12.64 21.15 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.302 0.482 . . . . 73.0 112.302 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.36 20.85 11.88 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.518 0.562 . . . . 73.340000000000003 112.518 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.425 ' HB ' HG21 ' A' ' 43' ' ' ILE . 92.7 t -81.79 125.55 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.0 0.428 . . . . 75.239999999999995 111.129 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -84.34 97.15 9.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.276 0.56 . . . . 74.299999999999997 110.662 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.59 105.3 15.26 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.392 -0.822 . . . . 74.450000000000003 110.647 -173.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.22 117.11 33.44 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.146 0.424 . . . . 72.439999999999998 112.146 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.55 112.54 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.164 0.507 . . . . 75.239999999999995 111.502 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.476 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 58.1 t -107.56 143.26 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 122.912 0.485 . . . . 74.510000000000005 111.463 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.439 ' HG1' ' HA ' ' A' ' 23' ' ' ASP . 49.8 p -133.81 122.52 23.37 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.718 0.294 . . . . 74.040000000000006 110.893 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -127.71 141.8 42.19 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 120.561 0.219 . . . . 74.140000000000001 111.295 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.76 -48.23 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.506 2.138 . . . . 71.010000000000005 113.062 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.917 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 67.6 p -155.78 145.02 20.78 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.021 0.378 . . . . 72.030000000000001 112.021 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG12 HG12 ' A' ' 91' ' ' VAL . 36.5 pt -123.86 -3.49 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.749 0.309 . . . . 73.329999999999998 111.494 176.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.42 47.22 6.99 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.219 -0.515 . . . . 75.319999999999993 113.169 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 56.96 20.35 5.29 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.174 0.435 . . . . 74.340000000000003 112.174 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.95 151.65 97.16 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.396 -0.365 . . . . 72.019999999999996 111.834 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.525 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 29.4 Cg_endo -60.59 117.32 4.07 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.841 2.361 . . . . 74.099999999999994 113.14 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.82 -51.83 65.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.868 0.692 . . . . 74.109999999999999 112.868 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -31.71 72.67 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.125 0.488 . . . . 74.329999999999998 111.588 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 63' ' ' PRO . 10.4 t70 -68.84 -34.8 76.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.205 0.526 . . . . 75.5 110.835 173.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -65.91 -55.94 14.32 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.859 -0.61 . . . . 75.129999999999995 110.892 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.5 p -56.97 -42.81 80.85 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.813 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.8 tp -53.03 -53.09 55.37 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.924 0.392 . . . . 74.540000000000006 111.953 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.604 ' HG2' HH21 ' A' ' 73' ' ' ARG . 37.8 mtmm -71.33 -36.88 71.7 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.314 0.487 . . . . 75.209999999999994 112.314 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.7 tp -65.85 -37.59 86.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.201 0.524 . . . . 75.109999999999999 111.257 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.74 84.12 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.297 -0.41 . . . . 74.329999999999998 111.616 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.604 HH21 ' HG2' ' A' ' 70' ' ' LYS . 41.3 mtm105 -58.91 -49.66 76.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.272 0.471 . . . . 73.239999999999995 112.272 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.459 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 11.7 pt20 -64.63 -15.27 60.96 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.135 0.42 . . . . 75.519999999999996 112.135 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.459 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 45.5 m0 -103.4 14.88 30.44 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.776 0.322 . . . . 75.519999999999996 111.543 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.37 -53.32 4.65 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.113 -0.565 . . . . 64.209999999999994 113.651 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.49 ' HA ' ' HB3' ' A' ' 82' ' ' ASN . 31.0 m -52.1 -27.27 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 113.505 0.928 . . . . 72.5 113.505 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.79 -11.92 48.7 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.799 -0.715 . . . . 73.439999999999998 113.918 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -58.95 109.51 0.84 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.355 0.577 . . . . 74.5 109.937 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 42.63 32.91 0.41 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.721 0.808 . . . . 74.25 112.291 -171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.529 ' HB3' ' HA2' ' A' ' 102' ' ' GLY . 0.5 OUTLIER 62.85 80.13 0.24 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.202 -0.908 . . . . 74.510000000000005 112.704 178.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.537 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 42.5 t30 -60.45 130.28 45.82 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 111.027 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.622 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -41.07 -60.65 1.16 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.2 1.185 . . . . 74.239999999999995 114.2 -171.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.622 ' H ' ' ND2' ' A' ' 83' ' ' ASN . 4.8 p-10 -95.04 24.27 4.99 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.044 -0.41 . . . . 73.420000000000002 112.034 -174.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.16 137.6 13.52 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.027 -0.606 . . . . 72.319999999999993 113.549 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 99' ' ' PHE . 49.1 tp -144.53 119.96 10.31 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.015 0.436 . . . . 74.140000000000001 111.246 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 63.1 tp -109.32 141.47 41.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.944 0.402 . . . . 70.439999999999998 111.363 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.1 tp -129.7 127.79 41.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.378 -0.374 . . . . 74.409999999999997 110.022 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 65.8 t -128.19 116.6 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 122.116 -0.365 . . . . 74.140000000000001 111.882 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.643 ' HA ' HG13 ' A' ' 97' ' ' VAL . 30.2 tp -95.45 120.97 36.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.247 -0.433 . . . . 72.209999999999994 111.001 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.572 HG11 ' HB3' ' A' ' 93' ' ' ASP . 60.1 t -110.5 99.94 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.771 0.319 . . . . 70.239999999999995 111.059 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.3 tp -53.76 -39.1 65.08 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.898 0.38 . . . . 75.420000000000002 111.457 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.917 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 56.1 t0 -39.33 -52.98 2.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.915 0.886 . . . . 72.319999999999993 112.061 173.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.449 ' OE1' ' HD2' ' A' ' 96' ' ' ARG . 11.1 pt20 -108.53 -4.21 17.41 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.227 0.455 . . . . 74.420000000000002 112.227 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 59.32 27.56 16.67 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.524 0.564 . . . . 73.140000000000001 112.524 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HD2' ' OE1' ' A' ' 94' ' ' GLN . 87.0 mtt180 -120.41 155.84 32.63 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.079 0.466 . . . . 74.430000000000007 111.39 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.7 HG22 ' SD ' ' A' ' 122' ' ' MET . 3.6 m -134.64 169.64 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.658 -0.701 . . . . 74.239999999999995 110.958 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -150.83 141.03 22.22 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.965 0.358 . . . . 74.230000000000004 111.965 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.475 ' HB3' HD11 ' A' ' 86' ' ' LEU . 97.0 m-85 -100.8 113.87 27.17 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.87 -0.605 . . . . 74.319999999999993 110.31 172.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -98.59 112.02 24.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 110.31 -0.256 . . . . 64.140000000000001 110.31 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.1 p -98.6 152.58 19.44 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.996 0.739 . . . . 72.530000000000001 112.996 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -88.57 166.95 34.85 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.394 -0.821 . . . . 72.150000000000006 111.906 168.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -65.17 1.0 1.11 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.979 0.733 . . . . 70.129999999999995 112.979 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.86 -42.46 6.02 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.496 -0.641 . . . . 71.239999999999995 111.496 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.52 -12.76 60.29 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.319 -0.441 . . . . 73.420000000000002 111.777 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -56.96 -17.29 9.13 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.216 0.45 . . . . 72.230000000000004 112.216 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.68 -7.55 85.84 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.179 -0.534 . . . . 74.329999999999998 113.598 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.1 -49.81 1.02 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.099 0.475 . . . . 75.230000000000004 111.822 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.2 mt -112.36 90.13 13.72 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.006 -0.543 . . . . 75.129999999999995 112.194 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.99 157.16 23.7 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.363 2.042 . . . . 75.040000000000006 112.893 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.49 -34.39 35.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.804 0.441 . . . . 70.519999999999996 111.949 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.91 -50.04 63.65 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.108 -0.568 . . . . 64.319999999999993 113.049 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.43 -45.43 88.49 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.156 0.503 . . . . 73.530000000000001 110.863 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 118' ' ' ILE . 80.0 mt -59.0 -39.53 82.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.881 -0.599 . . . . 74.409999999999997 110.946 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.3 t -57.46 -44.4 84.78 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.978 -0.555 . . . . 73.230000000000004 111.316 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -57.42 -51.59 68.8 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.777 0.322 . . . . 75.400000000000006 110.959 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 64.0 mt -50.91 -40.25 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.017 0.437 . . . . 75.319999999999993 111.328 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.612 HG21 HG21 ' A' ' 97' ' ' VAL . 76.8 mt -62.79 -56.41 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.124 -0.489 . . . . 72.209999999999994 111.991 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.463 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 10.5 t-80 -83.58 -23.49 31.94 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.14 0.792 . . . . 74.310000000000002 113.14 -171.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -91.82 -49.5 6.22 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 111.74 0.274 . . . . 74.420000000000002 111.74 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -79.42 -54.42 5.94 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.829 0.347 . . . . 75.030000000000001 111.484 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.7 ' SD ' HG22 ' A' ' 97' ' ' VAL . 61.9 mtt -82.6 -58.93 2.69 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.851 1.056 . . . . 72.129999999999995 113.851 -168.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.47 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 23.7 mm -43.2 -52.47 12.37 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 113.709 1.003 . . . . 73.319999999999993 113.709 -173.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.47 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 76.4 Cg_exo -51.65 -41.55 60.8 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.769 1.646 . . . . 61.43 113.056 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 91.3 m-70 -73.1 -40.51 64.92 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.237 -0.289 . . . . 72.420000000000002 111.679 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 122' ' ' MET . 15.9 m-30 -56.54 -40.45 75.14 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.118 0.485 . . . . 71.200000000000003 110.986 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -76.07 -37.13 58.61 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.121 -0.49 . . . . 72.209999999999994 111.325 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.5 m -66.19 -30.01 70.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.701 0.286 . . . . 64.109999999999999 111.676 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 123.51 -3.23 9.49 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.23 -0.509 . . . . 72.310000000000002 113.721 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 97.2 m-20 -104.07 87.49 2.78 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.086 0.402 . . . . 74.129999999999995 112.086 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -71.27 -45.12 63.88 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.175 0.512 . . . . 73.099999999999994 110.486 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.58 -48.06 82.65 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.962 -0.563 . . . . 71.030000000000001 111.755 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 29.2 tt0 -62.44 -38.58 90.28 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.291 -0.413 . . . . 73.140000000000001 111.111 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.27 -51.14 60.66 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.064 -0.589 . . . . 74.420000000000002 112.769 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.481 HD13 HD22 ' A' ' 90' ' ' LEU . 99.4 mt -57.67 -43.41 84.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.922 0.391 . . . . 72.519999999999996 110.895 175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.0 t -51.77 -56.91 11.06 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.986 -0.552 . . . . 74.010000000000005 111.894 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -63.34 -32.22 73.58 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.821 0.304 . . . . 73.510000000000005 111.821 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.17 54.06 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.959 -0.638 . . . . 74.040000000000006 112.408 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.6 t -59.12 -48.62 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.03 0.443 . . . . 73.209999999999994 111.066 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 62.3 tp -53.22 -46.55 69.16 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.774 -0.648 . . . . 71.420000000000002 111.073 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.03 87.36 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.164 -0.471 . . . . 71.430000000000007 111.657 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.96 -56.4 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.414 -0.357 . . . . 75.0 111.423 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -59.44 -35.37 73.91 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.297 0.48 . . . . 74.409999999999997 112.297 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 16.6 mm-40 -59.6 -34.13 72.36 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 122.112 -0.368 . . . . 75.329999999999998 111.587 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 65.4 t -66.21 -42.68 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.904 0.383 . . . . 74.420000000000002 110.719 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.85 -56.53 8.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.118 -0.492 . . . . 74.409999999999997 111.37 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 50.9 m-20 -56.41 -34.78 67.08 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.561 -0.29 . . . . 72.219999999999999 111.34 176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -48.81 -31.77 10.5 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.556 -0.354 . . . . 74.209999999999994 113.083 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.8 t -73.99 -47.73 35.24 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.642 0.258 . . . . 74.540000000000006 111.237 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.7 mt -70.09 -17.87 63.24 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.531 0.567 . . . . 64.420000000000002 112.531 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 147' ' ' ASP . 68.4 mm-40 -58.51 -20.32 44.96 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.914 0.388 . . . . 62.450000000000003 111.412 175.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -58.48 99.95 0.05 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.097 -0.501 . . . . 72.120000000000005 111.369 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -77.65 111.21 13.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.692 0.282 . . . . 72.519999999999996 111.466 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -97.61 120.08 37.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.166 0.507 . . . . 70.340000000000003 111.341 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -90.61 -15.94 29.6 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.294 -0.412 . . . . 72.099999999999994 111.321 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -55.98 119.05 5.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.023 0.439 . . . . 73.439999999999998 111.952 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 31.1 t60 . . . . . 0 C--O 1.252 1.214 0 CA-C-N 115.944 -0.571 . . . . 74.230000000000004 111.693 -178.161 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.717 0.294 . . . . 74.140000000000001 111.389 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -171.27 129.53 0.72 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.267 -0.424 . . . . 73.319999999999993 110.935 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.7 t -103.38 124.32 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.067 0.461 . . . . 71.209999999999994 111.586 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -99.16 113.25 25.39 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 111.443 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.652 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 2.9 mppt? -95.57 169.03 9.83 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.515 -0.55 . . . . 74.150000000000006 109.515 171.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.652 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 10.2 Cg_endo -51.01 -24.31 13.87 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.201 1.934 . . . . 65.329999999999998 113.198 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.42 -21.23 35.82 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 111.955 0.354 . . . . 74.349999999999994 111.955 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -82.94 -27.79 30.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.883 0.373 . . . . 70.450000000000003 110.977 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.9 t -76.87 120.81 83.24 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.104 -0.498 . . . . 75.430000000000007 111.234 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.43 127.73 21.71 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.335 2.023 . . . . 63.399999999999999 112.552 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -72.69 74.97 1.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.087 0.47 . . . . 74.319999999999993 111.473 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.0 m -57.62 -41.56 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 112.479 0.548 . . . . 72.109999999999999 112.479 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.516 HE22 ' HG ' ' A' ' 20' ' ' LEU . 25.4 mm-40 -75.74 -5.1 44.08 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.456 0.539 . . . . 74.209999999999994 112.456 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.0 tt -102.79 -32.33 9.86 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.151 0.5 . . . . 73.400000000000006 110.222 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.21 -61.35 1.38 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.534 0.568 . . . . 75.299999999999997 112.534 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -79.9 -52.49 7.8 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.489 0.552 . . . . 73.400000000000006 112.489 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.9 t 70.14 -61.75 0.45 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.624 0.769 . . . . 71.150000000000006 112.072 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.9 p -60.0 -32.92 71.31 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.906 0.384 . . . . 75.409999999999997 111.01 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -92.18 109.07 20.43 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.004 -0.369 . . . . 64.340000000000003 110.004 169.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.516 ' HG ' HE22 ' A' ' 13' ' ' GLN . 3.8 mp -97.11 15.02 23.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.436 0.636 . . . . 62.329999999999998 110.385 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.19 137.06 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.532 -0.758 . . . . 74.25 111.795 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 54' ' ' VAL . 30.4 m -119.81 103.25 9.2 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.901 0.382 . . . . 65.140000000000001 110.727 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -100.59 99.49 10.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.289 0.566 . . . . 73.230000000000004 112.438 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -118.49 -43.28 2.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.062 -0.517 . . . . 75.319999999999993 111.264 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.34 -24.65 67.45 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.28 0.844 . . . . 73.430000000000007 113.28 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.78 9.57 86.81 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.764 -0.732 . . . . 72.319999999999993 113.378 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.88 -14.3 60.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.978 0.418 . . . . 73.299999999999997 111.705 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.4 mt -103.09 139.36 38.72 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.41 -0.359 . . . . 74.310000000000002 110.969 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.2 t -106.23 159.99 15.69 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.328 -0.233 . . . . 74.409999999999997 110.835 175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -45.26 -48.95 12.8 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.556 0.947 . . . . 74.0 113.556 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.47 -48.73 76.45 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.79 0.328 . . . . 74.120000000000005 111.844 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -60.82 -40.6 93.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.867 0.365 . . . . 72.150000000000006 111.524 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.13 -45.26 92.78 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.232 -0.44 . . . . 74.519999999999996 110.778 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.0 -49.93 74.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.766 0.317 . . . . 75.219999999999999 111.607 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.12 -40.64 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.218 0.532 . . . . 74.430000000000007 111.154 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.504 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.5 ttm -63.1 -49.89 72.68 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.948 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -59.05 -40.58 85.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.609 0.242 . . . . 55.130000000000003 111.211 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.6 -46.49 93.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.108 -0.568 . . . . 52.299999999999997 112.91 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 43' ' ' ILE . 79.4 mtm180 -69.14 -43.41 74.41 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.823 0.305 . . . . 74.530000000000001 111.823 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 36' ' ' MET . 88.7 mt -61.32 -47.5 85.61 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.195 0.522 . . . . 72.209999999999994 111.054 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -62.72 -37.0 84.79 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.926 -0.579 . . . . 72.409999999999997 110.896 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.23 98.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.342 -0.39 . . . . 74.120000000000005 110.776 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.8 mt -59.82 -45.76 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.817 0.341 . . . . 73.239999999999995 110.779 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -58.51 -31.73 68.16 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.954 0.407 . . . . 73.329999999999998 111.001 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.9 t -93.79 -13.52 27.25 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.364 0.505 . . . . 51.229999999999997 112.364 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.8 m -106.8 -63.59 1.27 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.296 0.57 . . . . 74.099999999999994 111.29 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.688 ' ND1' HD23 ' A' ' 150' ' ' LEU . 32.6 m-70 -90.97 -8.3 49.63 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.486 -0.779 . . . . 71.010000000000005 111.198 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 67.33 5.93 4.55 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.279 0.631 . . . . 74.25 112.247 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.663 HG21 ' HB2' ' A' ' 84' ' ' ASN . 99.8 t -79.63 130.97 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 122.922 0.489 . . . . 73.129999999999995 111.987 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.402 ' HB2' HG13 ' A' ' 77' ' ' VAL . 1.8 mp0 -79.81 96.53 6.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.915 0.388 . . . . 73.109999999999999 110.297 174.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.402 ' HE2' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -104.78 98.78 8.47 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.424 -0.353 . . . . 73.329999999999998 110.492 -176.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.03 120.75 42.25 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.534 0.568 . . . . 74.340000000000003 112.534 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.92 137.49 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-O 121.025 0.441 . . . . 74.400000000000006 111.359 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.572 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 61.7 t -130.76 140.18 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.603 0.361 . . . . 72.209999999999994 111.037 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -128.61 122.46 30.96 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.624 0.249 . . . . 73.239999999999995 111.183 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.3 mt -128.23 140.85 39.49 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 111.622 0.23 . . . . 72.329999999999998 111.622 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.15 -55.97 1.91 Allowed 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.516 2.144 . . . . 74.219999999999999 112.248 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.3 t -155.62 148.97 24.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.341 -0.39 . . . . 73.319999999999993 111.817 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.73 20.47 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.353 0.597 . . . . 74.5 110.196 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.42 39.65 91.46 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.202 -0.523 . . . . 64.099999999999994 113.175 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.02 16.03 3.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.151 0.58 . . . . 72.409999999999997 112.293 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.01 151.41 80.53 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 122.055 -0.403 . . . . 73.420000000000002 111.775 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -56.97 110.15 0.55 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.685 2.256 . . . . 73.010000000000005 112.654 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.6 tp -52.19 -46.02 65.41 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.891 0.7 . . . . 75.129999999999995 112.891 -176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.551 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 38.3 mt-10 -66.71 -25.32 66.47 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.126 0.417 . . . . 73.519999999999996 112.126 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 23.3 t70 -75.39 -45.57 38.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.379 0.609 . . . . 75.219999999999999 110.02 173.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -57.65 -47.5 82.06 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.521 -0.763 . . . . 73.209999999999994 111.821 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.3 p -55.71 -50.17 71.05 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.78 0.324 . . . . 75.140000000000001 111.595 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.651 HD12 HD21 ' A' ' 79' ' ' ASN . 56.2 tp -55.33 -51.18 67.57 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.956 0.408 . . . . 74.430000000000007 111.36 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 66' ' ' ASP . 55.6 mtpt -60.24 -47.02 87.76 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.198 0.444 . . . . 75.150000000000006 112.198 -178.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.2 tp -66.18 -47.6 73.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.933 0.397 . . . . 75.019999999999996 111.732 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.584 ' HB1' HD22 ' A' ' 87' ' ' LEU . . . -61.57 -32.81 72.92 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.227 0.454 . . . . 65.420000000000002 112.227 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 44.3 mtm180 -59.53 -48.59 81.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.013 0.375 . . . . 72.219999999999999 112.013 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.578 ' NE2' ' HB2' ' A' ' 6' ' ' PRO . 11.5 pt20 -70.48 -13.62 62.19 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.818 0.342 . . . . 75.349999999999994 111.479 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.508 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 32.3 m0 -96.42 -17.43 20.59 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.854 0.359 . . . . 74.430000000000007 110.778 173.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.31 46.64 94.02 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 116.31 -0.405 . . . . 63.509999999999998 113.408 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 50' ' ' GLU . 57.7 t -119.31 -86.2 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 112.572 0.582 . . . . 71.409999999999997 112.572 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.05 90.95 0.86 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.85 -0.69 . . . . 73.049999999999997 113.118 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.651 HD21 HD12 ' A' ' 69' ' ' LEU . 17.6 m120 -148.16 23.1 1.07 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.992 0.396 . . . . 75.310000000000002 111.836 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 79' ' ' ASN . 31.8 tt0 70.18 -53.16 0.64 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.423 0.289 . . . . 70.519999999999996 111.398 -169.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -75.44 69.92 2.26 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.898 0.856 . . . . 73.030000000000001 111.221 -178.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 103' ' ' TYR . 56.4 t30 178.72 166.61 0.88 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.333 -1.303 . . . . 73.099999999999994 107.567 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.469 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -74.96 -122.07 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.733 -0.605 . . . . 72.400000000000006 111.489 177.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.663 ' HB2' HG21 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -83.72 70.61 10.37 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.911 -0.493 . . . . 75.099999999999994 112.056 -176.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -107.17 144.71 15.94 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.098 -0.501 . . . . 64.010000000000005 112.685 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.718 HD12 ' HB3' ' A' ' 99' ' ' PHE . 42.6 tp -145.16 124.59 13.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.875 0.369 . . . . 75.219999999999999 111.475 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.584 HD22 ' HB1' ' A' ' 72' ' ' ALA . 54.8 tp -111.54 138.26 48.31 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.756 0.312 . . . . 64.409999999999997 111.038 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.0 tp -128.26 102.52 6.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.708 0.29 . . . . 75.040000000000006 110.682 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 63.1 t -105.11 119.63 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.063 0.394 . . . . 73.519999999999996 112.063 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.543 ' HA ' HG13 ' A' ' 97' ' ' VAL . 41.9 tp -98.96 115.86 29.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.11 0.481 . . . . 65.310000000000002 111.109 175.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.427 HG11 ' H ' ' A' ' 94' ' ' GLN . 71.3 t -101.17 104.49 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.27 -0.423 . . . . 73.340000000000003 111.007 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.0 tp -55.75 -42.44 75.43 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.892 0.377 . . . . 71.540000000000006 111.638 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -50.99 -36.68 40.5 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.244 0.545 . . . . 74.209999999999994 111.771 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.427 ' H ' HG11 ' A' ' 91' ' ' VAL . 72.0 mt-30 -105.99 -10.19 16.7 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.108 -0.496 . . . . 75.310000000000002 111.933 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 53.4 35.13 19.69 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.675 0.62 . . . . 73.209999999999994 112.675 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -142.58 162.93 34.19 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.974 0.416 . . . . 75.340000000000003 111.874 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.577 HG23 ' SD ' ' A' ' 122' ' ' MET . 3.7 m -133.43 171.89 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.068 -0.515 . . . . 71.140000000000001 111.589 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 47.4 ttt85 -148.59 137.67 21.7 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.475 -0.329 . . . . 74.299999999999997 111.524 171.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.718 ' HB3' HD12 ' A' ' 86' ' ' LEU . 96.9 m-85 -93.0 108.4 19.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 110.543 172.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.04 122.41 37.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.577 0.227 . . . . 71.5 110.727 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.3 p -100.49 160.8 14.05 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.932 1.086 . . . . 74.310000000000002 113.932 -172.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -103.56 -164.24 25.3 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.932 -1.031 . . . . 74.409999999999997 111.809 167.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 5.3 t80 -76.56 -17.0 59.46 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.128 0.49 . . . . 73.099999999999994 111.591 -176.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.09 -23.46 57.17 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.236 -0.507 . . . . 72.450000000000003 113.205 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.4 mt -103.34 -4.21 24.51 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.012 0.434 . . . . 71.200000000000003 110.95 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -53.55 -35.44 60.75 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.812 -0.631 . . . . 64.209999999999994 111.174 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.39 18.05 58.14 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 121.244 -0.503 . . . . 72.150000000000006 113.88 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -137.83 -54.63 0.66 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.301 0.55 . . . . 63.32 111.44 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.65 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.5 mt -114.78 86.14 12.65 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.6 -0.727 . . . . 71.120000000000005 112.102 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.13 153.83 19.02 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.156 1.904 . . . . 72.219999999999999 112.404 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.38 -43.71 5.28 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.865 0.691 . . . . 74.310000000000002 112.865 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.91 -50.13 68.56 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.218 -0.515 . . . . 55.140000000000001 113.251 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.68 -48.15 83.08 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.969 0.414 . . . . 72.439999999999998 111.025 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.65 HD21 ' HB3' ' A' ' 109' ' ' LEU . 76.3 mt -58.31 -39.09 78.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.088 -0.505 . . . . 74.510000000000005 111.217 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.9 t -63.21 -37.23 86.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.11 -0.495 . . . . 71.420000000000002 111.335 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -70.61 -37.81 73.9 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 122.262 -0.274 . . . . 75.120000000000005 111.284 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 62.3 mt -55.15 -43.5 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.474 0.654 . . . . 74.129999999999995 110.04 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.7 mt -64.59 -52.9 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.45 -0.795 . . . . 74.140000000000001 111.489 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.5 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 5.4 t-80 -69.78 -39.35 76.68 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.6 0.593 . . . . 74.430000000000007 112.6 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.31 -39.41 22.92 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.753 0.649 . . . . 74.140000000000001 112.753 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -103.57 -46.29 4.59 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.602 0.593 . . . . 73.230000000000004 112.602 -174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.577 ' SD ' HG23 ' A' ' 97' ' ' VAL . 50.5 mtt -78.89 -48.01 15.44 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.185 0.809 . . . . 71.140000000000001 113.185 -173.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.5 ' CG1' ' HA ' ' A' ' 119' ' ' HIS . 23.0 mm -50.09 -52.23 55.04 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 112.98 0.733 . . . . 74.450000000000003 112.98 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 14.0 Cg_endo -55.7 -38.42 94.33 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 121.807 1.671 . . . . 63.240000000000002 112.315 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 41.5 m-70 -71.14 -51.4 25.18 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.04 0.385 . . . . 61.340000000000003 112.04 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.4 m-30 -55.92 -44.84 78.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.775 0.321 . . . . 75.129999999999995 111.297 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -62.57 -37.03 84.59 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.946 0.403 . . . . 72.010000000000005 111.16 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -77.3 -5.97 51.43 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.405 -0.361 . . . . 64.230000000000004 111.911 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.33 2.58 68.04 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.314 -0.469 . . . . 71.109999999999999 113.317 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 90.6 m-20 -89.35 76.46 7.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.826 0.346 . . . . 73.209999999999994 111.841 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -70.75 -46.07 63.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.004 0.431 . . . . 73.129999999999995 111.259 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.65 98.18 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.108 -0.496 . . . . 62.310000000000002 111.603 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 18.3 mm-40 -65.58 -42.91 91.2 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.348 -0.387 . . . . 74.439999999999998 110.902 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.33 -51.28 60.1 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.317 -0.468 . . . . 64.519999999999996 112.923 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.506 ' HA ' ' HE3' ' A' ' 122' ' ' MET . 95.9 mt -60.57 -38.65 85.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.015 0.436 . . . . 74.519999999999996 111.102 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.0 t -57.21 -57.98 10.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.987 -0.551 . . . . 73.430000000000007 112.345 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -76.11 -19.64 58.35 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 120.638 -0.425 . . . . 74.409999999999997 111.582 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.456 ' HA3' ' HE2' ' A' ' 122' ' ' MET . . . -61.79 -47.23 91.59 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.838 -0.696 . . . . 75.230000000000004 111.815 171.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.2 -46.25 96.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.205 0.526 . . . . 75.310000000000002 110.842 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.4 tp -55.34 -38.02 68.22 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.771 -0.649 . . . . 74.540000000000006 111.441 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.402 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -62.47 -55.47 27.32 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.197 -0.456 . . . . 61.439999999999998 111.379 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.402 ' HB ' ' HE2' ' A' ' 51' ' ' PHE . 66.7 t -57.46 -43.37 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.261 -0.427 . . . . 71.439999999999998 111.134 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -52.73 -45.36 66.95 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.122 -0.49 . . . . 73.349999999999994 111.367 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -69.52 -35.29 75.35 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.061 0.393 . . . . 73.239999999999995 112.061 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 141' ' ' ALA . 96.5 t -62.05 -51.59 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.944 0.402 . . . . 75.519999999999996 111.01 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.21 -45.14 95.78 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.923 0.392 . . . . 75.209999999999994 111.015 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.34 -30.1 66.46 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.008 0.432 . . . . 75.0 111.029 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.21 -27.07 70.74 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.125 -0.489 . . . . 71.420000000000002 113.544 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 35.0 t -150.26 77.66 1.31 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.562 0.579 . . . . 74.340000000000003 112.562 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.688 HD23 ' ND1' ' A' ' 47' ' ' HIS . 36.7 mt -79.95 80.94 6.3 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.338 0.59 . . . . 75.010000000000005 110.097 171.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 58.87 33.09 22.83 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.253 -0.885 . . . . 72.519999999999996 110.566 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -70.53 73.13 0.52 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.712 -0.676 . . . . 74.310000000000002 111.107 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -117.46 109.16 16.41 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.287 -0.415 . . . . 75.519999999999996 110.439 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -81.23 -33.2 33.01 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.978 0.418 . . . . 75.420000000000002 110.72 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -96.24 101.71 13.4 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.334 -0.394 . . . . 74.099999999999994 110.844 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -69.21 95.47 0.76 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.679 -0.237 . . . . 72.430000000000007 111.22 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.505 -0.759 . . . . 74.439999999999998 111.935 177.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.866 0.365 . . . . 72.420000000000002 111.686 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HE ' ' HB3' ' A' ' 2' ' ' ARG . 1.5 ptp180 -91.35 -25.47 19.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.033 0.382 . . . . 73.519999999999996 112.033 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.6 t 63.08 114.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 113.609 0.966 . . . . 74.099999999999994 113.609 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -107.41 130.02 54.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.952 -0.567 . . . . 73.200000000000003 110.973 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 26.1 mtpp -105.24 168.69 8.02 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 116.521 -0.309 . . . . 72.549999999999997 110.708 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 59.7 Cg_endo -69.62 58.19 1.47 Allowed 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.675 2.25 . . . . 71.049999999999997 112.65 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -176.85 -26.55 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.54 -0.755 . . . . 72.219999999999999 109.967 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.83 -35.04 67.19 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.268 0.556 . . . . 73.430000000000007 110.297 169.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.591 HG23 HD22 ' A' ' 56' ' ' LEU . 49.0 t -64.17 118.38 45.86 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.667 -0.697 . . . . 73.519999999999996 111.566 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HG2' HG23 ' A' ' 22' ' ' THR . 12.2 Cg_endo -56.14 121.9 10.81 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.45 2.1 . . . . 55.43 112.596 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.551 HD21 HD11 ' A' ' 14' ' ' LEU . 13.2 p-10 -72.63 70.64 0.94 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.356 0.598 . . . . 74.340000000000003 111.886 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -58.03 -43.58 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.792 -0.64 . . . . 75.049999999999997 112.641 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.457 ' NE2' ' HG ' ' A' ' 20' ' ' LEU . 8.2 tp-100 -71.46 -14.09 62.03 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.227 0.454 . . . . 74.099999999999994 112.227 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.551 HD11 HD21 ' A' ' 11' ' ' ASN . 10.1 tt -88.29 -29.99 19.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.118 0.485 . . . . 73.510000000000005 110.685 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.53 -35.35 13.64 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.131 0.491 . . . . 73.530000000000001 111.751 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD2' ' HG2' ' A' ' 19' ' ' ARG . 20.7 t70 -134.15 142.31 47.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.947 0.403 . . . . 74.040000000000006 111.244 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.7 p -107.64 -6.82 16.69 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.393 0.516 . . . . 63.240000000000002 112.393 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.1 p -75.57 -30.8 59.77 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.109 -0.369 . . . . 75.400000000000006 111.678 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.448 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 3.5 ptp85 -119.84 159.7 24.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.847 0.356 . . . . 74.319999999999993 111.051 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HG ' ' NE2' ' A' ' 13' ' ' GLN . 4.7 mp -132.72 14.47 4.4 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.71 0.29 . . . . 74.340000000000003 111.722 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.453 HG22 ' HB ' ' A' ' 53' ' ' VAL . 65.0 t -112.08 128.64 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 112.286 0.476 . . . . 71.530000000000001 112.286 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.444 HG23 ' HG2' ' A' ' 10' ' ' PRO . 89.3 m -100.55 109.79 21.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.004 0.431 . . . . 63.140000000000001 110.979 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -92.31 93.16 8.49 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.288 0.566 . . . . 73.430000000000007 112.352 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 55' ' ' THR . 10.2 mm-40 -106.65 -59.69 1.76 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.945 0.402 . . . . 75.010000000000005 110.536 174.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.55 74.6 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.473 -0.33 . . . . 73.510000000000005 111.856 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.79 50.14 70.92 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.312 -0.471 . . . . 60.310000000000002 112.929 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.619 HD23 HD21 ' A' ' 92' ' ' LEU . 97.7 mt -90.59 12.36 19.1 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.202 0.445 . . . . 72.25 112.202 -176.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mp -124.4 163.47 21.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.283 0.563 . . . . 75.150000000000006 111.597 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.7 t -82.97 155.9 23.74 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.764 -0.653 . . . . 70.140000000000001 110.914 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -53.05 -40.88 64.29 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.876 0.37 . . . . 75.549999999999997 111.896 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' O ' HG21 ' A' ' 35' ' ' VAL . . . -64.81 -46.36 82.3 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.9 0.381 . . . . 75.510000000000005 111.25 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -59.47 -41.06 88.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.484 -0.325 . . . . 71.140000000000001 111.619 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -55.78 -54.48 43.95 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.316 0.579 . . . . 75.340000000000003 110.912 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.27 -48.88 70.71 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.729 -0.669 . . . . 60.5 111.814 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 31' ' ' ALA . 99.0 t -64.4 -42.69 96.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.166 -0.47 . . . . 64.340000000000003 112.093 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.558 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.5 ttm -62.38 -51.1 68.95 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.199 -0.313 . . . . 74.439999999999998 110.937 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 59.4 m-80 -60.95 -38.38 85.67 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.643 0.259 . . . . 75.329999999999998 111.055 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.52 -48.36 86.57 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.045 -0.598 . . . . 75.019999999999996 112.9 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 43' ' ' ILE . 86.4 mtm180 -64.42 -46.17 84.36 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.843 0.312 . . . . 72.25 111.843 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 36' ' ' MET . 81.7 mt -56.32 -41.43 76.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.35 0.595 . . . . 75.510000000000005 110.867 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -67.63 -39.06 84.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.769 -0.65 . . . . 75.540000000000006 111.264 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.81 88.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.121 0.486 . . . . 75.409999999999997 110.823 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.429 HG23 ' HB2' ' A' ' 47' ' ' HIS . 70.8 mt -60.35 -41.88 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.1 -0.5 . . . . 73.540000000000006 110.681 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.473 ' NE ' ' HG2' ' A' ' 50' ' ' GLU . 12.7 tpt180 -50.85 -33.09 22.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.816 -0.629 . . . . 74.230000000000004 111.688 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.1 t -99.49 -60.2 1.58 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.323 -0.399 . . . . 73.5 111.741 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.7 t -59.29 -45.95 89.87 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.525 0.565 . . . . 71.239999999999995 112.525 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.429 ' HB2' HG23 ' A' ' 43' ' ' ILE . 91.1 m-70 -104.31 -9.26 18.67 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.776 0.322 . . . . 71.420000000000002 111.41 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.74 -5.68 1.4 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.216 0.821 . . . . 74.319999999999993 113.216 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.98 123.41 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.04 0.447 . . . . 74.200000000000003 111.994 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HG2' ' NE ' ' A' ' 44' ' ' ARG . 38.1 mt-10 -75.97 96.24 3.73 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.84 -0.43 . . . . 70.409999999999997 109.84 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.65 107.75 18.91 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.268 -0.424 . . . . 65.430000000000007 110.902 -173.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.14 147.16 37.93 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.042 0.386 . . . . 71.109999999999999 112.042 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.453 ' HB ' HG22 ' A' ' 21' ' ' VAL . 58.5 t -128.57 135.81 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.919 0.39 . . . . 74.230000000000004 111.264 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.433 HG21 HD23 ' A' ' 71' ' ' LEU . 60.5 t -128.56 134.47 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.713 0.292 . . . . 72.230000000000004 111.25 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 80.6 p -119.11 122.6 42.45 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.723 0.297 . . . . 72.349999999999994 111.385 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.591 HD22 HG23 ' A' ' 9' ' ' VAL . 89.7 mt -125.98 140.05 35.85 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-O 120.732 0.301 . . . . 71.409999999999997 111.57 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.3 -35.19 14.5 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.116 1.877 . . . . 75.140000000000001 112.432 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 73.3 p -161.37 144.87 12.77 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.351 0.5 . . . . 75.420000000000002 112.351 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 91' ' ' VAL . 32.3 pt -123.89 -11.4 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 121.002 0.43 . . . . 75.430000000000007 111.597 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.76 -113.47 5.76 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 114.386 0.514 . . . . 74.310000000000002 114.386 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -89.97 11.52 20.26 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.044 0.45 . . . . 62.340000000000003 112.044 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.2 118.87 71.71 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.924 -0.485 . . . . 63.409999999999997 111.88 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.658 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 29.1 Cg_endo -63.19 126.75 18.52 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.58 2.187 . . . . 75.439999999999998 112.346 176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.3 -45.5 80.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.943 0.72 . . . . 74.239999999999995 112.943 -171.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 1.2 pm0 -70.16 -36.04 74.43 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.35 0.5 . . . . 73.519999999999996 112.35 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.658 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 10.2 m-20 -71.99 -35.89 69.6 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.993 -0.442 . . . . 75.329999999999998 110.976 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.486 ' CZ ' HD13 ' A' ' 56' ' ' LEU . 58.2 t80 -59.21 -56.58 20.26 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.812 0.339 . . . . 61.119999999999997 111.181 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 47.1 p -52.76 -44.56 66.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.116 -0.493 . . . . 64.329999999999998 111.651 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.648 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 58.7 tp -61.7 -57.06 13.42 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.336 -0.393 . . . . 70.010000000000005 111.634 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -61.38 -34.92 76.13 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.145 0.424 . . . . 71.439999999999998 112.145 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.433 HD23 HG21 ' A' ' 54' ' ' VAL . 58.7 tp -69.79 -48.41 59.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.185 0.517 . . . . 74.310000000000002 111.097 177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.464 ' HB2' ' HA3' ' A' ' 78' ' ' GLY . . . -65.34 -31.73 73.0 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.074 0.398 . . . . 54.520000000000003 112.074 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.701 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 24.2 mtp180 -62.42 -50.05 73.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.026 0.38 . . . . 75.430000000000007 112.026 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.619 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 12.3 pt20 -67.88 -32.92 73.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.936 0.398 . . . . 73.140000000000001 111.088 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.619 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 27.7 m0 -71.45 -15.89 62.35 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.526 -0.307 . . . . 74.310000000000002 111.68 175.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.58 -39.15 3.07 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.277 -0.487 . . . . 72.209999999999994 112.746 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 19.4 t -52.26 -23.84 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 122.88 0.472 . . . . 65.349999999999994 112.158 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 72' ' ' ALA . . . -137.1 40.61 1.49 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.118 -0.563 . . . . 70.310000000000002 112.578 176.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 46.6 t-20 -61.03 85.96 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.788 0.328 . . . . 54.119999999999997 110.577 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.701 ' H ' ' HG2' ' A' ' 73' ' ' ARG . 7.9 tp10 43.2 69.98 0.35 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.626 0.727 . . . . 73.200000000000003 110.774 -172.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.632 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER 63.11 82.5 0.18 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.168 -0.924 . . . . 71.230000000000004 112.286 -176.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.486 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 24.4 t30 -81.11 160.32 24.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.951 -1.022 . . . . 73.040000000000006 111.165 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.14 123.86 23.78 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.672 -0.643 . . . . 75.140000000000001 111.527 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.881 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 3.6 p-10 46.22 41.27 8.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.198 0.999 . . . . 74.25 112.753 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.11 145.31 16.58 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.86 -0.609 . . . . 72.099999999999994 111.861 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.448 HD12 ' HB3' ' A' ' 99' ' ' PHE . 55.9 tp -144.87 131.0 19.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.953 0.377 . . . . 70.349999999999994 111.218 -177.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.4 tp -119.29 123.62 44.68 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.838 0.352 . . . . 75.120000000000005 111.478 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.5 tp -111.26 110.03 20.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.892 0.377 . . . . 74.430000000000007 110.972 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' A' ' 54' ' ' VAL . 93.1 t -110.52 129.15 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 122.181 -0.324 . . . . 72.219999999999999 111.811 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.527 ' HB2' HD22 ' A' ' 135' ' ' LEU . 43.5 tp -107.25 119.41 39.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.979 0.419 . . . . 73.25 111.037 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 59' ' ' ILE . 94.0 t -102.93 100.82 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.307 -0.406 . . . . 75.400000000000006 111.207 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.619 HD21 HD23 ' A' ' 27' ' ' LEU . 62.4 tp -59.19 -39.14 81.63 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.171 0.434 . . . . 73.099999999999994 112.171 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 14.9 t70 -47.53 -47.15 28.09 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.154 0.582 . . . . 74.420000000000002 112.189 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -108.46 8.79 27.56 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.126 -0.488 . . . . 70.230000000000004 111.103 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 32.77 58.01 0.43 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.552 1.141 . . . . 73.219999999999999 113.782 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -150.16 160.97 43.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.477 -0.783 . . . . 74.430000000000007 111.129 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.509 HG22 ' SD ' ' A' ' 122' ' ' MET . 4.3 m -126.21 171.8 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.057 0.456 . . . . 75.230000000000004 112.029 -174.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 98' ' ' ARG . 28.7 ttt85 -150.15 135.46 18.05 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.246 -0.434 . . . . 73.230000000000004 111.826 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.448 ' HB3' HD12 ' A' ' 86' ' ' LEU . 95.9 m-85 -94.01 115.04 27.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.144 -0.48 . . . . 74.109999999999999 110.154 171.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -101.1 112.66 25.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.844 0.354 . . . . 71.120000000000005 110.87 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.462 HG21 HD11 ' A' ' 114' ' ' LEU . 2.9 p -88.59 148.37 24.11 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.678 0.751 . . . . 72.049999999999997 112.921 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 81' ' ' LYS . . . -90.46 -170.23 43.44 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.225 -0.898 . . . . 74.329999999999998 112.199 168.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -24.6 65.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.055 0.455 . . . . 72.209999999999994 111.637 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.881 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -75.18 -30.47 58.84 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.003 -0.617 . . . . 61.399999999999999 113.432 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.13 -0.91 57.84 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.979 0.733 . . . . 74.349999999999994 112.979 -171.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -53.33 -32.06 47.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.906 0.335 . . . . 74.510000000000005 111.906 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.65 4.45 69.13 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.42 -0.419 . . . . 55.509999999999998 113.827 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -125.02 -60.11 1.37 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.381 0.61 . . . . 75.420000000000002 111.444 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.07 87.14 27.81 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.697 -0.683 . . . . 75.329999999999998 111.086 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.73 167.93 16.33 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.54 2.16 . . . . 75.209999999999994 113.558 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.08 -48.8 33.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.585 0.587 . . . . 70.420000000000002 112.585 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.37 -46.62 91.64 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.264 -0.493 . . . . 72.109999999999999 113.43 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.15 -48.94 77.86 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.891 0.377 . . . . 72.25 111.584 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.462 HD11 HG21 ' A' ' 101' ' ' THR . 86.8 mt -59.34 -43.03 92.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.277 -0.42 . . . . 75.540000000000006 111.275 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.4 t -63.41 -37.54 87.67 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.087 -0.506 . . . . 61.539999999999999 111.108 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -60.12 -55.34 35.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.394 -0.366 . . . . 73.450000000000003 111.219 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.9 mt -49.19 -46.21 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.044 0.449 . . . . 74.239999999999995 111.666 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.412 ' O ' HG12 ' A' ' 123' ' ' ILE . 58.2 mt -60.14 -54.91 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.135 0.493 . . . . 73.340000000000003 111.415 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -83.72 -9.17 59.02 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.176 0.806 . . . . 54.219999999999999 113.176 -173.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.12 -40.78 7.03 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.223 0.453 . . . . 73.430000000000007 112.223 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.07 -31.08 2.15 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.516 0.932 . . . . 74.25 113.516 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.509 ' SD ' HG22 ' A' ' 97' ' ' VAL . 36.0 mtt -69.04 -40.54 78.52 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.904 0.705 . . . . 73.420000000000002 112.904 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.477 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 46.7 mm -48.12 -57.04 11.4 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 112.894 0.702 . . . . 74.420000000000002 112.894 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.08 -37.64 86.95 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.053 1.835 . . . . 72.340000000000003 112.967 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -63.48 -53.09 57.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.802 0.334 . . . . 74.439999999999998 111.043 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.1 m-85 -59.63 -32.88 70.84 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.546 -0.297 . . . . 74.040000000000006 111.456 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 60.4 mtp85 -66.67 -43.32 84.84 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.241 0.544 . . . . 74.420000000000002 111.03 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.0 t -75.56 -0.82 21.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.858 -0.61 . . . . 73.530000000000001 112.112 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.15 3.93 90.03 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.182 -0.533 . . . . 74.109999999999999 112.48 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.751 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.2 m-20 -84.31 55.07 3.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.831 0.452 . . . . 64.340000000000003 111.349 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -56.22 -41.28 75.4 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.172 0.511 . . . . 71.310000000000002 110.91 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.81 -50.54 73.4 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.725 -0.67 . . . . 73.409999999999997 111.809 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.751 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 39.9 mm-40 -61.13 -40.02 92.22 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.342 -0.39 . . . . 73.219999999999999 111.739 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.49 -53.28 42.26 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.077 -0.582 . . . . 72.150000000000006 112.556 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.527 HD22 ' HB2' ' A' ' 90' ' ' LEU . 83.4 mt -61.15 -43.21 99.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.054 0.454 . . . . 75.340000000000003 111.187 175.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.8 t -60.37 -52.5 64.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.645 0.609 . . . . 52.229999999999997 112.645 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -27.25 59.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.601 0.239 . . . . 74.329999999999998 111.045 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.35 91.36 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.025 -0.607 . . . . 71.519999999999996 112.168 171.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 135' ' ' LEU . 56.7 t -56.59 -48.13 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.146 0.498 . . . . 71.439999999999998 110.806 172.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 50.8 tp -58.45 -40.59 83.05 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.767 -0.651 . . . . 72.109999999999999 111.157 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -58.64 -52.3 66.28 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.022 0.439 . . . . 74.349999999999994 111.031 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 81.1 t -57.26 -48.35 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.153 -0.476 . . . . 64.129999999999995 111.132 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -53.71 -43.19 68.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.916 -0.583 . . . . 74.049999999999997 111.53 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 96.5 mt-30 -68.4 -33.4 74.17 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 111.993 0.368 . . . . 73.530000000000001 111.993 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 141' ' ' ALA . 91.0 t -63.99 -55.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.068 0.461 . . . . 75.230000000000004 110.729 175.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 78.0 mt -53.23 -45.04 68.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.919 -0.582 . . . . 71.109999999999999 111.533 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -55.65 -37.11 67.82 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.194 -0.457 . . . . 75.219999999999999 111.9 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -89.37 -21.21 41.96 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.853 -0.689 . . . . 72.239999999999995 113.102 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.2 t -82.58 -24.65 33.84 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.322 0.49 . . . . 74.450000000000003 112.322 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 87.8 mt -68.05 78.53 0.23 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.867 0.365 . . . . 74.409999999999997 111.524 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 73.04 -31.2 0.22 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.201 0.815 . . . . 74.530000000000001 113.201 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -51.35 -26.88 8.38 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.295 0.85 . . . . 75.530000000000001 113.295 -170.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -69.02 -32.76 72.51 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.988 -0.445 . . . . 74.409999999999997 111.14 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -94.37 89.54 5.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.185 0.517 . . . . 65.409999999999997 110.271 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -72.78 121.14 19.4 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.965 -0.561 . . . . 74.239999999999995 112.472 -172.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -82.89 92.45 7.3 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.47 -0.332 . . . . 73.409999999999997 111.659 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.0 p80 . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 114.418 1.266 . . . . 72.540000000000006 114.418 178.319 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 tpt . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.627 0.251 . . . . 70.340000000000003 111.369 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -125.11 121.01 33.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.89 0.376 . . . . 73.540000000000006 111.497 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.92 139.08 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.661 -0.245 . . . . 74.439999999999998 110.707 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.41 ' CG ' HD23 ' A' ' 56' ' ' LEU . 44.8 m-85 -112.29 159.6 18.48 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.862 0.839 . . . . 65.219999999999999 113.242 -176.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 30.1 mmmt -126.02 158.79 64.83 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 114.867 -1.061 . . . . 73.230000000000004 109.935 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HB2' HE22 ' A' ' 74' ' ' GLN . 9.6 Cg_endo -51.8 -52.27 9.35 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.283 1.988 . . . . 74.430000000000007 113.219 -177.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.44 2.52 32.26 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.074 -0.391 . . . . 72.129999999999995 111.729 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 21.4 t70 -93.89 -13.32 27.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.279 0.561 . . . . 63.149999999999999 110.29 175.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 5' ' ' LYS . 69.4 t -82.7 133.56 49.02 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.908 -0.587 . . . . 74.340000000000003 110.871 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -52.99 111.09 0.57 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.298 1.999 . . . . 53.119999999999997 112.417 177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.466 ' HA ' ' CE2' ' A' ' 75' ' ' TRP . 10.9 p-10 -68.7 78.92 0.29 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.623 0.725 . . . . 75.430000000000007 112.351 -177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 17' ' ' SER . 29.2 m -78.26 10.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.988 0.736 . . . . 73.129999999999995 112.988 -177.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 15.7 mm100 -121.22 18.35 11.53 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.559 0.695 . . . . 70.239999999999995 110.518 171.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 tt -134.64 -45.27 0.74 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.455 -0.793 . . . . 65.230000000000004 109.181 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.37 -75.12 0.59 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.991 -0.549 . . . . 72.319999999999993 111.199 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.2 55.39 2.83 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.27 0.47 . . . . 55.119999999999997 112.27 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 58.2 m -67.46 -9.45 42.11 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.252 0.464 . . . . 74.239999999999995 112.252 -178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -86.78 -9.65 55.36 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.297 0.57 . . . . 72.510000000000005 111.496 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 19' ' ' ARG . 8.6 tpt180 -94.18 -62.25 1.37 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.986 -0.552 . . . . 74.439999999999998 111.041 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 40' ' ' LEU . 5.5 mp 74.68 -14.83 0.69 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.965 0.906 . . . . 75.129999999999995 111.884 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.82 146.93 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 122.669 0.387 . . . . 75.430000000000007 111.252 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 m -150.54 102.66 3.05 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.045 -0.409 . . . . 75.340000000000003 112.02 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 32.5 t70 -93.81 108.19 19.99 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.895 0.378 . . . . 74.400000000000006 111.46 176.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.518 ' HB2' HD22 ' A' ' 56' ' ' LEU . 6.6 mm-40 -113.37 -30.55 6.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.917 0.389 . . . . 71.439999999999998 110.922 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.56 -23.12 66.83 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.491 0.552 . . . . 64.420000000000002 112.491 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.42 45.46 6.92 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.084 -0.579 . . . . 60.219999999999999 112.731 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.504 HD11 HD13 ' A' ' 92' ' ' LEU . 83.5 mt -119.19 -32.75 4.32 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.106 0.41 . . . . 62.149999999999999 112.106 -175.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.1 132.69 36.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.178 0.514 . . . . 74.120000000000005 111.574 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.9 t -86.91 172.27 10.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.159 -0.473 . . . . 74.439999999999998 111.249 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -56.81 -40.68 76.42 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 111.906 0.336 . . . . 73.409999999999997 111.906 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.33 80.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.711 0.291 . . . . 72.319999999999993 111.254 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -56.02 -41.21 74.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.703 0.287 . . . . 74.340000000000003 111.169 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -59.98 -55.92 28.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.131 0.491 . . . . 75.5 111.489 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.403 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 8.0 tp10 -69.33 -43.04 74.49 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.472 0.545 . . . . 71.349999999999994 112.472 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.4 t -59.64 -39.84 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.088 0.471 . . . . 74.109999999999999 110.861 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.508 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.2 ttm -68.39 -43.09 78.04 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.387 -0.37 . . . . 70.420000000000002 110.789 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 34' ' ' GLU . 88.4 m-20 -51.07 -55.97 14.93 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.9 0.381 . . . . 73.430000000000007 111.486 177.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.47 -37.82 76.83 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.181 -0.533 . . . . 75.109999999999999 113.384 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -62.84 -53.59 51.81 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.174 0.512 . . . . 73.329999999999998 110.811 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.536 ' HB3' HD23 ' A' ' 20' ' ' LEU . 57.1 mt -61.72 -31.23 71.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.964 -0.562 . . . . 75.150000000000006 111.318 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.4 mtm-85 -74.5 -39.33 62.5 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.405 -0.362 . . . . 75.230000000000004 111.586 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.28 89.85 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.896 0.379 . . . . 64.519999999999996 111.563 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.04 -42.07 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.004 0.43 . . . . 70.310000000000002 111.704 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -74.22 -25.28 59.58 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.036 0.384 . . . . 74.5 112.036 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.5 t -66.67 -28.35 68.39 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.655 0.741 . . . . 74.549999999999997 109.641 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.6 p -104.64 -70.57 0.77 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.056 -0.974 . . . . 74.340000000000003 112.027 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.475 ' HE1' ' HB2' ' A' ' 150' ' ' LEU . 75.5 m-70 -76.86 -9.86 58.97 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.436 0.532 . . . . 70.109999999999999 112.436 -174.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.25 13.41 8.75 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.233 0.457 . . . . 65.420000000000002 112.233 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.544 ' HA ' ' HB2' ' A' ' 84' ' ' ASN . 85.9 t -79.01 129.89 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.445 0.535 . . . . 74.519999999999996 112.445 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.96 97.33 9.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.612 0.72 . . . . 74.219999999999999 110.477 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.483 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.1 t80 -103.49 105.62 15.91 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.295 -0.866 . . . . 73.420000000000002 110.507 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.55 140.6 37.31 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.406 0.521 . . . . 74.510000000000005 112.406 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -126.07 122.9 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 122.722 0.409 . . . . 74.540000000000006 111.273 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.57 138.88 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.853 0.358 . . . . 75.409999999999997 111.804 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.404 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 17.9 p -117.08 126.05 52.24 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.887 0.375 . . . . 75.099999999999994 110.902 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 24' ' ' GLU . 33.7 mt -131.45 146.59 62.6 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.634 -0.257 . . . . 72.319999999999993 110.686 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 37.6 Cg_exo -57.87 -68.68 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.119 1.88 . . . . 73.120000000000005 111.682 174.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.414 ' HA ' HG13 ' A' ' 91' ' ' VAL . 60.3 p -142.3 157.83 44.39 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.186 0.517 . . . . 61.140000000000001 110.94 175.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.3 pt -110.15 23.66 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.009 -0.541 . . . . 71.329999999999998 111.11 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.64 -144.18 30.01 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.094 -0.503 . . . . 45.549999999999997 112.244 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -96.29 9.69 40.32 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.296 0.569 . . . . 63.119999999999997 111.01 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.3 141.78 86.29 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 112.01 0.374 . . . . 72.340000000000003 112.01 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.572 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 43.6 Cg_endo -67.91 145.17 67.32 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.561 2.174 . . . . 72.200000000000003 112.801 177.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.3 tp -61.68 -46.77 88.27 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.443 0.535 . . . . 75.420000000000002 112.443 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.33 -53.09 62.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.221 0.452 . . . . 65.439999999999998 112.221 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.572 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 5.3 m-20 -60.06 -33.77 72.51 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.682 0.253 . . . . 70.140000000000001 111.682 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -64.45 -55.15 22.75 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.674 0.273 . . . . 73.319999999999993 111.274 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.5 p -58.78 -39.76 81.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.8 0.333 . . . . 70.040000000000006 111.259 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 57.2 tp -59.88 -55.04 39.11 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.292 -0.413 . . . . 74.519999999999996 111.145 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -60.27 -32.5 71.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.17 0.433 . . . . 74.349999999999994 112.17 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.603 HD23 HD23 ' A' ' 87' ' ' LEU . 34.9 tp -73.03 -48.43 36.23 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.987 0.422 . . . . 65.439999999999998 111.249 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.2 86.33 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.846 0.313 . . . . 73.209999999999994 111.846 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 67.8 mtp180 -61.44 -54.2 46.55 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.926 0.343 . . . . 74.340000000000003 111.926 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.447 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 11.9 pt20 -64.4 -27.28 68.9 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.861 0.362 . . . . 74.420000000000002 111.51 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 40.9 m0 -80.24 -2.27 44.27 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.889 0.329 . . . . 74.239999999999995 111.889 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.27 -46.39 3.4 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.26 -0.495 . . . . 51.030000000000001 113.473 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.533 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 17.8 m -49.6 -28.98 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.811 0.671 . . . . 71.010000000000005 112.811 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.37 40.56 1.67 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.102 -0.571 . . . . 75.310000000000002 112.621 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -42.31 -47.91 4.92 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.156 0.503 . . . . 74.230000000000004 111.349 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -174.39 90.04 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.338 -0.847 . . . . 73.120000000000005 109.416 167.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER 56.68 52.66 9.33 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.509 0.671 . . . . 75.420000000000002 111.112 -173.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.533 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 67.3 t30 -74.37 169.56 17.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.61 -0.723 . . . . 72.450000000000003 111.607 -177.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -70.9 138.9 50.53 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.846 -0.534 . . . . 71.340000000000003 112.083 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.781 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 36.3 p30 40.53 27.25 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.208 1.559 . . . . 73.019999999999996 115.208 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.88 123.83 7.61 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.785 -0.721 . . . . 73.319999999999993 111.882 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.6 tp -134.4 121.92 21.83 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.023 0.412 . . . . 73.510000000000005 111.307 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.603 HD23 HD23 ' A' ' 71' ' ' LEU . 57.4 tp -113.14 137.48 51.38 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.822 0.344 . . . . 75.530000000000001 111.754 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.3 tp -127.15 105.16 8.38 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.534 0.334 . . . . 74.239999999999995 110.876 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.84 129.69 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 111.9 0.333 . . . . 64.310000000000002 111.9 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HA ' HG13 ' A' ' 97' ' ' VAL . 27.6 tp -107.91 128.94 55.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.251 -0.431 . . . . 75.409999999999997 111.069 175.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.539 HG12 ' NE2' ' A' ' 94' ' ' GLN . 59.9 t -105.94 109.14 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.59 -0.277 . . . . 72.510000000000005 110.536 174.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.569 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 62.5 tp -55.94 -55.81 28.25 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.627 0.603 . . . . 73.329999999999998 112.627 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.61 -24.63 61.42 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.573 0.583 . . . . 73.349999999999994 112.573 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.539 ' NE2' HG12 ' A' ' 91' ' ' VAL . 40.3 mt-30 -103.45 -7.05 21.24 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.578 -0.283 . . . . 64.209999999999994 111.547 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 33.27 49.84 0.23 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.241 1.016 . . . . 75.400000000000006 113.254 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -141.87 155.11 45.54 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.573 -0.74 . . . . 74.239999999999995 110.317 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' A' ' 90' ' ' LEU . 5.8 m -128.49 171.74 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.84 0.353 . . . . 74.439999999999998 111.429 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.5 ttt85 -149.15 133.16 17.16 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.404 -0.362 . . . . 74.420000000000002 111.809 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 97.1 m-85 -95.03 112.51 24.2 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.01 -0.541 . . . . 75.120000000000005 110.401 172.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 15.6 tp10 -94.31 111.94 23.7 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.581 0.229 . . . . 74.219999999999999 110.428 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 p -98.15 145.51 26.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.033 0.753 . . . . 64.310000000000002 113.033 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -97.06 -173.99 34.53 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.298 -0.864 . . . . 50.329999999999998 112.142 167.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -63.71 -27.86 69.5 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.147 0.499 . . . . 70.420000000000002 112.054 -175.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.781 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -73.45 -9.0 77.2 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 120.935 -0.65 . . . . 40.530000000000001 113.692 -172.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.1 mt -129.24 4.87 5.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.636 0.606 . . . . 73.310000000000002 112.636 -175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.72 -41.59 97.83 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.913 0.387 . . . . 64.340000000000003 111.116 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.94 -23.38 69.37 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.325 -0.464 . . . . 62.229999999999997 113.22 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -92.41 -66.87 0.89 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.676 0.274 . . . . 75.329999999999998 111.655 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.606 ' HA ' HD23 ' A' ' 113' ' ' LEU . 3.0 mp -117.16 94.95 46.23 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.829 0.307 . . . . 73.049999999999997 111.829 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.42 174.68 11.6 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.659 2.239 . . . . 73.129999999999995 112.607 174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.86 -44.32 59.56 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.318 0.488 . . . . 74.329999999999998 112.318 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -59.65 -50.2 70.35 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.197 -0.525 . . . . 73.239999999999995 113.546 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.606 HD23 ' HA ' ' A' ' 109' ' ' LEU . 36.0 tp -60.76 -49.13 78.71 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.828 0.347 . . . . 73.120000000000005 111.404 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 118' ' ' ILE . 92.8 mt -56.34 -48.61 76.43 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 111.231 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.3 m -61.56 -36.41 80.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 111.367 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.402 ' NH2' HD13 ' A' ' 113' ' ' LEU . 44.3 ttp180 -65.45 -50.14 66.49 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.548 -0.296 . . . . 75.510000000000005 110.973 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.81 -47.37 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.23 0.538 . . . . 71.310000000000002 110.617 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 114' ' ' LEU . 84.0 mt -59.03 -57.11 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.749 -0.659 . . . . 71.549999999999997 112.383 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -84.21 -22.46 30.87 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.364 0.875 . . . . 74.230000000000004 113.364 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.19 -38.15 17.95 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.034 0.445 . . . . 63.340000000000003 111.787 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -113.25 -59.19 2.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 112.153 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.9 mtp -62.51 -48.4 79.74 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.241 0.83 . . . . 74.450000000000003 113.241 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.447 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 27.1 mm -57.76 -50.79 86.17 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.421 0.526 . . . . 72.129999999999995 112.421 -177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 85.0 Cg_exo -47.15 -34.8 18.33 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.348 2.032 . . . . 75.140000000000001 112.998 174.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -72.97 -49.25 30.25 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.629 0.252 . . . . 73.120000000000005 111.182 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.421 ' HD2' HD13 ' A' ' 123' ' ' ILE . 23.7 m-85 -57.4 -45.02 85.0 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.016 0.376 . . . . 73.439999999999998 112.016 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -62.3 -23.94 67.01 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.22 0.533 . . . . 73.230000000000004 111.1 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.0 m -92.77 7.43 43.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.062 -0.517 . . . . 54.100000000000001 111.559 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.75 -0.43 82.06 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.364 -0.446 . . . . 73.409999999999997 113.493 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.87 70.72 10.68 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 122.519 -0.4 . . . . 71.430000000000007 111.545 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -70.57 -42.33 71.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.016 0.436 . . . . 73.129999999999995 110.557 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.3 90.89 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.998 -0.546 . . . . 71.439999999999998 111.213 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.774 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 18.6 mp0 -59.69 -53.27 59.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.367 -0.379 . . . . 75.140000000000001 111.088 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.57 -49.87 59.4 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.359 -0.448 . . . . 70.030000000000001 113.647 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 139' ' ' VAL . 96.4 mt -65.67 -46.9 77.37 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.572 -0.369 . . . . 75.299999999999997 111.818 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 92.7 p -61.67 -50.53 72.13 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.716 0.293 . . . . 73.549999999999997 111.684 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -27.16 60.15 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.7 -0.227 . . . . 74.019999999999996 111.285 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.13 -47.62 79.44 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.12 -0.562 . . . . 74.0 112.402 173.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 135' ' ' LEU . 75.3 t -58.27 -44.13 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.253 0.549 . . . . 74.040000000000006 110.562 173.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.496 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 41.0 tp -63.96 -35.91 82.22 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.884 -0.598 . . . . 74.019999999999996 110.83 177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.63 -43.5 97.44 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.94 0.4 . . . . 72.230000000000004 111.282 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.87 -47.54 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.171 0.51 . . . . 73.030000000000001 110.671 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -56.16 -36.73 68.63 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.02 -0.536 . . . . 65.549999999999997 111.673 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 18.7 mm-40 -57.3 -29.84 64.24 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 120.82 0.343 . . . . 73.409999999999997 111.809 176.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.53 -49.68 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.851 0.358 . . . . 73.049999999999997 111.139 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -71.76 -58.3 3.59 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.071 0.397 . . . . 74.230000000000004 112.071 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -71.56 -14.3 62.05 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.871 0.323 . . . . 75.420000000000002 111.871 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -75.16 -16.24 80.7 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.085 -0.578 . . . . 70.230000000000004 112.511 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.1 t -102.6 -68.97 0.81 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.13 0.49 . . . . 74.420000000000002 110.39 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.475 ' HB2' ' HE1' ' A' ' 47' ' ' HIS . 80.7 mt -92.48 80.35 4.88 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.216 0.532 . . . . 73.230000000000004 110.803 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -70.37 -32.77 70.59 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.008 -0.542 . . . . 71.25 110.889 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -74.96 89.11 2.38 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.87 -0.605 . . . . 74.239999999999995 110.088 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -59.54 -23.94 63.27 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.87 1.063 . . . . 72.120000000000005 113.87 -172.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -66.9 87.2 0.14 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.262 0.554 . . . . 74.140000000000001 110.363 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -78.98 154.92 29.16 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.465 0.913 . . . . 74.030000000000001 113.465 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -76.14 139.87 41.49 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.245 -0.888 . . . . 74.140000000000001 111.895 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 119.139 -0.457 . . . . 74.120000000000005 111.296 174.258 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.565 0.222 . . . . 74.109999999999999 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -161.14 123.27 3.05 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.718 0.294 . . . . 74.409999999999997 110.991 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.8 t -78.27 111.32 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.023 0.44 . . . . 74.510000000000005 112.167 -175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.13 126.61 50.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.128 -0.487 . . . . 73.099999999999994 111.137 173.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 9' ' ' VAL . 67.6 mttm -89.04 151.46 46.96 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.446 -0.343 . . . . 75.400000000000006 110.983 176.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' HD3' ' CE2' ' A' ' 67' ' ' PHE . 39.7 Cg_endo -64.88 -19.63 64.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.872 1.714 . . . . 72.109999999999999 111.663 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.409 ' HA ' HE22 ' A' ' 74' ' ' GLN . 18.5 mt-10 -88.83 -7.69 55.72 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.391 -0.822 . . . . 75.510000000000005 111.165 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -112.52 2.04 16.12 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.908 -0.587 . . . . 63.549999999999997 111.876 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 5' ' ' LYS . 61.8 t -81.28 130.92 60.51 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.512 -0.313 . . . . 73.239999999999995 110.447 174.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.01 116.89 1.89 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.877 2.385 . . . . 72.409999999999997 113.314 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -68.29 70.29 0.16 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.005 0.431 . . . . 74.439999999999998 112.035 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -60.56 -25.42 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.7 0.63 . . . . 74.510000000000005 112.7 -175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -73.98 -25.09 59.74 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.901 0.381 . . . . 75.310000000000002 111.219 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tt -93.84 -32.61 13.87 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.076 -0.511 . . . . 72.409999999999997 111.038 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.88 -47.3 10.46 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.202 0.445 . . . . 54.299999999999997 112.202 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 18' ' ' THR . 18.4 m-20 -106.4 -65.62 1.07 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.592 0.59 . . . . 73.439999999999998 112.592 -177.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.8 p 61.65 0.72 0.51 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.985 0.914 . . . . 74.219999999999999 112.139 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 16' ' ' ASP . 5.8 t -110.5 -36.68 5.69 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.678 0.391 . . . . 70.439999999999998 111.641 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -87.11 -49.3 7.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.862 0.363 . . . . 72.239999999999995 111.629 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp 65.45 13.92 9.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.26 0.624 . . . . 74.230000000000004 112.155 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.8 t -102.41 128.72 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.0 0.428 . . . . 73.510000000000005 111.651 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 m -129.74 112.4 13.59 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.274 -0.421 . . . . 74.140000000000001 110.931 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -124.04 102.23 7.64 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.007 0.432 . . . . 70.310000000000002 111.894 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HB2' HD23 ' A' ' 56' ' ' LEU . 4.7 mp0 -102.93 -38.7 7.25 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.292 -0.413 . . . . 74.239999999999995 110.98 173.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.1 -20.92 66.3 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.074 0.768 . . . . 73.140000000000001 113.074 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.6 38.78 27.23 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.916 -0.659 . . . . 70.150000000000006 112.693 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.1 mt -100.81 -28.42 12.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.719 0.295 . . . . 74.019999999999996 111.393 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.2 mt -99.05 107.53 19.96 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.737 0.303 . . . . 75.109999999999999 111.321 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.1 t -74.57 160.53 30.76 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.353 -0.217 . . . . 75.200000000000003 110.903 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -46.47 -36.29 6.49 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.729 0.64 . . . . 74.5 112.729 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.49 -52.02 63.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.948 0.404 . . . . 65.409999999999997 111.333 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.497 ' HG3' ' HB1' ' A' ' 132' ' ' ALA . 14.6 mm100 -62.07 -40.7 96.7 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.928 0.394 . . . . 71.340000000000003 110.741 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.27 -44.74 88.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.211 -0.45 . . . . 74.430000000000007 110.865 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -57.93 -52.26 66.24 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.132 0.491 . . . . 75.340000000000003 111.126 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.69 -45.9 96.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.212 -0.449 . . . . 64.019999999999996 111.622 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 43.9 ttm -62.78 -44.38 96.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.503 -0.317 . . . . 75.030000000000001 111.375 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -53.55 -47.83 69.66 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.169 0.509 . . . . 72.450000000000003 110.656 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.85 -36.11 92.29 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.059 -0.591 . . . . 53.43 113.086 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.57 ' O ' HG13 ' A' ' 43' ' ' ILE . 6.2 mmp_? -67.3 -56.27 10.48 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.816 0.341 . . . . 74.239999999999995 111.12 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.62 -47.25 84.57 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.175 -0.466 . . . . 72.319999999999993 111.746 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -58.54 -45.99 87.77 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 111.19 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.76 80.81 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.908 0.385 . . . . 65.409999999999997 111.386 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.4 mt -65.64 -48.64 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.878 0.37 . . . . 53.420000000000002 111.424 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 48.5 ttt180 -66.83 -28.16 68.13 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.11 -0.369 . . . . 73.349999999999994 111.625 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 t -76.67 -49.73 15.43 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.804 0.335 . . . . 74.230000000000004 111.632 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.2 t -82.83 -54.18 5.3 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.323 0.49 . . . . 65.310000000000002 112.323 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.6 ' ND1' HD23 ' A' ' 150' ' ' LEU . 15.0 m-70 -87.56 -22.3 24.89 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.115 -0.493 . . . . 74.25 111.505 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 71.43 17.68 5.7 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.235 0.614 . . . . 73.319999999999993 111.443 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.787 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 84.2 t -87.48 119.25 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.106 -0.497 . . . . 74.310000000000002 111.284 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -80.96 96.69 7.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.244 0.545 . . . . 74.200000000000003 110.283 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -110.49 109.65 20.09 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.631 -0.713 . . . . 74.349999999999994 110.645 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.33 142.16 42.36 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.444 0.535 . . . . 63.5 112.444 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.22 132.82 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.321 -0.4 . . . . 70.120000000000005 111.214 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.483 HG23 HD21 ' A' ' 71' ' ' LEU . 41.8 t -130.92 138.79 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 122.463 0.305 . . . . 72.129999999999995 111.534 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 p -124.49 122.85 38.77 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.093 0.473 . . . . 75.519999999999996 111.573 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 24' ' ' GLU . 42.8 mt -131.85 145.36 57.14 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 116.516 -0.311 . . . . 71.439999999999998 110.92 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.59 -68.63 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.13 1.887 . . . . 71.040000000000006 112.684 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 m -131.0 156.04 45.8 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.207 -0.308 . . . . 71.120000000000005 110.785 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 91' ' ' VAL . 27.8 pt -122.21 2.08 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 121.14 0.495 . . . . 73.25 111.886 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.95 -122.7 10.2 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.211 -0.519 . . . . 74.109999999999999 113.178 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -103.49 4.95 36.54 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.978 0.362 . . . . 70.420000000000002 111.978 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.08 118.49 70.94 Favored Pre-proline 0 CA--C 1.538 0.497 0 O-C-N 122.402 -0.186 . . . . 74.209999999999994 110.685 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.474 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 32.0 Cg_endo -63.94 131.37 30.62 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.145 1.897 . . . . 71.209999999999994 112.354 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.5 tp -48.01 -40.4 22.6 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.41 0.522 . . . . 65.400000000000006 112.41 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.45 -45.37 91.2 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.215 0.45 . . . . 71.530000000000001 112.215 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 22.9 t70 -71.66 -34.57 69.83 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.464 0.649 . . . . 73.010000000000005 110.228 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.484 ' CE2' ' HD3' ' A' ' 6' ' ' PRO . 21.6 t80 -58.77 -52.37 65.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.521 -0.763 . . . . 74.310000000000002 110.914 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.5 p -61.74 -40.42 95.05 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.266 -0.425 . . . . 75.340000000000003 111.19 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.9 tp -57.48 -52.74 64.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.28 -0.418 . . . . 71.409999999999997 111.278 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 56.4 mtpt -60.35 -49.28 78.2 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.942 0.401 . . . . 74.439999999999998 111.764 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.483 HD21 HG23 ' A' ' 54' ' ' VAL . 34.2 tp -59.6 -45.03 93.12 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.338 -0.392 . . . . 73.420000000000002 111.735 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -48.19 73.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.348 0.499 . . . . 73.040000000000006 112.348 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.481 ' NH2' ' HG2' ' A' ' 70' ' ' LYS . 14.4 ptt180 -68.08 -31.38 70.97 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.916 0.388 . . . . 72.340000000000003 111.321 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.409 HE22 ' HA ' ' A' ' 7' ' ' GLU . 7.9 tt0 -70.91 -39.35 72.77 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.022 0.439 . . . . 53.329999999999998 111.246 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.409 ' CZ2' HD13 ' A' ' 71' ' ' LEU . 41.0 m0 -80.49 8.53 7.54 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.199 0.444 . . . . 73.540000000000006 112.199 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.5 -42.0 2.74 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.159 -0.543 . . . . 72.540000000000006 113.585 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -59.15 -4.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 113.535 0.939 . . . . 71.420000000000002 113.535 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.72 27.69 3.66 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.725 -0.75 . . . . 63.310000000000002 113.831 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -58.74 101.05 0.08 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 117.832 0.816 . . . . 75.450000000000003 111.087 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 13.1 pt-20 38.94 48.7 1.44 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.419 0.688 . . . . 73.420000000000002 111.641 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 13.7 mptt 70.09 81.56 0.17 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.123 -0.944 . . . . 75.409999999999997 111.548 -173.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -64.96 162.54 16.33 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.906 -0.588 . . . . 70.239999999999995 109.458 174.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.56 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -59.89 -99.08 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 112.968 0.729 . . . . 72.540000000000006 112.968 -178.102 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.787 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 15.3 m120 -76.22 78.05 3.02 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.506 -0.746 . . . . 73.319999999999993 111.778 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.9 135.49 7.72 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.162 -0.542 . . . . 52.100000000000001 112.809 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 99' ' ' PHE . 57.1 tp -147.26 119.89 8.56 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.752 0.31 . . . . 74.409999999999997 110.662 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.475 HD23 HD22 ' A' ' 71' ' ' LEU . 60.8 tp -107.55 132.81 52.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.856 0.36 . . . . 65.230000000000004 111.745 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.0 tp -121.85 112.23 18.09 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.378 -0.374 . . . . 73.140000000000001 111.127 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.18 126.9 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.878 0.37 . . . . 72.150000000000006 111.629 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.415 ' HA ' HG13 ' A' ' 97' ' ' VAL . 29.7 tp -109.84 120.64 43.11 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 111.335 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.548 HG22 HD11 ' A' ' 59' ' ' ILE . 51.8 t -100.92 103.46 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.581 -0.281 . . . . 74.439999999999998 110.745 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.1 tp -52.19 -44.89 64.95 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.307 0.484 . . . . 72.540000000000006 112.307 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.86 -31.55 66.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.036 -0.529 . . . . 73.540000000000006 112.249 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.484 HE22 HD13 ' A' ' 59' ' ' ILE . 51.2 mt-30 -110.56 -6.12 14.95 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.037 0.384 . . . . 75.150000000000006 112.037 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 42.17 31.02 0.22 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.672 0.789 . . . . 74.450000000000003 112.003 -171.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 58.2 mtt180 -107.25 142.33 37.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.774 -0.648 . . . . 74.329999999999998 110.972 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.415 HG13 ' HA ' ' A' ' 90' ' ' LEU . 4.1 m -131.01 163.14 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.973 0.416 . . . . 74.340000000000003 111.124 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -148.41 137.03 21.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.411 -0.359 . . . . 72.310000000000002 111.329 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.62 ' HB3' HD11 ' A' ' 86' ' ' LEU . 89.9 m-85 -100.08 113.5 26.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.019 -0.537 . . . . 74.409999999999997 110.104 173.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -95.76 114.45 26.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.372 -0.232 . . . . 73.420000000000002 110.372 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.54 147.67 23.83 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.213 0.819 . . . . 73.239999999999995 113.213 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -97.77 178.37 32.3 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.122 -0.944 . . . . 52.409999999999997 112.539 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -62.72 -19.38 63.86 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.444 0.535 . . . . 73.109999999999999 112.444 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.74 -18.24 56.82 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.032 -0.604 . . . . 73.349999999999994 113.33 -177.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.57 HD11 HG12 ' A' ' 49' ' ' VAL . 91.4 mt -111.54 -4.54 14.76 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.889 0.7 . . . . 72.010000000000005 112.889 -175.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -58.76 -30.51 67.58 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.082 0.401 . . . . 71.120000000000005 112.082 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.49 -18.24 79.27 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.042 -0.599 . . . . 73.340000000000003 113.062 174.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.511 ' HE1' ' HB3' ' A' ' 152' ' ' HIS . 34.6 m-85 -93.28 -57.39 2.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.277 0.56 . . . . 75.120000000000005 111.831 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.552 ' HB3' HD21 ' A' ' 114' ' ' LEU . 12.5 mt -119.64 89.0 40.39 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.611 -0.722 . . . . 75.400000000000006 112.253 -169.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.09 148.29 85.2 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.25 1.967 . . . . 74.329999999999998 111.571 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.25 -27.64 62.25 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.007 0.432 . . . . 74.349999999999994 111.385 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.53 -49.38 56.49 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.155 -0.545 . . . . 54.039999999999999 112.589 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.32 -44.26 84.03 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.158 0.504 . . . . 74.299999999999997 111.064 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 109' ' ' LEU . 89.6 mt -58.31 -43.17 88.02 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.263 -0.426 . . . . 60.43 111.083 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.6 m -62.88 -36.89 84.81 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.852 0.358 . . . . 74.040000000000006 111.118 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -60.21 -53.46 57.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.355 -0.384 . . . . 74.420000000000002 110.149 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.6 mt -51.53 -42.4 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.916 0.389 . . . . 73.219999999999999 111.234 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 114' ' ' LEU . 76.6 mt -58.67 -55.87 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.818 0.342 . . . . 72.319999999999993 111.478 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -76.22 -9.72 58.85 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.506 0.558 . . . . 75.439999999999998 112.506 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -95.42 -45.36 7.14 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.162 0.43 . . . . 74.230000000000004 112.162 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.667 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 92.6 mtt180 -127.59 -4.11 5.97 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.599 0.962 . . . . 74.140000000000001 113.599 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.75 ' HE3' ' HA3' ' A' ' 138' ' ' GLY . 17.0 mmt -103.46 -63.27 1.2 Allowed 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.85 -0.531 . . . . 73.510000000000005 111.786 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 43.5 mm -50.07 -49.97 72.05 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 112.719 0.637 . . . . 65.209999999999994 112.719 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 11.1 Cg_endo -52.76 -37.19 75.74 Favored 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.366 2.044 . . . . 61.409999999999997 112.874 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.41 ' NE2' ' HG3' ' A' ' 137' ' ' GLU . 86.5 m-70 -77.61 -48.65 16.34 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.543 -0.299 . . . . 74.129999999999995 111.434 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.7 m-85 -57.06 -40.12 76.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.772 0.32 . . . . 73.329999999999998 111.42 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -59.35 -35.78 74.5 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.997 0.427 . . . . 74.129999999999995 111.291 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.2 t -84.18 -3.44 58.15 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.247 -0.433 . . . . 73.340000000000003 111.691 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.42 6.68 88.45 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.111 -0.566 . . . . 65.120000000000005 112.888 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.682 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.6 m-20 -84.08 55.79 3.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.688 0.395 . . . . 70.0 111.72 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -56.43 -44.35 80.34 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.06 0.392 . . . . 64.340000000000003 112.06 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.497 ' HB1' ' HG3' ' A' ' 32' ' ' GLN . . . -66.85 -32.77 74.26 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.94 0.4 . . . . 74.120000000000005 112.042 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 53.3 mt-10 -76.54 -43.39 39.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.391 -0.368 . . . . 74.439999999999998 111.508 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.64 -49.75 67.82 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.389 -0.434 . . . . 73.219999999999999 112.994 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.608 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 92.2 mt -56.64 -39.75 74.22 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.746 0.308 . . . . 72.540000000000006 111.445 176.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.8 t -60.8 -45.69 93.43 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.085 0.469 . . . . 72.319999999999993 111.047 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 38.0 mm-40 -61.85 -44.86 95.98 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.996 -0.547 . . . . 72.430000000000007 111.819 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.75 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -60.88 -47.54 90.74 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.166 -0.54 . . . . 74.430000000000007 113.072 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 135' ' ' LEU . 83.4 t -60.55 -50.02 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.885 0.374 . . . . 73.209999999999994 111.511 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.93 -38.33 85.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.376 -0.374 . . . . 74.439999999999998 111.269 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.93 -54.63 44.76 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.996 0.427 . . . . 70.030000000000001 111.331 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.437 HG13 HD12 ' A' ' 109' ' ' LEU . 99.5 t -57.53 -47.7 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.147 -0.479 . . . . 71.040000000000006 111.133 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.411 HE22 ' NH1' ' A' ' 39' ' ' ARG . 63.4 tt0 -53.74 -37.7 63.62 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 111.817 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 144' ' ' GLN . 14.5 mm-40 -72.89 -38.99 66.76 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 111.609 0.225 . . . . 62.350000000000001 111.609 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.53 -42.87 95.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.998 0.427 . . . . 75.510000000000005 110.985 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 49' ' ' VAL . 77.2 mt -64.43 -49.9 69.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.124 -0.489 . . . . 73.129999999999995 111.168 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -55.38 -40.95 71.98 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.657 -0.701 . . . . 71.349999999999994 112.232 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.49 20.85 38.64 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.748 -0.739 . . . . 44.539999999999999 113.856 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.7 t -157.05 30.91 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.721 0.76 . . . . 74.030000000000001 112.165 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.6 HD23 ' ND1' ' A' ' 47' ' ' HIS . 61.8 mt -73.16 76.02 1.27 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.232 0.539 . . . . 75.239999999999995 112.079 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.46 4.14 7.65 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.728 -0.669 . . . . 71.209999999999994 111.983 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.511 ' HB3' ' HE1' ' A' ' 108' ' ' TYR . 51.5 t-80 -145.29 91.95 2.19 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.202 0.525 . . . . 74.310000000000002 112.392 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -90.9 -160.69 0.74 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.274 -0.421 . . . . 73.439999999999998 110.265 171.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.32 137.49 51.43 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.069 1.137 . . . . 75.450000000000003 114.069 -172.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -114.23 -37.01 4.51 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.274 -0.875 . . . . 72.439999999999998 109.869 170.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -110.13 131.45 55.05 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.0 -0.545 . . . . 72.140000000000001 110.963 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.588 -0.72 . . . . 63.439999999999998 110.76 174.074 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.485 0.183 . . . . 75.319999999999993 111.364 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -74.37 -28.38 61.09 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.83 0.347 . . . . 74.329999999999998 111.69 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG11 ' HE3' ' A' ' 5' ' ' LYS . 97.8 t 64.6 94.59 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.769 -0.65 . . . . 73.109999999999999 111.613 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -87.81 135.61 33.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.852 -0.613 . . . . 62.509999999999998 111.936 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HE3' HG11 ' A' ' 3' ' ' VAL . 25.7 mmtp -100.93 158.99 30.76 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.47 -0.567 . . . . 74.329999999999998 109.47 169.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 9.5 Cg_endo -56.65 -32.08 89.46 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.43 1.42 . . . . 73.310000000000002 112.038 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -78.13 -12.72 60.01 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.483 0.549 . . . . 75.030000000000001 112.483 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -85.35 -18.04 34.97 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.953 0.406 . . . . 75.420000000000002 110.976 173.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.474 HG22 HD21 ' A' ' 56' ' ' LEU . 60.3 t -79.03 128.0 77.72 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.137 -0.483 . . . . 73.010000000000005 111.388 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.23 108.25 0.32 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.301 2.0 . . . . 74.530000000000001 111.899 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.496 ' ND2' HD11 ' A' ' 14' ' ' LEU . 14.7 p-10 -66.57 82.14 0.1 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.741 0.781 . . . . 74.420000000000002 112.158 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.42 1.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.487 -0.779 . . . . 71.310000000000002 113.0 -177.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.649 HE22 ' HG ' ' A' ' 20' ' ' LEU . 28.0 mm-40 -100.7 9.99 41.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.834 0.35 . . . . 75.549999999999997 111.305 174.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.496 HD11 ' ND2' ' A' ' 11' ' ' ASN . 10.1 tt -124.11 -46.0 1.96 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.442 -0.344 . . . . 74.400000000000006 111.35 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.77 -68.29 0.7 Allowed 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.146 -0.346 . . . . 70.230000000000004 111.654 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -80.07 -61.95 1.83 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.942 0.349 . . . . 73.010000000000005 111.942 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 m 63.11 7.06 2.55 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.656 0.383 . . . . 62.340000000000003 111.818 -174.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -99.26 -43.69 6.51 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.119 0.414 . . . . 64.349999999999994 112.119 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -82.51 -35.92 26.9 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.581 0.585 . . . . 74.439999999999998 112.581 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.649 ' HG ' HE22 ' A' ' 13' ' ' GLN . 6.8 mp 63.19 3.83 1.44 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.735 0.643 . . . . 71.549999999999997 112.735 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.5 t -108.8 154.32 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.663 0.385 . . . . 74.439999999999998 111.166 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.3 m -142.5 108.74 5.25 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.479 0.311 . . . . 75.25 111.031 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.528 ' HA ' ' HG1' ' A' ' 55' ' ' THR . 20.7 p-10 -107.74 73.67 0.92 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.521 0.676 . . . . 73.510000000000005 112.616 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -79.18 -38.09 36.69 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.289 0.566 . . . . 71.129999999999995 110.453 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.19 66.59 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.918 -0.583 . . . . 71.400000000000006 112.403 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.26 19.2 73.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.152 -0.547 . . . . 74.010000000000005 113.195 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.11 0.12 54.27 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.053 0.39 . . . . 64.409999999999997 112.053 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -109.95 103.59 12.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.916 0.388 . . . . 74.019999999999996 111.04 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.7 t -70.33 165.98 21.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.368 -0.378 . . . . 64.239999999999995 111.403 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -46.72 -57.73 4.56 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.426 0.898 . . . . 74.099999999999994 113.426 -172.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.571 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . . . -68.06 -42.93 79.75 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.021 0.378 . . . . 74.530000000000001 112.021 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -62.26 -33.43 74.61 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.259 0.552 . . . . 74.319999999999993 111.069 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -74.2 -53.22 10.28 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.668 -0.696 . . . . 74.239999999999995 111.038 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.571 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 11.6 pt-20 -59.65 -43.59 93.85 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.129 0.418 . . . . 73.239999999999995 112.129 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.0 t -65.8 -33.67 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.143 0.497 . . . . 71.140000000000001 110.91 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.433 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 50.8 ttm -65.34 -40.5 93.75 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 122.052 -0.405 . . . . 72.409999999999997 110.651 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.475 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -57.93 -56.36 22.95 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.989 0.423 . . . . 74.010000000000005 111.703 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.57 -43.03 85.83 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.306 -0.473 . . . . 72.340000000000003 113.416 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.439 ' O ' HG13 ' A' ' 43' ' ' ILE . 73.4 mtm180 -62.55 -45.1 94.48 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 111.756 0.28 . . . . 74.209999999999994 111.756 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 36' ' ' MET . 89.1 mt -64.1 -50.84 66.71 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.025 0.44 . . . . 75.420000000000002 111.431 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -60.21 -37.79 81.37 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.272 -0.422 . . . . 74.200000000000003 111.447 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.33 -44.23 88.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.943 0.401 . . . . 73.310000000000002 111.271 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.651 HG23 ' HB ' ' A' ' 49' ' ' VAL . 63.5 mt -61.58 -38.79 81.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.937 0.398 . . . . 74.329999999999998 111.265 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 57.3 ttp180 -74.03 -33.24 63.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.917 0.389 . . . . 74.129999999999995 111.238 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.2 t -66.87 -38.53 86.5 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.1 0.476 . . . . 73.120000000000005 111.08 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.0 t -92.61 -61.67 1.55 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.99 -0.55 . . . . 62.32 112.162 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.524 ' HE1' HD22 ' A' ' 150' ' ' LEU . 76.7 m-70 -91.91 -4.97 54.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.649 0.611 . . . . 74.129999999999995 112.649 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.86 26.85 14.4 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.185 0.439 . . . . 65.329999999999998 112.185 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' HG23 ' A' ' 43' ' ' ILE . 62.5 t -90.7 128.31 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 112.215 0.45 . . . . 74.219999999999999 112.215 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -86.56 97.45 10.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.389 -0.369 . . . . 75.409999999999997 110.419 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.09 105.99 14.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.846 0.355 . . . . 74.439999999999998 110.539 -177.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.63 142.1 42.96 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.456 0.539 . . . . 65.140000000000001 112.456 -175.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.18 118.17 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.989 0.423 . . . . 74.400000000000006 111.437 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.535 HG23 HD22 ' A' ' 71' ' ' LEU . 61.8 t -114.62 142.27 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 122.516 0.326 . . . . 71.430000000000007 111.752 -178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.528 ' HG1' ' HA ' ' A' ' 23' ' ' ASP . 73.3 p -130.88 123.51 29.15 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.756 0.313 . . . . 62.43 111.293 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.474 HD21 HG22 ' A' ' 9' ' ' VAL . 68.2 mt -120.65 139.24 28.58 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 111.749 0.277 . . . . 72.340000000000003 111.749 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.506 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 83.2 Cg_endo -81.81 -11.75 11.25 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.634 2.222 . . . . 61.350000000000001 113.315 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.746 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 31.0 t -169.77 138.77 1.87 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.97 0.359 . . . . 73.340000000000003 111.97 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 3' ' ' VAL . 28.6 pt -136.86 -0.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 120.984 0.421 . . . . 74.329999999999998 110.365 170.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.27 -158.58 52.12 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 116.133 -0.485 . . . . 54.329999999999998 113.219 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.46 69.94 2.28 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.367 0.603 . . . . 73.200000000000003 110.873 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.55 142.44 41.88 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.731 -0.668 . . . . 73.040000000000006 111.26 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 77.1 Cg_endo -79.27 116.67 3.66 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.415 2.076 . . . . 75.439999999999998 113.092 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.51 -38.09 83.24 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.116 0.413 . . . . 73.450000000000003 112.116 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.03 -8.86 48.94 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.968 0.413 . . . . 74.209999999999994 111.967 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 31.1 t70 -96.59 -39.21 9.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.544 0.688 . . . . 74.239999999999995 109.632 170.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.454 ' CZ ' HD13 ' A' ' 56' ' ' LEU . 43.3 t80 -55.2 -50.21 69.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.038 -0.983 . . . . 73.120000000000005 111.785 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -52.68 -49.39 65.38 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.858 0.361 . . . . 73.549999999999997 111.809 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.7 tp -59.57 -49.72 76.66 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.242 -0.436 . . . . 72.420000000000002 111.576 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -60.56 -47.74 84.84 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.243 0.46 . . . . 74.510000000000005 112.243 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.535 HD22 HG23 ' A' ' 54' ' ' VAL . 51.2 tp -61.52 -47.85 83.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.242 0.544 . . . . 74.519999999999996 110.766 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.23 77.24 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.07 -0.514 . . . . 74.200000000000003 112.01 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -61.14 -52.37 65.12 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.844 0.354 . . . . 72.329999999999998 111.709 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.519 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 12.1 pt20 -72.05 -21.64 61.5 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 111.774 0.287 . . . . 75.439999999999998 111.774 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.519 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 30.3 m0 -91.03 -16.04 28.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.561 0.219 . . . . 74.519999999999996 111.451 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.51 40.44 99.11 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.387 -0.435 . . . . 74.510000000000005 113.238 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.08 -85.01 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 112.547 0.573 . . . . 73.310000000000002 112.547 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.21 60.87 4.45 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.225 -0.512 . . . . 75.420000000000002 113.853 -173.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -112.32 133.31 54.5 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.189 -0.594 . . . . 64.129999999999995 110.867 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -45.93 -27.4 0.89 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.251 0.834 . . . . 74.530000000000001 113.251 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.77 ' HD3' ' H ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -105.76 -7.68 18.23 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.478 0.547 . . . . 72.019999999999996 112.478 -176.07 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' TYR . 65.1 t30 -77.66 160.91 28.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.732 -0.47 . . . . 72.030000000000001 109.732 175.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.422 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -76.62 -109.3 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.623 -0.673 . . . . 64.200000000000003 112.505 -178.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.629 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.7 m-20 -81.23 78.98 7.97 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.433 -0.792 . . . . 75.340000000000003 111.724 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.93 140.69 11.65 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.164 -0.541 . . . . 64.129999999999995 113.339 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 99' ' ' PHE . 53.3 tp -148.77 124.61 10.57 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.858 0.463 . . . . 74.400000000000006 110.573 178.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.514 HD22 HD23 ' A' ' 71' ' ' LEU . 59.0 tp -115.1 132.68 56.52 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.696 0.284 . . . . 64.200000000000003 111.509 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.4 tp -122.4 123.25 40.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.795 0.438 . . . . 64.299999999999997 110.158 174.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 51.1 t -124.4 126.54 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.122 0.416 . . . . 72.0 112.122 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.641 ' HB2' HD21 ' A' ' 135' ' ' LEU . 24.1 tp -103.31 124.93 49.58 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.201 -0.454 . . . . 72.519999999999996 110.774 172.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.33 98.97 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.443 -0.344 . . . . 65.129999999999995 111.513 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.506 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 65.1 tp -55.68 -31.01 62.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.041 0.448 . . . . 70.0 111.561 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.746 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 11.5 t70 -49.97 -47.99 52.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.29 0.636 . . . . 75.400000000000006 111.759 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.494 ' OE1' ' HD2' ' A' ' 96' ' ' ARG . 8.9 pt20 -125.45 6.35 7.64 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.343 0.498 . . . . 72.209999999999994 112.343 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 56.91 30.79 18.58 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.063 0.764 . . . . 74.219999999999999 113.063 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.494 ' HD2' ' OE1' ' A' ' 94' ' ' GLN . 84.5 mtt180 -107.19 149.13 28.05 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.203 0.525 . . . . 75.519999999999996 111.676 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.633 HG13 ' HA ' ' A' ' 90' ' ' LEU . 5.9 m -139.27 160.97 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.675 -0.693 . . . . 64.200000000000003 111.165 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -160.32 145.55 14.86 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.648 0.611 . . . . 74.349999999999994 112.648 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.478 ' HB3' HD12 ' A' ' 86' ' ' LEU . 96.8 m-85 -97.27 146.77 24.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.764 -0.653 . . . . 73.409999999999997 110.323 169.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 5.9 tp10 -135.62 113.0 10.62 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.284 -0.26 . . . . 74.439999999999998 110.632 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 p -95.76 160.88 14.26 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.455 0.909 . . . . 72.409999999999997 113.455 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.42 -177.24 21.33 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 114.964 -1.017 . . . . 72.109999999999999 112.202 168.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' ASN . 19.5 t80 -65.34 -11.13 38.86 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.012 0.525 . . . . 73.120000000000005 112.337 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.67 -6.96 79.44 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.876 -0.678 . . . . 52.420000000000002 113.091 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.406 HD12 HG12 ' A' ' 49' ' ' VAL . 97.5 mt -127.67 -12.48 5.45 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.062 0.764 . . . . 73.109999999999999 113.062 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -17.97 16.7 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.373 0.879 . . . . 75.030000000000001 113.373 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.04 -26.19 69.41 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.148 -0.548 . . . . 54.409999999999997 113.079 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.476 ' OH ' ' HB3' ' A' ' 152' ' ' HIS . 62.9 m-85 -106.38 -44.07 4.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.933 0.397 . . . . 75.540000000000006 111.917 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.5 mt -119.23 84.53 28.12 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 112.59 0.589 . . . . 74.420000000000002 112.59 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.32 162.65 25.27 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.113 1.875 . . . . 72.120000000000005 112.251 171.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.33 -34.9 67.01 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.644 -177.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.75 -50.18 66.37 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.019 -0.61 . . . . 73.239999999999995 113.046 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.68 -45.79 88.66 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.867 0.365 . . . . 64.299999999999997 111.151 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.408 ' O ' HG13 ' A' ' 118' ' ' ILE . 94.5 mt -58.35 -43.63 88.41 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.364 -0.38 . . . . 74.430000000000007 110.935 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.5 m -62.67 -38.5 90.57 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.418 -0.356 . . . . 73.549999999999997 111.037 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -58.04 -53.46 57.95 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.979 0.419 . . . . 72.239999999999995 110.659 174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.2 mt -54.22 -49.48 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.006 0.431 . . . . 73.140000000000001 111.222 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.554 ' O ' HG12 ' A' ' 123' ' ' ILE . 96.9 mt -57.94 -56.81 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.974 -0.557 . . . . 75.150000000000006 111.936 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.406 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 46.2 m-70 -72.69 -40.87 65.89 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.828 0.677 . . . . 74.200000000000003 112.828 -173.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -78.84 -44.51 22.84 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.565 0.58 . . . . 75.129999999999995 112.565 -171.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -109.55 -32.91 6.95 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.199 0.814 . . . . 74.25 113.199 -173.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.548 ' HB3' ' HE2' ' A' ' 126' ' ' PHE . 85.4 mtp -87.94 -51.64 5.71 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.091 0.774 . . . . 73.030000000000001 113.091 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 118' ' ' ILE . 48.1 mm -51.77 -49.24 84.52 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 112.735 0.642 . . . . 73.530000000000001 112.735 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 87.1 Cg_exo -48.27 -28.81 11.83 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 122.665 2.243 . . . . 72.019999999999996 113.694 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.456 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 79.4 m-70 -83.32 -52.16 6.79 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.674 0.25 . . . . 72.299999999999997 111.674 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.548 ' HE2' ' HB3' ' A' ' 122' ' ' MET . 50.1 m-85 -56.83 -44.36 82.0 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.948 0.404 . . . . 73.450000000000003 111.468 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 123' ' ' ILE . 2.9 ptm180 -71.07 -10.26 59.46 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.279 -0.419 . . . . 74.030000000000001 111.64 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.9 m -110.41 -1.96 16.84 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 111.892 0.33 . . . . 74.349999999999994 111.892 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.61 -17.79 35.87 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.963 -0.637 . . . . 65.140000000000001 114.075 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.753 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 93.7 m-20 -80.08 81.32 6.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.322 0.561 . . . . 74.019999999999996 111.571 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -71.11 -54.65 10.33 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.873 0.368 . . . . 74.349999999999994 111.638 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.26 74.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.138 0.494 . . . . 73.010000000000005 111.842 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.753 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 5.5 mm-40 -74.52 -31.6 62.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.375 -0.375 . . . . 63.039999999999999 111.36 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.28 -42.4 57.42 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.029 -0.605 . . . . 75.310000000000002 112.366 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 90' ' ' LEU . 95.4 mt -62.32 -47.63 83.43 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.85 0.357 . . . . 65.400000000000006 111.611 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.3 p -59.28 -37.25 77.21 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.435 -0.348 . . . . 64.519999999999996 111.693 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -59.66 -48.78 80.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.719 0.295 . . . . 71.450000000000003 111.214 172.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.8 -50.48 67.2 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.024 -0.608 . . . . 63.009999999999998 112.941 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.0 t -57.75 -48.47 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.944 0.402 . . . . 74.430000000000007 111.314 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 55.1 tp -60.76 -41.08 94.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.237 -0.438 . . . . 74.120000000000005 111.292 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.39 -49.43 77.6 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.856 0.36 . . . . 72.409999999999997 111.324 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.49 -44.56 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.276 -0.42 . . . . 74.430000000000007 111.254 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -53.22 -41.88 65.79 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.15 -0.477 . . . . 74.319999999999993 111.306 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 85.1 mm-40 -60.26 -48.31 82.3 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.539 -0.3 . . . . 75.0 111.451 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.72 -49.63 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.021 0.378 . . . . 75.439999999999998 112.021 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 89.2 mt -70.36 -57.06 5.25 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.903 0.383 . . . . 73.109999999999999 111.77 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.35 -20.1 63.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.989 0.424 . . . . 72.129999999999995 111.708 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.92 -17.63 71.98 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.108 -0.568 . . . . 63.399999999999999 112.897 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 60.8 m -86.02 -64.83 1.09 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.639 -0.33 . . . . 70.310000000000002 111.718 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.524 HD22 ' HE1' ' A' ' 47' ' ' HIS . 94.2 mt 71.2 -53.78 0.67 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.101 1.149 . . . . 75.230000000000004 114.101 176.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -38.66 -39.37 0.48 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.372 1.249 . . . . 74.140000000000001 114.372 -167.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.476 ' HB3' ' OH ' ' A' ' 108' ' ' TYR . 61.7 t60 -118.94 33.22 5.74 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.736 0.643 . . . . 73.400000000000006 112.736 -166.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.438 ' HD2' ' O ' ' A' ' 150' ' ' LEU . 28.6 p80 -80.4 104.74 11.15 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.327 0.584 . . . . 74.530000000000001 110.977 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -95.62 131.9 41.35 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.083 0.468 . . . . 72.400000000000006 111.592 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -133.69 77.1 1.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.173 0.511 . . . . 72.439999999999998 111.17 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -104.77 -14.61 15.48 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.867 0.365 . . . . 71.239999999999995 110.974 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 119.156 -0.449 . . . . 73.129999999999995 110.711 178.102 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.525 0.202 . . . . 74.439999999999998 111.105 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -129.9 118.34 21.55 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.856 -0.424 . . . . 74.519999999999996 109.856 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.4 135.96 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.896 0.702 . . . . 71.519999999999996 112.896 -172.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.05 152.3 45.99 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.776 -0.647 . . . . 73.409999999999997 111.201 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -114.53 169.22 6.86 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 75.140000000000001 110.569 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.36 51.28 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.873 2.382 . . . . 74.120000000000005 112.117 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.36 -28.09 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.916 -0.583 . . . . 72.430000000000007 110.457 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -68.26 -28.76 67.49 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.289 0.566 . . . . 65.200000000000003 110.465 171.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.643 HG12 HG23 ' A' ' 22' ' ' THR . 60.7 t -70.46 122.27 85.97 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.481 -0.781 . . . . 74.409999999999997 111.525 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.419 ' HG2' HG21 ' A' ' 22' ' ' THR . 21.9 Cg_endo -61.1 119.86 7.24 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.323 2.015 . . . . 74.230000000000004 112.049 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . 5.6 p30 -64.23 85.89 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.954 0.724 . . . . 73.239999999999995 112.954 -176.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.32 0.48 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 112.505 0.557 . . . . 72.439999999999998 112.505 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -121.87 5.51 9.92 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.087 0.403 . . . . 72.219999999999999 112.087 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 6.8 tt -115.14 -54.73 2.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.427 -0.583 . . . . 74.239999999999995 109.427 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.72 -55.28 35.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.124 0.488 . . . . 72.340000000000003 110.839 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -127.46 -179.57 4.97 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.093 -0.503 . . . . 75.450000000000003 110.768 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.6 p -130.27 -11.53 4.11 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.644 -0.253 . . . . 73.5 111.615 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -81.0 -45.64 16.28 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.932 0.716 . . . . 72.530000000000001 112.932 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.627 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 32.5 tpt180 -52.67 -61.91 1.98 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.203 0.445 . . . . 73.209999999999994 112.203 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 40' ' ' LEU . 17.5 mt 63.19 6.99 2.57 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.218 0.451 . . . . 70.140000000000001 112.218 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.627 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 95.4 t -133.64 121.42 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.842 0.353 . . . . 73.420000000000002 111.774 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.643 HG23 HG12 ' A' ' 9' ' ' VAL . 89.0 m -111.88 102.8 11.04 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.77 0.319 . . . . 75.299999999999997 110.807 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' ' HG1' ' A' ' 55' ' ' THR . 7.6 p-10 -99.72 84.34 2.91 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.454 0.645 . . . . 74.530000000000001 111.936 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.57 ' HG2' HG22 ' A' ' 22' ' ' THR . 40.2 mm-40 -96.32 -44.83 7.06 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.115 -0.493 . . . . 73.420000000000002 110.786 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.64 -25.36 60.04 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.147 0.425 . . . . 62.439999999999998 112.147 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.99 44.59 45.37 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.376 -0.44 . . . . 54.210000000000001 113.14 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 92' ' ' LEU . 85.3 mt -102.27 -22.29 14.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.916 0.388 . . . . 72.129999999999995 111.884 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.4 mt -93.32 108.47 20.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.717 0.294 . . . . 74.340000000000003 111.12 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.512 ' HB2' ' OE1' ' A' ' 32' ' ' GLN . 49.1 m -78.52 162.08 26.58 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.534 -0.303 . . . . 71.510000000000005 111.117 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -44.98 -45.53 10.62 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.176 0.806 . . . . 75.140000000000001 113.176 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.88 -53.28 53.08 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.8 0.333 . . . . 74.019999999999996 111.708 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.534 ' HG2' ' HB1' ' A' ' 132' ' ' ALA . 22.6 mp0 -55.9 -40.63 73.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.065 0.46 . . . . 72.299999999999997 110.69 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.82 -52.8 63.89 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.095 -0.502 . . . . 75.109999999999999 111.02 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -55.12 -40.62 70.7 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.94 0.4 . . . . 71.230000000000004 111.608 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.05 -44.65 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.072 0.463 . . . . 75.319999999999993 111.715 177.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 52.1 ttm -70.35 -51.82 27.16 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.871 0.323 . . . . 71.230000000000004 111.871 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -54.48 -50.35 67.95 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.389 -0.369 . . . . 61.399999999999999 111.709 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.7 -38.06 86.34 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.001 -0.618 . . . . 71.439999999999998 113.59 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' ILE . 81.7 mtm180 -72.01 -49.52 36.25 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.95 0.375 . . . . 71.439999999999998 111.375 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' HB3' HD11 ' A' ' 20' ' ' LEU . 87.9 mt -57.14 -52.66 64.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.021 0.438 . . . . 75.25 111.049 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -54.64 -41.64 70.3 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.055 -0.521 . . . . 75.040000000000006 111.375 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.15 97.8 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.933 0.397 . . . . 70.340000000000003 111.389 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.478 ' HA ' ' HD2' ' A' ' 47' ' ' HIS . 74.0 mt -64.91 -42.79 95.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.978 0.418 . . . . 73.25 111.083 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.49 ' NH1' ' HG2' ' A' ' 50' ' ' GLU . 8.4 tpt180 -61.46 -38.69 88.14 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.159 -0.473 . . . . 71.530000000000001 111.518 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.3 t -83.36 -41.96 17.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.238 0.459 . . . . 74.0 112.238 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -82.3 -62.49 1.61 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.124 0.488 . . . . 74.019999999999996 112.042 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.484 ' ND1' HD23 ' A' ' 150' ' ' LEU . 51.7 m-70 -83.06 -14.3 54.08 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.093 -0.503 . . . . 64.150000000000006 111.655 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.11 17.21 10.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.827 0.451 . . . . 72.340000000000003 111.846 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.654 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 96.8 t -87.28 129.89 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.147 0.498 . . . . 75.299999999999997 111.339 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HG2' ' NH1' ' A' ' 44' ' ' ARG . 27.3 mt-10 -83.3 96.41 8.49 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.095 -0.502 . . . . 71.239999999999995 110.654 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -119.27 101.63 8.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.174 -0.466 . . . . 70.510000000000005 110.505 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.4 133.99 54.88 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.319 0.488 . . . . 63.219999999999999 112.319 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.16 112.73 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.078 0.466 . . . . 75.310000000000002 111.313 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.657 ' HB ' HG22 ' A' ' 89' ' ' VAL . 57.4 t -109.11 134.14 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.374 -0.375 . . . . 73.150000000000006 111.107 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.533 ' HG1' ' HA ' ' A' ' 23' ' ' ASP . 69.1 p -119.81 122.2 40.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.879 0.371 . . . . 63.009999999999998 111.472 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.535 HD21 HG23 ' A' ' 9' ' ' VAL . 77.9 mt -128.32 140.61 38.84 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.402 -0.363 . . . . 73.329999999999998 111.013 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 19.7 Cg_endo -61.29 -47.02 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.982 1.788 . . . . 75.400000000000006 112.078 175.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.406 ' HA ' HG11 ' A' ' 91' ' ' VAL . 43.8 t -157.72 145.63 18.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.94 0.4 . . . . 61.039999999999999 111.525 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 pt -101.66 9.08 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.196 0.522 . . . . 71.109999999999999 111.202 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.73 -133.95 18.16 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.154 -0.546 . . . . 72.0 113.305 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.43 -19.39 28.12 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.938 0.348 . . . . 75.150000000000006 111.938 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.58 143.99 89.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.555 0.576 . . . . 72.219999999999999 112.555 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.2 Cg_endo -75.77 127.7 10.35 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.565 2.177 . . . . 75.219999999999999 112.131 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.07 -32.61 72.25 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.341 0.497 . . . . 72.530000000000001 112.341 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.731 ' HG2' ' HD3' ' A' ' 98' ' ' ARG . 44.2 mt-10 -62.56 -43.2 99.4 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.176 0.513 . . . . 74.299999999999997 111.702 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.567 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 2.2 m-20 -76.96 -33.08 57.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.979 -0.555 . . . . 74.319999999999993 110.903 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -59.12 -52.7 64.6 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.052 -0.522 . . . . 65.230000000000004 110.941 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.8 p -59.32 -41.78 89.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.307 -0.406 . . . . 74.129999999999995 111.728 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 48.5 tp -57.16 -49.17 76.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.958 0.408 . . . . 64.450000000000003 111.217 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -62.33 -47.07 85.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.93 0.395 . . . . 72.109999999999999 111.51 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.05 -36.97 83.21 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.102 0.477 . . . . 74.099999999999994 111.429 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.51 -38.59 71.12 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.265 0.468 . . . . 73.409999999999997 112.265 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 25.9 mtp180 -61.79 -47.99 82.68 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.41 0.522 . . . . 70.25 112.41 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.5 pt20 -59.44 -38.1 79.81 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.885 0.374 . . . . 74.010000000000005 111.842 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.42 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 50.0 m0 -78.11 -4.61 48.27 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 111.817 0.303 . . . . 74.510000000000005 111.817 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.41 -35.05 3.02 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.045 -0.598 . . . . 73.200000000000003 112.578 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.592 ' HA ' HD21 ' A' ' 82' ' ' ASN . 46.9 t -49.3 -28.06 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.382 0.673 . . . . 75.219999999999999 112.751 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -127.21 24.05 5.4 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.847 -0.692 . . . . 63.119999999999997 113.668 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -63.18 90.17 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 117.18 0.49 . . . . 72.150000000000006 111.046 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 51.97 56.2 8.14 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.511 0.672 . . . . 74.230000000000004 110.846 -173.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 62.92 64.55 0.87 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.562 -0.744 . . . . 73.310000000000002 112.021 177.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.652 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 14.7 t30 -63.54 139.49 58.77 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.698 -0.683 . . . . 71.200000000000003 110.933 175.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.653 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -43.26 -72.42 0.06 Allowed 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 114.407 1.262 . . . . 75.349999999999994 114.407 -168.403 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.654 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 5.1 m-20 -87.98 21.79 2.59 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.508 -0.745 . . . . 73.420000000000002 112.286 -173.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 77' ' ' VAL . . . -81.51 128.22 8.34 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.02 -0.609 . . . . 63.32 114.468 -175.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 54.5 tp -145.12 118.81 9.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.785 0.434 . . . . 71.129999999999995 110.56 173.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.2 tp -116.1 126.82 54.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.88 0.372 . . . . 74.549999999999997 111.664 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 33.1 tp -116.07 111.86 20.91 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.03 -0.532 . . . . 72.239999999999995 110.813 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.657 HG22 ' HB ' ' A' ' 54' ' ' VAL . 70.4 t -118.23 130.07 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.714 0.293 . . . . 71.140000000000001 111.553 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.4 tp -109.72 125.88 53.12 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.96 0.41 . . . . 62.299999999999997 111.508 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 58' ' ' SER . 47.8 t -99.93 105.61 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.113 -0.494 . . . . 72.25 110.294 173.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.46 ' HB2' HD13 ' A' ' 27' ' ' LEU . 51.6 tp -57.09 -62.84 1.47 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.147 0.795 . . . . 74.409999999999997 113.147 -174.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.37 -27.16 68.87 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.283 0.475 . . . . 75.109999999999999 112.283 -171.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -97.14 -10.94 24.97 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.705 0.288 . . . . 73.510000000000005 111.343 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 50.97 67.39 0.95 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.562 0.696 . . . . 74.519999999999996 112.322 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -159.98 150.87 19.12 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.912 -0.586 . . . . 72.420000000000002 111.095 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.2 m -129.66 171.56 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.986 0.422 . . . . 75.140000000000001 111.759 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.731 ' HD3' ' HG2' ' A' ' 65' ' ' GLU . 6.0 mmm180 -141.11 153.5 45.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.327 0.584 . . . . 72.409999999999997 112.288 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.695 ' HB3' HD12 ' A' ' 114' ' ' LEU . 30.5 m-85 -129.86 111.49 12.63 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.265 -0.88 . . . . 72.239999999999995 110.129 175.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.7 tp10 -105.05 112.37 25.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.809 -0.178 . . . . 74.219999999999999 110.779 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 p -96.46 147.33 23.94 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.759 0.79 . . . . 73.319999999999993 112.874 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -95.41 174.13 31.93 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.178 -0.919 . . . . 65.519999999999996 112.696 171.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -56.02 -22.31 26.45 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.961 0.726 . . . . 75.420000000000002 112.961 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.68 -41.03 11.43 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.898 -0.668 . . . . 62.329999999999998 112.464 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.433 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 85.5 mt -81.1 -6.88 59.33 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.72 0.637 . . . . 72.329999999999998 112.72 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -59.57 -12.59 6.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.521 0.563 . . . . 72.109999999999999 112.521 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.96 -12.99 62.99 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.168 -0.539 . . . . 73.219999999999999 113.326 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.544 ' OH ' ' HB2' ' A' ' 152' ' ' HIS . 82.0 m-85 -117.32 -47.47 2.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.08 0.467 . . . . 72.549999999999997 111.947 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.59 93.04 48.77 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 115.886 -0.597 . . . . 73.150000000000006 112.435 -168.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.62 160.51 31.48 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.293 1.995 . . . . 74.099999999999994 111.968 170.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -55.31 -36.55 66.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.679 0.276 . . . . 72.230000000000004 111.721 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.73 -49.12 82.13 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.258 -0.496 . . . . 65.519999999999996 113.21 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 tp -60.12 -44.05 95.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.012 0.434 . . . . 75.230000000000004 111.272 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 99' ' ' PHE . 84.1 mt -62.31 -43.88 97.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.064 0.459 . . . . 74.129999999999995 110.969 177.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.4 t -64.42 -33.86 76.85 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.061 -0.518 . . . . 70.230000000000004 111.045 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -59.12 -52.3 66.33 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.004 -0.544 . . . . 74.549999999999997 110.385 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.23 -46.28 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.237 0.541 . . . . 75.439999999999998 110.937 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.429 HD11 ' HD2' ' A' ' 99' ' ' PHE . 72.4 mt -56.56 -56.01 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.584 -0.734 . . . . 64.349999999999994 111.79 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -81.38 -18.18 46.44 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.914 0.709 . . . . 73.510000000000005 112.914 -171.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -79.95 -58.59 3.09 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.683 0.278 . . . . 75.010000000000005 111.59 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -114.26 -34.64 5.25 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.201 0.815 . . . . 74.129999999999995 113.201 -174.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 118' ' ' ILE . 85.8 mtp -68.59 -47.5 66.6 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.327 0.491 . . . . 75.439999999999998 112.327 -174.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 26.3 mm -55.63 -55.26 42.4 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 112.983 0.735 . . . . 74.439999999999998 112.983 -178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 11.6 Cg_endo -54.78 -42.61 67.02 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.928 1.752 . . . . 74.349999999999994 112.536 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -60.88 -48.13 83.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.57 0.224 . . . . 73.109999999999999 111.412 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.521 ' HD1' ' HA ' ' A' ' 131' ' ' TYR . 22.9 m-30 -56.39 -47.49 78.84 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.879 0.371 . . . . 64.340000000000003 111.288 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -64.88 -33.14 75.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.907 0.384 . . . . 75.420000000000002 111.197 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.7 m -82.15 -1.15 47.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.498 -0.319 . . . . 54.109999999999999 111.773 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.69 -16.6 60.18 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.151 -0.547 . . . . 72.239999999999995 113.595 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.851 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 92.7 m-20 -80.05 65.24 5.14 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.234 0.517 . . . . 75.319999999999993 111.995 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.521 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 96.5 m-85 -64.05 -32.46 74.03 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.858 0.361 . . . . 73.200000000000003 111.154 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.534 ' HB1' ' HG2' ' A' ' 32' ' ' GLN . . . -71.02 -50.84 29.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.986 0.422 . . . . 74.219999999999999 111.417 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.851 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 5.8 mp0 -57.16 -42.44 81.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.144 -0.48 . . . . 74.209999999999994 111.606 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.0 -52.08 54.47 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.421 -0.419 . . . . 72.549999999999997 113.037 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.04 -39.95 96.26 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.915 0.388 . . . . 65.109999999999999 111.516 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.8 t -60.93 -43.88 98.01 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.159 0.429 . . . . 75.230000000000004 112.159 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -75.26 -28.78 59.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.485 0.179 . . . . 73.439999999999998 111.485 177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.01 -49.08 82.43 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.69 -0.767 . . . . 71.450000000000003 111.965 172.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.87 -49.13 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.068 0.461 . . . . 75.030000000000001 111.203 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 52.7 tp -58.44 -40.49 82.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.983 -0.553 . . . . 75.209999999999994 111.494 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -59.31 -46.79 87.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.859 0.361 . . . . 72.310000000000002 111.446 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.24 -47.17 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.052 0.453 . . . . 61.340000000000003 111.168 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -51.79 -45.76 63.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.177 -0.465 . . . . 73.310000000000002 111.677 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 84.5 mm-40 -59.34 -42.04 90.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.935 0.398 . . . . 73.329999999999998 111.464 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 141' ' ' ALA . 85.5 t -60.73 -50.78 79.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 120.856 0.36 . . . . 73.200000000000003 111.17 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.64 -56.49 20.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.876 0.325 . . . . 74.239999999999995 111.876 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -58.83 -33.96 71.0 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.096 0.406 . . . . 73.530000000000001 112.096 -175.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.9 -4.33 82.31 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.12 -0.562 . . . . 70.230000000000004 113.699 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.6 m -121.11 24.61 10.03 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.305 0.552 . . . . 75.519999999999996 111.962 -178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.484 HD23 ' ND1' ' A' ' 47' ' ' HIS . 93.8 mt -74.05 43.91 0.17 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.746 0.647 . . . . 72.409999999999997 112.746 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -113.13 -0.8 14.56 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.297 0.57 . . . . 71.549999999999997 111.021 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.544 ' HB2' ' OH ' ' A' ' 108' ' ' TYR . 84.5 m-70 -111.21 124.38 52.09 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.093 -0.503 . . . . 74.340000000000003 111.204 -177.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -147.35 113.89 5.99 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.083 0.468 . . . . 75.019999999999996 110.667 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -69.69 -17.68 63.5 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.018 0.437 . . . . 75.129999999999995 111.03 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -127.12 168.4 14.7 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.25 -0.432 . . . . 75.519999999999996 110.633 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -92.57 -60.42 1.83 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.166 0.508 . . . . 75.450000000000003 109.974 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 65.1 m80 . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.397 -0.811 . . . . 73.549999999999997 110.601 174.873 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.665 ' HE2' ' HB3' ' A' ' 58' ' ' SER . 19.6 ttt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.678 0.275 . . . . 74.530000000000001 110.842 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -107.95 136.1 48.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.829 0.347 . . . . 74.099999999999994 111.765 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.4 t -71.82 91.2 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.263 0.554 . . . . 74.200000000000003 110.449 170.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -75.37 148.29 39.35 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.481 0.658 . . . . 73.340000000000003 112.521 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.497 ' HG2' ' HD2' ' A' ' 6' ' ' PRO . 6.9 tttp -130.74 157.97 76.23 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 115.365 -0.834 . . . . 75.439999999999998 109.754 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.497 ' HD2' ' HG2' ' A' ' 5' ' ' LYS . 77.8 Cg_exo -52.14 -26.06 25.07 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.431 2.088 . . . . 71.319999999999993 113.373 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -88.48 -16.47 32.66 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.08 0.4 . . . . 72.420000000000002 112.08 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -94.23 -24.85 17.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.901 0.381 . . . . 70.450000000000003 111.148 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.4 t -61.79 129.9 91.95 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.268 -0.424 . . . . 75.129999999999995 111.764 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.44 114.56 1.81 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.618 2.212 . . . . 63.100000000000001 112.851 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -71.19 77.07 0.71 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.878 0.37 . . . . 72.299999999999997 111.399 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.7 m -62.87 -44.64 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 122.267 -0.271 . . . . 64.109999999999999 111.471 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -64.4 -14.88 59.05 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.054 0.454 . . . . 73.219999999999999 111.884 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.54 -49.66 7.04 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.998 0.428 . . . . 73.299999999999997 110.004 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.12 -74.9 0.49 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.208 0.447 . . . . 73.530000000000001 112.208 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -109.18 81.49 1.45 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.501 0.667 . . . . 61.229999999999997 111.223 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.47 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 60.6 p -72.99 -29.85 63.36 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.915 -0.584 . . . . 71.340000000000003 112.101 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.5 m -65.25 -15.55 62.61 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.939 0.4 . . . . 75.120000000000005 111.832 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.419 ' C ' ' H ' ' A' ' 21' ' ' VAL . 26.3 ttt85 -75.56 -55.45 5.66 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.616 -0.265 . . . . 75.209999999999994 110.93 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 17' ' ' SER . 1.3 mt 72.46 -26.7 0.18 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.639 0.776 . . . . 72.140000000000001 112.635 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.419 ' H ' ' C ' ' A' ' 19' ' ' ARG . 61.6 t -86.63 141.01 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 122.895 0.478 . . . . 74.420000000000002 111.19 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 m -147.13 104.85 3.71 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.594 0.235 . . . . 73.209999999999994 111.307 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.424 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 33.6 t70 -106.99 109.77 21.74 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.165 0.507 . . . . 74.319999999999993 111.827 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -109.31 -39.51 5.2 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.042 0.449 . . . . 73.310000000000002 110.602 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.81 -23.28 17.45 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.868 0.692 . . . . 73.420000000000002 112.868 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.05 45.3 7.66 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.849 -0.691 . . . . 72.019999999999996 112.703 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 131' ' ' TYR . 69.6 mt -117.72 -42.21 2.87 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.966 0.412 . . . . 75.430000000000007 111.558 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.03 104.6 14.22 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.834 0.349 . . . . 74.25 111.43 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 t -74.02 165.07 25.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.693 -0.23 . . . . 72.400000000000006 111.07 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -50.5 -55.77 14.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.017 0.747 . . . . 75.109999999999999 113.017 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . . . -59.0 -31.49 68.85 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.868 0.366 . . . . 54.140000000000001 111.916 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -73.84 -33.52 64.15 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.048 0.451 . . . . 74.099999999999994 110.649 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -69.29 -41.72 76.43 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.32 -0.4 . . . . 71.540000000000006 111.339 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 11.4 pt-20 -64.64 -38.96 92.8 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 111.996 0.369 . . . . 71.049999999999997 111.996 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.59 -49.16 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.267 0.556 . . . . 72.340000000000003 110.728 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.0 ttm -68.44 -29.34 67.97 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.068 -0.514 . . . . 73.420000000000002 110.916 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -65.13 -56.08 14.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.043 -0.526 . . . . 75.120000000000005 110.778 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.57 92.3 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.912 -0.661 . . . . 62.109999999999999 112.25 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.495 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.4 tpp180 -56.76 -54.48 45.83 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.184 0.594 . . . . 73.420000000000002 111.169 176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.57 -46.13 67.08 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.184 0.438 . . . . 70.239999999999995 112.184 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -58.57 -39.11 79.38 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.002 0.43 . . . . 74.150000000000006 110.926 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.71 81.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.193 -0.458 . . . . 61.130000000000003 111.077 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.567 ' HA ' ' HD2' ' A' ' 47' ' ' HIS . 66.2 mt -65.09 -45.59 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.657 0.265 . . . . 75.209999999999994 111.654 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 50.0 ttp180 -68.35 -26.65 65.7 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.095 -0.378 . . . . 75.319999999999993 111.838 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 t -89.15 -52.56 5.0 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.137 0.494 . . . . 74.329999999999998 111.155 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.1 m -72.22 -43.8 63.89 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.516 0.562 . . . . 74.219999999999999 112.516 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.567 ' HD2' ' HA ' ' A' ' 43' ' ' ILE . 75.3 m-70 -105.41 -15.91 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.343 0.497 . . . . 74.409999999999997 112.343 -175.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 68.02 20.69 9.03 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.128 0.49 . . . . 74.319999999999993 111.932 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.497 ' HB ' HG21 ' A' ' 43' ' ' ILE . 81.5 t -96.26 124.71 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.916 0.389 . . . . 74.409999999999997 111.239 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.47 97.31 9.96 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.437 0.637 . . . . 70.200000000000003 110.886 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.31 107.62 16.95 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.352 -0.84 . . . . 75.400000000000006 110.564 -176.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.76 145.17 38.56 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.057 0.391 . . . . 75.109999999999999 112.057 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.41 120.92 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.96 0.41 . . . . 74.200000000000003 111.381 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.39 128.94 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.299 -0.41 . . . . 71.109999999999999 111.614 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 22.3 p -110.79 123.72 50.62 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.922 0.391 . . . . 73.329999999999998 111.102 177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.8 mt -122.15 140.52 32.53 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 120.741 0.305 . . . . 62.520000000000003 111.275 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.15 -48.95 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.296 1.997 . . . . 72.200000000000003 112.65 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.665 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 77.7 p -150.88 144.91 25.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.699 0.285 . . . . 72.140000000000001 111.623 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.7 pt -120.78 11.0 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.115 0.483 . . . . 73.140000000000001 111.044 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.28 -124.03 24.4 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.272 -0.49 . . . . 54.399999999999999 113.142 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.15 16.27 24.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.884 0.373 . . . . 71.430000000000007 111.417 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . . . -77.36 138.41 63.87 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 112.031 0.382 . . . . 62.229999999999997 112.031 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 62' ' ' ALA . 4.6 Cg_exo -77.0 121.44 5.82 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.728 2.285 . . . . 65.209999999999994 111.808 175.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.6 tp -55.74 -39.3 70.96 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.914 0.387 . . . . 73.099999999999994 111.364 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.29 -45.43 84.13 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.12 -0.491 . . . . 73.510000000000005 112.037 175.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.63 -17.56 50.88 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.418 0.628 . . . . 73.329999999999998 110.871 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -76.78 -56.15 4.86 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.794 -0.639 . . . . 74.430000000000007 111.279 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.7 p -53.22 -52.53 58.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.573 0.583 . . . . 74.540000000000006 112.573 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.507 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 42.1 tp -53.31 -54.52 35.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.213 -0.449 . . . . 71.530000000000001 111.872 -177.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -61.77 -40.19 94.28 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.443 0.535 . . . . 74.209999999999994 112.443 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD23 HD22 ' A' ' 87' ' ' LEU . 63.0 tp -62.31 -45.46 93.13 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.326 0.584 . . . . 75.140000000000001 110.715 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.404 ' HB1' ' CA ' ' A' ' 78' ' ' GLY . . . -70.79 -30.21 66.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.061 -0.518 . . . . 65.140000000000001 112.113 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 75.8 mtp180 -64.59 -49.14 72.31 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.748 0.277 . . . . 74.099999999999994 111.748 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.79 -32.88 74.67 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.723 0.297 . . . . 74.319999999999993 111.439 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -74.23 -15.43 60.99 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.956 0.408 . . . . 75.409999999999997 110.986 173.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.56 27.15 72.99 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.374 -0.441 . . . . 74.409999999999997 113.359 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.451 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 22.4 t -116.4 -83.05 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.131 0.419 . . . . 70.319999999999993 112.131 -176.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' CA ' ' HB1' ' A' ' 72' ' ' ALA . . . -77.86 40.64 1.87 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.966 -0.635 . . . . 74.319999999999993 113.565 -176.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 44.4 t-20 -78.78 133.22 37.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.138 -0.69 . . . . 73.109999999999999 109.138 175.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -49.76 -31.49 11.64 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.714 0.635 . . . . 71.530000000000001 112.714 -175.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -103.0 1.32 33.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.416 0.524 . . . . 74.420000000000002 112.416 -178.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.628 ' HB2' ' HB3' ' A' ' 79' ' ' ASN . 66.3 t30 -85.23 172.74 10.93 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.136 0.493 . . . . 53.350000000000001 110.74 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.34 148.3 32.23 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.448 0.536 . . . . 74.030000000000001 112.448 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.473 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 3.6 m-20 58.04 19.35 5.89 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.058 0.762 . . . . 74.340000000000003 113.058 174.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 77' ' ' VAL . . . -106.27 132.09 10.96 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.801 -0.714 . . . . 71.230000000000004 113.487 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.632 HD12 HG21 ' A' ' 101' ' ' THR . 46.4 tp -147.17 126.89 13.4 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.023 0.44 . . . . 75.129999999999995 111.202 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.451 HD22 HD23 ' A' ' 71' ' ' LEU . 64.1 tp -120.22 134.24 55.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.822 0.344 . . . . 72.239999999999995 111.418 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.6 tp -119.41 111.79 18.6 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.175 -0.466 . . . . 65.0 110.75 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.96 130.47 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.799 0.333 . . . . 65.420000000000002 111.611 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.499 ' HB2' HD23 ' A' ' 135' ' ' LEU . 28.4 tp -110.04 124.42 51.43 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.183 -0.462 . . . . 73.219999999999999 111.096 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -105.07 105.81 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.746 0.307 . . . . 72.329999999999998 110.786 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 tp -57.78 -40.29 79.51 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.028 0.381 . . . . 75.340000000000003 112.028 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.2 -32.12 71.88 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.255 0.465 . . . . 74.430000000000007 112.255 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -105.29 -7.94 18.59 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 122.157 -0.339 . . . . 73.120000000000005 111.735 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 95' ' ' ARG . 48.8 mtm180 55.0 33.23 19.8 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.168 0.587 . . . . 75.219999999999999 112.531 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -137.54 161.64 35.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.853 0.359 . . . . 74.25 111.455 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.7 171.93 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.225 -0.443 . . . . 72.040000000000006 111.307 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -152.13 133.94 14.82 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.979 0.418 . . . . 70.140000000000001 111.894 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.512 ' HB3' HD11 ' A' ' 86' ' ' LEU . 97.4 m-85 -95.01 122.3 37.53 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.911 -0.586 . . . . 63.450000000000003 110.179 171.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -107.4 112.33 25.08 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.998 -0.371 . . . . 72.120000000000005 109.998 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.632 HG21 HD12 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -98.95 148.06 24.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.622 0.725 . . . . 64.230000000000004 112.696 -177.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -93.07 172.74 33.93 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.163 -0.926 . . . . 73.420000000000002 112.531 170.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' ASN . 55.3 t80 -54.61 -31.29 56.81 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.069 0.548 . . . . 74.540000000000006 111.925 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.473 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -67.74 -19.23 71.12 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 116.08 -0.509 . . . . 75.129999999999995 113.312 -177.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.446 HD13 HG11 ' A' ' 49' ' ' VAL . 91.3 mt -117.58 -5.49 11.18 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.94 0.348 . . . . 74.040000000000006 111.94 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -49.79 -44.05 48.75 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.858 0.463 . . . . 73.439999999999998 111.836 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.34 -25.41 75.49 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 114.468 0.547 . . . . 73.209999999999994 114.468 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.422 ' OH ' ' HA ' ' A' ' 152' ' ' HIS . 8.6 m-85 -97.96 -35.43 10.47 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.324 0.583 . . . . 75.219999999999999 110.88 -177.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.522 ' HB3' HD22 ' A' ' 114' ' ' LEU . 53.2 mt -126.57 73.45 74.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.366 -0.834 . . . . 73.150000000000006 110.701 -177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.04 156.17 52.12 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.075 1.85 . . . . 70.109999999999999 112.447 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -46.81 -45.88 20.37 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 112.672 0.619 . . . . 75.409999999999997 112.672 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.34 -39.08 96.75 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.399 -0.429 . . . . 74.340000000000003 113.537 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.5 tp -67.32 -47.21 71.23 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 122.511 -0.405 . . . . 73.439999999999998 111.138 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 109' ' ' LEU . 89.4 mt -58.0 -43.9 86.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.152 -0.476 . . . . 75.340000000000003 110.823 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 t -60.35 -41.57 93.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.972 -0.558 . . . . 74.409999999999997 110.981 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 43.3 ttm105 -57.93 -53.87 53.31 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.176 -0.466 . . . . 74.230000000000004 111.52 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.0 mt -51.99 -47.4 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.957 0.408 . . . . 71.310000000000002 111.215 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 114' ' ' LEU . 80.4 mt -55.72 -50.56 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.07 -0.513 . . . . 73.329999999999998 111.39 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.442 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 3.6 t-80 -80.39 -19.28 46.65 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.843 0.683 . . . . 74.140000000000001 112.843 -171.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -102.48 -46.74 4.68 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.488 0.922 . . . . 63.43 113.488 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.405 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 66.6 mtp180 -106.75 4.26 27.46 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.037 0.754 . . . . 75.209999999999994 113.037 -175.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 60.4 mtp -125.33 -51.9 1.63 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.61 0.596 . . . . 73.519999999999996 112.61 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.513 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 22.5 mm -51.77 -49.58 82.57 Favored Pre-proline 0 N--CA 1.48 1.029 0 N-CA-C 113.252 0.834 . . . . 65.120000000000005 113.252 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 14.7 Cg_endo -55.05 -29.51 65.59 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 122.143 1.896 . . . . 74.109999999999999 112.634 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.3 -50.61 15.49 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.518 -0.31 . . . . 73.510000000000005 110.769 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.449 ' HD1' ' HA ' ' A' ' 131' ' ' TYR . 21.8 m-85 -57.53 -42.3 82.6 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.711 0.291 . . . . 75.120000000000005 111.6 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -62.19 -35.54 79.18 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.966 0.412 . . . . 73.420000000000002 111.16 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.5 m -83.07 -1.9 53.96 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 111.921 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.58 -4.77 79.87 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.315 -0.469 . . . . 75.319999999999993 113.203 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.581 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.5 m-20 -81.36 67.52 7.33 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.526 -0.397 . . . . 72.5 111.418 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.449 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 97.6 m-85 -61.68 -47.83 83.55 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.009 0.433 . . . . 75.209999999999994 111.875 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.9 87.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.94 0.4 . . . . 74.349999999999994 111.791 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.581 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 19.7 mm-40 -67.15 -39.7 86.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.437 -0.347 . . . . 74.430000000000007 111.444 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.41 -44.64 95.15 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.898 -0.668 . . . . 55.450000000000003 112.611 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 90' ' ' LEU . 95.4 mt -60.96 -45.04 96.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.698 0.285 . . . . 75.519999999999996 111.27 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.0 m -55.38 -49.29 72.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.469 -0.332 . . . . 73.150000000000006 111.789 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 44.3 mm-40 -65.68 -40.99 92.94 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.969 0.359 . . . . 75.209999999999994 111.969 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.76 -50.91 62.55 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 120.934 -0.651 . . . . 72.530000000000001 112.733 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.21 -50.63 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.967 0.413 . . . . 73.120000000000005 111.552 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.449 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 58.5 tp -57.5 -45.58 84.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.163 -0.471 . . . . 74.019999999999996 111.17 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -57.6 -48.18 80.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.96 0.41 . . . . 72.129999999999995 111.628 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.16 -52.38 59.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.222 -0.444 . . . . 71.400000000000006 111.638 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -53.81 -42.09 68.03 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.807 0.337 . . . . 65.129999999999995 111.392 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 98.6 mt-30 -58.72 -46.69 86.77 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.392 -0.367 . . . . 71.430000000000007 111.178 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 141' ' ' ALA . 62.9 t -57.81 -50.11 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.83 0.348 . . . . 73.510000000000005 111.134 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.33 -48.27 79.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.431 -0.35 . . . . 73.430000000000007 111.72 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.47 -34.12 68.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.002 0.429 . . . . 44.450000000000003 111.386 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -94.39 5.65 71.0 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.224 -0.513 . . . . 52.450000000000003 113.188 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.3 m -126.36 22.55 7.09 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 122.63 -0.335 . . . . 64.420000000000002 111.814 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.532 HD23 ' ND1' ' A' ' 47' ' ' HIS . 77.5 mt -74.29 12.99 0.63 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.468 0.544 . . . . 75.129999999999995 112.468 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -61.23 -49.45 77.07 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.631 -0.258 . . . . 74.019999999999996 111.036 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.422 ' HA ' ' OH ' ' A' ' 108' ' ' TYR . 71.6 t60 52.56 32.59 11.88 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.286 0.565 . . . . 75.219999999999999 111.749 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -76.77 -5.43 48.13 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.916 0.388 . . . . 75.040000000000006 111.96 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -94.55 121.16 35.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.853 0.359 . . . . 70.519999999999996 111.422 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -141.05 130.87 24.31 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.151 -0.477 . . . . 74.25 111.139 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -99.5 136.6 39.19 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.423 0.527 . . . . 72.439999999999998 112.423 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 81.2 t60 . . . . . 0 C--O 1.252 1.233 0 CA-C-N 115.753 -0.658 . . . . 73.540000000000006 110.946 174.65 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.672 0.272 . . . . 74.0 111.225 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -102.76 123.34 46.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.818 0.342 . . . . 74.409999999999997 111.305 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.7 t -81.41 114.27 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.173 0.511 . . . . 73.310000000000002 112.298 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -97.93 129.27 44.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.084 -0.507 . . . . 73.230000000000004 111.257 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 68.1 mttm -105.86 164.18 15.53 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.861 -0.609 . . . . 72.049999999999997 110.29 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 31.9 Cg_endo -62.19 -15.0 41.43 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.965 1.777 . . . . 61.520000000000003 112.349 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -94.46 -0.83 54.43 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.182 -0.463 . . . . 71.239999999999995 111.737 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -97.67 -34.5 10.91 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.017 0.436 . . . . 71.140000000000001 110.873 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.69 122.11 65.98 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 115.964 -0.562 . . . . 70.049999999999997 111.601 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.62 126.93 19.38 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.728 2.285 . . . . 74.420000000000002 112.863 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -75.34 83.47 2.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.486 0.66 . . . . 74.230000000000004 111.492 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.57 -26.61 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.902 0.704 . . . . 73.239999999999995 112.902 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -61.0 -15.72 35.02 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.249 0.463 . . . . 75.409999999999997 112.249 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -75.72 -51.45 12.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.992 0.425 . . . . 72.5 110.338 176.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.65 -69.28 0.78 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.012 0.434 . . . . 63.310000000000002 111.561 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' A' ' 19' ' ' ARG . 3.2 m-20 -80.9 57.07 2.93 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.339 0.59 . . . . 75.319999999999993 112.021 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.3 p -65.47 -17.25 64.41 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.163 -0.471 . . . . 75.519999999999996 110.99 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 77.7 p -95.02 3.63 54.68 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.2 -0.455 . . . . 70.230000000000004 111.976 176.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 16' ' ' ASP . 13.2 ttm180 -105.34 -53.58 2.63 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.965 0.412 . . . . 73.549999999999997 110.7 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp 66.09 1.43 1.93 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.411 0.684 . . . . 74.310000000000002 112.705 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.3 t -107.54 140.82 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.904 0.383 . . . . 75.310000000000002 111.853 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 m -131.4 103.67 6.57 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.39 -0.368 . . . . 71.099999999999994 110.52 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.578 ' HA ' ' HG1' ' A' ' 55' ' ' THR . 12.3 p-10 -100.64 96.5 7.39 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.648 0.737 . . . . 71.349999999999994 112.179 -178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -100.72 -44.57 5.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.823 -0.626 . . . . 62.509999999999998 110.899 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.84 -24.04 67.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.26 0.467 . . . . 53.200000000000003 112.26 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.84 28.74 70.21 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.261 -0.495 . . . . 73.150000000000006 113.374 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.466 HD13 ' HB2' ' A' ' 92' ' ' LEU . 94.3 mt -86.5 7.38 26.27 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.541 -0.387 . . . . 74.430000000000007 111.668 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -116.46 121.94 43.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.458 -0.337 . . . . 74.319999999999993 111.543 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.1 m -65.38 146.06 55.38 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.176 -0.305 . . . . 74.219999999999999 110.176 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -48.39 -46.27 36.97 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.77 0.656 . . . . 72.239999999999995 112.77 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.485 ' O ' HG21 ' A' ' 35' ' ' VAL . . . -61.0 -46.7 89.72 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.225 -0.297 . . . . 64.519999999999996 111.186 175.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 15.0 mm-40 -57.71 -37.88 74.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.62 0.248 . . . . 75.310000000000002 111.572 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -54.66 -54.72 38.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.257 0.551 . . . . 75.150000000000006 110.347 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -66.29 -42.06 88.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.752 -0.658 . . . . 74.120000000000005 111.718 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG21 ' O ' ' A' ' 31' ' ' ALA . 85.9 t -59.0 -36.64 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.24 0.543 . . . . 74.310000000000002 110.851 176.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 42.5 ttm -71.9 -44.55 63.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.47 -0.332 . . . . 72.510000000000005 110.711 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -53.15 -54.42 36.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.855 0.36 . . . . 72.540000000000006 111.144 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.22 -33.15 57.72 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 116.157 -0.474 . . . . 74.209999999999994 113.626 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.52 HH12 ' HB3' ' A' ' 136' ' ' SER . 85.0 mtm180 -75.15 -49.13 20.51 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.643 -0.328 . . . . 75.25 111.567 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.84 -48.88 77.14 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.473 0.654 . . . . 75.349999999999994 111.0 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HD3' ' O ' ' A' ' 18' ' ' THR . 33.0 ttp180 -55.8 -42.44 75.62 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.279 -0.873 . . . . 74.230000000000004 111.643 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.76 75.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.855 0.359 . . . . 63.100000000000001 111.526 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.429 HG21 ' HB ' ' A' ' 49' ' ' VAL . 68.0 mt -61.29 -44.77 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.184 0.516 . . . . 74.209999999999994 111.241 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.583 ' HE ' ' HG2' ' A' ' 50' ' ' GLU . 1.5 tmt_? -61.9 -33.1 73.62 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.813 -0.63 . . . . 74.310000000000002 110.784 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.9 t -78.24 -48.6 15.41 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.976 0.361 . . . . 75.299999999999997 111.976 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.2 t -84.06 -68.03 0.75 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.04 0.385 . . . . 65.420000000000002 112.04 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -69.97 -13.6 62.31 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 111.767 0.284 . . . . 72.319999999999993 111.767 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 66.15 14.88 9.86 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.856 0.462 . . . . 72.420000000000002 111.916 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.666 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 61.6 t -84.42 115.8 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.324 -0.398 . . . . 72.310000000000002 110.914 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.583 ' HG2' ' HE ' ' A' ' 44' ' ' ARG . 36.8 mt-10 -76.31 95.58 3.8 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.335 0.588 . . . . 72.239999999999995 110.22 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.68 104.3 13.27 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.441 -0.799 . . . . 73.329999999999998 110.313 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.01 142.53 39.54 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.266 0.469 . . . . 70.310000000000002 112.266 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.6 t -123.22 126.33 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.003 0.43 . . . . 65.239999999999995 111.291 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.42 139.4 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 122.622 0.369 . . . . 74.310000000000002 111.076 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.578 ' HG1' ' HA ' ' A' ' 23' ' ' ASP . 76.7 p -121.04 122.63 40.5 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.817 0.342 . . . . 64.310000000000002 111.474 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -129.19 142.25 44.56 Favored Pre-proline 0 N--CA 1.471 0.624 0 CA-C-N 116.531 -0.304 . . . . 72.219999999999999 111.144 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.89 -55.57 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.268 1.979 . . . . 63.340000000000003 112.348 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.0 p -151.07 147.02 26.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.625 0.25 . . . . 74.5 111.305 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.7 pt -116.89 9.2 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.097 0.475 . . . . 75.439999999999998 111.819 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.23 -138.2 32.31 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.117 -0.563 . . . . 64.109999999999999 112.938 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -92.71 15.26 14.89 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.519 -0.401 . . . . 64.109999999999999 111.989 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.89 131.07 76.97 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.651 -0.25 . . . . 75.120000000000005 111.186 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.589 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 56.7 Cg_endo -71.7 125.51 11.18 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.259 1.972 . . . . 74.430000000000007 112.538 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.5 tp -62.37 -38.33 89.14 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.582 0.586 . . . . 74.120000000000005 112.582 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -61.32 -39.04 89.06 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.761 0.791 . . . . 74.409999999999997 110.759 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.589 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 2.0 m-20 -76.64 -37.02 57.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.041 -0.981 . . . . 71.120000000000005 110.918 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -55.05 -52.68 62.43 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.753 -0.658 . . . . 74.439999999999998 110.85 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.5 p -62.18 -36.46 81.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.974 -0.557 . . . . 71.439999999999998 111.966 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.2 tp -57.01 -50.32 73.1 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.128 0.489 . . . . 73.450000000000003 110.711 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -59.12 -50.33 74.47 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.094 -0.503 . . . . 75.219999999999999 111.756 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.447 HD23 HD23 ' A' ' 87' ' ' LEU . 27.9 tp -64.67 -42.58 95.27 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.989 0.423 . . . . 74.340000000000003 111.451 -176.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.5 93.83 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.855 0.36 . . . . 74.319999999999993 111.514 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -62.28 -52.47 63.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.466 -0.334 . . . . 74.120000000000005 111.771 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.405 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 10.3 pt20 -63.43 -28.01 69.69 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.907 0.336 . . . . 72.120000000000005 111.907 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.405 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 44.9 m0 -86.61 -2.64 58.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.335 0.495 . . . . 74.430000000000007 112.335 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.16 12.18 68.38 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.917 -0.659 . . . . 72.450000000000003 113.416 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 41.3 t -95.1 -16.5 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.996 0.426 . . . . 73.299999999999997 110.91 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.9 31.66 2.08 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 116.33 -0.395 . . . . 70.030000000000001 112.97 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -61.54 93.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.067 0.461 . . . . 71.140000000000001 112.024 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 49.77 56.12 8.36 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.516 0.674 . . . . 74.129999999999995 110.676 -174.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER 68.39 98.74 0.06 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.378 -0.828 . . . . 71.129999999999995 111.551 -178.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 42.9 t30 -98.59 160.08 14.51 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.413 -0.812 . . . . 73.239999999999995 110.624 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.502 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -68.48 -97.36 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 O-C-N 121.958 -0.464 . . . . 72.549999999999997 112.217 -178.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.666 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.2 m-20 -77.51 77.19 4.04 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.982 -0.449 . . . . 72.409999999999997 111.438 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.78 130.93 4.39 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.996 -0.621 . . . . 64.530000000000001 113.315 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.2 tp -144.51 123.05 12.45 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.933 0.396 . . . . 74.200000000000003 110.964 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.447 HD23 HD23 ' A' ' 71' ' ' LEU . 61.7 tp -112.97 135.11 54.1 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.864 0.364 . . . . 73.010000000000005 111.402 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 55.8 tp -124.98 120.81 32.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.695 0.398 . . . . 63.450000000000003 110.956 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 87.0 t -125.21 126.99 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.844 0.354 . . . . 75.239999999999995 111.53 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.47 HD22 HD13 ' A' ' 135' ' ' LEU . 29.6 tp -101.44 120.08 39.74 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.119 -0.491 . . . . 75.420000000000002 111.335 178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.9 t -104.61 102.28 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.867 0.365 . . . . 74.310000000000002 111.157 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.466 ' HB2' HD13 ' A' ' 27' ' ' LEU . 61.7 tp -56.87 -35.06 68.47 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 111.895 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -51.2 -36.49 41.65 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.832 0.679 . . . . 74.25 112.832 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -129.2 3.49 5.21 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.153 0.427 . . . . 74.109999999999999 112.153 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 57.37 20.82 6.24 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.939 0.399 . . . . 71.450000000000003 112.021 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -94.76 141.07 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 75.430000000000007 111.364 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.652 HG23 ' SD ' ' A' ' 122' ' ' MET . 4.4 m -129.89 144.66 37.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.769 -0.651 . . . . 74.329999999999998 110.497 177.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 14.6 tpt180 -121.32 128.48 52.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.856 0.36 . . . . 75.040000000000006 111.707 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.597 ' HB3' HD12 ' A' ' 114' ' ' LEU . 71.8 m-85 -100.69 102.29 13.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.089 -0.505 . . . . 73.409999999999997 109.755 171.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -98.51 112.88 24.77 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.898 0.38 . . . . 63.119999999999997 112.008 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.5 p -102.02 152.37 21.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.522 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.62 -95.44 0.61 Allowed Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.786 -0.721 . . . . 74.129999999999995 111.905 171.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -142.72 -23.56 0.64 Allowed 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.526 -0.397 . . . . 73.040000000000006 111.715 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.32 -29.61 75.68 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.858 -0.687 . . . . 74.439999999999998 113.3 -176.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.563 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 86.8 mt -92.93 0.32 57.38 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.447 0.536 . . . . 75.409999999999997 112.447 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -62.34 -19.99 63.92 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.003 0.43 . . . . 73.5 111.548 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.6 11.62 68.27 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.283 -0.484 . . . . 75.219999999999999 113.13 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.563 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 34.8 m-85 -136.58 -57.47 0.74 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.469 0.652 . . . . 74.310000000000002 110.355 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.475 ' HB3' HD21 ' A' ' 114' ' ' LEU . 12.2 mt -118.56 79.49 15.94 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.11 -0.95 . . . . 74.409999999999997 111.25 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.89 146.54 94.96 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.183 1.922 . . . . 74.140000000000001 112.714 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -51.28 -32.67 25.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 116.155 -0.475 . . . . 74.439999999999998 111.301 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.12 -44.82 75.2 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.36 -0.448 . . . . 73.120000000000005 113.143 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 tp -60.55 -49.69 76.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.207 0.527 . . . . 73.140000000000001 110.873 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.597 HD12 ' HB3' ' A' ' 99' ' ' PHE . 76.7 mt -56.93 -37.28 71.27 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.712 -0.676 . . . . 72.230000000000004 111.191 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.6 t -56.79 -46.85 81.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.122 -0.49 . . . . 63.25 111.383 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -65.11 -41.59 94.77 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.944 -0.302 . . . . 74.349999999999994 111.18 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.575 HG22 ' HD3' ' A' ' 121' ' ' ARG . 65.4 mt -50.34 -39.67 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.038 0.447 . . . . 75.200000000000003 111.19 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 122' ' ' MET . 62.3 mt -60.35 -51.01 77.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.007 -0.542 . . . . 75.409999999999997 111.363 175.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.404 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 12.9 m-70 -81.56 -19.1 42.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.821 0.674 . . . . 74.310000000000002 112.821 -175.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.498 ' HB3' ' HD2' ' A' ' 121' ' ' ARG . 9.3 t70 -83.36 -49.09 9.7 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.109 0.411 . . . . 72.400000000000006 112.109 -173.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.575 ' HD3' HG22 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -119.18 -31.25 4.75 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.155 0.798 . . . . 74.439999999999998 113.155 -177.3 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.722 ' HE1' ' HA3' ' A' ' 138' ' ' GLY . 37.0 mtt -73.28 -56.71 4.71 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.967 0.729 . . . . 74.510000000000005 112.967 -176.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.499 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 44.4 mm -50.58 -52.14 58.56 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.954 0.724 . . . . 73.209999999999994 112.954 -176.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 10.3 Cg_endo -52.23 -29.58 38.43 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.237 1.958 . . . . 72.450000000000003 113.254 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -84.15 -48.19 10.09 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.925 0.343 . . . . 74.310000000000002 111.925 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.2 m-85 -55.78 -46.64 77.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.279 0.561 . . . . 75.430000000000007 111.34 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -65.48 -17.04 64.26 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.727 -0.669 . . . . 73.239999999999995 111.722 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.2 t -90.05 -13.59 35.6 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.12 -0.491 . . . . 74.349999999999994 110.939 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.71 -0.61 61.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.982 -0.447 . . . . 73.319999999999993 111.982 -172.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.789 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.57 68.04 10.29 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.96 0.504 . . . . 74.310000000000002 111.202 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.401 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 96.1 m-85 -70.8 -48.24 55.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.661 0.267 . . . . 73.109999999999999 111.701 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.338 0.589 . . . . 61.310000000000002 111.289 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.789 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 9.2 tp10 -61.6 -50.19 73.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.578 -0.737 . . . . 71.150000000000006 110.884 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.81 -47.21 91.62 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.21 -0.45 . . . . 62.020000000000003 113.6 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.47 HD13 HD22 ' A' ' 90' ' ' LEU . 90.9 mt -57.72 -44.53 86.04 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 122.585 -0.362 . . . . 75.109999999999999 111.285 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.52 ' HB3' HH12 ' A' ' 39' ' ' ARG . 43.7 m -60.18 -44.06 95.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.474 -0.33 . . . . 73.310000000000002 111.557 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -61.07 -40.2 92.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.775 0.321 . . . . 75.200000000000003 111.5 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.722 ' HA3' ' HE1' ' A' ' 122' ' ' MET . . . -62.22 -51.32 57.49 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.944 -0.646 . . . . 74.349999999999994 112.835 176.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.21 -46.6 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.206 0.527 . . . . 74.329999999999998 111.265 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 47.8 tp -59.7 -39.42 84.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.847 -0.615 . . . . 74.209999999999994 111.413 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 145' ' ' VAL . . . -62.52 -50.5 71.1 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.922 0.392 . . . . 71.549999999999997 111.158 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.26 -48.5 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.112 0.482 . . . . 74.239999999999995 111.106 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -51.28 -40.37 58.79 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.8 -0.636 . . . . 74.109999999999999 111.751 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 79.8 mt-30 -69.74 -42.55 73.79 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 111.948 0.351 . . . . 73.439999999999998 111.948 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 141' ' ' ALA . 57.4 t -58.34 -50.8 77.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.803 0.335 . . . . 75.439999999999998 111.617 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.3 mt -53.21 -48.1 68.38 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.454 -0.339 . . . . 71.120000000000005 111.794 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -55.89 -34.4 65.49 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.935 0.398 . . . . 75.420000000000002 112.025 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -101.06 0.67 54.79 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.147 -0.549 . . . . 74.540000000000006 114.079 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.3 m -115.47 15.45 16.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 117.417 0.609 . . . . 71.420000000000002 112.097 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.56 -1.03 3.19 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.443 0.535 . . . . 75.150000000000006 112.443 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -45.51 -33.78 2.89 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.145 0.578 . . . . 75.549999999999997 112.452 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.442 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 58.0 t-80 -86.13 1.35 50.86 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.093 0.775 . . . . 73.109999999999999 113.093 -174.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' A' ' 154' ' ' HIS . 0.8 OUTLIER -69.88 71.53 0.37 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.735 1.013 . . . . 75.430000000000007 113.735 -172.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.444 ' HB3' ' O ' ' A' ' 153' ' ' HIS . 22.2 p80 174.97 7.63 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.103 0.409 . . . . 75.409999999999997 112.103 176.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -116.48 140.35 49.46 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.265 0.555 . . . . 74.200000000000003 112.395 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -138.05 -169.59 2.6 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.339 -0.846 . . . . 74.099999999999994 110.185 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 9.7 p80 . . . . . 0 C--O 1.252 1.216 0 CA-C-O 117.883 -1.055 . . . . 73.140000000000001 111.263 176.078 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.98 0.419 . . . . 65.120000000000005 111.052 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -87.89 117.9 27.05 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.001 0.429 . . . . 74.510000000000005 111.517 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -91.29 116.04 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.176 -0.465 . . . . 72.219999999999999 111.69 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -94.08 139.94 30.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.268 0.556 . . . . 65.010000000000005 112.072 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 56.8 mtpt -111.71 163.25 18.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.714 -0.675 . . . . 73.209999999999994 110.012 173.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 16.5 Cg_endo -55.38 -23.73 39.75 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.392 2.062 . . . . 71.209999999999994 112.854 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.34 -22.81 38.18 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.22 -0.446 . . . . 74.439999999999998 111.839 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -91.76 -19.69 22.32 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.83 0.347 . . . . 72.450000000000003 111.599 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.29 120.73 80.19 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.488 -0.324 . . . . 73.349999999999994 111.213 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.47 111.2 0.69 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.667 2.245 . . . . 75.319999999999993 112.978 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -70.81 82.57 0.64 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.346 0.593 . . . . 74.219999999999999 110.832 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.82 -28.31 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.414 0.524 . . . . 75.329999999999998 112.414 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -72.15 -24.53 61.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.893 0.378 . . . . 75.340000000000003 111.842 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tt -75.57 -39.71 57.72 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.19 -0.67 . . . . 73.219999999999999 109.19 171.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.86 -80.13 0.08 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.863 -0.608 . . . . 64.340000000000003 112.16 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -121.93 109.03 14.12 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.661 0.267 . . . . 74.010000000000005 111.584 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 p -59.12 -24.9 63.38 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.857 0.361 . . . . 73.230000000000004 111.765 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.4 m -61.78 -26.36 68.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.399 -0.364 . . . . 74.510000000000005 111.517 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -114.6 112.68 23.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.221 0.534 . . . . 74.310000000000002 110.954 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 4.6 mp -101.5 7.59 42.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.075 -0.511 . . . . 70.239999999999995 110.751 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 16.4 t -119.5 116.47 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.64 0.607 . . . . 73.010000000000005 112.64 -172.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.0 m -104.44 105.79 16.04 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.402 -0.363 . . . . 72.319999999999993 111.157 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.433 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 30.2 t70 -96.56 101.67 13.32 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 111.345 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HB2' HD22 ' A' ' 56' ' ' LEU . 27.7 mm-40 -103.77 -39.55 6.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.003 0.43 . . . . 71.030000000000001 111.065 177.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.85 -21.58 57.12 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.913 0.709 . . . . 65.409999999999997 112.913 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.22 55.46 5.16 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.938 -0.649 . . . . 64.230000000000004 112.486 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -122.13 -47.76 2.13 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.873 0.368 . . . . 74.329999999999998 111.466 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.22 115.24 13.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.136 0.493 . . . . 72.219999999999999 111.931 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 90.8 p -71.1 162.07 30.06 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.018 -0.537 . . . . 71.530000000000001 111.241 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -53.49 -35.51 60.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.123 0.487 . . . . 65.409999999999997 110.872 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.69 -48.48 69.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.932 -0.576 . . . . 75.299999999999997 111.244 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -60.46 -42.73 96.77 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.574 0.226 . . . . 74.310000000000002 111.59 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.01 -44.84 95.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.776 0.322 . . . . 72.430000000000007 110.926 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -54.57 -55.18 32.05 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.031 0.443 . . . . 74.400000000000006 111.238 177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.89 -46.08 97.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.897 -0.592 . . . . 75.040000000000006 111.811 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.509 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 50.0 ttm -66.84 -52.12 47.51 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.529 -0.305 . . . . 74.030000000000001 111.742 -176.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -62.88 -37.67 87.85 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.407 0.146 . . . . 75.430000000000007 111.236 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.67 -48.24 85.89 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.006 -0.616 . . . . 62.25 112.532 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 48.1 mtp180 -64.0 -47.55 79.85 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.308 0.243 . . . . 72.150000000000006 111.608 177.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 36' ' ' MET . 85.4 mt -58.57 -52.72 64.47 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.129 0.49 . . . . 74.299999999999997 111.361 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -60.18 -34.87 74.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.027 -0.533 . . . . 75.450000000000003 110.862 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.21 96.89 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.845 0.355 . . . . 60.0 111.143 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.519 HG21 ' HB ' ' A' ' 49' ' ' VAL . 70.8 mt -62.25 -42.27 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.488 -0.324 . . . . 75.519999999999996 110.78 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 28.1 tpt180 -61.51 -37.63 84.42 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.989 0.423 . . . . 74.530000000000001 111.088 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.4 m -70.11 -31.51 69.1 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.129 0.418 . . . . 65.400000000000006 112.129 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.6 t -98.72 -64.54 1.03 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.004 0.372 . . . . 65.329999999999998 112.004 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.607 ' HE1' HD22 ' A' ' 150' ' ' LEU . 76.0 m-70 -87.5 -10.56 51.43 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.5 0.556 . . . . 71.329999999999998 112.5 -175.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 69.08 3.46 4.07 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.312 0.486 . . . . 74.230000000000004 112.312 -176.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.835 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 93.2 t -64.45 122.62 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 121.008 0.432 . . . . 75.329999999999998 111.459 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -88.84 95.54 10.33 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.3 0.572 . . . . 75.219999999999999 109.865 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -113.17 102.7 10.62 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.646 -0.706 . . . . 74.239999999999995 111.013 -172.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -105.17 145.86 30.01 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.356 0.502 . . . . 74.329999999999998 112.356 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 61.3 t -124.23 138.3 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.394 -0.366 . . . . 75.340000000000003 110.933 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.1 t -133.29 143.31 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 122.231 -0.293 . . . . 64.200000000000003 111.118 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 28.4 p -125.54 123.15 38.5 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.803 0.335 . . . . 71.450000000000003 110.752 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 24' ' ' GLU . 81.8 mt -127.39 143.22 46.48 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 122.245 -0.284 . . . . 75.519999999999996 111.515 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.74 -61.48 0.28 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.598 2.199 . . . . 75.040000000000006 112.519 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.8 p -149.35 146.41 27.5 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.973 0.416 . . . . 72.129999999999995 112.046 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.468 HG12 HG13 ' A' ' 91' ' ' VAL . 31.9 pt -110.6 5.0 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.957 -0.565 . . . . 74.409999999999997 110.682 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.92 -120.4 22.02 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.886 -0.597 . . . . 73.299999999999997 113.526 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -97.83 4.86 49.65 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.895 0.378 . . . . 72.420000000000002 111.788 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.46 140.44 92.47 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 120.672 0.272 . . . . 74.329999999999998 111.731 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.5 Cg_endo -75.99 125.86 8.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.321 2.014 . . . . 75.340000000000003 112.518 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.3 tp -58.62 -42.01 87.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.046 0.451 . . . . 74.510000000000005 111.711 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.73 -59.68 4.19 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.875 -0.602 . . . . 74.219999999999999 111.057 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.649 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 3.3 m-20 -62.97 -41.53 99.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.705 -0.68 . . . . 64.129999999999995 111.627 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -53.62 -49.96 66.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.274 -0.421 . . . . 74.299999999999997 111.763 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.3 p -57.48 -48.86 78.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.412 -0.358 . . . . 75.439999999999998 111.891 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.4 -45.42 88.39 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.844 0.354 . . . . 75.530000000000001 111.712 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 66' ' ' ASP . 31.7 mmmt -56.25 -45.51 80.02 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.999 0.428 . . . . 74.329999999999998 111.661 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.42 -38.13 65.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.214 0.53 . . . . 75.219999999999999 111.297 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.81 -35.45 72.87 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.292 -0.413 . . . . 72.200000000000003 112.103 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -61.31 -53.91 50.66 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.321 0.489 . . . . 75.129999999999995 112.321 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.617 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 7.2 pt20 -67.06 -27.44 67.38 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.383 0.512 . . . . 75.409999999999997 112.383 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.617 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 16.3 m0 -80.74 -12.22 59.49 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.884 0.328 . . . . 74.420000000000002 111.884 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.76 -2.16 66.57 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.266 -0.492 . . . . 74.239999999999995 114.029 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.0 m -100.85 -4.42 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.714 0.635 . . . . 71.099999999999994 112.714 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.44 -29.99 1.13 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.01 -0.614 . . . . 73.140000000000001 113.935 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -59.21 127.15 30.72 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.487 -0.419 . . . . 73.25 111.287 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 43.71 28.17 0.21 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.939 0.896 . . . . 74.329999999999998 112.965 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER 64.46 93.23 0.06 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.246 0.832 . . . . 71.329999999999998 113.246 175.067 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.45 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 23.0 t-20 -74.24 132.66 42.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.244 0.545 . . . . 73.200000000000003 111.064 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.679 ' N ' HD21 ' A' ' 83' ' ' ASN . 0.0 OUTLIER -51.38 -64.29 0.86 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 112.772 0.656 . . . . 73.510000000000005 112.772 177.102 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.835 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 18.3 m120 -88.02 8.16 27.86 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.683 -0.636 . . . . 75.310000000000002 112.146 -177.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.99 124.62 9.23 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 114.735 0.654 . . . . 75.340000000000003 114.735 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.615 HD12 ' HB3' ' A' ' 99' ' ' PHE . 50.9 tp -144.23 119.59 10.26 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.705 0.402 . . . . 71.299999999999997 110.755 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.6 tp -110.99 135.44 51.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.817 0.341 . . . . 74.400000000000006 111.564 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -120.84 108.14 13.57 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.741 0.305 . . . . 74.230000000000004 110.863 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.0 t -108.5 120.15 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.075 0.398 . . . . 75.150000000000006 112.075 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.536 ' HB2' HD21 ' A' ' 135' ' ' LEU . 29.2 tp -100.1 129.4 46.13 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.193 -0.458 . . . . 73.219999999999999 111.014 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.468 HG13 HG12 ' A' ' 59' ' ' ILE . 44.2 t -116.98 107.79 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.462 -0.335 . . . . 65.109999999999999 110.683 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.1 tp -53.47 -44.36 68.91 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.044 0.449 . . . . 71.519999999999996 111.504 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -57.64 -33.5 68.36 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.95 -0.568 . . . . 71.200000000000003 112.265 177.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -92.66 -11.95 32.82 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 122.241 -0.287 . . . . 74.349999999999994 111.62 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 54.64 29.05 10.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.995 0.518 . . . . 73.409999999999997 111.891 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -149.81 173.53 13.64 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.09 0.471 . . . . 73.120000000000005 111.908 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.526 HG23 ' SD ' ' A' ' 122' ' ' MET . 8.9 m -135.41 171.93 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.877 -0.601 . . . . 74.409999999999997 111.056 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -145.8 141.52 28.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.926 0.393 . . . . 73.420000000000002 111.532 168.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.667 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 79.0 m-85 -98.36 124.9 43.27 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.887 -0.597 . . . . 75.420000000000002 110.373 172.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.99 119.25 38.92 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.275 -0.266 . . . . 73.409999999999997 110.726 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.565 HG21 HD13 ' A' ' 114' ' ' LEU . 18.5 p -98.19 139.11 34.47 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.03 0.443 . . . . 75.409999999999997 111.847 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -68.39 -80.84 0.21 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.582 -0.818 . . . . 54.32 112.297 173.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -155.66 -43.62 0.08 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.934 0.397 . . . . 74.319999999999993 112.044 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.535 ' H ' ' HA ' ' A' ' 83' ' ' ASN . . . -62.13 -41.76 99.71 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.516 -0.374 . . . . 71.510000000000005 113.617 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 88.2 mt -71.15 -3.08 18.13 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.251 0.834 . . . . 74.430000000000007 113.251 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -60.85 -15.49 30.89 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.939 -0.476 . . . . 70.319999999999993 112.03 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.7 1.18 80.95 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.177 -0.535 . . . . 62.049999999999997 113.301 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -136.94 -54.36 0.71 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.332 0.587 . . . . 74.019999999999996 111.452 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.6 mt -117.25 86.62 21.67 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.578 -0.737 . . . . 73.439999999999998 111.821 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.39 159.0 22.78 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.332 2.021 . . . . 75.430000000000007 112.529 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.428 ' HA ' HD12 ' A' ' 114' ' ' LEU . 14.3 t70 -45.91 -40.22 9.82 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 120.977 0.417 . . . . 74.420000000000002 111.746 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.03 72.11 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.336 -0.459 . . . . 70.310000000000002 113.284 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.26 -40.2 96.74 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.03 0.443 . . . . 75.230000000000004 111.095 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 86.1 mt -57.66 -48.17 80.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.052 -0.522 . . . . 72.340000000000003 111.127 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.4 t -69.08 -34.48 75.19 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.106 0.479 . . . . 63.329999999999998 110.804 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 116' ' ' ARG . 15.4 ttm180 -56.56 -53.92 51.93 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.115 -0.493 . . . . 72.430000000000007 110.904 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.12 -41.69 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.027 0.441 . . . . 72.340000000000003 111.528 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 60.4 mt -58.61 -54.51 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.165 0.507 . . . . 74.200000000000003 110.888 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -75.1 -14.9 60.62 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.28 -0.418 . . . . 70.329999999999998 112.008 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -79.21 -53.04 7.36 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.226 0.454 . . . . 74.329999999999998 112.226 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -133.72 -23.68 1.79 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.202 0.816 . . . . 73.200000000000003 113.202 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.846 ' HE2' ' HA3' ' A' ' 138' ' ' GLY . 36.4 mtt -67.56 -53.6 26.96 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.509 0.559 . . . . 74.319999999999993 112.509 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.444 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 47.7 mm -51.38 -53.63 47.44 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 112.85 0.685 . . . . 74.450000000000003 112.85 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 10.5 Cg_endo -53.58 -41.98 69.44 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.989 1.793 . . . . 74.319999999999993 112.623 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.468 ' CD2' ' HG3' ' A' ' 137' ' ' GLU . 60.5 m-70 -64.47 -50.68 66.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.279 -0.263 . . . . 75.530000000000001 111.491 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.6 m-85 -56.4 -45.25 80.72 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.854 0.359 . . . . 73.540000000000006 111.431 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 58.6 mtp180 -62.49 -34.82 77.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.963 0.411 . . . . 75.239999999999995 110.988 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.6 m -80.82 -4.44 54.69 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.104 -0.498 . . . . 62.310000000000002 111.87 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.7 -8.44 63.78 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.517 -0.373 . . . . 62.509999999999998 113.601 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.756 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.4 m-20 -78.81 72.41 5.33 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 122.327 -0.513 . . . . 63.109999999999999 112.139 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -71.45 -56.13 6.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.018 0.437 . . . . 65.010000000000005 111.177 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.91 89.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 111.468 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.756 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 9.4 tp10 -68.56 -46.43 69.48 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.17 -0.468 . . . . 74.109999999999999 110.768 176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.84 -41.75 67.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.579 -0.343 . . . . 52.149999999999999 113.267 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 90' ' ' LEU . 83.4 mt -60.65 -48.79 80.2 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.888 0.375 . . . . 75.239999999999995 111.178 175.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -60.56 -38.85 85.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.326 -0.397 . . . . 74.5 110.941 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.468 ' HG3' ' CD2' ' A' ' 125' ' ' HIS . 15.7 mm-40 -58.44 -51.37 70.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 111.503 175.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.846 ' HA3' ' HE2' ' A' ' 122' ' ' MET . . . -58.76 -47.94 87.71 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.9 -0.667 . . . . 75.340000000000003 112.444 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.29 -39.68 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.968 0.413 . . . . 74.400000000000006 111.218 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.45 ' HG ' HE21 ' A' ' 144' ' ' GLN . 27.9 tp -70.88 -33.99 71.15 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.381 -0.372 . . . . 74.409999999999997 110.667 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.52 -50.79 57.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.847 0.356 . . . . 74.200000000000003 110.86 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.7 t -57.47 -47.34 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.116 0.484 . . . . 75.299999999999997 110.535 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -53.81 -46.91 71.24 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.051 -0.522 . . . . 74.140000000000001 111.82 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.45 HE21 ' HG ' ' A' ' 140' ' ' LEU . 74.4 mt-30 -57.42 -38.1 73.82 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.841 0.353 . . . . 75.109999999999999 111.426 177.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.98 -49.08 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.707 0.289 . . . . 72.230000000000004 111.029 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.36 -58.21 4.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.867 0.321 . . . . 72.299999999999997 111.867 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.83 -23.09 67.22 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.045 0.45 . . . . 72.510000000000005 111.845 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.08 -18.7 58.91 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.205 -0.522 . . . . 72.329999999999998 112.856 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.0 t -74.24 -58.46 3.28 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.151 0.426 . . . . 75.140000000000001 112.151 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.607 HD22 ' HE1' ' A' ' 47' ' ' HIS . 1.7 pt? -66.83 -25.42 66.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.859 0.361 . . . . 72.129999999999995 111.395 -177.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.453 ' H ' HD21 ' A' ' 150' ' ' LEU . 44.1 mt-10 67.64 -8.8 0.48 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.636 0.774 . . . . 73.409999999999997 112.727 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.497 ' H ' ' HG ' ' A' ' 150' ' ' LEU . 31.7 t60 -77.44 118.19 19.64 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.646 -0.501 . . . . 74.209999999999994 109.646 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -49.73 118.08 2.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.235 0.457 . . . . 74.0 112.235 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -58.08 107.49 0.48 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.072 -0.513 . . . . 72.310000000000002 110.878 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -76.82 133.48 39.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.987 0.422 . . . . 74.430000000000007 111.647 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -93.47 141.97 27.86 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.376 -0.375 . . . . 72.549999999999997 110.661 175.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.4 m170 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.429 -0.796 . . . . 71.430000000000007 111.421 -175.44 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HG3' ' OG ' ' A' ' 58' ' ' SER . 51.5 ttm . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.865 0.364 . . . . 74.120000000000005 111.417 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -118.05 123.18 45.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.774 0.321 . . . . 71.439999999999998 110.665 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.03 101.8 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 121.044 0.449 . . . . 74.140000000000001 111.754 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -91.59 141.17 29.0 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.109 0.48 . . . . 75.310000000000002 111.405 174.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.761 ' HB2' ' HZ2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -111.45 158.35 36.52 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 116.316 -0.402 . . . . 74.310000000000002 110.647 175.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 64.4 Cg_endo -70.93 19.31 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.819 2.346 . . . . 64.450000000000003 114.541 -173.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.632 ' HA ' HE22 ' A' ' 74' ' ' GLN . 0.0 OUTLIER -126.38 -12.07 6.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.756 0.313 . . . . 63.009999999999998 111.657 173.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -97.45 -19.27 18.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.947 0.403 . . . . 54.009999999999998 111.121 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.21 130.92 84.04 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.322 -0.399 . . . . 73.040000000000006 111.412 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.04 110.84 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.828 2.352 . . . . 75.430000000000007 113.173 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -70.96 98.0 1.53 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 111.215 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 13' ' ' GLN . 27.8 m -93.26 -50.25 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 113.495 0.924 . . . . 73.0 113.495 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.564 ' HG3' HG22 ' A' ' 77' ' ' VAL . 15.1 mm100 -53.77 -33.75 56.85 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.654 1.353 . . . . 71.239999999999995 114.654 -169.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -77.48 5.34 9.1 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.617 0.599 . . . . 74.200000000000003 112.617 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.02 -51.56 0.06 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.196 0.522 . . . . 75.319999999999993 111.498 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -83.14 47.67 1.27 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.3 -0.409 . . . . 72.430000000000007 111.256 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 m -61.0 -11.79 9.32 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.689 0.626 . . . . 74.409999999999997 112.689 -176.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -77.71 -30.7 51.91 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.176 0.512 . . . . 65.219999999999999 110.635 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.455 ' HA ' ' OD1' ' A' ' 37' ' ' ASN . 13.0 ttm105 -108.34 95.04 5.39 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.452 0.644 . . . . 74.310000000000002 110.761 175.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 20' ' ' LEU . 3.9 mp -88.89 13.6 12.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.812 -0.631 . . . . 73.209999999999994 111.04 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.54 127.36 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.326 -0.397 . . . . 74.439999999999998 111.773 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.0 m -121.1 103.16 8.81 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.439 -0.346 . . . . 73.239999999999995 110.619 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -99.51 101.99 13.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.989 0.424 . . . . 73.349999999999994 111.495 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -103.0 -34.42 8.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.214 0.53 . . . . 75.510000000000005 110.714 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.32 -28.26 69.08 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.51 0.559 . . . . 71.150000000000006 112.51 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.68 28.43 51.36 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.886 -0.673 . . . . 71.120000000000005 112.432 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.51 -17.2 22.64 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.824 0.345 . . . . 74.519999999999996 111.319 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.4 mt -107.62 114.19 28.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.924 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 t -65.93 152.73 43.86 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.341 -0.224 . . . . 63.539999999999999 110.467 175.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -45.03 -51.78 9.61 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.854 0.687 . . . . 74.230000000000004 112.854 -174.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 35' ' ' VAL . . . -60.28 -50.26 74.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.646 0.26 . . . . 71.120000000000005 111.452 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -58.09 -39.87 79.68 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.177 0.513 . . . . 73.129999999999995 111.426 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -50.73 71.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.906 -0.588 . . . . 74.530000000000001 110.621 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.06 -30.75 71.8 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.724 0.297 . . . . 73.239999999999995 111.371 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 31' ' ' ALA . 74.8 t -62.01 -46.37 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.951 0.405 . . . . 72.129999999999995 110.35 172.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.695 ' SD ' HG23 ' A' ' 139' ' ' VAL . 51.7 tpp -60.3 -43.85 95.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.422 -0.354 . . . . 75.239999999999995 110.356 175.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.537 ' HB3' ' NH2' ' A' ' 41' ' ' ARG . 60.3 m-80 -56.74 -38.19 72.04 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.468 -0.333 . . . . 73.200000000000003 110.658 173.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.6 -46.32 94.65 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.887 -0.673 . . . . 60.409999999999997 112.203 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.5 mmp_? -57.61 -55.74 30.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.023 0.44 . . . . 75.019999999999996 111.174 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.87 -45.58 91.9 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.099 -0.5 . . . . 73.120000000000005 112.098 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.537 ' NH2' ' HB3' ' A' ' 37' ' ' ASN . 36.3 ttm180 -62.15 -40.75 97.03 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.018 0.527 . . . . 75.430000000000007 110.929 -178.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.64 -46.52 89.42 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.338 -0.392 . . . . 54.210000000000001 111.011 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.418 HG21 ' HB ' ' A' ' 49' ' ' VAL . 76.1 mt -59.79 -44.7 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.124 0.488 . . . . 73.140000000000001 110.96 175.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 31.7 tpt180 -62.42 -26.81 68.69 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.097 -0.501 . . . . 72.109999999999999 111.76 177.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.1 m -84.84 -54.06 4.93 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.148 0.499 . . . . 72.0 110.76 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.2 m -71.91 -56.9 4.87 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.719 -0.673 . . . . 73.439999999999998 112.42 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.478 ' ND1' HD13 ' A' ' 150' ' ' LEU . 80.1 m-70 -96.32 -10.57 27.51 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.115 0.413 . . . . 75.430000000000007 112.115 -173.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 70.55 1.47 3.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.974 0.731 . . . . 71.239999999999995 112.974 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HB ' HG21 ' A' ' 43' ' ' ILE . 99.2 t -66.59 132.09 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 112.352 0.501 . . . . 71.310000000000002 112.352 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HB3' HG11 ' A' ' 77' ' ' VAL . 44.3 mt-10 -82.18 96.74 7.93 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.08 0.466 . . . . 74.129999999999995 110.533 174.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -119.11 108.72 15.04 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 110.507 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.47 146.02 42.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.875 0.369 . . . . 73.439999999999998 111.971 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.4 t -128.38 121.74 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.831 0.348 . . . . 72.239999999999995 111.418 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.7 t -121.78 132.37 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 122.325 0.25 . . . . 75.239999999999995 111.419 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -116.59 123.06 46.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.927 0.394 . . . . 53.140000000000001 111.288 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.409 HD11 ' CZ ' ' A' ' 67' ' ' PHE . 83.8 mt -118.16 145.24 36.55 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-O 120.788 0.328 . . . . 74.409999999999997 111.37 177.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.95 -43.01 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.535 2.157 . . . . 74.329999999999998 112.354 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.89 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 23.8 m -153.14 143.47 22.46 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.055 0.391 . . . . 74.450000000000003 112.055 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.473 ' HB ' ' HB1' ' A' ' 62' ' ' ALA . 35.8 pt -128.67 -14.38 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.083 0.468 . . . . 74.540000000000006 110.653 172.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.04 -117.32 8.45 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.236 -0.438 . . . . 53.409999999999997 113.725 174.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.42 2.67 46.87 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.815 0.302 . . . . 74.450000000000003 111.815 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HB1' ' HB ' ' A' ' 59' ' ' ILE . . . -72.88 120.88 83.26 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 111.524 0.194 . . . . 64.040000000000006 111.524 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 31.8 Cg_endo -64.48 137.06 53.41 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.443 2.095 . . . . 73.319999999999993 112.654 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.97 -49.08 40.34 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.236 0.458 . . . . 72.439999999999998 112.236 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.26 -32.85 73.61 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.998 0.428 . . . . 74.120000000000005 111.849 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.578 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 3.4 m-20 -74.21 -38.55 63.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.89 0.376 . . . . 71.129999999999995 111.016 173.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 48.6 t80 -56.77 -54.15 49.68 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.995 0.426 . . . . 74.420000000000002 111.062 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.493 ' OG1' ' NH1' ' A' ' 98' ' ' ARG . 40.7 p -51.84 -42.48 62.62 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.959 -0.564 . . . . 75.040000000000006 111.441 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.3 tp -58.42 -54.8 42.89 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.133 -0.485 . . . . 73.25 111.657 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 14.9 mmmm -66.67 -42.29 86.77 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.628 0.603 . . . . 63.130000000000003 112.628 -173.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.3 tp -68.57 -47.98 65.4 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.207 0.527 . . . . 73.310000000000002 111.261 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.479 ' HB3' HD22 ' A' ' 87' ' ' LEU . . . -68.55 -31.04 69.98 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.453 0.538 . . . . 64.120000000000005 112.453 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 70' ' ' LYS . 13.3 ptm180 -70.67 -38.95 73.79 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.092 -0.243 . . . . 72.140000000000001 111.436 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.632 HE22 ' HA ' ' A' ' 7' ' ' GLU . 3.6 pt20 -72.51 -24.69 61.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.044 0.45 . . . . 62.409999999999997 110.811 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.515 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 39.6 m0 -88.69 -17.2 30.47 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.487 -0.324 . . . . 75.010000000000005 111.221 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.64 38.08 95.71 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.472 -0.394 . . . . 74.400000000000006 113.613 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.564 HG22 ' HG3' ' A' ' 13' ' ' GLN . 45.0 t -108.87 -87.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.173 0.434 . . . . 71.219999999999999 112.173 -176.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.75 102.16 2.22 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.225 -0.512 . . . . 63.350000000000001 112.9 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.481 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -144.74 156.3 43.99 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.477 -0.425 . . . . 65.040000000000006 110.714 178.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -43.66 -32.76 1.05 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.707 1.003 . . . . 71.340000000000003 113.707 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.656 ' HD3' ' H ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -114.51 20.28 15.49 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.596 0.591 . . . . 75.140000000000001 112.596 -174.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 103' ' ' TYR . 3.5 m-20 -95.8 -166.13 1.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.242 0.544 . . . . 75.25 112.053 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -97.36 -139.44 0.28 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.13 -0.486 . . . . 73.219999999999999 111.137 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.542 ' HA ' ' HG ' ' A' ' 105' ' ' LEU . 7.3 p30 -69.12 43.88 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.322 0.86 . . . . 54.109999999999999 113.322 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -92.49 140.39 15.09 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.934 -0.651 . . . . 61.420000000000002 112.74 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 99' ' ' PHE . 52.0 tp -143.05 119.74 11.14 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.871 0.367 . . . . 64.319999999999993 111.03 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 72' ' ' ALA . 58.4 tp -111.94 122.32 47.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.836 0.351 . . . . 73.150000000000006 111.216 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.3 tp -109.97 106.2 15.65 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.307 -0.406 . . . . 75.209999999999994 110.745 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 59.9 t -107.06 117.4 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 111.925 0.343 . . . . 73.109999999999999 111.925 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.487 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.9 tp -96.88 122.27 39.66 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.305 -0.407 . . . . 74.120000000000005 110.677 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.453 HG12 HG12 ' A' ' 59' ' ' ILE . 61.0 t -111.04 102.9 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.665 0.269 . . . . 74.439999999999998 111.176 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.5 tp -51.86 -41.74 62.08 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.0 0.428 . . . . 73.439999999999998 111.367 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.89 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 19.1 t0 -45.76 -43.16 12.82 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.5 0.72 . . . . 70.019999999999996 112.451 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -106.19 -6.79 18.26 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 111.906 0.336 . . . . 71.109999999999999 111.906 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.404 ' NH2' ' O ' ' A' ' 126' ' ' PHE . 77.9 mtp180 55.23 26.84 8.9 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.732 0.777 . . . . 74.219999999999999 110.509 -174.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -112.75 164.24 13.61 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.171 -0.922 . . . . 72.420000000000002 111.528 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.65 HG22 ' SD ' ' A' ' 122' ' ' MET . 11.1 m -137.42 171.75 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.025 -0.534 . . . . 75.310000000000002 110.511 172.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.493 ' NH1' ' OG1' ' A' ' 68' ' ' THR . 38.5 ttt-85 -153.04 142.82 22.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.788 0.327 . . . . 74.25 111.621 172.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HD11 ' A' ' 86' ' ' LEU . 95.1 m-85 -101.22 118.05 36.21 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.045 -0.525 . . . . 74.329999999999998 110.659 173.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.45 ' CD ' HH12 ' A' ' 98' ' ' ARG . 5.6 tp10 -105.64 112.6 25.74 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 110.346 -0.242 . . . . 74.420000000000002 110.346 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.8 p -103.27 158.89 16.01 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.791 0.805 . . . . 74.319999999999993 113.038 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . -104.5 -175.65 25.04 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 114.907 -1.042 . . . . 73.420000000000002 111.464 166.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -61.83 -24.17 66.72 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.405 -0.468 . . . . 74.040000000000006 112.009 -176.142 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.4 -20.27 79.64 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.928 -0.653 . . . . 74.450000000000003 113.203 -173.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 84' ' ' ASN . 91.8 mt -109.11 -7.5 15.31 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.407 0.521 . . . . 75.219999999999999 112.407 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -56.4 -25.72 50.95 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.11 0.411 . . . . 65.319999999999993 112.11 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.79 -21.26 59.89 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.169 -0.539 . . . . 62.009999999999998 113.62 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.435 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 82.0 m-85 -102.42 -53.74 2.83 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.268 0.556 . . . . 72.209999999999994 111.409 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -113.77 87.97 13.17 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.485 -0.78 . . . . 71.239999999999995 111.418 -173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 108' ' ' TYR . 6.5 Cg_exo -73.99 161.63 40.75 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.396 2.064 . . . . 70.120000000000005 112.34 176.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -51.45 -44.09 62.26 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.167 0.432 . . . . 74.340000000000003 112.167 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.51 -45.13 94.94 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.227 -0.511 . . . . 65.239999999999995 113.198 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.12 -42.94 99.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.767 0.318 . . . . 65.329999999999998 111.164 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.0 -44.75 91.72 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.012 0.434 . . . . 72.239999999999995 110.827 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.7 m -61.91 -36.63 81.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.086 -0.506 . . . . 74.219999999999999 111.053 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -60.9 -56.38 21.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.215 -0.448 . . . . 74.109999999999999 111.59 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.5 mt -50.63 -43.43 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.902 0.382 . . . . 73.129999999999995 111.684 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 122' ' ' MET . 64.3 mt -61.23 -51.31 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.296 -0.411 . . . . 74.010000000000005 111.754 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.445 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 25.1 m-70 -74.02 -48.17 31.99 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.025 0.75 . . . . 70.239999999999995 113.025 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.35 -54.19 22.79 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.592 0.59 . . . . 73.200000000000003 112.592 -174.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -97.33 -45.14 6.6 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.604 0.594 . . . . 75.030000000000001 112.604 -172.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.65 ' SD ' HG22 ' A' ' 97' ' ' VAL . 49.3 mtt -73.32 -54.26 8.79 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.708 1.003 . . . . 64.129999999999995 113.708 -173.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.489 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 32.8 mm -47.48 -51.86 40.9 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 113.391 0.886 . . . . 72.329999999999998 113.391 -175.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 72.0 Cg_exo -50.49 -39.59 54.79 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.155 1.903 . . . . 72.299999999999997 113.048 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.449 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 85.5 m-70 -74.42 -49.95 20.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.6 -0.273 . . . . 74.340000000000003 111.656 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.6 m-30 -56.34 -43.13 78.76 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.598 0.221 . . . . 61.310000000000002 111.598 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.5 -42.36 87.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.921 0.391 . . . . 63.409999999999997 111.302 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.7 m -74.94 -13.46 60.53 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.268 -0.423 . . . . 62.210000000000001 111.75 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.48 -0.69 59.89 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.286 -0.483 . . . . 72.129999999999995 112.52 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.606 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.8 m-20 -80.37 66.66 5.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.737 0.415 . . . . 74.299999999999997 111.303 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -65.13 -46.02 82.66 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.174 -0.329 . . . . 73.430000000000007 111.785 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.69 95.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.007 0.432 . . . . 72.310000000000002 111.462 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 51.9 mm-40 -59.82 -47.2 86.69 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.146 -0.479 . . . . 72.230000000000004 111.365 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.71 93.13 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.302 -0.475 . . . . 74.510000000000005 113.008 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.35 -43.05 96.86 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.808 0.337 . . . . 65.239999999999995 111.051 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.4 t -56.21 -53.48 56.63 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 70.109999999999999 111.904 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -68.4 -33.45 74.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.609 0.242 . . . . 72.019999999999996 111.395 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.555 ' HA3' ' HE2' ' A' ' 122' ' ' MET . . . -61.18 -52.46 51.74 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.072 -0.585 . . . . 64.430000000000007 112.712 176.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.695 HG23 ' SD ' ' A' ' 36' ' ' MET . 90.8 t -62.63 -43.6 98.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.023 0.44 . . . . 74.209999999999994 111.227 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.19 -38.36 76.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.262 -0.427 . . . . 74.310000000000002 110.929 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -61.31 -51.84 67.18 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.9 0.381 . . . . 72.219999999999999 111.052 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 85.7 t -54.32 -49.7 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.162 0.506 . . . . 75.049999999999997 110.972 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.409 ' HB2' HD12 ' A' ' 43' ' ' ILE . 36.5 tt0 -53.43 -46.5 69.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.974 -0.557 . . . . 72.219999999999999 111.653 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -65.09 -34.22 77.89 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.943 0.349 . . . . 64.239999999999995 111.943 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 141' ' ' ALA . 92.8 t -63.28 -49.07 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.064 0.459 . . . . 73.239999999999995 111.004 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.85 -57.06 8.79 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.051 0.453 . . . . 74.430000000000007 111.425 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.69 -37.94 85.98 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.12 -0.491 . . . . 73.230000000000004 111.943 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.28 -41.02 92.76 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.313 -0.47 . . . . 73.129999999999995 113.461 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 52.9 m -81.05 -41.26 22.9 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.051 0.453 . . . . 73.209999999999994 111.572 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.478 HD13 ' ND1' ' A' ' 47' ' ' HIS . 92.2 mt -81.04 75.77 8.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.428 0.633 . . . . 72.450000000000003 111.915 -177.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -84.44 -53.31 5.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.678 -0.692 . . . . 74.209999999999994 110.08 175.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -126.58 115.21 19.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.731 -0.668 . . . . 75.430000000000007 111.329 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -79.5 137.47 37.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 64.030000000000001 109.943 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -70.35 -10.46 59.1 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.502 0.556 . . . . 73.530000000000001 112.502 -173.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -74.69 142.68 44.42 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.648 0.261 . . . . 74.319999999999993 111.302 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -84.01 149.96 25.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.984 0.421 . . . . 74.430000000000007 111.818 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.932 -0.556 . . . . 73.439999999999998 111.082 179.529 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.562 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.265 0.555 . . . . 75.150000000000006 111.884 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 30.1 ttp180 -137.41 101.66 4.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.169 -0.469 . . . . 73.109999999999999 109.917 175.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.1 t -75.95 117.55 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 113.133 0.79 . . . . 75.019999999999996 113.133 -171.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -109.1 152.56 24.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.742 -0.663 . . . . 73.209999999999994 111.518 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.491 ' O ' HG21 ' A' ' 9' ' ' VAL . 40.7 mtmt -111.91 157.95 38.15 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.207 -0.451 . . . . 73.329999999999998 110.335 173.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.518 ' HD3' ' CE2' ' A' ' 67' ' ' PHE . 30.3 Cg_endo -62.33 -26.11 76.89 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.912 1.741 . . . . 71.340000000000003 111.323 176.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.447 ' HA ' HE22 ' A' ' 74' ' ' GLN . 18.1 mt-10 -79.26 -20.2 48.71 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.566 -0.743 . . . . 74.340000000000003 111.067 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -94.06 -24.49 17.58 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.855 -0.611 . . . . 62.32 111.511 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 5' ' ' LYS . 95.6 t -66.71 132.52 94.06 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.226 -0.443 . . . . 71.510000000000005 111.648 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.08 121.05 9.19 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.633 2.222 . . . . 73.409999999999997 113.106 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.531 ' OD1' ' HB3' ' A' ' 14' ' ' LEU . 2.8 p30 -70.34 85.95 0.59 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.477 0.547 . . . . 73.329999999999998 112.477 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.66 -26.77 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 112.223 0.453 . . . . 72.319999999999993 112.223 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.548 HE22 ' HA ' ' A' ' 20' ' ' LEU . 1.6 mp0 -87.22 31.29 0.73 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.593 0.711 . . . . 74.219999999999999 111.365 173.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.531 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 4.7 tt -143.43 -50.75 0.33 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.378 -0.971 . . . . 64.299999999999997 108.378 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -109.52 120.37 42.29 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.604 -0.725 . . . . 73.409999999999997 110.307 170.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 6.8 m-20 71.13 48.42 0.37 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.329 0.652 . . . . 72.310000000000002 111.646 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -59.45 -11.96 5.36 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.961 0.726 . . . . 61.229999999999997 112.961 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 t -60.86 -34.67 74.96 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.142 -0.349 . . . . 75.019999999999996 111.319 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 19' ' ' ARG . 8.0 ptp85 -97.12 132.48 42.86 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.096 0.474 . . . . 72.219999999999999 110.375 175.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.548 ' HA ' HE22 ' A' ' 13' ' ' GLN . 5.6 mp -108.63 12.67 25.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.153 0.501 . . . . 74.030000000000001 110.896 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.7 t -110.75 146.94 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.135 -0.484 . . . . 72.299999999999997 111.478 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 m -131.21 124.17 30.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.359 -0.382 . . . . 74.409999999999997 110.57 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' HA ' ' HG1' ' A' ' 55' ' ' THR . 8.4 p-10 -114.35 86.03 2.35 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.405 0.621 . . . . 73.310000000000002 112.492 -174.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.04 -38.48 8.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.908 0.385 . . . . 74.420000000000002 110.75 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.1 -26.65 64.08 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.982 0.42 . . . . 72.349999999999994 111.126 170.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.91 25.74 75.21 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.254 -0.498 . . . . 74.420000000000002 113.234 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.06 10.89 12.96 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.928 0.344 . . . . 74.400000000000006 111.928 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.457 HD23 HD12 ' A' ' 135' ' ' LEU . 97.0 mt -120.17 119.96 34.79 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.838 0.351 . . . . 74.329999999999998 111.438 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 31.5 t -81.05 159.49 24.77 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.554 -0.294 . . . . 74.219999999999999 110.72 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -54.61 -40.54 69.0 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.169 0.803 . . . . 72.150000000000006 113.169 -173.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.32 91.9 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.071 0.462 . . . . 75.420000000000002 111.247 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' A' ' 29' ' ' SER . 18.4 mp0 -66.93 -41.05 87.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.786 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.97 -44.05 91.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.968 0.413 . . . . 72.439999999999998 110.713 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -57.56 -57.58 12.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.754 -0.657 . . . . 75.319999999999993 111.552 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.73 -47.17 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.154 -0.475 . . . . 74.299999999999997 111.771 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.462 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.2 ttm -61.78 -51.56 67.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.528 -0.305 . . . . 74.049999999999997 111.662 -177.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -64.82 -35.76 82.15 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 121.01 -0.276 . . . . 63.509999999999998 111.326 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.77 -47.21 87.48 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.997 -0.62 . . . . 52.329999999999998 112.691 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.49 ' O ' HG13 ' A' ' 43' ' ' ILE . 7.4 mtp180 -67.06 -49.71 64.22 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.782 0.289 . . . . 74.430000000000007 111.782 176.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 36' ' ' MET . 91.2 mt -56.31 -41.18 75.55 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.267 0.556 . . . . 74.239999999999995 111.404 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -61.87 -46.63 88.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.078 -0.51 . . . . 75.349999999999994 110.419 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.21 86.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.984 0.421 . . . . 74.0 111.437 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 39' ' ' ARG . 75.9 mt -58.14 -49.8 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.365 -0.38 . . . . 75.519999999999996 111.434 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 26.3 ttp85 -69.09 -25.74 64.58 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.853 0.316 . . . . 75.299999999999997 111.853 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.9 t -83.28 -33.42 25.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.089 0.471 . . . . 73.109999999999999 111.892 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.7 t -97.24 -67.22 0.86 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.139 0.495 . . . . 73.439999999999998 111.672 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -74.27 -16.47 60.94 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.264 -0.425 . . . . 74.299999999999997 111.386 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 71.02 9.88 6.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.205 0.602 . . . . 74.329999999999998 112.087 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.857 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 85.8 t -81.41 122.52 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.98 0.419 . . . . 75.329999999999998 111.861 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.71 96.66 7.61 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.178 0.513 . . . . 73.219999999999999 110.226 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -111.94 105.13 13.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.909 -0.587 . . . . 73.400000000000006 110.863 -175.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.04 145.4 29.94 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.58 0.585 . . . . 73.129999999999995 112.58 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.53 107.76 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.022 0.439 . . . . 73.140000000000001 110.902 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.67 134.94 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.846 0.355 . . . . 74.010000000000005 111.53 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.403 ' HG1' ' HA ' ' A' ' 23' ' ' ASP . 62.9 p -113.52 122.53 47.56 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.753 0.311 . . . . 72.329999999999998 111.111 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -130.23 137.0 29.89 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 120.848 0.356 . . . . 75.310000000000002 111.542 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.436 ' HG2' ' O ' ' A' ' 2' ' ' ARG . 39.3 Cg_endo -67.09 -53.94 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.598 2.199 . . . . 65.010000000000005 113.264 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 20.3 m -141.75 136.11 30.42 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.17 -0.331 . . . . 73.209999999999994 111.649 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.469 HD12 ' NE2' ' A' ' 94' ' ' GLN . 31.9 pt -106.81 -28.91 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.92 0.39 . . . . 75.030000000000001 110.89 174.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.29 -116.53 7.18 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.124 -0.489 . . . . 44.420000000000002 114.229 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.78 -23.33 66.69 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.348 0.499 . . . . 72.349999999999994 112.348 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.28 128.17 86.53 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.4 0.519 . . . . 65.109999999999999 112.4 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.696 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 61.2 Cg_endo -73.38 136.11 23.49 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.581 2.187 . . . . 72.540000000000006 112.156 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.1 tp -52.57 -47.71 66.67 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.979 0.733 . . . . 74.200000000000003 112.979 -174.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.3 -58.24 8.44 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.132 -0.355 . . . . 71.109999999999999 111.628 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.696 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 1.8 m-20 -59.71 -29.79 68.35 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.743 0.306 . . . . 72.540000000000006 111.507 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CE2' ' HD3' ' A' ' 6' ' ' PRO . 26.5 t80 -61.52 -55.35 32.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.309 -0.405 . . . . 73.329999999999998 110.768 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.2 p -57.3 -39.85 76.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.297 -0.411 . . . . 74.230000000000004 111.325 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.494 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 53.9 tp -57.79 -53.98 52.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.4 -0.364 . . . . 74.439999999999998 111.469 177.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -51.87 -52.66 48.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.909 0.385 . . . . 72.219999999999999 111.673 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.404 HD23 HD23 ' A' ' 87' ' ' LEU . 33.6 tp -63.04 -38.61 91.89 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 111.3 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.86 -44.19 93.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.293 -0.412 . . . . 71.25 111.793 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 78' ' ' GLY . 20.6 mtm180 -66.95 -40.67 87.59 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.798 0.332 . . . . 75.150000000000006 110.927 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.447 HE22 ' HA ' ' A' ' 7' ' ' GLU . 7.7 tt0 -58.64 -42.06 87.42 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.016 0.436 . . . . 73.340000000000003 111.402 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -87.29 7.39 28.87 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.354 0.502 . . . . 71.329999999999998 112.354 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.71 -42.58 3.14 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.125 -0.559 . . . . 74.310000000000002 113.921 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -52.62 -17.5 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 113.647 0.98 . . . . 72.299999999999997 113.647 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.555 ' O ' ' HG2' ' A' ' 73' ' ' ARG . . . -135.63 26.38 3.18 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.376 -0.916 . . . . 71.109999999999999 114.718 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -40.79 -62.32 0.82 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.104 0.952 . . . . 75.239999999999995 111.36 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 11.0 pt-20 -140.57 51.2 1.66 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.918 -0.771 . . . . 72.329999999999998 108.918 166.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 5.0 mptp? 71.26 85.0 0.13 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.565 -1.198 . . . . 73.049999999999997 111.622 -171.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.412 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 53.3 t30 -72.8 155.9 39.46 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.392 -0.595 . . . . 73.120000000000005 109.392 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -53.65 -93.03 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 112.761 0.652 . . . . 73.010000000000005 112.761 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.857 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.1 m-20 -78.52 74.86 5.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.572 -0.705 . . . . 60.32 111.945 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.19 139.15 9.86 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.166 -0.54 . . . . 55.210000000000001 113.174 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 99' ' ' PHE . 47.7 tp -152.89 127.84 9.64 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.889 0.376 . . . . 75.140000000000001 111.131 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.404 HD23 HD23 ' A' ' 71' ' ' LEU . 64.0 tp -117.39 124.55 49.14 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.936 0.398 . . . . 74.519999999999996 112.045 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 45.4 tp -111.89 121.55 45.34 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.085 -0.507 . . . . 74.519999999999996 110.78 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.8 t -122.93 121.96 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 120.821 0.343 . . . . 75.329999999999998 111.82 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.669 ' HA ' HG13 ' A' ' 97' ' ' VAL . 35.0 tp -96.21 118.46 32.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.173 -0.467 . . . . 71.140000000000001 111.282 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.2 t -103.61 100.1 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.634 0.254 . . . . 75.109999999999999 111.099 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.8 tp -54.01 -40.65 67.19 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.119 0.485 . . . . 73.400000000000006 111.474 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 25.3 t70 -48.38 -30.69 5.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.523 0.729 . . . . 73.430000000000007 112.872 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 43.2 mt-30 -125.5 1.56 7.63 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.361 -0.212 . . . . 75.140000000000001 111.557 -178.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 9.3 ptp180 47.06 27.15 0.72 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.088 0.955 . . . . 73.140000000000001 112.278 -173.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 90.5 mtt180 -117.04 154.59 30.7 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.041 0.448 . . . . 74.219999999999999 111.498 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.669 HG13 ' HA ' ' A' ' 90' ' ' LEU . 4.1 m -134.32 171.26 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.912 -0.585 . . . . 75.420000000000002 111.328 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -152.29 144.42 23.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.831 0.348 . . . . 73.109999999999999 111.681 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.679 ' HB3' HD11 ' A' ' 86' ' ' LEU . 77.9 m-85 -104.49 105.58 15.75 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.991 -0.55 . . . . 73.109999999999999 110.372 173.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -83.13 112.58 19.95 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.118 -0.364 . . . . 75.5 110.308 177.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 109' ' ' LEU . 1.6 p -88.9 143.36 26.93 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.374 0.879 . . . . 72.239999999999995 113.374 -176.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -90.87 -177.97 43.66 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 114.894 -1.048 . . . . 71.519999999999996 112.384 168.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -60.93 -25.06 66.51 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.588 0.588 . . . . 74.420000000000002 112.588 -175.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.4 -22.85 57.95 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.886 -0.674 . . . . 74.120000000000005 113.413 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 86' ' ' LEU . 93.5 mt -108.84 4.77 23.89 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.535 0.569 . . . . 74.549999999999997 112.535 -174.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -56.79 -38.63 72.81 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.043 0.449 . . . . 74.120000000000005 111.889 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.85 -42.7 10.78 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.317 -0.468 . . . . 70.140000000000001 113.382 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -72.07 -41.7 67.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.137 0.494 . . . . 75.519999999999996 111.791 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.605 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.0 mt -131.75 83.9 56.21 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 115.974 -0.557 . . . . 74.400000000000006 111.991 -170.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.49 155.81 24.82 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.402 2.068 . . . . 60.439999999999998 112.365 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.0 -36.2 12.29 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.511 0.56 . . . . 74.319999999999993 112.511 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.46 -50.12 69.99 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.126 -0.559 . . . . 74.409999999999997 112.912 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.52 -42.71 99.22 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.276 0.56 . . . . 74.540000000000006 111.028 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.659 HD13 ' HB2' ' A' ' 99' ' ' PHE . 65.5 mt -62.43 -40.75 97.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.665 -0.698 . . . . 75.129999999999995 111.132 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.4 m -71.22 -32.25 68.58 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.178 -0.465 . . . . 75.049999999999997 111.419 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -56.02 -55.95 26.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.729 -0.214 . . . . 71.239999999999995 111.002 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.7 mt -51.0 -47.11 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.137 0.494 . . . . 72.420000000000002 111.031 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.564 ' O ' HG12 ' A' ' 123' ' ' ILE . 61.1 mt -55.97 -51.51 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.8 -0.636 . . . . 73.25 111.615 177.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -81.57 -11.45 59.15 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.944 0.72 . . . . 73.439999999999998 112.944 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -86.48 -52.42 5.59 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.788 0.292 . . . . 71.340000000000003 111.788 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.99 -39.86 2.06 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.109 0.781 . . . . 74.430000000000007 113.109 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.51 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 45.3 mtt -51.52 -52.64 45.23 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.664 0.616 . . . . 73.129999999999995 112.664 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.635 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 49.9 mm -53.01 -56.8 19.98 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 111.992 0.367 . . . . 73.400000000000006 111.992 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 82.6 Cg_exo -48.09 -47.08 20.35 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.301 2.001 . . . . 71.049999999999997 113.328 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -62.97 -49.19 75.68 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.695 0.284 . . . . 75.0 111.637 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.1 m-30 -57.49 -42.31 82.45 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.819 0.303 . . . . 73.519999999999996 111.819 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 70.5 mtp180 -66.66 -30.77 71.11 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.999 0.428 . . . . 71.430000000000007 111.152 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.9 m -78.08 -14.09 59.62 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.399 -0.364 . . . . 75.120000000000005 111.478 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.18 -7.02 62.02 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.292 -0.48 . . . . 72.230000000000004 112.473 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.719 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.9 m-20 -79.78 57.01 2.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.866 0.365 . . . . 74.510000000000005 111.602 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -61.63 -37.79 85.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.915 0.388 . . . . 71.239999999999995 111.322 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.404 ' HB1' ' HG2' ' A' ' 32' ' ' GLN . . . -64.87 -49.83 68.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.164 -0.471 . . . . 65.239999999999995 111.376 176.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.719 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 14.6 mp0 -63.03 -35.47 80.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.954 -0.566 . . . . 72.540000000000006 111.69 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.91 -55.12 30.1 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.152 -0.547 . . . . 72.530000000000001 112.352 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.457 HD12 HD23 ' A' ' 28' ' ' LEU . 89.0 mt -58.64 -38.17 77.52 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.39 -0.477 . . . . 73.510000000000005 110.949 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 58.0 m -60.02 -47.54 85.43 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.119 -0.491 . . . . 61.549999999999997 112.088 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.19 -36.02 66.47 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.102 -0.374 . . . . 73.0 111.207 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.452 ' HA3' ' HE2' ' A' ' 122' ' ' MET . . . -60.36 -49.73 75.38 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.31 -0.472 . . . . 71.319999999999993 113.031 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 135' ' ' LEU . 53.2 t -53.11 -47.76 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.055 0.455 . . . . 73.209999999999994 111.255 175.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 53.6 tp -62.8 -42.86 99.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.125 -0.489 . . . . 75.319999999999993 110.805 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.78 -47.68 84.71 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.962 0.41 . . . . 63.229999999999997 111.585 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.82 -47.37 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.331 -0.395 . . . . 64.299999999999997 111.246 176.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -56.67 -40.53 75.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.417 -0.356 . . . . 75.140000000000001 111.464 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 18.3 mm-40 -53.98 -35.13 61.49 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.195 0.442 . . . . 74.200000000000003 112.195 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.98 -42.23 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 120.993 0.425 . . . . 74.0 111.014 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.5 mt -71.08 -44.89 64.79 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.094 0.473 . . . . 74.120000000000005 111.218 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.85 -24.02 67.41 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.067 -0.515 . . . . 62.039999999999999 111.768 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.46 -5.53 85.88 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.049 -0.596 . . . . 60.409999999999997 112.332 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.9 t -104.89 -66.78 0.95 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.018 0.527 . . . . 75.239999999999995 111.321 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 87.6 mt 57.76 17.87 4.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.452 0.538 . . . . 64.319999999999993 112.452 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -69.29 -22.17 63.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.976 0.362 . . . . 73.549999999999997 111.976 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -74.66 93.17 2.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.778 0.323 . . . . 75.099999999999994 111.742 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.421 ' CG ' ' N ' ' A' ' 154' ' ' HIS . 45.1 t-80 -91.37 173.66 7.8 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 120.832 0.349 . . . . 75.439999999999998 111.109 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.421 ' N ' ' CG ' ' A' ' 153' ' ' HIS . 22.6 t60 -51.16 87.39 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.349 0.66 . . . . 72.209999999999994 112.737 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -102.64 -53.08 2.95 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.347 -0.388 . . . . 75.299999999999997 110.769 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -70.42 128.58 36.65 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.028 0.442 . . . . 73.129999999999995 111.119 177.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.3 p80 . . . . . 0 C--O 1.253 1.262 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 111.6 -177.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.733 0.301 . . . . 74.239999999999995 111.572 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -167.43 -46.8 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.349 0.595 . . . . 74.340000000000003 111.392 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.3 t 65.82 91.48 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 114.611 -1.177 . . . . 64.310000000000002 111.533 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -72.78 157.71 36.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.486 -0.779 . . . . 71.519999999999996 112.592 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.666 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 33.8 mmtp -136.58 160.76 65.37 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 114.965 -1.016 . . . . 72.319999999999993 109.808 174.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.88 -41.41 63.34 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.396 2.064 . . . . 74.519999999999996 112.834 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -86.49 7.65 25.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.979 0.419 . . . . 71.129999999999995 111.758 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.666 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 29.8 t70 -106.03 -34.26 7.63 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.166 0.508 . . . . 74.319999999999993 110.268 174.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 5' ' ' LYS . 65.1 t -65.89 129.58 94.3 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.675 -0.693 . . . . 75.510000000000005 111.503 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.44 123.99 13.84 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.498 2.132 . . . . 75.25 112.497 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -69.67 91.39 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.058 0.456 . . . . 75.530000000000001 111.947 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -69.98 -38.37 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.278 -0.419 . . . . 75.120000000000005 111.971 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 14.3 mm100 -64.77 170.25 4.35 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.8 -0.562 . . . . 62.439999999999998 110.79 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 20.2 mt 73.88 -41.6 0.49 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.423 0.527 . . . . 74.439999999999998 112.423 -173.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.09 -62.89 1.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.297 0.48 . . . . 73.519999999999996 112.297 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -84.76 32.39 0.52 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.113 0.482 . . . . 64.409999999999997 111.715 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -71.42 12.92 0.28 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.549 0.574 . . . . 71.120000000000005 112.549 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.2 p -77.47 -42.55 35.41 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.91 0.386 . . . . 74.409999999999997 110.974 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -98.71 -32.6 11.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.114 -0.494 . . . . 71.340000000000003 112.033 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.593 HD21 ' HG3' ' A' ' 44' ' ' ARG . 5.3 mp 62.18 11.98 4.77 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.069 0.396 . . . . 73.239999999999995 112.069 -176.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.07 136.03 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.797 0.332 . . . . 72.519999999999996 111.688 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.505 HG21 ' HG2' ' A' ' 24' ' ' GLU . 24.8 m -110.81 106.71 15.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.42 -0.355 . . . . 75.099999999999994 110.417 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -95.94 78.01 3.19 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.432 0.634 . . . . 65.129999999999995 112.361 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.505 ' HG2' HG21 ' A' ' 22' ' ' THR . 21.0 mm-40 -102.45 -46.65 4.71 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.042 0.449 . . . . 74.450000000000003 110.909 176.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.36 -23.74 67.54 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.168 0.433 . . . . 62.0 112.168 174.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.87 33.8 88.04 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.367 -0.444 . . . . 75.530000000000001 113.481 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.476 HD13 ' HB2' ' A' ' 92' ' ' LEU . 94.3 mt -92.02 12.62 21.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.09 0.404 . . . . 70.230000000000004 112.09 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -121.62 125.78 47.5 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.04 0.448 . . . . 75.310000000000002 111.472 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.3 t -77.26 172.29 13.51 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.121 -0.491 . . . . 65.439999999999998 110.712 173.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -54.72 -47.62 73.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.985 0.422 . . . . 54.310000000000002 111.331 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.44 ' O ' HG21 ' A' ' 35' ' ' VAL . . . -63.74 -48.28 77.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.41 -0.359 . . . . 64.5 111.533 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -59.69 -42.84 93.87 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.15 0.5 . . . . 72.109999999999999 111.339 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -64.84 -47.44 77.94 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.623 -0.717 . . . . 72.329999999999998 109.949 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.98 -53.76 54.4 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.168 -0.469 . . . . 74.519999999999996 111.982 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 31' ' ' ALA . 99.0 t -54.8 -47.16 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.961 0.41 . . . . 75.450000000000003 111.246 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.448 ' HE2' ' HB3' ' A' ' 135' ' ' LEU . 44.1 ttm -63.01 -42.97 99.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.442 -0.344 . . . . 74.310000000000002 111.227 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.416 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -57.09 -48.66 78.06 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.969 0.414 . . . . 74.209999999999994 111.094 176.382 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.9 -47.19 90.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.155 -0.475 . . . . 73.5 113.002 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 43' ' ' ILE . 99.6 mtt180 -62.6 -54.84 33.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 111.901 0.334 . . . . 74.340000000000003 111.901 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' A' ' 51' ' ' PHE . 70.9 mt -58.2 -48.17 81.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.868 0.366 . . . . 71.200000000000003 111.419 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -58.21 -47.05 84.68 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.331 -0.395 . . . . 62.539999999999999 111.098 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.9 -45.11 86.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.195 -0.457 . . . . 72.129999999999995 111.339 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.565 HG21 ' HB ' ' A' ' 49' ' ' VAL . 64.3 mt -65.97 -46.32 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.086 0.469 . . . . 71.310000000000002 111.274 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.593 ' HG3' HD21 ' A' ' 20' ' ' LEU . 5.5 tmm_? -65.9 -26.04 67.43 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 111.417 -176.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 t -91.77 -54.54 3.83 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.807 0.337 . . . . 75.230000000000004 111.549 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.3 t -67.63 -58.8 4.05 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.307 0.484 . . . . 74.010000000000005 112.307 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.49 -11.29 52.15 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.396 -0.365 . . . . 72.530000000000001 111.5 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.08 24.04 12.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.905 0.482 . . . . 51.020000000000003 111.993 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.565 ' HB ' HG21 ' A' ' 43' ' ' ILE . 90.2 t -96.28 117.28 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.24 -0.436 . . . . 73.239999999999995 111.576 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.03 96.16 2.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.082 0.467 . . . . 72.230000000000004 110.432 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.418 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -104.44 98.59 8.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.769 -0.65 . . . . 74.140000000000001 109.984 -179.063 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -102.52 119.71 39.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.1 0.407 . . . . 72.109999999999999 112.1 -175.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.454 HG23 HD23 ' A' ' 88' ' ' LEU . 96.0 t -104.91 110.86 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.282 0.563 . . . . 73.129999999999995 111.4 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.449 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 48.4 t -106.55 121.93 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.08 -0.509 . . . . 63.329999999999998 111.081 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 p -106.58 121.87 45.17 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.816 0.341 . . . . 74.340000000000003 110.92 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -126.4 139.63 35.13 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.553 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.55 -56.68 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.335 2.024 . . . . 70.319999999999993 112.86 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.6 p -144.96 139.48 27.57 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 111.933 0.345 . . . . 74.099999999999994 111.933 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.593 HG12 HG13 ' A' ' 91' ' ' VAL . 35.3 pt -117.65 -10.84 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 121.112 0.482 . . . . 73.349999999999994 110.826 171.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.27 -127.99 32.93 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.177 -0.465 . . . . 64.129999999999995 114.04 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.81 -16.62 63.84 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.841 0.682 . . . . 72.340000000000003 112.841 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.12 130.6 50.5 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 112.936 0.717 . . . . 54.140000000000001 112.936 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.629 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 60.6 Cg_endo -72.0 133.19 21.09 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.747 2.298 . . . . 73.239999999999995 112.054 174.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.57 -48.19 82.1 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.934 0.716 . . . . 73.409999999999997 112.934 -171.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -67.85 -45.87 73.4 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.117 -0.364 . . . . 73.329999999999998 111.918 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.629 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 33.3 m-20 -61.85 -37.85 86.04 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.979 0.418 . . . . 62.140000000000001 110.857 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.46 -50.07 75.05 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.125 -0.489 . . . . 72.340000000000003 111.042 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 78.0 p -63.14 -48.33 78.91 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.594 -0.275 . . . . 63.409999999999997 111.313 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.487 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 54.4 tp -54.87 -46.73 74.77 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.097 0.475 . . . . 72.310000000000002 111.196 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -54.86 -49.51 70.93 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.003 0.43 . . . . 74.319999999999993 111.66 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 tp -67.97 -36.61 80.35 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.054 -0.521 . . . . 74.219999999999999 111.639 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 77' ' ' VAL . . . -67.77 -39.94 84.08 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.388 -0.369 . . . . 71.0 111.776 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 41.1 mtp-105 -57.43 -54.23 49.18 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.077 0.399 . . . . 74.25 112.077 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.446 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.5 pt20 -64.28 -23.04 67.16 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.347 0.499 . . . . 75.409999999999997 112.347 -177.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.446 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 40.8 m0 -92.17 -15.29 27.82 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.809 0.3 . . . . 75.200000000000003 111.809 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.71 30.03 60.43 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.226 -0.512 . . . . 74.120000000000005 113.122 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.637 HG13 ' H ' ' A' ' 78' ' ' GLY . 3.4 t -134.66 179.36 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.0 0.52 . . . . 74.200000000000003 109.725 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.637 ' H ' HG13 ' A' ' 77' ' ' VAL . . . 60.11 -120.04 21.03 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.291 -0.48 . . . . 74.319999999999993 113.809 173.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB3' ' H ' ' A' ' 80' ' ' GLU . 21.2 m-80 56.86 -159.55 0.24 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.546 0.689 . . . . 73.319999999999993 112.218 177.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.411 ' H ' ' HB3' ' A' ' 79' ' ' ASN . 9.6 pt-20 -114.03 14.8 18.44 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.732 -0.667 . . . . 74.150000000000006 111.55 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -153.16 16.49 0.55 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.862 1.06 . . . . 71.340000000000003 113.862 -177.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.615 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 6.1 m120 -90.49 136.66 32.92 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.312 0.577 . . . . 74.540000000000006 112.306 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.411 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.2 OUTLIER -83.65 136.32 34.26 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.382 -0.372 . . . . 71.319999999999993 111.631 176.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.602 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 2.0 m-20 52.29 21.89 1.82 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.944 0.72 . . . . 71.340000000000003 112.944 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.66 129.43 9.89 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.205 -0.521 . . . . 60.140000000000001 113.176 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.593 HD12 ' HB3' ' A' ' 99' ' ' PHE . 39.8 tp -142.32 119.47 11.43 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.193 0.521 . . . . 75.099999999999994 111.441 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.8 tp -107.2 139.88 40.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.368 -0.378 . . . . 73.430000000000007 111.279 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.454 HD23 HG23 ' A' ' 53' ' ' VAL . 53.5 tp -131.76 114.06 14.29 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.529 -0.305 . . . . 75.019999999999996 111.04 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.27 121.51 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.076 0.399 . . . . 73.219999999999999 112.076 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.577 ' HA ' HG13 ' A' ' 97' ' ' VAL . 24.1 tp -101.37 129.29 47.34 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 111.223 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.593 HG13 HG12 ' A' ' 59' ' ' ILE . 31.9 t -115.02 99.2 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.92 0.39 . . . . 53.140000000000001 111.29 176.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.476 ' HB2' HD13 ' A' ' 27' ' ' LEU . 67.1 tp -51.54 -41.23 60.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.162 0.585 . . . . 72.120000000000005 112.357 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.22 -43.15 52.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.407 0.683 . . . . 71.140000000000001 112.748 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -118.54 8.51 12.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.104 0.409 . . . . 72.209999999999994 112.104 -174.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 59.46 20.02 8.41 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.706 1.002 . . . . 74.140000000000001 113.706 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -122.17 154.23 37.73 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.669 -0.644 . . . . 73.439999999999998 112.194 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.761 HG23 ' SD ' ' A' ' 122' ' ' MET . 6.3 m -129.24 171.39 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.654 -0.703 . . . . 64.329999999999998 111.382 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -147.66 130.08 15.76 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.34 -0.391 . . . . 74.030000000000001 111.842 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.698 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 93.8 m-85 -90.45 141.95 28.23 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.922 -0.581 . . . . 73.040000000000006 109.441 168.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -133.04 112.29 11.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.961 0.41 . . . . 73.450000000000003 111.914 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.584 HG21 HD13 ' A' ' 86' ' ' LEU . 17.5 p -106.83 142.02 37.13 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.008 -0.542 . . . . 63.420000000000002 111.223 175.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA3' ' H ' ' A' ' 82' ' ' ASN . . . -87.37 -83.98 1.17 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.805 -0.712 . . . . 63.409999999999997 113.724 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -137.1 -41.53 0.58 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.004 0.43 . . . . 75.219999999999999 111.397 -174.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.602 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -58.52 -39.43 93.11 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.257 -0.429 . . . . 72.340000000000003 114.071 -175.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.514 HD12 HG12 ' A' ' 49' ' ' VAL . 93.3 mt -91.97 -2.6 56.66 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.013 0.746 . . . . 74.439999999999998 113.013 -174.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -57.64 -21.66 40.99 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.556 0.576 . . . . 73.209999999999994 112.556 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.74 -28.58 56.76 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.91 -0.662 . . . . 71.439999999999998 112.894 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -109.97 -60.31 1.81 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.898 0.38 . . . . 64.549999999999997 111.043 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.425 HD13 HD13 ' A' ' 105' ' ' LEU . 16.3 mt -111.77 88.31 9.53 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.171 0.588 . . . . 72.030000000000001 111.563 -178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.16 152.26 18.39 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.969 1.779 . . . . 61.409999999999997 112.102 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -47.85 -36.32 11.81 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.685 0.279 . . . . 70.200000000000003 111.709 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.17 -49.9 73.52 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.253 -0.499 . . . . 61.420000000000002 113.182 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.73 -44.58 96.46 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.259 0.552 . . . . 74.439999999999998 111.045 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.698 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 66.6 mt -60.54 -44.54 96.0 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.753 -0.658 . . . . 64.209999999999994 110.874 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -59.74 -38.29 81.32 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.823 -0.626 . . . . 74.319999999999993 110.934 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.4 ttt-85 -60.27 -56.23 24.04 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.068 -0.514 . . . . 74.349999999999994 110.947 175.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 60.2 mt -51.01 -39.48 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 120.821 0.343 . . . . 75.329999999999998 111.784 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.524 ' O ' HG12 ' A' ' 123' ' ' ILE . 77.6 mt -55.84 -56.17 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.53 -0.305 . . . . 75.150000000000006 111.033 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -77.4 -23.59 50.63 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.382 0.512 . . . . 72.120000000000005 112.382 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -78.25 -40.31 37.58 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.164 0.431 . . . . 62.32 112.164 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 -126.12 -54.18 1.5 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.262 0.838 . . . . 73.129999999999995 113.262 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.761 ' SD ' HG23 ' A' ' 97' ' ' VAL . 38.5 mtt -59.21 -53.65 55.91 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.052 0.76 . . . . 71.010000000000005 113.052 -175.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.62 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 mm -53.86 -53.4 58.26 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 111.677 0.251 . . . . 74.120000000000005 111.677 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 92.3 Cg_exo -47.68 -48.18 16.45 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 122.287 1.991 . . . . 71.310000000000002 113.423 174.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -62.5 -46.96 86.07 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.706 0.262 . . . . 72.219999999999999 111.706 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -60.69 -41.33 94.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.738 0.304 . . . . 75.409999999999997 111.361 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 79.8 mtp180 -63.2 -31.43 72.58 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.045 0.45 . . . . 75.120000000000005 111.27 176.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.2 t -82.87 -18.37 40.54 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.261 -0.427 . . . . 64.340000000000003 111.449 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.88 1.92 34.27 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.545 -0.359 . . . . 73.510000000000005 113.571 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.863 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 85.7 m-20 -94.07 82.07 4.16 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.411 -0.464 . . . . 74.420000000000002 112.152 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -71.53 -53.63 13.18 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.225 -0.297 . . . . 74.209999999999994 111.455 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.79 -45.96 85.3 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.093 0.473 . . . . 65.400000000000006 111.554 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 7.1 tp10 -56.21 -53.16 60.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.041 -0.527 . . . . 72.340000000000003 111.178 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.87 -43.64 96.52 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.409 -0.424 . . . . 74.340000000000003 113.514 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.499 HD13 HD21 ' A' ' 90' ' ' LEU . 93.8 mt -59.77 -56.48 21.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.03 0.443 . . . . 73.420000000000002 111.413 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 30.8 t -56.18 -54.31 46.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.382 0.512 . . . . 74.400000000000006 112.382 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -30.25 60.96 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 111.576 0.213 . . . . 74.420000000000002 111.576 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.87 -48.0 86.6 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.201 -0.523 . . . . 52.210000000000001 112.408 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.3 t -57.79 -44.94 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.132 0.491 . . . . 75.420000000000002 110.606 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.3 tp -58.44 -37.4 75.34 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.953 -0.567 . . . . 61.509999999999998 111.391 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.6 97.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.092 0.472 . . . . 74.0 111.173 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.406 HG13 HD21 ' A' ' 109' ' ' LEU . 63.8 t -65.77 -45.93 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.788 -0.642 . . . . 75.239999999999995 110.764 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -53.87 -43.33 69.5 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.789 -0.641 . . . . 75.540000000000006 111.255 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -52.35 -41.0 62.69 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.277 0.473 . . . . 73.519999999999996 112.277 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.11 -36.4 76.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.871 0.367 . . . . 74.129999999999995 111.666 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.0 -54.82 24.35 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.601 -0.272 . . . . 74.209999999999994 111.324 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -57.47 -32.73 67.27 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.848 0.356 . . . . 73.420000000000002 111.948 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.65 -37.84 29.47 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.168 -0.539 . . . . 53.109999999999999 113.609 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 151' ' ' GLU . 78.1 p -75.96 -43.67 43.6 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 122.468 -0.43 . . . . 73.299999999999997 111.932 -177.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.6 mt -73.84 22.88 0.08 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.703 0.631 . . . . 72.439999999999998 112.703 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 149' ' ' SER . 49.5 tt0 -111.09 -9.61 14.37 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.404 0.621 . . . . 70.219999999999999 110.417 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -69.81 119.22 13.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.951 -0.568 . . . . 74.010000000000005 110.091 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -56.85 83.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.508 0.929 . . . . 73.019999999999996 113.508 -171.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -139.88 113.87 8.87 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.4 -0.818 . . . . 74.200000000000003 109.34 172.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -87.03 -14.24 42.13 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.678 0.621 . . . . 75.329999999999998 112.678 -171.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -79.66 117.6 20.72 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.083 -0.385 . . . . 73.219999999999999 111.272 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 . . . . . 0 C--O 1.253 1.278 0 CA-C-O 119.066 -0.492 . . . . 74.400000000000006 111.207 177.027 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.7 t . . . . . 0 CA--C 1.543 0.705 0 CA-C-O 121.329 0.585 . . . . 71.35 112.106 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -113.35 144.62 42.45 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.937 -0.574 . . . . 51.41 111.75 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.694 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 9.8 mtmp? -122.29 171.18 6.71 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 115.648 -0.705 . . . . 74.12 109.693 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.694 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 4.4 Cg_endo -45.61 -49.84 10.16 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.769 2.313 . . . . 64.33 113.963 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.79 10.78 10.56 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.421 0.526 . . . . 74.24 112.421 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 5' ' ' LYS . 38.6 m-20 -95.14 -14.86 23.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.082 0.467 . . . . 54.52 110.579 168.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.505 HG22 HD21 ' A' ' 56' ' ' LEU . 38.9 t -89.03 128.67 51.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.085 -0.507 . . . . 75.45 110.453 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.59 118.44 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.225 1.95 . . . . 62.51 112.29 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -63.82 78.48 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.032 0.444 . . . . 61.52 111.759 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ASP . 35.7 m -63.76 -39.45 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 111.981 0.363 . . . . 62.13 111.981 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -72.93 6.2 2.78 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.907 -0.496 . . . . 64.24 111.941 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.495 ' O ' HD23 ' A' ' 14' ' ' LEU . 8.9 tt -94.75 -20.99 19.03 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.354 0.597 . . . . 74.42 109.773 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.85 -56.0 0.56 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.828 -0.624 . . . . 72.51 111.653 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' VAL . 8.1 m-20 -78.49 77.96 4.96 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.034 0.445 . . . . 73.01 111.925 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.0 p -90.09 -11.22 41.99 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.623 0.249 . . . . 53.14 111.654 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -102.04 -8.85 21.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.822 0.304 . . . . 53.41 111.822 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -99.44 -58.6 1.89 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.975 0.417 . . . . 64.13 110.856 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.3 mp 70.03 -16.2 0.3 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.274 0.842 . . . . 71.22 113.274 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.3 t -86.0 144.14 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.111 -0.368 . . . . 74.4 111.513 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -145.28 103.12 3.81 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.379 -0.373 . . . . 73.41 111.271 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.428 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 26.1 t70 -103.36 109.63 21.32 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.999 0.428 . . . . 74.1 111.478 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB2' HD23 ' A' ' 56' ' ' LEU . 8.8 mm-40 -111.45 -29.88 7.61 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.089 -0.505 . . . . 70.32 110.708 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.402 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -58.29 -31.46 67.51 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.74 0.644 . . . . 74.24 112.74 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.88 25.77 51.69 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.899 -0.667 . . . . 75.41 112.231 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.507 HD11 HD13 ' A' ' 92' ' ' LEU . 97.8 mt -96.41 -33.61 11.83 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.733 0.302 . . . . 62.41 111.109 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.83 -176.02 5.88 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.183 0.516 . . . . 75.22 111.323 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.0 t -152.69 158.68 42.71 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.787 -0.449 . . . . 64.33 109.787 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -45.06 -48.86 11.8 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.521 0.563 . . . . 73.23 112.521 -173.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -57.51 -55.91 28.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.86 0.362 . . . . 72.44 111.776 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -57.34 -42.73 82.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.991 0.424 . . . . 75.23 111.496 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -64.47 -46.45 83.01 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.122 -0.49 . . . . 60.5 111.533 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 18.9 tp10 -65.53 -41.12 93.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.863 0.363 . . . . 74.31 111.524 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 31' ' ' ALA . 96.6 t -62.4 -39.66 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.116 0.484 . . . . 62.01 110.468 174.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.5 ttm -68.26 -36.86 80.07 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.028 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 34' ' ' GLU . 92.7 m-20 -56.11 -47.23 78.48 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.969 0.414 . . . . 73.02 110.46 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.41 -37.9 92.69 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.04 -0.6 . . . . 71.32 112.786 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 43' ' ' ILE . 66.5 mtt180 -65.95 -54.54 24.96 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.824 0.345 . . . . 63.43 111.251 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.97 -42.72 99.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.858 0.361 . . . . 63.34 111.472 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -61.69 -40.45 95.04 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.334 -0.394 . . . . 54.12 111.292 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.34 92.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.894 0.378 . . . . 73.44 110.981 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.635 HG22 ' HB ' ' A' ' 49' ' ' VAL . 51.5 mt -67.7 -39.39 82.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.085 0.469 . . . . 73.4 110.85 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.451 ' NH1' ' HG2' ' A' ' 50' ' ' GLU . 8.9 tpt180 -59.06 -29.86 67.63 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.762 -0.654 . . . . 54.43 111.407 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.1 t -93.64 -66.48 0.92 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.266 -0.424 . . . . 64.34 111.474 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 t -50.37 -60.95 2.48 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.371 0.508 . . . . 33.51 112.371 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -94.88 -3.1 49.39 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.477 -0.329 . . . . 73.44 111.601 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.83 13.41 7.49 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.364 0.505 . . . . 61.3 112.364 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 43' ' ' ILE . 63.3 t -84.83 128.29 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.334 0.494 . . . . 51.42 112.334 -174.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HG2' ' NH1' ' A' ' 44' ' ' ARG . 29.9 mt-10 -80.2 95.35 6.25 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.066 -0.515 . . . . 61.42 110.026 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -112.81 103.23 11.23 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.868 0.366 . . . . 63.34 110.733 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.85 133.81 49.03 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.19 0.441 . . . . 72.12 112.19 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.59 127.72 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.363 -0.38 . . . . 71.55 111.042 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.0 t -127.64 139.58 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.798 0.332 . . . . 74.43 111.354 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 19.6 p -124.04 130.22 52.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.701 0.286 . . . . 72.51 110.368 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 9' ' ' VAL . 71.7 mt -125.71 142.72 42.88 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-O 120.724 0.297 . . . . 75.54 111.644 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 32.5 Cg_exo -61.89 -49.16 7.22 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.549 2.166 . . . . 70.44 112.175 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.429 ' HA ' ' OD1' ' A' ' 93' ' ' ASP . 46.8 m -155.17 145.8 22.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.235 -0.439 . . . . 70.1 111.733 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.606 HG12 HG11 ' A' ' 91' ' ' VAL . 32.1 pt -112.4 -5.08 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.093 0.473 . . . . 60.42 110.71 170.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.27 -109.95 2.97 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 115.929 -0.578 . . . . 72.35 113.113 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -108.72 2.25 21.69 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.213 0.449 . . . . 53.12 112.213 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.95 140.39 97.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.186 0.439 . . . . 74.12 112.186 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.527 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 47.4 Cg_endo -68.49 121.44 8.38 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.359 2.039 . . . . 73.34 112.266 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.8 tp -58.64 -51.22 70.86 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.849 0.685 . . . . 55.31 112.849 -174.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.409 ' HG2' ' HE ' ' A' ' 98' ' ' ARG . 38.8 mt-10 -62.84 -48.24 79.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.852 0.358 . . . . 72.21 111.58 -178.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.527 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 6.1 m-20 -61.99 -37.48 84.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.698 0.285 . . . . 54.21 111.542 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.479 ' HE2' ' HA ' ' A' ' 5' ' ' LYS . 41.3 t80 -56.06 -53.79 52.82 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.876 0.37 . . . . 71.43 111.358 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.502 HG21 ' HB3' ' A' ' 98' ' ' ARG . 70.3 p -55.0 -46.2 75.15 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.289 -0.414 . . . . 74.12 111.764 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 48.4 tp -58.62 -49.15 78.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.935 0.398 . . . . 52.32 111.357 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.443 ' HE3' ' HG3' ' A' ' 6' ' ' PRO . 29.0 mtpp -57.76 -43.24 85.35 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.798 0.332 . . . . 73.31 111.765 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.497 HD23 HD21 ' A' ' 87' ' ' LEU . 44.6 tp -67.96 -43.58 78.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.137 0.494 . . . . 71.42 111.302 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.45 95.31 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.237 0.458 . . . . 70.52 112.237 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 47.3 mtm180 -63.26 -47.1 83.81 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.147 0.425 . . . . 74.13 112.147 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 6' ' ' PRO . 10.7 pt20 -67.81 -31.49 71.38 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.845 0.355 . . . . 75.0 111.639 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -76.41 -15.35 59.96 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.663 0.268 . . . . 75.11 111.682 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.27 -37.02 3.54 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.192 -0.528 . . . . 64.12 113.0 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 45.1 t . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.518 0.562 . . . . 64.4 112.518 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 41.0 t30 . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 110.262 -0.273 . . . . 72.35 110.262 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 84' ' ' ASN . 36.2 p-10 -56.35 -98.89 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 112.637 0.606 . . . . 72.03 112.637 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -86.02 81.64 8.41 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.894 -1.128 . . . . 64.52 111.074 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -147.47 142.68 10.43 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.63 -0.714 . . . . 74.42 112.873 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 99' ' ' PHE . 40.2 tp -151.47 128.73 11.23 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.806 0.442 . . . . 61.24 111.084 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.497 HD21 HD23 ' A' ' 71' ' ' LEU . 55.7 tp -109.28 144.29 37.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.948 0.404 . . . . 75.32 111.269 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.0 tp -130.43 125.96 35.79 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.312 -0.404 . . . . 75.21 110.414 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.6 t -127.0 125.09 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.878 0.371 . . . . 75.45 111.895 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.571 HD22 HD11 ' A' ' 135' ' ' LEU . 18.9 tp -101.0 134.1 44.5 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.928 -0.578 . . . . 70.32 110.531 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.606 HG11 HG12 ' A' ' 59' ' ' ILE . 48.2 t -118.92 109.67 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.803 0.335 . . . . 65.32 110.978 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.507 HD13 HD11 ' A' ' 27' ' ' LEU . 67.4 tp -59.49 -44.19 93.12 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.938 0.718 . . . . 74.3 112.938 -174.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' HA ' ' A' ' 58' ' ' SER . 1.2 p-10 -69.12 -17.9 63.9 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.08 0.467 . . . . 75.33 111.478 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -103.86 -18.81 14.49 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.323 -0.399 . . . . 65.01 111.573 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 57.93 27.21 14.37 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.254 0.549 . . . . 64.53 111.688 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -121.61 157.66 30.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.18 0.514 . . . . 62.24 111.653 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.28 158.69 38.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.675 -0.693 . . . . 64.3 110.066 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.502 ' HB3' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -148.59 130.97 15.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.945 0.403 . . . . 74.31 111.262 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.564 ' HB3' HD11 ' A' ' 86' ' ' LEU . 89.1 m-85 -97.12 153.23 18.09 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.124 -0.489 . . . . 72.31 111.246 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -137.23 111.81 8.71 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 122.18 -0.325 . . . . 74.11 110.515 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.408 HG23 HD13 ' A' ' 86' ' ' LEU . 20.4 p -101.11 142.51 32.45 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.341 0.591 . . . . 65.14 111.974 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -75.54 -94.14 0.16 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.816 -0.707 . . . . 75.03 113.008 174.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -147.62 -29.39 0.34 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.174 0.511 . . . . 62.34 111.577 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.28 -12.74 83.95 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.054 -0.593 . . . . 54.13 113.122 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.617 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 96.3 mt -103.85 1.19 31.17 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.113 0.412 . . . . 75.2 112.113 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.27 -23.89 67.62 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.241 0.543 . . . . 62.12 111.22 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.84 7.72 81.36 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.131 -0.486 . . . . 71.43 113.179 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.617 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 29.3 m-85 -133.87 -62.69 0.76 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.301 0.572 . . . . 74.14 111.038 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.31 90.61 14.48 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.563 -0.744 . . . . 73.11 111.991 -174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.6 148.12 41.63 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 121.744 1.63 . . . . 72.1 112.226 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -48.68 -42.65 35.42 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.151 0.426 . . . . 72.51 112.151 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.79 -44.89 95.6 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.107 -0.568 . . . . 52.43 113.13 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 117' ' ' ILE . 64.9 tp -57.71 -50.54 72.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.117 0.484 . . . . 74.4 110.625 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.8 mt -57.77 -38.41 75.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 74.32 111.136 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.7 t -66.33 -38.37 87.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.15 -0.477 . . . . 60.24 110.959 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -65.6 -44.93 85.07 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.6 -0.273 . . . . 73.05 111.13 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 113' ' ' LEU . 74.2 mt -50.96 -35.62 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.078 0.466 . . . . 72.54 111.212 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 122' ' ' MET . 64.6 mt -57.19 -48.46 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.09 -0.504 . . . . 61.32 110.786 174.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.444 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 42.3 m80 -72.71 -33.82 66.71 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.389 -0.369 . . . . 71.4 111.857 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -72.36 -43.27 64.28 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.264 0.838 . . . . 72.12 113.264 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 137' ' ' GLU . 15.7 mmm180 -118.45 -49.01 2.48 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.805 0.668 . . . . 72.02 112.805 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 13.2 mmt -59.67 -56.28 23.9 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.748 0.647 . . . . 71.35 112.748 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 118' ' ' ILE . 50.5 mm -55.26 -55.21 42.04 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 113.055 0.761 . . . . 74.51 113.055 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 9.8 Cg_endo -52.41 -32.98 54.7 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.282 1.988 . . . . 73.41 113.067 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 86.2 m-70 -79.85 -46.54 16.69 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.57 0.211 . . . . 74.14 111.57 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -56.8 -33.78 67.03 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.853 0.359 . . . . 75.25 111.323 178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 83.2 mtp180 -63.1 -39.44 94.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.028 0.442 . . . . 73.22 111.045 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.4 m -82.12 -11.37 58.79 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.408 -0.36 . . . . 62.1 111.625 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.61 5.47 60.11 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.486 -0.388 . . . . 73.31 112.832 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.75 77.4 9.78 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.877 0.37 . . . . 63.5 111.869 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -66.44 -41.08 89.68 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.002 -0.436 . . . . 74.22 111.514 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.15 87.61 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.023 0.439 . . . . 71.41 111.747 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 16.8 mp0 -63.7 -43.73 95.75 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.355 -0.384 . . . . 73.22 111.181 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.35 -52.96 48.51 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.965 -0.636 . . . . 33.33 112.536 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.571 HD11 HD22 ' A' ' 90' ' ' LEU . 95.9 mt -58.1 -51.65 68.83 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.013 0.375 . . . . 42.45 112.013 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 81.6 p -56.58 -50.78 70.93 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.914 0.339 . . . . 72.44 111.914 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 121' ' ' ARG . 27.2 mt-10 -72.15 -31.64 66.16 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.366 0.506 . . . . 72.23 112.366 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.63 -46.46 93.26 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.323 -0.941 . . . . 22.35 112.1 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 135' ' ' LEU . 98.7 t -63.6 -47.11 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.845 0.355 . . . . 55.31 111.212 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.93 -37.68 80.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.275 -0.42 . . . . 72.3 111.444 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.533 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -60.76 -52.37 65.4 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.923 0.392 . . . . 71.21 110.821 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.0 t -56.69 -46.69 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.36 0.6 . . . . 73.45 110.926 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -53.39 -51.23 63.22 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.651 -0.704 . . . . 71.43 111.692 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -65.59 -31.06 71.89 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.383 0.512 . . . . 64.14 112.383 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 141' ' ' ALA . 95.8 t -58.28 -48.65 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.111 0.482 . . . . 64.23 110.556 174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.79 -49.25 60.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.122 -0.49 . . . . 64.41 110.968 176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 CA--C 1.542 0.647 0 CA-C-N 115.65 -0.705 . . . . 72.43 112.229 -177.032 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.2 t . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 112.812 0.671 . . . . 74.33 112.812 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -116.55 158.73 23.19 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.55 -0.75 . . . . 75.44 110.353 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -127.22 160.44 59.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.61 -0.268 . . . . 74.25 111.292 176.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 57.6 Cg_endo -70.92 64.95 2.5 Favored 'Trans proline' 0 C--N 1.358 1.026 0 C-N-CA 122.458 2.105 . . . . 60.12 111.803 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -174.4 -35.47 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.157 -0.929 . . . . 74.44 110.394 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -71.82 -40.55 69.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.138 0.494 . . . . 60.13 110.693 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.93 126.2 41.98 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.426 -0.806 . . . . 65.32 111.905 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.65 123.06 11.14 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.681 2.254 . . . . 70.53 112.849 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -66.89 87.88 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.207 0.527 . . . . 54.34 111.084 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -69.71 -21.37 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.583 0.586 . . . . 75.14 112.583 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -70.11 -35.88 74.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.601 -0.687 . . . . 74.43 110.797 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.59 -33.68 64.74 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.819 -0.628 . . . . 72.34 109.996 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.18 -86.94 0.26 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.926 -0.579 . . . . 54.21 112.343 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.92 77.55 2.03 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.545 0.572 . . . . 72.44 112.545 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.4 t -72.76 -0.8 14.27 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.981 0.419 . . . . 55.05 111.354 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -81.0 -31.77 34.54 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.101 0.408 . . . . 73.44 112.101 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -100.41 -43.84 6.1 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.132 0.419 . . . . 75.2 112.132 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp 64.79 17.97 11.23 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.883 0.473 . . . . 72.52 111.983 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.59 130.71 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 112.106 0.41 . . . . 75.1 112.106 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.8 m -124.49 103.58 8.25 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.383 -0.372 . . . . 71.24 111.175 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 28' ' ' LEU . 27.4 t70 -102.47 109.05 20.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.804 0.335 . . . . 74.53 111.148 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -118.97 -21.96 7.49 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.8 0.333 . . . . 73.24 111.258 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.55 -24.59 67.65 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.019 0.377 . . . . 53.22 112.019 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.39 43.27 16.26 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.272 -0.489 . . . . 64.53 112.727 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.5 mt -115.4 -30.98 6.08 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.356 0.502 . . . . 65.24 112.356 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 23' ' ' ASP . 95.0 mt -75.58 106.68 7.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.006 0.431 . . . . 75.42 111.66 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -73.72 157.18 36.98 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.493 -0.321 . . . . 71.3 110.535 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -51.82 -55.25 21.03 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.032 0.752 . . . . 50.12 113.032 -170.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.07 -38.2 75.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.704 0.288 . . . . 75.14 111.574 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -71.35 -30.28 65.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.795 0.331 . . . . 53.13 111.065 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.87 -51.92 67.62 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.628 -0.26 . . . . 72.02 110.307 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -57.9 -32.87 68.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.745 0.307 . . . . 73.22 111.497 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.489 ' O ' ' HD2' ' A' ' 39' ' ' ARG . 91.5 t -60.0 -53.93 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.083 0.468 . . . . 72.44 110.98 174.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 46.5 ttm -69.87 -49.54 51.34 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.43 -0.35 . . . . 71.02 111.383 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -50.65 -52.49 39.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.726 0.41 . . . . 54.43 110.997 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.77 -43.31 94.65 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 116.211 -0.449 . . . . 61.42 113.174 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.546 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -58.93 -55.59 33.19 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.595 0.236 . . . . 73.0 111.322 177.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 mt -63.51 -47.22 82.58 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.374 0.607 . . . . 61.33 111.318 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -57.63 -47.08 83.19 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.612 -0.722 . . . . 71.22 111.345 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.31 93.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.56 -0.291 . . . . 75.52 111.521 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 39' ' ' ARG . 80.1 mt -60.54 -47.74 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.749 0.309 . . . . 75.24 111.152 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -64.8 -33.34 75.76 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 120.963 0.411 . . . . 73.34 111.217 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.8 t -82.73 -2.09 53.32 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.421 0.629 . . . . 64.32 111.289 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.3 m -130.09 -72.19 0.58 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.059 0.457 . . . . 75.2 111.377 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -79.75 -12.63 59.78 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.152 0.427 . . . . 73.5 112.152 -175.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.85 18.89 11.24 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.914 0.486 . . . . 73.43 112.105 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.752 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 94.2 t -86.0 132.79 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.457 -0.338 . . . . 71.13 111.199 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -86.77 96.29 10.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.222 0.534 . . . . 72.43 110.293 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -114.02 109.47 18.5 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.687 -0.688 . . . . 75.44 110.256 -175.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -117.7 142.77 46.87 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.112 0.412 . . . . 53.42 112.112 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.8 t -123.94 133.65 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.848 0.356 . . . . 75.14 111.39 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.414 HG21 HD21 ' A' ' 71' ' ' LEU . 48.4 t -126.53 137.99 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 122.497 0.319 . . . . 65.41 111.143 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 24.8 p -120.12 123.01 42.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.86 0.362 . . . . 74.33 111.159 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -127.17 147.24 61.01 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 120.629 0.252 . . . . 72.33 111.521 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.06 -57.52 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.372 2.048 . . . . 75.2 112.374 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 25.0 m -145.42 148.65 33.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.41 -0.359 . . . . 53.32 111.248 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 91' ' ' VAL . 28.7 pt -110.2 -2.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.305 0.574 . . . . 73.34 110.631 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.0 -113.43 5.07 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.66 -0.7 . . . . 61.22 114.329 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.42 1.28 53.85 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.489 0.552 . . . . 75.43 112.489 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.67 141.82 28.82 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 111.799 0.296 . . . . 71.53 111.799 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.76 143.11 18.38 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.858 2.372 . . . . 62.14 112.411 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.24 -51.35 70.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.1 0.407 . . . . 70.24 112.1 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.49 -35.13 79.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.275 0.472 . . . . 75.04 112.275 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.38 -42.24 83.72 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.257 0.551 . . . . 64.53 110.437 175.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.404 ' CD2' ' HD3' ' A' ' 6' ' ' PRO . 24.8 t80 -60.49 -53.38 58.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.737 -0.665 . . . . 71.01 111.884 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.413 HG21 ' HB3' ' A' ' 98' ' ' ARG . 22.0 p -51.12 -48.45 61.75 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.122 0.786 . . . . 61.4 113.122 -174.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 52.5 tp -66.71 -46.51 75.29 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.821 0.344 . . . . 54.32 111.724 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -64.82 -38.14 89.97 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.118 0.414 . . . . 75.21 112.118 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.414 HD21 HG21 ' A' ' 54' ' ' VAL . 63.3 tp -69.26 -40.76 77.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.154 0.502 . . . . 74.01 110.522 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.64 95.57 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.267 0.469 . . . . 73.03 112.267 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 53.8 mtp180 -60.65 -49.54 77.12 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.204 0.446 . . . . 74.24 112.204 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.666 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 11.8 pt20 -66.26 -21.09 66.28 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 120.947 0.404 . . . . 72.23 111.426 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.666 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 22.9 m0 -90.07 7.33 38.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.868 0.366 . . . . 74.41 111.406 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.18 -50.71 4.3 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.308 -0.473 . . . . 71.13 113.5 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 113.377 0.88 . . . . 71.0 113.377 -176.291 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.571 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 37.4 t30 . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 110.102 -0.333 . . . . 70.44 110.102 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.424 ' HA ' ' H ' ' A' ' 104' ' ' GLY . 27.7 p-10 -39.13 -67.13 0.23 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.765 1.024 . . . . 75.11 113.765 -170.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.752 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 81.1 m-20 -96.86 25.81 5.04 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.676 -0.64 . . . . 71.34 111.702 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.44 127.54 8.04 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.98 -0.629 . . . . 51.02 113.16 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 53.2 tp -145.05 119.3 9.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.081 0.467 . . . . 71.11 111.052 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.401 HD21 HD23 ' A' ' 71' ' ' LEU . 54.3 tp -117.45 142.08 47.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.883 0.373 . . . . 61.41 111.642 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.6 tp -128.68 118.71 23.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.031 -0.531 . . . . 65.23 110.754 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -113.8 129.43 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.864 0.364 . . . . 60.24 111.969 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.852 HD22 HD11 ' A' ' 135' ' ' LEU . 12.3 tp -102.37 124.09 47.32 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.966 0.506 . . . . 73.23 111.023 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 59' ' ' ILE . 58.3 t -111.82 98.33 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.912 0.387 . . . . 71.43 111.118 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.1 tp -54.5 -40.4 68.51 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.017 -0.538 . . . . 64.34 111.656 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.508 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 14.2 t70 -51.73 -37.46 51.15 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.861 -0.609 . . . . 41.05 112.427 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -112.87 -6.59 13.79 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.203 0.446 . . . . 73.01 112.203 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.532 ' HG2' ' HE1' ' A' ' 131' ' ' TYR . 99.6 mtt180 57.58 24.28 10.24 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.126 0.489 . . . . 64.54 111.628 -174.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -106.84 147.38 29.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.074 0.464 . . . . 71.33 111.725 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 90' ' ' LEU . 15.3 m -133.53 157.44 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.693 -0.685 . . . . 54.4 110.342 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.413 ' HB3' HG21 ' A' ' 68' ' ' THR . 76.6 ttt-85 -148.44 137.73 21.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.081 0.4 . . . . 75.4 112.081 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 97.1 m-85 -96.08 151.84 19.09 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.975 -0.557 . . . . 74.55 110.628 173.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 9.2 tp10 -138.01 114.53 10.42 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.435 -0.166 . . . . 71.33 110.715 175.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 p -98.06 157.14 16.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.728 0.775 . . . . 60.35 113.076 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -98.54 171.98 25.76 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.172 -0.922 . . . . 74.41 112.153 167.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -51.88 -24.67 6.56 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.991 0.738 . . . . 72.32 112.991 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.424 ' H ' ' HA ' ' A' ' 83' ' ' ASN . . . -80.61 -16.56 75.31 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.905 -0.664 . . . . 72.31 112.951 -174.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.476 HD11 HG13 ' A' ' 49' ' ' VAL . 93.6 mt -108.27 -10.81 15.32 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.366 0.506 . . . . 62.01 112.366 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -49.75 -32.44 13.72 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.675 0.62 . . . . 74.34 112.675 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.76 -22.38 64.21 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.03 -0.605 . . . . 51.35 113.978 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -102.97 -38.62 7.28 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.394 0.616 . . . . 71.41 111.471 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.482 ' HB3' HD21 ' A' ' 114' ' ' LEU . 25.7 mt -127.66 78.1 75.31 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 115.735 -0.666 . . . . 61.03 111.234 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.28 163.31 36.7 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.148 1.898 . . . . 64.42 112.722 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -52.56 -44.88 66.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.253 0.464 . . . . 63.04 112.253 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.62 98.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.259 -0.496 . . . . 54.23 113.169 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 109' ' ' LEU . 58.2 tp -65.39 -49.25 69.98 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 122.441 -0.446 . . . . 65.11 110.955 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 109' ' ' LEU . 91.0 mt -55.62 -44.17 76.8 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.054 0.454 . . . . 54.02 110.842 176.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -60.67 -43.47 97.63 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.937 -0.574 . . . . 64.33 111.102 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -57.52 -53.2 60.8 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.646 -0.252 . . . . 74.5 111.249 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.9 mt -50.82 -40.65 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.955 0.407 . . . . 73.22 111.213 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.687 ' O ' ' HB2' ' A' ' 122' ' ' MET . 77.8 mt -59.09 -44.85 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.03 -0.532 . . . . 73.02 111.248 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -83.23 -22.58 33.06 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.644 -0.66 . . . . 61.22 112.163 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.95 -55.89 3.84 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.532 0.333 . . . . 74.33 111.711 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 25.7 mtp180 -118.63 6.83 11.64 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.106 0.78 . . . . 71.34 113.106 -172.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.687 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 17.0 mmt -108.79 -62.8 1.42 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.025 0.441 . . . . 75.24 111.412 174.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.473 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 28.7 mm -47.33 -53.1 31.3 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 113.907 1.077 . . . . 62.44 113.907 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 13.7 Cg_endo -54.2 -34.5 79.31 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.225 1.95 . . . . 61.42 112.771 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 96.4 m-70 -77.97 -43.1 30.69 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.34 -0.391 . . . . 63.41 111.294 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.7 m-30 -59.75 -42.26 92.85 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.756 0.312 . . . . 74.55 111.258 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -59.3 -35.85 74.52 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.073 0.463 . . . . 73.33 111.247 176.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.2 m -82.77 -16.81 46.46 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.026 -0.534 . . . . 71.25 112.019 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.89 -2.62 52.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.467 -0.397 . . . . 51.35 112.796 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.814 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.3 m-20 -81.78 62.96 5.83 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 122.51 -0.406 . . . . 75.15 111.242 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.532 ' HE1' ' HG2' ' A' ' 95' ' ' ARG . 97.1 m-85 -58.72 -60.45 3.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.296 0.48 . . . . 72.12 112.296 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.475 ' HB1' HD23 ' A' ' 28' ' ' LEU . . . -63.75 -35.46 80.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.957 0.408 . . . . 73.2 111.949 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.814 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 6.9 tp10 -58.59 -50.16 74.83 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.19 0.519 . . . . 75.35 110.845 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.33 -46.83 93.62 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 115.859 -0.61 . . . . 72.43 112.874 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.852 HD11 HD22 ' A' ' 90' ' ' LEU . 85.2 mt -51.44 -48.9 62.58 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.039 0.447 . . . . 75.03 111.293 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.5 m -61.82 -38.4 88.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.084 -0.507 . . . . 72.32 111.506 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 5.3 mm-40 -64.2 -45.87 86.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.732 0.301 . . . . 75.53 111.668 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 142' ' ' VAL . . . -62.8 -46.48 93.55 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.069 -0.586 . . . . 75.45 112.883 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 135' ' ' LEU . 79.1 t -57.77 -48.6 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.065 0.46 . . . . 73.23 111.2 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.26 -41.12 83.58 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.233 -0.439 . . . . 71.52 111.009 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.52 ' HB2' ' HD3' ' A' ' 121' ' ' ARG . . . -59.65 -51.54 69.36 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.158 -0.474 . . . . 71.21 111.309 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 138' ' ' GLY . 97.5 t -56.33 -48.92 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.986 0.422 . . . . 71.51 110.978 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.443 ' OE1' ' HG3' ' A' ' 39' ' ' ARG . 65.0 tt0 -52.92 -44.13 66.78 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.15 -0.477 . . . . 70.33 111.701 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.27 -35.64 81.66 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.398 0.518 . . . . 75.53 112.398 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 141' ' ' ALA . 61.7 t -59.86 -46.31 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.395 0.616 . . . . 72.53 110.581 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.08 -35.75 71.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.783 -0.644 . . . . 52.31 111.17 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 N--CA 1.468 0.431 0 CA-C-N 116.308 -0.405 . . . . 70.3 110.963 -177.118 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 120.936 0.398 . . . . 54.4 111.764 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.413 ' CD1' ' HD2' ' A' ' 57' ' ' PRO . 57.2 m-85 -123.77 139.72 53.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.12 0.486 . . . . 73.22 111.66 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.58 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 34.9 mmtp -106.18 167.07 10.13 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.894 -0.594 . . . . 73.21 109.564 169.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 18.2 Cg_endo -58.58 -16.88 32.14 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.756 1.637 . . . . 63.3 112.307 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 5' ' ' LYS . 10.6 pt-20 -90.56 -16.63 28.42 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.031 -0.531 . . . . 75.1 111.941 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.97 -30.22 21.43 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.958 0.409 . . . . 70.45 111.079 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.39 123.27 85.07 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.038 -0.528 . . . . 74.25 111.741 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.37 117.26 3.46 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.812 2.341 . . . . 72.12 113.23 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.734 ' HB3' ' HB3' ' A' ' 14' ' ' LEU . 80.5 m-20 -68.5 79.16 0.27 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.321 0.489 . . . . 75.43 112.321 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 m -65.92 -53.47 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 111.684 0.253 . . . . 75.4 111.684 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.464 ' NE2' ' HG ' ' A' ' 20' ' ' LEU . 1.5 mp0 -70.45 1.76 4.69 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.75 0.648 . . . . 61.45 112.75 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 8.8 tt -109.15 -40.98 4.8 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.813 0.34 . . . . 64.41 110.759 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.07 -63.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.211 0.449 . . . . 41.21 112.211 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.52 -71.84 0.18 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.069 0.462 . . . . 62.14 111.3 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 m 73.73 -22.61 0.24 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.836 1.051 . . . . 60.42 113.836 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.53 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 9.4 t -82.32 -12.66 57.84 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.483 0.658 . . . . 70.43 110.769 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . 14.7 ptt-85 -126.87 145.19 50.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.614 -0.721 . . . . 70.21 109.186 171.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HG ' ' NE2' ' A' ' 13' ' ' GLN . 5.7 mp -119.47 14.66 12.84 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.85 0.357 . . . . 74.24 111.445 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.61 123.58 68.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.071 0.397 . . . . 74.01 112.071 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.6 m -120.66 102.98 8.77 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.39 -0.368 . . . . 65.11 110.824 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.418 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 25.7 t70 -97.73 103.73 15.69 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.034 0.445 . . . . 61.12 111.366 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB2' HD23 ' A' ' 56' ' ' LEU . 5.3 mm-40 -110.96 -28.42 8.36 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.335 -0.393 . . . . 62.21 111.632 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -64.08 -25.27 68.03 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.004 0.372 . . . . 73.41 112.004 172.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.55 44.58 9.29 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.016 -0.611 . . . . 62.41 112.354 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -115.93 -21.58 9.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.621 0.369 . . . . 54.52 111.593 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.0 mt -96.8 111.17 23.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.778 0.323 . . . . 44.01 111.536 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.5 t -67.55 151.06 47.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.505 0.193 . . . . 45.04 111.081 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -51.2 -42.67 61.06 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.306 0.484 . . . . 51.32 112.306 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.44 -40.03 94.97 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.105 0.479 . . . . 62.4 111.539 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -67.29 -39.95 86.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.872 0.368 . . . . 73.34 110.797 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.59 -42.39 98.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.315 -0.402 . . . . 54.41 111.487 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.05 -53.68 52.78 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.009 0.433 . . . . 74.42 111.107 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.72 -45.29 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.331 -0.395 . . . . 73.14 111.647 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 52.1 ttm -61.14 -47.98 83.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.638 -0.255 . . . . 45.15 111.5 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 56.0 m-80 -60.22 -37.75 81.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.662 0.267 . . . . 63.52 110.997 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.23 95.66 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.917 -0.659 . . . . 73.14 112.882 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.535 ' O ' HG13 ' A' ' 43' ' ' ILE . 98.6 mtt180 -64.0 -55.51 21.81 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.996 0.427 . . . . 65.13 110.872 174.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.85 -49.82 76.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.099 -0.501 . . . . 62.43 112.242 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' A' ' 18' ' ' THR . 30.9 ttp180 -58.09 -40.38 80.96 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.192 -0.458 . . . . 65.14 111.104 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.45 89.5 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.422 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 39' ' ' ARG . 86.4 mt -58.43 -49.45 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.752 0.311 . . . . 73.12 111.627 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 57.2 ttp180 -69.42 -26.84 64.82 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.14 -0.35 . . . . 74.04 111.529 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -82.13 -22.63 36.07 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.858 0.361 . . . . 61.24 111.098 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 m -102.8 -66.08 0.95 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.125 -0.489 . . . . 72.32 111.62 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -84.35 -8.99 58.82 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.302 -0.408 . . . . 71.1 112.017 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 68.54 15.01 9.15 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.939 0.495 . . . . 71.34 112.318 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.74 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 89.3 t -86.22 119.27 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.019 0.438 . . . . 72.34 111.934 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -78.15 96.13 5.1 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 74.34 110.184 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -115.76 106.1 13.48 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.388 -0.369 . . . . 71.44 110.722 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.65 146.63 34.47 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.942 0.401 . . . . 55.1 112.055 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.89 114.79 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.939 0.4 . . . . 65.52 111.284 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.463 ' HB ' HG22 ' A' ' 89' ' ' VAL . 48.7 t -118.88 132.7 68.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.839 0.352 . . . . 62.23 111.492 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.418 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 32.0 p -110.38 125.58 53.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.94 0.4 . . . . 70.41 111.129 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.447 HD23 ' HB2' ' A' ' 24' ' ' GLU . 55.1 mt -131.55 142.16 44.33 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.445 -0.343 . . . . 61.32 110.85 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.645 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 22.5 Cg_exo -64.59 -67.35 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.373 2.049 . . . . 74.12 112.076 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.9 t -133.64 157.74 45.0 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.135 0.493 . . . . 71.41 111.32 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 pt -120.35 9.9 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.915 -0.584 . . . . 65.53 111.078 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.0 -119.62 5.26 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 116.18 -0.464 . . . . 74.43 113.118 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -112.04 3.82 17.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.391 0.276 . . . . 72.35 111.722 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.86 139.14 96.71 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 111.795 0.295 . . . . 65.24 111.795 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.735 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 57.1 Cg_endo -71.07 125.31 11.34 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.354 2.036 . . . . 63.41 111.826 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.463 ' HG ' ' HB2' ' A' ' 98' ' ' ARG . 44.2 tp -56.25 -41.75 76.26 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.509 0.559 . . . . 61.12 112.509 -173.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.07 -35.16 79.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.106 0.479 . . . . 73.24 112.134 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.735 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 5.8 m-20 -86.74 -28.23 23.18 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.109 0.481 . . . . 72.04 111.356 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -57.37 -50.24 73.59 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.924 -0.58 . . . . 72.3 110.782 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 p -58.11 -37.65 74.96 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.769 -0.65 . . . . 65.14 112.049 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -62.25 -38.33 88.87 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 120.708 0.29 . . . . 63.02 111.671 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -66.97 -38.76 86.66 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.92 0.39 . . . . 63.24 111.554 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.551 HD23 HD21 ' A' ' 87' ' ' LEU . 45.5 tp -72.07 -42.61 66.0 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.173 0.511 . . . . 63.24 111.345 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.49 -44.4 95.99 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.302 0.482 . . . . 74.41 112.302 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -68.43 -25.2 64.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.046 0.387 . . . . 74.24 112.046 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -70.66 -42.67 70.5 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.997 0.427 . . . . 72.13 110.828 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -82.04 -15.7 52.69 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.157 -0.474 . . . . 74.04 112.256 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.58 9.37 64.7 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.881 -0.676 . . . . 62.44 112.75 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 t . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 120.869 0.366 . . . . 64.23 110.726 178.985 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.484 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 45.0 t30 . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 120.517 0.198 . . . . 64.42 111.136 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.474 ' CG ' ' H ' ' A' ' 84' ' ' ASN . 38.2 p-10 -62.62 -90.15 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 112.668 0.618 . . . . 74.42 112.668 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.74 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.1 m-20 -88.26 32.87 0.75 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.004 -1.06 . . . . 64.14 112.095 -173.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.67 127.72 8.76 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.171 -0.537 . . . . 62.3 113.694 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.6 tp -142.53 119.85 11.57 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.206 0.527 . . . . 72.45 111.042 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.551 HD21 HD23 ' A' ' 71' ' ' LEU . 56.7 tp -114.94 122.25 45.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.335 -0.393 . . . . 73.41 111.453 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.4 tp -111.36 114.04 26.92 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.36 -0.382 . . . . 74.0 111.003 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' A' ' 54' ' ' VAL . 84.5 t -119.06 131.56 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.866 0.365 . . . . 72.0 111.619 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.534 ' HB2' HD21 ' A' ' 135' ' ' LEU . 30.3 tp -106.22 130.74 54.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.362 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.795 HG11 HE21 ' A' ' 94' ' ' GLN . 86.2 t -106.12 109.7 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.372 -0.376 . . . . 71.55 111.101 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 69.0 tp -60.87 -41.01 95.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.131 0.419 . . . . 65.13 112.131 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.09 -47.31 85.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.219 0.533 . . . . 73.31 111.699 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.795 HE21 HG11 ' A' ' 91' ' ' VAL . 45.8 mt-30 -87.44 -15.35 37.96 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.981 -0.554 . . . . 73.01 112.356 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 95' ' ' ARG . 56.0 mtt180 58.99 36.43 24.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.098 0.407 . . . . 74.11 112.098 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -144.74 157.79 44.04 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.955 0.407 . . . . 64.14 111.519 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.551 HG21 ' SD ' ' A' ' 122' ' ' MET . 10.2 m -117.87 171.61 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.244 0.545 . . . . 62.34 112.066 -174.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.463 ' HB2' ' HG ' ' A' ' 64' ' ' LEU . 27.8 tpt180 -136.81 129.04 29.78 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.957 -0.565 . . . . 73.13 111.348 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -103.11 107.89 18.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.184 -0.462 . . . . 63.43 110.391 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -102.43 111.96 24.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.473 0.178 . . . . 64.34 110.897 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 p -103.86 150.36 24.22 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.238 0.542 . . . . 64.13 111.871 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -85.27 -145.0 7.46 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.795 -0.717 . . . . 64.35 112.171 169.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.15 -25.84 21.62 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 122.514 -0.404 . . . . 73.04 111.745 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.9 -28.52 62.55 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.017 -0.611 . . . . 61.24 113.697 -170.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 49' ' ' VAL . 96.9 mt -99.3 -0.67 40.74 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.744 0.646 . . . . 74.43 112.744 -174.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -61.48 -27.21 68.42 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.959 0.409 . . . . 74.35 112.052 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.35 3.6 86.91 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.429 -0.415 . . . . 51.24 113.667 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -126.54 -38.7 2.07 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.072 0.463 . . . . 74.01 111.583 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.516 ' HB3' HD21 ' A' ' 114' ' ' LEU . 17.4 mt -129.82 78.71 74.67 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.892 -0.595 . . . . 72.01 111.61 -171.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.21 151.36 48.97 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.442 2.095 . . . . 75.01 112.168 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -50.41 -35.29 27.76 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.299 0.481 . . . . 74.34 112.299 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.75 -48.95 80.92 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.177 -0.535 . . . . 61.23 112.559 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.0 tp -60.03 -44.98 94.27 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.093 0.473 . . . . 61.11 110.94 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 109' ' ' LEU . 85.4 mt -58.71 -39.17 80.04 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.994 -0.548 . . . . 65.51 111.105 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.8 t -65.28 -39.74 92.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.98 0.419 . . . . 72.32 110.89 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -57.04 -48.73 77.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.911 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.4 mt -53.05 -47.71 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.2 0.524 . . . . 75.24 111.386 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 122' ' ' MET . 67.5 mt -60.09 -55.64 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.008 -0.542 . . . . 54.42 111.697 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.483 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 65.1 m80 -70.27 -35.4 73.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.036 0.754 . . . . 73.42 113.036 -173.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.15 -38.12 21.08 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.259 0.837 . . . . 64.33 113.259 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.5 ' HD3' ' HB2' ' A' ' 141' ' ' ALA . 35.9 mtp180 -111.74 -33.3 6.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.275 0.843 . . . . 72.04 113.275 -173.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.551 ' SD ' HG21 ' A' ' 97' ' ' VAL . 53.5 mtt -84.41 -54.0 5.07 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.759 0.652 . . . . 73.54 112.759 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.504 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 46.9 mm -48.86 -50.25 62.64 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 113.257 0.836 . . . . 62.54 113.257 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 9.5 Cg_endo -51.98 -46.09 34.56 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 122.221 1.947 . . . . 65.23 112.852 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -70.06 -40.89 74.8 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.859 0.318 . . . . 74.12 111.859 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.0 m-30 -58.43 -41.17 84.43 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.023 0.439 . . . . 74.42 111.292 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -70.69 -39.44 73.49 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.066 0.46 . . . . 72.34 110.798 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.8 t -68.73 -22.36 64.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.156 -0.475 . . . . 73.44 111.569 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.13 -10.19 24.76 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.522 -0.371 . . . . 72.23 113.34 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.747 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 69.4 m-20 -85.57 77.39 9.86 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.503 -0.41 . . . . 63.2 111.707 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -62.58 -41.86 99.21 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.147 0.499 . . . . 65.2 110.945 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.23 -45.91 82.74 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.964 -0.562 . . . . 64.14 111.987 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.747 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 21.1 mm-40 -68.09 -32.39 72.68 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 111.86 0.319 . . . . 72.42 111.86 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 122' ' ' MET . . . -59.38 -44.89 96.26 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.386 -0.912 . . . . 21.34 111.753 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 90' ' ' LEU . 94.2 mt -66.08 -44.4 84.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.877 0.325 . . . . 63.12 111.877 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.8 p -62.5 -38.81 91.36 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.664 0.268 . . . . 72.23 111.191 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -66.14 -41.28 90.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.775 0.321 . . . . 62.45 111.416 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.14 -48.56 85.51 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.842 -0.694 . . . . 53.2 112.58 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 135' ' ' LEU . 89.3 t -56.39 -47.04 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.028 0.442 . . . . 75.42 111.055 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 44.3 tp -60.14 -39.77 87.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.864 -0.607 . . . . 72.13 111.069 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.5 ' HB2' ' HD3' ' A' ' 121' ' ' ARG . . . -61.89 -52.14 65.33 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.874 0.369 . . . . 53.04 111.51 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.85 -45.19 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.091 0.472 . . . . 71.51 110.978 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -54.6 -47.6 73.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.05 -0.523 . . . . 72.42 111.222 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 96.3 mt-30 -56.49 -45.57 80.91 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.394 -0.367 . . . . 74.11 111.757 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ALA . 60.6 t -57.15 -44.79 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.17 0.509 . . . . 73.1 111.285 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.2 -45.51 76.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.118 -0.492 . . . . 75.24 111.607 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 120.825 0.345 . . . . 71.13 111.713 176.919 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 121.108 0.48 . . . . 74.4 111.241 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.416 ' CD1' ' HD2' ' A' ' 57' ' ' PRO . 39.8 m-85 -91.43 125.32 36.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.213 0.53 . . . . 70.44 111.793 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 9.6 mtmp? -94.96 159.02 34.02 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.898 -0.592 . . . . 74.42 110.187 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 48.0 Cg_endo -66.6 -2.66 7.82 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.229 1.953 . . . . 74.13 113.039 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -107.28 -8.76 16.27 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.211 -0.449 . . . . 74.22 110.93 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.41 -26.89 19.65 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.002 0.43 . . . . 71.11 110.601 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.6 t -57.13 128.13 77.35 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.872 -0.604 . . . . 72.44 111.662 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.85 109.07 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.659 2.24 . . . . 74.41 112.721 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -69.19 77.92 0.35 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.042 0.449 . . . . 63.14 111.236 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 13' ' ' GLN . 28.6 m -67.64 -51.3 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.263 0.468 . . . . 72.12 112.263 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 12' ' ' VAL . 15.8 mm100 -56.97 -21.2 28.47 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.06 0.393 . . . . 73.52 112.06 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.68 -52.72 34.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.038 0.447 . . . . 63.1 109.967 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.28 -65.79 0.98 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.424 -0.353 . . . . 75.22 111.544 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -98.27 101.79 13.34 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.115 0.483 . . . . 62.13 111.966 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.7 p -82.79 -3.64 56.92 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.164 0.507 . . . . 74.5 110.522 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -78.91 -37.41 39.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.846 -0.616 . . . . 70.23 111.74 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -102.18 125.97 49.02 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.25 0.548 . . . . 61.32 110.527 173.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 20' ' ' LEU . 4.6 mp -109.33 8.62 25.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.274 0.559 . . . . 73.52 110.623 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.8 t -101.37 142.73 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.796 -0.638 . . . . 73.11 111.656 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.2 m -145.42 103.41 3.82 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.456 -0.338 . . . . 70.12 110.865 175.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.496 ' HB2' HD12 ' A' ' 28' ' ' LEU . 28.8 t70 -105.05 96.76 6.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.223 0.535 . . . . 74.05 111.59 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -97.45 -38.45 9.6 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.019 0.437 . . . . 71.31 110.336 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.588 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -57.09 -43.85 82.6 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.483 0.549 . . . . 74.44 112.483 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.19 36.3 6.34 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.03 -0.605 . . . . 65.0 112.301 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 92' ' ' LEU . 86.5 mt -103.6 -15.99 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.847 0.356 . . . . 75.32 111.443 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 23' ' ' ASP . 96.6 mt -90.8 -165.91 1.46 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.162 0.506 . . . . 74.35 111.553 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -161.68 153.52 19.18 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.966 -0.561 . . . . 73.03 110.019 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -47.93 -43.29 28.98 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.279 0.474 . . . . 64.1 112.279 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.14 -49.64 71.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.116 0.484 . . . . 75.21 111.622 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.458 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 12.5 mm-40 -71.33 -38.27 71.68 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.208 -0.451 . . . . 63.0 111.731 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.83 -36.48 84.03 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.044 0.45 . . . . 74.32 111.089 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.52 -54.97 23.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.139 -0.482 . . . . 64.25 110.918 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.8 -43.89 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.082 0.468 . . . . 63.11 111.282 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.423 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.6 ttm -64.22 -49.58 71.4 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.106 -0.497 . . . . 74.12 111.049 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -57.33 -48.17 79.66 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.636 0.255 . . . . 75.41 111.27 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.35 92.13 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.093 -0.575 . . . . 50.55 112.952 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.609 ' NH1' HD13 ' A' ' 140' ' ' LEU . 60.1 mtt180 -70.42 -49.9 44.11 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.983 0.364 . . . . 74.13 111.983 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 36' ' ' MET . 92.6 mt -55.18 -46.96 75.83 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.258 0.551 . . . . 75.44 111.042 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 41' ' ' ARG . 40.9 ttm180 -61.74 -42.77 99.4 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.811 -0.631 . . . . 74.22 110.76 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.05 79.62 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.159 -0.473 . . . . 61.25 111.198 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.562 HG22 ' HB ' ' A' ' 49' ' ' VAL . 81.8 mt -67.79 -41.6 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.052 0.453 . . . . 73.22 110.747 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 44.8 ttt180 -68.01 -27.85 66.91 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.022 0.439 . . . . 70.31 111.2 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.3 t -85.75 -32.22 21.98 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.074 0.464 . . . . 31.12 111.403 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 t -82.66 -61.9 1.75 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.079 0.466 . . . . 71.1 111.884 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -102.22 -0.39 33.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.876 -0.602 . . . . 75.14 111.602 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.48 10.81 5.13 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.843 0.457 . . . . 62.11 111.892 -176.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.562 ' HB ' HG22 ' A' ' 43' ' ' ILE . 78.6 t -77.38 111.44 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.042 0.449 . . . . 63.42 111.142 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HG2' ' HE ' ' A' ' 44' ' ' ARG . 40.7 mt-10 -82.16 95.92 7.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.676 0.75 . . . . 73.21 110.138 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -107.96 103.11 12.27 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.13 -0.941 . . . . 73.21 111.007 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.66 139.7 38.59 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.403 0.52 . . . . 55.54 112.403 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.5 t -124.08 119.42 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.982 0.42 . . . . 14.44 111.487 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.16 139.11 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.471 -0.331 . . . . 73.45 111.533 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 24.2 p -118.05 126.82 53.02 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.941 0.401 . . . . 73.4 111.015 176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 61.6 mt -125.68 140.95 37.8 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 120.672 0.272 . . . . 51.55 111.633 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.588 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 27.6 Cg_exo -62.89 -61.3 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.698 2.265 . . . . 60.4 113.019 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.449 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 78.2 p -148.17 145.41 28.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.814 0.302 . . . . 65.03 111.814 -176.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.507 HD13 HG21 ' A' ' 91' ' ' VAL . 34.5 pt -127.82 5.02 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.011 0.434 . . . . 72.14 111.593 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.6 -136.52 29.73 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.991 -0.624 . . . . 73.14 113.39 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -87.99 15.58 7.1 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.515 -0.403 . . . . 74.14 111.704 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.3 125.0 91.56 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 120.726 0.298 . . . . 74.44 111.607 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.93 108.84 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.262 1.974 . . . . 74.31 112.249 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.4 tp -57.94 -29.43 65.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.943 0.401 . . . . 72.12 112.042 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 9.3 mp0 -63.66 -32.62 74.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.24 0.543 . . . . 41.2 111.147 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.82 -33.1 16.63 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.457 0.646 . . . . 61.34 110.355 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -52.67 -51.76 58.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.913 0.885 . . . . 73.23 112.051 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.4 p -60.52 -31.21 70.29 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.476 0.547 . . . . 64.45 112.476 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.605 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.5 tp -56.06 -53.71 53.71 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.962 0.41 . . . . 71.42 110.987 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -60.84 -33.3 72.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.991 0.424 . . . . 72.44 112.093 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.503 HD23 HD21 ' A' ' 87' ' ' LEU . 34.3 tp -74.4 -54.95 6.59 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.994 0.426 . . . . 74.14 111.647 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.83 71.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.192 0.442 . . . . 74.43 112.192 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 57.5 mtp180 -64.89 -48.43 74.26 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.028 0.381 . . . . 45.52 112.028 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.567 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 10.5 pt20 -71.27 -25.53 62.49 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.933 0.397 . . . . 73.33 111.161 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.567 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 19.5 m0 -79.59 -4.93 53.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.538 -0.301 . . . . 75.02 111.744 174.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.33 -43.52 2.73 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.26 -0.495 . . . . 70.4 113.425 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 113.4 0.889 . . . . 72.21 113.4 -178.856 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 121.242 0.544 . . . . 63.31 112.091 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -157.74 -136.57 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.925 -0.579 . . . . 54.41 109.916 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.571 ' HA ' ' HG ' ' A' ' 105' ' ' LEU . 17.0 p-10 -72.64 26.91 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.494 -0.754 . . . . 62.21 112.543 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.21 150.18 25.81 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.616 -0.326 . . . . 34.32 112.533 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HB2' ' CD1' ' A' ' 105' ' ' LEU . 62.3 tp -142.66 127.04 17.72 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.89 0.376 . . . . 75.11 111.156 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.503 HD21 HD23 ' A' ' 71' ' ' LEU . 60.6 tp -108.21 133.78 51.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.844 0.354 . . . . 63.52 111.66 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.44 117.39 22.05 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.073 -0.512 . . . . 54.2 110.814 177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.99 129.83 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.729 0.3 . . . . 71.34 111.766 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.47 134.11 50.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.127 0.571 . . . . 75.32 111.078 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.507 HG21 HD13 ' A' ' 59' ' ' ILE . 87.1 t -118.63 105.3 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.926 0.394 . . . . 55.22 111.262 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 27' ' ' LEU . 68.1 tp -53.76 -39.21 65.18 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.114 -0.494 . . . . 50.12 112.017 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 31.7 t70 -50.77 -32.32 19.45 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.781 0.66 . . . . 74.11 112.781 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -123.67 -3.47 8.26 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.278 0.473 . . . . 71.43 112.278 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 61.25 11.15 3.4 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.398 0.518 . . . . 65.22 112.398 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -97.09 159.86 14.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.054 0.454 . . . . 64.21 111.341 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.692 HG21 ' SD ' ' A' ' 122' ' ' MET . 13.3 m -131.14 172.26 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.985 -0.552 . . . . 60.42 110.525 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -146.39 128.68 15.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.905 0.383 . . . . 64.24 111.639 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -103.97 125.19 50.17 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.692 -0.686 . . . . 73.21 110.434 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -120.21 117.12 27.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.999 0.428 . . . . 74.24 111.175 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.532 HG23 HD11 ' A' ' 114' ' ' LEU . 11.6 p -85.5 155.72 21.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.608 0.718 . . . . 64.54 112.584 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.72 -179.33 36.29 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.4 -0.818 . . . . 64.11 111.844 167.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -63.11 -11.13 17.81 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.874 0.47 . . . . 73.35 112.256 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.15 -32.03 13.17 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.584 -0.341 . . . . 74.24 113.475 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.571 ' HG ' ' HA ' ' A' ' 84' ' ' ASN . 48.1 mt -97.24 -5.04 37.79 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.402 0.89 . . . . 63.22 113.402 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -54.4 -28.63 44.96 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.882 0.697 . . . . 64.01 112.882 -177.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.69 -19.15 71.46 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.238 -0.506 . . . . 64.54 113.822 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -105.82 -40.17 5.81 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.936 0.398 . . . . 65.42 111.91 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.492 ' HB3' HD21 ' A' ' 114' ' ' LEU . 26.8 mt -130.48 88.25 47.75 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.102 -0.499 . . . . 74.22 112.222 -170.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.63 159.25 28.48 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.154 1.903 . . . . 74.25 112.045 172.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -50.46 -36.74 34.9 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.306 0.484 . . . . 72.33 112.306 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.71 -50.14 69.11 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.02 -0.609 . . . . 75.44 112.793 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.29 -43.28 99.14 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.874 0.368 . . . . 74.14 110.988 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.532 HD11 HG23 ' A' ' 101' ' ' THR . 89.6 mt -57.52 -45.09 85.43 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.28 -0.418 . . . . 64.44 110.886 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.2 m -64.4 -34.63 78.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.194 -0.457 . . . . 74.41 111.075 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -62.45 -48.17 80.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.476 -0.329 . . . . 74.11 110.716 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.2 mt -52.37 -45.78 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.338 0.59 . . . . 65.25 110.928 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 122' ' ' MET . 63.6 mt -60.75 -55.82 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.427 -0.806 . . . . 42.41 111.887 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.451 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 10.3 t-80 -75.94 -28.25 57.89 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.721 0.637 . . . . 72.51 112.721 -170.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.97 -49.46 17.64 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.232 0.456 . . . . 55.12 112.232 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -112.21 -44.22 3.44 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.147 0.795 . . . . 71.04 113.147 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.692 ' SD ' HG21 ' A' ' 97' ' ' VAL . 50.8 mtt -62.67 -50.99 69.01 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.524 0.565 . . . . 61.25 112.524 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.575 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 25.7 mm -53.51 -55.54 33.89 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 112.278 0.473 . . . . 63.53 112.278 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.575 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 83.7 Cg_exo -50.22 -46.14 30.15 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 122.15 1.9 . . . . 51.22 113.015 176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 61.0 m-70 -65.41 -49.14 70.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.847 0.314 . . . . 64.24 111.847 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.4 m-30 -61.37 -32.95 72.87 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.894 0.378 . . . . 71.43 111.495 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -69.31 -41.19 77.05 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.97 0.414 . . . . 64.51 110.599 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.0 t -74.24 -21.56 59.72 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.957 0.408 . . . . 63.01 111.661 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 112.16 -4.7 26.96 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.43 -0.414 . . . . 54.42 113.673 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.66 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 79.7 m-20 -83.8 77.49 9.87 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.323 0.49 . . . . 65.42 112.323 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -71.54 -39.48 70.68 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.899 0.38 . . . . 75.44 111.521 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.25 70.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.897 0.38 . . . . 70.44 111.332 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 20.2 mm-40 -61.98 -42.5 99.2 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.146 -0.479 . . . . 73.4 111.542 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.03 -50.64 64.2 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.184 -0.531 . . . . 72.22 112.959 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.54 -41.03 98.48 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.56 -0.377 . . . . 62.33 111.47 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -57.38 -54.76 43.13 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.395 -0.366 . . . . 54.51 111.5 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -68.64 -26.13 65.18 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.248 -0.283 . . . . 62.15 111.607 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.23 -44.8 96.5 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.822 -0.704 . . . . 74.35 112.225 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.68 -49.83 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.007 0.432 . . . . 62.22 110.865 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.609 HD13 ' NH1' ' A' ' 39' ' ' ARG . 54.6 tp -57.69 -41.01 80.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.115 -0.493 . . . . 74.4 111.526 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.43 -51.84 65.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.925 0.393 . . . . 62.14 111.59 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.424 HG13 HD11 ' A' ' 109' ' ' LEU . 86.9 t -60.77 -46.48 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.124 0.488 . . . . 53.11 110.841 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -52.27 -41.09 62.55 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.913 -0.585 . . . . 62.21 111.625 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 98.2 mt-30 -61.15 -48.82 79.85 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.818 0.342 . . . . 72.11 111.325 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.57 -48.29 86.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.185 -0.461 . . . . 73.34 111.657 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 49' ' ' VAL . 81.0 mt -65.21 -56.81 10.69 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.278 -0.419 . . . . 73.0 111.456 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 CA--C 1.541 0.634 0 CA-C-N 116.06 -0.518 . . . . 74.51 111.752 -178.395 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.553 HG22 ' HA3' ' A' ' 60' ' ' GLY . 60.6 t . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 115.005 1.483 . . . . 74.4 115.005 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 58' ' ' SER . 23.1 m-85 -112.61 126.48 55.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.102 -0.499 . . . . 74.34 110.528 169.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -111.38 158.9 34.89 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.178 -0.464 . . . . 74.23 110.906 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -49.44 -40.78 44.7 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.767 2.311 . . . . 65.43 113.799 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -82.78 -5.96 59.18 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.409 0.522 . . . . 72.4 112.409 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.68 -30.39 18.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.244 0.545 . . . . 62.31 110.279 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.3 130.44 93.53 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.886 -0.597 . . . . 74.25 110.832 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.56 118.55 5.47 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.239 1.959 . . . . 71.31 112.652 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -61.18 79.9 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.496 0.554 . . . . 64.04 112.496 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.08 -44.45 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.539 0.57 . . . . 73.14 112.539 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -61.25 -15.93 39.97 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.073 0.397 . . . . 64.32 112.073 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 tt -86.26 -32.83 20.91 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.869 0.366 . . . . 72.34 110.601 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -124.72 -70.73 0.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.316 -0.402 . . . . 40.4 111.792 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -77.83 36.24 0.21 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.522 0.564 . . . . 61.32 112.522 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.4 p -70.0 1.84 4.16 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.014 0.435 . . . . 62.44 111.368 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -70.72 -52.81 18.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.837 0.351 . . . . 72.34 111.169 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.624 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 26.8 ptt180 -88.9 -25.78 21.94 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.051 -0.522 . . . . 55.32 111.753 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.61 HD11 ' HE ' ' A' ' 44' ' ' ARG . 5.4 mp 66.61 3.04 2.75 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.996 0.739 . . . . 73.13 112.996 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.624 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 59.5 t -99.63 151.26 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 122.504 0.322 . . . . 55.44 111.617 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -133.07 121.69 23.04 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.479 0.311 . . . . 73.55 110.436 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.87 95.92 5.03 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.147 0.795 . . . . 74.33 113.147 -172.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB2' HD23 ' A' ' 56' ' ' LEU . 6.3 mp0 -102.08 -53.07 3.01 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.247 0.546 . . . . 70.41 110.549 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.45 -28.18 65.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.049 -0.523 . . . . 34.33 111.89 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.01 31.41 79.36 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 116.265 -0.425 . . . . 50.53 113.655 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.2 mt -78.73 -23.67 45.31 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.001 0.429 . . . . 65.22 111.213 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.462 HD23 ' HB1' ' A' ' 132' ' ' ALA . 82.9 mt -80.82 116.24 20.71 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.098 -0.501 . . . . 75.54 111.687 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.8 t -70.64 154.89 41.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 110.159 -0.311 . . . . 62.12 110.159 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -58.89 -32.7 69.74 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.902 0.334 . . . . 72.02 111.902 -175.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.77 -46.92 83.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.313 0.577 . . . . 34.23 110.784 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.87 -38.28 85.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.903 -0.59 . . . . 55.43 111.569 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -64.07 -49.17 73.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.995 -0.282 . . . . 72.15 110.78 172.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.04 -34.57 43.84 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.4 0.619 . . . . 74.51 111.091 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.482 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 45.1 t -82.62 -52.56 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.695 -0.684 . . . . 63.02 111.842 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 48.8 ttm -66.08 -51.67 55.99 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.172 -0.33 . . . . 55.14 111.749 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -52.84 -43.04 65.73 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.107 0.48 . . . . 72.41 110.304 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.39 -43.33 99.48 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.817 -0.629 . . . . 44.43 112.714 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 35' ' ' VAL . 95.0 mtt180 -57.86 -54.93 41.29 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.654 0.264 . . . . 55.14 111.08 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.7 mt -61.87 -45.27 94.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.123 0.487 . . . . 71.13 111.454 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -60.01 -40.55 89.63 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.113 -0.494 . . . . 75.51 111.106 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.46 -44.55 86.85 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.361 -0.382 . . . . 64.51 111.196 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 39' ' ' ARG . 82.1 mt -57.85 -48.3 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.906 0.384 . . . . 74.32 110.809 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.61 ' HE ' HD11 ' A' ' 20' ' ' LEU . 58.3 ttp85 -61.92 -32.48 72.88 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.317 -0.401 . . . . 73.2 111.621 177.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -80.63 -28.37 37.0 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.959 0.355 . . . . 62.31 111.959 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -99.57 -68.68 0.8 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.105 0.409 . . . . 51.43 112.105 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -85.96 -9.95 55.98 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.845 0.313 . . . . 73.45 111.845 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.46 14.14 9.28 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.591 0.589 . . . . 51.53 112.591 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.1 t -72.56 133.72 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.026 0.441 . . . . 72.55 111.758 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -86.5 95.87 9.86 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.275 0.56 . . . . 64.35 110.434 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -111.61 105.29 13.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.993 -0.549 . . . . 72.33 110.656 -174.612 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.95 120.54 40.8 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.208 0.447 . . . . 73.34 112.208 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t -111.15 128.81 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.803 0.335 . . . . 63.44 111.055 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.424 HG21 HD21 ' A' ' 71' ' ' LEU . 44.0 t -128.01 141.31 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 122.403 0.281 . . . . 71.11 111.22 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 p -125.88 120.76 31.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.849 0.357 . . . . 72.12 111.379 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 24' ' ' GLU . 85.2 mt -125.24 135.85 27.41 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-O 120.755 0.312 . . . . 74.14 111.468 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.576 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 72.8 Cg_endo -76.19 -25.23 10.27 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.394 2.063 . . . . 65.32 113.296 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.801 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 32.5 m -155.89 151.93 27.68 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.236 -0.29 . . . . 71.32 111.196 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.507 HD12 ' O ' ' A' ' 62' ' ' ALA . 31.0 pt -125.15 -32.27 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.855 0.36 . . . . 71.42 111.027 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.553 ' HA3' HG22 ' A' ' 3' ' ' VAL . . . 67.16 -116.6 8.21 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.268 -0.491 . . . . 43.12 113.626 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.24 67.36 9.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.612 0.72 . . . . 61.21 111.562 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 59' ' ' ILE . . . -159.42 106.97 1.5 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.509 -0.768 . . . . 61.55 110.808 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 18.2 Cg_endo -57.03 138.86 88.16 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.818 2.345 . . . . 74.21 113.119 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 tp -54.69 -56.1 22.77 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.203 0.816 . . . . 70.32 113.203 -172.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.546 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 23.3 mt-10 -76.25 -9.62 58.77 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.255 0.465 . . . . 73.1 112.255 -173.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.68 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 4.3 m-20 -90.45 -34.55 15.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.96 0.409 . . . . 75.44 110.49 170.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -59.86 -50.51 73.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.678 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.7 p -55.4 -42.68 74.4 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.115 -0.493 . . . . 72.23 111.629 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.46 -54.62 37.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.43 -0.35 . . . . 73.21 111.559 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -61.23 -41.86 97.61 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.021 0.378 . . . . 72.05 112.021 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.424 HD21 HG21 ' A' ' 54' ' ' VAL . 48.7 tp -65.39 -43.62 90.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.248 0.547 . . . . 74.31 110.964 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -67.45 -32.25 72.97 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.849 0.357 . . . . 74.31 111.433 177.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -59.3 -53.84 53.65 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.046 0.388 . . . . 72.45 112.046 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.505 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.1 pt20 -64.54 -31.21 72.33 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.87 0.367 . . . . 61.2 111.734 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.505 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 42.1 m0 -85.97 8.23 21.3 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.027 0.38 . . . . 54.54 112.027 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.96 -49.86 4.17 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 114.385 0.514 . . . . 62.55 114.385 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.528 ' HA ' ' HB3' ' A' ' 82' ' ' ASN . 27.1 m . . . . . 0 CA--C 1.546 0.791 0 N-CA-C 113.162 0.801 . . . . 63.41 113.162 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 32.8 t-20 . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 110.031 -0.359 . . . . 61.31 110.031 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.578 ' HA ' ' N ' ' A' ' 104' ' ' GLY . 30.3 p-10 -41.3 -44.95 2.86 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.367 0.877 . . . . 75.55 113.367 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -105.16 17.66 23.68 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.214 0.53 . . . . 71.24 111.905 -172.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.75 140.7 15.16 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.094 -0.574 . . . . 44.24 114.26 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 100' ' ' GLU . 51.7 tp -143.92 134.85 25.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.743 0.417 . . . . 74.12 110.858 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 60.0 tp -125.65 140.28 52.85 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.048 0.452 . . . . 72.2 111.778 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.8 tp -137.35 108.2 6.67 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.96 -0.564 . . . . 63.33 110.493 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.65 124.02 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 111.95 0.352 . . . . 73.05 111.95 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.594 ' HA ' HG12 ' A' ' 97' ' ' VAL . 36.8 tp -95.71 114.91 26.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.288 -0.415 . . . . 60.33 111.075 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 94' ' ' GLN . 95.5 t -100.03 94.15 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 120.899 0.38 . . . . 70.55 111.128 177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 52.8 tp -60.09 -27.61 67.14 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.819 0.342 . . . . 74.12 111.293 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.801 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 16.3 t0 -52.18 -35.13 48.03 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.831 0.824 . . . . 65.42 110.72 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.439 ' NE2' HD11 ' A' ' 59' ' ' ILE . 71.1 mt-30 -120.68 8.8 10.66 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.124 -0.944 . . . . 71.34 110.891 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 36.21 52.25 0.87 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.555 1.142 . . . . 70.15 113.536 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -153.33 162.32 41.41 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.881 -0.6 . . . . 61.2 110.91 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.681 HG21 ' SD ' ' A' ' 122' ' ' MET . 5.5 m -123.8 172.43 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.302 0.572 . . . . 74.24 112.186 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.546 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 65.6 ttt-85 -147.16 138.19 23.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.834 -0.621 . . . . 75.04 111.218 172.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -91.17 151.42 20.96 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.029 0.442 . . . . 74.2 111.083 173.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 17.2 tp10 -137.64 112.58 9.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.288 -0.414 . . . . 70.05 110.595 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.6 p -99.69 136.33 39.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.328 0.585 . . . . 73.13 112.528 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -76.99 -178.89 47.75 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.584 -0.817 . . . . 50.43 112.154 168.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -62.36 -18.69 62.13 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.355 0.872 . . . . 73.02 113.355 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.578 ' N ' ' HA ' ' A' ' 83' ' ' ASN . . . -88.04 -40.71 6.51 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.768 -0.73 . . . . 60.31 112.581 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.639 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 95.0 mt -69.16 -6.73 30.6 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.267 0.469 . . . . 64.41 112.267 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -58.57 -23.98 59.79 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.261 0.553 . . . . 74.32 110.913 173.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.09 22.51 39.05 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.119 -0.491 . . . . 74.41 113.209 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.639 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 68.3 m-85 -141.55 -57.48 0.48 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.264 0.554 . . . . 74.05 110.953 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.9 mt -113.36 91.92 21.31 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.563 -0.744 . . . . 75.51 111.675 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.96 151.73 81.6 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.545 2.163 . . . . 70.11 112.509 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -54.49 -41.62 69.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.949 0.404 . . . . 74.45 111.61 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.59 -47.51 89.69 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.335 -0.459 . . . . 63.0 112.903 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.3 tp -56.12 -50.7 70.36 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.868 0.366 . . . . 74.31 111.056 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.08 -36.34 74.92 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.357 -0.383 . . . . 71.51 111.382 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 m -64.99 -41.3 95.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.397 -0.365 . . . . 73.05 111.095 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -64.35 -44.8 90.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.588 -0.278 . . . . 74.03 111.136 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.8 mt -52.59 -48.1 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.1 0.476 . . . . 72.44 110.682 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.0 mt -61.53 -37.07 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.224 -0.444 . . . . 74.32 111.6 176.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 7.6 t-80 -83.3 -28.41 29.11 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.05 0.759 . . . . 54.02 113.05 -173.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.96 -48.32 4.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.129 0.418 . . . . 72.21 112.129 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.693 ' HA ' ' HE ' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -84.61 -15.33 45.92 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.497 0.554 . . . . 73.14 112.497 -175.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.681 ' SD ' HG21 ' A' ' 97' ' ' VAL . 60.7 mtt -120.79 -54.77 2.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.688 0.996 . . . . 73.21 113.688 -176.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.503 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 12.8 mm -46.38 -54.47 18.08 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.202 0.816 . . . . 72.2 113.202 -175.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.503 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 51.6 Cg_exo -55.28 -34.29 87.9 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.767 1.644 . . . . 71.12 112.572 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 96.0 m-70 -76.05 -50.47 14.68 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.166 -0.47 . . . . 73.44 111.772 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.9 m-30 -56.37 -44.01 79.75 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.832 0.349 . . . . 73.34 111.421 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -61.43 -31.08 71.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.121 0.486 . . . . 72.44 111.127 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -88.4 0.67 55.96 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.002 -0.545 . . . . 74.13 111.747 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.72 -7.41 79.79 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.336 -0.459 . . . . 73.52 113.096 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.825 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 13.2 m120 -75.54 67.69 2.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.757 0.423 . . . . 74.51 111.472 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -67.74 -54.34 20.12 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.066 -0.397 . . . . 72.34 111.65 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.462 ' HB1' HD23 ' A' ' 28' ' ' LEU . . . -61.51 -42.97 99.61 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.976 0.417 . . . . 63.21 111.514 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 1.3 mp0 -58.15 -43.09 87.18 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.234 -0.439 . . . . 54.34 111.259 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.91 99.95 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.148 -0.549 . . . . 75.2 112.437 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.492 HD11 HD22 ' A' ' 90' ' ' LEU . 93.3 mt -59.7 -42.43 92.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.737 0.303 . . . . 71.41 111.129 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.5 t -57.68 -48.75 78.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.524 -0.307 . . . . 73.44 111.26 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 133' ' ' GLU . 35.5 mm-40 -62.15 -43.85 97.92 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.956 0.407 . . . . 64.44 111.057 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.87 -54.2 39.48 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 116.166 -0.47 . . . . 41.13 113.385 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.25 -47.62 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.99 0.424 . . . . 63.53 111.379 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.483 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 48.5 tp -61.48 -38.36 87.0 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.187 -0.46 . . . . 65.03 111.047 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -61.37 -50.87 71.16 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.928 0.394 . . . . 71.42 111.263 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.26 -45.91 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.134 0.493 . . . . 71.35 110.818 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -54.82 -43.06 72.62 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.922 -0.581 . . . . 74.13 111.395 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 27.1 mt-30 -62.88 -41.3 99.35 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.704 0.261 . . . . 72.2 111.704 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ALA . 58.0 t -59.35 -50.09 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.858 0.361 . . . . 73.13 111.131 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -58.67 -44.26 90.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.497 0.665 . . . . 72.43 110.464 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 CA--C 1.547 0.83 0 CA-C-N 115.433 -0.803 . . . . 63.15 111.506 177.063 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 CA--C 1.543 0.698 0 N-CA-C 112.448 0.536 . . . . 74.52 112.448 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.424 ' HB2' HD13 ' A' ' 56' ' ' LEU . 21.9 m-85 -90.12 174.16 7.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.757 0.789 . . . . 72.44 112.354 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.557 ' H ' ' HB2' ' A' ' 8' ' ' ASP . 30.6 mmtp -132.31 153.27 81.19 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.924 -1.035 . . . . 74.14 109.404 170.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.446 ' HG2' ' HE3' ' A' ' 70' ' ' LYS . 11.1 Cg_endo -56.47 -29.35 77.64 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 121.898 1.732 . . . . 63.04 112.437 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -83.82 -12.56 55.44 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.168 0.433 . . . . 64.53 112.168 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.557 ' HB2' ' H ' ' A' ' 5' ' ' LYS . 3.0 m-20 -81.97 -27.32 33.29 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.92 0.39 . . . . 73.43 111.366 172.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.62 129.62 91.47 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 116.315 -0.402 . . . . 73.33 111.554 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -52.44 126.94 22.23 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.892 2.395 . . . . 75.1 113.329 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -71.93 73.2 0.86 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.889 0.375 . . . . 71.23 111.0 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.95 -38.56 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 112.263 0.468 . . . . 74.45 112.263 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 15.1 mm100 -72.53 74.89 1.06 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.606 0.717 . . . . 71.11 110.825 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt 177.06 -56.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.629 -1.168 . . . . 62.52 108.338 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.08 -47.86 5.61 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.259 -0.882 . . . . 61.22 110.93 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.692 ' HB3' ' HB3' ' A' ' 19' ' ' ARG . 7.8 m-20 -96.57 49.16 1.09 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.776 -0.647 . . . . 72.02 111.79 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.7 m -67.14 -13.8 62.29 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.501 -0.318 . . . . 73.11 111.657 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.6 p -97.87 -3.2 39.13 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.741 0.305 . . . . 72.42 111.489 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.692 ' HB3' ' HB3' ' A' ' 16' ' ' ASP . 78.9 ttt180 -105.21 -56.38 2.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.015 0.436 . . . . 64.35 110.977 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.3 mp 69.96 -13.62 0.41 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.731 0.812 . . . . 61.41 113.069 175.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.3 t -93.43 148.61 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.207 0.527 . . . . 72.04 112.124 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.7 m -143.54 102.61 3.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.2 -0.455 . . . . 71.41 110.591 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.43 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 23.8 t70 -106.1 93.06 4.41 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.292 0.568 . . . . 53.41 111.079 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' HB2' HD23 ' A' ' 56' ' ' LEU . 31.5 mm-40 -94.11 -37.01 11.82 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.957 -0.565 . . . . 65.43 110.841 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.24 -34.11 68.27 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.346 0.499 . . . . 62.23 112.346 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.74 47.29 6.78 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.824 -0.703 . . . . 61.52 112.06 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.7 mt -114.07 -33.32 5.74 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.909 0.385 . . . . 61.31 111.405 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.51 106.15 5.97 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.616 -0.266 . . . . 63.33 110.959 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.5 t -51.77 145.25 9.81 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.375 -0.375 . . . . 54.53 111.193 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -49.54 -30.5 8.59 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.27 0.47 . . . . 63.54 112.27 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -73.58 -51.09 18.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.749 0.309 . . . . 72.22 111.216 175.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -60.98 -42.12 97.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.87 0.367 . . . . 65.44 111.946 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -59.49 -54.18 49.53 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.312 0.577 . . . . 75.14 110.027 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -52.97 -52.61 57.56 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.438 -0.801 . . . . 74.4 112.085 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 31' ' ' ALA . 76.7 t -59.71 -41.99 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.231 -0.441 . . . . 73.33 111.855 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 48.2 ttm -61.34 -42.83 99.32 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.584 -0.28 . . . . 61.44 111.032 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -53.16 -51.94 60.4 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.06 0.457 . . . . 60.21 111.17 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.65 -38.02 93.16 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.166 -0.54 . . . . 44.41 113.242 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 43' ' ' ILE . 99.5 mtt180 -64.87 -54.64 27.76 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.656 -0.32 . . . . 71.14 111.458 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.69 -43.79 93.92 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.037 0.446 . . . . 72.54 111.379 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -57.64 -45.88 84.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.081 -0.509 . . . . 75.2 111.101 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.14 86.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.129 -0.487 . . . . 62.41 111.531 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.7 mt -56.19 -47.65 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.027 0.441 . . . . 65.21 111.375 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.476 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -62.66 -34.58 77.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.183 0.516 . . . . 74.13 110.711 178.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.8 m -89.75 -1.91 58.12 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.132 -0.486 . . . . 62.01 112.134 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.9 p -122.01 -61.87 1.45 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.011 0.434 . . . . 73.43 111.535 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -92.27 -2.18 56.61 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.831 0.348 . . . . 73.14 111.63 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 66.46 11.5 8.08 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.711 0.634 . . . . 71.23 112.711 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 43' ' ' ILE . 62.9 t -80.74 117.47 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.0 0.429 . . . . 72.23 111.619 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' CG ' ' HE ' ' A' ' 44' ' ' ARG . 36.3 mt-10 -78.59 96.58 5.52 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.443 0.639 . . . . 74.32 110.454 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.83 106.89 15.31 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.445 -0.798 . . . . 73.21 110.778 -172.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.98 144.89 40.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.742 0.306 . . . . 53.32 111.789 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.45 128.44 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.745 0.307 . . . . 65.21 111.43 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG21 HD21 ' A' ' 71' ' ' LEU . 58.1 t -129.98 134.97 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 120.708 0.29 . . . . 73.02 111.582 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 39.3 p -120.99 125.32 47.08 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.946 0.403 . . . . 73.43 111.626 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 24' ' ' GLU . 85.1 mt -127.21 145.78 55.52 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-O 120.667 0.27 . . . . 71.2 111.246 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 57.8 Cg_endo -72.16 -45.14 0.69 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.228 1.952 . . . . 54.42 112.997 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.5 m -149.33 137.55 20.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.651 0.262 . . . . 65.54 111.23 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.5 pt -119.28 9.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 121.097 0.475 . . . . 53.54 111.407 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.12 -136.39 32.58 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.292 -0.48 . . . . 32.24 113.082 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -91.4 7.38 41.39 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.603 -0.351 . . . . 74.21 111.478 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . . . -67.74 136.14 92.52 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.12 0.415 . . . . 72.51 112.12 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 62' ' ' ALA . 14.5 Cg_exo -69.59 132.83 24.44 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.586 2.19 . . . . 55.23 112.447 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.7 tp -62.63 -34.31 76.79 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.731 0.301 . . . . 75.54 111.758 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -73.94 -43.17 59.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.012 0.434 . . . . 73.11 111.303 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -61.61 -37.36 83.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.325 0.583 . . . . 74.51 110.149 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -58.79 -60.07 4.42 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.405 -0.816 . . . . 61.34 111.15 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.3 p -55.56 -41.68 73.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.101 -0.5 . . . . 75.2 111.751 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -55.65 -52.29 64.33 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 111.784 0.29 . . . . 74.4 111.784 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HE3' ' HG2' ' A' ' 6' ' ' PRO . 34.7 mtmt -64.92 -46.31 82.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.736 0.303 . . . . 72.4 111.507 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.581 HD21 HG21 ' A' ' 54' ' ' VAL . 40.1 tp -60.88 -42.85 98.74 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.983 0.421 . . . . 64.55 111.201 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.63 -45.88 81.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.275 -0.42 . . . . 61.3 112.048 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -73.76 -24.72 59.9 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.785 0.326 . . . . 73.13 111.743 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -66.62 -40.41 88.78 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.029 0.442 . . . . 55.32 110.886 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 49.5 m0 -93.24 -15.91 25.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.304 -0.407 . . . . 75.24 111.837 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 72.48 44.65 40.5 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.481 -0.39 . . . . 70.35 113.374 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 121.017 0.436 . . . . 65.14 111.711 -177.717 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 112.88 0.696 . . . . 52.42 112.88 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 104' ' ' GLY . 3.9 p-10 -154.55 -151.13 0.34 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.907 0.483 . . . . 73.35 110.209 -173.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -67.95 77.8 0.22 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.815 0.816 . . . . 54.4 111.68 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.52 143.25 12.47 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.338 -0.846 . . . . 64.54 111.47 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.714 HD11 ' HB3' ' A' ' 99' ' ' PHE . 31.3 tp -137.37 123.63 20.56 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.142 0.471 . . . . 72.54 111.591 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 59.5 tp -109.16 122.54 47.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.616 -0.265 . . . . 72.41 111.303 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.6 tp -114.19 111.75 22.05 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.516 0.326 . . . . 73.13 111.22 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.94 127.84 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.781 0.324 . . . . 41.21 111.794 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 135' ' ' LEU . 23.1 tp -104.52 121.86 44.35 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.268 -0.424 . . . . 72.21 111.138 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.43 HG11 ' NE2' ' A' ' 94' ' ' GLN . 48.6 t -104.26 103.82 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.853 -0.158 . . . . 72.34 110.885 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.666 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 65.1 tp -57.34 -36.92 71.76 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.802 0.667 . . . . 71.31 112.802 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -50.99 -56.52 12.08 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 120.744 0.307 . . . . 73.25 111.704 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.62 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 8.4 pm0 -98.33 9.18 43.65 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.87 0.367 . . . . 70.15 111.537 174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.486 ' HB2' ' HE1' ' A' ' 131' ' ' TYR . 40.2 ptt180 35.95 46.43 0.35 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.508 1.123 . . . . 72.31 113.707 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.62 ' HE ' ' HG3' ' A' ' 94' ' ' GLN . 26.8 ptt180 -126.45 154.64 43.41 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.891 0.377 . . . . 65.13 111.15 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.636 HG21 ' SD ' ' A' ' 122' ' ' MET . 5.7 m -122.42 171.18 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.234 -0.439 . . . . 73.03 111.804 -176.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.4 ttt85 -148.63 128.82 13.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.256 -0.429 . . . . 64.43 111.719 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.714 ' HB3' HD11 ' A' ' 86' ' ' LEU . 72.0 m-85 -92.66 118.78 31.4 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.303 -0.408 . . . . 71.21 110.013 170.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 8.1 tp10 -103.93 112.29 25.2 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.542 0.211 . . . . 74.44 111.441 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.591 HG23 HD11 ' A' ' 114' ' ' LEU . 7.7 p -96.31 133.24 40.93 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.141 0.496 . . . . 72.15 111.528 177.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.79 -63.52 2.7 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.953 -0.641 . . . . 73.52 112.518 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -168.59 -53.4 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.918 0.39 . . . . 72.01 111.838 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 83' ' ' ASN . . . -54.15 -31.82 49.59 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 114.699 0.639 . . . . 64.42 114.699 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 64.8 mt -78.82 -10.69 59.87 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.906 0.706 . . . . 71.42 112.906 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -57.54 -31.81 66.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.904 0.383 . . . . 72.42 111.284 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.96 -25.08 75.57 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.075 -0.583 . . . . 43.51 113.326 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -102.1 -67.77 0.86 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.414 -0.462 . . . . 60.13 111.276 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.608 ' HA ' HD23 ' A' ' 113' ' ' LEU . 1.6 mp -120.56 93.42 48.41 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 116.427 -0.351 . . . . 63.41 111.463 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.54 157.97 57.98 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.972 1.781 . . . . 71.12 111.529 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.535 ' HA ' HD12 ' A' ' 114' ' ' LEU . 10.0 p-10 -49.25 -33.78 13.57 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.325 0.491 . . . . 62.1 112.325 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.43 -45.51 96.25 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.956 -0.64 . . . . 53.53 112.991 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.608 HD23 ' HA ' ' A' ' 109' ' ' LEU . 53.0 tp -64.37 -35.41 80.78 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.032 0.444 . . . . 75.43 110.937 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.591 HD11 HG23 ' A' ' 101' ' ' THR . 89.1 mt -59.94 -45.27 93.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.896 0.379 . . . . 51.33 110.894 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.4 m -63.78 -36.34 83.57 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.368 -0.378 . . . . 50.13 111.091 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -55.16 -46.02 75.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.094 -0.503 . . . . 70.44 111.104 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.3 -51.99 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.317 -0.401 . . . . 63.14 111.498 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.2 mt -56.58 -55.69 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.239 0.542 . . . . 72.51 112.193 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.469 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 20.3 t-80 -71.0 -30.92 67.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.694 0.628 . . . . 75.14 112.694 -169.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -88.0 -44.51 10.94 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.385 0.513 . . . . 72.35 112.385 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -98.46 -44.55 6.46 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.687 0.625 . . . . 74.42 112.687 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.636 ' SD ' HG21 ' A' ' 97' ' ' VAL . 47.4 mtt -72.68 -48.57 37.98 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.033 0.753 . . . . 75.53 113.033 -175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.469 ' CG1' ' HA ' ' A' ' 119' ' ' HIS . 29.8 mm -49.79 -55.26 24.61 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 113.185 0.809 . . . . 63.32 113.185 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 16.9 Cg_endo -56.61 -38.67 95.06 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.0 1.8 . . . . 62.54 112.477 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -66.25 -49.39 67.33 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 111.602 0.223 . . . . 63.51 111.602 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.1 m-30 -59.69 -35.84 75.29 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.756 0.313 . . . . 72.12 111.271 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -67.29 -36.27 81.2 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.95 0.405 . . . . 71.44 111.554 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 m -78.1 -22.01 49.61 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.858 0.361 . . . . 72.04 111.588 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.41 0.32 32.93 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.442 -0.409 . . . . 73.34 112.865 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.8 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 83.2 m-20 -82.3 74.27 9.28 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.63 -0.335 . . . . 64.25 111.685 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.486 ' HE1' ' HB2' ' A' ' 95' ' ' ARG . 96.9 m-85 -70.93 -44.42 66.18 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.838 0.351 . . . . 73.41 111.298 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.51 -46.61 85.28 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.963 0.411 . . . . 63.03 111.406 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.8 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 27.3 mm-40 -62.25 -49.38 75.96 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.066 -0.516 . . . . 72.24 111.415 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.67 -51.59 51.46 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.427 -0.416 . . . . 63.43 113.154 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.574 HD11 HD22 ' A' ' 90' ' ' LEU . 78.2 mt -62.07 -43.38 98.96 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.604 -0.351 . . . . 75.21 111.504 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.7 t -57.84 -57.57 12.19 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.252 0.464 . . . . 63.5 112.252 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 140' ' ' LEU . 11.9 pt-20 -76.42 -19.81 57.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.913 0.338 . . . . 72.02 111.913 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.79 -50.37 61.74 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.674 -0.774 . . . . 55.23 111.766 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.6 -44.98 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.044 0.449 . . . . 63.41 110.81 172.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 56.2 tp -59.37 -38.05 79.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.074 -0.512 . . . . 73.42 111.165 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -60.24 -44.8 94.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.801 0.334 . . . . 65.23 111.086 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.431 HG13 HD22 ' A' ' 109' ' ' LEU . 90.7 t -59.27 -52.73 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.106 0.479 . . . . 72.34 110.856 174.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -53.05 -43.67 66.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.913 -0.585 . . . . 65.02 111.888 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 83.6 mm-40 -59.3 -37.93 78.97 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.924 0.342 . . . . 74.4 111.924 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 141' ' ' ALA . 91.5 t -64.23 -35.84 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.064 0.459 . . . . 73.21 111.173 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.25 -57.83 5.96 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.368 -0.378 . . . . 74.15 111.648 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.972 0.415 . . . . 75.34 111.485 177.801 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 112.734 0.642 . . . . 73.11 112.734 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -111.12 126.74 55.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.984 -0.553 . . . . 73.12 111.86 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -105.73 163.89 16.15 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 116.189 -0.459 . . . . 63.22 109.814 171.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 10.0 Cg_endo -51.53 -29.37 31.72 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.566 2.177 . . . . 63.33 114.118 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -82.87 -17.68 42.99 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.438 0.533 . . . . 72.32 112.438 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.88 -34.89 64.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.074 0.464 . . . . 64.13 110.527 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.405 HG22 HD21 ' A' ' 56' ' ' LEU . 64.9 t -64.7 127.05 92.08 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 115.84 -0.618 . . . . 65.44 111.466 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.21 133.0 31.38 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.376 2.05 . . . . 70.55 113.059 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -74.54 77.12 1.97 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.37 0.605 . . . . 75.42 110.69 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -59.79 -31.0 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 113.151 0.797 . . . . 73.43 113.151 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.34 -9.03 10.24 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.307 0.484 . . . . 74.11 112.307 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.1 tt -76.14 -41.68 49.23 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.209 0.528 . . . . 71.33 110.383 175.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.89 -51.68 3.36 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.043 -0.526 . . . . 70.44 112.39 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 19' ' ' ARG . 34.5 m-20 -114.85 86.59 2.47 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.017 0.747 . . . . 74.3 113.017 -173.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.4 p -78.89 -6.73 56.87 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.569 0.7 . . . . 75.21 110.398 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -93.06 -0.44 57.1 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.802 -0.636 . . . . 44.22 111.128 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 16' ' ' ASP . 18.4 ttt180 -113.31 -63.09 1.49 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.126 -0.488 . . . . 75.31 111.323 -174.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp 64.62 -0.02 1.04 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.224 0.61 . . . . 54.42 112.489 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.0 t -103.81 130.09 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.067 0.46 . . . . 65.13 111.816 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -125.72 112.59 16.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.972 -0.558 . . . . 73.42 110.094 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.68 100.4 7.59 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.363 0.505 . . . . 64.23 112.363 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.457 ' HB2' HD23 ' A' ' 56' ' ' LEU . 4.5 mp0 -98.54 -37.75 9.43 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.919 0.39 . . . . 75.34 110.937 173.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -57.24 -31.27 65.37 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.74 0.644 . . . . 61.12 112.74 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.44 39.44 8.33 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.836 -0.697 . . . . 61.1 112.328 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.18 -38.43 5.99 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.063 0.459 . . . . 71.54 111.286 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -90.6 98.88 12.04 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.184 0.516 . . . . 75.44 111.362 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.1 m -72.36 173.05 9.27 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.402 -0.363 . . . . 64.44 111.584 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -49.97 -47.3 52.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.29 0.478 . . . . 71.53 112.29 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.44 -47.27 76.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.932 0.396 . . . . 62.13 111.4 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -55.81 -43.63 77.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.198 -0.456 . . . . 53.12 111.132 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.76 -55.08 37.42 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.369 -0.378 . . . . 75.12 111.132 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.7 -38.87 61.37 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.053 0.454 . . . . 63.31 111.848 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.57 -43.0 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.002 0.43 . . . . 63.13 111.615 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 47.0 ttm -73.22 -45.99 52.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.636 0.255 . . . . 55.23 111.16 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -50.76 -42.79 58.01 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.901 0.48 . . . . 60.11 111.031 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.24 -47.55 90.5 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.154 -0.475 . . . . 63.04 113.561 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 43' ' ' ILE . 9.9 ptp180 -74.45 -34.73 63.24 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.439 -0.448 . . . . 74.42 112.064 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.415 HD22 ' O ' ' A' ' 51' ' ' PHE . 89.8 mt -67.91 -41.65 82.32 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.5 0.667 . . . . 72.04 110.487 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -59.13 -39.58 82.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.378 -0.828 . . . . 62.33 110.352 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.42 85.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.944 -0.571 . . . . 74.41 111.422 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 143' ' ' GLN . 77.2 mt -58.45 -51.9 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.155 -0.475 . . . . 74.13 111.735 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 62.7 ttp85 -65.14 -34.01 77.38 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.772 0.32 . . . . 72.32 111.592 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -76.46 -23.59 53.85 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.831 0.348 . . . . 60.3 111.66 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -100.02 -69.9 0.75 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.663 0.246 . . . . 73.12 111.663 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -87.05 -5.6 59.0 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.523 0.564 . . . . 64.43 112.523 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 67.08 19.83 10.42 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.493 0.553 . . . . 54.42 112.493 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.7 t -90.57 133.99 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.695 0.284 . . . . 70.35 111.627 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.3 96.97 10.78 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.072 0.463 . . . . 74.21 110.658 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -103.59 97.97 7.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.783 -0.644 . . . . 74.13 109.759 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.07 141.94 34.97 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.131 0.419 . . . . 74.42 112.131 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.93 123.9 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.454 -0.339 . . . . 71.22 111.119 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -121.61 136.01 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.399 0.28 . . . . 72.42 111.391 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -120.5 123.75 43.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.912 0.386 . . . . 72.11 111.432 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 24' ' ' GLU . 76.3 mt -124.15 145.36 48.11 Favored Pre-proline 0 N--CA 1.471 0.625 0 O-C-N 122.164 -0.335 . . . . 71.42 111.792 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 27.9 Cg_exo -63.11 -55.99 0.66 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.739 2.293 . . . . 72.45 112.542 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.6 m -150.78 148.58 28.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.758 0.314 . . . . 73.22 111.394 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 91' ' ' VAL . 24.4 pt -118.24 -6.65 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 120.956 0.408 . . . . 74.25 111.777 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.53 -116.18 8.43 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.535 -0.364 . . . . 62.02 113.841 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.3 -13.12 53.31 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.713 0.292 . . . . 73.23 111.761 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -65.49 124.83 88.29 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.606 -0.27 . . . . 64.12 111.329 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.3 Cg_endo -80.14 131.71 8.95 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.427 2.084 . . . . 73.13 112.607 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 96' ' ' ARG . 61.4 tp -59.33 -42.28 91.08 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.422 0.527 . . . . 64.34 112.422 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 8.6 mp0 -60.1 -44.29 94.96 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.031 0.443 . . . . 54.45 111.493 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 6.0 m-20 -74.48 -33.19 62.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.957 0.408 . . . . 75.35 110.809 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.44 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 37.3 t80 -56.6 -55.35 35.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.298 -0.41 . . . . 74.31 111.383 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.9 p -54.69 -46.07 74.06 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.285 -0.416 . . . . 74.34 111.66 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.569 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.0 tp -59.2 -54.59 45.19 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.375 -0.375 . . . . 75.4 111.327 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -58.94 -44.22 91.37 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.107 0.41 . . . . 72.15 112.107 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.598 HD23 HD21 ' A' ' 87' ' ' LEU . 54.7 tp -62.42 -45.35 93.5 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.156 0.503 . . . . 74.35 110.926 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.68 -35.99 81.45 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.905 0.384 . . . . 42.02 111.792 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 78.4 mtp180 -61.67 -53.98 48.93 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.511 -0.313 . . . . 53.25 111.595 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.503 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 16.2 pt20 -64.87 -33.73 76.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 111.987 0.366 . . . . 74.22 111.987 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.503 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 26.9 m0 -74.28 -4.48 36.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.929 0.395 . . . . 74.15 111.956 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.33 -1.01 72.64 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.277 -0.487 . . . . 75.42 113.414 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.402 ' HA ' ' ND2' ' A' ' 82' ' ' ASN . 4.4 t . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 121.291 0.567 . . . . 73.4 110.937 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.66 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 25.3 t-20 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 110.201 -0.296 . . . . 75.51 110.201 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.548 ' HA ' ' N ' ' A' ' 104' ' ' GLY . 27.6 p-10 -36.43 -63.65 0.38 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 113.958 1.096 . . . . 63.11 113.958 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -94.5 35.16 1.23 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.861 -0.524 . . . . 71.31 111.864 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.4 139.2 15.45 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.136 -0.554 . . . . 73.54 113.933 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 46.6 tp -149.98 122.93 8.76 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.009 0.433 . . . . 74.1 110.846 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.598 HD21 HD23 ' A' ' 71' ' ' LEU . 62.9 tp -122.95 131.79 53.87 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.937 0.399 . . . . 53.4 111.924 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.7 tp -121.35 117.3 26.61 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.146 -0.479 . . . . 72.25 110.889 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.22 124.73 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.943 0.402 . . . . 73.35 111.852 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.524 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.2 tp -103.47 118.59 37.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.056 -0.52 . . . . 74.01 111.007 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 59' ' ' ILE . 57.6 t -99.41 101.22 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.539 -0.3 . . . . 73.45 110.868 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.2 tp -48.93 -46.49 43.21 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.857 0.463 . . . . 72.41 111.994 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -45.27 -48.36 12.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.973 0.731 . . . . 73.11 112.973 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -111.15 4.58 19.42 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.18 0.437 . . . . 75.34 112.18 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 43.52 26.06 0.1 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.331 1.052 . . . . 63.12 113.467 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HG3' HD22 ' A' ' 64' ' ' LEU . 11.0 ptm85 -105.02 152.25 22.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.922 0.392 . . . . 73.54 111.042 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 90' ' ' LEU . 3.4 m -136.63 165.86 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.177 -0.465 . . . . 64.45 110.771 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -149.63 135.32 18.56 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.797 0.332 . . . . 73.33 111.61 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.55 ' HB2' HD13 ' A' ' 114' ' ' LEU . 80.8 m-85 -93.86 102.35 14.47 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.102 -0.499 . . . . 64.23 110.024 172.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -81.87 111.37 18.01 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 110.329 -0.249 . . . . 42.55 110.329 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.9 p -93.15 141.01 28.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.578 0.704 . . . . 60.0 112.581 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -84.37 166.81 42.37 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.676 -0.774 . . . . 70.44 111.743 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -54.28 -19.63 5.67 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.16 0.8 . . . . 75.55 113.16 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.548 ' N ' ' HA ' ' A' ' 83' ' ' ASN . . . -85.11 -20.52 57.25 Favored Glycine 0 N--CA 1.463 0.462 0 C-N-CA 120.815 -0.707 . . . . 50.2 112.805 -173.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.41 -4.3 29.27 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.351 0.26 . . . . 72.13 111.587 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -51.59 -39.95 58.91 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.269 0.47 . . . . 74.44 112.269 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.43 -12.51 58.76 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.225 -0.512 . . . . 53.14 114.113 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -118.38 -48.65 2.5 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.066 0.46 . . . . 70.23 111.7 -176.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.57 ' HB3' HD21 ' A' ' 114' ' ' LEU . 30.8 mt -118.02 86.44 25.81 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.92 -0.582 . . . . 72.53 112.296 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 88.9 Cg_endo -82.84 158.55 15.97 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.27 1.98 . . . . 74.13 112.398 172.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.45 -35.21 8.23 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.908 0.336 . . . . 71.23 111.908 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.27 -51.03 59.42 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.107 -0.568 . . . . 65.53 113.122 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 64.9 tp -62.73 -45.87 90.7 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.073 0.464 . . . . 71.13 110.674 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 109' ' ' LEU . 67.7 mt -59.22 -38.46 80.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.936 -0.575 . . . . 73.24 110.972 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.5 t -61.81 -40.14 94.21 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.174 -0.467 . . . . 61.21 110.942 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.45 -48.76 76.37 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.935 -0.306 . . . . 72.33 110.901 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.2 mt -50.71 -45.66 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.099 0.476 . . . . 74.1 110.908 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.538 ' O ' HG12 ' A' ' 123' ' ' ILE . 68.2 mt -64.9 -56.83 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.01 -0.541 . . . . 72.31 112.189 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -76.02 -34.37 59.68 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.602 0.964 . . . . 52.23 113.602 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.25 -32.59 33.27 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.858 0.361 . . . . 75.31 111.716 -171.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -123.57 -56.19 1.7 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.286 0.476 . . . . 71.34 112.286 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 91.4 mtp -64.06 -43.86 94.2 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.554 0.946 . . . . 74.31 113.554 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 118' ' ' ILE . 38.2 mm -57.54 -50.29 88.96 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 112.18 0.437 . . . . 74.12 112.18 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 86.9 Cg_exo -45.0 -44.7 14.77 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.204 1.936 . . . . 74.11 112.948 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -64.1 -51.9 61.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.614 -0.266 . . . . 72.1 111.535 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -56.95 -39.78 75.2 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.781 0.324 . . . . 74.25 111.664 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -67.44 -36.02 80.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.218 0.532 . . . . 63.34 110.994 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.5 t -74.28 -16.83 60.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.25 -0.432 . . . . 65.34 111.067 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.31 53.2 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 116.283 -0.417 . . . . 70.41 112.659 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.92 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 94.8 m-20 -81.31 72.0 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.052 0.454 . . . . 62.14 111.966 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -67.07 -45.65 76.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.825 0.345 . . . . 73.51 111.079 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.58 -47.33 67.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.05 0.452 . . . . 71.12 111.357 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.92 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 11.3 tp10 -59.75 -41.27 90.61 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.032 -0.531 . . . . 61.1 110.721 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.77 -53.96 34.42 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.831 -0.622 . . . . 63.35 113.258 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.2 -44.81 71.91 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 122.462 -0.434 . . . . 72.35 111.348 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.2 t -56.01 -51.67 66.95 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.231 0.456 . . . . 75.41 112.231 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -34.6 62.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.628 0.232 . . . . 73.51 111.628 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.82 -48.15 87.48 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.111 -0.566 . . . . 51.25 112.378 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.72 -43.74 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.17 0.51 . . . . 51.35 110.932 173.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.95 -38.97 87.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.971 -0.559 . . . . 74.42 110.795 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.3 96.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.095 0.474 . . . . 51.5 111.045 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.47 -51.43 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.139 -0.482 . . . . 74.11 111.427 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.487 ' HB2' HD11 ' A' ' 43' ' ' ILE . 63.3 tt0 -54.18 -40.19 67.3 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 121.128 -0.229 . . . . 71.45 111.536 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -57.29 -43.42 83.17 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.83 0.307 . . . . 74.52 111.83 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.79 -51.12 76.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.902 0.382 . . . . 43.22 111.15 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.62 -46.51 88.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.184 0.516 . . . . 73.13 111.079 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 CA--C 1.544 0.723 0 CA-C-N 115.783 -0.644 . . . . 54.1 111.263 177.406 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 121.061 0.458 . . . . 60.04 112.038 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -93.01 134.51 35.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.422 0.527 . . . . 75.12 112.422 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 1.3 mptm? -107.52 163.3 17.24 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.148 -0.478 . . . . 72.11 110.124 169.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 13.6 Cg_endo -54.87 -26.64 49.4 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.176 1.918 . . . . 72.52 112.716 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.44 -29.49 59.7 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.385 -0.371 . . . . 73.34 111.933 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.63 -29.65 56.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.929 0.395 . . . . 74.24 111.585 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.63 HG13 HG21 ' A' ' 22' ' ' THR . 50.5 t -62.87 127.55 90.77 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 116.185 -0.461 . . . . 64.52 111.494 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.64 130.39 31.37 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.66 2.24 . . . . 73.15 112.949 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -69.8 76.65 0.46 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.242 0.544 . . . . 43.32 112.045 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 m -58.29 -49.56 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.482 0.549 . . . . 73.14 112.482 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -60.89 -17.91 53.35 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.837 -0.54 . . . . 70.21 112.054 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.66 -52.33 5.6 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.869 0.366 . . . . 75.2 110.21 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.99 -75.84 0.49 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.526 -0.306 . . . . 63.14 111.703 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.92 48.76 0.61 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.47 0.545 . . . . 73.31 112.47 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 82.9 p -63.84 -9.21 13.69 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.963 0.411 . . . . 53.21 111.344 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -89.86 -26.08 20.69 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.085 -0.507 . . . . 74.31 111.374 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 21' ' ' VAL . 12.3 ttm180 -85.03 -45.1 12.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.913 0.387 . . . . 71.23 110.864 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.5 mp 59.15 15.12 3.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.484 0.713 . . . . 62.12 112.382 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.54 ' O ' ' HD2' ' A' ' 19' ' ' ARG . 88.0 t -129.39 126.1 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.965 0.412 . . . . 72.15 111.696 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.63 HG21 HG13 ' A' ' 9' ' ' VAL . 86.7 m -99.66 102.93 14.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.915 0.388 . . . . 71.42 110.11 173.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.98 98.18 8.67 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.371 0.605 . . . . 60.11 111.886 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -126.46 -30.85 2.81 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.835 0.35 . . . . 64.13 111.325 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . -59.11 -19.54 45.44 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 111.708 0.262 . . . . 54.34 111.708 171.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.74 40.02 98.22 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.505 -0.378 . . . . 55.34 113.697 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.1 mt -105.39 -2.73 23.48 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.083 0.401 . . . . 65.21 112.083 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.87 -175.1 2.79 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.931 0.396 . . . . 53.42 111.907 -176.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.9 t -158.79 170.4 22.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.665 0.386 . . . . 71.43 110.484 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -44.68 -45.33 9.69 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.956 0.725 . . . . 71.32 112.956 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -70.14 -55.95 8.09 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.288 -0.257 . . . . 64.43 111.632 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -55.59 -45.87 77.35 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 111.847 0.314 . . . . 74.24 111.847 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.68 -54.9 36.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.422 -0.354 . . . . 71.32 111.085 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.98 -41.27 82.65 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.178 0.436 . . . . 73.11 112.178 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.483 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 90.9 t -64.51 -50.06 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.887 0.375 . . . . 72.32 110.807 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.406 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.1 ttm -60.51 -43.7 96.79 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.532 -0.304 . . . . 42.22 111.478 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -58.48 -44.63 89.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.882 0.372 . . . . 63.55 111.011 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.88 -44.59 97.21 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.172 -0.537 . . . . 35.4 112.716 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.541 ' O ' HG13 ' A' ' 43' ' ' ILE . 5.8 mmp_? -55.34 -55.41 31.9 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.006 0.431 . . . . 71.41 110.96 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB3' HD22 ' A' ' 20' ' ' LEU . 87.7 mt -60.59 -44.39 96.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.032 -0.531 . . . . 64.05 111.891 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -63.16 -39.41 94.58 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.725 0.297 . . . . 75.12 110.863 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.93 -42.48 98.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.949 0.404 . . . . 74.32 111.017 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.3 mt -57.63 -47.18 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.014 -0.539 . . . . 72.1 111.453 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 14.4 ptm180 -77.67 -24.95 49.21 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.959 -0.463 . . . . 72.44 111.927 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.4 t -70.06 -35.5 74.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.945 0.402 . . . . 62.02 111.027 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.1 t -95.7 -56.43 2.68 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.132 -0.486 . . . . 73.24 112.215 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -98.44 -12.64 21.15 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.302 0.482 . . . . 73.0 112.302 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.36 20.85 11.88 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.518 0.562 . . . . 71.11 112.518 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 43' ' ' ILE . 92.7 t -81.79 125.55 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.0 0.428 . . . . 75.24 111.129 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -84.34 97.15 9.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.276 0.56 . . . . 73.24 110.662 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.408 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -106.59 105.3 15.26 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.392 -0.822 . . . . 74.44 110.647 -173.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.22 117.11 33.44 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.146 0.424 . . . . 44.41 112.146 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.55 112.54 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.164 0.507 . . . . 61.3 111.502 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 58.1 t -107.56 143.26 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 122.912 0.485 . . . . 64.24 111.463 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 49.8 p -133.81 122.52 23.37 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.718 0.294 . . . . 74.04 110.893 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -127.71 141.8 42.19 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 120.561 0.219 . . . . 74.14 111.295 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.76 -48.23 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.506 2.138 . . . . 62.14 113.062 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.935 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 67.6 p -155.78 145.02 20.78 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.021 0.378 . . . . 72.03 112.021 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 pt -123.86 -3.49 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.749 0.309 . . . . 73.12 111.494 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.42 47.22 6.99 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.219 -0.515 . . . . 23.35 113.169 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 56.96 20.35 5.29 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.174 0.435 . . . . 74.34 112.174 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.95 151.65 97.16 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.396 -0.365 . . . . 54.25 111.834 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 29.4 Cg_endo -60.59 117.32 4.07 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.841 2.361 . . . . 73.24 113.14 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.82 -51.83 65.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.868 0.692 . . . . 74.11 112.868 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -31.71 72.67 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.125 0.488 . . . . 74.33 111.588 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 63' ' ' PRO . 10.4 t70 -68.84 -34.8 76.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.205 0.526 . . . . 75.5 110.835 173.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -65.91 -55.94 14.32 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.859 -0.61 . . . . 74.15 110.892 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.5 p -56.97 -42.81 80.85 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.226 -0.443 . . . . 73.41 111.813 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.8 tp -53.03 -53.09 55.37 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.924 0.392 . . . . 73.45 111.953 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.631 ' HG2' HH21 ' A' ' 73' ' ' ARG . 37.8 mtmm -71.33 -36.88 71.7 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.314 0.487 . . . . 75.21 112.314 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.7 tp -65.85 -37.59 86.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.201 0.524 . . . . 75.11 111.257 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.74 84.12 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.297 -0.41 . . . . 74.33 111.616 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.631 HH21 ' HG2' ' A' ' 70' ' ' LYS . 41.3 mtm105 -58.91 -49.66 76.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.272 0.471 . . . . 62.33 112.272 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.467 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 18.8 pt20 -64.63 -15.27 60.96 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.135 0.42 . . . . 71.2 112.135 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.467 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 45.5 m0 -103.4 14.88 30.44 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.776 0.322 . . . . 75.15 111.543 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.37 -53.32 4.65 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.113 -0.565 . . . . 64.21 113.651 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.522 ' HA ' ' HB3' ' A' ' 82' ' ' ASN . 31.0 m . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 113.505 0.928 . . . . 72.5 113.505 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.549 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 42.5 t30 . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 120.76 0.314 . . . . 73.5 111.027 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -41.07 -60.65 1.16 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.2 1.185 . . . . 74.24 114.2 -171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -95.04 24.27 4.99 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.044 -0.41 . . . . 62.43 112.034 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.16 137.6 13.52 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.027 -0.606 . . . . 72.3 113.549 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 99' ' ' PHE . 49.1 tp -144.53 119.96 10.31 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.015 0.436 . . . . 74.14 111.246 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 63.1 tp -109.32 141.47 41.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.944 0.402 . . . . 70.44 111.363 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.1 tp -129.7 127.79 41.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.378 -0.374 . . . . 71.24 110.022 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 65.8 t -128.19 116.6 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 122.116 -0.365 . . . . 60.04 111.882 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.656 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.2 tp -95.45 120.97 36.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.247 -0.433 . . . . 72.21 111.001 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.589 HG12 ' HB3' ' A' ' 93' ' ' ASP . 60.1 t -110.5 99.94 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.771 0.319 . . . . 70.24 111.059 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.3 tp -53.76 -39.1 65.08 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.898 0.38 . . . . 73.12 111.457 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.935 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 56.1 t0 -39.33 -52.98 2.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.915 0.886 . . . . 62.35 112.061 173.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.458 ' OE1' ' HD2' ' A' ' 96' ' ' ARG . 11.1 pt20 -108.53 -4.21 17.41 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.227 0.455 . . . . 73.44 112.227 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 59.32 27.56 16.67 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.524 0.564 . . . . 61.42 112.524 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.458 ' HD2' ' OE1' ' A' ' 94' ' ' GLN . 87.0 mtt180 -120.41 155.84 32.63 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.079 0.466 . . . . 65.54 111.39 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.712 HG21 ' SD ' ' A' ' 122' ' ' MET . 3.6 m -134.64 169.64 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.658 -0.701 . . . . 62.34 110.958 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -150.83 141.03 22.22 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.965 0.358 . . . . 74.23 111.965 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.489 ' HB3' HD11 ' A' ' 86' ' ' LEU . 97.0 m-85 -100.8 113.87 27.17 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.87 -0.605 . . . . 74.14 110.31 172.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -98.59 112.02 24.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 110.31 -0.256 . . . . 61.31 110.31 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.1 p -98.6 152.58 19.44 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.996 0.739 . . . . 72.53 112.996 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -88.57 166.95 34.85 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.394 -0.821 . . . . 54.05 111.906 168.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -65.17 1.0 1.11 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.979 0.733 . . . . 70.13 112.979 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.86 -42.46 6.02 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.496 -0.641 . . . . 34.11 111.496 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.52 -12.76 60.29 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.319 -0.441 . . . . 72.52 111.777 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -56.96 -17.29 9.13 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.216 0.45 . . . . 71.13 112.216 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.68 -7.55 85.84 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.179 -0.534 . . . . 62.24 113.598 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.1 -49.81 1.02 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.099 0.475 . . . . 75.23 111.822 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.2 mt -112.36 90.13 13.72 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.006 -0.543 . . . . 63.41 112.194 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.99 157.16 23.7 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.363 2.042 . . . . 61.21 112.893 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.49 -34.39 35.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.804 0.441 . . . . 70.52 111.949 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.91 -50.04 63.65 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.108 -0.568 . . . . 60.14 113.049 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.43 -45.43 88.49 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.156 0.503 . . . . 71.33 110.863 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 118' ' ' ILE . 80.0 mt -59.0 -39.53 82.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.881 -0.599 . . . . 74.41 110.946 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.3 t -57.46 -44.4 84.78 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.978 -0.555 . . . . 54.51 111.316 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -57.42 -51.59 68.8 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.777 0.322 . . . . 75.4 110.959 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 64.0 mt -50.91 -40.25 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.017 0.437 . . . . 73.23 111.328 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.635 HG23 HG22 ' A' ' 97' ' ' VAL . 76.8 mt -62.79 -56.41 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.124 -0.489 . . . . 71.33 111.991 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 10.5 t-80 -83.58 -23.49 31.94 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.14 0.792 . . . . 64.11 113.14 -171.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -91.82 -49.5 6.22 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 111.74 0.274 . . . . 74.42 111.74 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -79.42 -54.42 5.94 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.829 0.347 . . . . 73.1 111.484 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.712 ' SD ' HG21 ' A' ' 97' ' ' VAL . 61.9 mtt -82.6 -58.93 2.69 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.851 1.056 . . . . 64.32 113.851 -168.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.49 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 23.7 mm -43.2 -52.47 12.37 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 113.709 1.003 . . . . 72.1 113.709 -173.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.49 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 76.4 Cg_exo -51.65 -41.55 60.8 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.769 1.646 . . . . 60.41 113.056 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.487 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 91.3 m-70 -73.1 -40.51 64.92 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.237 -0.289 . . . . 72.42 111.679 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 122' ' ' MET . 15.9 m-30 -56.54 -40.45 75.14 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.118 0.485 . . . . 71.1 110.986 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -76.07 -37.13 58.61 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.121 -0.49 . . . . 62.51 111.325 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.5 m -66.19 -30.01 70.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.701 0.286 . . . . 64.11 111.676 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 123.51 -3.23 9.49 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.23 -0.509 . . . . 72.31 113.721 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.794 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 97.2 m-20 -104.07 87.49 2.78 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.086 0.402 . . . . 70.01 112.086 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -71.27 -45.12 63.88 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.175 0.512 . . . . 70.41 110.486 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.58 -48.06 82.65 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.962 -0.563 . . . . 71.03 111.755 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.794 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 29.2 tt0 -62.44 -38.58 90.28 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.291 -0.413 . . . . 73.14 111.111 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.27 -51.14 60.66 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.064 -0.589 . . . . 74.42 112.769 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.498 HD11 HD22 ' A' ' 90' ' ' LEU . 99.4 mt -57.67 -43.41 84.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.922 0.391 . . . . 71.43 110.895 175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.0 t -51.77 -56.91 11.06 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.986 -0.552 . . . . 74.01 111.894 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -63.34 -32.22 73.58 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.821 0.304 . . . . 73.51 111.821 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.585 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -60.84 -52.17 54.06 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.959 -0.638 . . . . 51.02 112.408 175.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.6 t -59.12 -48.62 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.03 0.443 . . . . 64.52 111.066 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.511 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 62.3 tp -53.22 -46.55 69.16 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.774 -0.648 . . . . 71.42 111.073 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.03 87.36 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.164 -0.471 . . . . 71.43 111.657 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.96 -56.4 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.414 -0.357 . . . . 75.0 111.423 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -59.44 -35.37 73.91 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.297 0.48 . . . . 71.15 112.297 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 16.6 mm-40 -59.6 -34.13 72.36 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 122.112 -0.368 . . . . 75.31 111.587 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 65.4 t -66.21 -42.68 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.904 0.383 . . . . 74.42 110.719 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.85 -56.53 8.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.118 -0.492 . . . . 72.14 111.37 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 . . . . . 0 N--CA 1.467 0.425 0 CA-C-N 116.561 -0.29 . . . . 62.15 111.34 176.963 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.7 t . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.067 0.461 . . . . 71.21 111.586 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -99.16 113.25 25.39 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.443 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.659 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 2.9 mppt? -95.57 169.03 9.83 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.515 -0.55 . . . . 70.31 109.515 171.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.659 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 10.2 Cg_endo -51.01 -24.31 13.87 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.201 1.934 . . . . 53.23 113.198 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.42 -21.23 35.82 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 111.955 0.354 . . . . 44.23 111.955 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -82.94 -27.79 30.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.883 0.373 . . . . 64.54 110.977 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.404 HG22 HD21 ' A' ' 56' ' ' LEU . 34.9 t -76.87 120.81 83.24 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.104 -0.498 . . . . 62.32 111.234 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HG2' HG23 ' A' ' 22' ' ' THR . 27.6 Cg_endo -62.43 127.73 21.71 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.335 2.023 . . . . 52.51 112.552 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.407 ' HA ' ' CE2' ' A' ' 75' ' ' TRP . 2.0 m-20 -72.69 74.97 1.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.087 0.47 . . . . 74.02 111.473 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.0 m -57.62 -41.56 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 112.479 0.548 . . . . 71.4 112.479 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -75.74 -5.1 44.08 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.456 0.539 . . . . 73.43 112.456 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.0 tt -102.79 -32.33 9.86 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.151 0.5 . . . . 73.4 110.222 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.21 -61.35 1.38 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.534 0.568 . . . . 55.33 112.534 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -79.9 -52.49 7.8 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.489 0.552 . . . . 73.4 112.489 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.9 t 70.14 -61.75 0.45 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.624 0.769 . . . . 71.15 112.072 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.9 p -60.0 -32.92 71.31 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.906 0.384 . . . . 74.15 111.01 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -92.18 109.07 20.43 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.004 -0.369 . . . . 55.25 110.004 169.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mp -97.11 15.02 23.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.436 0.636 . . . . 62.2 110.385 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.19 137.06 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.532 -0.758 . . . . 74.25 111.795 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 54' ' ' VAL . 30.4 m -119.81 103.25 9.2 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.901 0.382 . . . . 53.34 110.727 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -100.59 99.49 10.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.289 0.566 . . . . 73.23 112.438 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -118.49 -43.28 2.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.062 -0.517 . . . . 74.03 111.264 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.34 -24.65 67.45 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.28 0.844 . . . . 64.21 113.28 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.78 9.57 86.81 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.764 -0.732 . . . . 71.52 113.378 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.88 -14.3 60.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.978 0.418 . . . . 73.3 111.705 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.4 mt -103.09 139.36 38.72 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.41 -0.359 . . . . 74.31 110.969 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.2 t -106.23 159.99 15.69 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.328 -0.233 . . . . 73.14 110.835 175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -45.26 -48.95 12.8 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.556 0.947 . . . . 74.0 113.556 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -63.47 -48.73 76.45 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.79 0.328 . . . . 53.54 111.844 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -60.82 -40.6 93.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.867 0.365 . . . . 61.22 111.524 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.13 -45.26 92.78 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.232 -0.44 . . . . 71.11 110.778 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.0 -49.93 74.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.766 0.317 . . . . 75.22 111.607 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 31' ' ' ALA . 87.8 t -60.12 -40.64 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.218 0.532 . . . . 73.13 111.154 177.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.518 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.5 ttm -63.1 -49.89 72.68 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.948 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -59.05 -40.58 85.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.609 0.242 . . . . 55.13 111.211 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.6 -46.49 93.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.108 -0.568 . . . . 52.3 112.91 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' ILE . 79.4 mtm180 -69.14 -43.41 74.41 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.823 0.305 . . . . 74.53 111.823 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 36' ' ' MET . 88.7 mt -61.32 -47.5 85.61 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.195 0.522 . . . . 55.43 111.054 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 41' ' ' ARG . 40.7 ttp180 -62.72 -37.0 84.79 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.926 -0.579 . . . . 72.33 110.896 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.23 98.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.342 -0.39 . . . . 74.12 110.776 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.8 mt -59.82 -45.76 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.817 0.341 . . . . 73.24 110.779 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -58.51 -31.73 68.16 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.954 0.407 . . . . 73.33 111.001 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.9 t -93.79 -13.52 27.25 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.364 0.505 . . . . 31.51 112.364 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.8 m -106.8 -63.59 1.27 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.296 0.57 . . . . 74.1 111.29 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -90.97 -8.3 49.63 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.486 -0.779 . . . . 64.12 111.198 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 67.33 5.93 4.55 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.279 0.631 . . . . 62.41 112.247 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.685 HG22 ' HB2' ' A' ' 84' ' ' ASN . 99.8 t -79.63 130.97 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 122.922 0.489 . . . . 63.45 111.987 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.418 ' HB2' HG13 ' A' ' 77' ' ' VAL . 1.8 mp0 -79.81 96.53 6.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.915 0.388 . . . . 73.11 110.297 174.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.408 ' HE2' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -104.78 98.78 8.47 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.424 -0.353 . . . . 73.33 110.492 -176.515 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.03 120.75 42.25 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.534 0.568 . . . . 74.24 112.534 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.92 137.49 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-O 121.025 0.441 . . . . 71.24 111.359 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.582 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 61.7 t -130.76 140.18 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.603 0.361 . . . . 72.21 111.037 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -128.61 122.46 30.96 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.624 0.249 . . . . 53.11 111.183 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.404 HD21 HG22 ' A' ' 9' ' ' VAL . 65.3 mt -128.23 140.85 39.49 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 111.622 0.23 . . . . 72.33 111.622 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.15 -55.97 1.91 Allowed 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.516 2.144 . . . . 74.22 112.248 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.3 t -155.62 148.97 24.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.341 -0.39 . . . . 73.32 111.817 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.73 20.47 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.353 0.597 . . . . 74.5 110.196 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.42 39.65 91.46 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.202 -0.523 . . . . 64.1 113.175 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.02 16.03 3.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.151 0.58 . . . . 72.41 112.293 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.01 151.41 80.53 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 122.055 -0.403 . . . . 65.35 111.775 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -56.97 110.15 0.55 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.685 2.256 . . . . 73.01 112.654 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.6 tp -52.19 -46.02 65.41 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.891 0.7 . . . . 75.13 112.891 -176.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 38.3 mt-10 -66.71 -25.32 66.47 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.126 0.417 . . . . 73.52 112.126 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 23.3 t70 -75.39 -45.57 38.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.379 0.609 . . . . 75.22 110.02 173.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -57.65 -47.5 82.06 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.521 -0.763 . . . . 72.0 111.821 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.3 p -55.71 -50.17 71.05 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.78 0.324 . . . . 75.14 111.595 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.526 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.2 tp -55.33 -51.18 67.57 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.956 0.408 . . . . 74.43 111.36 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 66' ' ' ASP . 55.6 mtpt -60.24 -47.02 87.76 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.198 0.444 . . . . 75.15 112.198 -178.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.2 tp -66.18 -47.6 73.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.933 0.397 . . . . 62.44 111.732 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.625 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -61.57 -32.81 72.92 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.227 0.454 . . . . 65.42 112.227 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 44.3 mtm180 -59.53 -48.59 81.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.013 0.375 . . . . 72.22 112.013 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.586 ' NE2' ' HB2' ' A' ' 6' ' ' PRO . 11.5 pt20 -70.48 -13.62 62.19 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.818 0.342 . . . . 75.35 111.479 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.526 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 32.3 m0 -96.42 -17.43 20.59 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.854 0.359 . . . . 74.43 110.778 173.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.31 46.64 94.02 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 116.31 -0.405 . . . . 63.51 113.408 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 50' ' ' GLU . 57.7 t . . . . . 0 CA--C 1.546 0.822 0 N-CA-C 112.572 0.582 . . . . 71.41 112.572 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 103' ' ' TYR . 56.4 t30 . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 107.567 -1.272 . . . . 73.1 107.567 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -74.96 -122.07 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.733 -0.605 . . . . 44.24 111.489 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.685 ' HB2' HG22 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.72 70.61 10.37 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.911 -0.493 . . . . 75.1 112.056 -176.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -107.17 144.71 15.94 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.098 -0.501 . . . . 64.01 112.685 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 99' ' ' PHE . 42.6 tp -145.16 124.59 13.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.875 0.369 . . . . 75.22 111.475 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 72' ' ' ALA . 54.8 tp -111.54 138.26 48.31 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.756 0.312 . . . . 64.41 111.038 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.0 tp -128.26 102.52 6.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.708 0.29 . . . . 75.04 110.682 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.11 119.63 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.063 0.394 . . . . 54.1 112.063 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HA ' HG12 ' A' ' 97' ' ' VAL . 41.9 tp -98.96 115.86 29.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.11 0.481 . . . . 61.33 111.109 175.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 94' ' ' GLN . 71.3 t -101.17 104.49 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.27 -0.423 . . . . 73.34 111.007 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.0 tp -55.75 -42.44 75.43 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.892 0.377 . . . . 71.54 111.638 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -50.99 -36.68 40.5 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.244 0.545 . . . . 74.21 111.771 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.439 ' H ' HG12 ' A' ' 91' ' ' VAL . 72.0 mt-30 -105.99 -10.19 16.7 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.108 -0.496 . . . . 74.2 111.933 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 53.4 35.13 19.69 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.675 0.62 . . . . 72.34 112.675 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -142.58 162.93 34.19 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.974 0.416 . . . . 75.34 111.874 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.582 HG21 ' SD ' ' A' ' 122' ' ' MET . 3.7 m -133.43 171.89 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.068 -0.515 . . . . 42.11 111.589 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.574 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 47.4 ttt85 -148.59 137.67 21.7 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.475 -0.329 . . . . 74.3 111.524 171.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.743 ' HB3' HD11 ' A' ' 86' ' ' LEU . 96.9 m-85 -93.0 108.4 19.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.196 -0.456 . . . . 72.22 110.543 172.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.6 tp10 -95.04 122.41 37.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.577 0.227 . . . . 71.5 110.727 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.3 p -100.49 160.8 14.05 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.932 1.086 . . . . 74.31 113.932 -172.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -103.56 -164.24 25.3 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.932 -1.031 . . . . 62.04 111.809 167.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 5.3 t80 -76.56 -17.0 59.46 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.128 0.49 . . . . 73.1 111.591 -176.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.09 -23.46 57.17 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.236 -0.507 . . . . 72.45 113.205 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.4 mt -103.34 -4.21 24.51 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.012 0.434 . . . . 71.2 110.95 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -53.55 -35.44 60.75 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.812 -0.631 . . . . 64.1 111.174 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.39 18.05 58.14 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 121.244 -0.503 . . . . 60.2 113.88 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -137.83 -54.63 0.66 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.301 0.55 . . . . 61.3 111.44 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.661 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.5 mt -114.78 86.14 12.65 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.6 -0.727 . . . . 65.53 112.102 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.13 153.83 19.02 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.156 1.904 . . . . 65.42 112.404 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.38 -43.71 5.28 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.865 0.691 . . . . 74.24 112.865 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.91 -50.13 68.56 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.218 -0.515 . . . . 54.22 113.251 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.68 -48.15 83.08 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.969 0.414 . . . . 32.44 111.025 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.661 HD21 ' HB3' ' A' ' 109' ' ' LEU . 76.3 mt -58.31 -39.09 78.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.088 -0.505 . . . . 74.13 111.217 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.9 t -63.21 -37.23 86.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.11 -0.495 . . . . 71.42 111.335 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -70.61 -37.81 73.9 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 122.262 -0.274 . . . . 75.12 111.284 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 62.3 mt -55.15 -43.5 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.474 0.654 . . . . 74.13 110.04 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.7 mt -64.59 -52.9 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.45 -0.795 . . . . 74.14 111.489 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 5.4 t-80 -69.78 -39.35 76.68 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.6 0.593 . . . . 74.43 112.6 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.31 -39.41 22.92 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.753 0.649 . . . . 71.24 112.753 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -103.57 -46.29 4.59 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.602 0.593 . . . . 73.14 112.602 -174.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.582 ' SD ' HG21 ' A' ' 97' ' ' VAL . 50.5 mtt -78.89 -48.01 15.44 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.185 0.809 . . . . 71.14 113.185 -173.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.515 ' CG1' ' HA ' ' A' ' 119' ' ' HIS . 23.0 mm -50.09 -52.23 55.04 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 112.98 0.733 . . . . 42.34 112.98 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 14.0 Cg_endo -55.7 -38.42 94.33 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 121.807 1.671 . . . . 52.14 112.315 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 41.5 m-70 -71.14 -51.4 25.18 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.04 0.385 . . . . 61.34 112.04 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.4 m-30 -55.92 -44.84 78.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.775 0.321 . . . . 61.14 111.297 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -62.57 -37.03 84.59 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.946 0.403 . . . . 72.01 111.16 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -77.3 -5.97 51.43 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.405 -0.361 . . . . 64.23 111.911 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.33 2.58 68.04 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.314 -0.469 . . . . 71.11 113.317 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.618 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 90.6 m-20 -89.35 76.46 7.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.826 0.346 . . . . 73.21 111.841 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -70.75 -46.07 63.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.004 0.431 . . . . 72.22 111.259 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.65 98.18 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.108 -0.496 . . . . 62.31 111.603 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.618 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 18.3 mm-40 -65.58 -42.91 91.2 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.348 -0.387 . . . . 74.44 110.902 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.33 -51.28 60.1 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.317 -0.468 . . . . 64.52 112.923 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.521 HD11 HD22 ' A' ' 90' ' ' LEU . 95.9 mt -60.57 -38.65 85.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.015 0.436 . . . . 74.52 111.102 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.0 t -57.21 -57.98 10.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.987 -0.551 . . . . 53.15 112.345 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -76.11 -19.64 58.35 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 120.638 -0.425 . . . . 74.41 111.582 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.79 -47.23 91.59 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.838 -0.696 . . . . 71.1 111.815 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.2 -46.25 96.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.205 0.526 . . . . 71.32 110.842 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.4 tp -55.34 -38.02 68.22 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.771 -0.649 . . . . 74.54 111.441 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -62.47 -55.47 27.32 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.197 -0.456 . . . . 54.32 111.379 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.408 ' HB ' ' HE2' ' A' ' 51' ' ' PHE . 66.7 t -57.46 -43.37 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.261 -0.427 . . . . 71.44 111.134 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -52.73 -45.36 66.95 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.122 -0.49 . . . . 60.41 111.367 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -69.52 -35.29 75.35 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.061 0.393 . . . . 61.52 112.061 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 141' ' ' ALA . 96.5 t -62.05 -51.59 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.944 0.402 . . . . 74.14 111.01 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.21 -45.14 95.78 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.923 0.392 . . . . 70.13 111.015 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.008 0.432 . . . . 75.0 111.029 175.792 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.6 t . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 113.609 0.966 . . . . 74.1 113.609 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -107.41 130.02 54.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.952 -0.567 . . . . 73.2 110.973 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 26.1 mtpp -105.24 168.69 8.02 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 116.521 -0.309 . . . . 52.12 110.708 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 59.7 Cg_endo -69.62 58.19 1.47 Allowed 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.675 2.25 . . . . 71.05 112.65 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -176.85 -26.55 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.54 -0.755 . . . . 72.22 109.967 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.83 -35.04 67.19 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.268 0.556 . . . . 73.43 110.297 169.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.609 HG22 HD21 ' A' ' 56' ' ' LEU . 49.0 t -64.17 118.38 45.86 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.667 -0.697 . . . . 64.32 111.566 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HG2' HG23 ' A' ' 22' ' ' THR . 12.2 Cg_endo -56.14 121.9 10.81 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.45 2.1 . . . . 55.43 112.596 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.607 HD22 HD13 ' A' ' 14' ' ' LEU . 13.2 p-10 -72.63 70.64 0.94 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.356 0.598 . . . . 74.34 111.886 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -58.03 -43.58 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.792 -0.64 . . . . 75.05 112.641 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.468 ' NE2' ' HG ' ' A' ' 20' ' ' LEU . 8.2 tp-100 -71.46 -14.09 62.03 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.227 0.454 . . . . 74.1 112.227 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.607 HD13 HD22 ' A' ' 11' ' ' ASN . 10.1 tt -88.29 -29.99 19.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.118 0.485 . . . . 73.51 110.685 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.53 -35.35 13.64 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.131 0.491 . . . . 73.53 111.751 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.459 ' OD2' ' HG2' ' A' ' 19' ' ' ARG . 20.7 t70 -134.15 142.31 47.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.947 0.403 . . . . 62.45 111.244 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.7 p -107.64 -6.82 16.69 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.393 0.516 . . . . 60.42 112.393 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.1 p -75.57 -30.8 59.77 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.109 -0.369 . . . . 71.44 111.678 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.459 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 3.5 ptp85 -119.84 159.7 24.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.847 0.356 . . . . 74.32 111.051 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HG ' ' NE2' ' A' ' 13' ' ' GLN . 4.7 mp -132.72 14.47 4.4 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.71 0.29 . . . . 71.42 111.722 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 53' ' ' VAL . 65.0 t -112.08 128.64 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 112.286 0.476 . . . . 63.31 112.286 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.476 HG23 ' HG2' ' A' ' 10' ' ' PRO . 89.3 m -100.55 109.79 21.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.004 0.431 . . . . 63.14 110.979 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -92.31 93.16 8.49 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.288 0.566 . . . . 73.43 112.352 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 55' ' ' THR . 10.2 mm-40 -106.65 -59.69 1.76 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.945 0.402 . . . . 74.33 110.536 174.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.55 74.6 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.473 -0.33 . . . . 73.51 111.856 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.79 50.14 70.92 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.312 -0.471 . . . . 44.31 112.929 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.611 HD21 HD22 ' A' ' 92' ' ' LEU . 97.7 mt -90.59 12.36 19.1 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.202 0.445 . . . . 52.04 112.202 -176.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mp -124.4 163.47 21.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.283 0.563 . . . . 75.15 111.597 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.7 t -82.97 155.9 23.74 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.764 -0.653 . . . . 70.14 110.914 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -53.05 -40.88 64.29 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.876 0.37 . . . . 75.53 111.896 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -64.81 -46.36 82.3 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.9 0.381 . . . . 75.51 111.25 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -59.47 -41.06 88.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.484 -0.325 . . . . 71.14 111.619 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -55.78 -54.48 43.95 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.316 0.579 . . . . 55.12 110.912 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.27 -48.88 70.71 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.729 -0.669 . . . . 55.01 111.814 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 31' ' ' ALA . 99.0 t -64.4 -42.69 96.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.166 -0.47 . . . . 64.34 112.093 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.573 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.5 ttm -62.38 -51.1 68.95 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.199 -0.313 . . . . 74.44 110.937 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 59.4 m-80 -60.95 -38.38 85.67 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.643 0.259 . . . . 65.14 111.055 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.52 -48.36 86.57 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.045 -0.598 . . . . 75.02 112.9 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 43' ' ' ILE . 86.4 mtm180 -64.42 -46.17 84.36 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.843 0.312 . . . . 71.23 111.843 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 36' ' ' MET . 81.7 mt -56.32 -41.43 76.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.35 0.595 . . . . 75.51 110.867 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -67.63 -39.06 84.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.769 -0.65 . . . . 75.23 111.264 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.81 88.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.121 0.486 . . . . 74.11 110.823 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.434 HG23 ' HB2' ' A' ' 47' ' ' HIS . 70.8 mt -60.35 -41.88 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.1 -0.5 . . . . 61.14 110.681 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.481 ' NE ' ' HG2' ' A' ' 50' ' ' GLU . 12.7 tpt180 -50.85 -33.09 22.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.816 -0.629 . . . . 74.23 111.688 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.1 t -99.49 -60.2 1.58 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.323 -0.399 . . . . 73.21 111.741 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.7 t -59.29 -45.95 89.87 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.525 0.565 . . . . 71.24 112.525 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.434 ' HB2' HG23 ' A' ' 43' ' ' ILE . 50.9 m80 -104.31 -9.26 18.67 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.776 0.322 . . . . 71.42 111.41 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.74 -5.68 1.4 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.216 0.821 . . . . 50.03 113.216 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.98 123.41 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.04 0.447 . . . . 72.41 111.994 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HG2' ' NE ' ' A' ' 44' ' ' ARG . 38.1 mt-10 -75.97 96.24 3.73 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.84 -0.43 . . . . 70.41 109.84 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.65 107.75 18.91 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.268 -0.424 . . . . 65.43 110.902 -173.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.14 147.16 37.93 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.042 0.386 . . . . 71.11 112.042 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 21' ' ' VAL . 58.5 t -128.57 135.81 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.919 0.39 . . . . 62.34 111.264 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 71' ' ' LEU . 60.5 t -128.56 134.47 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.713 0.292 . . . . 72.22 111.25 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 80.6 p -119.11 122.6 42.45 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.723 0.297 . . . . 50.21 111.385 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.609 HD21 HG22 ' A' ' 9' ' ' VAL . 89.7 mt -125.98 140.05 35.85 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-O 120.732 0.301 . . . . 71.41 111.57 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 52.6 Cg_endo -69.3 -35.19 14.5 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.116 1.877 . . . . 75.14 112.432 176.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 73.3 p -161.37 144.87 12.77 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.351 0.5 . . . . 75.42 112.351 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.458 HD13 HG21 ' A' ' 91' ' ' VAL . 32.3 pt -123.89 -11.4 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 121.002 0.43 . . . . 72.03 111.597 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.76 -113.47 5.76 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 114.386 0.514 . . . . 74.31 114.386 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -89.97 11.52 20.26 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.044 0.45 . . . . 62.34 112.044 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -85.2 118.87 71.71 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.924 -0.485 . . . . 63.41 111.88 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 29.1 Cg_endo -63.19 126.75 18.52 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.58 2.187 . . . . 71.34 112.346 176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.3 -45.5 80.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.943 0.72 . . . . 70.3 112.943 -171.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 1.2 pm0 -70.16 -36.04 74.43 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.35 0.5 . . . . 73.52 112.35 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.68 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 10.2 m-20 -71.99 -35.89 69.6 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.993 -0.442 . . . . 75.33 110.976 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 58.2 t80 -59.21 -56.58 20.26 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.812 0.339 . . . . 54.12 111.181 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 47.1 p -52.76 -44.56 66.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.116 -0.493 . . . . 62.35 111.651 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.65 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 58.7 tp -61.7 -57.06 13.42 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.336 -0.393 . . . . 51.41 111.634 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -61.38 -34.92 76.13 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.145 0.424 . . . . 65.41 112.145 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 54' ' ' VAL . 58.7 tp -69.79 -48.41 59.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.185 0.517 . . . . 72.2 111.097 177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.403 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -65.34 -31.73 73.0 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.074 0.398 . . . . 54.52 112.074 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.65 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 24.2 mtp180 -62.42 -50.05 73.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.026 0.38 . . . . 75.43 112.026 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.639 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 12.3 pt20 -67.88 -32.92 73.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.936 0.398 . . . . 72.22 111.088 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.639 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 27.7 m0 -71.45 -15.89 62.35 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.526 -0.307 . . . . 74.31 111.68 175.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.58 -39.15 3.07 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.277 -0.487 . . . . 72.21 112.746 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 19.4 t . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 122.88 0.472 . . . . 53.53 112.158 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.491 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 24.4 t30 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.864 0.364 . . . . 71.24 111.165 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -72.14 123.86 23.78 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.672 -0.643 . . . . 74.52 111.527 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.916 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 5.9 p30 46.22 41.27 8.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.198 0.999 . . . . 74.25 112.753 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.11 145.31 16.58 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.86 -0.609 . . . . 41.12 111.861 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 99' ' ' PHE . 55.9 tp -144.87 131.0 19.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.953 0.377 . . . . 70.1 111.218 -177.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 72' ' ' ALA . 55.4 tp -119.29 123.62 44.68 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.838 0.352 . . . . 75.12 111.478 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.5 tp -111.26 110.03 20.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.892 0.377 . . . . 61.35 110.972 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 54' ' ' VAL . 93.1 t -110.52 129.15 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 122.181 -0.324 . . . . 72.22 111.811 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.567 ' HB2' HD21 ' A' ' 135' ' ' LEU . 43.5 tp -107.25 119.41 39.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.979 0.419 . . . . 72.54 111.037 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.458 HG21 HD13 ' A' ' 59' ' ' ILE . 94.0 t -102.93 100.82 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.307 -0.406 . . . . 75.4 111.207 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.611 HD22 HD21 ' A' ' 27' ' ' LEU . 62.4 tp -59.19 -39.14 81.63 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.171 0.434 . . . . 70.45 112.171 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 14.9 t70 -47.53 -47.15 28.09 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.154 0.582 . . . . 50.34 112.189 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -108.46 8.79 27.56 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.126 -0.488 . . . . 53.41 111.103 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 32.77 58.01 0.43 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.552 1.141 . . . . 71.42 113.782 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -150.16 160.97 43.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.477 -0.783 . . . . 74.43 111.129 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.504 HG21 ' SD ' ' A' ' 122' ' ' MET . 4.3 m -126.21 171.8 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.057 0.456 . . . . 45.13 112.029 -174.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 98' ' ' ARG . 28.7 ttt85 -150.15 135.46 18.05 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.246 -0.434 . . . . 70.44 111.826 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.463 ' HB3' HD11 ' A' ' 86' ' ' LEU . 95.9 m-85 -94.01 115.04 27.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.144 -0.48 . . . . 74.11 110.154 171.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -101.1 112.66 25.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.844 0.354 . . . . 71.12 110.87 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.519 HG23 HD11 ' A' ' 114' ' ' LEU . 2.9 p -88.59 148.37 24.11 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.678 0.751 . . . . 72.05 112.921 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -90.46 -170.23 43.44 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.225 -0.898 . . . . 74.33 112.199 168.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -24.6 65.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.055 0.455 . . . . 71.34 111.637 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.916 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -75.18 -30.47 58.84 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.003 -0.617 . . . . 61.4 113.432 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.13 -0.91 57.84 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.979 0.733 . . . . 74.35 112.979 -171.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -53.33 -32.06 47.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.906 0.335 . . . . 74.23 111.906 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.65 4.45 69.13 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.42 -0.419 . . . . 54.15 113.827 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -125.02 -60.11 1.37 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.381 0.61 . . . . 75.42 111.444 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.07 87.14 27.81 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.697 -0.683 . . . . 63.33 111.086 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.73 167.93 16.33 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.54 2.16 . . . . 75.21 113.558 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.08 -48.8 33.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.585 0.587 . . . . 70.42 112.585 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.37 -46.62 91.64 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.264 -0.493 . . . . 72.11 113.43 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.15 -48.94 77.86 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.891 0.377 . . . . 71.52 111.584 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.519 HD11 HG23 ' A' ' 101' ' ' THR . 86.8 mt -59.34 -43.03 92.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.277 -0.42 . . . . 62.34 111.275 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.4 t -63.41 -37.54 87.67 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.087 -0.506 . . . . 43.03 111.108 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -60.12 -55.34 35.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.394 -0.366 . . . . 73.45 111.219 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.9 mt -49.19 -46.21 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.044 0.449 . . . . 74.24 111.666 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.412 ' O ' HG12 ' A' ' 123' ' ' ILE . 58.2 mt -60.14 -54.91 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.135 0.493 . . . . 72.43 111.415 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -83.72 -9.17 59.02 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.176 0.806 . . . . 53.12 113.176 -173.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.12 -40.78 7.03 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.223 0.453 . . . . 73.43 112.223 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.07 -31.08 2.15 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.516 0.932 . . . . 74.25 113.516 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.504 ' SD ' HG21 ' A' ' 97' ' ' VAL . 36.0 mtt -69.04 -40.54 78.52 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.904 0.705 . . . . 73.42 112.904 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.477 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 46.7 mm -48.12 -57.04 11.4 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 112.894 0.702 . . . . 72.22 112.894 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.08 -37.64 86.95 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.053 1.835 . . . . 62.13 112.967 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -63.48 -53.09 57.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.802 0.334 . . . . 74.44 111.043 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.1 m-85 -59.63 -32.88 70.84 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.546 -0.297 . . . . 74.04 111.456 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 60.4 mtp85 -66.67 -43.32 84.84 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.241 0.544 . . . . 74.42 111.03 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.0 t -75.56 -0.82 21.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.858 -0.61 . . . . 44.05 112.112 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.15 3.93 90.03 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.182 -0.533 . . . . 73.13 112.48 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.769 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.2 m-20 -84.31 55.07 3.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.831 0.452 . . . . 64.34 111.349 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -56.22 -41.28 75.4 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.172 0.511 . . . . 71.31 110.91 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.81 -50.54 73.4 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.725 -0.67 . . . . 73.41 111.809 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.769 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 39.9 mm-40 -61.13 -40.02 92.22 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.342 -0.39 . . . . 73.12 111.739 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.49 -53.28 42.26 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.077 -0.582 . . . . 72.15 112.556 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 90' ' ' LEU . 83.4 mt -61.15 -43.21 99.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.054 0.454 . . . . 75.34 111.187 175.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.8 t -60.37 -52.5 64.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.645 0.609 . . . . 42.53 112.645 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -27.25 59.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.601 0.239 . . . . 73.14 111.045 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.35 91.36 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.025 -0.607 . . . . 51.5 112.168 171.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 135' ' ' LEU . 56.7 t -56.59 -48.13 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.146 0.498 . . . . 71.24 110.806 172.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 50.8 tp -58.45 -40.59 83.05 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.767 -0.651 . . . . 60.11 111.157 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -58.64 -52.3 66.28 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.022 0.439 . . . . 74.35 111.031 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 81.1 t -57.26 -48.35 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.153 -0.476 . . . . 64.13 111.132 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -53.71 -43.19 68.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.916 -0.583 . . . . 74.05 111.53 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 96.5 mt-30 -68.4 -33.4 74.17 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 111.993 0.368 . . . . 64.53 111.993 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 141' ' ' ALA . 91.0 t -63.99 -55.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.068 0.461 . . . . 74.33 110.729 175.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.0 mt -53.23 -45.04 68.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.919 -0.582 . . . . 64.53 111.533 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 CA--C 1.541 0.609 0 CA-C-N 116.194 -0.457 . . . . 75.22 111.9 -178.394 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 120.481 0.181 . . . . 71.41 110.707 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.419 ' CG ' HD22 ' A' ' 56' ' ' LEU . 44.8 m-85 -112.29 159.6 18.48 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.862 0.839 . . . . 65.22 113.242 -176.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.538 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 30.1 mmmt -126.02 158.79 64.83 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 114.867 -1.061 . . . . 73.23 109.935 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HB2' HE22 ' A' ' 74' ' ' GLN . 9.6 Cg_endo -51.8 -52.27 9.35 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.283 1.988 . . . . 51.25 113.219 -177.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.44 2.52 32.26 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.074 -0.391 . . . . 72.13 111.729 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.538 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 21.4 t70 -93.89 -13.32 27.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.279 0.561 . . . . 63.15 110.29 175.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 5' ' ' LYS . 69.4 t -82.7 133.56 49.02 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.908 -0.587 . . . . 53.32 110.871 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -52.99 111.09 0.57 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.298 1.999 . . . . 33.1 112.417 177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.474 ' HA ' ' CE2' ' A' ' 75' ' ' TRP . 10.9 p-10 -68.7 78.92 0.29 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.623 0.725 . . . . 74.43 112.351 -177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' SER . 29.2 m -78.26 10.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.988 0.736 . . . . 72.01 112.988 -177.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 15.7 mm100 -121.22 18.35 11.53 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.559 0.695 . . . . 70.24 110.518 171.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.4 HD13 HD22 ' A' ' 11' ' ' ASN . 7.0 tt -134.64 -45.27 0.74 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.455 -0.793 . . . . 63.05 109.181 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.37 -75.12 0.59 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.991 -0.549 . . . . 72.32 111.199 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.2 55.39 2.83 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.27 0.47 . . . . 55.12 112.27 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 58.2 m -67.46 -9.45 42.11 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.252 0.464 . . . . 74.24 112.252 -178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -86.78 -9.65 55.36 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.297 0.57 . . . . 72.51 111.496 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.421 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 8.6 tpt180 -94.18 -62.25 1.37 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.986 -0.552 . . . . 65.23 111.041 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.563 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.5 mp 74.68 -14.83 0.69 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.965 0.906 . . . . 70.51 111.884 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.421 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 44.6 t -111.82 146.93 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 122.669 0.387 . . . . 65.52 111.252 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 m -150.54 102.66 3.05 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.045 -0.409 . . . . 75.34 112.02 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.411 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 32.5 t70 -93.81 108.19 19.99 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.895 0.378 . . . . 74.4 111.46 176.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.534 ' HB2' HD23 ' A' ' 56' ' ' LEU . 6.6 mm-40 -113.37 -30.55 6.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.917 0.389 . . . . 71.44 110.922 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.56 -23.12 66.83 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.491 0.552 . . . . 64.42 112.491 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.42 45.46 6.92 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.084 -0.579 . . . . 60.22 112.731 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.54 HD11 HD13 ' A' ' 92' ' ' LEU . 83.5 mt -119.19 -32.75 4.32 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.106 0.41 . . . . 62.15 112.106 -175.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.1 132.69 36.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.178 0.514 . . . . 74.12 111.574 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.9 t -86.91 172.27 10.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.249 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -56.81 -40.68 76.42 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 111.906 0.336 . . . . 70.34 111.906 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -64.13 -47.33 80.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.711 0.291 . . . . 72.32 111.254 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -56.02 -41.21 74.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.703 0.287 . . . . 74.34 111.169 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -59.98 -55.92 28.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.131 0.491 . . . . 75.5 111.489 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 8.0 tp10 -69.33 -43.04 74.49 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.472 0.545 . . . . 71.35 112.472 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 31' ' ' ALA . 90.4 t -59.64 -39.84 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.088 0.471 . . . . 74.11 110.861 176.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.522 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.2 ttm -68.39 -43.09 78.04 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.387 -0.37 . . . . 70.42 110.789 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 34' ' ' GLU . 88.4 m-20 -51.07 -55.97 14.93 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.9 0.381 . . . . 70.1 111.486 177.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.47 -37.82 76.83 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.181 -0.533 . . . . 54.34 113.384 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -62.84 -53.59 51.81 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.174 0.512 . . . . 73.33 110.811 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.563 ' HB3' HD22 ' A' ' 20' ' ' LEU . 57.1 mt -61.72 -31.23 71.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.964 -0.562 . . . . 75.15 111.318 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.4 mtm-85 -74.5 -39.33 62.5 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.405 -0.362 . . . . 71.45 111.586 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.28 89.85 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.896 0.379 . . . . 64.52 111.563 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.04 -42.07 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.004 0.43 . . . . 70.31 111.704 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 20.6 ttp180 -74.22 -25.28 59.58 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.036 0.384 . . . . 73.34 112.036 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.5 t -66.67 -28.35 68.39 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.655 0.741 . . . . 74.23 109.641 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.6 p -104.64 -70.57 0.77 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.056 -0.974 . . . . 74.34 112.027 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -76.86 -9.86 58.97 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.436 0.532 . . . . 61.31 112.436 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . . . 65.25 13.41 8.75 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.233 0.457 . . . . 53.53 112.233 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.536 ' HA ' ' HB2' ' A' ' 84' ' ' ASN . 85.9 t -79.01 129.89 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.445 0.535 . . . . 74.52 112.445 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.96 97.33 9.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.612 0.72 . . . . 74.22 110.477 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.483 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.1 t80 -103.49 105.62 15.91 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.295 -0.866 . . . . 73.42 110.507 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.55 140.6 37.31 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.406 0.521 . . . . 73.25 112.406 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -126.07 122.9 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 122.722 0.409 . . . . 63.13 111.273 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.57 138.88 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.853 0.358 . . . . 75.41 111.804 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 17.9 p -117.08 126.05 52.24 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.887 0.375 . . . . 73.04 110.902 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 24' ' ' GLU . 33.7 mt -131.45 146.59 62.6 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.634 -0.257 . . . . 63.14 110.686 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.629 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 37.6 Cg_exo -57.87 -68.68 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.119 1.88 . . . . 72.04 111.682 174.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.42 ' HA ' HG13 ' A' ' 91' ' ' VAL . 60.3 p -142.3 157.83 44.39 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.186 0.517 . . . . 61.14 110.94 175.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.3 pt -110.15 23.66 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.009 -0.541 . . . . 54.3 111.11 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.64 -144.18 30.01 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.094 -0.503 . . . . 45.55 112.244 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -96.29 9.69 40.32 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.296 0.569 . . . . 63.12 111.01 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.3 141.78 86.29 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 112.01 0.374 . . . . 72.34 112.01 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 43.6 Cg_endo -67.91 145.17 67.32 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.561 2.174 . . . . 64.1 112.801 177.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.3 tp -61.68 -46.77 88.27 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.443 0.535 . . . . 75.42 112.443 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.33 -53.09 62.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.221 0.452 . . . . 65.43 112.221 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.581 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 5.3 m-20 -60.06 -33.77 72.51 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.682 0.253 . . . . 70.14 111.682 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -64.45 -55.15 22.75 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.674 0.273 . . . . 73.32 111.274 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.5 p -58.78 -39.76 81.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.8 0.333 . . . . 44.41 111.259 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.474 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 57.2 tp -59.88 -55.04 39.11 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.292 -0.413 . . . . 63.24 111.145 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -60.27 -32.5 71.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.17 0.433 . . . . 74.35 112.17 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.638 HD23 HD21 ' A' ' 87' ' ' LEU . 34.9 tp -73.03 -48.43 36.23 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.987 0.422 . . . . 61.13 111.249 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.2 86.33 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.846 0.313 . . . . 72.31 111.846 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 67.8 mtp180 -61.44 -54.2 46.55 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.926 0.343 . . . . 65.3 111.926 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.463 HE22 ' HB2' ' A' ' 6' ' ' PRO . 11.9 pt20 -64.4 -27.28 68.9 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.861 0.362 . . . . 74.42 111.51 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 40.9 m0 -80.24 -2.27 44.27 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.889 0.329 . . . . 74.24 111.889 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.27 -46.39 3.4 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.26 -0.495 . . . . 51.03 113.473 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 17.8 m . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 112.811 0.671 . . . . 61.51 112.811 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 67.3 t30 . . . . . 0 CA--C 1.542 0.641 0 CA-C-O 121.218 0.532 . . . . 63.34 111.607 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -70.9 138.9 50.53 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.846 -0.534 . . . . 71.33 112.083 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.81 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 36.3 p30 40.53 27.25 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.208 1.559 . . . . 72.4 115.208 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.88 123.83 7.61 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.785 -0.721 . . . . 73.32 111.882 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.6 tp -134.4 121.92 21.83 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.023 0.412 . . . . 65.34 111.307 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.638 HD21 HD23 ' A' ' 71' ' ' LEU . 57.4 tp -113.14 137.48 51.38 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.822 0.344 . . . . 75.14 111.754 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.3 tp -127.15 105.16 8.38 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.534 0.334 . . . . 74.24 110.876 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.84 129.69 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 111.9 0.333 . . . . 62.24 111.9 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HA ' HG12 ' A' ' 97' ' ' VAL . 27.6 tp -107.91 128.94 55.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.251 -0.431 . . . . 75.41 111.069 175.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.549 HG11 ' NE2' ' A' ' 94' ' ' GLN . 59.9 t -105.94 109.14 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.59 -0.277 . . . . 72.51 110.536 174.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.629 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 62.5 tp -55.94 -55.81 28.25 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.627 0.603 . . . . 73.13 112.627 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.61 -24.63 61.42 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.573 0.583 . . . . 73.35 112.573 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.549 ' NE2' HG11 ' A' ' 91' ' ' VAL . 40.3 mt-30 -103.45 -7.05 21.24 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.578 -0.283 . . . . 62.3 111.547 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 33.27 49.84 0.23 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.241 1.016 . . . . 75.4 113.254 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.4 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 30.9 ptt180 -141.87 155.11 45.54 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.573 -0.74 . . . . 64.42 110.317 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 90' ' ' LEU . 5.8 m -128.49 171.74 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.84 0.353 . . . . 72.11 111.429 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.5 ttt85 -149.15 133.16 17.16 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.404 -0.362 . . . . 74.42 111.809 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 97.1 m-85 -95.03 112.51 24.2 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.01 -0.541 . . . . 74.12 110.401 172.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 15.6 tp10 -94.31 111.94 23.7 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.581 0.229 . . . . 74.22 110.428 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 p -98.15 145.51 26.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.033 0.753 . . . . 64.31 113.033 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -97.06 -173.99 34.53 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.298 -0.864 . . . . 42.52 112.142 167.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -63.71 -27.86 69.5 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.147 0.499 . . . . 62.52 112.054 -175.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.81 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -73.45 -9.0 77.2 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 120.935 -0.65 . . . . 40.53 113.692 -172.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.1 mt -129.24 4.87 5.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.636 0.606 . . . . 73.31 112.636 -175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.72 -41.59 97.83 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.913 0.387 . . . . 64.34 111.116 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.94 -23.38 69.37 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.325 -0.464 . . . . 62.23 113.22 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -92.41 -66.87 0.89 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.676 0.274 . . . . 75.33 111.655 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.604 ' HA ' HD23 ' A' ' 113' ' ' LEU . 3.0 mp -117.16 94.95 46.23 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.829 0.307 . . . . 73.05 111.829 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.42 174.68 11.6 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.659 2.239 . . . . 72.02 112.607 174.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.86 -44.32 59.56 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.318 0.488 . . . . 74.33 112.318 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -59.65 -50.2 70.35 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.197 -0.525 . . . . 73.23 113.546 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 109' ' ' LEU . 36.0 tp -60.76 -49.13 78.71 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.828 0.347 . . . . 64.54 111.404 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 118' ' ' ILE . 92.8 mt -56.34 -48.61 76.43 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.214 -0.448 . . . . 73.43 111.231 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.3 m -61.56 -36.41 80.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.191 -0.459 . . . . 64.34 111.367 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.409 ' NH2' HD13 ' A' ' 113' ' ' LEU . 44.3 ttp180 -65.45 -50.14 66.49 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.548 -0.296 . . . . 75.51 110.973 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.81 -47.37 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.23 0.538 . . . . 64.13 110.617 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 114' ' ' LEU . 84.0 mt -59.03 -57.11 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.749 -0.659 . . . . 64.22 112.383 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -84.21 -22.46 30.87 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.364 0.875 . . . . 74.23 113.364 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.19 -38.15 17.95 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.034 0.445 . . . . 63.34 111.787 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 121' ' ' ARG . 12.4 mtp180 -113.25 -59.19 2.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.253 -0.43 . . . . 74.41 112.153 -176.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.9 mtp -62.51 -48.4 79.74 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.241 0.83 . . . . 74.45 113.241 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 27.1 mm -57.76 -50.79 86.17 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.421 0.526 . . . . 65.41 112.421 -177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 85.0 Cg_exo -47.15 -34.8 18.33 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.348 2.032 . . . . 75.14 112.998 174.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -72.97 -49.25 30.25 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.629 0.252 . . . . 72.13 111.182 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.433 ' HD2' HD13 ' A' ' 123' ' ' ILE . 23.7 m-85 -57.4 -45.02 85.0 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.016 0.376 . . . . 73.44 112.016 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -62.3 -23.94 67.01 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.22 0.533 . . . . 64.21 111.1 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.0 m -92.77 7.43 43.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.062 -0.517 . . . . 45.02 111.559 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.75 -0.43 82.06 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.364 -0.446 . . . . 73.41 113.493 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.792 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.87 70.72 10.68 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 122.519 -0.4 . . . . 71.43 111.545 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -70.57 -42.33 71.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.016 0.436 . . . . 72.51 110.557 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.3 90.89 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.998 -0.546 . . . . 71.33 111.213 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.792 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 18.6 mp0 -59.69 -53.27 59.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.367 -0.379 . . . . 75.14 111.088 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.57 -49.87 59.4 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.359 -0.448 . . . . 70.03 113.647 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 139' ' ' VAL . 96.4 mt -65.67 -46.9 77.37 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.572 -0.369 . . . . 72.32 111.818 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 92.7 p -61.67 -50.53 72.13 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.716 0.293 . . . . 73.55 111.684 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -27.16 60.15 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.7 -0.227 . . . . 72.53 111.285 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.13 -47.62 79.44 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.12 -0.562 . . . . 65.31 112.402 173.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 135' ' ' LEU . 75.3 t -58.27 -44.13 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.253 0.549 . . . . 71.11 110.562 173.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.512 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 41.0 tp -63.96 -35.91 82.22 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.884 -0.598 . . . . 74.02 110.83 177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.63 -43.5 97.44 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.94 0.4 . . . . 62.44 111.282 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.87 -47.54 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.171 0.51 . . . . 64.12 110.671 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -56.16 -36.73 68.63 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.02 -0.536 . . . . 64.13 111.673 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 18.7 mm-40 -57.3 -29.84 64.24 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 120.82 0.343 . . . . 72.32 111.809 176.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.53 -49.68 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.851 0.358 . . . . 73.05 111.139 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -71.76 -58.3 3.59 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.071 0.397 . . . . 61.24 112.071 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 111.871 0.323 . . . . 75.42 111.871 179.025 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.023 0.44 . . . . 61.44 112.167 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.13 126.61 50.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.128 -0.487 . . . . 73.04 111.137 173.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.479 ' O ' HG23 ' A' ' 9' ' ' VAL . 67.6 mttm -89.04 151.46 46.96 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.446 -0.343 . . . . 45.01 110.983 176.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.479 ' HD3' ' CE2' ' A' ' 67' ' ' PHE . 39.7 Cg_endo -64.88 -19.63 64.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.872 1.714 . . . . 65.24 111.663 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.413 ' HA ' HE22 ' A' ' 74' ' ' GLN . 18.5 mt-10 -88.83 -7.69 55.72 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.391 -0.822 . . . . 75.51 111.165 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -112.52 2.04 16.12 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.908 -0.587 . . . . 62.14 111.876 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 5' ' ' LYS . 61.8 t -81.28 130.92 60.51 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.512 -0.313 . . . . 41.05 110.447 174.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.01 116.89 1.89 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.877 2.385 . . . . 62.3 113.314 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -68.29 70.29 0.16 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.005 0.431 . . . . 74.44 112.035 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -60.56 -25.42 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.7 0.63 . . . . 74.51 112.7 -175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -73.98 -25.09 59.74 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.901 0.381 . . . . 75.31 111.219 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tt -93.84 -32.61 13.87 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.076 -0.511 . . . . 62.01 111.038 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.88 -47.3 10.46 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.202 0.445 . . . . 54.03 112.202 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -106.4 -65.62 1.07 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.592 0.59 . . . . 73.44 112.592 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.8 p 61.65 0.72 0.51 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.985 0.914 . . . . 74.22 112.139 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -110.5 -36.68 5.69 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.678 0.391 . . . . 70.44 111.641 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -87.11 -49.3 7.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.862 0.363 . . . . 64.44 111.629 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp 65.45 13.92 9.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.26 0.624 . . . . 74.23 112.155 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.8 t -102.41 128.72 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.0 0.428 . . . . 73.51 111.651 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 m -129.74 112.4 13.59 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.274 -0.421 . . . . 65.42 110.931 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -124.04 102.23 7.64 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.007 0.432 . . . . 65.22 111.894 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.53 ' HB2' HD23 ' A' ' 56' ' ' LEU . 4.7 mp0 -102.93 -38.7 7.25 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.292 -0.413 . . . . 74.24 110.98 173.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.1 -20.92 66.3 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.074 0.768 . . . . 43.11 113.074 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.6 38.78 27.23 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.916 -0.659 . . . . 62.13 112.693 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.1 mt -100.81 -28.42 12.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.719 0.295 . . . . 73.3 111.393 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.2 mt -99.05 107.53 19.96 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.737 0.303 . . . . 75.11 111.321 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.1 t -74.57 160.53 30.76 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.353 -0.217 . . . . 72.22 110.903 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -46.47 -36.29 6.49 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.729 0.64 . . . . 74.5 112.729 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.49 -52.02 63.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.948 0.404 . . . . 40.33 111.333 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.503 ' HG3' ' HB1' ' A' ' 132' ' ' ALA . 14.6 mm100 -62.07 -40.7 96.7 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.928 0.394 . . . . 63.32 110.741 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.27 -44.74 88.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.211 -0.45 . . . . 72.33 110.865 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -57.93 -52.26 66.24 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.132 0.491 . . . . 75.24 111.126 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.69 -45.9 96.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.212 -0.449 . . . . 64.02 111.622 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 43.9 ttm -62.78 -44.38 96.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.503 -0.317 . . . . 75.03 111.375 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -53.55 -47.83 69.66 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.169 0.509 . . . . 72.45 110.656 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.85 -36.11 92.29 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.059 -0.591 . . . . 34.41 113.086 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.57 ' O ' HG13 ' A' ' 43' ' ' ILE . 6.2 mmp_? -67.3 -56.27 10.48 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.816 0.341 . . . . 74.24 111.12 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.62 -47.25 84.57 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.175 -0.466 . . . . 63.23 111.746 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -58.54 -45.99 87.77 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.207 -0.451 . . . . 74.53 111.19 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.76 80.81 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.908 0.385 . . . . 65.41 111.386 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.4 mt -65.64 -48.64 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.878 0.37 . . . . 35.12 111.424 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 48.5 ttt180 -66.83 -28.16 68.13 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.11 -0.369 . . . . 73.35 111.625 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 t -76.67 -49.73 15.43 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.804 0.335 . . . . 74.23 111.632 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.2 t -82.83 -54.18 5.3 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.323 0.49 . . . . 65.31 112.323 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -87.56 -22.3 24.89 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.115 -0.493 . . . . 74.25 111.505 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 71.43 17.68 5.7 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.235 0.614 . . . . 73.32 111.443 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.802 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 84.2 t -87.48 119.25 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.106 -0.497 . . . . 72.3 111.284 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -80.96 96.69 7.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.244 0.545 . . . . 74.04 110.283 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -110.49 109.65 20.09 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.631 -0.713 . . . . 74.35 110.645 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.33 142.16 42.36 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.444 0.535 . . . . 60.34 112.444 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.22 132.82 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.321 -0.4 . . . . 70.12 111.214 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 71' ' ' LEU . 41.8 t -130.92 138.79 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 122.463 0.305 . . . . 72.13 111.534 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 p -124.49 122.85 38.77 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.093 0.473 . . . . 73.54 111.573 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HB2' ' A' ' 24' ' ' GLU . 42.8 mt -131.85 145.36 57.14 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 116.516 -0.311 . . . . 62.13 110.92 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 28.2 Cg_endo -63.59 -68.63 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.13 1.887 . . . . 64.43 112.684 177.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 m -131.0 156.04 45.8 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.207 -0.308 . . . . 71.12 110.785 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.553 HD11 HE22 ' A' ' 94' ' ' GLN . 27.8 pt -122.21 2.08 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 121.14 0.495 . . . . 73.25 111.886 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.95 -122.7 10.2 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.211 -0.519 . . . . 72.02 113.178 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -103.49 4.95 36.54 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.978 0.362 . . . . 54.01 111.978 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.08 118.49 70.94 Favored Pre-proline 0 CA--C 1.538 0.497 0 O-C-N 122.402 -0.186 . . . . 71.21 110.685 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.495 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 32.0 Cg_endo -63.94 131.37 30.62 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.145 1.897 . . . . 63.01 112.354 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.5 tp -48.01 -40.4 22.6 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.41 0.522 . . . . 61.33 112.41 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.45 -45.37 91.2 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.215 0.45 . . . . 62.13 112.215 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.495 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 22.9 t70 -71.66 -34.57 69.83 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.464 0.649 . . . . 73.01 110.228 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.479 ' CE2' ' HD3' ' A' ' 6' ' ' PRO . 21.6 t80 -58.77 -52.37 65.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.521 -0.763 . . . . 74.31 110.914 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.5 p -61.74 -40.42 95.05 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.266 -0.425 . . . . 70.31 111.19 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.9 tp -57.48 -52.74 64.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.28 -0.418 . . . . 63.04 111.278 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 56.4 mtpt -60.35 -49.28 78.2 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.942 0.401 . . . . 74.44 111.764 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 54' ' ' VAL . 34.2 tp -59.6 -45.03 93.12 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.338 -0.392 . . . . 72.34 111.735 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -48.19 73.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.348 0.499 . . . . 73.04 112.348 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.492 ' NH2' ' HG2' ' A' ' 70' ' ' LYS . 14.4 ptt180 -68.08 -31.38 70.97 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.916 0.388 . . . . 65.34 111.321 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.413 HE22 ' HA ' ' A' ' 7' ' ' GLU . 7.9 tt0 -70.91 -39.35 72.77 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.022 0.439 . . . . 45.42 111.246 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.415 ' CZ2' HD11 ' A' ' 71' ' ' LEU . 41.0 m0 -80.49 8.53 7.54 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.199 0.444 . . . . 73.54 112.199 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.5 -42.0 2.74 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.159 -0.543 . . . . 71.34 113.585 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 113.535 0.939 . . . . 64.33 113.535 -178.059 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 109.458 -0.571 . . . . 70.24 109.458 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -59.89 -99.08 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 112.968 0.729 . . . . 72.54 112.968 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.802 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 33.5 m-80 -76.22 78.05 3.02 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.506 -0.746 . . . . 73.32 111.778 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.9 135.49 7.72 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.162 -0.542 . . . . 32.44 112.809 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 99' ' ' PHE . 57.1 tp -147.26 119.89 8.56 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.752 0.31 . . . . 74.41 110.662 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.483 HD21 HD23 ' A' ' 71' ' ' LEU . 60.8 tp -107.55 132.81 52.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.856 0.36 . . . . 64.01 111.745 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.0 tp -121.85 112.23 18.09 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.378 -0.374 . . . . 72.15 111.127 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.18 126.9 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.878 0.37 . . . . 72.15 111.629 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.42 ' HA ' HG12 ' A' ' 97' ' ' VAL . 29.7 tp -109.84 120.64 43.11 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.196 -0.456 . . . . 54.23 111.335 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.545 HG21 HD13 ' A' ' 59' ' ' ILE . 51.8 t -100.92 103.46 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.581 -0.281 . . . . 52.01 110.745 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 67.1 tp -52.19 -44.89 64.95 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.307 0.484 . . . . 72.54 112.307 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.86 -31.55 66.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.036 -0.529 . . . . 73.54 112.249 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.553 HE22 HD11 ' A' ' 59' ' ' ILE . 51.2 mt-30 -110.56 -6.12 14.95 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.037 0.384 . . . . 62.44 112.037 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 42.17 31.02 0.22 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.672 0.789 . . . . 74.45 112.003 -171.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 58.2 mtt180 -107.25 142.33 37.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.774 -0.648 . . . . 74.33 110.972 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 90' ' ' LEU . 4.1 m -131.01 163.14 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.973 0.416 . . . . 74.34 111.124 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -148.41 137.03 21.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.411 -0.359 . . . . 64.03 111.329 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.645 ' HB3' HD11 ' A' ' 86' ' ' LEU . 89.9 m-85 -100.08 113.5 26.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.019 -0.537 . . . . 74.41 110.104 173.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -95.76 114.45 26.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.372 -0.232 . . . . 72.44 110.372 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.54 147.67 23.83 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.213 0.819 . . . . 61.33 113.213 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -97.77 178.37 32.3 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.122 -0.944 . . . . 44.43 112.539 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -62.72 -19.38 63.86 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.444 0.535 . . . . 73.11 112.444 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.74 -18.24 56.82 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.032 -0.604 . . . . 61.12 113.33 -177.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.602 HD11 HG13 ' A' ' 49' ' ' VAL . 91.4 mt -111.54 -4.54 14.76 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.889 0.7 . . . . 72.01 112.889 -175.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -58.76 -30.51 67.58 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.082 0.401 . . . . 71.12 112.082 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.49 -18.24 79.27 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.042 -0.599 . . . . 60.34 113.062 174.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -93.28 -57.39 2.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.277 0.56 . . . . 75.12 111.831 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.548 ' HB3' HD21 ' A' ' 114' ' ' LEU . 12.5 mt -119.64 89.0 40.39 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.611 -0.722 . . . . 75.04 112.253 -169.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.09 148.29 85.2 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.25 1.967 . . . . 64.44 111.571 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.25 -27.64 62.25 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.007 0.432 . . . . 74.35 111.385 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.53 -49.38 56.49 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.155 -0.545 . . . . 54.04 112.589 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.32 -44.26 84.03 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.158 0.504 . . . . 74.3 111.064 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 109' ' ' LEU . 89.6 mt -58.31 -43.17 88.02 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.263 -0.426 . . . . 52.21 111.083 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.6 m -62.88 -36.89 84.81 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.852 0.358 . . . . 51.44 111.118 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -60.21 -53.46 57.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.355 -0.384 . . . . 72.04 110.149 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.6 mt -51.53 -42.4 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.916 0.389 . . . . 73.22 111.234 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 122' ' ' MET . 76.6 mt -58.67 -55.87 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.818 0.342 . . . . 51.24 111.478 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -76.22 -9.72 58.85 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.506 0.558 . . . . 72.14 112.506 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -95.42 -45.36 7.14 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.162 0.43 . . . . 74.23 112.162 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.698 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 92.6 mtt180 -127.59 -4.11 5.97 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.599 0.962 . . . . 71.15 113.599 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 17.0 mmt -103.46 -63.27 1.2 Allowed 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.85 -0.531 . . . . 73.51 111.786 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.555 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 43.5 mm -50.07 -49.97 72.05 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 112.719 0.637 . . . . 65.21 112.719 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 11.1 Cg_endo -52.76 -37.19 75.74 Favored 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.366 2.044 . . . . 61.41 112.874 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.426 ' NE2' ' HG3' ' A' ' 137' ' ' GLU . 86.5 m-70 -77.61 -48.65 16.34 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.543 -0.299 . . . . 70.4 111.434 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.7 m-85 -57.06 -40.12 76.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.772 0.32 . . . . 73.33 111.42 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -59.35 -35.78 74.5 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.997 0.427 . . . . 74.13 111.291 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.2 t -84.18 -3.44 58.15 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.247 -0.433 . . . . 63.32 111.691 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.42 6.68 88.45 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.111 -0.566 . . . . 60.12 112.888 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.697 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.6 m-20 -84.08 55.79 3.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.688 0.395 . . . . 63.21 111.72 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -56.43 -44.35 80.34 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.06 0.392 . . . . 64.34 112.06 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.503 ' HB1' ' HG3' ' A' ' 32' ' ' GLN . . . -66.85 -32.77 74.26 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.94 0.4 . . . . 74.12 112.042 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.697 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 53.3 mt-10 -76.54 -43.39 39.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.391 -0.368 . . . . 74.44 111.508 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.64 -49.75 67.82 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.389 -0.434 . . . . 73.22 112.994 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 139' ' ' VAL . 92.2 mt -56.64 -39.75 74.22 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.746 0.308 . . . . 64.14 111.445 176.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.8 t -60.8 -45.69 93.43 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.085 0.469 . . . . 72.32 111.047 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.698 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 38.0 mm-40 -61.85 -44.86 95.98 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.996 -0.547 . . . . 72.43 111.819 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.88 -47.54 90.74 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.166 -0.54 . . . . 74.43 113.072 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 135' ' ' LEU . 83.4 t -60.55 -50.02 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.885 0.374 . . . . 65.14 111.511 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.93 -38.33 85.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.376 -0.374 . . . . 74.44 111.269 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.93 -54.63 44.76 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.996 0.427 . . . . 55.22 111.331 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.446 HG13 HD11 ' A' ' 109' ' ' LEU . 99.5 t -57.53 -47.7 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.147 -0.479 . . . . 71.04 111.133 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.407 HE22 ' NH1' ' A' ' 39' ' ' ARG . 63.4 tt0 -53.74 -37.7 63.62 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.211 -0.45 . . . . 73.32 111.817 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 144' ' ' GLN . 14.5 mm-40 -72.89 -38.99 66.76 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 111.609 0.225 . . . . 62.35 111.609 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.53 -42.87 95.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.998 0.427 . . . . 75.51 110.985 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.401 HD13 HG21 ' A' ' 49' ' ' VAL . 77.2 mt -64.43 -49.9 69.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.124 -0.489 . . . . 73.13 111.168 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 CA--C 1.538 0.516 0 CA-C-N 115.657 -0.701 . . . . 71.34 112.232 -176.075 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.461 HG12 ' HE3' ' A' ' 5' ' ' LYS . 97.8 t . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 121.372 0.606 . . . . 73.11 111.613 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -87.81 135.61 33.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.852 -0.613 . . . . 60.21 111.936 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.461 ' HE3' HG12 ' A' ' 3' ' ' VAL . 25.7 mmtp -100.93 158.99 30.76 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.47 -0.567 . . . . 74.33 109.47 169.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 9.5 Cg_endo -56.65 -32.08 89.46 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.43 1.42 . . . . 73.31 112.038 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -78.13 -12.72 60.01 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.483 0.549 . . . . 75.03 112.483 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -85.35 -18.04 34.97 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.953 0.406 . . . . 63.42 110.976 173.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.473 HG22 HD21 ' A' ' 56' ' ' LEU . 60.3 t -79.03 128.0 77.72 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.137 -0.483 . . . . 73.01 111.388 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.23 108.25 0.32 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.301 2.0 . . . . 74.53 111.899 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.524 ' ND2' HD13 ' A' ' 14' ' ' LEU . 14.7 p-10 -66.57 82.14 0.1 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.741 0.781 . . . . 74.42 112.158 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.42 1.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.487 -0.779 . . . . 64.11 113.0 -177.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -100.7 9.99 41.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.834 0.35 . . . . 75.55 111.305 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD13 ' ND2' ' A' ' 11' ' ' ASN . 10.1 tt -124.11 -46.0 1.96 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.442 -0.344 . . . . 74.12 111.35 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.77 -68.29 0.7 Allowed 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.146 -0.346 . . . . 61.04 111.654 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -80.07 -61.95 1.83 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.942 0.349 . . . . 73.01 111.942 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 m 63.11 7.06 2.55 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.656 0.383 . . . . 62.34 111.818 -174.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -99.26 -43.69 6.51 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.119 0.414 . . . . 64.13 112.119 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.423 ' HB2' ' ND2' ' A' ' 37' ' ' ASN . 13.0 ptm180 -82.51 -35.92 26.9 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.581 0.585 . . . . 74.44 112.581 -177.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 mp 63.19 3.83 1.44 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.735 0.643 . . . . 71.55 112.735 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.5 t -108.8 154.32 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.663 0.385 . . . . 54.43 111.166 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.3 m -142.5 108.74 5.25 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.479 0.311 . . . . 75.25 111.031 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.53 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 20.7 p-10 -107.74 73.67 0.92 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.521 0.676 . . . . 72.14 112.616 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -79.18 -38.09 36.69 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.289 0.566 . . . . 71.13 110.453 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.19 66.59 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.918 -0.583 . . . . 54.3 112.403 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.26 19.2 73.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.152 -0.547 . . . . 41.42 113.195 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.11 0.12 54.27 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.053 0.39 . . . . 64.41 112.053 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -109.95 103.59 12.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.916 0.388 . . . . 74.02 111.04 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.7 t -70.33 165.98 21.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.368 -0.378 . . . . 64.24 111.403 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -46.72 -57.73 4.56 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.426 0.898 . . . . 74.1 113.426 -172.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.593 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . . . -68.06 -42.93 79.75 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.021 0.378 . . . . 74.53 112.021 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -62.26 -33.43 74.61 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.259 0.552 . . . . 74.32 111.069 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -74.2 -53.22 10.28 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.668 -0.696 . . . . 74.24 111.038 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 11.6 pt-20 -59.65 -43.59 93.85 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.129 0.418 . . . . 53.13 112.129 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 31' ' ' ALA . 89.0 t -65.8 -33.67 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.143 0.497 . . . . 71.14 110.91 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.447 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 50.8 ttm -65.34 -40.5 93.75 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 122.052 -0.405 . . . . 63.24 110.651 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 19' ' ' ARG . 4.2 m-20 -57.93 -56.36 22.95 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.989 0.423 . . . . 74.01 111.703 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.57 -43.03 85.83 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.306 -0.473 . . . . 72.34 113.416 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 73.4 mtm180 -62.55 -45.1 94.48 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 111.756 0.28 . . . . 72.13 111.756 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 36' ' ' MET . 89.1 mt -64.1 -50.84 66.71 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.025 0.44 . . . . 75.42 111.431 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -60.21 -37.79 81.37 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.272 -0.422 . . . . 74.2 111.447 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.33 -44.23 88.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.943 0.401 . . . . 73.31 111.271 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.651 HG22 ' HB ' ' A' ' 49' ' ' VAL . 63.5 mt -61.58 -38.79 81.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.937 0.398 . . . . 62.02 111.265 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 57.3 ttp180 -74.03 -33.24 63.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.917 0.389 . . . . 74.13 111.238 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.2 t -66.87 -38.53 86.5 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.1 0.476 . . . . 73.12 111.08 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.0 t -92.61 -61.67 1.55 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.99 -0.55 . . . . 62.32 112.162 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -91.91 -4.97 54.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.649 0.611 . . . . 63.01 112.649 -173.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.86 26.85 14.4 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.185 0.439 . . . . 63.41 112.185 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' HG22 ' A' ' 43' ' ' ILE . 62.5 t -90.7 128.31 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 112.215 0.45 . . . . 73.25 112.215 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -86.56 97.45 10.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.389 -0.369 . . . . 75.41 110.419 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.09 105.99 14.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.846 0.355 . . . . 74.44 110.539 -177.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.63 142.1 42.96 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.456 0.539 . . . . 65.14 112.456 -175.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.18 118.17 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.989 0.423 . . . . 74.34 111.437 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.544 HG21 HD21 ' A' ' 71' ' ' LEU . 61.8 t -114.62 142.27 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 122.516 0.326 . . . . 71.23 111.752 -178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.53 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 73.3 p -130.88 123.51 29.15 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.756 0.313 . . . . 62.21 111.293 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.473 HD21 HG22 ' A' ' 9' ' ' VAL . 68.2 mt -120.65 139.24 28.58 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 111.749 0.277 . . . . 72.34 111.749 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 83.2 Cg_endo -81.81 -11.75 11.25 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.634 2.222 . . . . 61.35 113.315 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.763 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 31.0 t -169.77 138.77 1.87 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.97 0.359 . . . . 73.34 111.97 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 3' ' ' VAL . 28.6 pt -136.86 -0.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 120.984 0.421 . . . . 71.23 110.365 170.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.27 -158.58 52.12 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 116.133 -0.485 . . . . 54.33 113.219 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.46 69.94 2.28 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.367 0.603 . . . . 73.2 110.873 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.55 142.44 41.88 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.731 -0.668 . . . . 73.04 111.26 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 77.1 Cg_endo -79.27 116.67 3.66 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.415 2.076 . . . . 73.42 113.092 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.51 -38.09 83.24 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.116 0.413 . . . . 73.24 112.116 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.03 -8.86 48.94 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.968 0.413 . . . . 74.21 111.967 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 31.1 t70 -96.59 -39.21 9.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.544 0.688 . . . . 74.24 109.632 170.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.463 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 43.3 t80 -55.2 -50.21 69.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.038 -0.983 . . . . 73.12 111.785 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -52.68 -49.39 65.38 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.858 0.361 . . . . 73.55 111.809 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.7 tp -59.57 -49.72 76.66 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.242 -0.436 . . . . 72.42 111.576 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -60.56 -47.74 84.84 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.243 0.46 . . . . 62.12 112.243 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 54' ' ' VAL . 51.2 tp -61.52 -47.85 83.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.242 0.544 . . . . 53.33 110.766 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.23 77.24 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.07 -0.514 . . . . 74.2 112.01 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -61.14 -52.37 65.12 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.844 0.354 . . . . 65.5 111.709 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.522 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 12.1 pt20 -72.05 -21.64 61.5 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 111.774 0.287 . . . . 64.31 111.774 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.522 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 30.3 m0 -91.03 -16.04 28.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.561 0.219 . . . . 73.13 111.451 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.51 40.44 99.11 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.387 -0.435 . . . . 74.44 113.238 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 112.547 0.573 . . . . 73.31 112.547 -175.81 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' TYR . 65.1 t30 . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 109.732 -0.47 . . . . 72.03 109.732 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -76.62 -109.3 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.623 -0.673 . . . . 62.42 112.505 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.651 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.7 m-20 -81.23 78.98 7.97 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.433 -0.792 . . . . 72.03 111.724 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.93 140.69 11.65 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.164 -0.541 . . . . 64.13 113.339 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 99' ' ' PHE . 53.3 tp -148.77 124.61 10.57 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.858 0.463 . . . . 74.4 110.573 178.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.533 HD21 HD23 ' A' ' 71' ' ' LEU . 59.0 tp -115.1 132.68 56.52 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.696 0.284 . . . . 62.24 111.509 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.4 tp -122.4 123.25 40.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.795 0.438 . . . . 55.03 110.158 174.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 51.1 t -124.4 126.54 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.122 0.416 . . . . 53.3 112.122 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.662 ' HB2' HD21 ' A' ' 135' ' ' LEU . 24.1 tp -103.31 124.93 49.58 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.201 -0.454 . . . . 72.52 110.774 172.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.33 98.97 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.443 -0.344 . . . . 50.23 111.513 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.607 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 65.1 tp -55.68 -31.01 62.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.041 0.448 . . . . 45.44 111.561 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.763 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 11.5 t70 -49.97 -47.99 52.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.29 0.636 . . . . 75.4 111.759 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.502 ' OE1' ' HD2' ' A' ' 96' ' ' ARG . 8.9 pt20 -125.45 6.35 7.64 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.343 0.498 . . . . 72.21 112.343 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 56.91 30.79 18.58 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.063 0.764 . . . . 74.22 113.063 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.502 ' HD2' ' OE1' ' A' ' 94' ' ' GLN . 84.5 mtt180 -107.19 149.13 28.05 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.203 0.525 . . . . 71.33 111.676 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 90' ' ' LEU . 5.9 m -139.27 160.97 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.675 -0.693 . . . . 43.31 111.165 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -160.32 145.55 14.86 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.648 0.611 . . . . 74.35 112.648 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' HB3' HD11 ' A' ' 86' ' ' LEU . 96.8 m-85 -97.27 146.77 24.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.764 -0.653 . . . . 73.41 110.323 169.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 5.9 tp10 -135.62 113.0 10.62 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.284 -0.26 . . . . 74.44 110.632 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.419 HG21 ' HB2' ' A' ' 109' ' ' LEU . 6.2 p -95.76 160.88 14.26 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.455 0.909 . . . . 72.41 113.455 -175.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.42 -177.24 21.33 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 114.964 -1.017 . . . . 72.11 112.202 168.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' ASN . 19.5 t80 -65.34 -11.13 38.86 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.012 0.525 . . . . 73.12 112.337 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.67 -6.96 79.44 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.876 -0.678 . . . . 52.42 113.091 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 49' ' ' VAL . 97.5 mt -127.67 -12.48 5.45 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.062 0.764 . . . . 73.02 113.062 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -57.54 -17.97 16.7 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.373 0.879 . . . . 75.03 113.373 -175.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.04 -26.19 69.41 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.148 -0.548 . . . . 54.41 113.079 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -106.38 -44.07 4.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.933 0.397 . . . . 75.54 111.917 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.419 ' HB2' HG21 ' A' ' 101' ' ' THR . 29.5 mt -119.23 84.53 28.12 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 112.59 0.589 . . . . 61.33 112.59 -170.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.32 162.65 25.27 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.113 1.875 . . . . 71.11 112.251 171.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.33 -34.9 67.01 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.841 0.353 . . . . 71.33 111.644 -177.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.75 -50.18 66.37 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.019 -0.61 . . . . 73.24 113.046 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 109' ' ' LEU . 56.6 tp -58.68 -45.79 88.66 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.867 0.365 . . . . 64.3 111.151 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.401 ' O ' HG13 ' A' ' 118' ' ' ILE . 94.5 mt -58.35 -43.63 88.41 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.364 -0.38 . . . . 74.43 110.935 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.5 m -62.67 -38.5 90.57 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.418 -0.356 . . . . 55.15 111.037 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -58.04 -53.46 57.95 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.979 0.419 . . . . 71.3 110.659 174.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.2 mt -54.22 -49.48 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.006 0.431 . . . . 55.53 111.222 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 123' ' ' ILE . 96.9 mt -57.94 -56.81 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.974 -0.557 . . . . 73.12 111.936 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 46.2 m-70 -72.69 -40.87 65.89 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.828 0.677 . . . . 74.2 112.828 -173.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -78.84 -44.51 22.84 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.565 0.58 . . . . 75.13 112.565 -171.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -109.55 -32.91 6.95 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.199 0.814 . . . . 54.23 113.199 -173.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.566 ' HB3' ' HE2' ' A' ' 126' ' ' PHE . 85.4 mtp -87.94 -51.64 5.71 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.091 0.774 . . . . 63.34 113.091 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 118' ' ' ILE . 48.1 mm -51.77 -49.24 84.52 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 112.735 0.642 . . . . 54.43 112.735 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 87.1 Cg_exo -48.27 -28.81 11.83 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 122.665 2.243 . . . . 72.02 113.694 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 79.4 m-70 -83.32 -52.16 6.79 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.674 0.25 . . . . 72.3 111.674 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.566 ' HE2' ' HB3' ' A' ' 122' ' ' MET . 50.1 m-85 -56.83 -44.36 82.0 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.948 0.404 . . . . 71.32 111.468 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 123' ' ' ILE . 2.9 ptm180 -71.07 -10.26 59.46 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.279 -0.419 . . . . 74.03 111.64 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.9 m -110.41 -1.96 16.84 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 111.892 0.33 . . . . 73.24 111.892 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.61 -17.79 35.87 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.963 -0.637 . . . . 35.1 114.075 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.762 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 93.7 m-20 -80.08 81.32 6.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.322 0.561 . . . . 74.02 111.571 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -71.11 -54.65 10.33 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.873 0.368 . . . . 71.11 111.638 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.26 74.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.138 0.494 . . . . 62.23 111.842 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 5.5 mm-40 -74.52 -31.6 62.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.375 -0.375 . . . . 61.1 111.36 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.28 -42.4 57.42 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.029 -0.605 . . . . 75.31 112.366 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 90' ' ' LEU . 95.4 mt -62.32 -47.63 83.43 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.85 0.357 . . . . 65.4 111.611 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.3 p -59.28 -37.25 77.21 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.435 -0.348 . . . . 53.44 111.693 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -59.66 -48.78 80.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.719 0.295 . . . . 64.13 111.214 172.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.8 -50.48 67.2 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.024 -0.608 . . . . 63.01 112.941 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.0 t -57.75 -48.47 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.944 0.402 . . . . 74.43 111.314 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.508 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 55.1 tp -60.76 -41.08 94.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.237 -0.438 . . . . 65.25 111.292 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.39 -49.43 77.6 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.856 0.36 . . . . 72.1 111.324 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.49 -44.56 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.276 -0.42 . . . . 44.12 111.254 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -53.22 -41.88 65.79 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.15 -0.477 . . . . 74.32 111.306 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 85.1 mm-40 -60.26 -48.31 82.3 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.539 -0.3 . . . . 75.0 111.451 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.72 -49.63 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.021 0.378 . . . . 74.42 112.021 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 89.2 mt -70.36 -57.06 5.25 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.903 0.383 . . . . 72.41 111.77 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 120.989 0.424 . . . . 71.05 111.708 -176.481 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 112.896 0.702 . . . . 71.52 112.896 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.05 152.3 45.99 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.776 -0.647 . . . . 72.5 111.201 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -114.53 169.22 6.86 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 74.31 110.569 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.36 51.28 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.873 2.382 . . . . 74.12 112.117 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.36 -28.09 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.916 -0.583 . . . . 64.33 110.457 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -68.26 -28.76 67.49 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.289 0.566 . . . . 53.02 110.465 171.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.661 HG13 HG21 ' A' ' 22' ' ' THR . 60.7 t -70.46 122.27 85.97 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.481 -0.781 . . . . 74.14 111.525 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HG2' HG23 ' A' ' 22' ' ' THR . 21.9 Cg_endo -61.1 119.86 7.24 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.323 2.015 . . . . 74.23 112.049 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . 5.6 p30 -64.23 85.89 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.954 0.724 . . . . 73.24 112.954 -176.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.32 0.48 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 112.505 0.557 . . . . 72.44 112.505 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -121.87 5.51 9.92 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.087 0.403 . . . . 72.22 112.087 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 6.8 tt -115.14 -54.73 2.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.427 -0.583 . . . . 74.24 109.427 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.72 -55.28 35.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.124 0.488 . . . . 62.34 110.839 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -127.46 -179.57 4.97 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.093 -0.503 . . . . 75.21 110.768 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.6 p -130.27 -11.53 4.11 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.644 -0.253 . . . . 73.12 111.615 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -81.0 -45.64 16.28 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.932 0.716 . . . . 72.53 112.932 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.708 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 32.5 tpt180 -52.67 -61.91 1.98 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.203 0.445 . . . . 73.21 112.203 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 40' ' ' LEU . 17.5 mt 63.19 6.99 2.57 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.218 0.451 . . . . 61.23 112.218 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.708 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 95.4 t -133.64 121.42 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.842 0.353 . . . . 64.3 111.774 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.661 HG21 HG13 ' A' ' 9' ' ' VAL . 89.0 m -111.88 102.8 11.04 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.77 0.319 . . . . 75.23 110.807 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.473 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 7.6 p-10 -99.72 84.34 2.91 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.454 0.645 . . . . 74.53 111.936 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.586 ' HG2' HG22 ' A' ' 22' ' ' THR . 40.2 mm-40 -96.32 -44.83 7.06 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.115 -0.493 . . . . 73.42 110.786 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.64 -25.36 60.04 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.147 0.425 . . . . 62.44 112.147 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.99 44.59 45.37 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.376 -0.44 . . . . 54.21 113.14 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 92' ' ' LEU . 85.3 mt -102.27 -22.29 14.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.916 0.388 . . . . 72.13 111.884 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.4 mt -93.32 108.47 20.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.717 0.294 . . . . 74.34 111.12 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.527 ' HB2' ' OE1' ' A' ' 32' ' ' GLN . 49.1 m -78.52 162.08 26.58 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.534 -0.303 . . . . 71.51 111.117 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -44.98 -45.53 10.62 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.176 0.806 . . . . 75.14 113.176 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -63.88 -53.28 53.08 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.8 0.333 . . . . 52.35 111.708 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.582 ' HG2' ' HB1' ' A' ' 132' ' ' ALA . 22.6 mp0 -55.9 -40.63 73.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.065 0.46 . . . . 64.34 110.69 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.82 -52.8 63.89 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.095 -0.502 . . . . 73.43 111.02 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -55.12 -40.62 70.7 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.94 0.4 . . . . 63.21 111.608 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 31' ' ' ALA . 46.6 t -71.05 -44.65 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.072 0.463 . . . . 54.21 111.715 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 52.1 ttm -70.35 -51.82 27.16 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.871 0.323 . . . . 71.23 111.871 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -54.48 -50.35 67.95 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.389 -0.369 . . . . 61.4 111.709 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.7 -38.06 86.34 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.001 -0.618 . . . . 70.12 113.59 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 43' ' ' ILE . 81.7 mtm180 -72.01 -49.52 36.25 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.95 0.375 . . . . 65.31 111.375 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.474 ' HB3' HD13 ' A' ' 20' ' ' LEU . 87.9 mt -57.14 -52.66 64.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.021 0.438 . . . . 44.12 111.049 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -54.64 -41.64 70.3 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.055 -0.521 . . . . 71.04 111.375 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.15 97.8 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.933 0.397 . . . . 63.1 111.389 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 39' ' ' ARG . 74.0 mt -64.91 -42.79 95.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.978 0.418 . . . . 61.12 111.083 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.493 ' NH1' ' HG2' ' A' ' 50' ' ' GLU . 8.4 tpt180 -61.46 -38.69 88.14 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.159 -0.473 . . . . 71.53 111.518 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.3 t -83.36 -41.96 17.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.238 0.459 . . . . 72.42 112.238 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -82.3 -62.49 1.61 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.124 0.488 . . . . 74.02 112.042 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -83.06 -14.3 54.08 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.093 -0.503 . . . . 61.33 111.655 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.11 17.21 10.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.827 0.451 . . . . 72.34 111.846 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.671 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 96.8 t -87.28 129.89 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.147 0.498 . . . . 44.42 111.339 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HG2' ' NH1' ' A' ' 44' ' ' ARG . 27.3 mt-10 -83.3 96.41 8.49 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.095 -0.502 . . . . 64.53 110.654 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -119.27 101.63 8.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.174 -0.466 . . . . 70.51 110.505 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.4 133.99 54.88 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.319 0.488 . . . . 62.42 112.319 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.16 112.73 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.078 0.466 . . . . 44.31 111.313 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.669 ' HB ' HG22 ' A' ' 89' ' ' VAL . 57.4 t -109.11 134.14 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.374 -0.375 . . . . 72.02 111.107 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 69.1 p -119.81 122.2 40.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.879 0.371 . . . . 61.34 111.472 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.555 HD21 HG22 ' A' ' 9' ' ' VAL . 77.9 mt -128.32 140.61 38.84 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.402 -0.363 . . . . 71.2 111.013 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.47 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 19.7 Cg_endo -61.29 -47.02 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.982 1.788 . . . . 75.2 112.078 175.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.425 ' HA ' HG13 ' A' ' 91' ' ' VAL . 43.8 t -157.72 145.63 18.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.94 0.4 . . . . 61.04 111.525 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 pt -101.66 9.08 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.196 0.522 . . . . 71.01 111.202 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.73 -133.95 18.16 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.154 -0.546 . . . . 61.34 113.305 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.43 -19.39 28.12 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.938 0.348 . . . . 75.15 111.938 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.58 143.99 89.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.555 0.576 . . . . 72.22 112.555 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.2 Cg_endo -75.77 127.7 10.35 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.565 2.177 . . . . 74.2 112.131 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.07 -32.61 72.25 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.341 0.497 . . . . 72.53 112.341 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.737 ' HG2' ' HD3' ' A' ' 98' ' ' ARG . 44.2 mt-10 -62.56 -43.2 99.4 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.176 0.513 . . . . 72.32 111.702 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 2.2 m-20 -76.96 -33.08 57.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.979 -0.555 . . . . 74.32 110.903 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -59.12 -52.7 64.6 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.052 -0.522 . . . . 64.35 110.941 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.8 p -59.32 -41.78 89.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.307 -0.406 . . . . 72.54 111.728 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 48.5 tp -57.16 -49.17 76.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.958 0.408 . . . . 64.45 111.217 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -62.33 -47.07 85.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.93 0.395 . . . . 71.14 111.51 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.05 -36.97 83.21 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.102 0.477 . . . . 70.13 111.429 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.51 -38.59 71.12 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.265 0.468 . . . . 73.41 112.265 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 25.9 mtp180 -61.79 -47.99 82.68 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.41 0.522 . . . . 61.42 112.41 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.421 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.5 pt20 -59.44 -38.1 79.81 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.885 0.374 . . . . 74.01 111.842 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 50.0 m0 -78.11 -4.61 48.27 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 111.817 0.303 . . . . 73.01 111.817 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.41 -35.05 3.02 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.045 -0.598 . . . . 73.2 112.578 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.519 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 46.9 t . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 123.382 0.673 . . . . 73.41 112.751 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.664 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 2.1 t-20 . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 120.361 0.124 . . . . 71.2 110.933 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -43.26 -72.42 0.06 Allowed 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 114.407 1.262 . . . . 75.35 114.407 -168.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.671 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 5.1 m-20 -87.98 21.79 2.59 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.508 -0.745 . . . . 73.42 112.286 -173.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 77' ' ' VAL . . . -81.51 128.22 8.34 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.02 -0.609 . . . . 63.32 114.468 -175.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 54.5 tp -145.12 118.81 9.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.785 0.434 . . . . 63.34 110.56 173.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.2 tp -116.1 126.82 54.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.88 0.372 . . . . 74.55 111.664 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 33.1 tp -116.07 111.86 20.91 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.03 -0.532 . . . . 64.21 110.813 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.669 HG22 ' HB ' ' A' ' 54' ' ' VAL . 70.4 t -118.23 130.07 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.714 0.293 . . . . 71.14 111.553 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.4 tp -109.72 125.88 53.12 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.96 0.41 . . . . 61.12 111.508 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 58' ' ' SER . 47.8 t -99.93 105.61 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.113 -0.494 . . . . 43.23 110.294 173.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 51.6 tp -57.09 -62.84 1.47 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.147 0.795 . . . . 70.11 113.147 -174.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.37 -27.16 68.87 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.283 0.475 . . . . 71.11 112.283 -171.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -97.14 -10.94 24.97 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.705 0.288 . . . . 73.51 111.343 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 50.97 67.39 0.95 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.562 0.696 . . . . 74.52 112.322 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -159.98 150.87 19.12 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.912 -0.586 . . . . 64.12 111.095 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.2 m -129.66 171.56 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.986 0.422 . . . . 72.41 111.759 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.737 ' HD3' ' HG2' ' A' ' 65' ' ' GLU . 6.0 mmm180 -141.11 153.5 45.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.327 0.584 . . . . 72.41 112.288 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.72 ' HB3' HD13 ' A' ' 114' ' ' LEU . 30.5 m-85 -129.86 111.49 12.63 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.265 -0.88 . . . . 62.51 110.129 175.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.7 tp10 -105.05 112.37 25.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.809 -0.178 . . . . 74.22 110.779 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.402 HG23 HD11 ' A' ' 114' ' ' LEU . 1.2 p -96.46 147.33 23.94 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.759 0.79 . . . . 73.32 112.874 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -95.41 174.13 31.93 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.178 -0.919 . . . . 54.55 112.696 171.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -56.02 -22.31 26.45 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.961 0.726 . . . . 72.43 112.961 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.68 -41.03 11.43 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.898 -0.668 . . . . 61.21 112.464 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.446 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 85.5 mt -81.1 -6.88 59.33 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.72 0.637 . . . . 72.33 112.72 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -59.57 -12.59 6.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.521 0.563 . . . . 72.11 112.521 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.96 -12.99 62.99 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.168 -0.539 . . . . 73.22 113.326 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -117.32 -47.47 2.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.08 0.467 . . . . 72.55 111.947 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.59 93.04 48.77 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 115.886 -0.597 . . . . 73.15 112.435 -168.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.62 160.51 31.48 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.293 1.995 . . . . 73.25 111.968 170.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -55.31 -36.55 66.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.679 0.276 . . . . 72.23 111.721 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.73 -49.12 82.13 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.258 -0.496 . . . . 65.52 113.21 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 tp -60.12 -44.05 95.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.012 0.434 . . . . 75.23 111.272 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.72 HD13 ' HB3' ' A' ' 99' ' ' PHE . 84.1 mt -62.31 -43.88 97.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.064 0.459 . . . . 73.04 110.969 177.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.4 t -64.42 -33.86 76.85 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.061 -0.518 . . . . 64.11 111.045 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -59.12 -52.3 66.33 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.004 -0.544 . . . . 74.33 110.385 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.23 -46.28 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.237 0.541 . . . . 75.44 110.937 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.438 HD11 ' HD2' ' A' ' 99' ' ' PHE . 72.4 mt -56.56 -56.01 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.584 -0.734 . . . . 51.25 111.79 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -81.38 -18.18 46.44 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.914 0.709 . . . . 70.23 112.914 -171.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -79.95 -58.59 3.09 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.683 0.278 . . . . 73.44 111.59 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -114.26 -34.64 5.25 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.201 0.815 . . . . 71.32 113.201 -174.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.428 ' SD ' ' HA ' ' A' ' 118' ' ' ILE . 85.8 mtp -68.59 -47.5 66.6 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.327 0.491 . . . . 75.11 112.327 -174.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.432 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 26.3 mm -55.63 -55.26 42.4 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 112.983 0.735 . . . . 72.35 112.983 -178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 11.6 Cg_endo -54.78 -42.61 67.02 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.928 1.752 . . . . 74.35 112.536 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -60.88 -48.13 83.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.57 0.224 . . . . 73.11 111.412 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.529 ' HD1' ' HA ' ' A' ' 131' ' ' TYR . 22.9 m-30 -56.39 -47.49 78.84 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.879 0.371 . . . . 64.34 111.288 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -64.88 -33.14 75.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.907 0.384 . . . . 75.13 111.197 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.7 m -82.15 -1.15 47.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.498 -0.319 . . . . 54.11 111.773 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.69 -16.6 60.18 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.151 -0.547 . . . . 72.24 113.595 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.864 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 92.7 m-20 -80.05 65.24 5.14 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.234 0.517 . . . . 64.25 111.995 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.529 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 96.5 m-85 -64.05 -32.46 74.03 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.858 0.361 . . . . 73.2 111.154 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.582 ' HB1' ' HG2' ' A' ' 32' ' ' GLN . . . -71.02 -50.84 29.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.986 0.422 . . . . 64.33 111.417 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.864 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 5.8 mp0 -57.16 -42.44 81.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.144 -0.48 . . . . 74.21 111.606 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.0 -52.08 54.47 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.421 -0.419 . . . . 62.24 113.037 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.04 -39.95 96.26 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.915 0.388 . . . . 64.34 111.516 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.8 t -60.93 -43.88 98.01 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.159 0.429 . . . . 61.15 112.159 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -75.26 -28.78 59.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.485 0.179 . . . . 73.44 111.485 177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.01 -49.08 82.43 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.69 -0.767 . . . . 43.44 111.965 172.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.87 -49.13 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.068 0.461 . . . . 72.25 111.203 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 52.7 tp -58.44 -40.49 82.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.983 -0.553 . . . . 75.21 111.494 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -59.31 -46.79 87.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.859 0.361 . . . . 65.3 111.446 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.24 -47.17 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.052 0.453 . . . . 53.34 111.168 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -51.79 -45.76 63.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.677 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 84.5 mm-40 -59.34 -42.04 90.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.935 0.398 . . . . 73.14 111.464 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 141' ' ' ALA . 85.5 t -60.73 -50.78 79.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 120.856 0.36 . . . . 54.15 111.17 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.64 -56.49 20.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.876 0.325 . . . . 72.51 111.876 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.096 0.406 . . . . 64.32 112.096 -175.972 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.4 t . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 121.263 0.554 . . . . 64.0 110.449 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -75.37 148.29 39.35 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.481 0.658 . . . . 73.34 112.521 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.524 ' HG2' ' HD2' ' A' ' 6' ' ' PRO . 6.9 tttp -130.74 157.97 76.23 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 115.365 -0.834 . . . . 72.31 109.754 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.524 ' HD2' ' HG2' ' A' ' 5' ' ' LYS . 77.8 Cg_exo -52.14 -26.06 25.07 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.431 2.088 . . . . 55.51 113.373 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -88.48 -16.47 32.66 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.08 0.4 . . . . 61.42 112.08 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -94.23 -24.85 17.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.901 0.381 . . . . 70.45 111.148 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.4 t -61.79 129.9 91.95 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.268 -0.424 . . . . 71.44 111.764 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.44 114.56 1.81 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.618 2.212 . . . . 61.23 112.851 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -71.19 77.07 0.71 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.878 0.37 . . . . 70.44 111.399 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.7 m -62.87 -44.64 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 122.267 -0.271 . . . . 64.11 111.471 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -64.4 -14.88 59.05 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.054 0.454 . . . . 73.22 111.884 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.54 -49.66 7.04 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.998 0.428 . . . . 65.12 110.004 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.12 -74.9 0.49 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.208 0.447 . . . . 73.53 112.208 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -109.18 81.49 1.45 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.501 0.667 . . . . 52.13 111.223 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 60.6 p -72.99 -29.85 63.36 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.915 -0.584 . . . . 42.12 112.101 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.5 m -65.25 -15.55 62.61 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.939 0.4 . . . . 62.14 111.832 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.3 ttt85 -75.56 -55.45 5.66 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.616 -0.265 . . . . 73.11 110.93 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 17' ' ' SER . 1.3 mt 72.46 -26.7 0.18 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.639 0.776 . . . . 72.14 112.635 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.63 141.01 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 122.895 0.478 . . . . 65.21 111.19 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 m -147.13 104.85 3.71 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.594 0.235 . . . . 72.1 111.307 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.429 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 33.6 t70 -106.99 109.77 21.74 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.165 0.507 . . . . 74.32 111.827 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -109.31 -39.51 5.2 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.042 0.449 . . . . 73.31 110.602 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.81 -23.28 17.45 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.868 0.692 . . . . 73.42 112.868 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.05 45.3 7.66 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.849 -0.691 . . . . 72.02 112.703 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.427 HD13 ' HB3' ' A' ' 131' ' ' TYR . 69.6 mt -117.72 -42.21 2.87 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.966 0.412 . . . . 75.43 111.558 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.03 104.6 14.22 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.834 0.349 . . . . 74.25 111.43 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 t -74.02 165.07 25.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.693 -0.23 . . . . 71.13 111.07 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -50.5 -55.77 14.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.017 0.747 . . . . 75.11 113.017 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . . . -59.0 -31.49 68.85 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.868 0.366 . . . . 54.14 111.916 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -73.84 -33.52 64.15 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.048 0.451 . . . . 63.44 110.649 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -69.29 -41.72 76.43 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.32 -0.4 . . . . 71.54 111.339 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 11.4 pt-20 -64.64 -38.96 92.8 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 111.996 0.369 . . . . 71.05 111.996 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.59 -49.16 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.267 0.556 . . . . 34.31 110.728 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.0 ttm -68.44 -29.34 67.97 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.068 -0.514 . . . . 72.22 110.916 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -65.13 -56.08 14.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.043 -0.526 . . . . 71.23 110.778 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.57 92.3 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.912 -0.661 . . . . 62.11 112.25 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.494 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.4 tpp180 -56.76 -54.48 45.83 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.184 0.594 . . . . 73.42 111.169 176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.57 -46.13 67.08 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.184 0.438 . . . . 52.42 112.184 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -58.57 -39.11 79.38 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.002 0.43 . . . . 63.12 110.926 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.71 81.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.193 -0.458 . . . . 61.13 111.077 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.509 HG22 ' HB ' ' A' ' 49' ' ' VAL . 66.2 mt -65.09 -45.59 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.657 0.265 . . . . 65.21 111.654 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 50.0 ttp180 -68.35 -26.65 65.7 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.095 -0.378 . . . . 75.32 111.838 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 t -89.15 -52.56 5.0 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.137 0.494 . . . . 61.44 111.155 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.1 m -72.22 -43.8 63.89 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.516 0.562 . . . . 74.22 112.516 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -105.41 -15.91 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.343 0.497 . . . . 72.25 112.343 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 68.02 20.69 9.03 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.128 0.49 . . . . 70.43 111.932 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.509 ' HB ' HG22 ' A' ' 43' ' ' ILE . 81.5 t -96.26 124.71 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.916 0.389 . . . . 61.12 111.239 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.47 97.31 9.96 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.437 0.637 . . . . 70.2 110.886 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.31 107.62 16.95 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.352 -0.84 . . . . 75.4 110.564 -176.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.76 145.17 38.56 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.057 0.391 . . . . 75.11 112.057 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.41 120.92 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.96 0.41 . . . . 74.2 111.381 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.39 128.94 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.299 -0.41 . . . . 41.32 111.614 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 22.3 p -110.79 123.72 50.62 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.922 0.391 . . . . 73.33 111.102 177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.8 mt -122.15 140.52 32.53 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 120.741 0.305 . . . . 62.52 111.275 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.15 -48.95 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.296 1.997 . . . . 65.54 112.65 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.7 p -150.88 144.91 25.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.699 0.285 . . . . 64.52 111.623 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 91' ' ' VAL . 32.7 pt -120.78 11.0 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.115 0.483 . . . . 73.14 111.044 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.28 -124.03 24.4 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.272 -0.49 . . . . 41.35 113.142 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.15 16.27 24.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.884 0.373 . . . . 70.41 111.417 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . . . -77.36 138.41 63.87 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 112.031 0.382 . . . . 62.23 112.031 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 62' ' ' ALA . 4.6 Cg_exo -77.0 121.44 5.82 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.728 2.285 . . . . 61.44 111.808 175.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.6 tp -55.74 -39.3 70.96 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.914 0.387 . . . . 73.1 111.364 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.29 -45.43 84.13 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.12 -0.491 . . . . 71.32 112.037 175.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.63 -17.56 50.88 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.418 0.628 . . . . 72.44 110.871 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -76.78 -56.15 4.86 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.794 -0.639 . . . . 74.43 111.279 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.7 p -53.22 -52.53 58.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.573 0.583 . . . . 74.54 112.573 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.502 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 42.1 tp -53.31 -54.52 35.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.213 -0.449 . . . . 71.53 111.872 -177.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -61.77 -40.19 94.28 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.443 0.535 . . . . 74.21 112.443 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 87' ' ' LEU . 63.0 tp -62.31 -45.46 93.13 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.326 0.584 . . . . 75.14 110.715 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.79 -30.21 66.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.061 -0.518 . . . . 43.44 112.113 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 75.8 mtp180 -64.59 -49.14 72.31 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.748 0.277 . . . . 51.41 111.748 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.79 -32.88 74.67 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.723 0.297 . . . . 72.12 111.439 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -74.23 -15.43 60.99 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.956 0.408 . . . . 75.41 110.986 173.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.56 27.15 72.99 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.374 -0.441 . . . . 74.41 113.359 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.466 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 22.4 t . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 112.131 0.419 . . . . 70.32 112.131 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 103' ' ' TYR . 66.3 t30 . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.136 0.493 . . . . 53.35 110.74 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.423 ' HA ' ' H ' ' A' ' 104' ' ' GLY . 10.3 p30 -110.34 148.3 32.23 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.448 0.536 . . . . 74.03 112.448 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.468 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 3.6 m-20 58.04 19.35 5.89 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.058 0.762 . . . . 64.11 113.058 174.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 77' ' ' VAL . . . -106.27 132.09 10.96 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.801 -0.714 . . . . 52.32 113.487 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 101' ' ' THR . 46.4 tp -147.17 126.89 13.4 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.023 0.44 . . . . 64.01 111.202 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.488 HD21 HD23 ' A' ' 71' ' ' LEU . 64.1 tp -120.22 134.24 55.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.822 0.344 . . . . 71.34 111.418 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.6 tp -119.41 111.79 18.6 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.175 -0.466 . . . . 61.52 110.75 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.96 130.47 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.799 0.333 . . . . 65.42 111.611 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 135' ' ' LEU . 28.4 tp -110.04 124.42 51.43 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.183 -0.462 . . . . 52.22 111.096 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.407 HG21 HD13 ' A' ' 59' ' ' ILE . 48.0 t -105.07 105.81 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.746 0.307 . . . . 72.33 110.786 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 tp -57.78 -40.29 79.51 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.028 0.381 . . . . 74.41 112.028 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.2 -32.12 71.88 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.255 0.465 . . . . 74.43 112.255 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -105.29 -7.94 18.59 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 122.157 -0.339 . . . . 73.12 111.735 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 95' ' ' ARG . 48.8 mtm180 55.0 33.23 19.8 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.168 0.587 . . . . 75.22 112.531 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -137.54 161.64 35.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.853 0.359 . . . . 73.24 111.455 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.406 HG21 ' CE ' ' A' ' 122' ' ' MET . 7.6 m -131.7 171.93 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.225 -0.443 . . . . 72.04 111.307 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -152.13 133.94 14.82 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.979 0.418 . . . . 60.52 111.894 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 86' ' ' LEU . 97.4 m-85 -95.01 122.3 37.53 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.911 -0.586 . . . . 61.2 110.179 171.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -107.4 112.33 25.08 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.998 -0.371 . . . . 63.11 109.998 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.64 HG23 HD13 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -98.95 148.06 24.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.622 0.725 . . . . 61.33 112.696 -177.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -93.07 172.74 33.93 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.163 -0.926 . . . . 73.42 112.531 170.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' ASN . 55.3 t80 -54.61 -31.29 56.81 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.069 0.548 . . . . 74.54 111.925 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -67.74 -19.23 71.12 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 116.08 -0.509 . . . . 75.13 113.312 -177.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.492 HD11 HG13 ' A' ' 49' ' ' VAL . 91.3 mt -117.58 -5.49 11.18 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.94 0.348 . . . . 72.24 111.94 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -49.79 -44.05 48.75 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.858 0.463 . . . . 73.44 111.836 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.34 -25.41 75.49 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 114.468 0.547 . . . . 73.21 114.468 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -97.96 -35.43 10.47 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.324 0.583 . . . . 75.22 110.88 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HB3' HD21 ' A' ' 114' ' ' LEU . 53.2 mt -126.57 73.45 74.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.366 -0.834 . . . . 73.15 110.701 -177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.04 156.17 52.12 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.075 1.85 . . . . 64.03 112.447 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -46.81 -45.88 20.37 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 112.672 0.619 . . . . 75.41 112.672 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.34 -39.08 96.75 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.399 -0.429 . . . . 74.34 113.537 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.5 tp -67.32 -47.21 71.23 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 122.511 -0.405 . . . . 73.15 111.138 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 109' ' ' LEU . 89.4 mt -58.0 -43.9 86.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.152 -0.476 . . . . 75.34 110.823 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 t -60.35 -41.57 93.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.972 -0.558 . . . . 74.41 110.981 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 116' ' ' ARG . 43.3 ttm105 -57.93 -53.87 53.31 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.176 -0.466 . . . . 74.05 111.52 175.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.0 mt -51.99 -47.4 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.957 0.408 . . . . 61.22 111.215 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 114' ' ' LEU . 80.4 mt -55.72 -50.56 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.07 -0.513 . . . . 73.01 111.39 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.456 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 3.6 t-80 -80.39 -19.28 46.65 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.843 0.683 . . . . 74.14 112.843 -171.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -102.48 -46.74 4.68 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.488 0.922 . . . . 63.43 113.488 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 66.6 mtp180 -106.75 4.26 27.46 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.037 0.754 . . . . 75.21 113.037 -175.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.406 ' CE ' HG21 ' A' ' 97' ' ' VAL . 60.4 mtp -125.33 -51.9 1.63 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.61 0.596 . . . . 73.52 112.61 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.517 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 22.5 mm -51.77 -49.58 82.57 Favored Pre-proline 0 N--CA 1.48 1.029 0 N-CA-C 113.252 0.834 . . . . 65.12 113.252 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 14.7 Cg_endo -55.05 -29.51 65.59 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 122.143 1.896 . . . . 62.24 112.634 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 90.3 m-70 -75.3 -50.61 15.49 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.518 -0.31 . . . . 73.51 110.769 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.454 ' HD1' ' HA ' ' A' ' 131' ' ' TYR . 21.8 m-85 -57.53 -42.3 82.6 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.711 0.291 . . . . 73.42 111.6 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -62.19 -35.54 79.18 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.966 0.412 . . . . 73.23 111.16 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.5 m -83.07 -1.9 53.96 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.207 -0.451 . . . . 75.41 111.921 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.58 -4.77 79.87 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.315 -0.469 . . . . 75.32 113.203 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.5 m-20 -81.36 67.52 7.33 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.526 -0.397 . . . . 72.5 111.418 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.454 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 97.6 m-85 -61.68 -47.83 83.55 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.009 0.433 . . . . 70.13 111.875 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.9 87.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.94 0.4 . . . . 72.44 111.791 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 19.7 mm-40 -67.15 -39.7 86.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.437 -0.347 . . . . 74.43 111.444 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.41 -44.64 95.15 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.898 -0.668 . . . . 55.45 112.611 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 90' ' ' LEU . 95.4 mt -60.96 -45.04 96.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.698 0.285 . . . . 74.43 111.27 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.0 m -55.38 -49.29 72.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.469 -0.332 . . . . 73.15 111.789 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 44.3 mm-40 -65.68 -40.99 92.94 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.969 0.359 . . . . 75.21 111.969 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.76 -50.91 62.55 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 120.934 -0.651 . . . . 72.53 112.733 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 135' ' ' LEU . 97.1 t -59.21 -50.63 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.967 0.413 . . . . 73.12 111.552 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.444 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 58.5 tp -57.5 -45.58 84.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.163 -0.471 . . . . 71.34 111.17 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -57.6 -48.18 80.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.96 0.41 . . . . 72.13 111.628 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.16 -52.38 59.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.222 -0.444 . . . . 70.42 111.638 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -53.81 -42.09 68.03 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.807 0.337 . . . . 65.13 111.392 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 98.6 mt-30 -58.72 -46.69 86.77 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.392 -0.367 . . . . 63.22 111.178 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 141' ' ' ALA . 62.9 t -57.81 -50.11 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.83 0.348 . . . . 73.51 111.134 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.33 -48.27 79.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.431 -0.35 . . . . 73.43 111.72 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.002 0.429 . . . . 44.45 111.386 -179.175 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.7 t . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.173 0.511 . . . . 73.31 112.298 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -97.93 129.27 44.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.084 -0.507 . . . . 73.23 111.257 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 68.1 mttm -105.86 164.18 15.53 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.861 -0.609 . . . . 71.44 110.29 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 31.9 Cg_endo -62.19 -15.0 41.43 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.965 1.777 . . . . 61.52 112.349 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -94.46 -0.83 54.43 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.182 -0.463 . . . . 64.41 111.737 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -97.67 -34.5 10.91 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.017 0.436 . . . . 65.51 110.873 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.69 122.11 65.98 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 115.964 -0.562 . . . . 70.05 111.601 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.62 126.93 19.38 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.728 2.285 . . . . 74.42 112.863 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -75.34 83.47 2.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.486 0.66 . . . . 74.23 111.492 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.57 -26.61 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.902 0.704 . . . . 73.24 112.902 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -61.0 -15.72 35.02 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.249 0.463 . . . . 75.41 112.249 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -75.72 -51.45 12.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.992 0.425 . . . . 72.5 110.338 176.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.65 -69.28 0.78 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.012 0.434 . . . . 63.31 111.561 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 19' ' ' ARG . 3.2 m-20 -80.9 57.07 2.93 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.339 0.59 . . . . 75.32 112.021 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.3 p -65.47 -17.25 64.41 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.163 -0.471 . . . . 75.52 110.99 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.416 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 77.7 p -95.02 3.63 54.68 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.2 -0.455 . . . . 51.43 111.976 176.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 16' ' ' ASP . 13.2 ttm180 -105.34 -53.58 2.63 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.965 0.412 . . . . 53.4 110.7 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp 66.09 1.43 1.93 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.411 0.684 . . . . 63.04 112.705 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.3 t -107.54 140.82 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.904 0.383 . . . . 62.44 111.853 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 m -131.4 103.67 6.57 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.39 -0.368 . . . . 54.31 110.52 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.419 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 12.3 p-10 -100.64 96.5 7.39 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.648 0.737 . . . . 70.21 112.179 -178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -100.72 -44.57 5.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.823 -0.626 . . . . 52.13 110.899 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.84 -24.04 67.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.26 0.467 . . . . 53.2 112.26 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.84 28.74 70.21 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.261 -0.495 . . . . 73.15 113.374 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 92' ' ' LEU . 94.3 mt -86.5 7.38 26.27 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.541 -0.387 . . . . 41.34 111.668 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 135' ' ' LEU . 95.8 mt -116.46 121.94 43.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.458 -0.337 . . . . 74.32 111.543 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.1 m -65.38 146.06 55.38 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.176 -0.305 . . . . 74.22 110.176 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -48.39 -46.27 36.97 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.77 0.656 . . . . 72.24 112.77 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -61.0 -46.7 89.72 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.225 -0.297 . . . . 50.11 111.186 175.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -57.71 -37.88 74.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.62 0.248 . . . . 75.31 111.572 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -54.66 -54.72 38.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.257 0.551 . . . . 63.32 110.347 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -66.29 -42.06 88.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.752 -0.658 . . . . 74.12 111.718 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 31' ' ' ALA . 85.9 t -59.0 -36.64 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.24 0.543 . . . . 45.21 110.851 176.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 42.5 ttm -71.9 -44.55 63.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.47 -0.332 . . . . 72.51 110.711 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -53.15 -54.42 36.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.855 0.36 . . . . 72.54 111.144 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.22 -33.15 57.72 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 116.157 -0.474 . . . . 74.21 113.626 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.539 HH12 ' HB3' ' A' ' 136' ' ' SER . 85.0 mtm180 -75.15 -49.13 20.51 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.643 -0.328 . . . . 75.25 111.567 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.84 -48.88 77.14 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.473 0.654 . . . . 75.35 111.0 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 18' ' ' THR . 33.0 ttp180 -55.8 -42.44 75.62 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.279 -0.873 . . . . 74.23 111.643 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.76 75.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.855 0.359 . . . . 63.1 111.526 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.449 HG22 ' HB ' ' A' ' 49' ' ' VAL . 68.0 mt -61.29 -44.77 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.184 0.516 . . . . 73.43 111.241 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.622 ' HE ' ' HG2' ' A' ' 50' ' ' GLU . 1.5 tmt_? -61.9 -33.1 73.62 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.813 -0.63 . . . . 74.31 110.784 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.9 t -78.24 -48.6 15.41 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.976 0.361 . . . . 75.3 111.976 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.2 t -84.06 -68.03 0.75 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.04 0.385 . . . . 65.42 112.04 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -69.97 -13.6 62.31 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 111.767 0.284 . . . . 72.32 111.767 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 66.15 14.88 9.86 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.856 0.462 . . . . 51.24 111.916 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.694 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 61.6 t -84.42 115.8 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.324 -0.398 . . . . 72.31 110.914 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.622 ' HG2' ' HE ' ' A' ' 44' ' ' ARG . 36.8 mt-10 -76.31 95.58 3.8 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.335 0.588 . . . . 72.24 110.22 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.68 104.3 13.27 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.441 -0.799 . . . . 54.11 110.313 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.01 142.53 39.54 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.266 0.469 . . . . 70.31 112.266 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.6 t -123.22 126.33 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.003 0.43 . . . . 65.24 111.291 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.42 139.4 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 122.622 0.369 . . . . 70.1 111.076 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 76.7 p -121.04 122.63 40.5 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.817 0.342 . . . . 60.44 111.474 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -129.19 142.25 44.56 Favored Pre-proline 0 N--CA 1.471 0.624 0 CA-C-N 116.531 -0.304 . . . . 72.21 111.144 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.89 -55.57 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.268 1.979 . . . . 63.34 112.348 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.0 p -151.07 147.02 26.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.625 0.25 . . . . 74.5 111.305 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.7 pt -116.89 9.2 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.097 0.475 . . . . 75.44 111.819 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.23 -138.2 32.31 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.117 -0.563 . . . . 62.2 112.938 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -92.71 15.26 14.89 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.519 -0.401 . . . . 63.05 111.989 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.89 131.07 76.97 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.651 -0.25 . . . . 74.21 111.186 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.592 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 56.7 Cg_endo -71.7 125.51 11.18 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.259 1.972 . . . . 74.43 112.538 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.5 tp -62.37 -38.33 89.14 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.582 0.586 . . . . 73.24 112.582 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 12.5 mp0 -61.32 -39.04 89.06 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.761 0.791 . . . . 74.3 110.759 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.592 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 2.0 m-20 -76.64 -37.02 57.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.041 -0.981 . . . . 71.12 110.918 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -55.05 -52.68 62.43 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.753 -0.658 . . . . 74.44 110.85 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.5 p -62.18 -36.46 81.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.974 -0.557 . . . . 64.22 111.966 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.2 tp -57.01 -50.32 73.1 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.128 0.489 . . . . 51.43 110.711 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -59.12 -50.33 74.47 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.094 -0.503 . . . . 53.53 111.756 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.475 HD23 HD21 ' A' ' 87' ' ' LEU . 27.9 tp -64.67 -42.58 95.27 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.989 0.423 . . . . 64.33 111.451 -176.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.5 93.83 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.855 0.36 . . . . 73.01 111.514 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -62.28 -52.47 63.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.466 -0.334 . . . . 74.12 111.771 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 10.3 pt20 -63.43 -28.01 69.69 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.907 0.336 . . . . 72.12 111.907 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.407 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 44.9 m0 -86.61 -2.64 58.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.335 0.495 . . . . 71.5 112.335 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.16 12.18 68.38 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.917 -0.659 . . . . 72.45 113.416 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 41.3 t . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 120.996 0.426 . . . . 73.3 110.91 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 42.9 t30 . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 120.615 0.245 . . . . 63.42 110.624 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.48 -97.36 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 O-C-N 121.958 -0.464 . . . . 72.4 112.217 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.694 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.2 m-20 -77.51 77.19 4.04 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.982 -0.449 . . . . 72.41 111.438 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.78 130.93 4.39 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.996 -0.621 . . . . 42.43 113.315 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.2 tp -144.51 123.05 12.45 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.933 0.396 . . . . 74.2 110.964 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.475 HD21 HD23 ' A' ' 71' ' ' LEU . 61.7 tp -112.97 135.11 54.1 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.864 0.364 . . . . 52.33 111.402 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 55.8 tp -124.98 120.81 32.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.695 0.398 . . . . 63.45 110.956 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 87.0 t -125.21 126.99 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.844 0.354 . . . . 75.24 111.53 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.504 HD22 HD11 ' A' ' 135' ' ' LEU . 29.6 tp -101.44 120.08 39.74 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.119 -0.491 . . . . 75.42 111.335 178.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.9 t -104.61 102.28 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.867 0.365 . . . . 73.43 111.157 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 27' ' ' LEU . 61.7 tp -56.87 -35.06 68.47 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.221 -0.445 . . . . 62.24 111.895 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -51.2 -36.49 41.65 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.832 0.679 . . . . 74.25 112.832 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -129.2 3.49 5.21 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.153 0.427 . . . . 74.11 112.153 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 57.37 20.82 6.24 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.939 0.399 . . . . 63.13 112.021 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -94.76 141.07 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 74.12 111.364 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.66 HG21 ' SD ' ' A' ' 122' ' ' MET . 4.4 m -129.89 144.66 37.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.769 -0.651 . . . . 74.33 110.497 177.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 14.6 tpt180 -121.32 128.48 52.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.856 0.36 . . . . 71.51 111.707 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.62 ' HB3' HD13 ' A' ' 114' ' ' LEU . 71.8 m-85 -100.69 102.29 13.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.089 -0.505 . . . . 73.41 109.755 171.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -98.51 112.88 24.77 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.898 0.38 . . . . 63.12 112.008 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.5 p -102.02 152.37 21.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.522 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.62 -95.44 0.61 Allowed Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.786 -0.721 . . . . 53.34 111.905 171.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -142.72 -23.56 0.64 Allowed 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.526 -0.397 . . . . 72.33 111.715 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.32 -29.61 75.68 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.858 -0.687 . . . . 74.44 113.3 -176.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.583 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 86.8 mt -92.93 0.32 57.38 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.447 0.536 . . . . 75.41 112.447 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -62.34 -19.99 63.92 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.003 0.43 . . . . 73.5 111.548 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.6 11.62 68.27 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.283 -0.484 . . . . 75.22 113.13 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.583 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 34.8 m-85 -136.58 -57.47 0.74 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.469 0.652 . . . . 74.0 110.355 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.492 ' HB3' HD21 ' A' ' 114' ' ' LEU . 12.2 mt -118.56 79.49 15.94 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.11 -0.95 . . . . 74.13 111.25 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.89 146.54 94.96 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.183 1.922 . . . . 73.05 112.714 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -51.28 -32.67 25.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 116.155 -0.475 . . . . 51.34 111.301 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.12 -44.82 75.2 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.36 -0.448 . . . . 73.12 113.143 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 tp -60.55 -49.69 76.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.207 0.527 . . . . 73.14 110.873 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 99' ' ' PHE . 76.7 mt -56.93 -37.28 71.27 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.712 -0.676 . . . . 61.23 111.191 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.6 t -56.79 -46.85 81.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.122 -0.49 . . . . 52.25 111.383 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -65.11 -41.59 94.77 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.944 -0.302 . . . . 70.31 111.18 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.581 HG23 ' HD3' ' A' ' 121' ' ' ARG . 65.4 mt -50.34 -39.67 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.038 0.447 . . . . 75.2 111.19 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 122' ' ' MET . 62.3 mt -60.35 -51.01 77.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.007 -0.542 . . . . 75.41 111.363 175.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.416 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 4.9 m80 -81.56 -19.1 42.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.821 0.674 . . . . 73.11 112.821 -175.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.511 ' HB3' ' HD2' ' A' ' 121' ' ' ARG . 9.3 t70 -83.36 -49.09 9.7 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.109 0.411 . . . . 72.4 112.109 -173.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.581 ' HD3' HG23 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -119.18 -31.25 4.75 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.155 0.798 . . . . 74.44 113.155 -177.3 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.66 ' SD ' HG21 ' A' ' 97' ' ' VAL . 37.0 mtt -73.28 -56.71 4.71 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.967 0.729 . . . . 53.25 112.967 -176.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.503 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 44.4 mm -50.58 -52.14 58.56 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.954 0.724 . . . . 73.21 112.954 -176.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 10.3 Cg_endo -52.23 -29.58 38.43 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.237 1.958 . . . . 72.24 113.254 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -84.15 -48.19 10.09 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.925 0.343 . . . . 74.31 111.925 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.2 m-85 -55.78 -46.64 77.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.279 0.561 . . . . 75.43 111.34 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -65.48 -17.04 64.26 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.727 -0.669 . . . . 73.24 111.722 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.2 t -90.05 -13.59 35.6 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.12 -0.491 . . . . 71.44 110.939 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.71 -0.61 61.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.982 -0.447 . . . . 72.13 111.982 -172.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.809 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.57 68.04 10.29 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.96 0.504 . . . . 74.31 111.202 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.406 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 96.1 m-85 -70.8 -48.24 55.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.661 0.267 . . . . 72.3 111.701 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.338 0.589 . . . . 61.31 111.289 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.809 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 9.2 tp10 -61.6 -50.19 73.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.578 -0.737 . . . . 71.15 110.884 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.81 -47.21 91.62 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.21 -0.45 . . . . 62.02 113.6 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 90' ' ' LEU . 90.9 mt -57.72 -44.53 86.04 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 122.585 -0.362 . . . . 71.32 111.285 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.539 ' HB3' HH12 ' A' ' 39' ' ' ARG . 43.7 m -60.18 -44.06 95.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.474 -0.33 . . . . 71.54 111.557 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -61.07 -40.2 92.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.775 0.321 . . . . 71.43 111.5 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.22 -51.32 57.49 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.944 -0.646 . . . . 55.03 112.835 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.21 -46.6 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.206 0.527 . . . . 72.24 111.265 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.425 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 47.8 tp -59.7 -39.42 84.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.847 -0.615 . . . . 74.21 111.413 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -62.52 -50.5 71.1 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.922 0.392 . . . . 71.55 111.158 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.26 -48.5 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.112 0.482 . . . . 52.52 111.106 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -51.28 -40.37 58.79 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.8 -0.636 . . . . 73.12 111.751 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 79.8 mt-30 -69.74 -42.55 73.79 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 111.948 0.351 . . . . 73.44 111.948 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ALA . 57.4 t -58.34 -50.8 77.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.803 0.335 . . . . 73.31 111.617 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.3 mt -53.21 -48.1 68.38 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.454 -0.339 . . . . 53.04 111.794 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 120.935 0.398 . . . . 75.42 112.025 -179.224 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 120.907 0.384 . . . . 72.22 111.69 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -94.08 139.94 30.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.268 0.556 . . . . 65.01 112.072 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 56.8 mtpt -111.71 163.25 18.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.714 -0.675 . . . . 72.5 110.012 173.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 16.5 Cg_endo -55.38 -23.73 39.75 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.392 2.062 . . . . 71.21 112.854 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.34 -22.81 38.18 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.22 -0.446 . . . . 74.44 111.839 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -91.76 -19.69 22.32 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.83 0.347 . . . . 72.45 111.599 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.29 120.73 80.19 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.488 -0.324 . . . . 71.33 111.213 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.47 111.2 0.69 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.667 2.245 . . . . 73.13 112.978 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -70.81 82.57 0.64 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.346 0.593 . . . . 74.22 110.832 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.82 -28.31 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.414 0.524 . . . . 72.41 112.414 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -72.15 -24.53 61.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.893 0.378 . . . . 74.51 111.842 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 14' ' ' LEU . 6.7 tt -75.57 -39.71 57.72 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.19 -0.67 . . . . 73.22 109.19 171.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.86 -80.13 0.08 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.863 -0.608 . . . . 64.34 112.16 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -121.93 109.03 14.12 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.661 0.267 . . . . 74.01 111.584 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 p -59.12 -24.9 63.38 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.857 0.361 . . . . 73.23 111.765 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.4 m -61.78 -26.36 68.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.399 -0.364 . . . . 70.12 111.517 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -114.6 112.68 23.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.221 0.534 . . . . 74.31 110.954 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 4.6 mp -101.5 7.59 42.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.075 -0.511 . . . . 62.34 110.751 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 16.4 t -119.5 116.47 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.64 0.607 . . . . 73.01 112.64 -172.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.0 m -104.44 105.79 16.04 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.402 -0.363 . . . . 54.13 111.157 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 30.2 t70 -96.56 101.67 13.32 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.081 0.467 . . . . 70.13 111.345 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.52 ' HB2' HD23 ' A' ' 56' ' ' LEU . 27.7 mm-40 -103.77 -39.55 6.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.003 0.43 . . . . 64.44 111.065 177.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.85 -21.58 57.12 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.913 0.709 . . . . 65.41 112.913 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.22 55.46 5.16 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.938 -0.649 . . . . 64.23 112.486 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -122.13 -47.76 2.13 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.873 0.368 . . . . 74.33 111.466 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.4 HD21 HD12 ' A' ' 135' ' ' LEU . 96.2 mt -74.22 115.24 13.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.136 0.493 . . . . 63.43 111.931 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 90.8 p -71.1 162.07 30.06 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.018 -0.537 . . . . 71.53 111.241 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -53.49 -35.51 60.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.123 0.487 . . . . 65.41 110.872 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.69 -48.48 69.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.932 -0.576 . . . . 74.45 111.244 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -60.46 -42.73 96.77 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.574 0.226 . . . . 74.31 111.59 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.01 -44.84 95.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.776 0.322 . . . . 72.43 110.926 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -54.57 -55.18 32.05 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.031 0.443 . . . . 74.22 111.238 177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.89 -46.08 97.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.897 -0.592 . . . . 51.14 111.811 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.522 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 50.0 ttm -66.84 -52.12 47.51 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.529 -0.305 . . . . 72.31 111.742 -176.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -62.88 -37.67 87.85 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.407 0.146 . . . . 74.15 111.236 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.67 -48.24 85.89 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.006 -0.616 . . . . 62.25 112.532 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 48.1 mtp180 -64.0 -47.55 79.85 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.308 0.243 . . . . 61.3 111.608 177.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 36' ' ' MET . 85.4 mt -58.57 -52.72 64.47 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.129 0.49 . . . . 63.12 111.361 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -60.18 -34.87 74.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.027 -0.533 . . . . 75.45 110.862 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.21 96.89 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.845 0.355 . . . . 52.54 111.143 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 49' ' ' VAL . 70.8 mt -62.25 -42.27 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.488 -0.324 . . . . 75.52 110.78 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 28.1 tpt180 -61.51 -37.63 84.42 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.989 0.423 . . . . 62.11 111.088 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.4 m -70.11 -31.51 69.1 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.129 0.418 . . . . 65.4 112.129 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.6 t -98.72 -64.54 1.03 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.004 0.372 . . . . 51.34 112.004 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -87.5 -10.56 51.43 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.5 0.556 . . . . 71.33 112.5 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 69.08 3.46 4.07 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.312 0.486 . . . . 74.23 112.312 -176.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.851 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 93.2 t -64.45 122.62 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 121.008 0.432 . . . . 75.33 111.459 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -88.84 95.54 10.33 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.3 0.572 . . . . 75.22 109.865 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -113.17 102.7 10.62 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.646 -0.706 . . . . 74.24 111.013 -172.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -105.17 145.86 30.01 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.356 0.502 . . . . 74.33 112.356 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 61.3 t -124.23 138.3 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.394 -0.366 . . . . 75.34 110.933 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.1 t -133.29 143.31 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 122.231 -0.293 . . . . 53.23 111.118 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 28.4 p -125.54 123.15 38.5 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.803 0.335 . . . . 71.42 110.752 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 24' ' ' GLU . 81.8 mt -127.39 143.22 46.48 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 122.245 -0.284 . . . . 75.52 111.515 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.74 -61.48 0.28 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.598 2.199 . . . . 75.04 112.519 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.8 p -149.35 146.41 27.5 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.973 0.416 . . . . 72.13 112.046 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.471 HG12 HG11 ' A' ' 91' ' ' VAL . 31.9 pt -110.6 5.0 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.957 -0.565 . . . . 73.32 110.682 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.92 -120.4 22.02 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.886 -0.597 . . . . 73.3 113.526 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -97.83 4.86 49.65 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.895 0.378 . . . . 72.42 111.788 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.46 140.44 92.47 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 120.672 0.272 . . . . 74.23 111.731 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.662 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.5 Cg_endo -75.99 125.86 8.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.321 2.014 . . . . 75.34 112.518 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.3 tp -58.62 -42.01 87.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.046 0.451 . . . . 71.4 111.711 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.73 -59.68 4.19 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.875 -0.602 . . . . 74.22 111.057 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.662 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 3.3 m-20 -62.97 -41.53 99.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.705 -0.68 . . . . 64.13 111.627 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -53.62 -49.96 66.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.274 -0.421 . . . . 64.34 111.763 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.3 p -57.48 -48.86 78.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.412 -0.358 . . . . 75.44 111.891 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.4 -45.42 88.39 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.844 0.354 . . . . 65.23 111.712 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 66' ' ' ASP . 31.7 mmmt -56.25 -45.51 80.02 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.999 0.428 . . . . 54.44 111.661 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.418 HD23 HD21 ' A' ' 87' ' ' LEU . 52.3 tp -73.42 -38.13 65.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.214 0.53 . . . . 73.14 111.297 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.81 -35.45 72.87 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.292 -0.413 . . . . 72.2 112.103 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -61.31 -53.91 50.66 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.321 0.489 . . . . 73.02 112.321 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.628 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 7.2 pt20 -67.06 -27.44 67.38 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.383 0.512 . . . . 64.52 112.383 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.628 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 16.3 m0 -80.74 -12.22 59.49 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.884 0.328 . . . . 74.42 111.884 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.76 -2.16 66.57 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.266 -0.492 . . . . 74.24 114.029 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.543 0.674 0 N-CA-C 112.714 0.635 . . . . 64.12 112.714 -177.474 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.439 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 23.0 t-20 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 121.244 0.545 . . . . 73.2 111.064 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.634 ' HA ' ' H ' ' A' ' 104' ' ' GLY . 28.1 p-10 -51.38 -64.29 0.86 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 112.772 0.656 . . . . 73.51 112.772 177.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.851 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 18.3 m120 -88.02 8.16 27.86 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.683 -0.636 . . . . 75.31 112.146 -177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.99 124.62 9.23 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 114.735 0.654 . . . . 75.34 114.735 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 99' ' ' PHE . 50.9 tp -144.23 119.59 10.26 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.705 0.402 . . . . 71.3 110.755 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.6 tp -110.99 135.44 51.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.817 0.341 . . . . 74.4 111.564 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -120.84 108.14 13.57 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.741 0.305 . . . . 74.23 110.863 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.0 t -108.5 120.15 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.075 0.398 . . . . 75.15 112.075 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.548 ' HB2' HD21 ' A' ' 135' ' ' LEU . 29.2 tp -100.1 129.4 46.13 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.014 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.471 HG11 HG12 ' A' ' 59' ' ' ILE . 44.2 t -116.98 107.79 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.462 -0.335 . . . . 65.11 110.683 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.1 tp -53.47 -44.36 68.91 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.044 0.449 . . . . 71.52 111.504 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -57.64 -33.5 68.36 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.95 -0.568 . . . . 71.2 112.265 177.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -92.66 -11.95 32.82 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 122.241 -0.287 . . . . 72.11 111.62 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 54.64 29.05 10.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.995 0.518 . . . . 73.41 111.891 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -149.81 173.53 13.64 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.09 0.471 . . . . 70.02 111.908 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.535 HG21 ' SD ' ' A' ' 122' ' ' MET . 8.9 m -135.41 171.93 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.877 -0.601 . . . . 70.13 111.056 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -145.8 141.52 28.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.926 0.393 . . . . 73.42 111.532 168.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.67 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 79.0 m-85 -98.36 124.9 43.27 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.887 -0.597 . . . . 71.22 110.373 172.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.99 119.25 38.92 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.275 -0.266 . . . . 73.41 110.726 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.591 HG23 HD11 ' A' ' 114' ' ' LEU . 18.5 p -98.19 139.11 34.47 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.03 0.443 . . . . 75.22 111.847 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -68.39 -80.84 0.21 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.582 -0.818 . . . . 54.32 112.297 173.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -155.66 -43.62 0.08 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.934 0.397 . . . . 74.32 112.044 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.634 ' H ' ' HA ' ' A' ' 83' ' ' ASN . . . -62.13 -41.76 99.71 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.516 -0.374 . . . . 62.13 113.617 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 88.2 mt -71.15 -3.08 18.13 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.251 0.834 . . . . 72.34 113.251 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -60.85 -15.49 30.89 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.939 -0.476 . . . . 70.11 112.03 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.7 1.18 80.95 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.177 -0.535 . . . . 62.05 113.301 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -136.94 -54.36 0.71 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.332 0.587 . . . . 74.02 111.452 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.423 ' HB3' HD21 ' A' ' 114' ' ' LEU . 14.6 mt -117.25 86.62 21.67 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.578 -0.737 . . . . 73.44 111.821 -174.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.39 159.0 22.78 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.332 2.021 . . . . 75.43 112.529 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.435 ' HA ' HD12 ' A' ' 114' ' ' LEU . 14.3 t70 -45.91 -40.22 9.82 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 120.977 0.417 . . . . 65.22 111.746 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.03 72.11 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.336 -0.459 . . . . 43.51 113.284 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.26 -40.2 96.74 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.03 0.443 . . . . 75.23 111.095 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.67 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 86.1 mt -57.66 -48.17 80.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.052 -0.522 . . . . 72.34 111.127 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.4 t -69.08 -34.48 75.19 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.106 0.479 . . . . 63.33 110.804 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 116' ' ' ARG . 15.4 ttm180 -56.56 -53.92 51.93 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.904 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.12 -41.69 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.027 0.441 . . . . 63.14 111.528 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.482 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 60.4 mt -58.61 -54.51 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.165 0.507 . . . . 64.42 110.888 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -75.1 -14.9 60.62 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.28 -0.418 . . . . 70.33 112.008 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -79.21 -53.04 7.36 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.226 0.454 . . . . 74.33 112.226 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -133.72 -23.68 1.79 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.202 0.816 . . . . 73.2 113.202 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.535 ' SD ' HG21 ' A' ' 97' ' ' VAL . 36.4 mtt -67.56 -53.6 26.96 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.509 0.559 . . . . 74.32 112.509 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 118' ' ' ILE . 47.7 mm -51.38 -53.63 47.44 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 112.85 0.685 . . . . 74.45 112.85 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 10.5 Cg_endo -53.58 -41.98 69.44 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.989 1.793 . . . . 74.32 112.623 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.475 ' CD2' ' HG3' ' A' ' 137' ' ' GLU . 60.5 m-70 -64.47 -50.68 66.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.279 -0.263 . . . . 75.53 111.491 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.6 m-85 -56.4 -45.25 80.72 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.854 0.359 . . . . 73.54 111.431 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 58.6 mtp180 -62.49 -34.82 77.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.963 0.411 . . . . 75.12 110.988 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.6 m -80.82 -4.44 54.69 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.104 -0.498 . . . . 62.31 111.87 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.7 -8.44 63.78 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.517 -0.373 . . . . 34.11 113.601 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.781 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.4 m-20 -78.81 72.41 5.33 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 122.327 -0.513 . . . . 62.23 112.139 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -71.45 -56.13 6.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.018 0.437 . . . . 65.01 111.177 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.91 89.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.184 -0.462 . . . . 72.14 111.468 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.781 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 9.4 tp10 -68.56 -46.43 69.48 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.17 -0.468 . . . . 63.1 110.768 176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.84 -41.75 67.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.579 -0.343 . . . . 52.15 113.267 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 90' ' ' LEU . 83.4 mt -60.65 -48.79 80.2 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.888 0.375 . . . . 75.24 111.178 175.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -60.56 -38.85 85.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.326 -0.397 . . . . 74.5 110.941 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.475 ' HG3' ' CD2' ' A' ' 125' ' ' HIS . 15.7 mm-40 -58.44 -51.37 70.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.173 -0.467 . . . . 60.44 111.503 175.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.439 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -58.76 -47.94 87.71 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.9 -0.667 . . . . 75.34 112.444 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.29 -39.68 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.968 0.413 . . . . 74.11 111.218 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.431 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 27.9 tp -70.88 -33.99 71.15 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.381 -0.372 . . . . 72.02 110.667 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.52 -50.79 57.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.847 0.356 . . . . 74.2 110.86 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.7 t -57.47 -47.34 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.116 0.484 . . . . 65.1 110.535 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -53.81 -46.91 71.24 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.051 -0.522 . . . . 74.14 111.82 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 27.3 mt-30 -57.42 -38.1 73.82 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.841 0.353 . . . . 71.41 111.426 177.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.98 -49.08 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.707 0.289 . . . . 72.23 111.029 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.36 -58.21 4.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.867 0.321 . . . . 72.3 111.867 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 121.045 0.45 . . . . 63.21 111.845 178.383 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 121.044 0.449 . . . . 74.14 111.754 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -91.59 141.17 29.0 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.109 0.48 . . . . 75.01 111.405 174.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.503 ' HB2' ' NZ ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -111.45 158.35 36.52 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 116.316 -0.402 . . . . 52.04 110.647 175.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 64.4 Cg_endo -70.93 19.31 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.819 2.346 . . . . 63.22 114.541 -173.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.498 ' OE2' ' HB2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -126.38 -12.07 6.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.756 0.313 . . . . 62.11 111.657 173.355 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -97.45 -19.27 18.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.947 0.403 . . . . 54.01 111.121 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.21 130.92 84.04 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.322 -0.399 . . . . 54.24 111.412 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.04 110.84 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.828 2.352 . . . . 54.32 113.173 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -70.96 98.0 1.53 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.215 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 13' ' ' GLN . 27.8 m -93.26 -50.25 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 113.495 0.924 . . . . 53.2 113.495 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.575 ' HG3' HG21 ' A' ' 77' ' ' VAL . 15.1 mm100 -53.77 -33.75 56.85 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.654 1.353 . . . . 63.14 114.654 -169.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.428 ' H ' ' CD2' ' A' ' 14' ' ' LEU . 1.6 pt? -77.48 5.34 9.1 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.617 0.599 . . . . 62.44 112.617 -175.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.02 -51.56 0.06 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.196 0.522 . . . . 75.32 111.498 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -83.14 47.67 1.27 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.3 -0.409 . . . . 64.22 111.256 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 m -61.0 -11.79 9.32 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.689 0.626 . . . . 74.41 112.689 -176.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -77.71 -30.7 51.91 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.176 0.512 . . . . 65.1 110.635 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.47 ' HA ' ' OD1' ' A' ' 37' ' ' ASN . 13.0 ttm105 -108.34 95.04 5.39 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.452 0.644 . . . . 74.31 110.761 175.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 20' ' ' LEU . 3.9 mp -88.89 13.6 12.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.812 -0.631 . . . . 73.21 111.04 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.54 127.36 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.326 -0.397 . . . . 63.22 111.773 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.0 m -121.1 103.16 8.81 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.439 -0.346 . . . . 73.24 110.619 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.4 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 24.1 t70 -99.51 101.99 13.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.989 0.424 . . . . 73.35 111.495 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HB2' HD23 ' A' ' 56' ' ' LEU . 23.6 mm-40 -103.0 -34.42 8.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.214 0.53 . . . . 71.52 110.714 176.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.32 -28.26 69.08 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.51 0.559 . . . . 71.15 112.51 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.68 28.43 51.36 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.886 -0.673 . . . . 71.12 112.432 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.51 -17.2 22.64 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.824 0.345 . . . . 63.43 111.319 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.4 mt -107.62 114.19 28.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.924 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 t -65.93 152.73 43.86 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.341 -0.224 . . . . 63.54 110.467 175.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -45.03 -51.78 9.61 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.854 0.687 . . . . 74.23 112.854 -174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -60.28 -50.26 74.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.646 0.26 . . . . 71.12 111.452 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -58.09 -39.87 79.68 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.177 0.513 . . . . 71.31 111.426 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -50.73 71.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.906 -0.588 . . . . 74.14 110.621 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.06 -30.75 71.8 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.724 0.297 . . . . 61.23 111.371 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 31' ' ' ALA . 74.8 t -62.01 -46.37 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.951 0.405 . . . . 63.33 110.35 172.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.708 ' SD ' HG21 ' A' ' 139' ' ' VAL . 51.7 tpp -60.3 -43.85 95.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.422 -0.354 . . . . 75.24 110.356 175.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.552 ' HB3' ' NH2' ' A' ' 41' ' ' ARG . 60.3 m-80 -56.74 -38.19 72.04 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.468 -0.333 . . . . 73.2 110.658 173.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.6 -46.32 94.65 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.887 -0.673 . . . . 41.23 112.203 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' A' ' 39' ' ' ARG . 1.5 mmp_? -57.61 -55.74 30.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.023 0.44 . . . . 63.43 111.174 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.87 -45.58 91.9 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.099 -0.5 . . . . 73.12 112.098 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' NH2' ' HB3' ' A' ' 37' ' ' ASN . 36.3 ttm180 -62.15 -40.75 97.03 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.018 0.527 . . . . 74.15 110.929 -178.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.64 -46.52 89.42 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.338 -0.392 . . . . 54.21 111.011 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.435 HG22 ' HB ' ' A' ' 49' ' ' VAL . 76.1 mt -59.79 -44.7 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.124 0.488 . . . . 64.23 110.96 175.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 31.7 tpt180 -62.42 -26.81 68.69 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.097 -0.501 . . . . 71.22 111.76 177.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.1 m -84.84 -54.06 4.93 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.148 0.499 . . . . 72.0 110.76 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.2 m -71.91 -56.9 4.87 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.719 -0.673 . . . . 72.21 112.42 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -96.32 -10.57 27.51 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.115 0.413 . . . . 72.54 112.115 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 70.55 1.47 3.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.974 0.731 . . . . 70.1 112.974 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 43' ' ' ILE . 99.2 t -66.59 132.09 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 112.352 0.501 . . . . 65.25 112.352 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.448 ' HB3' HG13 ' A' ' 77' ' ' VAL . 44.3 mt-10 -82.18 96.74 7.93 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.08 0.466 . . . . 74.13 110.533 174.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -119.11 108.72 15.04 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.507 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.47 146.02 42.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.875 0.369 . . . . 31.51 111.971 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.4 t -128.38 121.74 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.831 0.348 . . . . 65.5 111.418 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.7 t -121.78 132.37 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 122.325 0.25 . . . . 75.24 111.419 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 30.7 p -116.59 123.06 46.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.927 0.394 . . . . 52.33 111.288 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.424 HD11 ' CZ ' ' A' ' 67' ' ' PHE . 83.8 mt -118.16 145.24 36.55 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-O 120.788 0.328 . . . . 74.41 111.37 177.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.95 -43.01 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.535 2.157 . . . . 72.34 112.354 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.912 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 23.8 m -153.14 143.47 22.46 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.055 0.391 . . . . 62.42 112.055 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 35.8 pt -128.67 -14.38 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.083 0.468 . . . . 74.54 110.653 172.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.04 -117.32 8.45 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.236 -0.438 . . . . 35.34 113.725 174.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.42 2.67 46.87 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.815 0.302 . . . . 53.35 111.815 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -72.88 120.88 83.26 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 111.524 0.194 . . . . 64.04 111.524 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 31.8 Cg_endo -64.48 137.06 53.41 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.443 2.095 . . . . 72.13 112.654 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.97 -49.08 40.34 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.236 0.458 . . . . 72.44 112.236 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.26 -32.85 73.61 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.998 0.428 . . . . 74.12 111.849 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.593 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 3.4 m-20 -74.21 -38.55 63.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.89 0.376 . . . . 71.13 111.016 173.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.424 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 48.6 t80 -56.77 -54.15 49.68 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.995 0.426 . . . . 74.42 111.062 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.493 ' OG1' ' NH1' ' A' ' 98' ' ' ARG . 40.7 p -51.84 -42.48 62.62 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.959 -0.564 . . . . 75.04 111.441 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.3 tp -58.42 -54.8 42.89 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.133 -0.485 . . . . 73.25 111.657 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 14.9 mmmm -66.67 -42.29 86.77 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.628 0.603 . . . . 62.13 112.628 -173.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.3 tp -68.57 -47.98 65.4 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.207 0.527 . . . . 73.31 111.261 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.529 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -68.55 -31.04 69.98 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.453 0.538 . . . . 62.35 112.453 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 70' ' ' LYS . 13.3 ptm180 -70.67 -38.95 73.79 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.092 -0.243 . . . . 62.5 111.436 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.529 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 10.6 pt20 -72.51 -24.69 61.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.044 0.45 . . . . 53.41 110.811 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.529 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 39.6 m0 -88.69 -17.2 30.47 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.487 -0.324 . . . . 73.32 111.221 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.64 38.08 95.71 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.472 -0.394 . . . . 74.4 113.613 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.575 HG21 ' HG3' ' A' ' 13' ' ' GLN . 45.0 t . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 112.173 0.434 . . . . 71.22 112.173 -176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 103' ' ' TYR . 3.5 m-20 . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 121.242 0.544 . . . . 63.04 112.053 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -97.36 -139.44 0.28 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.13 -0.486 . . . . 73.22 111.137 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.547 ' HA ' ' HG ' ' A' ' 105' ' ' LEU . 7.3 p30 -69.12 43.88 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.322 0.86 . . . . 52.44 113.322 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -92.49 140.39 15.09 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.934 -0.651 . . . . 61.42 112.74 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 99' ' ' PHE . 52.0 tp -143.05 119.74 11.14 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.871 0.367 . . . . 64.11 111.03 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 72' ' ' ALA . 58.4 tp -111.94 122.32 47.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.836 0.351 . . . . 65.52 111.216 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.3 tp -109.97 106.2 15.65 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.307 -0.406 . . . . 75.21 110.745 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 59.9 t -107.06 117.4 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 111.925 0.343 . . . . 73.11 111.925 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.487 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.9 tp -96.88 122.27 39.66 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.305 -0.407 . . . . 72.22 110.677 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.457 HG11 HG12 ' A' ' 59' ' ' ILE . 61.0 t -111.04 102.9 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.665 0.269 . . . . 71.31 111.176 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.5 tp -51.86 -41.74 62.08 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.0 0.428 . . . . 72.34 111.367 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.912 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 19.1 t0 -45.76 -43.16 12.82 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.5 0.72 . . . . 70.02 112.451 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.401 ' NE2' HD11 ' A' ' 59' ' ' ILE . 49.3 mt-30 -106.19 -6.79 18.26 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 111.906 0.336 . . . . 71.11 111.906 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.404 ' NH2' ' O ' ' A' ' 126' ' ' PHE . 77.9 mtp180 55.23 26.84 8.9 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.732 0.777 . . . . 73.51 110.509 -174.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -112.75 164.24 13.61 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.171 -0.922 . . . . 64.42 111.528 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.668 HG21 ' SD ' ' A' ' 122' ' ' MET . 11.1 m -137.42 171.75 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.025 -0.534 . . . . 61.22 110.511 172.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.493 ' NH1' ' OG1' ' A' ' 68' ' ' THR . 38.5 ttt-85 -153.04 142.82 22.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.788 0.327 . . . . 70.01 111.621 172.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HD11 ' A' ' 86' ' ' LEU . 95.1 m-85 -101.22 118.05 36.21 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.045 -0.525 . . . . 74.33 110.659 173.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.451 ' CD ' HH12 ' A' ' 98' ' ' ARG . 5.6 tp10 -105.64 112.6 25.74 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 110.346 -0.242 . . . . 74.42 110.346 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.8 p -103.27 158.89 16.01 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.791 0.805 . . . . 74.32 113.038 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.5 -175.65 25.04 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 114.907 -1.042 . . . . 73.42 111.464 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.423 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -61.83 -24.17 66.72 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.405 -0.468 . . . . 74.04 112.009 -176.142 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.4 -20.27 79.64 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.928 -0.653 . . . . 74.45 113.203 -173.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HG ' ' HA ' ' A' ' 84' ' ' ASN . 91.8 mt -109.11 -7.5 15.31 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.407 0.521 . . . . 75.22 112.407 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -56.4 -25.72 50.95 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.11 0.411 . . . . 65.32 112.11 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.79 -21.26 59.89 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.169 -0.539 . . . . 31.54 113.62 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 82.0 m-85 -102.42 -53.74 2.83 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.268 0.556 . . . . 72.21 111.409 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -113.77 87.97 13.17 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.485 -0.78 . . . . 70.2 111.418 -173.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 108' ' ' TYR . 6.5 Cg_exo -73.99 161.63 40.75 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.396 2.064 . . . . 52.15 112.34 176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -51.45 -44.09 62.26 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.167 0.432 . . . . 72.44 112.167 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.51 -45.13 94.94 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.227 -0.511 . . . . 65.24 113.198 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.12 -42.94 99.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.767 0.318 . . . . 65.33 111.164 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.0 -44.75 91.72 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.012 0.434 . . . . 64.34 110.827 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.7 m -61.91 -36.63 81.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.086 -0.506 . . . . 74.22 111.053 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -60.9 -56.38 21.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.215 -0.448 . . . . 73.11 111.59 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.5 mt -50.63 -43.43 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.902 0.382 . . . . 72.44 111.684 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' ' 122' ' ' MET . 64.3 mt -61.23 -51.31 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.296 -0.411 . . . . 74.01 111.754 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.463 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 25.1 m-70 -74.02 -48.17 31.99 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.025 0.75 . . . . 70.24 113.025 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.35 -54.19 22.79 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.592 0.59 . . . . 73.2 112.592 -174.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -97.33 -45.14 6.6 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.604 0.594 . . . . 63.44 112.604 -172.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.668 ' SD ' HG21 ' A' ' 97' ' ' VAL . 49.3 mtt -73.32 -54.26 8.79 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.708 1.003 . . . . 64.13 113.708 -173.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.506 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 32.8 mm -47.48 -51.86 40.9 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 113.391 0.886 . . . . 63.34 113.391 -175.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.506 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 72.0 Cg_exo -50.49 -39.59 54.79 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.155 1.903 . . . . 72.3 113.048 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.464 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 85.5 m-70 -74.42 -49.95 20.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.6 -0.273 . . . . 71.24 111.656 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.6 m-30 -56.34 -43.13 78.76 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.598 0.221 . . . . 50.21 111.598 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.5 -42.36 87.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.921 0.391 . . . . 63.41 111.302 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.7 m -74.94 -13.46 60.53 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.268 -0.423 . . . . 45.11 111.75 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.48 -0.69 59.89 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.286 -0.483 . . . . 72.13 112.52 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.8 m-20 -80.37 66.66 5.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.737 0.415 . . . . 64.02 111.303 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -65.13 -46.02 82.66 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.174 -0.329 . . . . 73.43 111.785 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.69 95.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.007 0.432 . . . . 71.3 111.462 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 51.9 mm-40 -59.82 -47.2 86.69 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.146 -0.479 . . . . 72.23 111.365 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.71 93.13 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.302 -0.475 . . . . 74.51 113.008 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.35 -43.05 96.86 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.808 0.337 . . . . 65.1 111.051 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.4 t -56.21 -53.48 56.63 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 64.3 111.904 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -68.4 -33.45 74.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.609 0.242 . . . . 72.02 111.395 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.18 -52.46 51.74 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.072 -0.585 . . . . 43.31 112.712 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.708 HG21 ' SD ' ' A' ' 36' ' ' MET . 90.8 t -62.63 -43.6 98.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.023 0.44 . . . . 74.21 111.227 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.19 -38.36 76.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.262 -0.427 . . . . 74.31 110.929 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -61.31 -51.84 67.18 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.9 0.381 . . . . 64.42 111.052 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 85.7 t -54.32 -49.7 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.162 0.506 . . . . 75.05 110.972 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.425 ' HB2' HD11 ' A' ' 43' ' ' ILE . 36.5 tt0 -53.43 -46.5 69.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.974 -0.557 . . . . 63.14 111.653 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -65.09 -34.22 77.89 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.943 0.349 . . . . 63.52 111.943 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 141' ' ' ALA . 92.8 t -63.28 -49.07 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.064 0.459 . . . . 73.24 111.004 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.85 -57.06 8.79 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.051 0.453 . . . . 74.43 111.425 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.541 0.604 0 CA-C-N 116.12 -0.491 . . . . 73.23 111.943 -177.041 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.1 t . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 113.133 0.79 . . . . 61.11 113.133 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -109.1 152.56 24.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.742 -0.663 . . . . 73.21 111.518 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.7 mtmt -111.91 157.95 38.15 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.207 -0.451 . . . . 73.33 110.335 173.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.523 ' HD3' ' CE2' ' A' ' 67' ' ' PHE . 30.3 Cg_endo -62.33 -26.11 76.89 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.912 1.741 . . . . 61.52 111.323 176.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -79.26 -20.2 48.71 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.566 -0.743 . . . . 63.22 111.067 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -94.06 -24.49 17.58 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.855 -0.611 . . . . 62.32 111.511 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.6 t -66.71 132.52 94.06 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.226 -0.443 . . . . 43.2 111.648 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.08 121.05 9.19 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.633 2.222 . . . . 73.41 113.106 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' A' ' 14' ' ' LEU . 2.8 p30 -70.34 85.95 0.59 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.477 0.547 . . . . 73.33 112.477 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.66 -26.77 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 112.223 0.453 . . . . 72.32 112.223 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.575 HE22 ' HA ' ' A' ' 20' ' ' LEU . 1.6 mp0 -87.22 31.29 0.73 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.593 0.711 . . . . 71.52 111.365 173.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.541 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 4.7 tt -143.43 -50.75 0.33 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.378 -0.971 . . . . 64.3 108.378 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -109.52 120.37 42.29 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.604 -0.725 . . . . 34.14 110.307 170.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 6.8 m-20 71.13 48.42 0.37 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.329 0.652 . . . . 72.31 111.646 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -59.45 -11.96 5.36 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.961 0.726 . . . . 61.23 112.961 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 t -60.86 -34.67 74.96 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.142 -0.349 . . . . 54.41 111.319 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 19' ' ' ARG . 8.0 ptp85 -97.12 132.48 42.86 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.096 0.474 . . . . 64.12 110.375 175.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.575 ' HA ' HE22 ' A' ' 13' ' ' GLN . 5.6 mp -108.63 12.67 25.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.153 0.501 . . . . 62.1 110.896 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.7 t -110.75 146.94 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.135 -0.484 . . . . 24.43 111.478 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 m -131.21 124.17 30.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.359 -0.382 . . . . 74.41 110.57 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.35 86.03 2.35 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.405 0.621 . . . . 73.31 112.492 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.04 -38.48 8.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.908 0.385 . . . . 73.02 110.75 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.1 -26.65 64.08 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.982 0.42 . . . . 72.35 111.126 170.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.91 25.74 75.21 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.254 -0.498 . . . . 73.04 113.234 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 132' ' ' ALA . 78.8 mt -86.06 10.89 12.96 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.928 0.344 . . . . 74.4 111.928 -177.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.48 HD21 HD12 ' A' ' 135' ' ' LEU . 97.0 mt -120.17 119.96 34.79 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.838 0.351 . . . . 64.43 111.438 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.493 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 31.5 t -81.05 159.49 24.77 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.554 -0.294 . . . . 74.11 110.72 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -54.61 -40.54 69.0 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.169 0.803 . . . . 72.15 113.169 -173.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.32 91.9 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.071 0.462 . . . . 75.42 111.247 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.493 ' OE1' ' HB3' ' A' ' 29' ' ' SER . 18.4 mp0 -66.93 -41.05 87.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.786 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.97 -44.05 91.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.968 0.413 . . . . 72.44 110.713 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -57.56 -57.58 12.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.754 -0.657 . . . . 73.42 111.552 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.73 -47.17 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.154 -0.475 . . . . 74.3 111.771 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.475 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.2 ttm -61.78 -51.56 67.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.528 -0.305 . . . . 74.05 111.662 -177.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -64.82 -35.76 82.15 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 121.01 -0.276 . . . . 63.51 111.326 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.77 -47.21 87.48 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.997 -0.62 . . . . 52.33 112.691 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.493 ' O ' HG13 ' A' ' 43' ' ' ILE . 7.4 mtp180 -67.06 -49.71 64.22 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.782 0.289 . . . . 74.43 111.782 176.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 36' ' ' MET . 91.2 mt -56.31 -41.18 75.55 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.267 0.556 . . . . 72.31 111.404 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -61.87 -46.63 88.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.419 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.21 86.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.984 0.421 . . . . 74.0 111.437 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 39' ' ' ARG . 75.9 mt -58.14 -49.8 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.365 -0.38 . . . . 63.52 111.434 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 26.3 ttp85 -69.09 -25.74 64.58 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.853 0.316 . . . . 75.3 111.853 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.9 t -83.28 -33.42 25.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.089 0.471 . . . . 54.51 111.892 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.7 t -97.24 -67.22 0.86 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.139 0.495 . . . . 73.44 111.672 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -74.27 -16.47 60.94 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.264 -0.425 . . . . 74.3 111.386 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 71.02 9.88 6.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.205 0.602 . . . . 63.23 112.087 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.885 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 85.8 t -81.41 122.52 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.98 0.419 . . . . 73.31 111.861 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.71 96.66 7.61 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.178 0.513 . . . . 73.22 110.226 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -111.94 105.13 13.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.909 -0.587 . . . . 73.4 110.863 -175.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.04 145.4 29.94 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.58 0.585 . . . . 73.13 112.58 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.53 107.76 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.022 0.439 . . . . 72.01 110.902 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.67 134.94 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.846 0.355 . . . . 74.01 111.53 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -113.52 122.53 47.56 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.753 0.311 . . . . 72.33 111.111 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -130.23 137.0 29.89 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 120.848 0.356 . . . . 74.14 111.542 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 39.3 Cg_endo -67.09 -53.94 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.598 2.199 . . . . 62.2 113.264 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 20.3 m -141.75 136.11 30.42 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.17 -0.331 . . . . 73.21 111.649 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.9 pt -106.81 -28.91 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.92 0.39 . . . . 75.03 110.89 174.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.29 -116.53 7.18 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.124 -0.489 . . . . 31.04 114.229 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.78 -23.33 66.69 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.348 0.499 . . . . 72.35 112.348 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.28 128.17 86.53 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.4 0.519 . . . . 65.11 112.4 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.709 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 61.2 Cg_endo -73.38 136.11 23.49 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.581 2.187 . . . . 54.43 112.156 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.1 tp -52.57 -47.71 66.67 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.979 0.733 . . . . 73.13 112.979 -174.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.3 -58.24 8.44 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.132 -0.355 . . . . 71.11 111.628 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.709 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 1.8 m-20 -59.71 -29.79 68.35 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.743 0.306 . . . . 61.32 111.507 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.523 ' CE2' ' HD3' ' A' ' 6' ' ' PRO . 26.5 t80 -61.52 -55.35 32.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.309 -0.405 . . . . 73.33 110.768 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.2 p -57.3 -39.85 76.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.297 -0.411 . . . . 50.43 111.325 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.502 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 53.9 tp -57.79 -53.98 52.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.4 -0.364 . . . . 65.53 111.469 177.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -51.87 -52.66 48.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.909 0.385 . . . . 71.35 111.673 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.422 HD23 HD21 ' A' ' 87' ' ' LEU . 33.6 tp -63.04 -38.61 91.89 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.193 -0.458 . . . . 74.32 111.3 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.86 -44.19 93.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.293 -0.412 . . . . 71.25 111.793 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 20.6 mtm180 -66.95 -40.67 87.59 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.798 0.332 . . . . 75.15 110.927 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -58.64 -42.06 87.42 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.016 0.436 . . . . 73.34 111.402 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -87.29 7.39 28.87 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.354 0.502 . . . . 65.42 112.354 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.71 -42.58 3.14 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.125 -0.559 . . . . 74.31 113.921 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 113.647 0.98 . . . . 61.43 113.647 -176.105 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.415 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 53.3 t30 . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 109.392 -0.595 . . . . 72.31 109.392 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.65 -93.03 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 112.761 0.652 . . . . 73.01 112.761 -176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.885 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.1 m-20 -78.52 74.86 5.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.572 -0.705 . . . . 60.32 111.945 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.19 139.15 9.86 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.166 -0.54 . . . . 41.41 113.174 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 99' ' ' PHE . 47.7 tp -152.89 127.84 9.64 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.889 0.376 . . . . 34.34 111.131 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.422 HD21 HD23 ' A' ' 71' ' ' LEU . 64.0 tp -117.39 124.55 49.14 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.936 0.398 . . . . 72.3 112.045 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 45.4 tp -111.89 121.55 45.34 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.085 -0.507 . . . . 74.52 110.78 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.8 t -122.93 121.96 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 120.821 0.343 . . . . 75.33 111.82 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' A' ' 97' ' ' VAL . 35.0 tp -96.21 118.46 32.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.173 -0.467 . . . . 71.14 111.282 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.2 t -103.61 100.1 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.634 0.254 . . . . 75.11 111.099 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 63.8 tp -54.01 -40.65 67.19 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.119 0.485 . . . . 73.33 111.474 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.487 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 25.3 t70 -48.38 -30.69 5.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.523 0.729 . . . . 54.12 112.872 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 46.5 mt-30 -125.5 1.56 7.63 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.361 -0.212 . . . . 75.14 111.557 -178.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 9.3 ptp180 47.06 27.15 0.72 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.088 0.955 . . . . 73.14 112.278 -173.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 90.5 mtt180 -117.04 154.59 30.7 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.041 0.448 . . . . 74.22 111.498 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 90' ' ' LEU . 4.1 m -134.32 171.26 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.912 -0.585 . . . . 75.42 111.328 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -152.29 144.42 23.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.831 0.348 . . . . 70.21 111.681 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.697 ' HB3' HD11 ' A' ' 86' ' ' LEU . 77.9 m-85 -104.49 105.58 15.75 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.991 -0.55 . . . . 64.25 110.372 173.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -83.13 112.58 19.95 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.118 -0.364 . . . . 75.5 110.308 177.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 109' ' ' LEU . 1.6 p -88.9 143.36 26.93 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.374 0.879 . . . . 61.51 113.374 -176.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -90.87 -177.97 43.66 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 114.894 -1.048 . . . . 71.52 112.384 168.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -60.93 -25.06 66.51 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.588 0.588 . . . . 74.42 112.588 -175.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.4 -22.85 57.95 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.886 -0.674 . . . . 74.12 113.413 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 86' ' ' LEU . 93.5 mt -108.84 4.77 23.89 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.535 0.569 . . . . 74.55 112.535 -174.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -56.79 -38.63 72.81 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.043 0.449 . . . . 63.41 111.889 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.85 -42.7 10.78 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.317 -0.468 . . . . 70.14 113.382 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -72.07 -41.7 67.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.137 0.494 . . . . 75.52 111.791 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.618 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.0 mt -131.75 83.9 56.21 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 115.974 -0.557 . . . . 74.4 111.991 -170.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.49 155.81 24.82 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.402 2.068 . . . . 60.44 112.365 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.0 -36.2 12.29 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.511 0.56 . . . . 74.32 112.511 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.46 -50.12 69.99 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.126 -0.559 . . . . 74.41 112.912 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.52 -42.71 99.22 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.276 0.56 . . . . 51.4 111.028 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.69 HD13 ' HB2' ' A' ' 99' ' ' PHE . 65.5 mt -62.43 -40.75 97.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.665 -0.698 . . . . 72.31 111.132 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.4 m -71.22 -32.25 68.58 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.178 -0.465 . . . . 75.05 111.419 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -56.02 -55.95 26.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.729 -0.214 . . . . 65.23 111.002 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.7 mt -51.0 -47.11 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.137 0.494 . . . . 52.43 111.031 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.576 ' O ' HG12 ' A' ' 123' ' ' ILE . 61.1 mt -55.97 -51.51 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.8 -0.636 . . . . 64.23 111.615 177.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -81.57 -11.45 59.15 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.944 0.72 . . . . 73.13 112.944 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -86.48 -52.42 5.59 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.788 0.292 . . . . 71.34 111.788 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.99 -39.86 2.06 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.109 0.781 . . . . 74.43 113.109 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.512 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 45.3 mtt -51.52 -52.64 45.23 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.664 0.616 . . . . 71.15 112.664 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.648 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 49.9 mm -53.01 -56.8 19.98 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 111.992 0.367 . . . . 53.43 111.992 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 82.6 Cg_exo -48.09 -47.08 20.35 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.301 2.001 . . . . 63.4 113.328 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -62.97 -49.19 75.68 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.695 0.284 . . . . 73.12 111.637 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.1 m-30 -57.49 -42.31 82.45 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.819 0.303 . . . . 73.52 111.819 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 70.5 mtp180 -66.66 -30.77 71.11 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.999 0.428 . . . . 71.43 111.152 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.9 m -78.08 -14.09 59.62 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.399 -0.364 . . . . 75.12 111.478 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.18 -7.02 62.02 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.292 -0.48 . . . . 64.33 112.473 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.735 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.9 m-20 -79.78 57.01 2.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.866 0.365 . . . . 73.35 111.602 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -61.63 -37.79 85.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.915 0.388 . . . . 71.24 111.322 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.453 ' HB1' ' HG2' ' A' ' 32' ' ' GLN . . . -64.87 -49.83 68.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.164 -0.471 . . . . 62.5 111.376 176.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.735 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 14.6 mp0 -63.03 -35.47 80.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.954 -0.566 . . . . 55.11 111.69 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.91 -55.12 30.1 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.152 -0.547 . . . . 13.33 112.352 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.486 HD11 HD22 ' A' ' 90' ' ' LEU . 89.0 mt -58.64 -38.17 77.52 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.39 -0.477 . . . . 62.34 110.949 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 58.0 m -60.02 -47.54 85.43 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.119 -0.491 . . . . 51.05 112.088 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.19 -36.02 66.47 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.102 -0.374 . . . . 73.0 111.207 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.36 -49.73 75.38 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.31 -0.472 . . . . 61.21 113.031 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 135' ' ' LEU . 53.2 t -53.11 -47.76 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.055 0.455 . . . . 71.34 111.255 175.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.555 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 53.6 tp -62.8 -42.86 99.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.125 -0.489 . . . . 75.32 110.805 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.78 -47.68 84.71 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.962 0.41 . . . . 53.02 111.585 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.82 -47.37 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.331 -0.395 . . . . 64.3 111.246 176.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -56.67 -40.53 75.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.417 -0.356 . . . . 74.3 111.464 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 18.3 mm-40 -53.98 -35.13 61.49 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.195 0.442 . . . . 74.2 112.195 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.98 -42.23 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 120.993 0.425 . . . . 74.0 111.014 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.5 mt -71.08 -44.89 64.79 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.094 0.473 . . . . 74.12 111.218 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 116.067 -0.515 . . . . 34.24 111.768 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 121.408 0.623 . . . . 62.12 111.533 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -72.78 157.71 36.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.486 -0.779 . . . . 71.52 112.592 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.748 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 33.8 mmtp -136.58 160.76 65.37 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 114.965 -1.016 . . . . 72.32 109.808 174.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.88 -41.41 63.34 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.396 2.064 . . . . 74.52 112.834 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -86.49 7.65 25.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.979 0.419 . . . . 63.12 111.758 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.748 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 29.8 t70 -106.03 -34.26 7.63 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.166 0.508 . . . . 74.32 110.268 174.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 5' ' ' LYS . 65.1 t -65.89 129.58 94.3 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.675 -0.693 . . . . 75.22 111.503 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.44 123.99 13.84 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.498 2.132 . . . . 75.25 112.497 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -69.67 91.39 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.058 0.456 . . . . 75.53 111.947 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -69.98 -38.37 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.278 -0.419 . . . . 71.13 111.971 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 14.3 mm100 -64.77 170.25 4.35 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.8 -0.562 . . . . 54.31 110.79 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 20.2 mt 73.88 -41.6 0.49 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.423 0.527 . . . . 33.23 112.423 -173.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.09 -62.89 1.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.297 0.48 . . . . 73.52 112.297 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -84.76 32.39 0.52 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.113 0.482 . . . . 61.51 111.715 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -71.42 12.92 0.28 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.549 0.574 . . . . 61.05 112.549 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.2 p -77.47 -42.55 35.41 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.91 0.386 . . . . 44.43 110.974 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.3 ptp85 -98.71 -32.6 11.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.114 -0.494 . . . . 71.34 112.033 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.602 HD21 ' HG3' ' A' ' 44' ' ' ARG . 5.3 mp 62.18 11.98 4.77 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.069 0.396 . . . . 73.24 112.069 -176.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 19' ' ' ARG . 58.6 t -107.07 136.03 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.797 0.332 . . . . 72.52 111.688 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.531 HG22 ' HG2' ' A' ' 24' ' ' GLU . 24.8 m -110.81 106.71 15.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.42 -0.355 . . . . 64.14 110.417 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -95.94 78.01 3.19 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.432 0.634 . . . . 65.13 112.361 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.531 ' HG2' HG22 ' A' ' 22' ' ' THR . 21.0 mm-40 -102.45 -46.65 4.71 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.042 0.449 . . . . 74.45 110.909 176.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.36 -23.74 67.54 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.168 0.433 . . . . 62.0 112.168 174.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.87 33.8 88.04 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.367 -0.444 . . . . 75.53 113.481 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 92' ' ' LEU . 94.3 mt -92.02 12.62 21.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.09 0.404 . . . . 64.15 112.09 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -121.62 125.78 47.5 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.04 0.448 . . . . 75.31 111.472 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.3 t -77.26 172.29 13.51 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.121 -0.491 . . . . 54.45 110.712 173.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -54.72 -47.62 73.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.985 0.422 . . . . 33.34 111.331 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -63.74 -48.28 77.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.41 -0.359 . . . . 51.32 111.533 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -59.69 -42.84 93.87 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.15 0.5 . . . . 63.0 111.339 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -64.84 -47.44 77.94 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.623 -0.717 . . . . 72.33 109.949 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.98 -53.76 54.4 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.168 -0.469 . . . . 74.52 111.982 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 31' ' ' ALA . 99.0 t -54.8 -47.16 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.961 0.41 . . . . 75.45 111.246 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.1 ttm -63.01 -42.97 99.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.442 -0.344 . . . . 74.31 111.227 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -57.09 -48.66 78.06 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.969 0.414 . . . . 74.21 111.094 176.382 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.9 -47.19 90.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.155 -0.475 . . . . 61.43 113.002 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 43' ' ' ILE . 99.6 mtt180 -62.6 -54.84 33.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 111.901 0.334 . . . . 74.34 111.901 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 51' ' ' PHE . 70.9 mt -58.2 -48.17 81.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.868 0.366 . . . . 64.14 111.419 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -58.21 -47.05 84.68 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.331 -0.395 . . . . 62.54 111.098 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.9 -45.11 86.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.195 -0.457 . . . . 70.15 111.339 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.575 HG22 ' HB ' ' A' ' 49' ' ' VAL . 64.3 mt -65.97 -46.32 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.086 0.469 . . . . 71.31 111.274 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.602 ' HG3' HD21 ' A' ' 20' ' ' LEU . 5.5 tmm_? -65.9 -26.04 67.43 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.162 -0.472 . . . . 74.44 111.417 -176.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 t -91.77 -54.54 3.83 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.807 0.337 . . . . 34.33 111.549 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.3 t -67.63 -58.8 4.05 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.307 0.484 . . . . 74.01 112.307 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.49 -11.29 52.15 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.396 -0.365 . . . . 63.01 111.5 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.08 24.04 12.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.905 0.482 . . . . 32.01 111.993 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.575 ' HB ' HG22 ' A' ' 43' ' ' ILE . 90.2 t -96.28 117.28 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.24 -0.436 . . . . 73.24 111.576 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.03 96.16 2.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.082 0.467 . . . . 72.23 110.432 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.427 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -104.44 98.59 8.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.769 -0.65 . . . . 72.04 109.984 -179.063 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -102.52 119.71 39.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.1 0.407 . . . . 72.11 112.1 -175.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.466 HG22 HD23 ' A' ' 88' ' ' LEU . 96.0 t -104.91 110.86 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.282 0.563 . . . . 64.31 111.4 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.441 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 48.4 t -106.55 121.93 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.08 -0.509 . . . . 53.53 111.081 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 p -106.58 121.87 45.17 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.816 0.341 . . . . 74.34 110.92 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -126.4 139.63 35.13 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-O 120.818 0.342 . . . . 74.32 111.553 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.55 -56.68 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.335 2.024 . . . . 51.31 112.86 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.6 p -144.96 139.48 27.57 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 111.933 0.345 . . . . 74.1 111.933 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.612 HG12 HG11 ' A' ' 91' ' ' VAL . 35.3 pt -117.65 -10.84 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 121.112 0.482 . . . . 73.35 110.826 171.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.27 -127.99 32.93 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.177 -0.465 . . . . 50.12 114.04 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.81 -16.62 63.84 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.841 0.682 . . . . 63.23 112.841 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.12 130.6 50.5 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 112.936 0.717 . . . . 43.14 112.936 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.654 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 60.6 Cg_endo -72.0 133.19 21.09 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.747 2.298 . . . . 70.53 112.054 174.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.57 -48.19 82.1 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.934 0.716 . . . . 73.41 112.934 -171.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -67.85 -45.87 73.4 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.117 -0.364 . . . . 73.33 111.918 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.654 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 33.3 m-20 -61.85 -37.85 86.04 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.979 0.418 . . . . 61.01 110.857 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.46 -50.07 75.05 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.125 -0.489 . . . . 72.34 111.042 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 78.0 p -63.14 -48.33 78.91 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.594 -0.275 . . . . 63.33 111.313 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 54.4 tp -54.87 -46.73 74.77 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.097 0.475 . . . . 64.34 111.196 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -54.86 -49.51 70.93 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.003 0.43 . . . . 65.42 111.66 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 tp -67.97 -36.61 80.35 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.054 -0.521 . . . . 74.22 111.639 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 77' ' ' VAL . . . -67.77 -39.94 84.08 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.388 -0.369 . . . . 55.4 111.776 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 41.1 mtp-105 -57.43 -54.23 49.18 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.077 0.399 . . . . 73.55 112.077 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.448 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 12.5 pt20 -64.28 -23.04 67.16 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.347 0.499 . . . . 75.41 112.347 -177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.448 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 40.8 m0 -92.17 -15.29 27.82 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.809 0.3 . . . . 74.51 111.809 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.71 30.03 60.43 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.226 -0.512 . . . . 55.21 113.122 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.605 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 3.4 t . . . . . 0 N--CA 1.475 0.819 0 C-N-CA 123.0 0.52 . . . . 74.2 109.725 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 121.312 0.577 . . . . 74.54 112.306 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.434 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.2 OUTLIER -83.65 136.32 34.26 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.382 -0.372 . . . . 62.13 111.631 176.475 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.594 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 2.0 m-20 52.29 21.89 1.82 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.944 0.72 . . . . 61.31 112.944 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.66 129.43 9.89 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.205 -0.521 . . . . 53.4 113.176 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 99' ' ' PHE . 39.8 tp -142.32 119.47 11.43 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.193 0.521 . . . . 75.1 111.441 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.8 tp -107.2 139.88 40.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.368 -0.378 . . . . 73.43 111.279 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD23 HG22 ' A' ' 53' ' ' VAL . 53.5 tp -131.76 114.06 14.29 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.529 -0.305 . . . . 72.23 111.04 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.27 121.51 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.076 0.399 . . . . 63.54 112.076 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 97' ' ' VAL . 24.1 tp -101.37 129.29 47.34 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.173 -0.467 . . . . 73.34 111.223 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.612 HG11 HG12 ' A' ' 59' ' ' ILE . 31.9 t -115.02 99.2 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.92 0.39 . . . . 51.43 111.29 176.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 27' ' ' LEU . 67.1 tp -51.54 -41.23 60.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.162 0.585 . . . . 72.12 112.357 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.22 -43.15 52.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.407 0.683 . . . . 71.14 112.748 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -118.54 8.51 12.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.104 0.409 . . . . 63.32 112.104 -174.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 59.46 20.02 8.41 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.706 1.002 . . . . 73.24 113.706 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -122.17 154.23 37.73 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.669 -0.644 . . . . 73.44 112.194 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.763 HG21 ' SD ' ' A' ' 122' ' ' MET . 6.3 m -129.24 171.39 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.654 -0.703 . . . . 64.33 111.382 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -147.66 130.08 15.76 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.34 -0.391 . . . . 74.03 111.842 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.71 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 93.8 m-85 -90.45 141.95 28.23 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.922 -0.581 . . . . 72.42 109.441 168.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 26.2 tt0 -133.04 112.29 11.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.961 0.41 . . . . 73.45 111.914 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.596 HG23 HD13 ' A' ' 86' ' ' LEU . 17.5 p -106.83 142.02 37.13 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.008 -0.542 . . . . 60.2 111.223 175.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.37 -83.98 1.17 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.805 -0.712 . . . . 43.23 113.724 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -137.1 -41.53 0.58 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.004 0.43 . . . . 74.42 111.397 -174.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.594 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -58.52 -39.43 93.11 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.257 -0.429 . . . . 72.34 114.071 -175.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.528 HD11 HG13 ' A' ' 49' ' ' VAL . 93.3 mt -91.97 -2.6 56.66 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.013 0.746 . . . . 74.44 113.013 -174.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -57.64 -21.66 40.99 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.556 0.576 . . . . 73.21 112.556 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.74 -28.58 56.76 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.91 -0.662 . . . . 71.21 112.894 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -109.97 -60.31 1.81 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.898 0.38 . . . . 64.55 111.043 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.443 HD12 HD13 ' A' ' 105' ' ' LEU . 16.3 mt -111.77 88.31 9.53 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.171 0.588 . . . . 61.43 111.563 -178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.16 152.26 18.39 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.969 1.779 . . . . 61.41 112.102 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -47.85 -36.32 11.81 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.685 0.279 . . . . 70.2 111.709 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.17 -49.9 73.52 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.253 -0.499 . . . . 61.42 113.182 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.73 -44.58 96.46 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.259 0.552 . . . . 74.44 111.045 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 66.6 mt -60.54 -44.54 96.0 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.753 -0.658 . . . . 63.21 110.874 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -59.74 -38.29 81.32 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.823 -0.626 . . . . 74.32 110.934 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.4 ttt-85 -60.27 -56.23 24.04 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.068 -0.514 . . . . 61.31 110.947 175.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 60.2 mt -51.01 -39.48 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 120.821 0.343 . . . . 75.33 111.784 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.542 ' O ' HG12 ' A' ' 123' ' ' ILE . 77.6 mt -55.84 -56.17 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.53 -0.305 . . . . 71.53 111.033 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -77.4 -23.59 50.63 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.382 0.512 . . . . 72.12 112.382 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -78.25 -40.31 37.58 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.164 0.431 . . . . 62.32 112.164 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 -126.12 -54.18 1.5 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.262 0.838 . . . . 54.12 113.262 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.763 ' SD ' HG21 ' A' ' 97' ' ' VAL . 38.5 mtt -59.21 -53.65 55.91 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.052 0.76 . . . . 64.44 113.052 -175.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.642 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 mm -53.86 -53.4 58.26 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 111.677 0.251 . . . . 71.02 111.677 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 92.3 Cg_exo -47.68 -48.18 16.45 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 122.287 1.991 . . . . 71.31 113.423 174.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -62.5 -46.96 86.07 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.706 0.262 . . . . 72.1 111.706 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -60.69 -41.33 94.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.738 0.304 . . . . 75.41 111.361 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -63.2 -31.43 72.58 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.045 0.45 . . . . 74.24 111.27 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.2 t -82.87 -18.37 40.54 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.261 -0.427 . . . . 51.14 111.449 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.88 1.92 34.27 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.545 -0.359 . . . . 73.51 113.571 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.9 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 85.7 m-20 -94.07 82.07 4.16 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.411 -0.464 . . . . 73.12 112.152 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -71.53 -53.63 13.18 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.225 -0.297 . . . . 74.21 111.455 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.79 -45.96 85.3 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.093 0.473 . . . . 65.4 111.554 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.9 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 7.1 tp10 -56.21 -53.16 60.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.041 -0.527 . . . . 55.44 111.178 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.87 -43.64 96.52 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.409 -0.424 . . . . 60.04 113.514 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 90' ' ' LEU . 93.8 mt -59.77 -56.48 21.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.03 0.443 . . . . 73.42 111.413 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 30.8 t -56.18 -54.31 46.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.382 0.512 . . . . 52.31 112.382 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -30.25 60.96 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 111.576 0.213 . . . . 74.42 111.576 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.87 -48.0 86.6 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.201 -0.523 . . . . 42.4 112.408 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 135' ' ' LEU . 72.3 t -57.79 -44.94 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.132 0.491 . . . . 74.23 110.606 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.3 tp -58.44 -37.4 75.34 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.953 -0.567 . . . . 61.04 111.391 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.6 97.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.092 0.472 . . . . 55.03 111.173 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.424 HG13 HD22 ' A' ' 109' ' ' LEU . 63.8 t -65.77 -45.93 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.788 -0.642 . . . . 75.24 110.764 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -53.87 -43.33 69.5 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.789 -0.641 . . . . 75.54 111.255 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -52.35 -41.0 62.69 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.277 0.473 . . . . 73.11 112.277 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.11 -36.4 76.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.871 0.367 . . . . 74.13 111.666 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.0 -54.82 24.35 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.601 -0.272 . . . . 74.21 111.324 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 CA--C 1.543 0.675 0 CA-C-O 120.848 0.356 . . . . 73.42 111.948 176.983 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' HG3' ' OG ' ' A' ' 58' ' ' SER . 49.6 ttm . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.964 0.412 . . . . 74.44 111.625 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -110.56 122.51 47.94 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.581 -0.281 . . . . 72.21 110.679 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.7 t -72.47 127.17 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.329 0.585 . . . . 71.35 112.106 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -113.35 144.62 42.45 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.937 -0.574 . . . . 51.41 111.75 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.694 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 9.8 mtmp? -122.29 171.18 6.71 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 115.648 -0.705 . . . . 74.12 109.693 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.694 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 4.4 Cg_endo -45.61 -49.84 10.16 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.769 2.313 . . . . 64.33 113.963 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.79 10.78 10.56 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.421 0.526 . . . . 74.24 112.421 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 5' ' ' LYS . 38.6 m-20 -95.14 -14.86 23.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.082 0.467 . . . . 54.52 110.579 168.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.505 HG22 HD21 ' A' ' 56' ' ' LEU . 38.9 t -89.03 128.67 51.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.085 -0.507 . . . . 75.45 110.453 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.59 118.44 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.225 1.95 . . . . 62.51 112.29 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -63.82 78.48 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.032 0.444 . . . . 61.52 111.759 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ASP . 35.7 m -63.76 -39.45 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 111.981 0.363 . . . . 62.13 111.981 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -72.93 6.2 2.78 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.907 -0.496 . . . . 64.24 111.941 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.495 ' O ' HD23 ' A' ' 14' ' ' LEU . 8.9 tt -94.75 -20.99 19.03 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.354 0.597 . . . . 74.42 109.773 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.85 -56.0 0.56 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.828 -0.624 . . . . 72.51 111.653 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' VAL . 8.1 m-20 -78.49 77.96 4.96 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.034 0.445 . . . . 73.01 111.925 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.0 p -90.09 -11.22 41.99 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.623 0.249 . . . . 53.14 111.654 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -102.04 -8.85 21.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.822 0.304 . . . . 53.41 111.822 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -99.44 -58.6 1.89 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.975 0.417 . . . . 64.13 110.856 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.3 mp 70.03 -16.2 0.3 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.274 0.842 . . . . 71.22 113.274 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.3 t -86.0 144.14 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.111 -0.368 . . . . 74.4 111.513 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -145.28 103.12 3.81 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.379 -0.373 . . . . 73.41 111.271 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.428 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 26.1 t70 -103.36 109.63 21.32 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.999 0.428 . . . . 74.1 111.478 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB2' HD23 ' A' ' 56' ' ' LEU . 8.8 mm-40 -111.45 -29.88 7.61 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.089 -0.505 . . . . 70.32 110.708 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.402 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -58.29 -31.46 67.51 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.74 0.644 . . . . 74.24 112.74 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.88 25.77 51.69 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.899 -0.667 . . . . 75.41 112.231 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.507 HD11 HD13 ' A' ' 92' ' ' LEU . 97.8 mt -96.41 -33.61 11.83 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.733 0.302 . . . . 62.41 111.109 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.83 -176.02 5.88 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.183 0.516 . . . . 75.22 111.323 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.0 t -152.69 158.68 42.71 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.787 -0.449 . . . . 64.33 109.787 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -45.06 -48.86 11.8 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.521 0.563 . . . . 73.23 112.521 -173.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -57.51 -55.91 28.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.86 0.362 . . . . 72.44 111.776 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -57.34 -42.73 82.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.991 0.424 . . . . 75.23 111.496 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -64.47 -46.45 83.01 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.122 -0.49 . . . . 60.5 111.533 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 18.9 tp10 -65.53 -41.12 93.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.863 0.363 . . . . 74.31 111.524 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 31' ' ' ALA . 96.6 t -62.4 -39.66 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.116 0.484 . . . . 62.01 110.468 174.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.5 ttm -68.26 -36.86 80.07 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.028 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 34' ' ' GLU . 92.7 m-20 -56.11 -47.23 78.48 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.969 0.414 . . . . 73.02 110.46 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.41 -37.9 92.69 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.04 -0.6 . . . . 71.32 112.786 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 43' ' ' ILE . 66.5 mtt180 -65.95 -54.54 24.96 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.824 0.345 . . . . 63.43 111.251 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.97 -42.72 99.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.858 0.361 . . . . 63.34 111.472 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -61.69 -40.45 95.04 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.334 -0.394 . . . . 54.12 111.292 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.34 92.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.894 0.378 . . . . 73.44 110.981 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.635 HG22 ' HB ' ' A' ' 49' ' ' VAL . 51.5 mt -67.7 -39.39 82.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.085 0.469 . . . . 73.4 110.85 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' NH1' ' HG2' ' A' ' 50' ' ' GLU . 8.9 tpt180 -59.06 -29.86 67.63 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.762 -0.654 . . . . 54.43 111.407 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.1 t -93.64 -66.48 0.92 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.266 -0.424 . . . . 64.34 111.474 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 37.3 t -50.37 -60.95 2.48 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.371 0.508 . . . . 33.51 112.371 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -94.88 -3.1 49.39 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.477 -0.329 . . . . 73.44 111.601 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.83 13.41 7.49 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.364 0.505 . . . . 61.3 112.364 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 43' ' ' ILE . 63.3 t -84.83 128.29 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.334 0.494 . . . . 51.42 112.334 -174.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HG2' ' NH1' ' A' ' 44' ' ' ARG . 29.9 mt-10 -80.2 95.35 6.25 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.066 -0.515 . . . . 61.42 110.026 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -112.81 103.23 11.23 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.868 0.366 . . . . 63.34 110.733 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.85 133.81 49.03 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.19 0.441 . . . . 72.12 112.19 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.59 127.72 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.363 -0.38 . . . . 71.55 111.042 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.0 t -127.64 139.58 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.798 0.332 . . . . 74.43 111.354 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 19.6 p -124.04 130.22 52.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.701 0.286 . . . . 72.51 110.368 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 9' ' ' VAL . 71.7 mt -125.71 142.72 42.88 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-O 120.724 0.297 . . . . 75.54 111.644 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 32.5 Cg_exo -61.89 -49.16 7.22 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.549 2.166 . . . . 70.44 112.175 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.478 ' OG ' ' HG3' ' A' ' 1' ' ' MET . 46.8 m -155.17 145.8 22.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.235 -0.439 . . . . 70.1 111.733 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.606 HG12 HG11 ' A' ' 91' ' ' VAL . 32.1 pt -112.4 -5.08 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.093 0.473 . . . . 60.42 110.71 170.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.27 -109.95 2.97 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 115.929 -0.578 . . . . 72.35 113.113 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -108.72 2.25 21.69 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.213 0.449 . . . . 53.12 112.213 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.95 140.39 97.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.186 0.439 . . . . 74.12 112.186 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.527 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 47.4 Cg_endo -68.49 121.44 8.38 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.359 2.039 . . . . 73.34 112.266 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.8 tp -58.64 -51.22 70.86 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.849 0.685 . . . . 55.31 112.849 -174.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.409 ' HG2' ' HE ' ' A' ' 98' ' ' ARG . 38.8 mt-10 -62.84 -48.24 79.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.852 0.358 . . . . 72.21 111.58 -178.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.527 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 6.1 m-20 -61.99 -37.48 84.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.698 0.285 . . . . 54.21 111.542 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.479 ' HE2' ' HA ' ' A' ' 5' ' ' LYS . 41.3 t80 -56.06 -53.79 52.82 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.876 0.37 . . . . 71.43 111.358 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.502 HG21 ' HB3' ' A' ' 98' ' ' ARG . 70.3 p -55.0 -46.2 75.15 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.289 -0.414 . . . . 74.12 111.764 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 48.4 tp -58.62 -49.15 78.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.935 0.398 . . . . 52.32 111.357 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.443 ' HE3' ' HG3' ' A' ' 6' ' ' PRO . 29.0 mtpp -57.76 -43.24 85.35 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.798 0.332 . . . . 73.31 111.765 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.497 HD23 HD21 ' A' ' 87' ' ' LEU . 44.6 tp -67.96 -43.58 78.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.137 0.494 . . . . 71.42 111.302 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.45 95.31 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.237 0.458 . . . . 70.52 112.237 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 47.3 mtm180 -63.26 -47.1 83.81 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.147 0.425 . . . . 74.13 112.147 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 6' ' ' PRO . 10.7 pt20 -67.81 -31.49 71.38 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.845 0.355 . . . . 75.0 111.639 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -76.41 -15.35 59.96 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.663 0.268 . . . . 75.11 111.682 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 79' ' ' ASN . . . 95.27 -37.02 3.54 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.192 -0.528 . . . . 64.12 113.0 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 45.1 t -54.35 -22.51 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.518 0.562 . . . . 64.4 112.518 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.62 22.69 4.33 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.223 -0.513 . . . . 64.13 112.918 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.443 ' HB2' ' HA2' ' A' ' 76' ' ' GLY . 18.8 t-20 -67.55 98.74 0.7 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.493 -0.416 . . . . 64.12 110.978 -177.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 44.88 64.19 1.46 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.808 -0.633 . . . . 73.24 111.355 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 3.3 mptp? 60.38 76.69 0.35 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.722 -0.672 . . . . 73.44 112.457 175.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 41.0 t30 -72.5 148.57 44.93 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.698 -0.683 . . . . 72.35 110.262 175.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 84' ' ' ASN . 36.2 p-10 -56.35 -98.89 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 112.637 0.606 . . . . 72.03 112.637 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -86.02 81.64 8.41 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.894 -1.128 . . . . 64.52 111.074 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -147.47 142.68 10.43 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.63 -0.714 . . . . 74.42 112.873 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 99' ' ' PHE . 40.2 tp -151.47 128.73 11.23 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.806 0.442 . . . . 61.24 111.084 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.497 HD21 HD23 ' A' ' 71' ' ' LEU . 55.7 tp -109.28 144.29 37.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.948 0.404 . . . . 75.32 111.269 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.0 tp -130.43 125.96 35.79 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.312 -0.404 . . . . 75.21 110.414 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.6 t -127.0 125.09 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.878 0.371 . . . . 75.45 111.895 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.571 HD22 HD11 ' A' ' 135' ' ' LEU . 18.9 tp -101.0 134.1 44.5 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.928 -0.578 . . . . 70.32 110.531 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.606 HG11 HG12 ' A' ' 59' ' ' ILE . 48.2 t -118.92 109.67 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.803 0.335 . . . . 65.32 110.978 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.507 HD13 HD11 ' A' ' 27' ' ' LEU . 67.4 tp -59.49 -44.19 93.12 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.938 0.718 . . . . 74.3 112.938 -174.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' HA ' ' A' ' 58' ' ' SER . 1.2 p-10 -69.12 -17.9 63.9 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.08 0.467 . . . . 75.33 111.478 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -103.86 -18.81 14.49 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.323 -0.399 . . . . 65.01 111.573 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 57.93 27.21 14.37 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.254 0.549 . . . . 64.53 111.688 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -121.61 157.66 30.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.18 0.514 . . . . 62.24 111.653 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.28 158.69 38.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.675 -0.693 . . . . 64.3 110.066 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.502 ' HB3' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -148.59 130.97 15.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.945 0.403 . . . . 74.31 111.262 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.564 ' HB3' HD11 ' A' ' 86' ' ' LEU . 89.1 m-85 -97.12 153.23 18.09 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.124 -0.489 . . . . 72.31 111.246 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -137.23 111.81 8.71 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 122.18 -0.325 . . . . 74.11 110.515 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.408 HG23 HD13 ' A' ' 86' ' ' LEU . 20.4 p -101.11 142.51 32.45 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.341 0.591 . . . . 65.14 111.974 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 81' ' ' LYS . . . -75.54 -94.14 0.16 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.816 -0.707 . . . . 75.03 113.008 174.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.478 ' HB2' ' HB3' ' A' ' 81' ' ' LYS . 25.0 t80 -147.62 -29.39 0.34 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.174 0.511 . . . . 62.34 111.577 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.28 -12.74 83.95 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.054 -0.593 . . . . 54.13 113.122 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.617 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 96.3 mt -103.85 1.19 31.17 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.113 0.412 . . . . 75.2 112.113 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.27 -23.89 67.62 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.241 0.543 . . . . 62.12 111.22 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.84 7.72 81.36 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.131 -0.486 . . . . 71.43 113.179 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.617 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 29.3 m-85 -133.87 -62.69 0.76 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.301 0.572 . . . . 74.14 111.038 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.31 90.61 14.48 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.563 -0.744 . . . . 73.11 111.991 -174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.6 148.12 41.63 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 121.744 1.63 . . . . 72.1 112.226 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -48.68 -42.65 35.42 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.151 0.426 . . . . 72.51 112.151 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.79 -44.89 95.6 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.107 -0.568 . . . . 52.43 113.13 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 117' ' ' ILE . 64.9 tp -57.71 -50.54 72.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.117 0.484 . . . . 74.4 110.625 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.8 mt -57.77 -38.41 75.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 74.32 111.136 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.7 t -66.33 -38.37 87.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.15 -0.477 . . . . 60.24 110.959 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -65.6 -44.93 85.07 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.6 -0.273 . . . . 73.05 111.13 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 113' ' ' LEU . 74.2 mt -50.96 -35.62 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.078 0.466 . . . . 72.54 111.212 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 122' ' ' MET . 64.6 mt -57.19 -48.46 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.09 -0.504 . . . . 61.32 110.786 174.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.444 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 42.3 m80 -72.71 -33.82 66.71 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.389 -0.369 . . . . 71.4 111.857 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -72.36 -43.27 64.28 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.264 0.838 . . . . 72.12 113.264 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 137' ' ' GLU . 15.7 mmm180 -118.45 -49.01 2.48 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.805 0.668 . . . . 72.02 112.805 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 13.2 mmt -59.67 -56.28 23.9 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.748 0.647 . . . . 71.35 112.748 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 118' ' ' ILE . 50.5 mm -55.26 -55.21 42.04 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 113.055 0.761 . . . . 74.51 113.055 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 9.8 Cg_endo -52.41 -32.98 54.7 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.282 1.988 . . . . 73.41 113.067 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 86.2 m-70 -79.85 -46.54 16.69 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.57 0.211 . . . . 74.14 111.57 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -56.8 -33.78 67.03 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.853 0.359 . . . . 75.25 111.323 178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 83.2 mtp180 -63.1 -39.44 94.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.028 0.442 . . . . 73.22 111.045 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.4 m -82.12 -11.37 58.79 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.408 -0.36 . . . . 62.1 111.625 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.61 5.47 60.11 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.486 -0.388 . . . . 73.31 112.832 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.75 77.4 9.78 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.877 0.37 . . . . 63.5 111.869 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -66.44 -41.08 89.68 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.002 -0.436 . . . . 74.22 111.514 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.15 87.61 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.023 0.439 . . . . 71.41 111.747 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 16.8 mp0 -63.7 -43.73 95.75 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.355 -0.384 . . . . 73.22 111.181 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.35 -52.96 48.51 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.965 -0.636 . . . . 33.33 112.536 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.571 HD11 HD22 ' A' ' 90' ' ' LEU . 95.9 mt -58.1 -51.65 68.83 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.013 0.375 . . . . 42.45 112.013 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 81.6 p -56.58 -50.78 70.93 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.914 0.339 . . . . 72.44 111.914 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 121' ' ' ARG . 27.2 mt-10 -72.15 -31.64 66.16 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.366 0.506 . . . . 72.23 112.366 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.63 -46.46 93.26 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.323 -0.941 . . . . 22.35 112.1 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 135' ' ' LEU . 98.7 t -63.6 -47.11 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.845 0.355 . . . . 55.31 111.212 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.93 -37.68 80.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.275 -0.42 . . . . 72.3 111.444 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.533 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -60.76 -52.37 65.4 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.923 0.392 . . . . 71.21 110.821 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.0 t -56.69 -46.69 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.36 0.6 . . . . 73.45 110.926 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -53.39 -51.23 63.22 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.651 -0.704 . . . . 71.43 111.692 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -65.59 -31.06 71.89 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.383 0.512 . . . . 64.14 112.383 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 141' ' ' ALA . 95.8 t -58.28 -48.65 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.111 0.482 . . . . 64.23 110.556 174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.79 -49.25 60.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.122 -0.49 . . . . 64.41 110.968 176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -56.6 -32.27 65.1 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.65 -0.705 . . . . 72.43 112.229 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.34 -22.39 56.82 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.212 -0.518 . . . . 53.22 113.484 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.7 t -92.77 -50.68 5.45 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 122.429 -0.454 . . . . 73.4 111.83 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 154' ' ' HIS . 94.0 mt -92.01 84.52 5.33 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.566 0.698 . . . . 71.04 111.0 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.8 -22.02 65.09 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.199 -0.909 . . . . 51.54 112.26 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -127.2 149.02 50.17 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.573 0.225 . . . . 71.02 111.559 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.446 ' HA ' ' O ' ' A' ' 46' ' ' SER . 42.9 t60 -45.31 106.37 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.429 -0.351 . . . . 74.45 111.087 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.435 ' HB3' HD13 ' A' ' 150' ' ' LEU . 16.7 t-80 -112.5 118.04 34.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.261 0.553 . . . . 74.31 112.386 -170.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -108.68 131.79 54.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.081 -0.509 . . . . 62.51 110.495 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -74.25 -82.13 0.06 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.591 0.589 . . . . 73.43 112.591 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.834 -0.603 . . . . 75.12 111.708 -176.802 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.768 0.318 . . . . 74.32 111.347 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -163.09 124.85 2.52 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.521 -0.309 . . . . 73.33 111.168 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.2 t -73.18 123.51 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 112.812 0.671 . . . . 74.33 112.812 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -116.55 158.73 23.19 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.55 -0.75 . . . . 75.44 110.353 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -127.22 160.44 59.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.61 -0.268 . . . . 74.25 111.292 176.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 57.6 Cg_endo -70.92 64.95 2.5 Favored 'Trans proline' 0 C--N 1.358 1.026 0 C-N-CA 122.458 2.105 . . . . 60.12 111.803 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -174.4 -35.47 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.157 -0.929 . . . . 74.44 110.394 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -71.82 -40.55 69.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.138 0.494 . . . . 60.13 110.693 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.93 126.2 41.98 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.426 -0.806 . . . . 65.32 111.905 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.65 123.06 11.14 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.681 2.254 . . . . 70.53 112.849 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -66.89 87.88 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.207 0.527 . . . . 54.34 111.084 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -69.71 -21.37 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.583 0.586 . . . . 75.14 112.583 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -70.11 -35.88 74.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.601 -0.687 . . . . 74.43 110.797 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.59 -33.68 64.74 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.819 -0.628 . . . . 72.34 109.996 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.18 -86.94 0.26 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.926 -0.579 . . . . 54.21 112.343 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.92 77.55 2.03 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.545 0.572 . . . . 72.44 112.545 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.4 t -72.76 -0.8 14.27 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.981 0.419 . . . . 55.05 111.354 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -81.0 -31.77 34.54 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.101 0.408 . . . . 73.44 112.101 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -100.41 -43.84 6.1 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.132 0.419 . . . . 75.2 112.132 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp 64.79 17.97 11.23 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.883 0.473 . . . . 72.52 111.983 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.59 130.71 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 112.106 0.41 . . . . 75.1 112.106 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.8 m -124.49 103.58 8.25 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.383 -0.372 . . . . 71.24 111.175 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 28' ' ' LEU . 27.4 t70 -102.47 109.05 20.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.804 0.335 . . . . 74.53 111.148 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -118.97 -21.96 7.49 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.8 0.333 . . . . 73.24 111.258 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.55 -24.59 67.65 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.019 0.377 . . . . 53.22 112.019 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.39 43.27 16.26 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.272 -0.489 . . . . 64.53 112.727 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.5 mt -115.4 -30.98 6.08 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.356 0.502 . . . . 65.24 112.356 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 23' ' ' ASP . 95.0 mt -75.58 106.68 7.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.006 0.431 . . . . 75.42 111.66 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -73.72 157.18 36.98 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.493 -0.321 . . . . 71.3 110.535 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -51.82 -55.25 21.03 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.032 0.752 . . . . 50.12 113.032 -170.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.07 -38.2 75.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.704 0.288 . . . . 75.14 111.574 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -71.35 -30.28 65.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.795 0.331 . . . . 53.13 111.065 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.87 -51.92 67.62 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.628 -0.26 . . . . 72.02 110.307 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -57.9 -32.87 68.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.745 0.307 . . . . 73.22 111.497 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.489 ' O ' ' HD2' ' A' ' 39' ' ' ARG . 91.5 t -60.0 -53.93 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.083 0.468 . . . . 72.44 110.98 174.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 46.5 ttm -69.87 -49.54 51.34 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.43 -0.35 . . . . 71.02 111.383 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -50.65 -52.49 39.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.726 0.41 . . . . 54.43 110.997 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.77 -43.31 94.65 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 116.211 -0.449 . . . . 61.42 113.174 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.546 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -58.93 -55.59 33.19 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.595 0.236 . . . . 73.0 111.322 177.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 mt -63.51 -47.22 82.58 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.374 0.607 . . . . 61.33 111.318 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -57.63 -47.08 83.19 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.612 -0.722 . . . . 71.22 111.345 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.31 93.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.56 -0.291 . . . . 75.52 111.521 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 39' ' ' ARG . 80.1 mt -60.54 -47.74 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.749 0.309 . . . . 75.24 111.152 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -64.8 -33.34 75.76 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 120.963 0.411 . . . . 73.34 111.217 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.8 t -82.73 -2.09 53.32 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.421 0.629 . . . . 64.32 111.289 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 154' ' ' HIS . 48.3 m -130.09 -72.19 0.58 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.059 0.457 . . . . 75.2 111.377 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.675 ' ND1' ' HB2' ' A' ' 150' ' ' LEU . 93.3 m-70 -79.75 -12.63 59.78 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.152 0.427 . . . . 73.5 112.152 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.85 18.89 11.24 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.914 0.486 . . . . 73.43 112.105 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.752 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 94.2 t -86.0 132.79 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.457 -0.338 . . . . 71.13 111.199 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -86.77 96.29 10.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.222 0.534 . . . . 72.43 110.293 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -114.02 109.47 18.5 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.687 -0.688 . . . . 75.44 110.256 -175.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -117.7 142.77 46.87 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.112 0.412 . . . . 53.42 112.112 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.8 t -123.94 133.65 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.848 0.356 . . . . 75.14 111.39 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.414 HG21 HD21 ' A' ' 71' ' ' LEU . 48.4 t -126.53 137.99 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 122.497 0.319 . . . . 65.41 111.143 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 24.8 p -120.12 123.01 42.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.86 0.362 . . . . 74.33 111.159 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -127.17 147.24 61.01 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 120.629 0.252 . . . . 72.33 111.521 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.06 -57.52 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.372 2.048 . . . . 75.2 112.374 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 25.0 m -145.42 148.65 33.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.41 -0.359 . . . . 53.32 111.248 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 91' ' ' VAL . 28.7 pt -110.2 -2.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.305 0.574 . . . . 73.34 110.631 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.0 -113.43 5.07 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.66 -0.7 . . . . 61.22 114.329 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.42 1.28 53.85 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.489 0.552 . . . . 75.43 112.489 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.67 141.82 28.82 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 111.799 0.296 . . . . 71.53 111.799 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.76 143.11 18.38 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.858 2.372 . . . . 62.14 112.411 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.24 -51.35 70.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.1 0.407 . . . . 70.24 112.1 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.49 -35.13 79.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.275 0.472 . . . . 75.04 112.275 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.38 -42.24 83.72 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.257 0.551 . . . . 64.53 110.437 175.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.404 ' CD2' ' HD3' ' A' ' 6' ' ' PRO . 24.8 t80 -60.49 -53.38 58.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.737 -0.665 . . . . 71.01 111.884 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.413 HG21 ' HB3' ' A' ' 98' ' ' ARG . 22.0 p -51.12 -48.45 61.75 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.122 0.786 . . . . 61.4 113.122 -174.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 52.5 tp -66.71 -46.51 75.29 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.821 0.344 . . . . 54.32 111.724 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -64.82 -38.14 89.97 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.118 0.414 . . . . 75.21 112.118 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.414 HD21 HG21 ' A' ' 54' ' ' VAL . 63.3 tp -69.26 -40.76 77.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.154 0.502 . . . . 74.01 110.522 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.64 95.57 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.267 0.469 . . . . 73.03 112.267 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 53.8 mtp180 -60.65 -49.54 77.12 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.204 0.446 . . . . 74.24 112.204 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.666 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 11.8 pt20 -66.26 -21.09 66.28 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 120.947 0.404 . . . . 72.23 111.426 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.666 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 22.9 m0 -90.07 7.33 38.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.868 0.366 . . . . 74.41 111.406 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.461 ' HA2' ' ND2' ' A' ' 79' ' ' ASN . . . 86.18 -50.71 4.3 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.308 -0.473 . . . . 71.13 113.5 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -54.47 -26.22 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 113.377 0.88 . . . . 71.0 113.377 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.08 -9.27 59.62 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.973 -0.632 . . . . 73.11 114.349 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.461 ' ND2' ' HA2' ' A' ' 76' ' ' GLY . 93.9 m-20 -53.83 101.7 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.599 0.7 . . . . 74.35 111.317 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 38.03 40.49 0.31 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.698 0.799 . . . . 64.13 112.132 -173.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER 65.48 83.43 0.17 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.115 -0.948 . . . . 74.13 112.013 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.571 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 37.4 t30 -68.46 138.79 55.54 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.994 -0.548 . . . . 70.44 110.102 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.424 ' HA ' ' H ' ' A' ' 104' ' ' GLY . 27.7 p-10 -39.13 -67.13 0.23 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.765 1.024 . . . . 75.11 113.765 -170.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.752 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 81.1 m-20 -96.86 25.81 5.04 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.676 -0.64 . . . . 71.34 111.702 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.44 127.54 8.04 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.98 -0.629 . . . . 51.02 113.16 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 53.2 tp -145.05 119.3 9.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.081 0.467 . . . . 71.11 111.052 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.401 HD21 HD23 ' A' ' 71' ' ' LEU . 54.3 tp -117.45 142.08 47.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.883 0.373 . . . . 61.41 111.642 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.6 tp -128.68 118.71 23.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.031 -0.531 . . . . 65.23 110.754 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -113.8 129.43 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.864 0.364 . . . . 60.24 111.969 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.852 HD22 HD11 ' A' ' 135' ' ' LEU . 12.3 tp -102.37 124.09 47.32 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.966 0.506 . . . . 73.23 111.023 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 59' ' ' ILE . 58.3 t -111.82 98.33 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.912 0.387 . . . . 71.43 111.118 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.1 tp -54.5 -40.4 68.51 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.017 -0.538 . . . . 64.34 111.656 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.508 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 14.2 t70 -51.73 -37.46 51.15 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.861 -0.609 . . . . 41.05 112.427 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -112.87 -6.59 13.79 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.203 0.446 . . . . 73.01 112.203 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.532 ' HG2' ' HE1' ' A' ' 131' ' ' TYR . 99.6 mtt180 57.58 24.28 10.24 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.126 0.489 . . . . 64.54 111.628 -174.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -106.84 147.38 29.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.074 0.464 . . . . 71.33 111.725 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 90' ' ' LEU . 15.3 m -133.53 157.44 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.693 -0.685 . . . . 54.4 110.342 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' HB3' HG21 ' A' ' 68' ' ' THR . 76.6 ttt-85 -148.44 137.73 21.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.081 0.4 . . . . 75.4 112.081 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 97.1 m-85 -96.08 151.84 19.09 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.975 -0.557 . . . . 74.55 110.628 173.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 9.2 tp10 -138.01 114.53 10.42 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.435 -0.166 . . . . 71.33 110.715 175.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 p -98.06 157.14 16.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.728 0.775 . . . . 60.35 113.076 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -98.54 171.98 25.76 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.172 -0.922 . . . . 74.41 112.153 167.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -51.88 -24.67 6.56 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.991 0.738 . . . . 72.32 112.991 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.424 ' H ' ' HA ' ' A' ' 83' ' ' ASN . . . -80.61 -16.56 75.31 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.905 -0.664 . . . . 72.31 112.951 -174.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.476 HD11 HG13 ' A' ' 49' ' ' VAL . 93.6 mt -108.27 -10.81 15.32 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.366 0.506 . . . . 62.01 112.366 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -49.75 -32.44 13.72 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.675 0.62 . . . . 74.34 112.675 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.76 -22.38 64.21 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.03 -0.605 . . . . 51.35 113.978 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -102.97 -38.62 7.28 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.394 0.616 . . . . 71.41 111.471 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.482 ' HB3' HD21 ' A' ' 114' ' ' LEU . 25.7 mt -127.66 78.1 75.31 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 115.735 -0.666 . . . . 61.03 111.234 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.28 163.31 36.7 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.148 1.898 . . . . 64.42 112.722 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -52.56 -44.88 66.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.253 0.464 . . . . 63.04 112.253 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.62 98.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.259 -0.496 . . . . 54.23 113.169 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 109' ' ' LEU . 58.2 tp -65.39 -49.25 69.98 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 122.441 -0.446 . . . . 65.11 110.955 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 109' ' ' LEU . 91.0 mt -55.62 -44.17 76.8 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.054 0.454 . . . . 54.02 110.842 176.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -60.67 -43.47 97.63 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.937 -0.574 . . . . 64.33 111.102 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -57.52 -53.2 60.8 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.646 -0.252 . . . . 74.5 111.249 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.9 mt -50.82 -40.65 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.955 0.407 . . . . 73.22 111.213 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.687 ' O ' ' HB2' ' A' ' 122' ' ' MET . 77.8 mt -59.09 -44.85 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.03 -0.532 . . . . 73.02 111.248 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -83.23 -22.58 33.06 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.644 -0.66 . . . . 61.22 112.163 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.95 -55.89 3.84 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.532 0.333 . . . . 74.33 111.711 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 25.7 mtp180 -118.63 6.83 11.64 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.106 0.78 . . . . 71.34 113.106 -172.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.687 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 17.0 mmt -108.79 -62.8 1.42 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.025 0.441 . . . . 75.24 111.412 174.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.473 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 28.7 mm -47.33 -53.1 31.3 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 113.907 1.077 . . . . 62.44 113.907 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 13.7 Cg_endo -54.2 -34.5 79.31 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.225 1.95 . . . . 61.42 112.771 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 96.4 m-70 -77.97 -43.1 30.69 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.34 -0.391 . . . . 63.41 111.294 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.7 m-30 -59.75 -42.26 92.85 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.756 0.312 . . . . 74.55 111.258 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -59.3 -35.85 74.52 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.073 0.463 . . . . 73.33 111.247 176.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.2 m -82.77 -16.81 46.46 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.026 -0.534 . . . . 71.25 112.019 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.89 -2.62 52.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.467 -0.397 . . . . 51.35 112.796 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.814 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.3 m-20 -81.78 62.96 5.83 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 122.51 -0.406 . . . . 75.15 111.242 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.532 ' HE1' ' HG2' ' A' ' 95' ' ' ARG . 97.1 m-85 -58.72 -60.45 3.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.296 0.48 . . . . 72.12 112.296 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.475 ' HB1' HD23 ' A' ' 28' ' ' LEU . . . -63.75 -35.46 80.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.957 0.408 . . . . 73.2 111.949 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.814 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 6.9 tp10 -58.59 -50.16 74.83 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.19 0.519 . . . . 75.35 110.845 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.33 -46.83 93.62 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 115.859 -0.61 . . . . 72.43 112.874 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.852 HD11 HD22 ' A' ' 90' ' ' LEU . 85.2 mt -51.44 -48.9 62.58 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.039 0.447 . . . . 75.03 111.293 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.5 m -61.82 -38.4 88.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.084 -0.507 . . . . 72.32 111.506 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 5.3 mm-40 -64.2 -45.87 86.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.732 0.301 . . . . 75.53 111.668 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 142' ' ' VAL . . . -62.8 -46.48 93.55 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.069 -0.586 . . . . 75.45 112.883 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 135' ' ' LEU . 79.1 t -57.77 -48.6 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.065 0.46 . . . . 73.23 111.2 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.26 -41.12 83.58 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.233 -0.439 . . . . 71.52 111.009 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.52 ' HB2' ' HD3' ' A' ' 121' ' ' ARG . . . -59.65 -51.54 69.36 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.158 -0.474 . . . . 71.21 111.309 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 138' ' ' GLY . 97.5 t -56.33 -48.92 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.986 0.422 . . . . 71.51 110.978 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.443 ' OE1' ' HG3' ' A' ' 39' ' ' ARG . 65.0 tt0 -52.92 -44.13 66.78 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.15 -0.477 . . . . 70.33 111.701 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.27 -35.64 81.66 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.398 0.518 . . . . 75.53 112.398 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 141' ' ' ALA . 61.7 t -59.86 -46.31 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.395 0.616 . . . . 72.53 110.581 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.08 -35.75 71.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.783 -0.644 . . . . 52.31 111.17 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.74 -52.69 64.02 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.308 -0.405 . . . . 70.3 110.963 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.22 41.12 1.77 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.071 -0.585 . . . . 73.12 112.674 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 56.8 m -155.0 -58.24 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.004 0.43 . . . . 74.22 111.23 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.675 ' HB2' ' ND1' ' A' ' 47' ' ' HIS . 41.5 mt -107.15 22.17 16.4 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.466 -0.334 . . . . 71.32 111.835 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -49.48 -38.74 31.16 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.913 0.708 . . . . 74.12 112.913 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -65.86 -9.15 26.51 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.246 0.461 . . . . 73.35 112.246 -174.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -91.22 4.58 51.93 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.912 0.338 . . . . 70.41 111.912 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 8.7 p-80 -61.25 139.58 58.12 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.03 0.752 . . . . 71.43 113.03 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -116.18 -30.99 5.81 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.365 -0.379 . . . . 62.43 111.429 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 76.7 t60 66.4 20.9 10.94 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.158 0.504 . . . . 75.45 111.928 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 26.9 t60 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.637 -0.696 . . . . 73.11 111.054 -179.498 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptp . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.45 0.167 . . . . 44.24 111.172 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.497 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 20.2 ttm180 -168.11 130.89 1.52 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.786 0.327 . . . . 75.45 111.482 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.82 133.6 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.936 0.398 . . . . 54.4 111.764 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.413 ' CD1' ' HD2' ' A' ' 57' ' ' PRO . 57.2 m-85 -123.77 139.72 53.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.12 0.486 . . . . 73.22 111.66 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.58 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 34.9 mmtp -106.18 167.07 10.13 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.894 -0.594 . . . . 73.21 109.564 169.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 18.2 Cg_endo -58.58 -16.88 32.14 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.756 1.637 . . . . 63.3 112.307 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 5' ' ' LYS . 10.6 pt-20 -90.56 -16.63 28.42 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.031 -0.531 . . . . 75.1 111.941 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.97 -30.22 21.43 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.958 0.409 . . . . 70.45 111.079 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.39 123.27 85.07 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.038 -0.528 . . . . 74.25 111.741 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.37 117.26 3.46 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.812 2.341 . . . . 72.12 113.23 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.734 ' HB3' ' HB3' ' A' ' 14' ' ' LEU . 80.5 m-20 -68.5 79.16 0.27 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.321 0.489 . . . . 75.43 112.321 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 m -65.92 -53.47 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 111.684 0.253 . . . . 75.4 111.684 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.464 ' NE2' ' HG ' ' A' ' 20' ' ' LEU . 1.5 mp0 -70.45 1.76 4.69 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.75 0.648 . . . . 61.45 112.75 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 8.8 tt -109.15 -40.98 4.8 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.813 0.34 . . . . 64.41 110.759 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.07 -63.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.211 0.449 . . . . 41.21 112.211 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.52 -71.84 0.18 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.069 0.462 . . . . 62.14 111.3 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 m 73.73 -22.61 0.24 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.836 1.051 . . . . 60.42 113.836 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.53 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 9.4 t -82.32 -12.66 57.84 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.483 0.658 . . . . 70.43 110.769 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . 14.7 ptt-85 -126.87 145.19 50.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.614 -0.721 . . . . 70.21 109.186 171.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HG ' ' NE2' ' A' ' 13' ' ' GLN . 5.7 mp -119.47 14.66 12.84 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.85 0.357 . . . . 74.24 111.445 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.61 123.58 68.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.071 0.397 . . . . 74.01 112.071 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.6 m -120.66 102.98 8.77 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.39 -0.368 . . . . 65.11 110.824 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 25.7 t70 -97.73 103.73 15.69 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.034 0.445 . . . . 61.12 111.366 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB2' HD23 ' A' ' 56' ' ' LEU . 5.3 mm-40 -110.96 -28.42 8.36 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.335 -0.393 . . . . 62.21 111.632 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -64.08 -25.27 68.03 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.004 0.372 . . . . 73.41 112.004 172.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.55 44.58 9.29 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.016 -0.611 . . . . 62.41 112.354 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -115.93 -21.58 9.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.621 0.369 . . . . 54.52 111.593 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.0 mt -96.8 111.17 23.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.778 0.323 . . . . 44.01 111.536 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.5 t -67.55 151.06 47.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.505 0.193 . . . . 45.04 111.081 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -51.2 -42.67 61.06 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.306 0.484 . . . . 51.32 112.306 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.44 -40.03 94.97 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.105 0.479 . . . . 62.4 111.539 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -67.29 -39.95 86.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.872 0.368 . . . . 73.34 110.797 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.59 -42.39 98.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.315 -0.402 . . . . 54.41 111.487 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.05 -53.68 52.78 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.009 0.433 . . . . 74.42 111.107 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.72 -45.29 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.331 -0.395 . . . . 73.14 111.647 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 52.1 ttm -61.14 -47.98 83.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.638 -0.255 . . . . 45.15 111.5 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 56.0 m-80 -60.22 -37.75 81.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.662 0.267 . . . . 63.52 110.997 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.23 95.66 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.917 -0.659 . . . . 73.14 112.882 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' O ' HG13 ' A' ' 43' ' ' ILE . 98.6 mtt180 -64.0 -55.51 21.81 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.996 0.427 . . . . 65.13 110.872 174.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.85 -49.82 76.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.099 -0.501 . . . . 62.43 112.242 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' A' ' 18' ' ' THR . 30.9 ttp180 -58.09 -40.38 80.96 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.192 -0.458 . . . . 65.14 111.104 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.45 89.5 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.422 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 39' ' ' ARG . 86.4 mt -58.43 -49.45 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.752 0.311 . . . . 73.12 111.627 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 57.2 ttp180 -69.42 -26.84 64.82 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.14 -0.35 . . . . 74.04 111.529 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -82.13 -22.63 36.07 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.858 0.361 . . . . 61.24 111.098 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 154' ' ' HIS . 45.6 m -102.8 -66.08 0.95 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.125 -0.489 . . . . 72.32 111.62 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.643 ' ND1' ' HB2' ' A' ' 150' ' ' LEU . 83.7 m-70 -84.35 -8.99 58.82 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.302 -0.408 . . . . 71.1 112.017 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 68.54 15.01 9.15 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.939 0.495 . . . . 71.34 112.318 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.74 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 89.3 t -86.22 119.27 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.019 0.438 . . . . 72.34 111.934 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -78.15 96.13 5.1 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 74.34 110.184 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -115.76 106.1 13.48 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.388 -0.369 . . . . 71.44 110.722 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.65 146.63 34.47 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.942 0.401 . . . . 55.1 112.055 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.89 114.79 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.939 0.4 . . . . 65.52 111.284 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.463 ' HB ' HG22 ' A' ' 89' ' ' VAL . 48.7 t -118.88 132.7 68.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.839 0.352 . . . . 62.23 111.492 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.418 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 32.0 p -110.38 125.58 53.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.94 0.4 . . . . 70.41 111.129 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.447 HD23 ' HB2' ' A' ' 24' ' ' GLU . 55.1 mt -131.55 142.16 44.33 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.445 -0.343 . . . . 61.32 110.85 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.645 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 22.5 Cg_exo -64.59 -67.35 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.373 2.049 . . . . 74.12 112.076 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.9 t -133.64 157.74 45.0 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.135 0.493 . . . . 71.41 111.32 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 pt -120.35 9.9 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.915 -0.584 . . . . 65.53 111.078 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.0 -119.62 5.26 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 116.18 -0.464 . . . . 74.43 113.118 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -112.04 3.82 17.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.391 0.276 . . . . 72.35 111.722 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.86 139.14 96.71 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 111.795 0.295 . . . . 65.24 111.795 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.735 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 57.1 Cg_endo -71.07 125.31 11.34 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.354 2.036 . . . . 63.41 111.826 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.463 ' HG ' ' HB2' ' A' ' 98' ' ' ARG . 44.2 tp -56.25 -41.75 76.26 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.509 0.559 . . . . 61.12 112.509 -173.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.07 -35.16 79.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.106 0.479 . . . . 73.24 112.134 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.735 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 5.8 m-20 -86.74 -28.23 23.18 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.109 0.481 . . . . 72.04 111.356 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -57.37 -50.24 73.59 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.924 -0.58 . . . . 72.3 110.782 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 p -58.11 -37.65 74.96 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.769 -0.65 . . . . 65.14 112.049 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -62.25 -38.33 88.87 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 120.708 0.29 . . . . 63.02 111.671 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -66.97 -38.76 86.66 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.92 0.39 . . . . 63.24 111.554 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.551 HD23 HD21 ' A' ' 87' ' ' LEU . 45.5 tp -72.07 -42.61 66.0 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.173 0.511 . . . . 63.24 111.345 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.49 -44.4 95.99 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.302 0.482 . . . . 74.41 112.302 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' CB ' ' HA ' ' A' ' 79' ' ' ASN . 15.0 ptp180 -68.43 -25.2 64.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.046 0.387 . . . . 74.24 112.046 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -70.66 -42.67 70.5 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.997 0.427 . . . . 72.13 110.828 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -82.04 -15.7 52.69 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.157 -0.474 . . . . 74.04 112.256 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.58 9.37 64.7 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.881 -0.676 . . . . 62.44 112.75 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 t -86.72 -12.17 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.869 0.366 . . . . 64.23 110.726 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.86 67.31 0.13 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.905 -0.664 . . . . 72.21 113.435 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.449 ' HA ' ' CB ' ' A' ' 73' ' ' ARG . 2.3 m-20 -59.23 -46.48 88.37 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.304 0.573 . . . . 64.02 110.536 176.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.5 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -135.71 -83.79 0.39 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.178 -0.919 . . . . 75.42 109.227 169.408 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.5 ' HD2' ' O ' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -123.03 85.35 2.41 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.263 0.554 . . . . 75.44 110.892 169.28 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.484 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 45.0 t30 -71.12 153.5 42.48 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.823 -0.626 . . . . 64.42 111.136 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.474 ' CG ' ' H ' ' A' ' 84' ' ' ASN . 38.2 p-10 -62.62 -90.15 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 112.668 0.618 . . . . 74.42 112.668 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.74 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.1 m-20 -88.26 32.87 0.75 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.004 -1.06 . . . . 64.14 112.095 -173.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.67 127.72 8.76 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.171 -0.537 . . . . 62.3 113.694 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.6 tp -142.53 119.85 11.57 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.206 0.527 . . . . 72.45 111.042 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.551 HD21 HD23 ' A' ' 71' ' ' LEU . 56.7 tp -114.94 122.25 45.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.335 -0.393 . . . . 73.41 111.453 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.4 tp -111.36 114.04 26.92 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.36 -0.382 . . . . 74.0 111.003 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' A' ' 54' ' ' VAL . 84.5 t -119.06 131.56 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.866 0.365 . . . . 72.0 111.619 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.534 ' HB2' HD21 ' A' ' 135' ' ' LEU . 30.3 tp -106.22 130.74 54.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.362 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.795 HG11 HE21 ' A' ' 94' ' ' GLN . 86.2 t -106.12 109.7 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.372 -0.376 . . . . 71.55 111.101 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 69.0 tp -60.87 -41.01 95.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.131 0.419 . . . . 65.13 112.131 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.09 -47.31 85.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.219 0.533 . . . . 73.31 111.699 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.795 HE21 HG11 ' A' ' 91' ' ' VAL . 45.8 mt-30 -87.44 -15.35 37.96 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.981 -0.554 . . . . 73.01 112.356 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 95' ' ' ARG . 56.0 mtt180 58.99 36.43 24.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.098 0.407 . . . . 74.11 112.098 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -144.74 157.79 44.04 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.955 0.407 . . . . 64.14 111.519 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.551 HG21 ' SD ' ' A' ' 122' ' ' MET . 10.2 m -117.87 171.61 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.244 0.545 . . . . 62.34 112.066 -174.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.463 ' HB2' ' HG ' ' A' ' 64' ' ' LEU . 27.8 tpt180 -136.81 129.04 29.78 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.957 -0.565 . . . . 73.13 111.348 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -103.11 107.89 18.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.184 -0.462 . . . . 63.43 110.391 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -102.43 111.96 24.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.473 0.178 . . . . 64.34 110.897 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 p -103.86 150.36 24.22 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.238 0.542 . . . . 64.13 111.871 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -85.27 -145.0 7.46 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.795 -0.717 . . . . 64.35 112.171 169.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.15 -25.84 21.62 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 122.514 -0.404 . . . . 73.04 111.745 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.9 -28.52 62.55 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.017 -0.611 . . . . 61.24 113.697 -170.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 49' ' ' VAL . 96.9 mt -99.3 -0.67 40.74 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.744 0.646 . . . . 74.43 112.744 -174.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -61.48 -27.21 68.42 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.959 0.409 . . . . 74.35 112.052 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.35 3.6 86.91 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.429 -0.415 . . . . 51.24 113.667 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -126.54 -38.7 2.07 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.072 0.463 . . . . 74.01 111.583 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.516 ' HB3' HD21 ' A' ' 114' ' ' LEU . 17.4 mt -129.82 78.71 74.67 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.892 -0.595 . . . . 72.01 111.61 -171.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.21 151.36 48.97 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.442 2.095 . . . . 75.01 112.168 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -50.41 -35.29 27.76 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.299 0.481 . . . . 74.34 112.299 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.75 -48.95 80.92 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.177 -0.535 . . . . 61.23 112.559 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.0 tp -60.03 -44.98 94.27 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.093 0.473 . . . . 61.11 110.94 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 109' ' ' LEU . 85.4 mt -58.71 -39.17 80.04 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.994 -0.548 . . . . 65.51 111.105 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.8 t -65.28 -39.74 92.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.98 0.419 . . . . 72.32 110.89 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -57.04 -48.73 77.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.911 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.4 mt -53.05 -47.71 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.2 0.524 . . . . 75.24 111.386 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 122' ' ' MET . 67.5 mt -60.09 -55.64 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.008 -0.542 . . . . 54.42 111.697 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.483 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 65.1 m80 -70.27 -35.4 73.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.036 0.754 . . . . 73.42 113.036 -173.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.15 -38.12 21.08 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.259 0.837 . . . . 64.33 113.259 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.5 ' HD3' ' HB2' ' A' ' 141' ' ' ALA . 35.9 mtp180 -111.74 -33.3 6.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.275 0.843 . . . . 72.04 113.275 -173.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.551 ' SD ' HG21 ' A' ' 97' ' ' VAL . 53.5 mtt -84.41 -54.0 5.07 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.759 0.652 . . . . 73.54 112.759 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.504 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 46.9 mm -48.86 -50.25 62.64 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 113.257 0.836 . . . . 62.54 113.257 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 9.5 Cg_endo -51.98 -46.09 34.56 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 122.221 1.947 . . . . 65.23 112.852 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -70.06 -40.89 74.8 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.859 0.318 . . . . 74.12 111.859 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.0 m-30 -58.43 -41.17 84.43 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.023 0.439 . . . . 74.42 111.292 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -70.69 -39.44 73.49 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.066 0.46 . . . . 72.34 110.798 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.8 t -68.73 -22.36 64.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.156 -0.475 . . . . 73.44 111.569 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.13 -10.19 24.76 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.522 -0.371 . . . . 72.23 113.34 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.747 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 69.4 m-20 -85.57 77.39 9.86 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.503 -0.41 . . . . 63.2 111.707 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -62.58 -41.86 99.21 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.147 0.499 . . . . 65.2 110.945 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.23 -45.91 82.74 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.964 -0.562 . . . . 64.14 111.987 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.747 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 21.1 mm-40 -68.09 -32.39 72.68 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 111.86 0.319 . . . . 72.42 111.86 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 122' ' ' MET . . . -59.38 -44.89 96.26 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.386 -0.912 . . . . 21.34 111.753 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 90' ' ' LEU . 94.2 mt -66.08 -44.4 84.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.877 0.325 . . . . 63.12 111.877 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.8 p -62.5 -38.81 91.36 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.664 0.268 . . . . 72.23 111.191 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -66.14 -41.28 90.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.775 0.321 . . . . 62.45 111.416 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.14 -48.56 85.51 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.842 -0.694 . . . . 53.2 112.58 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 135' ' ' LEU . 89.3 t -56.39 -47.04 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.028 0.442 . . . . 75.42 111.055 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 44.3 tp -60.14 -39.77 87.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.864 -0.607 . . . . 72.13 111.069 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.5 ' HB2' ' HD3' ' A' ' 121' ' ' ARG . . . -61.89 -52.14 65.33 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.874 0.369 . . . . 53.04 111.51 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.85 -45.19 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.091 0.472 . . . . 71.51 110.978 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -54.6 -47.6 73.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.05 -0.523 . . . . 72.42 111.222 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 96.3 mt-30 -56.49 -45.57 80.91 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.394 -0.367 . . . . 74.11 111.757 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ALA . 60.6 t -57.15 -44.79 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.17 0.509 . . . . 73.1 111.285 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.2 -45.51 76.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.118 -0.492 . . . . 75.24 111.607 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 151' ' ' GLU . 65.8 m-20 -61.9 -22.41 65.55 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.825 0.345 . . . . 71.13 111.713 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.26 4.69 85.78 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.073 -0.584 . . . . 61.55 112.833 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.1 m -130.59 -50.69 1.07 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.466 0.543 . . . . 45.42 112.466 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.643 ' HB2' ' ND1' ' A' ' 47' ' ' HIS . 56.0 mt -117.44 31.25 6.83 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.553 0.341 . . . . 75.33 111.72 -174.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 0.3 OUTLIER -50.13 -38.26 38.19 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.669 0.988 . . . . 73.12 113.669 -173.26 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -73.97 2.56 8.4 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.609 0.596 . . . . 72.23 112.609 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 157' ' ' HIS . 55.3 m170 -96.42 122.38 39.25 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.026 -0.421 . . . . 74.34 111.894 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 79.3 t60 -152.54 -65.66 0.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.14 -0.482 . . . . 73.44 110.821 172.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -81.57 -14.06 57.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.578 0.704 . . . . 75.43 110.451 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -141.62 115.86 9.43 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.295 -0.866 . . . . 74.34 110.094 171.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 153' ' ' HIS . 17.9 p-80 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 119.04 -0.505 . . . . 75.43 112.09 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.054 0.454 . . . . 71.0 111.74 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -164.4 138.47 5.36 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.827 -0.624 . . . . 75.33 110.27 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.64 102.17 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.108 0.48 . . . . 74.4 111.241 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.416 ' CD1' ' HD2' ' A' ' 57' ' ' PRO . 39.8 m-85 -91.43 125.32 36.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.213 0.53 . . . . 70.44 111.793 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 9.6 mtmp? -94.96 159.02 34.02 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.898 -0.592 . . . . 74.42 110.187 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 48.0 Cg_endo -66.6 -2.66 7.82 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.229 1.953 . . . . 74.13 113.039 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -107.28 -8.76 16.27 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.211 -0.449 . . . . 74.22 110.93 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.41 -26.89 19.65 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.002 0.43 . . . . 71.11 110.601 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.6 t -57.13 128.13 77.35 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.872 -0.604 . . . . 72.44 111.662 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.85 109.07 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.659 2.24 . . . . 74.41 112.721 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -69.19 77.92 0.35 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.042 0.449 . . . . 63.14 111.236 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 13' ' ' GLN . 28.6 m -67.64 -51.3 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.263 0.468 . . . . 72.12 112.263 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 12' ' ' VAL . 15.8 mm100 -56.97 -21.2 28.47 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.06 0.393 . . . . 73.52 112.06 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.68 -52.72 34.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.038 0.447 . . . . 63.1 109.967 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.28 -65.79 0.98 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.424 -0.353 . . . . 75.22 111.544 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -98.27 101.79 13.34 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.115 0.483 . . . . 62.13 111.966 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.7 p -82.79 -3.64 56.92 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.164 0.507 . . . . 74.5 110.522 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -78.91 -37.41 39.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.846 -0.616 . . . . 70.23 111.74 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -102.18 125.97 49.02 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.25 0.548 . . . . 61.32 110.527 173.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 20' ' ' LEU . 4.6 mp -109.33 8.62 25.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.274 0.559 . . . . 73.52 110.623 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.8 t -101.37 142.73 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.796 -0.638 . . . . 73.11 111.656 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.2 m -145.42 103.41 3.82 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.456 -0.338 . . . . 70.12 110.865 175.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.496 ' HB2' HD12 ' A' ' 28' ' ' LEU . 28.8 t70 -105.05 96.76 6.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.223 0.535 . . . . 74.05 111.59 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -97.45 -38.45 9.6 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.019 0.437 . . . . 71.31 110.336 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.588 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -57.09 -43.85 82.6 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.483 0.549 . . . . 74.44 112.483 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.19 36.3 6.34 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.03 -0.605 . . . . 65.0 112.301 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 92' ' ' LEU . 86.5 mt -103.6 -15.99 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.847 0.356 . . . . 75.32 111.443 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 23' ' ' ASP . 96.6 mt -90.8 -165.91 1.46 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.162 0.506 . . . . 74.35 111.553 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -161.68 153.52 19.18 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.966 -0.561 . . . . 73.03 110.019 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -47.93 -43.29 28.98 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.279 0.474 . . . . 64.1 112.279 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.14 -49.64 71.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.116 0.484 . . . . 75.21 111.622 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.458 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 12.5 mm-40 -71.33 -38.27 71.68 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.208 -0.451 . . . . 63.0 111.731 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.83 -36.48 84.03 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.044 0.45 . . . . 74.32 111.089 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.52 -54.97 23.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.139 -0.482 . . . . 64.25 110.918 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.8 -43.89 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.082 0.468 . . . . 63.11 111.282 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.423 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.6 ttm -64.22 -49.58 71.4 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.106 -0.497 . . . . 74.12 111.049 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -57.33 -48.17 79.66 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.636 0.255 . . . . 75.41 111.27 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.35 92.13 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.093 -0.575 . . . . 50.55 112.952 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.609 ' NH1' HD13 ' A' ' 140' ' ' LEU . 60.1 mtt180 -70.42 -49.9 44.11 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.983 0.364 . . . . 74.13 111.983 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 36' ' ' MET . 92.6 mt -55.18 -46.96 75.83 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.258 0.551 . . . . 75.44 111.042 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 41' ' ' ARG . 40.9 ttm180 -61.74 -42.77 99.4 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.811 -0.631 . . . . 74.22 110.76 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.05 79.62 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.159 -0.473 . . . . 61.25 111.198 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.562 HG22 ' HB ' ' A' ' 49' ' ' VAL . 81.8 mt -67.79 -41.6 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.052 0.453 . . . . 73.22 110.747 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 44.8 ttt180 -68.01 -27.85 66.91 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.022 0.439 . . . . 70.31 111.2 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 13.3 t -85.75 -32.22 21.98 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.074 0.464 . . . . 31.12 111.403 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.403 ' HA ' ' H ' ' A' ' 156' ' ' HIS . 41.4 t -82.66 -61.9 1.75 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.079 0.466 . . . . 71.1 111.884 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.615 ' ND1' HD12 ' A' ' 150' ' ' LEU . 43.7 m-70 -102.22 -0.39 33.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.876 -0.602 . . . . 75.14 111.602 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.48 10.81 5.13 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.843 0.457 . . . . 62.11 111.892 -176.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.562 ' HB ' HG22 ' A' ' 43' ' ' ILE . 78.6 t -77.38 111.44 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.042 0.449 . . . . 63.42 111.142 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HG2' ' HE ' ' A' ' 44' ' ' ARG . 40.7 mt-10 -82.16 95.92 7.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.676 0.75 . . . . 73.21 110.138 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -107.96 103.11 12.27 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.13 -0.941 . . . . 73.21 111.007 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.66 139.7 38.59 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.403 0.52 . . . . 55.54 112.403 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.5 t -124.08 119.42 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.982 0.42 . . . . 14.44 111.487 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.16 139.11 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.471 -0.331 . . . . 73.45 111.533 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 24.2 p -118.05 126.82 53.02 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.941 0.401 . . . . 73.4 111.015 176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 61.6 mt -125.68 140.95 37.8 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 120.672 0.272 . . . . 51.55 111.633 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.588 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 27.6 Cg_exo -62.89 -61.3 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.698 2.265 . . . . 60.4 113.019 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.449 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 78.2 p -148.17 145.41 28.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.814 0.302 . . . . 65.03 111.814 -176.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.507 HD13 HG21 ' A' ' 91' ' ' VAL . 34.5 pt -127.82 5.02 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.011 0.434 . . . . 72.14 111.593 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.6 -136.52 29.73 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.991 -0.624 . . . . 73.14 113.39 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -87.99 15.58 7.1 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.515 -0.403 . . . . 74.14 111.704 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.3 125.0 91.56 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 120.726 0.298 . . . . 74.44 111.607 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.93 108.84 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.262 1.974 . . . . 74.31 112.249 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.4 tp -57.94 -29.43 65.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.943 0.401 . . . . 72.12 112.042 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 9.3 mp0 -63.66 -32.62 74.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.24 0.543 . . . . 41.2 111.147 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.82 -33.1 16.63 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.457 0.646 . . . . 61.34 110.355 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -52.67 -51.76 58.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.913 0.885 . . . . 73.23 112.051 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.4 p -60.52 -31.21 70.29 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.476 0.547 . . . . 64.45 112.476 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.605 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.5 tp -56.06 -53.71 53.71 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.962 0.41 . . . . 71.42 110.987 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -60.84 -33.3 72.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.991 0.424 . . . . 72.44 112.093 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.503 HD23 HD21 ' A' ' 87' ' ' LEU . 34.3 tp -74.4 -54.95 6.59 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.994 0.426 . . . . 74.14 111.647 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.621 ' HB1' ' HA3' ' A' ' 78' ' ' GLY . . . -57.17 -36.83 71.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.192 0.442 . . . . 74.43 112.192 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 57.5 mtp180 -64.89 -48.43 74.26 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.028 0.381 . . . . 45.52 112.028 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.567 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 10.5 pt20 -71.27 -25.53 62.49 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.933 0.397 . . . . 73.33 111.161 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.567 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 19.5 m0 -79.59 -4.93 53.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.538 -0.301 . . . . 75.02 111.744 174.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.33 -43.52 2.73 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.26 -0.495 . . . . 70.4 113.425 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -53.81 -18.91 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 113.4 0.889 . . . . 72.21 113.4 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.621 ' HA3' ' HB1' ' A' ' 72' ' ' ALA . . . -141.43 39.34 1.43 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.754 -0.736 . . . . 70.02 113.83 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 17.5 p-10 -67.21 82.74 0.13 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.26 0.552 . . . . 74.41 110.679 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 60.13 50.16 6.73 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.591 0.71 . . . . 74.2 109.702 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 3.7 mptp? 65.5 81.84 0.2 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.365 -0.834 . . . . 72.12 111.191 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -62.54 -76.47 0.06 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.482 -0.781 . . . . 63.31 112.091 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -157.74 -136.57 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.925 -0.579 . . . . 54.41 109.916 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.571 ' HA ' ' HG ' ' A' ' 105' ' ' LEU . 17.0 p-10 -72.64 26.91 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.494 -0.754 . . . . 62.21 112.543 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.21 150.18 25.81 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.616 -0.326 . . . . 34.32 112.533 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HB2' ' CD1' ' A' ' 105' ' ' LEU . 62.3 tp -142.66 127.04 17.72 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.89 0.376 . . . . 75.11 111.156 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.503 HD21 HD23 ' A' ' 71' ' ' LEU . 60.6 tp -108.21 133.78 51.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.844 0.354 . . . . 63.52 111.66 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.44 117.39 22.05 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.073 -0.512 . . . . 54.2 110.814 177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.99 129.83 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.729 0.3 . . . . 71.34 111.766 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.47 134.11 50.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.127 0.571 . . . . 75.32 111.078 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.507 HG21 HD13 ' A' ' 59' ' ' ILE . 87.1 t -118.63 105.3 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.926 0.394 . . . . 55.22 111.262 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 27' ' ' LEU . 68.1 tp -53.76 -39.21 65.18 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.114 -0.494 . . . . 50.12 112.017 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 31.7 t70 -50.77 -32.32 19.45 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.781 0.66 . . . . 74.11 112.781 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -123.67 -3.47 8.26 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.278 0.473 . . . . 71.43 112.278 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 61.25 11.15 3.4 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.398 0.518 . . . . 65.22 112.398 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -97.09 159.86 14.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.054 0.454 . . . . 64.21 111.341 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.692 HG21 ' SD ' ' A' ' 122' ' ' MET . 13.3 m -131.14 172.26 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.985 -0.552 . . . . 60.42 110.525 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -146.39 128.68 15.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.905 0.383 . . . . 64.24 111.639 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -103.97 125.19 50.17 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.692 -0.686 . . . . 73.21 110.434 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -120.21 117.12 27.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.999 0.428 . . . . 74.24 111.175 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.532 HG23 HD11 ' A' ' 114' ' ' LEU . 11.6 p -85.5 155.72 21.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.608 0.718 . . . . 64.54 112.584 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.72 -179.33 36.29 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.4 -0.818 . . . . 64.11 111.844 167.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -63.11 -11.13 17.81 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.874 0.47 . . . . 73.35 112.256 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.15 -32.03 13.17 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.584 -0.341 . . . . 74.24 113.475 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.571 ' HG ' ' HA ' ' A' ' 84' ' ' ASN . 48.1 mt -97.24 -5.04 37.79 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.402 0.89 . . . . 63.22 113.402 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -54.4 -28.63 44.96 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.882 0.697 . . . . 64.01 112.882 -177.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.69 -19.15 71.46 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.238 -0.506 . . . . 64.54 113.822 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -105.82 -40.17 5.81 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.936 0.398 . . . . 65.42 111.91 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.492 ' HB3' HD21 ' A' ' 114' ' ' LEU . 26.8 mt -130.48 88.25 47.75 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.102 -0.499 . . . . 74.22 112.222 -170.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.63 159.25 28.48 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.154 1.903 . . . . 74.25 112.045 172.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -50.46 -36.74 34.9 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.306 0.484 . . . . 72.33 112.306 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.71 -50.14 69.11 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.02 -0.609 . . . . 75.44 112.793 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.29 -43.28 99.14 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.874 0.368 . . . . 74.14 110.988 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.532 HD11 HG23 ' A' ' 101' ' ' THR . 89.6 mt -57.52 -45.09 85.43 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.28 -0.418 . . . . 64.44 110.886 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.2 m -64.4 -34.63 78.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.194 -0.457 . . . . 74.41 111.075 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -62.45 -48.17 80.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.476 -0.329 . . . . 74.11 110.716 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.2 mt -52.37 -45.78 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.338 0.59 . . . . 65.25 110.928 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 122' ' ' MET . 63.6 mt -60.75 -55.82 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.427 -0.806 . . . . 42.41 111.887 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.451 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 10.3 t-80 -75.94 -28.25 57.89 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.721 0.637 . . . . 72.51 112.721 -170.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.97 -49.46 17.64 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.232 0.456 . . . . 55.12 112.232 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -112.21 -44.22 3.44 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.147 0.795 . . . . 71.04 113.147 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.692 ' SD ' HG21 ' A' ' 97' ' ' VAL . 50.8 mtt -62.67 -50.99 69.01 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.524 0.565 . . . . 61.25 112.524 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.575 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 25.7 mm -53.51 -55.54 33.89 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 112.278 0.473 . . . . 63.53 112.278 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.575 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 83.7 Cg_exo -50.22 -46.14 30.15 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 122.15 1.9 . . . . 51.22 113.015 176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 61.0 m-70 -65.41 -49.14 70.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.847 0.314 . . . . 64.24 111.847 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.4 m-30 -61.37 -32.95 72.87 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.894 0.378 . . . . 71.43 111.495 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -69.31 -41.19 77.05 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.97 0.414 . . . . 64.51 110.599 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.0 t -74.24 -21.56 59.72 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.957 0.408 . . . . 63.01 111.661 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 112.16 -4.7 26.96 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.43 -0.414 . . . . 54.42 113.673 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.66 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 79.7 m-20 -83.8 77.49 9.87 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.323 0.49 . . . . 65.42 112.323 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -71.54 -39.48 70.68 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.899 0.38 . . . . 75.44 111.521 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.25 70.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.897 0.38 . . . . 70.44 111.332 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 20.2 mm-40 -61.98 -42.5 99.2 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.146 -0.479 . . . . 73.4 111.542 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.03 -50.64 64.2 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.184 -0.531 . . . . 72.22 112.959 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.54 -41.03 98.48 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.56 -0.377 . . . . 62.33 111.47 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -57.38 -54.76 43.13 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.395 -0.366 . . . . 54.51 111.5 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -68.64 -26.13 65.18 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.248 -0.283 . . . . 62.15 111.607 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.23 -44.8 96.5 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.822 -0.704 . . . . 74.35 112.225 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.68 -49.83 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.007 0.432 . . . . 62.22 110.865 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.609 HD13 ' NH1' ' A' ' 39' ' ' ARG . 54.6 tp -57.69 -41.01 80.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.115 -0.493 . . . . 74.4 111.526 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.43 -51.84 65.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.925 0.393 . . . . 62.14 111.59 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.424 HG13 HD11 ' A' ' 109' ' ' LEU . 86.9 t -60.77 -46.48 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.124 0.488 . . . . 53.11 110.841 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -52.27 -41.09 62.55 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.913 -0.585 . . . . 62.21 111.625 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 98.2 mt-30 -61.15 -48.82 79.85 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.818 0.342 . . . . 72.11 111.325 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.57 -48.29 86.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.185 -0.461 . . . . 73.34 111.657 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 49' ' ' VAL . 81.0 mt -65.21 -56.81 10.69 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.278 -0.419 . . . . 73.0 111.456 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.422 ' HA ' ' HE1' ' A' ' 47' ' ' HIS . 31.2 t70 -62.53 -27.92 69.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.06 -0.518 . . . . 74.51 111.752 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.92 -39.42 28.19 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.99 -0.624 . . . . 63.34 113.013 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.6 m -65.11 -40.26 94.28 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.187 0.44 . . . . 75.01 112.187 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.615 HD12 ' ND1' ' A' ' 47' ' ' HIS . 43.0 mt -78.4 80.02 4.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.501 0.667 . . . . 71.45 112.248 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -22.72 22.61 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.624 -0.716 . . . . 75.2 110.247 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -57.18 -38.79 74.15 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.252 -0.885 . . . . 63.34 111.886 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -162.94 155.23 18.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.344 -0.389 . . . . 53.11 110.028 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -92.96 -177.49 4.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.446 0.535 . . . . 73.34 112.446 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -47.97 147.23 2.14 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.226 1.195 . . . . 74.55 114.226 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 45' ' ' SER . 74.7 m80 -86.08 -173.32 4.52 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.562 -0.745 . . . . 74.05 111.066 174.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.8 -0.619 . . . . 72.25 112.049 179.244 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.638 0.256 . . . . 64.12 111.041 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 58' ' ' SER . 17.4 ptp180 -109.8 -1.55 17.83 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.735 0.302 . . . . 64.42 111.74 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.553 HG22 ' HA3' ' A' ' 60' ' ' GLY . 60.6 t 52.6 107.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 115.005 1.483 . . . . 74.4 115.005 170.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 58' ' ' SER . 23.1 m-85 -112.61 126.48 55.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.102 -0.499 . . . . 74.34 110.528 169.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -111.38 158.9 34.89 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.178 -0.464 . . . . 74.23 110.906 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -49.44 -40.78 44.7 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.767 2.311 . . . . 65.43 113.799 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -82.78 -5.96 59.18 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.409 0.522 . . . . 72.4 112.409 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.68 -30.39 18.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.244 0.545 . . . . 62.31 110.279 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.3 130.44 93.53 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.886 -0.597 . . . . 74.25 110.832 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.56 118.55 5.47 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.239 1.959 . . . . 71.31 112.652 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -61.18 79.9 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.496 0.554 . . . . 64.04 112.496 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.08 -44.45 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.539 0.57 . . . . 73.14 112.539 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -61.25 -15.93 39.97 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.073 0.397 . . . . 64.32 112.073 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 tt -86.26 -32.83 20.91 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.869 0.366 . . . . 72.34 110.601 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -124.72 -70.73 0.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.316 -0.402 . . . . 40.4 111.792 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -77.83 36.24 0.21 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.522 0.564 . . . . 61.32 112.522 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.4 p -70.0 1.84 4.16 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.014 0.435 . . . . 62.44 111.368 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -70.72 -52.81 18.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.837 0.351 . . . . 72.34 111.169 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.624 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 26.8 ptt180 -88.9 -25.78 21.94 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.051 -0.522 . . . . 55.32 111.753 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.61 HD11 ' HE ' ' A' ' 44' ' ' ARG . 5.4 mp 66.61 3.04 2.75 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.996 0.739 . . . . 73.13 112.996 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.624 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 59.5 t -99.63 151.26 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 122.504 0.322 . . . . 55.44 111.617 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -133.07 121.69 23.04 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.479 0.311 . . . . 73.55 110.436 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.87 95.92 5.03 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.147 0.795 . . . . 74.33 113.147 -172.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB2' HD23 ' A' ' 56' ' ' LEU . 6.3 mp0 -102.08 -53.07 3.01 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.247 0.546 . . . . 70.41 110.549 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.45 -28.18 65.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.049 -0.523 . . . . 34.33 111.89 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.01 31.41 79.36 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 116.265 -0.425 . . . . 50.53 113.655 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.2 mt -78.73 -23.67 45.31 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.001 0.429 . . . . 65.22 111.213 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.462 HD23 ' HB1' ' A' ' 132' ' ' ALA . 82.9 mt -80.82 116.24 20.71 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.098 -0.501 . . . . 75.54 111.687 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.8 t -70.64 154.89 41.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 110.159 -0.311 . . . . 62.12 110.159 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -58.89 -32.7 69.74 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.902 0.334 . . . . 72.02 111.902 -175.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.77 -46.92 83.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.313 0.577 . . . . 34.23 110.784 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.87 -38.28 85.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.903 -0.59 . . . . 55.43 111.569 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -64.07 -49.17 73.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.995 -0.282 . . . . 72.15 110.78 172.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.04 -34.57 43.84 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.4 0.619 . . . . 74.51 111.091 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.482 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 45.1 t -82.62 -52.56 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.695 -0.684 . . . . 63.02 111.842 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 48.8 ttm -66.08 -51.67 55.99 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.172 -0.33 . . . . 55.14 111.749 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -52.84 -43.04 65.73 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.107 0.48 . . . . 72.41 110.304 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.39 -43.33 99.48 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.817 -0.629 . . . . 44.43 112.714 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 35' ' ' VAL . 95.0 mtt180 -57.86 -54.93 41.29 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.654 0.264 . . . . 55.14 111.08 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.7 mt -61.87 -45.27 94.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.123 0.487 . . . . 71.13 111.454 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -60.01 -40.55 89.63 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.113 -0.494 . . . . 75.51 111.106 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.46 -44.55 86.85 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.361 -0.382 . . . . 64.51 111.196 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 39' ' ' ARG . 82.1 mt -57.85 -48.3 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.906 0.384 . . . . 74.32 110.809 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.61 ' HE ' HD11 ' A' ' 20' ' ' LEU . 58.3 ttp85 -61.92 -32.48 72.88 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.317 -0.401 . . . . 73.2 111.621 177.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -80.63 -28.37 37.0 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.959 0.355 . . . . 62.31 111.959 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -99.57 -68.68 0.8 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.105 0.409 . . . . 51.43 112.105 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -85.96 -9.95 55.98 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.845 0.313 . . . . 73.45 111.845 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.46 14.14 9.28 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.591 0.589 . . . . 51.53 112.591 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.4 ' HA ' HD21 ' A' ' 84' ' ' ASN . 65.1 t -72.56 133.72 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.026 0.441 . . . . 72.55 111.758 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -86.5 95.87 9.86 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.275 0.56 . . . . 64.35 110.434 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -111.61 105.29 13.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.993 -0.549 . . . . 72.33 110.656 -174.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.95 120.54 40.8 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.208 0.447 . . . . 73.34 112.208 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t -111.15 128.81 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.803 0.335 . . . . 63.44 111.055 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.424 HG21 HD21 ' A' ' 71' ' ' LEU . 44.0 t -128.01 141.31 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 122.403 0.281 . . . . 71.11 111.22 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 p -125.88 120.76 31.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.849 0.357 . . . . 72.12 111.379 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 24' ' ' GLU . 85.2 mt -125.24 135.85 27.41 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-O 120.755 0.312 . . . . 74.14 111.468 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.576 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 72.8 Cg_endo -76.19 -25.23 10.27 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.394 2.063 . . . . 65.32 113.296 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.801 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 32.5 m -155.89 151.93 27.68 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.236 -0.29 . . . . 71.32 111.196 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.507 HD12 ' O ' ' A' ' 62' ' ' ALA . 31.0 pt -125.15 -32.27 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.855 0.36 . . . . 71.42 111.027 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.553 ' HA3' HG22 ' A' ' 3' ' ' VAL . . . 67.16 -116.6 8.21 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.268 -0.491 . . . . 43.12 113.626 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.24 67.36 9.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.612 0.72 . . . . 61.21 111.562 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 59' ' ' ILE . . . -159.42 106.97 1.5 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.509 -0.768 . . . . 61.55 110.808 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 18.2 Cg_endo -57.03 138.86 88.16 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.818 2.345 . . . . 74.21 113.119 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 tp -54.69 -56.1 22.77 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.203 0.816 . . . . 70.32 113.203 -172.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.546 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 23.3 mt-10 -76.25 -9.62 58.77 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.255 0.465 . . . . 73.1 112.255 -173.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.68 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 4.3 m-20 -90.45 -34.55 15.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.96 0.409 . . . . 75.44 110.49 170.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -59.86 -50.51 73.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.678 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.7 p -55.4 -42.68 74.4 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.115 -0.493 . . . . 72.23 111.629 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.46 -54.62 37.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.43 -0.35 . . . . 73.21 111.559 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -61.23 -41.86 97.61 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.021 0.378 . . . . 72.05 112.021 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.424 HD21 HG21 ' A' ' 54' ' ' VAL . 48.7 tp -65.39 -43.62 90.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.248 0.547 . . . . 74.31 110.964 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.422 ' HB1' ' HA3' ' A' ' 78' ' ' GLY . . . -67.45 -32.25 72.97 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.849 0.357 . . . . 74.31 111.433 177.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.3 mtp180 -59.3 -53.84 53.65 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.046 0.388 . . . . 72.45 112.046 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.505 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.1 pt20 -64.54 -31.21 72.33 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.87 0.367 . . . . 61.2 111.734 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.505 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 42.1 m0 -85.97 8.23 21.3 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.027 0.38 . . . . 54.54 112.027 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.96 -49.86 4.17 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 114.385 0.514 . . . . 62.55 114.385 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.528 ' HA ' ' HB3' ' A' ' 82' ' ' ASN . 27.1 m -50.86 -33.99 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 113.162 0.801 . . . . 63.41 113.162 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' HB1' ' A' ' 72' ' ' ALA . . . -113.71 13.84 22.43 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.931 -0.652 . . . . 72.12 113.312 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 25.2 t-20 -58.57 -48.6 80.37 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.223 0.535 . . . . 61.13 110.974 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.92 46.44 0.77 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.584 -0.735 . . . . 62.45 109.979 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 62.91 76.13 0.38 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.304 -0.862 . . . . 73.15 112.153 -177.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 32.8 t-20 -67.43 119.86 12.95 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.373 -0.376 . . . . 61.31 110.031 174.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.578 ' HA ' ' N ' ' A' ' 104' ' ' GLY . 30.3 p-10 -41.3 -44.95 2.86 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.367 0.877 . . . . 75.55 113.367 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' A' ' 49' ' ' VAL . 9.6 t30 -105.16 17.66 23.68 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.214 0.53 . . . . 71.24 111.905 -172.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.75 140.7 15.16 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.094 -0.574 . . . . 44.24 114.26 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 100' ' ' GLU . 51.7 tp -143.92 134.85 25.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.743 0.417 . . . . 74.12 110.858 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 60.0 tp -125.65 140.28 52.85 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.048 0.452 . . . . 72.2 111.778 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.8 tp -137.35 108.2 6.67 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.96 -0.564 . . . . 63.33 110.493 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.65 124.02 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 111.95 0.352 . . . . 73.05 111.95 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.594 ' HA ' HG12 ' A' ' 97' ' ' VAL . 36.8 tp -95.71 114.91 26.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.288 -0.415 . . . . 60.33 111.075 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 94' ' ' GLN . 95.5 t -100.03 94.15 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 120.899 0.38 . . . . 70.55 111.128 177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 52.8 tp -60.09 -27.61 67.14 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.819 0.342 . . . . 74.12 111.293 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.801 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 16.3 t0 -52.18 -35.13 48.03 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.831 0.824 . . . . 65.42 110.72 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.439 ' NE2' HD11 ' A' ' 59' ' ' ILE . 71.1 mt-30 -120.68 8.8 10.66 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.124 -0.944 . . . . 71.34 110.891 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 36.21 52.25 0.87 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.555 1.142 . . . . 70.15 113.536 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -153.33 162.32 41.41 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.881 -0.6 . . . . 61.2 110.91 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.681 HG21 ' SD ' ' A' ' 122' ' ' MET . 5.5 m -123.8 172.43 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.302 0.572 . . . . 74.24 112.186 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.546 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 65.6 ttt-85 -147.16 138.19 23.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.834 -0.621 . . . . 75.04 111.218 172.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -91.17 151.42 20.96 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.029 0.442 . . . . 74.2 111.083 173.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 17.2 tp10 -137.64 112.58 9.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.288 -0.414 . . . . 70.05 110.595 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.6 p -99.69 136.33 39.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.328 0.585 . . . . 73.13 112.528 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -76.99 -178.89 47.75 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.584 -0.817 . . . . 50.43 112.154 168.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -62.36 -18.69 62.13 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.355 0.872 . . . . 73.02 113.355 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.578 ' N ' ' HA ' ' A' ' 83' ' ' ASN . . . -88.04 -40.71 6.51 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.768 -0.73 . . . . 60.31 112.581 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.639 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 95.0 mt -69.16 -6.73 30.6 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.267 0.469 . . . . 64.41 112.267 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -58.57 -23.98 59.79 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.261 0.553 . . . . 74.32 110.913 173.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.09 22.51 39.05 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.119 -0.491 . . . . 74.41 113.209 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.639 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 68.3 m-85 -141.55 -57.48 0.48 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.264 0.554 . . . . 74.05 110.953 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.9 mt -113.36 91.92 21.31 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.563 -0.744 . . . . 75.51 111.675 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.96 151.73 81.6 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.545 2.163 . . . . 70.11 112.509 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -54.49 -41.62 69.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.949 0.404 . . . . 74.45 111.61 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.59 -47.51 89.69 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.335 -0.459 . . . . 63.0 112.903 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.3 tp -56.12 -50.7 70.36 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.868 0.366 . . . . 74.31 111.056 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.08 -36.34 74.92 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.357 -0.383 . . . . 71.51 111.382 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 m -64.99 -41.3 95.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.397 -0.365 . . . . 73.05 111.095 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -64.35 -44.8 90.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.588 -0.278 . . . . 74.03 111.136 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.8 mt -52.59 -48.1 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.1 0.476 . . . . 72.44 110.682 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.0 mt -61.53 -37.07 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.224 -0.444 . . . . 74.32 111.6 176.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 7.6 t-80 -83.3 -28.41 29.11 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.05 0.759 . . . . 54.02 113.05 -173.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.96 -48.32 4.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.129 0.418 . . . . 72.21 112.129 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.693 ' HA ' ' HE ' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -84.61 -15.33 45.92 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.497 0.554 . . . . 73.14 112.497 -175.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.681 ' SD ' HG21 ' A' ' 97' ' ' VAL . 60.7 mtt -120.79 -54.77 2.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.688 0.996 . . . . 73.21 113.688 -176.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.503 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 12.8 mm -46.38 -54.47 18.08 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.202 0.816 . . . . 72.2 113.202 -175.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.503 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 51.6 Cg_exo -55.28 -34.29 87.9 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.767 1.644 . . . . 71.12 112.572 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 96.0 m-70 -76.05 -50.47 14.68 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.166 -0.47 . . . . 73.44 111.772 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.9 m-30 -56.37 -44.01 79.75 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.832 0.349 . . . . 73.34 111.421 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -61.43 -31.08 71.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.121 0.486 . . . . 72.44 111.127 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -88.4 0.67 55.96 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.002 -0.545 . . . . 74.13 111.747 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.72 -7.41 79.79 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.336 -0.459 . . . . 73.52 113.096 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.825 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 13.2 m120 -75.54 67.69 2.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.757 0.423 . . . . 74.51 111.472 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -67.74 -54.34 20.12 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.066 -0.397 . . . . 72.34 111.65 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.462 ' HB1' HD23 ' A' ' 28' ' ' LEU . . . -61.51 -42.97 99.61 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.976 0.417 . . . . 63.21 111.514 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 1.3 mp0 -58.15 -43.09 87.18 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.234 -0.439 . . . . 54.34 111.259 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.91 99.95 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.148 -0.549 . . . . 75.2 112.437 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.492 HD11 HD22 ' A' ' 90' ' ' LEU . 93.3 mt -59.7 -42.43 92.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.737 0.303 . . . . 71.41 111.129 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.5 t -57.68 -48.75 78.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.524 -0.307 . . . . 73.44 111.26 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 133' ' ' GLU . 35.5 mm-40 -62.15 -43.85 97.92 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.956 0.407 . . . . 64.44 111.057 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.87 -54.2 39.48 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 116.166 -0.47 . . . . 41.13 113.385 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.25 -47.62 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.99 0.424 . . . . 63.53 111.379 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.483 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 48.5 tp -61.48 -38.36 87.0 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.187 -0.46 . . . . 65.03 111.047 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -61.37 -50.87 71.16 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.928 0.394 . . . . 71.42 111.263 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.26 -45.91 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.134 0.493 . . . . 71.35 110.818 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -54.82 -43.06 72.62 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.922 -0.581 . . . . 74.13 111.395 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 27.1 mt-30 -62.88 -41.3 99.35 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.704 0.261 . . . . 72.2 111.704 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ALA . 58.0 t -59.35 -50.09 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.858 0.361 . . . . 73.13 111.131 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -58.67 -44.26 90.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.497 0.665 . . . . 72.43 110.464 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -66.13 -14.61 62.09 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.433 -0.803 . . . . 63.15 111.506 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.8 0.4 86.45 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.519 -0.372 . . . . 45.34 113.177 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 96.5 p -118.17 -52.12 2.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.915 0.388 . . . . 74.12 110.543 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 82.5 mt 65.32 5.92 3.37 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.838 0.681 . . . . 74.24 112.838 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -102.0 21.67 14.37 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.858 0.361 . . . . 63.24 111.821 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -130.39 89.24 2.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.439 -0.346 . . . . 72.23 110.959 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -131.1 7.86 4.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.672 0.273 . . . . 73.03 111.65 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -109.93 130.07 55.58 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.198 0.523 . . . . 64.34 112.157 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -132.12 130.25 40.93 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.939 -0.573 . . . . 70.13 109.62 174.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -104.34 168.78 8.87 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.771 0.656 . . . . 73.55 112.771 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 115.379 -0.828 . . . . 60.24 110.917 174.233 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.725 0.297 . . . . 73.53 111.051 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -169.12 11.23 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.303 -0.408 . . . . 64.3 111.573 171.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.53 123.47 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.448 0.536 . . . . 74.52 112.448 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.424 ' HB2' HD13 ' A' ' 56' ' ' LEU . 21.9 m-85 -90.12 174.16 7.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.757 0.789 . . . . 72.44 112.354 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.557 ' H ' ' HB2' ' A' ' 8' ' ' ASP . 30.6 mmtp -132.31 153.27 81.19 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.924 -1.035 . . . . 74.14 109.404 170.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.446 ' HG2' ' HE3' ' A' ' 70' ' ' LYS . 11.1 Cg_endo -56.47 -29.35 77.64 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 121.898 1.732 . . . . 63.04 112.437 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -83.82 -12.56 55.44 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.168 0.433 . . . . 64.53 112.168 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.557 ' HB2' ' H ' ' A' ' 5' ' ' LYS . 3.0 m-20 -81.97 -27.32 33.29 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.92 0.39 . . . . 73.43 111.366 172.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.62 129.62 91.47 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 116.315 -0.402 . . . . 73.33 111.554 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -52.44 126.94 22.23 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.892 2.395 . . . . 75.1 113.329 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -71.93 73.2 0.86 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.889 0.375 . . . . 71.23 111.0 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.95 -38.56 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 112.263 0.468 . . . . 74.45 112.263 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 15.1 mm100 -72.53 74.89 1.06 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.606 0.717 . . . . 71.11 110.825 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt 177.06 -56.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.629 -1.168 . . . . 62.52 108.338 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.08 -47.86 5.61 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.259 -0.882 . . . . 61.22 110.93 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.692 ' HB3' ' HB3' ' A' ' 19' ' ' ARG . 7.8 m-20 -96.57 49.16 1.09 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.776 -0.647 . . . . 72.02 111.79 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.7 m -67.14 -13.8 62.29 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.501 -0.318 . . . . 73.11 111.657 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.6 p -97.87 -3.2 39.13 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.741 0.305 . . . . 72.42 111.489 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.692 ' HB3' ' HB3' ' A' ' 16' ' ' ASP . 78.9 ttt180 -105.21 -56.38 2.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.015 0.436 . . . . 64.35 110.977 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.3 mp 69.96 -13.62 0.41 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.731 0.812 . . . . 61.41 113.069 175.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.3 t -93.43 148.61 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.207 0.527 . . . . 72.04 112.124 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.7 m -143.54 102.61 3.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.2 -0.455 . . . . 71.41 110.591 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.43 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 23.8 t70 -106.1 93.06 4.41 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.292 0.568 . . . . 53.41 111.079 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' HB2' HD23 ' A' ' 56' ' ' LEU . 31.5 mm-40 -94.11 -37.01 11.82 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.957 -0.565 . . . . 65.43 110.841 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.24 -34.11 68.27 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.346 0.499 . . . . 62.23 112.346 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.74 47.29 6.78 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.824 -0.703 . . . . 61.52 112.06 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.7 mt -114.07 -33.32 5.74 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.909 0.385 . . . . 61.31 111.405 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.51 106.15 5.97 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.616 -0.266 . . . . 63.33 110.959 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.5 t -51.77 145.25 9.81 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.375 -0.375 . . . . 54.53 111.193 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -49.54 -30.5 8.59 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.27 0.47 . . . . 63.54 112.27 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -73.58 -51.09 18.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.749 0.309 . . . . 72.22 111.216 175.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -60.98 -42.12 97.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.87 0.367 . . . . 65.44 111.946 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -59.49 -54.18 49.53 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.312 0.577 . . . . 75.14 110.027 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -52.97 -52.61 57.56 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.438 -0.801 . . . . 74.4 112.085 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 31' ' ' ALA . 76.7 t -59.71 -41.99 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.231 -0.441 . . . . 73.33 111.855 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 48.2 ttm -61.34 -42.83 99.32 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.584 -0.28 . . . . 61.44 111.032 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -53.16 -51.94 60.4 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.06 0.457 . . . . 60.21 111.17 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.65 -38.02 93.16 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.166 -0.54 . . . . 44.41 113.242 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 43' ' ' ILE . 99.5 mtt180 -64.87 -54.64 27.76 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.656 -0.32 . . . . 71.14 111.458 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.69 -43.79 93.92 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.037 0.446 . . . . 72.54 111.379 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -57.64 -45.88 84.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.081 -0.509 . . . . 75.2 111.101 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.14 86.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.129 -0.487 . . . . 62.41 111.531 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.7 mt -56.19 -47.65 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.027 0.441 . . . . 65.21 111.375 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.476 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -62.66 -34.58 77.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.183 0.516 . . . . 74.13 110.711 178.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.8 m -89.75 -1.91 58.12 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.132 -0.486 . . . . 62.01 112.134 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.9 p -122.01 -61.87 1.45 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.011 0.434 . . . . 73.43 111.535 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -92.27 -2.18 56.61 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.831 0.348 . . . . 73.14 111.63 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 66.46 11.5 8.08 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.711 0.634 . . . . 71.23 112.711 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 43' ' ' ILE . 62.9 t -80.74 117.47 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.0 0.429 . . . . 72.23 111.619 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' CG ' ' HE ' ' A' ' 44' ' ' ARG . 36.3 mt-10 -78.59 96.58 5.52 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.443 0.639 . . . . 74.32 110.454 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.83 106.89 15.31 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.445 -0.798 . . . . 73.21 110.778 -172.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.98 144.89 40.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.742 0.306 . . . . 53.32 111.789 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.45 128.44 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.745 0.307 . . . . 65.21 111.43 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG21 HD21 ' A' ' 71' ' ' LEU . 58.1 t -129.98 134.97 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 120.708 0.29 . . . . 73.02 111.582 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 39.3 p -120.99 125.32 47.08 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.946 0.403 . . . . 73.43 111.626 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 24' ' ' GLU . 85.1 mt -127.21 145.78 55.52 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-O 120.667 0.27 . . . . 71.2 111.246 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 57.8 Cg_endo -72.16 -45.14 0.69 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.228 1.952 . . . . 54.42 112.997 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.5 m -149.33 137.55 20.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.651 0.262 . . . . 65.54 111.23 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.5 pt -119.28 9.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 121.097 0.475 . . . . 53.54 111.407 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.12 -136.39 32.58 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.292 -0.48 . . . . 32.24 113.082 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -91.4 7.38 41.39 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.603 -0.351 . . . . 74.21 111.478 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . . . -67.74 136.14 92.52 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.12 0.415 . . . . 72.51 112.12 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 62' ' ' ALA . 14.5 Cg_exo -69.59 132.83 24.44 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.586 2.19 . . . . 55.23 112.447 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.7 tp -62.63 -34.31 76.79 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.731 0.301 . . . . 75.54 111.758 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -73.94 -43.17 59.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.012 0.434 . . . . 73.11 111.303 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -61.61 -37.36 83.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.325 0.583 . . . . 74.51 110.149 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -58.79 -60.07 4.42 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.405 -0.816 . . . . 61.34 111.15 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.3 p -55.56 -41.68 73.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.101 -0.5 . . . . 75.2 111.751 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -55.65 -52.29 64.33 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 111.784 0.29 . . . . 74.4 111.784 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HE3' ' HG2' ' A' ' 6' ' ' PRO . 34.7 mtmt -64.92 -46.31 82.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.736 0.303 . . . . 72.4 111.507 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.581 HD21 HG21 ' A' ' 54' ' ' VAL . 40.1 tp -60.88 -42.85 98.74 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.983 0.421 . . . . 64.55 111.201 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.63 -45.88 81.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.275 -0.42 . . . . 61.3 112.048 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.482 ' HA ' ' ND2' ' A' ' 79' ' ' ASN . 36.6 ptt180 -73.76 -24.72 59.9 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.785 0.326 . . . . 73.13 111.743 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -66.62 -40.41 88.78 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.029 0.442 . . . . 55.32 110.886 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 49.5 m0 -93.24 -15.91 25.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.304 -0.407 . . . . 75.24 111.837 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 72.48 44.65 40.5 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.481 -0.39 . . . . 70.35 113.374 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.97 -76.92 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.017 0.436 . . . . 65.14 111.711 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.76 71.8 0.38 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 121.434 -0.412 . . . . 71.5 112.285 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 73' ' ' ARG . 0.9 OUTLIER -74.13 46.56 0.25 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.278 0.473 . . . . 73.05 112.278 -177.145 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 79' ' ' ASN . 43.6 tt0 71.62 -28.1 0.18 Allowed 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 113.158 0.799 . . . . 72.13 113.158 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -144.51 32.8 1.18 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.64 0.607 . . . . 60.33 112.64 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 79' ' ' ASN . 9.8 m-20 -79.49 -101.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.88 0.696 . . . . 52.42 112.88 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 104' ' ' GLY . 3.9 p-10 -154.55 -151.13 0.34 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.907 0.483 . . . . 73.35 110.209 -173.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -67.95 77.8 0.22 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.815 0.816 . . . . 54.4 111.68 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.52 143.25 12.47 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.338 -0.846 . . . . 64.54 111.47 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.714 HD11 ' HB3' ' A' ' 99' ' ' PHE . 31.3 tp -137.37 123.63 20.56 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.142 0.471 . . . . 72.54 111.591 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 59.5 tp -109.16 122.54 47.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.616 -0.265 . . . . 72.41 111.303 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.6 tp -114.19 111.75 22.05 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.516 0.326 . . . . 73.13 111.22 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.94 127.84 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.781 0.324 . . . . 41.21 111.794 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 135' ' ' LEU . 23.1 tp -104.52 121.86 44.35 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.268 -0.424 . . . . 72.21 111.138 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.43 HG11 ' NE2' ' A' ' 94' ' ' GLN . 48.6 t -104.26 103.82 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.853 -0.158 . . . . 72.34 110.885 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.666 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 65.1 tp -57.34 -36.92 71.76 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.802 0.667 . . . . 71.31 112.802 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -50.99 -56.52 12.08 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 120.744 0.307 . . . . 73.25 111.704 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.62 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 8.4 pm0 -98.33 9.18 43.65 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.87 0.367 . . . . 70.15 111.537 174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.486 ' HB2' ' HE1' ' A' ' 131' ' ' TYR . 40.2 ptt180 35.95 46.43 0.35 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.508 1.123 . . . . 72.31 113.707 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.62 ' HE ' ' HG3' ' A' ' 94' ' ' GLN . 26.8 ptt180 -126.45 154.64 43.41 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.891 0.377 . . . . 65.13 111.15 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.636 HG21 ' SD ' ' A' ' 122' ' ' MET . 5.7 m -122.42 171.18 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.234 -0.439 . . . . 73.03 111.804 -176.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.4 ttt85 -148.63 128.82 13.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.256 -0.429 . . . . 64.43 111.719 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.714 ' HB3' HD11 ' A' ' 86' ' ' LEU . 72.0 m-85 -92.66 118.78 31.4 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.303 -0.408 . . . . 71.21 110.013 170.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 8.1 tp10 -103.93 112.29 25.2 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.542 0.211 . . . . 74.44 111.441 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.591 HG23 HD11 ' A' ' 114' ' ' LEU . 7.7 p -96.31 133.24 40.93 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.141 0.496 . . . . 72.15 111.528 177.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 81' ' ' LYS . . . -73.79 -63.52 2.7 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.953 -0.641 . . . . 73.52 112.518 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -168.59 -53.4 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.918 0.39 . . . . 72.01 111.838 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 83' ' ' ASN . . . -54.15 -31.82 49.59 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 114.699 0.639 . . . . 64.42 114.699 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 64.8 mt -78.82 -10.69 59.87 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.906 0.706 . . . . 71.42 112.906 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -57.54 -31.81 66.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.904 0.383 . . . . 72.42 111.284 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.96 -25.08 75.57 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.075 -0.583 . . . . 43.51 113.326 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.402 ' HE1' HD21 ' A' ' 150' ' ' LEU . 74.0 m-85 -102.1 -67.77 0.86 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.414 -0.462 . . . . 60.13 111.276 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.608 ' HA ' HD23 ' A' ' 113' ' ' LEU . 1.6 mp -120.56 93.42 48.41 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 116.427 -0.351 . . . . 63.41 111.463 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.54 157.97 57.98 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.972 1.781 . . . . 71.12 111.529 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.535 ' HA ' HD12 ' A' ' 114' ' ' LEU . 10.0 p-10 -49.25 -33.78 13.57 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.325 0.491 . . . . 62.1 112.325 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.43 -45.51 96.25 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.956 -0.64 . . . . 53.53 112.991 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.608 HD23 ' HA ' ' A' ' 109' ' ' LEU . 53.0 tp -64.37 -35.41 80.78 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.032 0.444 . . . . 75.43 110.937 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.591 HD11 HG23 ' A' ' 101' ' ' THR . 89.1 mt -59.94 -45.27 93.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.896 0.379 . . . . 51.33 110.894 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.4 m -63.78 -36.34 83.57 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.368 -0.378 . . . . 50.13 111.091 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -55.16 -46.02 75.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.094 -0.503 . . . . 70.44 111.104 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.3 -51.99 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.317 -0.401 . . . . 63.14 111.498 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.2 mt -56.58 -55.69 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.239 0.542 . . . . 72.51 112.193 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.469 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 20.3 t-80 -71.0 -30.92 67.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.694 0.628 . . . . 75.14 112.694 -169.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -88.0 -44.51 10.94 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.385 0.513 . . . . 72.35 112.385 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -98.46 -44.55 6.46 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.687 0.625 . . . . 74.42 112.687 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.636 ' SD ' HG21 ' A' ' 97' ' ' VAL . 47.4 mtt -72.68 -48.57 37.98 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.033 0.753 . . . . 75.53 113.033 -175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.469 ' CG1' ' HA ' ' A' ' 119' ' ' HIS . 29.8 mm -49.79 -55.26 24.61 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 113.185 0.809 . . . . 63.32 113.185 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 16.9 Cg_endo -56.61 -38.67 95.06 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.0 1.8 . . . . 62.54 112.477 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -66.25 -49.39 67.33 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 111.602 0.223 . . . . 63.51 111.602 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.1 m-30 -59.69 -35.84 75.29 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.756 0.313 . . . . 72.12 111.271 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -67.29 -36.27 81.2 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.95 0.405 . . . . 71.44 111.554 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 m -78.1 -22.01 49.61 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.858 0.361 . . . . 72.04 111.588 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.41 0.32 32.93 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.442 -0.409 . . . . 73.34 112.865 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.8 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 83.2 m-20 -82.3 74.27 9.28 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.63 -0.335 . . . . 64.25 111.685 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.486 ' HE1' ' HB2' ' A' ' 95' ' ' ARG . 96.9 m-85 -70.93 -44.42 66.18 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.838 0.351 . . . . 73.41 111.298 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.51 -46.61 85.28 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.963 0.411 . . . . 63.03 111.406 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.8 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 27.3 mm-40 -62.25 -49.38 75.96 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.066 -0.516 . . . . 72.24 111.415 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.67 -51.59 51.46 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.427 -0.416 . . . . 63.43 113.154 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.574 HD11 HD22 ' A' ' 90' ' ' LEU . 78.2 mt -62.07 -43.38 98.96 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.604 -0.351 . . . . 75.21 111.504 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.7 t -57.84 -57.57 12.19 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.252 0.464 . . . . 63.5 112.252 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 140' ' ' LEU . 11.9 pt-20 -76.42 -19.81 57.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.913 0.338 . . . . 72.02 111.913 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.79 -50.37 61.74 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.674 -0.774 . . . . 55.23 111.766 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.6 -44.98 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.044 0.449 . . . . 63.41 110.81 172.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 56.2 tp -59.37 -38.05 79.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.074 -0.512 . . . . 73.42 111.165 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -60.24 -44.8 94.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.801 0.334 . . . . 65.23 111.086 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.431 HG13 HD22 ' A' ' 109' ' ' LEU . 90.7 t -59.27 -52.73 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.106 0.479 . . . . 72.34 110.856 174.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -53.05 -43.67 66.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.913 -0.585 . . . . 65.02 111.888 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 83.6 mm-40 -59.3 -37.93 78.97 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.924 0.342 . . . . 74.4 111.924 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 141' ' ' ALA . 91.5 t -64.23 -35.84 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.064 0.459 . . . . 73.21 111.173 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.25 -57.83 5.96 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.368 -0.378 . . . . 74.15 111.648 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.73 -33.15 74.99 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.972 0.415 . . . . 75.34 111.485 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.71 -45.26 85.89 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 116.26 -0.427 . . . . 60.45 113.541 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 87.8 p -73.37 -31.5 63.95 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 122.242 -0.564 . . . . 70.34 111.319 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.402 HD21 ' HE1' ' A' ' 108' ' ' TYR . 74.2 mt -92.98 40.05 1.05 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.914 0.388 . . . . 74.32 111.809 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.85 17.97 1.4 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.756 0.313 . . . . 54.14 111.647 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -54.69 125.15 18.74 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.451 0.301 . . . . 72.42 110.702 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 17.7 p80 47.11 42.09 12.42 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.191 0.996 . . . . 71.11 113.146 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -71.91 74.22 0.88 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.616 0.722 . . . . 62.52 110.808 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -92.15 93.51 8.74 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.914 -0.584 . . . . 74.54 111.645 -173.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -100.75 -9.56 21.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.024 0.44 . . . . 74.31 111.038 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 44.7 m80 . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.97 -0.538 . . . . 74.25 111.043 175.56 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ttt . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.662 0.268 . . . . 72.4 111.54 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -126.41 122.4 35.2 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.813 0.339 . . . . 74.4 110.355 174.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t -88.02 125.76 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 112.734 0.642 . . . . 73.11 112.734 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -111.12 126.74 55.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.984 -0.553 . . . . 73.12 111.86 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -105.73 163.89 16.15 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 116.189 -0.459 . . . . 63.22 109.814 171.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 10.0 Cg_endo -51.53 -29.37 31.72 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.566 2.177 . . . . 63.33 114.118 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -82.87 -17.68 42.99 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.438 0.533 . . . . 72.32 112.438 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.88 -34.89 64.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.074 0.464 . . . . 64.13 110.527 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.405 HG22 HD21 ' A' ' 56' ' ' LEU . 64.9 t -64.7 127.05 92.08 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 115.84 -0.618 . . . . 65.44 111.466 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.21 133.0 31.38 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.376 2.05 . . . . 70.55 113.059 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -74.54 77.12 1.97 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.37 0.605 . . . . 75.42 110.69 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -59.79 -31.0 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 113.151 0.797 . . . . 73.43 113.151 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.34 -9.03 10.24 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.307 0.484 . . . . 74.11 112.307 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.1 tt -76.14 -41.68 49.23 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.209 0.528 . . . . 71.33 110.383 175.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.89 -51.68 3.36 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.043 -0.526 . . . . 70.44 112.39 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 19' ' ' ARG . 34.5 m-20 -114.85 86.59 2.47 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.017 0.747 . . . . 74.3 113.017 -173.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.4 p -78.89 -6.73 56.87 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.569 0.7 . . . . 75.21 110.398 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -93.06 -0.44 57.1 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.802 -0.636 . . . . 44.22 111.128 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 16' ' ' ASP . 18.4 ttt180 -113.31 -63.09 1.49 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.126 -0.488 . . . . 75.31 111.323 -174.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp 64.62 -0.02 1.04 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.224 0.61 . . . . 54.42 112.489 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.0 t -103.81 130.09 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.067 0.46 . . . . 65.13 111.816 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -125.72 112.59 16.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.972 -0.558 . . . . 73.42 110.094 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.68 100.4 7.59 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.363 0.505 . . . . 64.23 112.363 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' HB2' HD23 ' A' ' 56' ' ' LEU . 4.5 mp0 -98.54 -37.75 9.43 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.919 0.39 . . . . 75.34 110.937 173.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -57.24 -31.27 65.37 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.74 0.644 . . . . 61.12 112.74 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.44 39.44 8.33 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.836 -0.697 . . . . 61.1 112.328 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.18 -38.43 5.99 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.063 0.459 . . . . 71.54 111.286 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -90.6 98.88 12.04 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.184 0.516 . . . . 75.44 111.362 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.1 m -72.36 173.05 9.27 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.402 -0.363 . . . . 64.44 111.584 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -49.97 -47.3 52.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.29 0.478 . . . . 71.53 112.29 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.44 -47.27 76.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.932 0.396 . . . . 62.13 111.4 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -55.81 -43.63 77.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.198 -0.456 . . . . 53.12 111.132 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.76 -55.08 37.42 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.369 -0.378 . . . . 75.12 111.132 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.7 -38.87 61.37 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.053 0.454 . . . . 63.31 111.848 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.57 -43.0 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.002 0.43 . . . . 63.13 111.615 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 47.0 ttm -73.22 -45.99 52.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.636 0.255 . . . . 55.23 111.16 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -50.76 -42.79 58.01 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.901 0.48 . . . . 60.11 111.031 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.24 -47.55 90.5 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.154 -0.475 . . . . 63.04 113.561 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 43' ' ' ILE . 9.9 ptp180 -74.45 -34.73 63.24 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.439 -0.448 . . . . 74.42 112.064 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.415 HD22 ' O ' ' A' ' 51' ' ' PHE . 89.8 mt -67.91 -41.65 82.32 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.5 0.667 . . . . 72.04 110.487 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -59.13 -39.58 82.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.378 -0.828 . . . . 62.33 110.352 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.42 85.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.944 -0.571 . . . . 74.41 111.422 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 143' ' ' GLN . 77.2 mt -58.45 -51.9 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.155 -0.475 . . . . 74.13 111.735 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 62.7 ttp85 -65.14 -34.01 77.38 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.772 0.32 . . . . 72.32 111.592 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -76.46 -23.59 53.85 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.831 0.348 . . . . 60.3 111.66 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -100.02 -69.9 0.75 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.663 0.246 . . . . 73.12 111.663 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -87.05 -5.6 59.0 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.523 0.564 . . . . 64.43 112.523 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 67.08 19.83 10.42 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.493 0.553 . . . . 54.42 112.493 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.7 t -90.57 133.99 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.695 0.284 . . . . 70.35 111.627 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.3 96.97 10.78 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.072 0.463 . . . . 74.21 110.658 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -103.59 97.97 7.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.783 -0.644 . . . . 74.13 109.759 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.07 141.94 34.97 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.131 0.419 . . . . 74.42 112.131 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.93 123.9 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.454 -0.339 . . . . 71.22 111.119 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -121.61 136.01 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.399 0.28 . . . . 72.42 111.391 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -120.5 123.75 43.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.912 0.386 . . . . 72.11 111.432 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 24' ' ' GLU . 76.3 mt -124.15 145.36 48.11 Favored Pre-proline 0 N--CA 1.471 0.625 0 O-C-N 122.164 -0.335 . . . . 71.42 111.792 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 27.9 Cg_exo -63.11 -55.99 0.66 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.739 2.293 . . . . 72.45 112.542 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.6 m -150.78 148.58 28.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.758 0.314 . . . . 73.22 111.394 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 91' ' ' VAL . 24.4 pt -118.24 -6.65 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 120.956 0.408 . . . . 74.25 111.777 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.53 -116.18 8.43 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.535 -0.364 . . . . 62.02 113.841 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.3 -13.12 53.31 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.713 0.292 . . . . 73.23 111.761 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -65.49 124.83 88.29 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.606 -0.27 . . . . 64.12 111.329 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.3 Cg_endo -80.14 131.71 8.95 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.427 2.084 . . . . 73.13 112.607 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 96' ' ' ARG . 61.4 tp -59.33 -42.28 91.08 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.422 0.527 . . . . 64.34 112.422 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 8.6 mp0 -60.1 -44.29 94.96 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.031 0.443 . . . . 54.45 111.493 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 6.0 m-20 -74.48 -33.19 62.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.957 0.408 . . . . 75.35 110.809 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.44 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 37.3 t80 -56.6 -55.35 35.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.298 -0.41 . . . . 74.31 111.383 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.9 p -54.69 -46.07 74.06 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.285 -0.416 . . . . 74.34 111.66 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.569 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.0 tp -59.2 -54.59 45.19 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.375 -0.375 . . . . 75.4 111.327 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -58.94 -44.22 91.37 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.107 0.41 . . . . 72.15 112.107 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.598 HD23 HD21 ' A' ' 87' ' ' LEU . 54.7 tp -62.42 -45.35 93.5 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.156 0.503 . . . . 74.35 110.926 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.68 -35.99 81.45 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.905 0.384 . . . . 42.02 111.792 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 78.4 mtp180 -61.67 -53.98 48.93 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.511 -0.313 . . . . 53.25 111.595 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.503 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 16.2 pt20 -64.87 -33.73 76.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 111.987 0.366 . . . . 74.22 111.987 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.503 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 26.9 m0 -74.28 -4.48 36.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.929 0.395 . . . . 74.15 111.956 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.33 -1.01 72.64 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.277 -0.487 . . . . 75.42 113.414 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.402 ' HA ' ' ND2' ' A' ' 82' ' ' ASN . 4.4 t -102.94 15.17 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.291 0.567 . . . . 73.4 110.937 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.11 28.49 0.3 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.265 -0.969 . . . . 71.32 114.535 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -67.31 89.01 0.2 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.113 0.957 . . . . 74.4 110.228 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 57.65 66.06 1.21 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.714 -0.675 . . . . 64.4 110.816 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 11.8 mptt 59.78 91.95 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.561 -0.745 . . . . 72.42 112.473 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.66 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 25.3 t-20 -84.52 119.33 25.05 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 110.201 -0.296 . . . . 75.51 110.201 176.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.548 ' HA ' ' N ' ' A' ' 104' ' ' GLY . 27.6 p-10 -36.43 -63.65 0.38 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 113.958 1.096 . . . . 63.11 113.958 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -94.5 35.16 1.23 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.861 -0.524 . . . . 71.31 111.864 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.4 139.2 15.45 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.136 -0.554 . . . . 73.54 113.933 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 46.6 tp -149.98 122.93 8.76 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.009 0.433 . . . . 74.1 110.846 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.598 HD21 HD23 ' A' ' 71' ' ' LEU . 62.9 tp -122.95 131.79 53.87 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.937 0.399 . . . . 53.4 111.924 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.7 tp -121.35 117.3 26.61 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.146 -0.479 . . . . 72.25 110.889 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.22 124.73 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.943 0.402 . . . . 73.35 111.852 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.524 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.2 tp -103.47 118.59 37.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.056 -0.52 . . . . 74.01 111.007 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 59' ' ' ILE . 57.6 t -99.41 101.22 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.539 -0.3 . . . . 73.45 110.868 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.2 tp -48.93 -46.49 43.21 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.857 0.463 . . . . 72.41 111.994 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -45.27 -48.36 12.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.973 0.731 . . . . 73.11 112.973 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -111.15 4.58 19.42 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.18 0.437 . . . . 75.34 112.18 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 43.52 26.06 0.1 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.331 1.052 . . . . 63.12 113.467 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HG3' HD22 ' A' ' 64' ' ' LEU . 11.0 ptm85 -105.02 152.25 22.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.922 0.392 . . . . 73.54 111.042 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 90' ' ' LEU . 3.4 m -136.63 165.86 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.177 -0.465 . . . . 64.45 110.771 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -149.63 135.32 18.56 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.797 0.332 . . . . 73.33 111.61 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.55 ' HB2' HD13 ' A' ' 114' ' ' LEU . 80.8 m-85 -93.86 102.35 14.47 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.102 -0.499 . . . . 64.23 110.024 172.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -81.87 111.37 18.01 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 110.329 -0.249 . . . . 42.55 110.329 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.9 p -93.15 141.01 28.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.578 0.704 . . . . 60.0 112.581 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -84.37 166.81 42.37 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.676 -0.774 . . . . 70.44 111.743 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -54.28 -19.63 5.67 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.16 0.8 . . . . 75.55 113.16 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.548 ' N ' ' HA ' ' A' ' 83' ' ' ASN . . . -85.11 -20.52 57.25 Favored Glycine 0 N--CA 1.463 0.462 0 C-N-CA 120.815 -0.707 . . . . 50.2 112.805 -173.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.41 -4.3 29.27 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.351 0.26 . . . . 72.13 111.587 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -51.59 -39.95 58.91 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.269 0.47 . . . . 74.44 112.269 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.43 -12.51 58.76 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.225 -0.512 . . . . 53.14 114.113 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -118.38 -48.65 2.5 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.066 0.46 . . . . 70.23 111.7 -176.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.57 ' HB3' HD21 ' A' ' 114' ' ' LEU . 30.8 mt -118.02 86.44 25.81 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.92 -0.582 . . . . 72.53 112.296 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 88.9 Cg_endo -82.84 158.55 15.97 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.27 1.98 . . . . 74.13 112.398 172.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.45 -35.21 8.23 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.908 0.336 . . . . 71.23 111.908 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.27 -51.03 59.42 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.107 -0.568 . . . . 65.53 113.122 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 64.9 tp -62.73 -45.87 90.7 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.073 0.464 . . . . 71.13 110.674 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 109' ' ' LEU . 67.7 mt -59.22 -38.46 80.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.936 -0.575 . . . . 73.24 110.972 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.5 t -61.81 -40.14 94.21 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.174 -0.467 . . . . 61.21 110.942 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.45 -48.76 76.37 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.935 -0.306 . . . . 72.33 110.901 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.2 mt -50.71 -45.66 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.099 0.476 . . . . 74.1 110.908 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.538 ' O ' HG12 ' A' ' 123' ' ' ILE . 68.2 mt -64.9 -56.83 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.01 -0.541 . . . . 72.31 112.189 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -76.02 -34.37 59.68 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.602 0.964 . . . . 52.23 113.602 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.25 -32.59 33.27 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.858 0.361 . . . . 75.31 111.716 -171.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -123.57 -56.19 1.7 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.286 0.476 . . . . 71.34 112.286 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 91.4 mtp -64.06 -43.86 94.2 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.554 0.946 . . . . 74.31 113.554 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 118' ' ' ILE . 38.2 mm -57.54 -50.29 88.96 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 112.18 0.437 . . . . 74.12 112.18 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 86.9 Cg_exo -45.0 -44.7 14.77 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.204 1.936 . . . . 74.11 112.948 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -64.1 -51.9 61.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.614 -0.266 . . . . 72.1 111.535 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -56.95 -39.78 75.2 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.781 0.324 . . . . 74.25 111.664 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -67.44 -36.02 80.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.218 0.532 . . . . 63.34 110.994 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.5 t -74.28 -16.83 60.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.25 -0.432 . . . . 65.34 111.067 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.31 53.2 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 116.283 -0.417 . . . . 70.41 112.659 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.92 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 94.8 m-20 -81.31 72.0 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.052 0.454 . . . . 62.14 111.966 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -67.07 -45.65 76.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.825 0.345 . . . . 73.51 111.079 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.58 -47.33 67.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.05 0.452 . . . . 71.12 111.357 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.92 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 11.3 tp10 -59.75 -41.27 90.61 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.032 -0.531 . . . . 61.1 110.721 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.77 -53.96 34.42 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.831 -0.622 . . . . 63.35 113.258 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.2 -44.81 71.91 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 122.462 -0.434 . . . . 72.35 111.348 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.2 t -56.01 -51.67 66.95 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.231 0.456 . . . . 75.41 112.231 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -34.6 62.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.628 0.232 . . . . 73.51 111.628 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.82 -48.15 87.48 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.111 -0.566 . . . . 51.25 112.378 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.72 -43.74 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.17 0.51 . . . . 51.35 110.932 173.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.95 -38.97 87.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.971 -0.559 . . . . 74.42 110.795 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.3 96.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.095 0.474 . . . . 51.5 111.045 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.47 -51.43 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.139 -0.482 . . . . 74.11 111.427 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.487 ' HB2' HD11 ' A' ' 43' ' ' ILE . 63.3 tt0 -54.18 -40.19 67.3 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 121.128 -0.229 . . . . 71.45 111.536 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -57.29 -43.42 83.17 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.83 0.307 . . . . 74.52 111.83 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.79 -51.12 76.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.902 0.382 . . . . 43.22 111.15 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.62 -46.51 88.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.184 0.516 . . . . 73.13 111.079 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -59.7 -31.32 69.48 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.783 -0.644 . . . . 54.1 111.263 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.8 -22.8 75.68 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.28 -0.486 . . . . 65.23 112.715 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 28.8 t -83.08 -65.51 1.0 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.986 0.422 . . . . 71.35 111.131 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.1 mt -122.14 86.25 2.55 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.328 0.585 . . . . 64.21 110.941 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.17 39.67 0.19 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.865 -0.607 . . . . 75.42 111.981 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -133.2 108.98 9.13 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.148 -0.345 . . . . 73.55 110.954 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -57.66 137.99 55.86 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.888 0.375 . . . . 72.13 111.445 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -103.21 118.73 37.45 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.498 -0.319 . . . . 70.41 111.006 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -90.27 -9.69 46.99 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.976 0.417 . . . . 72.52 111.104 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -74.59 112.54 10.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.507 -0.315 . . . . 73.42 111.401 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 17.4 p80 . . . . . 0 C--O 1.254 1.332 0 CA-C-N 116.69 -0.232 . . . . 71.32 111.136 -179.58 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ttt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.768 0.318 . . . . 63.33 111.047 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.417 ' HD2' ' CE2' ' A' ' 4' ' ' TYR . 34.6 ttm180 -156.58 106.8 2.33 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.413 -0.358 . . . . 73.33 110.073 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.96 103.38 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.061 0.458 . . . . 60.04 112.038 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 2' ' ' ARG . 15.3 m-85 -93.01 134.51 35.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.422 0.527 . . . . 75.12 112.422 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 1.3 mptm? -107.52 163.3 17.24 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.148 -0.478 . . . . 72.11 110.124 169.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 13.6 Cg_endo -54.87 -26.64 49.4 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.176 1.918 . . . . 72.52 112.716 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.44 -29.49 59.7 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.385 -0.371 . . . . 73.34 111.933 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.63 -29.65 56.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.929 0.395 . . . . 74.24 111.585 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.63 HG13 HG21 ' A' ' 22' ' ' THR . 50.5 t -62.87 127.55 90.77 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 116.185 -0.461 . . . . 64.52 111.494 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.64 130.39 31.37 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.66 2.24 . . . . 73.15 112.949 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -69.8 76.65 0.46 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.242 0.544 . . . . 43.32 112.045 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 m -58.29 -49.56 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.482 0.549 . . . . 73.14 112.482 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -60.89 -17.91 53.35 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.837 -0.54 . . . . 70.21 112.054 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.66 -52.33 5.6 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.869 0.366 . . . . 75.2 110.21 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.99 -75.84 0.49 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.526 -0.306 . . . . 63.14 111.703 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.92 48.76 0.61 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.47 0.545 . . . . 73.31 112.47 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 82.9 p -63.84 -9.21 13.69 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.963 0.411 . . . . 53.21 111.344 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -89.86 -26.08 20.69 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.085 -0.507 . . . . 74.31 111.374 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 21' ' ' VAL . 12.3 ttm180 -85.03 -45.1 12.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.913 0.387 . . . . 71.23 110.864 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.5 mp 59.15 15.12 3.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.484 0.713 . . . . 62.12 112.382 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.54 ' O ' ' HD2' ' A' ' 19' ' ' ARG . 88.0 t -129.39 126.1 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.965 0.412 . . . . 72.15 111.696 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.63 HG21 HG13 ' A' ' 9' ' ' VAL . 86.7 m -99.66 102.93 14.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.915 0.388 . . . . 71.42 110.11 173.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.98 98.18 8.67 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.371 0.605 . . . . 60.11 111.886 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -126.46 -30.85 2.81 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.835 0.35 . . . . 64.13 111.325 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . -59.11 -19.54 45.44 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 111.708 0.262 . . . . 54.34 111.708 171.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.74 40.02 98.22 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.505 -0.378 . . . . 55.34 113.697 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.1 mt -105.39 -2.73 23.48 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.083 0.401 . . . . 65.21 112.083 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.87 -175.1 2.79 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.931 0.396 . . . . 53.42 111.907 -176.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.9 t -158.79 170.4 22.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.665 0.386 . . . . 71.43 110.484 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -44.68 -45.33 9.69 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.956 0.725 . . . . 71.32 112.956 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -70.14 -55.95 8.09 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.288 -0.257 . . . . 64.43 111.632 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -55.59 -45.87 77.35 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 111.847 0.314 . . . . 74.24 111.847 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.68 -54.9 36.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.422 -0.354 . . . . 71.32 111.085 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.98 -41.27 82.65 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.178 0.436 . . . . 73.11 112.178 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.483 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 90.9 t -64.51 -50.06 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.887 0.375 . . . . 72.32 110.807 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.406 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.1 ttm -60.51 -43.7 96.79 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.532 -0.304 . . . . 42.22 111.478 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -58.48 -44.63 89.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.882 0.372 . . . . 63.55 111.011 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.88 -44.59 97.21 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.172 -0.537 . . . . 35.4 112.716 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.541 ' O ' HG13 ' A' ' 43' ' ' ILE . 5.8 mmp_? -55.34 -55.41 31.9 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.006 0.431 . . . . 71.41 110.96 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB3' HD22 ' A' ' 20' ' ' LEU . 87.7 mt -60.59 -44.39 96.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.032 -0.531 . . . . 64.05 111.891 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -63.16 -39.41 94.58 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.725 0.297 . . . . 75.12 110.863 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.93 -42.48 98.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.949 0.404 . . . . 74.32 111.017 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.3 mt -57.63 -47.18 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.014 -0.539 . . . . 72.1 111.453 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 14.4 ptm180 -77.67 -24.95 49.21 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.959 -0.463 . . . . 72.44 111.927 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.4 t -70.06 -35.5 74.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.945 0.402 . . . . 62.02 111.027 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.1 t -95.7 -56.43 2.68 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.132 -0.486 . . . . 73.24 112.215 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -98.44 -12.64 21.15 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.302 0.482 . . . . 73.0 112.302 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.36 20.85 11.88 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.518 0.562 . . . . 71.11 112.518 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 43' ' ' ILE . 92.7 t -81.79 125.55 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.0 0.428 . . . . 75.24 111.129 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -84.34 97.15 9.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.276 0.56 . . . . 73.24 110.662 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.408 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -106.59 105.3 15.26 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.392 -0.822 . . . . 74.44 110.647 -173.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.22 117.11 33.44 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.146 0.424 . . . . 44.41 112.146 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.55 112.54 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.164 0.507 . . . . 61.3 111.502 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 58.1 t -107.56 143.26 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 122.912 0.485 . . . . 64.24 111.463 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 49.8 p -133.81 122.52 23.37 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.718 0.294 . . . . 74.04 110.893 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -127.71 141.8 42.19 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 120.561 0.219 . . . . 74.14 111.295 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.76 -48.23 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.506 2.138 . . . . 62.14 113.062 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.935 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 67.6 p -155.78 145.02 20.78 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.021 0.378 . . . . 72.03 112.021 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 pt -123.86 -3.49 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.749 0.309 . . . . 73.12 111.494 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.42 47.22 6.99 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.219 -0.515 . . . . 23.35 113.169 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 56.96 20.35 5.29 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.174 0.435 . . . . 74.34 112.174 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.95 151.65 97.16 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.396 -0.365 . . . . 54.25 111.834 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 29.4 Cg_endo -60.59 117.32 4.07 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.841 2.361 . . . . 73.24 113.14 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.82 -51.83 65.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.868 0.692 . . . . 74.11 112.868 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -31.71 72.67 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.125 0.488 . . . . 74.33 111.588 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 63' ' ' PRO . 10.4 t70 -68.84 -34.8 76.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.205 0.526 . . . . 75.5 110.835 173.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -65.91 -55.94 14.32 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.859 -0.61 . . . . 74.15 110.892 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.5 p -56.97 -42.81 80.85 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.226 -0.443 . . . . 73.41 111.813 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.8 tp -53.03 -53.09 55.37 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.924 0.392 . . . . 73.45 111.953 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.631 ' HG2' HH21 ' A' ' 73' ' ' ARG . 37.8 mtmm -71.33 -36.88 71.7 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.314 0.487 . . . . 75.21 112.314 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.7 tp -65.85 -37.59 86.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.201 0.524 . . . . 75.11 111.257 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.74 84.12 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.297 -0.41 . . . . 74.33 111.616 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.631 HH21 ' HG2' ' A' ' 70' ' ' LYS . 41.3 mtm105 -58.91 -49.66 76.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.272 0.471 . . . . 62.33 112.272 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.467 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 18.8 pt20 -64.63 -15.27 60.96 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.135 0.42 . . . . 71.2 112.135 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.467 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 45.5 m0 -103.4 14.88 30.44 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.776 0.322 . . . . 75.15 111.543 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.37 -53.32 4.65 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.113 -0.565 . . . . 64.21 113.651 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.522 ' HA ' ' HB3' ' A' ' 82' ' ' ASN . 31.0 m -52.1 -27.27 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 113.505 0.928 . . . . 72.5 113.505 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.79 -11.92 48.7 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.799 -0.715 . . . . 73.44 113.918 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -58.95 109.51 0.84 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.355 0.577 . . . . 74.5 109.937 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 42.63 32.91 0.41 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.721 0.808 . . . . 60.15 112.291 -171.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HB3' ' HA2' ' A' ' 102' ' ' GLY . 0.5 OUTLIER 62.85 80.13 0.24 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.202 -0.908 . . . . 74.32 112.704 178.269 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.549 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 42.5 t30 -60.45 130.28 45.82 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.201 -0.454 . . . . 73.5 111.027 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -41.07 -60.65 1.16 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.2 1.185 . . . . 74.24 114.2 -171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -95.04 24.27 4.99 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.044 -0.41 . . . . 62.43 112.034 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.16 137.6 13.52 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.027 -0.606 . . . . 72.3 113.549 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 99' ' ' PHE . 49.1 tp -144.53 119.96 10.31 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.015 0.436 . . . . 74.14 111.246 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 63.1 tp -109.32 141.47 41.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.944 0.402 . . . . 70.44 111.363 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.1 tp -129.7 127.79 41.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.378 -0.374 . . . . 71.24 110.022 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 65.8 t -128.19 116.6 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 122.116 -0.365 . . . . 60.04 111.882 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.656 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.2 tp -95.45 120.97 36.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.247 -0.433 . . . . 72.21 111.001 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.589 HG12 ' HB3' ' A' ' 93' ' ' ASP . 60.1 t -110.5 99.94 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.771 0.319 . . . . 70.24 111.059 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.3 tp -53.76 -39.1 65.08 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.898 0.38 . . . . 73.12 111.457 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.935 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 56.1 t0 -39.33 -52.98 2.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.915 0.886 . . . . 62.35 112.061 173.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.458 ' OE1' ' HD2' ' A' ' 96' ' ' ARG . 11.1 pt20 -108.53 -4.21 17.41 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.227 0.455 . . . . 73.44 112.227 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 59.32 27.56 16.67 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.524 0.564 . . . . 61.42 112.524 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.458 ' HD2' ' OE1' ' A' ' 94' ' ' GLN . 87.0 mtt180 -120.41 155.84 32.63 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.079 0.466 . . . . 65.54 111.39 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.712 HG21 ' SD ' ' A' ' 122' ' ' MET . 3.6 m -134.64 169.64 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.658 -0.701 . . . . 62.34 110.958 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -150.83 141.03 22.22 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.965 0.358 . . . . 74.23 111.965 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.489 ' HB3' HD11 ' A' ' 86' ' ' LEU . 97.0 m-85 -100.8 113.87 27.17 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.87 -0.605 . . . . 74.14 110.31 172.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -98.59 112.02 24.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 110.31 -0.256 . . . . 61.31 110.31 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.1 p -98.6 152.58 19.44 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.996 0.739 . . . . 72.53 112.996 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -88.57 166.95 34.85 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.394 -0.821 . . . . 54.05 111.906 168.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -65.17 1.0 1.11 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.979 0.733 . . . . 70.13 112.979 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.86 -42.46 6.02 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.496 -0.641 . . . . 34.11 111.496 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.52 -12.76 60.29 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.319 -0.441 . . . . 72.52 111.777 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -56.96 -17.29 9.13 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.216 0.45 . . . . 71.13 112.216 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.68 -7.55 85.84 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.179 -0.534 . . . . 62.24 113.598 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.1 -49.81 1.02 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.099 0.475 . . . . 75.23 111.822 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.2 mt -112.36 90.13 13.72 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.006 -0.543 . . . . 63.41 112.194 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.99 157.16 23.7 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.363 2.042 . . . . 61.21 112.893 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.49 -34.39 35.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.804 0.441 . . . . 70.52 111.949 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.91 -50.04 63.65 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.108 -0.568 . . . . 60.14 113.049 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.43 -45.43 88.49 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.156 0.503 . . . . 71.33 110.863 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 118' ' ' ILE . 80.0 mt -59.0 -39.53 82.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.881 -0.599 . . . . 74.41 110.946 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.3 t -57.46 -44.4 84.78 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.978 -0.555 . . . . 54.51 111.316 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -57.42 -51.59 68.8 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.777 0.322 . . . . 75.4 110.959 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 64.0 mt -50.91 -40.25 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.017 0.437 . . . . 73.23 111.328 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.635 HG23 HG22 ' A' ' 97' ' ' VAL . 76.8 mt -62.79 -56.41 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.124 -0.489 . . . . 71.33 111.991 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 10.5 t-80 -83.58 -23.49 31.94 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.14 0.792 . . . . 64.11 113.14 -171.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -91.82 -49.5 6.22 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 111.74 0.274 . . . . 74.42 111.74 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -79.42 -54.42 5.94 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.829 0.347 . . . . 73.1 111.484 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.712 ' SD ' HG21 ' A' ' 97' ' ' VAL . 61.9 mtt -82.6 -58.93 2.69 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.851 1.056 . . . . 64.32 113.851 -168.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.49 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 23.7 mm -43.2 -52.47 12.37 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 113.709 1.003 . . . . 72.1 113.709 -173.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.49 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 76.4 Cg_exo -51.65 -41.55 60.8 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.769 1.646 . . . . 60.41 113.056 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.487 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 91.3 m-70 -73.1 -40.51 64.92 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.237 -0.289 . . . . 72.42 111.679 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 122' ' ' MET . 15.9 m-30 -56.54 -40.45 75.14 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.118 0.485 . . . . 71.1 110.986 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -76.07 -37.13 58.61 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.121 -0.49 . . . . 62.51 111.325 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.5 m -66.19 -30.01 70.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.701 0.286 . . . . 64.11 111.676 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 123.51 -3.23 9.49 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.23 -0.509 . . . . 72.31 113.721 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.794 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 97.2 m-20 -104.07 87.49 2.78 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.086 0.402 . . . . 70.01 112.086 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -71.27 -45.12 63.88 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.175 0.512 . . . . 70.41 110.486 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.58 -48.06 82.65 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.962 -0.563 . . . . 71.03 111.755 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.794 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 29.2 tt0 -62.44 -38.58 90.28 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.291 -0.413 . . . . 73.14 111.111 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.27 -51.14 60.66 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.064 -0.589 . . . . 74.42 112.769 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.498 HD11 HD22 ' A' ' 90' ' ' LEU . 99.4 mt -57.67 -43.41 84.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.922 0.391 . . . . 71.43 110.895 175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.0 t -51.77 -56.91 11.06 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.986 -0.552 . . . . 74.01 111.894 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -63.34 -32.22 73.58 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.821 0.304 . . . . 73.51 111.821 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.585 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -60.84 -52.17 54.06 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.959 -0.638 . . . . 51.02 112.408 175.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.6 t -59.12 -48.62 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.03 0.443 . . . . 64.52 111.066 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.511 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 62.3 tp -53.22 -46.55 69.16 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.774 -0.648 . . . . 71.42 111.073 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.03 87.36 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.164 -0.471 . . . . 71.43 111.657 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.96 -56.4 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.414 -0.357 . . . . 75.0 111.423 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -59.44 -35.37 73.91 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.297 0.48 . . . . 71.15 112.297 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 16.6 mm-40 -59.6 -34.13 72.36 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 122.112 -0.368 . . . . 75.31 111.587 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 65.4 t -66.21 -42.68 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.904 0.383 . . . . 74.42 110.719 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.85 -56.53 8.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.118 -0.492 . . . . 72.14 111.37 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 50.9 m-20 -56.41 -34.78 67.08 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.561 -0.29 . . . . 62.15 111.34 176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -48.81 -31.77 10.5 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.556 -0.354 . . . . 74.21 113.083 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.8 t -73.99 -47.73 35.24 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.642 0.258 . . . . 64.01 111.237 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.7 mt -70.09 -17.87 63.24 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.531 0.567 . . . . 44.01 112.531 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 147' ' ' ASP . 68.4 mm-40 -58.51 -20.32 44.96 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.914 0.388 . . . . 62.11 111.412 175.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -58.48 99.95 0.05 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.097 -0.501 . . . . 55.22 111.369 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -77.65 111.21 13.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.692 0.282 . . . . 72.52 111.466 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -97.61 120.08 37.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.166 0.507 . . . . 70.34 111.341 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -90.61 -15.94 29.6 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.294 -0.412 . . . . 65.21 111.321 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -55.98 119.05 5.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.023 0.439 . . . . 73.33 111.952 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 31.1 t60 . . . . . 0 C--O 1.252 1.214 0 CA-C-N 115.944 -0.571 . . . . 65.11 111.693 -178.161 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.717 0.294 . . . . 74.14 111.389 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -171.27 129.53 0.72 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.267 -0.424 . . . . 53.42 110.935 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.7 t -103.38 124.32 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.067 0.461 . . . . 71.21 111.586 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -99.16 113.25 25.39 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.443 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.659 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 2.9 mppt? -95.57 169.03 9.83 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.515 -0.55 . . . . 70.31 109.515 171.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.659 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 10.2 Cg_endo -51.01 -24.31 13.87 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.201 1.934 . . . . 53.23 113.198 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.42 -21.23 35.82 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 111.955 0.354 . . . . 44.23 111.955 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -82.94 -27.79 30.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.883 0.373 . . . . 64.54 110.977 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG22 HD21 ' A' ' 56' ' ' LEU . 34.9 t -76.87 120.81 83.24 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.104 -0.498 . . . . 62.32 111.234 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HG2' HG23 ' A' ' 22' ' ' THR . 27.6 Cg_endo -62.43 127.73 21.71 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.335 2.023 . . . . 52.51 112.552 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.407 ' HA ' ' CE2' ' A' ' 75' ' ' TRP . 2.0 m-20 -72.69 74.97 1.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.087 0.47 . . . . 74.02 111.473 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.0 m -57.62 -41.56 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 112.479 0.548 . . . . 71.4 112.479 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -75.74 -5.1 44.08 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.456 0.539 . . . . 73.43 112.456 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.0 tt -102.79 -32.33 9.86 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.151 0.5 . . . . 73.4 110.222 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.21 -61.35 1.38 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.534 0.568 . . . . 55.33 112.534 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -79.9 -52.49 7.8 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.489 0.552 . . . . 73.4 112.489 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.9 t 70.14 -61.75 0.45 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.624 0.769 . . . . 71.15 112.072 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.9 p -60.0 -32.92 71.31 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.906 0.384 . . . . 74.15 111.01 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -92.18 109.07 20.43 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.004 -0.369 . . . . 55.25 110.004 169.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mp -97.11 15.02 23.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.436 0.636 . . . . 62.2 110.385 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.19 137.06 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.532 -0.758 . . . . 74.25 111.795 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 54' ' ' VAL . 30.4 m -119.81 103.25 9.2 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.901 0.382 . . . . 53.34 110.727 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -100.59 99.49 10.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.289 0.566 . . . . 73.23 112.438 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -118.49 -43.28 2.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.062 -0.517 . . . . 74.03 111.264 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.34 -24.65 67.45 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.28 0.844 . . . . 64.21 113.28 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.78 9.57 86.81 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.764 -0.732 . . . . 71.52 113.378 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.88 -14.3 60.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.978 0.418 . . . . 73.3 111.705 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.4 mt -103.09 139.36 38.72 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.41 -0.359 . . . . 74.31 110.969 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.2 t -106.23 159.99 15.69 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.328 -0.233 . . . . 73.14 110.835 175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -45.26 -48.95 12.8 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.556 0.947 . . . . 74.0 113.556 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -63.47 -48.73 76.45 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.79 0.328 . . . . 53.54 111.844 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -60.82 -40.6 93.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.867 0.365 . . . . 61.22 111.524 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.13 -45.26 92.78 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.232 -0.44 . . . . 71.11 110.778 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.0 -49.93 74.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.766 0.317 . . . . 75.22 111.607 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 31' ' ' ALA . 87.8 t -60.12 -40.64 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.218 0.532 . . . . 73.13 111.154 177.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.518 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.5 ttm -63.1 -49.89 72.68 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.948 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -59.05 -40.58 85.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.609 0.242 . . . . 55.13 111.211 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.6 -46.49 93.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.108 -0.568 . . . . 52.3 112.91 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' ILE . 79.4 mtm180 -69.14 -43.41 74.41 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.823 0.305 . . . . 74.53 111.823 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 36' ' ' MET . 88.7 mt -61.32 -47.5 85.61 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.195 0.522 . . . . 55.43 111.054 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 41' ' ' ARG . 40.7 ttp180 -62.72 -37.0 84.79 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.926 -0.579 . . . . 72.33 110.896 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.23 98.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.342 -0.39 . . . . 74.12 110.776 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.8 mt -59.82 -45.76 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.817 0.341 . . . . 73.24 110.779 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -58.51 -31.73 68.16 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.954 0.407 . . . . 73.33 111.001 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.9 t -93.79 -13.52 27.25 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.364 0.505 . . . . 31.51 112.364 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.8 m -106.8 -63.59 1.27 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.296 0.57 . . . . 74.1 111.29 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.703 ' ND1' HD21 ' A' ' 150' ' ' LEU . 32.6 m-70 -90.97 -8.3 49.63 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.486 -0.779 . . . . 64.12 111.198 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 67.33 5.93 4.55 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.279 0.631 . . . . 62.41 112.247 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.685 HG22 ' HB2' ' A' ' 84' ' ' ASN . 99.8 t -79.63 130.97 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 122.922 0.489 . . . . 63.45 111.987 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' HB2' HG13 ' A' ' 77' ' ' VAL . 1.8 mp0 -79.81 96.53 6.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.915 0.388 . . . . 73.11 110.297 174.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.408 ' HE2' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -104.78 98.78 8.47 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.424 -0.353 . . . . 73.33 110.492 -176.515 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.03 120.75 42.25 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.534 0.568 . . . . 74.24 112.534 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.92 137.49 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-O 121.025 0.441 . . . . 71.24 111.359 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.582 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 61.7 t -130.76 140.18 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.603 0.361 . . . . 72.21 111.037 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -128.61 122.46 30.96 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.624 0.249 . . . . 53.11 111.183 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.404 HD21 HG22 ' A' ' 9' ' ' VAL . 65.3 mt -128.23 140.85 39.49 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 111.622 0.23 . . . . 72.33 111.622 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.15 -55.97 1.91 Allowed 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.516 2.144 . . . . 74.22 112.248 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.3 t -155.62 148.97 24.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.341 -0.39 . . . . 73.32 111.817 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.73 20.47 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.353 0.597 . . . . 74.5 110.196 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.42 39.65 91.46 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.202 -0.523 . . . . 64.1 113.175 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.02 16.03 3.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.151 0.58 . . . . 72.41 112.293 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.01 151.41 80.53 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 122.055 -0.403 . . . . 65.35 111.775 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -56.97 110.15 0.55 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.685 2.256 . . . . 73.01 112.654 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.6 tp -52.19 -46.02 65.41 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.891 0.7 . . . . 75.13 112.891 -176.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 38.3 mt-10 -66.71 -25.32 66.47 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.126 0.417 . . . . 73.52 112.126 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 23.3 t70 -75.39 -45.57 38.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.379 0.609 . . . . 75.22 110.02 173.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -57.65 -47.5 82.06 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.521 -0.763 . . . . 72.0 111.821 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.3 p -55.71 -50.17 71.05 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.78 0.324 . . . . 75.14 111.595 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.526 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.2 tp -55.33 -51.18 67.57 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.956 0.408 . . . . 74.43 111.36 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 66' ' ' ASP . 55.6 mtpt -60.24 -47.02 87.76 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.198 0.444 . . . . 75.15 112.198 -178.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.2 tp -66.18 -47.6 73.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.933 0.397 . . . . 62.44 111.732 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.674 ' C ' HD22 ' A' ' 79' ' ' ASN . . . -61.57 -32.81 72.92 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.227 0.454 . . . . 65.42 112.227 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 44.3 mtm180 -59.53 -48.59 81.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.013 0.375 . . . . 72.22 112.013 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.586 ' NE2' ' HB2' ' A' ' 6' ' ' PRO . 11.5 pt20 -70.48 -13.62 62.19 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.818 0.342 . . . . 75.35 111.479 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.526 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 32.3 m0 -96.42 -17.43 20.59 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.854 0.359 . . . . 74.43 110.778 173.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.31 46.64 94.02 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 116.31 -0.405 . . . . 63.51 113.408 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 50' ' ' GLU . 57.7 t -119.31 -86.2 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 112.572 0.582 . . . . 71.41 112.572 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.05 90.95 0.86 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.85 -0.69 . . . . 73.05 113.118 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.674 HD22 ' C ' ' A' ' 72' ' ' ALA . 37.1 m-80 -148.16 23.1 1.07 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.992 0.396 . . . . 75.31 111.836 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 79' ' ' ASN . 31.8 tt0 70.18 -53.16 0.64 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.423 0.289 . . . . 51.34 111.398 -169.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.498 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -75.44 69.92 2.26 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.898 0.856 . . . . 71.04 111.221 -178.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 103' ' ' TYR . 56.4 t30 178.72 166.61 0.88 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.333 -1.303 . . . . 73.1 107.567 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -74.96 -122.07 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.733 -0.605 . . . . 44.24 111.489 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.685 ' HB2' HG22 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.72 70.61 10.37 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.911 -0.493 . . . . 75.1 112.056 -176.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -107.17 144.71 15.94 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.098 -0.501 . . . . 64.01 112.685 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 99' ' ' PHE . 42.6 tp -145.16 124.59 13.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.875 0.369 . . . . 75.22 111.475 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 72' ' ' ALA . 54.8 tp -111.54 138.26 48.31 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.756 0.312 . . . . 64.41 111.038 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.0 tp -128.26 102.52 6.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.708 0.29 . . . . 75.04 110.682 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.11 119.63 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.063 0.394 . . . . 54.1 112.063 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HA ' HG12 ' A' ' 97' ' ' VAL . 41.9 tp -98.96 115.86 29.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.11 0.481 . . . . 61.33 111.109 175.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 94' ' ' GLN . 71.3 t -101.17 104.49 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.27 -0.423 . . . . 73.34 111.007 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.0 tp -55.75 -42.44 75.43 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.892 0.377 . . . . 71.54 111.638 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -50.99 -36.68 40.5 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.244 0.545 . . . . 74.21 111.771 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.439 ' H ' HG12 ' A' ' 91' ' ' VAL . 72.0 mt-30 -105.99 -10.19 16.7 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.108 -0.496 . . . . 74.2 111.933 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 53.4 35.13 19.69 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.675 0.62 . . . . 72.34 112.675 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -142.58 162.93 34.19 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.974 0.416 . . . . 75.34 111.874 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.582 HG21 ' SD ' ' A' ' 122' ' ' MET . 3.7 m -133.43 171.89 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.068 -0.515 . . . . 42.11 111.589 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.574 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 47.4 ttt85 -148.59 137.67 21.7 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.475 -0.329 . . . . 74.3 111.524 171.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.743 ' HB3' HD11 ' A' ' 86' ' ' LEU . 96.9 m-85 -93.0 108.4 19.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.196 -0.456 . . . . 72.22 110.543 172.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.6 tp10 -95.04 122.41 37.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.577 0.227 . . . . 71.5 110.727 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.3 p -100.49 160.8 14.05 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.932 1.086 . . . . 74.31 113.932 -172.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -103.56 -164.24 25.3 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.932 -1.031 . . . . 62.04 111.809 167.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 5.3 t80 -76.56 -17.0 59.46 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.128 0.49 . . . . 73.1 111.591 -176.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.09 -23.46 57.17 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.236 -0.507 . . . . 72.45 113.205 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.4 mt -103.34 -4.21 24.51 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.012 0.434 . . . . 71.2 110.95 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -53.55 -35.44 60.75 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.812 -0.631 . . . . 64.1 111.174 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.39 18.05 58.14 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 121.244 -0.503 . . . . 60.2 113.88 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -137.83 -54.63 0.66 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.301 0.55 . . . . 61.3 111.44 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.661 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.5 mt -114.78 86.14 12.65 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.6 -0.727 . . . . 65.53 112.102 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.13 153.83 19.02 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.156 1.904 . . . . 65.42 112.404 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.38 -43.71 5.28 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.865 0.691 . . . . 74.24 112.865 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.91 -50.13 68.56 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.218 -0.515 . . . . 54.22 113.251 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.68 -48.15 83.08 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.969 0.414 . . . . 32.44 111.025 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.661 HD21 ' HB3' ' A' ' 109' ' ' LEU . 76.3 mt -58.31 -39.09 78.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.088 -0.505 . . . . 74.13 111.217 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.9 t -63.21 -37.23 86.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.11 -0.495 . . . . 71.42 111.335 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -70.61 -37.81 73.9 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 122.262 -0.274 . . . . 75.12 111.284 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 62.3 mt -55.15 -43.5 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.474 0.654 . . . . 74.13 110.04 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.7 mt -64.59 -52.9 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.45 -0.795 . . . . 74.14 111.489 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 5.4 t-80 -69.78 -39.35 76.68 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.6 0.593 . . . . 74.43 112.6 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.31 -39.41 22.92 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.753 0.649 . . . . 71.24 112.753 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -103.57 -46.29 4.59 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.602 0.593 . . . . 73.14 112.602 -174.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.582 ' SD ' HG21 ' A' ' 97' ' ' VAL . 50.5 mtt -78.89 -48.01 15.44 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.185 0.809 . . . . 71.14 113.185 -173.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.515 ' CG1' ' HA ' ' A' ' 119' ' ' HIS . 23.0 mm -50.09 -52.23 55.04 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 112.98 0.733 . . . . 42.34 112.98 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 14.0 Cg_endo -55.7 -38.42 94.33 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 121.807 1.671 . . . . 52.14 112.315 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 41.5 m-70 -71.14 -51.4 25.18 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.04 0.385 . . . . 61.34 112.04 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.4 m-30 -55.92 -44.84 78.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.775 0.321 . . . . 61.14 111.297 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -62.57 -37.03 84.59 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.946 0.403 . . . . 72.01 111.16 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -77.3 -5.97 51.43 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.405 -0.361 . . . . 64.23 111.911 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.33 2.58 68.04 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.314 -0.469 . . . . 71.11 113.317 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.618 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 90.6 m-20 -89.35 76.46 7.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.826 0.346 . . . . 73.21 111.841 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -70.75 -46.07 63.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.004 0.431 . . . . 72.22 111.259 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.65 98.18 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.108 -0.496 . . . . 62.31 111.603 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.618 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 18.3 mm-40 -65.58 -42.91 91.2 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.348 -0.387 . . . . 74.44 110.902 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.33 -51.28 60.1 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.317 -0.468 . . . . 64.52 112.923 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.521 HD11 HD22 ' A' ' 90' ' ' LEU . 95.9 mt -60.57 -38.65 85.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.015 0.436 . . . . 74.52 111.102 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.0 t -57.21 -57.98 10.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.987 -0.551 . . . . 53.15 112.345 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -76.11 -19.64 58.35 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 120.638 -0.425 . . . . 74.41 111.582 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.79 -47.23 91.59 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.838 -0.696 . . . . 71.1 111.815 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.2 -46.25 96.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.205 0.526 . . . . 71.32 110.842 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.4 tp -55.34 -38.02 68.22 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.771 -0.649 . . . . 74.54 111.441 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -62.47 -55.47 27.32 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.197 -0.456 . . . . 54.32 111.379 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.408 ' HB ' ' HE2' ' A' ' 51' ' ' PHE . 66.7 t -57.46 -43.37 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.261 -0.427 . . . . 71.44 111.134 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -52.73 -45.36 66.95 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.122 -0.49 . . . . 60.41 111.367 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -69.52 -35.29 75.35 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.061 0.393 . . . . 61.52 112.061 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 141' ' ' ALA . 96.5 t -62.05 -51.59 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.944 0.402 . . . . 74.14 111.01 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.21 -45.14 95.78 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.923 0.392 . . . . 70.13 111.015 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.34 -30.1 66.46 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.008 0.432 . . . . 75.0 111.029 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.21 -27.07 70.74 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.125 -0.489 . . . . 71.42 113.544 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 35.0 t -150.26 77.66 1.31 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.562 0.579 . . . . 74.34 112.562 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.703 HD21 ' ND1' ' A' ' 47' ' ' HIS . 36.7 mt -79.95 80.94 6.3 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.338 0.59 . . . . 75.01 110.097 171.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 58.87 33.09 22.83 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.253 -0.885 . . . . 72.52 110.566 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -70.53 73.13 0.52 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.712 -0.676 . . . . 74.31 111.107 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -117.46 109.16 16.41 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.287 -0.415 . . . . 75.52 110.439 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -81.23 -33.2 33.01 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.978 0.418 . . . . 71.3 110.72 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -96.24 101.71 13.4 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.334 -0.394 . . . . 74.1 110.844 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -69.21 95.47 0.76 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.679 -0.237 . . . . 72.43 111.22 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.505 -0.759 . . . . 74.44 111.935 177.99 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.866 0.365 . . . . 34.21 111.686 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.425 ' HE ' ' HB3' ' A' ' 2' ' ' ARG . 1.5 ptp180 -91.35 -25.47 19.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.033 0.382 . . . . 73.15 112.033 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.6 t 63.08 114.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 113.609 0.966 . . . . 74.1 113.609 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -107.41 130.02 54.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.952 -0.567 . . . . 73.2 110.973 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 26.1 mtpp -105.24 168.69 8.02 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 116.521 -0.309 . . . . 52.12 110.708 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 59.7 Cg_endo -69.62 58.19 1.47 Allowed 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.675 2.25 . . . . 71.05 112.65 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -176.85 -26.55 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.54 -0.755 . . . . 72.22 109.967 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.83 -35.04 67.19 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.268 0.556 . . . . 73.43 110.297 169.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.609 HG22 HD21 ' A' ' 56' ' ' LEU . 49.0 t -64.17 118.38 45.86 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.667 -0.697 . . . . 64.32 111.566 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HG2' HG23 ' A' ' 22' ' ' THR . 12.2 Cg_endo -56.14 121.9 10.81 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.45 2.1 . . . . 55.43 112.596 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.607 HD22 HD13 ' A' ' 14' ' ' LEU . 13.2 p-10 -72.63 70.64 0.94 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.356 0.598 . . . . 74.34 111.886 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -58.03 -43.58 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.792 -0.64 . . . . 75.05 112.641 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.468 ' NE2' ' HG ' ' A' ' 20' ' ' LEU . 8.2 tp-100 -71.46 -14.09 62.03 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.227 0.454 . . . . 74.1 112.227 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.607 HD13 HD22 ' A' ' 11' ' ' ASN . 10.1 tt -88.29 -29.99 19.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.118 0.485 . . . . 73.51 110.685 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.53 -35.35 13.64 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.131 0.491 . . . . 73.53 111.751 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.459 ' OD2' ' HG2' ' A' ' 19' ' ' ARG . 20.7 t70 -134.15 142.31 47.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.947 0.403 . . . . 62.45 111.244 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.7 p -107.64 -6.82 16.69 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.393 0.516 . . . . 60.42 112.393 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.1 p -75.57 -30.8 59.77 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.109 -0.369 . . . . 71.44 111.678 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.459 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 3.5 ptp85 -119.84 159.7 24.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.847 0.356 . . . . 74.32 111.051 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HG ' ' NE2' ' A' ' 13' ' ' GLN . 4.7 mp -132.72 14.47 4.4 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.71 0.29 . . . . 71.42 111.722 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 53' ' ' VAL . 65.0 t -112.08 128.64 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 112.286 0.476 . . . . 63.31 112.286 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.476 HG23 ' HG2' ' A' ' 10' ' ' PRO . 89.3 m -100.55 109.79 21.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.004 0.431 . . . . 63.14 110.979 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -92.31 93.16 8.49 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.288 0.566 . . . . 73.43 112.352 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 55' ' ' THR . 10.2 mm-40 -106.65 -59.69 1.76 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.945 0.402 . . . . 74.33 110.536 174.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.55 74.6 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.473 -0.33 . . . . 73.51 111.856 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.79 50.14 70.92 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.312 -0.471 . . . . 44.31 112.929 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.611 HD21 HD22 ' A' ' 92' ' ' LEU . 97.7 mt -90.59 12.36 19.1 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.202 0.445 . . . . 52.04 112.202 -176.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mp -124.4 163.47 21.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.283 0.563 . . . . 75.15 111.597 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.7 t -82.97 155.9 23.74 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.764 -0.653 . . . . 70.14 110.914 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -53.05 -40.88 64.29 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.876 0.37 . . . . 75.53 111.896 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -64.81 -46.36 82.3 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.9 0.381 . . . . 75.51 111.25 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -59.47 -41.06 88.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.484 -0.325 . . . . 71.14 111.619 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -55.78 -54.48 43.95 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.316 0.579 . . . . 55.12 110.912 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.27 -48.88 70.71 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.729 -0.669 . . . . 55.01 111.814 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 31' ' ' ALA . 99.0 t -64.4 -42.69 96.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.166 -0.47 . . . . 64.34 112.093 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.573 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.5 ttm -62.38 -51.1 68.95 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.199 -0.313 . . . . 74.44 110.937 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 59.4 m-80 -60.95 -38.38 85.67 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.643 0.259 . . . . 65.14 111.055 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.52 -48.36 86.57 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.045 -0.598 . . . . 75.02 112.9 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 43' ' ' ILE . 86.4 mtm180 -64.42 -46.17 84.36 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.843 0.312 . . . . 71.23 111.843 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 36' ' ' MET . 81.7 mt -56.32 -41.43 76.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.35 0.595 . . . . 75.51 110.867 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -67.63 -39.06 84.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.769 -0.65 . . . . 75.23 111.264 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.81 88.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.121 0.486 . . . . 74.11 110.823 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.434 HG23 ' HB2' ' A' ' 47' ' ' HIS . 70.8 mt -60.35 -41.88 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.1 -0.5 . . . . 61.14 110.681 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.481 ' NE ' ' HG2' ' A' ' 50' ' ' GLU . 12.7 tpt180 -50.85 -33.09 22.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.816 -0.629 . . . . 74.23 111.688 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.1 t -99.49 -60.2 1.58 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.323 -0.399 . . . . 73.21 111.741 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.7 t -59.29 -45.95 89.87 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.525 0.565 . . . . 71.24 112.525 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.434 ' HB2' HG23 ' A' ' 43' ' ' ILE . 91.1 m-70 -104.31 -9.26 18.67 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.776 0.322 . . . . 71.42 111.41 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.74 -5.68 1.4 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.216 0.821 . . . . 50.03 113.216 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.98 123.41 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.04 0.447 . . . . 72.41 111.994 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HG2' ' NE ' ' A' ' 44' ' ' ARG . 38.1 mt-10 -75.97 96.24 3.73 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.84 -0.43 . . . . 70.41 109.84 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.65 107.75 18.91 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.268 -0.424 . . . . 65.43 110.902 -173.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.14 147.16 37.93 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.042 0.386 . . . . 71.11 112.042 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 21' ' ' VAL . 58.5 t -128.57 135.81 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.919 0.39 . . . . 62.34 111.264 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 71' ' ' LEU . 60.5 t -128.56 134.47 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.713 0.292 . . . . 72.22 111.25 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 80.6 p -119.11 122.6 42.45 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.723 0.297 . . . . 50.21 111.385 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.609 HD21 HG22 ' A' ' 9' ' ' VAL . 89.7 mt -125.98 140.05 35.85 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-O 120.732 0.301 . . . . 71.41 111.57 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 52.6 Cg_endo -69.3 -35.19 14.5 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.116 1.877 . . . . 75.14 112.432 176.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 73.3 p -161.37 144.87 12.77 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.351 0.5 . . . . 75.42 112.351 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.458 HD13 HG21 ' A' ' 91' ' ' VAL . 32.3 pt -123.89 -11.4 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 121.002 0.43 . . . . 72.03 111.597 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.76 -113.47 5.76 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 114.386 0.514 . . . . 74.31 114.386 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -89.97 11.52 20.26 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.044 0.45 . . . . 62.34 112.044 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -85.2 118.87 71.71 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.924 -0.485 . . . . 63.41 111.88 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 29.1 Cg_endo -63.19 126.75 18.52 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.58 2.187 . . . . 71.34 112.346 176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.3 -45.5 80.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.943 0.72 . . . . 70.3 112.943 -171.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 1.2 pm0 -70.16 -36.04 74.43 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.35 0.5 . . . . 73.52 112.35 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.68 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 10.2 m-20 -71.99 -35.89 69.6 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.993 -0.442 . . . . 75.33 110.976 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 58.2 t80 -59.21 -56.58 20.26 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.812 0.339 . . . . 54.12 111.181 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 47.1 p -52.76 -44.56 66.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.116 -0.493 . . . . 62.35 111.651 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.65 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 58.7 tp -61.7 -57.06 13.42 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.336 -0.393 . . . . 51.41 111.634 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -61.38 -34.92 76.13 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.145 0.424 . . . . 65.41 112.145 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 54' ' ' VAL . 58.7 tp -69.79 -48.41 59.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.185 0.517 . . . . 72.2 111.097 177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB1' ' HA3' ' A' ' 78' ' ' GLY . . . -65.34 -31.73 73.0 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.074 0.398 . . . . 54.52 112.074 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.735 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 24.2 mtp180 -62.42 -50.05 73.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.026 0.38 . . . . 75.43 112.026 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.639 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 12.3 pt20 -67.88 -32.92 73.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.936 0.398 . . . . 72.22 111.088 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.639 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 27.7 m0 -71.45 -15.89 62.35 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.526 -0.307 . . . . 74.31 111.68 175.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.58 -39.15 3.07 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.277 -0.487 . . . . 72.21 112.746 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 19.4 t -52.26 -23.84 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 122.88 0.472 . . . . 53.53 112.158 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.494 ' HA3' ' HB1' ' A' ' 72' ' ' ALA . . . -137.1 40.61 1.49 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.118 -0.563 . . . . 70.31 112.578 176.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 46.6 t-20 -61.03 85.96 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.788 0.328 . . . . 54.12 110.577 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.735 ' H ' ' HG2' ' A' ' 73' ' ' ARG . 7.9 tp10 43.2 69.98 0.35 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.626 0.727 . . . . 73.2 110.774 -172.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.633 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER 63.11 82.5 0.18 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.168 -0.924 . . . . 63.34 112.286 -176.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.491 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 24.4 t30 -81.11 160.32 24.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.951 -1.022 . . . . 71.24 111.165 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -72.14 123.86 23.78 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.672 -0.643 . . . . 74.52 111.527 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.916 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 5.9 p30 46.22 41.27 8.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.198 0.999 . . . . 74.25 112.753 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.11 145.31 16.58 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.86 -0.609 . . . . 41.12 111.861 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 99' ' ' PHE . 55.9 tp -144.87 131.0 19.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.953 0.377 . . . . 70.1 111.218 -177.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 72' ' ' ALA . 55.4 tp -119.29 123.62 44.68 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.838 0.352 . . . . 75.12 111.478 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.5 tp -111.26 110.03 20.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.892 0.377 . . . . 61.35 110.972 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 54' ' ' VAL . 93.1 t -110.52 129.15 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 122.181 -0.324 . . . . 72.22 111.811 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.567 ' HB2' HD21 ' A' ' 135' ' ' LEU . 43.5 tp -107.25 119.41 39.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.979 0.419 . . . . 72.54 111.037 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.458 HG21 HD13 ' A' ' 59' ' ' ILE . 94.0 t -102.93 100.82 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.307 -0.406 . . . . 75.4 111.207 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.611 HD22 HD21 ' A' ' 27' ' ' LEU . 62.4 tp -59.19 -39.14 81.63 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.171 0.434 . . . . 70.45 112.171 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 14.9 t70 -47.53 -47.15 28.09 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.154 0.582 . . . . 50.34 112.189 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -108.46 8.79 27.56 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.126 -0.488 . . . . 53.41 111.103 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 32.77 58.01 0.43 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.552 1.141 . . . . 71.42 113.782 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -150.16 160.97 43.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.477 -0.783 . . . . 74.43 111.129 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.504 HG21 ' SD ' ' A' ' 122' ' ' MET . 4.3 m -126.21 171.8 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.057 0.456 . . . . 45.13 112.029 -174.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 98' ' ' ARG . 28.7 ttt85 -150.15 135.46 18.05 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.246 -0.434 . . . . 70.44 111.826 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.463 ' HB3' HD11 ' A' ' 86' ' ' LEU . 95.9 m-85 -94.01 115.04 27.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.144 -0.48 . . . . 74.11 110.154 171.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -101.1 112.66 25.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.844 0.354 . . . . 71.12 110.87 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.519 HG23 HD11 ' A' ' 114' ' ' LEU . 2.9 p -88.59 148.37 24.11 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.678 0.751 . . . . 72.05 112.921 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 81' ' ' LYS . . . -90.46 -170.23 43.44 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.225 -0.898 . . . . 74.33 112.199 168.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -24.6 65.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.055 0.455 . . . . 71.34 111.637 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.916 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -75.18 -30.47 58.84 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.003 -0.617 . . . . 61.4 113.432 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.13 -0.91 57.84 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.979 0.733 . . . . 74.35 112.979 -171.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -53.33 -32.06 47.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.906 0.335 . . . . 74.23 111.906 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.65 4.45 69.13 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.42 -0.419 . . . . 54.15 113.827 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -125.02 -60.11 1.37 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.381 0.61 . . . . 75.42 111.444 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.07 87.14 27.81 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.697 -0.683 . . . . 63.33 111.086 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.73 167.93 16.33 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.54 2.16 . . . . 75.21 113.558 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.08 -48.8 33.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.585 0.587 . . . . 70.42 112.585 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.37 -46.62 91.64 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.264 -0.493 . . . . 72.11 113.43 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.15 -48.94 77.86 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.891 0.377 . . . . 71.52 111.584 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.519 HD11 HG23 ' A' ' 101' ' ' THR . 86.8 mt -59.34 -43.03 92.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.277 -0.42 . . . . 62.34 111.275 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.4 t -63.41 -37.54 87.67 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.087 -0.506 . . . . 43.03 111.108 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -60.12 -55.34 35.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.394 -0.366 . . . . 73.45 111.219 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.9 mt -49.19 -46.21 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.044 0.449 . . . . 74.24 111.666 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.412 ' O ' HG12 ' A' ' 123' ' ' ILE . 58.2 mt -60.14 -54.91 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.135 0.493 . . . . 72.43 111.415 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -83.72 -9.17 59.02 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.176 0.806 . . . . 53.12 113.176 -173.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.12 -40.78 7.03 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.223 0.453 . . . . 73.43 112.223 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.07 -31.08 2.15 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.516 0.932 . . . . 74.25 113.516 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.504 ' SD ' HG21 ' A' ' 97' ' ' VAL . 36.0 mtt -69.04 -40.54 78.52 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.904 0.705 . . . . 73.42 112.904 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.477 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 46.7 mm -48.12 -57.04 11.4 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 112.894 0.702 . . . . 72.22 112.894 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.08 -37.64 86.95 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.053 1.835 . . . . 62.13 112.967 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -63.48 -53.09 57.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.802 0.334 . . . . 74.44 111.043 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.1 m-85 -59.63 -32.88 70.84 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.546 -0.297 . . . . 74.04 111.456 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 60.4 mtp85 -66.67 -43.32 84.84 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.241 0.544 . . . . 74.42 111.03 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.0 t -75.56 -0.82 21.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.858 -0.61 . . . . 44.05 112.112 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.15 3.93 90.03 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.182 -0.533 . . . . 73.13 112.48 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.769 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.2 m-20 -84.31 55.07 3.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.831 0.452 . . . . 64.34 111.349 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -56.22 -41.28 75.4 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.172 0.511 . . . . 71.31 110.91 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.81 -50.54 73.4 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.725 -0.67 . . . . 73.41 111.809 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.769 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 39.9 mm-40 -61.13 -40.02 92.22 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.342 -0.39 . . . . 73.12 111.739 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.49 -53.28 42.26 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.077 -0.582 . . . . 72.15 112.556 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 90' ' ' LEU . 83.4 mt -61.15 -43.21 99.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.054 0.454 . . . . 75.34 111.187 175.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.8 t -60.37 -52.5 64.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.645 0.609 . . . . 42.53 112.645 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -27.25 59.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.601 0.239 . . . . 73.14 111.045 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.35 91.36 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.025 -0.607 . . . . 51.5 112.168 171.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 135' ' ' LEU . 56.7 t -56.59 -48.13 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.146 0.498 . . . . 71.24 110.806 172.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 50.8 tp -58.45 -40.59 83.05 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.767 -0.651 . . . . 60.11 111.157 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -58.64 -52.3 66.28 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.022 0.439 . . . . 74.35 111.031 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 81.1 t -57.26 -48.35 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.153 -0.476 . . . . 64.13 111.132 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -53.71 -43.19 68.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.916 -0.583 . . . . 74.05 111.53 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 96.5 mt-30 -68.4 -33.4 74.17 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 111.993 0.368 . . . . 64.53 111.993 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 141' ' ' ALA . 91.0 t -63.99 -55.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.068 0.461 . . . . 74.33 110.729 175.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 78.0 mt -53.23 -45.04 68.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.919 -0.582 . . . . 64.53 111.533 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -55.65 -37.11 67.82 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.194 -0.457 . . . . 75.22 111.9 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -89.37 -21.21 41.96 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.853 -0.689 . . . . 72.24 113.102 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.2 t -82.58 -24.65 33.84 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.322 0.49 . . . . 74.45 112.322 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 87.8 mt -68.05 78.53 0.23 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.867 0.365 . . . . 74.41 111.524 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 73.04 -31.2 0.22 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.201 0.815 . . . . 74.53 113.201 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -51.35 -26.88 8.38 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.295 0.85 . . . . 75.53 113.295 -170.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -69.02 -32.76 72.51 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.988 -0.445 . . . . 64.02 111.14 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -94.37 89.54 5.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.185 0.517 . . . . 60.12 110.271 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -72.78 121.14 19.4 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.965 -0.561 . . . . 65.12 112.472 -172.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -82.89 92.45 7.3 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.47 -0.332 . . . . 64.31 111.659 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.0 p80 . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 114.418 1.266 . . . . 72.54 114.418 178.319 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 tpt . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.627 0.251 . . . . 54.12 111.369 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -125.11 121.01 33.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.89 0.376 . . . . 73.54 111.497 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.92 139.08 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.661 -0.245 . . . . 71.41 110.707 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.419 ' CG ' HD22 ' A' ' 56' ' ' LEU . 44.8 m-85 -112.29 159.6 18.48 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.862 0.839 . . . . 65.22 113.242 -176.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.538 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 30.1 mmmt -126.02 158.79 64.83 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 114.867 -1.061 . . . . 73.23 109.935 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HB2' HE22 ' A' ' 74' ' ' GLN . 9.6 Cg_endo -51.8 -52.27 9.35 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.283 1.988 . . . . 51.25 113.219 -177.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.44 2.52 32.26 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.074 -0.391 . . . . 72.13 111.729 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.538 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 21.4 t70 -93.89 -13.32 27.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.279 0.561 . . . . 63.15 110.29 175.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 5' ' ' LYS . 69.4 t -82.7 133.56 49.02 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.908 -0.587 . . . . 53.32 110.871 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -52.99 111.09 0.57 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.298 1.999 . . . . 33.1 112.417 177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.474 ' HA ' ' CE2' ' A' ' 75' ' ' TRP . 10.9 p-10 -68.7 78.92 0.29 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.623 0.725 . . . . 74.43 112.351 -177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' SER . 29.2 m -78.26 10.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.988 0.736 . . . . 72.01 112.988 -177.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 15.7 mm100 -121.22 18.35 11.53 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.559 0.695 . . . . 70.24 110.518 171.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.4 HD13 HD22 ' A' ' 11' ' ' ASN . 7.0 tt -134.64 -45.27 0.74 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.455 -0.793 . . . . 63.05 109.181 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.37 -75.12 0.59 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.991 -0.549 . . . . 72.32 111.199 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.2 55.39 2.83 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.27 0.47 . . . . 55.12 112.27 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 58.2 m -67.46 -9.45 42.11 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.252 0.464 . . . . 74.24 112.252 -178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -86.78 -9.65 55.36 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.297 0.57 . . . . 72.51 111.496 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.421 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 8.6 tpt180 -94.18 -62.25 1.37 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.986 -0.552 . . . . 65.23 111.041 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.563 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.5 mp 74.68 -14.83 0.69 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.965 0.906 . . . . 70.51 111.884 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.421 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 44.6 t -111.82 146.93 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 122.669 0.387 . . . . 65.52 111.252 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 m -150.54 102.66 3.05 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.045 -0.409 . . . . 75.34 112.02 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.411 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 32.5 t70 -93.81 108.19 19.99 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.895 0.378 . . . . 74.4 111.46 176.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.534 ' HB2' HD23 ' A' ' 56' ' ' LEU . 6.6 mm-40 -113.37 -30.55 6.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.917 0.389 . . . . 71.44 110.922 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.56 -23.12 66.83 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.491 0.552 . . . . 64.42 112.491 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.42 45.46 6.92 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.084 -0.579 . . . . 60.22 112.731 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.54 HD11 HD13 ' A' ' 92' ' ' LEU . 83.5 mt -119.19 -32.75 4.32 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.106 0.41 . . . . 62.15 112.106 -175.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.1 132.69 36.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.178 0.514 . . . . 74.12 111.574 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.9 t -86.91 172.27 10.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.249 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -56.81 -40.68 76.42 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 111.906 0.336 . . . . 70.34 111.906 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -64.13 -47.33 80.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.711 0.291 . . . . 72.32 111.254 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -56.02 -41.21 74.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.703 0.287 . . . . 74.34 111.169 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -59.98 -55.92 28.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.131 0.491 . . . . 75.5 111.489 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 8.0 tp10 -69.33 -43.04 74.49 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.472 0.545 . . . . 71.35 112.472 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 31' ' ' ALA . 90.4 t -59.64 -39.84 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.088 0.471 . . . . 74.11 110.861 176.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.522 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.2 ttm -68.39 -43.09 78.04 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.387 -0.37 . . . . 70.42 110.789 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 34' ' ' GLU . 88.4 m-20 -51.07 -55.97 14.93 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.9 0.381 . . . . 70.1 111.486 177.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.47 -37.82 76.83 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.181 -0.533 . . . . 54.34 113.384 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -62.84 -53.59 51.81 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.174 0.512 . . . . 73.33 110.811 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.563 ' HB3' HD22 ' A' ' 20' ' ' LEU . 57.1 mt -61.72 -31.23 71.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.964 -0.562 . . . . 75.15 111.318 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.4 mtm-85 -74.5 -39.33 62.5 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.405 -0.362 . . . . 71.45 111.586 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.28 89.85 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.896 0.379 . . . . 64.52 111.563 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.04 -42.07 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.004 0.43 . . . . 70.31 111.704 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 20.6 ttp180 -74.22 -25.28 59.58 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.036 0.384 . . . . 73.34 112.036 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.5 t -66.67 -28.35 68.39 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.655 0.741 . . . . 74.23 109.641 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.6 p -104.64 -70.57 0.77 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.056 -0.974 . . . . 74.34 112.027 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.475 ' HE1' ' HB2' ' A' ' 150' ' ' LEU . 75.5 m-70 -76.86 -9.86 58.97 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.436 0.532 . . . . 61.31 112.436 -174.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . . . 65.25 13.41 8.75 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.233 0.457 . . . . 53.53 112.233 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.536 ' HA ' ' HB2' ' A' ' 84' ' ' ASN . 85.9 t -79.01 129.89 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.445 0.535 . . . . 74.52 112.445 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.96 97.33 9.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.612 0.72 . . . . 74.22 110.477 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.483 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.1 t80 -103.49 105.62 15.91 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.295 -0.866 . . . . 73.42 110.507 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.55 140.6 37.31 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.406 0.521 . . . . 73.25 112.406 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -126.07 122.9 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 122.722 0.409 . . . . 63.13 111.273 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.57 138.88 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.853 0.358 . . . . 75.41 111.804 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 17.9 p -117.08 126.05 52.24 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.887 0.375 . . . . 73.04 110.902 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 24' ' ' GLU . 33.7 mt -131.45 146.59 62.6 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.634 -0.257 . . . . 63.14 110.686 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.629 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 37.6 Cg_exo -57.87 -68.68 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.119 1.88 . . . . 72.04 111.682 174.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.42 ' HA ' HG13 ' A' ' 91' ' ' VAL . 60.3 p -142.3 157.83 44.39 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.186 0.517 . . . . 61.14 110.94 175.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.3 pt -110.15 23.66 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.009 -0.541 . . . . 54.3 111.11 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.64 -144.18 30.01 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.094 -0.503 . . . . 45.55 112.244 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -96.29 9.69 40.32 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.296 0.569 . . . . 63.12 111.01 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.3 141.78 86.29 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 112.01 0.374 . . . . 72.34 112.01 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 43.6 Cg_endo -67.91 145.17 67.32 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.561 2.174 . . . . 64.1 112.801 177.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.3 tp -61.68 -46.77 88.27 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.443 0.535 . . . . 75.42 112.443 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.33 -53.09 62.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.221 0.452 . . . . 65.43 112.221 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.581 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 5.3 m-20 -60.06 -33.77 72.51 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.682 0.253 . . . . 70.14 111.682 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -64.45 -55.15 22.75 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.674 0.273 . . . . 73.32 111.274 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.5 p -58.78 -39.76 81.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.8 0.333 . . . . 44.41 111.259 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.474 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 57.2 tp -59.88 -55.04 39.11 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.292 -0.413 . . . . 63.24 111.145 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -60.27 -32.5 71.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.17 0.433 . . . . 74.35 112.17 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.638 HD23 HD21 ' A' ' 87' ' ' LEU . 34.9 tp -73.03 -48.43 36.23 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.987 0.422 . . . . 61.13 111.249 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.417 ' HB1' ' HA3' ' A' ' 78' ' ' GLY . . . -63.28 -37.2 86.33 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.846 0.313 . . . . 72.31 111.846 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 67.8 mtp180 -61.44 -54.2 46.55 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.926 0.343 . . . . 65.3 111.926 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.463 HE22 ' HB2' ' A' ' 6' ' ' PRO . 11.9 pt20 -64.4 -27.28 68.9 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.861 0.362 . . . . 74.42 111.51 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 40.9 m0 -80.24 -2.27 44.27 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.889 0.329 . . . . 74.24 111.889 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.27 -46.39 3.4 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.26 -0.495 . . . . 51.03 113.473 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 17.8 m -49.6 -28.98 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.811 0.671 . . . . 61.51 112.811 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 72' ' ' ALA . . . -129.37 40.56 1.67 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.102 -0.571 . . . . 75.31 112.621 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -42.31 -47.91 4.92 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.156 0.503 . . . . 74.23 111.349 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -174.39 90.04 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.338 -0.847 . . . . 73.12 109.416 167.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.6 OUTLIER 56.68 52.66 9.33 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.509 0.671 . . . . 75.42 111.112 -173.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 67.3 t30 -74.37 169.56 17.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.61 -0.723 . . . . 63.34 111.607 -177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -70.9 138.9 50.53 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.846 -0.534 . . . . 71.33 112.083 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.81 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 36.3 p30 40.53 27.25 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.208 1.559 . . . . 72.4 115.208 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.88 123.83 7.61 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.785 -0.721 . . . . 73.32 111.882 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.6 tp -134.4 121.92 21.83 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.023 0.412 . . . . 65.34 111.307 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.638 HD21 HD23 ' A' ' 71' ' ' LEU . 57.4 tp -113.14 137.48 51.38 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.822 0.344 . . . . 75.14 111.754 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.3 tp -127.15 105.16 8.38 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.534 0.334 . . . . 74.24 110.876 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.84 129.69 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 111.9 0.333 . . . . 62.24 111.9 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HA ' HG12 ' A' ' 97' ' ' VAL . 27.6 tp -107.91 128.94 55.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.251 -0.431 . . . . 75.41 111.069 175.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.549 HG11 ' NE2' ' A' ' 94' ' ' GLN . 59.9 t -105.94 109.14 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.59 -0.277 . . . . 72.51 110.536 174.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.629 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 62.5 tp -55.94 -55.81 28.25 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.627 0.603 . . . . 73.13 112.627 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.61 -24.63 61.42 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.573 0.583 . . . . 73.35 112.573 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.549 ' NE2' HG11 ' A' ' 91' ' ' VAL . 40.3 mt-30 -103.45 -7.05 21.24 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.578 -0.283 . . . . 62.3 111.547 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 33.27 49.84 0.23 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.241 1.016 . . . . 75.4 113.254 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.4 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 30.9 ptt180 -141.87 155.11 45.54 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.573 -0.74 . . . . 64.42 110.317 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 90' ' ' LEU . 5.8 m -128.49 171.74 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.84 0.353 . . . . 72.11 111.429 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.5 ttt85 -149.15 133.16 17.16 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.404 -0.362 . . . . 74.42 111.809 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 97.1 m-85 -95.03 112.51 24.2 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.01 -0.541 . . . . 74.12 110.401 172.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 15.6 tp10 -94.31 111.94 23.7 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.581 0.229 . . . . 74.22 110.428 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 p -98.15 145.51 26.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.033 0.753 . . . . 64.31 113.033 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -97.06 -173.99 34.53 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.298 -0.864 . . . . 42.52 112.142 167.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -63.71 -27.86 69.5 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.147 0.499 . . . . 62.52 112.054 -175.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.81 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -73.45 -9.0 77.2 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 120.935 -0.65 . . . . 40.53 113.692 -172.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.1 mt -129.24 4.87 5.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.636 0.606 . . . . 73.31 112.636 -175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.72 -41.59 97.83 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.913 0.387 . . . . 64.34 111.116 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.94 -23.38 69.37 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.325 -0.464 . . . . 62.23 113.22 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -92.41 -66.87 0.89 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.676 0.274 . . . . 75.33 111.655 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.604 ' HA ' HD23 ' A' ' 113' ' ' LEU . 3.0 mp -117.16 94.95 46.23 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.829 0.307 . . . . 73.05 111.829 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.42 174.68 11.6 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.659 2.239 . . . . 72.02 112.607 174.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.86 -44.32 59.56 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.318 0.488 . . . . 74.33 112.318 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -59.65 -50.2 70.35 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.197 -0.525 . . . . 73.23 113.546 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 109' ' ' LEU . 36.0 tp -60.76 -49.13 78.71 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.828 0.347 . . . . 64.54 111.404 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 118' ' ' ILE . 92.8 mt -56.34 -48.61 76.43 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.214 -0.448 . . . . 73.43 111.231 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.3 m -61.56 -36.41 80.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.191 -0.459 . . . . 64.34 111.367 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.409 ' NH2' HD13 ' A' ' 113' ' ' LEU . 44.3 ttp180 -65.45 -50.14 66.49 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.548 -0.296 . . . . 75.51 110.973 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.81 -47.37 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.23 0.538 . . . . 64.13 110.617 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 114' ' ' LEU . 84.0 mt -59.03 -57.11 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.749 -0.659 . . . . 64.22 112.383 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -84.21 -22.46 30.87 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.364 0.875 . . . . 74.23 113.364 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.19 -38.15 17.95 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.034 0.445 . . . . 63.34 111.787 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 121' ' ' ARG . 12.4 mtp180 -113.25 -59.19 2.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.253 -0.43 . . . . 74.41 112.153 -176.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.9 mtp -62.51 -48.4 79.74 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.241 0.83 . . . . 74.45 113.241 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 27.1 mm -57.76 -50.79 86.17 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.421 0.526 . . . . 65.41 112.421 -177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 85.0 Cg_exo -47.15 -34.8 18.33 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.348 2.032 . . . . 75.14 112.998 174.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -72.97 -49.25 30.25 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.629 0.252 . . . . 72.13 111.182 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.433 ' HD2' HD13 ' A' ' 123' ' ' ILE . 23.7 m-85 -57.4 -45.02 85.0 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.016 0.376 . . . . 73.44 112.016 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -62.3 -23.94 67.01 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.22 0.533 . . . . 64.21 111.1 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.0 m -92.77 7.43 43.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.062 -0.517 . . . . 45.02 111.559 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.75 -0.43 82.06 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.364 -0.446 . . . . 73.41 113.493 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.792 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.87 70.72 10.68 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 122.519 -0.4 . . . . 71.43 111.545 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -70.57 -42.33 71.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.016 0.436 . . . . 72.51 110.557 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.3 90.89 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.998 -0.546 . . . . 71.33 111.213 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.792 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 18.6 mp0 -59.69 -53.27 59.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.367 -0.379 . . . . 75.14 111.088 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.57 -49.87 59.4 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.359 -0.448 . . . . 70.03 113.647 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 139' ' ' VAL . 96.4 mt -65.67 -46.9 77.37 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.572 -0.369 . . . . 72.32 111.818 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 92.7 p -61.67 -50.53 72.13 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.716 0.293 . . . . 73.55 111.684 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -27.16 60.15 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.7 -0.227 . . . . 72.53 111.285 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.13 -47.62 79.44 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.12 -0.562 . . . . 65.31 112.402 173.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 135' ' ' LEU . 75.3 t -58.27 -44.13 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.253 0.549 . . . . 71.11 110.562 173.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.512 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 41.0 tp -63.96 -35.91 82.22 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.884 -0.598 . . . . 74.02 110.83 177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.63 -43.5 97.44 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.94 0.4 . . . . 62.44 111.282 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.87 -47.54 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.171 0.51 . . . . 64.12 110.671 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -56.16 -36.73 68.63 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.02 -0.536 . . . . 64.13 111.673 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 18.7 mm-40 -57.3 -29.84 64.24 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 120.82 0.343 . . . . 72.32 111.809 176.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.53 -49.68 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.851 0.358 . . . . 73.05 111.139 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -71.76 -58.3 3.59 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.071 0.397 . . . . 61.24 112.071 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -71.56 -14.3 62.05 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.871 0.323 . . . . 75.42 111.871 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -75.16 -16.24 80.7 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.085 -0.578 . . . . 63.4 112.511 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.1 t -102.6 -68.97 0.81 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.13 0.49 . . . . 74.42 110.39 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.475 ' HB2' ' HE1' ' A' ' 47' ' ' HIS . 80.7 mt -92.48 80.35 4.88 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.216 0.532 . . . . 73.23 110.803 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -70.37 -32.77 70.59 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.008 -0.542 . . . . 71.25 110.889 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -74.96 89.11 2.38 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.87 -0.605 . . . . 73.24 110.088 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -59.54 -23.94 63.27 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.87 1.063 . . . . 72.12 113.87 -172.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -66.9 87.2 0.14 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.262 0.554 . . . . 74.14 110.363 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -78.98 154.92 29.16 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.465 0.913 . . . . 74.03 113.465 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -76.14 139.87 41.49 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.245 -0.888 . . . . 74.14 111.895 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 119.139 -0.457 . . . . 74.12 111.296 174.258 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.565 0.222 . . . . 74.11 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -161.14 123.27 3.05 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.718 0.294 . . . . 64.12 110.991 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.8 t -78.27 111.32 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.023 0.44 . . . . 61.44 112.167 -175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.13 126.61 50.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.128 -0.487 . . . . 73.04 111.137 173.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.479 ' O ' HG23 ' A' ' 9' ' ' VAL . 67.6 mttm -89.04 151.46 46.96 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.446 -0.343 . . . . 45.01 110.983 176.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.479 ' HD3' ' CE2' ' A' ' 67' ' ' PHE . 39.7 Cg_endo -64.88 -19.63 64.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.872 1.714 . . . . 65.24 111.663 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' HA ' HE22 ' A' ' 74' ' ' GLN . 18.5 mt-10 -88.83 -7.69 55.72 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.391 -0.822 . . . . 75.51 111.165 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -112.52 2.04 16.12 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.908 -0.587 . . . . 62.14 111.876 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 5' ' ' LYS . 61.8 t -81.28 130.92 60.51 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.512 -0.313 . . . . 41.05 110.447 174.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.01 116.89 1.89 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.877 2.385 . . . . 62.3 113.314 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -68.29 70.29 0.16 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.005 0.431 . . . . 74.44 112.035 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -60.56 -25.42 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.7 0.63 . . . . 74.51 112.7 -175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -73.98 -25.09 59.74 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.901 0.381 . . . . 75.31 111.219 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tt -93.84 -32.61 13.87 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.076 -0.511 . . . . 62.01 111.038 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.88 -47.3 10.46 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.202 0.445 . . . . 54.03 112.202 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -106.4 -65.62 1.07 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.592 0.59 . . . . 73.44 112.592 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.8 p 61.65 0.72 0.51 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.985 0.914 . . . . 74.22 112.139 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -110.5 -36.68 5.69 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.678 0.391 . . . . 70.44 111.641 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -87.11 -49.3 7.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.862 0.363 . . . . 64.44 111.629 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp 65.45 13.92 9.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.26 0.624 . . . . 74.23 112.155 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.8 t -102.41 128.72 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.0 0.428 . . . . 73.51 111.651 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 m -129.74 112.4 13.59 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.274 -0.421 . . . . 65.42 110.931 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -124.04 102.23 7.64 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.007 0.432 . . . . 65.22 111.894 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.53 ' HB2' HD23 ' A' ' 56' ' ' LEU . 4.7 mp0 -102.93 -38.7 7.25 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.292 -0.413 . . . . 74.24 110.98 173.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.1 -20.92 66.3 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.074 0.768 . . . . 43.11 113.074 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.6 38.78 27.23 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.916 -0.659 . . . . 62.13 112.693 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.1 mt -100.81 -28.42 12.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.719 0.295 . . . . 73.3 111.393 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.2 mt -99.05 107.53 19.96 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.737 0.303 . . . . 75.11 111.321 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.1 t -74.57 160.53 30.76 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.353 -0.217 . . . . 72.22 110.903 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -46.47 -36.29 6.49 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.729 0.64 . . . . 74.5 112.729 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.49 -52.02 63.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.948 0.404 . . . . 40.33 111.333 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.503 ' HG3' ' HB1' ' A' ' 132' ' ' ALA . 14.6 mm100 -62.07 -40.7 96.7 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.928 0.394 . . . . 63.32 110.741 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.27 -44.74 88.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.211 -0.45 . . . . 72.33 110.865 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -57.93 -52.26 66.24 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.132 0.491 . . . . 75.24 111.126 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.69 -45.9 96.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.212 -0.449 . . . . 64.02 111.622 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 43.9 ttm -62.78 -44.38 96.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.503 -0.317 . . . . 75.03 111.375 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -53.55 -47.83 69.66 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.169 0.509 . . . . 72.45 110.656 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.85 -36.11 92.29 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.059 -0.591 . . . . 34.41 113.086 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.57 ' O ' HG13 ' A' ' 43' ' ' ILE . 6.2 mmp_? -67.3 -56.27 10.48 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.816 0.341 . . . . 74.24 111.12 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.62 -47.25 84.57 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.175 -0.466 . . . . 63.23 111.746 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -58.54 -45.99 87.77 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.207 -0.451 . . . . 74.53 111.19 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.76 80.81 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.908 0.385 . . . . 65.41 111.386 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.4 mt -65.64 -48.64 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.878 0.37 . . . . 35.12 111.424 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 48.5 ttt180 -66.83 -28.16 68.13 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.11 -0.369 . . . . 73.35 111.625 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 t -76.67 -49.73 15.43 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.804 0.335 . . . . 74.23 111.632 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.2 t -82.83 -54.18 5.3 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.323 0.49 . . . . 65.31 112.323 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.613 ' ND1' HD21 ' A' ' 150' ' ' LEU . 15.0 m-70 -87.56 -22.3 24.89 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.115 -0.493 . . . . 74.25 111.505 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 71.43 17.68 5.7 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.235 0.614 . . . . 73.32 111.443 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.802 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 84.2 t -87.48 119.25 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.106 -0.497 . . . . 72.3 111.284 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -80.96 96.69 7.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.244 0.545 . . . . 74.04 110.283 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -110.49 109.65 20.09 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.631 -0.713 . . . . 74.35 110.645 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.33 142.16 42.36 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.444 0.535 . . . . 60.34 112.444 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.22 132.82 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.321 -0.4 . . . . 70.12 111.214 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 71' ' ' LEU . 41.8 t -130.92 138.79 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 122.463 0.305 . . . . 72.13 111.534 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 p -124.49 122.85 38.77 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.093 0.473 . . . . 73.54 111.573 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HB2' ' A' ' 24' ' ' GLU . 42.8 mt -131.85 145.36 57.14 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 116.516 -0.311 . . . . 62.13 110.92 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 28.2 Cg_endo -63.59 -68.63 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.13 1.887 . . . . 64.43 112.684 177.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 m -131.0 156.04 45.8 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.207 -0.308 . . . . 71.12 110.785 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.553 HD11 HE22 ' A' ' 94' ' ' GLN . 27.8 pt -122.21 2.08 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 121.14 0.495 . . . . 73.25 111.886 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.95 -122.7 10.2 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.211 -0.519 . . . . 72.02 113.178 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -103.49 4.95 36.54 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.978 0.362 . . . . 54.01 111.978 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.08 118.49 70.94 Favored Pre-proline 0 CA--C 1.538 0.497 0 O-C-N 122.402 -0.186 . . . . 71.21 110.685 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.495 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 32.0 Cg_endo -63.94 131.37 30.62 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.145 1.897 . . . . 63.01 112.354 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.5 tp -48.01 -40.4 22.6 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.41 0.522 . . . . 61.33 112.41 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.45 -45.37 91.2 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.215 0.45 . . . . 62.13 112.215 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.495 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 22.9 t70 -71.66 -34.57 69.83 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.464 0.649 . . . . 73.01 110.228 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.479 ' CE2' ' HD3' ' A' ' 6' ' ' PRO . 21.6 t80 -58.77 -52.37 65.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.521 -0.763 . . . . 74.31 110.914 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.5 p -61.74 -40.42 95.05 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.266 -0.425 . . . . 70.31 111.19 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.9 tp -57.48 -52.74 64.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.28 -0.418 . . . . 63.04 111.278 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 56.4 mtpt -60.35 -49.28 78.2 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.942 0.401 . . . . 74.44 111.764 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 54' ' ' VAL . 34.2 tp -59.6 -45.03 93.12 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.338 -0.392 . . . . 72.34 111.735 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -48.19 73.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.348 0.499 . . . . 73.04 112.348 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.492 ' NH2' ' HG2' ' A' ' 70' ' ' LYS . 14.4 ptt180 -68.08 -31.38 70.97 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.916 0.388 . . . . 65.34 111.321 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.413 HE22 ' HA ' ' A' ' 7' ' ' GLU . 7.9 tt0 -70.91 -39.35 72.77 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.022 0.439 . . . . 45.42 111.246 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.415 ' CZ2' HD11 ' A' ' 71' ' ' LEU . 41.0 m0 -80.49 8.53 7.54 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.199 0.444 . . . . 73.54 112.199 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.5 -42.0 2.74 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.159 -0.543 . . . . 71.34 113.585 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -59.15 -4.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 113.535 0.939 . . . . 64.33 113.535 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.72 27.69 3.66 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.725 -0.75 . . . . 32.04 113.831 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -58.74 101.05 0.08 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 117.832 0.816 . . . . 54.32 111.087 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 13.1 pt-20 38.94 48.7 1.44 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.419 0.688 . . . . 73.42 111.641 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 13.7 mptt 70.09 81.56 0.17 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.123 -0.944 . . . . 55.3 111.548 -173.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -64.96 162.54 16.33 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.906 -0.588 . . . . 70.24 109.458 174.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -59.89 -99.08 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 112.968 0.729 . . . . 72.54 112.968 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.802 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 15.3 m120 -76.22 78.05 3.02 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.506 -0.746 . . . . 73.32 111.778 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.9 135.49 7.72 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.162 -0.542 . . . . 32.44 112.809 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 99' ' ' PHE . 57.1 tp -147.26 119.89 8.56 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.752 0.31 . . . . 74.41 110.662 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.483 HD21 HD23 ' A' ' 71' ' ' LEU . 60.8 tp -107.55 132.81 52.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.856 0.36 . . . . 64.01 111.745 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.0 tp -121.85 112.23 18.09 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.378 -0.374 . . . . 72.15 111.127 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.18 126.9 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.878 0.37 . . . . 72.15 111.629 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.42 ' HA ' HG12 ' A' ' 97' ' ' VAL . 29.7 tp -109.84 120.64 43.11 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.196 -0.456 . . . . 54.23 111.335 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.545 HG21 HD13 ' A' ' 59' ' ' ILE . 51.8 t -100.92 103.46 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.581 -0.281 . . . . 52.01 110.745 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 67.1 tp -52.19 -44.89 64.95 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.307 0.484 . . . . 72.54 112.307 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.86 -31.55 66.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.036 -0.529 . . . . 73.54 112.249 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.553 HE22 HD11 ' A' ' 59' ' ' ILE . 51.2 mt-30 -110.56 -6.12 14.95 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.037 0.384 . . . . 62.44 112.037 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 42.17 31.02 0.22 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.672 0.789 . . . . 74.45 112.003 -171.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 58.2 mtt180 -107.25 142.33 37.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.774 -0.648 . . . . 74.33 110.972 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 90' ' ' LEU . 4.1 m -131.01 163.14 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.973 0.416 . . . . 74.34 111.124 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -148.41 137.03 21.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.411 -0.359 . . . . 64.03 111.329 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.645 ' HB3' HD11 ' A' ' 86' ' ' LEU . 89.9 m-85 -100.08 113.5 26.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.019 -0.537 . . . . 74.41 110.104 173.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -95.76 114.45 26.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.372 -0.232 . . . . 72.44 110.372 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.54 147.67 23.83 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.213 0.819 . . . . 61.33 113.213 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -97.77 178.37 32.3 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.122 -0.944 . . . . 44.43 112.539 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -62.72 -19.38 63.86 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.444 0.535 . . . . 73.11 112.444 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.74 -18.24 56.82 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.032 -0.604 . . . . 61.12 113.33 -177.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.602 HD11 HG13 ' A' ' 49' ' ' VAL . 91.4 mt -111.54 -4.54 14.76 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.889 0.7 . . . . 72.01 112.889 -175.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -58.76 -30.51 67.58 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.082 0.401 . . . . 71.12 112.082 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.49 -18.24 79.27 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.042 -0.599 . . . . 60.34 113.062 174.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.513 ' HE1' ' HB3' ' A' ' 152' ' ' HIS . 34.6 m-85 -93.28 -57.39 2.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.277 0.56 . . . . 75.12 111.831 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.548 ' HB3' HD21 ' A' ' 114' ' ' LEU . 12.5 mt -119.64 89.0 40.39 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.611 -0.722 . . . . 75.04 112.253 -169.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.09 148.29 85.2 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.25 1.967 . . . . 64.44 111.571 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.25 -27.64 62.25 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.007 0.432 . . . . 74.35 111.385 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.53 -49.38 56.49 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.155 -0.545 . . . . 54.04 112.589 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.32 -44.26 84.03 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.158 0.504 . . . . 74.3 111.064 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 109' ' ' LEU . 89.6 mt -58.31 -43.17 88.02 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.263 -0.426 . . . . 52.21 111.083 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.6 m -62.88 -36.89 84.81 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.852 0.358 . . . . 51.44 111.118 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -60.21 -53.46 57.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.355 -0.384 . . . . 72.04 110.149 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.6 mt -51.53 -42.4 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.916 0.389 . . . . 73.22 111.234 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 122' ' ' MET . 76.6 mt -58.67 -55.87 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.818 0.342 . . . . 51.24 111.478 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -76.22 -9.72 58.85 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.506 0.558 . . . . 72.14 112.506 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -95.42 -45.36 7.14 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.162 0.43 . . . . 74.23 112.162 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.698 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 92.6 mtt180 -127.59 -4.11 5.97 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.599 0.962 . . . . 71.15 113.599 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 17.0 mmt -103.46 -63.27 1.2 Allowed 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.85 -0.531 . . . . 73.51 111.786 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.555 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 43.5 mm -50.07 -49.97 72.05 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 112.719 0.637 . . . . 65.21 112.719 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 11.1 Cg_endo -52.76 -37.19 75.74 Favored 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.366 2.044 . . . . 61.41 112.874 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.426 ' NE2' ' HG3' ' A' ' 137' ' ' GLU . 86.5 m-70 -77.61 -48.65 16.34 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.543 -0.299 . . . . 70.4 111.434 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.7 m-85 -57.06 -40.12 76.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.772 0.32 . . . . 73.33 111.42 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -59.35 -35.78 74.5 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.997 0.427 . . . . 74.13 111.291 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.2 t -84.18 -3.44 58.15 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.247 -0.433 . . . . 63.32 111.691 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.42 6.68 88.45 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.111 -0.566 . . . . 60.12 112.888 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.697 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.6 m-20 -84.08 55.79 3.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.688 0.395 . . . . 63.21 111.72 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -56.43 -44.35 80.34 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.06 0.392 . . . . 64.34 112.06 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.503 ' HB1' ' HG3' ' A' ' 32' ' ' GLN . . . -66.85 -32.77 74.26 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.94 0.4 . . . . 74.12 112.042 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.697 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 53.3 mt-10 -76.54 -43.39 39.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.391 -0.368 . . . . 74.44 111.508 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.64 -49.75 67.82 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.389 -0.434 . . . . 73.22 112.994 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 139' ' ' VAL . 92.2 mt -56.64 -39.75 74.22 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.746 0.308 . . . . 64.14 111.445 176.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.8 t -60.8 -45.69 93.43 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.085 0.469 . . . . 72.32 111.047 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.698 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 38.0 mm-40 -61.85 -44.86 95.98 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.996 -0.547 . . . . 72.43 111.819 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.88 -47.54 90.74 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.166 -0.54 . . . . 74.43 113.072 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 135' ' ' LEU . 83.4 t -60.55 -50.02 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.885 0.374 . . . . 65.14 111.511 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.93 -38.33 85.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.376 -0.374 . . . . 74.44 111.269 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.93 -54.63 44.76 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.996 0.427 . . . . 55.22 111.331 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.446 HG13 HD11 ' A' ' 109' ' ' LEU . 99.5 t -57.53 -47.7 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.147 -0.479 . . . . 71.04 111.133 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.407 HE22 ' NH1' ' A' ' 39' ' ' ARG . 63.4 tt0 -53.74 -37.7 63.62 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.211 -0.45 . . . . 73.32 111.817 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 144' ' ' GLN . 14.5 mm-40 -72.89 -38.99 66.76 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 111.609 0.225 . . . . 62.35 111.609 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.53 -42.87 95.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.998 0.427 . . . . 75.51 110.985 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.401 HD13 HG21 ' A' ' 49' ' ' VAL . 77.2 mt -64.43 -49.9 69.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.124 -0.489 . . . . 73.13 111.168 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -55.38 -40.95 71.98 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.657 -0.701 . . . . 71.34 112.232 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.49 20.85 38.64 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.748 -0.739 . . . . 44.54 113.856 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.7 t -157.05 30.91 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.721 0.76 . . . . 63.42 112.165 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.613 HD21 ' ND1' ' A' ' 47' ' ' HIS . 61.8 mt -73.16 76.02 1.27 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.232 0.539 . . . . 62.22 112.079 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.46 4.14 7.65 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.728 -0.669 . . . . 54.12 111.983 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.513 ' HB3' ' HE1' ' A' ' 108' ' ' TYR . 51.5 t-80 -145.29 91.95 2.19 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.202 0.525 . . . . 74.31 112.392 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -90.9 -160.69 0.74 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.274 -0.421 . . . . 73.02 110.265 171.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.32 137.49 51.43 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.069 1.137 . . . . 75.45 114.069 -172.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -114.23 -37.01 4.51 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.274 -0.875 . . . . 53.14 109.869 170.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -110.13 131.45 55.05 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.0 -0.545 . . . . 72.14 110.963 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.588 -0.72 . . . . 63.44 110.76 174.074 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.501 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.485 0.183 . . . . 73.31 111.364 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -74.37 -28.38 61.09 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.83 0.347 . . . . 71.13 111.69 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.461 HG12 ' HE3' ' A' ' 5' ' ' LYS . 97.8 t 64.6 94.59 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.769 -0.65 . . . . 73.11 111.613 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -87.81 135.61 33.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.852 -0.613 . . . . 60.21 111.936 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.461 ' HE3' HG12 ' A' ' 3' ' ' VAL . 25.7 mmtp -100.93 158.99 30.76 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.47 -0.567 . . . . 74.33 109.47 169.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 9.5 Cg_endo -56.65 -32.08 89.46 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.43 1.42 . . . . 73.31 112.038 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -78.13 -12.72 60.01 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.483 0.549 . . . . 75.03 112.483 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -85.35 -18.04 34.97 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.953 0.406 . . . . 63.42 110.976 173.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.473 HG22 HD21 ' A' ' 56' ' ' LEU . 60.3 t -79.03 128.0 77.72 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.137 -0.483 . . . . 73.01 111.388 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.23 108.25 0.32 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.301 2.0 . . . . 74.53 111.899 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.524 ' ND2' HD13 ' A' ' 14' ' ' LEU . 14.7 p-10 -66.57 82.14 0.1 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.741 0.781 . . . . 74.42 112.158 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.42 1.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.487 -0.779 . . . . 64.11 113.0 -177.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -100.7 9.99 41.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.834 0.35 . . . . 75.55 111.305 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD13 ' ND2' ' A' ' 11' ' ' ASN . 10.1 tt -124.11 -46.0 1.96 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.442 -0.344 . . . . 74.12 111.35 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.77 -68.29 0.7 Allowed 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.146 -0.346 . . . . 61.04 111.654 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -80.07 -61.95 1.83 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.942 0.349 . . . . 73.01 111.942 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 m 63.11 7.06 2.55 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.656 0.383 . . . . 62.34 111.818 -174.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -99.26 -43.69 6.51 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.119 0.414 . . . . 64.13 112.119 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.423 ' HB2' ' ND2' ' A' ' 37' ' ' ASN . 13.0 ptm180 -82.51 -35.92 26.9 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.581 0.585 . . . . 74.44 112.581 -177.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 mp 63.19 3.83 1.44 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.735 0.643 . . . . 71.55 112.735 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.5 t -108.8 154.32 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.663 0.385 . . . . 54.43 111.166 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.3 m -142.5 108.74 5.25 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.479 0.311 . . . . 75.25 111.031 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.53 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 20.7 p-10 -107.74 73.67 0.92 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.521 0.676 . . . . 72.14 112.616 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -79.18 -38.09 36.69 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.289 0.566 . . . . 71.13 110.453 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.19 66.59 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.918 -0.583 . . . . 54.3 112.403 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.26 19.2 73.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.152 -0.547 . . . . 41.42 113.195 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.11 0.12 54.27 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.053 0.39 . . . . 64.41 112.053 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -109.95 103.59 12.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.916 0.388 . . . . 74.02 111.04 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.7 t -70.33 165.98 21.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.368 -0.378 . . . . 64.24 111.403 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -46.72 -57.73 4.56 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.426 0.898 . . . . 74.1 113.426 -172.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.593 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . . . -68.06 -42.93 79.75 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.021 0.378 . . . . 74.53 112.021 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -62.26 -33.43 74.61 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.259 0.552 . . . . 74.32 111.069 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -74.2 -53.22 10.28 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.668 -0.696 . . . . 74.24 111.038 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 11.6 pt-20 -59.65 -43.59 93.85 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.129 0.418 . . . . 53.13 112.129 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 31' ' ' ALA . 89.0 t -65.8 -33.67 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.143 0.497 . . . . 71.14 110.91 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.447 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 50.8 ttm -65.34 -40.5 93.75 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 122.052 -0.405 . . . . 63.24 110.651 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 19' ' ' ARG . 4.2 m-20 -57.93 -56.36 22.95 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.989 0.423 . . . . 74.01 111.703 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.57 -43.03 85.83 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.306 -0.473 . . . . 72.34 113.416 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 73.4 mtm180 -62.55 -45.1 94.48 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 111.756 0.28 . . . . 72.13 111.756 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 36' ' ' MET . 89.1 mt -64.1 -50.84 66.71 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.025 0.44 . . . . 75.42 111.431 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -60.21 -37.79 81.37 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.272 -0.422 . . . . 74.2 111.447 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.33 -44.23 88.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.943 0.401 . . . . 73.31 111.271 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.651 HG22 ' HB ' ' A' ' 49' ' ' VAL . 63.5 mt -61.58 -38.79 81.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.937 0.398 . . . . 62.02 111.265 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 57.3 ttp180 -74.03 -33.24 63.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.917 0.389 . . . . 74.13 111.238 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.2 t -66.87 -38.53 86.5 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.1 0.476 . . . . 73.12 111.08 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.0 t -92.61 -61.67 1.55 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.99 -0.55 . . . . 62.32 112.162 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.539 ' HE1' HD23 ' A' ' 150' ' ' LEU . 76.7 m-70 -91.91 -4.97 54.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.649 0.611 . . . . 63.01 112.649 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.86 26.85 14.4 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.185 0.439 . . . . 63.41 112.185 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' HG22 ' A' ' 43' ' ' ILE . 62.5 t -90.7 128.31 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 112.215 0.45 . . . . 73.25 112.215 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -86.56 97.45 10.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.389 -0.369 . . . . 75.41 110.419 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.09 105.99 14.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.846 0.355 . . . . 74.44 110.539 -177.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.63 142.1 42.96 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.456 0.539 . . . . 65.14 112.456 -175.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.18 118.17 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.989 0.423 . . . . 74.34 111.437 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.544 HG21 HD21 ' A' ' 71' ' ' LEU . 61.8 t -114.62 142.27 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 122.516 0.326 . . . . 71.23 111.752 -178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.53 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 73.3 p -130.88 123.51 29.15 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.756 0.313 . . . . 62.21 111.293 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.473 HD21 HG22 ' A' ' 9' ' ' VAL . 68.2 mt -120.65 139.24 28.58 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 111.749 0.277 . . . . 72.34 111.749 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 83.2 Cg_endo -81.81 -11.75 11.25 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.634 2.222 . . . . 61.35 113.315 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.763 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 31.0 t -169.77 138.77 1.87 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.97 0.359 . . . . 73.34 111.97 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 3' ' ' VAL . 28.6 pt -136.86 -0.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 120.984 0.421 . . . . 71.23 110.365 170.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.27 -158.58 52.12 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 116.133 -0.485 . . . . 54.33 113.219 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.46 69.94 2.28 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.367 0.603 . . . . 73.2 110.873 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.55 142.44 41.88 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.731 -0.668 . . . . 73.04 111.26 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 77.1 Cg_endo -79.27 116.67 3.66 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.415 2.076 . . . . 73.42 113.092 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.51 -38.09 83.24 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.116 0.413 . . . . 73.24 112.116 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.03 -8.86 48.94 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.968 0.413 . . . . 74.21 111.967 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 31.1 t70 -96.59 -39.21 9.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.544 0.688 . . . . 74.24 109.632 170.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.463 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 43.3 t80 -55.2 -50.21 69.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.038 -0.983 . . . . 73.12 111.785 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -52.68 -49.39 65.38 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.858 0.361 . . . . 73.55 111.809 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.7 tp -59.57 -49.72 76.66 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.242 -0.436 . . . . 72.42 111.576 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -60.56 -47.74 84.84 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.243 0.46 . . . . 62.12 112.243 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 54' ' ' VAL . 51.2 tp -61.52 -47.85 83.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.242 0.544 . . . . 53.33 110.766 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.23 77.24 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.07 -0.514 . . . . 74.2 112.01 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -61.14 -52.37 65.12 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.844 0.354 . . . . 65.5 111.709 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.522 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 12.1 pt20 -72.05 -21.64 61.5 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 111.774 0.287 . . . . 64.31 111.774 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.522 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 30.3 m0 -91.03 -16.04 28.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.561 0.219 . . . . 73.13 111.451 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.51 40.44 99.11 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.387 -0.435 . . . . 74.44 113.238 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.08 -85.01 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 112.547 0.573 . . . . 73.31 112.547 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.21 60.87 4.45 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.225 -0.512 . . . . 75.42 113.853 -173.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.414 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 12.6 m120 -112.32 133.31 54.5 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.189 -0.594 . . . . 64.01 110.867 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -45.93 -27.4 0.89 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.251 0.834 . . . . 64.43 113.251 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.794 ' HD3' ' H ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -105.76 -7.68 18.23 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.478 0.547 . . . . 72.02 112.478 -176.07 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' TYR . 65.1 t30 -77.66 160.91 28.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.732 -0.47 . . . . 72.03 109.732 175.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -76.62 -109.3 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.623 -0.673 . . . . 62.42 112.505 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.651 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.7 m-20 -81.23 78.98 7.97 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.433 -0.792 . . . . 72.03 111.724 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.93 140.69 11.65 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.164 -0.541 . . . . 64.13 113.339 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 99' ' ' PHE . 53.3 tp -148.77 124.61 10.57 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.858 0.463 . . . . 74.4 110.573 178.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.533 HD21 HD23 ' A' ' 71' ' ' LEU . 59.0 tp -115.1 132.68 56.52 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.696 0.284 . . . . 62.24 111.509 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.4 tp -122.4 123.25 40.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.795 0.438 . . . . 55.03 110.158 174.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 51.1 t -124.4 126.54 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.122 0.416 . . . . 53.3 112.122 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.662 ' HB2' HD21 ' A' ' 135' ' ' LEU . 24.1 tp -103.31 124.93 49.58 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.201 -0.454 . . . . 72.52 110.774 172.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.33 98.97 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.443 -0.344 . . . . 50.23 111.513 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.607 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 65.1 tp -55.68 -31.01 62.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.041 0.448 . . . . 45.44 111.561 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.763 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 11.5 t70 -49.97 -47.99 52.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.29 0.636 . . . . 75.4 111.759 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.502 ' OE1' ' HD2' ' A' ' 96' ' ' ARG . 8.9 pt20 -125.45 6.35 7.64 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.343 0.498 . . . . 72.21 112.343 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 56.91 30.79 18.58 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.063 0.764 . . . . 74.22 113.063 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.502 ' HD2' ' OE1' ' A' ' 94' ' ' GLN . 84.5 mtt180 -107.19 149.13 28.05 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.203 0.525 . . . . 71.33 111.676 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 90' ' ' LEU . 5.9 m -139.27 160.97 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.675 -0.693 . . . . 43.31 111.165 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -160.32 145.55 14.86 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.648 0.611 . . . . 74.35 112.648 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' HB3' HD11 ' A' ' 86' ' ' LEU . 96.8 m-85 -97.27 146.77 24.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.764 -0.653 . . . . 73.41 110.323 169.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 5.9 tp10 -135.62 113.0 10.62 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.284 -0.26 . . . . 74.44 110.632 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.419 HG21 ' HB2' ' A' ' 109' ' ' LEU . 6.2 p -95.76 160.88 14.26 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.455 0.909 . . . . 72.41 113.455 -175.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.42 -177.24 21.33 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 114.964 -1.017 . . . . 72.11 112.202 168.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' ASN . 19.5 t80 -65.34 -11.13 38.86 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.012 0.525 . . . . 73.12 112.337 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.67 -6.96 79.44 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.876 -0.678 . . . . 52.42 113.091 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 49' ' ' VAL . 97.5 mt -127.67 -12.48 5.45 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.062 0.764 . . . . 73.02 113.062 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -57.54 -17.97 16.7 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.373 0.879 . . . . 75.03 113.373 -175.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.04 -26.19 69.41 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.148 -0.548 . . . . 54.41 113.079 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' A' ' 152' ' ' HIS . 62.9 m-85 -106.38 -44.07 4.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.933 0.397 . . . . 75.54 111.917 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' HB2' HG21 ' A' ' 101' ' ' THR . 29.5 mt -119.23 84.53 28.12 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 112.59 0.589 . . . . 61.33 112.59 -170.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.32 162.65 25.27 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.113 1.875 . . . . 71.11 112.251 171.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.33 -34.9 67.01 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.841 0.353 . . . . 71.33 111.644 -177.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.75 -50.18 66.37 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.019 -0.61 . . . . 73.24 113.046 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 109' ' ' LEU . 56.6 tp -58.68 -45.79 88.66 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.867 0.365 . . . . 64.3 111.151 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.401 ' O ' HG13 ' A' ' 118' ' ' ILE . 94.5 mt -58.35 -43.63 88.41 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.364 -0.38 . . . . 74.43 110.935 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.5 m -62.67 -38.5 90.57 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.418 -0.356 . . . . 55.15 111.037 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -58.04 -53.46 57.95 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.979 0.419 . . . . 71.3 110.659 174.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.2 mt -54.22 -49.48 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.006 0.431 . . . . 55.53 111.222 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 123' ' ' ILE . 96.9 mt -57.94 -56.81 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.974 -0.557 . . . . 73.12 111.936 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 46.2 m-70 -72.69 -40.87 65.89 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.828 0.677 . . . . 74.2 112.828 -173.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -78.84 -44.51 22.84 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.565 0.58 . . . . 75.13 112.565 -171.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -109.55 -32.91 6.95 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.199 0.814 . . . . 54.23 113.199 -173.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.566 ' HB3' ' HE2' ' A' ' 126' ' ' PHE . 85.4 mtp -87.94 -51.64 5.71 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.091 0.774 . . . . 63.34 113.091 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 118' ' ' ILE . 48.1 mm -51.77 -49.24 84.52 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 112.735 0.642 . . . . 54.43 112.735 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 87.1 Cg_exo -48.27 -28.81 11.83 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 122.665 2.243 . . . . 72.02 113.694 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 79.4 m-70 -83.32 -52.16 6.79 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.674 0.25 . . . . 72.3 111.674 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.566 ' HE2' ' HB3' ' A' ' 122' ' ' MET . 50.1 m-85 -56.83 -44.36 82.0 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.948 0.404 . . . . 71.32 111.468 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 123' ' ' ILE . 2.9 ptm180 -71.07 -10.26 59.46 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.279 -0.419 . . . . 74.03 111.64 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.9 m -110.41 -1.96 16.84 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 111.892 0.33 . . . . 73.24 111.892 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.61 -17.79 35.87 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.963 -0.637 . . . . 35.1 114.075 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.762 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 93.7 m-20 -80.08 81.32 6.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.322 0.561 . . . . 74.02 111.571 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -71.11 -54.65 10.33 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.873 0.368 . . . . 71.11 111.638 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.26 74.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.138 0.494 . . . . 62.23 111.842 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 5.5 mm-40 -74.52 -31.6 62.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.375 -0.375 . . . . 61.1 111.36 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.28 -42.4 57.42 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.029 -0.605 . . . . 75.31 112.366 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 90' ' ' LEU . 95.4 mt -62.32 -47.63 83.43 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.85 0.357 . . . . 65.4 111.611 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.3 p -59.28 -37.25 77.21 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.435 -0.348 . . . . 53.44 111.693 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -59.66 -48.78 80.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.719 0.295 . . . . 64.13 111.214 172.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.8 -50.48 67.2 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.024 -0.608 . . . . 63.01 112.941 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.0 t -57.75 -48.47 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.944 0.402 . . . . 74.43 111.314 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.508 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 55.1 tp -60.76 -41.08 94.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.237 -0.438 . . . . 65.25 111.292 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.39 -49.43 77.6 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.856 0.36 . . . . 72.1 111.324 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.49 -44.56 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.276 -0.42 . . . . 44.12 111.254 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -53.22 -41.88 65.79 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.15 -0.477 . . . . 74.32 111.306 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 85.1 mm-40 -60.26 -48.31 82.3 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.539 -0.3 . . . . 75.0 111.451 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.72 -49.63 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.021 0.378 . . . . 74.42 112.021 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 89.2 mt -70.36 -57.06 5.25 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.903 0.383 . . . . 72.41 111.77 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.35 -20.1 63.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.989 0.424 . . . . 71.05 111.708 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.92 -17.63 71.98 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.108 -0.568 . . . . 63.4 112.897 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 60.8 m -86.02 -64.83 1.09 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.639 -0.33 . . . . 70.31 111.718 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.539 HD23 ' HE1' ' A' ' 47' ' ' HIS . 94.2 mt 71.2 -53.78 0.67 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.101 1.149 . . . . 74.41 114.101 176.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -38.66 -39.37 0.48 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.372 1.249 . . . . 74.14 114.372 -167.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.489 ' HB3' ' OH ' ' A' ' 108' ' ' TYR . 61.7 t60 -118.94 33.22 5.74 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.736 0.643 . . . . 73.13 112.736 -166.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.496 ' O ' ' CD2' ' A' ' 153' ' ' HIS . 35.3 p-80 -80.4 104.74 11.15 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.327 0.584 . . . . 73.22 110.977 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -95.62 131.9 41.35 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.083 0.468 . . . . 72.4 111.592 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -133.69 77.1 1.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.173 0.511 . . . . 72.44 111.17 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -104.77 -14.61 15.48 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.867 0.365 . . . . 71.24 110.974 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 119.156 -0.449 . . . . 65.25 110.711 178.102 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.525 0.202 . . . . 74.44 111.105 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -129.9 118.34 21.55 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.856 -0.424 . . . . 74.52 109.856 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.4 135.96 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.896 0.702 . . . . 71.52 112.896 -172.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.05 152.3 45.99 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.776 -0.647 . . . . 72.5 111.201 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -114.53 169.22 6.86 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 74.31 110.569 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.36 51.28 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.873 2.382 . . . . 74.12 112.117 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.36 -28.09 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.916 -0.583 . . . . 64.33 110.457 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -68.26 -28.76 67.49 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.289 0.566 . . . . 53.02 110.465 171.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.661 HG13 HG21 ' A' ' 22' ' ' THR . 60.7 t -70.46 122.27 85.97 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.481 -0.781 . . . . 74.14 111.525 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HG2' HG23 ' A' ' 22' ' ' THR . 21.9 Cg_endo -61.1 119.86 7.24 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.323 2.015 . . . . 74.23 112.049 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . 5.6 p30 -64.23 85.89 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.954 0.724 . . . . 73.24 112.954 -176.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.32 0.48 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 112.505 0.557 . . . . 72.44 112.505 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -121.87 5.51 9.92 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.087 0.403 . . . . 72.22 112.087 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 6.8 tt -115.14 -54.73 2.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.427 -0.583 . . . . 74.24 109.427 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.72 -55.28 35.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.124 0.488 . . . . 62.34 110.839 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -127.46 -179.57 4.97 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.093 -0.503 . . . . 75.21 110.768 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.6 p -130.27 -11.53 4.11 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.644 -0.253 . . . . 73.12 111.615 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -81.0 -45.64 16.28 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.932 0.716 . . . . 72.53 112.932 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.708 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 32.5 tpt180 -52.67 -61.91 1.98 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.203 0.445 . . . . 73.21 112.203 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 40' ' ' LEU . 17.5 mt 63.19 6.99 2.57 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.218 0.451 . . . . 61.23 112.218 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.708 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 95.4 t -133.64 121.42 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.842 0.353 . . . . 64.3 111.774 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.661 HG21 HG13 ' A' ' 9' ' ' VAL . 89.0 m -111.88 102.8 11.04 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.77 0.319 . . . . 75.23 110.807 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.473 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 7.6 p-10 -99.72 84.34 2.91 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.454 0.645 . . . . 74.53 111.936 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.586 ' HG2' HG22 ' A' ' 22' ' ' THR . 40.2 mm-40 -96.32 -44.83 7.06 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.115 -0.493 . . . . 73.42 110.786 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.64 -25.36 60.04 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.147 0.425 . . . . 62.44 112.147 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.99 44.59 45.37 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.376 -0.44 . . . . 54.21 113.14 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 92' ' ' LEU . 85.3 mt -102.27 -22.29 14.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.916 0.388 . . . . 72.13 111.884 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.4 mt -93.32 108.47 20.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.717 0.294 . . . . 74.34 111.12 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.527 ' HB2' ' OE1' ' A' ' 32' ' ' GLN . 49.1 m -78.52 162.08 26.58 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.534 -0.303 . . . . 71.51 111.117 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -44.98 -45.53 10.62 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.176 0.806 . . . . 75.14 113.176 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -63.88 -53.28 53.08 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.8 0.333 . . . . 52.35 111.708 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.582 ' HG2' ' HB1' ' A' ' 132' ' ' ALA . 22.6 mp0 -55.9 -40.63 73.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.065 0.46 . . . . 64.34 110.69 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.82 -52.8 63.89 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.095 -0.502 . . . . 73.43 111.02 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -55.12 -40.62 70.7 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.94 0.4 . . . . 63.21 111.608 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 31' ' ' ALA . 46.6 t -71.05 -44.65 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.072 0.463 . . . . 54.21 111.715 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 52.1 ttm -70.35 -51.82 27.16 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.871 0.323 . . . . 71.23 111.871 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -54.48 -50.35 67.95 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.389 -0.369 . . . . 61.4 111.709 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.7 -38.06 86.34 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.001 -0.618 . . . . 70.12 113.59 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 43' ' ' ILE . 81.7 mtm180 -72.01 -49.52 36.25 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.95 0.375 . . . . 65.31 111.375 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.474 ' HB3' HD13 ' A' ' 20' ' ' LEU . 87.9 mt -57.14 -52.66 64.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.021 0.438 . . . . 44.12 111.049 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -54.64 -41.64 70.3 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.055 -0.521 . . . . 71.04 111.375 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.15 97.8 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.933 0.397 . . . . 63.1 111.389 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.486 ' HA ' ' HD2' ' A' ' 47' ' ' HIS . 74.0 mt -64.91 -42.79 95.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.978 0.418 . . . . 61.12 111.083 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.493 ' NH1' ' HG2' ' A' ' 50' ' ' GLU . 8.4 tpt180 -61.46 -38.69 88.14 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.159 -0.473 . . . . 71.53 111.518 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.3 t -83.36 -41.96 17.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.238 0.459 . . . . 72.42 112.238 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -82.3 -62.49 1.61 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.124 0.488 . . . . 74.02 112.042 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.493 ' ND1' HD21 ' A' ' 150' ' ' LEU . 51.7 m-70 -83.06 -14.3 54.08 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.093 -0.503 . . . . 61.33 111.655 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.11 17.21 10.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.827 0.451 . . . . 72.34 111.846 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.671 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 96.8 t -87.28 129.89 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.147 0.498 . . . . 44.42 111.339 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HG2' ' NH1' ' A' ' 44' ' ' ARG . 27.3 mt-10 -83.3 96.41 8.49 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.095 -0.502 . . . . 64.53 110.654 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -119.27 101.63 8.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.174 -0.466 . . . . 70.51 110.505 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.4 133.99 54.88 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.319 0.488 . . . . 62.42 112.319 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.16 112.73 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.078 0.466 . . . . 44.31 111.313 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.669 ' HB ' HG22 ' A' ' 89' ' ' VAL . 57.4 t -109.11 134.14 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.374 -0.375 . . . . 72.02 111.107 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 69.1 p -119.81 122.2 40.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.879 0.371 . . . . 61.34 111.472 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.555 HD21 HG22 ' A' ' 9' ' ' VAL . 77.9 mt -128.32 140.61 38.84 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.402 -0.363 . . . . 71.2 111.013 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.47 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 19.7 Cg_endo -61.29 -47.02 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.982 1.788 . . . . 75.2 112.078 175.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.425 ' HA ' HG13 ' A' ' 91' ' ' VAL . 43.8 t -157.72 145.63 18.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.94 0.4 . . . . 61.04 111.525 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 pt -101.66 9.08 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.196 0.522 . . . . 71.01 111.202 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.73 -133.95 18.16 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.154 -0.546 . . . . 61.34 113.305 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.43 -19.39 28.12 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.938 0.348 . . . . 75.15 111.938 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.58 143.99 89.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.555 0.576 . . . . 72.22 112.555 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.2 Cg_endo -75.77 127.7 10.35 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.565 2.177 . . . . 74.2 112.131 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.07 -32.61 72.25 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.341 0.497 . . . . 72.53 112.341 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.737 ' HG2' ' HD3' ' A' ' 98' ' ' ARG . 44.2 mt-10 -62.56 -43.2 99.4 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.176 0.513 . . . . 72.32 111.702 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 2.2 m-20 -76.96 -33.08 57.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.979 -0.555 . . . . 74.32 110.903 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -59.12 -52.7 64.6 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.052 -0.522 . . . . 64.35 110.941 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.8 p -59.32 -41.78 89.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.307 -0.406 . . . . 72.54 111.728 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 48.5 tp -57.16 -49.17 76.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.958 0.408 . . . . 64.45 111.217 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -62.33 -47.07 85.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.93 0.395 . . . . 71.14 111.51 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.05 -36.97 83.21 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.102 0.477 . . . . 70.13 111.429 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.51 -38.59 71.12 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.265 0.468 . . . . 73.41 112.265 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 25.9 mtp180 -61.79 -47.99 82.68 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.41 0.522 . . . . 61.42 112.41 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.421 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.5 pt20 -59.44 -38.1 79.81 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.885 0.374 . . . . 74.01 111.842 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 50.0 m0 -78.11 -4.61 48.27 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 111.817 0.303 . . . . 73.01 111.817 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.41 -35.05 3.02 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.045 -0.598 . . . . 73.2 112.578 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.519 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 46.9 t -49.3 -28.06 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.382 0.673 . . . . 73.41 112.751 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -127.21 24.05 5.4 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.847 -0.692 . . . . 63.12 113.668 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -63.18 90.17 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 117.18 0.49 . . . . 72.15 111.046 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 51.97 56.2 8.14 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.511 0.672 . . . . 74.23 110.846 -173.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 62.92 64.55 0.87 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.562 -0.744 . . . . 61.53 112.021 177.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.664 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 2.1 t-20 -63.54 139.49 58.77 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.698 -0.683 . . . . 71.2 110.933 175.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -43.26 -72.42 0.06 Allowed 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 114.407 1.262 . . . . 75.35 114.407 -168.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.671 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 5.1 m-20 -87.98 21.79 2.59 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.508 -0.745 . . . . 73.42 112.286 -173.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 77' ' ' VAL . . . -81.51 128.22 8.34 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.02 -0.609 . . . . 63.32 114.468 -175.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 54.5 tp -145.12 118.81 9.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.785 0.434 . . . . 63.34 110.56 173.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.2 tp -116.1 126.82 54.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.88 0.372 . . . . 74.55 111.664 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 33.1 tp -116.07 111.86 20.91 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.03 -0.532 . . . . 64.21 110.813 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.669 HG22 ' HB ' ' A' ' 54' ' ' VAL . 70.4 t -118.23 130.07 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.714 0.293 . . . . 71.14 111.553 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.4 tp -109.72 125.88 53.12 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.96 0.41 . . . . 61.12 111.508 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 58' ' ' SER . 47.8 t -99.93 105.61 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.113 -0.494 . . . . 43.23 110.294 173.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 51.6 tp -57.09 -62.84 1.47 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.147 0.795 . . . . 70.11 113.147 -174.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.37 -27.16 68.87 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.283 0.475 . . . . 71.11 112.283 -171.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -97.14 -10.94 24.97 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.705 0.288 . . . . 73.51 111.343 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 50.97 67.39 0.95 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.562 0.696 . . . . 74.52 112.322 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -159.98 150.87 19.12 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.912 -0.586 . . . . 64.12 111.095 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.2 m -129.66 171.56 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.986 0.422 . . . . 72.41 111.759 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.737 ' HD3' ' HG2' ' A' ' 65' ' ' GLU . 6.0 mmm180 -141.11 153.5 45.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.327 0.584 . . . . 72.41 112.288 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.72 ' HB3' HD13 ' A' ' 114' ' ' LEU . 30.5 m-85 -129.86 111.49 12.63 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.265 -0.88 . . . . 62.51 110.129 175.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.7 tp10 -105.05 112.37 25.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.809 -0.178 . . . . 74.22 110.779 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.402 HG23 HD11 ' A' ' 114' ' ' LEU . 1.2 p -96.46 147.33 23.94 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.759 0.79 . . . . 73.32 112.874 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -95.41 174.13 31.93 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.178 -0.919 . . . . 54.55 112.696 171.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -56.02 -22.31 26.45 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.961 0.726 . . . . 72.43 112.961 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.68 -41.03 11.43 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.898 -0.668 . . . . 61.21 112.464 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.446 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 85.5 mt -81.1 -6.88 59.33 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.72 0.637 . . . . 72.33 112.72 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -59.57 -12.59 6.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.521 0.563 . . . . 72.11 112.521 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.96 -12.99 62.99 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.168 -0.539 . . . . 73.22 113.326 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.561 ' OH ' ' HB2' ' A' ' 152' ' ' HIS . 82.0 m-85 -117.32 -47.47 2.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.08 0.467 . . . . 72.55 111.947 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.59 93.04 48.77 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 115.886 -0.597 . . . . 73.15 112.435 -168.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.62 160.51 31.48 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.293 1.995 . . . . 73.25 111.968 170.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -55.31 -36.55 66.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.679 0.276 . . . . 72.23 111.721 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.73 -49.12 82.13 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.258 -0.496 . . . . 65.52 113.21 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 tp -60.12 -44.05 95.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.012 0.434 . . . . 75.23 111.272 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.72 HD13 ' HB3' ' A' ' 99' ' ' PHE . 84.1 mt -62.31 -43.88 97.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.064 0.459 . . . . 73.04 110.969 177.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.4 t -64.42 -33.86 76.85 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.061 -0.518 . . . . 64.11 111.045 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -59.12 -52.3 66.33 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.004 -0.544 . . . . 74.33 110.385 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.23 -46.28 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.237 0.541 . . . . 75.44 110.937 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.438 HD11 ' HD2' ' A' ' 99' ' ' PHE . 72.4 mt -56.56 -56.01 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.584 -0.734 . . . . 51.25 111.79 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -81.38 -18.18 46.44 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.914 0.709 . . . . 70.23 112.914 -171.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -79.95 -58.59 3.09 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.683 0.278 . . . . 73.44 111.59 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -114.26 -34.64 5.25 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.201 0.815 . . . . 71.32 113.201 -174.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.428 ' SD ' ' HA ' ' A' ' 118' ' ' ILE . 85.8 mtp -68.59 -47.5 66.6 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.327 0.491 . . . . 75.11 112.327 -174.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.432 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 26.3 mm -55.63 -55.26 42.4 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 112.983 0.735 . . . . 72.35 112.983 -178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 11.6 Cg_endo -54.78 -42.61 67.02 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.928 1.752 . . . . 74.35 112.536 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -60.88 -48.13 83.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.57 0.224 . . . . 73.11 111.412 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.529 ' HD1' ' HA ' ' A' ' 131' ' ' TYR . 22.9 m-30 -56.39 -47.49 78.84 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.879 0.371 . . . . 64.34 111.288 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -64.88 -33.14 75.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.907 0.384 . . . . 75.13 111.197 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.7 m -82.15 -1.15 47.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.498 -0.319 . . . . 54.11 111.773 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.69 -16.6 60.18 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.151 -0.547 . . . . 72.24 113.595 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.864 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 92.7 m-20 -80.05 65.24 5.14 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.234 0.517 . . . . 64.25 111.995 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.529 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 96.5 m-85 -64.05 -32.46 74.03 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.858 0.361 . . . . 73.2 111.154 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.582 ' HB1' ' HG2' ' A' ' 32' ' ' GLN . . . -71.02 -50.84 29.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.986 0.422 . . . . 64.33 111.417 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.864 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 5.8 mp0 -57.16 -42.44 81.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.144 -0.48 . . . . 74.21 111.606 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.0 -52.08 54.47 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.421 -0.419 . . . . 62.24 113.037 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.04 -39.95 96.26 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.915 0.388 . . . . 64.34 111.516 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.8 t -60.93 -43.88 98.01 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.159 0.429 . . . . 61.15 112.159 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -75.26 -28.78 59.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.485 0.179 . . . . 73.44 111.485 177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.01 -49.08 82.43 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.69 -0.767 . . . . 43.44 111.965 172.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.87 -49.13 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.068 0.461 . . . . 72.25 111.203 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 52.7 tp -58.44 -40.49 82.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.983 -0.553 . . . . 75.21 111.494 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -59.31 -46.79 87.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.859 0.361 . . . . 65.3 111.446 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.24 -47.17 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.052 0.453 . . . . 53.34 111.168 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -51.79 -45.76 63.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.677 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 84.5 mm-40 -59.34 -42.04 90.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.935 0.398 . . . . 73.14 111.464 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 141' ' ' ALA . 85.5 t -60.73 -50.78 79.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 120.856 0.36 . . . . 54.15 111.17 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.64 -56.49 20.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.876 0.325 . . . . 72.51 111.876 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -58.83 -33.96 71.0 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.096 0.406 . . . . 64.32 112.096 -175.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.9 -4.33 82.31 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.12 -0.562 . . . . 70.23 113.699 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.6 m -121.11 24.61 10.03 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.305 0.552 . . . . 74.02 111.962 -178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.493 HD21 ' ND1' ' A' ' 47' ' ' HIS . 93.8 mt -74.05 43.91 0.17 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.746 0.647 . . . . 52.1 112.746 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -113.13 -0.8 14.56 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.297 0.57 . . . . 62.14 111.021 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.561 ' HB2' ' OH ' ' A' ' 108' ' ' TYR . 84.5 m-70 -111.21 124.38 52.09 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.093 -0.503 . . . . 74.34 111.204 -177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -147.35 113.89 5.99 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.083 0.468 . . . . 75.02 110.667 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -69.69 -17.68 63.5 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.018 0.437 . . . . 72.53 111.03 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -127.12 168.4 14.7 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.25 -0.432 . . . . 75.52 110.633 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -92.57 -60.42 1.83 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.166 0.508 . . . . 72.3 109.974 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 65.1 m80 . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.397 -0.811 . . . . 72.53 110.601 174.873 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ttt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.678 0.275 . . . . 73.12 110.842 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -107.95 136.1 48.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.829 0.347 . . . . 74.1 111.765 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.4 t -71.82 91.2 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.263 0.554 . . . . 64.0 110.449 170.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -75.37 148.29 39.35 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.481 0.658 . . . . 73.34 112.521 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' HG2' ' HD2' ' A' ' 6' ' ' PRO . 6.9 tttp -130.74 157.97 76.23 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 115.365 -0.834 . . . . 72.31 109.754 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.524 ' HD2' ' HG2' ' A' ' 5' ' ' LYS . 77.8 Cg_exo -52.14 -26.06 25.07 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.431 2.088 . . . . 55.51 113.373 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -88.48 -16.47 32.66 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.08 0.4 . . . . 61.42 112.08 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -94.23 -24.85 17.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.901 0.381 . . . . 70.45 111.148 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.4 t -61.79 129.9 91.95 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.268 -0.424 . . . . 71.44 111.764 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.44 114.56 1.81 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.618 2.212 . . . . 61.23 112.851 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -71.19 77.07 0.71 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.878 0.37 . . . . 70.44 111.399 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.7 m -62.87 -44.64 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 122.267 -0.271 . . . . 64.11 111.471 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -64.4 -14.88 59.05 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.054 0.454 . . . . 73.22 111.884 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.54 -49.66 7.04 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.998 0.428 . . . . 65.12 110.004 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.12 -74.9 0.49 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.208 0.447 . . . . 73.53 112.208 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -109.18 81.49 1.45 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.501 0.667 . . . . 52.13 111.223 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 60.6 p -72.99 -29.85 63.36 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.915 -0.584 . . . . 42.12 112.101 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.5 m -65.25 -15.55 62.61 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.939 0.4 . . . . 62.14 111.832 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.3 ttt85 -75.56 -55.45 5.66 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.616 -0.265 . . . . 73.11 110.93 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 17' ' ' SER . 1.3 mt 72.46 -26.7 0.18 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.639 0.776 . . . . 72.14 112.635 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.63 141.01 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 122.895 0.478 . . . . 65.21 111.19 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 m -147.13 104.85 3.71 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.594 0.235 . . . . 72.1 111.307 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.429 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 33.6 t70 -106.99 109.77 21.74 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.165 0.507 . . . . 74.32 111.827 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -109.31 -39.51 5.2 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.042 0.449 . . . . 73.31 110.602 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.81 -23.28 17.45 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.868 0.692 . . . . 73.42 112.868 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.05 45.3 7.66 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.849 -0.691 . . . . 72.02 112.703 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.427 HD13 ' HB3' ' A' ' 131' ' ' TYR . 69.6 mt -117.72 -42.21 2.87 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.966 0.412 . . . . 75.43 111.558 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.03 104.6 14.22 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.834 0.349 . . . . 74.25 111.43 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 t -74.02 165.07 25.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.693 -0.23 . . . . 71.13 111.07 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -50.5 -55.77 14.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.017 0.747 . . . . 75.11 113.017 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . . . -59.0 -31.49 68.85 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.868 0.366 . . . . 54.14 111.916 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -73.84 -33.52 64.15 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.048 0.451 . . . . 63.44 110.649 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -69.29 -41.72 76.43 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.32 -0.4 . . . . 71.54 111.339 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 11.4 pt-20 -64.64 -38.96 92.8 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 111.996 0.369 . . . . 71.05 111.996 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.59 -49.16 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.267 0.556 . . . . 34.31 110.728 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.0 ttm -68.44 -29.34 67.97 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.068 -0.514 . . . . 72.22 110.916 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -65.13 -56.08 14.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.043 -0.526 . . . . 71.23 110.778 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.57 92.3 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.912 -0.661 . . . . 62.11 112.25 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.494 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.4 tpp180 -56.76 -54.48 45.83 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.184 0.594 . . . . 73.42 111.169 176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.57 -46.13 67.08 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.184 0.438 . . . . 52.42 112.184 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -58.57 -39.11 79.38 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.002 0.43 . . . . 63.12 110.926 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.71 81.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.193 -0.458 . . . . 61.13 111.077 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.572 ' HA ' ' HD2' ' A' ' 47' ' ' HIS . 66.2 mt -65.09 -45.59 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.657 0.265 . . . . 65.21 111.654 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 50.0 ttp180 -68.35 -26.65 65.7 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.095 -0.378 . . . . 75.32 111.838 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 t -89.15 -52.56 5.0 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.137 0.494 . . . . 61.44 111.155 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.1 m -72.22 -43.8 63.89 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.516 0.562 . . . . 74.22 112.516 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.572 ' HD2' ' HA ' ' A' ' 43' ' ' ILE . 75.3 m-70 -105.41 -15.91 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.343 0.497 . . . . 72.25 112.343 -175.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 68.02 20.69 9.03 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.128 0.49 . . . . 70.43 111.932 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' HB ' HG22 ' A' ' 43' ' ' ILE . 81.5 t -96.26 124.71 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.916 0.389 . . . . 61.12 111.239 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.47 97.31 9.96 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.437 0.637 . . . . 70.2 110.886 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.31 107.62 16.95 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.352 -0.84 . . . . 75.4 110.564 -176.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.76 145.17 38.56 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.057 0.391 . . . . 75.11 112.057 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.41 120.92 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.96 0.41 . . . . 74.2 111.381 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.39 128.94 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.299 -0.41 . . . . 41.32 111.614 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 22.3 p -110.79 123.72 50.62 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.922 0.391 . . . . 73.33 111.102 177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.8 mt -122.15 140.52 32.53 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 120.741 0.305 . . . . 62.52 111.275 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.15 -48.95 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.296 1.997 . . . . 65.54 112.65 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.7 p -150.88 144.91 25.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.699 0.285 . . . . 64.52 111.623 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 91' ' ' VAL . 32.7 pt -120.78 11.0 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.115 0.483 . . . . 73.14 111.044 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.28 -124.03 24.4 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.272 -0.49 . . . . 41.35 113.142 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.15 16.27 24.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.884 0.373 . . . . 70.41 111.417 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . . . -77.36 138.41 63.87 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 112.031 0.382 . . . . 62.23 112.031 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 62' ' ' ALA . 4.6 Cg_exo -77.0 121.44 5.82 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.728 2.285 . . . . 61.44 111.808 175.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.6 tp -55.74 -39.3 70.96 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.914 0.387 . . . . 73.1 111.364 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.29 -45.43 84.13 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.12 -0.491 . . . . 71.32 112.037 175.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.63 -17.56 50.88 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.418 0.628 . . . . 72.44 110.871 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -76.78 -56.15 4.86 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.794 -0.639 . . . . 74.43 111.279 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.7 p -53.22 -52.53 58.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.573 0.583 . . . . 74.54 112.573 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.502 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 42.1 tp -53.31 -54.52 35.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.213 -0.449 . . . . 71.53 111.872 -177.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -61.77 -40.19 94.28 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.443 0.535 . . . . 74.21 112.443 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 87' ' ' LEU . 63.0 tp -62.31 -45.46 93.13 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.326 0.584 . . . . 75.14 110.715 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HB1' ' CA ' ' A' ' 78' ' ' GLY . . . -70.79 -30.21 66.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.061 -0.518 . . . . 43.44 112.113 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 75.8 mtp180 -64.59 -49.14 72.31 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.748 0.277 . . . . 51.41 111.748 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.79 -32.88 74.67 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.723 0.297 . . . . 72.12 111.439 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -74.23 -15.43 60.99 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.956 0.408 . . . . 75.41 110.986 173.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.56 27.15 72.99 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.374 -0.441 . . . . 74.41 113.359 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.466 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 22.4 t -116.4 -83.05 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.131 0.419 . . . . 70.32 112.131 -176.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.429 ' CA ' ' HB1' ' A' ' 72' ' ' ALA . . . -77.86 40.64 1.87 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.966 -0.635 . . . . 71.41 113.565 -176.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.661 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 44.4 t-20 -78.78 133.22 37.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.138 -0.69 . . . . 73.11 109.138 175.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -49.76 -31.49 11.64 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.714 0.635 . . . . 71.01 112.714 -175.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -103.0 1.32 33.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.416 0.524 . . . . 74.42 112.416 -178.591 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.661 ' HB2' ' HB3' ' A' ' 79' ' ' ASN . 66.3 t30 -85.23 172.74 10.93 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.136 0.493 . . . . 53.35 110.74 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.423 ' HA ' ' H ' ' A' ' 104' ' ' GLY . 10.3 p30 -110.34 148.3 32.23 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.448 0.536 . . . . 74.03 112.448 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.468 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 3.6 m-20 58.04 19.35 5.89 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.058 0.762 . . . . 64.11 113.058 174.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 77' ' ' VAL . . . -106.27 132.09 10.96 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.801 -0.714 . . . . 52.32 113.487 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 101' ' ' THR . 46.4 tp -147.17 126.89 13.4 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.023 0.44 . . . . 64.01 111.202 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.488 HD21 HD23 ' A' ' 71' ' ' LEU . 64.1 tp -120.22 134.24 55.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.822 0.344 . . . . 71.34 111.418 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.6 tp -119.41 111.79 18.6 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.175 -0.466 . . . . 61.52 110.75 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.96 130.47 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.799 0.333 . . . . 65.42 111.611 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 135' ' ' LEU . 28.4 tp -110.04 124.42 51.43 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.183 -0.462 . . . . 52.22 111.096 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.407 HG21 HD13 ' A' ' 59' ' ' ILE . 48.0 t -105.07 105.81 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.746 0.307 . . . . 72.33 110.786 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 tp -57.78 -40.29 79.51 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.028 0.381 . . . . 74.41 112.028 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.2 -32.12 71.88 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.255 0.465 . . . . 74.43 112.255 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -105.29 -7.94 18.59 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 122.157 -0.339 . . . . 73.12 111.735 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 95' ' ' ARG . 48.8 mtm180 55.0 33.23 19.8 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.168 0.587 . . . . 75.22 112.531 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -137.54 161.64 35.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.853 0.359 . . . . 73.24 111.455 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.406 HG21 ' CE ' ' A' ' 122' ' ' MET . 7.6 m -131.7 171.93 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.225 -0.443 . . . . 72.04 111.307 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -152.13 133.94 14.82 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.979 0.418 . . . . 60.52 111.894 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 86' ' ' LEU . 97.4 m-85 -95.01 122.3 37.53 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.911 -0.586 . . . . 61.2 110.179 171.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -107.4 112.33 25.08 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.998 -0.371 . . . . 63.11 109.998 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.64 HG23 HD13 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -98.95 148.06 24.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.622 0.725 . . . . 61.33 112.696 -177.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -93.07 172.74 33.93 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.163 -0.926 . . . . 73.42 112.531 170.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' ASN . 55.3 t80 -54.61 -31.29 56.81 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.069 0.548 . . . . 74.54 111.925 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -67.74 -19.23 71.12 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 116.08 -0.509 . . . . 75.13 113.312 -177.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.492 HD11 HG13 ' A' ' 49' ' ' VAL . 91.3 mt -117.58 -5.49 11.18 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.94 0.348 . . . . 72.24 111.94 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -49.79 -44.05 48.75 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.858 0.463 . . . . 73.44 111.836 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.34 -25.41 75.49 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 114.468 0.547 . . . . 73.21 114.468 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' A' ' 152' ' ' HIS . 8.6 m-85 -97.96 -35.43 10.47 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.324 0.583 . . . . 75.22 110.88 -177.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HB3' HD21 ' A' ' 114' ' ' LEU . 53.2 mt -126.57 73.45 74.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.366 -0.834 . . . . 73.15 110.701 -177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.04 156.17 52.12 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.075 1.85 . . . . 64.03 112.447 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -46.81 -45.88 20.37 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 112.672 0.619 . . . . 75.41 112.672 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.34 -39.08 96.75 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.399 -0.429 . . . . 74.34 113.537 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.5 tp -67.32 -47.21 71.23 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 122.511 -0.405 . . . . 73.15 111.138 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 109' ' ' LEU . 89.4 mt -58.0 -43.9 86.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.152 -0.476 . . . . 75.34 110.823 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 t -60.35 -41.57 93.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.972 -0.558 . . . . 74.41 110.981 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 116' ' ' ARG . 43.3 ttm105 -57.93 -53.87 53.31 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.176 -0.466 . . . . 74.05 111.52 175.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.0 mt -51.99 -47.4 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.957 0.408 . . . . 61.22 111.215 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 114' ' ' LEU . 80.4 mt -55.72 -50.56 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.07 -0.513 . . . . 73.01 111.39 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.456 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 3.6 t-80 -80.39 -19.28 46.65 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.843 0.683 . . . . 74.14 112.843 -171.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -102.48 -46.74 4.68 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.488 0.922 . . . . 63.43 113.488 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 66.6 mtp180 -106.75 4.26 27.46 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.037 0.754 . . . . 75.21 113.037 -175.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.406 ' CE ' HG21 ' A' ' 97' ' ' VAL . 60.4 mtp -125.33 -51.9 1.63 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.61 0.596 . . . . 73.52 112.61 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.517 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 22.5 mm -51.77 -49.58 82.57 Favored Pre-proline 0 N--CA 1.48 1.029 0 N-CA-C 113.252 0.834 . . . . 65.12 113.252 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 14.7 Cg_endo -55.05 -29.51 65.59 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 122.143 1.896 . . . . 62.24 112.634 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 90.3 m-70 -75.3 -50.61 15.49 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.518 -0.31 . . . . 73.51 110.769 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.454 ' HD1' ' HA ' ' A' ' 131' ' ' TYR . 21.8 m-85 -57.53 -42.3 82.6 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.711 0.291 . . . . 73.42 111.6 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -62.19 -35.54 79.18 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.966 0.412 . . . . 73.23 111.16 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.5 m -83.07 -1.9 53.96 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.207 -0.451 . . . . 75.41 111.921 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.58 -4.77 79.87 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.315 -0.469 . . . . 75.32 113.203 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.5 m-20 -81.36 67.52 7.33 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.526 -0.397 . . . . 72.5 111.418 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.454 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 97.6 m-85 -61.68 -47.83 83.55 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.009 0.433 . . . . 70.13 111.875 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.9 87.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.94 0.4 . . . . 72.44 111.791 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 19.7 mm-40 -67.15 -39.7 86.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.437 -0.347 . . . . 74.43 111.444 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.41 -44.64 95.15 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.898 -0.668 . . . . 55.45 112.611 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 90' ' ' LEU . 95.4 mt -60.96 -45.04 96.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.698 0.285 . . . . 74.43 111.27 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.0 m -55.38 -49.29 72.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.469 -0.332 . . . . 73.15 111.789 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 44.3 mm-40 -65.68 -40.99 92.94 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.969 0.359 . . . . 75.21 111.969 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.76 -50.91 62.55 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 120.934 -0.651 . . . . 72.53 112.733 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 135' ' ' LEU . 97.1 t -59.21 -50.63 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.967 0.413 . . . . 73.12 111.552 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.444 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 58.5 tp -57.5 -45.58 84.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.163 -0.471 . . . . 71.34 111.17 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -57.6 -48.18 80.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.96 0.41 . . . . 72.13 111.628 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.16 -52.38 59.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.222 -0.444 . . . . 70.42 111.638 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -53.81 -42.09 68.03 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.807 0.337 . . . . 65.13 111.392 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 98.6 mt-30 -58.72 -46.69 86.77 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.392 -0.367 . . . . 63.22 111.178 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 141' ' ' ALA . 62.9 t -57.81 -50.11 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.83 0.348 . . . . 73.51 111.134 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.33 -48.27 79.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.431 -0.35 . . . . 73.43 111.72 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.47 -34.12 68.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.002 0.429 . . . . 44.45 111.386 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -94.39 5.65 71.0 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.224 -0.513 . . . . 52.45 113.188 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.3 m -126.36 22.55 7.09 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 122.63 -0.335 . . . . 64.42 111.814 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.551 HD21 ' ND1' ' A' ' 47' ' ' HIS . 77.5 mt -74.29 12.99 0.63 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.468 0.544 . . . . 72.54 112.468 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -61.23 -49.45 77.07 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.631 -0.258 . . . . 74.02 111.036 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.426 ' HA ' ' OH ' ' A' ' 108' ' ' TYR . 71.6 t60 52.56 32.59 11.88 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.286 0.565 . . . . 75.22 111.749 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -76.77 -5.43 48.13 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.916 0.388 . . . . 73.33 111.96 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -94.55 121.16 35.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.853 0.359 . . . . 70.52 111.422 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -141.05 130.87 24.31 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.151 -0.477 . . . . 74.25 111.139 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -99.5 136.6 39.19 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.423 0.527 . . . . 72.44 112.423 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 81.2 t60 . . . . . 0 C--O 1.252 1.233 0 CA-C-N 115.753 -0.658 . . . . 73.54 110.946 174.65 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.672 0.272 . . . . 74.0 111.225 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -102.76 123.34 46.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.818 0.342 . . . . 73.03 111.305 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.7 t -81.41 114.27 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.173 0.511 . . . . 73.31 112.298 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -97.93 129.27 44.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.084 -0.507 . . . . 73.23 111.257 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 68.1 mttm -105.86 164.18 15.53 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.861 -0.609 . . . . 71.44 110.29 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 31.9 Cg_endo -62.19 -15.0 41.43 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.965 1.777 . . . . 61.52 112.349 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -94.46 -0.83 54.43 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.182 -0.463 . . . . 64.41 111.737 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -97.67 -34.5 10.91 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.017 0.436 . . . . 65.51 110.873 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.69 122.11 65.98 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 115.964 -0.562 . . . . 70.05 111.601 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.62 126.93 19.38 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.728 2.285 . . . . 74.42 112.863 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -75.34 83.47 2.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.486 0.66 . . . . 74.23 111.492 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.57 -26.61 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.902 0.704 . . . . 73.24 112.902 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -61.0 -15.72 35.02 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.249 0.463 . . . . 75.41 112.249 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -75.72 -51.45 12.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.992 0.425 . . . . 72.5 110.338 176.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.65 -69.28 0.78 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.012 0.434 . . . . 63.31 111.561 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 19' ' ' ARG . 3.2 m-20 -80.9 57.07 2.93 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.339 0.59 . . . . 75.32 112.021 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.3 p -65.47 -17.25 64.41 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.163 -0.471 . . . . 75.52 110.99 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.416 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 77.7 p -95.02 3.63 54.68 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.2 -0.455 . . . . 51.43 111.976 176.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 16' ' ' ASP . 13.2 ttm180 -105.34 -53.58 2.63 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.965 0.412 . . . . 53.4 110.7 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp 66.09 1.43 1.93 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.411 0.684 . . . . 63.04 112.705 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.3 t -107.54 140.82 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.904 0.383 . . . . 62.44 111.853 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 m -131.4 103.67 6.57 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.39 -0.368 . . . . 54.31 110.52 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 12.3 p-10 -100.64 96.5 7.39 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.648 0.737 . . . . 70.21 112.179 -178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -100.72 -44.57 5.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.823 -0.626 . . . . 52.13 110.899 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.84 -24.04 67.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.26 0.467 . . . . 53.2 112.26 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.84 28.74 70.21 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.261 -0.495 . . . . 73.15 113.374 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 92' ' ' LEU . 94.3 mt -86.5 7.38 26.27 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.541 -0.387 . . . . 41.34 111.668 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 135' ' ' LEU . 95.8 mt -116.46 121.94 43.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.458 -0.337 . . . . 74.32 111.543 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.1 m -65.38 146.06 55.38 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.176 -0.305 . . . . 74.22 110.176 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -48.39 -46.27 36.97 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.77 0.656 . . . . 72.24 112.77 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -61.0 -46.7 89.72 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.225 -0.297 . . . . 50.11 111.186 175.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -57.71 -37.88 74.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.62 0.248 . . . . 75.31 111.572 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -54.66 -54.72 38.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.257 0.551 . . . . 63.32 110.347 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -66.29 -42.06 88.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.752 -0.658 . . . . 74.12 111.718 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 31' ' ' ALA . 85.9 t -59.0 -36.64 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.24 0.543 . . . . 45.21 110.851 176.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 42.5 ttm -71.9 -44.55 63.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.47 -0.332 . . . . 72.51 110.711 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -53.15 -54.42 36.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.855 0.36 . . . . 72.54 111.144 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.22 -33.15 57.72 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 116.157 -0.474 . . . . 74.21 113.626 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.539 HH12 ' HB3' ' A' ' 136' ' ' SER . 85.0 mtm180 -75.15 -49.13 20.51 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.643 -0.328 . . . . 75.25 111.567 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.84 -48.88 77.14 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.473 0.654 . . . . 75.35 111.0 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 18' ' ' THR . 33.0 ttp180 -55.8 -42.44 75.62 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.279 -0.873 . . . . 74.23 111.643 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.76 75.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.855 0.359 . . . . 63.1 111.526 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.449 HG22 ' HB ' ' A' ' 49' ' ' VAL . 68.0 mt -61.29 -44.77 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.184 0.516 . . . . 73.43 111.241 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.622 ' HE ' ' HG2' ' A' ' 50' ' ' GLU . 1.5 tmt_? -61.9 -33.1 73.62 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.813 -0.63 . . . . 74.31 110.784 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.9 t -78.24 -48.6 15.41 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.976 0.361 . . . . 75.3 111.976 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.2 t -84.06 -68.03 0.75 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.04 0.385 . . . . 65.42 112.04 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -69.97 -13.6 62.31 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 111.767 0.284 . . . . 72.32 111.767 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 66.15 14.88 9.86 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.856 0.462 . . . . 51.24 111.916 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.694 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 61.6 t -84.42 115.8 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.324 -0.398 . . . . 72.31 110.914 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.622 ' HG2' ' HE ' ' A' ' 44' ' ' ARG . 36.8 mt-10 -76.31 95.58 3.8 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.335 0.588 . . . . 72.24 110.22 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.68 104.3 13.27 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.441 -0.799 . . . . 54.11 110.313 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.01 142.53 39.54 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.266 0.469 . . . . 70.31 112.266 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.6 t -123.22 126.33 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.003 0.43 . . . . 65.24 111.291 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.42 139.4 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 122.622 0.369 . . . . 70.1 111.076 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 76.7 p -121.04 122.63 40.5 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.817 0.342 . . . . 60.44 111.474 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -129.19 142.25 44.56 Favored Pre-proline 0 N--CA 1.471 0.624 0 CA-C-N 116.531 -0.304 . . . . 72.21 111.144 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.89 -55.57 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.268 1.979 . . . . 63.34 112.348 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.0 p -151.07 147.02 26.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.625 0.25 . . . . 74.5 111.305 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.7 pt -116.89 9.2 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.097 0.475 . . . . 75.44 111.819 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.23 -138.2 32.31 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.117 -0.563 . . . . 62.2 112.938 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -92.71 15.26 14.89 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.519 -0.401 . . . . 63.05 111.989 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.89 131.07 76.97 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.651 -0.25 . . . . 74.21 111.186 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.592 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 56.7 Cg_endo -71.7 125.51 11.18 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.259 1.972 . . . . 74.43 112.538 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.5 tp -62.37 -38.33 89.14 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.582 0.586 . . . . 73.24 112.582 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 12.5 mp0 -61.32 -39.04 89.06 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.761 0.791 . . . . 74.3 110.759 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.592 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 2.0 m-20 -76.64 -37.02 57.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.041 -0.981 . . . . 71.12 110.918 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -55.05 -52.68 62.43 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.753 -0.658 . . . . 74.44 110.85 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.5 p -62.18 -36.46 81.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.974 -0.557 . . . . 64.22 111.966 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.2 tp -57.01 -50.32 73.1 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.128 0.489 . . . . 51.43 110.711 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -59.12 -50.33 74.47 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.094 -0.503 . . . . 53.53 111.756 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.475 HD23 HD21 ' A' ' 87' ' ' LEU . 27.9 tp -64.67 -42.58 95.27 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.989 0.423 . . . . 64.33 111.451 -176.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.5 93.83 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.855 0.36 . . . . 73.01 111.514 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -62.28 -52.47 63.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.466 -0.334 . . . . 74.12 111.771 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 10.3 pt20 -63.43 -28.01 69.69 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.907 0.336 . . . . 72.12 111.907 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.407 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 44.9 m0 -86.61 -2.64 58.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.335 0.495 . . . . 71.5 112.335 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.16 12.18 68.38 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.917 -0.659 . . . . 72.45 113.416 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 41.3 t -95.1 -16.5 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.996 0.426 . . . . 73.3 110.91 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.9 31.66 2.08 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 116.33 -0.395 . . . . 70.03 112.97 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -61.54 93.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.067 0.461 . . . . 71.14 112.024 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 49.77 56.12 8.36 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.516 0.674 . . . . 73.12 110.676 -174.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.5 OUTLIER 68.39 98.74 0.06 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.378 -0.828 . . . . 71.13 111.551 -178.709 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 42.9 t30 -98.59 160.08 14.51 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.413 -0.812 . . . . 63.42 110.624 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -68.48 -97.36 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 O-C-N 121.958 -0.464 . . . . 72.4 112.217 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.694 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.2 m-20 -77.51 77.19 4.04 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.982 -0.449 . . . . 72.41 111.438 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.78 130.93 4.39 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.996 -0.621 . . . . 42.43 113.315 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.2 tp -144.51 123.05 12.45 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.933 0.396 . . . . 74.2 110.964 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.475 HD21 HD23 ' A' ' 71' ' ' LEU . 61.7 tp -112.97 135.11 54.1 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.864 0.364 . . . . 52.33 111.402 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 55.8 tp -124.98 120.81 32.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.695 0.398 . . . . 63.45 110.956 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 87.0 t -125.21 126.99 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.844 0.354 . . . . 75.24 111.53 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.504 HD22 HD11 ' A' ' 135' ' ' LEU . 29.6 tp -101.44 120.08 39.74 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.119 -0.491 . . . . 75.42 111.335 178.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.9 t -104.61 102.28 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.867 0.365 . . . . 73.43 111.157 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 27' ' ' LEU . 61.7 tp -56.87 -35.06 68.47 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.221 -0.445 . . . . 62.24 111.895 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -51.2 -36.49 41.65 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.832 0.679 . . . . 74.25 112.832 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -129.2 3.49 5.21 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.153 0.427 . . . . 74.11 112.153 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 57.37 20.82 6.24 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.939 0.399 . . . . 63.13 112.021 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -94.76 141.07 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 74.12 111.364 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.66 HG21 ' SD ' ' A' ' 122' ' ' MET . 4.4 m -129.89 144.66 37.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.769 -0.651 . . . . 74.33 110.497 177.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 14.6 tpt180 -121.32 128.48 52.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.856 0.36 . . . . 71.51 111.707 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.62 ' HB3' HD13 ' A' ' 114' ' ' LEU . 71.8 m-85 -100.69 102.29 13.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.089 -0.505 . . . . 73.41 109.755 171.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -98.51 112.88 24.77 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.898 0.38 . . . . 63.12 112.008 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.5 p -102.02 152.37 21.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.522 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.62 -95.44 0.61 Allowed Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.786 -0.721 . . . . 53.34 111.905 171.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -142.72 -23.56 0.64 Allowed 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.526 -0.397 . . . . 72.33 111.715 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.32 -29.61 75.68 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.858 -0.687 . . . . 74.44 113.3 -176.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.583 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 86.8 mt -92.93 0.32 57.38 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.447 0.536 . . . . 75.41 112.447 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -62.34 -19.99 63.92 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.003 0.43 . . . . 73.5 111.548 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.6 11.62 68.27 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.283 -0.484 . . . . 75.22 113.13 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.583 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 34.8 m-85 -136.58 -57.47 0.74 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.469 0.652 . . . . 74.0 110.355 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.492 ' HB3' HD21 ' A' ' 114' ' ' LEU . 12.2 mt -118.56 79.49 15.94 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.11 -0.95 . . . . 74.13 111.25 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.89 146.54 94.96 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.183 1.922 . . . . 73.05 112.714 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -51.28 -32.67 25.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 116.155 -0.475 . . . . 51.34 111.301 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.12 -44.82 75.2 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.36 -0.448 . . . . 73.12 113.143 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 tp -60.55 -49.69 76.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.207 0.527 . . . . 73.14 110.873 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 99' ' ' PHE . 76.7 mt -56.93 -37.28 71.27 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.712 -0.676 . . . . 61.23 111.191 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.6 t -56.79 -46.85 81.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.122 -0.49 . . . . 52.25 111.383 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -65.11 -41.59 94.77 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.944 -0.302 . . . . 70.31 111.18 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.581 HG23 ' HD3' ' A' ' 121' ' ' ARG . 65.4 mt -50.34 -39.67 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.038 0.447 . . . . 75.2 111.19 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 122' ' ' MET . 62.3 mt -60.35 -51.01 77.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.007 -0.542 . . . . 75.41 111.363 175.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.416 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 4.9 m80 -81.56 -19.1 42.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.821 0.674 . . . . 73.11 112.821 -175.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.511 ' HB3' ' HD2' ' A' ' 121' ' ' ARG . 9.3 t70 -83.36 -49.09 9.7 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.109 0.411 . . . . 72.4 112.109 -173.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.581 ' HD3' HG23 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -119.18 -31.25 4.75 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.155 0.798 . . . . 74.44 113.155 -177.3 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.66 ' SD ' HG21 ' A' ' 97' ' ' VAL . 37.0 mtt -73.28 -56.71 4.71 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.967 0.729 . . . . 53.25 112.967 -176.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.503 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 44.4 mm -50.58 -52.14 58.56 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.954 0.724 . . . . 73.21 112.954 -176.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 10.3 Cg_endo -52.23 -29.58 38.43 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.237 1.958 . . . . 72.24 113.254 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -84.15 -48.19 10.09 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.925 0.343 . . . . 74.31 111.925 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.2 m-85 -55.78 -46.64 77.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.279 0.561 . . . . 75.43 111.34 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -65.48 -17.04 64.26 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.727 -0.669 . . . . 73.24 111.722 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.2 t -90.05 -13.59 35.6 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.12 -0.491 . . . . 71.44 110.939 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.71 -0.61 61.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.982 -0.447 . . . . 72.13 111.982 -172.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.809 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.57 68.04 10.29 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.96 0.504 . . . . 74.31 111.202 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.406 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 96.1 m-85 -70.8 -48.24 55.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.661 0.267 . . . . 72.3 111.701 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.338 0.589 . . . . 61.31 111.289 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.809 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 9.2 tp10 -61.6 -50.19 73.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.578 -0.737 . . . . 71.15 110.884 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.81 -47.21 91.62 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.21 -0.45 . . . . 62.02 113.6 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 90' ' ' LEU . 90.9 mt -57.72 -44.53 86.04 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 122.585 -0.362 . . . . 71.32 111.285 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.539 ' HB3' HH12 ' A' ' 39' ' ' ARG . 43.7 m -60.18 -44.06 95.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.474 -0.33 . . . . 71.54 111.557 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -61.07 -40.2 92.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.775 0.321 . . . . 71.43 111.5 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.22 -51.32 57.49 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.944 -0.646 . . . . 55.03 112.835 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.21 -46.6 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.206 0.527 . . . . 72.24 111.265 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.425 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 47.8 tp -59.7 -39.42 84.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.847 -0.615 . . . . 74.21 111.413 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -62.52 -50.5 71.1 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.922 0.392 . . . . 71.55 111.158 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.26 -48.5 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.112 0.482 . . . . 52.52 111.106 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -51.28 -40.37 58.79 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.8 -0.636 . . . . 73.12 111.751 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 79.8 mt-30 -69.74 -42.55 73.79 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 111.948 0.351 . . . . 73.44 111.948 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ALA . 57.4 t -58.34 -50.8 77.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.803 0.335 . . . . 73.31 111.617 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.3 mt -53.21 -48.1 68.38 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.454 -0.339 . . . . 53.04 111.794 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -55.89 -34.4 65.49 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.935 0.398 . . . . 75.42 112.025 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -101.06 0.67 54.79 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.147 -0.549 . . . . 74.54 114.079 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.3 m -115.47 15.45 16.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 117.417 0.609 . . . . 71.42 112.097 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.56 -1.03 3.19 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.443 0.535 . . . . 74.15 112.443 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -45.51 -33.78 2.89 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.145 0.578 . . . . 72.11 112.452 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 58.0 t-80 -86.13 1.35 50.86 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.093 0.775 . . . . 70.42 113.093 -174.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.442 ' O ' ' HB3' ' A' ' 154' ' ' HIS . 0.0 OUTLIER -69.88 71.53 0.37 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.735 1.013 . . . . 75.43 113.735 -172.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.442 ' HB3' ' O ' ' A' ' 153' ' ' HIS . 22.2 p80 174.97 7.63 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.103 0.409 . . . . 75.41 112.103 176.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -116.48 140.35 49.46 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.265 0.555 . . . . 74.2 112.395 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -138.05 -169.59 2.6 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.339 -0.846 . . . . 74.1 110.185 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 9.7 p80 . . . . . 0 C--O 1.252 1.216 0 CA-C-O 117.883 -1.055 . . . . 73.14 111.263 176.078 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.98 0.419 . . . . 65.12 111.052 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -87.89 117.9 27.05 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.001 0.429 . . . . 72.13 111.517 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -91.29 116.04 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.176 -0.465 . . . . 72.22 111.69 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -94.08 139.94 30.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.268 0.556 . . . . 65.01 112.072 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 56.8 mtpt -111.71 163.25 18.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.714 -0.675 . . . . 72.5 110.012 173.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 16.5 Cg_endo -55.38 -23.73 39.75 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.392 2.062 . . . . 71.21 112.854 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.34 -22.81 38.18 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.22 -0.446 . . . . 74.44 111.839 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -91.76 -19.69 22.32 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.83 0.347 . . . . 72.45 111.599 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.29 120.73 80.19 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.488 -0.324 . . . . 71.33 111.213 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.47 111.2 0.69 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.667 2.245 . . . . 73.13 112.978 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -70.81 82.57 0.64 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.346 0.593 . . . . 74.22 110.832 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.82 -28.31 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.414 0.524 . . . . 72.41 112.414 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -72.15 -24.53 61.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.893 0.378 . . . . 74.51 111.842 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 14' ' ' LEU . 6.7 tt -75.57 -39.71 57.72 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.19 -0.67 . . . . 73.22 109.19 171.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.86 -80.13 0.08 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.863 -0.608 . . . . 64.34 112.16 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -121.93 109.03 14.12 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.661 0.267 . . . . 74.01 111.584 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 p -59.12 -24.9 63.38 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.857 0.361 . . . . 73.23 111.765 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.4 m -61.78 -26.36 68.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.399 -0.364 . . . . 70.12 111.517 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -114.6 112.68 23.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.221 0.534 . . . . 74.31 110.954 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 4.6 mp -101.5 7.59 42.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.075 -0.511 . . . . 62.34 110.751 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 16.4 t -119.5 116.47 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.64 0.607 . . . . 73.01 112.64 -172.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.0 m -104.44 105.79 16.04 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.402 -0.363 . . . . 54.13 111.157 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 30.2 t70 -96.56 101.67 13.32 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.081 0.467 . . . . 70.13 111.345 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.52 ' HB2' HD23 ' A' ' 56' ' ' LEU . 27.7 mm-40 -103.77 -39.55 6.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.003 0.43 . . . . 64.44 111.065 177.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.85 -21.58 57.12 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.913 0.709 . . . . 65.41 112.913 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.22 55.46 5.16 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.938 -0.649 . . . . 64.23 112.486 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -122.13 -47.76 2.13 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.873 0.368 . . . . 74.33 111.466 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.4 HD21 HD12 ' A' ' 135' ' ' LEU . 96.2 mt -74.22 115.24 13.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.136 0.493 . . . . 63.43 111.931 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 90.8 p -71.1 162.07 30.06 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.018 -0.537 . . . . 71.53 111.241 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -53.49 -35.51 60.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.123 0.487 . . . . 65.41 110.872 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.69 -48.48 69.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.932 -0.576 . . . . 74.45 111.244 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -60.46 -42.73 96.77 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.574 0.226 . . . . 74.31 111.59 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.01 -44.84 95.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.776 0.322 . . . . 72.43 110.926 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -54.57 -55.18 32.05 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.031 0.443 . . . . 74.22 111.238 177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.89 -46.08 97.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.897 -0.592 . . . . 51.14 111.811 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.522 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 50.0 ttm -66.84 -52.12 47.51 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.529 -0.305 . . . . 72.31 111.742 -176.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -62.88 -37.67 87.85 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.407 0.146 . . . . 74.15 111.236 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.67 -48.24 85.89 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.006 -0.616 . . . . 62.25 112.532 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 48.1 mtp180 -64.0 -47.55 79.85 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.308 0.243 . . . . 61.3 111.608 177.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 36' ' ' MET . 85.4 mt -58.57 -52.72 64.47 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.129 0.49 . . . . 63.12 111.361 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -60.18 -34.87 74.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.027 -0.533 . . . . 75.45 110.862 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.21 96.89 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.845 0.355 . . . . 52.54 111.143 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 49' ' ' VAL . 70.8 mt -62.25 -42.27 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.488 -0.324 . . . . 75.52 110.78 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 28.1 tpt180 -61.51 -37.63 84.42 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.989 0.423 . . . . 62.11 111.088 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.4 m -70.11 -31.51 69.1 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.129 0.418 . . . . 65.4 112.129 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.6 t -98.72 -64.54 1.03 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.004 0.372 . . . . 51.34 112.004 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.619 ' HE1' HD22 ' A' ' 150' ' ' LEU . 76.0 m-70 -87.5 -10.56 51.43 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.5 0.556 . . . . 71.33 112.5 -175.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 69.08 3.46 4.07 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.312 0.486 . . . . 74.23 112.312 -176.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.851 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 93.2 t -64.45 122.62 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 121.008 0.432 . . . . 75.33 111.459 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -88.84 95.54 10.33 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.3 0.572 . . . . 75.22 109.865 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -113.17 102.7 10.62 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.646 -0.706 . . . . 74.24 111.013 -172.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -105.17 145.86 30.01 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.356 0.502 . . . . 74.33 112.356 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 61.3 t -124.23 138.3 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.394 -0.366 . . . . 75.34 110.933 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.1 t -133.29 143.31 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 122.231 -0.293 . . . . 53.23 111.118 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 28.4 p -125.54 123.15 38.5 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.803 0.335 . . . . 71.42 110.752 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 24' ' ' GLU . 81.8 mt -127.39 143.22 46.48 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 122.245 -0.284 . . . . 75.52 111.515 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.74 -61.48 0.28 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.598 2.199 . . . . 75.04 112.519 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.8 p -149.35 146.41 27.5 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.973 0.416 . . . . 72.13 112.046 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.471 HG12 HG11 ' A' ' 91' ' ' VAL . 31.9 pt -110.6 5.0 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.957 -0.565 . . . . 73.32 110.682 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.92 -120.4 22.02 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.886 -0.597 . . . . 73.3 113.526 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -97.83 4.86 49.65 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.895 0.378 . . . . 72.42 111.788 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.46 140.44 92.47 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 120.672 0.272 . . . . 74.23 111.731 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.662 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.5 Cg_endo -75.99 125.86 8.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.321 2.014 . . . . 75.34 112.518 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.3 tp -58.62 -42.01 87.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.046 0.451 . . . . 71.4 111.711 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.73 -59.68 4.19 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.875 -0.602 . . . . 74.22 111.057 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.662 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 3.3 m-20 -62.97 -41.53 99.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.705 -0.68 . . . . 64.13 111.627 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -53.62 -49.96 66.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.274 -0.421 . . . . 64.34 111.763 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.3 p -57.48 -48.86 78.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.412 -0.358 . . . . 75.44 111.891 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.4 -45.42 88.39 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.844 0.354 . . . . 65.23 111.712 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 66' ' ' ASP . 31.7 mmmt -56.25 -45.51 80.02 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.999 0.428 . . . . 54.44 111.661 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.418 HD23 HD21 ' A' ' 87' ' ' LEU . 52.3 tp -73.42 -38.13 65.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.214 0.53 . . . . 73.14 111.297 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.81 -35.45 72.87 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.292 -0.413 . . . . 72.2 112.103 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -61.31 -53.91 50.66 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.321 0.489 . . . . 73.02 112.321 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.628 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 7.2 pt20 -67.06 -27.44 67.38 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.383 0.512 . . . . 64.52 112.383 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.628 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 16.3 m0 -80.74 -12.22 59.49 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.884 0.328 . . . . 74.42 111.884 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.76 -2.16 66.57 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.266 -0.492 . . . . 74.24 114.029 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.0 m -100.85 -4.42 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.714 0.635 . . . . 64.12 112.714 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.44 -29.99 1.13 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.01 -0.614 . . . . 73.14 113.935 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -59.21 127.15 30.72 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.487 -0.419 . . . . 73.25 111.287 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 43.71 28.17 0.21 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.939 0.896 . . . . 65.44 112.965 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER 64.46 93.23 0.06 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.246 0.832 . . . . 71.33 113.246 175.067 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.439 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 23.0 t-20 -74.24 132.66 42.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.244 0.545 . . . . 73.2 111.064 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.634 ' HA ' ' H ' ' A' ' 104' ' ' GLY . 28.1 p-10 -51.38 -64.29 0.86 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 112.772 0.656 . . . . 73.51 112.772 177.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.851 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 18.3 m120 -88.02 8.16 27.86 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.683 -0.636 . . . . 75.31 112.146 -177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.99 124.62 9.23 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 114.735 0.654 . . . . 75.34 114.735 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 99' ' ' PHE . 50.9 tp -144.23 119.59 10.26 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.705 0.402 . . . . 71.3 110.755 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.6 tp -110.99 135.44 51.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.817 0.341 . . . . 74.4 111.564 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -120.84 108.14 13.57 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.741 0.305 . . . . 74.23 110.863 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.0 t -108.5 120.15 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.075 0.398 . . . . 75.15 112.075 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.548 ' HB2' HD21 ' A' ' 135' ' ' LEU . 29.2 tp -100.1 129.4 46.13 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.014 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.471 HG11 HG12 ' A' ' 59' ' ' ILE . 44.2 t -116.98 107.79 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.462 -0.335 . . . . 65.11 110.683 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.1 tp -53.47 -44.36 68.91 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.044 0.449 . . . . 71.52 111.504 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -57.64 -33.5 68.36 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.95 -0.568 . . . . 71.2 112.265 177.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -92.66 -11.95 32.82 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 122.241 -0.287 . . . . 72.11 111.62 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 54.64 29.05 10.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.995 0.518 . . . . 73.41 111.891 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -149.81 173.53 13.64 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.09 0.471 . . . . 70.02 111.908 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.535 HG21 ' SD ' ' A' ' 122' ' ' MET . 8.9 m -135.41 171.93 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.877 -0.601 . . . . 70.13 111.056 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -145.8 141.52 28.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.926 0.393 . . . . 73.42 111.532 168.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.67 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 79.0 m-85 -98.36 124.9 43.27 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.887 -0.597 . . . . 71.22 110.373 172.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.99 119.25 38.92 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.275 -0.266 . . . . 73.41 110.726 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.591 HG23 HD11 ' A' ' 114' ' ' LEU . 18.5 p -98.19 139.11 34.47 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.03 0.443 . . . . 75.22 111.847 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -68.39 -80.84 0.21 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.582 -0.818 . . . . 54.32 112.297 173.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.425 ' HB2' ' HB3' ' A' ' 81' ' ' LYS . 9.4 t80 -155.66 -43.62 0.08 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.934 0.397 . . . . 74.32 112.044 -177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.634 ' H ' ' HA ' ' A' ' 83' ' ' ASN . . . -62.13 -41.76 99.71 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.516 -0.374 . . . . 62.13 113.617 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 88.2 mt -71.15 -3.08 18.13 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.251 0.834 . . . . 72.34 113.251 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -60.85 -15.49 30.89 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.939 -0.476 . . . . 70.11 112.03 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.7 1.18 80.95 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.177 -0.535 . . . . 62.05 113.301 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -136.94 -54.36 0.71 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.332 0.587 . . . . 74.02 111.452 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.423 ' HB3' HD21 ' A' ' 114' ' ' LEU . 14.6 mt -117.25 86.62 21.67 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.578 -0.737 . . . . 73.44 111.821 -174.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.39 159.0 22.78 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.332 2.021 . . . . 75.43 112.529 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.435 ' HA ' HD12 ' A' ' 114' ' ' LEU . 14.3 t70 -45.91 -40.22 9.82 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 120.977 0.417 . . . . 65.22 111.746 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.03 72.11 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.336 -0.459 . . . . 43.51 113.284 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.26 -40.2 96.74 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.03 0.443 . . . . 75.23 111.095 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.67 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 86.1 mt -57.66 -48.17 80.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.052 -0.522 . . . . 72.34 111.127 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.4 t -69.08 -34.48 75.19 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.106 0.479 . . . . 63.33 110.804 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 116' ' ' ARG . 15.4 ttm180 -56.56 -53.92 51.93 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.904 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.12 -41.69 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.027 0.441 . . . . 63.14 111.528 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.482 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 60.4 mt -58.61 -54.51 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.165 0.507 . . . . 64.42 110.888 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -75.1 -14.9 60.62 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.28 -0.418 . . . . 70.33 112.008 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -79.21 -53.04 7.36 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.226 0.454 . . . . 74.33 112.226 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -133.72 -23.68 1.79 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.202 0.816 . . . . 73.2 113.202 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.535 ' SD ' HG21 ' A' ' 97' ' ' VAL . 36.4 mtt -67.56 -53.6 26.96 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.509 0.559 . . . . 74.32 112.509 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 118' ' ' ILE . 47.7 mm -51.38 -53.63 47.44 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 112.85 0.685 . . . . 74.45 112.85 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 10.5 Cg_endo -53.58 -41.98 69.44 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.989 1.793 . . . . 74.32 112.623 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.475 ' CD2' ' HG3' ' A' ' 137' ' ' GLU . 60.5 m-70 -64.47 -50.68 66.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.279 -0.263 . . . . 75.53 111.491 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.6 m-85 -56.4 -45.25 80.72 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.854 0.359 . . . . 73.54 111.431 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 58.6 mtp180 -62.49 -34.82 77.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.963 0.411 . . . . 75.12 110.988 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.6 m -80.82 -4.44 54.69 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.104 -0.498 . . . . 62.31 111.87 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.7 -8.44 63.78 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.517 -0.373 . . . . 34.11 113.601 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.781 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.4 m-20 -78.81 72.41 5.33 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 122.327 -0.513 . . . . 62.23 112.139 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -71.45 -56.13 6.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.018 0.437 . . . . 65.01 111.177 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.91 89.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.184 -0.462 . . . . 72.14 111.468 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.781 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 9.4 tp10 -68.56 -46.43 69.48 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.17 -0.468 . . . . 63.1 110.768 176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.84 -41.75 67.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.579 -0.343 . . . . 52.15 113.267 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 90' ' ' LEU . 83.4 mt -60.65 -48.79 80.2 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.888 0.375 . . . . 75.24 111.178 175.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -60.56 -38.85 85.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.326 -0.397 . . . . 74.5 110.941 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.475 ' HG3' ' CD2' ' A' ' 125' ' ' HIS . 15.7 mm-40 -58.44 -51.37 70.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.173 -0.467 . . . . 60.44 111.503 175.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.439 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -58.76 -47.94 87.71 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.9 -0.667 . . . . 75.34 112.444 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.29 -39.68 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.968 0.413 . . . . 74.11 111.218 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.431 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 27.9 tp -70.88 -33.99 71.15 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.381 -0.372 . . . . 72.02 110.667 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.52 -50.79 57.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.847 0.356 . . . . 74.2 110.86 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.7 t -57.47 -47.34 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.116 0.484 . . . . 65.1 110.535 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -53.81 -46.91 71.24 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.051 -0.522 . . . . 74.14 111.82 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 27.3 mt-30 -57.42 -38.1 73.82 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.841 0.353 . . . . 71.41 111.426 177.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.98 -49.08 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.707 0.289 . . . . 72.23 111.029 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.36 -58.21 4.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.867 0.321 . . . . 72.3 111.867 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.83 -23.09 67.22 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.045 0.45 . . . . 63.21 111.845 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.08 -18.7 58.91 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.205 -0.522 . . . . 72.33 112.856 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.0 t -74.24 -58.46 3.28 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.151 0.426 . . . . 61.41 112.151 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.619 HD22 ' HE1' ' A' ' 47' ' ' HIS . 1.7 pt? -66.83 -25.42 66.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.859 0.361 . . . . 71.0 111.395 -177.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.45 ' H ' HD23 ' A' ' 150' ' ' LEU . 44.1 mt-10 67.64 -8.8 0.48 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.636 0.774 . . . . 73.41 112.727 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.575 ' H ' ' HG ' ' A' ' 150' ' ' LEU . 31.7 t60 -77.44 118.19 19.64 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.646 -0.501 . . . . 74.21 109.646 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -49.73 118.08 2.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.235 0.457 . . . . 74.0 112.235 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -58.08 107.49 0.48 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.072 -0.513 . . . . 72.31 110.878 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -76.82 133.48 39.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.987 0.422 . . . . 74.43 111.647 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -93.47 141.97 27.86 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.376 -0.375 . . . . 72.55 110.661 175.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.4 m170 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.429 -0.796 . . . . 71.35 111.421 -175.44 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.508 ' HG3' ' OG ' ' A' ' 58' ' ' SER . 51.5 ttm . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.865 0.364 . . . . 74.12 111.417 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -118.05 123.18 45.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.774 0.321 . . . . 71.24 110.665 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.03 101.8 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 121.044 0.449 . . . . 74.14 111.754 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -91.59 141.17 29.0 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.109 0.48 . . . . 75.01 111.405 174.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.503 ' HB2' ' NZ ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -111.45 158.35 36.52 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 116.316 -0.402 . . . . 52.04 110.647 175.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 64.4 Cg_endo -70.93 19.31 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.819 2.346 . . . . 63.22 114.541 -173.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.498 ' OE2' ' HB2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -126.38 -12.07 6.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.756 0.313 . . . . 62.11 111.657 173.355 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -97.45 -19.27 18.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.947 0.403 . . . . 54.01 111.121 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.21 130.92 84.04 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.322 -0.399 . . . . 54.24 111.412 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.04 110.84 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.828 2.352 . . . . 54.32 113.173 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -70.96 98.0 1.53 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.215 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 13' ' ' GLN . 27.8 m -93.26 -50.25 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 113.495 0.924 . . . . 53.2 113.495 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.575 ' HG3' HG21 ' A' ' 77' ' ' VAL . 15.1 mm100 -53.77 -33.75 56.85 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.654 1.353 . . . . 63.14 114.654 -169.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.428 ' H ' ' CD2' ' A' ' 14' ' ' LEU . 1.6 pt? -77.48 5.34 9.1 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.617 0.599 . . . . 62.44 112.617 -175.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.02 -51.56 0.06 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.196 0.522 . . . . 75.32 111.498 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -83.14 47.67 1.27 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.3 -0.409 . . . . 64.22 111.256 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 m -61.0 -11.79 9.32 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.689 0.626 . . . . 74.41 112.689 -176.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -77.71 -30.7 51.91 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.176 0.512 . . . . 65.1 110.635 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.47 ' HA ' ' OD1' ' A' ' 37' ' ' ASN . 13.0 ttm105 -108.34 95.04 5.39 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.452 0.644 . . . . 74.31 110.761 175.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 20' ' ' LEU . 3.9 mp -88.89 13.6 12.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.812 -0.631 . . . . 73.21 111.04 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.54 127.36 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.326 -0.397 . . . . 63.22 111.773 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.0 m -121.1 103.16 8.81 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.439 -0.346 . . . . 73.24 110.619 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.4 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 24.1 t70 -99.51 101.99 13.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.989 0.424 . . . . 73.35 111.495 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HB2' HD23 ' A' ' 56' ' ' LEU . 23.6 mm-40 -103.0 -34.42 8.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.214 0.53 . . . . 71.52 110.714 176.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.32 -28.26 69.08 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.51 0.559 . . . . 71.15 112.51 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.68 28.43 51.36 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.886 -0.673 . . . . 71.12 112.432 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.51 -17.2 22.64 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.824 0.345 . . . . 63.43 111.319 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.4 mt -107.62 114.19 28.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.924 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 t -65.93 152.73 43.86 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.341 -0.224 . . . . 63.54 110.467 175.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -45.03 -51.78 9.61 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.854 0.687 . . . . 74.23 112.854 -174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -60.28 -50.26 74.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.646 0.26 . . . . 71.12 111.452 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -58.09 -39.87 79.68 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.177 0.513 . . . . 71.31 111.426 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -50.73 71.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.906 -0.588 . . . . 74.14 110.621 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.06 -30.75 71.8 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.724 0.297 . . . . 61.23 111.371 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 31' ' ' ALA . 74.8 t -62.01 -46.37 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.951 0.405 . . . . 63.33 110.35 172.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.708 ' SD ' HG21 ' A' ' 139' ' ' VAL . 51.7 tpp -60.3 -43.85 95.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.422 -0.354 . . . . 75.24 110.356 175.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.552 ' HB3' ' NH2' ' A' ' 41' ' ' ARG . 60.3 m-80 -56.74 -38.19 72.04 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.468 -0.333 . . . . 73.2 110.658 173.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.6 -46.32 94.65 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.887 -0.673 . . . . 41.23 112.203 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' A' ' 39' ' ' ARG . 1.5 mmp_? -57.61 -55.74 30.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.023 0.44 . . . . 63.43 111.174 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.87 -45.58 91.9 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.099 -0.5 . . . . 73.12 112.098 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' NH2' ' HB3' ' A' ' 37' ' ' ASN . 36.3 ttm180 -62.15 -40.75 97.03 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.018 0.527 . . . . 74.15 110.929 -178.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.64 -46.52 89.42 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.338 -0.392 . . . . 54.21 111.011 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.435 HG22 ' HB ' ' A' ' 49' ' ' VAL . 76.1 mt -59.79 -44.7 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.124 0.488 . . . . 64.23 110.96 175.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 31.7 tpt180 -62.42 -26.81 68.69 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.097 -0.501 . . . . 71.22 111.76 177.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.1 m -84.84 -54.06 4.93 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.148 0.499 . . . . 72.0 110.76 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.2 m -71.91 -56.9 4.87 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.719 -0.673 . . . . 72.21 112.42 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.479 ' ND1' HD12 ' A' ' 150' ' ' LEU . 80.1 m-70 -96.32 -10.57 27.51 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.115 0.413 . . . . 72.54 112.115 -173.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 70.55 1.47 3.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.974 0.731 . . . . 70.1 112.974 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 43' ' ' ILE . 99.2 t -66.59 132.09 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 112.352 0.501 . . . . 65.25 112.352 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.448 ' HB3' HG13 ' A' ' 77' ' ' VAL . 44.3 mt-10 -82.18 96.74 7.93 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.08 0.466 . . . . 74.13 110.533 174.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -119.11 108.72 15.04 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.507 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.47 146.02 42.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.875 0.369 . . . . 31.51 111.971 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.4 t -128.38 121.74 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.831 0.348 . . . . 65.5 111.418 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.7 t -121.78 132.37 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 122.325 0.25 . . . . 75.24 111.419 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 30.7 p -116.59 123.06 46.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.927 0.394 . . . . 52.33 111.288 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.424 HD11 ' CZ ' ' A' ' 67' ' ' PHE . 83.8 mt -118.16 145.24 36.55 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-O 120.788 0.328 . . . . 74.41 111.37 177.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.95 -43.01 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.535 2.157 . . . . 72.34 112.354 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.912 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 23.8 m -153.14 143.47 22.46 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.055 0.391 . . . . 62.42 112.055 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 35.8 pt -128.67 -14.38 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.083 0.468 . . . . 74.54 110.653 172.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.04 -117.32 8.45 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.236 -0.438 . . . . 35.34 113.725 174.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.42 2.67 46.87 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.815 0.302 . . . . 53.35 111.815 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -72.88 120.88 83.26 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 111.524 0.194 . . . . 64.04 111.524 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 31.8 Cg_endo -64.48 137.06 53.41 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.443 2.095 . . . . 72.13 112.654 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.97 -49.08 40.34 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.236 0.458 . . . . 72.44 112.236 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.26 -32.85 73.61 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.998 0.428 . . . . 74.12 111.849 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.593 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 3.4 m-20 -74.21 -38.55 63.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.89 0.376 . . . . 71.13 111.016 173.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.424 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 48.6 t80 -56.77 -54.15 49.68 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.995 0.426 . . . . 74.42 111.062 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.493 ' OG1' ' NH1' ' A' ' 98' ' ' ARG . 40.7 p -51.84 -42.48 62.62 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.959 -0.564 . . . . 75.04 111.441 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.3 tp -58.42 -54.8 42.89 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.133 -0.485 . . . . 73.25 111.657 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 14.9 mmmm -66.67 -42.29 86.77 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.628 0.603 . . . . 62.13 112.628 -173.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.3 tp -68.57 -47.98 65.4 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.207 0.527 . . . . 73.31 111.261 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.529 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -68.55 -31.04 69.98 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.453 0.538 . . . . 62.35 112.453 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 70' ' ' LYS . 13.3 ptm180 -70.67 -38.95 73.79 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.092 -0.243 . . . . 62.5 111.436 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.529 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 10.6 pt20 -72.51 -24.69 61.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.044 0.45 . . . . 53.41 110.811 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.529 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 39.6 m0 -88.69 -17.2 30.47 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.487 -0.324 . . . . 73.32 111.221 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.64 38.08 95.71 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.472 -0.394 . . . . 74.4 113.613 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.575 HG21 ' HG3' ' A' ' 13' ' ' GLN . 45.0 t -108.87 -87.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.173 0.434 . . . . 71.22 112.173 -176.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.75 102.16 2.22 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.225 -0.512 . . . . 63.35 112.9 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.491 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -144.74 156.3 43.99 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.477 -0.425 . . . . 54.2 110.714 178.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -43.66 -32.76 1.05 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.707 1.003 . . . . 71.34 113.707 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.688 ' HD3' ' H ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -114.51 20.28 15.49 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.596 0.591 . . . . 74.23 112.596 -174.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 103' ' ' TYR . 3.5 m-20 -95.8 -166.13 1.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.242 0.544 . . . . 63.04 112.053 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -97.36 -139.44 0.28 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.13 -0.486 . . . . 73.22 111.137 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.547 ' HA ' ' HG ' ' A' ' 105' ' ' LEU . 7.3 p30 -69.12 43.88 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.322 0.86 . . . . 52.44 113.322 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -92.49 140.39 15.09 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.934 -0.651 . . . . 61.42 112.74 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 99' ' ' PHE . 52.0 tp -143.05 119.74 11.14 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.871 0.367 . . . . 64.11 111.03 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 72' ' ' ALA . 58.4 tp -111.94 122.32 47.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.836 0.351 . . . . 65.52 111.216 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.3 tp -109.97 106.2 15.65 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.307 -0.406 . . . . 75.21 110.745 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 59.9 t -107.06 117.4 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 111.925 0.343 . . . . 73.11 111.925 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.487 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.9 tp -96.88 122.27 39.66 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.305 -0.407 . . . . 72.22 110.677 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.457 HG11 HG12 ' A' ' 59' ' ' ILE . 61.0 t -111.04 102.9 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.665 0.269 . . . . 71.31 111.176 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.5 tp -51.86 -41.74 62.08 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.0 0.428 . . . . 72.34 111.367 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.912 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 19.1 t0 -45.76 -43.16 12.82 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.5 0.72 . . . . 70.02 112.451 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.401 ' NE2' HD11 ' A' ' 59' ' ' ILE . 49.3 mt-30 -106.19 -6.79 18.26 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 111.906 0.336 . . . . 71.11 111.906 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.404 ' NH2' ' O ' ' A' ' 126' ' ' PHE . 77.9 mtp180 55.23 26.84 8.9 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.732 0.777 . . . . 73.51 110.509 -174.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -112.75 164.24 13.61 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.171 -0.922 . . . . 64.42 111.528 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.668 HG21 ' SD ' ' A' ' 122' ' ' MET . 11.1 m -137.42 171.75 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.025 -0.534 . . . . 61.22 110.511 172.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.493 ' NH1' ' OG1' ' A' ' 68' ' ' THR . 38.5 ttt-85 -153.04 142.82 22.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.788 0.327 . . . . 70.01 111.621 172.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HD11 ' A' ' 86' ' ' LEU . 95.1 m-85 -101.22 118.05 36.21 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.045 -0.525 . . . . 74.33 110.659 173.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' CD ' HH12 ' A' ' 98' ' ' ARG . 5.6 tp10 -105.64 112.6 25.74 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 110.346 -0.242 . . . . 74.42 110.346 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.8 p -103.27 158.89 16.01 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.791 0.805 . . . . 74.32 113.038 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . -104.5 -175.65 25.04 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 114.907 -1.042 . . . . 73.42 111.464 166.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.423 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -61.83 -24.17 66.72 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.405 -0.468 . . . . 74.04 112.009 -176.142 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.4 -20.27 79.64 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.928 -0.653 . . . . 74.45 113.203 -173.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HG ' ' HA ' ' A' ' 84' ' ' ASN . 91.8 mt -109.11 -7.5 15.31 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.407 0.521 . . . . 75.22 112.407 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -56.4 -25.72 50.95 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.11 0.411 . . . . 65.32 112.11 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.79 -21.26 59.89 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.169 -0.539 . . . . 31.54 113.62 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 82.0 m-85 -102.42 -53.74 2.83 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.268 0.556 . . . . 72.21 111.409 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -113.77 87.97 13.17 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.485 -0.78 . . . . 70.2 111.418 -173.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 108' ' ' TYR . 6.5 Cg_exo -73.99 161.63 40.75 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.396 2.064 . . . . 52.15 112.34 176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -51.45 -44.09 62.26 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.167 0.432 . . . . 72.44 112.167 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.51 -45.13 94.94 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.227 -0.511 . . . . 65.24 113.198 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.12 -42.94 99.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.767 0.318 . . . . 65.33 111.164 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.0 -44.75 91.72 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.012 0.434 . . . . 64.34 110.827 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.7 m -61.91 -36.63 81.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.086 -0.506 . . . . 74.22 111.053 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -60.9 -56.38 21.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.215 -0.448 . . . . 73.11 111.59 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.5 mt -50.63 -43.43 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.902 0.382 . . . . 72.44 111.684 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' ' 122' ' ' MET . 64.3 mt -61.23 -51.31 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.296 -0.411 . . . . 74.01 111.754 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.463 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 25.1 m-70 -74.02 -48.17 31.99 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.025 0.75 . . . . 70.24 113.025 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.35 -54.19 22.79 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.592 0.59 . . . . 73.2 112.592 -174.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -97.33 -45.14 6.6 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.604 0.594 . . . . 63.44 112.604 -172.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.668 ' SD ' HG21 ' A' ' 97' ' ' VAL . 49.3 mtt -73.32 -54.26 8.79 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.708 1.003 . . . . 64.13 113.708 -173.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.506 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 32.8 mm -47.48 -51.86 40.9 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 113.391 0.886 . . . . 63.34 113.391 -175.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.506 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 72.0 Cg_exo -50.49 -39.59 54.79 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.155 1.903 . . . . 72.3 113.048 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.464 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 85.5 m-70 -74.42 -49.95 20.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.6 -0.273 . . . . 71.24 111.656 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.6 m-30 -56.34 -43.13 78.76 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.598 0.221 . . . . 50.21 111.598 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.5 -42.36 87.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.921 0.391 . . . . 63.41 111.302 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.7 m -74.94 -13.46 60.53 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.268 -0.423 . . . . 45.11 111.75 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.48 -0.69 59.89 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.286 -0.483 . . . . 72.13 112.52 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.8 m-20 -80.37 66.66 5.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.737 0.415 . . . . 64.02 111.303 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -65.13 -46.02 82.66 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.174 -0.329 . . . . 73.43 111.785 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.69 95.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.007 0.432 . . . . 71.3 111.462 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 51.9 mm-40 -59.82 -47.2 86.69 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.146 -0.479 . . . . 72.23 111.365 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.71 93.13 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.302 -0.475 . . . . 74.51 113.008 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.35 -43.05 96.86 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.808 0.337 . . . . 65.1 111.051 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.4 t -56.21 -53.48 56.63 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 64.3 111.904 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -68.4 -33.45 74.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.609 0.242 . . . . 72.02 111.395 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.18 -52.46 51.74 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.072 -0.585 . . . . 43.31 112.712 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.708 HG21 ' SD ' ' A' ' 36' ' ' MET . 90.8 t -62.63 -43.6 98.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.023 0.44 . . . . 74.21 111.227 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.19 -38.36 76.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.262 -0.427 . . . . 74.31 110.929 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -61.31 -51.84 67.18 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.9 0.381 . . . . 64.42 111.052 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 85.7 t -54.32 -49.7 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.162 0.506 . . . . 75.05 110.972 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.425 ' HB2' HD11 ' A' ' 43' ' ' ILE . 36.5 tt0 -53.43 -46.5 69.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.974 -0.557 . . . . 63.14 111.653 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -65.09 -34.22 77.89 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.943 0.349 . . . . 63.52 111.943 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 141' ' ' ALA . 92.8 t -63.28 -49.07 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.064 0.459 . . . . 73.24 111.004 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.85 -57.06 8.79 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.051 0.453 . . . . 74.43 111.425 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.69 -37.94 85.98 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.12 -0.491 . . . . 73.23 111.943 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.28 -41.02 92.76 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.313 -0.47 . . . . 70.41 113.461 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 52.9 m -81.05 -41.26 22.9 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.051 0.453 . . . . 73.21 111.572 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.479 HD12 ' ND1' ' A' ' 47' ' ' HIS . 92.2 mt -81.04 75.77 8.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.428 0.633 . . . . 61.14 111.915 -177.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -84.44 -53.31 5.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.678 -0.692 . . . . 74.21 110.08 175.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -126.58 115.21 19.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.731 -0.668 . . . . 74.13 111.329 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -79.5 137.47 37.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 64.03 109.943 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -70.35 -10.46 59.1 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.502 0.556 . . . . 73.53 112.502 -173.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -74.69 142.68 44.42 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.648 0.261 . . . . 74.32 111.302 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -84.01 149.96 25.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.984 0.421 . . . . 74.43 111.818 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.932 -0.556 . . . . 73.44 111.082 179.529 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.265 0.555 . . . . 75.15 111.884 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 30.1 ttp180 -137.41 101.66 4.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.169 -0.469 . . . . 73.11 109.917 175.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.1 t -75.95 117.55 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 113.133 0.79 . . . . 61.11 113.133 -171.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -109.1 152.56 24.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.742 -0.663 . . . . 73.21 111.518 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.7 mtmt -111.91 157.95 38.15 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.207 -0.451 . . . . 73.33 110.335 173.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.523 ' HD3' ' CE2' ' A' ' 67' ' ' PHE . 30.3 Cg_endo -62.33 -26.11 76.89 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.912 1.741 . . . . 61.52 111.323 176.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -79.26 -20.2 48.71 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.566 -0.743 . . . . 63.22 111.067 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -94.06 -24.49 17.58 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.855 -0.611 . . . . 62.32 111.511 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.6 t -66.71 132.52 94.06 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.226 -0.443 . . . . 43.2 111.648 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.08 121.05 9.19 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.633 2.222 . . . . 73.41 113.106 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' A' ' 14' ' ' LEU . 2.8 p30 -70.34 85.95 0.59 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.477 0.547 . . . . 73.33 112.477 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.66 -26.77 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 112.223 0.453 . . . . 72.32 112.223 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.575 HE22 ' HA ' ' A' ' 20' ' ' LEU . 1.6 mp0 -87.22 31.29 0.73 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.593 0.711 . . . . 71.52 111.365 173.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.541 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 4.7 tt -143.43 -50.75 0.33 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.378 -0.971 . . . . 64.3 108.378 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -109.52 120.37 42.29 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.604 -0.725 . . . . 34.14 110.307 170.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 6.8 m-20 71.13 48.42 0.37 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.329 0.652 . . . . 72.31 111.646 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -59.45 -11.96 5.36 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.961 0.726 . . . . 61.23 112.961 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 t -60.86 -34.67 74.96 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.142 -0.349 . . . . 54.41 111.319 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 19' ' ' ARG . 8.0 ptp85 -97.12 132.48 42.86 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.096 0.474 . . . . 64.12 110.375 175.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.575 ' HA ' HE22 ' A' ' 13' ' ' GLN . 5.6 mp -108.63 12.67 25.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.153 0.501 . . . . 62.1 110.896 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.7 t -110.75 146.94 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.135 -0.484 . . . . 24.43 111.478 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 m -131.21 124.17 30.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.359 -0.382 . . . . 74.41 110.57 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.35 86.03 2.35 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.405 0.621 . . . . 73.31 112.492 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.04 -38.48 8.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.908 0.385 . . . . 73.02 110.75 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.1 -26.65 64.08 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.982 0.42 . . . . 72.35 111.126 170.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.91 25.74 75.21 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.254 -0.498 . . . . 73.04 113.234 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 132' ' ' ALA . 78.8 mt -86.06 10.89 12.96 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.928 0.344 . . . . 74.4 111.928 -177.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.48 HD21 HD12 ' A' ' 135' ' ' LEU . 97.0 mt -120.17 119.96 34.79 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.838 0.351 . . . . 64.43 111.438 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.493 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 31.5 t -81.05 159.49 24.77 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.554 -0.294 . . . . 74.11 110.72 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -54.61 -40.54 69.0 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.169 0.803 . . . . 72.15 113.169 -173.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.32 91.9 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.071 0.462 . . . . 75.42 111.247 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.493 ' OE1' ' HB3' ' A' ' 29' ' ' SER . 18.4 mp0 -66.93 -41.05 87.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.786 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.97 -44.05 91.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.968 0.413 . . . . 72.44 110.713 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -57.56 -57.58 12.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.754 -0.657 . . . . 73.42 111.552 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.73 -47.17 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.154 -0.475 . . . . 74.3 111.771 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.475 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.2 ttm -61.78 -51.56 67.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.528 -0.305 . . . . 74.05 111.662 -177.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -64.82 -35.76 82.15 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 121.01 -0.276 . . . . 63.51 111.326 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.77 -47.21 87.48 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.997 -0.62 . . . . 52.33 112.691 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.493 ' O ' HG13 ' A' ' 43' ' ' ILE . 7.4 mtp180 -67.06 -49.71 64.22 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.782 0.289 . . . . 74.43 111.782 176.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 36' ' ' MET . 91.2 mt -56.31 -41.18 75.55 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.267 0.556 . . . . 72.31 111.404 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -61.87 -46.63 88.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.419 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.21 86.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.984 0.421 . . . . 74.0 111.437 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 39' ' ' ARG . 75.9 mt -58.14 -49.8 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.365 -0.38 . . . . 63.52 111.434 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 26.3 ttp85 -69.09 -25.74 64.58 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.853 0.316 . . . . 75.3 111.853 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.9 t -83.28 -33.42 25.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.089 0.471 . . . . 54.51 111.892 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.7 t -97.24 -67.22 0.86 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.139 0.495 . . . . 73.44 111.672 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -74.27 -16.47 60.94 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.264 -0.425 . . . . 74.3 111.386 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 71.02 9.88 6.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.205 0.602 . . . . 63.23 112.087 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.885 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 85.8 t -81.41 122.52 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.98 0.419 . . . . 73.31 111.861 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.71 96.66 7.61 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.178 0.513 . . . . 73.22 110.226 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -111.94 105.13 13.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.909 -0.587 . . . . 73.4 110.863 -175.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.04 145.4 29.94 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.58 0.585 . . . . 73.13 112.58 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.53 107.76 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.022 0.439 . . . . 72.01 110.902 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.67 134.94 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.846 0.355 . . . . 74.01 111.53 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -113.52 122.53 47.56 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.753 0.311 . . . . 72.33 111.111 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -130.23 137.0 29.89 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 120.848 0.356 . . . . 74.14 111.542 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 39.3 Cg_endo -67.09 -53.94 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.598 2.199 . . . . 62.2 113.264 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 20.3 m -141.75 136.11 30.42 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.17 -0.331 . . . . 73.21 111.649 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.9 pt -106.81 -28.91 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.92 0.39 . . . . 75.03 110.89 174.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.29 -116.53 7.18 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.124 -0.489 . . . . 31.04 114.229 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.78 -23.33 66.69 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.348 0.499 . . . . 72.35 112.348 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.28 128.17 86.53 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.4 0.519 . . . . 65.11 112.4 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.709 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 61.2 Cg_endo -73.38 136.11 23.49 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.581 2.187 . . . . 54.43 112.156 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.1 tp -52.57 -47.71 66.67 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.979 0.733 . . . . 73.13 112.979 -174.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.3 -58.24 8.44 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.132 -0.355 . . . . 71.11 111.628 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.709 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 1.8 m-20 -59.71 -29.79 68.35 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.743 0.306 . . . . 61.32 111.507 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.523 ' CE2' ' HD3' ' A' ' 6' ' ' PRO . 26.5 t80 -61.52 -55.35 32.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.309 -0.405 . . . . 73.33 110.768 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.2 p -57.3 -39.85 76.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.297 -0.411 . . . . 50.43 111.325 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.502 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 53.9 tp -57.79 -53.98 52.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.4 -0.364 . . . . 65.53 111.469 177.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -51.87 -52.66 48.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.909 0.385 . . . . 71.35 111.673 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.422 HD23 HD21 ' A' ' 87' ' ' LEU . 33.6 tp -63.04 -38.61 91.89 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.193 -0.458 . . . . 74.32 111.3 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.86 -44.19 93.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.293 -0.412 . . . . 71.25 111.793 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 78' ' ' GLY . 20.6 mtm180 -66.95 -40.67 87.59 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.798 0.332 . . . . 75.15 110.927 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -58.64 -42.06 87.42 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.016 0.436 . . . . 73.34 111.402 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -87.29 7.39 28.87 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.354 0.502 . . . . 65.42 112.354 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.71 -42.58 3.14 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.125 -0.559 . . . . 74.31 113.921 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -52.62 -17.5 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 113.647 0.98 . . . . 61.43 113.647 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.568 ' O ' ' HG2' ' A' ' 73' ' ' ARG . . . -135.63 26.38 3.18 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.376 -0.916 . . . . 71.11 114.718 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -40.79 -62.32 0.82 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.104 0.952 . . . . 52.31 111.36 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 11.0 pt-20 -140.57 51.2 1.66 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.918 -0.771 . . . . 72.33 108.918 166.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 5.0 mptp? 71.26 85.0 0.13 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.565 -1.198 . . . . 73.05 111.622 -171.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.415 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 53.3 t30 -72.8 155.9 39.46 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.392 -0.595 . . . . 72.31 109.392 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.65 -93.03 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 112.761 0.652 . . . . 73.01 112.761 -176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.885 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.1 m-20 -78.52 74.86 5.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.572 -0.705 . . . . 60.32 111.945 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.19 139.15 9.86 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.166 -0.54 . . . . 41.41 113.174 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 99' ' ' PHE . 47.7 tp -152.89 127.84 9.64 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.889 0.376 . . . . 34.34 111.131 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.422 HD21 HD23 ' A' ' 71' ' ' LEU . 64.0 tp -117.39 124.55 49.14 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.936 0.398 . . . . 72.3 112.045 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 45.4 tp -111.89 121.55 45.34 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.085 -0.507 . . . . 74.52 110.78 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.8 t -122.93 121.96 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 120.821 0.343 . . . . 75.33 111.82 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' A' ' 97' ' ' VAL . 35.0 tp -96.21 118.46 32.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.173 -0.467 . . . . 71.14 111.282 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.2 t -103.61 100.1 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.634 0.254 . . . . 75.11 111.099 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 63.8 tp -54.01 -40.65 67.19 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.119 0.485 . . . . 73.33 111.474 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.487 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 25.3 t70 -48.38 -30.69 5.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.523 0.729 . . . . 54.12 112.872 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 46.5 mt-30 -125.5 1.56 7.63 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.361 -0.212 . . . . 75.14 111.557 -178.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 9.3 ptp180 47.06 27.15 0.72 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.088 0.955 . . . . 73.14 112.278 -173.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 90.5 mtt180 -117.04 154.59 30.7 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.041 0.448 . . . . 74.22 111.498 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 90' ' ' LEU . 4.1 m -134.32 171.26 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.912 -0.585 . . . . 75.42 111.328 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -152.29 144.42 23.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.831 0.348 . . . . 70.21 111.681 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.697 ' HB3' HD11 ' A' ' 86' ' ' LEU . 77.9 m-85 -104.49 105.58 15.75 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.991 -0.55 . . . . 64.25 110.372 173.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -83.13 112.58 19.95 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.118 -0.364 . . . . 75.5 110.308 177.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 109' ' ' LEU . 1.6 p -88.9 143.36 26.93 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.374 0.879 . . . . 61.51 113.374 -176.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -90.87 -177.97 43.66 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 114.894 -1.048 . . . . 71.52 112.384 168.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -60.93 -25.06 66.51 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.588 0.588 . . . . 74.42 112.588 -175.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.4 -22.85 57.95 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.886 -0.674 . . . . 74.12 113.413 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 86' ' ' LEU . 93.5 mt -108.84 4.77 23.89 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.535 0.569 . . . . 74.55 112.535 -174.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -56.79 -38.63 72.81 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.043 0.449 . . . . 63.41 111.889 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.85 -42.7 10.78 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.317 -0.468 . . . . 70.14 113.382 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -72.07 -41.7 67.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.137 0.494 . . . . 75.52 111.791 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.618 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.0 mt -131.75 83.9 56.21 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 115.974 -0.557 . . . . 74.4 111.991 -170.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.49 155.81 24.82 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.402 2.068 . . . . 60.44 112.365 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.0 -36.2 12.29 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.511 0.56 . . . . 74.32 112.511 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.46 -50.12 69.99 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.126 -0.559 . . . . 74.41 112.912 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.52 -42.71 99.22 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.276 0.56 . . . . 51.4 111.028 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.69 HD13 ' HB2' ' A' ' 99' ' ' PHE . 65.5 mt -62.43 -40.75 97.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.665 -0.698 . . . . 72.31 111.132 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.4 m -71.22 -32.25 68.58 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.178 -0.465 . . . . 75.05 111.419 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -56.02 -55.95 26.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.729 -0.214 . . . . 65.23 111.002 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.7 mt -51.0 -47.11 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.137 0.494 . . . . 52.43 111.031 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.576 ' O ' HG12 ' A' ' 123' ' ' ILE . 61.1 mt -55.97 -51.51 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.8 -0.636 . . . . 64.23 111.615 177.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -81.57 -11.45 59.15 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.944 0.72 . . . . 73.13 112.944 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -86.48 -52.42 5.59 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.788 0.292 . . . . 71.34 111.788 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.99 -39.86 2.06 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.109 0.781 . . . . 74.43 113.109 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.512 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 45.3 mtt -51.52 -52.64 45.23 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.664 0.616 . . . . 71.15 112.664 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.648 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 49.9 mm -53.01 -56.8 19.98 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 111.992 0.367 . . . . 53.43 111.992 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 82.6 Cg_exo -48.09 -47.08 20.35 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.301 2.001 . . . . 63.4 113.328 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -62.97 -49.19 75.68 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.695 0.284 . . . . 73.12 111.637 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.1 m-30 -57.49 -42.31 82.45 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.819 0.303 . . . . 73.52 111.819 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 70.5 mtp180 -66.66 -30.77 71.11 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.999 0.428 . . . . 71.43 111.152 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.9 m -78.08 -14.09 59.62 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.399 -0.364 . . . . 75.12 111.478 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.18 -7.02 62.02 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.292 -0.48 . . . . 64.33 112.473 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.735 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.9 m-20 -79.78 57.01 2.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.866 0.365 . . . . 73.35 111.602 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -61.63 -37.79 85.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.915 0.388 . . . . 71.24 111.322 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.453 ' HB1' ' HG2' ' A' ' 32' ' ' GLN . . . -64.87 -49.83 68.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.164 -0.471 . . . . 62.5 111.376 176.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.735 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 14.6 mp0 -63.03 -35.47 80.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.954 -0.566 . . . . 55.11 111.69 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.91 -55.12 30.1 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.152 -0.547 . . . . 13.33 112.352 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.486 HD11 HD22 ' A' ' 90' ' ' LEU . 89.0 mt -58.64 -38.17 77.52 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.39 -0.477 . . . . 62.34 110.949 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 58.0 m -60.02 -47.54 85.43 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.119 -0.491 . . . . 51.05 112.088 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.19 -36.02 66.47 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.102 -0.374 . . . . 73.0 111.207 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.36 -49.73 75.38 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.31 -0.472 . . . . 61.21 113.031 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 135' ' ' LEU . 53.2 t -53.11 -47.76 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.055 0.455 . . . . 71.34 111.255 175.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.555 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 53.6 tp -62.8 -42.86 99.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.125 -0.489 . . . . 75.32 110.805 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.78 -47.68 84.71 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.962 0.41 . . . . 53.02 111.585 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.82 -47.37 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.331 -0.395 . . . . 64.3 111.246 176.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -56.67 -40.53 75.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.417 -0.356 . . . . 74.3 111.464 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 18.3 mm-40 -53.98 -35.13 61.49 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.195 0.442 . . . . 74.2 112.195 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.98 -42.23 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 120.993 0.425 . . . . 74.0 111.014 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.5 mt -71.08 -44.89 64.79 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.094 0.473 . . . . 74.12 111.218 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.85 -24.02 67.41 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.067 -0.515 . . . . 34.24 111.768 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.46 -5.53 85.88 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.049 -0.596 . . . . 60.41 112.332 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.9 t -104.89 -66.78 0.95 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.018 0.527 . . . . 75.24 111.321 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 87.6 mt 57.76 17.87 4.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.452 0.538 . . . . 62.12 112.452 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -69.29 -22.17 63.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.976 0.362 . . . . 73.31 111.976 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -74.66 93.17 2.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.778 0.323 . . . . 72.02 111.742 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.421 ' CG ' ' N ' ' A' ' 154' ' ' HIS . 45.1 t-80 -91.37 173.66 7.8 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 120.832 0.349 . . . . 75.44 111.109 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.421 ' N ' ' CG ' ' A' ' 153' ' ' HIS . 22.6 t60 -51.16 87.39 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.349 0.66 . . . . 71.31 112.737 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -102.64 -53.08 2.95 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.347 -0.388 . . . . 75.3 110.769 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -70.42 128.58 36.65 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.028 0.442 . . . . 73.13 111.119 177.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.3 p80 . . . . . 0 C--O 1.253 1.262 0 CA-C-N 116.174 -0.466 . . . . 72.25 111.6 -177.937 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.733 0.301 . . . . 74.24 111.572 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 2' ' ' ARG . 19.3 ttt180 -167.43 -46.8 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.349 0.595 . . . . 62.1 111.392 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.3 t 65.82 91.48 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 114.611 -1.177 . . . . 62.12 111.533 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -72.78 157.71 36.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.486 -0.779 . . . . 71.52 112.592 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.748 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 33.8 mmtp -136.58 160.76 65.37 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 114.965 -1.016 . . . . 72.32 109.808 174.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.88 -41.41 63.34 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.396 2.064 . . . . 74.52 112.834 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -86.49 7.65 25.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.979 0.419 . . . . 63.12 111.758 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.748 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 29.8 t70 -106.03 -34.26 7.63 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.166 0.508 . . . . 74.32 110.268 174.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 5' ' ' LYS . 65.1 t -65.89 129.58 94.3 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.675 -0.693 . . . . 75.22 111.503 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.44 123.99 13.84 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.498 2.132 . . . . 75.25 112.497 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -69.67 91.39 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.058 0.456 . . . . 75.53 111.947 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -69.98 -38.37 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.278 -0.419 . . . . 71.13 111.971 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 14.3 mm100 -64.77 170.25 4.35 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.8 -0.562 . . . . 54.31 110.79 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 20.2 mt 73.88 -41.6 0.49 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.423 0.527 . . . . 33.23 112.423 -173.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.09 -62.89 1.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.297 0.48 . . . . 73.52 112.297 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -84.76 32.39 0.52 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.113 0.482 . . . . 61.51 111.715 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -71.42 12.92 0.28 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.549 0.574 . . . . 61.05 112.549 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.2 p -77.47 -42.55 35.41 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.91 0.386 . . . . 44.43 110.974 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.3 ptp85 -98.71 -32.6 11.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.114 -0.494 . . . . 71.34 112.033 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.602 HD21 ' HG3' ' A' ' 44' ' ' ARG . 5.3 mp 62.18 11.98 4.77 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.069 0.396 . . . . 73.24 112.069 -176.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 19' ' ' ARG . 58.6 t -107.07 136.03 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.797 0.332 . . . . 72.52 111.688 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.531 HG22 ' HG2' ' A' ' 24' ' ' GLU . 24.8 m -110.81 106.71 15.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.42 -0.355 . . . . 64.14 110.417 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -95.94 78.01 3.19 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.432 0.634 . . . . 65.13 112.361 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.531 ' HG2' HG22 ' A' ' 22' ' ' THR . 21.0 mm-40 -102.45 -46.65 4.71 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.042 0.449 . . . . 74.45 110.909 176.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.36 -23.74 67.54 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.168 0.433 . . . . 62.0 112.168 174.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.87 33.8 88.04 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.367 -0.444 . . . . 75.53 113.481 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 92' ' ' LEU . 94.3 mt -92.02 12.62 21.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.09 0.404 . . . . 64.15 112.09 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -121.62 125.78 47.5 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.04 0.448 . . . . 75.31 111.472 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.3 t -77.26 172.29 13.51 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.121 -0.491 . . . . 54.45 110.712 173.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -54.72 -47.62 73.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.985 0.422 . . . . 33.34 111.331 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -63.74 -48.28 77.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.41 -0.359 . . . . 51.32 111.533 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -59.69 -42.84 93.87 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.15 0.5 . . . . 63.0 111.339 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -64.84 -47.44 77.94 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.623 -0.717 . . . . 72.33 109.949 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.98 -53.76 54.4 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.168 -0.469 . . . . 74.52 111.982 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 31' ' ' ALA . 99.0 t -54.8 -47.16 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.961 0.41 . . . . 75.45 111.246 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.1 ttm -63.01 -42.97 99.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.442 -0.344 . . . . 74.31 111.227 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -57.09 -48.66 78.06 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.969 0.414 . . . . 74.21 111.094 176.382 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.9 -47.19 90.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.155 -0.475 . . . . 61.43 113.002 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 43' ' ' ILE . 99.6 mtt180 -62.6 -54.84 33.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 111.901 0.334 . . . . 74.34 111.901 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 51' ' ' PHE . 70.9 mt -58.2 -48.17 81.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.868 0.366 . . . . 64.14 111.419 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -58.21 -47.05 84.68 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.331 -0.395 . . . . 62.54 111.098 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.9 -45.11 86.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.195 -0.457 . . . . 70.15 111.339 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.575 HG22 ' HB ' ' A' ' 49' ' ' VAL . 64.3 mt -65.97 -46.32 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.086 0.469 . . . . 71.31 111.274 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.602 ' HG3' HD21 ' A' ' 20' ' ' LEU . 5.5 tmm_? -65.9 -26.04 67.43 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.162 -0.472 . . . . 74.44 111.417 -176.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 t -91.77 -54.54 3.83 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.807 0.337 . . . . 34.33 111.549 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.3 t -67.63 -58.8 4.05 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.307 0.484 . . . . 74.01 112.307 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.49 -11.29 52.15 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.396 -0.365 . . . . 63.01 111.5 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.08 24.04 12.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.905 0.482 . . . . 32.01 111.993 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.575 ' HB ' HG22 ' A' ' 43' ' ' ILE . 90.2 t -96.28 117.28 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.24 -0.436 . . . . 73.24 111.576 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.03 96.16 2.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.082 0.467 . . . . 72.23 110.432 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.427 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -104.44 98.59 8.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.769 -0.65 . . . . 72.04 109.984 -179.063 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -102.52 119.71 39.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.1 0.407 . . . . 72.11 112.1 -175.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.466 HG22 HD23 ' A' ' 88' ' ' LEU . 96.0 t -104.91 110.86 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.282 0.563 . . . . 64.31 111.4 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.441 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 48.4 t -106.55 121.93 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.08 -0.509 . . . . 53.53 111.081 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 p -106.58 121.87 45.17 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.816 0.341 . . . . 74.34 110.92 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -126.4 139.63 35.13 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-O 120.818 0.342 . . . . 74.32 111.553 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.55 -56.68 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.335 2.024 . . . . 51.31 112.86 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.6 p -144.96 139.48 27.57 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 111.933 0.345 . . . . 74.1 111.933 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.612 HG12 HG11 ' A' ' 91' ' ' VAL . 35.3 pt -117.65 -10.84 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 121.112 0.482 . . . . 73.35 110.826 171.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.27 -127.99 32.93 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.177 -0.465 . . . . 50.12 114.04 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.81 -16.62 63.84 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.841 0.682 . . . . 63.23 112.841 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.12 130.6 50.5 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 112.936 0.717 . . . . 43.14 112.936 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.654 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 60.6 Cg_endo -72.0 133.19 21.09 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.747 2.298 . . . . 70.53 112.054 174.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.57 -48.19 82.1 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.934 0.716 . . . . 73.41 112.934 -171.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -67.85 -45.87 73.4 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.117 -0.364 . . . . 73.33 111.918 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.654 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 33.3 m-20 -61.85 -37.85 86.04 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.979 0.418 . . . . 61.01 110.857 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.46 -50.07 75.05 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.125 -0.489 . . . . 72.34 111.042 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 78.0 p -63.14 -48.33 78.91 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.594 -0.275 . . . . 63.33 111.313 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 54.4 tp -54.87 -46.73 74.77 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.097 0.475 . . . . 64.34 111.196 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -54.86 -49.51 70.93 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.003 0.43 . . . . 65.42 111.66 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 tp -67.97 -36.61 80.35 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.054 -0.521 . . . . 74.22 111.639 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 77' ' ' VAL . . . -67.77 -39.94 84.08 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.388 -0.369 . . . . 55.4 111.776 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 41.1 mtp-105 -57.43 -54.23 49.18 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.077 0.399 . . . . 73.55 112.077 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.448 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 12.5 pt20 -64.28 -23.04 67.16 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.347 0.499 . . . . 75.41 112.347 -177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.448 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 40.8 m0 -92.17 -15.29 27.82 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.809 0.3 . . . . 74.51 111.809 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.71 30.03 60.43 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.226 -0.512 . . . . 55.21 113.122 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.636 HG12 ' H ' ' A' ' 78' ' ' GLY . 3.4 t -134.66 179.36 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.0 0.52 . . . . 74.2 109.725 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.636 ' H ' HG12 ' A' ' 77' ' ' VAL . . . 60.11 -120.04 21.03 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.291 -0.48 . . . . 53.43 113.809 173.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.422 ' HB3' ' H ' ' A' ' 80' ' ' GLU . 21.2 m-80 56.86 -159.55 0.24 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.546 0.689 . . . . 73.32 112.218 177.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.422 ' H ' ' HB3' ' A' ' 79' ' ' ASN . 9.6 pt-20 -114.03 14.8 18.44 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.732 -0.667 . . . . 74.15 111.55 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.429 ' N ' ' HD3' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -153.16 16.49 0.55 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.862 1.06 . . . . 71.34 113.862 -177.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.617 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 6.1 m120 -90.49 136.66 32.92 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.312 0.577 . . . . 74.54 112.306 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.434 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.2 OUTLIER -83.65 136.32 34.26 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.382 -0.372 . . . . 62.13 111.631 176.475 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.594 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 2.0 m-20 52.29 21.89 1.82 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.944 0.72 . . . . 61.31 112.944 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.66 129.43 9.89 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.205 -0.521 . . . . 53.4 113.176 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 99' ' ' PHE . 39.8 tp -142.32 119.47 11.43 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.193 0.521 . . . . 75.1 111.441 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.8 tp -107.2 139.88 40.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.368 -0.378 . . . . 73.43 111.279 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD23 HG22 ' A' ' 53' ' ' VAL . 53.5 tp -131.76 114.06 14.29 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.529 -0.305 . . . . 72.23 111.04 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.27 121.51 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.076 0.399 . . . . 63.54 112.076 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 97' ' ' VAL . 24.1 tp -101.37 129.29 47.34 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.173 -0.467 . . . . 73.34 111.223 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.612 HG11 HG12 ' A' ' 59' ' ' ILE . 31.9 t -115.02 99.2 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.92 0.39 . . . . 51.43 111.29 176.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 27' ' ' LEU . 67.1 tp -51.54 -41.23 60.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.162 0.585 . . . . 72.12 112.357 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.22 -43.15 52.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.407 0.683 . . . . 71.14 112.748 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -118.54 8.51 12.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.104 0.409 . . . . 63.32 112.104 -174.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 59.46 20.02 8.41 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.706 1.002 . . . . 73.24 113.706 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -122.17 154.23 37.73 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.669 -0.644 . . . . 73.44 112.194 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.763 HG21 ' SD ' ' A' ' 122' ' ' MET . 6.3 m -129.24 171.39 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.654 -0.703 . . . . 64.33 111.382 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -147.66 130.08 15.76 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.34 -0.391 . . . . 74.03 111.842 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.71 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 93.8 m-85 -90.45 141.95 28.23 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.922 -0.581 . . . . 72.42 109.441 168.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 26.2 tt0 -133.04 112.29 11.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.961 0.41 . . . . 73.45 111.914 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.596 HG23 HD13 ' A' ' 86' ' ' LEU . 17.5 p -106.83 142.02 37.13 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.008 -0.542 . . . . 60.2 111.223 175.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.478 ' HA3' ' H ' ' A' ' 82' ' ' ASN . . . -87.37 -83.98 1.17 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.805 -0.712 . . . . 43.23 113.724 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -137.1 -41.53 0.58 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.004 0.43 . . . . 74.42 111.397 -174.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.594 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -58.52 -39.43 93.11 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.257 -0.429 . . . . 72.34 114.071 -175.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.528 HD11 HG13 ' A' ' 49' ' ' VAL . 93.3 mt -91.97 -2.6 56.66 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.013 0.746 . . . . 74.44 113.013 -174.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -57.64 -21.66 40.99 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.556 0.576 . . . . 73.21 112.556 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.74 -28.58 56.76 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.91 -0.662 . . . . 71.21 112.894 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -109.97 -60.31 1.81 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.898 0.38 . . . . 64.55 111.043 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.443 HD12 HD13 ' A' ' 105' ' ' LEU . 16.3 mt -111.77 88.31 9.53 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.171 0.588 . . . . 61.43 111.563 -178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.16 152.26 18.39 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.969 1.779 . . . . 61.41 112.102 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -47.85 -36.32 11.81 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.685 0.279 . . . . 70.2 111.709 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.17 -49.9 73.52 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.253 -0.499 . . . . 61.42 113.182 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.73 -44.58 96.46 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.259 0.552 . . . . 74.44 111.045 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 66.6 mt -60.54 -44.54 96.0 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.753 -0.658 . . . . 63.21 110.874 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -59.74 -38.29 81.32 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.823 -0.626 . . . . 74.32 110.934 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.4 ttt-85 -60.27 -56.23 24.04 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.068 -0.514 . . . . 61.31 110.947 175.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 60.2 mt -51.01 -39.48 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 120.821 0.343 . . . . 75.33 111.784 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.542 ' O ' HG12 ' A' ' 123' ' ' ILE . 77.6 mt -55.84 -56.17 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.53 -0.305 . . . . 71.53 111.033 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -77.4 -23.59 50.63 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.382 0.512 . . . . 72.12 112.382 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -78.25 -40.31 37.58 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.164 0.431 . . . . 62.32 112.164 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 -126.12 -54.18 1.5 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.262 0.838 . . . . 54.12 113.262 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.763 ' SD ' HG21 ' A' ' 97' ' ' VAL . 38.5 mtt -59.21 -53.65 55.91 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.052 0.76 . . . . 64.44 113.052 -175.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.642 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 mm -53.86 -53.4 58.26 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 111.677 0.251 . . . . 71.02 111.677 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 92.3 Cg_exo -47.68 -48.18 16.45 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 122.287 1.991 . . . . 71.31 113.423 174.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -62.5 -46.96 86.07 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.706 0.262 . . . . 72.1 111.706 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -60.69 -41.33 94.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.738 0.304 . . . . 75.41 111.361 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -63.2 -31.43 72.58 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.045 0.45 . . . . 74.24 111.27 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.2 t -82.87 -18.37 40.54 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.261 -0.427 . . . . 51.14 111.449 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.88 1.92 34.27 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.545 -0.359 . . . . 73.51 113.571 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.9 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 85.7 m-20 -94.07 82.07 4.16 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.411 -0.464 . . . . 73.12 112.152 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -71.53 -53.63 13.18 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.225 -0.297 . . . . 74.21 111.455 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.79 -45.96 85.3 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.093 0.473 . . . . 65.4 111.554 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.9 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 7.1 tp10 -56.21 -53.16 60.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.041 -0.527 . . . . 55.44 111.178 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.87 -43.64 96.52 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.409 -0.424 . . . . 60.04 113.514 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 90' ' ' LEU . 93.8 mt -59.77 -56.48 21.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.03 0.443 . . . . 73.42 111.413 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 30.8 t -56.18 -54.31 46.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.382 0.512 . . . . 52.31 112.382 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -30.25 60.96 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 111.576 0.213 . . . . 74.42 111.576 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.87 -48.0 86.6 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.201 -0.523 . . . . 42.4 112.408 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 135' ' ' LEU . 72.3 t -57.79 -44.94 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.132 0.491 . . . . 74.23 110.606 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.3 tp -58.44 -37.4 75.34 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.953 -0.567 . . . . 61.04 111.391 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.6 97.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.092 0.472 . . . . 55.03 111.173 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.424 HG13 HD22 ' A' ' 109' ' ' LEU . 63.8 t -65.77 -45.93 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.788 -0.642 . . . . 75.24 110.764 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -53.87 -43.33 69.5 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.789 -0.641 . . . . 75.54 111.255 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -52.35 -41.0 62.69 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.277 0.473 . . . . 73.11 112.277 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.11 -36.4 76.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.871 0.367 . . . . 74.13 111.666 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.0 -54.82 24.35 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.601 -0.272 . . . . 74.21 111.324 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -57.47 -32.73 67.27 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.848 0.356 . . . . 73.42 111.948 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.65 -37.84 29.47 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.168 -0.539 . . . . 43.43 113.609 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 78.1 p -75.96 -43.67 43.6 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 122.468 -0.43 . . . . 73.3 111.932 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.6 mt -73.84 22.88 0.08 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.703 0.631 . . . . 51.34 112.703 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -111.09 -9.61 14.37 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.404 0.621 . . . . 64.04 110.417 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -69.81 119.22 13.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.951 -0.568 . . . . 74.01 110.091 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -56.85 83.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.508 0.929 . . . . 73.02 113.508 -171.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -139.88 113.87 8.87 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.4 -0.818 . . . . 73.22 109.34 172.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -87.03 -14.24 42.13 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.678 0.621 . . . . 70.33 112.678 -171.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -79.66 117.6 20.72 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.083 -0.385 . . . . 73.11 111.272 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 . . . . . 0 C--O 1.253 1.278 0 CA-C-O 119.066 -0.492 . . . . 72.42 111.207 177.027 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.7 t . . . . . 0 CA--C 1.543 0.705 0 CA-C-O 121.329 0.585 . . . . 71.35 112.106 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -113.35 144.62 42.45 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.937 -0.574 . . . . 51.41 111.75 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.694 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 9.8 mtmp? -122.29 171.18 6.71 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 115.648 -0.705 . . . . 74.12 109.693 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.694 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 4.4 Cg_endo -45.61 -49.84 10.16 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.769 2.313 . . . . 64.33 113.963 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.79 10.78 10.56 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.421 0.526 . . . . 74.24 112.421 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 5' ' ' LYS . 38.6 m-20 -95.14 -14.86 23.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.082 0.467 . . . . 54.52 110.579 168.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.505 HG22 HD21 ' A' ' 56' ' ' LEU . 38.9 t -89.03 128.67 51.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.085 -0.507 . . . . 75.45 110.453 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.59 118.44 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.225 1.95 . . . . 62.51 112.29 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -63.82 78.48 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.032 0.444 . . . . 61.52 111.759 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ASP . 35.7 m -63.76 -39.45 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 111.981 0.363 . . . . 62.13 111.981 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.448 HE22 ' HG ' ' A' ' 20' ' ' LEU . 27.0 mm-40 -72.93 6.2 2.78 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.907 -0.496 . . . . 64.24 111.941 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.495 ' O ' HD23 ' A' ' 14' ' ' LEU . 8.9 tt -94.75 -20.99 19.03 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.354 0.597 . . . . 74.42 109.773 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.85 -56.0 0.56 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.828 -0.624 . . . . 72.51 111.653 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' VAL . 8.1 m-20 -78.49 77.96 4.96 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.034 0.445 . . . . 73.01 111.925 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.0 p -90.09 -11.22 41.99 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.623 0.249 . . . . 53.14 111.654 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -102.04 -8.85 21.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.822 0.304 . . . . 53.41 111.822 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -99.44 -58.6 1.89 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.975 0.417 . . . . 64.13 110.856 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.448 ' HG ' HE22 ' A' ' 13' ' ' GLN . 5.3 mp 70.03 -16.2 0.3 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.274 0.842 . . . . 71.22 113.274 175.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.3 t -86.0 144.14 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.111 -0.368 . . . . 74.4 111.513 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -145.28 103.12 3.81 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.379 -0.373 . . . . 73.41 111.271 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.428 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 26.1 t70 -103.36 109.63 21.32 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.999 0.428 . . . . 74.1 111.478 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB2' HD23 ' A' ' 56' ' ' LEU . 8.8 mm-40 -111.45 -29.88 7.61 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.089 -0.505 . . . . 70.32 110.708 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.402 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -58.29 -31.46 67.51 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.74 0.644 . . . . 74.24 112.74 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.88 25.77 51.69 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.899 -0.667 . . . . 75.41 112.231 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.507 HD11 HD13 ' A' ' 92' ' ' LEU . 97.8 mt -96.41 -33.61 11.83 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.733 0.302 . . . . 62.41 111.109 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.83 -176.02 5.88 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.183 0.516 . . . . 75.22 111.323 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.0 t -152.69 158.68 42.71 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.787 -0.449 . . . . 64.33 109.787 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -45.06 -48.86 11.8 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.521 0.563 . . . . 73.23 112.521 -173.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -57.51 -55.91 28.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.86 0.362 . . . . 72.44 111.776 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -57.34 -42.73 82.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.991 0.424 . . . . 75.23 111.496 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -64.47 -46.45 83.01 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.122 -0.49 . . . . 60.5 111.533 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 18.9 tp10 -65.53 -41.12 93.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.863 0.363 . . . . 74.31 111.524 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 31' ' ' ALA . 96.6 t -62.4 -39.66 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.116 0.484 . . . . 62.01 110.468 174.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.5 ttm -68.26 -36.86 80.07 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.028 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 34' ' ' GLU . 92.7 m-20 -56.11 -47.23 78.48 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.969 0.414 . . . . 73.02 110.46 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.41 -37.9 92.69 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.04 -0.6 . . . . 71.32 112.786 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 43' ' ' ILE . 66.5 mtt180 -65.95 -54.54 24.96 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.824 0.345 . . . . 63.43 111.251 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.97 -42.72 99.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.858 0.361 . . . . 63.34 111.472 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -61.69 -40.45 95.04 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.334 -0.394 . . . . 54.12 111.292 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.34 92.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.894 0.378 . . . . 73.44 110.981 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.635 HG22 ' HB ' ' A' ' 49' ' ' VAL . 51.5 mt -67.7 -39.39 82.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.085 0.469 . . . . 73.4 110.85 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.451 ' NH1' ' HG2' ' A' ' 50' ' ' GLU . 8.9 tpt180 -59.06 -29.86 67.63 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.762 -0.654 . . . . 54.43 111.407 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.1 t -93.64 -66.48 0.92 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.266 -0.424 . . . . 64.34 111.474 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 t -50.37 -60.95 2.48 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.371 0.508 . . . . 33.51 112.371 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -94.88 -3.1 49.39 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.477 -0.329 . . . . 73.44 111.601 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.83 13.41 7.49 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.364 0.505 . . . . 61.3 112.364 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 43' ' ' ILE . 63.3 t -84.83 128.29 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.334 0.494 . . . . 51.42 112.334 -174.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HG2' ' NH1' ' A' ' 44' ' ' ARG . 29.9 mt-10 -80.2 95.35 6.25 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.066 -0.515 . . . . 61.42 110.026 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -112.81 103.23 11.23 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.868 0.366 . . . . 63.34 110.733 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.85 133.81 49.03 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.19 0.441 . . . . 72.12 112.19 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.59 127.72 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.363 -0.38 . . . . 71.55 111.042 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.0 t -127.64 139.58 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.798 0.332 . . . . 74.43 111.354 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 19.6 p -124.04 130.22 52.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.701 0.286 . . . . 72.51 110.368 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 9' ' ' VAL . 71.7 mt -125.71 142.72 42.88 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-O 120.724 0.297 . . . . 75.54 111.644 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 32.5 Cg_exo -61.89 -49.16 7.22 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.549 2.166 . . . . 70.44 112.175 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.429 ' HA ' ' OD1' ' A' ' 93' ' ' ASP . 46.8 m -155.17 145.8 22.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.235 -0.439 . . . . 70.1 111.733 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.606 HG12 HG11 ' A' ' 91' ' ' VAL . 32.1 pt -112.4 -5.08 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.093 0.473 . . . . 60.42 110.71 170.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.27 -109.95 2.97 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 115.929 -0.578 . . . . 72.35 113.113 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -108.72 2.25 21.69 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.213 0.449 . . . . 53.12 112.213 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.95 140.39 97.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.186 0.439 . . . . 74.12 112.186 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.527 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 47.4 Cg_endo -68.49 121.44 8.38 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.359 2.039 . . . . 73.34 112.266 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.8 tp -58.64 -51.22 70.86 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.849 0.685 . . . . 55.31 112.849 -174.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.409 ' HG2' ' HE ' ' A' ' 98' ' ' ARG . 38.8 mt-10 -62.84 -48.24 79.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.852 0.358 . . . . 72.21 111.58 -178.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.527 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 6.1 m-20 -61.99 -37.48 84.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.698 0.285 . . . . 54.21 111.542 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.479 ' HE2' ' HA ' ' A' ' 5' ' ' LYS . 41.3 t80 -56.06 -53.79 52.82 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.876 0.37 . . . . 71.43 111.358 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.502 HG21 ' HB3' ' A' ' 98' ' ' ARG . 70.3 p -55.0 -46.2 75.15 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.289 -0.414 . . . . 74.12 111.764 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 48.4 tp -58.62 -49.15 78.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.935 0.398 . . . . 52.32 111.357 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.443 ' HE3' ' HG3' ' A' ' 6' ' ' PRO . 29.0 mtpp -57.76 -43.24 85.35 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.798 0.332 . . . . 73.31 111.765 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.497 HD23 HD21 ' A' ' 87' ' ' LEU . 44.6 tp -67.96 -43.58 78.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.137 0.494 . . . . 71.42 111.302 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.45 95.31 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.237 0.458 . . . . 70.52 112.237 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 47.3 mtm180 -63.26 -47.1 83.81 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.147 0.425 . . . . 74.13 112.147 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 6' ' ' PRO . 10.7 pt20 -67.81 -31.49 71.38 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.845 0.355 . . . . 75.0 111.639 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -76.41 -15.35 59.96 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.663 0.268 . . . . 75.11 111.682 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.27 -37.02 3.54 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.192 -0.528 . . . . 64.12 113.0 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 45.1 t . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.518 0.562 . . . . 64.4 112.518 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 41.0 t30 . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 110.262 -0.273 . . . . 72.35 110.262 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.626 HD22 ' N ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -56.35 -98.89 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 112.637 0.606 . . . . 72.03 112.637 -177.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -86.02 81.64 8.41 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.894 -1.128 . . . . 64.52 111.074 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -147.47 142.68 10.43 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.63 -0.714 . . . . 74.42 112.873 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 99' ' ' PHE . 40.2 tp -151.47 128.73 11.23 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.806 0.442 . . . . 61.24 111.084 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.497 HD21 HD23 ' A' ' 71' ' ' LEU . 55.7 tp -109.28 144.29 37.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.948 0.404 . . . . 75.32 111.269 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.0 tp -130.43 125.96 35.79 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.312 -0.404 . . . . 75.21 110.414 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.6 t -127.0 125.09 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.878 0.371 . . . . 75.45 111.895 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.571 HD22 HD11 ' A' ' 135' ' ' LEU . 18.9 tp -101.0 134.1 44.5 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.928 -0.578 . . . . 70.32 110.531 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.606 HG11 HG12 ' A' ' 59' ' ' ILE . 48.2 t -118.92 109.67 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.803 0.335 . . . . 65.32 110.978 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.507 HD13 HD11 ' A' ' 27' ' ' LEU . 67.4 tp -59.49 -44.19 93.12 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.938 0.718 . . . . 74.3 112.938 -174.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' HA ' ' A' ' 58' ' ' SER . 1.2 p-10 -69.12 -17.9 63.9 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.08 0.467 . . . . 75.33 111.478 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -103.86 -18.81 14.49 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.323 -0.399 . . . . 65.01 111.573 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 57.93 27.21 14.37 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.254 0.549 . . . . 64.53 111.688 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -121.61 157.66 30.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.18 0.514 . . . . 62.24 111.653 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.28 158.69 38.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.675 -0.693 . . . . 64.3 110.066 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.502 ' HB3' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -148.59 130.97 15.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.945 0.403 . . . . 74.31 111.262 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.564 ' HB3' HD11 ' A' ' 86' ' ' LEU . 89.1 m-85 -97.12 153.23 18.09 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.124 -0.489 . . . . 72.31 111.246 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -137.23 111.81 8.71 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 122.18 -0.325 . . . . 74.11 110.515 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.408 HG23 HD13 ' A' ' 86' ' ' LEU . 20.4 p -101.11 142.51 32.45 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.341 0.591 . . . . 65.14 111.974 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -75.54 -94.14 0.16 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.816 -0.707 . . . . 75.03 113.008 174.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -147.62 -29.39 0.34 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.174 0.511 . . . . 62.34 111.577 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.28 -12.74 83.95 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.054 -0.593 . . . . 54.13 113.122 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.617 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 96.3 mt -103.85 1.19 31.17 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.113 0.412 . . . . 75.2 112.113 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.27 -23.89 67.62 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.241 0.543 . . . . 62.12 111.22 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.84 7.72 81.36 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.131 -0.486 . . . . 71.43 113.179 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.617 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 29.3 m-85 -133.87 -62.69 0.76 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.301 0.572 . . . . 74.14 111.038 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.31 90.61 14.48 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.563 -0.744 . . . . 73.11 111.991 -174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.6 148.12 41.63 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 121.744 1.63 . . . . 72.1 112.226 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -48.68 -42.65 35.42 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.151 0.426 . . . . 72.51 112.151 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.79 -44.89 95.6 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.107 -0.568 . . . . 52.43 113.13 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 117' ' ' ILE . 64.9 tp -57.71 -50.54 72.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.117 0.484 . . . . 74.4 110.625 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.8 mt -57.77 -38.41 75.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 74.32 111.136 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.7 t -66.33 -38.37 87.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.15 -0.477 . . . . 60.24 110.959 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -65.6 -44.93 85.07 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.6 -0.273 . . . . 73.05 111.13 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 113' ' ' LEU . 74.2 mt -50.96 -35.62 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.078 0.466 . . . . 72.54 111.212 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 122' ' ' MET . 64.6 mt -57.19 -48.46 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.09 -0.504 . . . . 61.32 110.786 174.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.444 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 31.2 m-70 -72.71 -33.82 66.71 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.389 -0.369 . . . . 71.4 111.857 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -72.36 -43.27 64.28 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.264 0.838 . . . . 72.12 113.264 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 137' ' ' GLU . 15.7 mmm180 -118.45 -49.01 2.48 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.805 0.668 . . . . 72.02 112.805 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 13.2 mmt -59.67 -56.28 23.9 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.748 0.647 . . . . 71.35 112.748 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 118' ' ' ILE . 50.5 mm -55.26 -55.21 42.04 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 113.055 0.761 . . . . 74.51 113.055 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 9.8 Cg_endo -52.41 -32.98 54.7 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.282 1.988 . . . . 73.41 113.067 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 86.2 m-70 -79.85 -46.54 16.69 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.57 0.211 . . . . 74.14 111.57 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -56.8 -33.78 67.03 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.853 0.359 . . . . 75.25 111.323 178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 83.2 mtp180 -63.1 -39.44 94.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.028 0.442 . . . . 73.22 111.045 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.4 m -82.12 -11.37 58.79 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.408 -0.36 . . . . 62.1 111.625 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.61 5.47 60.11 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.486 -0.388 . . . . 73.31 112.832 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.75 77.4 9.78 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.877 0.37 . . . . 63.5 111.869 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -66.44 -41.08 89.68 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.002 -0.436 . . . . 74.22 111.514 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.15 87.61 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.023 0.439 . . . . 71.41 111.747 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 16.8 mp0 -63.7 -43.73 95.75 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.355 -0.384 . . . . 73.22 111.181 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.35 -52.96 48.51 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.965 -0.636 . . . . 33.33 112.536 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.571 HD11 HD22 ' A' ' 90' ' ' LEU . 95.9 mt -58.1 -51.65 68.83 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.013 0.375 . . . . 42.45 112.013 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 81.6 p -56.58 -50.78 70.93 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.914 0.339 . . . . 72.44 111.914 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 121' ' ' ARG . 27.2 mt-10 -72.15 -31.64 66.16 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.366 0.506 . . . . 72.23 112.366 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.63 -46.46 93.26 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.323 -0.941 . . . . 22.35 112.1 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 135' ' ' LEU . 98.7 t -63.6 -47.11 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.845 0.355 . . . . 55.31 111.212 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.93 -37.68 80.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.275 -0.42 . . . . 72.3 111.444 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.533 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -60.76 -52.37 65.4 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.923 0.392 . . . . 71.21 110.821 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.0 t -56.69 -46.69 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.36 0.6 . . . . 73.45 110.926 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -53.39 -51.23 63.22 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.651 -0.704 . . . . 71.43 111.692 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -65.59 -31.06 71.89 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.383 0.512 . . . . 64.14 112.383 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 141' ' ' ALA . 95.8 t -58.28 -48.65 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.111 0.482 . . . . 64.23 110.556 174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.79 -49.25 60.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.122 -0.49 . . . . 64.41 110.968 176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 CA--C 1.542 0.647 0 CA-C-N 115.65 -0.705 . . . . 72.43 112.229 -177.032 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.2 t . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 112.812 0.671 . . . . 74.33 112.812 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -116.55 158.73 23.19 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.55 -0.75 . . . . 75.44 110.353 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -127.22 160.44 59.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.61 -0.268 . . . . 74.25 111.292 176.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 57.6 Cg_endo -70.92 64.95 2.5 Favored 'Trans proline' 0 C--N 1.358 1.026 0 C-N-CA 122.458 2.105 . . . . 60.12 111.803 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -174.4 -35.47 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.157 -0.929 . . . . 74.44 110.394 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -71.82 -40.55 69.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.138 0.494 . . . . 60.13 110.693 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.93 126.2 41.98 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.426 -0.806 . . . . 65.32 111.905 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.65 123.06 11.14 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.681 2.254 . . . . 70.53 112.849 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -66.89 87.88 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.207 0.527 . . . . 54.34 111.084 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.452 HG23 HE21 ' A' ' 13' ' ' GLN . 28.0 m -69.71 -21.37 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.583 0.586 . . . . 75.14 112.583 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.594 HE22 ' HG ' ' A' ' 20' ' ' LEU . 27.9 mm-40 -70.11 -35.88 74.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.601 -0.687 . . . . 74.43 110.797 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.59 -33.68 64.74 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.819 -0.628 . . . . 72.34 109.996 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.18 -86.94 0.26 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.926 -0.579 . . . . 54.21 112.343 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.92 77.55 2.03 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.545 0.572 . . . . 72.44 112.545 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.4 t -72.76 -0.8 14.27 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.981 0.419 . . . . 55.05 111.354 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -81.0 -31.77 34.54 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.101 0.408 . . . . 73.44 112.101 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -100.41 -43.84 6.1 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.132 0.419 . . . . 75.2 112.132 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.594 ' HG ' HE22 ' A' ' 13' ' ' GLN . 5.0 mp 64.79 17.97 11.23 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.883 0.473 . . . . 72.52 111.983 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.59 130.71 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 112.106 0.41 . . . . 75.1 112.106 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.8 m -124.49 103.58 8.25 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.383 -0.372 . . . . 71.24 111.175 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 28' ' ' LEU . 27.4 t70 -102.47 109.05 20.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.804 0.335 . . . . 74.53 111.148 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -118.97 -21.96 7.49 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.8 0.333 . . . . 73.24 111.258 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.55 -24.59 67.65 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.019 0.377 . . . . 53.22 112.019 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.39 43.27 16.26 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.272 -0.489 . . . . 64.53 112.727 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.5 mt -115.4 -30.98 6.08 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.356 0.502 . . . . 65.24 112.356 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 23' ' ' ASP . 95.0 mt -75.58 106.68 7.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.006 0.431 . . . . 75.42 111.66 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -73.72 157.18 36.98 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.493 -0.321 . . . . 71.3 110.535 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -51.82 -55.25 21.03 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.032 0.752 . . . . 50.12 113.032 -170.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.07 -38.2 75.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.704 0.288 . . . . 75.14 111.574 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -71.35 -30.28 65.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.795 0.331 . . . . 53.13 111.065 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.87 -51.92 67.62 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.628 -0.26 . . . . 72.02 110.307 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -57.9 -32.87 68.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.745 0.307 . . . . 73.22 111.497 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.489 ' O ' ' HD2' ' A' ' 39' ' ' ARG . 91.5 t -60.0 -53.93 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.083 0.468 . . . . 72.44 110.98 174.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 46.5 ttm -69.87 -49.54 51.34 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.43 -0.35 . . . . 71.02 111.383 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -50.65 -52.49 39.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.726 0.41 . . . . 54.43 110.997 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.77 -43.31 94.65 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 116.211 -0.449 . . . . 61.42 113.174 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.546 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -58.93 -55.59 33.19 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.595 0.236 . . . . 73.0 111.322 177.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 mt -63.51 -47.22 82.58 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.374 0.607 . . . . 61.33 111.318 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -57.63 -47.08 83.19 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.612 -0.722 . . . . 71.22 111.345 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.31 93.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.56 -0.291 . . . . 75.52 111.521 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 39' ' ' ARG . 80.1 mt -60.54 -47.74 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.749 0.309 . . . . 75.24 111.152 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -64.8 -33.34 75.76 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 120.963 0.411 . . . . 73.34 111.217 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.8 t -82.73 -2.09 53.32 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.421 0.629 . . . . 64.32 111.289 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.3 m -130.09 -72.19 0.58 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.059 0.457 . . . . 75.2 111.377 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -79.75 -12.63 59.78 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.152 0.427 . . . . 73.5 112.152 -175.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.85 18.89 11.24 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.914 0.486 . . . . 73.43 112.105 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.752 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 94.2 t -86.0 132.79 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.457 -0.338 . . . . 71.13 111.199 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -86.77 96.29 10.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.222 0.534 . . . . 72.43 110.293 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -114.02 109.47 18.5 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.687 -0.688 . . . . 75.44 110.256 -175.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -117.7 142.77 46.87 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.112 0.412 . . . . 53.42 112.112 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.8 t -123.94 133.65 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.848 0.356 . . . . 75.14 111.39 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.414 HG21 HD21 ' A' ' 71' ' ' LEU . 48.4 t -126.53 137.99 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 122.497 0.319 . . . . 65.41 111.143 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 24.8 p -120.12 123.01 42.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.86 0.362 . . . . 74.33 111.159 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -127.17 147.24 61.01 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 120.629 0.252 . . . . 72.33 111.521 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.06 -57.52 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.372 2.048 . . . . 75.2 112.374 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 25.0 m -145.42 148.65 33.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.41 -0.359 . . . . 53.32 111.248 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.475 HD11 ' NE2' ' A' ' 94' ' ' GLN . 28.7 pt -110.2 -2.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.305 0.574 . . . . 73.34 110.631 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.0 -113.43 5.07 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.66 -0.7 . . . . 61.22 114.329 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.42 1.28 53.85 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.489 0.552 . . . . 75.43 112.489 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.67 141.82 28.82 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 111.799 0.296 . . . . 71.53 111.799 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.76 143.11 18.38 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.858 2.372 . . . . 62.14 112.411 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.24 -51.35 70.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.1 0.407 . . . . 70.24 112.1 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.49 -35.13 79.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.275 0.472 . . . . 75.04 112.275 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.38 -42.24 83.72 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.257 0.551 . . . . 64.53 110.437 175.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.404 ' CD2' ' HD3' ' A' ' 6' ' ' PRO . 24.8 t80 -60.49 -53.38 58.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.737 -0.665 . . . . 71.01 111.884 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.413 HG21 ' HB3' ' A' ' 98' ' ' ARG . 22.0 p -51.12 -48.45 61.75 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.122 0.786 . . . . 61.4 113.122 -174.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 52.5 tp -66.71 -46.51 75.29 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.821 0.344 . . . . 54.32 111.724 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -64.82 -38.14 89.97 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.118 0.414 . . . . 75.21 112.118 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.414 HD21 HG21 ' A' ' 54' ' ' VAL . 63.3 tp -69.26 -40.76 77.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.154 0.502 . . . . 74.01 110.522 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.64 95.57 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.267 0.469 . . . . 73.03 112.267 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 53.8 mtp180 -60.65 -49.54 77.12 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.204 0.446 . . . . 74.24 112.204 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.666 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 11.8 pt20 -66.26 -21.09 66.28 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 120.947 0.404 . . . . 72.23 111.426 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.666 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 22.9 m0 -90.07 7.33 38.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.868 0.366 . . . . 74.41 111.406 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.18 -50.71 4.3 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.308 -0.473 . . . . 71.13 113.5 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 113.377 0.88 . . . . 71.0 113.377 -176.291 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.571 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 37.4 t30 . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 110.102 -0.333 . . . . 70.44 110.102 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.589 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -39.13 -67.13 0.23 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.765 1.024 . . . . 75.11 113.765 -170.11 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.752 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 81.1 m-20 -96.86 25.81 5.04 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.676 -0.64 . . . . 71.34 111.702 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.44 127.54 8.04 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.98 -0.629 . . . . 51.02 113.16 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 53.2 tp -145.05 119.3 9.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.081 0.467 . . . . 71.11 111.052 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.401 HD21 HD23 ' A' ' 71' ' ' LEU . 54.3 tp -117.45 142.08 47.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.883 0.373 . . . . 61.41 111.642 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.6 tp -128.68 118.71 23.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.031 -0.531 . . . . 65.23 110.754 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -113.8 129.43 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.864 0.364 . . . . 60.24 111.969 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.852 HD22 HD11 ' A' ' 135' ' ' LEU . 12.3 tp -102.37 124.09 47.32 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.966 0.506 . . . . 73.23 111.023 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 59' ' ' ILE . 58.3 t -111.82 98.33 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.912 0.387 . . . . 71.43 111.118 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.1 tp -54.5 -40.4 68.51 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.017 -0.538 . . . . 64.34 111.656 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.508 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 14.2 t70 -51.73 -37.46 51.15 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.861 -0.609 . . . . 41.05 112.427 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.475 ' NE2' HD11 ' A' ' 59' ' ' ILE . 49.9 mt-30 -112.87 -6.59 13.79 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.203 0.446 . . . . 73.01 112.203 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.532 ' HG2' ' HE1' ' A' ' 131' ' ' TYR . 99.6 mtt180 57.58 24.28 10.24 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.126 0.489 . . . . 64.54 111.628 -174.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -106.84 147.38 29.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.074 0.464 . . . . 71.33 111.725 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 90' ' ' LEU . 15.3 m -133.53 157.44 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.693 -0.685 . . . . 54.4 110.342 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.413 ' HB3' HG21 ' A' ' 68' ' ' THR . 76.6 ttt-85 -148.44 137.73 21.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.081 0.4 . . . . 75.4 112.081 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 97.1 m-85 -96.08 151.84 19.09 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.975 -0.557 . . . . 74.55 110.628 173.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 9.2 tp10 -138.01 114.53 10.42 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.435 -0.166 . . . . 71.33 110.715 175.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 p -98.06 157.14 16.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.728 0.775 . . . . 60.35 113.076 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -98.54 171.98 25.76 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.172 -0.922 . . . . 74.41 112.153 167.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -51.88 -24.67 6.56 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.991 0.738 . . . . 72.32 112.991 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.424 ' H ' ' HA ' ' A' ' 83' ' ' ASN . . . -80.61 -16.56 75.31 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.905 -0.664 . . . . 72.31 112.951 -174.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.476 HD11 HG13 ' A' ' 49' ' ' VAL . 93.6 mt -108.27 -10.81 15.32 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.366 0.506 . . . . 62.01 112.366 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -49.75 -32.44 13.72 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.675 0.62 . . . . 74.34 112.675 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.76 -22.38 64.21 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.03 -0.605 . . . . 51.35 113.978 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -102.97 -38.62 7.28 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.394 0.616 . . . . 71.41 111.471 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.482 ' HB3' HD21 ' A' ' 114' ' ' LEU . 25.7 mt -127.66 78.1 75.31 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 115.735 -0.666 . . . . 61.03 111.234 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.28 163.31 36.7 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.148 1.898 . . . . 64.42 112.722 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -52.56 -44.88 66.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.253 0.464 . . . . 63.04 112.253 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.62 98.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.259 -0.496 . . . . 54.23 113.169 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 109' ' ' LEU . 58.2 tp -65.39 -49.25 69.98 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 122.441 -0.446 . . . . 65.11 110.955 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 109' ' ' LEU . 91.0 mt -55.62 -44.17 76.8 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.054 0.454 . . . . 54.02 110.842 176.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -60.67 -43.47 97.63 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.937 -0.574 . . . . 64.33 111.102 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -57.52 -53.2 60.8 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.646 -0.252 . . . . 74.5 111.249 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.9 mt -50.82 -40.65 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.955 0.407 . . . . 73.22 111.213 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.687 ' O ' ' HB2' ' A' ' 122' ' ' MET . 77.8 mt -59.09 -44.85 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.03 -0.532 . . . . 73.02 111.248 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -83.23 -22.58 33.06 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.644 -0.66 . . . . 61.22 112.163 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.95 -55.89 3.84 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.532 0.333 . . . . 74.33 111.711 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 25.7 mtp180 -118.63 6.83 11.64 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.106 0.78 . . . . 71.34 113.106 -172.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.687 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 17.0 mmt -108.79 -62.8 1.42 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.025 0.441 . . . . 75.24 111.412 174.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.473 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 28.7 mm -47.33 -53.1 31.3 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 113.907 1.077 . . . . 62.44 113.907 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 13.7 Cg_endo -54.2 -34.5 79.31 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.225 1.95 . . . . 61.42 112.771 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 96.4 m-70 -77.97 -43.1 30.69 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.34 -0.391 . . . . 63.41 111.294 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.7 m-30 -59.75 -42.26 92.85 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.756 0.312 . . . . 74.55 111.258 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -59.3 -35.85 74.52 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.073 0.463 . . . . 73.33 111.247 176.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.2 m -82.77 -16.81 46.46 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.026 -0.534 . . . . 71.25 112.019 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.89 -2.62 52.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.467 -0.397 . . . . 51.35 112.796 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.814 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.3 m-20 -81.78 62.96 5.83 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 122.51 -0.406 . . . . 75.15 111.242 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.532 ' HE1' ' HG2' ' A' ' 95' ' ' ARG . 97.1 m-85 -58.72 -60.45 3.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.296 0.48 . . . . 72.12 112.296 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.475 ' HB1' HD23 ' A' ' 28' ' ' LEU . . . -63.75 -35.46 80.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.957 0.408 . . . . 73.2 111.949 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.814 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 6.9 tp10 -58.59 -50.16 74.83 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.19 0.519 . . . . 75.35 110.845 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.33 -46.83 93.62 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 115.859 -0.61 . . . . 72.43 112.874 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.852 HD11 HD22 ' A' ' 90' ' ' LEU . 85.2 mt -51.44 -48.9 62.58 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.039 0.447 . . . . 75.03 111.293 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.5 m -61.82 -38.4 88.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.084 -0.507 . . . . 72.32 111.506 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 5.3 mm-40 -64.2 -45.87 86.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.732 0.301 . . . . 75.53 111.668 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 142' ' ' VAL . . . -62.8 -46.48 93.55 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.069 -0.586 . . . . 75.45 112.883 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 135' ' ' LEU . 79.1 t -57.77 -48.6 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.065 0.46 . . . . 73.23 111.2 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.26 -41.12 83.58 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.233 -0.439 . . . . 71.52 111.009 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.52 ' HB2' ' HD3' ' A' ' 121' ' ' ARG . . . -59.65 -51.54 69.36 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.158 -0.474 . . . . 71.21 111.309 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 138' ' ' GLY . 97.5 t -56.33 -48.92 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.986 0.422 . . . . 71.51 110.978 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.443 ' OE1' ' HG3' ' A' ' 39' ' ' ARG . 65.0 tt0 -52.92 -44.13 66.78 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.15 -0.477 . . . . 70.33 111.701 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.27 -35.64 81.66 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.398 0.518 . . . . 75.53 112.398 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 141' ' ' ALA . 61.7 t -59.86 -46.31 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.395 0.616 . . . . 72.53 110.581 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.08 -35.75 71.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.783 -0.644 . . . . 52.31 111.17 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 N--CA 1.468 0.431 0 CA-C-N 116.308 -0.405 . . . . 70.3 110.963 -177.118 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 120.936 0.398 . . . . 54.4 111.764 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.413 ' CD1' ' HD2' ' A' ' 57' ' ' PRO . 57.2 m-85 -123.77 139.72 53.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.12 0.486 . . . . 73.22 111.66 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.58 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 34.9 mmtp -106.18 167.07 10.13 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.894 -0.594 . . . . 73.21 109.564 169.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 18.2 Cg_endo -58.58 -16.88 32.14 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.756 1.637 . . . . 63.3 112.307 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 5' ' ' LYS . 10.6 pt-20 -90.56 -16.63 28.42 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.031 -0.531 . . . . 75.1 111.941 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.97 -30.22 21.43 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.958 0.409 . . . . 70.45 111.079 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.39 123.27 85.07 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.038 -0.528 . . . . 74.25 111.741 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.37 117.26 3.46 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.812 2.341 . . . . 72.12 113.23 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.734 ' HB3' ' HB3' ' A' ' 14' ' ' LEU . 80.5 m-20 -68.5 79.16 0.27 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.321 0.489 . . . . 75.43 112.321 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 m -65.92 -53.47 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 111.684 0.253 . . . . 75.4 111.684 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.464 ' NE2' ' HG ' ' A' ' 20' ' ' LEU . 1.5 mp0 -70.45 1.76 4.69 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.75 0.648 . . . . 61.45 112.75 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 8.8 tt -109.15 -40.98 4.8 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.813 0.34 . . . . 64.41 110.759 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.07 -63.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.211 0.449 . . . . 41.21 112.211 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.52 -71.84 0.18 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.069 0.462 . . . . 62.14 111.3 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 m 73.73 -22.61 0.24 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.836 1.051 . . . . 60.42 113.836 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.53 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 9.4 t -82.32 -12.66 57.84 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.483 0.658 . . . . 70.43 110.769 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . 14.7 ptt-85 -126.87 145.19 50.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.614 -0.721 . . . . 70.21 109.186 171.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HG ' ' NE2' ' A' ' 13' ' ' GLN . 5.7 mp -119.47 14.66 12.84 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.85 0.357 . . . . 74.24 111.445 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.61 123.58 68.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.071 0.397 . . . . 74.01 112.071 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.6 m -120.66 102.98 8.77 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.39 -0.368 . . . . 65.11 110.824 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.418 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 25.7 t70 -97.73 103.73 15.69 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.034 0.445 . . . . 61.12 111.366 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB2' HD23 ' A' ' 56' ' ' LEU . 5.3 mm-40 -110.96 -28.42 8.36 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.335 -0.393 . . . . 62.21 111.632 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -64.08 -25.27 68.03 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.004 0.372 . . . . 73.41 112.004 172.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.55 44.58 9.29 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.016 -0.611 . . . . 62.41 112.354 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -115.93 -21.58 9.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.621 0.369 . . . . 54.52 111.593 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.0 mt -96.8 111.17 23.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.778 0.323 . . . . 44.01 111.536 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.5 t -67.55 151.06 47.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.505 0.193 . . . . 45.04 111.081 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -51.2 -42.67 61.06 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.306 0.484 . . . . 51.32 112.306 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.44 -40.03 94.97 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.105 0.479 . . . . 62.4 111.539 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -67.29 -39.95 86.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.872 0.368 . . . . 73.34 110.797 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.59 -42.39 98.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.315 -0.402 . . . . 54.41 111.487 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.05 -53.68 52.78 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.009 0.433 . . . . 74.42 111.107 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.72 -45.29 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.331 -0.395 . . . . 73.14 111.647 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 52.1 ttm -61.14 -47.98 83.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.638 -0.255 . . . . 45.15 111.5 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 56.0 m-80 -60.22 -37.75 81.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.662 0.267 . . . . 63.52 110.997 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.23 95.66 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.917 -0.659 . . . . 73.14 112.882 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.535 ' O ' HG13 ' A' ' 43' ' ' ILE . 98.6 mtt180 -64.0 -55.51 21.81 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.996 0.427 . . . . 65.13 110.872 174.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.85 -49.82 76.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.099 -0.501 . . . . 62.43 112.242 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' A' ' 18' ' ' THR . 30.9 ttp180 -58.09 -40.38 80.96 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.192 -0.458 . . . . 65.14 111.104 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.45 89.5 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.422 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 39' ' ' ARG . 86.4 mt -58.43 -49.45 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.752 0.311 . . . . 73.12 111.627 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 57.2 ttp180 -69.42 -26.84 64.82 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.14 -0.35 . . . . 74.04 111.529 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -82.13 -22.63 36.07 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.858 0.361 . . . . 61.24 111.098 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 m -102.8 -66.08 0.95 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.125 -0.489 . . . . 72.32 111.62 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -84.35 -8.99 58.82 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.302 -0.408 . . . . 71.1 112.017 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 68.54 15.01 9.15 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.939 0.495 . . . . 71.34 112.318 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.74 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 89.3 t -86.22 119.27 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.019 0.438 . . . . 72.34 111.934 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -78.15 96.13 5.1 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 74.34 110.184 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -115.76 106.1 13.48 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.388 -0.369 . . . . 71.44 110.722 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.65 146.63 34.47 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.942 0.401 . . . . 55.1 112.055 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.89 114.79 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.939 0.4 . . . . 65.52 111.284 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.463 ' HB ' HG22 ' A' ' 89' ' ' VAL . 48.7 t -118.88 132.7 68.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.839 0.352 . . . . 62.23 111.492 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.418 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 32.0 p -110.38 125.58 53.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.94 0.4 . . . . 70.41 111.129 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.447 HD23 ' HB2' ' A' ' 24' ' ' GLU . 55.1 mt -131.55 142.16 44.33 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.445 -0.343 . . . . 61.32 110.85 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.645 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 22.5 Cg_exo -64.59 -67.35 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.373 2.049 . . . . 74.12 112.076 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.9 t -133.64 157.74 45.0 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.135 0.493 . . . . 71.41 111.32 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 pt -120.35 9.9 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.915 -0.584 . . . . 65.53 111.078 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.0 -119.62 5.26 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 116.18 -0.464 . . . . 74.43 113.118 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -112.04 3.82 17.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.391 0.276 . . . . 72.35 111.722 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.86 139.14 96.71 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 111.795 0.295 . . . . 65.24 111.795 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.735 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 57.1 Cg_endo -71.07 125.31 11.34 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.354 2.036 . . . . 63.41 111.826 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.463 ' HG ' ' HB2' ' A' ' 98' ' ' ARG . 44.2 tp -56.25 -41.75 76.26 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.509 0.559 . . . . 61.12 112.509 -173.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.07 -35.16 79.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.106 0.479 . . . . 73.24 112.134 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.735 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 5.8 m-20 -86.74 -28.23 23.18 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.109 0.481 . . . . 72.04 111.356 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -57.37 -50.24 73.59 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.924 -0.58 . . . . 72.3 110.782 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 p -58.11 -37.65 74.96 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.769 -0.65 . . . . 65.14 112.049 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -62.25 -38.33 88.87 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 120.708 0.29 . . . . 63.02 111.671 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -66.97 -38.76 86.66 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.92 0.39 . . . . 63.24 111.554 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.551 HD23 HD21 ' A' ' 87' ' ' LEU . 45.5 tp -72.07 -42.61 66.0 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.173 0.511 . . . . 63.24 111.345 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.49 -44.4 95.99 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.302 0.482 . . . . 74.41 112.302 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -68.43 -25.2 64.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.046 0.387 . . . . 74.24 112.046 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -70.66 -42.67 70.5 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.997 0.427 . . . . 72.13 110.828 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -82.04 -15.7 52.69 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.157 -0.474 . . . . 74.04 112.256 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.58 9.37 64.7 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.881 -0.676 . . . . 62.44 112.75 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 t . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 120.869 0.366 . . . . 64.23 110.726 178.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.484 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 45.0 t30 . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 120.517 0.198 . . . . 64.42 111.136 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.579 HD22 ' N ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -62.62 -90.15 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 112.668 0.618 . . . . 74.42 112.668 -177.654 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.74 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.1 m-20 -88.26 32.87 0.75 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.004 -1.06 . . . . 64.14 112.095 -173.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.67 127.72 8.76 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.171 -0.537 . . . . 62.3 113.694 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.6 tp -142.53 119.85 11.57 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.206 0.527 . . . . 72.45 111.042 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.551 HD21 HD23 ' A' ' 71' ' ' LEU . 56.7 tp -114.94 122.25 45.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.335 -0.393 . . . . 73.41 111.453 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.4 tp -111.36 114.04 26.92 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.36 -0.382 . . . . 74.0 111.003 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' A' ' 54' ' ' VAL . 84.5 t -119.06 131.56 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.866 0.365 . . . . 72.0 111.619 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.534 ' HB2' HD21 ' A' ' 135' ' ' LEU . 30.3 tp -106.22 130.74 54.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.362 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.795 HG11 HE21 ' A' ' 94' ' ' GLN . 86.2 t -106.12 109.7 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.372 -0.376 . . . . 71.55 111.101 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 69.0 tp -60.87 -41.01 95.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.131 0.419 . . . . 65.13 112.131 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.09 -47.31 85.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.219 0.533 . . . . 73.31 111.699 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.795 HE21 HG11 ' A' ' 91' ' ' VAL . 45.8 mt-30 -87.44 -15.35 37.96 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.981 -0.554 . . . . 73.01 112.356 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 95' ' ' ARG . 56.0 mtt180 58.99 36.43 24.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.098 0.407 . . . . 74.11 112.098 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -144.74 157.79 44.04 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.955 0.407 . . . . 64.14 111.519 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.551 HG21 ' SD ' ' A' ' 122' ' ' MET . 10.2 m -117.87 171.61 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.244 0.545 . . . . 62.34 112.066 -174.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.463 ' HB2' ' HG ' ' A' ' 64' ' ' LEU . 27.8 tpt180 -136.81 129.04 29.78 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.957 -0.565 . . . . 73.13 111.348 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -103.11 107.89 18.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.184 -0.462 . . . . 63.43 110.391 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -102.43 111.96 24.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.473 0.178 . . . . 64.34 110.897 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 p -103.86 150.36 24.22 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.238 0.542 . . . . 64.13 111.871 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -85.27 -145.0 7.46 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.795 -0.717 . . . . 64.35 112.171 169.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.15 -25.84 21.62 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 122.514 -0.404 . . . . 73.04 111.745 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.9 -28.52 62.55 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.017 -0.611 . . . . 61.24 113.697 -170.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 49' ' ' VAL . 96.9 mt -99.3 -0.67 40.74 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.744 0.646 . . . . 74.43 112.744 -174.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -61.48 -27.21 68.42 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.959 0.409 . . . . 74.35 112.052 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.35 3.6 86.91 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.429 -0.415 . . . . 51.24 113.667 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -126.54 -38.7 2.07 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.072 0.463 . . . . 74.01 111.583 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.516 ' HB3' HD21 ' A' ' 114' ' ' LEU . 17.4 mt -129.82 78.71 74.67 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.892 -0.595 . . . . 72.01 111.61 -171.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.21 151.36 48.97 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.442 2.095 . . . . 75.01 112.168 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -50.41 -35.29 27.76 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.299 0.481 . . . . 74.34 112.299 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.75 -48.95 80.92 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.177 -0.535 . . . . 61.23 112.559 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.0 tp -60.03 -44.98 94.27 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.093 0.473 . . . . 61.11 110.94 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 109' ' ' LEU . 85.4 mt -58.71 -39.17 80.04 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.994 -0.548 . . . . 65.51 111.105 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.8 t -65.28 -39.74 92.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.98 0.419 . . . . 72.32 110.89 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -57.04 -48.73 77.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.911 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.4 mt -53.05 -47.71 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.2 0.524 . . . . 75.24 111.386 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 122' ' ' MET . 67.5 mt -60.09 -55.64 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.008 -0.542 . . . . 54.42 111.697 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.483 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 49.4 m-70 -70.27 -35.4 73.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.036 0.754 . . . . 73.42 113.036 -173.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.15 -38.12 21.08 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.259 0.837 . . . . 64.33 113.259 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.5 ' HD3' ' HB2' ' A' ' 141' ' ' ALA . 35.9 mtp180 -111.74 -33.3 6.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.275 0.843 . . . . 72.04 113.275 -173.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.551 ' SD ' HG21 ' A' ' 97' ' ' VAL . 53.5 mtt -84.41 -54.0 5.07 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.759 0.652 . . . . 73.54 112.759 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.504 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 46.9 mm -48.86 -50.25 62.64 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 113.257 0.836 . . . . 62.54 113.257 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 9.5 Cg_endo -51.98 -46.09 34.56 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 122.221 1.947 . . . . 65.23 112.852 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -70.06 -40.89 74.8 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.859 0.318 . . . . 74.12 111.859 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.0 m-30 -58.43 -41.17 84.43 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.023 0.439 . . . . 74.42 111.292 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -70.69 -39.44 73.49 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.066 0.46 . . . . 72.34 110.798 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.8 t -68.73 -22.36 64.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.156 -0.475 . . . . 73.44 111.569 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.13 -10.19 24.76 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.522 -0.371 . . . . 72.23 113.34 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.747 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 69.4 m-20 -85.57 77.39 9.86 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.503 -0.41 . . . . 63.2 111.707 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -62.58 -41.86 99.21 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.147 0.499 . . . . 65.2 110.945 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.23 -45.91 82.74 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.964 -0.562 . . . . 64.14 111.987 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.747 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 21.1 mm-40 -68.09 -32.39 72.68 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 111.86 0.319 . . . . 72.42 111.86 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 122' ' ' MET . . . -59.38 -44.89 96.26 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.386 -0.912 . . . . 21.34 111.753 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 90' ' ' LEU . 94.2 mt -66.08 -44.4 84.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.877 0.325 . . . . 63.12 111.877 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.8 p -62.5 -38.81 91.36 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.664 0.268 . . . . 72.23 111.191 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -66.14 -41.28 90.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.775 0.321 . . . . 62.45 111.416 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.14 -48.56 85.51 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.842 -0.694 . . . . 53.2 112.58 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 135' ' ' LEU . 89.3 t -56.39 -47.04 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.028 0.442 . . . . 75.42 111.055 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 44.3 tp -60.14 -39.77 87.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.864 -0.607 . . . . 72.13 111.069 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.5 ' HB2' ' HD3' ' A' ' 121' ' ' ARG . . . -61.89 -52.14 65.33 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.874 0.369 . . . . 53.04 111.51 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.85 -45.19 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.091 0.472 . . . . 71.51 110.978 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -54.6 -47.6 73.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.05 -0.523 . . . . 72.42 111.222 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 96.3 mt-30 -56.49 -45.57 80.91 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.394 -0.367 . . . . 74.11 111.757 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ALA . 60.6 t -57.15 -44.79 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.17 0.509 . . . . 73.1 111.285 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.2 -45.51 76.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.118 -0.492 . . . . 75.24 111.607 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 120.825 0.345 . . . . 71.13 111.713 176.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 121.108 0.48 . . . . 74.4 111.241 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.416 ' CD1' ' HD2' ' A' ' 57' ' ' PRO . 39.8 m-85 -91.43 125.32 36.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.213 0.53 . . . . 70.44 111.793 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 9.6 mtmp? -94.96 159.02 34.02 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.898 -0.592 . . . . 74.42 110.187 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 48.0 Cg_endo -66.6 -2.66 7.82 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.229 1.953 . . . . 74.13 113.039 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -107.28 -8.76 16.27 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.211 -0.449 . . . . 74.22 110.93 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.41 -26.89 19.65 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.002 0.43 . . . . 71.11 110.601 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.6 t -57.13 128.13 77.35 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.872 -0.604 . . . . 72.44 111.662 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.85 109.07 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.659 2.24 . . . . 74.41 112.721 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -69.19 77.92 0.35 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.042 0.449 . . . . 63.14 111.236 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 13' ' ' GLN . 28.6 m -67.64 -51.3 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.263 0.468 . . . . 72.12 112.263 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 12' ' ' VAL . 27.9 mm-40 -56.97 -21.2 28.47 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.06 0.393 . . . . 73.52 112.06 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.68 -52.72 34.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.038 0.447 . . . . 63.1 109.967 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.28 -65.79 0.98 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.424 -0.353 . . . . 75.22 111.544 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -98.27 101.79 13.34 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.115 0.483 . . . . 62.13 111.966 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.7 p -82.79 -3.64 56.92 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.164 0.507 . . . . 74.5 110.522 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -78.91 -37.41 39.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.846 -0.616 . . . . 70.23 111.74 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -102.18 125.97 49.02 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.25 0.548 . . . . 61.32 110.527 173.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 20' ' ' LEU . 4.6 mp -109.33 8.62 25.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.274 0.559 . . . . 73.52 110.623 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.8 t -101.37 142.73 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.796 -0.638 . . . . 73.11 111.656 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.2 m -145.42 103.41 3.82 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.456 -0.338 . . . . 70.12 110.865 175.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.496 ' HB2' HD12 ' A' ' 28' ' ' LEU . 28.8 t70 -105.05 96.76 6.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.223 0.535 . . . . 74.05 111.59 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -97.45 -38.45 9.6 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.019 0.437 . . . . 71.31 110.336 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.588 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -57.09 -43.85 82.6 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.483 0.549 . . . . 74.44 112.483 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.19 36.3 6.34 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.03 -0.605 . . . . 65.0 112.301 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 92' ' ' LEU . 86.5 mt -103.6 -15.99 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.847 0.356 . . . . 75.32 111.443 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 23' ' ' ASP . 96.6 mt -90.8 -165.91 1.46 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.162 0.506 . . . . 74.35 111.553 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -161.68 153.52 19.18 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.966 -0.561 . . . . 73.03 110.019 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -47.93 -43.29 28.98 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.279 0.474 . . . . 64.1 112.279 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.14 -49.64 71.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.116 0.484 . . . . 75.21 111.622 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.458 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 12.5 mm-40 -71.33 -38.27 71.68 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.208 -0.451 . . . . 63.0 111.731 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.83 -36.48 84.03 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.044 0.45 . . . . 74.32 111.089 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.52 -54.97 23.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.139 -0.482 . . . . 64.25 110.918 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.8 -43.89 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.082 0.468 . . . . 63.11 111.282 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.423 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.6 ttm -64.22 -49.58 71.4 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.106 -0.497 . . . . 74.12 111.049 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -57.33 -48.17 79.66 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.636 0.255 . . . . 75.41 111.27 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.35 92.13 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.093 -0.575 . . . . 50.55 112.952 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.609 ' NH1' HD13 ' A' ' 140' ' ' LEU . 60.1 mtt180 -70.42 -49.9 44.11 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.983 0.364 . . . . 74.13 111.983 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 36' ' ' MET . 92.6 mt -55.18 -46.96 75.83 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.258 0.551 . . . . 75.44 111.042 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 41' ' ' ARG . 40.9 ttm180 -61.74 -42.77 99.4 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.811 -0.631 . . . . 74.22 110.76 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.05 79.62 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.159 -0.473 . . . . 61.25 111.198 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.562 HG22 ' HB ' ' A' ' 49' ' ' VAL . 81.8 mt -67.79 -41.6 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.052 0.453 . . . . 73.22 110.747 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 44.8 ttt180 -68.01 -27.85 66.91 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.022 0.439 . . . . 70.31 111.2 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.3 t -85.75 -32.22 21.98 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.074 0.464 . . . . 31.12 111.403 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.4 t -82.66 -61.9 1.75 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.079 0.466 . . . . 71.1 111.884 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.422 ' HE1' ' HA ' ' A' ' 147' ' ' ASP . 43.7 m-70 -102.22 -0.39 33.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.876 -0.602 . . . . 75.14 111.602 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.48 10.81 5.13 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.843 0.457 . . . . 62.11 111.892 -176.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.562 ' HB ' HG22 ' A' ' 43' ' ' ILE . 78.6 t -77.38 111.44 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.042 0.449 . . . . 63.42 111.142 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HG2' ' HE ' ' A' ' 44' ' ' ARG . 40.7 mt-10 -82.16 95.92 7.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.676 0.75 . . . . 73.21 110.138 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -107.96 103.11 12.27 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.13 -0.941 . . . . 73.21 111.007 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.66 139.7 38.59 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.403 0.52 . . . . 55.54 112.403 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.5 t -124.08 119.42 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.982 0.42 . . . . 14.44 111.487 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.16 139.11 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.471 -0.331 . . . . 73.45 111.533 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 24.2 p -118.05 126.82 53.02 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.941 0.401 . . . . 73.4 111.015 176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 61.6 mt -125.68 140.95 37.8 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 120.672 0.272 . . . . 51.55 111.633 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.588 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 27.6 Cg_exo -62.89 -61.3 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.698 2.265 . . . . 60.4 113.019 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.449 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 78.2 p -148.17 145.41 28.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.814 0.302 . . . . 65.03 111.814 -176.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.507 HD13 HG21 ' A' ' 91' ' ' VAL . 34.5 pt -127.82 5.02 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.011 0.434 . . . . 72.14 111.593 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.6 -136.52 29.73 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.991 -0.624 . . . . 73.14 113.39 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -87.99 15.58 7.1 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.515 -0.403 . . . . 74.14 111.704 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.3 125.0 91.56 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 120.726 0.298 . . . . 74.44 111.607 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.93 108.84 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.262 1.974 . . . . 74.31 112.249 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.4 tp -57.94 -29.43 65.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.943 0.401 . . . . 72.12 112.042 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 9.3 mp0 -63.66 -32.62 74.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.24 0.543 . . . . 41.2 111.147 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.82 -33.1 16.63 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.457 0.646 . . . . 61.34 110.355 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -52.67 -51.76 58.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.913 0.885 . . . . 73.23 112.051 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.4 p -60.52 -31.21 70.29 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.476 0.547 . . . . 64.45 112.476 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.605 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.5 tp -56.06 -53.71 53.71 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.962 0.41 . . . . 71.42 110.987 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -60.84 -33.3 72.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.991 0.424 . . . . 72.44 112.093 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.503 HD23 HD21 ' A' ' 87' ' ' LEU . 34.3 tp -74.4 -54.95 6.59 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.994 0.426 . . . . 74.14 111.647 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.83 71.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.192 0.442 . . . . 74.43 112.192 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 57.5 mtp180 -64.89 -48.43 74.26 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.028 0.381 . . . . 45.52 112.028 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.567 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 10.5 pt20 -71.27 -25.53 62.49 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.933 0.397 . . . . 73.33 111.161 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.567 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 19.5 m0 -79.59 -4.93 53.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.538 -0.301 . . . . 75.02 111.744 174.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.33 -43.52 2.73 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.26 -0.495 . . . . 70.4 113.425 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 113.4 0.889 . . . . 72.21 113.4 -178.856 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.3 t30 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 121.242 0.544 . . . . 63.31 112.091 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -157.74 -136.57 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.925 -0.579 . . . . 54.41 109.916 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.571 ' HA ' ' HG ' ' A' ' 105' ' ' LEU . 17.0 p-10 -72.64 26.91 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.494 -0.754 . . . . 62.21 112.543 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.21 150.18 25.81 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.616 -0.326 . . . . 34.32 112.533 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HB2' ' CD1' ' A' ' 105' ' ' LEU . 62.3 tp -142.66 127.04 17.72 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.89 0.376 . . . . 75.11 111.156 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.503 HD21 HD23 ' A' ' 71' ' ' LEU . 60.6 tp -108.21 133.78 51.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.844 0.354 . . . . 63.52 111.66 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.44 117.39 22.05 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.073 -0.512 . . . . 54.2 110.814 177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.99 129.83 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.729 0.3 . . . . 71.34 111.766 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.47 134.11 50.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.127 0.571 . . . . 75.32 111.078 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.507 HG21 HD13 ' A' ' 59' ' ' ILE . 87.1 t -118.63 105.3 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.926 0.394 . . . . 55.22 111.262 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 27' ' ' LEU . 68.1 tp -53.76 -39.21 65.18 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.114 -0.494 . . . . 50.12 112.017 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 31.7 t70 -50.77 -32.32 19.45 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.781 0.66 . . . . 74.11 112.781 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -123.67 -3.47 8.26 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.278 0.473 . . . . 71.43 112.278 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 61.25 11.15 3.4 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.398 0.518 . . . . 65.22 112.398 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -97.09 159.86 14.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.054 0.454 . . . . 64.21 111.341 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.692 HG21 ' SD ' ' A' ' 122' ' ' MET . 13.3 m -131.14 172.26 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.985 -0.552 . . . . 60.42 110.525 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -146.39 128.68 15.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.905 0.383 . . . . 64.24 111.639 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -103.97 125.19 50.17 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.692 -0.686 . . . . 73.21 110.434 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -120.21 117.12 27.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.999 0.428 . . . . 74.24 111.175 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.532 HG23 HD11 ' A' ' 114' ' ' LEU . 11.6 p -85.5 155.72 21.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.608 0.718 . . . . 64.54 112.584 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.72 -179.33 36.29 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.4 -0.818 . . . . 64.11 111.844 167.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -63.11 -11.13 17.81 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.874 0.47 . . . . 73.35 112.256 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.15 -32.03 13.17 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.584 -0.341 . . . . 74.24 113.475 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.571 ' HG ' ' HA ' ' A' ' 84' ' ' ASN . 48.1 mt -97.24 -5.04 37.79 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.402 0.89 . . . . 63.22 113.402 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -54.4 -28.63 44.96 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.882 0.697 . . . . 64.01 112.882 -177.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.69 -19.15 71.46 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.238 -0.506 . . . . 64.54 113.822 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -105.82 -40.17 5.81 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.936 0.398 . . . . 65.42 111.91 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.492 ' HB3' HD21 ' A' ' 114' ' ' LEU . 26.8 mt -130.48 88.25 47.75 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.102 -0.499 . . . . 74.22 112.222 -170.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.63 159.25 28.48 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.154 1.903 . . . . 74.25 112.045 172.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -50.46 -36.74 34.9 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.306 0.484 . . . . 72.33 112.306 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.71 -50.14 69.11 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.02 -0.609 . . . . 75.44 112.793 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.29 -43.28 99.14 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.874 0.368 . . . . 74.14 110.988 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.532 HD11 HG23 ' A' ' 101' ' ' THR . 89.6 mt -57.52 -45.09 85.43 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.28 -0.418 . . . . 64.44 110.886 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.2 m -64.4 -34.63 78.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.194 -0.457 . . . . 74.41 111.075 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -62.45 -48.17 80.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.476 -0.329 . . . . 74.11 110.716 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.2 mt -52.37 -45.78 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.338 0.59 . . . . 65.25 110.928 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 122' ' ' MET . 63.6 mt -60.75 -55.82 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.427 -0.806 . . . . 42.41 111.887 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.451 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 10.3 t-80 -75.94 -28.25 57.89 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.721 0.637 . . . . 72.51 112.721 -170.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.97 -49.46 17.64 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.232 0.456 . . . . 55.12 112.232 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -112.21 -44.22 3.44 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.147 0.795 . . . . 71.04 113.147 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.692 ' SD ' HG21 ' A' ' 97' ' ' VAL . 50.8 mtt -62.67 -50.99 69.01 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.524 0.565 . . . . 61.25 112.524 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.575 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 25.7 mm -53.51 -55.54 33.89 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 112.278 0.473 . . . . 63.53 112.278 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.575 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 83.7 Cg_exo -50.22 -46.14 30.15 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 122.15 1.9 . . . . 51.22 113.015 176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 61.0 m-70 -65.41 -49.14 70.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.847 0.314 . . . . 64.24 111.847 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.4 m-30 -61.37 -32.95 72.87 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.894 0.378 . . . . 71.43 111.495 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -69.31 -41.19 77.05 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.97 0.414 . . . . 64.51 110.599 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.0 t -74.24 -21.56 59.72 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.957 0.408 . . . . 63.01 111.661 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 112.16 -4.7 26.96 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.43 -0.414 . . . . 54.42 113.673 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.66 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 79.7 m-20 -83.8 77.49 9.87 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.323 0.49 . . . . 65.42 112.323 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -71.54 -39.48 70.68 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.899 0.38 . . . . 75.44 111.521 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.25 70.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.897 0.38 . . . . 70.44 111.332 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 20.2 mm-40 -61.98 -42.5 99.2 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.146 -0.479 . . . . 73.4 111.542 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.03 -50.64 64.2 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.184 -0.531 . . . . 72.22 112.959 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.54 -41.03 98.48 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.56 -0.377 . . . . 62.33 111.47 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -57.38 -54.76 43.13 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.395 -0.366 . . . . 54.51 111.5 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -68.64 -26.13 65.18 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.248 -0.283 . . . . 62.15 111.607 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.23 -44.8 96.5 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.822 -0.704 . . . . 74.35 112.225 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.68 -49.83 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.007 0.432 . . . . 62.22 110.865 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.609 HD13 ' NH1' ' A' ' 39' ' ' ARG . 54.6 tp -57.69 -41.01 80.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.115 -0.493 . . . . 74.4 111.526 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.43 -51.84 65.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.925 0.393 . . . . 62.14 111.59 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.424 HG13 HD11 ' A' ' 109' ' ' LEU . 86.9 t -60.77 -46.48 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.124 0.488 . . . . 53.11 110.841 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -52.27 -41.09 62.55 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.913 -0.585 . . . . 62.21 111.625 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 98.2 mt-30 -61.15 -48.82 79.85 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.818 0.342 . . . . 72.11 111.325 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.57 -48.29 86.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.185 -0.461 . . . . 73.34 111.657 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 49' ' ' VAL . 81.0 mt -65.21 -56.81 10.69 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.278 -0.419 . . . . 73.0 111.456 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.422 ' HA ' ' HE1' ' A' ' 47' ' ' HIS . 31.2 t70 . . . . . 0 CA--C 1.541 0.634 0 CA-C-N 116.06 -0.518 . . . . 74.51 111.752 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.553 HG22 ' HA3' ' A' ' 60' ' ' GLY . 60.6 t . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 115.005 1.483 . . . . 74.4 115.005 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 58' ' ' SER . 23.1 m-85 -112.61 126.48 55.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.102 -0.499 . . . . 74.34 110.528 169.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -111.38 158.9 34.89 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.178 -0.464 . . . . 74.23 110.906 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -49.44 -40.78 44.7 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.767 2.311 . . . . 65.43 113.799 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -82.78 -5.96 59.18 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.409 0.522 . . . . 72.4 112.409 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.68 -30.39 18.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.244 0.545 . . . . 62.31 110.279 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.3 130.44 93.53 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.886 -0.597 . . . . 74.25 110.832 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.56 118.55 5.47 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.239 1.959 . . . . 71.31 112.652 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.716 HD22 ' HB3' ' A' ' 14' ' ' LEU . 1.0 OUTLIER -61.18 79.9 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.496 0.554 . . . . 64.04 112.496 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.08 -44.45 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.539 0.57 . . . . 73.14 112.539 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -61.25 -15.93 39.97 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.073 0.397 . . . . 64.32 112.073 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.716 ' HB3' HD22 ' A' ' 11' ' ' ASN . 9.6 tt -86.26 -32.83 20.91 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.869 0.366 . . . . 72.34 110.601 176.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -124.72 -70.73 0.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.316 -0.402 . . . . 40.4 111.792 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -77.83 36.24 0.21 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.522 0.564 . . . . 61.32 112.522 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.4 p -70.0 1.84 4.16 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.014 0.435 . . . . 62.44 111.368 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -70.72 -52.81 18.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.837 0.351 . . . . 72.34 111.169 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.624 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 26.8 ptt180 -88.9 -25.78 21.94 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.051 -0.522 . . . . 55.32 111.753 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.61 HD11 ' HE ' ' A' ' 44' ' ' ARG . 5.4 mp 66.61 3.04 2.75 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.996 0.739 . . . . 73.13 112.996 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.624 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 59.5 t -99.63 151.26 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 122.504 0.322 . . . . 55.44 111.617 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -133.07 121.69 23.04 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.479 0.311 . . . . 73.55 110.436 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.87 95.92 5.03 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.147 0.795 . . . . 74.33 113.147 -172.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB2' HD23 ' A' ' 56' ' ' LEU . 6.3 mp0 -102.08 -53.07 3.01 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.247 0.546 . . . . 70.41 110.549 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.45 -28.18 65.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.049 -0.523 . . . . 34.33 111.89 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.01 31.41 79.36 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 116.265 -0.425 . . . . 50.53 113.655 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.2 mt -78.73 -23.67 45.31 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.001 0.429 . . . . 65.22 111.213 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.462 HD23 ' HB1' ' A' ' 132' ' ' ALA . 82.9 mt -80.82 116.24 20.71 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.098 -0.501 . . . . 75.54 111.687 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.8 t -70.64 154.89 41.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 110.159 -0.311 . . . . 62.12 110.159 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -58.89 -32.7 69.74 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.902 0.334 . . . . 72.02 111.902 -175.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.77 -46.92 83.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.313 0.577 . . . . 34.23 110.784 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.87 -38.28 85.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.903 -0.59 . . . . 55.43 111.569 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -64.07 -49.17 73.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.995 -0.282 . . . . 72.15 110.78 172.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.04 -34.57 43.84 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.4 0.619 . . . . 74.51 111.091 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.482 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 45.1 t -82.62 -52.56 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.695 -0.684 . . . . 63.02 111.842 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 48.8 ttm -66.08 -51.67 55.99 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.172 -0.33 . . . . 55.14 111.749 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -52.84 -43.04 65.73 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.107 0.48 . . . . 72.41 110.304 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.39 -43.33 99.48 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.817 -0.629 . . . . 44.43 112.714 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 35' ' ' VAL . 95.0 mtt180 -57.86 -54.93 41.29 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.654 0.264 . . . . 55.14 111.08 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.7 mt -61.87 -45.27 94.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.123 0.487 . . . . 71.13 111.454 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -60.01 -40.55 89.63 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.113 -0.494 . . . . 75.51 111.106 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.46 -44.55 86.85 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.361 -0.382 . . . . 64.51 111.196 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 39' ' ' ARG . 82.1 mt -57.85 -48.3 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.906 0.384 . . . . 74.32 110.809 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.61 ' HE ' HD11 ' A' ' 20' ' ' LEU . 58.3 ttp85 -61.92 -32.48 72.88 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.317 -0.401 . . . . 73.2 111.621 177.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -80.63 -28.37 37.0 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.959 0.355 . . . . 62.31 111.959 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -99.57 -68.68 0.8 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.105 0.409 . . . . 51.43 112.105 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -85.96 -9.95 55.98 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.845 0.313 . . . . 73.45 111.845 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.46 14.14 9.28 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.591 0.589 . . . . 51.53 112.591 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.4 ' HA ' HD21 ' A' ' 84' ' ' ASN . 65.1 t -72.56 133.72 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.026 0.441 . . . . 72.55 111.758 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -86.5 95.87 9.86 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.275 0.56 . . . . 64.35 110.434 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -111.61 105.29 13.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.993 -0.549 . . . . 72.33 110.656 -174.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.95 120.54 40.8 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.208 0.447 . . . . 73.34 112.208 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t -111.15 128.81 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.803 0.335 . . . . 63.44 111.055 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.424 HG21 HD21 ' A' ' 71' ' ' LEU . 44.0 t -128.01 141.31 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 122.403 0.281 . . . . 71.11 111.22 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 p -125.88 120.76 31.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.849 0.357 . . . . 72.12 111.379 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 24' ' ' GLU . 85.2 mt -125.24 135.85 27.41 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-O 120.755 0.312 . . . . 74.14 111.468 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.576 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 72.8 Cg_endo -76.19 -25.23 10.27 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.394 2.063 . . . . 65.32 113.296 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.801 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 32.5 m -155.89 151.93 27.68 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.236 -0.29 . . . . 71.32 111.196 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.507 HD12 ' O ' ' A' ' 62' ' ' ALA . 31.0 pt -125.15 -32.27 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.855 0.36 . . . . 71.42 111.027 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.553 ' HA3' HG22 ' A' ' 3' ' ' VAL . . . 67.16 -116.6 8.21 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.268 -0.491 . . . . 43.12 113.626 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.24 67.36 9.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.612 0.72 . . . . 61.21 111.562 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 59' ' ' ILE . . . -159.42 106.97 1.5 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.509 -0.768 . . . . 61.55 110.808 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 18.2 Cg_endo -57.03 138.86 88.16 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.818 2.345 . . . . 74.21 113.119 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 tp -54.69 -56.1 22.77 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.203 0.816 . . . . 70.32 113.203 -172.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.546 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 23.3 mt-10 -76.25 -9.62 58.77 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.255 0.465 . . . . 73.1 112.255 -173.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.68 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 4.3 m-20 -90.45 -34.55 15.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.96 0.409 . . . . 75.44 110.49 170.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -59.86 -50.51 73.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.678 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.7 p -55.4 -42.68 74.4 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.115 -0.493 . . . . 72.23 111.629 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.46 -54.62 37.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.43 -0.35 . . . . 73.21 111.559 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -61.23 -41.86 97.61 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.021 0.378 . . . . 72.05 112.021 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.424 HD21 HG21 ' A' ' 54' ' ' VAL . 48.7 tp -65.39 -43.62 90.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.248 0.547 . . . . 74.31 110.964 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -67.45 -32.25 72.97 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.849 0.357 . . . . 74.31 111.433 177.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -59.3 -53.84 53.65 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.046 0.388 . . . . 72.45 112.046 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.505 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.1 pt20 -64.54 -31.21 72.33 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.87 0.367 . . . . 61.2 111.734 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.505 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 42.1 m0 -85.97 8.23 21.3 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.027 0.38 . . . . 54.54 112.027 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.96 -49.86 4.17 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 114.385 0.514 . . . . 62.55 114.385 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.528 ' HA ' ' HB3' ' A' ' 82' ' ' ASN . 27.1 m . . . . . 0 CA--C 1.546 0.791 0 N-CA-C 113.162 0.801 . . . . 63.41 113.162 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 32.8 t-20 . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 110.031 -0.359 . . . . 61.31 110.031 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.654 HD22 ' N ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -41.3 -44.95 2.86 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.367 0.877 . . . . 75.55 113.367 -178.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.492 ' H ' ' ND2' ' A' ' 83' ' ' ASN . 9.6 t30 -105.16 17.66 23.68 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.214 0.53 . . . . 71.24 111.905 -172.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.75 140.7 15.16 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.094 -0.574 . . . . 44.24 114.26 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 100' ' ' GLU . 51.7 tp -143.92 134.85 25.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.743 0.417 . . . . 74.12 110.858 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 60.0 tp -125.65 140.28 52.85 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.048 0.452 . . . . 72.2 111.778 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.8 tp -137.35 108.2 6.67 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.96 -0.564 . . . . 63.33 110.493 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.65 124.02 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 111.95 0.352 . . . . 73.05 111.95 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.594 ' HA ' HG12 ' A' ' 97' ' ' VAL . 36.8 tp -95.71 114.91 26.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.288 -0.415 . . . . 60.33 111.075 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 94' ' ' GLN . 95.5 t -100.03 94.15 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 120.899 0.38 . . . . 70.55 111.128 177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 52.8 tp -60.09 -27.61 67.14 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.819 0.342 . . . . 74.12 111.293 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.801 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 16.3 t0 -52.18 -35.13 48.03 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.831 0.824 . . . . 65.42 110.72 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.439 ' NE2' HD11 ' A' ' 59' ' ' ILE . 71.1 mt-30 -120.68 8.8 10.66 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.124 -0.944 . . . . 71.34 110.891 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 36.21 52.25 0.87 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.555 1.142 . . . . 70.15 113.536 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -153.33 162.32 41.41 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.881 -0.6 . . . . 61.2 110.91 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.681 HG21 ' SD ' ' A' ' 122' ' ' MET . 5.5 m -123.8 172.43 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.302 0.572 . . . . 74.24 112.186 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.546 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 65.6 ttt-85 -147.16 138.19 23.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.834 -0.621 . . . . 75.04 111.218 172.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -91.17 151.42 20.96 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.029 0.442 . . . . 74.2 111.083 173.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 17.2 tp10 -137.64 112.58 9.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.288 -0.414 . . . . 70.05 110.595 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.6 p -99.69 136.33 39.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.328 0.585 . . . . 73.13 112.528 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -76.99 -178.89 47.75 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.584 -0.817 . . . . 50.43 112.154 168.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -62.36 -18.69 62.13 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.355 0.872 . . . . 73.02 113.355 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.578 ' N ' ' HA ' ' A' ' 83' ' ' ASN . . . -88.04 -40.71 6.51 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.768 -0.73 . . . . 60.31 112.581 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.639 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 95.0 mt -69.16 -6.73 30.6 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.267 0.469 . . . . 64.41 112.267 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -58.57 -23.98 59.79 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.261 0.553 . . . . 74.32 110.913 173.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.09 22.51 39.05 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.119 -0.491 . . . . 74.41 113.209 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.639 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 68.3 m-85 -141.55 -57.48 0.48 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.264 0.554 . . . . 74.05 110.953 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.9 mt -113.36 91.92 21.31 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.563 -0.744 . . . . 75.51 111.675 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.96 151.73 81.6 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.545 2.163 . . . . 70.11 112.509 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -54.49 -41.62 69.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.949 0.404 . . . . 74.45 111.61 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.59 -47.51 89.69 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.335 -0.459 . . . . 63.0 112.903 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.3 tp -56.12 -50.7 70.36 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.868 0.366 . . . . 74.31 111.056 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.08 -36.34 74.92 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.357 -0.383 . . . . 71.51 111.382 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 m -64.99 -41.3 95.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.397 -0.365 . . . . 73.05 111.095 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -64.35 -44.8 90.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.588 -0.278 . . . . 74.03 111.136 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.8 mt -52.59 -48.1 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.1 0.476 . . . . 72.44 110.682 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.0 mt -61.53 -37.07 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.224 -0.444 . . . . 74.32 111.6 176.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 7.6 t-80 -83.3 -28.41 29.11 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.05 0.759 . . . . 54.02 113.05 -173.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.96 -48.32 4.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.129 0.418 . . . . 72.21 112.129 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.693 ' HA ' ' HE ' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -84.61 -15.33 45.92 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.497 0.554 . . . . 73.14 112.497 -175.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.681 ' SD ' HG21 ' A' ' 97' ' ' VAL . 60.7 mtt -120.79 -54.77 2.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.688 0.996 . . . . 73.21 113.688 -176.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.503 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 12.8 mm -46.38 -54.47 18.08 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.202 0.816 . . . . 72.2 113.202 -175.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.503 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 51.6 Cg_exo -55.28 -34.29 87.9 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.767 1.644 . . . . 71.12 112.572 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 96.0 m-70 -76.05 -50.47 14.68 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.166 -0.47 . . . . 73.44 111.772 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.9 m-30 -56.37 -44.01 79.75 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.832 0.349 . . . . 73.34 111.421 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -61.43 -31.08 71.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.121 0.486 . . . . 72.44 111.127 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -88.4 0.67 55.96 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.002 -0.545 . . . . 74.13 111.747 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.72 -7.41 79.79 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.336 -0.459 . . . . 73.52 113.096 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.825 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 13.2 m120 -75.54 67.69 2.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.757 0.423 . . . . 74.51 111.472 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -67.74 -54.34 20.12 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.066 -0.397 . . . . 72.34 111.65 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.462 ' HB1' HD23 ' A' ' 28' ' ' LEU . . . -61.51 -42.97 99.61 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.976 0.417 . . . . 63.21 111.514 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 1.3 mp0 -58.15 -43.09 87.18 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.234 -0.439 . . . . 54.34 111.259 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.91 99.95 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.148 -0.549 . . . . 75.2 112.437 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.492 HD11 HD22 ' A' ' 90' ' ' LEU . 93.3 mt -59.7 -42.43 92.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.737 0.303 . . . . 71.41 111.129 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.5 t -57.68 -48.75 78.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.524 -0.307 . . . . 73.44 111.26 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 133' ' ' GLU . 35.5 mm-40 -62.15 -43.85 97.92 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.956 0.407 . . . . 64.44 111.057 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.87 -54.2 39.48 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 116.166 -0.47 . . . . 41.13 113.385 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.25 -47.62 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.99 0.424 . . . . 63.53 111.379 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.528 ' HG ' HE21 ' A' ' 144' ' ' GLN . 48.5 tp -61.48 -38.36 87.0 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.187 -0.46 . . . . 65.03 111.047 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -61.37 -50.87 71.16 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.928 0.394 . . . . 71.42 111.263 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.26 -45.91 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.134 0.493 . . . . 71.35 110.818 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -54.82 -43.06 72.62 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.922 -0.581 . . . . 74.13 111.395 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.528 HE21 ' HG ' ' A' ' 140' ' ' LEU . 79.2 mt-30 -62.88 -41.3 99.35 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.704 0.261 . . . . 72.2 111.704 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ALA . 58.0 t -59.35 -50.09 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.858 0.361 . . . . 73.13 111.131 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -58.67 -44.26 90.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.497 0.665 . . . . 72.43 110.464 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 CA--C 1.547 0.83 0 CA-C-N 115.433 -0.803 . . . . 63.15 111.506 177.063 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 CA--C 1.543 0.698 0 N-CA-C 112.448 0.536 . . . . 74.52 112.448 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.424 ' HB2' HD13 ' A' ' 56' ' ' LEU . 21.9 m-85 -90.12 174.16 7.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.757 0.789 . . . . 72.44 112.354 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.557 ' H ' ' HB2' ' A' ' 8' ' ' ASP . 30.6 mmtp -132.31 153.27 81.19 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.924 -1.035 . . . . 74.14 109.404 170.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.446 ' HG2' ' HE3' ' A' ' 70' ' ' LYS . 11.1 Cg_endo -56.47 -29.35 77.64 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 121.898 1.732 . . . . 63.04 112.437 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -83.82 -12.56 55.44 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.168 0.433 . . . . 64.53 112.168 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.557 ' HB2' ' H ' ' A' ' 5' ' ' LYS . 3.0 m-20 -81.97 -27.32 33.29 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.92 0.39 . . . . 73.43 111.366 172.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.62 129.62 91.47 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 116.315 -0.402 . . . . 73.33 111.554 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -52.44 126.94 22.23 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.892 2.395 . . . . 75.1 113.329 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.439 ' C ' HD22 ' A' ' 11' ' ' ASN . 0.2 OUTLIER -71.93 73.2 0.86 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.889 0.375 . . . . 71.23 111.0 -178.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.95 -38.56 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 112.263 0.468 . . . . 74.45 112.263 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.601 HE22 ' HG ' ' A' ' 20' ' ' LEU . 25.5 mm-40 -72.53 74.89 1.06 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.606 0.717 . . . . 71.11 110.825 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt 177.06 -56.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.629 -1.168 . . . . 62.52 108.338 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.08 -47.86 5.61 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.259 -0.882 . . . . 61.22 110.93 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.692 ' HB3' ' HB3' ' A' ' 19' ' ' ARG . 7.8 m-20 -96.57 49.16 1.09 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.776 -0.647 . . . . 72.02 111.79 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.7 m -67.14 -13.8 62.29 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.501 -0.318 . . . . 73.11 111.657 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.6 p -97.87 -3.2 39.13 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.741 0.305 . . . . 72.42 111.489 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.692 ' HB3' ' HB3' ' A' ' 16' ' ' ASP . 78.9 ttt180 -105.21 -56.38 2.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.015 0.436 . . . . 64.35 110.977 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.601 ' HG ' HE22 ' A' ' 13' ' ' GLN . 5.3 mp 69.96 -13.62 0.41 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.731 0.812 . . . . 61.41 113.069 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.3 t -93.43 148.61 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.207 0.527 . . . . 72.04 112.124 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.7 m -143.54 102.61 3.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.2 -0.455 . . . . 71.41 110.591 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.43 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 23.8 t70 -106.1 93.06 4.41 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.292 0.568 . . . . 53.41 111.079 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' HB2' HD23 ' A' ' 56' ' ' LEU . 31.5 mm-40 -94.11 -37.01 11.82 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.957 -0.565 . . . . 65.43 110.841 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.24 -34.11 68.27 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.346 0.499 . . . . 62.23 112.346 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.74 47.29 6.78 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.824 -0.703 . . . . 61.52 112.06 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.7 mt -114.07 -33.32 5.74 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.909 0.385 . . . . 61.31 111.405 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.51 106.15 5.97 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.616 -0.266 . . . . 63.33 110.959 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.5 t -51.77 145.25 9.81 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.375 -0.375 . . . . 54.53 111.193 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -49.54 -30.5 8.59 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.27 0.47 . . . . 63.54 112.27 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -73.58 -51.09 18.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.749 0.309 . . . . 72.22 111.216 175.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -60.98 -42.12 97.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.87 0.367 . . . . 65.44 111.946 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -59.49 -54.18 49.53 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.312 0.577 . . . . 75.14 110.027 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -52.97 -52.61 57.56 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.438 -0.801 . . . . 74.4 112.085 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 31' ' ' ALA . 76.7 t -59.71 -41.99 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.231 -0.441 . . . . 73.33 111.855 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 48.2 ttm -61.34 -42.83 99.32 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.584 -0.28 . . . . 61.44 111.032 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -53.16 -51.94 60.4 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.06 0.457 . . . . 60.21 111.17 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.65 -38.02 93.16 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.166 -0.54 . . . . 44.41 113.242 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 43' ' ' ILE . 99.5 mtt180 -64.87 -54.64 27.76 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.656 -0.32 . . . . 71.14 111.458 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.69 -43.79 93.92 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.037 0.446 . . . . 72.54 111.379 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -57.64 -45.88 84.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.081 -0.509 . . . . 75.2 111.101 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.14 86.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.129 -0.487 . . . . 62.41 111.531 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.7 mt -56.19 -47.65 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.027 0.441 . . . . 65.21 111.375 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.476 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -62.66 -34.58 77.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.183 0.516 . . . . 74.13 110.711 178.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.8 m -89.75 -1.91 58.12 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.132 -0.486 . . . . 62.01 112.134 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.9 p -122.01 -61.87 1.45 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.011 0.434 . . . . 73.43 111.535 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -92.27 -2.18 56.61 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.831 0.348 . . . . 73.14 111.63 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 66.46 11.5 8.08 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.711 0.634 . . . . 71.23 112.711 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 43' ' ' ILE . 62.9 t -80.74 117.47 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.0 0.429 . . . . 72.23 111.619 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' CG ' ' HE ' ' A' ' 44' ' ' ARG . 36.3 mt-10 -78.59 96.58 5.52 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.443 0.639 . . . . 74.32 110.454 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.83 106.89 15.31 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.445 -0.798 . . . . 73.21 110.778 -172.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.98 144.89 40.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.742 0.306 . . . . 53.32 111.789 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.45 128.44 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.745 0.307 . . . . 65.21 111.43 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG21 HD21 ' A' ' 71' ' ' LEU . 58.1 t -129.98 134.97 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 120.708 0.29 . . . . 73.02 111.582 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 39.3 p -120.99 125.32 47.08 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.946 0.403 . . . . 73.43 111.626 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 24' ' ' GLU . 85.1 mt -127.21 145.78 55.52 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-O 120.667 0.27 . . . . 71.2 111.246 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 57.8 Cg_endo -72.16 -45.14 0.69 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.228 1.952 . . . . 54.42 112.997 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.5 m -149.33 137.55 20.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.651 0.262 . . . . 65.54 111.23 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.5 pt -119.28 9.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 121.097 0.475 . . . . 53.54 111.407 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.12 -136.39 32.58 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.292 -0.48 . . . . 32.24 113.082 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -91.4 7.38 41.39 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.603 -0.351 . . . . 74.21 111.478 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . . . -67.74 136.14 92.52 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.12 0.415 . . . . 72.51 112.12 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 62' ' ' ALA . 14.5 Cg_exo -69.59 132.83 24.44 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.586 2.19 . . . . 55.23 112.447 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.7 tp -62.63 -34.31 76.79 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.731 0.301 . . . . 75.54 111.758 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -73.94 -43.17 59.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.012 0.434 . . . . 73.11 111.303 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -61.61 -37.36 83.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.325 0.583 . . . . 74.51 110.149 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -58.79 -60.07 4.42 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.405 -0.816 . . . . 61.34 111.15 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.3 p -55.56 -41.68 73.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.101 -0.5 . . . . 75.2 111.751 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -55.65 -52.29 64.33 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 111.784 0.29 . . . . 74.4 111.784 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HE3' ' HG2' ' A' ' 6' ' ' PRO . 34.7 mtmt -64.92 -46.31 82.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.736 0.303 . . . . 72.4 111.507 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.581 HD21 HG21 ' A' ' 54' ' ' VAL . 40.1 tp -60.88 -42.85 98.74 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.983 0.421 . . . . 64.55 111.201 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.63 -45.88 81.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.275 -0.42 . . . . 61.3 112.048 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -73.76 -24.72 59.9 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.785 0.326 . . . . 73.13 111.743 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -66.62 -40.41 88.78 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.029 0.442 . . . . 55.32 110.886 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 49.5 m0 -93.24 -15.91 25.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.304 -0.407 . . . . 75.24 111.837 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 72.48 44.65 40.5 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.481 -0.39 . . . . 70.35 113.374 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 121.017 0.436 . . . . 65.14 111.711 -177.717 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 112.88 0.696 . . . . 52.42 112.88 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 104' ' ' GLY . 3.9 p-10 -154.55 -151.13 0.34 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.907 0.483 . . . . 73.35 110.209 -173.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -67.95 77.8 0.22 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.815 0.816 . . . . 54.4 111.68 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.52 143.25 12.47 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.338 -0.846 . . . . 64.54 111.47 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.714 HD11 ' HB3' ' A' ' 99' ' ' PHE . 31.3 tp -137.37 123.63 20.56 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.142 0.471 . . . . 72.54 111.591 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 59.5 tp -109.16 122.54 47.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.616 -0.265 . . . . 72.41 111.303 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.6 tp -114.19 111.75 22.05 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.516 0.326 . . . . 73.13 111.22 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.94 127.84 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.781 0.324 . . . . 41.21 111.794 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 135' ' ' LEU . 23.1 tp -104.52 121.86 44.35 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.268 -0.424 . . . . 72.21 111.138 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.43 HG11 ' NE2' ' A' ' 94' ' ' GLN . 48.6 t -104.26 103.82 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.853 -0.158 . . . . 72.34 110.885 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.666 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 65.1 tp -57.34 -36.92 71.76 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.802 0.667 . . . . 71.31 112.802 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -50.99 -56.52 12.08 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 120.744 0.307 . . . . 73.25 111.704 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.62 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 8.4 pm0 -98.33 9.18 43.65 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.87 0.367 . . . . 70.15 111.537 174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.486 ' HB2' ' HE1' ' A' ' 131' ' ' TYR . 40.2 ptt180 35.95 46.43 0.35 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.508 1.123 . . . . 72.31 113.707 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.62 ' HE ' ' HG3' ' A' ' 94' ' ' GLN . 26.8 ptt180 -126.45 154.64 43.41 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.891 0.377 . . . . 65.13 111.15 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.636 HG21 ' SD ' ' A' ' 122' ' ' MET . 5.7 m -122.42 171.18 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.234 -0.439 . . . . 73.03 111.804 -176.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.4 ttt85 -148.63 128.82 13.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.256 -0.429 . . . . 64.43 111.719 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.714 ' HB3' HD11 ' A' ' 86' ' ' LEU . 72.0 m-85 -92.66 118.78 31.4 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.303 -0.408 . . . . 71.21 110.013 170.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 8.1 tp10 -103.93 112.29 25.2 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.542 0.211 . . . . 74.44 111.441 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.591 HG23 HD11 ' A' ' 114' ' ' LEU . 7.7 p -96.31 133.24 40.93 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.141 0.496 . . . . 72.15 111.528 177.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.79 -63.52 2.7 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.953 -0.641 . . . . 73.52 112.518 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -168.59 -53.4 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.918 0.39 . . . . 72.01 111.838 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 83' ' ' ASN . . . -54.15 -31.82 49.59 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 114.699 0.639 . . . . 64.42 114.699 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 64.8 mt -78.82 -10.69 59.87 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.906 0.706 . . . . 71.42 112.906 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -57.54 -31.81 66.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.904 0.383 . . . . 72.42 111.284 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.96 -25.08 75.57 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.075 -0.583 . . . . 43.51 113.326 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -102.1 -67.77 0.86 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.414 -0.462 . . . . 60.13 111.276 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.608 ' HA ' HD23 ' A' ' 113' ' ' LEU . 1.6 mp -120.56 93.42 48.41 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 116.427 -0.351 . . . . 63.41 111.463 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.54 157.97 57.98 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.972 1.781 . . . . 71.12 111.529 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.535 ' HA ' HD12 ' A' ' 114' ' ' LEU . 10.0 p-10 -49.25 -33.78 13.57 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.325 0.491 . . . . 62.1 112.325 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.43 -45.51 96.25 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.956 -0.64 . . . . 53.53 112.991 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.608 HD23 ' HA ' ' A' ' 109' ' ' LEU . 53.0 tp -64.37 -35.41 80.78 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.032 0.444 . . . . 75.43 110.937 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.591 HD11 HG23 ' A' ' 101' ' ' THR . 89.1 mt -59.94 -45.27 93.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.896 0.379 . . . . 51.33 110.894 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.4 m -63.78 -36.34 83.57 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.368 -0.378 . . . . 50.13 111.091 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -55.16 -46.02 75.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.094 -0.503 . . . . 70.44 111.104 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.3 -51.99 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.317 -0.401 . . . . 63.14 111.498 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.2 mt -56.58 -55.69 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.239 0.542 . . . . 72.51 112.193 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.469 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 20.3 t-80 -71.0 -30.92 67.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.694 0.628 . . . . 75.14 112.694 -169.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -88.0 -44.51 10.94 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.385 0.513 . . . . 72.35 112.385 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -98.46 -44.55 6.46 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.687 0.625 . . . . 74.42 112.687 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.636 ' SD ' HG21 ' A' ' 97' ' ' VAL . 47.4 mtt -72.68 -48.57 37.98 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.033 0.753 . . . . 75.53 113.033 -175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.469 ' CG1' ' HA ' ' A' ' 119' ' ' HIS . 29.8 mm -49.79 -55.26 24.61 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 113.185 0.809 . . . . 63.32 113.185 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 16.9 Cg_endo -56.61 -38.67 95.06 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.0 1.8 . . . . 62.54 112.477 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -66.25 -49.39 67.33 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 111.602 0.223 . . . . 63.51 111.602 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.1 m-30 -59.69 -35.84 75.29 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.756 0.313 . . . . 72.12 111.271 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -67.29 -36.27 81.2 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.95 0.405 . . . . 71.44 111.554 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 m -78.1 -22.01 49.61 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.858 0.361 . . . . 72.04 111.588 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.41 0.32 32.93 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.442 -0.409 . . . . 73.34 112.865 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.8 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 83.2 m-20 -82.3 74.27 9.28 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.63 -0.335 . . . . 64.25 111.685 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.486 ' HE1' ' HB2' ' A' ' 95' ' ' ARG . 96.9 m-85 -70.93 -44.42 66.18 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.838 0.351 . . . . 73.41 111.298 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.51 -46.61 85.28 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.963 0.411 . . . . 63.03 111.406 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.8 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 27.3 mm-40 -62.25 -49.38 75.96 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.066 -0.516 . . . . 72.24 111.415 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.67 -51.59 51.46 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.427 -0.416 . . . . 63.43 113.154 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.574 HD11 HD22 ' A' ' 90' ' ' LEU . 78.2 mt -62.07 -43.38 98.96 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.604 -0.351 . . . . 75.21 111.504 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.7 t -57.84 -57.57 12.19 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.252 0.464 . . . . 63.5 112.252 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 140' ' ' LEU . 11.9 pt-20 -76.42 -19.81 57.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.913 0.338 . . . . 72.02 111.913 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.79 -50.37 61.74 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.674 -0.774 . . . . 55.23 111.766 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.6 -44.98 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.044 0.449 . . . . 63.41 110.81 172.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 56.2 tp -59.37 -38.05 79.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.074 -0.512 . . . . 73.42 111.165 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -60.24 -44.8 94.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.801 0.334 . . . . 65.23 111.086 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.431 HG13 HD22 ' A' ' 109' ' ' LEU . 90.7 t -59.27 -52.73 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.106 0.479 . . . . 72.34 110.856 174.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -53.05 -43.67 66.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.913 -0.585 . . . . 65.02 111.888 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 83.6 mm-40 -59.3 -37.93 78.97 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.924 0.342 . . . . 74.4 111.924 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 141' ' ' ALA . 91.5 t -64.23 -35.84 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.064 0.459 . . . . 73.21 111.173 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.25 -57.83 5.96 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.368 -0.378 . . . . 74.15 111.648 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.972 0.415 . . . . 75.34 111.485 177.801 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 112.734 0.642 . . . . 73.11 112.734 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -111.12 126.74 55.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.984 -0.553 . . . . 73.12 111.86 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -105.73 163.89 16.15 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 116.189 -0.459 . . . . 63.22 109.814 171.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 10.0 Cg_endo -51.53 -29.37 31.72 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.566 2.177 . . . . 63.33 114.118 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -82.87 -17.68 42.99 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.438 0.533 . . . . 72.32 112.438 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.88 -34.89 64.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.074 0.464 . . . . 64.13 110.527 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.405 HG22 HD21 ' A' ' 56' ' ' LEU . 64.9 t -64.7 127.05 92.08 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 115.84 -0.618 . . . . 65.44 111.466 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.21 133.0 31.38 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.376 2.05 . . . . 70.55 113.059 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.777 HD22 ' HB2' ' A' ' 14' ' ' LEU . 8.1 t30 -74.54 77.12 1.97 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.37 0.605 . . . . 75.42 110.69 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -59.79 -31.0 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 113.151 0.797 . . . . 73.43 113.151 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.34 -9.03 10.24 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.307 0.484 . . . . 74.11 112.307 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.777 ' HB2' HD22 ' A' ' 11' ' ' ASN . 8.1 tt -76.14 -41.68 49.23 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.209 0.528 . . . . 71.33 110.383 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.89 -51.68 3.36 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.043 -0.526 . . . . 70.44 112.39 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 19' ' ' ARG . 34.5 m-20 -114.85 86.59 2.47 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.017 0.747 . . . . 74.3 113.017 -173.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.4 p -78.89 -6.73 56.87 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.569 0.7 . . . . 75.21 110.398 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -93.06 -0.44 57.1 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.802 -0.636 . . . . 44.22 111.128 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 16' ' ' ASP . 18.4 ttt180 -113.31 -63.09 1.49 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.126 -0.488 . . . . 75.31 111.323 -174.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp 64.62 -0.02 1.04 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.224 0.61 . . . . 54.42 112.489 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.0 t -103.81 130.09 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.067 0.46 . . . . 65.13 111.816 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -125.72 112.59 16.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.972 -0.558 . . . . 73.42 110.094 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.68 100.4 7.59 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.363 0.505 . . . . 64.23 112.363 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.457 ' HB2' HD23 ' A' ' 56' ' ' LEU . 4.5 mp0 -98.54 -37.75 9.43 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.919 0.39 . . . . 75.34 110.937 173.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -57.24 -31.27 65.37 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.74 0.644 . . . . 61.12 112.74 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.44 39.44 8.33 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.836 -0.697 . . . . 61.1 112.328 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.18 -38.43 5.99 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.063 0.459 . . . . 71.54 111.286 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -90.6 98.88 12.04 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.184 0.516 . . . . 75.44 111.362 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.1 m -72.36 173.05 9.27 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.402 -0.363 . . . . 64.44 111.584 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -49.97 -47.3 52.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.29 0.478 . . . . 71.53 112.29 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.44 -47.27 76.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.932 0.396 . . . . 62.13 111.4 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -55.81 -43.63 77.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.198 -0.456 . . . . 53.12 111.132 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.76 -55.08 37.42 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.369 -0.378 . . . . 75.12 111.132 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.7 -38.87 61.37 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.053 0.454 . . . . 63.31 111.848 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.57 -43.0 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.002 0.43 . . . . 63.13 111.615 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 47.0 ttm -73.22 -45.99 52.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.636 0.255 . . . . 55.23 111.16 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -50.76 -42.79 58.01 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.901 0.48 . . . . 60.11 111.031 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.24 -47.55 90.5 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.154 -0.475 . . . . 63.04 113.561 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 43' ' ' ILE . 9.9 ptp180 -74.45 -34.73 63.24 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.439 -0.448 . . . . 74.42 112.064 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.415 HD22 ' O ' ' A' ' 51' ' ' PHE . 89.8 mt -67.91 -41.65 82.32 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.5 0.667 . . . . 72.04 110.487 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -59.13 -39.58 82.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.378 -0.828 . . . . 62.33 110.352 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.42 85.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.944 -0.571 . . . . 74.41 111.422 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 143' ' ' GLN . 77.2 mt -58.45 -51.9 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.155 -0.475 . . . . 74.13 111.735 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 62.7 ttp85 -65.14 -34.01 77.38 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.772 0.32 . . . . 72.32 111.592 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -76.46 -23.59 53.85 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.831 0.348 . . . . 60.3 111.66 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -100.02 -69.9 0.75 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.663 0.246 . . . . 73.12 111.663 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -87.05 -5.6 59.0 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.523 0.564 . . . . 64.43 112.523 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 67.08 19.83 10.42 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.493 0.553 . . . . 54.42 112.493 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.7 t -90.57 133.99 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.695 0.284 . . . . 70.35 111.627 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.3 96.97 10.78 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.072 0.463 . . . . 74.21 110.658 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -103.59 97.97 7.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.783 -0.644 . . . . 74.13 109.759 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.07 141.94 34.97 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.131 0.419 . . . . 74.42 112.131 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.93 123.9 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.454 -0.339 . . . . 71.22 111.119 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -121.61 136.01 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.399 0.28 . . . . 72.42 111.391 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -120.5 123.75 43.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.912 0.386 . . . . 72.11 111.432 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 24' ' ' GLU . 76.3 mt -124.15 145.36 48.11 Favored Pre-proline 0 N--CA 1.471 0.625 0 O-C-N 122.164 -0.335 . . . . 71.42 111.792 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 27.9 Cg_exo -63.11 -55.99 0.66 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.739 2.293 . . . . 72.45 112.542 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.6 m -150.78 148.58 28.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.758 0.314 . . . . 73.22 111.394 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 91' ' ' VAL . 24.4 pt -118.24 -6.65 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 120.956 0.408 . . . . 74.25 111.777 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.53 -116.18 8.43 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.535 -0.364 . . . . 62.02 113.841 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.3 -13.12 53.31 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.713 0.292 . . . . 73.23 111.761 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -65.49 124.83 88.29 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.606 -0.27 . . . . 64.12 111.329 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.3 Cg_endo -80.14 131.71 8.95 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.427 2.084 . . . . 73.13 112.607 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 96' ' ' ARG . 61.4 tp -59.33 -42.28 91.08 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.422 0.527 . . . . 64.34 112.422 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 8.6 mp0 -60.1 -44.29 94.96 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.031 0.443 . . . . 54.45 111.493 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 6.0 m-20 -74.48 -33.19 62.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.957 0.408 . . . . 75.35 110.809 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.44 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 37.3 t80 -56.6 -55.35 35.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.298 -0.41 . . . . 74.31 111.383 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.9 p -54.69 -46.07 74.06 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.285 -0.416 . . . . 74.34 111.66 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.569 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.0 tp -59.2 -54.59 45.19 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.375 -0.375 . . . . 75.4 111.327 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -58.94 -44.22 91.37 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.107 0.41 . . . . 72.15 112.107 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.598 HD23 HD21 ' A' ' 87' ' ' LEU . 54.7 tp -62.42 -45.35 93.5 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.156 0.503 . . . . 74.35 110.926 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.68 -35.99 81.45 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.905 0.384 . . . . 42.02 111.792 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 78.4 mtp180 -61.67 -53.98 48.93 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.511 -0.313 . . . . 53.25 111.595 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.503 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 10.3 pt20 -64.87 -33.73 76.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 111.987 0.366 . . . . 74.22 111.987 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.503 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 26.9 m0 -74.28 -4.48 36.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.929 0.395 . . . . 74.15 111.956 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.33 -1.01 72.64 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.277 -0.487 . . . . 75.42 113.414 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.402 ' HA ' ' ND2' ' A' ' 82' ' ' ASN . 4.4 t . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 121.291 0.567 . . . . 73.4 110.937 -177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.66 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 25.3 t-20 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 110.201 -0.296 . . . . 75.51 110.201 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.677 HD22 ' N ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -36.43 -63.65 0.38 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 113.958 1.096 . . . . 63.11 113.958 -176.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.582 ' H ' ' ND2' ' A' ' 83' ' ' ASN . 2.9 p-10 -94.5 35.16 1.23 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.861 -0.524 . . . . 71.31 111.864 -176.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.4 139.2 15.45 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.136 -0.554 . . . . 73.54 113.933 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 46.6 tp -149.98 122.93 8.76 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.009 0.433 . . . . 74.1 110.846 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.598 HD21 HD23 ' A' ' 71' ' ' LEU . 62.9 tp -122.95 131.79 53.87 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.937 0.399 . . . . 53.4 111.924 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.7 tp -121.35 117.3 26.61 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.146 -0.479 . . . . 72.25 110.889 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.22 124.73 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.943 0.402 . . . . 73.35 111.852 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.524 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.2 tp -103.47 118.59 37.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.056 -0.52 . . . . 74.01 111.007 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 59' ' ' ILE . 57.6 t -99.41 101.22 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.539 -0.3 . . . . 73.45 110.868 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.2 tp -48.93 -46.49 43.21 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.857 0.463 . . . . 72.41 111.994 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -45.27 -48.36 12.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.973 0.731 . . . . 73.11 112.973 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -111.15 4.58 19.42 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.18 0.437 . . . . 75.34 112.18 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 43.52 26.06 0.1 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.331 1.052 . . . . 63.12 113.467 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HG3' HD22 ' A' ' 64' ' ' LEU . 11.0 ptm85 -105.02 152.25 22.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.922 0.392 . . . . 73.54 111.042 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 90' ' ' LEU . 3.4 m -136.63 165.86 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.177 -0.465 . . . . 64.45 110.771 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -149.63 135.32 18.56 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.797 0.332 . . . . 73.33 111.61 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.55 ' HB2' HD13 ' A' ' 114' ' ' LEU . 80.8 m-85 -93.86 102.35 14.47 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.102 -0.499 . . . . 64.23 110.024 172.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -81.87 111.37 18.01 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 110.329 -0.249 . . . . 42.55 110.329 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.9 p -93.15 141.01 28.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.578 0.704 . . . . 60.0 112.581 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -84.37 166.81 42.37 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.676 -0.774 . . . . 70.44 111.743 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -54.28 -19.63 5.67 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.16 0.8 . . . . 75.55 113.16 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.548 ' N ' ' HA ' ' A' ' 83' ' ' ASN . . . -85.11 -20.52 57.25 Favored Glycine 0 N--CA 1.463 0.462 0 C-N-CA 120.815 -0.707 . . . . 50.2 112.805 -173.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.41 -4.3 29.27 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.351 0.26 . . . . 72.13 111.587 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -51.59 -39.95 58.91 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.269 0.47 . . . . 74.44 112.269 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.43 -12.51 58.76 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.225 -0.512 . . . . 53.14 114.113 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -118.38 -48.65 2.5 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.066 0.46 . . . . 70.23 111.7 -176.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.57 ' HB3' HD21 ' A' ' 114' ' ' LEU . 30.8 mt -118.02 86.44 25.81 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.92 -0.582 . . . . 72.53 112.296 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 88.9 Cg_endo -82.84 158.55 15.97 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.27 1.98 . . . . 74.13 112.398 172.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.45 -35.21 8.23 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.908 0.336 . . . . 71.23 111.908 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.27 -51.03 59.42 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.107 -0.568 . . . . 65.53 113.122 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 64.9 tp -62.73 -45.87 90.7 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.073 0.464 . . . . 71.13 110.674 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 109' ' ' LEU . 67.7 mt -59.22 -38.46 80.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.936 -0.575 . . . . 73.24 110.972 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.5 t -61.81 -40.14 94.21 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.174 -0.467 . . . . 61.21 110.942 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.45 -48.76 76.37 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.935 -0.306 . . . . 72.33 110.901 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.2 mt -50.71 -45.66 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.099 0.476 . . . . 74.1 110.908 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.538 ' O ' HG12 ' A' ' 123' ' ' ILE . 68.2 mt -64.9 -56.83 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.01 -0.541 . . . . 72.31 112.189 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -76.02 -34.37 59.68 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.602 0.964 . . . . 52.23 113.602 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.25 -32.59 33.27 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.858 0.361 . . . . 75.31 111.716 -171.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -123.57 -56.19 1.7 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.286 0.476 . . . . 71.34 112.286 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 91.4 mtp -64.06 -43.86 94.2 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.554 0.946 . . . . 74.31 113.554 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 118' ' ' ILE . 38.2 mm -57.54 -50.29 88.96 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 112.18 0.437 . . . . 74.12 112.18 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 86.9 Cg_exo -45.0 -44.7 14.77 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.204 1.936 . . . . 74.11 112.948 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -64.1 -51.9 61.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.614 -0.266 . . . . 72.1 111.535 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -56.95 -39.78 75.2 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.781 0.324 . . . . 74.25 111.664 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -67.44 -36.02 80.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.218 0.532 . . . . 63.34 110.994 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.5 t -74.28 -16.83 60.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.25 -0.432 . . . . 65.34 111.067 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.31 53.2 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 116.283 -0.417 . . . . 70.41 112.659 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.92 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 94.8 m-20 -81.31 72.0 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.052 0.454 . . . . 62.14 111.966 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -67.07 -45.65 76.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.825 0.345 . . . . 73.51 111.079 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.58 -47.33 67.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.05 0.452 . . . . 71.12 111.357 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.92 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 11.3 tp10 -59.75 -41.27 90.61 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.032 -0.531 . . . . 61.1 110.721 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.77 -53.96 34.42 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.831 -0.622 . . . . 63.35 113.258 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.2 -44.81 71.91 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 122.462 -0.434 . . . . 72.35 111.348 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.2 t -56.01 -51.67 66.95 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.231 0.456 . . . . 75.41 112.231 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -34.6 62.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.628 0.232 . . . . 73.51 111.628 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.82 -48.15 87.48 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.111 -0.566 . . . . 51.25 112.378 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.72 -43.74 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.17 0.51 . . . . 51.35 110.932 173.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.95 -38.97 87.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.971 -0.559 . . . . 74.42 110.795 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.3 96.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.095 0.474 . . . . 51.5 111.045 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.47 -51.43 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.139 -0.482 . . . . 74.11 111.427 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.487 ' HB2' HD11 ' A' ' 43' ' ' ILE . 10.2 tt0 -54.18 -40.19 67.3 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 121.128 -0.229 . . . . 71.45 111.536 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -57.29 -43.42 83.17 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.83 0.307 . . . . 74.52 111.83 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.79 -51.12 76.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.902 0.382 . . . . 43.22 111.15 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.62 -46.51 88.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.184 0.516 . . . . 73.13 111.079 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 CA--C 1.544 0.723 0 CA-C-N 115.783 -0.644 . . . . 54.1 111.263 177.406 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 121.061 0.458 . . . . 60.04 112.038 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -93.01 134.51 35.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.422 0.527 . . . . 75.12 112.422 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 1.3 mptm? -107.52 163.3 17.24 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.148 -0.478 . . . . 72.11 110.124 169.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 13.6 Cg_endo -54.87 -26.64 49.4 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.176 1.918 . . . . 72.52 112.716 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.44 -29.49 59.7 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.385 -0.371 . . . . 73.34 111.933 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.63 -29.65 56.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.929 0.395 . . . . 74.24 111.585 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.63 HG13 HG21 ' A' ' 22' ' ' THR . 50.5 t -62.87 127.55 90.77 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 116.185 -0.461 . . . . 64.52 111.494 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.64 130.39 31.37 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.66 2.24 . . . . 73.15 112.949 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -69.8 76.65 0.46 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.242 0.544 . . . . 43.32 112.045 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 m -58.29 -49.56 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.482 0.549 . . . . 73.14 112.482 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -60.89 -17.91 53.35 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.837 -0.54 . . . . 70.21 112.054 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.66 -52.33 5.6 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.869 0.366 . . . . 75.2 110.21 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.99 -75.84 0.49 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.526 -0.306 . . . . 63.14 111.703 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.92 48.76 0.61 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.47 0.545 . . . . 73.31 112.47 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 82.9 p -63.84 -9.21 13.69 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.963 0.411 . . . . 53.21 111.344 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -89.86 -26.08 20.69 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.085 -0.507 . . . . 74.31 111.374 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 21' ' ' VAL . 12.3 ttm180 -85.03 -45.1 12.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.913 0.387 . . . . 71.23 110.864 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.5 mp 59.15 15.12 3.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.484 0.713 . . . . 62.12 112.382 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.54 ' O ' ' HD2' ' A' ' 19' ' ' ARG . 88.0 t -129.39 126.1 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.965 0.412 . . . . 72.15 111.696 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.63 HG21 HG13 ' A' ' 9' ' ' VAL . 86.7 m -99.66 102.93 14.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.915 0.388 . . . . 71.42 110.11 173.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.98 98.18 8.67 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.371 0.605 . . . . 60.11 111.886 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -126.46 -30.85 2.81 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.835 0.35 . . . . 64.13 111.325 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . -59.11 -19.54 45.44 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 111.708 0.262 . . . . 54.34 111.708 171.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.74 40.02 98.22 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.505 -0.378 . . . . 55.34 113.697 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.1 mt -105.39 -2.73 23.48 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.083 0.401 . . . . 65.21 112.083 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.87 -175.1 2.79 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.931 0.396 . . . . 53.42 111.907 -176.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.9 t -158.79 170.4 22.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.665 0.386 . . . . 71.43 110.484 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -44.68 -45.33 9.69 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.956 0.725 . . . . 71.32 112.956 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -70.14 -55.95 8.09 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.288 -0.257 . . . . 64.43 111.632 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -55.59 -45.87 77.35 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 111.847 0.314 . . . . 74.24 111.847 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.68 -54.9 36.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.422 -0.354 . . . . 71.32 111.085 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.98 -41.27 82.65 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.178 0.436 . . . . 73.11 112.178 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.483 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 90.9 t -64.51 -50.06 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.887 0.375 . . . . 72.32 110.807 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.406 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.1 ttm -60.51 -43.7 96.79 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.532 -0.304 . . . . 42.22 111.478 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.48 -44.63 89.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.882 0.372 . . . . 63.55 111.011 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.88 -44.59 97.21 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.172 -0.537 . . . . 35.4 112.716 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.541 ' O ' HG13 ' A' ' 43' ' ' ILE . 5.8 mmp_? -55.34 -55.41 31.9 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.006 0.431 . . . . 71.41 110.96 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB3' HD22 ' A' ' 20' ' ' LEU . 87.7 mt -60.59 -44.39 96.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.032 -0.531 . . . . 64.05 111.891 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -63.16 -39.41 94.58 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.725 0.297 . . . . 75.12 110.863 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.93 -42.48 98.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.949 0.404 . . . . 74.32 111.017 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.3 mt -57.63 -47.18 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.014 -0.539 . . . . 72.1 111.453 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 14.4 ptm180 -77.67 -24.95 49.21 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.959 -0.463 . . . . 72.44 111.927 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.4 t -70.06 -35.5 74.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.945 0.402 . . . . 62.02 111.027 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.1 t -95.7 -56.43 2.68 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.132 -0.486 . . . . 73.24 112.215 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -98.44 -12.64 21.15 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.302 0.482 . . . . 73.0 112.302 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.36 20.85 11.88 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.518 0.562 . . . . 71.11 112.518 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 43' ' ' ILE . 92.7 t -81.79 125.55 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.0 0.428 . . . . 75.24 111.129 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -84.34 97.15 9.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.276 0.56 . . . . 73.24 110.662 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.408 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -106.59 105.3 15.26 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.392 -0.822 . . . . 74.44 110.647 -173.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.22 117.11 33.44 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.146 0.424 . . . . 44.41 112.146 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.55 112.54 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.164 0.507 . . . . 61.3 111.502 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 58.1 t -107.56 143.26 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 122.912 0.485 . . . . 64.24 111.463 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 49.8 p -133.81 122.52 23.37 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.718 0.294 . . . . 74.04 110.893 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -127.71 141.8 42.19 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 120.561 0.219 . . . . 74.14 111.295 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.76 -48.23 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.506 2.138 . . . . 62.14 113.062 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.935 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 67.6 p -155.78 145.02 20.78 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.021 0.378 . . . . 72.03 112.021 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 pt -123.86 -3.49 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.749 0.309 . . . . 73.12 111.494 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.42 47.22 6.99 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.219 -0.515 . . . . 23.35 113.169 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 56.96 20.35 5.29 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.174 0.435 . . . . 74.34 112.174 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.95 151.65 97.16 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.396 -0.365 . . . . 54.25 111.834 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 29.4 Cg_endo -60.59 117.32 4.07 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.841 2.361 . . . . 73.24 113.14 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.82 -51.83 65.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.868 0.692 . . . . 74.11 112.868 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -31.71 72.67 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.125 0.488 . . . . 74.33 111.588 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 63' ' ' PRO . 10.4 t70 -68.84 -34.8 76.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.205 0.526 . . . . 75.5 110.835 173.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -65.91 -55.94 14.32 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.859 -0.61 . . . . 74.15 110.892 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.5 p -56.97 -42.81 80.85 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.226 -0.443 . . . . 73.41 111.813 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.8 tp -53.03 -53.09 55.37 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.924 0.392 . . . . 73.45 111.953 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.631 ' HG2' HH21 ' A' ' 73' ' ' ARG . 37.8 mtmm -71.33 -36.88 71.7 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.314 0.487 . . . . 75.21 112.314 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.7 tp -65.85 -37.59 86.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.201 0.524 . . . . 75.11 111.257 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.74 84.12 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.297 -0.41 . . . . 74.33 111.616 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.631 HH21 ' HG2' ' A' ' 70' ' ' LYS . 41.3 mtm105 -58.91 -49.66 76.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.272 0.471 . . . . 62.33 112.272 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.467 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 11.7 pt20 -64.63 -15.27 60.96 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.135 0.42 . . . . 71.2 112.135 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.467 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 45.5 m0 -103.4 14.88 30.44 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.776 0.322 . . . . 75.15 111.543 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.37 -53.32 4.65 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.113 -0.565 . . . . 64.21 113.651 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.522 ' HA ' ' HB3' ' A' ' 82' ' ' ASN . 31.0 m . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 113.505 0.928 . . . . 72.5 113.505 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.549 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 42.5 t30 . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 120.76 0.314 . . . . 73.5 111.027 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.615 HD22 ' N ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -41.07 -60.65 1.16 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.2 1.185 . . . . 74.24 114.2 -171.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.607 ' H ' ' ND2' ' A' ' 83' ' ' ASN . 4.8 p-10 -95.04 24.27 4.99 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.044 -0.41 . . . . 62.43 112.034 -174.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.16 137.6 13.52 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.027 -0.606 . . . . 72.3 113.549 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 99' ' ' PHE . 49.1 tp -144.53 119.96 10.31 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.015 0.436 . . . . 74.14 111.246 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 63.1 tp -109.32 141.47 41.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.944 0.402 . . . . 70.44 111.363 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.1 tp -129.7 127.79 41.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.378 -0.374 . . . . 71.24 110.022 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 65.8 t -128.19 116.6 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 122.116 -0.365 . . . . 60.04 111.882 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.656 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.2 tp -95.45 120.97 36.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.247 -0.433 . . . . 72.21 111.001 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.589 HG12 ' HB3' ' A' ' 93' ' ' ASP . 60.1 t -110.5 99.94 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.771 0.319 . . . . 70.24 111.059 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.3 tp -53.76 -39.1 65.08 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.898 0.38 . . . . 73.12 111.457 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.935 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 56.1 t0 -39.33 -52.98 2.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.915 0.886 . . . . 62.35 112.061 173.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.458 ' OE1' ' HD2' ' A' ' 96' ' ' ARG . 11.1 pt20 -108.53 -4.21 17.41 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.227 0.455 . . . . 73.44 112.227 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 59.32 27.56 16.67 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.524 0.564 . . . . 61.42 112.524 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.458 ' HD2' ' OE1' ' A' ' 94' ' ' GLN . 87.0 mtt180 -120.41 155.84 32.63 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.079 0.466 . . . . 65.54 111.39 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.712 HG21 ' SD ' ' A' ' 122' ' ' MET . 3.6 m -134.64 169.64 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.658 -0.701 . . . . 62.34 110.958 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -150.83 141.03 22.22 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.965 0.358 . . . . 74.23 111.965 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.489 ' HB3' HD11 ' A' ' 86' ' ' LEU . 97.0 m-85 -100.8 113.87 27.17 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.87 -0.605 . . . . 74.14 110.31 172.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -98.59 112.02 24.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 110.31 -0.256 . . . . 61.31 110.31 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.1 p -98.6 152.58 19.44 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.996 0.739 . . . . 72.53 112.996 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -88.57 166.95 34.85 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.394 -0.821 . . . . 54.05 111.906 168.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -65.17 1.0 1.11 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.979 0.733 . . . . 70.13 112.979 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.86 -42.46 6.02 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.496 -0.641 . . . . 34.11 111.496 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.52 -12.76 60.29 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.319 -0.441 . . . . 72.52 111.777 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -56.96 -17.29 9.13 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.216 0.45 . . . . 71.13 112.216 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.68 -7.55 85.84 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.179 -0.534 . . . . 62.24 113.598 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.1 -49.81 1.02 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.099 0.475 . . . . 75.23 111.822 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.2 mt -112.36 90.13 13.72 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.006 -0.543 . . . . 63.41 112.194 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.99 157.16 23.7 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.363 2.042 . . . . 61.21 112.893 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.49 -34.39 35.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.804 0.441 . . . . 70.52 111.949 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.91 -50.04 63.65 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.108 -0.568 . . . . 60.14 113.049 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.43 -45.43 88.49 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.156 0.503 . . . . 71.33 110.863 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 118' ' ' ILE . 80.0 mt -59.0 -39.53 82.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.881 -0.599 . . . . 74.41 110.946 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.3 t -57.46 -44.4 84.78 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.978 -0.555 . . . . 54.51 111.316 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -57.42 -51.59 68.8 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.777 0.322 . . . . 75.4 110.959 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 64.0 mt -50.91 -40.25 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.017 0.437 . . . . 73.23 111.328 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.635 HG23 HG22 ' A' ' 97' ' ' VAL . 76.8 mt -62.79 -56.41 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.124 -0.489 . . . . 71.33 111.991 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 10.5 t-80 -83.58 -23.49 31.94 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.14 0.792 . . . . 64.11 113.14 -171.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -91.82 -49.5 6.22 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 111.74 0.274 . . . . 74.42 111.74 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -79.42 -54.42 5.94 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.829 0.347 . . . . 73.1 111.484 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.712 ' SD ' HG21 ' A' ' 97' ' ' VAL . 61.9 mtt -82.6 -58.93 2.69 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.851 1.056 . . . . 64.32 113.851 -168.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.49 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 23.7 mm -43.2 -52.47 12.37 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 113.709 1.003 . . . . 72.1 113.709 -173.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.49 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 76.4 Cg_exo -51.65 -41.55 60.8 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.769 1.646 . . . . 60.41 113.056 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.487 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 91.3 m-70 -73.1 -40.51 64.92 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.237 -0.289 . . . . 72.42 111.679 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 122' ' ' MET . 15.9 m-30 -56.54 -40.45 75.14 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.118 0.485 . . . . 71.1 110.986 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -76.07 -37.13 58.61 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.121 -0.49 . . . . 62.51 111.325 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.5 m -66.19 -30.01 70.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.701 0.286 . . . . 64.11 111.676 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 123.51 -3.23 9.49 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.23 -0.509 . . . . 72.31 113.721 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.794 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 97.2 m-20 -104.07 87.49 2.78 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.086 0.402 . . . . 70.01 112.086 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -71.27 -45.12 63.88 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.175 0.512 . . . . 70.41 110.486 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.58 -48.06 82.65 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.962 -0.563 . . . . 71.03 111.755 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.794 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 29.2 tt0 -62.44 -38.58 90.28 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.291 -0.413 . . . . 73.14 111.111 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.27 -51.14 60.66 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.064 -0.589 . . . . 74.42 112.769 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.498 HD11 HD22 ' A' ' 90' ' ' LEU . 99.4 mt -57.67 -43.41 84.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.922 0.391 . . . . 71.43 110.895 175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.0 t -51.77 -56.91 11.06 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.986 -0.552 . . . . 74.01 111.894 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -63.34 -32.22 73.58 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.821 0.304 . . . . 73.51 111.821 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.585 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -60.84 -52.17 54.06 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.959 -0.638 . . . . 51.02 112.408 175.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.6 t -59.12 -48.62 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.03 0.443 . . . . 64.52 111.066 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.511 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 62.3 tp -53.22 -46.55 69.16 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.774 -0.648 . . . . 71.42 111.073 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.03 87.36 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.164 -0.471 . . . . 71.43 111.657 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.96 -56.4 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.414 -0.357 . . . . 75.0 111.423 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -59.44 -35.37 73.91 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.297 0.48 . . . . 71.15 112.297 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 16.6 mm-40 -59.6 -34.13 72.36 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 122.112 -0.368 . . . . 75.31 111.587 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 65.4 t -66.21 -42.68 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.904 0.383 . . . . 74.42 110.719 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.85 -56.53 8.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.118 -0.492 . . . . 72.14 111.37 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 . . . . . 0 N--CA 1.467 0.425 0 CA-C-N 116.561 -0.29 . . . . 62.15 111.34 176.963 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.7 t . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.067 0.461 . . . . 71.21 111.586 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -99.16 113.25 25.39 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.443 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.659 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 2.9 mppt? -95.57 169.03 9.83 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.515 -0.55 . . . . 70.31 109.515 171.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.659 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 10.2 Cg_endo -51.01 -24.31 13.87 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.201 1.934 . . . . 53.23 113.198 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.42 -21.23 35.82 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 111.955 0.354 . . . . 44.23 111.955 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -82.94 -27.79 30.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.883 0.373 . . . . 64.54 110.977 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.404 HG22 HD21 ' A' ' 56' ' ' LEU . 34.9 t -76.87 120.81 83.24 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.104 -0.498 . . . . 62.32 111.234 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HG2' HG23 ' A' ' 22' ' ' THR . 27.6 Cg_endo -62.43 127.73 21.71 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.335 2.023 . . . . 52.51 112.552 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.407 ' HA ' ' CE2' ' A' ' 75' ' ' TRP . 2.0 m-20 -72.69 74.97 1.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.087 0.47 . . . . 74.02 111.473 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.0 m -57.62 -41.56 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 112.479 0.548 . . . . 71.4 112.479 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.527 HE22 ' HG ' ' A' ' 20' ' ' LEU . 25.4 mm-40 -75.74 -5.1 44.08 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.456 0.539 . . . . 73.43 112.456 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.0 tt -102.79 -32.33 9.86 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.151 0.5 . . . . 73.4 110.222 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.21 -61.35 1.38 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.534 0.568 . . . . 55.33 112.534 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -79.9 -52.49 7.8 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.489 0.552 . . . . 73.4 112.489 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.9 t 70.14 -61.75 0.45 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.624 0.769 . . . . 71.15 112.072 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.9 p -60.0 -32.92 71.31 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.906 0.384 . . . . 74.15 111.01 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -92.18 109.07 20.43 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.004 -0.369 . . . . 55.25 110.004 169.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.527 ' HG ' HE22 ' A' ' 13' ' ' GLN . 3.8 mp -97.11 15.02 23.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.436 0.636 . . . . 62.2 110.385 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.19 137.06 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.532 -0.758 . . . . 74.25 111.795 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 54' ' ' VAL . 30.4 m -119.81 103.25 9.2 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.901 0.382 . . . . 53.34 110.727 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -100.59 99.49 10.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.289 0.566 . . . . 73.23 112.438 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -118.49 -43.28 2.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.062 -0.517 . . . . 74.03 111.264 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.34 -24.65 67.45 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.28 0.844 . . . . 64.21 113.28 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.78 9.57 86.81 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.764 -0.732 . . . . 71.52 113.378 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.88 -14.3 60.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.978 0.418 . . . . 73.3 111.705 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.4 mt -103.09 139.36 38.72 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.41 -0.359 . . . . 74.31 110.969 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.2 t -106.23 159.99 15.69 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.328 -0.233 . . . . 73.14 110.835 175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -45.26 -48.95 12.8 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.556 0.947 . . . . 74.0 113.556 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -63.47 -48.73 76.45 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.79 0.328 . . . . 53.54 111.844 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -60.82 -40.6 93.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.867 0.365 . . . . 61.22 111.524 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.13 -45.26 92.78 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.232 -0.44 . . . . 71.11 110.778 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.0 -49.93 74.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.766 0.317 . . . . 75.22 111.607 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 31' ' ' ALA . 87.8 t -60.12 -40.64 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.218 0.532 . . . . 73.13 111.154 177.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.518 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.5 ttm -63.1 -49.89 72.68 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.948 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -59.05 -40.58 85.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.609 0.242 . . . . 55.13 111.211 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.6 -46.49 93.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.108 -0.568 . . . . 52.3 112.91 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' ILE . 79.4 mtm180 -69.14 -43.41 74.41 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.823 0.305 . . . . 74.53 111.823 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 36' ' ' MET . 88.7 mt -61.32 -47.5 85.61 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.195 0.522 . . . . 55.43 111.054 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 41' ' ' ARG . 40.7 ttp180 -62.72 -37.0 84.79 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.926 -0.579 . . . . 72.33 110.896 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.23 98.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.342 -0.39 . . . . 74.12 110.776 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.8 mt -59.82 -45.76 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.817 0.341 . . . . 73.24 110.779 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -58.51 -31.73 68.16 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.954 0.407 . . . . 73.33 111.001 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.9 t -93.79 -13.52 27.25 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.364 0.505 . . . . 31.51 112.364 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.8 m -106.8 -63.59 1.27 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.296 0.57 . . . . 74.1 111.29 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.401 ' HD2' HG23 ' A' ' 43' ' ' ILE . 32.6 m-70 -90.97 -8.3 49.63 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.486 -0.779 . . . . 64.12 111.198 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 67.33 5.93 4.55 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.279 0.631 . . . . 62.41 112.247 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.685 HG22 ' HB2' ' A' ' 84' ' ' ASN . 99.8 t -79.63 130.97 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 122.922 0.489 . . . . 63.45 111.987 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.418 ' HB2' HG13 ' A' ' 77' ' ' VAL . 1.8 mp0 -79.81 96.53 6.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.915 0.388 . . . . 73.11 110.297 174.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.408 ' HE2' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -104.78 98.78 8.47 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.424 -0.353 . . . . 73.33 110.492 -176.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.03 120.75 42.25 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.534 0.568 . . . . 74.24 112.534 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.92 137.49 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-O 121.025 0.441 . . . . 71.24 111.359 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.582 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 61.7 t -130.76 140.18 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.603 0.361 . . . . 72.21 111.037 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -128.61 122.46 30.96 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.624 0.249 . . . . 53.11 111.183 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.404 HD21 HG22 ' A' ' 9' ' ' VAL . 65.3 mt -128.23 140.85 39.49 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 111.622 0.23 . . . . 72.33 111.622 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.15 -55.97 1.91 Allowed 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.516 2.144 . . . . 74.22 112.248 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.3 t -155.62 148.97 24.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.341 -0.39 . . . . 73.32 111.817 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.73 20.47 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.353 0.597 . . . . 74.5 110.196 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.42 39.65 91.46 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.202 -0.523 . . . . 64.1 113.175 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.02 16.03 3.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.151 0.58 . . . . 72.41 112.293 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.01 151.41 80.53 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 122.055 -0.403 . . . . 65.35 111.775 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -56.97 110.15 0.55 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.685 2.256 . . . . 73.01 112.654 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.6 tp -52.19 -46.02 65.41 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.891 0.7 . . . . 75.13 112.891 -176.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 38.3 mt-10 -66.71 -25.32 66.47 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.126 0.417 . . . . 73.52 112.126 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 23.3 t70 -75.39 -45.57 38.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.379 0.609 . . . . 75.22 110.02 173.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -57.65 -47.5 82.06 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.521 -0.763 . . . . 72.0 111.821 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.3 p -55.71 -50.17 71.05 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.78 0.324 . . . . 75.14 111.595 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.526 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.2 tp -55.33 -51.18 67.57 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.956 0.408 . . . . 74.43 111.36 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 66' ' ' ASP . 55.6 mtpt -60.24 -47.02 87.76 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.198 0.444 . . . . 75.15 112.198 -178.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.2 tp -66.18 -47.6 73.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.933 0.397 . . . . 62.44 111.732 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.625 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -61.57 -32.81 72.92 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.227 0.454 . . . . 65.42 112.227 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 44.3 mtm180 -59.53 -48.59 81.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.013 0.375 . . . . 72.22 112.013 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.586 ' NE2' ' HB2' ' A' ' 6' ' ' PRO . 11.5 pt20 -70.48 -13.62 62.19 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.818 0.342 . . . . 75.35 111.479 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.526 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 32.3 m0 -96.42 -17.43 20.59 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.854 0.359 . . . . 74.43 110.778 173.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.31 46.64 94.02 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 116.31 -0.405 . . . . 63.51 113.408 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 50' ' ' GLU . 57.7 t . . . . . 0 CA--C 1.546 0.822 0 N-CA-C 112.572 0.582 . . . . 71.41 112.572 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 103' ' ' TYR . 56.4 t30 . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 107.567 -1.272 . . . . 73.1 107.567 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -74.96 -122.07 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.733 -0.605 . . . . 44.24 111.489 177.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.685 ' HB2' HG22 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -83.72 70.61 10.37 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.911 -0.493 . . . . 75.1 112.056 -176.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -107.17 144.71 15.94 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.098 -0.501 . . . . 64.01 112.685 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 99' ' ' PHE . 42.6 tp -145.16 124.59 13.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.875 0.369 . . . . 75.22 111.475 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 72' ' ' ALA . 54.8 tp -111.54 138.26 48.31 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.756 0.312 . . . . 64.41 111.038 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.0 tp -128.26 102.52 6.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.708 0.29 . . . . 75.04 110.682 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.11 119.63 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.063 0.394 . . . . 54.1 112.063 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HA ' HG12 ' A' ' 97' ' ' VAL . 41.9 tp -98.96 115.86 29.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.11 0.481 . . . . 61.33 111.109 175.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 94' ' ' GLN . 71.3 t -101.17 104.49 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.27 -0.423 . . . . 73.34 111.007 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.0 tp -55.75 -42.44 75.43 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.892 0.377 . . . . 71.54 111.638 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -50.99 -36.68 40.5 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.244 0.545 . . . . 74.21 111.771 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.439 ' H ' HG12 ' A' ' 91' ' ' VAL . 72.0 mt-30 -105.99 -10.19 16.7 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.108 -0.496 . . . . 74.2 111.933 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 53.4 35.13 19.69 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.675 0.62 . . . . 72.34 112.675 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -142.58 162.93 34.19 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.974 0.416 . . . . 75.34 111.874 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.582 HG21 ' SD ' ' A' ' 122' ' ' MET . 3.7 m -133.43 171.89 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.068 -0.515 . . . . 42.11 111.589 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.574 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 47.4 ttt85 -148.59 137.67 21.7 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.475 -0.329 . . . . 74.3 111.524 171.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.743 ' HB3' HD11 ' A' ' 86' ' ' LEU . 96.9 m-85 -93.0 108.4 19.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.196 -0.456 . . . . 72.22 110.543 172.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.6 tp10 -95.04 122.41 37.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.577 0.227 . . . . 71.5 110.727 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.3 p -100.49 160.8 14.05 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.932 1.086 . . . . 74.31 113.932 -172.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -103.56 -164.24 25.3 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.932 -1.031 . . . . 62.04 111.809 167.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 5.3 t80 -76.56 -17.0 59.46 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.128 0.49 . . . . 73.1 111.591 -176.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.09 -23.46 57.17 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.236 -0.507 . . . . 72.45 113.205 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.4 mt -103.34 -4.21 24.51 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.012 0.434 . . . . 71.2 110.95 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -53.55 -35.44 60.75 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.812 -0.631 . . . . 64.1 111.174 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.39 18.05 58.14 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 121.244 -0.503 . . . . 60.2 113.88 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -137.83 -54.63 0.66 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.301 0.55 . . . . 61.3 111.44 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.661 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.5 mt -114.78 86.14 12.65 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.6 -0.727 . . . . 65.53 112.102 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.13 153.83 19.02 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.156 1.904 . . . . 65.42 112.404 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.38 -43.71 5.28 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.865 0.691 . . . . 74.24 112.865 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.91 -50.13 68.56 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.218 -0.515 . . . . 54.22 113.251 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.68 -48.15 83.08 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.969 0.414 . . . . 32.44 111.025 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.661 HD21 ' HB3' ' A' ' 109' ' ' LEU . 76.3 mt -58.31 -39.09 78.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.088 -0.505 . . . . 74.13 111.217 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.9 t -63.21 -37.23 86.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.11 -0.495 . . . . 71.42 111.335 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -70.61 -37.81 73.9 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 122.262 -0.274 . . . . 75.12 111.284 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 62.3 mt -55.15 -43.5 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.474 0.654 . . . . 74.13 110.04 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.7 mt -64.59 -52.9 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.45 -0.795 . . . . 74.14 111.489 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 5.4 t-80 -69.78 -39.35 76.68 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.6 0.593 . . . . 74.43 112.6 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.31 -39.41 22.92 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.753 0.649 . . . . 71.24 112.753 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -103.57 -46.29 4.59 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.602 0.593 . . . . 73.14 112.602 -174.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.582 ' SD ' HG21 ' A' ' 97' ' ' VAL . 50.5 mtt -78.89 -48.01 15.44 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.185 0.809 . . . . 71.14 113.185 -173.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.515 ' CG1' ' HA ' ' A' ' 119' ' ' HIS . 23.0 mm -50.09 -52.23 55.04 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 112.98 0.733 . . . . 42.34 112.98 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 14.0 Cg_endo -55.7 -38.42 94.33 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 121.807 1.671 . . . . 52.14 112.315 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 41.5 m-70 -71.14 -51.4 25.18 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.04 0.385 . . . . 61.34 112.04 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.4 m-30 -55.92 -44.84 78.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.775 0.321 . . . . 61.14 111.297 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -62.57 -37.03 84.59 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.946 0.403 . . . . 72.01 111.16 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -77.3 -5.97 51.43 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.405 -0.361 . . . . 64.23 111.911 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.33 2.58 68.04 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.314 -0.469 . . . . 71.11 113.317 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.618 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 90.6 m-20 -89.35 76.46 7.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.826 0.346 . . . . 73.21 111.841 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -70.75 -46.07 63.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.004 0.431 . . . . 72.22 111.259 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.65 98.18 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.108 -0.496 . . . . 62.31 111.603 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.618 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 18.3 mm-40 -65.58 -42.91 91.2 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.348 -0.387 . . . . 74.44 110.902 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.33 -51.28 60.1 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.317 -0.468 . . . . 64.52 112.923 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.521 HD11 HD22 ' A' ' 90' ' ' LEU . 95.9 mt -60.57 -38.65 85.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.015 0.436 . . . . 74.52 111.102 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.0 t -57.21 -57.98 10.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.987 -0.551 . . . . 53.15 112.345 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -76.11 -19.64 58.35 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 120.638 -0.425 . . . . 74.41 111.582 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.79 -47.23 91.59 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.838 -0.696 . . . . 71.1 111.815 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.2 -46.25 96.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.205 0.526 . . . . 71.32 110.842 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.4 tp -55.34 -38.02 68.22 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.771 -0.649 . . . . 74.54 111.441 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -62.47 -55.47 27.32 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.197 -0.456 . . . . 54.32 111.379 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.408 ' HB ' ' HE2' ' A' ' 51' ' ' PHE . 66.7 t -57.46 -43.37 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.261 -0.427 . . . . 71.44 111.134 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -52.73 -45.36 66.95 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.122 -0.49 . . . . 60.41 111.367 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -69.52 -35.29 75.35 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.061 0.393 . . . . 61.52 112.061 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 141' ' ' ALA . 96.5 t -62.05 -51.59 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.944 0.402 . . . . 74.14 111.01 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.21 -45.14 95.78 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.923 0.392 . . . . 70.13 111.015 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.008 0.432 . . . . 75.0 111.029 175.792 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.6 t . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 113.609 0.966 . . . . 74.1 113.609 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -107.41 130.02 54.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.952 -0.567 . . . . 73.2 110.973 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 26.1 mtpp -105.24 168.69 8.02 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 116.521 -0.309 . . . . 52.12 110.708 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 59.7 Cg_endo -69.62 58.19 1.47 Allowed 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.675 2.25 . . . . 71.05 112.65 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -176.85 -26.55 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.54 -0.755 . . . . 72.22 109.967 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.83 -35.04 67.19 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.268 0.556 . . . . 73.43 110.297 169.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.609 HG22 HD21 ' A' ' 56' ' ' LEU . 49.0 t -64.17 118.38 45.86 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.667 -0.697 . . . . 64.32 111.566 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HG2' HG23 ' A' ' 22' ' ' THR . 12.2 Cg_endo -56.14 121.9 10.81 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.45 2.1 . . . . 55.43 112.596 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.607 HD22 HD13 ' A' ' 14' ' ' LEU . 13.2 p-10 -72.63 70.64 0.94 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.356 0.598 . . . . 74.34 111.886 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -58.03 -43.58 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.792 -0.64 . . . . 75.05 112.641 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.468 ' NE2' ' HG ' ' A' ' 20' ' ' LEU . 8.2 tp-100 -71.46 -14.09 62.03 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.227 0.454 . . . . 74.1 112.227 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.607 HD13 HD22 ' A' ' 11' ' ' ASN . 10.1 tt -88.29 -29.99 19.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.118 0.485 . . . . 73.51 110.685 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.53 -35.35 13.64 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.131 0.491 . . . . 73.53 111.751 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.459 ' OD2' ' HG2' ' A' ' 19' ' ' ARG . 20.7 t70 -134.15 142.31 47.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.947 0.403 . . . . 62.45 111.244 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.7 p -107.64 -6.82 16.69 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.393 0.516 . . . . 60.42 112.393 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.1 p -75.57 -30.8 59.77 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.109 -0.369 . . . . 71.44 111.678 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.459 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 3.5 ptp85 -119.84 159.7 24.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.847 0.356 . . . . 74.32 111.051 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HG ' ' NE2' ' A' ' 13' ' ' GLN . 4.7 mp -132.72 14.47 4.4 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.71 0.29 . . . . 71.42 111.722 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 53' ' ' VAL . 65.0 t -112.08 128.64 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 112.286 0.476 . . . . 63.31 112.286 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.476 HG23 ' HG2' ' A' ' 10' ' ' PRO . 89.3 m -100.55 109.79 21.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.004 0.431 . . . . 63.14 110.979 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -92.31 93.16 8.49 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.288 0.566 . . . . 73.43 112.352 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 55' ' ' THR . 10.2 mm-40 -106.65 -59.69 1.76 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.945 0.402 . . . . 74.33 110.536 174.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.55 74.6 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.473 -0.33 . . . . 73.51 111.856 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.79 50.14 70.92 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.312 -0.471 . . . . 44.31 112.929 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.611 HD21 HD22 ' A' ' 92' ' ' LEU . 97.7 mt -90.59 12.36 19.1 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.202 0.445 . . . . 52.04 112.202 -176.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mp -124.4 163.47 21.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.283 0.563 . . . . 75.15 111.597 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.7 t -82.97 155.9 23.74 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.764 -0.653 . . . . 70.14 110.914 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -53.05 -40.88 64.29 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.876 0.37 . . . . 75.53 111.896 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -64.81 -46.36 82.3 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.9 0.381 . . . . 75.51 111.25 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -59.47 -41.06 88.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.484 -0.325 . . . . 71.14 111.619 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -55.78 -54.48 43.95 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.316 0.579 . . . . 55.12 110.912 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.27 -48.88 70.71 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.729 -0.669 . . . . 55.01 111.814 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 31' ' ' ALA . 99.0 t -64.4 -42.69 96.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.166 -0.47 . . . . 64.34 112.093 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.573 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.5 ttm -62.38 -51.1 68.95 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.199 -0.313 . . . . 74.44 110.937 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 59.4 m-80 -60.95 -38.38 85.67 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.643 0.259 . . . . 65.14 111.055 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.52 -48.36 86.57 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.045 -0.598 . . . . 75.02 112.9 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 43' ' ' ILE . 86.4 mtm180 -64.42 -46.17 84.36 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.843 0.312 . . . . 71.23 111.843 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 36' ' ' MET . 81.7 mt -56.32 -41.43 76.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.35 0.595 . . . . 75.51 110.867 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -67.63 -39.06 84.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.769 -0.65 . . . . 75.23 111.264 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.81 88.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.121 0.486 . . . . 74.11 110.823 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.434 HG23 ' HB2' ' A' ' 47' ' ' HIS . 70.8 mt -60.35 -41.88 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.1 -0.5 . . . . 61.14 110.681 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.481 ' NE ' ' HG2' ' A' ' 50' ' ' GLU . 12.7 tpt180 -50.85 -33.09 22.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.816 -0.629 . . . . 74.23 111.688 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.1 t -99.49 -60.2 1.58 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.323 -0.399 . . . . 73.21 111.741 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.7 t -59.29 -45.95 89.87 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.525 0.565 . . . . 71.24 112.525 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.434 ' HB2' HG23 ' A' ' 43' ' ' ILE . 91.1 m-70 -104.31 -9.26 18.67 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.776 0.322 . . . . 71.42 111.41 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.74 -5.68 1.4 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.216 0.821 . . . . 50.03 113.216 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.98 123.41 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.04 0.447 . . . . 72.41 111.994 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HG2' ' NE ' ' A' ' 44' ' ' ARG . 38.1 mt-10 -75.97 96.24 3.73 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.84 -0.43 . . . . 70.41 109.84 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.65 107.75 18.91 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.268 -0.424 . . . . 65.43 110.902 -173.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.14 147.16 37.93 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.042 0.386 . . . . 71.11 112.042 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 21' ' ' VAL . 58.5 t -128.57 135.81 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.919 0.39 . . . . 62.34 111.264 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 71' ' ' LEU . 60.5 t -128.56 134.47 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.713 0.292 . . . . 72.22 111.25 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 80.6 p -119.11 122.6 42.45 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.723 0.297 . . . . 50.21 111.385 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.609 HD21 HG22 ' A' ' 9' ' ' VAL . 89.7 mt -125.98 140.05 35.85 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-O 120.732 0.301 . . . . 71.41 111.57 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 52.6 Cg_endo -69.3 -35.19 14.5 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.116 1.877 . . . . 75.14 112.432 176.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 73.3 p -161.37 144.87 12.77 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.351 0.5 . . . . 75.42 112.351 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.458 HD13 HG21 ' A' ' 91' ' ' VAL . 32.3 pt -123.89 -11.4 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 121.002 0.43 . . . . 72.03 111.597 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.76 -113.47 5.76 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 114.386 0.514 . . . . 74.31 114.386 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -89.97 11.52 20.26 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.044 0.45 . . . . 62.34 112.044 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -85.2 118.87 71.71 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.924 -0.485 . . . . 63.41 111.88 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 29.1 Cg_endo -63.19 126.75 18.52 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.58 2.187 . . . . 71.34 112.346 176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.3 -45.5 80.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.943 0.72 . . . . 70.3 112.943 -171.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 1.2 pm0 -70.16 -36.04 74.43 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.35 0.5 . . . . 73.52 112.35 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.68 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 10.2 m-20 -71.99 -35.89 69.6 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.993 -0.442 . . . . 75.33 110.976 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 58.2 t80 -59.21 -56.58 20.26 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.812 0.339 . . . . 54.12 111.181 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 47.1 p -52.76 -44.56 66.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.116 -0.493 . . . . 62.35 111.651 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.65 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 58.7 tp -61.7 -57.06 13.42 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.336 -0.393 . . . . 51.41 111.634 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -61.38 -34.92 76.13 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.145 0.424 . . . . 65.41 112.145 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 54' ' ' VAL . 58.7 tp -69.79 -48.41 59.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.185 0.517 . . . . 72.2 111.097 177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.403 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -65.34 -31.73 73.0 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.074 0.398 . . . . 54.52 112.074 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.65 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 24.2 mtp180 -62.42 -50.05 73.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.026 0.38 . . . . 75.43 112.026 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.639 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 12.3 pt20 -67.88 -32.92 73.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.936 0.398 . . . . 72.22 111.088 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.639 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 27.7 m0 -71.45 -15.89 62.35 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.526 -0.307 . . . . 74.31 111.68 175.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.58 -39.15 3.07 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.277 -0.487 . . . . 72.21 112.746 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 19.4 t . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 122.88 0.472 . . . . 53.53 112.158 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.491 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 24.4 t30 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.864 0.364 . . . . 71.24 111.165 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.14 123.86 23.78 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.672 -0.643 . . . . 74.52 111.527 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.916 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 3.6 p-10 46.22 41.27 8.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.198 0.999 . . . . 74.25 112.753 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.11 145.31 16.58 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.86 -0.609 . . . . 41.12 111.861 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 99' ' ' PHE . 55.9 tp -144.87 131.0 19.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.953 0.377 . . . . 70.1 111.218 -177.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 72' ' ' ALA . 55.4 tp -119.29 123.62 44.68 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.838 0.352 . . . . 75.12 111.478 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.5 tp -111.26 110.03 20.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.892 0.377 . . . . 61.35 110.972 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 54' ' ' VAL . 93.1 t -110.52 129.15 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 122.181 -0.324 . . . . 72.22 111.811 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.567 ' HB2' HD21 ' A' ' 135' ' ' LEU . 43.5 tp -107.25 119.41 39.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.979 0.419 . . . . 72.54 111.037 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.458 HG21 HD13 ' A' ' 59' ' ' ILE . 94.0 t -102.93 100.82 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.307 -0.406 . . . . 75.4 111.207 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.611 HD22 HD21 ' A' ' 27' ' ' LEU . 62.4 tp -59.19 -39.14 81.63 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.171 0.434 . . . . 70.45 112.171 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 14.9 t70 -47.53 -47.15 28.09 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.154 0.582 . . . . 50.34 112.189 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -108.46 8.79 27.56 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.126 -0.488 . . . . 53.41 111.103 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 32.77 58.01 0.43 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.552 1.141 . . . . 71.42 113.782 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -150.16 160.97 43.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.477 -0.783 . . . . 74.43 111.129 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.504 HG21 ' SD ' ' A' ' 122' ' ' MET . 4.3 m -126.21 171.8 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.057 0.456 . . . . 45.13 112.029 -174.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 98' ' ' ARG . 28.7 ttt85 -150.15 135.46 18.05 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.246 -0.434 . . . . 70.44 111.826 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.463 ' HB3' HD11 ' A' ' 86' ' ' LEU . 95.9 m-85 -94.01 115.04 27.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.144 -0.48 . . . . 74.11 110.154 171.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -101.1 112.66 25.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.844 0.354 . . . . 71.12 110.87 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.519 HG23 HD11 ' A' ' 114' ' ' LEU . 2.9 p -88.59 148.37 24.11 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.678 0.751 . . . . 72.05 112.921 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -90.46 -170.23 43.44 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.225 -0.898 . . . . 74.33 112.199 168.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -24.6 65.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.055 0.455 . . . . 71.34 111.637 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.916 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -75.18 -30.47 58.84 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.003 -0.617 . . . . 61.4 113.432 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.13 -0.91 57.84 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.979 0.733 . . . . 74.35 112.979 -171.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -53.33 -32.06 47.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.906 0.335 . . . . 74.23 111.906 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.65 4.45 69.13 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.42 -0.419 . . . . 54.15 113.827 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -125.02 -60.11 1.37 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.381 0.61 . . . . 75.42 111.444 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.07 87.14 27.81 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.697 -0.683 . . . . 63.33 111.086 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.73 167.93 16.33 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.54 2.16 . . . . 75.21 113.558 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.08 -48.8 33.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.585 0.587 . . . . 70.42 112.585 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.37 -46.62 91.64 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.264 -0.493 . . . . 72.11 113.43 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.15 -48.94 77.86 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.891 0.377 . . . . 71.52 111.584 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.519 HD11 HG23 ' A' ' 101' ' ' THR . 86.8 mt -59.34 -43.03 92.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.277 -0.42 . . . . 62.34 111.275 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.4 t -63.41 -37.54 87.67 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.087 -0.506 . . . . 43.03 111.108 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -60.12 -55.34 35.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.394 -0.366 . . . . 73.45 111.219 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.9 mt -49.19 -46.21 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.044 0.449 . . . . 74.24 111.666 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.412 ' O ' HG12 ' A' ' 123' ' ' ILE . 58.2 mt -60.14 -54.91 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.135 0.493 . . . . 72.43 111.415 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -83.72 -9.17 59.02 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.176 0.806 . . . . 53.12 113.176 -173.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.12 -40.78 7.03 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.223 0.453 . . . . 73.43 112.223 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.07 -31.08 2.15 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.516 0.932 . . . . 74.25 113.516 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.504 ' SD ' HG21 ' A' ' 97' ' ' VAL . 36.0 mtt -69.04 -40.54 78.52 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.904 0.705 . . . . 73.42 112.904 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.477 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 46.7 mm -48.12 -57.04 11.4 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 112.894 0.702 . . . . 72.22 112.894 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.08 -37.64 86.95 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.053 1.835 . . . . 62.13 112.967 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -63.48 -53.09 57.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.802 0.334 . . . . 74.44 111.043 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.1 m-85 -59.63 -32.88 70.84 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.546 -0.297 . . . . 74.04 111.456 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 60.4 mtp85 -66.67 -43.32 84.84 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.241 0.544 . . . . 74.42 111.03 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.0 t -75.56 -0.82 21.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.858 -0.61 . . . . 44.05 112.112 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.15 3.93 90.03 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.182 -0.533 . . . . 73.13 112.48 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.769 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.2 m-20 -84.31 55.07 3.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.831 0.452 . . . . 64.34 111.349 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -56.22 -41.28 75.4 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.172 0.511 . . . . 71.31 110.91 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.81 -50.54 73.4 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.725 -0.67 . . . . 73.41 111.809 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.769 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 39.9 mm-40 -61.13 -40.02 92.22 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.342 -0.39 . . . . 73.12 111.739 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.49 -53.28 42.26 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.077 -0.582 . . . . 72.15 112.556 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 90' ' ' LEU . 83.4 mt -61.15 -43.21 99.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.054 0.454 . . . . 75.34 111.187 175.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.8 t -60.37 -52.5 64.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.645 0.609 . . . . 42.53 112.645 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -27.25 59.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.601 0.239 . . . . 73.14 111.045 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.35 91.36 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.025 -0.607 . . . . 51.5 112.168 171.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 135' ' ' LEU . 56.7 t -56.59 -48.13 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.146 0.498 . . . . 71.24 110.806 172.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 50.8 tp -58.45 -40.59 83.05 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.767 -0.651 . . . . 60.11 111.157 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -58.64 -52.3 66.28 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.022 0.439 . . . . 74.35 111.031 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 81.1 t -57.26 -48.35 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.153 -0.476 . . . . 64.13 111.132 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -53.71 -43.19 68.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.916 -0.583 . . . . 74.05 111.53 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 96.5 mt-30 -68.4 -33.4 74.17 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 111.993 0.368 . . . . 64.53 111.993 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 141' ' ' ALA . 91.0 t -63.99 -55.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.068 0.461 . . . . 74.33 110.729 175.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.0 mt -53.23 -45.04 68.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.919 -0.582 . . . . 64.53 111.533 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 CA--C 1.541 0.609 0 CA-C-N 116.194 -0.457 . . . . 75.22 111.9 -178.394 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 120.481 0.181 . . . . 71.41 110.707 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.419 ' CG ' HD22 ' A' ' 56' ' ' LEU . 44.8 m-85 -112.29 159.6 18.48 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.862 0.839 . . . . 65.22 113.242 -176.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.538 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 30.1 mmmt -126.02 158.79 64.83 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 114.867 -1.061 . . . . 73.23 109.935 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HB2' HE22 ' A' ' 74' ' ' GLN . 9.6 Cg_endo -51.8 -52.27 9.35 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.283 1.988 . . . . 51.25 113.219 -177.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.44 2.52 32.26 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.074 -0.391 . . . . 72.13 111.729 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.538 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 21.4 t70 -93.89 -13.32 27.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.279 0.561 . . . . 63.15 110.29 175.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 5' ' ' LYS . 69.4 t -82.7 133.56 49.02 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.908 -0.587 . . . . 53.32 110.871 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -52.99 111.09 0.57 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.298 1.999 . . . . 33.1 112.417 177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.474 ' HA ' ' CE2' ' A' ' 75' ' ' TRP . 10.9 p-10 -68.7 78.92 0.29 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.623 0.725 . . . . 74.43 112.351 -177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' SER . 29.2 m -78.26 10.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.988 0.736 . . . . 72.01 112.988 -177.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 15.7 mm100 -121.22 18.35 11.53 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.559 0.695 . . . . 70.24 110.518 171.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.4 HD13 HD22 ' A' ' 11' ' ' ASN . 7.0 tt -134.64 -45.27 0.74 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.455 -0.793 . . . . 63.05 109.181 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.37 -75.12 0.59 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.991 -0.549 . . . . 72.32 111.199 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.2 55.39 2.83 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.27 0.47 . . . . 55.12 112.27 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 58.2 m -67.46 -9.45 42.11 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.252 0.464 . . . . 74.24 112.252 -178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -86.78 -9.65 55.36 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.297 0.57 . . . . 72.51 111.496 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.421 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 8.6 tpt180 -94.18 -62.25 1.37 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.986 -0.552 . . . . 65.23 111.041 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.563 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.5 mp 74.68 -14.83 0.69 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.965 0.906 . . . . 70.51 111.884 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.421 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 44.6 t -111.82 146.93 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 122.669 0.387 . . . . 65.52 111.252 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 m -150.54 102.66 3.05 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.045 -0.409 . . . . 75.34 112.02 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.411 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 32.5 t70 -93.81 108.19 19.99 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.895 0.378 . . . . 74.4 111.46 176.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.534 ' HB2' HD23 ' A' ' 56' ' ' LEU . 6.6 mm-40 -113.37 -30.55 6.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.917 0.389 . . . . 71.44 110.922 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.56 -23.12 66.83 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.491 0.552 . . . . 64.42 112.491 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.42 45.46 6.92 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.084 -0.579 . . . . 60.22 112.731 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.54 HD11 HD13 ' A' ' 92' ' ' LEU . 83.5 mt -119.19 -32.75 4.32 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.106 0.41 . . . . 62.15 112.106 -175.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.1 132.69 36.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.178 0.514 . . . . 74.12 111.574 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.9 t -86.91 172.27 10.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.249 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -56.81 -40.68 76.42 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 111.906 0.336 . . . . 70.34 111.906 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -64.13 -47.33 80.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.711 0.291 . . . . 72.32 111.254 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -56.02 -41.21 74.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.703 0.287 . . . . 74.34 111.169 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -59.98 -55.92 28.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.131 0.491 . . . . 75.5 111.489 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 8.0 tp10 -69.33 -43.04 74.49 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.472 0.545 . . . . 71.35 112.472 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 31' ' ' ALA . 90.4 t -59.64 -39.84 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.088 0.471 . . . . 74.11 110.861 176.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.522 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.2 ttm -68.39 -43.09 78.04 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.387 -0.37 . . . . 70.42 110.789 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 34' ' ' GLU . 88.4 m-20 -51.07 -55.97 14.93 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.9 0.381 . . . . 70.1 111.486 177.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.47 -37.82 76.83 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.181 -0.533 . . . . 54.34 113.384 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -62.84 -53.59 51.81 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.174 0.512 . . . . 73.33 110.811 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.563 ' HB3' HD22 ' A' ' 20' ' ' LEU . 57.1 mt -61.72 -31.23 71.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.964 -0.562 . . . . 75.15 111.318 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.4 mtm-85 -74.5 -39.33 62.5 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.405 -0.362 . . . . 71.45 111.586 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.28 89.85 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.896 0.379 . . . . 64.52 111.563 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.04 -42.07 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.004 0.43 . . . . 70.31 111.704 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 20.6 ttp180 -74.22 -25.28 59.58 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.036 0.384 . . . . 73.34 112.036 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.5 t -66.67 -28.35 68.39 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.655 0.741 . . . . 74.23 109.641 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.6 p -104.64 -70.57 0.77 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.056 -0.974 . . . . 74.34 112.027 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -76.86 -9.86 58.97 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.436 0.532 . . . . 61.31 112.436 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . . . 65.25 13.41 8.75 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.233 0.457 . . . . 53.53 112.233 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.536 ' HA ' ' HB2' ' A' ' 84' ' ' ASN . 85.9 t -79.01 129.89 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.445 0.535 . . . . 74.52 112.445 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.96 97.33 9.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.612 0.72 . . . . 74.22 110.477 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.483 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.1 t80 -103.49 105.62 15.91 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.295 -0.866 . . . . 73.42 110.507 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.55 140.6 37.31 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.406 0.521 . . . . 73.25 112.406 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -126.07 122.9 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 122.722 0.409 . . . . 63.13 111.273 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.57 138.88 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.853 0.358 . . . . 75.41 111.804 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 17.9 p -117.08 126.05 52.24 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.887 0.375 . . . . 73.04 110.902 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 24' ' ' GLU . 33.7 mt -131.45 146.59 62.6 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.634 -0.257 . . . . 63.14 110.686 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.629 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 37.6 Cg_exo -57.87 -68.68 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.119 1.88 . . . . 72.04 111.682 174.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.42 ' HA ' HG13 ' A' ' 91' ' ' VAL . 60.3 p -142.3 157.83 44.39 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.186 0.517 . . . . 61.14 110.94 175.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.3 pt -110.15 23.66 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.009 -0.541 . . . . 54.3 111.11 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.64 -144.18 30.01 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.094 -0.503 . . . . 45.55 112.244 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -96.29 9.69 40.32 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.296 0.569 . . . . 63.12 111.01 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.3 141.78 86.29 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 112.01 0.374 . . . . 72.34 112.01 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 43.6 Cg_endo -67.91 145.17 67.32 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.561 2.174 . . . . 64.1 112.801 177.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.3 tp -61.68 -46.77 88.27 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.443 0.535 . . . . 75.42 112.443 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.33 -53.09 62.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.221 0.452 . . . . 65.43 112.221 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.581 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 5.3 m-20 -60.06 -33.77 72.51 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.682 0.253 . . . . 70.14 111.682 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -64.45 -55.15 22.75 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.674 0.273 . . . . 73.32 111.274 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.5 p -58.78 -39.76 81.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.8 0.333 . . . . 44.41 111.259 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.474 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 57.2 tp -59.88 -55.04 39.11 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.292 -0.413 . . . . 63.24 111.145 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -60.27 -32.5 71.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.17 0.433 . . . . 74.35 112.17 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.638 HD23 HD21 ' A' ' 87' ' ' LEU . 34.9 tp -73.03 -48.43 36.23 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.987 0.422 . . . . 61.13 111.249 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.2 86.33 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.846 0.313 . . . . 72.31 111.846 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 67.8 mtp180 -61.44 -54.2 46.55 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.926 0.343 . . . . 65.3 111.926 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.463 HE22 ' HB2' ' A' ' 6' ' ' PRO . 11.9 pt20 -64.4 -27.28 68.9 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.861 0.362 . . . . 74.42 111.51 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 40.9 m0 -80.24 -2.27 44.27 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.889 0.329 . . . . 74.24 111.889 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.27 -46.39 3.4 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.26 -0.495 . . . . 51.03 113.473 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 17.8 m . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 112.811 0.671 . . . . 61.51 112.811 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 67.3 t30 . . . . . 0 CA--C 1.542 0.641 0 CA-C-O 121.218 0.532 . . . . 63.34 111.607 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -70.9 138.9 50.53 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.846 -0.534 . . . . 71.33 112.083 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.81 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 36.3 p30 40.53 27.25 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.208 1.559 . . . . 72.4 115.208 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.88 123.83 7.61 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.785 -0.721 . . . . 73.32 111.882 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.6 tp -134.4 121.92 21.83 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.023 0.412 . . . . 65.34 111.307 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.638 HD21 HD23 ' A' ' 71' ' ' LEU . 57.4 tp -113.14 137.48 51.38 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.822 0.344 . . . . 75.14 111.754 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.3 tp -127.15 105.16 8.38 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.534 0.334 . . . . 74.24 110.876 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.84 129.69 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 111.9 0.333 . . . . 62.24 111.9 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HA ' HG12 ' A' ' 97' ' ' VAL . 27.6 tp -107.91 128.94 55.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.251 -0.431 . . . . 75.41 111.069 175.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.549 HG11 ' NE2' ' A' ' 94' ' ' GLN . 59.9 t -105.94 109.14 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.59 -0.277 . . . . 72.51 110.536 174.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.629 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 62.5 tp -55.94 -55.81 28.25 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.627 0.603 . . . . 73.13 112.627 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.61 -24.63 61.42 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.573 0.583 . . . . 73.35 112.573 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.549 ' NE2' HG11 ' A' ' 91' ' ' VAL . 40.3 mt-30 -103.45 -7.05 21.24 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.578 -0.283 . . . . 62.3 111.547 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 33.27 49.84 0.23 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.241 1.016 . . . . 75.4 113.254 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.4 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 30.9 ptt180 -141.87 155.11 45.54 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.573 -0.74 . . . . 64.42 110.317 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 90' ' ' LEU . 5.8 m -128.49 171.74 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.84 0.353 . . . . 72.11 111.429 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.5 ttt85 -149.15 133.16 17.16 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.404 -0.362 . . . . 74.42 111.809 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 97.1 m-85 -95.03 112.51 24.2 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.01 -0.541 . . . . 74.12 110.401 172.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 15.6 tp10 -94.31 111.94 23.7 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.581 0.229 . . . . 74.22 110.428 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 p -98.15 145.51 26.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.033 0.753 . . . . 64.31 113.033 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -97.06 -173.99 34.53 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.298 -0.864 . . . . 42.52 112.142 167.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -63.71 -27.86 69.5 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.147 0.499 . . . . 62.52 112.054 -175.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.81 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -73.45 -9.0 77.2 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 120.935 -0.65 . . . . 40.53 113.692 -172.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.1 mt -129.24 4.87 5.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.636 0.606 . . . . 73.31 112.636 -175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.72 -41.59 97.83 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.913 0.387 . . . . 64.34 111.116 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.94 -23.38 69.37 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.325 -0.464 . . . . 62.23 113.22 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -92.41 -66.87 0.89 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.676 0.274 . . . . 75.33 111.655 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.604 ' HA ' HD23 ' A' ' 113' ' ' LEU . 3.0 mp -117.16 94.95 46.23 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.829 0.307 . . . . 73.05 111.829 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.42 174.68 11.6 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.659 2.239 . . . . 72.02 112.607 174.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.86 -44.32 59.56 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.318 0.488 . . . . 74.33 112.318 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -59.65 -50.2 70.35 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.197 -0.525 . . . . 73.23 113.546 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 109' ' ' LEU . 36.0 tp -60.76 -49.13 78.71 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.828 0.347 . . . . 64.54 111.404 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 118' ' ' ILE . 92.8 mt -56.34 -48.61 76.43 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.214 -0.448 . . . . 73.43 111.231 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.3 m -61.56 -36.41 80.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.191 -0.459 . . . . 64.34 111.367 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.409 ' NH2' HD13 ' A' ' 113' ' ' LEU . 44.3 ttp180 -65.45 -50.14 66.49 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.548 -0.296 . . . . 75.51 110.973 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.81 -47.37 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.23 0.538 . . . . 64.13 110.617 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 114' ' ' LEU . 84.0 mt -59.03 -57.11 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.749 -0.659 . . . . 64.22 112.383 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -84.21 -22.46 30.87 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.364 0.875 . . . . 74.23 113.364 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.19 -38.15 17.95 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.034 0.445 . . . . 63.34 111.787 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 121' ' ' ARG . 12.4 mtp180 -113.25 -59.19 2.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.253 -0.43 . . . . 74.41 112.153 -176.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.9 mtp -62.51 -48.4 79.74 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.241 0.83 . . . . 74.45 113.241 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 27.1 mm -57.76 -50.79 86.17 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.421 0.526 . . . . 65.41 112.421 -177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 85.0 Cg_exo -47.15 -34.8 18.33 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.348 2.032 . . . . 75.14 112.998 174.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -72.97 -49.25 30.25 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.629 0.252 . . . . 72.13 111.182 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.433 ' HD2' HD13 ' A' ' 123' ' ' ILE . 23.7 m-85 -57.4 -45.02 85.0 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.016 0.376 . . . . 73.44 112.016 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -62.3 -23.94 67.01 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.22 0.533 . . . . 64.21 111.1 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.0 m -92.77 7.43 43.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.062 -0.517 . . . . 45.02 111.559 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.75 -0.43 82.06 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.364 -0.446 . . . . 73.41 113.493 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.792 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.87 70.72 10.68 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 122.519 -0.4 . . . . 71.43 111.545 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -70.57 -42.33 71.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.016 0.436 . . . . 72.51 110.557 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.3 90.89 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.998 -0.546 . . . . 71.33 111.213 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.792 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 18.6 mp0 -59.69 -53.27 59.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.367 -0.379 . . . . 75.14 111.088 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.57 -49.87 59.4 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.359 -0.448 . . . . 70.03 113.647 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 139' ' ' VAL . 96.4 mt -65.67 -46.9 77.37 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.572 -0.369 . . . . 72.32 111.818 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 92.7 p -61.67 -50.53 72.13 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.716 0.293 . . . . 73.55 111.684 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -27.16 60.15 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.7 -0.227 . . . . 72.53 111.285 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.13 -47.62 79.44 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.12 -0.562 . . . . 65.31 112.402 173.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 135' ' ' LEU . 75.3 t -58.27 -44.13 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.253 0.549 . . . . 71.11 110.562 173.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.512 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 41.0 tp -63.96 -35.91 82.22 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.884 -0.598 . . . . 74.02 110.83 177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.63 -43.5 97.44 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.94 0.4 . . . . 62.44 111.282 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.87 -47.54 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.171 0.51 . . . . 64.12 110.671 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -56.16 -36.73 68.63 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.02 -0.536 . . . . 64.13 111.673 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 18.7 mm-40 -57.3 -29.84 64.24 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 120.82 0.343 . . . . 72.32 111.809 176.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.53 -49.68 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.851 0.358 . . . . 73.05 111.139 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -71.76 -58.3 3.59 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.071 0.397 . . . . 61.24 112.071 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 111.871 0.323 . . . . 75.42 111.871 179.025 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.023 0.44 . . . . 61.44 112.167 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.13 126.61 50.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.128 -0.487 . . . . 73.04 111.137 173.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.479 ' O ' HG23 ' A' ' 9' ' ' VAL . 67.6 mttm -89.04 151.46 46.96 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.446 -0.343 . . . . 45.01 110.983 176.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.479 ' HD3' ' CE2' ' A' ' 67' ' ' PHE . 39.7 Cg_endo -64.88 -19.63 64.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.872 1.714 . . . . 65.24 111.663 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.413 ' HA ' HE22 ' A' ' 74' ' ' GLN . 18.5 mt-10 -88.83 -7.69 55.72 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.391 -0.822 . . . . 75.51 111.165 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -112.52 2.04 16.12 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.908 -0.587 . . . . 62.14 111.876 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 5' ' ' LYS . 61.8 t -81.28 130.92 60.51 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.512 -0.313 . . . . 41.05 110.447 174.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.01 116.89 1.89 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.877 2.385 . . . . 62.3 113.314 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -68.29 70.29 0.16 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.005 0.431 . . . . 74.44 112.035 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -60.56 -25.42 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.7 0.63 . . . . 74.51 112.7 -175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -73.98 -25.09 59.74 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.901 0.381 . . . . 75.31 111.219 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tt -93.84 -32.61 13.87 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.076 -0.511 . . . . 62.01 111.038 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.88 -47.3 10.46 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.202 0.445 . . . . 54.03 112.202 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -106.4 -65.62 1.07 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.592 0.59 . . . . 73.44 112.592 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.8 p 61.65 0.72 0.51 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.985 0.914 . . . . 74.22 112.139 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -110.5 -36.68 5.69 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.678 0.391 . . . . 70.44 111.641 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -87.11 -49.3 7.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.862 0.363 . . . . 64.44 111.629 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp 65.45 13.92 9.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.26 0.624 . . . . 74.23 112.155 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.8 t -102.41 128.72 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.0 0.428 . . . . 73.51 111.651 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 m -129.74 112.4 13.59 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.274 -0.421 . . . . 65.42 110.931 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -124.04 102.23 7.64 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.007 0.432 . . . . 65.22 111.894 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.53 ' HB2' HD23 ' A' ' 56' ' ' LEU . 4.7 mp0 -102.93 -38.7 7.25 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.292 -0.413 . . . . 74.24 110.98 173.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.1 -20.92 66.3 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.074 0.768 . . . . 43.11 113.074 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.6 38.78 27.23 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.916 -0.659 . . . . 62.13 112.693 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.1 mt -100.81 -28.42 12.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.719 0.295 . . . . 73.3 111.393 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.2 mt -99.05 107.53 19.96 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.737 0.303 . . . . 75.11 111.321 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.1 t -74.57 160.53 30.76 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.353 -0.217 . . . . 72.22 110.903 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -46.47 -36.29 6.49 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.729 0.64 . . . . 74.5 112.729 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.49 -52.02 63.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.948 0.404 . . . . 40.33 111.333 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.503 ' HG3' ' HB1' ' A' ' 132' ' ' ALA . 14.6 mm100 -62.07 -40.7 96.7 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.928 0.394 . . . . 63.32 110.741 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.27 -44.74 88.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.211 -0.45 . . . . 72.33 110.865 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -57.93 -52.26 66.24 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.132 0.491 . . . . 75.24 111.126 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.69 -45.9 96.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.212 -0.449 . . . . 64.02 111.622 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 43.9 ttm -62.78 -44.38 96.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.503 -0.317 . . . . 75.03 111.375 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -53.55 -47.83 69.66 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.169 0.509 . . . . 72.45 110.656 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.85 -36.11 92.29 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.059 -0.591 . . . . 34.41 113.086 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.57 ' O ' HG13 ' A' ' 43' ' ' ILE . 6.2 mmp_? -67.3 -56.27 10.48 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.816 0.341 . . . . 74.24 111.12 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.62 -47.25 84.57 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.175 -0.466 . . . . 63.23 111.746 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -58.54 -45.99 87.77 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.207 -0.451 . . . . 74.53 111.19 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.76 80.81 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.908 0.385 . . . . 65.41 111.386 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.4 mt -65.64 -48.64 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.878 0.37 . . . . 35.12 111.424 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 48.5 ttt180 -66.83 -28.16 68.13 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.11 -0.369 . . . . 73.35 111.625 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 t -76.67 -49.73 15.43 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.804 0.335 . . . . 74.23 111.632 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.2 t -82.83 -54.18 5.3 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.323 0.49 . . . . 65.31 112.323 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -87.56 -22.3 24.89 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.115 -0.493 . . . . 74.25 111.505 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 71.43 17.68 5.7 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.235 0.614 . . . . 73.32 111.443 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.802 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 84.2 t -87.48 119.25 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.106 -0.497 . . . . 72.3 111.284 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -80.96 96.69 7.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.244 0.545 . . . . 74.04 110.283 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -110.49 109.65 20.09 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.631 -0.713 . . . . 74.35 110.645 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.33 142.16 42.36 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.444 0.535 . . . . 60.34 112.444 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.22 132.82 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.321 -0.4 . . . . 70.12 111.214 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 71' ' ' LEU . 41.8 t -130.92 138.79 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 122.463 0.305 . . . . 72.13 111.534 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 p -124.49 122.85 38.77 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.093 0.473 . . . . 73.54 111.573 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HB2' ' A' ' 24' ' ' GLU . 42.8 mt -131.85 145.36 57.14 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 116.516 -0.311 . . . . 62.13 110.92 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 28.2 Cg_endo -63.59 -68.63 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.13 1.887 . . . . 64.43 112.684 177.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 m -131.0 156.04 45.8 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.207 -0.308 . . . . 71.12 110.785 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.553 HD11 HE22 ' A' ' 94' ' ' GLN . 27.8 pt -122.21 2.08 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 121.14 0.495 . . . . 73.25 111.886 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.95 -122.7 10.2 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.211 -0.519 . . . . 72.02 113.178 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -103.49 4.95 36.54 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.978 0.362 . . . . 54.01 111.978 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.08 118.49 70.94 Favored Pre-proline 0 CA--C 1.538 0.497 0 O-C-N 122.402 -0.186 . . . . 71.21 110.685 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.495 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 32.0 Cg_endo -63.94 131.37 30.62 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.145 1.897 . . . . 63.01 112.354 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.5 tp -48.01 -40.4 22.6 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.41 0.522 . . . . 61.33 112.41 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.45 -45.37 91.2 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.215 0.45 . . . . 62.13 112.215 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.495 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 22.9 t70 -71.66 -34.57 69.83 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.464 0.649 . . . . 73.01 110.228 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.479 ' CE2' ' HD3' ' A' ' 6' ' ' PRO . 21.6 t80 -58.77 -52.37 65.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.521 -0.763 . . . . 74.31 110.914 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.5 p -61.74 -40.42 95.05 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.266 -0.425 . . . . 70.31 111.19 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.9 tp -57.48 -52.74 64.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.28 -0.418 . . . . 63.04 111.278 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 56.4 mtpt -60.35 -49.28 78.2 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.942 0.401 . . . . 74.44 111.764 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 54' ' ' VAL . 34.2 tp -59.6 -45.03 93.12 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.338 -0.392 . . . . 72.34 111.735 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -48.19 73.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.348 0.499 . . . . 73.04 112.348 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.492 ' NH2' ' HG2' ' A' ' 70' ' ' LYS . 14.4 ptt180 -68.08 -31.38 70.97 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.916 0.388 . . . . 65.34 111.321 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.413 HE22 ' HA ' ' A' ' 7' ' ' GLU . 7.9 tt0 -70.91 -39.35 72.77 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.022 0.439 . . . . 45.42 111.246 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.415 ' CZ2' HD11 ' A' ' 71' ' ' LEU . 41.0 m0 -80.49 8.53 7.54 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.199 0.444 . . . . 73.54 112.199 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.5 -42.0 2.74 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.159 -0.543 . . . . 71.34 113.585 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 113.535 0.939 . . . . 64.33 113.535 -178.059 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 109.458 -0.571 . . . . 70.24 109.458 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.552 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -59.89 -99.08 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 112.968 0.729 . . . . 72.54 112.968 -178.102 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.802 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 15.3 m120 -76.22 78.05 3.02 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.506 -0.746 . . . . 73.32 111.778 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.9 135.49 7.72 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.162 -0.542 . . . . 32.44 112.809 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 99' ' ' PHE . 57.1 tp -147.26 119.89 8.56 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.752 0.31 . . . . 74.41 110.662 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.483 HD21 HD23 ' A' ' 71' ' ' LEU . 60.8 tp -107.55 132.81 52.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.856 0.36 . . . . 64.01 111.745 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.0 tp -121.85 112.23 18.09 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.378 -0.374 . . . . 72.15 111.127 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.18 126.9 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.878 0.37 . . . . 72.15 111.629 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.42 ' HA ' HG12 ' A' ' 97' ' ' VAL . 29.7 tp -109.84 120.64 43.11 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.196 -0.456 . . . . 54.23 111.335 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.545 HG21 HD13 ' A' ' 59' ' ' ILE . 51.8 t -100.92 103.46 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.581 -0.281 . . . . 52.01 110.745 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 67.1 tp -52.19 -44.89 64.95 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.307 0.484 . . . . 72.54 112.307 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.86 -31.55 66.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.036 -0.529 . . . . 73.54 112.249 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.553 HE22 HD11 ' A' ' 59' ' ' ILE . 51.2 mt-30 -110.56 -6.12 14.95 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.037 0.384 . . . . 62.44 112.037 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 42.17 31.02 0.22 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.672 0.789 . . . . 74.45 112.003 -171.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 58.2 mtt180 -107.25 142.33 37.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.774 -0.648 . . . . 74.33 110.972 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 90' ' ' LEU . 4.1 m -131.01 163.14 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.973 0.416 . . . . 74.34 111.124 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -148.41 137.03 21.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.411 -0.359 . . . . 64.03 111.329 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.645 ' HB3' HD11 ' A' ' 86' ' ' LEU . 89.9 m-85 -100.08 113.5 26.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.019 -0.537 . . . . 74.41 110.104 173.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -95.76 114.45 26.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.372 -0.232 . . . . 72.44 110.372 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.54 147.67 23.83 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.213 0.819 . . . . 61.33 113.213 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -97.77 178.37 32.3 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.122 -0.944 . . . . 44.43 112.539 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -62.72 -19.38 63.86 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.444 0.535 . . . . 73.11 112.444 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.74 -18.24 56.82 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.032 -0.604 . . . . 61.12 113.33 -177.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.602 HD11 HG13 ' A' ' 49' ' ' VAL . 91.4 mt -111.54 -4.54 14.76 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.889 0.7 . . . . 72.01 112.889 -175.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -58.76 -30.51 67.58 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.082 0.401 . . . . 71.12 112.082 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.49 -18.24 79.27 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.042 -0.599 . . . . 60.34 113.062 174.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -93.28 -57.39 2.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.277 0.56 . . . . 75.12 111.831 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.548 ' HB3' HD21 ' A' ' 114' ' ' LEU . 12.5 mt -119.64 89.0 40.39 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.611 -0.722 . . . . 75.04 112.253 -169.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.09 148.29 85.2 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.25 1.967 . . . . 64.44 111.571 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.25 -27.64 62.25 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.007 0.432 . . . . 74.35 111.385 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.53 -49.38 56.49 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.155 -0.545 . . . . 54.04 112.589 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.32 -44.26 84.03 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.158 0.504 . . . . 74.3 111.064 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 109' ' ' LEU . 89.6 mt -58.31 -43.17 88.02 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.263 -0.426 . . . . 52.21 111.083 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.6 m -62.88 -36.89 84.81 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.852 0.358 . . . . 51.44 111.118 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -60.21 -53.46 57.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.355 -0.384 . . . . 72.04 110.149 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.6 mt -51.53 -42.4 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.916 0.389 . . . . 73.22 111.234 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 122' ' ' MET . 76.6 mt -58.67 -55.87 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.818 0.342 . . . . 51.24 111.478 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -76.22 -9.72 58.85 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.506 0.558 . . . . 72.14 112.506 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -95.42 -45.36 7.14 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.162 0.43 . . . . 74.23 112.162 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.698 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 92.6 mtt180 -127.59 -4.11 5.97 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.599 0.962 . . . . 71.15 113.599 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 17.0 mmt -103.46 -63.27 1.2 Allowed 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.85 -0.531 . . . . 73.51 111.786 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.555 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 43.5 mm -50.07 -49.97 72.05 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 112.719 0.637 . . . . 65.21 112.719 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 11.1 Cg_endo -52.76 -37.19 75.74 Favored 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.366 2.044 . . . . 61.41 112.874 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.426 ' NE2' ' HG3' ' A' ' 137' ' ' GLU . 86.5 m-70 -77.61 -48.65 16.34 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.543 -0.299 . . . . 70.4 111.434 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.7 m-85 -57.06 -40.12 76.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.772 0.32 . . . . 73.33 111.42 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -59.35 -35.78 74.5 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.997 0.427 . . . . 74.13 111.291 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.2 t -84.18 -3.44 58.15 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.247 -0.433 . . . . 63.32 111.691 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.42 6.68 88.45 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.111 -0.566 . . . . 60.12 112.888 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.697 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.6 m-20 -84.08 55.79 3.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.688 0.395 . . . . 63.21 111.72 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -56.43 -44.35 80.34 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.06 0.392 . . . . 64.34 112.06 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.503 ' HB1' ' HG3' ' A' ' 32' ' ' GLN . . . -66.85 -32.77 74.26 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.94 0.4 . . . . 74.12 112.042 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.697 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 53.3 mt-10 -76.54 -43.39 39.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.391 -0.368 . . . . 74.44 111.508 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.64 -49.75 67.82 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.389 -0.434 . . . . 73.22 112.994 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 139' ' ' VAL . 92.2 mt -56.64 -39.75 74.22 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.746 0.308 . . . . 64.14 111.445 176.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.8 t -60.8 -45.69 93.43 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.085 0.469 . . . . 72.32 111.047 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.698 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 38.0 mm-40 -61.85 -44.86 95.98 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.996 -0.547 . . . . 72.43 111.819 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.88 -47.54 90.74 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.166 -0.54 . . . . 74.43 113.072 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 135' ' ' LEU . 83.4 t -60.55 -50.02 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.885 0.374 . . . . 65.14 111.511 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.93 -38.33 85.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.376 -0.374 . . . . 74.44 111.269 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.93 -54.63 44.76 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.996 0.427 . . . . 55.22 111.331 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.446 HG13 HD11 ' A' ' 109' ' ' LEU . 99.5 t -57.53 -47.7 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.147 -0.479 . . . . 71.04 111.133 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.407 HE22 ' NH1' ' A' ' 39' ' ' ARG . 63.4 tt0 -53.74 -37.7 63.62 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.211 -0.45 . . . . 73.32 111.817 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 144' ' ' GLN . 14.5 mm-40 -72.89 -38.99 66.76 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 111.609 0.225 . . . . 62.35 111.609 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.53 -42.87 95.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.998 0.427 . . . . 75.51 110.985 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.401 HD13 HG21 ' A' ' 49' ' ' VAL . 77.2 mt -64.43 -49.9 69.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.124 -0.489 . . . . 73.13 111.168 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 CA--C 1.538 0.516 0 CA-C-N 115.657 -0.701 . . . . 71.34 112.232 -176.075 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.461 HG12 ' HE3' ' A' ' 5' ' ' LYS . 97.8 t . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 121.372 0.606 . . . . 73.11 111.613 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -87.81 135.61 33.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.852 -0.613 . . . . 60.21 111.936 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.461 ' HE3' HG12 ' A' ' 3' ' ' VAL . 25.7 mmtp -100.93 158.99 30.76 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.47 -0.567 . . . . 74.33 109.47 169.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 9.5 Cg_endo -56.65 -32.08 89.46 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.43 1.42 . . . . 73.31 112.038 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -78.13 -12.72 60.01 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.483 0.549 . . . . 75.03 112.483 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -85.35 -18.04 34.97 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.953 0.406 . . . . 63.42 110.976 173.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.473 HG22 HD21 ' A' ' 56' ' ' LEU . 60.3 t -79.03 128.0 77.72 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.137 -0.483 . . . . 73.01 111.388 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.23 108.25 0.32 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.301 2.0 . . . . 74.53 111.899 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.524 ' ND2' HD13 ' A' ' 14' ' ' LEU . 14.7 p-10 -66.57 82.14 0.1 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.741 0.781 . . . . 74.42 112.158 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.42 1.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.487 -0.779 . . . . 64.11 113.0 -177.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.677 HE22 ' HG ' ' A' ' 20' ' ' LEU . 28.0 mm-40 -100.7 9.99 41.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.834 0.35 . . . . 75.55 111.305 174.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD13 ' ND2' ' A' ' 11' ' ' ASN . 10.1 tt -124.11 -46.0 1.96 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.442 -0.344 . . . . 74.12 111.35 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.77 -68.29 0.7 Allowed 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.146 -0.346 . . . . 61.04 111.654 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -80.07 -61.95 1.83 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.942 0.349 . . . . 73.01 111.942 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 m 63.11 7.06 2.55 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.656 0.383 . . . . 62.34 111.818 -174.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -99.26 -43.69 6.51 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.119 0.414 . . . . 64.13 112.119 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -82.51 -35.92 26.9 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.581 0.585 . . . . 74.44 112.581 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.677 ' HG ' HE22 ' A' ' 13' ' ' GLN . 6.8 mp 63.19 3.83 1.44 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.735 0.643 . . . . 71.55 112.735 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.5 t -108.8 154.32 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.663 0.385 . . . . 54.43 111.166 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.3 m -142.5 108.74 5.25 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.479 0.311 . . . . 75.25 111.031 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.53 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 20.7 p-10 -107.74 73.67 0.92 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.521 0.676 . . . . 72.14 112.616 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -79.18 -38.09 36.69 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.289 0.566 . . . . 71.13 110.453 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.19 66.59 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.918 -0.583 . . . . 54.3 112.403 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.26 19.2 73.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.152 -0.547 . . . . 41.42 113.195 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.11 0.12 54.27 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.053 0.39 . . . . 64.41 112.053 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -109.95 103.59 12.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.916 0.388 . . . . 74.02 111.04 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.7 t -70.33 165.98 21.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.368 -0.378 . . . . 64.24 111.403 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -46.72 -57.73 4.56 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.426 0.898 . . . . 74.1 113.426 -172.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.593 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . . . -68.06 -42.93 79.75 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.021 0.378 . . . . 74.53 112.021 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -62.26 -33.43 74.61 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.259 0.552 . . . . 74.32 111.069 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -74.2 -53.22 10.28 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.668 -0.696 . . . . 74.24 111.038 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 11.6 pt-20 -59.65 -43.59 93.85 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.129 0.418 . . . . 53.13 112.129 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 31' ' ' ALA . 89.0 t -65.8 -33.67 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.143 0.497 . . . . 71.14 110.91 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.447 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 50.8 ttm -65.34 -40.5 93.75 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 122.052 -0.405 . . . . 63.24 110.651 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.493 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -57.93 -56.36 22.95 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.989 0.423 . . . . 74.01 111.703 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.57 -43.03 85.83 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.306 -0.473 . . . . 72.34 113.416 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 73.4 mtm180 -62.55 -45.1 94.48 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 111.756 0.28 . . . . 72.13 111.756 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 36' ' ' MET . 89.1 mt -64.1 -50.84 66.71 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.025 0.44 . . . . 75.42 111.431 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -60.21 -37.79 81.37 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.272 -0.422 . . . . 74.2 111.447 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.33 -44.23 88.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.943 0.401 . . . . 73.31 111.271 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.651 HG22 ' HB ' ' A' ' 49' ' ' VAL . 63.5 mt -61.58 -38.79 81.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.937 0.398 . . . . 62.02 111.265 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 57.3 ttp180 -74.03 -33.24 63.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.917 0.389 . . . . 74.13 111.238 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.2 t -66.87 -38.53 86.5 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.1 0.476 . . . . 73.12 111.08 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.0 t -92.61 -61.67 1.55 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.99 -0.55 . . . . 62.32 112.162 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -91.91 -4.97 54.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.649 0.611 . . . . 63.01 112.649 -173.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.86 26.85 14.4 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.185 0.439 . . . . 63.41 112.185 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' HG22 ' A' ' 43' ' ' ILE . 62.5 t -90.7 128.31 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 112.215 0.45 . . . . 73.25 112.215 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -86.56 97.45 10.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.389 -0.369 . . . . 75.41 110.419 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.09 105.99 14.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.846 0.355 . . . . 74.44 110.539 -177.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.63 142.1 42.96 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.456 0.539 . . . . 65.14 112.456 -175.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.18 118.17 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.989 0.423 . . . . 74.34 111.437 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.544 HG21 HD21 ' A' ' 71' ' ' LEU . 61.8 t -114.62 142.27 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 122.516 0.326 . . . . 71.23 111.752 -178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.53 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 73.3 p -130.88 123.51 29.15 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.756 0.313 . . . . 62.21 111.293 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.473 HD21 HG22 ' A' ' 9' ' ' VAL . 68.2 mt -120.65 139.24 28.58 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 111.749 0.277 . . . . 72.34 111.749 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 83.2 Cg_endo -81.81 -11.75 11.25 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.634 2.222 . . . . 61.35 113.315 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.763 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 31.0 t -169.77 138.77 1.87 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.97 0.359 . . . . 73.34 111.97 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 3' ' ' VAL . 28.6 pt -136.86 -0.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 120.984 0.421 . . . . 71.23 110.365 170.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.27 -158.58 52.12 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 116.133 -0.485 . . . . 54.33 113.219 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.46 69.94 2.28 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.367 0.603 . . . . 73.2 110.873 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.55 142.44 41.88 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.731 -0.668 . . . . 73.04 111.26 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 77.1 Cg_endo -79.27 116.67 3.66 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.415 2.076 . . . . 73.42 113.092 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.51 -38.09 83.24 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.116 0.413 . . . . 73.24 112.116 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.03 -8.86 48.94 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.968 0.413 . . . . 74.21 111.967 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 31.1 t70 -96.59 -39.21 9.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.544 0.688 . . . . 74.24 109.632 170.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.463 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 43.3 t80 -55.2 -50.21 69.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.038 -0.983 . . . . 73.12 111.785 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -52.68 -49.39 65.38 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.858 0.361 . . . . 73.55 111.809 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.7 tp -59.57 -49.72 76.66 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.242 -0.436 . . . . 72.42 111.576 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -60.56 -47.74 84.84 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.243 0.46 . . . . 62.12 112.243 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 54' ' ' VAL . 51.2 tp -61.52 -47.85 83.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.242 0.544 . . . . 53.33 110.766 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.23 77.24 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.07 -0.514 . . . . 74.2 112.01 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -61.14 -52.37 65.12 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.844 0.354 . . . . 65.5 111.709 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.522 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 12.1 pt20 -72.05 -21.64 61.5 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 111.774 0.287 . . . . 64.31 111.774 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.522 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 30.3 m0 -91.03 -16.04 28.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.561 0.219 . . . . 73.13 111.451 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.51 40.44 99.11 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.387 -0.435 . . . . 74.44 113.238 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 112.547 0.573 . . . . 73.31 112.547 -175.81 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' TYR . 65.1 t30 . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 109.732 -0.47 . . . . 72.03 109.732 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.437 HD22 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -76.62 -109.3 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.623 -0.673 . . . . 62.42 112.505 -178.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.651 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.7 m-20 -81.23 78.98 7.97 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.433 -0.792 . . . . 72.03 111.724 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.93 140.69 11.65 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.164 -0.541 . . . . 64.13 113.339 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 99' ' ' PHE . 53.3 tp -148.77 124.61 10.57 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.858 0.463 . . . . 74.4 110.573 178.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.533 HD21 HD23 ' A' ' 71' ' ' LEU . 59.0 tp -115.1 132.68 56.52 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.696 0.284 . . . . 62.24 111.509 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.4 tp -122.4 123.25 40.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.795 0.438 . . . . 55.03 110.158 174.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 51.1 t -124.4 126.54 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.122 0.416 . . . . 53.3 112.122 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.662 ' HB2' HD21 ' A' ' 135' ' ' LEU . 24.1 tp -103.31 124.93 49.58 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.201 -0.454 . . . . 72.52 110.774 172.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.33 98.97 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.443 -0.344 . . . . 50.23 111.513 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.607 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 65.1 tp -55.68 -31.01 62.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.041 0.448 . . . . 45.44 111.561 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.763 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 11.5 t70 -49.97 -47.99 52.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.29 0.636 . . . . 75.4 111.759 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.502 ' OE1' ' HD2' ' A' ' 96' ' ' ARG . 8.9 pt20 -125.45 6.35 7.64 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.343 0.498 . . . . 72.21 112.343 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 56.91 30.79 18.58 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.063 0.764 . . . . 74.22 113.063 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.502 ' HD2' ' OE1' ' A' ' 94' ' ' GLN . 84.5 mtt180 -107.19 149.13 28.05 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.203 0.525 . . . . 71.33 111.676 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 90' ' ' LEU . 5.9 m -139.27 160.97 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.675 -0.693 . . . . 43.31 111.165 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -160.32 145.55 14.86 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.648 0.611 . . . . 74.35 112.648 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' HB3' HD11 ' A' ' 86' ' ' LEU . 96.8 m-85 -97.27 146.77 24.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.764 -0.653 . . . . 73.41 110.323 169.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 5.9 tp10 -135.62 113.0 10.62 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.284 -0.26 . . . . 74.44 110.632 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.419 HG21 ' HB2' ' A' ' 109' ' ' LEU . 6.2 p -95.76 160.88 14.26 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.455 0.909 . . . . 72.41 113.455 -175.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.42 -177.24 21.33 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 114.964 -1.017 . . . . 72.11 112.202 168.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' ASN . 19.5 t80 -65.34 -11.13 38.86 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.012 0.525 . . . . 73.12 112.337 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.67 -6.96 79.44 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.876 -0.678 . . . . 52.42 113.091 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 49' ' ' VAL . 97.5 mt -127.67 -12.48 5.45 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.062 0.764 . . . . 73.02 113.062 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -57.54 -17.97 16.7 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.373 0.879 . . . . 75.03 113.373 -175.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.04 -26.19 69.41 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.148 -0.548 . . . . 54.41 113.079 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -106.38 -44.07 4.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.933 0.397 . . . . 75.54 111.917 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.419 ' HB2' HG21 ' A' ' 101' ' ' THR . 29.5 mt -119.23 84.53 28.12 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 112.59 0.589 . . . . 61.33 112.59 -170.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.32 162.65 25.27 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.113 1.875 . . . . 71.11 112.251 171.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.33 -34.9 67.01 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.841 0.353 . . . . 71.33 111.644 -177.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.75 -50.18 66.37 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.019 -0.61 . . . . 73.24 113.046 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 109' ' ' LEU . 56.6 tp -58.68 -45.79 88.66 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.867 0.365 . . . . 64.3 111.151 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.401 ' O ' HG13 ' A' ' 118' ' ' ILE . 94.5 mt -58.35 -43.63 88.41 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.364 -0.38 . . . . 74.43 110.935 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.5 m -62.67 -38.5 90.57 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.418 -0.356 . . . . 55.15 111.037 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -58.04 -53.46 57.95 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.979 0.419 . . . . 71.3 110.659 174.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.2 mt -54.22 -49.48 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.006 0.431 . . . . 55.53 111.222 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 123' ' ' ILE . 96.9 mt -57.94 -56.81 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.974 -0.557 . . . . 73.12 111.936 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 46.2 m-70 -72.69 -40.87 65.89 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.828 0.677 . . . . 74.2 112.828 -173.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -78.84 -44.51 22.84 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.565 0.58 . . . . 75.13 112.565 -171.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -109.55 -32.91 6.95 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.199 0.814 . . . . 54.23 113.199 -173.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.566 ' HB3' ' HE2' ' A' ' 126' ' ' PHE . 85.4 mtp -87.94 -51.64 5.71 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.091 0.774 . . . . 63.34 113.091 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 118' ' ' ILE . 48.1 mm -51.77 -49.24 84.52 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 112.735 0.642 . . . . 54.43 112.735 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 87.1 Cg_exo -48.27 -28.81 11.83 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 122.665 2.243 . . . . 72.02 113.694 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 79.4 m-70 -83.32 -52.16 6.79 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.674 0.25 . . . . 72.3 111.674 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.566 ' HE2' ' HB3' ' A' ' 122' ' ' MET . 50.1 m-85 -56.83 -44.36 82.0 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.948 0.404 . . . . 71.32 111.468 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 123' ' ' ILE . 2.9 ptm180 -71.07 -10.26 59.46 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.279 -0.419 . . . . 74.03 111.64 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.9 m -110.41 -1.96 16.84 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 111.892 0.33 . . . . 73.24 111.892 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.61 -17.79 35.87 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.963 -0.637 . . . . 35.1 114.075 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.762 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 93.7 m-20 -80.08 81.32 6.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.322 0.561 . . . . 74.02 111.571 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -71.11 -54.65 10.33 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.873 0.368 . . . . 71.11 111.638 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.26 74.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.138 0.494 . . . . 62.23 111.842 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 5.5 mm-40 -74.52 -31.6 62.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.375 -0.375 . . . . 61.1 111.36 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.28 -42.4 57.42 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.029 -0.605 . . . . 75.31 112.366 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 90' ' ' LEU . 95.4 mt -62.32 -47.63 83.43 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.85 0.357 . . . . 65.4 111.611 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.3 p -59.28 -37.25 77.21 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.435 -0.348 . . . . 53.44 111.693 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -59.66 -48.78 80.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.719 0.295 . . . . 64.13 111.214 172.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.8 -50.48 67.2 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.024 -0.608 . . . . 63.01 112.941 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.0 t -57.75 -48.47 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.944 0.402 . . . . 74.43 111.314 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.508 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 55.1 tp -60.76 -41.08 94.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.237 -0.438 . . . . 65.25 111.292 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.39 -49.43 77.6 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.856 0.36 . . . . 72.1 111.324 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.49 -44.56 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.276 -0.42 . . . . 44.12 111.254 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -53.22 -41.88 65.79 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.15 -0.477 . . . . 74.32 111.306 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 85.1 mm-40 -60.26 -48.31 82.3 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.539 -0.3 . . . . 75.0 111.451 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.72 -49.63 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.021 0.378 . . . . 74.42 112.021 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 89.2 mt -70.36 -57.06 5.25 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.903 0.383 . . . . 72.41 111.77 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 120.989 0.424 . . . . 71.05 111.708 -176.481 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 112.896 0.702 . . . . 71.52 112.896 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.05 152.3 45.99 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.776 -0.647 . . . . 72.5 111.201 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -114.53 169.22 6.86 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 74.31 110.569 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.36 51.28 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.873 2.382 . . . . 74.12 112.117 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.36 -28.09 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.916 -0.583 . . . . 64.33 110.457 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -68.26 -28.76 67.49 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.289 0.566 . . . . 53.02 110.465 171.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.661 HG13 HG21 ' A' ' 22' ' ' THR . 60.7 t -70.46 122.27 85.97 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.481 -0.781 . . . . 74.14 111.525 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HG2' HG23 ' A' ' 22' ' ' THR . 21.9 Cg_endo -61.1 119.86 7.24 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.323 2.015 . . . . 74.23 112.049 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . 5.6 p30 -64.23 85.89 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.954 0.724 . . . . 73.24 112.954 -176.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.32 0.48 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 112.505 0.557 . . . . 72.44 112.505 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -121.87 5.51 9.92 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.087 0.403 . . . . 72.22 112.087 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 6.8 tt -115.14 -54.73 2.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.427 -0.583 . . . . 74.24 109.427 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.72 -55.28 35.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.124 0.488 . . . . 62.34 110.839 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -127.46 -179.57 4.97 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.093 -0.503 . . . . 75.21 110.768 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.6 p -130.27 -11.53 4.11 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.644 -0.253 . . . . 73.12 111.615 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -81.0 -45.64 16.28 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.932 0.716 . . . . 72.53 112.932 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.708 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 32.5 tpt180 -52.67 -61.91 1.98 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.203 0.445 . . . . 73.21 112.203 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 40' ' ' LEU . 17.5 mt 63.19 6.99 2.57 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.218 0.451 . . . . 61.23 112.218 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.708 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 95.4 t -133.64 121.42 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.842 0.353 . . . . 64.3 111.774 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.661 HG21 HG13 ' A' ' 9' ' ' VAL . 89.0 m -111.88 102.8 11.04 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.77 0.319 . . . . 75.23 110.807 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.473 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 7.6 p-10 -99.72 84.34 2.91 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.454 0.645 . . . . 74.53 111.936 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.586 ' HG2' HG22 ' A' ' 22' ' ' THR . 40.2 mm-40 -96.32 -44.83 7.06 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.115 -0.493 . . . . 73.42 110.786 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.64 -25.36 60.04 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.147 0.425 . . . . 62.44 112.147 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.99 44.59 45.37 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.376 -0.44 . . . . 54.21 113.14 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 92' ' ' LEU . 85.3 mt -102.27 -22.29 14.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.916 0.388 . . . . 72.13 111.884 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.4 mt -93.32 108.47 20.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.717 0.294 . . . . 74.34 111.12 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.527 ' HB2' ' OE1' ' A' ' 32' ' ' GLN . 49.1 m -78.52 162.08 26.58 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.534 -0.303 . . . . 71.51 111.117 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -44.98 -45.53 10.62 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.176 0.806 . . . . 75.14 113.176 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -63.88 -53.28 53.08 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.8 0.333 . . . . 52.35 111.708 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.582 ' HG2' ' HB1' ' A' ' 132' ' ' ALA . 22.6 mp0 -55.9 -40.63 73.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.065 0.46 . . . . 64.34 110.69 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.82 -52.8 63.89 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.095 -0.502 . . . . 73.43 111.02 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -55.12 -40.62 70.7 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.94 0.4 . . . . 63.21 111.608 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 31' ' ' ALA . 46.6 t -71.05 -44.65 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.072 0.463 . . . . 54.21 111.715 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 52.1 ttm -70.35 -51.82 27.16 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.871 0.323 . . . . 71.23 111.871 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -54.48 -50.35 67.95 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.389 -0.369 . . . . 61.4 111.709 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.7 -38.06 86.34 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.001 -0.618 . . . . 70.12 113.59 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 43' ' ' ILE . 81.7 mtm180 -72.01 -49.52 36.25 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.95 0.375 . . . . 65.31 111.375 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.474 ' HB3' HD13 ' A' ' 20' ' ' LEU . 87.9 mt -57.14 -52.66 64.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.021 0.438 . . . . 44.12 111.049 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -54.64 -41.64 70.3 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.055 -0.521 . . . . 71.04 111.375 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.15 97.8 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.933 0.397 . . . . 63.1 111.389 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.486 ' HA ' ' HD2' ' A' ' 47' ' ' HIS . 74.0 mt -64.91 -42.79 95.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.978 0.418 . . . . 61.12 111.083 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.493 ' NH1' ' HG2' ' A' ' 50' ' ' GLU . 8.4 tpt180 -61.46 -38.69 88.14 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.159 -0.473 . . . . 71.53 111.518 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.3 t -83.36 -41.96 17.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.238 0.459 . . . . 72.42 112.238 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -82.3 -62.49 1.61 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.124 0.488 . . . . 74.02 112.042 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.486 ' HD2' ' HA ' ' A' ' 43' ' ' ILE . 51.7 m-70 -83.06 -14.3 54.08 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.093 -0.503 . . . . 61.33 111.655 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.11 17.21 10.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.827 0.451 . . . . 72.34 111.846 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.671 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 96.8 t -87.28 129.89 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.147 0.498 . . . . 44.42 111.339 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HG2' ' NH1' ' A' ' 44' ' ' ARG . 27.3 mt-10 -83.3 96.41 8.49 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.095 -0.502 . . . . 64.53 110.654 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -119.27 101.63 8.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.174 -0.466 . . . . 70.51 110.505 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.4 133.99 54.88 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.319 0.488 . . . . 62.42 112.319 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.16 112.73 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.078 0.466 . . . . 44.31 111.313 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.669 ' HB ' HG22 ' A' ' 89' ' ' VAL . 57.4 t -109.11 134.14 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.374 -0.375 . . . . 72.02 111.107 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 69.1 p -119.81 122.2 40.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.879 0.371 . . . . 61.34 111.472 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.555 HD21 HG22 ' A' ' 9' ' ' VAL . 77.9 mt -128.32 140.61 38.84 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.402 -0.363 . . . . 71.2 111.013 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.47 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 19.7 Cg_endo -61.29 -47.02 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.982 1.788 . . . . 75.2 112.078 175.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.425 ' HA ' HG13 ' A' ' 91' ' ' VAL . 43.8 t -157.72 145.63 18.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.94 0.4 . . . . 61.04 111.525 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 pt -101.66 9.08 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.196 0.522 . . . . 71.01 111.202 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.73 -133.95 18.16 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.154 -0.546 . . . . 61.34 113.305 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.43 -19.39 28.12 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.938 0.348 . . . . 75.15 111.938 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.58 143.99 89.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.555 0.576 . . . . 72.22 112.555 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.2 Cg_endo -75.77 127.7 10.35 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.565 2.177 . . . . 74.2 112.131 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.07 -32.61 72.25 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.341 0.497 . . . . 72.53 112.341 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.737 ' HG2' ' HD3' ' A' ' 98' ' ' ARG . 44.2 mt-10 -62.56 -43.2 99.4 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.176 0.513 . . . . 72.32 111.702 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 2.2 m-20 -76.96 -33.08 57.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.979 -0.555 . . . . 74.32 110.903 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -59.12 -52.7 64.6 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.052 -0.522 . . . . 64.35 110.941 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.8 p -59.32 -41.78 89.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.307 -0.406 . . . . 72.54 111.728 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 48.5 tp -57.16 -49.17 76.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.958 0.408 . . . . 64.45 111.217 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -62.33 -47.07 85.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.93 0.395 . . . . 71.14 111.51 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.05 -36.97 83.21 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.102 0.477 . . . . 70.13 111.429 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.51 -38.59 71.12 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.265 0.468 . . . . 73.41 112.265 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 25.9 mtp180 -61.79 -47.99 82.68 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.41 0.522 . . . . 61.42 112.41 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.421 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.5 pt20 -59.44 -38.1 79.81 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.885 0.374 . . . . 74.01 111.842 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 50.0 m0 -78.11 -4.61 48.27 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 111.817 0.303 . . . . 73.01 111.817 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.41 -35.05 3.02 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.045 -0.598 . . . . 73.2 112.578 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.69 ' HA ' HD22 ' A' ' 82' ' ' ASN . 46.9 t . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 123.382 0.673 . . . . 73.41 112.751 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.69 HD22 ' HA ' ' A' ' 77' ' ' VAL . 14.7 t30 . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 120.361 0.124 . . . . 71.2 110.933 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.639 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -43.26 -72.42 0.06 Allowed 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 114.407 1.262 . . . . 75.35 114.407 -168.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.671 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 5.1 m-20 -87.98 21.79 2.59 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.508 -0.745 . . . . 73.42 112.286 -173.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 77' ' ' VAL . . . -81.51 128.22 8.34 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.02 -0.609 . . . . 63.32 114.468 -175.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 54.5 tp -145.12 118.81 9.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.785 0.434 . . . . 63.34 110.56 173.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.2 tp -116.1 126.82 54.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.88 0.372 . . . . 74.55 111.664 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 33.1 tp -116.07 111.86 20.91 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.03 -0.532 . . . . 64.21 110.813 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.669 HG22 ' HB ' ' A' ' 54' ' ' VAL . 70.4 t -118.23 130.07 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.714 0.293 . . . . 71.14 111.553 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.4 tp -109.72 125.88 53.12 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.96 0.41 . . . . 61.12 111.508 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 58' ' ' SER . 47.8 t -99.93 105.61 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.113 -0.494 . . . . 43.23 110.294 173.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 51.6 tp -57.09 -62.84 1.47 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.147 0.795 . . . . 70.11 113.147 -174.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.37 -27.16 68.87 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.283 0.475 . . . . 71.11 112.283 -171.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -97.14 -10.94 24.97 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.705 0.288 . . . . 73.51 111.343 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 50.97 67.39 0.95 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.562 0.696 . . . . 74.52 112.322 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -159.98 150.87 19.12 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.912 -0.586 . . . . 64.12 111.095 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.2 m -129.66 171.56 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.986 0.422 . . . . 72.41 111.759 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.737 ' HD3' ' HG2' ' A' ' 65' ' ' GLU . 6.0 mmm180 -141.11 153.5 45.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.327 0.584 . . . . 72.41 112.288 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.72 ' HB3' HD13 ' A' ' 114' ' ' LEU . 30.5 m-85 -129.86 111.49 12.63 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.265 -0.88 . . . . 62.51 110.129 175.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.7 tp10 -105.05 112.37 25.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.809 -0.178 . . . . 74.22 110.779 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.402 HG23 HD11 ' A' ' 114' ' ' LEU . 1.2 p -96.46 147.33 23.94 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.759 0.79 . . . . 73.32 112.874 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -95.41 174.13 31.93 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.178 -0.919 . . . . 54.55 112.696 171.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -56.02 -22.31 26.45 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.961 0.726 . . . . 72.43 112.961 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.68 -41.03 11.43 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.898 -0.668 . . . . 61.21 112.464 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.446 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 85.5 mt -81.1 -6.88 59.33 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.72 0.637 . . . . 72.33 112.72 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -59.57 -12.59 6.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.521 0.563 . . . . 72.11 112.521 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.96 -12.99 62.99 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.168 -0.539 . . . . 73.22 113.326 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -117.32 -47.47 2.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.08 0.467 . . . . 72.55 111.947 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.59 93.04 48.77 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 115.886 -0.597 . . . . 73.15 112.435 -168.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.62 160.51 31.48 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.293 1.995 . . . . 73.25 111.968 170.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -55.31 -36.55 66.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.679 0.276 . . . . 72.23 111.721 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.73 -49.12 82.13 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.258 -0.496 . . . . 65.52 113.21 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 tp -60.12 -44.05 95.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.012 0.434 . . . . 75.23 111.272 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.72 HD13 ' HB3' ' A' ' 99' ' ' PHE . 84.1 mt -62.31 -43.88 97.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.064 0.459 . . . . 73.04 110.969 177.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.4 t -64.42 -33.86 76.85 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.061 -0.518 . . . . 64.11 111.045 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -59.12 -52.3 66.33 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.004 -0.544 . . . . 74.33 110.385 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.23 -46.28 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.237 0.541 . . . . 75.44 110.937 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.438 HD11 ' HD2' ' A' ' 99' ' ' PHE . 72.4 mt -56.56 -56.01 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.584 -0.734 . . . . 51.25 111.79 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -81.38 -18.18 46.44 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.914 0.709 . . . . 70.23 112.914 -171.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -79.95 -58.59 3.09 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.683 0.278 . . . . 73.44 111.59 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -114.26 -34.64 5.25 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.201 0.815 . . . . 71.32 113.201 -174.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.428 ' SD ' ' HA ' ' A' ' 118' ' ' ILE . 85.8 mtp -68.59 -47.5 66.6 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.327 0.491 . . . . 75.11 112.327 -174.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.432 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 26.3 mm -55.63 -55.26 42.4 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 112.983 0.735 . . . . 72.35 112.983 -178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 11.6 Cg_endo -54.78 -42.61 67.02 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.928 1.752 . . . . 74.35 112.536 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -60.88 -48.13 83.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.57 0.224 . . . . 73.11 111.412 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.529 ' HD1' ' HA ' ' A' ' 131' ' ' TYR . 22.9 m-30 -56.39 -47.49 78.84 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.879 0.371 . . . . 64.34 111.288 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -64.88 -33.14 75.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.907 0.384 . . . . 75.13 111.197 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.7 m -82.15 -1.15 47.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.498 -0.319 . . . . 54.11 111.773 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.69 -16.6 60.18 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.151 -0.547 . . . . 72.24 113.595 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.864 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 92.7 m-20 -80.05 65.24 5.14 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.234 0.517 . . . . 64.25 111.995 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.529 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 96.5 m-85 -64.05 -32.46 74.03 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.858 0.361 . . . . 73.2 111.154 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.582 ' HB1' ' HG2' ' A' ' 32' ' ' GLN . . . -71.02 -50.84 29.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.986 0.422 . . . . 64.33 111.417 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.864 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 5.8 mp0 -57.16 -42.44 81.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.144 -0.48 . . . . 74.21 111.606 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.0 -52.08 54.47 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.421 -0.419 . . . . 62.24 113.037 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.04 -39.95 96.26 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.915 0.388 . . . . 64.34 111.516 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.8 t -60.93 -43.88 98.01 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.159 0.429 . . . . 61.15 112.159 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -75.26 -28.78 59.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.485 0.179 . . . . 73.44 111.485 177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.01 -49.08 82.43 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.69 -0.767 . . . . 43.44 111.965 172.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.87 -49.13 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.068 0.461 . . . . 72.25 111.203 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 52.7 tp -58.44 -40.49 82.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.983 -0.553 . . . . 75.21 111.494 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -59.31 -46.79 87.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.859 0.361 . . . . 65.3 111.446 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.24 -47.17 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.052 0.453 . . . . 53.34 111.168 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -51.79 -45.76 63.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.677 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 84.5 mm-40 -59.34 -42.04 90.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.935 0.398 . . . . 73.14 111.464 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 141' ' ' ALA . 85.5 t -60.73 -50.78 79.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 120.856 0.36 . . . . 54.15 111.17 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.64 -56.49 20.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.876 0.325 . . . . 72.51 111.876 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.096 0.406 . . . . 64.32 112.096 -175.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.4 t . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 121.263 0.554 . . . . 64.0 110.449 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -75.37 148.29 39.35 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.481 0.658 . . . . 73.34 112.521 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.524 ' HG2' ' HD2' ' A' ' 6' ' ' PRO . 6.9 tttp -130.74 157.97 76.23 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 115.365 -0.834 . . . . 72.31 109.754 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.524 ' HD2' ' HG2' ' A' ' 5' ' ' LYS . 77.8 Cg_exo -52.14 -26.06 25.07 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.431 2.088 . . . . 55.51 113.373 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -88.48 -16.47 32.66 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.08 0.4 . . . . 61.42 112.08 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -94.23 -24.85 17.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.901 0.381 . . . . 70.45 111.148 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.4 t -61.79 129.9 91.95 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.268 -0.424 . . . . 71.44 111.764 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.44 114.56 1.81 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.618 2.212 . . . . 61.23 112.851 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -71.19 77.07 0.71 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.878 0.37 . . . . 70.44 111.399 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.7 m -62.87 -44.64 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 122.267 -0.271 . . . . 64.11 111.471 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -64.4 -14.88 59.05 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.054 0.454 . . . . 73.22 111.884 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.54 -49.66 7.04 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.998 0.428 . . . . 65.12 110.004 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.12 -74.9 0.49 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.208 0.447 . . . . 73.53 112.208 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -109.18 81.49 1.45 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.501 0.667 . . . . 52.13 111.223 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 60.6 p -72.99 -29.85 63.36 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.915 -0.584 . . . . 42.12 112.101 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.5 m -65.25 -15.55 62.61 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.939 0.4 . . . . 62.14 111.832 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.3 ttt85 -75.56 -55.45 5.66 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.616 -0.265 . . . . 73.11 110.93 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 17' ' ' SER . 1.3 mt 72.46 -26.7 0.18 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.639 0.776 . . . . 72.14 112.635 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.63 141.01 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 122.895 0.478 . . . . 65.21 111.19 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 m -147.13 104.85 3.71 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.594 0.235 . . . . 72.1 111.307 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.429 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 33.6 t70 -106.99 109.77 21.74 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.165 0.507 . . . . 74.32 111.827 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -109.31 -39.51 5.2 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.042 0.449 . . . . 73.31 110.602 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.81 -23.28 17.45 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.868 0.692 . . . . 73.42 112.868 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.05 45.3 7.66 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.849 -0.691 . . . . 72.02 112.703 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.427 HD13 ' HB3' ' A' ' 131' ' ' TYR . 69.6 mt -117.72 -42.21 2.87 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.966 0.412 . . . . 75.43 111.558 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.03 104.6 14.22 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.834 0.349 . . . . 74.25 111.43 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 t -74.02 165.07 25.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.693 -0.23 . . . . 71.13 111.07 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -50.5 -55.77 14.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.017 0.747 . . . . 75.11 113.017 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . . . -59.0 -31.49 68.85 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.868 0.366 . . . . 54.14 111.916 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -73.84 -33.52 64.15 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.048 0.451 . . . . 63.44 110.649 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -69.29 -41.72 76.43 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.32 -0.4 . . . . 71.54 111.339 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 11.4 pt-20 -64.64 -38.96 92.8 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 111.996 0.369 . . . . 71.05 111.996 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.59 -49.16 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.267 0.556 . . . . 34.31 110.728 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.0 ttm -68.44 -29.34 67.97 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.068 -0.514 . . . . 72.22 110.916 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -65.13 -56.08 14.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.043 -0.526 . . . . 71.23 110.778 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.57 92.3 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.912 -0.661 . . . . 62.11 112.25 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.494 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.4 tpp180 -56.76 -54.48 45.83 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.184 0.594 . . . . 73.42 111.169 176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.57 -46.13 67.08 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.184 0.438 . . . . 52.42 112.184 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -58.57 -39.11 79.38 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.002 0.43 . . . . 63.12 110.926 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.71 81.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.193 -0.458 . . . . 61.13 111.077 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.572 ' HA ' ' HD2' ' A' ' 47' ' ' HIS . 66.2 mt -65.09 -45.59 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.657 0.265 . . . . 65.21 111.654 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 50.0 ttp180 -68.35 -26.65 65.7 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.095 -0.378 . . . . 75.32 111.838 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 t -89.15 -52.56 5.0 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.137 0.494 . . . . 61.44 111.155 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.1 m -72.22 -43.8 63.89 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.516 0.562 . . . . 74.22 112.516 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.572 ' HD2' ' HA ' ' A' ' 43' ' ' ILE . 75.3 m-70 -105.41 -15.91 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.343 0.497 . . . . 72.25 112.343 -175.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 68.02 20.69 9.03 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.128 0.49 . . . . 70.43 111.932 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.509 ' HB ' HG22 ' A' ' 43' ' ' ILE . 81.5 t -96.26 124.71 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.916 0.389 . . . . 61.12 111.239 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.47 97.31 9.96 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.437 0.637 . . . . 70.2 110.886 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.31 107.62 16.95 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.352 -0.84 . . . . 75.4 110.564 -176.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.76 145.17 38.56 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.057 0.391 . . . . 75.11 112.057 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.41 120.92 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.96 0.41 . . . . 74.2 111.381 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.39 128.94 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.299 -0.41 . . . . 41.32 111.614 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 22.3 p -110.79 123.72 50.62 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.922 0.391 . . . . 73.33 111.102 177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.8 mt -122.15 140.52 32.53 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 120.741 0.305 . . . . 62.52 111.275 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.15 -48.95 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.296 1.997 . . . . 65.54 112.65 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.7 p -150.88 144.91 25.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.699 0.285 . . . . 64.52 111.623 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 91' ' ' VAL . 32.7 pt -120.78 11.0 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.115 0.483 . . . . 73.14 111.044 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.28 -124.03 24.4 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.272 -0.49 . . . . 41.35 113.142 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.15 16.27 24.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.884 0.373 . . . . 70.41 111.417 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . . . -77.36 138.41 63.87 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 112.031 0.382 . . . . 62.23 112.031 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 62' ' ' ALA . 4.6 Cg_exo -77.0 121.44 5.82 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.728 2.285 . . . . 61.44 111.808 175.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.6 tp -55.74 -39.3 70.96 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.914 0.387 . . . . 73.1 111.364 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.29 -45.43 84.13 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.12 -0.491 . . . . 71.32 112.037 175.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.63 -17.56 50.88 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.418 0.628 . . . . 72.44 110.871 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -76.78 -56.15 4.86 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.794 -0.639 . . . . 74.43 111.279 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.7 p -53.22 -52.53 58.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.573 0.583 . . . . 74.54 112.573 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.502 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 42.1 tp -53.31 -54.52 35.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.213 -0.449 . . . . 71.53 111.872 -177.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -61.77 -40.19 94.28 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.443 0.535 . . . . 74.21 112.443 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 87' ' ' LEU . 63.0 tp -62.31 -45.46 93.13 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.326 0.584 . . . . 75.14 110.715 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.79 -30.21 66.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.061 -0.518 . . . . 43.44 112.113 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 75.8 mtp180 -64.59 -49.14 72.31 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.748 0.277 . . . . 51.41 111.748 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.79 -32.88 74.67 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.723 0.297 . . . . 72.12 111.439 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -74.23 -15.43 60.99 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.956 0.408 . . . . 75.41 110.986 173.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.56 27.15 72.99 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.374 -0.441 . . . . 74.41 113.359 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.466 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 22.4 t . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 112.131 0.419 . . . . 70.32 112.131 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 103' ' ' TYR . 66.3 t30 . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.136 0.493 . . . . 53.35 110.74 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.423 ' HA ' ' H ' ' A' ' 104' ' ' GLY . 0.2 OUTLIER -110.34 148.3 32.23 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.448 0.536 . . . . 74.03 112.448 178.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.468 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 3.6 m-20 58.04 19.35 5.89 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.058 0.762 . . . . 64.11 113.058 174.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 77' ' ' VAL . . . -106.27 132.09 10.96 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.801 -0.714 . . . . 52.32 113.487 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 101' ' ' THR . 46.4 tp -147.17 126.89 13.4 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.023 0.44 . . . . 64.01 111.202 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.488 HD21 HD23 ' A' ' 71' ' ' LEU . 64.1 tp -120.22 134.24 55.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.822 0.344 . . . . 71.34 111.418 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.6 tp -119.41 111.79 18.6 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.175 -0.466 . . . . 61.52 110.75 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.96 130.47 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.799 0.333 . . . . 65.42 111.611 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 135' ' ' LEU . 28.4 tp -110.04 124.42 51.43 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.183 -0.462 . . . . 52.22 111.096 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.407 HG21 HD13 ' A' ' 59' ' ' ILE . 48.0 t -105.07 105.81 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.746 0.307 . . . . 72.33 110.786 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 tp -57.78 -40.29 79.51 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.028 0.381 . . . . 74.41 112.028 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.2 -32.12 71.88 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.255 0.465 . . . . 74.43 112.255 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -105.29 -7.94 18.59 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 122.157 -0.339 . . . . 73.12 111.735 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 95' ' ' ARG . 48.8 mtm180 55.0 33.23 19.8 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.168 0.587 . . . . 75.22 112.531 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -137.54 161.64 35.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.853 0.359 . . . . 73.24 111.455 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.406 HG21 ' CE ' ' A' ' 122' ' ' MET . 7.6 m -131.7 171.93 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.225 -0.443 . . . . 72.04 111.307 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -152.13 133.94 14.82 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.979 0.418 . . . . 60.52 111.894 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 86' ' ' LEU . 97.4 m-85 -95.01 122.3 37.53 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.911 -0.586 . . . . 61.2 110.179 171.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -107.4 112.33 25.08 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.998 -0.371 . . . . 63.11 109.998 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.64 HG23 HD13 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -98.95 148.06 24.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.622 0.725 . . . . 61.33 112.696 -177.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -93.07 172.74 33.93 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.163 -0.926 . . . . 73.42 112.531 170.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' ASN . 55.3 t80 -54.61 -31.29 56.81 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.069 0.548 . . . . 74.54 111.925 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -67.74 -19.23 71.12 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 116.08 -0.509 . . . . 75.13 113.312 -177.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.492 HD11 HG13 ' A' ' 49' ' ' VAL . 91.3 mt -117.58 -5.49 11.18 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.94 0.348 . . . . 72.24 111.94 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -49.79 -44.05 48.75 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.858 0.463 . . . . 73.44 111.836 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.34 -25.41 75.49 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 114.468 0.547 . . . . 73.21 114.468 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -97.96 -35.43 10.47 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.324 0.583 . . . . 75.22 110.88 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HB3' HD21 ' A' ' 114' ' ' LEU . 53.2 mt -126.57 73.45 74.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.366 -0.834 . . . . 73.15 110.701 -177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.04 156.17 52.12 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.075 1.85 . . . . 64.03 112.447 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -46.81 -45.88 20.37 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 112.672 0.619 . . . . 75.41 112.672 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.34 -39.08 96.75 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.399 -0.429 . . . . 74.34 113.537 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.5 tp -67.32 -47.21 71.23 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 122.511 -0.405 . . . . 73.15 111.138 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 109' ' ' LEU . 89.4 mt -58.0 -43.9 86.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.152 -0.476 . . . . 75.34 110.823 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 t -60.35 -41.57 93.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.972 -0.558 . . . . 74.41 110.981 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 116' ' ' ARG . 43.3 ttm105 -57.93 -53.87 53.31 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.176 -0.466 . . . . 74.05 111.52 175.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.0 mt -51.99 -47.4 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.957 0.408 . . . . 61.22 111.215 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 114' ' ' LEU . 80.4 mt -55.72 -50.56 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.07 -0.513 . . . . 73.01 111.39 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.456 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 3.6 t-80 -80.39 -19.28 46.65 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.843 0.683 . . . . 74.14 112.843 -171.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -102.48 -46.74 4.68 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.488 0.922 . . . . 63.43 113.488 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 66.6 mtp180 -106.75 4.26 27.46 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.037 0.754 . . . . 75.21 113.037 -175.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.406 ' CE ' HG21 ' A' ' 97' ' ' VAL . 60.4 mtp -125.33 -51.9 1.63 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.61 0.596 . . . . 73.52 112.61 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.517 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 22.5 mm -51.77 -49.58 82.57 Favored Pre-proline 0 N--CA 1.48 1.029 0 N-CA-C 113.252 0.834 . . . . 65.12 113.252 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 14.7 Cg_endo -55.05 -29.51 65.59 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 122.143 1.896 . . . . 62.24 112.634 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 90.3 m-70 -75.3 -50.61 15.49 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.518 -0.31 . . . . 73.51 110.769 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.454 ' HD1' ' HA ' ' A' ' 131' ' ' TYR . 21.8 m-85 -57.53 -42.3 82.6 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.711 0.291 . . . . 73.42 111.6 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -62.19 -35.54 79.18 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.966 0.412 . . . . 73.23 111.16 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.5 m -83.07 -1.9 53.96 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.207 -0.451 . . . . 75.41 111.921 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.58 -4.77 79.87 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.315 -0.469 . . . . 75.32 113.203 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.5 m-20 -81.36 67.52 7.33 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.526 -0.397 . . . . 72.5 111.418 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.454 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 97.6 m-85 -61.68 -47.83 83.55 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.009 0.433 . . . . 70.13 111.875 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.9 87.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.94 0.4 . . . . 72.44 111.791 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 19.7 mm-40 -67.15 -39.7 86.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.437 -0.347 . . . . 74.43 111.444 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.41 -44.64 95.15 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.898 -0.668 . . . . 55.45 112.611 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 90' ' ' LEU . 95.4 mt -60.96 -45.04 96.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.698 0.285 . . . . 74.43 111.27 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.0 m -55.38 -49.29 72.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.469 -0.332 . . . . 73.15 111.789 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 44.3 mm-40 -65.68 -40.99 92.94 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.969 0.359 . . . . 75.21 111.969 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.76 -50.91 62.55 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 120.934 -0.651 . . . . 72.53 112.733 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 135' ' ' LEU . 97.1 t -59.21 -50.63 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.967 0.413 . . . . 73.12 111.552 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.444 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 58.5 tp -57.5 -45.58 84.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.163 -0.471 . . . . 71.34 111.17 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -57.6 -48.18 80.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.96 0.41 . . . . 72.13 111.628 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.16 -52.38 59.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.222 -0.444 . . . . 70.42 111.638 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -53.81 -42.09 68.03 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.807 0.337 . . . . 65.13 111.392 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 98.6 mt-30 -58.72 -46.69 86.77 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.392 -0.367 . . . . 63.22 111.178 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 141' ' ' ALA . 62.9 t -57.81 -50.11 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.83 0.348 . . . . 73.51 111.134 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.33 -48.27 79.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.431 -0.35 . . . . 73.43 111.72 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.002 0.429 . . . . 44.45 111.386 -179.175 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.7 t . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.173 0.511 . . . . 73.31 112.298 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -97.93 129.27 44.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.084 -0.507 . . . . 73.23 111.257 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 68.1 mttm -105.86 164.18 15.53 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.861 -0.609 . . . . 71.44 110.29 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 31.9 Cg_endo -62.19 -15.0 41.43 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.965 1.777 . . . . 61.52 112.349 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -94.46 -0.83 54.43 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.182 -0.463 . . . . 64.41 111.737 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -97.67 -34.5 10.91 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.017 0.436 . . . . 65.51 110.873 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.69 122.11 65.98 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 115.964 -0.562 . . . . 70.05 111.601 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.62 126.93 19.38 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.728 2.285 . . . . 74.42 112.863 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -75.34 83.47 2.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.486 0.66 . . . . 74.23 111.492 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.57 -26.61 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.902 0.704 . . . . 73.24 112.902 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -61.0 -15.72 35.02 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.249 0.463 . . . . 75.41 112.249 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -75.72 -51.45 12.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.992 0.425 . . . . 72.5 110.338 176.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.65 -69.28 0.78 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.012 0.434 . . . . 63.31 111.561 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 19' ' ' ARG . 3.2 m-20 -80.9 57.07 2.93 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.339 0.59 . . . . 75.32 112.021 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.3 p -65.47 -17.25 64.41 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.163 -0.471 . . . . 75.52 110.99 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.416 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 77.7 p -95.02 3.63 54.68 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.2 -0.455 . . . . 51.43 111.976 176.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 16' ' ' ASP . 13.2 ttm180 -105.34 -53.58 2.63 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.965 0.412 . . . . 53.4 110.7 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp 66.09 1.43 1.93 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.411 0.684 . . . . 63.04 112.705 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.3 t -107.54 140.82 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.904 0.383 . . . . 62.44 111.853 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 m -131.4 103.67 6.57 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.39 -0.368 . . . . 54.31 110.52 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.419 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 12.3 p-10 -100.64 96.5 7.39 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.648 0.737 . . . . 70.21 112.179 -178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -100.72 -44.57 5.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.823 -0.626 . . . . 52.13 110.899 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.84 -24.04 67.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.26 0.467 . . . . 53.2 112.26 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.84 28.74 70.21 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.261 -0.495 . . . . 73.15 113.374 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 92' ' ' LEU . 94.3 mt -86.5 7.38 26.27 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.541 -0.387 . . . . 41.34 111.668 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 135' ' ' LEU . 95.8 mt -116.46 121.94 43.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.458 -0.337 . . . . 74.32 111.543 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.1 m -65.38 146.06 55.38 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.176 -0.305 . . . . 74.22 110.176 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -48.39 -46.27 36.97 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.77 0.656 . . . . 72.24 112.77 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -61.0 -46.7 89.72 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.225 -0.297 . . . . 50.11 111.186 175.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -57.71 -37.88 74.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.62 0.248 . . . . 75.31 111.572 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -54.66 -54.72 38.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.257 0.551 . . . . 63.32 110.347 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -66.29 -42.06 88.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.752 -0.658 . . . . 74.12 111.718 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 31' ' ' ALA . 85.9 t -59.0 -36.64 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.24 0.543 . . . . 45.21 110.851 176.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 42.5 ttm -71.9 -44.55 63.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.47 -0.332 . . . . 72.51 110.711 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -53.15 -54.42 36.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.855 0.36 . . . . 72.54 111.144 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.22 -33.15 57.72 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 116.157 -0.474 . . . . 74.21 113.626 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.539 HH12 ' HB3' ' A' ' 136' ' ' SER . 85.0 mtm180 -75.15 -49.13 20.51 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.643 -0.328 . . . . 75.25 111.567 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.84 -48.88 77.14 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.473 0.654 . . . . 75.35 111.0 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 18' ' ' THR . 33.0 ttp180 -55.8 -42.44 75.62 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.279 -0.873 . . . . 74.23 111.643 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.76 75.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.855 0.359 . . . . 63.1 111.526 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.449 HG22 ' HB ' ' A' ' 49' ' ' VAL . 68.0 mt -61.29 -44.77 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.184 0.516 . . . . 73.43 111.241 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.622 ' HE ' ' HG2' ' A' ' 50' ' ' GLU . 1.5 tmt_? -61.9 -33.1 73.62 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.813 -0.63 . . . . 74.31 110.784 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.9 t -78.24 -48.6 15.41 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.976 0.361 . . . . 75.3 111.976 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.2 t -84.06 -68.03 0.75 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.04 0.385 . . . . 65.42 112.04 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -69.97 -13.6 62.31 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 111.767 0.284 . . . . 72.32 111.767 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 66.15 14.88 9.86 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.856 0.462 . . . . 51.24 111.916 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.694 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 61.6 t -84.42 115.8 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.324 -0.398 . . . . 72.31 110.914 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.622 ' HG2' ' HE ' ' A' ' 44' ' ' ARG . 36.8 mt-10 -76.31 95.58 3.8 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.335 0.588 . . . . 72.24 110.22 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.68 104.3 13.27 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.441 -0.799 . . . . 54.11 110.313 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.01 142.53 39.54 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.266 0.469 . . . . 70.31 112.266 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.6 t -123.22 126.33 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.003 0.43 . . . . 65.24 111.291 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.42 139.4 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 122.622 0.369 . . . . 70.1 111.076 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 76.7 p -121.04 122.63 40.5 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.817 0.342 . . . . 60.44 111.474 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -129.19 142.25 44.56 Favored Pre-proline 0 N--CA 1.471 0.624 0 CA-C-N 116.531 -0.304 . . . . 72.21 111.144 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.89 -55.57 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.268 1.979 . . . . 63.34 112.348 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.0 p -151.07 147.02 26.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.625 0.25 . . . . 74.5 111.305 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.7 pt -116.89 9.2 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.097 0.475 . . . . 75.44 111.819 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.23 -138.2 32.31 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.117 -0.563 . . . . 62.2 112.938 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -92.71 15.26 14.89 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.519 -0.401 . . . . 63.05 111.989 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.89 131.07 76.97 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.651 -0.25 . . . . 74.21 111.186 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.592 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 56.7 Cg_endo -71.7 125.51 11.18 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.259 1.972 . . . . 74.43 112.538 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.5 tp -62.37 -38.33 89.14 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.582 0.586 . . . . 73.24 112.582 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 12.5 mp0 -61.32 -39.04 89.06 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.761 0.791 . . . . 74.3 110.759 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.592 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 2.0 m-20 -76.64 -37.02 57.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.041 -0.981 . . . . 71.12 110.918 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -55.05 -52.68 62.43 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.753 -0.658 . . . . 74.44 110.85 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.5 p -62.18 -36.46 81.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.974 -0.557 . . . . 64.22 111.966 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.2 tp -57.01 -50.32 73.1 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.128 0.489 . . . . 51.43 110.711 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -59.12 -50.33 74.47 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.094 -0.503 . . . . 53.53 111.756 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.475 HD23 HD21 ' A' ' 87' ' ' LEU . 27.9 tp -64.67 -42.58 95.27 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.989 0.423 . . . . 64.33 111.451 -176.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.5 93.83 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.855 0.36 . . . . 73.01 111.514 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -62.28 -52.47 63.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.466 -0.334 . . . . 74.12 111.771 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 10.3 pt20 -63.43 -28.01 69.69 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.907 0.336 . . . . 72.12 111.907 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.407 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 44.9 m0 -86.61 -2.64 58.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.335 0.495 . . . . 71.5 112.335 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.16 12.18 68.38 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.917 -0.659 . . . . 72.45 113.416 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 41.3 t . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 120.996 0.426 . . . . 73.3 110.91 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 42.9 t30 . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 120.615 0.245 . . . . 63.42 110.624 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.519 HD22 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -68.48 -97.36 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 O-C-N 121.958 -0.464 . . . . 72.4 112.217 -178.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.694 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.2 m-20 -77.51 77.19 4.04 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.982 -0.449 . . . . 72.41 111.438 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.78 130.93 4.39 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.996 -0.621 . . . . 42.43 113.315 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.2 tp -144.51 123.05 12.45 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.933 0.396 . . . . 74.2 110.964 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.475 HD21 HD23 ' A' ' 71' ' ' LEU . 61.7 tp -112.97 135.11 54.1 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.864 0.364 . . . . 52.33 111.402 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 55.8 tp -124.98 120.81 32.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.695 0.398 . . . . 63.45 110.956 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 87.0 t -125.21 126.99 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.844 0.354 . . . . 75.24 111.53 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.504 HD22 HD11 ' A' ' 135' ' ' LEU . 29.6 tp -101.44 120.08 39.74 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.119 -0.491 . . . . 75.42 111.335 178.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.9 t -104.61 102.28 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.867 0.365 . . . . 73.43 111.157 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 27' ' ' LEU . 61.7 tp -56.87 -35.06 68.47 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.221 -0.445 . . . . 62.24 111.895 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -51.2 -36.49 41.65 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.832 0.679 . . . . 74.25 112.832 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -129.2 3.49 5.21 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.153 0.427 . . . . 74.11 112.153 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 57.37 20.82 6.24 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.939 0.399 . . . . 63.13 112.021 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -94.76 141.07 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 74.12 111.364 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.66 HG21 ' SD ' ' A' ' 122' ' ' MET . 4.4 m -129.89 144.66 37.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.769 -0.651 . . . . 74.33 110.497 177.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 14.6 tpt180 -121.32 128.48 52.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.856 0.36 . . . . 71.51 111.707 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.62 ' HB3' HD13 ' A' ' 114' ' ' LEU . 71.8 m-85 -100.69 102.29 13.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.089 -0.505 . . . . 73.41 109.755 171.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -98.51 112.88 24.77 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.898 0.38 . . . . 63.12 112.008 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.5 p -102.02 152.37 21.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.522 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.62 -95.44 0.61 Allowed Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.786 -0.721 . . . . 53.34 111.905 171.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -142.72 -23.56 0.64 Allowed 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.526 -0.397 . . . . 72.33 111.715 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.32 -29.61 75.68 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.858 -0.687 . . . . 74.44 113.3 -176.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.583 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 86.8 mt -92.93 0.32 57.38 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.447 0.536 . . . . 75.41 112.447 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -62.34 -19.99 63.92 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.003 0.43 . . . . 73.5 111.548 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.6 11.62 68.27 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.283 -0.484 . . . . 75.22 113.13 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.583 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 34.8 m-85 -136.58 -57.47 0.74 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.469 0.652 . . . . 74.0 110.355 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.492 ' HB3' HD21 ' A' ' 114' ' ' LEU . 12.2 mt -118.56 79.49 15.94 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.11 -0.95 . . . . 74.13 111.25 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.89 146.54 94.96 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.183 1.922 . . . . 73.05 112.714 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -51.28 -32.67 25.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 116.155 -0.475 . . . . 51.34 111.301 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.12 -44.82 75.2 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.36 -0.448 . . . . 73.12 113.143 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 tp -60.55 -49.69 76.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.207 0.527 . . . . 73.14 110.873 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 99' ' ' PHE . 76.7 mt -56.93 -37.28 71.27 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.712 -0.676 . . . . 61.23 111.191 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.6 t -56.79 -46.85 81.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.122 -0.49 . . . . 52.25 111.383 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -65.11 -41.59 94.77 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.944 -0.302 . . . . 70.31 111.18 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.581 HG23 ' HD3' ' A' ' 121' ' ' ARG . 65.4 mt -50.34 -39.67 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.038 0.447 . . . . 75.2 111.19 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 122' ' ' MET . 62.3 mt -60.35 -51.01 77.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.007 -0.542 . . . . 75.41 111.363 175.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.416 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 12.9 m-70 -81.56 -19.1 42.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.821 0.674 . . . . 73.11 112.821 -175.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.511 ' HB3' ' HD2' ' A' ' 121' ' ' ARG . 9.3 t70 -83.36 -49.09 9.7 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.109 0.411 . . . . 72.4 112.109 -173.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.581 ' HD3' HG23 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -119.18 -31.25 4.75 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.155 0.798 . . . . 74.44 113.155 -177.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.66 ' SD ' HG21 ' A' ' 97' ' ' VAL . 37.0 mtt -73.28 -56.71 4.71 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.967 0.729 . . . . 53.25 112.967 -176.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.503 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 44.4 mm -50.58 -52.14 58.56 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.954 0.724 . . . . 73.21 112.954 -176.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 10.3 Cg_endo -52.23 -29.58 38.43 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.237 1.958 . . . . 72.24 113.254 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -84.15 -48.19 10.09 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.925 0.343 . . . . 74.31 111.925 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.2 m-85 -55.78 -46.64 77.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.279 0.561 . . . . 75.43 111.34 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -65.48 -17.04 64.26 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.727 -0.669 . . . . 73.24 111.722 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.2 t -90.05 -13.59 35.6 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.12 -0.491 . . . . 71.44 110.939 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.71 -0.61 61.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.982 -0.447 . . . . 72.13 111.982 -172.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.809 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.57 68.04 10.29 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.96 0.504 . . . . 74.31 111.202 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.406 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 96.1 m-85 -70.8 -48.24 55.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.661 0.267 . . . . 72.3 111.701 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.338 0.589 . . . . 61.31 111.289 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.809 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 9.2 tp10 -61.6 -50.19 73.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.578 -0.737 . . . . 71.15 110.884 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.81 -47.21 91.62 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.21 -0.45 . . . . 62.02 113.6 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 90' ' ' LEU . 90.9 mt -57.72 -44.53 86.04 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 122.585 -0.362 . . . . 71.32 111.285 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.539 ' HB3' HH12 ' A' ' 39' ' ' ARG . 43.7 m -60.18 -44.06 95.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.474 -0.33 . . . . 71.54 111.557 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -61.07 -40.2 92.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.775 0.321 . . . . 71.43 111.5 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.22 -51.32 57.49 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.944 -0.646 . . . . 55.03 112.835 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.21 -46.6 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.206 0.527 . . . . 72.24 111.265 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.425 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 47.8 tp -59.7 -39.42 84.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.847 -0.615 . . . . 74.21 111.413 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -62.52 -50.5 71.1 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.922 0.392 . . . . 71.55 111.158 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.26 -48.5 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.112 0.482 . . . . 52.52 111.106 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -51.28 -40.37 58.79 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.8 -0.636 . . . . 73.12 111.751 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 79.8 mt-30 -69.74 -42.55 73.79 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 111.948 0.351 . . . . 73.44 111.948 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ALA . 57.4 t -58.34 -50.8 77.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.803 0.335 . . . . 73.31 111.617 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.3 mt -53.21 -48.1 68.38 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.454 -0.339 . . . . 53.04 111.794 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 120.935 0.398 . . . . 75.42 112.025 -179.224 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 120.907 0.384 . . . . 72.22 111.69 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -94.08 139.94 30.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.268 0.556 . . . . 65.01 112.072 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 56.8 mtpt -111.71 163.25 18.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.714 -0.675 . . . . 72.5 110.012 173.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 16.5 Cg_endo -55.38 -23.73 39.75 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.392 2.062 . . . . 71.21 112.854 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.34 -22.81 38.18 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.22 -0.446 . . . . 74.44 111.839 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -91.76 -19.69 22.32 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.83 0.347 . . . . 72.45 111.599 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.29 120.73 80.19 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.488 -0.324 . . . . 71.33 111.213 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.47 111.2 0.69 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.667 2.245 . . . . 73.13 112.978 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -70.81 82.57 0.64 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.346 0.593 . . . . 74.22 110.832 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.82 -28.31 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.414 0.524 . . . . 72.41 112.414 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' A' ' 20' ' ' LEU . 26.6 mm-40 -72.15 -24.53 61.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.893 0.378 . . . . 74.51 111.842 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 14' ' ' LEU . 6.7 tt -75.57 -39.71 57.72 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.19 -0.67 . . . . 73.22 109.19 171.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.86 -80.13 0.08 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.863 -0.608 . . . . 64.34 112.16 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -121.93 109.03 14.12 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.661 0.267 . . . . 74.01 111.584 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 p -59.12 -24.9 63.38 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.857 0.361 . . . . 73.23 111.765 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.4 m -61.78 -26.36 68.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.399 -0.364 . . . . 70.12 111.517 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -114.6 112.68 23.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.221 0.534 . . . . 74.31 110.954 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 4.6 mp -101.5 7.59 42.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.075 -0.511 . . . . 62.34 110.751 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 16.4 t -119.5 116.47 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.64 0.607 . . . . 73.01 112.64 -172.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.0 m -104.44 105.79 16.04 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.402 -0.363 . . . . 54.13 111.157 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 30.2 t70 -96.56 101.67 13.32 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.081 0.467 . . . . 70.13 111.345 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.52 ' HB2' HD23 ' A' ' 56' ' ' LEU . 27.7 mm-40 -103.77 -39.55 6.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.003 0.43 . . . . 64.44 111.065 177.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.85 -21.58 57.12 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.913 0.709 . . . . 65.41 112.913 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.22 55.46 5.16 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.938 -0.649 . . . . 64.23 112.486 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -122.13 -47.76 2.13 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.873 0.368 . . . . 74.33 111.466 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.4 HD21 HD12 ' A' ' 135' ' ' LEU . 96.2 mt -74.22 115.24 13.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.136 0.493 . . . . 63.43 111.931 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 90.8 p -71.1 162.07 30.06 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.018 -0.537 . . . . 71.53 111.241 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -53.49 -35.51 60.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.123 0.487 . . . . 65.41 110.872 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.69 -48.48 69.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.932 -0.576 . . . . 74.45 111.244 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -60.46 -42.73 96.77 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.574 0.226 . . . . 74.31 111.59 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.01 -44.84 95.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.776 0.322 . . . . 72.43 110.926 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -54.57 -55.18 32.05 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.031 0.443 . . . . 74.22 111.238 177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.89 -46.08 97.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.897 -0.592 . . . . 51.14 111.811 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.522 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 50.0 ttm -66.84 -52.12 47.51 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.529 -0.305 . . . . 72.31 111.742 -176.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -62.88 -37.67 87.85 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.407 0.146 . . . . 74.15 111.236 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.67 -48.24 85.89 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.006 -0.616 . . . . 62.25 112.532 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 48.1 mtp180 -64.0 -47.55 79.85 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.308 0.243 . . . . 61.3 111.608 177.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 36' ' ' MET . 85.4 mt -58.57 -52.72 64.47 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.129 0.49 . . . . 63.12 111.361 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -60.18 -34.87 74.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.027 -0.533 . . . . 75.45 110.862 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.21 96.89 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.845 0.355 . . . . 52.54 111.143 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 49' ' ' VAL . 70.8 mt -62.25 -42.27 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.488 -0.324 . . . . 75.52 110.78 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 28.1 tpt180 -61.51 -37.63 84.42 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.989 0.423 . . . . 62.11 111.088 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.4 m -70.11 -31.51 69.1 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.129 0.418 . . . . 65.4 112.129 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.6 t -98.72 -64.54 1.03 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.004 0.372 . . . . 51.34 112.004 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -87.5 -10.56 51.43 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.5 0.556 . . . . 71.33 112.5 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 69.08 3.46 4.07 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.312 0.486 . . . . 74.23 112.312 -176.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.851 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 93.2 t -64.45 122.62 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 121.008 0.432 . . . . 75.33 111.459 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -88.84 95.54 10.33 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.3 0.572 . . . . 75.22 109.865 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -113.17 102.7 10.62 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.646 -0.706 . . . . 74.24 111.013 -172.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -105.17 145.86 30.01 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.356 0.502 . . . . 74.33 112.356 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 61.3 t -124.23 138.3 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.394 -0.366 . . . . 75.34 110.933 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.1 t -133.29 143.31 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 122.231 -0.293 . . . . 53.23 111.118 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 28.4 p -125.54 123.15 38.5 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.803 0.335 . . . . 71.42 110.752 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 24' ' ' GLU . 81.8 mt -127.39 143.22 46.48 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 122.245 -0.284 . . . . 75.52 111.515 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.74 -61.48 0.28 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.598 2.199 . . . . 75.04 112.519 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.8 p -149.35 146.41 27.5 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.973 0.416 . . . . 72.13 112.046 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.471 HG12 HG11 ' A' ' 91' ' ' VAL . 31.9 pt -110.6 5.0 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.957 -0.565 . . . . 73.32 110.682 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.92 -120.4 22.02 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.886 -0.597 . . . . 73.3 113.526 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -97.83 4.86 49.65 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.895 0.378 . . . . 72.42 111.788 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.46 140.44 92.47 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 120.672 0.272 . . . . 74.23 111.731 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.662 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.5 Cg_endo -75.99 125.86 8.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.321 2.014 . . . . 75.34 112.518 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.3 tp -58.62 -42.01 87.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.046 0.451 . . . . 71.4 111.711 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.73 -59.68 4.19 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.875 -0.602 . . . . 74.22 111.057 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.662 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 3.3 m-20 -62.97 -41.53 99.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.705 -0.68 . . . . 64.13 111.627 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -53.62 -49.96 66.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.274 -0.421 . . . . 64.34 111.763 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.3 p -57.48 -48.86 78.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.412 -0.358 . . . . 75.44 111.891 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.4 -45.42 88.39 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.844 0.354 . . . . 65.23 111.712 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 66' ' ' ASP . 31.7 mmmt -56.25 -45.51 80.02 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.999 0.428 . . . . 54.44 111.661 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.418 HD23 HD21 ' A' ' 87' ' ' LEU . 52.3 tp -73.42 -38.13 65.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.214 0.53 . . . . 73.14 111.297 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.81 -35.45 72.87 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.292 -0.413 . . . . 72.2 112.103 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -61.31 -53.91 50.66 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.321 0.489 . . . . 73.02 112.321 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.628 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 7.2 pt20 -67.06 -27.44 67.38 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.383 0.512 . . . . 64.52 112.383 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.628 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 16.3 m0 -80.74 -12.22 59.49 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.884 0.328 . . . . 74.42 111.884 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.76 -2.16 66.57 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.266 -0.492 . . . . 74.24 114.029 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.543 0.674 0 N-CA-C 112.714 0.635 . . . . 64.12 112.714 -177.474 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.439 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 23.0 t-20 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 121.244 0.545 . . . . 73.2 111.064 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.698 HD22 ' N ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -51.38 -64.29 0.86 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 112.772 0.656 . . . . 73.51 112.772 177.102 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.851 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 18.3 m120 -88.02 8.16 27.86 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.683 -0.636 . . . . 75.31 112.146 -177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.99 124.62 9.23 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 114.735 0.654 . . . . 75.34 114.735 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 99' ' ' PHE . 50.9 tp -144.23 119.59 10.26 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.705 0.402 . . . . 71.3 110.755 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.6 tp -110.99 135.44 51.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.817 0.341 . . . . 74.4 111.564 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -120.84 108.14 13.57 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.741 0.305 . . . . 74.23 110.863 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.0 t -108.5 120.15 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.075 0.398 . . . . 75.15 112.075 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.548 ' HB2' HD21 ' A' ' 135' ' ' LEU . 29.2 tp -100.1 129.4 46.13 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.014 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.471 HG11 HG12 ' A' ' 59' ' ' ILE . 44.2 t -116.98 107.79 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.462 -0.335 . . . . 65.11 110.683 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.1 tp -53.47 -44.36 68.91 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.044 0.449 . . . . 71.52 111.504 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -57.64 -33.5 68.36 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.95 -0.568 . . . . 71.2 112.265 177.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -92.66 -11.95 32.82 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 122.241 -0.287 . . . . 72.11 111.62 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 54.64 29.05 10.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.995 0.518 . . . . 73.41 111.891 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -149.81 173.53 13.64 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.09 0.471 . . . . 70.02 111.908 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.535 HG21 ' SD ' ' A' ' 122' ' ' MET . 8.9 m -135.41 171.93 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.877 -0.601 . . . . 70.13 111.056 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -145.8 141.52 28.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.926 0.393 . . . . 73.42 111.532 168.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.67 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 79.0 m-85 -98.36 124.9 43.27 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.887 -0.597 . . . . 71.22 110.373 172.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.99 119.25 38.92 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.275 -0.266 . . . . 73.41 110.726 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.591 HG23 HD11 ' A' ' 114' ' ' LEU . 18.5 p -98.19 139.11 34.47 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.03 0.443 . . . . 75.22 111.847 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -68.39 -80.84 0.21 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.582 -0.818 . . . . 54.32 112.297 173.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -155.66 -43.62 0.08 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.934 0.397 . . . . 74.32 112.044 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.634 ' H ' ' HA ' ' A' ' 83' ' ' ASN . . . -62.13 -41.76 99.71 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.516 -0.374 . . . . 62.13 113.617 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 88.2 mt -71.15 -3.08 18.13 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.251 0.834 . . . . 72.34 113.251 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -60.85 -15.49 30.89 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.939 -0.476 . . . . 70.11 112.03 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.7 1.18 80.95 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.177 -0.535 . . . . 62.05 113.301 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -136.94 -54.36 0.71 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.332 0.587 . . . . 74.02 111.452 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.423 ' HB3' HD21 ' A' ' 114' ' ' LEU . 14.6 mt -117.25 86.62 21.67 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.578 -0.737 . . . . 73.44 111.821 -174.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.39 159.0 22.78 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.332 2.021 . . . . 75.43 112.529 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.435 ' HA ' HD12 ' A' ' 114' ' ' LEU . 14.3 t70 -45.91 -40.22 9.82 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 120.977 0.417 . . . . 65.22 111.746 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.03 72.11 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.336 -0.459 . . . . 43.51 113.284 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.26 -40.2 96.74 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.03 0.443 . . . . 75.23 111.095 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.67 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 86.1 mt -57.66 -48.17 80.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.052 -0.522 . . . . 72.34 111.127 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.4 t -69.08 -34.48 75.19 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.106 0.479 . . . . 63.33 110.804 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 116' ' ' ARG . 15.4 ttm180 -56.56 -53.92 51.93 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.904 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.12 -41.69 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.027 0.441 . . . . 63.14 111.528 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.482 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 60.4 mt -58.61 -54.51 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.165 0.507 . . . . 64.42 110.888 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -75.1 -14.9 60.62 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.28 -0.418 . . . . 70.33 112.008 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -79.21 -53.04 7.36 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.226 0.454 . . . . 74.33 112.226 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -133.72 -23.68 1.79 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.202 0.816 . . . . 73.2 113.202 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.535 ' SD ' HG21 ' A' ' 97' ' ' VAL . 36.4 mtt -67.56 -53.6 26.96 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.509 0.559 . . . . 74.32 112.509 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 118' ' ' ILE . 47.7 mm -51.38 -53.63 47.44 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 112.85 0.685 . . . . 74.45 112.85 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 10.5 Cg_endo -53.58 -41.98 69.44 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.989 1.793 . . . . 74.32 112.623 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.475 ' CD2' ' HG3' ' A' ' 137' ' ' GLU . 60.5 m-70 -64.47 -50.68 66.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.279 -0.263 . . . . 75.53 111.491 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.6 m-85 -56.4 -45.25 80.72 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.854 0.359 . . . . 73.54 111.431 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 58.6 mtp180 -62.49 -34.82 77.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.963 0.411 . . . . 75.12 110.988 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.6 m -80.82 -4.44 54.69 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.104 -0.498 . . . . 62.31 111.87 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.7 -8.44 63.78 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.517 -0.373 . . . . 34.11 113.601 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.781 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.4 m-20 -78.81 72.41 5.33 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 122.327 -0.513 . . . . 62.23 112.139 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -71.45 -56.13 6.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.018 0.437 . . . . 65.01 111.177 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.91 89.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.184 -0.462 . . . . 72.14 111.468 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.781 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 9.4 tp10 -68.56 -46.43 69.48 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.17 -0.468 . . . . 63.1 110.768 176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.84 -41.75 67.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.579 -0.343 . . . . 52.15 113.267 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 90' ' ' LEU . 83.4 mt -60.65 -48.79 80.2 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.888 0.375 . . . . 75.24 111.178 175.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -60.56 -38.85 85.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.326 -0.397 . . . . 74.5 110.941 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.475 ' HG3' ' CD2' ' A' ' 125' ' ' HIS . 15.7 mm-40 -58.44 -51.37 70.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.173 -0.467 . . . . 60.44 111.503 175.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.439 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -58.76 -47.94 87.71 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.9 -0.667 . . . . 75.34 112.444 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.29 -39.68 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.968 0.413 . . . . 74.11 111.218 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.492 ' HG ' HE21 ' A' ' 144' ' ' GLN . 27.9 tp -70.88 -33.99 71.15 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.381 -0.372 . . . . 72.02 110.667 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.52 -50.79 57.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.847 0.356 . . . . 74.2 110.86 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.7 t -57.47 -47.34 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.116 0.484 . . . . 65.1 110.535 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -53.81 -46.91 71.24 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.051 -0.522 . . . . 74.14 111.82 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.492 HE21 ' HG ' ' A' ' 140' ' ' LEU . 74.4 mt-30 -57.42 -38.1 73.82 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.841 0.353 . . . . 71.41 111.426 177.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.98 -49.08 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.707 0.289 . . . . 72.23 111.029 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.36 -58.21 4.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.867 0.321 . . . . 72.3 111.867 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 121.045 0.45 . . . . 63.21 111.845 178.383 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 121.044 0.449 . . . . 74.14 111.754 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -91.59 141.17 29.0 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.109 0.48 . . . . 75.01 111.405 174.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.503 ' HB2' ' NZ ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -111.45 158.35 36.52 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 116.316 -0.402 . . . . 52.04 110.647 175.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 64.4 Cg_endo -70.93 19.31 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.819 2.346 . . . . 63.22 114.541 -173.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.676 ' HA ' HE22 ' A' ' 74' ' ' GLN . 0.0 OUTLIER -126.38 -12.07 6.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.756 0.313 . . . . 62.11 111.657 173.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -97.45 -19.27 18.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.947 0.403 . . . . 54.01 111.121 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.21 130.92 84.04 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.322 -0.399 . . . . 54.24 111.412 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.04 110.84 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.828 2.352 . . . . 54.32 113.173 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -70.96 98.0 1.53 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.215 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 13' ' ' GLN . 27.8 m -93.26 -50.25 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 113.495 0.924 . . . . 53.2 113.495 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.575 ' HG3' HG21 ' A' ' 77' ' ' VAL . 15.1 mm100 -53.77 -33.75 56.85 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.654 1.353 . . . . 63.14 114.654 -169.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.428 ' H ' ' CD2' ' A' ' 14' ' ' LEU . 1.6 pt? -77.48 5.34 9.1 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.617 0.599 . . . . 62.44 112.617 -175.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.02 -51.56 0.06 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.196 0.522 . . . . 75.32 111.498 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -83.14 47.67 1.27 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.3 -0.409 . . . . 64.22 111.256 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 m -61.0 -11.79 9.32 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.689 0.626 . . . . 74.41 112.689 -176.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -77.71 -30.7 51.91 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.176 0.512 . . . . 65.1 110.635 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.47 ' HA ' ' OD1' ' A' ' 37' ' ' ASN . 13.0 ttm105 -108.34 95.04 5.39 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.452 0.644 . . . . 74.31 110.761 175.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 20' ' ' LEU . 3.9 mp -88.89 13.6 12.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.812 -0.631 . . . . 73.21 111.04 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.54 127.36 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.326 -0.397 . . . . 63.22 111.773 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.0 m -121.1 103.16 8.81 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.439 -0.346 . . . . 73.24 110.619 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.4 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 24.1 t70 -99.51 101.99 13.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.989 0.424 . . . . 73.35 111.495 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HB2' HD23 ' A' ' 56' ' ' LEU . 23.6 mm-40 -103.0 -34.42 8.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.214 0.53 . . . . 71.52 110.714 176.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.32 -28.26 69.08 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.51 0.559 . . . . 71.15 112.51 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.68 28.43 51.36 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.886 -0.673 . . . . 71.12 112.432 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.51 -17.2 22.64 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.824 0.345 . . . . 63.43 111.319 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.4 mt -107.62 114.19 28.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.924 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 t -65.93 152.73 43.86 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.341 -0.224 . . . . 63.54 110.467 175.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -45.03 -51.78 9.61 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.854 0.687 . . . . 74.23 112.854 -174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -60.28 -50.26 74.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.646 0.26 . . . . 71.12 111.452 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -58.09 -39.87 79.68 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.177 0.513 . . . . 71.31 111.426 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -50.73 71.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.906 -0.588 . . . . 74.14 110.621 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.06 -30.75 71.8 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.724 0.297 . . . . 61.23 111.371 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 31' ' ' ALA . 74.8 t -62.01 -46.37 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.951 0.405 . . . . 63.33 110.35 172.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.708 ' SD ' HG21 ' A' ' 139' ' ' VAL . 51.7 tpp -60.3 -43.85 95.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.422 -0.354 . . . . 75.24 110.356 175.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.552 ' HB3' ' NH2' ' A' ' 41' ' ' ARG . 60.3 m-80 -56.74 -38.19 72.04 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.468 -0.333 . . . . 73.2 110.658 173.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.6 -46.32 94.65 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.887 -0.673 . . . . 41.23 112.203 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' A' ' 39' ' ' ARG . 1.5 mmp_? -57.61 -55.74 30.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.023 0.44 . . . . 63.43 111.174 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.87 -45.58 91.9 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.099 -0.5 . . . . 73.12 112.098 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' NH2' ' HB3' ' A' ' 37' ' ' ASN . 36.3 ttm180 -62.15 -40.75 97.03 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.018 0.527 . . . . 74.15 110.929 -178.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.64 -46.52 89.42 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.338 -0.392 . . . . 54.21 111.011 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.435 HG22 ' HB ' ' A' ' 49' ' ' VAL . 76.1 mt -59.79 -44.7 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.124 0.488 . . . . 64.23 110.96 175.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 31.7 tpt180 -62.42 -26.81 68.69 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.097 -0.501 . . . . 71.22 111.76 177.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.1 m -84.84 -54.06 4.93 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.148 0.499 . . . . 72.0 110.76 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.2 m -71.91 -56.9 4.87 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.719 -0.673 . . . . 72.21 112.42 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -96.32 -10.57 27.51 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.115 0.413 . . . . 72.54 112.115 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 70.55 1.47 3.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.974 0.731 . . . . 70.1 112.974 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 43' ' ' ILE . 99.2 t -66.59 132.09 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 112.352 0.501 . . . . 65.25 112.352 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.448 ' HB3' HG13 ' A' ' 77' ' ' VAL . 44.3 mt-10 -82.18 96.74 7.93 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.08 0.466 . . . . 74.13 110.533 174.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -119.11 108.72 15.04 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.507 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.47 146.02 42.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.875 0.369 . . . . 31.51 111.971 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.4 t -128.38 121.74 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.831 0.348 . . . . 65.5 111.418 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.7 t -121.78 132.37 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 122.325 0.25 . . . . 75.24 111.419 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 30.7 p -116.59 123.06 46.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.927 0.394 . . . . 52.33 111.288 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.424 HD11 ' CZ ' ' A' ' 67' ' ' PHE . 83.8 mt -118.16 145.24 36.55 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-O 120.788 0.328 . . . . 74.41 111.37 177.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.95 -43.01 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.535 2.157 . . . . 72.34 112.354 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.912 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 23.8 m -153.14 143.47 22.46 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.055 0.391 . . . . 62.42 112.055 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 35.8 pt -128.67 -14.38 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.083 0.468 . . . . 74.54 110.653 172.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.04 -117.32 8.45 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.236 -0.438 . . . . 35.34 113.725 174.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.42 2.67 46.87 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.815 0.302 . . . . 53.35 111.815 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -72.88 120.88 83.26 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 111.524 0.194 . . . . 64.04 111.524 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 31.8 Cg_endo -64.48 137.06 53.41 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.443 2.095 . . . . 72.13 112.654 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.97 -49.08 40.34 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.236 0.458 . . . . 72.44 112.236 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.26 -32.85 73.61 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.998 0.428 . . . . 74.12 111.849 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.593 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 3.4 m-20 -74.21 -38.55 63.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.89 0.376 . . . . 71.13 111.016 173.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.424 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 48.6 t80 -56.77 -54.15 49.68 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.995 0.426 . . . . 74.42 111.062 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.493 ' OG1' ' NH1' ' A' ' 98' ' ' ARG . 40.7 p -51.84 -42.48 62.62 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.959 -0.564 . . . . 75.04 111.441 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.3 tp -58.42 -54.8 42.89 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.133 -0.485 . . . . 73.25 111.657 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 14.9 mmmm -66.67 -42.29 86.77 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.628 0.603 . . . . 62.13 112.628 -173.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.3 tp -68.57 -47.98 65.4 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.207 0.527 . . . . 73.31 111.261 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.529 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -68.55 -31.04 69.98 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.453 0.538 . . . . 62.35 112.453 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 70' ' ' LYS . 13.3 ptm180 -70.67 -38.95 73.79 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.092 -0.243 . . . . 62.5 111.436 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.676 HE22 ' HA ' ' A' ' 7' ' ' GLU . 3.6 pt20 -72.51 -24.69 61.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.044 0.45 . . . . 53.41 110.811 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.529 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 39.6 m0 -88.69 -17.2 30.47 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.487 -0.324 . . . . 73.32 111.221 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.64 38.08 95.71 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.472 -0.394 . . . . 74.4 113.613 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.575 HG21 ' HG3' ' A' ' 13' ' ' GLN . 45.0 t . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 112.173 0.434 . . . . 71.22 112.173 -176.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 103' ' ' TYR . 3.5 m-20 . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 121.242 0.544 . . . . 63.04 112.053 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -97.36 -139.44 0.28 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.13 -0.486 . . . . 73.22 111.137 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.547 ' HA ' ' HG ' ' A' ' 105' ' ' LEU . 7.3 p30 -69.12 43.88 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.322 0.86 . . . . 52.44 113.322 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -92.49 140.39 15.09 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.934 -0.651 . . . . 61.42 112.74 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 99' ' ' PHE . 52.0 tp -143.05 119.74 11.14 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.871 0.367 . . . . 64.11 111.03 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 72' ' ' ALA . 58.4 tp -111.94 122.32 47.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.836 0.351 . . . . 65.52 111.216 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.3 tp -109.97 106.2 15.65 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.307 -0.406 . . . . 75.21 110.745 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 59.9 t -107.06 117.4 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 111.925 0.343 . . . . 73.11 111.925 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.487 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.9 tp -96.88 122.27 39.66 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.305 -0.407 . . . . 72.22 110.677 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.457 HG11 HG12 ' A' ' 59' ' ' ILE . 61.0 t -111.04 102.9 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.665 0.269 . . . . 71.31 111.176 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.5 tp -51.86 -41.74 62.08 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.0 0.428 . . . . 72.34 111.367 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.912 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 19.1 t0 -45.76 -43.16 12.82 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.5 0.72 . . . . 70.02 112.451 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.401 ' NE2' HD11 ' A' ' 59' ' ' ILE . 49.3 mt-30 -106.19 -6.79 18.26 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 111.906 0.336 . . . . 71.11 111.906 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.404 ' NH2' ' O ' ' A' ' 126' ' ' PHE . 77.9 mtp180 55.23 26.84 8.9 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.732 0.777 . . . . 73.51 110.509 -174.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -112.75 164.24 13.61 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.171 -0.922 . . . . 64.42 111.528 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.668 HG21 ' SD ' ' A' ' 122' ' ' MET . 11.1 m -137.42 171.75 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.025 -0.534 . . . . 61.22 110.511 172.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.493 ' NH1' ' OG1' ' A' ' 68' ' ' THR . 38.5 ttt-85 -153.04 142.82 22.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.788 0.327 . . . . 70.01 111.621 172.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HD11 ' A' ' 86' ' ' LEU . 95.1 m-85 -101.22 118.05 36.21 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.045 -0.525 . . . . 74.33 110.659 173.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.451 ' CD ' HH12 ' A' ' 98' ' ' ARG . 5.6 tp10 -105.64 112.6 25.74 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 110.346 -0.242 . . . . 74.42 110.346 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.8 p -103.27 158.89 16.01 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.791 0.805 . . . . 74.32 113.038 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.5 -175.65 25.04 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 114.907 -1.042 . . . . 73.42 111.464 166.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.423 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -61.83 -24.17 66.72 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.405 -0.468 . . . . 74.04 112.009 -176.142 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.4 -20.27 79.64 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.928 -0.653 . . . . 74.45 113.203 -173.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HG ' ' HA ' ' A' ' 84' ' ' ASN . 91.8 mt -109.11 -7.5 15.31 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.407 0.521 . . . . 75.22 112.407 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -56.4 -25.72 50.95 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.11 0.411 . . . . 65.32 112.11 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.79 -21.26 59.89 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.169 -0.539 . . . . 31.54 113.62 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 82.0 m-85 -102.42 -53.74 2.83 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.268 0.556 . . . . 72.21 111.409 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -113.77 87.97 13.17 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.485 -0.78 . . . . 70.2 111.418 -173.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 108' ' ' TYR . 6.5 Cg_exo -73.99 161.63 40.75 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.396 2.064 . . . . 52.15 112.34 176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -51.45 -44.09 62.26 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.167 0.432 . . . . 72.44 112.167 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.51 -45.13 94.94 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.227 -0.511 . . . . 65.24 113.198 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.12 -42.94 99.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.767 0.318 . . . . 65.33 111.164 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.0 -44.75 91.72 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.012 0.434 . . . . 64.34 110.827 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.7 m -61.91 -36.63 81.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.086 -0.506 . . . . 74.22 111.053 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -60.9 -56.38 21.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.215 -0.448 . . . . 73.11 111.59 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.5 mt -50.63 -43.43 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.902 0.382 . . . . 72.44 111.684 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' ' 122' ' ' MET . 64.3 mt -61.23 -51.31 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.296 -0.411 . . . . 74.01 111.754 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.463 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 25.1 m-70 -74.02 -48.17 31.99 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.025 0.75 . . . . 70.24 113.025 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.35 -54.19 22.79 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.592 0.59 . . . . 73.2 112.592 -174.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -97.33 -45.14 6.6 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.604 0.594 . . . . 63.44 112.604 -172.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.668 ' SD ' HG21 ' A' ' 97' ' ' VAL . 49.3 mtt -73.32 -54.26 8.79 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.708 1.003 . . . . 64.13 113.708 -173.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.506 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 32.8 mm -47.48 -51.86 40.9 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 113.391 0.886 . . . . 63.34 113.391 -175.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.506 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 72.0 Cg_exo -50.49 -39.59 54.79 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.155 1.903 . . . . 72.3 113.048 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.464 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 85.5 m-70 -74.42 -49.95 20.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.6 -0.273 . . . . 71.24 111.656 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.6 m-30 -56.34 -43.13 78.76 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.598 0.221 . . . . 50.21 111.598 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.5 -42.36 87.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.921 0.391 . . . . 63.41 111.302 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.7 m -74.94 -13.46 60.53 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.268 -0.423 . . . . 45.11 111.75 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.48 -0.69 59.89 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.286 -0.483 . . . . 72.13 112.52 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.8 m-20 -80.37 66.66 5.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.737 0.415 . . . . 64.02 111.303 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -65.13 -46.02 82.66 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.174 -0.329 . . . . 73.43 111.785 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.69 95.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.007 0.432 . . . . 71.3 111.462 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 51.9 mm-40 -59.82 -47.2 86.69 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.146 -0.479 . . . . 72.23 111.365 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.71 93.13 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.302 -0.475 . . . . 74.51 113.008 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.35 -43.05 96.86 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.808 0.337 . . . . 65.1 111.051 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.4 t -56.21 -53.48 56.63 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 64.3 111.904 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -68.4 -33.45 74.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.609 0.242 . . . . 72.02 111.395 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.18 -52.46 51.74 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.072 -0.585 . . . . 43.31 112.712 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.708 HG21 ' SD ' ' A' ' 36' ' ' MET . 90.8 t -62.63 -43.6 98.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.023 0.44 . . . . 74.21 111.227 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.19 -38.36 76.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.262 -0.427 . . . . 74.31 110.929 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -61.31 -51.84 67.18 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.9 0.381 . . . . 64.42 111.052 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 85.7 t -54.32 -49.7 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.162 0.506 . . . . 75.05 110.972 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.425 ' HB2' HD11 ' A' ' 43' ' ' ILE . 36.5 tt0 -53.43 -46.5 69.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.974 -0.557 . . . . 63.14 111.653 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -65.09 -34.22 77.89 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.943 0.349 . . . . 63.52 111.943 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 141' ' ' ALA . 92.8 t -63.28 -49.07 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.064 0.459 . . . . 73.24 111.004 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.85 -57.06 8.79 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.051 0.453 . . . . 74.43 111.425 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.541 0.604 0 CA-C-N 116.12 -0.491 . . . . 73.23 111.943 -177.041 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.1 t . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 113.133 0.79 . . . . 61.11 113.133 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -109.1 152.56 24.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.742 -0.663 . . . . 73.21 111.518 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.7 mtmt -111.91 157.95 38.15 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.207 -0.451 . . . . 73.33 110.335 173.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.523 ' HD3' ' CE2' ' A' ' 67' ' ' PHE . 30.3 Cg_endo -62.33 -26.11 76.89 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.912 1.741 . . . . 61.52 111.323 176.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' HA ' HE22 ' A' ' 74' ' ' GLN . 18.1 mt-10 -79.26 -20.2 48.71 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.566 -0.743 . . . . 63.22 111.067 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -94.06 -24.49 17.58 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.855 -0.611 . . . . 62.32 111.511 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.6 t -66.71 132.52 94.06 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.226 -0.443 . . . . 43.2 111.648 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.08 121.05 9.19 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.633 2.222 . . . . 73.41 113.106 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' A' ' 14' ' ' LEU . 2.8 p30 -70.34 85.95 0.59 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.477 0.547 . . . . 73.33 112.477 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.66 -26.77 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 112.223 0.453 . . . . 72.32 112.223 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.575 HE22 ' HA ' ' A' ' 20' ' ' LEU . 1.6 mp0 -87.22 31.29 0.73 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.593 0.711 . . . . 71.52 111.365 173.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.541 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 4.7 tt -143.43 -50.75 0.33 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.378 -0.971 . . . . 64.3 108.378 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -109.52 120.37 42.29 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.604 -0.725 . . . . 34.14 110.307 170.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 6.8 m-20 71.13 48.42 0.37 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.329 0.652 . . . . 72.31 111.646 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -59.45 -11.96 5.36 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.961 0.726 . . . . 61.23 112.961 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 t -60.86 -34.67 74.96 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.142 -0.349 . . . . 54.41 111.319 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 19' ' ' ARG . 8.0 ptp85 -97.12 132.48 42.86 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.096 0.474 . . . . 64.12 110.375 175.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.575 ' HA ' HE22 ' A' ' 13' ' ' GLN . 5.6 mp -108.63 12.67 25.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.153 0.501 . . . . 62.1 110.896 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.7 t -110.75 146.94 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.135 -0.484 . . . . 24.43 111.478 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 m -131.21 124.17 30.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.359 -0.382 . . . . 74.41 110.57 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.35 86.03 2.35 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.405 0.621 . . . . 73.31 112.492 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.04 -38.48 8.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.908 0.385 . . . . 73.02 110.75 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.1 -26.65 64.08 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.982 0.42 . . . . 72.35 111.126 170.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.91 25.74 75.21 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.254 -0.498 . . . . 73.04 113.234 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 132' ' ' ALA . 78.8 mt -86.06 10.89 12.96 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.928 0.344 . . . . 74.4 111.928 -177.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.48 HD21 HD12 ' A' ' 135' ' ' LEU . 97.0 mt -120.17 119.96 34.79 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.838 0.351 . . . . 64.43 111.438 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.493 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 31.5 t -81.05 159.49 24.77 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.554 -0.294 . . . . 74.11 110.72 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -54.61 -40.54 69.0 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.169 0.803 . . . . 72.15 113.169 -173.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.32 91.9 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.071 0.462 . . . . 75.42 111.247 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.493 ' OE1' ' HB3' ' A' ' 29' ' ' SER . 18.4 mp0 -66.93 -41.05 87.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.786 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.97 -44.05 91.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.968 0.413 . . . . 72.44 110.713 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -57.56 -57.58 12.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.754 -0.657 . . . . 73.42 111.552 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.73 -47.17 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.154 -0.475 . . . . 74.3 111.771 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.475 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.2 ttm -61.78 -51.56 67.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.528 -0.305 . . . . 74.05 111.662 -177.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -64.82 -35.76 82.15 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 121.01 -0.276 . . . . 63.51 111.326 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.77 -47.21 87.48 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.997 -0.62 . . . . 52.33 112.691 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.493 ' O ' HG13 ' A' ' 43' ' ' ILE . 7.4 mtp180 -67.06 -49.71 64.22 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.782 0.289 . . . . 74.43 111.782 176.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 36' ' ' MET . 91.2 mt -56.31 -41.18 75.55 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.267 0.556 . . . . 72.31 111.404 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -61.87 -46.63 88.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.419 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.21 86.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.984 0.421 . . . . 74.0 111.437 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 39' ' ' ARG . 75.9 mt -58.14 -49.8 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.365 -0.38 . . . . 63.52 111.434 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 26.3 ttp85 -69.09 -25.74 64.58 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.853 0.316 . . . . 75.3 111.853 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.9 t -83.28 -33.42 25.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.089 0.471 . . . . 54.51 111.892 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.7 t -97.24 -67.22 0.86 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.139 0.495 . . . . 73.44 111.672 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -74.27 -16.47 60.94 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.264 -0.425 . . . . 74.3 111.386 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 71.02 9.88 6.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.205 0.602 . . . . 63.23 112.087 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.885 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 85.8 t -81.41 122.52 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.98 0.419 . . . . 73.31 111.861 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.71 96.66 7.61 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.178 0.513 . . . . 73.22 110.226 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -111.94 105.13 13.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.909 -0.587 . . . . 73.4 110.863 -175.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.04 145.4 29.94 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.58 0.585 . . . . 73.13 112.58 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.53 107.76 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.022 0.439 . . . . 72.01 110.902 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.67 134.94 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.846 0.355 . . . . 74.01 111.53 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -113.52 122.53 47.56 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.753 0.311 . . . . 72.33 111.111 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -130.23 137.0 29.89 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 120.848 0.356 . . . . 74.14 111.542 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 39.3 Cg_endo -67.09 -53.94 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.598 2.199 . . . . 62.2 113.264 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 20.3 m -141.75 136.11 30.42 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.17 -0.331 . . . . 73.21 111.649 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.497 HD11 ' NE2' ' A' ' 94' ' ' GLN . 31.9 pt -106.81 -28.91 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.92 0.39 . . . . 75.03 110.89 174.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.29 -116.53 7.18 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.124 -0.489 . . . . 31.04 114.229 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.78 -23.33 66.69 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.348 0.499 . . . . 72.35 112.348 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.28 128.17 86.53 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.4 0.519 . . . . 65.11 112.4 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.709 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 61.2 Cg_endo -73.38 136.11 23.49 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.581 2.187 . . . . 54.43 112.156 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.1 tp -52.57 -47.71 66.67 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.979 0.733 . . . . 73.13 112.979 -174.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.3 -58.24 8.44 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.132 -0.355 . . . . 71.11 111.628 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.709 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 1.8 m-20 -59.71 -29.79 68.35 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.743 0.306 . . . . 61.32 111.507 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.523 ' CE2' ' HD3' ' A' ' 6' ' ' PRO . 26.5 t80 -61.52 -55.35 32.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.309 -0.405 . . . . 73.33 110.768 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.2 p -57.3 -39.85 76.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.297 -0.411 . . . . 50.43 111.325 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.502 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 53.9 tp -57.79 -53.98 52.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.4 -0.364 . . . . 65.53 111.469 177.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -51.87 -52.66 48.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.909 0.385 . . . . 71.35 111.673 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.422 HD23 HD21 ' A' ' 87' ' ' LEU . 33.6 tp -63.04 -38.61 91.89 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.193 -0.458 . . . . 74.32 111.3 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.86 -44.19 93.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.293 -0.412 . . . . 71.25 111.793 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 20.6 mtm180 -66.95 -40.67 87.59 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.798 0.332 . . . . 75.15 110.927 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.529 HE22 ' HA ' ' A' ' 7' ' ' GLU . 7.7 tt0 -58.64 -42.06 87.42 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.016 0.436 . . . . 73.34 111.402 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -87.29 7.39 28.87 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.354 0.502 . . . . 65.42 112.354 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.71 -42.58 3.14 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.125 -0.559 . . . . 74.31 113.921 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 113.647 0.98 . . . . 61.43 113.647 -176.105 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.415 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 53.3 t30 . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 109.392 -0.595 . . . . 72.31 109.392 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.553 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -53.65 -93.03 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 112.761 0.652 . . . . 73.01 112.761 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.885 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.1 m-20 -78.52 74.86 5.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.572 -0.705 . . . . 60.32 111.945 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.19 139.15 9.86 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.166 -0.54 . . . . 41.41 113.174 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 99' ' ' PHE . 47.7 tp -152.89 127.84 9.64 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.889 0.376 . . . . 34.34 111.131 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.422 HD21 HD23 ' A' ' 71' ' ' LEU . 64.0 tp -117.39 124.55 49.14 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.936 0.398 . . . . 72.3 112.045 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 45.4 tp -111.89 121.55 45.34 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.085 -0.507 . . . . 74.52 110.78 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.8 t -122.93 121.96 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 120.821 0.343 . . . . 75.33 111.82 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' A' ' 97' ' ' VAL . 35.0 tp -96.21 118.46 32.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.173 -0.467 . . . . 71.14 111.282 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.2 t -103.61 100.1 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.634 0.254 . . . . 75.11 111.099 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 63.8 tp -54.01 -40.65 67.19 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.119 0.485 . . . . 73.33 111.474 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.487 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 25.3 t70 -48.38 -30.69 5.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.523 0.729 . . . . 54.12 112.872 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.497 ' NE2' HD11 ' A' ' 59' ' ' ILE . 43.2 mt-30 -125.5 1.56 7.63 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.361 -0.212 . . . . 75.14 111.557 -178.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 9.3 ptp180 47.06 27.15 0.72 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.088 0.955 . . . . 73.14 112.278 -173.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 90.5 mtt180 -117.04 154.59 30.7 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.041 0.448 . . . . 74.22 111.498 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 90' ' ' LEU . 4.1 m -134.32 171.26 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.912 -0.585 . . . . 75.42 111.328 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -152.29 144.42 23.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.831 0.348 . . . . 70.21 111.681 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.697 ' HB3' HD11 ' A' ' 86' ' ' LEU . 77.9 m-85 -104.49 105.58 15.75 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.991 -0.55 . . . . 64.25 110.372 173.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -83.13 112.58 19.95 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.118 -0.364 . . . . 75.5 110.308 177.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 109' ' ' LEU . 1.6 p -88.9 143.36 26.93 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.374 0.879 . . . . 61.51 113.374 -176.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -90.87 -177.97 43.66 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 114.894 -1.048 . . . . 71.52 112.384 168.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -60.93 -25.06 66.51 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.588 0.588 . . . . 74.42 112.588 -175.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.4 -22.85 57.95 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.886 -0.674 . . . . 74.12 113.413 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 86' ' ' LEU . 93.5 mt -108.84 4.77 23.89 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.535 0.569 . . . . 74.55 112.535 -174.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -56.79 -38.63 72.81 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.043 0.449 . . . . 63.41 111.889 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.85 -42.7 10.78 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.317 -0.468 . . . . 70.14 113.382 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -72.07 -41.7 67.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.137 0.494 . . . . 75.52 111.791 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.618 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.0 mt -131.75 83.9 56.21 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 115.974 -0.557 . . . . 74.4 111.991 -170.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.49 155.81 24.82 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.402 2.068 . . . . 60.44 112.365 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.0 -36.2 12.29 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.511 0.56 . . . . 74.32 112.511 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.46 -50.12 69.99 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.126 -0.559 . . . . 74.41 112.912 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.52 -42.71 99.22 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.276 0.56 . . . . 51.4 111.028 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.69 HD13 ' HB2' ' A' ' 99' ' ' PHE . 65.5 mt -62.43 -40.75 97.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.665 -0.698 . . . . 72.31 111.132 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.4 m -71.22 -32.25 68.58 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.178 -0.465 . . . . 75.05 111.419 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -56.02 -55.95 26.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.729 -0.214 . . . . 65.23 111.002 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.7 mt -51.0 -47.11 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.137 0.494 . . . . 52.43 111.031 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.576 ' O ' HG12 ' A' ' 123' ' ' ILE . 61.1 mt -55.97 -51.51 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.8 -0.636 . . . . 64.23 111.615 177.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -81.57 -11.45 59.15 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.944 0.72 . . . . 73.13 112.944 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -86.48 -52.42 5.59 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.788 0.292 . . . . 71.34 111.788 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.99 -39.86 2.06 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.109 0.781 . . . . 74.43 113.109 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.512 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 45.3 mtt -51.52 -52.64 45.23 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.664 0.616 . . . . 71.15 112.664 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.648 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 49.9 mm -53.01 -56.8 19.98 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 111.992 0.367 . . . . 53.43 111.992 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 82.6 Cg_exo -48.09 -47.08 20.35 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.301 2.001 . . . . 63.4 113.328 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -62.97 -49.19 75.68 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.695 0.284 . . . . 73.12 111.637 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.1 m-30 -57.49 -42.31 82.45 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.819 0.303 . . . . 73.52 111.819 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 70.5 mtp180 -66.66 -30.77 71.11 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.999 0.428 . . . . 71.43 111.152 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.9 m -78.08 -14.09 59.62 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.399 -0.364 . . . . 75.12 111.478 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.18 -7.02 62.02 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.292 -0.48 . . . . 64.33 112.473 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.735 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.9 m-20 -79.78 57.01 2.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.866 0.365 . . . . 73.35 111.602 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -61.63 -37.79 85.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.915 0.388 . . . . 71.24 111.322 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.453 ' HB1' ' HG2' ' A' ' 32' ' ' GLN . . . -64.87 -49.83 68.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.164 -0.471 . . . . 62.5 111.376 176.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.735 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 14.6 mp0 -63.03 -35.47 80.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.954 -0.566 . . . . 55.11 111.69 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.91 -55.12 30.1 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.152 -0.547 . . . . 13.33 112.352 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.486 HD11 HD22 ' A' ' 90' ' ' LEU . 89.0 mt -58.64 -38.17 77.52 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.39 -0.477 . . . . 62.34 110.949 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 58.0 m -60.02 -47.54 85.43 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.119 -0.491 . . . . 51.05 112.088 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.19 -36.02 66.47 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.102 -0.374 . . . . 73.0 111.207 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.36 -49.73 75.38 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.31 -0.472 . . . . 61.21 113.031 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 135' ' ' LEU . 53.2 t -53.11 -47.76 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.055 0.455 . . . . 71.34 111.255 175.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.555 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 53.6 tp -62.8 -42.86 99.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.125 -0.489 . . . . 75.32 110.805 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.78 -47.68 84.71 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.962 0.41 . . . . 53.02 111.585 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.82 -47.37 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.331 -0.395 . . . . 64.3 111.246 176.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -56.67 -40.53 75.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.417 -0.356 . . . . 74.3 111.464 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 18.3 mm-40 -53.98 -35.13 61.49 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.195 0.442 . . . . 74.2 112.195 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.98 -42.23 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 120.993 0.425 . . . . 74.0 111.014 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.5 mt -71.08 -44.89 64.79 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.094 0.473 . . . . 74.12 111.218 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 116.067 -0.515 . . . . 34.24 111.768 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 121.408 0.623 . . . . 62.12 111.533 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -72.78 157.71 36.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.486 -0.779 . . . . 71.52 112.592 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.748 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 33.8 mmtp -136.58 160.76 65.37 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 114.965 -1.016 . . . . 72.32 109.808 174.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.88 -41.41 63.34 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.396 2.064 . . . . 74.52 112.834 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -86.49 7.65 25.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.979 0.419 . . . . 63.12 111.758 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.748 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 29.8 t70 -106.03 -34.26 7.63 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.166 0.508 . . . . 74.32 110.268 174.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 5' ' ' LYS . 65.1 t -65.89 129.58 94.3 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.675 -0.693 . . . . 75.22 111.503 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.44 123.99 13.84 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.498 2.132 . . . . 75.25 112.497 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -69.67 91.39 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.058 0.456 . . . . 75.53 111.947 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -69.98 -38.37 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.278 -0.419 . . . . 71.13 111.971 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 14.3 mm100 -64.77 170.25 4.35 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.8 -0.562 . . . . 54.31 110.79 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 20.2 mt 73.88 -41.6 0.49 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.423 0.527 . . . . 33.23 112.423 -173.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.09 -62.89 1.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.297 0.48 . . . . 73.52 112.297 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -84.76 32.39 0.52 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.113 0.482 . . . . 61.51 111.715 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -71.42 12.92 0.28 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.549 0.574 . . . . 61.05 112.549 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.2 p -77.47 -42.55 35.41 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.91 0.386 . . . . 44.43 110.974 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.3 ptp85 -98.71 -32.6 11.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.114 -0.494 . . . . 71.34 112.033 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.602 HD21 ' HG3' ' A' ' 44' ' ' ARG . 5.3 mp 62.18 11.98 4.77 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.069 0.396 . . . . 73.24 112.069 -176.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 19' ' ' ARG . 58.6 t -107.07 136.03 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.797 0.332 . . . . 72.52 111.688 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.531 HG22 ' HG2' ' A' ' 24' ' ' GLU . 24.8 m -110.81 106.71 15.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.42 -0.355 . . . . 64.14 110.417 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -95.94 78.01 3.19 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.432 0.634 . . . . 65.13 112.361 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.531 ' HG2' HG22 ' A' ' 22' ' ' THR . 21.0 mm-40 -102.45 -46.65 4.71 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.042 0.449 . . . . 74.45 110.909 176.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.36 -23.74 67.54 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.168 0.433 . . . . 62.0 112.168 174.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.87 33.8 88.04 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.367 -0.444 . . . . 75.53 113.481 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 92' ' ' LEU . 94.3 mt -92.02 12.62 21.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.09 0.404 . . . . 64.15 112.09 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -121.62 125.78 47.5 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.04 0.448 . . . . 75.31 111.472 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.3 t -77.26 172.29 13.51 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.121 -0.491 . . . . 54.45 110.712 173.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -54.72 -47.62 73.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.985 0.422 . . . . 33.34 111.331 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -63.74 -48.28 77.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.41 -0.359 . . . . 51.32 111.533 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -59.69 -42.84 93.87 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.15 0.5 . . . . 63.0 111.339 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -64.84 -47.44 77.94 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.623 -0.717 . . . . 72.33 109.949 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.98 -53.76 54.4 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.168 -0.469 . . . . 74.52 111.982 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 31' ' ' ALA . 99.0 t -54.8 -47.16 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.961 0.41 . . . . 75.45 111.246 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.1 ttm -63.01 -42.97 99.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.442 -0.344 . . . . 74.31 111.227 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -57.09 -48.66 78.06 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.969 0.414 . . . . 74.21 111.094 176.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.9 -47.19 90.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.155 -0.475 . . . . 61.43 113.002 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 43' ' ' ILE . 99.6 mtt180 -62.6 -54.84 33.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 111.901 0.334 . . . . 74.34 111.901 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 51' ' ' PHE . 70.9 mt -58.2 -48.17 81.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.868 0.366 . . . . 64.14 111.419 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -58.21 -47.05 84.68 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.331 -0.395 . . . . 62.54 111.098 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.9 -45.11 86.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.195 -0.457 . . . . 70.15 111.339 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.575 HG22 ' HB ' ' A' ' 49' ' ' VAL . 64.3 mt -65.97 -46.32 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.086 0.469 . . . . 71.31 111.274 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.602 ' HG3' HD21 ' A' ' 20' ' ' LEU . 5.5 tmm_? -65.9 -26.04 67.43 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.162 -0.472 . . . . 74.44 111.417 -176.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 t -91.77 -54.54 3.83 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.807 0.337 . . . . 34.33 111.549 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.3 t -67.63 -58.8 4.05 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.307 0.484 . . . . 74.01 112.307 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.49 -11.29 52.15 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.396 -0.365 . . . . 63.01 111.5 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.08 24.04 12.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.905 0.482 . . . . 32.01 111.993 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.575 ' HB ' HG22 ' A' ' 43' ' ' ILE . 90.2 t -96.28 117.28 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.24 -0.436 . . . . 73.24 111.576 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.03 96.16 2.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.082 0.467 . . . . 72.23 110.432 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.427 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -104.44 98.59 8.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.769 -0.65 . . . . 72.04 109.984 -179.063 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -102.52 119.71 39.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.1 0.407 . . . . 72.11 112.1 -175.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.466 HG22 HD23 ' A' ' 88' ' ' LEU . 96.0 t -104.91 110.86 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.282 0.563 . . . . 64.31 111.4 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.441 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 48.4 t -106.55 121.93 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.08 -0.509 . . . . 53.53 111.081 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 p -106.58 121.87 45.17 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.816 0.341 . . . . 74.34 110.92 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -126.4 139.63 35.13 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-O 120.818 0.342 . . . . 74.32 111.553 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.55 -56.68 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.335 2.024 . . . . 51.31 112.86 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.6 p -144.96 139.48 27.57 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 111.933 0.345 . . . . 74.1 111.933 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.612 HG12 HG11 ' A' ' 91' ' ' VAL . 35.3 pt -117.65 -10.84 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 121.112 0.482 . . . . 73.35 110.826 171.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.27 -127.99 32.93 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.177 -0.465 . . . . 50.12 114.04 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.81 -16.62 63.84 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.841 0.682 . . . . 63.23 112.841 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.12 130.6 50.5 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 112.936 0.717 . . . . 43.14 112.936 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.654 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 60.6 Cg_endo -72.0 133.19 21.09 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.747 2.298 . . . . 70.53 112.054 174.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.57 -48.19 82.1 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.934 0.716 . . . . 73.41 112.934 -171.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -67.85 -45.87 73.4 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.117 -0.364 . . . . 73.33 111.918 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.654 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 33.3 m-20 -61.85 -37.85 86.04 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.979 0.418 . . . . 61.01 110.857 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.46 -50.07 75.05 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.125 -0.489 . . . . 72.34 111.042 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 78.0 p -63.14 -48.33 78.91 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.594 -0.275 . . . . 63.33 111.313 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 54.4 tp -54.87 -46.73 74.77 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.097 0.475 . . . . 64.34 111.196 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -54.86 -49.51 70.93 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.003 0.43 . . . . 65.42 111.66 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 tp -67.97 -36.61 80.35 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.054 -0.521 . . . . 74.22 111.639 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 77' ' ' VAL . . . -67.77 -39.94 84.08 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.388 -0.369 . . . . 55.4 111.776 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 41.1 mtp-105 -57.43 -54.23 49.18 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.077 0.399 . . . . 73.55 112.077 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.448 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.5 pt20 -64.28 -23.04 67.16 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.347 0.499 . . . . 75.41 112.347 -177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.448 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 40.8 m0 -92.17 -15.29 27.82 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.809 0.3 . . . . 74.51 111.809 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.71 30.03 60.43 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.226 -0.512 . . . . 55.21 113.122 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.605 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 3.4 t . . . . . 0 N--CA 1.475 0.819 0 C-N-CA 123.0 0.52 . . . . 74.2 109.725 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 121.312 0.577 . . . . 74.54 112.306 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.434 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.2 OUTLIER -83.65 136.32 34.26 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.382 -0.372 . . . . 62.13 111.631 176.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.594 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 2.0 m-20 52.29 21.89 1.82 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.944 0.72 . . . . 61.31 112.944 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.66 129.43 9.89 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.205 -0.521 . . . . 53.4 113.176 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 99' ' ' PHE . 39.8 tp -142.32 119.47 11.43 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.193 0.521 . . . . 75.1 111.441 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.8 tp -107.2 139.88 40.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.368 -0.378 . . . . 73.43 111.279 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD23 HG22 ' A' ' 53' ' ' VAL . 53.5 tp -131.76 114.06 14.29 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.529 -0.305 . . . . 72.23 111.04 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.27 121.51 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.076 0.399 . . . . 63.54 112.076 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 97' ' ' VAL . 24.1 tp -101.37 129.29 47.34 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.173 -0.467 . . . . 73.34 111.223 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.612 HG11 HG12 ' A' ' 59' ' ' ILE . 31.9 t -115.02 99.2 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.92 0.39 . . . . 51.43 111.29 176.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 27' ' ' LEU . 67.1 tp -51.54 -41.23 60.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.162 0.585 . . . . 72.12 112.357 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.22 -43.15 52.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.407 0.683 . . . . 71.14 112.748 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -118.54 8.51 12.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.104 0.409 . . . . 63.32 112.104 -174.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 59.46 20.02 8.41 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.706 1.002 . . . . 73.24 113.706 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -122.17 154.23 37.73 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.669 -0.644 . . . . 73.44 112.194 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.763 HG21 ' SD ' ' A' ' 122' ' ' MET . 6.3 m -129.24 171.39 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.654 -0.703 . . . . 64.33 111.382 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -147.66 130.08 15.76 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.34 -0.391 . . . . 74.03 111.842 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.71 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 93.8 m-85 -90.45 141.95 28.23 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.922 -0.581 . . . . 72.42 109.441 168.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 26.2 tt0 -133.04 112.29 11.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.961 0.41 . . . . 73.45 111.914 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.596 HG23 HD13 ' A' ' 86' ' ' LEU . 17.5 p -106.83 142.02 37.13 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.008 -0.542 . . . . 60.2 111.223 175.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.37 -83.98 1.17 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.805 -0.712 . . . . 43.23 113.724 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -137.1 -41.53 0.58 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.004 0.43 . . . . 74.42 111.397 -174.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.594 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -58.52 -39.43 93.11 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.257 -0.429 . . . . 72.34 114.071 -175.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.528 HD11 HG13 ' A' ' 49' ' ' VAL . 93.3 mt -91.97 -2.6 56.66 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.013 0.746 . . . . 74.44 113.013 -174.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -57.64 -21.66 40.99 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.556 0.576 . . . . 73.21 112.556 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.74 -28.58 56.76 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.91 -0.662 . . . . 71.21 112.894 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -109.97 -60.31 1.81 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.898 0.38 . . . . 64.55 111.043 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.443 HD12 HD13 ' A' ' 105' ' ' LEU . 16.3 mt -111.77 88.31 9.53 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.171 0.588 . . . . 61.43 111.563 -178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.16 152.26 18.39 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.969 1.779 . . . . 61.41 112.102 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -47.85 -36.32 11.81 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.685 0.279 . . . . 70.2 111.709 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.17 -49.9 73.52 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.253 -0.499 . . . . 61.42 113.182 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.73 -44.58 96.46 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.259 0.552 . . . . 74.44 111.045 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 66.6 mt -60.54 -44.54 96.0 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.753 -0.658 . . . . 63.21 110.874 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -59.74 -38.29 81.32 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.823 -0.626 . . . . 74.32 110.934 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.4 ttt-85 -60.27 -56.23 24.04 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.068 -0.514 . . . . 61.31 110.947 175.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 60.2 mt -51.01 -39.48 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 120.821 0.343 . . . . 75.33 111.784 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.542 ' O ' HG12 ' A' ' 123' ' ' ILE . 77.6 mt -55.84 -56.17 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.53 -0.305 . . . . 71.53 111.033 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -77.4 -23.59 50.63 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.382 0.512 . . . . 72.12 112.382 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -78.25 -40.31 37.58 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.164 0.431 . . . . 62.32 112.164 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 -126.12 -54.18 1.5 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.262 0.838 . . . . 54.12 113.262 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.763 ' SD ' HG21 ' A' ' 97' ' ' VAL . 38.5 mtt -59.21 -53.65 55.91 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.052 0.76 . . . . 64.44 113.052 -175.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.642 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 mm -53.86 -53.4 58.26 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 111.677 0.251 . . . . 71.02 111.677 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 92.3 Cg_exo -47.68 -48.18 16.45 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 122.287 1.991 . . . . 71.31 113.423 174.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -62.5 -46.96 86.07 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.706 0.262 . . . . 72.1 111.706 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -60.69 -41.33 94.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.738 0.304 . . . . 75.41 111.361 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -63.2 -31.43 72.58 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.045 0.45 . . . . 74.24 111.27 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.2 t -82.87 -18.37 40.54 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.261 -0.427 . . . . 51.14 111.449 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.88 1.92 34.27 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.545 -0.359 . . . . 73.51 113.571 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.9 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 85.7 m-20 -94.07 82.07 4.16 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.411 -0.464 . . . . 73.12 112.152 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -71.53 -53.63 13.18 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.225 -0.297 . . . . 74.21 111.455 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.79 -45.96 85.3 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.093 0.473 . . . . 65.4 111.554 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.9 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 7.1 tp10 -56.21 -53.16 60.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.041 -0.527 . . . . 55.44 111.178 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.87 -43.64 96.52 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.409 -0.424 . . . . 60.04 113.514 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 90' ' ' LEU . 93.8 mt -59.77 -56.48 21.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.03 0.443 . . . . 73.42 111.413 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 30.8 t -56.18 -54.31 46.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.382 0.512 . . . . 52.31 112.382 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -30.25 60.96 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 111.576 0.213 . . . . 74.42 111.576 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.87 -48.0 86.6 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.201 -0.523 . . . . 42.4 112.408 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 135' ' ' LEU . 72.3 t -57.79 -44.94 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.132 0.491 . . . . 74.23 110.606 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.3 tp -58.44 -37.4 75.34 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.953 -0.567 . . . . 61.04 111.391 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.6 97.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.092 0.472 . . . . 55.03 111.173 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.424 HG13 HD22 ' A' ' 109' ' ' LEU . 63.8 t -65.77 -45.93 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.788 -0.642 . . . . 75.24 110.764 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -53.87 -43.33 69.5 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.789 -0.641 . . . . 75.54 111.255 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -52.35 -41.0 62.69 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.277 0.473 . . . . 73.11 112.277 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.11 -36.4 76.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.871 0.367 . . . . 74.13 111.666 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.0 -54.82 24.35 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.601 -0.272 . . . . 74.21 111.324 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 CA--C 1.543 0.675 0 CA-C-O 120.848 0.356 . . . . 73.42 111.948 176.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' HG3' ' OG ' ' A' ' 58' ' ' SER . 49.6 ttm . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.964 0.412 . . . . 74.44 111.625 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -110.56 122.51 47.94 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.581 -0.281 . . . . 72.21 110.679 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.7 t -72.47 127.17 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.329 0.585 . . . . 71.35 112.106 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -113.35 144.62 42.45 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.937 -0.574 . . . . 51.41 111.75 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.694 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 9.8 mtmp? -122.29 171.18 6.71 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 115.648 -0.705 . . . . 74.12 109.693 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.694 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 4.4 Cg_endo -45.61 -49.84 10.16 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.769 2.313 . . . . 64.33 113.963 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.79 10.78 10.56 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.421 0.526 . . . . 74.24 112.421 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 5' ' ' LYS . 38.6 m-20 -95.14 -14.86 23.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.082 0.467 . . . . 54.52 110.579 168.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.505 HG22 HD21 ' A' ' 56' ' ' LEU . 38.9 t -89.03 128.67 51.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.085 -0.507 . . . . 75.45 110.453 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.59 118.44 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.225 1.95 . . . . 62.51 112.29 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -63.82 78.48 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.032 0.444 . . . . 61.52 111.759 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ASP . 35.7 m -63.76 -39.45 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 111.981 0.363 . . . . 62.13 111.981 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.448 HE22 ' HG ' ' A' ' 20' ' ' LEU . 27.0 mm-40 -72.93 6.2 2.78 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.907 -0.496 . . . . 64.24 111.941 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.495 ' O ' HD23 ' A' ' 14' ' ' LEU . 8.9 tt -94.75 -20.99 19.03 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.354 0.597 . . . . 74.42 109.773 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.85 -56.0 0.56 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.828 -0.624 . . . . 72.51 111.653 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' VAL . 8.1 m-20 -78.49 77.96 4.96 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.034 0.445 . . . . 73.01 111.925 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.0 p -90.09 -11.22 41.99 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.623 0.249 . . . . 53.14 111.654 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -102.04 -8.85 21.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.822 0.304 . . . . 53.41 111.822 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -99.44 -58.6 1.89 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.975 0.417 . . . . 64.13 110.856 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.448 ' HG ' HE22 ' A' ' 13' ' ' GLN . 5.3 mp 70.03 -16.2 0.3 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.274 0.842 . . . . 71.22 113.274 175.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.3 t -86.0 144.14 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.111 -0.368 . . . . 74.4 111.513 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -145.28 103.12 3.81 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.379 -0.373 . . . . 73.41 111.271 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.428 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 26.1 t70 -103.36 109.63 21.32 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.999 0.428 . . . . 74.1 111.478 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB2' HD23 ' A' ' 56' ' ' LEU . 8.8 mm-40 -111.45 -29.88 7.61 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.089 -0.505 . . . . 70.32 110.708 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.402 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -58.29 -31.46 67.51 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.74 0.644 . . . . 74.24 112.74 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.88 25.77 51.69 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.899 -0.667 . . . . 75.41 112.231 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.507 HD11 HD13 ' A' ' 92' ' ' LEU . 97.8 mt -96.41 -33.61 11.83 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.733 0.302 . . . . 62.41 111.109 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.83 -176.02 5.88 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.183 0.516 . . . . 75.22 111.323 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.0 t -152.69 158.68 42.71 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.787 -0.449 . . . . 64.33 109.787 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -45.06 -48.86 11.8 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.521 0.563 . . . . 73.23 112.521 -173.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -57.51 -55.91 28.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.86 0.362 . . . . 72.44 111.776 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -57.34 -42.73 82.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.991 0.424 . . . . 75.23 111.496 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -64.47 -46.45 83.01 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.122 -0.49 . . . . 60.5 111.533 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 18.9 tp10 -65.53 -41.12 93.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.863 0.363 . . . . 74.31 111.524 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 31' ' ' ALA . 96.6 t -62.4 -39.66 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.116 0.484 . . . . 62.01 110.468 174.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.5 ttm -68.26 -36.86 80.07 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.028 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 34' ' ' GLU . 92.7 m-20 -56.11 -47.23 78.48 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.969 0.414 . . . . 73.02 110.46 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.41 -37.9 92.69 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.04 -0.6 . . . . 71.32 112.786 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 43' ' ' ILE . 66.5 mtt180 -65.95 -54.54 24.96 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.824 0.345 . . . . 63.43 111.251 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.97 -42.72 99.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.858 0.361 . . . . 63.34 111.472 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -61.69 -40.45 95.04 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.334 -0.394 . . . . 54.12 111.292 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.12 -44.34 92.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.894 0.378 . . . . 73.44 110.981 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.635 HG22 ' HB ' ' A' ' 49' ' ' VAL . 51.5 mt -67.7 -39.39 82.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.085 0.469 . . . . 73.4 110.85 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' NH1' ' HG2' ' A' ' 50' ' ' GLU . 8.9 tpt180 -59.06 -29.86 67.63 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.762 -0.654 . . . . 54.43 111.407 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.1 t -93.64 -66.48 0.92 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.266 -0.424 . . . . 64.34 111.474 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 153' ' ' HIS . 37.3 t -50.37 -60.95 2.48 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.371 0.508 . . . . 33.51 112.371 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -94.88 -3.1 49.39 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.477 -0.329 . . . . 73.44 111.601 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.83 13.41 7.49 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.364 0.505 . . . . 61.3 112.364 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 43' ' ' ILE . 63.3 t -84.83 128.29 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 112.334 0.494 . . . . 51.42 112.334 -174.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HG2' ' NH1' ' A' ' 44' ' ' ARG . 29.9 mt-10 -80.2 95.35 6.25 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.066 -0.515 . . . . 61.42 110.026 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -112.81 103.23 11.23 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.868 0.366 . . . . 63.34 110.733 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.85 133.81 49.03 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.19 0.441 . . . . 72.12 112.19 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.59 127.72 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.363 -0.38 . . . . 71.55 111.042 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.0 t -127.64 139.58 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.798 0.332 . . . . 74.43 111.354 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 19.6 p -124.04 130.22 52.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.701 0.286 . . . . 72.51 110.368 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 9' ' ' VAL . 71.7 mt -125.71 142.72 42.88 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-O 120.724 0.297 . . . . 75.54 111.644 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 32.5 Cg_exo -61.89 -49.16 7.22 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.549 2.166 . . . . 70.44 112.175 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.478 ' OG ' ' HG3' ' A' ' 1' ' ' MET . 46.8 m -155.17 145.8 22.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.235 -0.439 . . . . 70.1 111.733 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.606 HG12 HG11 ' A' ' 91' ' ' VAL . 32.1 pt -112.4 -5.08 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.093 0.473 . . . . 60.42 110.71 170.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.27 -109.95 2.97 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 115.929 -0.578 . . . . 72.35 113.113 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -108.72 2.25 21.69 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.213 0.449 . . . . 53.12 112.213 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.95 140.39 97.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.186 0.439 . . . . 74.12 112.186 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.527 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 47.4 Cg_endo -68.49 121.44 8.38 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.359 2.039 . . . . 73.34 112.266 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.8 tp -58.64 -51.22 70.86 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.849 0.685 . . . . 55.31 112.849 -174.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.409 ' HG2' ' HE ' ' A' ' 98' ' ' ARG . 38.8 mt-10 -62.84 -48.24 79.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.852 0.358 . . . . 72.21 111.58 -178.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.527 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 6.1 m-20 -61.99 -37.48 84.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.698 0.285 . . . . 54.21 111.542 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.479 ' HE2' ' HA ' ' A' ' 5' ' ' LYS . 41.3 t80 -56.06 -53.79 52.82 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.876 0.37 . . . . 71.43 111.358 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.502 HG21 ' HB3' ' A' ' 98' ' ' ARG . 70.3 p -55.0 -46.2 75.15 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.289 -0.414 . . . . 74.12 111.764 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 48.4 tp -58.62 -49.15 78.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.935 0.398 . . . . 52.32 111.357 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.443 ' HE3' ' HG3' ' A' ' 6' ' ' PRO . 29.0 mtpp -57.76 -43.24 85.35 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.798 0.332 . . . . 73.31 111.765 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.497 HD23 HD21 ' A' ' 87' ' ' LEU . 44.6 tp -67.96 -43.58 78.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.137 0.494 . . . . 71.42 111.302 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.45 95.31 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.237 0.458 . . . . 70.52 112.237 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 47.3 mtm180 -63.26 -47.1 83.81 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.147 0.425 . . . . 74.13 112.147 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 6' ' ' PRO . 10.7 pt20 -67.81 -31.49 71.38 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.845 0.355 . . . . 75.0 111.639 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -76.41 -15.35 59.96 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.663 0.268 . . . . 75.11 111.682 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 79' ' ' ASN . . . 95.27 -37.02 3.54 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.192 -0.528 . . . . 64.12 113.0 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 45.1 t -54.35 -22.51 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.518 0.562 . . . . 64.4 112.518 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.62 22.69 4.33 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.223 -0.513 . . . . 64.13 112.918 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.443 ' HB2' ' HA2' ' A' ' 76' ' ' GLY . 18.8 t-20 -67.55 98.74 0.7 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.493 -0.416 . . . . 64.12 110.978 -177.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 44.88 64.19 1.46 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.808 -0.633 . . . . 73.24 111.355 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.591 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 3.3 mptp? 60.38 76.69 0.35 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.722 -0.672 . . . . 73.44 112.457 175.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 41.0 t30 -72.5 148.57 44.93 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.698 -0.683 . . . . 72.35 110.262 175.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.626 HD22 ' N ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -56.35 -98.89 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 112.637 0.606 . . . . 72.03 112.637 -177.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -86.02 81.64 8.41 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.894 -1.128 . . . . 64.52 111.074 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -147.47 142.68 10.43 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.63 -0.714 . . . . 74.42 112.873 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 99' ' ' PHE . 40.2 tp -151.47 128.73 11.23 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.806 0.442 . . . . 61.24 111.084 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.497 HD21 HD23 ' A' ' 71' ' ' LEU . 55.7 tp -109.28 144.29 37.62 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.948 0.404 . . . . 75.32 111.269 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.0 tp -130.43 125.96 35.79 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.312 -0.404 . . . . 75.21 110.414 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.6 t -127.0 125.09 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.878 0.371 . . . . 75.45 111.895 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.571 HD22 HD11 ' A' ' 135' ' ' LEU . 18.9 tp -101.0 134.1 44.5 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.928 -0.578 . . . . 70.32 110.531 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.606 HG11 HG12 ' A' ' 59' ' ' ILE . 48.2 t -118.92 109.67 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.803 0.335 . . . . 65.32 110.978 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.507 HD13 HD11 ' A' ' 27' ' ' LEU . 67.4 tp -59.49 -44.19 93.12 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.938 0.718 . . . . 74.3 112.938 -174.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.429 ' OD1' ' HA ' ' A' ' 58' ' ' SER . 1.2 p-10 -69.12 -17.9 63.9 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.08 0.467 . . . . 75.33 111.478 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -103.86 -18.81 14.49 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.323 -0.399 . . . . 65.01 111.573 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 57.93 27.21 14.37 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.254 0.549 . . . . 64.53 111.688 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -121.61 157.66 30.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.18 0.514 . . . . 62.24 111.653 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.28 158.69 38.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.675 -0.693 . . . . 64.3 110.066 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.502 ' HB3' HG21 ' A' ' 68' ' ' THR . 0.0 OUTLIER -148.59 130.97 15.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.945 0.403 . . . . 74.31 111.262 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.564 ' HB3' HD11 ' A' ' 86' ' ' LEU . 89.1 m-85 -97.12 153.23 18.09 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.124 -0.489 . . . . 72.31 111.246 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -137.23 111.81 8.71 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 122.18 -0.325 . . . . 74.11 110.515 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.408 HG23 HD13 ' A' ' 86' ' ' LEU . 20.4 p -101.11 142.51 32.45 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.341 0.591 . . . . 65.14 111.974 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 81' ' ' LYS . . . -75.54 -94.14 0.16 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.816 -0.707 . . . . 75.03 113.008 174.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.478 ' HB2' ' HB3' ' A' ' 81' ' ' LYS . 25.0 t80 -147.62 -29.39 0.34 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.174 0.511 . . . . 62.34 111.577 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.28 -12.74 83.95 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.054 -0.593 . . . . 54.13 113.122 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.617 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 96.3 mt -103.85 1.19 31.17 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.113 0.412 . . . . 75.2 112.113 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.27 -23.89 67.62 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.241 0.543 . . . . 62.12 111.22 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.84 7.72 81.36 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.131 -0.486 . . . . 71.43 113.179 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.617 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 29.3 m-85 -133.87 -62.69 0.76 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.301 0.572 . . . . 74.14 111.038 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.31 90.61 14.48 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.563 -0.744 . . . . 73.11 111.991 -174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.6 148.12 41.63 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 121.744 1.63 . . . . 72.1 112.226 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -48.68 -42.65 35.42 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.151 0.426 . . . . 72.51 112.151 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.79 -44.89 95.6 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.107 -0.568 . . . . 52.43 113.13 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 117' ' ' ILE . 64.9 tp -57.71 -50.54 72.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.117 0.484 . . . . 74.4 110.625 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 81.8 mt -57.77 -38.41 75.39 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 74.32 111.136 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.7 t -66.33 -38.37 87.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.15 -0.477 . . . . 60.24 110.959 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -65.6 -44.93 85.07 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.6 -0.273 . . . . 73.05 111.13 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 113' ' ' LEU . 74.2 mt -50.96 -35.62 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.078 0.466 . . . . 72.54 111.212 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 122' ' ' MET . 64.6 mt -57.19 -48.46 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.09 -0.504 . . . . 61.32 110.786 174.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.444 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 31.2 m-70 -72.71 -33.82 66.71 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.389 -0.369 . . . . 71.4 111.857 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -72.36 -43.27 64.28 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.264 0.838 . . . . 72.12 113.264 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 137' ' ' GLU . 15.7 mmm180 -118.45 -49.01 2.48 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.805 0.668 . . . . 72.02 112.805 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 13.2 mmt -59.67 -56.28 23.9 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.748 0.647 . . . . 71.35 112.748 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 118' ' ' ILE . 50.5 mm -55.26 -55.21 42.04 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 113.055 0.761 . . . . 74.51 113.055 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 9.8 Cg_endo -52.41 -32.98 54.7 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.282 1.988 . . . . 73.41 113.067 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 86.2 m-70 -79.85 -46.54 16.69 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.57 0.211 . . . . 74.14 111.57 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -56.8 -33.78 67.03 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.853 0.359 . . . . 75.25 111.323 178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 83.2 mtp180 -63.1 -39.44 94.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.028 0.442 . . . . 73.22 111.045 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.4 m -82.12 -11.37 58.79 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.408 -0.36 . . . . 62.1 111.625 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.61 5.47 60.11 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.486 -0.388 . . . . 73.31 112.832 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.75 77.4 9.78 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.877 0.37 . . . . 63.5 111.869 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -66.44 -41.08 89.68 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.002 -0.436 . . . . 74.22 111.514 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.15 87.61 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.023 0.439 . . . . 71.41 111.747 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 16.8 mp0 -63.7 -43.73 95.75 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.355 -0.384 . . . . 73.22 111.181 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.35 -52.96 48.51 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.965 -0.636 . . . . 33.33 112.536 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.571 HD11 HD22 ' A' ' 90' ' ' LEU . 95.9 mt -58.1 -51.65 68.83 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.013 0.375 . . . . 42.45 112.013 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 81.6 p -56.58 -50.78 70.93 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.914 0.339 . . . . 72.44 111.914 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 121' ' ' ARG . 27.2 mt-10 -72.15 -31.64 66.16 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.366 0.506 . . . . 72.23 112.366 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.63 -46.46 93.26 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.323 -0.941 . . . . 22.35 112.1 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 135' ' ' LEU . 98.7 t -63.6 -47.11 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.845 0.355 . . . . 55.31 111.212 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.93 -37.68 80.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.275 -0.42 . . . . 72.3 111.444 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.533 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -60.76 -52.37 65.4 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.923 0.392 . . . . 71.21 110.821 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.0 t -56.69 -46.69 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.36 0.6 . . . . 73.45 110.926 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -53.39 -51.23 63.22 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.651 -0.704 . . . . 71.43 111.692 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -65.59 -31.06 71.89 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.383 0.512 . . . . 64.14 112.383 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 141' ' ' ALA . 95.8 t -58.28 -48.65 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.111 0.482 . . . . 64.23 110.556 174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.79 -49.25 60.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.122 -0.49 . . . . 64.41 110.968 176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -56.6 -32.27 65.1 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.65 -0.705 . . . . 72.43 112.229 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.34 -22.39 56.82 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.212 -0.518 . . . . 53.22 113.484 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.7 t -92.77 -50.68 5.45 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 122.429 -0.454 . . . . 73.4 111.83 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 154' ' ' HIS . 94.0 mt -92.01 84.52 5.33 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.566 0.698 . . . . 71.04 111.0 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.8 -22.02 65.09 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.199 -0.909 . . . . 51.54 112.26 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -127.2 149.02 50.17 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.573 0.225 . . . . 71.02 111.559 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.446 ' HA ' ' O ' ' A' ' 46' ' ' SER . 42.9 t60 -45.31 106.37 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.429 -0.351 . . . . 74.45 111.087 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.435 ' HB3' HD13 ' A' ' 150' ' ' LEU . 16.7 t-80 -112.5 118.04 34.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.261 0.553 . . . . 74.31 112.386 -170.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -108.68 131.79 54.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.081 -0.509 . . . . 62.51 110.495 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -74.25 -82.13 0.06 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.591 0.589 . . . . 73.43 112.591 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.834 -0.603 . . . . 75.12 111.708 -176.802 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.768 0.318 . . . . 74.32 111.347 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -163.09 124.85 2.52 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.521 -0.309 . . . . 73.33 111.168 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.2 t -73.18 123.51 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 112.812 0.671 . . . . 74.33 112.812 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -116.55 158.73 23.19 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.55 -0.75 . . . . 75.44 110.353 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -127.22 160.44 59.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.61 -0.268 . . . . 74.25 111.292 176.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 57.6 Cg_endo -70.92 64.95 2.5 Favored 'Trans proline' 0 C--N 1.358 1.026 0 C-N-CA 122.458 2.105 . . . . 60.12 111.803 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -174.4 -35.47 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.157 -0.929 . . . . 74.44 110.394 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -71.82 -40.55 69.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.138 0.494 . . . . 60.13 110.693 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.93 126.2 41.98 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.426 -0.806 . . . . 65.32 111.905 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.65 123.06 11.14 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.681 2.254 . . . . 70.53 112.849 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -66.89 87.88 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.207 0.527 . . . . 54.34 111.084 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.452 HG23 HE21 ' A' ' 13' ' ' GLN . 28.0 m -69.71 -21.37 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.583 0.586 . . . . 75.14 112.583 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.594 HE22 ' HG ' ' A' ' 20' ' ' LEU . 27.9 mm-40 -70.11 -35.88 74.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.601 -0.687 . . . . 74.43 110.797 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.59 -33.68 64.74 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.819 -0.628 . . . . 72.34 109.996 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.18 -86.94 0.26 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.926 -0.579 . . . . 54.21 112.343 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -99.92 77.55 2.03 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.545 0.572 . . . . 72.44 112.545 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.4 t -72.76 -0.8 14.27 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.981 0.419 . . . . 55.05 111.354 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -81.0 -31.77 34.54 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.101 0.408 . . . . 73.44 112.101 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -100.41 -43.84 6.1 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.132 0.419 . . . . 75.2 112.132 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.594 ' HG ' HE22 ' A' ' 13' ' ' GLN . 5.0 mp 64.79 17.97 11.23 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.883 0.473 . . . . 72.52 111.983 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.59 130.71 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 112.106 0.41 . . . . 75.1 112.106 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.8 m -124.49 103.58 8.25 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.383 -0.372 . . . . 71.24 111.175 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 28' ' ' LEU . 27.4 t70 -102.47 109.05 20.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.804 0.335 . . . . 74.53 111.148 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -118.97 -21.96 7.49 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.8 0.333 . . . . 73.24 111.258 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.55 -24.59 67.65 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.019 0.377 . . . . 53.22 112.019 170.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.39 43.27 16.26 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.272 -0.489 . . . . 64.53 112.727 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.5 mt -115.4 -30.98 6.08 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.356 0.502 . . . . 65.24 112.356 -175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 23' ' ' ASP . 95.0 mt -75.58 106.68 7.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.006 0.431 . . . . 75.42 111.66 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 t -73.72 157.18 36.98 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.493 -0.321 . . . . 71.3 110.535 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -51.82 -55.25 21.03 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.032 0.752 . . . . 50.12 113.032 -170.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.07 -38.2 75.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.704 0.288 . . . . 75.14 111.574 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -71.35 -30.28 65.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.795 0.331 . . . . 53.13 111.065 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.87 -51.92 67.62 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.628 -0.26 . . . . 72.02 110.307 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -57.9 -32.87 68.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.745 0.307 . . . . 73.22 111.497 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.489 ' O ' ' HD2' ' A' ' 39' ' ' ARG . 91.5 t -60.0 -53.93 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.083 0.468 . . . . 72.44 110.98 174.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 46.5 ttm -69.87 -49.54 51.34 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.43 -0.35 . . . . 71.02 111.383 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -50.65 -52.49 39.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.726 0.41 . . . . 54.43 110.997 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.77 -43.31 94.65 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 116.211 -0.449 . . . . 61.42 113.174 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.546 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -58.93 -55.59 33.19 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.595 0.236 . . . . 73.0 111.322 177.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 mt -63.51 -47.22 82.58 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.374 0.607 . . . . 61.33 111.318 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -57.63 -47.08 83.19 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.612 -0.722 . . . . 71.22 111.345 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.31 93.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.56 -0.291 . . . . 75.52 111.521 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 39' ' ' ARG . 80.1 mt -60.54 -47.74 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 120.749 0.309 . . . . 75.24 111.152 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -64.8 -33.34 75.76 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 120.963 0.411 . . . . 73.34 111.217 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.8 t -82.73 -2.09 53.32 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.421 0.629 . . . . 64.32 111.289 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 154' ' ' HIS . 48.3 m -130.09 -72.19 0.58 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.059 0.457 . . . . 75.2 111.377 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.675 ' ND1' ' HB2' ' A' ' 150' ' ' LEU . 93.3 m-70 -79.75 -12.63 59.78 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.152 0.427 . . . . 73.5 112.152 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.85 18.89 11.24 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.914 0.486 . . . . 73.43 112.105 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.752 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 94.2 t -86.0 132.79 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.457 -0.338 . . . . 71.13 111.199 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -86.77 96.29 10.13 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.222 0.534 . . . . 72.43 110.293 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -114.02 109.47 18.5 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.687 -0.688 . . . . 75.44 110.256 -175.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -117.7 142.77 46.87 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.112 0.412 . . . . 53.42 112.112 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.8 t -123.94 133.65 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.848 0.356 . . . . 75.14 111.39 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.414 HG21 HD21 ' A' ' 71' ' ' LEU . 48.4 t -126.53 137.99 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 122.497 0.319 . . . . 65.41 111.143 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 24.8 p -120.12 123.01 42.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 120.86 0.362 . . . . 74.33 111.159 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -127.17 147.24 61.01 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 120.629 0.252 . . . . 72.33 111.521 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.06 -57.52 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.372 2.048 . . . . 75.2 112.374 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 25.0 m -145.42 148.65 33.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.41 -0.359 . . . . 53.32 111.248 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.475 HD11 ' NE2' ' A' ' 94' ' ' GLN . 28.7 pt -110.2 -2.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.305 0.574 . . . . 73.34 110.631 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.0 -113.43 5.07 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.66 -0.7 . . . . 61.22 114.329 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.42 1.28 53.85 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.489 0.552 . . . . 75.43 112.489 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.67 141.82 28.82 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 111.799 0.296 . . . . 71.53 111.799 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.76 143.11 18.38 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.858 2.372 . . . . 62.14 112.411 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.24 -51.35 70.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.1 0.407 . . . . 70.24 112.1 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.49 -35.13 79.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.275 0.472 . . . . 75.04 112.275 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.38 -42.24 83.72 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.257 0.551 . . . . 64.53 110.437 175.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.404 ' CD2' ' HD3' ' A' ' 6' ' ' PRO . 24.8 t80 -60.49 -53.38 58.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.737 -0.665 . . . . 71.01 111.884 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.413 HG21 ' HB3' ' A' ' 98' ' ' ARG . 22.0 p -51.12 -48.45 61.75 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.122 0.786 . . . . 61.4 113.122 -174.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 52.5 tp -66.71 -46.51 75.29 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.821 0.344 . . . . 54.32 111.724 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -64.82 -38.14 89.97 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.118 0.414 . . . . 75.21 112.118 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.414 HD21 HG21 ' A' ' 54' ' ' VAL . 63.3 tp -69.26 -40.76 77.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.154 0.502 . . . . 74.01 110.522 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.64 95.57 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.267 0.469 . . . . 73.03 112.267 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 53.8 mtp180 -60.65 -49.54 77.12 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.204 0.446 . . . . 74.24 112.204 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.666 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 11.8 pt20 -66.26 -21.09 66.28 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 120.947 0.404 . . . . 72.23 111.426 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.666 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 22.9 m0 -90.07 7.33 38.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.868 0.366 . . . . 74.41 111.406 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.461 ' HA2' ' ND2' ' A' ' 79' ' ' ASN . . . 86.18 -50.71 4.3 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.308 -0.473 . . . . 71.13 113.5 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -54.47 -26.22 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 N-CA-C 113.377 0.88 . . . . 71.0 113.377 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.08 -9.27 59.62 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.973 -0.632 . . . . 73.11 114.349 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.461 ' ND2' ' HA2' ' A' ' 76' ' ' GLY . 93.9 m-20 -53.83 101.7 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.599 0.7 . . . . 74.35 111.317 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 38.03 40.49 0.31 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.698 0.799 . . . . 64.13 112.132 -173.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER 65.48 83.43 0.17 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.115 -0.948 . . . . 74.13 112.013 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.571 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 37.4 t30 -68.46 138.79 55.54 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.994 -0.548 . . . . 70.44 110.102 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.589 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -39.13 -67.13 0.23 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.765 1.024 . . . . 75.11 113.765 -170.11 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.752 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 81.1 m-20 -96.86 25.81 5.04 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.676 -0.64 . . . . 71.34 111.702 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.44 127.54 8.04 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.98 -0.629 . . . . 51.02 113.16 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 53.2 tp -145.05 119.3 9.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.081 0.467 . . . . 71.11 111.052 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.401 HD21 HD23 ' A' ' 71' ' ' LEU . 54.3 tp -117.45 142.08 47.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.883 0.373 . . . . 61.41 111.642 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.6 tp -128.68 118.71 23.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.031 -0.531 . . . . 65.23 110.754 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -113.8 129.43 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.864 0.364 . . . . 60.24 111.969 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.852 HD22 HD11 ' A' ' 135' ' ' LEU . 12.3 tp -102.37 124.09 47.32 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.966 0.506 . . . . 73.23 111.023 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 59' ' ' ILE . 58.3 t -111.82 98.33 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.912 0.387 . . . . 71.43 111.118 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.1 tp -54.5 -40.4 68.51 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.017 -0.538 . . . . 64.34 111.656 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.508 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 14.2 t70 -51.73 -37.46 51.15 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.861 -0.609 . . . . 41.05 112.427 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.475 ' NE2' HD11 ' A' ' 59' ' ' ILE . 49.9 mt-30 -112.87 -6.59 13.79 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.203 0.446 . . . . 73.01 112.203 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.532 ' HG2' ' HE1' ' A' ' 131' ' ' TYR . 99.6 mtt180 57.58 24.28 10.24 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.126 0.489 . . . . 64.54 111.628 -174.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -106.84 147.38 29.8 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.074 0.464 . . . . 71.33 111.725 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 90' ' ' LEU . 15.3 m -133.53 157.44 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.693 -0.685 . . . . 54.4 110.342 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' HB3' HG21 ' A' ' 68' ' ' THR . 76.6 ttt-85 -148.44 137.73 21.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.081 0.4 . . . . 75.4 112.081 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 97.1 m-85 -96.08 151.84 19.09 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.975 -0.557 . . . . 74.55 110.628 173.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 9.2 tp10 -138.01 114.53 10.42 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.435 -0.166 . . . . 71.33 110.715 175.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 p -98.06 157.14 16.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.728 0.775 . . . . 60.35 113.076 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -98.54 171.98 25.76 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.172 -0.922 . . . . 74.41 112.153 167.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -51.88 -24.67 6.56 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.991 0.738 . . . . 72.32 112.991 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.424 ' H ' ' HA ' ' A' ' 83' ' ' ASN . . . -80.61 -16.56 75.31 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.905 -0.664 . . . . 72.31 112.951 -174.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.476 HD11 HG13 ' A' ' 49' ' ' VAL . 93.6 mt -108.27 -10.81 15.32 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.366 0.506 . . . . 62.01 112.366 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -49.75 -32.44 13.72 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.675 0.62 . . . . 74.34 112.675 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.76 -22.38 64.21 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.03 -0.605 . . . . 51.35 113.978 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -102.97 -38.62 7.28 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.394 0.616 . . . . 71.41 111.471 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.482 ' HB3' HD21 ' A' ' 114' ' ' LEU . 25.7 mt -127.66 78.1 75.31 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 115.735 -0.666 . . . . 61.03 111.234 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.28 163.31 36.7 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.148 1.898 . . . . 64.42 112.722 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -52.56 -44.88 66.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.253 0.464 . . . . 63.04 112.253 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.62 98.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.259 -0.496 . . . . 54.23 113.169 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 109' ' ' LEU . 58.2 tp -65.39 -49.25 69.98 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 122.441 -0.446 . . . . 65.11 110.955 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 109' ' ' LEU . 91.0 mt -55.62 -44.17 76.8 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.054 0.454 . . . . 54.02 110.842 176.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -60.67 -43.47 97.63 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.937 -0.574 . . . . 64.33 111.102 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -57.52 -53.2 60.8 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.646 -0.252 . . . . 74.5 111.249 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.9 mt -50.82 -40.65 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.955 0.407 . . . . 73.22 111.213 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.687 ' O ' ' HB2' ' A' ' 122' ' ' MET . 77.8 mt -59.09 -44.85 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.03 -0.532 . . . . 73.02 111.248 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -83.23 -22.58 33.06 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.644 -0.66 . . . . 61.22 112.163 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.95 -55.89 3.84 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.532 0.333 . . . . 74.33 111.711 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 25.7 mtp180 -118.63 6.83 11.64 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.106 0.78 . . . . 71.34 113.106 -172.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.687 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 17.0 mmt -108.79 -62.8 1.42 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.025 0.441 . . . . 75.24 111.412 174.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.473 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 28.7 mm -47.33 -53.1 31.3 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 113.907 1.077 . . . . 62.44 113.907 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 13.7 Cg_endo -54.2 -34.5 79.31 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.225 1.95 . . . . 61.42 112.771 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 96.4 m-70 -77.97 -43.1 30.69 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.34 -0.391 . . . . 63.41 111.294 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.7 m-30 -59.75 -42.26 92.85 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.756 0.312 . . . . 74.55 111.258 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -59.3 -35.85 74.52 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.073 0.463 . . . . 73.33 111.247 176.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.2 m -82.77 -16.81 46.46 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.026 -0.534 . . . . 71.25 112.019 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.89 -2.62 52.11 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.467 -0.397 . . . . 51.35 112.796 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.814 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.3 m-20 -81.78 62.96 5.83 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 122.51 -0.406 . . . . 75.15 111.242 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.532 ' HE1' ' HG2' ' A' ' 95' ' ' ARG . 97.1 m-85 -58.72 -60.45 3.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.296 0.48 . . . . 72.12 112.296 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.475 ' HB1' HD23 ' A' ' 28' ' ' LEU . . . -63.75 -35.46 80.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.957 0.408 . . . . 73.2 111.949 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.814 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 6.9 tp10 -58.59 -50.16 74.83 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.19 0.519 . . . . 75.35 110.845 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.33 -46.83 93.62 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 115.859 -0.61 . . . . 72.43 112.874 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.852 HD11 HD22 ' A' ' 90' ' ' LEU . 85.2 mt -51.44 -48.9 62.58 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.039 0.447 . . . . 75.03 111.293 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.5 m -61.82 -38.4 88.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.084 -0.507 . . . . 72.32 111.506 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 5.3 mm-40 -64.2 -45.87 86.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.732 0.301 . . . . 75.53 111.668 176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 142' ' ' VAL . . . -62.8 -46.48 93.55 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.069 -0.586 . . . . 75.45 112.883 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 135' ' ' LEU . 79.1 t -57.77 -48.6 83.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.065 0.46 . . . . 73.23 111.2 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.8 tp -58.26 -41.12 83.58 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.233 -0.439 . . . . 71.52 111.009 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.52 ' HB2' ' HD3' ' A' ' 121' ' ' ARG . . . -59.65 -51.54 69.36 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.158 -0.474 . . . . 71.21 111.309 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 138' ' ' GLY . 97.5 t -56.33 -48.92 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.986 0.422 . . . . 71.51 110.978 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.443 ' OE1' ' HG3' ' A' ' 39' ' ' ARG . 65.0 tt0 -52.92 -44.13 66.78 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.15 -0.477 . . . . 70.33 111.701 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.27 -35.64 81.66 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.398 0.518 . . . . 75.53 112.398 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 141' ' ' ALA . 61.7 t -59.86 -46.31 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.395 0.616 . . . . 72.53 110.581 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.08 -35.75 71.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.783 -0.644 . . . . 52.31 111.17 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -60.74 -52.69 64.02 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.308 -0.405 . . . . 70.3 110.963 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.22 41.12 1.77 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.071 -0.585 . . . . 73.12 112.674 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 56.8 m -155.0 -58.24 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.004 0.43 . . . . 74.22 111.23 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.675 ' HB2' ' ND1' ' A' ' 47' ' ' HIS . 41.5 mt -107.15 22.17 16.4 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.466 -0.334 . . . . 71.32 111.835 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -49.48 -38.74 31.16 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.913 0.708 . . . . 74.12 112.913 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -65.86 -9.15 26.51 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.246 0.461 . . . . 73.35 112.246 -174.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -91.22 4.58 51.93 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.912 0.338 . . . . 70.41 111.912 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 8.7 p-80 -61.25 139.58 58.12 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.03 0.752 . . . . 71.43 113.03 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -116.18 -30.99 5.81 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.365 -0.379 . . . . 62.43 111.429 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 76.7 t60 66.4 20.9 10.94 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.158 0.504 . . . . 75.45 111.928 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 26.9 t60 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.637 -0.696 . . . . 73.11 111.054 -179.498 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptp . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.45 0.167 . . . . 44.24 111.172 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.497 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 20.2 ttm180 -168.11 130.89 1.52 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.786 0.327 . . . . 75.45 111.482 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.82 133.6 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.936 0.398 . . . . 54.4 111.764 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.413 ' CD1' ' HD2' ' A' ' 57' ' ' PRO . 57.2 m-85 -123.77 139.72 53.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.12 0.486 . . . . 73.22 111.66 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.58 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 34.9 mmtp -106.18 167.07 10.13 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.894 -0.594 . . . . 73.21 109.564 169.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 18.2 Cg_endo -58.58 -16.88 32.14 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.756 1.637 . . . . 63.3 112.307 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 5' ' ' LYS . 10.6 pt-20 -90.56 -16.63 28.42 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.031 -0.531 . . . . 75.1 111.941 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.97 -30.22 21.43 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.958 0.409 . . . . 70.45 111.079 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -66.39 123.27 85.07 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.038 -0.528 . . . . 74.25 111.741 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.37 117.26 3.46 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.812 2.341 . . . . 72.12 113.23 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.734 ' HB3' ' HB3' ' A' ' 14' ' ' LEU . 80.5 m-20 -68.5 79.16 0.27 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.321 0.489 . . . . 75.43 112.321 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 m -65.92 -53.47 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 111.684 0.253 . . . . 75.4 111.684 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.464 ' NE2' ' HG ' ' A' ' 20' ' ' LEU . 1.5 mp0 -70.45 1.76 4.69 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.75 0.648 . . . . 61.45 112.75 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 11' ' ' ASN . 8.8 tt -109.15 -40.98 4.8 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.813 0.34 . . . . 64.41 110.759 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.07 -63.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.211 0.449 . . . . 41.21 112.211 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.52 -71.84 0.18 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.069 0.462 . . . . 62.14 111.3 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 m 73.73 -22.61 0.24 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.836 1.051 . . . . 60.42 113.836 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.53 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 9.4 t -82.32 -12.66 57.84 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.483 0.658 . . . . 70.43 110.769 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . 14.7 ptt-85 -126.87 145.19 50.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.614 -0.721 . . . . 70.21 109.186 171.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HG ' ' NE2' ' A' ' 13' ' ' GLN . 5.7 mp -119.47 14.66 12.84 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.85 0.357 . . . . 74.24 111.445 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.61 123.58 68.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.071 0.397 . . . . 74.01 112.071 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.6 m -120.66 102.98 8.77 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.39 -0.368 . . . . 65.11 110.824 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 25.7 t70 -97.73 103.73 15.69 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.034 0.445 . . . . 61.12 111.366 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB2' HD23 ' A' ' 56' ' ' LEU . 5.3 mm-40 -110.96 -28.42 8.36 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.335 -0.393 . . . . 62.21 111.632 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -64.08 -25.27 68.03 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.004 0.372 . . . . 73.41 112.004 172.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.55 44.58 9.29 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.016 -0.611 . . . . 62.41 112.354 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.9 mt -115.93 -21.58 9.46 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.621 0.369 . . . . 54.52 111.593 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.0 mt -96.8 111.17 23.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.778 0.323 . . . . 44.01 111.536 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.5 t -67.55 151.06 47.99 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.505 0.193 . . . . 45.04 111.081 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -51.2 -42.67 61.06 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.306 0.484 . . . . 51.32 112.306 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.44 -40.03 94.97 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.105 0.479 . . . . 62.4 111.539 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -67.29 -39.95 86.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.872 0.368 . . . . 73.34 110.797 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.59 -42.39 98.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.315 -0.402 . . . . 54.41 111.487 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.05 -53.68 52.78 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.009 0.433 . . . . 74.42 111.107 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.72 -45.29 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.331 -0.395 . . . . 73.14 111.647 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 52.1 ttm -61.14 -47.98 83.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.638 -0.255 . . . . 45.15 111.5 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 56.0 m-80 -60.22 -37.75 81.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.662 0.267 . . . . 63.52 110.997 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.23 95.66 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.917 -0.659 . . . . 73.14 112.882 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' O ' HG13 ' A' ' 43' ' ' ILE . 98.6 mtt180 -64.0 -55.51 21.81 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.996 0.427 . . . . 65.13 110.872 174.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.85 -49.82 76.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.099 -0.501 . . . . 62.43 112.242 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' A' ' 18' ' ' THR . 30.9 ttp180 -58.09 -40.38 80.96 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.192 -0.458 . . . . 65.14 111.104 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.45 89.5 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.422 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 39' ' ' ARG . 86.4 mt -58.43 -49.45 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.752 0.311 . . . . 73.12 111.627 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 57.2 ttp180 -69.42 -26.84 64.82 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.14 -0.35 . . . . 74.04 111.529 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.4 t -82.13 -22.63 36.07 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.858 0.361 . . . . 61.24 111.098 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 154' ' ' HIS . 45.6 m -102.8 -66.08 0.95 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.125 -0.489 . . . . 72.32 111.62 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.643 ' ND1' ' HB2' ' A' ' 150' ' ' LEU . 83.7 m-70 -84.35 -8.99 58.82 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.302 -0.408 . . . . 71.1 112.017 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 68.54 15.01 9.15 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.939 0.495 . . . . 71.34 112.318 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.74 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 89.3 t -86.22 119.27 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.019 0.438 . . . . 72.34 111.934 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -78.15 96.13 5.1 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 74.34 110.184 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -115.76 106.1 13.48 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.388 -0.369 . . . . 71.44 110.722 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.65 146.63 34.47 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.942 0.401 . . . . 55.1 112.055 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.89 114.79 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.939 0.4 . . . . 65.52 111.284 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.463 ' HB ' HG22 ' A' ' 89' ' ' VAL . 48.7 t -118.88 132.7 68.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.839 0.352 . . . . 62.23 111.492 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.418 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 32.0 p -110.38 125.58 53.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.94 0.4 . . . . 70.41 111.129 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.447 HD23 ' HB2' ' A' ' 24' ' ' GLU . 55.1 mt -131.55 142.16 44.33 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.445 -0.343 . . . . 61.32 110.85 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.645 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 22.5 Cg_exo -64.59 -67.35 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.373 2.049 . . . . 74.12 112.076 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.9 t -133.64 157.74 45.0 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.135 0.493 . . . . 71.41 111.32 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 pt -120.35 9.9 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.915 -0.584 . . . . 65.53 111.078 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.0 -119.62 5.26 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 116.18 -0.464 . . . . 74.43 113.118 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -112.04 3.82 17.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.391 0.276 . . . . 72.35 111.722 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.86 139.14 96.71 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 111.795 0.295 . . . . 65.24 111.795 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.735 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 57.1 Cg_endo -71.07 125.31 11.34 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.354 2.036 . . . . 63.41 111.826 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.463 ' HG ' ' HB2' ' A' ' 98' ' ' ARG . 44.2 tp -56.25 -41.75 76.26 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.509 0.559 . . . . 61.12 112.509 -173.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.07 -35.16 79.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.106 0.479 . . . . 73.24 112.134 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.735 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 5.8 m-20 -86.74 -28.23 23.18 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.109 0.481 . . . . 72.04 111.356 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -57.37 -50.24 73.59 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.924 -0.58 . . . . 72.3 110.782 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 p -58.11 -37.65 74.96 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.769 -0.65 . . . . 65.14 112.049 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -62.25 -38.33 88.87 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 120.708 0.29 . . . . 63.02 111.671 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -66.97 -38.76 86.66 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.92 0.39 . . . . 63.24 111.554 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.551 HD23 HD21 ' A' ' 87' ' ' LEU . 45.5 tp -72.07 -42.61 66.0 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.173 0.511 . . . . 63.24 111.345 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.49 -44.4 95.99 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.302 0.482 . . . . 74.41 112.302 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' CB ' ' HA ' ' A' ' 79' ' ' ASN . 15.0 ptp180 -68.43 -25.2 64.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.046 0.387 . . . . 74.24 112.046 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -70.66 -42.67 70.5 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.997 0.427 . . . . 72.13 110.828 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -82.04 -15.7 52.69 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.157 -0.474 . . . . 74.04 112.256 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.58 9.37 64.7 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.881 -0.676 . . . . 62.44 112.75 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 t -86.72 -12.17 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.869 0.366 . . . . 64.23 110.726 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.86 67.31 0.13 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.905 -0.664 . . . . 72.21 113.435 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.449 ' HA ' ' CB ' ' A' ' 73' ' ' ARG . 2.3 m-20 -59.23 -46.48 88.37 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.304 0.573 . . . . 64.02 110.536 176.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.5 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -135.71 -83.79 0.39 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.178 -0.919 . . . . 75.42 109.227 169.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.5 ' HD2' ' O ' ' A' ' 80' ' ' GLU . 0.7 OUTLIER -123.03 85.35 2.41 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.263 0.554 . . . . 75.44 110.892 169.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.484 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 45.0 t30 -71.12 153.5 42.48 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.823 -0.626 . . . . 64.42 111.136 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.579 HD22 ' N ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -62.62 -90.15 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 112.668 0.618 . . . . 74.42 112.668 -177.654 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.74 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.1 m-20 -88.26 32.87 0.75 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.004 -1.06 . . . . 64.14 112.095 -173.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.67 127.72 8.76 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.171 -0.537 . . . . 62.3 113.694 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.6 tp -142.53 119.85 11.57 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.206 0.527 . . . . 72.45 111.042 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.551 HD21 HD23 ' A' ' 71' ' ' LEU . 56.7 tp -114.94 122.25 45.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.335 -0.393 . . . . 73.41 111.453 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.4 tp -111.36 114.04 26.92 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.36 -0.382 . . . . 74.0 111.003 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' A' ' 54' ' ' VAL . 84.5 t -119.06 131.56 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.866 0.365 . . . . 72.0 111.619 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.534 ' HB2' HD21 ' A' ' 135' ' ' LEU . 30.3 tp -106.22 130.74 54.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.362 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.795 HG11 HE21 ' A' ' 94' ' ' GLN . 86.2 t -106.12 109.7 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.372 -0.376 . . . . 71.55 111.101 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 69.0 tp -60.87 -41.01 95.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.131 0.419 . . . . 65.13 112.131 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.09 -47.31 85.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.219 0.533 . . . . 73.31 111.699 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.795 HE21 HG11 ' A' ' 91' ' ' VAL . 45.8 mt-30 -87.44 -15.35 37.96 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.981 -0.554 . . . . 73.01 112.356 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 95' ' ' ARG . 56.0 mtt180 58.99 36.43 24.44 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.098 0.407 . . . . 74.11 112.098 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -144.74 157.79 44.04 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.955 0.407 . . . . 64.14 111.519 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.551 HG21 ' SD ' ' A' ' 122' ' ' MET . 10.2 m -117.87 171.61 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.244 0.545 . . . . 62.34 112.066 -174.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.463 ' HB2' ' HG ' ' A' ' 64' ' ' LEU . 27.8 tpt180 -136.81 129.04 29.78 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.957 -0.565 . . . . 73.13 111.348 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -103.11 107.89 18.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.184 -0.462 . . . . 63.43 110.391 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -102.43 111.96 24.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.473 0.178 . . . . 64.34 110.897 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 p -103.86 150.36 24.22 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.238 0.542 . . . . 64.13 111.871 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -85.27 -145.0 7.46 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.795 -0.717 . . . . 64.35 112.171 169.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.15 -25.84 21.62 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 122.514 -0.404 . . . . 73.04 111.745 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.9 -28.52 62.55 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.017 -0.611 . . . . 61.24 113.697 -170.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 49' ' ' VAL . 96.9 mt -99.3 -0.67 40.74 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.744 0.646 . . . . 74.43 112.744 -174.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -61.48 -27.21 68.42 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.959 0.409 . . . . 74.35 112.052 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.35 3.6 86.91 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.429 -0.415 . . . . 51.24 113.667 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -126.54 -38.7 2.07 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.072 0.463 . . . . 74.01 111.583 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.516 ' HB3' HD21 ' A' ' 114' ' ' LEU . 17.4 mt -129.82 78.71 74.67 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.892 -0.595 . . . . 72.01 111.61 -171.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.21 151.36 48.97 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.442 2.095 . . . . 75.01 112.168 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -50.41 -35.29 27.76 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.299 0.481 . . . . 74.34 112.299 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.75 -48.95 80.92 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.177 -0.535 . . . . 61.23 112.559 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.0 tp -60.03 -44.98 94.27 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.093 0.473 . . . . 61.11 110.94 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 109' ' ' LEU . 85.4 mt -58.71 -39.17 80.04 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.994 -0.548 . . . . 65.51 111.105 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.8 t -65.28 -39.74 92.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.98 0.419 . . . . 72.32 110.89 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -57.04 -48.73 77.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.911 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.4 mt -53.05 -47.71 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.2 0.524 . . . . 75.24 111.386 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 122' ' ' MET . 67.5 mt -60.09 -55.64 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.008 -0.542 . . . . 54.42 111.697 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.483 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 49.4 m-70 -70.27 -35.4 73.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.036 0.754 . . . . 73.42 113.036 -173.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.15 -38.12 21.08 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.259 0.837 . . . . 64.33 113.259 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.5 ' HD3' ' HB2' ' A' ' 141' ' ' ALA . 35.9 mtp180 -111.74 -33.3 6.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.275 0.843 . . . . 72.04 113.275 -173.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.551 ' SD ' HG21 ' A' ' 97' ' ' VAL . 53.5 mtt -84.41 -54.0 5.07 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.759 0.652 . . . . 73.54 112.759 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.504 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 46.9 mm -48.86 -50.25 62.64 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 113.257 0.836 . . . . 62.54 113.257 -175.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 9.5 Cg_endo -51.98 -46.09 34.56 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 122.221 1.947 . . . . 65.23 112.852 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -70.06 -40.89 74.8 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.859 0.318 . . . . 74.12 111.859 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.0 m-30 -58.43 -41.17 84.43 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.023 0.439 . . . . 74.42 111.292 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -70.69 -39.44 73.49 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.066 0.46 . . . . 72.34 110.798 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.8 t -68.73 -22.36 64.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.156 -0.475 . . . . 73.44 111.569 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.13 -10.19 24.76 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.522 -0.371 . . . . 72.23 113.34 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.747 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 69.4 m-20 -85.57 77.39 9.86 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.503 -0.41 . . . . 63.2 111.707 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -62.58 -41.86 99.21 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.147 0.499 . . . . 65.2 110.945 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.23 -45.91 82.74 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.964 -0.562 . . . . 64.14 111.987 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.747 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 21.1 mm-40 -68.09 -32.39 72.68 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 111.86 0.319 . . . . 72.42 111.86 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 122' ' ' MET . . . -59.38 -44.89 96.26 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.386 -0.912 . . . . 21.34 111.753 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 90' ' ' LEU . 94.2 mt -66.08 -44.4 84.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.877 0.325 . . . . 63.12 111.877 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.8 p -62.5 -38.81 91.36 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.664 0.268 . . . . 72.23 111.191 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -66.14 -41.28 90.66 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.775 0.321 . . . . 62.45 111.416 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.14 -48.56 85.51 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.842 -0.694 . . . . 53.2 112.58 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 135' ' ' LEU . 89.3 t -56.39 -47.04 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.028 0.442 . . . . 75.42 111.055 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 44.3 tp -60.14 -39.77 87.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.864 -0.607 . . . . 72.13 111.069 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.5 ' HB2' ' HD3' ' A' ' 121' ' ' ARG . . . -61.89 -52.14 65.33 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.874 0.369 . . . . 53.04 111.51 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.85 -45.19 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.091 0.472 . . . . 71.51 110.978 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -54.6 -47.6 73.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.05 -0.523 . . . . 72.42 111.222 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 96.3 mt-30 -56.49 -45.57 80.91 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.394 -0.367 . . . . 74.11 111.757 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ALA . 60.6 t -57.15 -44.79 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.17 0.509 . . . . 73.1 111.285 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.2 -45.51 76.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.118 -0.492 . . . . 75.24 111.607 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 151' ' ' GLU . 65.8 m-20 -61.9 -22.41 65.55 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.825 0.345 . . . . 71.13 111.713 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.26 4.69 85.78 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.073 -0.584 . . . . 61.55 112.833 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.1 m -130.59 -50.69 1.07 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.466 0.543 . . . . 45.42 112.466 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.643 ' HB2' ' ND1' ' A' ' 47' ' ' HIS . 56.0 mt -117.44 31.25 6.83 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.553 0.341 . . . . 75.33 111.72 -174.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 147' ' ' ASP . 0.3 OUTLIER -50.13 -38.26 38.19 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.669 0.988 . . . . 73.12 113.669 -173.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -73.97 2.56 8.4 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.609 0.596 . . . . 72.23 112.609 -174.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 157' ' ' HIS . 55.3 m170 -96.42 122.38 39.25 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.026 -0.421 . . . . 74.34 111.894 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 79.3 t60 -152.54 -65.66 0.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.14 -0.482 . . . . 73.44 110.821 172.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -81.57 -14.06 57.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.578 0.704 . . . . 75.43 110.451 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -141.62 115.86 9.43 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.295 -0.866 . . . . 74.34 110.094 171.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 153' ' ' HIS . 17.9 p-80 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 119.04 -0.505 . . . . 75.43 112.09 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.054 0.454 . . . . 71.0 111.74 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -164.4 138.47 5.36 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.827 -0.624 . . . . 75.33 110.27 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -80.64 102.17 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.108 0.48 . . . . 74.4 111.241 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.416 ' CD1' ' HD2' ' A' ' 57' ' ' PRO . 39.8 m-85 -91.43 125.32 36.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.213 0.53 . . . . 70.44 111.793 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 9.6 mtmp? -94.96 159.02 34.02 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.898 -0.592 . . . . 74.42 110.187 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 48.0 Cg_endo -66.6 -2.66 7.82 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.229 1.953 . . . . 74.13 113.039 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -107.28 -8.76 16.27 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.211 -0.449 . . . . 74.22 110.93 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.41 -26.89 19.65 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.002 0.43 . . . . 71.11 110.601 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.6 t -57.13 128.13 77.35 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.872 -0.604 . . . . 72.44 111.662 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.85 109.07 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.659 2.24 . . . . 74.41 112.721 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -69.19 77.92 0.35 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.042 0.449 . . . . 63.14 111.236 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 13' ' ' GLN . 28.6 m -67.64 -51.3 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.263 0.468 . . . . 72.12 112.263 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 12' ' ' VAL . 27.9 mm-40 -56.97 -21.2 28.47 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.06 0.393 . . . . 73.52 112.06 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tt -67.68 -52.72 34.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.038 0.447 . . . . 63.1 109.967 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.28 -65.79 0.98 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.424 -0.353 . . . . 75.22 111.544 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -98.27 101.79 13.34 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.115 0.483 . . . . 62.13 111.966 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.7 p -82.79 -3.64 56.92 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.164 0.507 . . . . 74.5 110.522 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -78.91 -37.41 39.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.846 -0.616 . . . . 70.23 111.74 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -102.18 125.97 49.02 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.25 0.548 . . . . 61.32 110.527 173.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 20' ' ' LEU . 4.6 mp -109.33 8.62 25.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.274 0.559 . . . . 73.52 110.623 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.8 t -101.37 142.73 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.796 -0.638 . . . . 73.11 111.656 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.2 m -145.42 103.41 3.82 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.456 -0.338 . . . . 70.12 110.865 175.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.496 ' HB2' HD12 ' A' ' 28' ' ' LEU . 28.8 t70 -105.05 96.76 6.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.223 0.535 . . . . 74.05 111.59 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -97.45 -38.45 9.6 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.019 0.437 . . . . 71.31 110.336 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.588 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -57.09 -43.85 82.6 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.483 0.549 . . . . 74.44 112.483 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.19 36.3 6.34 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.03 -0.605 . . . . 65.0 112.301 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 92' ' ' LEU . 86.5 mt -103.6 -15.99 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.847 0.356 . . . . 75.32 111.443 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 23' ' ' ASP . 96.6 mt -90.8 -165.91 1.46 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.162 0.506 . . . . 74.35 111.553 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -161.68 153.52 19.18 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.966 -0.561 . . . . 73.03 110.019 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -47.93 -43.29 28.98 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.279 0.474 . . . . 64.1 112.279 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.14 -49.64 71.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.116 0.484 . . . . 75.21 111.622 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.458 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 12.5 mm-40 -71.33 -38.27 71.68 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.208 -0.451 . . . . 63.0 111.731 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.83 -36.48 84.03 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.044 0.45 . . . . 74.32 111.089 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.52 -54.97 23.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.139 -0.482 . . . . 64.25 110.918 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.8 -43.89 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.082 0.468 . . . . 63.11 111.282 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.423 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.6 ttm -64.22 -49.58 71.4 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.106 -0.497 . . . . 74.12 111.049 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -57.33 -48.17 79.66 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.636 0.255 . . . . 75.41 111.27 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.35 92.13 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.093 -0.575 . . . . 50.55 112.952 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.609 ' NH1' HD13 ' A' ' 140' ' ' LEU . 60.1 mtt180 -70.42 -49.9 44.11 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.983 0.364 . . . . 74.13 111.983 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 36' ' ' MET . 92.6 mt -55.18 -46.96 75.83 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.258 0.551 . . . . 75.44 111.042 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 41' ' ' ARG . 40.9 ttm180 -61.74 -42.77 99.4 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.811 -0.631 . . . . 74.22 110.76 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.61 -36.05 79.62 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.159 -0.473 . . . . 61.25 111.198 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.562 HG22 ' HB ' ' A' ' 49' ' ' VAL . 81.8 mt -67.79 -41.6 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.052 0.453 . . . . 73.22 110.747 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 44.8 ttt180 -68.01 -27.85 66.91 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.022 0.439 . . . . 70.31 111.2 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 13.3 t -85.75 -32.22 21.98 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.074 0.464 . . . . 31.12 111.403 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.403 ' HA ' ' H ' ' A' ' 156' ' ' HIS . 41.4 t -82.66 -61.9 1.75 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.079 0.466 . . . . 71.1 111.884 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.615 ' ND1' HD12 ' A' ' 150' ' ' LEU . 43.7 m-70 -102.22 -0.39 33.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.876 -0.602 . . . . 75.14 111.602 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.48 10.81 5.13 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.843 0.457 . . . . 62.11 111.892 -176.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.562 ' HB ' HG22 ' A' ' 43' ' ' ILE . 78.6 t -77.38 111.44 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.042 0.449 . . . . 63.42 111.142 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HG2' ' HE ' ' A' ' 44' ' ' ARG . 40.7 mt-10 -82.16 95.92 7.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.676 0.75 . . . . 73.21 110.138 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -107.96 103.11 12.27 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.13 -0.941 . . . . 73.21 111.007 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.66 139.7 38.59 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.403 0.52 . . . . 55.54 112.403 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.5 t -124.08 119.42 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.982 0.42 . . . . 14.44 111.487 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.16 139.11 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.471 -0.331 . . . . 73.45 111.533 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 24.2 p -118.05 126.82 53.02 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.941 0.401 . . . . 73.4 111.015 176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 61.6 mt -125.68 140.95 37.8 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 120.672 0.272 . . . . 51.55 111.633 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.588 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 27.6 Cg_exo -62.89 -61.3 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.698 2.265 . . . . 60.4 113.019 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.449 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 78.2 p -148.17 145.41 28.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.814 0.302 . . . . 65.03 111.814 -176.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.507 HD13 HG21 ' A' ' 91' ' ' VAL . 34.5 pt -127.82 5.02 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.011 0.434 . . . . 72.14 111.593 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.6 -136.52 29.73 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.991 -0.624 . . . . 73.14 113.39 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -87.99 15.58 7.1 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.515 -0.403 . . . . 74.14 111.704 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.3 125.0 91.56 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 120.726 0.298 . . . . 74.44 111.607 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.93 108.84 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.262 1.974 . . . . 74.31 112.249 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.4 tp -57.94 -29.43 65.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.943 0.401 . . . . 72.12 112.042 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 9.3 mp0 -63.66 -32.62 74.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.24 0.543 . . . . 41.2 111.147 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.82 -33.1 16.63 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.457 0.646 . . . . 61.34 110.355 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -52.67 -51.76 58.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.913 0.885 . . . . 73.23 112.051 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.4 p -60.52 -31.21 70.29 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.476 0.547 . . . . 64.45 112.476 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.605 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.5 tp -56.06 -53.71 53.71 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.962 0.41 . . . . 71.42 110.987 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -60.84 -33.3 72.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.991 0.424 . . . . 72.44 112.093 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.503 HD23 HD21 ' A' ' 87' ' ' LEU . 34.3 tp -74.4 -54.95 6.59 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.994 0.426 . . . . 74.14 111.647 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.621 ' HB1' ' HA3' ' A' ' 78' ' ' GLY . . . -57.17 -36.83 71.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.192 0.442 . . . . 74.43 112.192 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 57.5 mtp180 -64.89 -48.43 74.26 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.028 0.381 . . . . 45.52 112.028 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.567 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 10.5 pt20 -71.27 -25.53 62.49 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.933 0.397 . . . . 73.33 111.161 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.567 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 19.5 m0 -79.59 -4.93 53.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.538 -0.301 . . . . 75.02 111.744 174.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.33 -43.52 2.73 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.26 -0.495 . . . . 70.4 113.425 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -53.81 -18.91 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 113.4 0.889 . . . . 72.21 113.4 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.621 ' HA3' ' HB1' ' A' ' 72' ' ' ALA . . . -141.43 39.34 1.43 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.754 -0.736 . . . . 70.02 113.83 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 17.5 p-10 -67.21 82.74 0.13 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.26 0.552 . . . . 74.41 110.679 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 60.13 50.16 6.73 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.591 0.71 . . . . 74.2 109.702 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 3.7 mptp? 65.5 81.84 0.2 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.365 -0.834 . . . . 72.12 111.191 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -62.54 -76.47 0.06 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.482 -0.781 . . . . 63.31 112.091 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -157.74 -136.57 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.925 -0.579 . . . . 54.41 109.916 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.571 ' HA ' ' HG ' ' A' ' 105' ' ' LEU . 17.0 p-10 -72.64 26.91 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.494 -0.754 . . . . 62.21 112.543 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.21 150.18 25.81 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.616 -0.326 . . . . 34.32 112.533 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HB2' ' CD1' ' A' ' 105' ' ' LEU . 62.3 tp -142.66 127.04 17.72 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.89 0.376 . . . . 75.11 111.156 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.503 HD21 HD23 ' A' ' 71' ' ' LEU . 60.6 tp -108.21 133.78 51.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.844 0.354 . . . . 63.52 111.66 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.44 117.39 22.05 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.073 -0.512 . . . . 54.2 110.814 177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.99 129.83 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.729 0.3 . . . . 71.34 111.766 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.47 134.11 50.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.127 0.571 . . . . 75.32 111.078 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.507 HG21 HD13 ' A' ' 59' ' ' ILE . 87.1 t -118.63 105.3 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.926 0.394 . . . . 55.22 111.262 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 27' ' ' LEU . 68.1 tp -53.76 -39.21 65.18 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.114 -0.494 . . . . 50.12 112.017 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 31.7 t70 -50.77 -32.32 19.45 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.781 0.66 . . . . 74.11 112.781 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -123.67 -3.47 8.26 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.278 0.473 . . . . 71.43 112.278 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 61.25 11.15 3.4 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.398 0.518 . . . . 65.22 112.398 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -97.09 159.86 14.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.054 0.454 . . . . 64.21 111.341 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.692 HG21 ' SD ' ' A' ' 122' ' ' MET . 13.3 m -131.14 172.26 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.985 -0.552 . . . . 60.42 110.525 175.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -146.39 128.68 15.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.905 0.383 . . . . 64.24 111.639 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -103.97 125.19 50.17 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.692 -0.686 . . . . 73.21 110.434 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -120.21 117.12 27.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.999 0.428 . . . . 74.24 111.175 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.532 HG23 HD11 ' A' ' 114' ' ' LEU . 11.6 p -85.5 155.72 21.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.608 0.718 . . . . 64.54 112.584 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.72 -179.33 36.29 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.4 -0.818 . . . . 64.11 111.844 167.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -63.11 -11.13 17.81 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.874 0.47 . . . . 73.35 112.256 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.15 -32.03 13.17 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.584 -0.341 . . . . 74.24 113.475 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.571 ' HG ' ' HA ' ' A' ' 84' ' ' ASN . 48.1 mt -97.24 -5.04 37.79 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.402 0.89 . . . . 63.22 113.402 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -54.4 -28.63 44.96 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.882 0.697 . . . . 64.01 112.882 -177.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.69 -19.15 71.46 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.238 -0.506 . . . . 64.54 113.822 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -105.82 -40.17 5.81 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.936 0.398 . . . . 65.42 111.91 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.492 ' HB3' HD21 ' A' ' 114' ' ' LEU . 26.8 mt -130.48 88.25 47.75 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.102 -0.499 . . . . 74.22 112.222 -170.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.63 159.25 28.48 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.154 1.903 . . . . 74.25 112.045 172.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -50.46 -36.74 34.9 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.306 0.484 . . . . 72.33 112.306 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.71 -50.14 69.11 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.02 -0.609 . . . . 75.44 112.793 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.29 -43.28 99.14 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.874 0.368 . . . . 74.14 110.988 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.532 HD11 HG23 ' A' ' 101' ' ' THR . 89.6 mt -57.52 -45.09 85.43 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.28 -0.418 . . . . 64.44 110.886 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.2 m -64.4 -34.63 78.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.194 -0.457 . . . . 74.41 111.075 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -62.45 -48.17 80.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.476 -0.329 . . . . 74.11 110.716 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.2 mt -52.37 -45.78 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.338 0.59 . . . . 65.25 110.928 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 122' ' ' MET . 63.6 mt -60.75 -55.82 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.427 -0.806 . . . . 42.41 111.887 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.451 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 10.3 t-80 -75.94 -28.25 57.89 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.721 0.637 . . . . 72.51 112.721 -170.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.97 -49.46 17.64 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.232 0.456 . . . . 55.12 112.232 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -112.21 -44.22 3.44 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.147 0.795 . . . . 71.04 113.147 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.692 ' SD ' HG21 ' A' ' 97' ' ' VAL . 50.8 mtt -62.67 -50.99 69.01 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.524 0.565 . . . . 61.25 112.524 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.575 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 25.7 mm -53.51 -55.54 33.89 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 112.278 0.473 . . . . 63.53 112.278 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.575 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 83.7 Cg_exo -50.22 -46.14 30.15 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 122.15 1.9 . . . . 51.22 113.015 176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 61.0 m-70 -65.41 -49.14 70.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.847 0.314 . . . . 64.24 111.847 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.4 m-30 -61.37 -32.95 72.87 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.894 0.378 . . . . 71.43 111.495 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -69.31 -41.19 77.05 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.97 0.414 . . . . 64.51 110.599 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.0 t -74.24 -21.56 59.72 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.957 0.408 . . . . 63.01 111.661 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 112.16 -4.7 26.96 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.43 -0.414 . . . . 54.42 113.673 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.66 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 79.7 m-20 -83.8 77.49 9.87 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.323 0.49 . . . . 65.42 112.323 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -71.54 -39.48 70.68 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.899 0.38 . . . . 75.44 111.521 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.25 70.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.897 0.38 . . . . 70.44 111.332 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 20.2 mm-40 -61.98 -42.5 99.2 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.146 -0.479 . . . . 73.4 111.542 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.03 -50.64 64.2 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.184 -0.531 . . . . 72.22 112.959 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.54 -41.03 98.48 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.56 -0.377 . . . . 62.33 111.47 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -57.38 -54.76 43.13 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.395 -0.366 . . . . 54.51 111.5 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -68.64 -26.13 65.18 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.248 -0.283 . . . . 62.15 111.607 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.23 -44.8 96.5 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.822 -0.704 . . . . 74.35 112.225 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.68 -49.83 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.007 0.432 . . . . 62.22 110.865 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.609 HD13 ' NH1' ' A' ' 39' ' ' ARG . 54.6 tp -57.69 -41.01 80.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.115 -0.493 . . . . 74.4 111.526 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.43 -51.84 65.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.925 0.393 . . . . 62.14 111.59 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.424 HG13 HD11 ' A' ' 109' ' ' LEU . 86.9 t -60.77 -46.48 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.124 0.488 . . . . 53.11 110.841 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -52.27 -41.09 62.55 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.913 -0.585 . . . . 62.21 111.625 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 98.2 mt-30 -61.15 -48.82 79.85 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.818 0.342 . . . . 72.11 111.325 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.57 -48.29 86.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.185 -0.461 . . . . 73.34 111.657 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 49' ' ' VAL . 81.0 mt -65.21 -56.81 10.69 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.278 -0.419 . . . . 73.0 111.456 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.422 ' HA ' ' HE1' ' A' ' 47' ' ' HIS . 31.2 t70 -62.53 -27.92 69.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.06 -0.518 . . . . 74.51 111.752 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.92 -39.42 28.19 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.99 -0.624 . . . . 63.34 113.013 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.6 m -65.11 -40.26 94.28 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.187 0.44 . . . . 75.01 112.187 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.615 HD12 ' ND1' ' A' ' 47' ' ' HIS . 43.0 mt -78.4 80.02 4.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.501 0.667 . . . . 71.45 112.248 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -22.72 22.61 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.624 -0.716 . . . . 75.2 110.247 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -57.18 -38.79 74.15 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.252 -0.885 . . . . 63.34 111.886 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -162.94 155.23 18.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.344 -0.389 . . . . 53.11 110.028 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -92.96 -177.49 4.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.446 0.535 . . . . 73.34 112.446 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -47.97 147.23 2.14 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.226 1.195 . . . . 74.55 114.226 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 45' ' ' SER . 94.0 m-70 -86.08 -173.32 4.52 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.562 -0.745 . . . . 74.05 111.066 174.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.8 -0.619 . . . . 72.25 112.049 179.244 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.638 0.256 . . . . 64.12 111.041 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 58' ' ' SER . 17.4 ptp180 -109.8 -1.55 17.83 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.735 0.302 . . . . 64.42 111.74 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.553 HG22 ' HA3' ' A' ' 60' ' ' GLY . 60.6 t 52.6 107.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 115.005 1.483 . . . . 74.4 115.005 170.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 58' ' ' SER . 23.1 m-85 -112.61 126.48 55.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.102 -0.499 . . . . 74.34 110.528 169.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -111.38 158.9 34.89 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.178 -0.464 . . . . 74.23 110.906 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -49.44 -40.78 44.7 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.767 2.311 . . . . 65.43 113.799 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -82.78 -5.96 59.18 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.409 0.522 . . . . 72.4 112.409 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.68 -30.39 18.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.244 0.545 . . . . 62.31 110.279 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.3 130.44 93.53 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.886 -0.597 . . . . 74.25 110.832 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.56 118.55 5.47 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.239 1.959 . . . . 71.31 112.652 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.716 HD22 ' HB3' ' A' ' 14' ' ' LEU . 1.0 OUTLIER -61.18 79.9 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.496 0.554 . . . . 64.04 112.496 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.08 -44.45 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.539 0.57 . . . . 73.14 112.539 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -61.25 -15.93 39.97 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.073 0.397 . . . . 64.32 112.073 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.716 ' HB3' HD22 ' A' ' 11' ' ' ASN . 9.6 tt -86.26 -32.83 20.91 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.869 0.366 . . . . 72.34 110.601 176.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -124.72 -70.73 0.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.316 -0.402 . . . . 40.4 111.792 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -77.83 36.24 0.21 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.522 0.564 . . . . 61.32 112.522 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.4 p -70.0 1.84 4.16 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.014 0.435 . . . . 62.44 111.368 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -70.72 -52.81 18.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.837 0.351 . . . . 72.34 111.169 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.624 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 26.8 ptt180 -88.9 -25.78 21.94 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.051 -0.522 . . . . 55.32 111.753 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.61 HD11 ' HE ' ' A' ' 44' ' ' ARG . 5.4 mp 66.61 3.04 2.75 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 112.996 0.739 . . . . 73.13 112.996 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.624 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 59.5 t -99.63 151.26 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 122.504 0.322 . . . . 55.44 111.617 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -133.07 121.69 23.04 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.479 0.311 . . . . 73.55 110.436 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.87 95.92 5.03 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.147 0.795 . . . . 74.33 113.147 -172.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB2' HD23 ' A' ' 56' ' ' LEU . 6.3 mp0 -102.08 -53.07 3.01 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.247 0.546 . . . . 70.41 110.549 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.45 -28.18 65.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.049 -0.523 . . . . 34.33 111.89 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.01 31.41 79.36 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 116.265 -0.425 . . . . 50.53 113.655 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.2 mt -78.73 -23.67 45.31 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.001 0.429 . . . . 65.22 111.213 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.462 HD23 ' HB1' ' A' ' 132' ' ' ALA . 82.9 mt -80.82 116.24 20.71 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.098 -0.501 . . . . 75.54 111.687 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.8 t -70.64 154.89 41.41 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 110.159 -0.311 . . . . 62.12 110.159 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -58.89 -32.7 69.74 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.902 0.334 . . . . 72.02 111.902 -175.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.77 -46.92 83.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.313 0.577 . . . . 34.23 110.784 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.87 -38.28 85.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.903 -0.59 . . . . 55.43 111.569 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -64.07 -49.17 73.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.995 -0.282 . . . . 72.15 110.78 172.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.04 -34.57 43.84 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.4 0.619 . . . . 74.51 111.091 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.482 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 45.1 t -82.62 -52.56 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.695 -0.684 . . . . 63.02 111.842 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 48.8 ttm -66.08 -51.67 55.99 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.172 -0.33 . . . . 55.14 111.749 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -52.84 -43.04 65.73 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.107 0.48 . . . . 72.41 110.304 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.39 -43.33 99.48 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.817 -0.629 . . . . 44.43 112.714 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 35' ' ' VAL . 95.0 mtt180 -57.86 -54.93 41.29 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.654 0.264 . . . . 55.14 111.08 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.7 mt -61.87 -45.27 94.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.123 0.487 . . . . 71.13 111.454 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -60.01 -40.55 89.63 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.113 -0.494 . . . . 75.51 111.106 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.46 -44.55 86.85 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.361 -0.382 . . . . 64.51 111.196 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 39' ' ' ARG . 82.1 mt -57.85 -48.3 84.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.906 0.384 . . . . 74.32 110.809 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.61 ' HE ' HD11 ' A' ' 20' ' ' LEU . 58.3 ttp85 -61.92 -32.48 72.88 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.317 -0.401 . . . . 73.2 111.621 177.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -80.63 -28.37 37.0 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.959 0.355 . . . . 62.31 111.959 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -99.57 -68.68 0.8 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.105 0.409 . . . . 51.43 112.105 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -85.96 -9.95 55.98 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.845 0.313 . . . . 73.45 111.845 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 65.46 14.14 9.28 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.591 0.589 . . . . 51.53 112.591 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.4 ' HA ' HD21 ' A' ' 84' ' ' ASN . 65.1 t -72.56 133.72 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.026 0.441 . . . . 72.55 111.758 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -86.5 95.87 9.86 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.275 0.56 . . . . 64.35 110.434 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -111.61 105.29 13.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.993 -0.549 . . . . 72.33 110.656 -174.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.95 120.54 40.8 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.208 0.447 . . . . 73.34 112.208 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t -111.15 128.81 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.803 0.335 . . . . 63.44 111.055 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.424 HG21 HD21 ' A' ' 71' ' ' LEU . 44.0 t -128.01 141.31 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 122.403 0.281 . . . . 71.11 111.22 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 p -125.88 120.76 31.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.849 0.357 . . . . 72.12 111.379 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 24' ' ' GLU . 85.2 mt -125.24 135.85 27.41 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-O 120.755 0.312 . . . . 74.14 111.468 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.576 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 72.8 Cg_endo -76.19 -25.23 10.27 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.394 2.063 . . . . 65.32 113.296 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.801 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 32.5 m -155.89 151.93 27.68 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.236 -0.29 . . . . 71.32 111.196 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.507 HD12 ' O ' ' A' ' 62' ' ' ALA . 31.0 pt -125.15 -32.27 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.855 0.36 . . . . 71.42 111.027 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.553 ' HA3' HG22 ' A' ' 3' ' ' VAL . . . 67.16 -116.6 8.21 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.268 -0.491 . . . . 43.12 113.626 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.24 67.36 9.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.612 0.72 . . . . 61.21 111.562 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 59' ' ' ILE . . . -159.42 106.97 1.5 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.509 -0.768 . . . . 61.55 110.808 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 18.2 Cg_endo -57.03 138.86 88.16 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.818 2.345 . . . . 74.21 113.119 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 tp -54.69 -56.1 22.77 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.203 0.816 . . . . 70.32 113.203 -172.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.546 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 23.3 mt-10 -76.25 -9.62 58.77 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.255 0.465 . . . . 73.1 112.255 -173.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.68 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 4.3 m-20 -90.45 -34.55 15.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.96 0.409 . . . . 75.44 110.49 170.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -59.86 -50.51 73.49 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.678 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.7 p -55.4 -42.68 74.4 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.115 -0.493 . . . . 72.23 111.629 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.46 -54.62 37.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.43 -0.35 . . . . 73.21 111.559 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -61.23 -41.86 97.61 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.021 0.378 . . . . 72.05 112.021 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.424 HD21 HG21 ' A' ' 54' ' ' VAL . 48.7 tp -65.39 -43.62 90.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.248 0.547 . . . . 74.31 110.964 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.422 ' HB1' ' HA3' ' A' ' 78' ' ' GLY . . . -67.45 -32.25 72.97 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.849 0.357 . . . . 74.31 111.433 177.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' ASN . 11.3 mtp180 -59.3 -53.84 53.65 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.046 0.388 . . . . 72.45 112.046 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.505 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.1 pt20 -64.54 -31.21 72.33 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.87 0.367 . . . . 61.2 111.734 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.505 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 42.1 m0 -85.97 8.23 21.3 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.027 0.38 . . . . 54.54 112.027 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.96 -49.86 4.17 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 114.385 0.514 . . . . 62.55 114.385 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.528 ' HA ' ' HB3' ' A' ' 82' ' ' ASN . 27.1 m -50.86 -33.99 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 113.162 0.801 . . . . 63.41 113.162 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.422 ' HA3' ' HB1' ' A' ' 72' ' ' ALA . . . -113.71 13.84 22.43 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.931 -0.652 . . . . 72.12 113.312 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 25.2 t-20 -58.57 -48.6 80.37 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.223 0.535 . . . . 61.13 110.974 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.92 46.44 0.77 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.584 -0.735 . . . . 62.45 109.979 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 62.91 76.13 0.38 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.304 -0.862 . . . . 73.15 112.153 -177.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 32.8 t-20 -67.43 119.86 12.95 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.373 -0.376 . . . . 61.31 110.031 174.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.654 HD22 ' N ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -41.3 -44.95 2.86 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.367 0.877 . . . . 75.55 113.367 -178.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.492 ' H ' ' ND2' ' A' ' 83' ' ' ASN . 9.6 t30 -105.16 17.66 23.68 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.214 0.53 . . . . 71.24 111.905 -172.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.75 140.7 15.16 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.094 -0.574 . . . . 44.24 114.26 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 100' ' ' GLU . 51.7 tp -143.92 134.85 25.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.743 0.417 . . . . 74.12 110.858 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 60.0 tp -125.65 140.28 52.85 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.048 0.452 . . . . 72.2 111.778 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.8 tp -137.35 108.2 6.67 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.96 -0.564 . . . . 63.33 110.493 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.65 124.02 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 111.95 0.352 . . . . 73.05 111.95 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.594 ' HA ' HG12 ' A' ' 97' ' ' VAL . 36.8 tp -95.71 114.91 26.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.288 -0.415 . . . . 60.33 111.075 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 94' ' ' GLN . 95.5 t -100.03 94.15 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 120.899 0.38 . . . . 70.55 111.128 177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 52.8 tp -60.09 -27.61 67.14 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.819 0.342 . . . . 74.12 111.293 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.801 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 16.3 t0 -52.18 -35.13 48.03 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.831 0.824 . . . . 65.42 110.72 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.439 ' NE2' HD11 ' A' ' 59' ' ' ILE . 71.1 mt-30 -120.68 8.8 10.66 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.124 -0.944 . . . . 71.34 110.891 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 36.21 52.25 0.87 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.555 1.142 . . . . 70.15 113.536 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -153.33 162.32 41.41 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.881 -0.6 . . . . 61.2 110.91 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.681 HG21 ' SD ' ' A' ' 122' ' ' MET . 5.5 m -123.8 172.43 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.302 0.572 . . . . 74.24 112.186 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.546 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 65.6 ttt-85 -147.16 138.19 23.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.834 -0.621 . . . . 75.04 111.218 172.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -91.17 151.42 20.96 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.029 0.442 . . . . 74.2 111.083 173.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 17.2 tp10 -137.64 112.58 9.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.288 -0.414 . . . . 70.05 110.595 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.6 p -99.69 136.33 39.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.328 0.585 . . . . 73.13 112.528 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -76.99 -178.89 47.75 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.584 -0.817 . . . . 50.43 112.154 168.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -62.36 -18.69 62.13 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.355 0.872 . . . . 73.02 113.355 -173.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.578 ' N ' ' HA ' ' A' ' 83' ' ' ASN . . . -88.04 -40.71 6.51 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.768 -0.73 . . . . 60.31 112.581 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.639 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 95.0 mt -69.16 -6.73 30.6 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.267 0.469 . . . . 64.41 112.267 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -58.57 -23.98 59.79 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.261 0.553 . . . . 74.32 110.913 173.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.09 22.51 39.05 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.119 -0.491 . . . . 74.41 113.209 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.639 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 68.3 m-85 -141.55 -57.48 0.48 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.264 0.554 . . . . 74.05 110.953 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.9 mt -113.36 91.92 21.31 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.563 -0.744 . . . . 75.51 111.675 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.96 151.73 81.6 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.545 2.163 . . . . 70.11 112.509 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -54.49 -41.62 69.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.949 0.404 . . . . 74.45 111.61 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.59 -47.51 89.69 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.335 -0.459 . . . . 63.0 112.903 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.3 tp -56.12 -50.7 70.36 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.868 0.366 . . . . 74.31 111.056 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.08 -36.34 74.92 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.357 -0.383 . . . . 71.51 111.382 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 m -64.99 -41.3 95.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.397 -0.365 . . . . 73.05 111.095 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -64.35 -44.8 90.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.588 -0.278 . . . . 74.03 111.136 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.8 mt -52.59 -48.1 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.1 0.476 . . . . 72.44 110.682 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.0 mt -61.53 -37.07 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.224 -0.444 . . . . 74.32 111.6 176.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 7.6 t-80 -83.3 -28.41 29.11 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.05 0.759 . . . . 54.02 113.05 -173.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.96 -48.32 4.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.129 0.418 . . . . 72.21 112.129 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.693 ' HA ' ' HE ' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -84.61 -15.33 45.92 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.497 0.554 . . . . 73.14 112.497 -175.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.681 ' SD ' HG21 ' A' ' 97' ' ' VAL . 60.7 mtt -120.79 -54.77 2.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.688 0.996 . . . . 73.21 113.688 -176.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.503 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 12.8 mm -46.38 -54.47 18.08 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.202 0.816 . . . . 72.2 113.202 -175.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.503 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 51.6 Cg_exo -55.28 -34.29 87.9 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.767 1.644 . . . . 71.12 112.572 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 96.0 m-70 -76.05 -50.47 14.68 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.166 -0.47 . . . . 73.44 111.772 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.9 m-30 -56.37 -44.01 79.75 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.832 0.349 . . . . 73.34 111.421 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -61.43 -31.08 71.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.121 0.486 . . . . 72.44 111.127 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -88.4 0.67 55.96 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.002 -0.545 . . . . 74.13 111.747 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.72 -7.41 79.79 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.336 -0.459 . . . . 73.52 113.096 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.825 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 13.2 m120 -75.54 67.69 2.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.757 0.423 . . . . 74.51 111.472 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -67.74 -54.34 20.12 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.066 -0.397 . . . . 72.34 111.65 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.462 ' HB1' HD23 ' A' ' 28' ' ' LEU . . . -61.51 -42.97 99.61 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.976 0.417 . . . . 63.21 111.514 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 1.3 mp0 -58.15 -43.09 87.18 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.234 -0.439 . . . . 54.34 111.259 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.91 99.95 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.148 -0.549 . . . . 75.2 112.437 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.492 HD11 HD22 ' A' ' 90' ' ' LEU . 93.3 mt -59.7 -42.43 92.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.737 0.303 . . . . 71.41 111.129 175.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.5 t -57.68 -48.75 78.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.524 -0.307 . . . . 73.44 111.26 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 133' ' ' GLU . 35.5 mm-40 -62.15 -43.85 97.92 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.956 0.407 . . . . 64.44 111.057 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.87 -54.2 39.48 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 116.166 -0.47 . . . . 41.13 113.385 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.25 -47.62 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.99 0.424 . . . . 63.53 111.379 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.528 ' HG ' HE21 ' A' ' 144' ' ' GLN . 48.5 tp -61.48 -38.36 87.0 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.187 -0.46 . . . . 65.03 111.047 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -61.37 -50.87 71.16 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.928 0.394 . . . . 71.42 111.263 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.26 -45.91 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.134 0.493 . . . . 71.35 110.818 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -54.82 -43.06 72.62 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.922 -0.581 . . . . 74.13 111.395 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.528 HE21 ' HG ' ' A' ' 140' ' ' LEU . 79.2 mt-30 -62.88 -41.3 99.35 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.704 0.261 . . . . 72.2 111.704 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 141' ' ' ALA . 58.0 t -59.35 -50.09 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.858 0.361 . . . . 73.13 111.131 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -58.67 -44.26 90.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.497 0.665 . . . . 72.43 110.464 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -66.13 -14.61 62.09 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.433 -0.803 . . . . 63.15 111.506 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.8 0.4 86.45 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.519 -0.372 . . . . 45.34 113.177 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 96.5 p -118.17 -52.12 2.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.915 0.388 . . . . 74.12 110.543 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 82.5 mt 65.32 5.92 3.37 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.838 0.681 . . . . 74.24 112.838 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -102.0 21.67 14.37 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.858 0.361 . . . . 63.24 111.821 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -130.39 89.24 2.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.439 -0.346 . . . . 72.23 110.959 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -131.1 7.86 4.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.672 0.273 . . . . 73.03 111.65 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -109.93 130.07 55.58 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.198 0.523 . . . . 64.34 112.157 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -132.12 130.25 40.93 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.939 -0.573 . . . . 70.13 109.62 174.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -104.34 168.78 8.87 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.771 0.656 . . . . 73.55 112.771 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 115.379 -0.828 . . . . 60.24 110.917 174.233 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.725 0.297 . . . . 73.53 111.051 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -169.12 11.23 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.303 -0.408 . . . . 64.3 111.573 171.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.53 123.47 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.448 0.536 . . . . 74.52 112.448 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.424 ' HB2' HD13 ' A' ' 56' ' ' LEU . 21.9 m-85 -90.12 174.16 7.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.757 0.789 . . . . 72.44 112.354 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.557 ' H ' ' HB2' ' A' ' 8' ' ' ASP . 30.6 mmtp -132.31 153.27 81.19 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.924 -1.035 . . . . 74.14 109.404 170.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.446 ' HG2' ' HE3' ' A' ' 70' ' ' LYS . 11.1 Cg_endo -56.47 -29.35 77.64 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 121.898 1.732 . . . . 63.04 112.437 176.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -83.82 -12.56 55.44 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.168 0.433 . . . . 64.53 112.168 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.557 ' HB2' ' H ' ' A' ' 5' ' ' LYS . 3.0 m-20 -81.97 -27.32 33.29 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.92 0.39 . . . . 73.43 111.366 172.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.6 t -61.62 129.62 91.47 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 116.315 -0.402 . . . . 73.33 111.554 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -52.44 126.94 22.23 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.892 2.395 . . . . 75.1 113.329 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.439 ' C ' HD22 ' A' ' 11' ' ' ASN . 0.2 OUTLIER -71.93 73.2 0.86 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.889 0.375 . . . . 71.23 111.0 -178.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.95 -38.56 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 112.263 0.468 . . . . 74.45 112.263 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.601 HE22 ' HG ' ' A' ' 20' ' ' LEU . 25.5 mm-40 -72.53 74.89 1.06 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.606 0.717 . . . . 71.11 110.825 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt 177.06 -56.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.629 -1.168 . . . . 62.52 108.338 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.08 -47.86 5.61 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.259 -0.882 . . . . 61.22 110.93 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.692 ' HB3' ' HB3' ' A' ' 19' ' ' ARG . 7.8 m-20 -96.57 49.16 1.09 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.776 -0.647 . . . . 72.02 111.79 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.7 m -67.14 -13.8 62.29 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.501 -0.318 . . . . 73.11 111.657 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.6 p -97.87 -3.2 39.13 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.741 0.305 . . . . 72.42 111.489 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.692 ' HB3' ' HB3' ' A' ' 16' ' ' ASP . 78.9 ttt180 -105.21 -56.38 2.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.015 0.436 . . . . 64.35 110.977 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.601 ' HG ' HE22 ' A' ' 13' ' ' GLN . 5.3 mp 69.96 -13.62 0.41 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.731 0.812 . . . . 61.41 113.069 175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.3 t -93.43 148.61 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.207 0.527 . . . . 72.04 112.124 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.7 m -143.54 102.61 3.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.2 -0.455 . . . . 71.41 110.591 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.43 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 23.8 t70 -106.1 93.06 4.41 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.292 0.568 . . . . 53.41 111.079 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' HB2' HD23 ' A' ' 56' ' ' LEU . 31.5 mm-40 -94.11 -37.01 11.82 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.957 -0.565 . . . . 65.43 110.841 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.24 -34.11 68.27 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.346 0.499 . . . . 62.23 112.346 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.74 47.29 6.78 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.824 -0.703 . . . . 61.52 112.06 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.7 mt -114.07 -33.32 5.74 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.909 0.385 . . . . 61.31 111.405 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.51 106.15 5.97 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.616 -0.266 . . . . 63.33 110.959 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.5 t -51.77 145.25 9.81 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.375 -0.375 . . . . 54.53 111.193 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -49.54 -30.5 8.59 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.27 0.47 . . . . 63.54 112.27 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -73.58 -51.09 18.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.749 0.309 . . . . 72.22 111.216 175.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -60.98 -42.12 97.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.87 0.367 . . . . 65.44 111.946 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -59.49 -54.18 49.53 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.312 0.577 . . . . 75.14 110.027 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -52.97 -52.61 57.56 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.438 -0.801 . . . . 74.4 112.085 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 31' ' ' ALA . 76.7 t -59.71 -41.99 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.231 -0.441 . . . . 73.33 111.855 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 48.2 ttm -61.34 -42.83 99.32 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.584 -0.28 . . . . 61.44 111.032 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -53.16 -51.94 60.4 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.06 0.457 . . . . 60.21 111.17 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.65 -38.02 93.16 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.166 -0.54 . . . . 44.41 113.242 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 43' ' ' ILE . 99.5 mtt180 -64.87 -54.64 27.76 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.656 -0.32 . . . . 71.14 111.458 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.69 -43.79 93.92 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.037 0.446 . . . . 72.54 111.379 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -57.64 -45.88 84.89 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.081 -0.509 . . . . 75.2 111.101 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.89 -47.14 86.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.129 -0.487 . . . . 62.41 111.531 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.7 mt -56.19 -47.65 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.027 0.441 . . . . 65.21 111.375 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.476 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -62.66 -34.58 77.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.183 0.516 . . . . 74.13 110.711 178.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.8 m -89.75 -1.91 58.12 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.132 -0.486 . . . . 62.01 112.134 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.9 p -122.01 -61.87 1.45 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.011 0.434 . . . . 73.43 111.535 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -92.27 -2.18 56.61 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.831 0.348 . . . . 73.14 111.63 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 66.46 11.5 8.08 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.711 0.634 . . . . 71.23 112.711 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 43' ' ' ILE . 62.9 t -80.74 117.47 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.0 0.429 . . . . 72.23 111.619 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' CG ' ' HE ' ' A' ' 44' ' ' ARG . 36.3 mt-10 -78.59 96.58 5.52 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.443 0.639 . . . . 74.32 110.454 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.83 106.89 15.31 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.445 -0.798 . . . . 73.21 110.778 -172.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.98 144.89 40.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.742 0.306 . . . . 53.32 111.789 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.45 128.44 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.745 0.307 . . . . 65.21 111.43 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG21 HD21 ' A' ' 71' ' ' LEU . 58.1 t -129.98 134.97 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 120.708 0.29 . . . . 73.02 111.582 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 39.3 p -120.99 125.32 47.08 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.946 0.403 . . . . 73.43 111.626 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 24' ' ' GLU . 85.1 mt -127.21 145.78 55.52 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-O 120.667 0.27 . . . . 71.2 111.246 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 57.8 Cg_endo -72.16 -45.14 0.69 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.228 1.952 . . . . 54.42 112.997 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.5 m -149.33 137.55 20.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.651 0.262 . . . . 65.54 111.23 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.5 pt -119.28 9.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 121.097 0.475 . . . . 53.54 111.407 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.12 -136.39 32.58 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.292 -0.48 . . . . 32.24 113.082 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -91.4 7.38 41.39 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.603 -0.351 . . . . 74.21 111.478 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . . . -67.74 136.14 92.52 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.12 0.415 . . . . 72.51 112.12 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 62' ' ' ALA . 14.5 Cg_exo -69.59 132.83 24.44 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.586 2.19 . . . . 55.23 112.447 176.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.7 tp -62.63 -34.31 76.79 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.731 0.301 . . . . 75.54 111.758 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -73.94 -43.17 59.17 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.012 0.434 . . . . 73.11 111.303 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -61.61 -37.36 83.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.325 0.583 . . . . 74.51 110.149 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -58.79 -60.07 4.42 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.405 -0.816 . . . . 61.34 111.15 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.3 p -55.56 -41.68 73.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.101 -0.5 . . . . 75.2 111.751 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -55.65 -52.29 64.33 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 111.784 0.29 . . . . 74.4 111.784 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HE3' ' HG2' ' A' ' 6' ' ' PRO . 34.7 mtmt -64.92 -46.31 82.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.736 0.303 . . . . 72.4 111.507 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.581 HD21 HG21 ' A' ' 54' ' ' VAL . 40.1 tp -60.88 -42.85 98.74 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.983 0.421 . . . . 64.55 111.201 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.63 -45.88 81.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.275 -0.42 . . . . 61.3 112.048 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.482 ' HA ' ' ND2' ' A' ' 79' ' ' ASN . 36.6 ptt180 -73.76 -24.72 59.9 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.785 0.326 . . . . 73.13 111.743 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -66.62 -40.41 88.78 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.029 0.442 . . . . 55.32 110.886 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 49.5 m0 -93.24 -15.91 25.36 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.304 -0.407 . . . . 75.24 111.837 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 72.48 44.65 40.5 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.481 -0.39 . . . . 70.35 113.374 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.97 -76.92 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 121.017 0.436 . . . . 65.14 111.711 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.76 71.8 0.38 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 121.434 -0.412 . . . . 71.5 112.285 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 73' ' ' ARG . 0.9 OUTLIER -74.13 46.56 0.25 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.278 0.473 . . . . 73.05 112.278 -177.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 79' ' ' ASN . 43.6 tt0 71.62 -28.1 0.18 Allowed 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 113.158 0.799 . . . . 72.13 113.158 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -144.51 32.8 1.18 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.64 0.607 . . . . 60.33 112.64 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 79' ' ' ASN . 9.8 m-20 -79.49 -101.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.88 0.696 . . . . 52.42 112.88 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 104' ' ' GLY . 3.9 p-10 -154.55 -151.13 0.34 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.907 0.483 . . . . 73.35 110.209 -173.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -67.95 77.8 0.22 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.815 0.816 . . . . 54.4 111.68 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.52 143.25 12.47 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.338 -0.846 . . . . 64.54 111.47 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.714 HD11 ' HB3' ' A' ' 99' ' ' PHE . 31.3 tp -137.37 123.63 20.56 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.142 0.471 . . . . 72.54 111.591 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 100' ' ' GLU . 59.5 tp -109.16 122.54 47.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.616 -0.265 . . . . 72.41 111.303 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.6 tp -114.19 111.75 22.05 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.516 0.326 . . . . 73.13 111.22 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.94 127.84 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.781 0.324 . . . . 41.21 111.794 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 135' ' ' LEU . 23.1 tp -104.52 121.86 44.35 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.268 -0.424 . . . . 72.21 111.138 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.43 HG11 ' NE2' ' A' ' 94' ' ' GLN . 48.6 t -104.26 103.82 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.853 -0.158 . . . . 72.34 110.885 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.666 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 65.1 tp -57.34 -36.92 71.76 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.802 0.667 . . . . 71.31 112.802 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -50.99 -56.52 12.08 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 120.744 0.307 . . . . 73.25 111.704 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.62 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 8.4 pm0 -98.33 9.18 43.65 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.87 0.367 . . . . 70.15 111.537 174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.486 ' HB2' ' HE1' ' A' ' 131' ' ' TYR . 40.2 ptt180 35.95 46.43 0.35 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.508 1.123 . . . . 72.31 113.707 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.62 ' HE ' ' HG3' ' A' ' 94' ' ' GLN . 26.8 ptt180 -126.45 154.64 43.41 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.891 0.377 . . . . 65.13 111.15 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.636 HG21 ' SD ' ' A' ' 122' ' ' MET . 5.7 m -122.42 171.18 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.234 -0.439 . . . . 73.03 111.804 -176.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.4 ttt85 -148.63 128.82 13.7 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.256 -0.429 . . . . 64.43 111.719 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.714 ' HB3' HD11 ' A' ' 86' ' ' LEU . 72.0 m-85 -92.66 118.78 31.4 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.303 -0.408 . . . . 71.21 110.013 170.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 8.1 tp10 -103.93 112.29 25.2 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.542 0.211 . . . . 74.44 111.441 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.591 HG23 HD11 ' A' ' 114' ' ' LEU . 7.7 p -96.31 133.24 40.93 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.141 0.496 . . . . 72.15 111.528 177.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 81' ' ' LYS . . . -73.79 -63.52 2.7 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.953 -0.641 . . . . 73.52 112.518 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -168.59 -53.4 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.918 0.39 . . . . 72.01 111.838 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 83' ' ' ASN . . . -54.15 -31.82 49.59 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 114.699 0.639 . . . . 64.42 114.699 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 64.8 mt -78.82 -10.69 59.87 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.906 0.706 . . . . 71.42 112.906 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -57.54 -31.81 66.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.904 0.383 . . . . 72.42 111.284 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.96 -25.08 75.57 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.075 -0.583 . . . . 43.51 113.326 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.402 ' HE1' HD21 ' A' ' 150' ' ' LEU . 74.0 m-85 -102.1 -67.77 0.86 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.414 -0.462 . . . . 60.13 111.276 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.608 ' HA ' HD23 ' A' ' 113' ' ' LEU . 1.6 mp -120.56 93.42 48.41 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 116.427 -0.351 . . . . 63.41 111.463 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.54 157.97 57.98 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.972 1.781 . . . . 71.12 111.529 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.535 ' HA ' HD12 ' A' ' 114' ' ' LEU . 10.0 p-10 -49.25 -33.78 13.57 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.325 0.491 . . . . 62.1 112.325 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.43 -45.51 96.25 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.956 -0.64 . . . . 53.53 112.991 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.608 HD23 ' HA ' ' A' ' 109' ' ' LEU . 53.0 tp -64.37 -35.41 80.78 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.032 0.444 . . . . 75.43 110.937 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.591 HD11 HG23 ' A' ' 101' ' ' THR . 89.1 mt -59.94 -45.27 93.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.896 0.379 . . . . 51.33 110.894 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.4 m -63.78 -36.34 83.57 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.368 -0.378 . . . . 50.13 111.091 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -55.16 -46.02 75.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.094 -0.503 . . . . 70.44 111.104 173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.3 -51.99 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.317 -0.401 . . . . 63.14 111.498 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.2 mt -56.58 -55.69 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.239 0.542 . . . . 72.51 112.193 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.469 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 20.3 t-80 -71.0 -30.92 67.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.694 0.628 . . . . 75.14 112.694 -169.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -88.0 -44.51 10.94 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.385 0.513 . . . . 72.35 112.385 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -98.46 -44.55 6.46 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.687 0.625 . . . . 74.42 112.687 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.636 ' SD ' HG21 ' A' ' 97' ' ' VAL . 47.4 mtt -72.68 -48.57 37.98 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.033 0.753 . . . . 75.53 113.033 -175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.469 ' CG1' ' HA ' ' A' ' 119' ' ' HIS . 29.8 mm -49.79 -55.26 24.61 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 113.185 0.809 . . . . 63.32 113.185 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 16.9 Cg_endo -56.61 -38.67 95.06 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.0 1.8 . . . . 62.54 112.477 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -66.25 -49.39 67.33 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 111.602 0.223 . . . . 63.51 111.602 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.1 m-30 -59.69 -35.84 75.29 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.756 0.313 . . . . 72.12 111.271 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -67.29 -36.27 81.2 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.95 0.405 . . . . 71.44 111.554 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 m -78.1 -22.01 49.61 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.858 0.361 . . . . 72.04 111.588 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.41 0.32 32.93 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.442 -0.409 . . . . 73.34 112.865 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.8 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 83.2 m-20 -82.3 74.27 9.28 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.63 -0.335 . . . . 64.25 111.685 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.486 ' HE1' ' HB2' ' A' ' 95' ' ' ARG . 96.9 m-85 -70.93 -44.42 66.18 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.838 0.351 . . . . 73.41 111.298 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.51 -46.61 85.28 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.963 0.411 . . . . 63.03 111.406 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.8 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 27.3 mm-40 -62.25 -49.38 75.96 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.066 -0.516 . . . . 72.24 111.415 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.67 -51.59 51.46 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.427 -0.416 . . . . 63.43 113.154 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.574 HD11 HD22 ' A' ' 90' ' ' LEU . 78.2 mt -62.07 -43.38 98.96 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.604 -0.351 . . . . 75.21 111.504 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.7 t -57.84 -57.57 12.19 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.252 0.464 . . . . 63.5 112.252 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 140' ' ' LEU . 11.9 pt-20 -76.42 -19.81 57.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.913 0.338 . . . . 72.02 111.913 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.79 -50.37 61.74 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.674 -0.774 . . . . 55.23 111.766 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.2 t -59.6 -44.98 94.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.044 0.449 . . . . 63.41 110.81 172.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 56.2 tp -59.37 -38.05 79.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.074 -0.512 . . . . 73.42 111.165 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -60.24 -44.8 94.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.801 0.334 . . . . 65.23 111.086 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.431 HG13 HD22 ' A' ' 109' ' ' LEU . 90.7 t -59.27 -52.73 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.106 0.479 . . . . 72.34 110.856 174.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -53.05 -43.67 66.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.913 -0.585 . . . . 65.02 111.888 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 83.6 mm-40 -59.3 -37.93 78.97 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.924 0.342 . . . . 74.4 111.924 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 141' ' ' ALA . 91.5 t -64.23 -35.84 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.064 0.459 . . . . 73.21 111.173 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.25 -57.83 5.96 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.368 -0.378 . . . . 74.15 111.648 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.73 -33.15 74.99 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.972 0.415 . . . . 75.34 111.485 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.71 -45.26 85.89 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 116.26 -0.427 . . . . 60.45 113.541 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 87.8 p -73.37 -31.5 63.95 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 122.242 -0.564 . . . . 70.34 111.319 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.402 HD21 ' HE1' ' A' ' 108' ' ' TYR . 74.2 mt -92.98 40.05 1.05 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.914 0.388 . . . . 74.32 111.809 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.85 17.97 1.4 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.756 0.313 . . . . 54.14 111.647 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -54.69 125.15 18.74 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.451 0.301 . . . . 72.42 110.702 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 17.7 p80 47.11 42.09 12.42 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.191 0.996 . . . . 71.11 113.146 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 74.22 0.88 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.616 0.722 . . . . 62.52 110.808 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -92.15 93.51 8.74 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.914 -0.584 . . . . 74.54 111.645 -173.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -100.75 -9.56 21.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.024 0.44 . . . . 74.31 111.038 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 44.7 m80 . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.97 -0.538 . . . . 74.25 111.043 175.56 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ttt . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.662 0.268 . . . . 72.4 111.54 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -126.41 122.4 35.2 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.813 0.339 . . . . 74.4 110.355 174.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t -88.02 125.76 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 112.734 0.642 . . . . 73.11 112.734 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -111.12 126.74 55.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.984 -0.553 . . . . 73.12 111.86 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -105.73 163.89 16.15 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 116.189 -0.459 . . . . 63.22 109.814 171.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 10.0 Cg_endo -51.53 -29.37 31.72 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.566 2.177 . . . . 63.33 114.118 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -82.87 -17.68 42.99 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.438 0.533 . . . . 72.32 112.438 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.88 -34.89 64.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.074 0.464 . . . . 64.13 110.527 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.405 HG22 HD21 ' A' ' 56' ' ' LEU . 64.9 t -64.7 127.05 92.08 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 115.84 -0.618 . . . . 65.44 111.466 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.21 133.0 31.38 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.376 2.05 . . . . 70.55 113.059 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.777 HD22 ' HB2' ' A' ' 14' ' ' LEU . 8.1 t30 -74.54 77.12 1.97 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.37 0.605 . . . . 75.42 110.69 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -59.79 -31.0 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 113.151 0.797 . . . . 73.43 113.151 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.34 -9.03 10.24 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.307 0.484 . . . . 74.11 112.307 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.777 ' HB2' HD22 ' A' ' 11' ' ' ASN . 8.1 tt -76.14 -41.68 49.23 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.209 0.528 . . . . 71.33 110.383 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.89 -51.68 3.36 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.043 -0.526 . . . . 70.44 112.39 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 19' ' ' ARG . 34.5 m-20 -114.85 86.59 2.47 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.017 0.747 . . . . 74.3 113.017 -173.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.4 p -78.89 -6.73 56.87 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.569 0.7 . . . . 75.21 110.398 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -93.06 -0.44 57.1 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.802 -0.636 . . . . 44.22 111.128 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 16' ' ' ASP . 18.4 ttt180 -113.31 -63.09 1.49 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.126 -0.488 . . . . 75.31 111.323 -174.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp 64.62 -0.02 1.04 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.224 0.61 . . . . 54.42 112.489 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.0 t -103.81 130.09 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.067 0.46 . . . . 65.13 111.816 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 m -125.72 112.59 16.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.972 -0.558 . . . . 73.42 110.094 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.68 100.4 7.59 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.363 0.505 . . . . 64.23 112.363 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' HB2' HD23 ' A' ' 56' ' ' LEU . 4.5 mp0 -98.54 -37.75 9.43 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.919 0.39 . . . . 75.34 110.937 173.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . . . -57.24 -31.27 65.37 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.74 0.644 . . . . 61.12 112.74 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.44 39.44 8.33 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.836 -0.697 . . . . 61.1 112.328 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -107.18 -38.43 5.99 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.063 0.459 . . . . 71.54 111.286 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -90.6 98.88 12.04 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.184 0.516 . . . . 75.44 111.362 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.1 m -72.36 173.05 9.27 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.402 -0.363 . . . . 64.44 111.584 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -49.97 -47.3 52.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.29 0.478 . . . . 71.53 112.29 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.44 -47.27 76.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.932 0.396 . . . . 62.13 111.4 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -55.81 -43.63 77.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.198 -0.456 . . . . 53.12 111.132 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.76 -55.08 37.42 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 116.369 -0.378 . . . . 75.12 111.132 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.7 -38.87 61.37 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.053 0.454 . . . . 63.31 111.848 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.57 -43.0 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.002 0.43 . . . . 63.13 111.615 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 47.0 ttm -73.22 -45.99 52.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.636 0.255 . . . . 55.23 111.16 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -50.76 -42.79 58.01 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.901 0.48 . . . . 60.11 111.031 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.24 -47.55 90.5 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.154 -0.475 . . . . 63.04 113.561 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 43' ' ' ILE . 9.9 ptp180 -74.45 -34.73 63.24 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.439 -0.448 . . . . 74.42 112.064 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.415 HD22 ' O ' ' A' ' 51' ' ' PHE . 89.8 mt -67.91 -41.65 82.32 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.5 0.667 . . . . 72.04 110.487 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -59.13 -39.58 82.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.378 -0.828 . . . . 62.33 110.352 173.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.42 85.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.944 -0.571 . . . . 74.41 111.422 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 143' ' ' GLN . 77.2 mt -58.45 -51.9 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.155 -0.475 . . . . 74.13 111.735 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 62.7 ttp85 -65.14 -34.01 77.38 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.772 0.32 . . . . 72.32 111.592 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -76.46 -23.59 53.85 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.831 0.348 . . . . 60.3 111.66 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -100.02 -69.9 0.75 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.663 0.246 . . . . 73.12 111.663 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -87.05 -5.6 59.0 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.523 0.564 . . . . 64.43 112.523 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 67.08 19.83 10.42 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.493 0.553 . . . . 54.42 112.493 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.7 t -90.57 133.99 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.695 0.284 . . . . 70.35 111.627 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.3 96.97 10.78 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.072 0.463 . . . . 74.21 110.658 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -103.59 97.97 7.92 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.783 -0.644 . . . . 74.13 109.759 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.07 141.94 34.97 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.131 0.419 . . . . 74.42 112.131 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.93 123.9 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.454 -0.339 . . . . 71.22 111.119 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -121.61 136.01 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.399 0.28 . . . . 72.42 111.391 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 p -120.5 123.75 43.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.912 0.386 . . . . 72.11 111.432 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 24' ' ' GLU . 76.3 mt -124.15 145.36 48.11 Favored Pre-proline 0 N--CA 1.471 0.625 0 O-C-N 122.164 -0.335 . . . . 71.42 111.792 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HG3' ' HA ' ' A' ' 25' ' ' ALA . 27.9 Cg_exo -63.11 -55.99 0.66 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.739 2.293 . . . . 72.45 112.542 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.6 m -150.78 148.58 28.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.758 0.314 . . . . 73.22 111.394 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 91' ' ' VAL . 24.4 pt -118.24 -6.65 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 120.956 0.408 . . . . 74.25 111.777 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.53 -116.18 8.43 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.535 -0.364 . . . . 62.02 113.841 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.3 -13.12 53.31 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.713 0.292 . . . . 73.23 111.761 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -65.49 124.83 88.29 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.606 -0.27 . . . . 64.12 111.329 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.3 Cg_endo -80.14 131.71 8.95 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.427 2.084 . . . . 73.13 112.607 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 96' ' ' ARG . 61.4 tp -59.33 -42.28 91.08 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.422 0.527 . . . . 64.34 112.422 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 8.6 mp0 -60.1 -44.29 94.96 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.031 0.443 . . . . 54.45 111.493 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 6.0 m-20 -74.48 -33.19 62.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.957 0.408 . . . . 75.35 110.809 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.44 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 37.3 t80 -56.6 -55.35 35.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.298 -0.41 . . . . 74.31 111.383 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.9 p -54.69 -46.07 74.06 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.285 -0.416 . . . . 74.34 111.66 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.569 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 56.0 tp -59.2 -54.59 45.19 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.375 -0.375 . . . . 75.4 111.327 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -58.94 -44.22 91.37 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.107 0.41 . . . . 72.15 112.107 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.598 HD23 HD21 ' A' ' 87' ' ' LEU . 54.7 tp -62.42 -45.35 93.5 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.156 0.503 . . . . 74.35 110.926 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.68 -35.99 81.45 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.905 0.384 . . . . 42.02 111.792 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 78.4 mtp180 -61.67 -53.98 48.93 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.511 -0.313 . . . . 53.25 111.595 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.503 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 10.3 pt20 -64.87 -33.73 76.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 111.987 0.366 . . . . 74.22 111.987 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.503 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 26.9 m0 -74.28 -4.48 36.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.929 0.395 . . . . 74.15 111.956 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.639 ' HA2' HD21 ' A' ' 79' ' ' ASN . . . 78.33 -1.01 72.64 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.277 -0.487 . . . . 75.42 113.414 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.402 ' HA ' ' ND2' ' A' ' 82' ' ' ASN . 4.4 t -102.94 15.17 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.291 0.567 . . . . 73.4 110.937 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.11 28.49 0.3 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.265 -0.969 . . . . 71.32 114.535 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.639 HD21 ' HA2' ' A' ' 76' ' ' GLY . 60.3 m-80 -67.31 89.01 0.2 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.113 0.957 . . . . 74.4 110.228 175.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 57.65 66.06 1.21 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.714 -0.675 . . . . 64.4 110.816 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 11.8 mptt 59.78 91.95 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.561 -0.745 . . . . 72.42 112.473 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.66 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 25.3 t-20 -84.52 119.33 25.05 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 110.201 -0.296 . . . . 75.51 110.201 176.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.677 HD22 ' N ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -36.43 -63.65 0.38 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 113.958 1.096 . . . . 63.11 113.958 -176.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.582 ' H ' ' ND2' ' A' ' 83' ' ' ASN . 2.9 p-10 -94.5 35.16 1.23 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 121.861 -0.524 . . . . 71.31 111.864 -176.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.4 139.2 15.45 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.136 -0.554 . . . . 73.54 113.933 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 46.6 tp -149.98 122.93 8.76 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.009 0.433 . . . . 74.1 110.846 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.598 HD21 HD23 ' A' ' 71' ' ' LEU . 62.9 tp -122.95 131.79 53.87 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.937 0.399 . . . . 53.4 111.924 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.7 tp -121.35 117.3 26.61 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.146 -0.479 . . . . 72.25 110.889 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.22 124.73 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.943 0.402 . . . . 73.35 111.852 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.524 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.2 tp -103.47 118.59 37.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.056 -0.52 . . . . 74.01 111.007 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 59' ' ' ILE . 57.6 t -99.41 101.22 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.539 -0.3 . . . . 73.45 110.868 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.2 tp -48.93 -46.49 43.21 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.857 0.463 . . . . 72.41 111.994 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -45.27 -48.36 12.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.973 0.731 . . . . 73.11 112.973 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -111.15 4.58 19.42 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.18 0.437 . . . . 75.34 112.18 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 43.52 26.06 0.1 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.331 1.052 . . . . 63.12 113.467 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HG3' HD22 ' A' ' 64' ' ' LEU . 11.0 ptm85 -105.02 152.25 22.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.922 0.392 . . . . 73.54 111.042 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 90' ' ' LEU . 3.4 m -136.63 165.86 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.177 -0.465 . . . . 64.45 110.771 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -149.63 135.32 18.56 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.797 0.332 . . . . 73.33 111.61 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.55 ' HB2' HD13 ' A' ' 114' ' ' LEU . 80.8 m-85 -93.86 102.35 14.47 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.102 -0.499 . . . . 64.23 110.024 172.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -81.87 111.37 18.01 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 110.329 -0.249 . . . . 42.55 110.329 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.9 p -93.15 141.01 28.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.578 0.704 . . . . 60.0 112.581 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -84.37 166.81 42.37 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.676 -0.774 . . . . 70.44 111.743 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -54.28 -19.63 5.67 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.16 0.8 . . . . 75.55 113.16 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.548 ' N ' ' HA ' ' A' ' 83' ' ' ASN . . . -85.11 -20.52 57.25 Favored Glycine 0 N--CA 1.463 0.462 0 C-N-CA 120.815 -0.707 . . . . 50.2 112.805 -173.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.41 -4.3 29.27 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.351 0.26 . . . . 72.13 111.587 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -51.59 -39.95 58.91 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.269 0.47 . . . . 74.44 112.269 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.43 -12.51 58.76 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.225 -0.512 . . . . 53.14 114.113 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -118.38 -48.65 2.5 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.066 0.46 . . . . 70.23 111.7 -176.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.57 ' HB3' HD21 ' A' ' 114' ' ' LEU . 30.8 mt -118.02 86.44 25.81 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.92 -0.582 . . . . 72.53 112.296 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 88.9 Cg_endo -82.84 158.55 15.97 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.27 1.98 . . . . 74.13 112.398 172.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.45 -35.21 8.23 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 111.908 0.336 . . . . 71.23 111.908 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.27 -51.03 59.42 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.107 -0.568 . . . . 65.53 113.122 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 64.9 tp -62.73 -45.87 90.7 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.073 0.464 . . . . 71.13 110.674 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 109' ' ' LEU . 67.7 mt -59.22 -38.46 80.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.936 -0.575 . . . . 73.24 110.972 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.5 t -61.81 -40.14 94.21 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.174 -0.467 . . . . 61.21 110.942 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.45 -48.76 76.37 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.935 -0.306 . . . . 72.33 110.901 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.2 mt -50.71 -45.66 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.099 0.476 . . . . 74.1 110.908 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.538 ' O ' HG12 ' A' ' 123' ' ' ILE . 68.2 mt -64.9 -56.83 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.01 -0.541 . . . . 72.31 112.189 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -76.02 -34.37 59.68 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.602 0.964 . . . . 52.23 113.602 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.25 -32.59 33.27 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.858 0.361 . . . . 75.31 111.716 -171.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -123.57 -56.19 1.7 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.286 0.476 . . . . 71.34 112.286 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 91.4 mtp -64.06 -43.86 94.2 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.554 0.946 . . . . 74.31 113.554 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 118' ' ' ILE . 38.2 mm -57.54 -50.29 88.96 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 112.18 0.437 . . . . 74.12 112.18 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 86.9 Cg_exo -45.0 -44.7 14.77 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.204 1.936 . . . . 74.11 112.948 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -64.1 -51.9 61.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.614 -0.266 . . . . 72.1 111.535 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -56.95 -39.78 75.2 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.781 0.324 . . . . 74.25 111.664 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -67.44 -36.02 80.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.218 0.532 . . . . 63.34 110.994 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.5 t -74.28 -16.83 60.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.25 -0.432 . . . . 65.34 111.067 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.31 53.2 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 116.283 -0.417 . . . . 70.41 112.659 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.92 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 94.8 m-20 -81.31 72.0 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.052 0.454 . . . . 62.14 111.966 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -67.07 -45.65 76.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.825 0.345 . . . . 73.51 111.079 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.58 -47.33 67.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.05 0.452 . . . . 71.12 111.357 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.92 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 11.3 tp10 -59.75 -41.27 90.61 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.032 -0.531 . . . . 61.1 110.721 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.77 -53.96 34.42 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.831 -0.622 . . . . 63.35 113.258 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.2 -44.81 71.91 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 122.462 -0.434 . . . . 72.35 111.348 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.2 t -56.01 -51.67 66.95 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.231 0.456 . . . . 75.41 112.231 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -34.6 62.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.628 0.232 . . . . 73.51 111.628 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.82 -48.15 87.48 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.111 -0.566 . . . . 51.25 112.378 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.72 -43.74 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.17 0.51 . . . . 51.35 110.932 173.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.8 tp -60.95 -38.97 87.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.971 -0.559 . . . . 74.42 110.795 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.3 96.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.095 0.474 . . . . 51.5 111.045 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.47 -51.43 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.139 -0.482 . . . . 74.11 111.427 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.487 ' HB2' HD11 ' A' ' 43' ' ' ILE . 10.2 tt0 -54.18 -40.19 67.3 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 121.128 -0.229 . . . . 71.45 111.536 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -57.29 -43.42 83.17 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.83 0.307 . . . . 74.52 111.83 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.79 -51.12 76.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.902 0.382 . . . . 43.22 111.15 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.62 -46.51 88.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.184 0.516 . . . . 73.13 111.079 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -59.7 -31.32 69.48 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.783 -0.644 . . . . 54.1 111.263 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.8 -22.8 75.68 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.28 -0.486 . . . . 65.23 112.715 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 28.8 t -83.08 -65.51 1.0 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.986 0.422 . . . . 71.35 111.131 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.1 mt -122.14 86.25 2.55 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.328 0.585 . . . . 64.21 110.941 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.17 39.67 0.19 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.865 -0.607 . . . . 75.42 111.981 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -133.2 108.98 9.13 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.148 -0.345 . . . . 73.55 110.954 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -57.66 137.99 55.86 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.888 0.375 . . . . 72.13 111.445 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -103.21 118.73 37.45 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.498 -0.319 . . . . 70.41 111.006 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -90.27 -9.69 46.99 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.976 0.417 . . . . 72.52 111.104 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -74.59 112.54 10.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.507 -0.315 . . . . 73.42 111.401 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 17.4 p80 . . . . . 0 C--O 1.254 1.332 0 CA-C-N 116.69 -0.232 . . . . 71.32 111.136 -179.58 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ttt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.768 0.318 . . . . 63.33 111.047 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.417 ' HD2' ' CE2' ' A' ' 4' ' ' TYR . 34.6 ttm180 -156.58 106.8 2.33 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.413 -0.358 . . . . 73.33 110.073 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.96 103.38 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.061 0.458 . . . . 60.04 112.038 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 2' ' ' ARG . 15.3 m-85 -93.01 134.51 35.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.422 0.527 . . . . 75.12 112.422 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 1.3 mptm? -107.52 163.3 17.24 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.148 -0.478 . . . . 72.11 110.124 169.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 13.6 Cg_endo -54.87 -26.64 49.4 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.176 1.918 . . . . 72.52 112.716 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.44 -29.49 59.7 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.385 -0.371 . . . . 73.34 111.933 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.63 -29.65 56.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.929 0.395 . . . . 74.24 111.585 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.63 HG13 HG21 ' A' ' 22' ' ' THR . 50.5 t -62.87 127.55 90.77 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 116.185 -0.461 . . . . 64.52 111.494 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.64 130.39 31.37 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.66 2.24 . . . . 73.15 112.949 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -69.8 76.65 0.46 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.242 0.544 . . . . 43.32 112.045 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 m -58.29 -49.56 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.482 0.549 . . . . 73.14 112.482 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -60.89 -17.91 53.35 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.837 -0.54 . . . . 70.21 112.054 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.66 -52.33 5.6 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.869 0.366 . . . . 75.2 110.21 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.99 -75.84 0.49 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.526 -0.306 . . . . 63.14 111.703 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.92 48.76 0.61 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.47 0.545 . . . . 73.31 112.47 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 82.9 p -63.84 -9.21 13.69 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.963 0.411 . . . . 53.21 111.344 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -89.86 -26.08 20.69 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.085 -0.507 . . . . 74.31 111.374 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.54 ' HD2' ' O ' ' A' ' 21' ' ' VAL . 12.3 ttm180 -85.03 -45.1 12.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.913 0.387 . . . . 71.23 110.864 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.5 mp 59.15 15.12 3.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.484 0.713 . . . . 62.12 112.382 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.54 ' O ' ' HD2' ' A' ' 19' ' ' ARG . 88.0 t -129.39 126.1 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.965 0.412 . . . . 72.15 111.696 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.63 HG21 HG13 ' A' ' 9' ' ' VAL . 86.7 m -99.66 102.93 14.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.915 0.388 . . . . 71.42 110.11 173.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.98 98.18 8.67 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.371 0.605 . . . . 60.11 111.886 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -126.46 -30.85 2.81 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.835 0.35 . . . . 64.13 111.325 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . -59.11 -19.54 45.44 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 111.708 0.262 . . . . 54.34 111.708 171.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.74 40.02 98.22 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.505 -0.378 . . . . 55.34 113.697 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.1 mt -105.39 -2.73 23.48 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.083 0.401 . . . . 65.21 112.083 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.87 -175.1 2.79 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.931 0.396 . . . . 53.42 111.907 -176.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.9 t -158.79 170.4 22.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.665 0.386 . . . . 71.43 110.484 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -44.68 -45.33 9.69 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.956 0.725 . . . . 71.32 112.956 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -70.14 -55.95 8.09 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.288 -0.257 . . . . 64.43 111.632 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -55.59 -45.87 77.35 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 111.847 0.314 . . . . 74.24 111.847 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.68 -54.9 36.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.422 -0.354 . . . . 71.32 111.085 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.98 -41.27 82.65 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.178 0.436 . . . . 73.11 112.178 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.483 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 90.9 t -64.51 -50.06 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.887 0.375 . . . . 72.32 110.807 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.406 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.1 ttm -60.51 -43.7 96.79 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.532 -0.304 . . . . 42.22 111.478 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.48 -44.63 89.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.882 0.372 . . . . 63.55 111.011 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.88 -44.59 97.21 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.172 -0.537 . . . . 35.4 112.716 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.541 ' O ' HG13 ' A' ' 43' ' ' ILE . 5.8 mmp_? -55.34 -55.41 31.9 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.006 0.431 . . . . 71.41 110.96 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB3' HD22 ' A' ' 20' ' ' LEU . 87.7 mt -60.59 -44.39 96.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.032 -0.531 . . . . 64.05 111.891 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -63.16 -39.41 94.58 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.725 0.297 . . . . 75.12 110.863 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.93 -42.48 98.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.949 0.404 . . . . 74.32 111.017 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.3 mt -57.63 -47.18 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.014 -0.539 . . . . 72.1 111.453 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 14.4 ptm180 -77.67 -24.95 49.21 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.959 -0.463 . . . . 72.44 111.927 178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.4 t -70.06 -35.5 74.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.945 0.402 . . . . 62.02 111.027 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.1 t -95.7 -56.43 2.68 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.132 -0.486 . . . . 73.24 112.215 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -98.44 -12.64 21.15 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.302 0.482 . . . . 73.0 112.302 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.36 20.85 11.88 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.518 0.562 . . . . 71.11 112.518 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 43' ' ' ILE . 92.7 t -81.79 125.55 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.0 0.428 . . . . 75.24 111.129 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -84.34 97.15 9.3 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.276 0.56 . . . . 73.24 110.662 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.408 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -106.59 105.3 15.26 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.392 -0.822 . . . . 74.44 110.647 -173.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.22 117.11 33.44 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.146 0.424 . . . . 44.41 112.146 -177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.55 112.54 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.164 0.507 . . . . 61.3 111.502 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 58.1 t -107.56 143.26 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 122.912 0.485 . . . . 64.24 111.463 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 49.8 p -133.81 122.52 23.37 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.718 0.294 . . . . 74.04 110.893 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -127.71 141.8 42.19 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 120.561 0.219 . . . . 74.14 111.295 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.76 -48.23 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.506 2.138 . . . . 62.14 113.062 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.935 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 67.6 p -155.78 145.02 20.78 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.021 0.378 . . . . 72.03 112.021 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 pt -123.86 -3.49 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.749 0.309 . . . . 73.12 111.494 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.42 47.22 6.99 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.219 -0.515 . . . . 23.35 113.169 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 56.96 20.35 5.29 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.174 0.435 . . . . 74.34 112.174 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.95 151.65 97.16 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.396 -0.365 . . . . 54.25 111.834 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 29.4 Cg_endo -60.59 117.32 4.07 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.841 2.361 . . . . 73.24 113.14 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.82 -51.83 65.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.868 0.692 . . . . 74.11 112.868 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -31.71 72.67 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.125 0.488 . . . . 74.33 111.588 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 63' ' ' PRO . 10.4 t70 -68.84 -34.8 76.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.205 0.526 . . . . 75.5 110.835 173.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -65.91 -55.94 14.32 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.859 -0.61 . . . . 74.15 110.892 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.5 p -56.97 -42.81 80.85 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.226 -0.443 . . . . 73.41 111.813 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.8 tp -53.03 -53.09 55.37 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.924 0.392 . . . . 73.45 111.953 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.631 ' HG2' HH21 ' A' ' 73' ' ' ARG . 37.8 mtmm -71.33 -36.88 71.7 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.314 0.487 . . . . 75.21 112.314 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.7 tp -65.85 -37.59 86.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.201 0.524 . . . . 75.11 111.257 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.74 84.12 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.297 -0.41 . . . . 74.33 111.616 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.631 HH21 ' HG2' ' A' ' 70' ' ' LYS . 41.3 mtm105 -58.91 -49.66 76.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.272 0.471 . . . . 62.33 112.272 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.467 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 11.7 pt20 -64.63 -15.27 60.96 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.135 0.42 . . . . 71.2 112.135 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.467 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 45.5 m0 -103.4 14.88 30.44 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.776 0.322 . . . . 75.15 111.543 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.37 -53.32 4.65 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 121.113 -0.565 . . . . 64.21 113.651 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.522 ' HA ' ' HB3' ' A' ' 82' ' ' ASN . 31.0 m -52.1 -27.27 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 113.505 0.928 . . . . 72.5 113.505 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.79 -11.92 48.7 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.799 -0.715 . . . . 73.44 113.918 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -58.95 109.51 0.84 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.355 0.577 . . . . 74.5 109.937 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 42.63 32.91 0.41 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.721 0.808 . . . . 60.15 112.291 -171.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HB3' ' HA2' ' A' ' 102' ' ' GLY . 0.5 OUTLIER 62.85 80.13 0.24 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.202 -0.908 . . . . 74.32 112.704 178.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.549 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 42.5 t30 -60.45 130.28 45.82 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.201 -0.454 . . . . 73.5 111.027 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.615 HD22 ' N ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -41.07 -60.65 1.16 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.2 1.185 . . . . 74.24 114.2 -171.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.607 ' H ' ' ND2' ' A' ' 83' ' ' ASN . 4.8 p-10 -95.04 24.27 4.99 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.044 -0.41 . . . . 62.43 112.034 -174.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.16 137.6 13.52 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.027 -0.606 . . . . 72.3 113.549 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 99' ' ' PHE . 49.1 tp -144.53 119.96 10.31 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.015 0.436 . . . . 74.14 111.246 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 63.1 tp -109.32 141.47 41.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.944 0.402 . . . . 70.44 111.363 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.1 tp -129.7 127.79 41.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.378 -0.374 . . . . 71.24 110.022 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 65.8 t -128.19 116.6 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 O-C-N 122.116 -0.365 . . . . 60.04 111.882 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.656 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.2 tp -95.45 120.97 36.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.247 -0.433 . . . . 72.21 111.001 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.589 HG12 ' HB3' ' A' ' 93' ' ' ASP . 60.1 t -110.5 99.94 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.771 0.319 . . . . 70.24 111.059 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.3 tp -53.76 -39.1 65.08 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.898 0.38 . . . . 73.12 111.457 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.935 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 56.1 t0 -39.33 -52.98 2.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.915 0.886 . . . . 62.35 112.061 173.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.458 ' OE1' ' HD2' ' A' ' 96' ' ' ARG . 11.1 pt20 -108.53 -4.21 17.41 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.227 0.455 . . . . 73.44 112.227 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 59.32 27.56 16.67 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.524 0.564 . . . . 61.42 112.524 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.458 ' HD2' ' OE1' ' A' ' 94' ' ' GLN . 87.0 mtt180 -120.41 155.84 32.63 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.079 0.466 . . . . 65.54 111.39 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.712 HG21 ' SD ' ' A' ' 122' ' ' MET . 3.6 m -134.64 169.64 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.658 -0.701 . . . . 62.34 110.958 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -150.83 141.03 22.22 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.965 0.358 . . . . 74.23 111.965 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.489 ' HB3' HD11 ' A' ' 86' ' ' LEU . 97.0 m-85 -100.8 113.87 27.17 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.87 -0.605 . . . . 74.14 110.31 172.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -98.59 112.02 24.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 110.31 -0.256 . . . . 61.31 110.31 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.1 p -98.6 152.58 19.44 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.996 0.739 . . . . 72.53 112.996 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -88.57 166.95 34.85 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.394 -0.821 . . . . 54.05 111.906 168.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -65.17 1.0 1.11 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.979 0.733 . . . . 70.13 112.979 -175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.86 -42.46 6.02 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.496 -0.641 . . . . 34.11 111.496 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.52 -12.76 60.29 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.319 -0.441 . . . . 72.52 111.777 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -56.96 -17.29 9.13 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.216 0.45 . . . . 71.13 112.216 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.68 -7.55 85.84 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.179 -0.534 . . . . 62.24 113.598 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.1 -49.81 1.02 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.099 0.475 . . . . 75.23 111.822 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.2 mt -112.36 90.13 13.72 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.006 -0.543 . . . . 63.41 112.194 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.99 157.16 23.7 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.363 2.042 . . . . 61.21 112.893 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.49 -34.39 35.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.804 0.441 . . . . 70.52 111.949 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.91 -50.04 63.65 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.108 -0.568 . . . . 60.14 113.049 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.43 -45.43 88.49 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.156 0.503 . . . . 71.33 110.863 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 118' ' ' ILE . 80.0 mt -59.0 -39.53 82.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.881 -0.599 . . . . 74.41 110.946 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.3 t -57.46 -44.4 84.78 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.978 -0.555 . . . . 54.51 111.316 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -57.42 -51.59 68.8 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.777 0.322 . . . . 75.4 110.959 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 64.0 mt -50.91 -40.25 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.017 0.437 . . . . 73.23 111.328 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.635 HG23 HG22 ' A' ' 97' ' ' VAL . 76.8 mt -62.79 -56.41 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.124 -0.489 . . . . 71.33 111.991 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 10.5 t-80 -83.58 -23.49 31.94 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.14 0.792 . . . . 64.11 113.14 -171.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -91.82 -49.5 6.22 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 111.74 0.274 . . . . 74.42 111.74 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -79.42 -54.42 5.94 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.829 0.347 . . . . 73.1 111.484 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.712 ' SD ' HG21 ' A' ' 97' ' ' VAL . 61.9 mtt -82.6 -58.93 2.69 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.851 1.056 . . . . 64.32 113.851 -168.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.49 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 23.7 mm -43.2 -52.47 12.37 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 113.709 1.003 . . . . 72.1 113.709 -173.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.49 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 76.4 Cg_exo -51.65 -41.55 60.8 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 121.769 1.646 . . . . 60.41 113.056 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.487 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 91.3 m-70 -73.1 -40.51 64.92 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.237 -0.289 . . . . 72.42 111.679 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 122' ' ' MET . 15.9 m-30 -56.54 -40.45 75.14 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.118 0.485 . . . . 71.1 110.986 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -76.07 -37.13 58.61 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.121 -0.49 . . . . 62.51 111.325 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.5 m -66.19 -30.01 70.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.701 0.286 . . . . 64.11 111.676 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 123.51 -3.23 9.49 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.23 -0.509 . . . . 72.31 113.721 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.794 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 97.2 m-20 -104.07 87.49 2.78 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.086 0.402 . . . . 70.01 112.086 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -71.27 -45.12 63.88 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.175 0.512 . . . . 70.41 110.486 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.58 -48.06 82.65 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.962 -0.563 . . . . 71.03 111.755 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.794 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 29.2 tt0 -62.44 -38.58 90.28 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.291 -0.413 . . . . 73.14 111.111 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.27 -51.14 60.66 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.064 -0.589 . . . . 74.42 112.769 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.498 HD11 HD22 ' A' ' 90' ' ' LEU . 99.4 mt -57.67 -43.41 84.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.922 0.391 . . . . 71.43 110.895 175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.0 t -51.77 -56.91 11.06 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.986 -0.552 . . . . 74.01 111.894 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -63.34 -32.22 73.58 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 111.821 0.304 . . . . 73.51 111.821 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.585 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -60.84 -52.17 54.06 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.959 -0.638 . . . . 51.02 112.408 175.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.6 t -59.12 -48.62 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.03 0.443 . . . . 64.52 111.066 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.511 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 62.3 tp -53.22 -46.55 69.16 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.774 -0.648 . . . . 71.42 111.073 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.03 87.36 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.164 -0.471 . . . . 71.43 111.657 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.96 -56.4 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.414 -0.357 . . . . 75.0 111.423 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -59.44 -35.37 73.91 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.297 0.48 . . . . 71.15 112.297 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 16.6 mm-40 -59.6 -34.13 72.36 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 122.112 -0.368 . . . . 75.31 111.587 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 65.4 t -66.21 -42.68 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.904 0.383 . . . . 74.42 110.719 174.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.85 -56.53 8.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.118 -0.492 . . . . 72.14 111.37 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 50.9 m-20 -56.41 -34.78 67.08 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.561 -0.29 . . . . 62.15 111.34 176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -48.81 -31.77 10.5 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.556 -0.354 . . . . 74.21 113.083 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.8 t -73.99 -47.73 35.24 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.642 0.258 . . . . 64.01 111.237 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.7 mt -70.09 -17.87 63.24 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.531 0.567 . . . . 44.01 112.531 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 147' ' ' ASP . 68.4 mm-40 -58.51 -20.32 44.96 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.914 0.388 . . . . 62.11 111.412 175.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -58.48 99.95 0.05 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.097 -0.501 . . . . 55.22 111.369 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -77.65 111.21 13.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.692 0.282 . . . . 72.52 111.466 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -97.61 120.08 37.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.166 0.507 . . . . 70.34 111.341 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -90.61 -15.94 29.6 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.294 -0.412 . . . . 65.21 111.321 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -55.98 119.05 5.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.023 0.439 . . . . 73.33 111.952 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 31.1 t60 . . . . . 0 C--O 1.252 1.214 0 CA-C-N 115.944 -0.571 . . . . 65.11 111.693 -178.161 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.717 0.294 . . . . 74.14 111.389 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -171.27 129.53 0.72 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.267 -0.424 . . . . 53.42 110.935 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.7 t -103.38 124.32 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.067 0.461 . . . . 71.21 111.586 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -99.16 113.25 25.39 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.443 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.659 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 2.9 mppt? -95.57 169.03 9.83 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.515 -0.55 . . . . 70.31 109.515 171.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.659 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 10.2 Cg_endo -51.01 -24.31 13.87 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.201 1.934 . . . . 53.23 113.198 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.42 -21.23 35.82 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 111.955 0.354 . . . . 44.23 111.955 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -82.94 -27.79 30.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.883 0.373 . . . . 64.54 110.977 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG22 HD21 ' A' ' 56' ' ' LEU . 34.9 t -76.87 120.81 83.24 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.104 -0.498 . . . . 62.32 111.234 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HG2' HG23 ' A' ' 22' ' ' THR . 27.6 Cg_endo -62.43 127.73 21.71 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.335 2.023 . . . . 52.51 112.552 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.407 ' HA ' ' CE2' ' A' ' 75' ' ' TRP . 2.0 m-20 -72.69 74.97 1.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.087 0.47 . . . . 74.02 111.473 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.0 m -57.62 -41.56 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 112.479 0.548 . . . . 71.4 112.479 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.527 HE22 ' HG ' ' A' ' 20' ' ' LEU . 25.4 mm-40 -75.74 -5.1 44.08 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.456 0.539 . . . . 73.43 112.456 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.0 tt -102.79 -32.33 9.86 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.151 0.5 . . . . 73.4 110.222 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.21 -61.35 1.38 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.534 0.568 . . . . 55.33 112.534 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -79.9 -52.49 7.8 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.489 0.552 . . . . 73.4 112.489 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.9 t 70.14 -61.75 0.45 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.624 0.769 . . . . 71.15 112.072 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.9 p -60.0 -32.92 71.31 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.906 0.384 . . . . 74.15 111.01 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -92.18 109.07 20.43 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.004 -0.369 . . . . 55.25 110.004 169.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.527 ' HG ' HE22 ' A' ' 13' ' ' GLN . 3.8 mp -97.11 15.02 23.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.436 0.636 . . . . 62.2 110.385 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.19 137.06 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.532 -0.758 . . . . 74.25 111.795 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 54' ' ' VAL . 30.4 m -119.81 103.25 9.2 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.901 0.382 . . . . 53.34 110.727 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -100.59 99.49 10.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.289 0.566 . . . . 73.23 112.438 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -118.49 -43.28 2.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.062 -0.517 . . . . 74.03 111.264 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.34 -24.65 67.45 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.28 0.844 . . . . 64.21 113.28 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.78 9.57 86.81 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.764 -0.732 . . . . 71.52 113.378 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.88 -14.3 60.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.978 0.418 . . . . 73.3 111.705 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.4 mt -103.09 139.36 38.72 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.41 -0.359 . . . . 74.31 110.969 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.2 t -106.23 159.99 15.69 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.328 -0.233 . . . . 73.14 110.835 175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -45.26 -48.95 12.8 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.556 0.947 . . . . 74.0 113.556 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -63.47 -48.73 76.45 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.79 0.328 . . . . 53.54 111.844 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -60.82 -40.6 93.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.867 0.365 . . . . 61.22 111.524 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.13 -45.26 92.78 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.232 -0.44 . . . . 71.11 110.778 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.0 -49.93 74.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.766 0.317 . . . . 75.22 111.607 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 31' ' ' ALA . 87.8 t -60.12 -40.64 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.218 0.532 . . . . 73.13 111.154 177.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.518 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 49.5 ttm -63.1 -49.89 72.68 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.948 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -59.05 -40.58 85.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.609 0.242 . . . . 55.13 111.211 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.6 -46.49 93.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.108 -0.568 . . . . 52.3 112.91 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' ILE . 79.4 mtm180 -69.14 -43.41 74.41 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.823 0.305 . . . . 74.53 111.823 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 36' ' ' MET . 88.7 mt -61.32 -47.5 85.61 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.195 0.522 . . . . 55.43 111.054 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 41' ' ' ARG . 40.7 ttp180 -62.72 -37.0 84.79 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.926 -0.579 . . . . 72.33 110.896 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.23 98.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.342 -0.39 . . . . 74.12 110.776 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.8 mt -59.82 -45.76 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.817 0.341 . . . . 73.24 110.779 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -58.51 -31.73 68.16 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.954 0.407 . . . . 73.33 111.001 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.9 t -93.79 -13.52 27.25 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.364 0.505 . . . . 31.51 112.364 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.8 m -106.8 -63.59 1.27 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.296 0.57 . . . . 74.1 111.29 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.703 ' ND1' HD21 ' A' ' 150' ' ' LEU . 32.6 m-70 -90.97 -8.3 49.63 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.486 -0.779 . . . . 64.12 111.198 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 67.33 5.93 4.55 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.279 0.631 . . . . 62.41 112.247 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.685 HG22 ' HB2' ' A' ' 84' ' ' ASN . 99.8 t -79.63 130.97 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 122.922 0.489 . . . . 63.45 111.987 -175.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' HB2' HG13 ' A' ' 77' ' ' VAL . 1.8 mp0 -79.81 96.53 6.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.915 0.388 . . . . 73.11 110.297 174.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.408 ' HE2' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -104.78 98.78 8.47 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.424 -0.353 . . . . 73.33 110.492 -176.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.03 120.75 42.25 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.534 0.568 . . . . 74.24 112.534 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.92 137.49 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-O 121.025 0.441 . . . . 71.24 111.359 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.582 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 61.7 t -130.76 140.18 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.603 0.361 . . . . 72.21 111.037 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -128.61 122.46 30.96 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.624 0.249 . . . . 53.11 111.183 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.404 HD21 HG22 ' A' ' 9' ' ' VAL . 65.3 mt -128.23 140.85 39.49 Favored Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 111.622 0.23 . . . . 72.33 111.622 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.15 -55.97 1.91 Allowed 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.516 2.144 . . . . 74.22 112.248 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.3 t -155.62 148.97 24.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.341 -0.39 . . . . 73.32 111.817 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.73 20.47 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.353 0.597 . . . . 74.5 110.196 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.42 39.65 91.46 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.202 -0.523 . . . . 64.1 113.175 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.02 16.03 3.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.151 0.58 . . . . 72.41 112.293 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.01 151.41 80.53 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 122.055 -0.403 . . . . 65.35 111.775 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -56.97 110.15 0.55 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.685 2.256 . . . . 73.01 112.654 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.6 tp -52.19 -46.02 65.41 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.891 0.7 . . . . 75.13 112.891 -176.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HG2' ' HD2' ' A' ' 98' ' ' ARG . 38.3 mt-10 -66.71 -25.32 66.47 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.126 0.417 . . . . 73.52 112.126 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 23.3 t70 -75.39 -45.57 38.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.379 0.609 . . . . 75.22 110.02 173.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -57.65 -47.5 82.06 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.521 -0.763 . . . . 72.0 111.821 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.3 p -55.71 -50.17 71.05 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.78 0.324 . . . . 75.14 111.595 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.708 HD12 HD22 ' A' ' 79' ' ' ASN . 56.2 tp -55.33 -51.18 67.57 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.956 0.408 . . . . 74.43 111.36 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 66' ' ' ASP . 55.6 mtpt -60.24 -47.02 87.76 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.198 0.444 . . . . 75.15 112.198 -178.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.2 tp -66.18 -47.6 73.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.933 0.397 . . . . 62.44 111.732 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.625 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -61.57 -32.81 72.92 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.227 0.454 . . . . 65.42 112.227 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 44.3 mtm180 -59.53 -48.59 81.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.013 0.375 . . . . 72.22 112.013 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.586 ' NE2' ' HB2' ' A' ' 6' ' ' PRO . 11.5 pt20 -70.48 -13.62 62.19 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.818 0.342 . . . . 75.35 111.479 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.526 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 32.3 m0 -96.42 -17.43 20.59 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.854 0.359 . . . . 74.43 110.778 173.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.31 46.64 94.02 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 116.31 -0.405 . . . . 63.51 113.408 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 50' ' ' GLU . 57.7 t -119.31 -86.2 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 112.572 0.582 . . . . 71.41 112.572 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.05 90.95 0.86 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.85 -0.69 . . . . 73.05 113.118 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.708 HD22 HD12 ' A' ' 69' ' ' LEU . 17.6 m120 -148.16 23.1 1.07 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.992 0.396 . . . . 75.31 111.836 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 79' ' ' ASN . 31.8 tt0 70.18 -53.16 0.64 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.423 0.289 . . . . 51.34 111.398 -169.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.498 ' HD2' ' O ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -75.44 69.92 2.26 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.898 0.856 . . . . 71.04 111.221 -178.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 103' ' ' TYR . 56.4 t30 178.72 166.61 0.88 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.333 -1.303 . . . . 73.1 107.567 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -74.96 -122.07 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.733 -0.605 . . . . 44.24 111.489 177.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.685 ' HB2' HG22 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -83.72 70.61 10.37 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.911 -0.493 . . . . 75.1 112.056 -176.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -107.17 144.71 15.94 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.098 -0.501 . . . . 64.01 112.685 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 99' ' ' PHE . 42.6 tp -145.16 124.59 13.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.875 0.369 . . . . 75.22 111.475 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 72' ' ' ALA . 54.8 tp -111.54 138.26 48.31 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.756 0.312 . . . . 64.41 111.038 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.0 tp -128.26 102.52 6.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.708 0.29 . . . . 75.04 110.682 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.11 119.63 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.063 0.394 . . . . 54.1 112.063 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HA ' HG12 ' A' ' 97' ' ' VAL . 41.9 tp -98.96 115.86 29.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.11 0.481 . . . . 61.33 111.109 175.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 94' ' ' GLN . 71.3 t -101.17 104.49 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.27 -0.423 . . . . 73.34 111.007 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.0 tp -55.75 -42.44 75.43 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.892 0.377 . . . . 71.54 111.638 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -50.99 -36.68 40.5 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.244 0.545 . . . . 74.21 111.771 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.439 ' H ' HG12 ' A' ' 91' ' ' VAL . 72.0 mt-30 -105.99 -10.19 16.7 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.108 -0.496 . . . . 74.2 111.933 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 53.4 35.13 19.69 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.675 0.62 . . . . 72.34 112.675 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -142.58 162.93 34.19 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.974 0.416 . . . . 75.34 111.874 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.582 HG21 ' SD ' ' A' ' 122' ' ' MET . 3.7 m -133.43 171.89 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.068 -0.515 . . . . 42.11 111.589 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.574 ' HD2' ' HG2' ' A' ' 65' ' ' GLU . 47.4 ttt85 -148.59 137.67 21.7 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.475 -0.329 . . . . 74.3 111.524 171.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.743 ' HB3' HD11 ' A' ' 86' ' ' LEU . 96.9 m-85 -93.0 108.4 19.98 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.196 -0.456 . . . . 72.22 110.543 172.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.6 tp10 -95.04 122.41 37.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.577 0.227 . . . . 71.5 110.727 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.3 p -100.49 160.8 14.05 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.932 1.086 . . . . 74.31 113.932 -172.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -103.56 -164.24 25.3 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 114.932 -1.031 . . . . 62.04 111.809 167.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 5.3 t80 -76.56 -17.0 59.46 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.128 0.49 . . . . 73.1 111.591 -176.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.09 -23.46 57.17 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.236 -0.507 . . . . 72.45 113.205 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.4 mt -103.34 -4.21 24.51 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.012 0.434 . . . . 71.2 110.95 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -53.55 -35.44 60.75 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.812 -0.631 . . . . 64.1 111.174 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.39 18.05 58.14 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 121.244 -0.503 . . . . 60.2 113.88 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -137.83 -54.63 0.66 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.301 0.55 . . . . 61.3 111.44 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.661 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.5 mt -114.78 86.14 12.65 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.6 -0.727 . . . . 65.53 112.102 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.13 153.83 19.02 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.156 1.904 . . . . 65.42 112.404 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.38 -43.71 5.28 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.865 0.691 . . . . 74.24 112.865 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.91 -50.13 68.56 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.218 -0.515 . . . . 54.22 113.251 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.68 -48.15 83.08 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.969 0.414 . . . . 32.44 111.025 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.661 HD21 ' HB3' ' A' ' 109' ' ' LEU . 76.3 mt -58.31 -39.09 78.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.088 -0.505 . . . . 74.13 111.217 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.9 t -63.21 -37.23 86.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.11 -0.495 . . . . 71.42 111.335 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -70.61 -37.81 73.9 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 122.262 -0.274 . . . . 75.12 111.284 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 62.3 mt -55.15 -43.5 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.474 0.654 . . . . 74.13 110.04 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 122' ' ' MET . 73.7 mt -64.59 -52.9 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.45 -0.795 . . . . 74.14 111.489 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 5.4 t-80 -69.78 -39.35 76.68 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.6 0.593 . . . . 74.43 112.6 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.31 -39.41 22.92 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.753 0.649 . . . . 71.24 112.753 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -103.57 -46.29 4.59 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.602 0.593 . . . . 73.14 112.602 -174.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.582 ' SD ' HG21 ' A' ' 97' ' ' VAL . 50.5 mtt -78.89 -48.01 15.44 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.185 0.809 . . . . 71.14 113.185 -173.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.515 ' CG1' ' HA ' ' A' ' 119' ' ' HIS . 23.0 mm -50.09 -52.23 55.04 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 112.98 0.733 . . . . 42.34 112.98 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 14.0 Cg_endo -55.7 -38.42 94.33 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 121.807 1.671 . . . . 52.14 112.315 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 41.5 m-70 -71.14 -51.4 25.18 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.04 0.385 . . . . 61.34 112.04 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.4 m-30 -55.92 -44.84 78.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.775 0.321 . . . . 61.14 111.297 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -62.57 -37.03 84.59 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.946 0.403 . . . . 72.01 111.16 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -77.3 -5.97 51.43 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.405 -0.361 . . . . 64.23 111.911 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.33 2.58 68.04 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.314 -0.469 . . . . 71.11 113.317 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.618 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 90.6 m-20 -89.35 76.46 7.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.826 0.346 . . . . 73.21 111.841 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -70.75 -46.07 63.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.004 0.431 . . . . 72.22 111.259 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.65 98.18 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.108 -0.496 . . . . 62.31 111.603 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.618 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 18.3 mm-40 -65.58 -42.91 91.2 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.348 -0.387 . . . . 74.44 110.902 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.33 -51.28 60.1 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.317 -0.468 . . . . 64.52 112.923 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.521 HD11 HD22 ' A' ' 90' ' ' LEU . 95.9 mt -60.57 -38.65 85.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.015 0.436 . . . . 74.52 111.102 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.0 t -57.21 -57.98 10.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.987 -0.551 . . . . 53.15 112.345 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -76.11 -19.64 58.35 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 120.638 -0.425 . . . . 74.41 111.582 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.79 -47.23 91.59 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.838 -0.696 . . . . 71.1 111.815 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.2 -46.25 96.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.205 0.526 . . . . 71.32 110.842 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.4 tp -55.34 -38.02 68.22 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.771 -0.649 . . . . 74.54 111.441 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -62.47 -55.47 27.32 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.197 -0.456 . . . . 54.32 111.379 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.408 ' HB ' ' HE2' ' A' ' 51' ' ' PHE . 66.7 t -57.46 -43.37 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.261 -0.427 . . . . 71.44 111.134 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -52.73 -45.36 66.95 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.122 -0.49 . . . . 60.41 111.367 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -69.52 -35.29 75.35 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.061 0.393 . . . . 61.52 112.061 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 141' ' ' ALA . 96.5 t -62.05 -51.59 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.944 0.402 . . . . 74.14 111.01 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.21 -45.14 95.78 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.923 0.392 . . . . 70.13 111.015 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.34 -30.1 66.46 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.008 0.432 . . . . 75.0 111.029 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.21 -27.07 70.74 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.125 -0.489 . . . . 71.42 113.544 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 35.0 t -150.26 77.66 1.31 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.562 0.579 . . . . 74.34 112.562 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.703 HD21 ' ND1' ' A' ' 47' ' ' HIS . 36.7 mt -79.95 80.94 6.3 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.338 0.59 . . . . 75.01 110.097 171.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 58.87 33.09 22.83 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.253 -0.885 . . . . 72.52 110.566 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -70.53 73.13 0.52 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.712 -0.676 . . . . 74.31 111.107 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -117.46 109.16 16.41 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.287 -0.415 . . . . 75.52 110.439 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -81.23 -33.2 33.01 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.978 0.418 . . . . 71.3 110.72 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -96.24 101.71 13.4 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.334 -0.394 . . . . 74.1 110.844 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -69.21 95.47 0.76 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.679 -0.237 . . . . 72.43 111.22 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.505 -0.759 . . . . 74.44 111.935 177.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.866 0.365 . . . . 34.21 111.686 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.425 ' HE ' ' HB3' ' A' ' 2' ' ' ARG . 1.5 ptp180 -91.35 -25.47 19.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.033 0.382 . . . . 73.15 112.033 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.6 t 63.08 114.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 113.609 0.966 . . . . 74.1 113.609 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -107.41 130.02 54.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.952 -0.567 . . . . 73.2 110.973 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 26.1 mtpp -105.24 168.69 8.02 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 116.521 -0.309 . . . . 52.12 110.708 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 59.7 Cg_endo -69.62 58.19 1.47 Allowed 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.675 2.25 . . . . 71.05 112.65 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -176.85 -26.55 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.54 -0.755 . . . . 72.22 109.967 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.83 -35.04 67.19 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.268 0.556 . . . . 73.43 110.297 169.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.609 HG22 HD21 ' A' ' 56' ' ' LEU . 49.0 t -64.17 118.38 45.86 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.667 -0.697 . . . . 64.32 111.566 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HG2' HG23 ' A' ' 22' ' ' THR . 12.2 Cg_endo -56.14 121.9 10.81 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.45 2.1 . . . . 55.43 112.596 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.607 HD22 HD13 ' A' ' 14' ' ' LEU . 13.2 p-10 -72.63 70.64 0.94 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.356 0.598 . . . . 74.34 111.886 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -58.03 -43.58 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.792 -0.64 . . . . 75.05 112.641 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.468 ' NE2' ' HG ' ' A' ' 20' ' ' LEU . 8.2 tp-100 -71.46 -14.09 62.03 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.227 0.454 . . . . 74.1 112.227 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.607 HD13 HD22 ' A' ' 11' ' ' ASN . 10.1 tt -88.29 -29.99 19.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.118 0.485 . . . . 73.51 110.685 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.53 -35.35 13.64 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.131 0.491 . . . . 73.53 111.751 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.459 ' OD2' ' HG2' ' A' ' 19' ' ' ARG . 20.7 t70 -134.15 142.31 47.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.947 0.403 . . . . 62.45 111.244 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.7 p -107.64 -6.82 16.69 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.393 0.516 . . . . 60.42 112.393 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.1 p -75.57 -30.8 59.77 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.109 -0.369 . . . . 71.44 111.678 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.459 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 3.5 ptp85 -119.84 159.7 24.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.847 0.356 . . . . 74.32 111.051 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HG ' ' NE2' ' A' ' 13' ' ' GLN . 4.7 mp -132.72 14.47 4.4 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.71 0.29 . . . . 71.42 111.722 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 53' ' ' VAL . 65.0 t -112.08 128.64 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 112.286 0.476 . . . . 63.31 112.286 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.476 HG23 ' HG2' ' A' ' 10' ' ' PRO . 89.3 m -100.55 109.79 21.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.004 0.431 . . . . 63.14 110.979 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -92.31 93.16 8.49 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.288 0.566 . . . . 73.43 112.352 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 55' ' ' THR . 10.2 mm-40 -106.65 -59.69 1.76 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.945 0.402 . . . . 74.33 110.536 174.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.55 74.6 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.473 -0.33 . . . . 73.51 111.856 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.79 50.14 70.92 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.312 -0.471 . . . . 44.31 112.929 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.611 HD21 HD22 ' A' ' 92' ' ' LEU . 97.7 mt -90.59 12.36 19.1 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.202 0.445 . . . . 52.04 112.202 -176.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mp -124.4 163.47 21.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.283 0.563 . . . . 75.15 111.597 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.7 t -82.97 155.9 23.74 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.764 -0.653 . . . . 70.14 110.914 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -53.05 -40.88 64.29 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.876 0.37 . . . . 75.53 111.896 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -64.81 -46.36 82.3 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.9 0.381 . . . . 75.51 111.25 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -59.47 -41.06 88.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.484 -0.325 . . . . 71.14 111.619 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -55.78 -54.48 43.95 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.316 0.579 . . . . 55.12 110.912 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.27 -48.88 70.71 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.729 -0.669 . . . . 55.01 111.814 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 31' ' ' ALA . 99.0 t -64.4 -42.69 96.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.166 -0.47 . . . . 64.34 112.093 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.573 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.5 ttm -62.38 -51.1 68.95 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.199 -0.313 . . . . 74.44 110.937 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 59.4 m-80 -60.95 -38.38 85.67 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.643 0.259 . . . . 65.14 111.055 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.52 -48.36 86.57 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.045 -0.598 . . . . 75.02 112.9 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 43' ' ' ILE . 86.4 mtm180 -64.42 -46.17 84.36 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.843 0.312 . . . . 71.23 111.843 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 36' ' ' MET . 81.7 mt -56.32 -41.43 76.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.35 0.595 . . . . 75.51 110.867 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -67.63 -39.06 84.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.769 -0.65 . . . . 75.23 111.264 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.81 88.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.121 0.486 . . . . 74.11 110.823 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.434 HG23 ' HB2' ' A' ' 47' ' ' HIS . 70.8 mt -60.35 -41.88 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.1 -0.5 . . . . 61.14 110.681 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.481 ' NE ' ' HG2' ' A' ' 50' ' ' GLU . 12.7 tpt180 -50.85 -33.09 22.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.816 -0.629 . . . . 74.23 111.688 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.1 t -99.49 -60.2 1.58 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.323 -0.399 . . . . 73.21 111.741 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.7 t -59.29 -45.95 89.87 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.525 0.565 . . . . 71.24 112.525 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.434 ' HB2' HG23 ' A' ' 43' ' ' ILE . 91.1 m-70 -104.31 -9.26 18.67 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.776 0.322 . . . . 71.42 111.41 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.74 -5.68 1.4 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.216 0.821 . . . . 50.03 113.216 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.98 123.41 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.04 0.447 . . . . 72.41 111.994 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HG2' ' NE ' ' A' ' 44' ' ' ARG . 38.1 mt-10 -75.97 96.24 3.73 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.84 -0.43 . . . . 70.41 109.84 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.65 107.75 18.91 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.268 -0.424 . . . . 65.43 110.902 -173.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.14 147.16 37.93 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.042 0.386 . . . . 71.11 112.042 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 21' ' ' VAL . 58.5 t -128.57 135.81 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 120.919 0.39 . . . . 62.34 111.264 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 71' ' ' LEU . 60.5 t -128.56 134.47 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.713 0.292 . . . . 72.22 111.25 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 80.6 p -119.11 122.6 42.45 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.723 0.297 . . . . 50.21 111.385 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.609 HD21 HG22 ' A' ' 9' ' ' VAL . 89.7 mt -125.98 140.05 35.85 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-O 120.732 0.301 . . . . 71.41 111.57 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 52.6 Cg_endo -69.3 -35.19 14.5 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.116 1.877 . . . . 75.14 112.432 176.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 73.3 p -161.37 144.87 12.77 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.351 0.5 . . . . 75.42 112.351 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.458 HD13 HG21 ' A' ' 91' ' ' VAL . 32.3 pt -123.89 -11.4 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 121.002 0.43 . . . . 72.03 111.597 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.76 -113.47 5.76 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 114.386 0.514 . . . . 74.31 114.386 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -89.97 11.52 20.26 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.044 0.45 . . . . 62.34 112.044 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -85.2 118.87 71.71 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.924 -0.485 . . . . 63.41 111.88 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 29.1 Cg_endo -63.19 126.75 18.52 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.58 2.187 . . . . 71.34 112.346 176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.3 -45.5 80.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.943 0.72 . . . . 70.3 112.943 -171.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 1.2 pm0 -70.16 -36.04 74.43 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.35 0.5 . . . . 73.52 112.35 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.68 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 10.2 m-20 -71.99 -35.89 69.6 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.993 -0.442 . . . . 75.33 110.976 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 58.2 t80 -59.21 -56.58 20.26 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.812 0.339 . . . . 54.12 111.181 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 47.1 p -52.76 -44.56 66.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.116 -0.493 . . . . 62.35 111.651 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.65 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 58.7 tp -61.7 -57.06 13.42 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.336 -0.393 . . . . 51.41 111.634 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -61.38 -34.92 76.13 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.145 0.424 . . . . 65.41 112.145 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 54' ' ' VAL . 58.7 tp -69.79 -48.41 59.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.185 0.517 . . . . 72.2 111.097 177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB1' ' HA3' ' A' ' 78' ' ' GLY . . . -65.34 -31.73 73.0 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.074 0.398 . . . . 54.52 112.074 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.735 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 24.2 mtp180 -62.42 -50.05 73.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.026 0.38 . . . . 75.43 112.026 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.639 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 12.3 pt20 -67.88 -32.92 73.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.936 0.398 . . . . 72.22 111.088 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.639 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 27.7 m0 -71.45 -15.89 62.35 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.526 -0.307 . . . . 74.31 111.68 175.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.58 -39.15 3.07 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.277 -0.487 . . . . 72.21 112.746 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 19.4 t -52.26 -23.84 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 122.88 0.472 . . . . 53.53 112.158 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.494 ' HA3' ' HB1' ' A' ' 72' ' ' ALA . . . -137.1 40.61 1.49 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.118 -0.563 . . . . 70.31 112.578 176.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 46.6 t-20 -61.03 85.96 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.788 0.328 . . . . 54.12 110.577 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.735 ' H ' ' HG2' ' A' ' 73' ' ' ARG . 7.9 tp10 43.2 69.98 0.35 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.626 0.727 . . . . 73.2 110.774 -172.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.633 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER 63.11 82.5 0.18 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.168 -0.924 . . . . 63.34 112.286 -176.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.491 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 24.4 t30 -81.11 160.32 24.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.951 -1.022 . . . . 71.24 111.165 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.14 123.86 23.78 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.672 -0.643 . . . . 74.52 111.527 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.916 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 3.6 p-10 46.22 41.27 8.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.198 0.999 . . . . 74.25 112.753 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.11 145.31 16.58 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.86 -0.609 . . . . 41.12 111.861 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 99' ' ' PHE . 55.9 tp -144.87 131.0 19.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.953 0.377 . . . . 70.1 111.218 -177.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 72' ' ' ALA . 55.4 tp -119.29 123.62 44.68 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.838 0.352 . . . . 75.12 111.478 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 56.5 tp -111.26 110.03 20.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.892 0.377 . . . . 61.35 110.972 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 54' ' ' VAL . 93.1 t -110.52 129.15 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 122.181 -0.324 . . . . 72.22 111.811 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.567 ' HB2' HD21 ' A' ' 135' ' ' LEU . 43.5 tp -107.25 119.41 39.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.979 0.419 . . . . 72.54 111.037 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.458 HG21 HD13 ' A' ' 59' ' ' ILE . 94.0 t -102.93 100.82 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.307 -0.406 . . . . 75.4 111.207 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.611 HD22 HD21 ' A' ' 27' ' ' LEU . 62.4 tp -59.19 -39.14 81.63 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.171 0.434 . . . . 70.45 112.171 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 14.9 t70 -47.53 -47.15 28.09 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.154 0.582 . . . . 50.34 112.189 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -108.46 8.79 27.56 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.126 -0.488 . . . . 53.41 111.103 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 32.77 58.01 0.43 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.552 1.141 . . . . 71.42 113.782 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -150.16 160.97 43.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.477 -0.783 . . . . 74.43 111.129 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.504 HG21 ' SD ' ' A' ' 122' ' ' MET . 4.3 m -126.21 171.8 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.057 0.456 . . . . 45.13 112.029 -174.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 98' ' ' ARG . 28.7 ttt85 -150.15 135.46 18.05 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.246 -0.434 . . . . 70.44 111.826 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.463 ' HB3' HD11 ' A' ' 86' ' ' LEU . 95.9 m-85 -94.01 115.04 27.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.144 -0.48 . . . . 74.11 110.154 171.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -101.1 112.66 25.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.844 0.354 . . . . 71.12 110.87 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.519 HG23 HD11 ' A' ' 114' ' ' LEU . 2.9 p -88.59 148.37 24.11 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.678 0.751 . . . . 72.05 112.921 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 81' ' ' LYS . . . -90.46 -170.23 43.44 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.225 -0.898 . . . . 74.33 112.199 168.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -24.6 65.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.055 0.455 . . . . 71.34 111.637 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.916 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -75.18 -30.47 58.84 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.003 -0.617 . . . . 61.4 113.432 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.13 -0.91 57.84 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.979 0.733 . . . . 74.35 112.979 -171.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -53.33 -32.06 47.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.906 0.335 . . . . 74.23 111.906 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.65 4.45 69.13 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.42 -0.419 . . . . 54.15 113.827 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -125.02 -60.11 1.37 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.381 0.61 . . . . 75.42 111.444 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.07 87.14 27.81 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.697 -0.683 . . . . 63.33 111.086 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.73 167.93 16.33 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.54 2.16 . . . . 75.21 113.558 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.08 -48.8 33.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.585 0.587 . . . . 70.42 112.585 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.37 -46.62 91.64 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.264 -0.493 . . . . 72.11 113.43 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.15 -48.94 77.86 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.891 0.377 . . . . 71.52 111.584 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.519 HD11 HG23 ' A' ' 101' ' ' THR . 86.8 mt -59.34 -43.03 92.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.277 -0.42 . . . . 62.34 111.275 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.4 t -63.41 -37.54 87.67 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.087 -0.506 . . . . 43.03 111.108 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -60.12 -55.34 35.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.394 -0.366 . . . . 73.45 111.219 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.9 mt -49.19 -46.21 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.044 0.449 . . . . 74.24 111.666 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.412 ' O ' HG12 ' A' ' 123' ' ' ILE . 58.2 mt -60.14 -54.91 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.135 0.493 . . . . 72.43 111.415 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -83.72 -9.17 59.02 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.176 0.806 . . . . 53.12 113.176 -173.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -101.12 -40.78 7.03 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.223 0.453 . . . . 73.43 112.223 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.07 -31.08 2.15 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.516 0.932 . . . . 74.25 113.516 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.504 ' SD ' HG21 ' A' ' 97' ' ' VAL . 36.0 mtt -69.04 -40.54 78.52 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.904 0.705 . . . . 73.42 112.904 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.477 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 46.7 mm -48.12 -57.04 11.4 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 112.894 0.702 . . . . 72.22 112.894 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.08 -37.64 86.95 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.053 1.835 . . . . 62.13 112.967 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -63.48 -53.09 57.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.802 0.334 . . . . 74.44 111.043 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.1 m-85 -59.63 -32.88 70.84 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.546 -0.297 . . . . 74.04 111.456 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 60.4 mtp85 -66.67 -43.32 84.84 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.241 0.544 . . . . 74.42 111.03 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.0 t -75.56 -0.82 21.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.858 -0.61 . . . . 44.05 112.112 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.15 3.93 90.03 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.182 -0.533 . . . . 73.13 112.48 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.769 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.2 m-20 -84.31 55.07 3.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.831 0.452 . . . . 64.34 111.349 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -56.22 -41.28 75.4 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.172 0.511 . . . . 71.31 110.91 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.81 -50.54 73.4 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.725 -0.67 . . . . 73.41 111.809 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.769 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 39.9 mm-40 -61.13 -40.02 92.22 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.342 -0.39 . . . . 73.12 111.739 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.49 -53.28 42.26 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.077 -0.582 . . . . 72.15 112.556 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 90' ' ' LEU . 83.4 mt -61.15 -43.21 99.24 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.054 0.454 . . . . 75.34 111.187 175.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.8 t -60.37 -52.5 64.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.645 0.609 . . . . 42.53 112.645 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -27.25 59.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.601 0.239 . . . . 73.14 111.045 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.35 91.36 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.025 -0.607 . . . . 51.5 112.168 171.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 135' ' ' LEU . 56.7 t -56.59 -48.13 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.146 0.498 . . . . 71.24 110.806 172.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 50.8 tp -58.45 -40.59 83.05 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.767 -0.651 . . . . 60.11 111.157 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -58.64 -52.3 66.28 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.022 0.439 . . . . 74.35 111.031 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 81.1 t -57.26 -48.35 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.153 -0.476 . . . . 64.13 111.132 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -53.71 -43.19 68.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.916 -0.583 . . . . 74.05 111.53 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 96.5 mt-30 -68.4 -33.4 74.17 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 111.993 0.368 . . . . 64.53 111.993 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 141' ' ' ALA . 91.0 t -63.99 -55.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.068 0.461 . . . . 74.33 110.729 175.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 78.0 mt -53.23 -45.04 68.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.919 -0.582 . . . . 64.53 111.533 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -55.65 -37.11 67.82 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.194 -0.457 . . . . 75.22 111.9 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -89.37 -21.21 41.96 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.853 -0.689 . . . . 72.24 113.102 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.2 t -82.58 -24.65 33.84 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.322 0.49 . . . . 74.45 112.322 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 87.8 mt -68.05 78.53 0.23 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.867 0.365 . . . . 74.41 111.524 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 73.04 -31.2 0.22 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.201 0.815 . . . . 74.53 113.201 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -51.35 -26.88 8.38 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.295 0.85 . . . . 75.53 113.295 -170.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -69.02 -32.76 72.51 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.988 -0.445 . . . . 64.02 111.14 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -94.37 89.54 5.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.185 0.517 . . . . 60.12 110.271 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -72.78 121.14 19.4 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.965 -0.561 . . . . 65.12 112.472 -172.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -82.89 92.45 7.3 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.47 -0.332 . . . . 64.31 111.659 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.0 p80 . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 114.418 1.266 . . . . 72.54 114.418 178.319 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 tpt . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.627 0.251 . . . . 54.12 111.369 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -125.11 121.01 33.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.89 0.376 . . . . 73.54 111.497 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.92 139.08 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.661 -0.245 . . . . 71.41 110.707 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.419 ' CG ' HD22 ' A' ' 56' ' ' LEU . 44.8 m-85 -112.29 159.6 18.48 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.862 0.839 . . . . 65.22 113.242 -176.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.538 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 30.1 mmmt -126.02 158.79 64.83 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 114.867 -1.061 . . . . 73.23 109.935 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HB2' HE22 ' A' ' 74' ' ' GLN . 9.6 Cg_endo -51.8 -52.27 9.35 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.283 1.988 . . . . 51.25 113.219 -177.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.44 2.52 32.26 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.074 -0.391 . . . . 72.13 111.729 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.538 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 21.4 t70 -93.89 -13.32 27.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.279 0.561 . . . . 63.15 110.29 175.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 5' ' ' LYS . 69.4 t -82.7 133.56 49.02 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.908 -0.587 . . . . 53.32 110.871 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -52.99 111.09 0.57 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.298 1.999 . . . . 33.1 112.417 177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.474 ' HA ' ' CE2' ' A' ' 75' ' ' TRP . 10.9 p-10 -68.7 78.92 0.29 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.623 0.725 . . . . 74.43 112.351 -177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' SER . 29.2 m -78.26 10.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.988 0.736 . . . . 72.01 112.988 -177.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 15.7 mm100 -121.22 18.35 11.53 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.559 0.695 . . . . 70.24 110.518 171.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.4 HD13 HD22 ' A' ' 11' ' ' ASN . 7.0 tt -134.64 -45.27 0.74 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.455 -0.793 . . . . 63.05 109.181 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.37 -75.12 0.59 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.991 -0.549 . . . . 72.32 111.199 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.2 55.39 2.83 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.27 0.47 . . . . 55.12 112.27 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 58.2 m -67.46 -9.45 42.11 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.252 0.464 . . . . 74.24 112.252 -178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -86.78 -9.65 55.36 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.297 0.57 . . . . 72.51 111.496 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.421 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 8.6 tpt180 -94.18 -62.25 1.37 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.986 -0.552 . . . . 65.23 111.041 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.563 HD22 ' HB3' ' A' ' 40' ' ' LEU . 5.5 mp 74.68 -14.83 0.69 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.965 0.906 . . . . 70.51 111.884 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.421 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 44.6 t -111.82 146.93 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 122.669 0.387 . . . . 65.52 111.252 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 m -150.54 102.66 3.05 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.045 -0.409 . . . . 75.34 112.02 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.411 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 32.5 t70 -93.81 108.19 19.99 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.895 0.378 . . . . 74.4 111.46 176.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.534 ' HB2' HD23 ' A' ' 56' ' ' LEU . 6.6 mm-40 -113.37 -30.55 6.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.917 0.389 . . . . 71.44 110.922 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.56 -23.12 66.83 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.491 0.552 . . . . 64.42 112.491 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.42 45.46 6.92 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.084 -0.579 . . . . 60.22 112.731 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.54 HD11 HD13 ' A' ' 92' ' ' LEU . 83.5 mt -119.19 -32.75 4.32 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.106 0.41 . . . . 62.15 112.106 -175.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.1 132.69 36.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.178 0.514 . . . . 74.12 111.574 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.9 t -86.91 172.27 10.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.249 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -56.81 -40.68 76.42 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 111.906 0.336 . . . . 70.34 111.906 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -64.13 -47.33 80.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.711 0.291 . . . . 72.32 111.254 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -56.02 -41.21 74.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.703 0.287 . . . . 74.34 111.169 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -59.98 -55.92 28.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.131 0.491 . . . . 75.5 111.489 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 8.0 tp10 -69.33 -43.04 74.49 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.472 0.545 . . . . 71.35 112.472 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 31' ' ' ALA . 90.4 t -59.64 -39.84 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.088 0.471 . . . . 74.11 110.861 176.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.522 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.2 ttm -68.39 -43.09 78.04 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.387 -0.37 . . . . 70.42 110.789 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 34' ' ' GLU . 88.4 m-20 -51.07 -55.97 14.93 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.9 0.381 . . . . 70.1 111.486 177.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.47 -37.82 76.83 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.181 -0.533 . . . . 54.34 113.384 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -62.84 -53.59 51.81 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.174 0.512 . . . . 73.33 110.811 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.563 ' HB3' HD22 ' A' ' 20' ' ' LEU . 57.1 mt -61.72 -31.23 71.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.964 -0.562 . . . . 75.15 111.318 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.4 mtm-85 -74.5 -39.33 62.5 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.405 -0.362 . . . . 71.45 111.586 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.28 89.85 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.896 0.379 . . . . 64.52 111.563 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.04 -42.07 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.004 0.43 . . . . 70.31 111.704 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 20.6 ttp180 -74.22 -25.28 59.58 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.036 0.384 . . . . 73.34 112.036 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.5 t -66.67 -28.35 68.39 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.655 0.741 . . . . 74.23 109.641 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.6 p -104.64 -70.57 0.77 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.056 -0.974 . . . . 74.34 112.027 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.475 ' HE1' ' HB2' ' A' ' 150' ' ' LEU . 75.5 m-70 -76.86 -9.86 58.97 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.436 0.532 . . . . 61.31 112.436 -174.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . . . 65.25 13.41 8.75 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.233 0.457 . . . . 53.53 112.233 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.536 ' HA ' ' HB2' ' A' ' 84' ' ' ASN . 85.9 t -79.01 129.89 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 112.445 0.535 . . . . 74.52 112.445 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.96 97.33 9.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.612 0.72 . . . . 74.22 110.477 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.483 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.1 t80 -103.49 105.62 15.91 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.295 -0.866 . . . . 73.42 110.507 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.55 140.6 37.31 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.406 0.521 . . . . 73.25 112.406 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -126.07 122.9 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 122.722 0.409 . . . . 63.13 111.273 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -128.57 138.88 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.853 0.358 . . . . 75.41 111.804 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 17.9 p -117.08 126.05 52.24 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.887 0.375 . . . . 73.04 110.902 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 24' ' ' GLU . 33.7 mt -131.45 146.59 62.6 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.634 -0.257 . . . . 63.14 110.686 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.629 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 37.6 Cg_exo -57.87 -68.68 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.119 1.88 . . . . 72.04 111.682 174.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.42 ' HA ' HG13 ' A' ' 91' ' ' VAL . 60.3 p -142.3 157.83 44.39 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.186 0.517 . . . . 61.14 110.94 175.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.3 pt -110.15 23.66 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.009 -0.541 . . . . 54.3 111.11 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.64 -144.18 30.01 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.094 -0.503 . . . . 45.55 112.244 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -96.29 9.69 40.32 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.296 0.569 . . . . 63.12 111.01 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.3 141.78 86.29 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 112.01 0.374 . . . . 72.34 112.01 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 43.6 Cg_endo -67.91 145.17 67.32 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.561 2.174 . . . . 64.1 112.801 177.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.3 tp -61.68 -46.77 88.27 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.443 0.535 . . . . 75.42 112.443 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.33 -53.09 62.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.221 0.452 . . . . 65.43 112.221 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.581 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 5.3 m-20 -60.06 -33.77 72.51 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.682 0.253 . . . . 70.14 111.682 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -64.45 -55.15 22.75 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.674 0.273 . . . . 73.32 111.274 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.5 p -58.78 -39.76 81.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.8 0.333 . . . . 44.41 111.259 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.474 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 57.2 tp -59.88 -55.04 39.11 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.292 -0.413 . . . . 63.24 111.145 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -60.27 -32.5 71.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.17 0.433 . . . . 74.35 112.17 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.638 HD23 HD21 ' A' ' 87' ' ' LEU . 34.9 tp -73.03 -48.43 36.23 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.987 0.422 . . . . 61.13 111.249 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.417 ' HB1' ' HA3' ' A' ' 78' ' ' GLY . . . -63.28 -37.2 86.33 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.846 0.313 . . . . 72.31 111.846 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 67.8 mtp180 -61.44 -54.2 46.55 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.926 0.343 . . . . 65.3 111.926 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.463 HE22 ' HB2' ' A' ' 6' ' ' PRO . 11.9 pt20 -64.4 -27.28 68.9 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.861 0.362 . . . . 74.42 111.51 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 40.9 m0 -80.24 -2.27 44.27 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.889 0.329 . . . . 74.24 111.889 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.27 -46.39 3.4 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.26 -0.495 . . . . 51.03 113.473 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 17.8 m -49.6 -28.98 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.811 0.671 . . . . 61.51 112.811 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 72' ' ' ALA . . . -129.37 40.56 1.67 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.102 -0.571 . . . . 75.31 112.621 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -42.31 -47.91 4.92 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.156 0.503 . . . . 74.23 111.349 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -174.39 90.04 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.338 -0.847 . . . . 73.12 109.416 167.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.6 OUTLIER 56.68 52.66 9.33 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.509 0.671 . . . . 75.42 111.112 -173.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 67.3 t30 -74.37 169.56 17.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.61 -0.723 . . . . 63.34 111.607 -177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -70.9 138.9 50.53 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.846 -0.534 . . . . 71.33 112.083 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.81 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 36.3 p30 40.53 27.25 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.208 1.559 . . . . 72.4 115.208 174.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.88 123.83 7.61 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.785 -0.721 . . . . 73.32 111.882 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.6 tp -134.4 121.92 21.83 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.023 0.412 . . . . 65.34 111.307 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.638 HD21 HD23 ' A' ' 71' ' ' LEU . 57.4 tp -113.14 137.48 51.38 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.822 0.344 . . . . 75.14 111.754 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.3 tp -127.15 105.16 8.38 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.534 0.334 . . . . 74.24 110.876 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.84 129.69 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 111.9 0.333 . . . . 62.24 111.9 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HA ' HG12 ' A' ' 97' ' ' VAL . 27.6 tp -107.91 128.94 55.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.251 -0.431 . . . . 75.41 111.069 175.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.549 HG11 ' NE2' ' A' ' 94' ' ' GLN . 59.9 t -105.94 109.14 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.59 -0.277 . . . . 72.51 110.536 174.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.629 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 62.5 tp -55.94 -55.81 28.25 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.627 0.603 . . . . 73.13 112.627 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.61 -24.63 61.42 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.573 0.583 . . . . 73.35 112.573 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.549 ' NE2' HG11 ' A' ' 91' ' ' VAL . 40.3 mt-30 -103.45 -7.05 21.24 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.578 -0.283 . . . . 62.3 111.547 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 33.27 49.84 0.23 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.241 1.016 . . . . 75.4 113.254 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.4 ' HG2' ' HB3' ' A' ' 94' ' ' GLN . 30.9 ptt180 -141.87 155.11 45.54 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.573 -0.74 . . . . 64.42 110.317 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 90' ' ' LEU . 5.8 m -128.49 171.74 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.84 0.353 . . . . 72.11 111.429 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.5 ttt85 -149.15 133.16 17.16 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.404 -0.362 . . . . 74.42 111.809 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 97.1 m-85 -95.03 112.51 24.2 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.01 -0.541 . . . . 74.12 110.401 172.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 15.6 tp10 -94.31 111.94 23.7 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.581 0.229 . . . . 74.22 110.428 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 p -98.15 145.51 26.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.033 0.753 . . . . 64.31 113.033 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -97.06 -173.99 34.53 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.298 -0.864 . . . . 42.52 112.142 167.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -63.71 -27.86 69.5 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.147 0.499 . . . . 62.52 112.054 -175.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.81 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -73.45 -9.0 77.2 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 120.935 -0.65 . . . . 40.53 113.692 -172.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.1 mt -129.24 4.87 5.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.636 0.606 . . . . 73.31 112.636 -175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.72 -41.59 97.83 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.913 0.387 . . . . 64.34 111.116 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.94 -23.38 69.37 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.325 -0.464 . . . . 62.23 113.22 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -92.41 -66.87 0.89 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.676 0.274 . . . . 75.33 111.655 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.604 ' HA ' HD23 ' A' ' 113' ' ' LEU . 3.0 mp -117.16 94.95 46.23 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.829 0.307 . . . . 73.05 111.829 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.42 174.68 11.6 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.659 2.239 . . . . 72.02 112.607 174.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -50.86 -44.32 59.56 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.318 0.488 . . . . 74.33 112.318 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -59.65 -50.2 70.35 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.197 -0.525 . . . . 73.23 113.546 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 109' ' ' LEU . 36.0 tp -60.76 -49.13 78.71 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.828 0.347 . . . . 64.54 111.404 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 118' ' ' ILE . 92.8 mt -56.34 -48.61 76.43 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.214 -0.448 . . . . 73.43 111.231 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.3 m -61.56 -36.41 80.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.191 -0.459 . . . . 64.34 111.367 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.409 ' NH2' HD13 ' A' ' 113' ' ' LEU . 44.3 ttp180 -65.45 -50.14 66.49 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.548 -0.296 . . . . 75.51 110.973 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.6 mt -51.81 -47.37 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.23 0.538 . . . . 64.13 110.617 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 114' ' ' LEU . 84.0 mt -59.03 -57.11 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.749 -0.659 . . . . 64.22 112.383 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -84.21 -22.46 30.87 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.364 0.875 . . . . 74.23 113.364 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.19 -38.15 17.95 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.034 0.445 . . . . 63.34 111.787 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 121' ' ' ARG . 12.4 mtp180 -113.25 -59.19 2.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.253 -0.43 . . . . 74.41 112.153 -176.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.9 mtp -62.51 -48.4 79.74 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.241 0.83 . . . . 74.45 113.241 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 27.1 mm -57.76 -50.79 86.17 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.421 0.526 . . . . 65.41 112.421 -177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 85.0 Cg_exo -47.15 -34.8 18.33 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.348 2.032 . . . . 75.14 112.998 174.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -72.97 -49.25 30.25 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.629 0.252 . . . . 72.13 111.182 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.433 ' HD2' HD13 ' A' ' 123' ' ' ILE . 23.7 m-85 -57.4 -45.02 85.0 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.016 0.376 . . . . 73.44 112.016 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -62.3 -23.94 67.01 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.22 0.533 . . . . 64.21 111.1 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.0 m -92.77 7.43 43.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.062 -0.517 . . . . 45.02 111.559 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.75 -0.43 82.06 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.364 -0.446 . . . . 73.41 113.493 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.792 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.87 70.72 10.68 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 122.519 -0.4 . . . . 71.43 111.545 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -70.57 -42.33 71.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.016 0.436 . . . . 72.51 110.557 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.3 90.89 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.998 -0.546 . . . . 71.33 111.213 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.792 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 18.6 mp0 -59.69 -53.27 59.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.367 -0.379 . . . . 75.14 111.088 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.57 -49.87 59.4 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.359 -0.448 . . . . 70.03 113.647 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 139' ' ' VAL . 96.4 mt -65.67 -46.9 77.37 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.572 -0.369 . . . . 72.32 111.818 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 92.7 p -61.67 -50.53 72.13 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.716 0.293 . . . . 73.55 111.684 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -27.16 60.15 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.7 -0.227 . . . . 72.53 111.285 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.13 -47.62 79.44 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.12 -0.562 . . . . 65.31 112.402 173.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 135' ' ' LEU . 75.3 t -58.27 -44.13 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.253 0.549 . . . . 71.11 110.562 173.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.512 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 41.0 tp -63.96 -35.91 82.22 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.884 -0.598 . . . . 74.02 110.83 177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.63 -43.5 97.44 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.94 0.4 . . . . 62.44 111.282 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.87 -47.54 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.171 0.51 . . . . 64.12 110.671 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -56.16 -36.73 68.63 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.02 -0.536 . . . . 64.13 111.673 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 18.7 mm-40 -57.3 -29.84 64.24 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 120.82 0.343 . . . . 72.32 111.809 176.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.53 -49.68 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 120.851 0.358 . . . . 73.05 111.139 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -71.76 -58.3 3.59 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.071 0.397 . . . . 61.24 112.071 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -71.56 -14.3 62.05 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.871 0.323 . . . . 75.42 111.871 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -75.16 -16.24 80.7 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.085 -0.578 . . . . 63.4 112.511 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.1 t -102.6 -68.97 0.81 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.13 0.49 . . . . 74.42 110.39 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.475 ' HB2' ' HE1' ' A' ' 47' ' ' HIS . 80.7 mt -92.48 80.35 4.88 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.216 0.532 . . . . 73.23 110.803 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -70.37 -32.77 70.59 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.008 -0.542 . . . . 71.25 110.889 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -74.96 89.11 2.38 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.87 -0.605 . . . . 73.24 110.088 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -59.54 -23.94 63.27 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.87 1.063 . . . . 72.12 113.87 -172.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -66.9 87.2 0.14 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.262 0.554 . . . . 74.14 110.363 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.465 ' H ' ' CD2' ' A' ' 155' ' ' HIS . 6.4 p80 -78.98 154.92 29.16 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.465 0.913 . . . . 74.03 113.465 -171.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -76.14 139.87 41.49 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.245 -0.888 . . . . 74.14 111.895 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 119.139 -0.457 . . . . 74.12 111.296 174.258 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.565 0.222 . . . . 74.11 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -161.14 123.27 3.05 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.718 0.294 . . . . 64.12 110.991 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.8 t -78.27 111.32 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.023 0.44 . . . . 61.44 112.167 -175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.13 126.61 50.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.128 -0.487 . . . . 73.04 111.137 173.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.479 ' O ' HG23 ' A' ' 9' ' ' VAL . 67.6 mttm -89.04 151.46 46.96 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.446 -0.343 . . . . 45.01 110.983 176.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.479 ' HD3' ' CE2' ' A' ' 67' ' ' PHE . 39.7 Cg_endo -64.88 -19.63 64.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.872 1.714 . . . . 65.24 111.663 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' HA ' HE22 ' A' ' 74' ' ' GLN . 18.5 mt-10 -88.83 -7.69 55.72 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.391 -0.822 . . . . 75.51 111.165 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -112.52 2.04 16.12 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.908 -0.587 . . . . 62.14 111.876 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 5' ' ' LYS . 61.8 t -81.28 130.92 60.51 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.512 -0.313 . . . . 41.05 110.447 174.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.01 116.89 1.89 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.877 2.385 . . . . 62.3 113.314 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -68.29 70.29 0.16 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.005 0.431 . . . . 74.44 112.035 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -60.56 -25.42 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.7 0.63 . . . . 74.51 112.7 -175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -73.98 -25.09 59.74 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.901 0.381 . . . . 75.31 111.219 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tt -93.84 -32.61 13.87 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.076 -0.511 . . . . 62.01 111.038 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.88 -47.3 10.46 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.202 0.445 . . . . 54.03 112.202 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -106.4 -65.62 1.07 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.592 0.59 . . . . 73.44 112.592 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.8 p 61.65 0.72 0.51 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.985 0.914 . . . . 74.22 112.139 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -110.5 -36.68 5.69 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.678 0.391 . . . . 70.44 111.641 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -87.11 -49.3 7.4 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.862 0.363 . . . . 64.44 111.629 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp 65.45 13.92 9.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.26 0.624 . . . . 74.23 112.155 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.8 t -102.41 128.72 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.0 0.428 . . . . 73.51 111.651 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 m -129.74 112.4 13.59 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.274 -0.421 . . . . 65.42 110.931 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -124.04 102.23 7.64 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.007 0.432 . . . . 65.22 111.894 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.53 ' HB2' HD23 ' A' ' 56' ' ' LEU . 4.7 mp0 -102.93 -38.7 7.25 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.292 -0.413 . . . . 74.24 110.98 173.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.1 -20.92 66.3 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.074 0.768 . . . . 43.11 113.074 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.6 38.78 27.23 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.916 -0.659 . . . . 62.13 112.693 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.1 mt -100.81 -28.42 12.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.719 0.295 . . . . 73.3 111.393 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.2 mt -99.05 107.53 19.96 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.737 0.303 . . . . 75.11 111.321 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.1 t -74.57 160.53 30.76 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.353 -0.217 . . . . 72.22 110.903 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -46.47 -36.29 6.49 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.729 0.64 . . . . 74.5 112.729 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.49 -52.02 63.1 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.948 0.404 . . . . 40.33 111.333 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.503 ' HG3' ' HB1' ' A' ' 132' ' ' ALA . 14.6 mm100 -62.07 -40.7 96.7 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.928 0.394 . . . . 63.32 110.741 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.27 -44.74 88.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.211 -0.45 . . . . 72.33 110.865 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -57.93 -52.26 66.24 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.132 0.491 . . . . 75.24 111.126 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.69 -45.9 96.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.212 -0.449 . . . . 64.02 111.622 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 43.9 ttm -62.78 -44.38 96.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.503 -0.317 . . . . 75.03 111.375 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -53.55 -47.83 69.66 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.169 0.509 . . . . 72.45 110.656 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.85 -36.11 92.29 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.059 -0.591 . . . . 34.41 113.086 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.57 ' O ' HG13 ' A' ' 43' ' ' ILE . 6.2 mmp_? -67.3 -56.27 10.48 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.816 0.341 . . . . 74.24 111.12 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.62 -47.25 84.57 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.175 -0.466 . . . . 63.23 111.746 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -58.54 -45.99 87.77 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.207 -0.451 . . . . 74.53 111.19 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.76 80.81 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.908 0.385 . . . . 65.41 111.386 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 39' ' ' ARG . 76.4 mt -65.64 -48.64 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.878 0.37 . . . . 35.12 111.424 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 48.5 ttt180 -66.83 -28.16 68.13 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.11 -0.369 . . . . 73.35 111.625 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 t -76.67 -49.73 15.43 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.804 0.335 . . . . 74.23 111.632 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.2 t -82.83 -54.18 5.3 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.323 0.49 . . . . 65.31 112.323 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.613 ' ND1' HD21 ' A' ' 150' ' ' LEU . 15.0 m-70 -87.56 -22.3 24.89 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.115 -0.493 . . . . 74.25 111.505 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 71.43 17.68 5.7 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.235 0.614 . . . . 73.32 111.443 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.802 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 84.2 t -87.48 119.25 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.106 -0.497 . . . . 72.3 111.284 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -80.96 96.69 7.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.244 0.545 . . . . 74.04 110.283 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -110.49 109.65 20.09 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.631 -0.713 . . . . 74.35 110.645 -174.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.33 142.16 42.36 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.444 0.535 . . . . 60.34 112.444 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.22 132.82 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.321 -0.4 . . . . 70.12 111.214 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 71' ' ' LEU . 41.8 t -130.92 138.79 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 122.463 0.305 . . . . 72.13 111.534 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 p -124.49 122.85 38.77 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.093 0.473 . . . . 73.54 111.573 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HB2' ' A' ' 24' ' ' GLU . 42.8 mt -131.85 145.36 57.14 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 116.516 -0.311 . . . . 62.13 110.92 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 28.2 Cg_endo -63.59 -68.63 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.13 1.887 . . . . 64.43 112.684 177.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 m -131.0 156.04 45.8 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.207 -0.308 . . . . 71.12 110.785 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.553 HD11 HE22 ' A' ' 94' ' ' GLN . 27.8 pt -122.21 2.08 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 121.14 0.495 . . . . 73.25 111.886 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.95 -122.7 10.2 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.211 -0.519 . . . . 72.02 113.178 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -103.49 4.95 36.54 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.978 0.362 . . . . 54.01 111.978 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.08 118.49 70.94 Favored Pre-proline 0 CA--C 1.538 0.497 0 O-C-N 122.402 -0.186 . . . . 71.21 110.685 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.495 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 32.0 Cg_endo -63.94 131.37 30.62 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.145 1.897 . . . . 63.01 112.354 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.5 tp -48.01 -40.4 22.6 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.41 0.522 . . . . 61.33 112.41 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.45 -45.37 91.2 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.215 0.45 . . . . 62.13 112.215 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.495 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 22.9 t70 -71.66 -34.57 69.83 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.464 0.649 . . . . 73.01 110.228 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.479 ' CE2' ' HD3' ' A' ' 6' ' ' PRO . 21.6 t80 -58.77 -52.37 65.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.521 -0.763 . . . . 74.31 110.914 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.5 p -61.74 -40.42 95.05 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.266 -0.425 . . . . 70.31 111.19 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.9 tp -57.48 -52.74 64.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.28 -0.418 . . . . 63.04 111.278 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 56.4 mtpt -60.35 -49.28 78.2 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.942 0.401 . . . . 74.44 111.764 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 54' ' ' VAL . 34.2 tp -59.6 -45.03 93.12 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.338 -0.392 . . . . 72.34 111.735 -177.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -48.19 73.66 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.348 0.499 . . . . 73.04 112.348 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.492 ' NH2' ' HG2' ' A' ' 70' ' ' LYS . 14.4 ptt180 -68.08 -31.38 70.97 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.916 0.388 . . . . 65.34 111.321 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.413 HE22 ' HA ' ' A' ' 7' ' ' GLU . 7.9 tt0 -70.91 -39.35 72.77 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.022 0.439 . . . . 45.42 111.246 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.415 ' CZ2' HD11 ' A' ' 71' ' ' LEU . 41.0 m0 -80.49 8.53 7.54 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.199 0.444 . . . . 73.54 112.199 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.5 -42.0 2.74 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.159 -0.543 . . . . 71.34 113.585 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -59.15 -4.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 113.535 0.939 . . . . 64.33 113.535 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.72 27.69 3.66 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.725 -0.75 . . . . 32.04 113.831 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -58.74 101.05 0.08 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 117.832 0.816 . . . . 54.32 111.087 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 13.1 pt-20 38.94 48.7 1.44 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.419 0.688 . . . . 73.42 111.641 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 13.7 mptt 70.09 81.56 0.17 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.123 -0.944 . . . . 55.3 111.548 -173.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -64.96 162.54 16.33 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.906 -0.588 . . . . 70.24 109.458 174.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.552 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -59.89 -99.08 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 112.968 0.729 . . . . 72.54 112.968 -178.102 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.802 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 15.3 m120 -76.22 78.05 3.02 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.506 -0.746 . . . . 73.32 111.778 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.9 135.49 7.72 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.162 -0.542 . . . . 32.44 112.809 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 99' ' ' PHE . 57.1 tp -147.26 119.89 8.56 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.752 0.31 . . . . 74.41 110.662 177.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.483 HD21 HD23 ' A' ' 71' ' ' LEU . 60.8 tp -107.55 132.81 52.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.856 0.36 . . . . 64.01 111.745 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.0 tp -121.85 112.23 18.09 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.378 -0.374 . . . . 72.15 111.127 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.18 126.9 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.878 0.37 . . . . 72.15 111.629 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.42 ' HA ' HG12 ' A' ' 97' ' ' VAL . 29.7 tp -109.84 120.64 43.11 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.196 -0.456 . . . . 54.23 111.335 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.545 HG21 HD13 ' A' ' 59' ' ' ILE . 51.8 t -100.92 103.46 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.581 -0.281 . . . . 52.01 110.745 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 67.1 tp -52.19 -44.89 64.95 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.307 0.484 . . . . 72.54 112.307 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -57.86 -31.55 66.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.036 -0.529 . . . . 73.54 112.249 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.553 HE22 HD11 ' A' ' 59' ' ' ILE . 51.2 mt-30 -110.56 -6.12 14.95 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.037 0.384 . . . . 62.44 112.037 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 42.17 31.02 0.22 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.672 0.789 . . . . 74.45 112.003 -171.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 58.2 mtt180 -107.25 142.33 37.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.774 -0.648 . . . . 74.33 110.972 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 90' ' ' LEU . 4.1 m -131.01 163.14 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.973 0.416 . . . . 74.34 111.124 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -148.41 137.03 21.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.411 -0.359 . . . . 64.03 111.329 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.645 ' HB3' HD11 ' A' ' 86' ' ' LEU . 89.9 m-85 -100.08 113.5 26.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.019 -0.537 . . . . 74.41 110.104 173.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -95.76 114.45 26.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.372 -0.232 . . . . 72.44 110.372 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.54 147.67 23.83 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.213 0.819 . . . . 61.33 113.213 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -97.77 178.37 32.3 Favored Glycine 0 CA--C 1.52 0.345 0 CA-C-N 115.122 -0.944 . . . . 44.43 112.539 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -62.72 -19.38 63.86 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.444 0.535 . . . . 73.11 112.444 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.74 -18.24 56.82 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.032 -0.604 . . . . 61.12 113.33 -177.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.602 HD11 HG13 ' A' ' 49' ' ' VAL . 91.4 mt -111.54 -4.54 14.76 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.889 0.7 . . . . 72.01 112.889 -175.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -58.76 -30.51 67.58 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.082 0.401 . . . . 71.12 112.082 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.49 -18.24 79.27 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.042 -0.599 . . . . 60.34 113.062 174.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.513 ' HE1' ' HB3' ' A' ' 152' ' ' HIS . 34.6 m-85 -93.28 -57.39 2.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.277 0.56 . . . . 75.12 111.831 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.548 ' HB3' HD21 ' A' ' 114' ' ' LEU . 12.5 mt -119.64 89.0 40.39 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.611 -0.722 . . . . 75.04 112.253 -169.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.09 148.29 85.2 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.25 1.967 . . . . 64.44 111.571 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.25 -27.64 62.25 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.007 0.432 . . . . 74.35 111.385 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.53 -49.38 56.49 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.155 -0.545 . . . . 54.04 112.589 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.32 -44.26 84.03 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.158 0.504 . . . . 74.3 111.064 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 109' ' ' LEU . 89.6 mt -58.31 -43.17 88.02 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.263 -0.426 . . . . 52.21 111.083 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.6 m -62.88 -36.89 84.81 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.852 0.358 . . . . 51.44 111.118 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -60.21 -53.46 57.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.355 -0.384 . . . . 72.04 110.149 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.6 mt -51.53 -42.4 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.916 0.389 . . . . 73.22 111.234 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 122' ' ' MET . 76.6 mt -58.67 -55.87 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.818 0.342 . . . . 51.24 111.478 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -76.22 -9.72 58.85 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.506 0.558 . . . . 72.14 112.506 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -95.42 -45.36 7.14 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.162 0.43 . . . . 74.23 112.162 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.698 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 92.6 mtt180 -127.59 -4.11 5.97 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.599 0.962 . . . . 71.15 113.599 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 17.0 mmt -103.46 -63.27 1.2 Allowed 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.85 -0.531 . . . . 73.51 111.786 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.555 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 43.5 mm -50.07 -49.97 72.05 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 112.719 0.637 . . . . 65.21 112.719 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 11.1 Cg_endo -52.76 -37.19 75.74 Favored 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.366 2.044 . . . . 61.41 112.874 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.426 ' NE2' ' HG3' ' A' ' 137' ' ' GLU . 86.5 m-70 -77.61 -48.65 16.34 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.543 -0.299 . . . . 70.4 111.434 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 20.7 m-85 -57.06 -40.12 76.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.772 0.32 . . . . 73.33 111.42 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -59.35 -35.78 74.5 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.997 0.427 . . . . 74.13 111.291 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.2 t -84.18 -3.44 58.15 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.247 -0.433 . . . . 63.32 111.691 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.42 6.68 88.45 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.111 -0.566 . . . . 60.12 112.888 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.697 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 2.6 m-20 -84.08 55.79 3.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.688 0.395 . . . . 63.21 111.72 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -56.43 -44.35 80.34 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.06 0.392 . . . . 64.34 112.06 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.503 ' HB1' ' HG3' ' A' ' 32' ' ' GLN . . . -66.85 -32.77 74.26 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.94 0.4 . . . . 74.12 112.042 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.697 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 53.3 mt-10 -76.54 -43.39 39.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.391 -0.368 . . . . 74.44 111.508 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.64 -49.75 67.82 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.389 -0.434 . . . . 73.22 112.994 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 139' ' ' VAL . 92.2 mt -56.64 -39.75 74.22 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.746 0.308 . . . . 64.14 111.445 176.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.8 t -60.8 -45.69 93.43 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.085 0.469 . . . . 72.32 111.047 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.698 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 38.0 mm-40 -61.85 -44.86 95.98 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.996 -0.547 . . . . 72.43 111.819 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.88 -47.54 90.74 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.166 -0.54 . . . . 74.43 113.072 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 135' ' ' LEU . 83.4 t -60.55 -50.02 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.885 0.374 . . . . 65.14 111.511 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.9 tp -60.93 -38.33 85.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.376 -0.374 . . . . 74.44 111.269 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.93 -54.63 44.76 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.996 0.427 . . . . 55.22 111.331 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.446 HG13 HD11 ' A' ' 109' ' ' LEU . 99.5 t -57.53 -47.7 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.147 -0.479 . . . . 71.04 111.133 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.407 HE22 ' NH1' ' A' ' 39' ' ' ARG . 63.4 tt0 -53.74 -37.7 63.62 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.211 -0.45 . . . . 73.32 111.817 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 144' ' ' GLN . 14.5 mm-40 -72.89 -38.99 66.76 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 111.609 0.225 . . . . 62.35 111.609 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.53 -42.87 95.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.998 0.427 . . . . 75.51 110.985 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.401 HD13 HG21 ' A' ' 49' ' ' VAL . 77.2 mt -64.43 -49.9 69.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.124 -0.489 . . . . 73.13 111.168 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -55.38 -40.95 71.98 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.657 -0.701 . . . . 71.34 112.232 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.49 20.85 38.64 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.748 -0.739 . . . . 44.54 113.856 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.7 t -157.05 30.91 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.721 0.76 . . . . 63.42 112.165 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.613 HD21 ' ND1' ' A' ' 47' ' ' HIS . 61.8 mt -73.16 76.02 1.27 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.232 0.539 . . . . 62.22 112.079 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.46 4.14 7.65 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.728 -0.669 . . . . 54.12 111.983 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.513 ' HB3' ' HE1' ' A' ' 108' ' ' TYR . 51.5 t-80 -145.29 91.95 2.19 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.202 0.525 . . . . 74.31 112.392 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -90.9 -160.69 0.74 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.274 -0.421 . . . . 73.02 110.265 171.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.32 137.49 51.43 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.069 1.137 . . . . 75.45 114.069 -172.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -114.23 -37.01 4.51 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.274 -0.875 . . . . 53.14 109.869 170.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -110.13 131.45 55.05 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.0 -0.545 . . . . 72.14 110.963 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.588 -0.72 . . . . 63.44 110.76 174.074 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.501 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.485 0.183 . . . . 73.31 111.364 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -74.37 -28.38 61.09 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.83 0.347 . . . . 71.13 111.69 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.461 HG12 ' HE3' ' A' ' 5' ' ' LYS . 97.8 t 64.6 94.59 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.769 -0.65 . . . . 73.11 111.613 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -87.81 135.61 33.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.852 -0.613 . . . . 60.21 111.936 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.461 ' HE3' HG12 ' A' ' 3' ' ' VAL . 25.7 mmtp -100.93 158.99 30.76 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.47 -0.567 . . . . 74.33 109.47 169.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 9.5 Cg_endo -56.65 -32.08 89.46 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.43 1.42 . . . . 73.31 112.038 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -78.13 -12.72 60.01 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.483 0.549 . . . . 75.03 112.483 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -85.35 -18.04 34.97 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.953 0.406 . . . . 63.42 110.976 173.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.473 HG22 HD21 ' A' ' 56' ' ' LEU . 60.3 t -79.03 128.0 77.72 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.137 -0.483 . . . . 73.01 111.388 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.23 108.25 0.32 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.301 2.0 . . . . 74.53 111.899 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.524 ' ND2' HD13 ' A' ' 14' ' ' LEU . 14.7 p-10 -66.57 82.14 0.1 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.741 0.781 . . . . 74.42 112.158 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.42 1.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.487 -0.779 . . . . 64.11 113.0 -177.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.677 HE22 ' HG ' ' A' ' 20' ' ' LEU . 28.0 mm-40 -100.7 9.99 41.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.834 0.35 . . . . 75.55 111.305 174.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD13 ' ND2' ' A' ' 11' ' ' ASN . 10.1 tt -124.11 -46.0 1.96 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.442 -0.344 . . . . 74.12 111.35 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.77 -68.29 0.7 Allowed 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.146 -0.346 . . . . 61.04 111.654 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -80.07 -61.95 1.83 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.942 0.349 . . . . 73.01 111.942 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 m 63.11 7.06 2.55 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.656 0.383 . . . . 62.34 111.818 -174.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -99.26 -43.69 6.51 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.119 0.414 . . . . 64.13 112.119 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -82.51 -35.92 26.9 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.581 0.585 . . . . 74.44 112.581 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.677 ' HG ' HE22 ' A' ' 13' ' ' GLN . 6.8 mp 63.19 3.83 1.44 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.735 0.643 . . . . 71.55 112.735 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.5 t -108.8 154.32 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.663 0.385 . . . . 54.43 111.166 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.3 m -142.5 108.74 5.25 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.479 0.311 . . . . 75.25 111.031 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.53 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 20.7 p-10 -107.74 73.67 0.92 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.521 0.676 . . . . 72.14 112.616 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -79.18 -38.09 36.69 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.289 0.566 . . . . 71.13 110.453 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.19 66.59 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.918 -0.583 . . . . 54.3 112.403 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.26 19.2 73.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.152 -0.547 . . . . 41.42 113.195 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.11 0.12 54.27 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.053 0.39 . . . . 64.41 112.053 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -109.95 103.59 12.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.916 0.388 . . . . 74.02 111.04 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.7 t -70.33 165.98 21.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.368 -0.378 . . . . 64.24 111.403 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -46.72 -57.73 4.56 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.426 0.898 . . . . 74.1 113.426 -172.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.593 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . . . -68.06 -42.93 79.75 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.021 0.378 . . . . 74.53 112.021 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -62.26 -33.43 74.61 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.259 0.552 . . . . 74.32 111.069 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -74.2 -53.22 10.28 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.668 -0.696 . . . . 74.24 111.038 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 11.6 pt-20 -59.65 -43.59 93.85 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.129 0.418 . . . . 53.13 112.129 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 31' ' ' ALA . 89.0 t -65.8 -33.67 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.143 0.497 . . . . 71.14 110.91 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.447 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 50.8 ttm -65.34 -40.5 93.75 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 122.052 -0.405 . . . . 63.24 110.651 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.493 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -57.93 -56.36 22.95 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.989 0.423 . . . . 74.01 111.703 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.57 -43.03 85.83 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.306 -0.473 . . . . 72.34 113.416 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 73.4 mtm180 -62.55 -45.1 94.48 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 111.756 0.28 . . . . 72.13 111.756 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 36' ' ' MET . 89.1 mt -64.1 -50.84 66.71 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.025 0.44 . . . . 75.42 111.431 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -60.21 -37.79 81.37 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.272 -0.422 . . . . 74.2 111.447 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.33 -44.23 88.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.943 0.401 . . . . 73.31 111.271 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.651 HG22 ' HB ' ' A' ' 49' ' ' VAL . 63.5 mt -61.58 -38.79 81.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.937 0.398 . . . . 62.02 111.265 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 57.3 ttp180 -74.03 -33.24 63.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.917 0.389 . . . . 74.13 111.238 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.2 t -66.87 -38.53 86.5 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.1 0.476 . . . . 73.12 111.08 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.0 t -92.61 -61.67 1.55 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.99 -0.55 . . . . 62.32 112.162 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.539 ' HE1' HD23 ' A' ' 150' ' ' LEU . 76.7 m-70 -91.91 -4.97 54.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.649 0.611 . . . . 63.01 112.649 -173.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 63.86 26.85 14.4 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.185 0.439 . . . . 63.41 112.185 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' HG22 ' A' ' 43' ' ' ILE . 62.5 t -90.7 128.31 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 112.215 0.45 . . . . 73.25 112.215 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -86.56 97.45 10.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.389 -0.369 . . . . 75.41 110.419 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.09 105.99 14.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.846 0.355 . . . . 74.44 110.539 -177.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.63 142.1 42.96 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.456 0.539 . . . . 65.14 112.456 -175.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.18 118.17 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.989 0.423 . . . . 74.34 111.437 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.544 HG21 HD21 ' A' ' 71' ' ' LEU . 61.8 t -114.62 142.27 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 122.516 0.326 . . . . 71.23 111.752 -178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.53 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 73.3 p -130.88 123.51 29.15 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.756 0.313 . . . . 62.21 111.293 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.473 HD21 HG22 ' A' ' 9' ' ' VAL . 68.2 mt -120.65 139.24 28.58 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 111.749 0.277 . . . . 72.34 111.749 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 83.2 Cg_endo -81.81 -11.75 11.25 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.634 2.222 . . . . 61.35 113.315 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.763 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 31.0 t -169.77 138.77 1.87 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.97 0.359 . . . . 73.34 111.97 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 3' ' ' VAL . 28.6 pt -136.86 -0.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 120.984 0.421 . . . . 71.23 110.365 170.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.27 -158.58 52.12 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 116.133 -0.485 . . . . 54.33 113.219 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.46 69.94 2.28 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.367 0.603 . . . . 73.2 110.873 176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.55 142.44 41.88 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.731 -0.668 . . . . 73.04 111.26 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 66' ' ' ASP . 77.1 Cg_endo -79.27 116.67 3.66 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.415 2.076 . . . . 73.42 113.092 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.51 -38.09 83.24 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.116 0.413 . . . . 73.24 112.116 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.03 -8.86 48.94 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.968 0.413 . . . . 74.21 111.967 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 31.1 t70 -96.59 -39.21 9.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.544 0.688 . . . . 74.24 109.632 170.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.463 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 43.3 t80 -55.2 -50.21 69.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.038 -0.983 . . . . 73.12 111.785 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.8 p -52.68 -49.39 65.38 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.858 0.361 . . . . 73.55 111.809 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.7 tp -59.57 -49.72 76.66 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.242 -0.436 . . . . 72.42 111.576 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -60.56 -47.74 84.84 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.243 0.46 . . . . 62.12 112.243 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 54' ' ' VAL . 51.2 tp -61.52 -47.85 83.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.242 0.544 . . . . 53.33 110.766 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.32 -34.23 77.24 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.07 -0.514 . . . . 74.2 112.01 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -61.14 -52.37 65.12 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.844 0.354 . . . . 65.5 111.709 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.522 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 12.1 pt20 -72.05 -21.64 61.5 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 111.774 0.287 . . . . 64.31 111.774 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.522 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 30.3 m0 -91.03 -16.04 28.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.561 0.219 . . . . 73.13 111.451 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.51 40.44 99.11 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.387 -0.435 . . . . 74.44 113.238 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.08 -85.01 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 112.547 0.573 . . . . 73.31 112.547 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.21 60.87 4.45 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.225 -0.512 . . . . 75.42 113.853 -173.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.414 ' HB3' ' HE3' ' A' ' 81' ' ' LYS . 12.6 m120 -112.32 133.31 54.5 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.189 -0.594 . . . . 64.01 110.867 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -45.93 -27.4 0.89 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.251 0.834 . . . . 64.43 113.251 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.794 ' HD3' ' H ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -105.76 -7.68 18.23 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.478 0.547 . . . . 72.02 112.478 -176.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' TYR . 65.1 t30 -77.66 160.91 28.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.732 -0.47 . . . . 72.03 109.732 175.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.437 HD22 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -76.62 -109.3 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.623 -0.673 . . . . 62.42 112.505 -178.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.651 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.7 m-20 -81.23 78.98 7.97 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.433 -0.792 . . . . 72.03 111.724 -175.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.93 140.69 11.65 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.164 -0.541 . . . . 64.13 113.339 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 99' ' ' PHE . 53.3 tp -148.77 124.61 10.57 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.858 0.463 . . . . 74.4 110.573 178.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.533 HD21 HD23 ' A' ' 71' ' ' LEU . 59.0 tp -115.1 132.68 56.52 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.696 0.284 . . . . 62.24 111.509 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.4 tp -122.4 123.25 40.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.795 0.438 . . . . 55.03 110.158 174.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 51.1 t -124.4 126.54 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.122 0.416 . . . . 53.3 112.122 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.662 ' HB2' HD21 ' A' ' 135' ' ' LEU . 24.1 tp -103.31 124.93 49.58 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.201 -0.454 . . . . 72.52 110.774 172.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.33 98.97 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.443 -0.344 . . . . 50.23 111.513 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.607 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 65.1 tp -55.68 -31.01 62.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.041 0.448 . . . . 45.44 111.561 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.763 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 11.5 t70 -49.97 -47.99 52.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.29 0.636 . . . . 75.4 111.759 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.502 ' OE1' ' HD2' ' A' ' 96' ' ' ARG . 8.9 pt20 -125.45 6.35 7.64 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.343 0.498 . . . . 72.21 112.343 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 56.91 30.79 18.58 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.063 0.764 . . . . 74.22 113.063 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.502 ' HD2' ' OE1' ' A' ' 94' ' ' GLN . 84.5 mtt180 -107.19 149.13 28.05 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.203 0.525 . . . . 71.33 111.676 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 90' ' ' LEU . 5.9 m -139.27 160.97 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.675 -0.693 . . . . 43.31 111.165 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -160.32 145.55 14.86 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.648 0.611 . . . . 74.35 112.648 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' HB3' HD11 ' A' ' 86' ' ' LEU . 96.8 m-85 -97.27 146.77 24.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.764 -0.653 . . . . 73.41 110.323 169.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 5.9 tp10 -135.62 113.0 10.62 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.284 -0.26 . . . . 74.44 110.632 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.419 HG21 ' HB2' ' A' ' 109' ' ' LEU . 6.2 p -95.76 160.88 14.26 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.455 0.909 . . . . 72.41 113.455 -175.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.42 -177.24 21.33 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 114.964 -1.017 . . . . 72.11 112.202 168.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' ASN . 19.5 t80 -65.34 -11.13 38.86 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.012 0.525 . . . . 73.12 112.337 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.67 -6.96 79.44 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.876 -0.678 . . . . 52.42 113.091 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 49' ' ' VAL . 97.5 mt -127.67 -12.48 5.45 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.062 0.764 . . . . 73.02 113.062 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -57.54 -17.97 16.7 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.373 0.879 . . . . 75.03 113.373 -175.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.04 -26.19 69.41 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.148 -0.548 . . . . 54.41 113.079 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' A' ' 152' ' ' HIS . 62.9 m-85 -106.38 -44.07 4.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.933 0.397 . . . . 75.54 111.917 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' HB2' HG21 ' A' ' 101' ' ' THR . 29.5 mt -119.23 84.53 28.12 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 112.59 0.589 . . . . 61.33 112.59 -170.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.32 162.65 25.27 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.113 1.875 . . . . 71.11 112.251 171.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.33 -34.9 67.01 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.841 0.353 . . . . 71.33 111.644 -177.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.75 -50.18 66.37 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.019 -0.61 . . . . 73.24 113.046 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 109' ' ' LEU . 56.6 tp -58.68 -45.79 88.66 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.867 0.365 . . . . 64.3 111.151 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.401 ' O ' HG13 ' A' ' 118' ' ' ILE . 94.5 mt -58.35 -43.63 88.41 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.364 -0.38 . . . . 74.43 110.935 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.5 m -62.67 -38.5 90.57 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.418 -0.356 . . . . 55.15 111.037 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -58.04 -53.46 57.95 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.979 0.419 . . . . 71.3 110.659 174.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.2 mt -54.22 -49.48 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.006 0.431 . . . . 55.53 111.222 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 123' ' ' ILE . 96.9 mt -57.94 -56.81 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.974 -0.557 . . . . 73.12 111.936 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 46.2 m-70 -72.69 -40.87 65.89 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.828 0.677 . . . . 74.2 112.828 -173.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -78.84 -44.51 22.84 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.565 0.58 . . . . 75.13 112.565 -171.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -109.55 -32.91 6.95 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.199 0.814 . . . . 54.23 113.199 -173.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.566 ' HB3' ' HE2' ' A' ' 126' ' ' PHE . 85.4 mtp -87.94 -51.64 5.71 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.091 0.774 . . . . 63.34 113.091 -172.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 118' ' ' ILE . 48.1 mm -51.77 -49.24 84.52 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 112.735 0.642 . . . . 54.43 112.735 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 87.1 Cg_exo -48.27 -28.81 11.83 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 122.665 2.243 . . . . 72.02 113.694 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 79.4 m-70 -83.32 -52.16 6.79 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.674 0.25 . . . . 72.3 111.674 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.566 ' HE2' ' HB3' ' A' ' 122' ' ' MET . 50.1 m-85 -56.83 -44.36 82.0 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.948 0.404 . . . . 71.32 111.468 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 123' ' ' ILE . 2.9 ptm180 -71.07 -10.26 59.46 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.279 -0.419 . . . . 74.03 111.64 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.9 m -110.41 -1.96 16.84 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 111.892 0.33 . . . . 73.24 111.892 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.61 -17.79 35.87 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.963 -0.637 . . . . 35.1 114.075 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.762 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 93.7 m-20 -80.08 81.32 6.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.322 0.561 . . . . 74.02 111.571 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -71.11 -54.65 10.33 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.873 0.368 . . . . 71.11 111.638 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.26 74.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.138 0.494 . . . . 62.23 111.842 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 5.5 mm-40 -74.52 -31.6 62.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.375 -0.375 . . . . 61.1 111.36 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.28 -42.4 57.42 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.029 -0.605 . . . . 75.31 112.366 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 90' ' ' LEU . 95.4 mt -62.32 -47.63 83.43 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.85 0.357 . . . . 65.4 111.611 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.3 p -59.28 -37.25 77.21 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.435 -0.348 . . . . 53.44 111.693 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -59.66 -48.78 80.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.719 0.295 . . . . 64.13 111.214 172.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.8 -50.48 67.2 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.024 -0.608 . . . . 63.01 112.941 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.0 t -57.75 -48.47 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.944 0.402 . . . . 74.43 111.314 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.508 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 55.1 tp -60.76 -41.08 94.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.237 -0.438 . . . . 65.25 111.292 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.39 -49.43 77.6 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.856 0.36 . . . . 72.1 111.324 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.49 -44.56 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.276 -0.42 . . . . 44.12 111.254 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -53.22 -41.88 65.79 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.15 -0.477 . . . . 74.32 111.306 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 85.1 mm-40 -60.26 -48.31 82.3 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.539 -0.3 . . . . 75.0 111.451 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.72 -49.63 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.021 0.378 . . . . 74.42 112.021 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 89.2 mt -70.36 -57.06 5.25 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.903 0.383 . . . . 72.41 111.77 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.35 -20.1 63.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.989 0.424 . . . . 71.05 111.708 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.92 -17.63 71.98 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.108 -0.568 . . . . 63.4 112.897 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 60.8 m -86.02 -64.83 1.09 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.639 -0.33 . . . . 70.31 111.718 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.539 HD23 ' HE1' ' A' ' 47' ' ' HIS . 94.2 mt 71.2 -53.78 0.67 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.101 1.149 . . . . 74.41 114.101 176.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -38.66 -39.37 0.48 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.372 1.249 . . . . 74.14 114.372 -167.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.489 ' HB3' ' OH ' ' A' ' 108' ' ' TYR . 61.7 t60 -118.94 33.22 5.74 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.736 0.643 . . . . 73.13 112.736 -166.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.442 ' HD2' ' O ' ' A' ' 150' ' ' LEU . 28.6 p80 -80.4 104.74 11.15 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.327 0.584 . . . . 73.22 110.977 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -95.62 131.9 41.35 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.083 0.468 . . . . 72.4 111.592 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -133.69 77.1 1.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.173 0.511 . . . . 72.44 111.17 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -104.77 -14.61 15.48 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.867 0.365 . . . . 71.24 110.974 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 119.156 -0.449 . . . . 65.25 110.711 178.102 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.525 0.202 . . . . 74.44 111.105 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -129.9 118.34 21.55 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.856 -0.424 . . . . 74.52 109.856 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.4 135.96 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 112.896 0.702 . . . . 71.52 112.896 -172.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.05 152.3 45.99 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.776 -0.647 . . . . 72.5 111.201 175.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -114.53 169.22 6.86 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 74.31 110.569 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.36 51.28 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.873 2.382 . . . . 74.12 112.117 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.36 -28.09 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.916 -0.583 . . . . 64.33 110.457 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -68.26 -28.76 67.49 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.289 0.566 . . . . 53.02 110.465 171.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.661 HG13 HG21 ' A' ' 22' ' ' THR . 60.7 t -70.46 122.27 85.97 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.481 -0.781 . . . . 74.14 111.525 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HG2' HG23 ' A' ' 22' ' ' THR . 21.9 Cg_endo -61.1 119.86 7.24 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.323 2.015 . . . . 74.23 112.049 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . 5.6 p30 -64.23 85.89 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.954 0.724 . . . . 73.24 112.954 -176.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.32 0.48 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 112.505 0.557 . . . . 72.44 112.505 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -121.87 5.51 9.92 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.087 0.403 . . . . 72.22 112.087 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 6.8 tt -115.14 -54.73 2.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.427 -0.583 . . . . 74.24 109.427 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.72 -55.28 35.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.124 0.488 . . . . 62.34 110.839 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -127.46 -179.57 4.97 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.093 -0.503 . . . . 75.21 110.768 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.6 p -130.27 -11.53 4.11 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.644 -0.253 . . . . 73.12 111.615 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -81.0 -45.64 16.28 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.932 0.716 . . . . 72.53 112.932 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.708 ' HG3' ' H ' ' A' ' 21' ' ' VAL . 32.5 tpt180 -52.67 -61.91 1.98 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.203 0.445 . . . . 73.21 112.203 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 40' ' ' LEU . 17.5 mt 63.19 6.99 2.57 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.218 0.451 . . . . 61.23 112.218 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.708 ' H ' ' HG3' ' A' ' 19' ' ' ARG . 95.4 t -133.64 121.42 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.842 0.353 . . . . 64.3 111.774 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.661 HG21 HG13 ' A' ' 9' ' ' VAL . 89.0 m -111.88 102.8 11.04 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.77 0.319 . . . . 75.23 110.807 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.473 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 7.6 p-10 -99.72 84.34 2.91 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.454 0.645 . . . . 74.53 111.936 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.586 ' HG2' HG22 ' A' ' 22' ' ' THR . 40.2 mm-40 -96.32 -44.83 7.06 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.115 -0.493 . . . . 73.42 110.786 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.64 -25.36 60.04 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.147 0.425 . . . . 62.44 112.147 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.99 44.59 45.37 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.376 -0.44 . . . . 54.21 113.14 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 92' ' ' LEU . 85.3 mt -102.27 -22.29 14.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.916 0.388 . . . . 72.13 111.884 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.4 mt -93.32 108.47 20.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.717 0.294 . . . . 74.34 111.12 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.527 ' HB2' ' OE1' ' A' ' 32' ' ' GLN . 49.1 m -78.52 162.08 26.58 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.534 -0.303 . . . . 71.51 111.117 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -44.98 -45.53 10.62 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.176 0.806 . . . . 75.14 113.176 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -63.88 -53.28 53.08 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.8 0.333 . . . . 52.35 111.708 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.582 ' HG2' ' HB1' ' A' ' 132' ' ' ALA . 22.6 mp0 -55.9 -40.63 73.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.065 0.46 . . . . 64.34 110.69 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.82 -52.8 63.89 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.095 -0.502 . . . . 73.43 111.02 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -55.12 -40.62 70.7 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.94 0.4 . . . . 63.21 111.608 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 31' ' ' ALA . 46.6 t -71.05 -44.65 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.072 0.463 . . . . 54.21 111.715 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 52.1 ttm -70.35 -51.82 27.16 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.871 0.323 . . . . 71.23 111.871 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -54.48 -50.35 67.95 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.389 -0.369 . . . . 61.4 111.709 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.7 -38.06 86.34 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.001 -0.618 . . . . 70.12 113.59 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 43' ' ' ILE . 81.7 mtm180 -72.01 -49.52 36.25 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.95 0.375 . . . . 65.31 111.375 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.474 ' HB3' HD13 ' A' ' 20' ' ' LEU . 87.9 mt -57.14 -52.66 64.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.021 0.438 . . . . 44.12 111.049 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -54.64 -41.64 70.3 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.055 -0.521 . . . . 71.04 111.375 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.15 97.8 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.933 0.397 . . . . 63.1 111.389 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.486 ' HA ' ' HD2' ' A' ' 47' ' ' HIS . 74.0 mt -64.91 -42.79 95.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.978 0.418 . . . . 61.12 111.083 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.493 ' NH1' ' HG2' ' A' ' 50' ' ' GLU . 8.4 tpt180 -61.46 -38.69 88.14 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.159 -0.473 . . . . 71.53 111.518 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.3 t -83.36 -41.96 17.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.238 0.459 . . . . 72.42 112.238 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.9 t -82.3 -62.49 1.61 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.124 0.488 . . . . 74.02 112.042 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.493 ' ND1' HD21 ' A' ' 150' ' ' LEU . 51.7 m-70 -83.06 -14.3 54.08 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.093 -0.503 . . . . 61.33 111.655 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.11 17.21 10.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.827 0.451 . . . . 72.34 111.846 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.671 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 96.8 t -87.28 129.89 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.147 0.498 . . . . 44.42 111.339 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HG2' ' NH1' ' A' ' 44' ' ' ARG . 27.3 mt-10 -83.3 96.41 8.49 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.095 -0.502 . . . . 64.53 110.654 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -119.27 101.63 8.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.174 -0.466 . . . . 70.51 110.505 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.4 133.99 54.88 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.319 0.488 . . . . 62.42 112.319 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.16 112.73 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.078 0.466 . . . . 44.31 111.313 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.669 ' HB ' HG22 ' A' ' 89' ' ' VAL . 57.4 t -109.11 134.14 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.374 -0.375 . . . . 72.02 111.107 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 69.1 p -119.81 122.2 40.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.879 0.371 . . . . 61.34 111.472 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.555 HD21 HG22 ' A' ' 9' ' ' VAL . 77.9 mt -128.32 140.61 38.84 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.402 -0.363 . . . . 71.2 111.013 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.47 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 19.7 Cg_endo -61.29 -47.02 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.982 1.788 . . . . 75.2 112.078 175.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.425 ' HA ' HG13 ' A' ' 91' ' ' VAL . 43.8 t -157.72 145.63 18.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.94 0.4 . . . . 61.04 111.525 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 pt -101.66 9.08 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.196 0.522 . . . . 71.01 111.202 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.73 -133.95 18.16 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.154 -0.546 . . . . 61.34 113.305 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.43 -19.39 28.12 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.938 0.348 . . . . 75.15 111.938 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.58 143.99 89.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.555 0.576 . . . . 72.22 112.555 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.2 Cg_endo -75.77 127.7 10.35 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.565 2.177 . . . . 74.2 112.131 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.07 -32.61 72.25 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.341 0.497 . . . . 72.53 112.341 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.737 ' HG2' ' HD3' ' A' ' 98' ' ' ARG . 44.2 mt-10 -62.56 -43.2 99.4 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.176 0.513 . . . . 72.32 111.702 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 2.2 m-20 -76.96 -33.08 57.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.979 -0.555 . . . . 74.32 110.903 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -59.12 -52.7 64.6 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.052 -0.522 . . . . 64.35 110.941 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.8 p -59.32 -41.78 89.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.307 -0.406 . . . . 72.54 111.728 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 48.5 tp -57.16 -49.17 76.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.958 0.408 . . . . 64.45 111.217 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -62.33 -47.07 85.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.93 0.395 . . . . 71.14 111.51 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.05 -36.97 83.21 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.102 0.477 . . . . 70.13 111.429 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.51 -38.59 71.12 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.265 0.468 . . . . 73.41 112.265 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 25.9 mtp180 -61.79 -47.99 82.68 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.41 0.522 . . . . 61.42 112.41 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.421 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.5 pt20 -59.44 -38.1 79.81 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.885 0.374 . . . . 74.01 111.842 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.421 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 50.0 m0 -78.11 -4.61 48.27 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 111.817 0.303 . . . . 73.01 111.817 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.41 -35.05 3.02 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.045 -0.598 . . . . 73.2 112.578 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.69 ' HA ' HD22 ' A' ' 82' ' ' ASN . 46.9 t -49.3 -28.06 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.382 0.673 . . . . 73.41 112.751 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -127.21 24.05 5.4 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.847 -0.692 . . . . 63.12 113.668 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -63.18 90.17 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 117.18 0.49 . . . . 72.15 111.046 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 51.97 56.2 8.14 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.511 0.672 . . . . 74.23 110.846 -173.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 62.92 64.55 0.87 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.562 -0.744 . . . . 61.53 112.021 177.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.69 HD22 ' HA ' ' A' ' 77' ' ' VAL . 14.7 t30 -63.54 139.49 58.77 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.698 -0.683 . . . . 71.2 110.933 175.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.639 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -43.26 -72.42 0.06 Allowed 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 114.407 1.262 . . . . 75.35 114.407 -168.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.671 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 5.1 m-20 -87.98 21.79 2.59 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.508 -0.745 . . . . 73.42 112.286 -173.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 77' ' ' VAL . . . -81.51 128.22 8.34 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.02 -0.609 . . . . 63.32 114.468 -175.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 54.5 tp -145.12 118.81 9.18 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.785 0.434 . . . . 63.34 110.56 173.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.2 tp -116.1 126.82 54.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.88 0.372 . . . . 74.55 111.664 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 33.1 tp -116.07 111.86 20.91 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.03 -0.532 . . . . 64.21 110.813 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.669 HG22 ' HB ' ' A' ' 54' ' ' VAL . 70.4 t -118.23 130.07 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.714 0.293 . . . . 71.14 111.553 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.4 tp -109.72 125.88 53.12 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.96 0.41 . . . . 61.12 111.508 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 58' ' ' SER . 47.8 t -99.93 105.61 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.113 -0.494 . . . . 43.23 110.294 173.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 51.6 tp -57.09 -62.84 1.47 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.147 0.795 . . . . 70.11 113.147 -174.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.37 -27.16 68.87 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.283 0.475 . . . . 71.11 112.283 -171.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -97.14 -10.94 24.97 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.705 0.288 . . . . 73.51 111.343 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 50.97 67.39 0.95 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.562 0.696 . . . . 74.52 112.322 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -159.98 150.87 19.12 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.912 -0.586 . . . . 64.12 111.095 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.2 m -129.66 171.56 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.986 0.422 . . . . 72.41 111.759 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.737 ' HD3' ' HG2' ' A' ' 65' ' ' GLU . 6.0 mmm180 -141.11 153.5 45.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.327 0.584 . . . . 72.41 112.288 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.72 ' HB3' HD13 ' A' ' 114' ' ' LEU . 30.5 m-85 -129.86 111.49 12.63 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.265 -0.88 . . . . 62.51 110.129 175.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 7.7 tp10 -105.05 112.37 25.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.809 -0.178 . . . . 74.22 110.779 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.402 HG23 HD11 ' A' ' 114' ' ' LEU . 1.2 p -96.46 147.33 23.94 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.759 0.79 . . . . 73.32 112.874 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -95.41 174.13 31.93 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.178 -0.919 . . . . 54.55 112.696 171.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -56.02 -22.31 26.45 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.961 0.726 . . . . 72.43 112.961 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.68 -41.03 11.43 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.898 -0.668 . . . . 61.21 112.464 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.446 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 85.5 mt -81.1 -6.88 59.33 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.72 0.637 . . . . 72.33 112.72 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -59.57 -12.59 6.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.521 0.563 . . . . 72.11 112.521 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -88.96 -12.99 62.99 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.168 -0.539 . . . . 73.22 113.326 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.561 ' OH ' ' HB2' ' A' ' 152' ' ' HIS . 82.0 m-85 -117.32 -47.47 2.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.08 0.467 . . . . 72.55 111.947 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.59 93.04 48.77 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 115.886 -0.597 . . . . 73.15 112.435 -168.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.62 160.51 31.48 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.293 1.995 . . . . 73.25 111.968 170.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -55.31 -36.55 66.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.679 0.276 . . . . 72.23 111.721 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.73 -49.12 82.13 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.258 -0.496 . . . . 65.52 113.21 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.6 tp -60.12 -44.05 95.18 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.012 0.434 . . . . 75.23 111.272 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.72 HD13 ' HB3' ' A' ' 99' ' ' PHE . 84.1 mt -62.31 -43.88 97.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.064 0.459 . . . . 73.04 110.969 177.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.4 t -64.42 -33.86 76.85 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.061 -0.518 . . . . 64.11 111.045 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -59.12 -52.3 66.33 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.004 -0.544 . . . . 74.33 110.385 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.2 mt -52.23 -46.28 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.237 0.541 . . . . 75.44 110.937 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.438 HD11 ' HD2' ' A' ' 99' ' ' PHE . 72.4 mt -56.56 -56.01 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.584 -0.734 . . . . 51.25 111.79 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -81.38 -18.18 46.44 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.914 0.709 . . . . 70.23 112.914 -171.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -79.95 -58.59 3.09 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.683 0.278 . . . . 73.44 111.59 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -114.26 -34.64 5.25 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.201 0.815 . . . . 71.32 113.201 -174.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.428 ' SD ' ' HA ' ' A' ' 118' ' ' ILE . 85.8 mtp -68.59 -47.5 66.6 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.327 0.491 . . . . 75.11 112.327 -174.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.432 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 26.3 mm -55.63 -55.26 42.4 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 112.983 0.735 . . . . 72.35 112.983 -178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 11.6 Cg_endo -54.78 -42.61 67.02 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.928 1.752 . . . . 74.35 112.536 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -60.88 -48.13 83.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.57 0.224 . . . . 73.11 111.412 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.529 ' HD1' ' HA ' ' A' ' 131' ' ' TYR . 22.9 m-30 -56.39 -47.49 78.84 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.879 0.371 . . . . 64.34 111.288 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -64.88 -33.14 75.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.907 0.384 . . . . 75.13 111.197 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.7 m -82.15 -1.15 47.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.498 -0.319 . . . . 54.11 111.773 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.69 -16.6 60.18 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.151 -0.547 . . . . 72.24 113.595 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.864 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 92.7 m-20 -80.05 65.24 5.14 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.234 0.517 . . . . 64.25 111.995 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.529 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 96.5 m-85 -64.05 -32.46 74.03 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.858 0.361 . . . . 73.2 111.154 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.582 ' HB1' ' HG2' ' A' ' 32' ' ' GLN . . . -71.02 -50.84 29.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.986 0.422 . . . . 64.33 111.417 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.864 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 5.8 mp0 -57.16 -42.44 81.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.144 -0.48 . . . . 74.21 111.606 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.0 -52.08 54.47 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.421 -0.419 . . . . 62.24 113.037 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.04 -39.95 96.26 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.915 0.388 . . . . 64.34 111.516 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.8 t -60.93 -43.88 98.01 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.159 0.429 . . . . 61.15 112.159 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -75.26 -28.78 59.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.485 0.179 . . . . 73.44 111.485 177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.01 -49.08 82.43 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.69 -0.767 . . . . 43.44 111.965 172.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.87 -49.13 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.068 0.461 . . . . 72.25 111.203 173.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 52.7 tp -58.44 -40.49 82.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.983 -0.553 . . . . 75.21 111.494 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -59.31 -46.79 87.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.859 0.361 . . . . 65.3 111.446 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.24 -47.17 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.052 0.453 . . . . 53.34 111.168 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -51.79 -45.76 63.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.677 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 84.5 mm-40 -59.34 -42.04 90.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.935 0.398 . . . . 73.14 111.464 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 141' ' ' ALA . 85.5 t -60.73 -50.78 79.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 120.856 0.36 . . . . 54.15 111.17 177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.64 -56.49 20.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.876 0.325 . . . . 72.51 111.876 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -58.83 -33.96 71.0 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.096 0.406 . . . . 64.32 112.096 -175.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.9 -4.33 82.31 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.12 -0.562 . . . . 70.23 113.699 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.6 m -121.11 24.61 10.03 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.305 0.552 . . . . 74.02 111.962 -178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.493 HD21 ' ND1' ' A' ' 47' ' ' HIS . 93.8 mt -74.05 43.91 0.17 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.746 0.647 . . . . 52.1 112.746 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -113.13 -0.8 14.56 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.297 0.57 . . . . 62.14 111.021 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.561 ' HB2' ' OH ' ' A' ' 108' ' ' TYR . 84.5 m-70 -111.21 124.38 52.09 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.093 -0.503 . . . . 74.34 111.204 -177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -147.35 113.89 5.99 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.083 0.468 . . . . 75.02 110.667 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -69.69 -17.68 63.5 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.018 0.437 . . . . 72.53 111.03 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -127.12 168.4 14.7 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.25 -0.432 . . . . 75.52 110.633 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -92.57 -60.42 1.83 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.166 0.508 . . . . 72.3 109.974 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 65.1 m80 . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.397 -0.811 . . . . 72.53 110.601 174.873 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ttt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.678 0.275 . . . . 73.12 110.842 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -107.95 136.1 48.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.829 0.347 . . . . 74.1 111.765 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.4 t -71.82 91.2 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.263 0.554 . . . . 64.0 110.449 170.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -75.37 148.29 39.35 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.481 0.658 . . . . 73.34 112.521 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' HG2' ' HD2' ' A' ' 6' ' ' PRO . 6.9 tttp -130.74 157.97 76.23 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 115.365 -0.834 . . . . 72.31 109.754 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.524 ' HD2' ' HG2' ' A' ' 5' ' ' LYS . 77.8 Cg_exo -52.14 -26.06 25.07 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.431 2.088 . . . . 55.51 113.373 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -88.48 -16.47 32.66 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.08 0.4 . . . . 61.42 112.08 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -94.23 -24.85 17.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.901 0.381 . . . . 70.45 111.148 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.4 t -61.79 129.9 91.95 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.268 -0.424 . . . . 71.44 111.764 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.44 114.56 1.81 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.618 2.212 . . . . 61.23 112.851 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -71.19 77.07 0.71 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.878 0.37 . . . . 70.44 111.399 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.7 m -62.87 -44.64 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 122.267 -0.271 . . . . 64.11 111.471 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -64.4 -14.88 59.05 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.054 0.454 . . . . 73.22 111.884 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.54 -49.66 7.04 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.998 0.428 . . . . 65.12 110.004 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.12 -74.9 0.49 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.208 0.447 . . . . 73.53 112.208 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -109.18 81.49 1.45 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.501 0.667 . . . . 52.13 111.223 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 60.6 p -72.99 -29.85 63.36 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.915 -0.584 . . . . 42.12 112.101 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.5 m -65.25 -15.55 62.61 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.939 0.4 . . . . 62.14 111.832 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.3 ttt85 -75.56 -55.45 5.66 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.616 -0.265 . . . . 73.11 110.93 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 17' ' ' SER . 1.3 mt 72.46 -26.7 0.18 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.639 0.776 . . . . 72.14 112.635 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.63 141.01 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 122.895 0.478 . . . . 65.21 111.19 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 m -147.13 104.85 3.71 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.594 0.235 . . . . 72.1 111.307 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.429 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 33.6 t70 -106.99 109.77 21.74 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.165 0.507 . . . . 74.32 111.827 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -109.31 -39.51 5.2 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.042 0.449 . . . . 73.31 110.602 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.81 -23.28 17.45 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.868 0.692 . . . . 73.42 112.868 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.05 45.3 7.66 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.849 -0.691 . . . . 72.02 112.703 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.427 HD13 ' HB3' ' A' ' 131' ' ' TYR . 69.6 mt -117.72 -42.21 2.87 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.966 0.412 . . . . 75.43 111.558 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.03 104.6 14.22 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.834 0.349 . . . . 74.25 111.43 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 t -74.02 165.07 25.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.693 -0.23 . . . . 71.13 111.07 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -50.5 -55.77 14.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.017 0.747 . . . . 75.11 113.017 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . . . -59.0 -31.49 68.85 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.868 0.366 . . . . 54.14 111.916 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -73.84 -33.52 64.15 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.048 0.451 . . . . 63.44 110.649 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -69.29 -41.72 76.43 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.32 -0.4 . . . . 71.54 111.339 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 11.4 pt-20 -64.64 -38.96 92.8 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 111.996 0.369 . . . . 71.05 111.996 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.59 -49.16 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.267 0.556 . . . . 34.31 110.728 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.0 ttm -68.44 -29.34 67.97 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.068 -0.514 . . . . 72.22 110.916 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -65.13 -56.08 14.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.043 -0.526 . . . . 71.23 110.778 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.57 92.3 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.912 -0.661 . . . . 62.11 112.25 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.494 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.4 tpp180 -56.76 -54.48 45.83 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.184 0.594 . . . . 73.42 111.169 176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.57 -46.13 67.08 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.184 0.438 . . . . 52.42 112.184 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -58.57 -39.11 79.38 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.002 0.43 . . . . 63.12 110.926 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.71 81.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.193 -0.458 . . . . 61.13 111.077 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.572 ' HA ' ' HD2' ' A' ' 47' ' ' HIS . 66.2 mt -65.09 -45.59 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.657 0.265 . . . . 65.21 111.654 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 50.0 ttp180 -68.35 -26.65 65.7 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.095 -0.378 . . . . 75.32 111.838 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 t -89.15 -52.56 5.0 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.137 0.494 . . . . 61.44 111.155 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.1 m -72.22 -43.8 63.89 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.516 0.562 . . . . 74.22 112.516 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.572 ' HD2' ' HA ' ' A' ' 43' ' ' ILE . 75.3 m-70 -105.41 -15.91 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.343 0.497 . . . . 72.25 112.343 -175.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 68.02 20.69 9.03 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.128 0.49 . . . . 70.43 111.932 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' HB ' HG22 ' A' ' 43' ' ' ILE . 81.5 t -96.26 124.71 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.916 0.389 . . . . 61.12 111.239 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.47 97.31 9.96 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.437 0.637 . . . . 70.2 110.886 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.31 107.62 16.95 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.352 -0.84 . . . . 75.4 110.564 -176.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.76 145.17 38.56 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.057 0.391 . . . . 75.11 112.057 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.41 120.92 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.96 0.41 . . . . 74.2 111.381 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.39 128.94 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.299 -0.41 . . . . 41.32 111.614 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 22.3 p -110.79 123.72 50.62 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.922 0.391 . . . . 73.33 111.102 177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.8 mt -122.15 140.52 32.53 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 120.741 0.305 . . . . 62.52 111.275 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.15 -48.95 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.296 1.997 . . . . 65.54 112.65 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.7 p -150.88 144.91 25.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.699 0.285 . . . . 64.52 111.623 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 91' ' ' VAL . 32.7 pt -120.78 11.0 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.115 0.483 . . . . 73.14 111.044 175.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.28 -124.03 24.4 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.272 -0.49 . . . . 41.35 113.142 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.15 16.27 24.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.884 0.373 . . . . 70.41 111.417 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . . . -77.36 138.41 63.87 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 112.031 0.382 . . . . 62.23 112.031 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 62' ' ' ALA . 4.6 Cg_exo -77.0 121.44 5.82 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.728 2.285 . . . . 61.44 111.808 175.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.6 tp -55.74 -39.3 70.96 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.914 0.387 . . . . 73.1 111.364 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.29 -45.43 84.13 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.12 -0.491 . . . . 71.32 112.037 175.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.63 -17.56 50.88 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.418 0.628 . . . . 72.44 110.871 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -76.78 -56.15 4.86 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.794 -0.639 . . . . 74.43 111.279 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.7 p -53.22 -52.53 58.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.573 0.583 . . . . 74.54 112.573 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.502 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 42.1 tp -53.31 -54.52 35.28 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.213 -0.449 . . . . 71.53 111.872 -177.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -61.77 -40.19 94.28 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.443 0.535 . . . . 74.21 112.443 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 87' ' ' LEU . 63.0 tp -62.31 -45.46 93.13 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.326 0.584 . . . . 75.14 110.715 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HB1' ' CA ' ' A' ' 78' ' ' GLY . . . -70.79 -30.21 66.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.061 -0.518 . . . . 43.44 112.113 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 75.8 mtp180 -64.59 -49.14 72.31 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.748 0.277 . . . . 51.41 111.748 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.79 -32.88 74.67 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.723 0.297 . . . . 72.12 111.439 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -74.23 -15.43 60.99 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.956 0.408 . . . . 75.41 110.986 173.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.56 27.15 72.99 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.374 -0.441 . . . . 74.41 113.359 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.466 ' O ' ' HA3' ' A' ' 85' ' ' GLY . 22.4 t -116.4 -83.05 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.131 0.419 . . . . 70.32 112.131 -176.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.429 ' CA ' ' HB1' ' A' ' 72' ' ' ALA . . . -77.86 40.64 1.87 Allowed Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.966 -0.635 . . . . 71.41 113.565 -176.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.661 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 44.4 t-20 -78.78 133.22 37.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.138 -0.69 . . . . 73.11 109.138 175.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -49.76 -31.49 11.64 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.714 0.635 . . . . 71.01 112.714 -175.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -103.0 1.32 33.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.416 0.524 . . . . 74.42 112.416 -178.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.661 ' HB2' ' HB3' ' A' ' 79' ' ' ASN . 66.3 t30 -85.23 172.74 10.93 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.136 0.493 . . . . 53.35 110.74 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.423 ' HA ' ' H ' ' A' ' 104' ' ' GLY . 0.2 OUTLIER -110.34 148.3 32.23 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.448 0.536 . . . . 74.03 112.448 178.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.468 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 3.6 m-20 58.04 19.35 5.89 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.058 0.762 . . . . 64.11 113.058 174.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 77' ' ' VAL . . . -106.27 132.09 10.96 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.801 -0.714 . . . . 52.32 113.487 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 101' ' ' THR . 46.4 tp -147.17 126.89 13.4 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.023 0.44 . . . . 64.01 111.202 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.488 HD21 HD23 ' A' ' 71' ' ' LEU . 64.1 tp -120.22 134.24 55.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.822 0.344 . . . . 71.34 111.418 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.6 tp -119.41 111.79 18.6 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.175 -0.466 . . . . 61.52 110.75 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.96 130.47 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.799 0.333 . . . . 65.42 111.611 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 135' ' ' LEU . 28.4 tp -110.04 124.42 51.43 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.183 -0.462 . . . . 52.22 111.096 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.407 HG21 HD13 ' A' ' 59' ' ' ILE . 48.0 t -105.07 105.81 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.746 0.307 . . . . 72.33 110.786 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 tp -57.78 -40.29 79.51 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.028 0.381 . . . . 74.41 112.028 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.2 -32.12 71.88 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.255 0.465 . . . . 74.43 112.255 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -105.29 -7.94 18.59 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 122.157 -0.339 . . . . 73.12 111.735 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 95' ' ' ARG . 48.8 mtm180 55.0 33.23 19.8 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.168 0.587 . . . . 75.22 112.531 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -137.54 161.64 35.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.853 0.359 . . . . 73.24 111.455 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.406 HG21 ' CE ' ' A' ' 122' ' ' MET . 7.6 m -131.7 171.93 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.225 -0.443 . . . . 72.04 111.307 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 31.5 ttt85 -152.13 133.94 14.82 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.979 0.418 . . . . 60.52 111.894 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 86' ' ' LEU . 97.4 m-85 -95.01 122.3 37.53 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.911 -0.586 . . . . 61.2 110.179 171.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -107.4 112.33 25.08 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.998 -0.371 . . . . 63.11 109.998 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.64 HG23 HD13 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -98.95 148.06 24.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.622 0.725 . . . . 61.33 112.696 -177.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -93.07 172.74 33.93 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.163 -0.926 . . . . 73.42 112.531 170.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' ASN . 55.3 t80 -54.61 -31.29 56.81 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.069 0.548 . . . . 74.54 111.925 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -67.74 -19.23 71.12 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 116.08 -0.509 . . . . 75.13 113.312 -177.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.492 HD11 HG13 ' A' ' 49' ' ' VAL . 91.3 mt -117.58 -5.49 11.18 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.94 0.348 . . . . 72.24 111.94 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -49.79 -44.05 48.75 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.858 0.463 . . . . 73.44 111.836 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.34 -25.41 75.49 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 114.468 0.547 . . . . 73.21 114.468 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' A' ' 152' ' ' HIS . 8.6 m-85 -97.96 -35.43 10.47 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.324 0.583 . . . . 75.22 110.88 -177.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HB3' HD21 ' A' ' 114' ' ' LEU . 53.2 mt -126.57 73.45 74.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.366 -0.834 . . . . 73.15 110.701 -177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.04 156.17 52.12 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.075 1.85 . . . . 64.03 112.447 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -46.81 -45.88 20.37 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 112.672 0.619 . . . . 75.41 112.672 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.34 -39.08 96.75 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.399 -0.429 . . . . 74.34 113.537 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.5 tp -67.32 -47.21 71.23 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 122.511 -0.405 . . . . 73.15 111.138 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 109' ' ' LEU . 89.4 mt -58.0 -43.9 86.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.152 -0.476 . . . . 75.34 110.823 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 t -60.35 -41.57 93.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.972 -0.558 . . . . 74.41 110.981 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 116' ' ' ARG . 43.3 ttm105 -57.93 -53.87 53.31 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.176 -0.466 . . . . 74.05 111.52 175.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.0 mt -51.99 -47.4 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.957 0.408 . . . . 61.22 111.215 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 114' ' ' LEU . 80.4 mt -55.72 -50.56 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.07 -0.513 . . . . 73.01 111.39 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.456 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 3.6 t-80 -80.39 -19.28 46.65 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.843 0.683 . . . . 74.14 112.843 -171.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -102.48 -46.74 4.68 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.488 0.922 . . . . 63.43 113.488 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 66.6 mtp180 -106.75 4.26 27.46 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.037 0.754 . . . . 75.21 113.037 -175.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.406 ' CE ' HG21 ' A' ' 97' ' ' VAL . 60.4 mtp -125.33 -51.9 1.63 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.61 0.596 . . . . 73.52 112.61 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.517 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 22.5 mm -51.77 -49.58 82.57 Favored Pre-proline 0 N--CA 1.48 1.029 0 N-CA-C 113.252 0.834 . . . . 65.12 113.252 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 14.7 Cg_endo -55.05 -29.51 65.59 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 122.143 1.896 . . . . 62.24 112.634 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 90.3 m-70 -75.3 -50.61 15.49 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.518 -0.31 . . . . 73.51 110.769 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.454 ' HD1' ' HA ' ' A' ' 131' ' ' TYR . 21.8 m-85 -57.53 -42.3 82.6 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.711 0.291 . . . . 73.42 111.6 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -62.19 -35.54 79.18 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.966 0.412 . . . . 73.23 111.16 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.5 m -83.07 -1.9 53.96 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.207 -0.451 . . . . 75.41 111.921 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.58 -4.77 79.87 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.315 -0.469 . . . . 75.32 113.203 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.5 m-20 -81.36 67.52 7.33 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.526 -0.397 . . . . 72.5 111.418 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.454 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 97.6 m-85 -61.68 -47.83 83.55 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.009 0.433 . . . . 70.13 111.875 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.9 87.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.94 0.4 . . . . 72.44 111.791 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 19.7 mm-40 -67.15 -39.7 86.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.437 -0.347 . . . . 74.43 111.444 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.41 -44.64 95.15 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.898 -0.668 . . . . 55.45 112.611 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 90' ' ' LEU . 95.4 mt -60.96 -45.04 96.36 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.698 0.285 . . . . 74.43 111.27 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.0 m -55.38 -49.29 72.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.469 -0.332 . . . . 73.15 111.789 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 44.3 mm-40 -65.68 -40.99 92.94 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.969 0.359 . . . . 75.21 111.969 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.76 -50.91 62.55 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 120.934 -0.651 . . . . 72.53 112.733 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 135' ' ' LEU . 97.1 t -59.21 -50.63 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.967 0.413 . . . . 73.12 111.552 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.444 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 58.5 tp -57.5 -45.58 84.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.163 -0.471 . . . . 71.34 111.17 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -57.6 -48.18 80.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.96 0.41 . . . . 72.13 111.628 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.16 -52.38 59.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.222 -0.444 . . . . 70.42 111.638 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -53.81 -42.09 68.03 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.807 0.337 . . . . 65.13 111.392 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 98.6 mt-30 -58.72 -46.69 86.77 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.392 -0.367 . . . . 63.22 111.178 177.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 141' ' ' ALA . 62.9 t -57.81 -50.11 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.83 0.348 . . . . 73.51 111.134 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.33 -48.27 79.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.431 -0.35 . . . . 73.43 111.72 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.47 -34.12 68.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.002 0.429 . . . . 44.45 111.386 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -94.39 5.65 71.0 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.224 -0.513 . . . . 52.45 113.188 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.3 m -126.36 22.55 7.09 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 122.63 -0.335 . . . . 64.42 111.814 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.551 HD21 ' ND1' ' A' ' 47' ' ' HIS . 77.5 mt -74.29 12.99 0.63 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.468 0.544 . . . . 72.54 112.468 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -61.23 -49.45 77.07 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.631 -0.258 . . . . 74.02 111.036 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.426 ' HA ' ' OH ' ' A' ' 108' ' ' TYR . 71.6 t60 52.56 32.59 11.88 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.286 0.565 . . . . 75.22 111.749 175.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -76.77 -5.43 48.13 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.916 0.388 . . . . 73.33 111.96 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -94.55 121.16 35.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.853 0.359 . . . . 70.52 111.422 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -141.05 130.87 24.31 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.151 -0.477 . . . . 74.25 111.139 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -99.5 136.6 39.19 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.423 0.527 . . . . 72.44 112.423 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 81.2 t60 . . . . . 0 C--O 1.252 1.233 0 CA-C-N 115.753 -0.658 . . . . 73.54 110.946 174.65 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.672 0.272 . . . . 74.0 111.225 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -102.76 123.34 46.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.818 0.342 . . . . 73.03 111.305 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.7 t -81.41 114.27 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.173 0.511 . . . . 73.31 112.298 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -97.93 129.27 44.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.084 -0.507 . . . . 73.23 111.257 175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 68.1 mttm -105.86 164.18 15.53 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.861 -0.609 . . . . 71.44 110.29 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 31.9 Cg_endo -62.19 -15.0 41.43 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.965 1.777 . . . . 61.52 112.349 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -94.46 -0.83 54.43 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.182 -0.463 . . . . 64.41 111.737 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -97.67 -34.5 10.91 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.017 0.436 . . . . 65.51 110.873 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.69 122.11 65.98 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 115.964 -0.562 . . . . 70.05 111.601 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.62 126.93 19.38 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.728 2.285 . . . . 74.42 112.863 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -75.34 83.47 2.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.486 0.66 . . . . 74.23 111.492 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.57 -26.61 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.902 0.704 . . . . 73.24 112.902 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -61.0 -15.72 35.02 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.249 0.463 . . . . 75.41 112.249 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -75.72 -51.45 12.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.992 0.425 . . . . 72.5 110.338 176.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.65 -69.28 0.78 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.012 0.434 . . . . 63.31 111.561 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 19' ' ' ARG . 3.2 m-20 -80.9 57.07 2.93 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.339 0.59 . . . . 75.32 112.021 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.3 p -65.47 -17.25 64.41 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.163 -0.471 . . . . 75.52 110.99 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.416 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 77.7 p -95.02 3.63 54.68 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.2 -0.455 . . . . 51.43 111.976 176.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 16' ' ' ASP . 13.2 ttm180 -105.34 -53.58 2.63 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.965 0.412 . . . . 53.4 110.7 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp 66.09 1.43 1.93 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.411 0.684 . . . . 63.04 112.705 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.3 t -107.54 140.82 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.904 0.383 . . . . 62.44 111.853 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 m -131.4 103.67 6.57 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.39 -0.368 . . . . 54.31 110.52 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 12.3 p-10 -100.64 96.5 7.39 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.648 0.737 . . . . 70.21 112.179 -178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -100.72 -44.57 5.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.823 -0.626 . . . . 52.13 110.899 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.84 -24.04 67.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.26 0.467 . . . . 53.2 112.26 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.84 28.74 70.21 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.261 -0.495 . . . . 73.15 113.374 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 92' ' ' LEU . 94.3 mt -86.5 7.38 26.27 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.541 -0.387 . . . . 41.34 111.668 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 135' ' ' LEU . 95.8 mt -116.46 121.94 43.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.458 -0.337 . . . . 74.32 111.543 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.1 m -65.38 146.06 55.38 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.176 -0.305 . . . . 74.22 110.176 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -48.39 -46.27 36.97 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.77 0.656 . . . . 72.24 112.77 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -61.0 -46.7 89.72 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.225 -0.297 . . . . 50.11 111.186 175.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -57.71 -37.88 74.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.62 0.248 . . . . 75.31 111.572 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -54.66 -54.72 38.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.257 0.551 . . . . 63.32 110.347 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -66.29 -42.06 88.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.752 -0.658 . . . . 74.12 111.718 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 31' ' ' ALA . 85.9 t -59.0 -36.64 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.24 0.543 . . . . 45.21 110.851 176.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 42.5 ttm -71.9 -44.55 63.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.47 -0.332 . . . . 72.51 110.711 176.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -53.15 -54.42 36.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.855 0.36 . . . . 72.54 111.144 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.22 -33.15 57.72 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 116.157 -0.474 . . . . 74.21 113.626 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.539 HH12 ' HB3' ' A' ' 136' ' ' SER . 85.0 mtm180 -75.15 -49.13 20.51 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.643 -0.328 . . . . 75.25 111.567 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.84 -48.88 77.14 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.473 0.654 . . . . 75.35 111.0 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 18' ' ' THR . 33.0 ttp180 -55.8 -42.44 75.62 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.279 -0.873 . . . . 74.23 111.643 178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.31 -49.76 75.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.855 0.359 . . . . 63.1 111.526 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.449 HG22 ' HB ' ' A' ' 49' ' ' VAL . 68.0 mt -61.29 -44.77 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.184 0.516 . . . . 73.43 111.241 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.622 ' HE ' ' HG2' ' A' ' 50' ' ' GLU . 1.5 tmt_? -61.9 -33.1 73.62 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.813 -0.63 . . . . 74.31 110.784 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.9 t -78.24 -48.6 15.41 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.976 0.361 . . . . 75.3 111.976 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.2 t -84.06 -68.03 0.75 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.04 0.385 . . . . 65.42 112.04 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -69.97 -13.6 62.31 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 111.767 0.284 . . . . 72.32 111.767 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 66.15 14.88 9.86 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.856 0.462 . . . . 51.24 111.916 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.694 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 61.6 t -84.42 115.8 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.324 -0.398 . . . . 72.31 110.914 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.622 ' HG2' ' HE ' ' A' ' 44' ' ' ARG . 36.8 mt-10 -76.31 95.58 3.8 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.335 0.588 . . . . 72.24 110.22 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.68 104.3 13.27 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.441 -0.799 . . . . 54.11 110.313 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.01 142.53 39.54 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.266 0.469 . . . . 70.31 112.266 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.6 t -123.22 126.33 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.003 0.43 . . . . 65.24 111.291 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.42 139.4 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 122.622 0.369 . . . . 70.1 111.076 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 76.7 p -121.04 122.63 40.5 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.817 0.342 . . . . 60.44 111.474 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -129.19 142.25 44.56 Favored Pre-proline 0 N--CA 1.471 0.624 0 CA-C-N 116.531 -0.304 . . . . 72.21 111.144 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.89 -55.57 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.268 1.979 . . . . 63.34 112.348 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.0 p -151.07 147.02 26.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.625 0.25 . . . . 74.5 111.305 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.7 pt -116.89 9.2 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.097 0.475 . . . . 75.44 111.819 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.23 -138.2 32.31 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.117 -0.563 . . . . 62.2 112.938 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -92.71 15.26 14.89 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.519 -0.401 . . . . 63.05 111.989 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.89 131.07 76.97 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.651 -0.25 . . . . 74.21 111.186 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.592 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 56.7 Cg_endo -71.7 125.51 11.18 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.259 1.972 . . . . 74.43 112.538 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.5 tp -62.37 -38.33 89.14 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.582 0.586 . . . . 73.24 112.582 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 12.5 mp0 -61.32 -39.04 89.06 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.761 0.791 . . . . 74.3 110.759 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.592 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 2.0 m-20 -76.64 -37.02 57.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.041 -0.981 . . . . 71.12 110.918 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -55.05 -52.68 62.43 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.753 -0.658 . . . . 74.44 110.85 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.5 p -62.18 -36.46 81.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.974 -0.557 . . . . 64.22 111.966 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.2 tp -57.01 -50.32 73.1 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.128 0.489 . . . . 51.43 110.711 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -59.12 -50.33 74.47 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.094 -0.503 . . . . 53.53 111.756 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.475 HD23 HD21 ' A' ' 87' ' ' LEU . 27.9 tp -64.67 -42.58 95.27 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.989 0.423 . . . . 64.33 111.451 -176.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.5 93.83 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.855 0.36 . . . . 73.01 111.514 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -62.28 -52.47 63.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.466 -0.334 . . . . 74.12 111.771 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 10.3 pt20 -63.43 -28.01 69.69 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.907 0.336 . . . . 72.12 111.907 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.407 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 44.9 m0 -86.61 -2.64 58.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.335 0.495 . . . . 71.5 112.335 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.16 12.18 68.38 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.917 -0.659 . . . . 72.45 113.416 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 41.3 t -95.1 -16.5 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.996 0.426 . . . . 73.3 110.91 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.9 31.66 2.08 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 116.33 -0.395 . . . . 70.03 112.97 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -61.54 93.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.067 0.461 . . . . 71.14 112.024 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 49.77 56.12 8.36 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.516 0.674 . . . . 73.12 110.676 -174.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.5 OUTLIER 68.39 98.74 0.06 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.378 -0.828 . . . . 71.13 111.551 -178.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 77' ' ' VAL . 42.9 t30 -98.59 160.08 14.51 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.413 -0.812 . . . . 63.42 110.624 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.519 HD22 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -68.48 -97.36 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 O-C-N 121.958 -0.464 . . . . 72.4 112.217 -178.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.694 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.2 m-20 -77.51 77.19 4.04 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.982 -0.449 . . . . 72.41 111.438 178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.78 130.93 4.39 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.996 -0.621 . . . . 42.43 113.315 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.2 tp -144.51 123.05 12.45 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.933 0.396 . . . . 74.2 110.964 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.475 HD21 HD23 ' A' ' 71' ' ' LEU . 61.7 tp -112.97 135.11 54.1 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.864 0.364 . . . . 52.33 111.402 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 55.8 tp -124.98 120.81 32.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.695 0.398 . . . . 63.45 110.956 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 87.0 t -125.21 126.99 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.844 0.354 . . . . 75.24 111.53 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.504 HD22 HD11 ' A' ' 135' ' ' LEU . 29.6 tp -101.44 120.08 39.74 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.119 -0.491 . . . . 75.42 111.335 178.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.9 t -104.61 102.28 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.867 0.365 . . . . 73.43 111.157 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 27' ' ' LEU . 61.7 tp -56.87 -35.06 68.47 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.221 -0.445 . . . . 62.24 111.895 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -51.2 -36.49 41.65 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.832 0.679 . . . . 74.25 112.832 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -129.2 3.49 5.21 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.153 0.427 . . . . 74.11 112.153 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 57.37 20.82 6.24 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.939 0.399 . . . . 63.13 112.021 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -94.76 141.07 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 74.12 111.364 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.66 HG21 ' SD ' ' A' ' 122' ' ' MET . 4.4 m -129.89 144.66 37.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.769 -0.651 . . . . 74.33 110.497 177.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 14.6 tpt180 -121.32 128.48 52.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.856 0.36 . . . . 71.51 111.707 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.62 ' HB3' HD13 ' A' ' 114' ' ' LEU . 71.8 m-85 -100.69 102.29 13.36 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.089 -0.505 . . . . 73.41 109.755 171.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -98.51 112.88 24.77 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.898 0.38 . . . . 63.12 112.008 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.5 p -102.02 152.37 21.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.522 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.62 -95.44 0.61 Allowed Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.786 -0.721 . . . . 53.34 111.905 171.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -142.72 -23.56 0.64 Allowed 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.526 -0.397 . . . . 72.33 111.715 173.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.32 -29.61 75.68 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.858 -0.687 . . . . 74.44 113.3 -176.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.583 ' HA ' ' HD2' ' A' ' 108' ' ' TYR . 86.8 mt -92.93 0.32 57.38 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.447 0.536 . . . . 75.41 112.447 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -62.34 -19.99 63.92 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.003 0.43 . . . . 73.5 111.548 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.6 11.62 68.27 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.283 -0.484 . . . . 75.22 113.13 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.583 ' HD2' ' HA ' ' A' ' 105' ' ' LEU . 34.8 m-85 -136.58 -57.47 0.74 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.469 0.652 . . . . 74.0 110.355 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.492 ' HB3' HD21 ' A' ' 114' ' ' LEU . 12.2 mt -118.56 79.49 15.94 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.11 -0.95 . . . . 74.13 111.25 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.89 146.54 94.96 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.183 1.922 . . . . 73.05 112.714 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -51.28 -32.67 25.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 116.155 -0.475 . . . . 51.34 111.301 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.12 -44.82 75.2 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.36 -0.448 . . . . 73.12 113.143 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 tp -60.55 -49.69 76.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.207 0.527 . . . . 73.14 110.873 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 99' ' ' PHE . 76.7 mt -56.93 -37.28 71.27 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.712 -0.676 . . . . 61.23 111.191 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.6 t -56.79 -46.85 81.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.122 -0.49 . . . . 52.25 111.383 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -65.11 -41.59 94.77 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.944 -0.302 . . . . 70.31 111.18 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.581 HG23 ' HD3' ' A' ' 121' ' ' ARG . 65.4 mt -50.34 -39.67 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.038 0.447 . . . . 75.2 111.19 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 122' ' ' MET . 62.3 mt -60.35 -51.01 77.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.007 -0.542 . . . . 75.41 111.363 175.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.416 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 12.9 m-70 -81.56 -19.1 42.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.821 0.674 . . . . 73.11 112.821 -175.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.511 ' HB3' ' HD2' ' A' ' 121' ' ' ARG . 9.3 t70 -83.36 -49.09 9.7 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.109 0.411 . . . . 72.4 112.109 -173.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.581 ' HD3' HG23 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -119.18 -31.25 4.75 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.155 0.798 . . . . 74.44 113.155 -177.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.66 ' SD ' HG21 ' A' ' 97' ' ' VAL . 37.0 mtt -73.28 -56.71 4.71 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.967 0.729 . . . . 53.25 112.967 -176.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.503 ' N ' ' HD2' ' A' ' 124' ' ' PRO . 44.4 mm -50.58 -52.14 58.56 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.954 0.724 . . . . 73.21 112.954 -176.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 10.3 Cg_endo -52.23 -29.58 38.43 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.237 1.958 . . . . 72.24 113.254 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -84.15 -48.19 10.09 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.925 0.343 . . . . 74.31 111.925 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.2 m-85 -55.78 -46.64 77.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.279 0.561 . . . . 75.43 111.34 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -65.48 -17.04 64.26 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.727 -0.669 . . . . 73.24 111.722 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.2 t -90.05 -13.59 35.6 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.12 -0.491 . . . . 71.44 110.939 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.71 -0.61 61.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.982 -0.447 . . . . 72.13 111.982 -172.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.809 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.8 m-20 -85.57 68.04 10.29 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.96 0.504 . . . . 74.31 111.202 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.406 ' HA ' ' HD1' ' A' ' 126' ' ' PHE . 96.1 m-85 -70.8 -48.24 55.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.661 0.267 . . . . 72.3 111.701 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.338 0.589 . . . . 61.31 111.289 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.809 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 9.2 tp10 -61.6 -50.19 73.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.578 -0.737 . . . . 71.15 110.884 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.81 -47.21 91.62 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 116.21 -0.45 . . . . 62.02 113.6 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 90' ' ' LEU . 90.9 mt -57.72 -44.53 86.04 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 122.585 -0.362 . . . . 71.32 111.285 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.539 ' HB3' HH12 ' A' ' 39' ' ' ARG . 43.7 m -60.18 -44.06 95.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.474 -0.33 . . . . 71.54 111.557 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -61.07 -40.2 92.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.775 0.321 . . . . 71.43 111.5 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.22 -51.32 57.49 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.944 -0.646 . . . . 55.03 112.835 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.21 -46.6 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.206 0.527 . . . . 72.24 111.265 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.425 ' O ' ' HG3' ' A' ' 144' ' ' GLN . 47.8 tp -59.7 -39.42 84.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.847 -0.615 . . . . 74.21 111.413 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -62.52 -50.5 71.1 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.922 0.392 . . . . 71.55 111.158 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.26 -48.5 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.112 0.482 . . . . 52.52 111.106 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -51.28 -40.37 58.79 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.8 -0.636 . . . . 73.12 111.751 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 140' ' ' LEU . 79.8 mt-30 -69.74 -42.55 73.79 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 111.948 0.351 . . . . 73.44 111.948 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ALA . 57.4 t -58.34 -50.8 77.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.803 0.335 . . . . 73.31 111.617 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.3 mt -53.21 -48.1 68.38 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.454 -0.339 . . . . 53.04 111.794 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -55.89 -34.4 65.49 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.935 0.398 . . . . 75.42 112.025 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -101.06 0.67 54.79 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.147 -0.549 . . . . 74.54 114.079 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.3 m -115.47 15.45 16.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 117.417 0.609 . . . . 71.42 112.097 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.56 -1.03 3.19 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.443 0.535 . . . . 74.15 112.443 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -45.51 -33.78 2.89 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.145 0.578 . . . . 72.11 112.452 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 108' ' ' TYR . 58.0 t-80 -86.13 1.35 50.86 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.093 0.775 . . . . 70.42 113.093 -174.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.442 ' O ' ' HB3' ' A' ' 154' ' ' HIS . 0.8 OUTLIER -69.88 71.53 0.37 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.735 1.013 . . . . 75.43 113.735 -172.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.442 ' HB3' ' O ' ' A' ' 153' ' ' HIS . 22.2 p80 174.97 7.63 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.103 0.409 . . . . 75.41 112.103 176.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -116.48 140.35 49.46 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.265 0.555 . . . . 74.2 112.395 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -138.05 -169.59 2.6 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.339 -0.846 . . . . 74.1 110.185 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 9.7 p80 . . . . . 0 C--O 1.252 1.216 0 CA-C-O 117.883 -1.055 . . . . 73.14 111.263 176.078 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.98 0.419 . . . . 65.12 111.052 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -87.89 117.9 27.05 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.001 0.429 . . . . 72.13 111.517 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -91.29 116.04 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.176 -0.465 . . . . 72.22 111.69 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -94.08 139.94 30.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.268 0.556 . . . . 65.01 112.072 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 56.8 mtpt -111.71 163.25 18.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.714 -0.675 . . . . 72.5 110.012 173.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 16.5 Cg_endo -55.38 -23.73 39.75 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.392 2.062 . . . . 71.21 112.854 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.34 -22.81 38.18 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.22 -0.446 . . . . 74.44 111.839 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -91.76 -19.69 22.32 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.83 0.347 . . . . 72.45 111.599 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.29 120.73 80.19 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.488 -0.324 . . . . 71.33 111.213 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.47 111.2 0.69 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.667 2.245 . . . . 73.13 112.978 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -70.81 82.57 0.64 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.346 0.593 . . . . 74.22 110.832 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.82 -28.31 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.414 0.524 . . . . 72.41 112.414 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' A' ' 20' ' ' LEU . 26.6 mm-40 -72.15 -24.53 61.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.893 0.378 . . . . 74.51 111.842 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 14' ' ' LEU . 6.7 tt -75.57 -39.71 57.72 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.19 -0.67 . . . . 73.22 109.19 171.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.86 -80.13 0.08 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.863 -0.608 . . . . 64.34 112.16 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -121.93 109.03 14.12 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.661 0.267 . . . . 74.01 111.584 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 p -59.12 -24.9 63.38 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 120.857 0.361 . . . . 73.23 111.765 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.4 m -61.78 -26.36 68.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.399 -0.364 . . . . 70.12 111.517 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -114.6 112.68 23.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.221 0.534 . . . . 74.31 110.954 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 4.6 mp -101.5 7.59 42.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.075 -0.511 . . . . 62.34 110.751 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 16.4 t -119.5 116.47 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.64 0.607 . . . . 73.01 112.64 -172.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.0 m -104.44 105.79 16.04 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.402 -0.363 . . . . 54.13 111.157 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 30.2 t70 -96.56 101.67 13.32 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.081 0.467 . . . . 70.13 111.345 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.52 ' HB2' HD23 ' A' ' 56' ' ' LEU . 27.7 mm-40 -103.77 -39.55 6.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.003 0.43 . . . . 64.44 111.065 177.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.85 -21.58 57.12 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.913 0.709 . . . . 65.41 112.913 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.22 55.46 5.16 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.938 -0.649 . . . . 64.23 112.486 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -122.13 -47.76 2.13 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.873 0.368 . . . . 74.33 111.466 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.4 HD21 HD12 ' A' ' 135' ' ' LEU . 96.2 mt -74.22 115.24 13.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.136 0.493 . . . . 63.43 111.931 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 90.8 p -71.1 162.07 30.06 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.018 -0.537 . . . . 71.53 111.241 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -53.49 -35.51 60.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.123 0.487 . . . . 65.41 110.872 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.69 -48.48 69.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.932 -0.576 . . . . 74.45 111.244 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -60.46 -42.73 96.77 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.574 0.226 . . . . 74.31 111.59 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.01 -44.84 95.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.776 0.322 . . . . 72.43 110.926 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -54.57 -55.18 32.05 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.031 0.443 . . . . 74.22 111.238 177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.89 -46.08 97.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.897 -0.592 . . . . 51.14 111.811 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.522 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 50.0 ttm -66.84 -52.12 47.51 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.529 -0.305 . . . . 72.31 111.742 -176.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -62.88 -37.67 87.85 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.407 0.146 . . . . 74.15 111.236 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.67 -48.24 85.89 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.006 -0.616 . . . . 62.25 112.532 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 48.1 mtp180 -64.0 -47.55 79.85 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.308 0.243 . . . . 61.3 111.608 177.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 36' ' ' MET . 85.4 mt -58.57 -52.72 64.47 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.129 0.49 . . . . 63.12 111.361 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -60.18 -34.87 74.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.027 -0.533 . . . . 75.45 110.862 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.14 -42.21 96.89 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.845 0.355 . . . . 52.54 111.143 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 49' ' ' VAL . 70.8 mt -62.25 -42.27 94.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.488 -0.324 . . . . 75.52 110.78 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 28.1 tpt180 -61.51 -37.63 84.42 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.989 0.423 . . . . 62.11 111.088 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.4 m -70.11 -31.51 69.1 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.129 0.418 . . . . 65.4 112.129 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.6 t -98.72 -64.54 1.03 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.004 0.372 . . . . 51.34 112.004 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.619 ' HE1' HD22 ' A' ' 150' ' ' LEU . 76.0 m-70 -87.5 -10.56 51.43 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.5 0.556 . . . . 71.33 112.5 -175.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 69.08 3.46 4.07 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.312 0.486 . . . . 74.23 112.312 -176.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.851 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 93.2 t -64.45 122.62 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 121.008 0.432 . . . . 75.33 111.459 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -88.84 95.54 10.33 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.3 0.572 . . . . 75.22 109.865 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -113.17 102.7 10.62 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.646 -0.706 . . . . 74.24 111.013 -172.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -105.17 145.86 30.01 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.356 0.502 . . . . 74.33 112.356 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 61.3 t -124.23 138.3 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.394 -0.366 . . . . 75.34 110.933 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.1 t -133.29 143.31 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 122.231 -0.293 . . . . 53.23 111.118 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 28.4 p -125.54 123.15 38.5 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.803 0.335 . . . . 71.42 110.752 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 24' ' ' GLU . 81.8 mt -127.39 143.22 46.48 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 122.245 -0.284 . . . . 75.52 111.515 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.74 -61.48 0.28 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.598 2.199 . . . . 75.04 112.519 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.8 p -149.35 146.41 27.5 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.973 0.416 . . . . 72.13 112.046 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.471 HG12 HG11 ' A' ' 91' ' ' VAL . 31.9 pt -110.6 5.0 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.957 -0.565 . . . . 73.32 110.682 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.92 -120.4 22.02 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 115.886 -0.597 . . . . 73.3 113.526 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -97.83 4.86 49.65 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.895 0.378 . . . . 72.42 111.788 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.46 140.44 92.47 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 120.672 0.272 . . . . 74.23 111.731 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.662 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 73.5 Cg_endo -75.99 125.86 8.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.321 2.014 . . . . 75.34 112.518 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.3 tp -58.62 -42.01 87.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.046 0.451 . . . . 71.4 111.711 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.73 -59.68 4.19 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.875 -0.602 . . . . 74.22 111.057 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.662 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 3.3 m-20 -62.97 -41.53 99.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.705 -0.68 . . . . 64.13 111.627 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -53.62 -49.96 66.72 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.274 -0.421 . . . . 64.34 111.763 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.3 p -57.48 -48.86 78.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.412 -0.358 . . . . 75.44 111.891 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.4 -45.42 88.39 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.844 0.354 . . . . 65.23 111.712 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 66' ' ' ASP . 31.7 mmmt -56.25 -45.51 80.02 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.999 0.428 . . . . 54.44 111.661 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.418 HD23 HD21 ' A' ' 87' ' ' LEU . 52.3 tp -73.42 -38.13 65.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.214 0.53 . . . . 73.14 111.297 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.81 -35.45 72.87 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.292 -0.413 . . . . 72.2 112.103 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -61.31 -53.91 50.66 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.321 0.489 . . . . 73.02 112.321 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.628 ' HG3' ' HD1' ' A' ' 75' ' ' TRP . 7.2 pt20 -67.06 -27.44 67.38 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.383 0.512 . . . . 64.52 112.383 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.628 ' HD1' ' HG3' ' A' ' 74' ' ' GLN . 16.3 m0 -80.74 -12.22 59.49 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.884 0.328 . . . . 74.42 111.884 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.76 -2.16 66.57 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.266 -0.492 . . . . 74.24 114.029 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.0 m -100.85 -4.42 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 112.714 0.635 . . . . 64.12 112.714 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.44 -29.99 1.13 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.01 -0.614 . . . . 73.14 113.935 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -59.21 127.15 30.72 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.487 -0.419 . . . . 73.25 111.287 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 43.71 28.17 0.21 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.939 0.896 . . . . 65.44 112.965 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER 64.46 93.23 0.06 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.246 0.832 . . . . 71.33 113.246 175.067 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.439 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 23.0 t-20 -74.24 132.66 42.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.244 0.545 . . . . 73.2 111.064 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.698 HD22 ' N ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -51.38 -64.29 0.86 Allowed 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 112.772 0.656 . . . . 73.51 112.772 177.102 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.851 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 18.3 m120 -88.02 8.16 27.86 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.683 -0.636 . . . . 75.31 112.146 -177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.99 124.62 9.23 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 114.735 0.654 . . . . 75.34 114.735 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 99' ' ' PHE . 50.9 tp -144.23 119.59 10.26 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.705 0.402 . . . . 71.3 110.755 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.6 tp -110.99 135.44 51.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.817 0.341 . . . . 74.4 111.564 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 tp -120.84 108.14 13.57 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.741 0.305 . . . . 74.23 110.863 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 64.0 t -108.5 120.15 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.075 0.398 . . . . 75.15 112.075 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.548 ' HB2' HD21 ' A' ' 135' ' ' LEU . 29.2 tp -100.1 129.4 46.13 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.014 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.471 HG11 HG12 ' A' ' 59' ' ' ILE . 44.2 t -116.98 107.79 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.462 -0.335 . . . . 65.11 110.683 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.1 tp -53.47 -44.36 68.91 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.044 0.449 . . . . 71.52 111.504 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -57.64 -33.5 68.36 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.95 -0.568 . . . . 71.2 112.265 177.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -92.66 -11.95 32.82 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 122.241 -0.287 . . . . 72.11 111.62 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 54.64 29.05 10.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.995 0.518 . . . . 73.41 111.891 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -149.81 173.53 13.64 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.09 0.471 . . . . 70.02 111.908 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.535 HG21 ' SD ' ' A' ' 122' ' ' MET . 8.9 m -135.41 171.93 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.877 -0.601 . . . . 70.13 111.056 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -145.8 141.52 28.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.926 0.393 . . . . 73.42 111.532 168.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.67 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 79.0 m-85 -98.36 124.9 43.27 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.887 -0.597 . . . . 71.22 110.373 172.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.99 119.25 38.92 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.275 -0.266 . . . . 73.41 110.726 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.591 HG23 HD11 ' A' ' 114' ' ' LEU . 18.5 p -98.19 139.11 34.47 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.03 0.443 . . . . 75.22 111.847 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -68.39 -80.84 0.21 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.582 -0.818 . . . . 54.32 112.297 173.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.425 ' HB2' ' HB3' ' A' ' 81' ' ' LYS . 9.4 t80 -155.66 -43.62 0.08 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.934 0.397 . . . . 74.32 112.044 -177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.634 ' H ' ' HA ' ' A' ' 83' ' ' ASN . . . -62.13 -41.76 99.71 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.516 -0.374 . . . . 62.13 113.617 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 86' ' ' LEU . 88.2 mt -71.15 -3.08 18.13 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.251 0.834 . . . . 72.34 113.251 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -60.85 -15.49 30.89 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.939 -0.476 . . . . 70.11 112.03 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.7 1.18 80.95 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.177 -0.535 . . . . 62.05 113.301 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -136.94 -54.36 0.71 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.332 0.587 . . . . 74.02 111.452 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.423 ' HB3' HD21 ' A' ' 114' ' ' LEU . 14.6 mt -117.25 86.62 21.67 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 115.578 -0.737 . . . . 73.44 111.821 -174.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.39 159.0 22.78 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.332 2.021 . . . . 75.43 112.529 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.435 ' HA ' HD12 ' A' ' 114' ' ' LEU . 14.3 t70 -45.91 -40.22 9.82 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 120.977 0.417 . . . . 65.22 111.746 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.03 72.11 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.336 -0.459 . . . . 43.51 113.284 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.26 -40.2 96.74 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.03 0.443 . . . . 75.23 111.095 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.67 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 86.1 mt -57.66 -48.17 80.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.052 -0.522 . . . . 72.34 111.127 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.4 t -69.08 -34.48 75.19 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.106 0.479 . . . . 63.33 110.804 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 116' ' ' ARG . 15.4 ttm180 -56.56 -53.92 51.93 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.904 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.4 mt -51.12 -41.69 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.027 0.441 . . . . 63.14 111.528 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.482 ' HA ' ' HB2' ' A' ' 122' ' ' MET . 60.4 mt -58.61 -54.51 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.165 0.507 . . . . 64.42 110.888 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -75.1 -14.9 60.62 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.28 -0.418 . . . . 70.33 112.008 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -79.21 -53.04 7.36 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.226 0.454 . . . . 74.33 112.226 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -133.72 -23.68 1.79 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.202 0.816 . . . . 73.2 113.202 -176.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.535 ' SD ' HG21 ' A' ' 97' ' ' VAL . 36.4 mtt -67.56 -53.6 26.96 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.509 0.559 . . . . 74.32 112.509 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 118' ' ' ILE . 47.7 mm -51.38 -53.63 47.44 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 112.85 0.685 . . . . 74.45 112.85 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 123' ' ' ILE . 10.5 Cg_endo -53.58 -41.98 69.44 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.989 1.793 . . . . 74.32 112.623 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.475 ' CD2' ' HG3' ' A' ' 137' ' ' GLU . 60.5 m-70 -64.47 -50.68 66.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.279 -0.263 . . . . 75.53 111.491 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.6 m-85 -56.4 -45.25 80.72 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.854 0.359 . . . . 73.54 111.431 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 58.6 mtp180 -62.49 -34.82 77.61 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.963 0.411 . . . . 75.12 110.988 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.6 m -80.82 -4.44 54.69 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.104 -0.498 . . . . 62.31 111.87 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.7 -8.44 63.78 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.517 -0.373 . . . . 34.11 113.601 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.781 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 2.4 m-20 -78.81 72.41 5.33 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 122.327 -0.513 . . . . 62.23 112.139 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -71.45 -56.13 6.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.018 0.437 . . . . 65.01 111.177 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.91 89.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.184 -0.462 . . . . 72.14 111.468 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.781 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 9.4 tp10 -68.56 -46.43 69.48 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.17 -0.468 . . . . 63.1 110.768 176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.84 -41.75 67.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.579 -0.343 . . . . 52.15 113.267 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 90' ' ' LEU . 83.4 mt -60.65 -48.79 80.2 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.888 0.375 . . . . 75.24 111.178 175.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -60.56 -38.85 85.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.326 -0.397 . . . . 74.5 110.941 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.475 ' HG3' ' CD2' ' A' ' 125' ' ' HIS . 15.7 mm-40 -58.44 -51.37 70.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.173 -0.467 . . . . 60.44 111.503 175.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.439 ' HA3' ' HE3' ' A' ' 122' ' ' MET . . . -58.76 -47.94 87.71 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.9 -0.667 . . . . 75.34 112.444 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.29 -39.68 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.968 0.413 . . . . 74.11 111.218 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.492 ' HG ' HE21 ' A' ' 144' ' ' GLN . 27.9 tp -70.88 -33.99 71.15 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.381 -0.372 . . . . 72.02 110.667 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.52 -50.79 57.12 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.847 0.356 . . . . 74.2 110.86 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.7 t -57.47 -47.34 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.116 0.484 . . . . 65.1 110.535 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -53.81 -46.91 71.24 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.051 -0.522 . . . . 74.14 111.82 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.492 HE21 ' HG ' ' A' ' 140' ' ' LEU . 74.4 mt-30 -57.42 -38.1 73.82 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.841 0.353 . . . . 71.41 111.426 177.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.98 -49.08 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.707 0.289 . . . . 72.23 111.029 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.36 -58.21 4.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.867 0.321 . . . . 72.3 111.867 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.83 -23.09 67.22 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.045 0.45 . . . . 63.21 111.845 178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.08 -18.7 58.91 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.205 -0.522 . . . . 72.33 112.856 175.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.0 t -74.24 -58.46 3.28 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.151 0.426 . . . . 61.41 112.151 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.619 HD22 ' HE1' ' A' ' 47' ' ' HIS . 1.7 pt? -66.83 -25.42 66.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.859 0.361 . . . . 71.0 111.395 -177.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.45 ' H ' HD23 ' A' ' 150' ' ' LEU . 44.1 mt-10 67.64 -8.8 0.48 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.636 0.774 . . . . 73.41 112.727 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.575 ' H ' ' HG ' ' A' ' 150' ' ' LEU . 31.7 t60 -77.44 118.19 19.64 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.646 -0.501 . . . . 74.21 109.646 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -49.73 118.08 2.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.235 0.457 . . . . 74.0 112.235 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -58.08 107.49 0.48 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.072 -0.513 . . . . 72.31 110.878 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -76.82 133.48 39.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.987 0.422 . . . . 74.43 111.647 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -93.47 141.97 27.86 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.376 -0.375 . . . . 72.55 110.661 175.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.4 m170 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.429 -0.796 . . . . 71.35 111.421 -175.44 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.508 ' HG3' ' OG ' ' A' ' 58' ' ' SER . 51.5 ttm . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.865 0.364 . . . . 74.12 111.417 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -118.05 123.18 45.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.774 0.321 . . . . 71.24 110.665 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.03 101.8 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 121.044 0.449 . . . . 74.14 111.754 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -91.59 141.17 29.0 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.109 0.48 . . . . 75.01 111.405 174.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.503 ' HB2' ' NZ ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -111.45 158.35 36.52 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 116.316 -0.402 . . . . 52.04 110.647 175.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 64.4 Cg_endo -70.93 19.31 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.819 2.346 . . . . 63.22 114.541 -173.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.676 ' HA ' HE22 ' A' ' 74' ' ' GLN . 0.0 OUTLIER -126.38 -12.07 6.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.756 0.313 . . . . 62.11 111.657 173.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -97.45 -19.27 18.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.947 0.403 . . . . 54.01 111.121 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.21 130.92 84.04 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.322 -0.399 . . . . 54.24 111.412 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.04 110.84 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.828 2.352 . . . . 54.32 113.173 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -70.96 98.0 1.53 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.215 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 13' ' ' GLN . 27.8 m -93.26 -50.25 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 113.495 0.924 . . . . 53.2 113.495 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.575 ' HG3' HG21 ' A' ' 77' ' ' VAL . 15.1 mm100 -53.77 -33.75 56.85 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.654 1.353 . . . . 63.14 114.654 -169.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.428 ' H ' ' CD2' ' A' ' 14' ' ' LEU . 1.6 pt? -77.48 5.34 9.1 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.617 0.599 . . . . 62.44 112.617 -175.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.02 -51.56 0.06 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.196 0.522 . . . . 75.32 111.498 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -83.14 47.67 1.27 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.3 -0.409 . . . . 64.22 111.256 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 m -61.0 -11.79 9.32 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.689 0.626 . . . . 74.41 112.689 -176.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -77.71 -30.7 51.91 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.176 0.512 . . . . 65.1 110.635 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.47 ' HA ' ' OD1' ' A' ' 37' ' ' ASN . 13.0 ttm105 -108.34 95.04 5.39 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.452 0.644 . . . . 74.31 110.761 175.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 20' ' ' LEU . 3.9 mp -88.89 13.6 12.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.812 -0.631 . . . . 73.21 111.04 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.54 127.36 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.326 -0.397 . . . . 63.22 111.773 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.0 m -121.1 103.16 8.81 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.439 -0.346 . . . . 73.24 110.619 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.4 ' HA ' ' OG1' ' A' ' 55' ' ' THR . 24.1 t70 -99.51 101.99 13.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.989 0.424 . . . . 73.35 111.495 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HB2' HD23 ' A' ' 56' ' ' LEU . 23.6 mm-40 -103.0 -34.42 8.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.214 0.53 . . . . 71.52 110.714 176.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.32 -28.26 69.08 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.51 0.559 . . . . 71.15 112.51 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.68 28.43 51.36 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.886 -0.673 . . . . 71.12 112.432 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.51 -17.2 22.64 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.824 0.345 . . . . 63.43 111.319 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.4 mt -107.62 114.19 28.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.924 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 t -65.93 152.73 43.86 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.341 -0.224 . . . . 63.54 110.467 175.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -45.03 -51.78 9.61 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.854 0.687 . . . . 74.23 112.854 -174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -60.28 -50.26 74.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.646 0.26 . . . . 71.12 111.452 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -58.09 -39.87 79.68 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.177 0.513 . . . . 71.31 111.426 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -50.73 71.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.906 -0.588 . . . . 74.14 110.621 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.06 -30.75 71.8 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.724 0.297 . . . . 61.23 111.371 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 31' ' ' ALA . 74.8 t -62.01 -46.37 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.951 0.405 . . . . 63.33 110.35 172.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.708 ' SD ' HG21 ' A' ' 139' ' ' VAL . 51.7 tpp -60.3 -43.85 95.94 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.422 -0.354 . . . . 75.24 110.356 175.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.552 ' HB3' ' NH2' ' A' ' 41' ' ' ARG . 60.3 m-80 -56.74 -38.19 72.04 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.468 -0.333 . . . . 73.2 110.658 173.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.6 -46.32 94.65 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.887 -0.673 . . . . 41.23 112.203 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' A' ' 39' ' ' ARG . 1.5 mmp_? -57.61 -55.74 30.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.023 0.44 . . . . 63.43 111.174 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.7 mt -62.87 -45.58 91.9 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.099 -0.5 . . . . 73.12 112.098 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' NH2' ' HB3' ' A' ' 37' ' ' ASN . 36.3 ttm180 -62.15 -40.75 97.03 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.018 0.527 . . . . 74.15 110.929 -178.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.64 -46.52 89.42 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.338 -0.392 . . . . 54.21 111.011 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.435 HG22 ' HB ' ' A' ' 49' ' ' VAL . 76.1 mt -59.79 -44.7 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.124 0.488 . . . . 64.23 110.96 175.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 31.7 tpt180 -62.42 -26.81 68.69 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.097 -0.501 . . . . 71.22 111.76 177.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.1 m -84.84 -54.06 4.93 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.148 0.499 . . . . 72.0 110.76 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.2 m -71.91 -56.9 4.87 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.719 -0.673 . . . . 72.21 112.42 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.479 ' ND1' HD12 ' A' ' 150' ' ' LEU . 80.1 m-70 -96.32 -10.57 27.51 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.115 0.413 . . . . 72.54 112.115 -173.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 70.55 1.47 3.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.974 0.731 . . . . 70.1 112.974 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 43' ' ' ILE . 99.2 t -66.59 132.09 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 112.352 0.501 . . . . 65.25 112.352 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.448 ' HB3' HG13 ' A' ' 77' ' ' VAL . 44.3 mt-10 -82.18 96.74 7.93 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.08 0.466 . . . . 74.13 110.533 174.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -119.11 108.72 15.04 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.507 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.47 146.02 42.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.875 0.369 . . . . 31.51 111.971 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.4 t -128.38 121.74 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.831 0.348 . . . . 65.5 111.418 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.7 t -121.78 132.37 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 122.325 0.25 . . . . 75.24 111.419 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 23' ' ' ASP . 30.7 p -116.59 123.06 46.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.927 0.394 . . . . 52.33 111.288 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.424 HD11 ' CZ ' ' A' ' 67' ' ' PHE . 83.8 mt -118.16 145.24 36.55 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-O 120.788 0.328 . . . . 74.41 111.37 177.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.95 -43.01 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.535 2.157 . . . . 72.34 112.354 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.912 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 23.8 m -153.14 143.47 22.46 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.055 0.391 . . . . 62.42 112.055 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 35.8 pt -128.67 -14.38 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.083 0.468 . . . . 74.54 110.653 172.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.04 -117.32 8.45 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.236 -0.438 . . . . 35.34 113.725 174.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.42 2.67 46.87 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.815 0.302 . . . . 53.35 111.815 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -72.88 120.88 83.26 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 111.524 0.194 . . . . 64.04 111.524 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 31.8 Cg_endo -64.48 137.06 53.41 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.443 2.095 . . . . 72.13 112.654 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.97 -49.08 40.34 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.236 0.458 . . . . 72.44 112.236 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.26 -32.85 73.61 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.998 0.428 . . . . 74.12 111.849 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.593 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 3.4 m-20 -74.21 -38.55 63.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.89 0.376 . . . . 71.13 111.016 173.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.424 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 48.6 t80 -56.77 -54.15 49.68 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.995 0.426 . . . . 74.42 111.062 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.493 ' OG1' ' NH1' ' A' ' 98' ' ' ARG . 40.7 p -51.84 -42.48 62.62 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.959 -0.564 . . . . 75.04 111.441 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.3 tp -58.42 -54.8 42.89 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.133 -0.485 . . . . 73.25 111.657 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 14.9 mmmm -66.67 -42.29 86.77 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.628 0.603 . . . . 62.13 112.628 -173.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.3 tp -68.57 -47.98 65.4 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.207 0.527 . . . . 73.31 111.261 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.529 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -68.55 -31.04 69.98 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.453 0.538 . . . . 62.35 112.453 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 70' ' ' LYS . 13.3 ptm180 -70.67 -38.95 73.79 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.092 -0.243 . . . . 62.5 111.436 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.676 HE22 ' HA ' ' A' ' 7' ' ' GLU . 3.6 pt20 -72.51 -24.69 61.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.044 0.45 . . . . 53.41 110.811 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.529 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 39.6 m0 -88.69 -17.2 30.47 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.487 -0.324 . . . . 73.32 111.221 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.64 38.08 95.71 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.472 -0.394 . . . . 74.4 113.613 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.575 HG21 ' HG3' ' A' ' 13' ' ' GLN . 45.0 t -108.87 -87.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.173 0.434 . . . . 71.22 112.173 -176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.75 102.16 2.22 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.225 -0.512 . . . . 63.35 112.9 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.491 ' O ' ' HA2' ' A' ' 102' ' ' GLY . 0.2 OUTLIER -144.74 156.3 43.99 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.477 -0.425 . . . . 54.2 110.714 178.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -43.66 -32.76 1.05 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.707 1.003 . . . . 71.34 113.707 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.688 ' HD3' ' H ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -114.51 20.28 15.49 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.596 0.591 . . . . 74.23 112.596 -174.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 103' ' ' TYR . 3.5 m-20 -95.8 -166.13 1.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.242 0.544 . . . . 63.04 112.053 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -97.36 -139.44 0.28 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.13 -0.486 . . . . 73.22 111.137 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.547 ' HA ' ' HG ' ' A' ' 105' ' ' LEU . 7.3 p30 -69.12 43.88 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.322 0.86 . . . . 52.44 113.322 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -92.49 140.39 15.09 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.934 -0.651 . . . . 61.42 112.74 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 99' ' ' PHE . 52.0 tp -143.05 119.74 11.14 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.871 0.367 . . . . 64.11 111.03 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 72' ' ' ALA . 58.4 tp -111.94 122.32 47.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.836 0.351 . . . . 65.52 111.216 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.3 tp -109.97 106.2 15.65 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.307 -0.406 . . . . 75.21 110.745 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 59.9 t -107.06 117.4 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 111.925 0.343 . . . . 73.11 111.925 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.487 ' HA ' HG12 ' A' ' 97' ' ' VAL . 30.9 tp -96.88 122.27 39.66 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.305 -0.407 . . . . 72.22 110.677 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.457 HG11 HG12 ' A' ' 59' ' ' ILE . 61.0 t -111.04 102.9 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.665 0.269 . . . . 71.31 111.176 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.5 tp -51.86 -41.74 62.08 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.0 0.428 . . . . 72.34 111.367 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.912 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 19.1 t0 -45.76 -43.16 12.82 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.5 0.72 . . . . 70.02 112.451 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.401 ' NE2' HD11 ' A' ' 59' ' ' ILE . 49.3 mt-30 -106.19 -6.79 18.26 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 111.906 0.336 . . . . 71.11 111.906 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.404 ' NH2' ' O ' ' A' ' 126' ' ' PHE . 77.9 mtp180 55.23 26.84 8.9 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.732 0.777 . . . . 73.51 110.509 -174.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -112.75 164.24 13.61 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.171 -0.922 . . . . 64.42 111.528 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.668 HG21 ' SD ' ' A' ' 122' ' ' MET . 11.1 m -137.42 171.75 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.025 -0.534 . . . . 61.22 110.511 172.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.493 ' NH1' ' OG1' ' A' ' 68' ' ' THR . 38.5 ttt-85 -153.04 142.82 22.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.788 0.327 . . . . 70.01 111.621 172.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HD11 ' A' ' 86' ' ' LEU . 95.1 m-85 -101.22 118.05 36.21 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.045 -0.525 . . . . 74.33 110.659 173.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' CD ' HH12 ' A' ' 98' ' ' ARG . 5.6 tp10 -105.64 112.6 25.74 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 110.346 -0.242 . . . . 74.42 110.346 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.8 p -103.27 158.89 16.01 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.791 0.805 . . . . 74.32 113.038 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . -104.5 -175.65 25.04 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 114.907 -1.042 . . . . 73.42 111.464 166.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.423 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 0.1 OUTLIER -61.83 -24.17 66.72 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.405 -0.468 . . . . 74.04 112.009 -176.142 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.4 -20.27 79.64 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.928 -0.653 . . . . 74.45 113.203 -173.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HG ' ' HA ' ' A' ' 84' ' ' ASN . 91.8 mt -109.11 -7.5 15.31 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.407 0.521 . . . . 75.22 112.407 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -56.4 -25.72 50.95 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.11 0.411 . . . . 65.32 112.11 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.79 -21.26 59.89 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.169 -0.539 . . . . 31.54 113.62 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 82.0 m-85 -102.42 -53.74 2.83 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.268 0.556 . . . . 72.21 111.409 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -113.77 87.97 13.17 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.485 -0.78 . . . . 70.2 111.418 -173.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 108' ' ' TYR . 6.5 Cg_exo -73.99 161.63 40.75 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.396 2.064 . . . . 52.15 112.34 176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -51.45 -44.09 62.26 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.167 0.432 . . . . 72.44 112.167 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.51 -45.13 94.94 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.227 -0.511 . . . . 65.24 113.198 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.12 -42.94 99.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.767 0.318 . . . . 65.33 111.164 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.0 -44.75 91.72 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.012 0.434 . . . . 64.34 110.827 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.7 m -61.91 -36.63 81.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.086 -0.506 . . . . 74.22 111.053 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -60.9 -56.38 21.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.215 -0.448 . . . . 73.11 111.59 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.5 mt -50.63 -43.43 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.902 0.382 . . . . 72.44 111.684 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' ' 122' ' ' MET . 64.3 mt -61.23 -51.31 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.296 -0.411 . . . . 74.01 111.754 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.463 ' HA ' ' CG1' ' A' ' 123' ' ' ILE . 25.1 m-70 -74.02 -48.17 31.99 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.025 0.75 . . . . 70.24 113.025 -175.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.35 -54.19 22.79 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.592 0.59 . . . . 73.2 112.592 -174.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -97.33 -45.14 6.6 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.604 0.594 . . . . 63.44 112.604 -172.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.668 ' SD ' HG21 ' A' ' 97' ' ' VAL . 49.3 mtt -73.32 -54.26 8.79 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.708 1.003 . . . . 64.13 113.708 -173.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.506 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 32.8 mm -47.48 -51.86 40.9 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 113.391 0.886 . . . . 63.34 113.391 -175.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.506 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 72.0 Cg_exo -50.49 -39.59 54.79 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.155 1.903 . . . . 72.3 113.048 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.464 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 85.5 m-70 -74.42 -49.95 20.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.6 -0.273 . . . . 71.24 111.656 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 22.6 m-30 -56.34 -43.13 78.76 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.598 0.221 . . . . 50.21 111.598 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.5 -42.36 87.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.921 0.391 . . . . 63.41 111.302 175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.7 m -74.94 -13.46 60.53 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.268 -0.423 . . . . 45.11 111.75 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.48 -0.69 59.89 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.286 -0.483 . . . . 72.13 112.52 -177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.8 m-20 -80.37 66.66 5.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.737 0.415 . . . . 64.02 111.303 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -65.13 -46.02 82.66 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.174 -0.329 . . . . 73.43 111.785 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.69 95.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.007 0.432 . . . . 71.3 111.462 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 51.9 mm-40 -59.82 -47.2 86.69 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.146 -0.479 . . . . 72.23 111.365 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.71 93.13 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.302 -0.475 . . . . 74.51 113.008 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.35 -43.05 96.86 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.808 0.337 . . . . 65.1 111.051 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.4 t -56.21 -53.48 56.63 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 64.3 111.904 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -68.4 -33.45 74.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.609 0.242 . . . . 72.02 111.395 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.18 -52.46 51.74 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.072 -0.585 . . . . 43.31 112.712 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.708 HG21 ' SD ' ' A' ' 36' ' ' MET . 90.8 t -62.63 -43.6 98.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.023 0.44 . . . . 74.21 111.227 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.19 -38.36 76.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.262 -0.427 . . . . 74.31 110.929 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 145' ' ' VAL . . . -61.31 -51.84 67.18 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.9 0.381 . . . . 64.42 111.052 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 85.7 t -54.32 -49.7 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.162 0.506 . . . . 75.05 110.972 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.425 ' HB2' HD11 ' A' ' 43' ' ' ILE . 36.5 tt0 -53.43 -46.5 69.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.974 -0.557 . . . . 63.14 111.653 176.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -65.09 -34.22 77.89 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.943 0.349 . . . . 63.52 111.943 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 141' ' ' ALA . 92.8 t -63.28 -49.07 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.064 0.459 . . . . 73.24 111.004 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.85 -57.06 8.79 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.051 0.453 . . . . 74.43 111.425 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.69 -37.94 85.98 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.12 -0.491 . . . . 73.23 111.943 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.28 -41.02 92.76 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.313 -0.47 . . . . 70.41 113.461 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 52.9 m -81.05 -41.26 22.9 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.051 0.453 . . . . 73.21 111.572 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.479 HD12 ' ND1' ' A' ' 47' ' ' HIS . 92.2 mt -81.04 75.77 8.01 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.428 0.633 . . . . 61.14 111.915 -177.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -84.44 -53.31 5.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.678 -0.692 . . . . 74.21 110.08 175.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -126.58 115.21 19.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.731 -0.668 . . . . 74.13 111.329 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -79.5 137.47 37.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 64.03 109.943 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -70.35 -10.46 59.1 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.502 0.556 . . . . 73.53 112.502 -173.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -74.69 142.68 44.42 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.648 0.261 . . . . 74.32 111.302 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -84.01 149.96 25.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.984 0.421 . . . . 74.43 111.818 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.932 -0.556 . . . . 73.44 111.082 179.529 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.265 0.555 . . . . 75.15 111.884 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 57' ' ' PRO . 30.1 ttp180 -137.41 101.66 4.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.169 -0.469 . . . . 73.11 109.917 175.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.1 t -75.95 117.55 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 113.133 0.79 . . . . 61.11 113.133 -171.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -109.1 152.56 24.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.742 -0.663 . . . . 73.21 111.518 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 9' ' ' VAL . 40.7 mtmt -111.91 157.95 38.15 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.207 -0.451 . . . . 73.33 110.335 173.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.523 ' HD3' ' CE2' ' A' ' 67' ' ' PHE . 30.3 Cg_endo -62.33 -26.11 76.89 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.912 1.741 . . . . 61.52 111.323 176.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' HA ' HE22 ' A' ' 74' ' ' GLN . 18.1 mt-10 -79.26 -20.2 48.71 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.566 -0.743 . . . . 63.22 111.067 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -94.06 -24.49 17.58 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.855 -0.611 . . . . 62.32 111.511 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.6 t -66.71 132.52 94.06 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.226 -0.443 . . . . 43.2 111.648 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.08 121.05 9.19 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.633 2.222 . . . . 73.41 113.106 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' A' ' 14' ' ' LEU . 2.8 p30 -70.34 85.95 0.59 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.477 0.547 . . . . 73.33 112.477 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.66 -26.77 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 112.223 0.453 . . . . 72.32 112.223 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.575 HE22 ' HA ' ' A' ' 20' ' ' LEU . 1.6 mp0 -87.22 31.29 0.73 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.593 0.711 . . . . 71.52 111.365 173.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.541 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 4.7 tt -143.43 -50.75 0.33 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.378 -0.971 . . . . 64.3 108.378 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 16' ' ' ASP . . . -109.52 120.37 42.29 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.604 -0.725 . . . . 34.14 110.307 170.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 6.8 m-20 71.13 48.42 0.37 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.329 0.652 . . . . 72.31 111.646 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -59.45 -11.96 5.36 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.961 0.726 . . . . 61.23 112.961 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.7 t -60.86 -34.67 74.96 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.142 -0.349 . . . . 54.41 111.319 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 19' ' ' ARG . 8.0 ptp85 -97.12 132.48 42.86 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.096 0.474 . . . . 64.12 110.375 175.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.575 ' HA ' HE22 ' A' ' 13' ' ' GLN . 5.6 mp -108.63 12.67 25.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.153 0.501 . . . . 62.1 110.896 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.7 t -110.75 146.94 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.135 -0.484 . . . . 24.43 111.478 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 m -131.21 124.17 30.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.359 -0.382 . . . . 74.41 110.57 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.35 86.03 2.35 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.405 0.621 . . . . 73.31 112.492 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.04 -38.48 8.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.908 0.385 . . . . 73.02 110.75 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.1 -26.65 64.08 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.982 0.42 . . . . 72.35 111.126 170.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.91 25.74 75.21 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.254 -0.498 . . . . 73.04 113.234 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 132' ' ' ALA . 78.8 mt -86.06 10.89 12.96 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.928 0.344 . . . . 74.4 111.928 -177.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.48 HD21 HD12 ' A' ' 135' ' ' LEU . 97.0 mt -120.17 119.96 34.79 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.838 0.351 . . . . 64.43 111.438 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.493 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 31.5 t -81.05 159.49 24.77 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.554 -0.294 . . . . 74.11 110.72 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -54.61 -40.54 69.0 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.169 0.803 . . . . 72.15 113.169 -173.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.32 91.9 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.071 0.462 . . . . 75.42 111.247 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.493 ' OE1' ' HB3' ' A' ' 29' ' ' SER . 18.4 mp0 -66.93 -41.05 87.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.786 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.97 -44.05 91.48 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.968 0.413 . . . . 72.44 110.713 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -57.56 -57.58 12.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.754 -0.657 . . . . 73.42 111.552 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.73 -47.17 94.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.154 -0.475 . . . . 74.3 111.771 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.475 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.2 ttm -61.78 -51.56 67.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.528 -0.305 . . . . 74.05 111.662 -177.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -64.82 -35.76 82.15 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 121.01 -0.276 . . . . 63.51 111.326 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.77 -47.21 87.48 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.997 -0.62 . . . . 52.33 112.691 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.493 ' O ' HG13 ' A' ' 43' ' ' ILE . 7.4 mtp180 -67.06 -49.71 64.22 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.782 0.289 . . . . 74.43 111.782 176.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 36' ' ' MET . 91.2 mt -56.31 -41.18 75.55 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.267 0.556 . . . . 72.31 111.404 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -61.87 -46.63 88.61 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.419 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.21 86.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.984 0.421 . . . . 74.0 111.437 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 39' ' ' ARG . 75.9 mt -58.14 -49.8 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.365 -0.38 . . . . 63.52 111.434 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 26.3 ttp85 -69.09 -25.74 64.58 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.853 0.316 . . . . 75.3 111.853 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.9 t -83.28 -33.42 25.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.089 0.471 . . . . 54.51 111.892 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.7 t -97.24 -67.22 0.86 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.139 0.495 . . . . 73.44 111.672 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -74.27 -16.47 60.94 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.264 -0.425 . . . . 74.3 111.386 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 71.02 9.88 6.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.205 0.602 . . . . 63.23 112.087 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.885 ' HA ' ' HB3' ' A' ' 84' ' ' ASN . 85.8 t -81.41 122.52 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.98 0.419 . . . . 73.31 111.861 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.71 96.66 7.61 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.178 0.513 . . . . 73.22 110.226 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -111.94 105.13 13.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.909 -0.587 . . . . 73.4 110.863 -175.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.04 145.4 29.94 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.58 0.585 . . . . 73.13 112.58 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.53 107.76 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.022 0.439 . . . . 72.01 110.902 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.67 134.94 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.846 0.355 . . . . 74.01 111.53 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -113.52 122.53 47.56 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.753 0.311 . . . . 72.33 111.111 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -130.23 137.0 29.89 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 120.848 0.356 . . . . 74.14 111.542 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . 39.3 Cg_endo -67.09 -53.94 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.598 2.199 . . . . 62.2 113.264 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 93' ' ' ASP . 20.3 m -141.75 136.11 30.42 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.17 -0.331 . . . . 73.21 111.649 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.497 HD11 ' NE2' ' A' ' 94' ' ' GLN . 31.9 pt -106.81 -28.91 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.92 0.39 . . . . 75.03 110.89 174.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.29 -116.53 7.18 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.124 -0.489 . . . . 31.04 114.229 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.78 -23.33 66.69 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.348 0.499 . . . . 72.35 112.348 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.28 128.17 86.53 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.4 0.519 . . . . 65.11 112.4 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.709 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 61.2 Cg_endo -73.38 136.11 23.49 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.581 2.187 . . . . 54.43 112.156 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.1 tp -52.57 -47.71 66.67 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.979 0.733 . . . . 73.13 112.979 -174.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.3 -58.24 8.44 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.132 -0.355 . . . . 71.11 111.628 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.709 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 1.8 m-20 -59.71 -29.79 68.35 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.743 0.306 . . . . 61.32 111.507 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.523 ' CE2' ' HD3' ' A' ' 6' ' ' PRO . 26.5 t80 -61.52 -55.35 32.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.309 -0.405 . . . . 73.33 110.768 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.2 p -57.3 -39.85 76.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.297 -0.411 . . . . 50.43 111.325 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.502 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 53.9 tp -57.79 -53.98 52.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.4 -0.364 . . . . 65.53 111.469 177.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -51.87 -52.66 48.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.909 0.385 . . . . 71.35 111.673 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.422 HD23 HD21 ' A' ' 87' ' ' LEU . 33.6 tp -63.04 -38.61 91.89 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.193 -0.458 . . . . 74.32 111.3 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.86 -44.19 93.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.293 -0.412 . . . . 71.25 111.793 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 78' ' ' GLY . 20.6 mtm180 -66.95 -40.67 87.59 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.798 0.332 . . . . 75.15 110.927 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.529 HE22 ' HA ' ' A' ' 7' ' ' GLU . 7.7 tt0 -58.64 -42.06 87.42 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.016 0.436 . . . . 73.34 111.402 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -87.29 7.39 28.87 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.354 0.502 . . . . 65.42 112.354 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.71 -42.58 3.14 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.125 -0.559 . . . . 74.31 113.921 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -52.62 -17.5 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 113.647 0.98 . . . . 61.43 113.647 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.568 ' O ' ' HG2' ' A' ' 73' ' ' ARG . . . -135.63 26.38 3.18 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.376 -0.916 . . . . 71.11 114.718 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -40.79 -62.32 0.82 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.104 0.952 . . . . 52.31 111.36 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 11.0 pt-20 -140.57 51.2 1.66 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.918 -0.771 . . . . 72.33 108.918 166.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 5.0 mptp? 71.26 85.0 0.13 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.565 -1.198 . . . . 73.05 111.622 -171.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.415 ' O ' ' HA3' ' A' ' 102' ' ' GLY . 53.3 t30 -72.8 155.9 39.46 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.392 -0.595 . . . . 72.31 109.392 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.553 ' ND2' ' H ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -53.65 -93.03 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 112.761 0.652 . . . . 73.01 112.761 -176.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.885 ' HB3' ' HA ' ' A' ' 49' ' ' VAL . 2.1 m-20 -78.52 74.86 5.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.572 -0.705 . . . . 60.32 111.945 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.19 139.15 9.86 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.166 -0.54 . . . . 41.41 113.174 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 99' ' ' PHE . 47.7 tp -152.89 127.84 9.64 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.889 0.376 . . . . 34.34 111.131 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.422 HD21 HD23 ' A' ' 71' ' ' LEU . 64.0 tp -117.39 124.55 49.14 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.936 0.398 . . . . 72.3 112.045 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 45.4 tp -111.89 121.55 45.34 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.085 -0.507 . . . . 74.52 110.78 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.8 t -122.93 121.96 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 120.821 0.343 . . . . 75.33 111.82 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' A' ' 97' ' ' VAL . 35.0 tp -96.21 118.46 32.82 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.173 -0.467 . . . . 71.14 111.282 176.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.2 t -103.61 100.1 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.634 0.254 . . . . 75.11 111.099 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 63.8 tp -54.01 -40.65 67.19 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.119 0.485 . . . . 73.33 111.474 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.487 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 25.3 t70 -48.38 -30.69 5.23 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.523 0.729 . . . . 54.12 112.872 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.497 ' NE2' HD11 ' A' ' 59' ' ' ILE . 43.2 mt-30 -125.5 1.56 7.63 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.361 -0.212 . . . . 75.14 111.557 -178.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 9.3 ptp180 47.06 27.15 0.72 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.088 0.955 . . . . 73.14 112.278 -173.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 90.5 mtt180 -117.04 154.59 30.7 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.041 0.448 . . . . 74.22 111.498 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 90' ' ' LEU . 4.1 m -134.32 171.26 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.912 -0.585 . . . . 75.42 111.328 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -152.29 144.42 23.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.831 0.348 . . . . 70.21 111.681 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.697 ' HB3' HD11 ' A' ' 86' ' ' LEU . 77.9 m-85 -104.49 105.58 15.75 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.991 -0.55 . . . . 64.25 110.372 173.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -83.13 112.58 19.95 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.118 -0.364 . . . . 75.5 110.308 177.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 109' ' ' LEU . 1.6 p -88.9 143.36 26.93 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.374 0.879 . . . . 61.51 113.374 -176.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 82' ' ' ASN . . . -90.87 -177.97 43.66 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 114.894 -1.048 . . . . 71.52 112.384 168.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -60.93 -25.06 66.51 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.588 0.588 . . . . 74.42 112.588 -175.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.4 -22.85 57.95 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.886 -0.674 . . . . 74.12 113.413 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 86' ' ' LEU . 93.5 mt -108.84 4.77 23.89 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.535 0.569 . . . . 74.55 112.535 -174.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -56.79 -38.63 72.81 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.043 0.449 . . . . 63.41 111.889 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.85 -42.7 10.78 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.317 -0.468 . . . . 70.14 113.382 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -72.07 -41.7 67.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.137 0.494 . . . . 75.52 111.791 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.618 ' HB3' HD21 ' A' ' 114' ' ' LEU . 21.0 mt -131.75 83.9 56.21 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 115.974 -0.557 . . . . 74.4 111.991 -170.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.49 155.81 24.82 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.402 2.068 . . . . 60.44 112.365 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.0 -36.2 12.29 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.511 0.56 . . . . 74.32 112.511 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.46 -50.12 69.99 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.126 -0.559 . . . . 74.41 112.912 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.52 -42.71 99.22 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.276 0.56 . . . . 51.4 111.028 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.69 HD13 ' HB2' ' A' ' 99' ' ' PHE . 65.5 mt -62.43 -40.75 97.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.665 -0.698 . . . . 72.31 111.132 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.4 m -71.22 -32.25 68.58 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.178 -0.465 . . . . 75.05 111.419 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -56.02 -55.95 26.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.729 -0.214 . . . . 65.23 111.002 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.7 mt -51.0 -47.11 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.137 0.494 . . . . 52.43 111.031 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.576 ' O ' HG12 ' A' ' 123' ' ' ILE . 61.1 mt -55.97 -51.51 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.8 -0.636 . . . . 64.23 111.615 177.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -81.57 -11.45 59.15 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.944 0.72 . . . . 73.13 112.944 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -86.48 -52.42 5.59 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.788 0.292 . . . . 71.34 111.788 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.99 -39.86 2.06 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.109 0.781 . . . . 74.43 113.109 -176.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.512 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 45.3 mtt -51.52 -52.64 45.23 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.664 0.616 . . . . 71.15 112.664 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.648 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 49.9 mm -53.01 -56.8 19.98 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 111.992 0.367 . . . . 53.43 111.992 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 82.6 Cg_exo -48.09 -47.08 20.35 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.301 2.001 . . . . 63.4 113.328 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -62.97 -49.19 75.68 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.695 0.284 . . . . 73.12 111.637 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 23.1 m-30 -57.49 -42.31 82.45 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.819 0.303 . . . . 73.52 111.819 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 70.5 mtp180 -66.66 -30.77 71.11 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.999 0.428 . . . . 71.43 111.152 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.9 m -78.08 -14.09 59.62 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.399 -0.364 . . . . 75.12 111.478 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.18 -7.02 62.02 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.292 -0.48 . . . . 64.33 112.473 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.735 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . 1.9 m-20 -79.78 57.01 2.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.866 0.365 . . . . 73.35 111.602 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -61.63 -37.79 85.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.915 0.388 . . . . 71.24 111.322 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.453 ' HB1' ' HG2' ' A' ' 32' ' ' GLN . . . -64.87 -49.83 68.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.164 -0.471 . . . . 62.5 111.376 176.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.735 ' HB2' ' HB3' ' A' ' 130' ' ' ASN . 14.6 mp0 -63.03 -35.47 80.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.954 -0.566 . . . . 55.11 111.69 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.91 -55.12 30.1 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.152 -0.547 . . . . 13.33 112.352 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.486 HD11 HD22 ' A' ' 90' ' ' LEU . 89.0 mt -58.64 -38.17 77.52 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.39 -0.477 . . . . 62.34 110.949 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 58.0 m -60.02 -47.54 85.43 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.119 -0.491 . . . . 51.05 112.088 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.19 -36.02 66.47 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.102 -0.374 . . . . 73.0 111.207 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.36 -49.73 75.38 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.31 -0.472 . . . . 61.21 113.031 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 135' ' ' LEU . 53.2 t -53.11 -47.76 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.055 0.455 . . . . 71.34 111.255 175.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.555 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 53.6 tp -62.8 -42.86 99.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.125 -0.489 . . . . 75.32 110.805 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.78 -47.68 84.71 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.962 0.41 . . . . 53.02 111.585 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.82 -47.37 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.331 -0.395 . . . . 64.3 111.246 176.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -56.67 -40.53 75.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.417 -0.356 . . . . 74.3 111.464 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 18.3 mm-40 -53.98 -35.13 61.49 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.195 0.442 . . . . 74.2 112.195 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.98 -42.23 91.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 120.993 0.425 . . . . 74.0 111.014 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.5 mt -71.08 -44.89 64.79 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.094 0.473 . . . . 74.12 111.218 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.85 -24.02 67.41 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.067 -0.515 . . . . 34.24 111.768 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.46 -5.53 85.88 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.049 -0.596 . . . . 60.41 112.332 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.9 t -104.89 -66.78 0.95 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.018 0.527 . . . . 75.24 111.321 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 87.6 mt 57.76 17.87 4.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.452 0.538 . . . . 62.12 112.452 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -69.29 -22.17 63.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.976 0.362 . . . . 73.31 111.976 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -74.66 93.17 2.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.778 0.323 . . . . 72.02 111.742 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.421 ' CG ' ' N ' ' A' ' 154' ' ' HIS . 45.1 t-80 -91.37 173.66 7.8 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 120.832 0.349 . . . . 75.44 111.109 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.421 ' N ' ' CG ' ' A' ' 153' ' ' HIS . 22.6 t60 -51.16 87.39 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.349 0.66 . . . . 71.31 112.737 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -102.64 -53.08 2.95 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.347 -0.388 . . . . 75.3 110.769 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -70.42 128.58 36.65 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.028 0.442 . . . . 73.13 111.119 177.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.3 p80 . . . . . 0 C--O 1.253 1.262 0 CA-C-N 116.174 -0.466 . . . . 72.25 111.6 -177.937 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.733 0.301 . . . . 74.24 111.572 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 2' ' ' ARG . 19.3 ttt180 -167.43 -46.8 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.349 0.595 . . . . 62.1 111.392 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.3 t 65.82 91.48 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 114.611 -1.177 . . . . 62.12 111.533 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -72.78 157.71 36.98 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.486 -0.779 . . . . 71.52 112.592 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.748 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 33.8 mmtp -136.58 160.76 65.37 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 114.965 -1.016 . . . . 72.32 109.808 174.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.88 -41.41 63.34 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.396 2.064 . . . . 74.52 112.834 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -86.49 7.65 25.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.979 0.419 . . . . 63.12 111.758 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.748 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 29.8 t70 -106.03 -34.26 7.63 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.166 0.508 . . . . 74.32 110.268 174.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 5' ' ' LYS . 65.1 t -65.89 129.58 94.3 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.675 -0.693 . . . . 75.22 111.503 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.44 123.99 13.84 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.498 2.132 . . . . 75.25 112.497 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -69.67 91.39 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.058 0.456 . . . . 75.53 111.947 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.6 m -69.98 -38.37 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.278 -0.419 . . . . 71.13 111.971 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 14.3 mm100 -64.77 170.25 4.35 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.8 -0.562 . . . . 54.31 110.79 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 20.2 mt 73.88 -41.6 0.49 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.423 0.527 . . . . 33.23 112.423 -173.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.09 -62.89 1.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.297 0.48 . . . . 73.52 112.297 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -84.76 32.39 0.52 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.113 0.482 . . . . 61.51 111.715 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -71.42 12.92 0.28 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.549 0.574 . . . . 61.05 112.549 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.2 p -77.47 -42.55 35.41 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.91 0.386 . . . . 44.43 110.974 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.3 ptp85 -98.71 -32.6 11.31 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.114 -0.494 . . . . 71.34 112.033 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.602 HD21 ' HG3' ' A' ' 44' ' ' ARG . 5.3 mp 62.18 11.98 4.77 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.069 0.396 . . . . 73.24 112.069 -176.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 19' ' ' ARG . 58.6 t -107.07 136.03 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.797 0.332 . . . . 72.52 111.688 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.531 HG22 ' HG2' ' A' ' 24' ' ' GLU . 24.8 m -110.81 106.71 15.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.42 -0.355 . . . . 64.14 110.417 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -95.94 78.01 3.19 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.432 0.634 . . . . 65.13 112.361 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.531 ' HG2' HG22 ' A' ' 22' ' ' THR . 21.0 mm-40 -102.45 -46.65 4.71 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.042 0.449 . . . . 74.45 110.909 176.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.36 -23.74 67.54 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.168 0.433 . . . . 62.0 112.168 174.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.87 33.8 88.04 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.367 -0.444 . . . . 75.53 113.481 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 92' ' ' LEU . 94.3 mt -92.02 12.62 21.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.09 0.404 . . . . 64.15 112.09 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -121.62 125.78 47.5 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.04 0.448 . . . . 75.31 111.472 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.3 t -77.26 172.29 13.51 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.121 -0.491 . . . . 54.45 110.712 173.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -54.72 -47.62 73.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.985 0.422 . . . . 33.34 111.331 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -63.74 -48.28 77.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.41 -0.359 . . . . 51.32 111.533 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -59.69 -42.84 93.87 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.15 0.5 . . . . 63.0 111.339 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -64.84 -47.44 77.94 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.623 -0.717 . . . . 72.33 109.949 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.98 -53.76 54.4 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.168 -0.469 . . . . 74.52 111.982 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 31' ' ' ALA . 99.0 t -54.8 -47.16 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.961 0.41 . . . . 75.45 111.246 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.1 ttm -63.01 -42.97 99.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.442 -0.344 . . . . 74.31 111.227 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -57.09 -48.66 78.06 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.969 0.414 . . . . 74.21 111.094 176.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.9 -47.19 90.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.155 -0.475 . . . . 61.43 113.002 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 43' ' ' ILE . 99.6 mtt180 -62.6 -54.84 33.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 111.901 0.334 . . . . 74.34 111.901 179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 51' ' ' PHE . 70.9 mt -58.2 -48.17 81.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.868 0.366 . . . . 64.14 111.419 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -58.21 -47.05 84.68 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.331 -0.395 . . . . 62.54 111.098 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.9 -45.11 86.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.195 -0.457 . . . . 70.15 111.339 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.575 HG22 ' HB ' ' A' ' 49' ' ' VAL . 64.3 mt -65.97 -46.32 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.086 0.469 . . . . 71.31 111.274 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.602 ' HG3' HD21 ' A' ' 20' ' ' LEU . 5.5 tmm_? -65.9 -26.04 67.43 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.162 -0.472 . . . . 74.44 111.417 -176.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 t -91.77 -54.54 3.83 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.807 0.337 . . . . 34.33 111.549 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.3 t -67.63 -58.8 4.05 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.307 0.484 . . . . 74.01 112.307 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -86.49 -11.29 52.15 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.396 -0.365 . . . . 63.01 111.5 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 44' ' ' ARG . . . 65.08 24.04 12.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.905 0.482 . . . . 32.01 111.993 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.575 ' HB ' HG22 ' A' ' 43' ' ' ILE . 90.2 t -96.28 117.28 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.24 -0.436 . . . . 73.24 111.576 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.03 96.16 2.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.082 0.467 . . . . 72.23 110.432 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.427 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -104.44 98.59 8.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.769 -0.65 . . . . 72.04 109.984 -179.063 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 20' ' ' LEU . . . -102.52 119.71 39.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.1 0.407 . . . . 72.11 112.1 -175.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.466 HG22 HD23 ' A' ' 88' ' ' LEU . 96.0 t -104.91 110.86 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.282 0.563 . . . . 64.31 111.4 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.441 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 48.4 t -106.55 121.93 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.08 -0.509 . . . . 53.53 111.081 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.3 p -106.58 121.87 45.17 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.816 0.341 . . . . 74.34 110.92 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -126.4 139.63 35.13 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-O 120.818 0.342 . . . . 74.32 111.553 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.55 -56.68 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.335 2.024 . . . . 51.31 112.86 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.6 p -144.96 139.48 27.57 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 111.933 0.345 . . . . 74.1 111.933 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.612 HG12 HG11 ' A' ' 91' ' ' VAL . 35.3 pt -117.65 -10.84 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 121.112 0.482 . . . . 73.35 110.826 171.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.27 -127.99 32.93 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.177 -0.465 . . . . 50.12 114.04 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.81 -16.62 63.84 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.841 0.682 . . . . 63.23 112.841 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.12 130.6 50.5 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 112.936 0.717 . . . . 43.14 112.936 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.654 ' HG2' ' HB2' ' A' ' 66' ' ' ASP . 60.6 Cg_endo -72.0 133.19 21.09 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.747 2.298 . . . . 70.53 112.054 174.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.57 -48.19 82.1 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.934 0.716 . . . . 73.41 112.934 -171.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -67.85 -45.87 73.4 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.117 -0.364 . . . . 73.33 111.918 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.654 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 33.3 m-20 -61.85 -37.85 86.04 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.979 0.418 . . . . 61.01 110.857 176.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.46 -50.07 75.05 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.125 -0.489 . . . . 72.34 111.042 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 78.0 p -63.14 -48.33 78.91 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.594 -0.275 . . . . 63.33 111.313 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 54.4 tp -54.87 -46.73 74.77 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.097 0.475 . . . . 64.34 111.196 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -54.86 -49.51 70.93 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.003 0.43 . . . . 65.42 111.66 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 tp -67.97 -36.61 80.35 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.054 -0.521 . . . . 74.22 111.639 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 77' ' ' VAL . . . -67.77 -39.94 84.08 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.388 -0.369 . . . . 55.4 111.776 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 41.1 mtp-105 -57.43 -54.23 49.18 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.077 0.399 . . . . 73.55 112.077 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.448 ' HG3' ' CD1' ' A' ' 75' ' ' TRP . 8.5 pt20 -64.28 -23.04 67.16 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.347 0.499 . . . . 75.41 112.347 -177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.448 ' CD1' ' HG3' ' A' ' 74' ' ' GLN . 40.8 m0 -92.17 -15.29 27.82 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.809 0.3 . . . . 74.51 111.809 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.71 30.03 60.43 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.226 -0.512 . . . . 55.21 113.122 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.636 HG12 ' H ' ' A' ' 78' ' ' GLY . 3.4 t -134.66 179.36 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.0 0.52 . . . . 74.2 109.725 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.636 ' H ' HG12 ' A' ' 77' ' ' VAL . . . 60.11 -120.04 21.03 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.291 -0.48 . . . . 53.43 113.809 173.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.422 ' HB3' ' H ' ' A' ' 80' ' ' GLU . 21.2 m-80 56.86 -159.55 0.24 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.546 0.689 . . . . 73.32 112.218 177.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.422 ' H ' ' HB3' ' A' ' 79' ' ' ASN . 9.6 pt-20 -114.03 14.8 18.44 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.732 -0.667 . . . . 74.15 111.55 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.429 ' N ' ' HD3' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -153.16 16.49 0.55 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.862 1.06 . . . . 71.34 113.862 -177.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.617 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 6.1 m120 -90.49 136.66 32.92 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.312 0.577 . . . . 74.54 112.306 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.434 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.2 OUTLIER -83.65 136.32 34.26 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.382 -0.372 . . . . 62.13 111.631 176.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.594 ' H ' ' HA3' ' A' ' 104' ' ' GLY . 2.0 m-20 52.29 21.89 1.82 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.944 0.72 . . . . 61.31 112.944 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -101.66 129.43 9.89 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.205 -0.521 . . . . 53.4 113.176 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 99' ' ' PHE . 39.8 tp -142.32 119.47 11.43 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.193 0.521 . . . . 75.1 111.441 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 54.8 tp -107.2 139.88 40.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.368 -0.378 . . . . 73.43 111.279 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD23 HG22 ' A' ' 53' ' ' VAL . 53.5 tp -131.76 114.06 14.29 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.529 -0.305 . . . . 72.23 111.04 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.27 121.51 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.076 0.399 . . . . 63.54 112.076 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 97' ' ' VAL . 24.1 tp -101.37 129.29 47.34 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.173 -0.467 . . . . 73.34 111.223 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.612 HG11 HG12 ' A' ' 59' ' ' ILE . 31.9 t -115.02 99.2 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.92 0.39 . . . . 51.43 111.29 176.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 27' ' ' LEU . 67.1 tp -51.54 -41.23 60.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.162 0.585 . . . . 72.12 112.357 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.22 -43.15 52.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.407 0.683 . . . . 71.14 112.748 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -118.54 8.51 12.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.104 0.409 . . . . 63.32 112.104 -174.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 59.46 20.02 8.41 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.706 1.002 . . . . 73.24 113.706 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -122.17 154.23 37.73 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.669 -0.644 . . . . 73.44 112.194 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.763 HG21 ' SD ' ' A' ' 122' ' ' MET . 6.3 m -129.24 171.39 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.654 -0.703 . . . . 64.33 111.382 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.9 ttt85 -147.66 130.08 15.76 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.34 -0.391 . . . . 74.03 111.842 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.71 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 93.8 m-85 -90.45 141.95 28.23 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.922 -0.581 . . . . 72.42 109.441 168.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 26.2 tt0 -133.04 112.29 11.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.961 0.41 . . . . 73.45 111.914 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.596 HG23 HD13 ' A' ' 86' ' ' LEU . 17.5 p -106.83 142.02 37.13 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.008 -0.542 . . . . 60.2 111.223 175.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.478 ' HA3' ' H ' ' A' ' 82' ' ' ASN . . . -87.37 -83.98 1.17 Allowed Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.805 -0.712 . . . . 43.23 113.724 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -137.1 -41.53 0.58 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.004 0.43 . . . . 74.42 111.397 -174.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.594 ' HA3' ' H ' ' A' ' 84' ' ' ASN . . . -58.52 -39.43 93.11 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.257 -0.429 . . . . 72.34 114.071 -175.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.528 HD11 HG13 ' A' ' 49' ' ' VAL . 93.3 mt -91.97 -2.6 56.66 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.013 0.746 . . . . 74.44 113.013 -174.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -57.64 -21.66 40.99 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.556 0.576 . . . . 73.21 112.556 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.74 -28.58 56.76 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.91 -0.662 . . . . 71.21 112.894 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -109.97 -60.31 1.81 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.898 0.38 . . . . 64.55 111.043 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.443 HD12 HD13 ' A' ' 105' ' ' LEU . 16.3 mt -111.77 88.31 9.53 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.171 0.588 . . . . 61.43 111.563 -178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -81.16 152.26 18.39 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.969 1.779 . . . . 61.41 112.102 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -47.85 -36.32 11.81 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.685 0.279 . . . . 70.2 111.709 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.17 -49.9 73.52 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.253 -0.499 . . . . 61.42 113.182 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.73 -44.58 96.46 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.259 0.552 . . . . 74.44 111.045 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' A' ' 99' ' ' PHE . 66.6 mt -60.54 -44.54 96.0 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.753 -0.658 . . . . 63.21 110.874 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -59.74 -38.29 81.32 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.823 -0.626 . . . . 74.32 110.934 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.4 ttt-85 -60.27 -56.23 24.04 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.068 -0.514 . . . . 61.31 110.947 175.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 60.2 mt -51.01 -39.48 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 120.821 0.343 . . . . 75.33 111.784 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.542 ' O ' HG12 ' A' ' 123' ' ' ILE . 77.6 mt -55.84 -56.17 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.53 -0.305 . . . . 71.53 111.033 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -77.4 -23.59 50.63 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.382 0.512 . . . . 72.12 112.382 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -78.25 -40.31 37.58 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.164 0.431 . . . . 62.32 112.164 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 -126.12 -54.18 1.5 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.262 0.838 . . . . 54.12 113.262 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.763 ' SD ' HG21 ' A' ' 97' ' ' VAL . 38.5 mtt -59.21 -53.65 55.91 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.052 0.76 . . . . 64.44 113.052 -175.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.642 ' HB ' ' HD3' ' A' ' 124' ' ' PRO . 49.3 mm -53.86 -53.4 58.26 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 111.677 0.251 . . . . 71.02 111.677 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 123' ' ' ILE . 92.3 Cg_exo -47.68 -48.18 16.45 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 122.287 1.991 . . . . 71.31 113.423 174.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -62.5 -46.96 86.07 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 111.706 0.262 . . . . 72.1 111.706 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -60.69 -41.33 94.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.738 0.304 . . . . 75.41 111.361 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -63.2 -31.43 72.58 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.045 0.45 . . . . 74.24 111.27 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.2 t -82.87 -18.37 40.54 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.261 -0.427 . . . . 51.14 111.449 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.88 1.92 34.27 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.545 -0.359 . . . . 73.51 113.571 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.9 ' HB3' ' HB3' ' A' ' 133' ' ' GLU . 85.7 m-20 -94.07 82.07 4.16 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.411 -0.464 . . . . 73.12 112.152 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -71.53 -53.63 13.18 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.225 -0.297 . . . . 74.21 111.455 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.79 -45.96 85.3 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.093 0.473 . . . . 65.4 111.554 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.9 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 7.1 tp10 -56.21 -53.16 60.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.041 -0.527 . . . . 55.44 111.178 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.87 -43.64 96.52 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.409 -0.424 . . . . 60.04 113.514 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 90' ' ' LEU . 93.8 mt -59.77 -56.48 21.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.03 0.443 . . . . 73.42 111.413 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 30.8 t -56.18 -54.31 46.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.382 0.512 . . . . 52.31 112.382 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -30.25 60.96 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 111.576 0.213 . . . . 74.42 111.576 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.87 -48.0 86.6 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.201 -0.523 . . . . 42.4 112.408 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 135' ' ' LEU . 72.3 t -57.79 -44.94 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.132 0.491 . . . . 74.23 110.606 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.3 tp -58.44 -37.4 75.34 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.953 -0.567 . . . . 61.04 111.391 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.58 -41.6 97.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.092 0.472 . . . . 55.03 111.173 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.424 HG13 HD22 ' A' ' 109' ' ' LEU . 63.8 t -65.77 -45.93 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.788 -0.642 . . . . 75.24 110.764 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -53.87 -43.33 69.5 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.789 -0.641 . . . . 75.54 111.255 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -52.35 -41.0 62.69 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.277 0.473 . . . . 73.11 112.277 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.11 -36.4 76.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.871 0.367 . . . . 74.13 111.666 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.0 -54.82 24.35 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.601 -0.272 . . . . 74.21 111.324 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -57.47 -32.73 67.27 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.848 0.356 . . . . 73.42 111.948 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.65 -37.84 29.47 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.168 -0.539 . . . . 43.43 113.609 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 78.1 p -75.96 -43.67 43.6 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 122.468 -0.43 . . . . 73.3 111.932 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.6 mt -73.84 22.88 0.08 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.703 0.631 . . . . 51.34 112.703 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -111.09 -9.61 14.37 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.404 0.621 . . . . 64.04 110.417 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -69.81 119.22 13.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.951 -0.568 . . . . 74.01 110.091 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -56.85 83.02 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.508 0.929 . . . . 73.02 113.508 -171.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -139.88 113.87 8.87 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.4 -0.818 . . . . 73.22 109.34 172.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -87.03 -14.24 42.13 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.678 0.621 . . . . 70.33 112.678 -171.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -79.66 117.6 20.72 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.083 -0.385 . . . . 73.11 111.272 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 . . . . . 0 C--O 1.253 1.278 0 CA-C-O 119.066 -0.492 . . . . 72.42 111.207 177.027 . . . . . . . . 0 0 . 1 stop_ save_